Citrus Sinensis ID: 001873
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1001 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGR3 | 1091 | Probable LRR receptor-lik | no | no | 0.951 | 0.872 | 0.715 | 0.0 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.921 | 0.808 | 0.5 | 0.0 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.964 | 0.850 | 0.477 | 0.0 | |
| C0LGF5 | 1072 | Probable LRR receptor-lik | no | no | 0.940 | 0.877 | 0.457 | 0.0 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.940 | 0.853 | 0.388 | 0.0 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.960 | 0.854 | 0.382 | 0.0 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.960 | 0.872 | 0.374 | 1e-180 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.887 | 0.710 | 0.356 | 1e-158 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.886 | 0.708 | 0.352 | 1e-153 | |
| Q9FZ59 | 1088 | Leucine-rich repeat recep | no | no | 0.960 | 0.883 | 0.358 | 1e-152 |
| >sp|C0LGR3|Y4265_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g26540 OS=Arabidopsis thaliana GN=At4g26540 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1319 bits (3413), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 689/963 (71%), Positives = 805/963 (83%), Gaps = 11/963 (1%)
Query: 32 CDALDEQGQALLTWKNSLNSSTDALSSWNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQ 91
C +LD+QGQALL+WK+ LN S DA SSW+ A+TSPC W G+ C+ GEV EI LK +DLQ
Sbjct: 22 CFSLDQQGQALLSWKSQLNISGDAFSSWHVADTSPCNWVGVKCNRRGEVSEIQLKGMDLQ 81
Query: 92 GSLP-SIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLR 150
GSLP + + LKSL L +SS NLTG IPKE GD+ EL +DLS NSL G+IP E+ RL+
Sbjct: 82 GSLPVTSLRSLKSLTSLTLSSLNLTGVIPKEIGDFTELELLDLSDNSLSGDIPVEIFRLK 141
Query: 151 KLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQN 210
KL++L LNTN LEG IP +IGNLS L L L+DN+LSG+IP+SIG L LQV RAGGN+N
Sbjct: 142 KLKTLSLNTNNLEGHIPMEIGNLSGLVELMLFDNKLSGEIPRSIGELKNLQVLRAGGNKN 201
Query: 211 LKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNC 270
L+GELPWEIGNC NLVMLGLAETS+SG +P+SIG L+R+QTIAIYTSLLSGPIP+EIG C
Sbjct: 202 LRGELPWEIGNCENLVMLGLAETSLSGKLPASIGNLKRVQTIAIYTSLLSGPIPDEIGYC 261
Query: 271 SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNL 330
+ELQNLYLYQNSISG IP IG L KL+SLLLWQN+LVG IP ELG+C EL ++DFS+NL
Sbjct: 262 TELQNLYLYQNSISGSIPTTIGGLKKLQSLLLWQNNLVGKIPTELGNCPELWLIDFSENL 321
Query: 331 LTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNI 390
LTG+IPRSFG L LQELQLSVNQ+SGTIP E+ CT LTHLEIDNN I+GEIP+ + N+
Sbjct: 322 LTGTIPRSFGKLENLQELQLSVNQISGTIPEELTNCTKLTHLEIDNNLITGEIPSLMSNL 381
Query: 391 NGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSND 450
LT+FFAW+NKLTGNIP+SLSQC+ELQA+D SYN+LSG IPKEIFGLRNLTKLLLLSND
Sbjct: 382 RSLTMFFAWQNKLTGNIPQSLSQCRELQAIDLSYNSLSGSIPKEIFGLRNLTKLLLLSND 441
Query: 451 LSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGC 510
LSGFIPPDIGNCT L RLRLN NRL+G+IPSE+GNLK+LNFVD+SEN LVG IPP++ GC
Sbjct: 442 LSGFIPPDIGNCTNLYRLRLNGNRLAGSIPSEIGNLKNLNFVDISENRLVGSIPPAISGC 501
Query: 511 QSLEFLDLHSNGLTGS-VPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQL 569
+SLEFLDLH+N L+GS + TLP SL+ +D SDN LS +L IG LTEL+KL L+KN+L
Sbjct: 502 ESLEFLDLHTNSLSGSLLGTTLPKSLKFIDFSDNALSSTLPPGIGLLTELTKLNLAKNRL 561
Query: 570 SGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGL 629
SG IP EI +CR L LL++G N FSGEIP ELGQI SL ISLNLS N+F GEIPS FS L
Sbjct: 562 SGEIPREISTCRSLQLLNLGENDFSGEIPDELGQIPSLAISLNLSCNRFVGEIPSRFSDL 621
Query: 630 TKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRGL 689
LG+LD+SHN+L+G+L+ L LQNLVSLN+S+NDFSG+LPNTPFFR+LPLSDLASNRGL
Sbjct: 622 KNLGVLDVSHNQLTGNLNVLTDLQNLVSLNISYNDFSGDLPNTPFFRRLPLSDLASNRGL 681
Query: 690 YISGGVVSPTDSLPAGQARSAMKLVMSILVSASAVLVLLAIYVLVRTRMANNSFTAD--D 747
YIS + + D P + S ++L + ILV +AVLVL+A+Y LVR R A + D
Sbjct: 682 YISNAISTRPD--PTTRNSSVVRLTILILVVVTAVLVLMAVYTLVRARAAGKQLLGEEID 739
Query: 748 TWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAF 807
+WE+TLYQKLDFSIDD+V+NLTSANVIGTGSSGVVYR+TIP+GE+LAVKKMWS +ESGAF
Sbjct: 740 SWEVTLYQKLDFSIDDIVKNLTSANVIGTGSSGVVYRITIPSGESLAVKKMWSKEESGAF 799
Query: 808 SSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGA-DWEARYE 866
+SEI+TLGSIRH+NIVRLLGW SN+NLKLLFYDYLPNGSLSS LHGAGKGG DWEARY+
Sbjct: 800 NSEIKTLGSIRHRNIVRLLGWCSNRNLKLLFYDYLPNGSLSSRLHGAGKGGCVDWEARYD 859
Query: 867 VVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG---SGDDNC 923
VVLGVAHALAYLHHDC+P I+HGDVKAMNVLLGP ++ YLADFGLAR +SG +G D
Sbjct: 860 VVLGVAHALAYLHHDCLPTIIHGDVKAMNVLLGPHFEPYLADFGLARTISGYPNTGIDLA 919
Query: 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLV 983
TN RP +AGSYGYMAPEHASMQRITEKSDVYS+GVVLLEVLTG+HPLDP LPGGA LV
Sbjct: 920 KPTN-RPPMAGSYGYMAPEHASMQRITEKSDVYSYGVVLLEVLTGKHPLDPDLPGGAHLV 978
Query: 984 QWT 986
+W
Sbjct: 979 KWV 981
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 932 bits (2410), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/958 (50%), Positives = 655/958 (68%), Gaps = 36/958 (3%)
Query: 58 SWNPAETSPCK-WFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTG 116
+WN + +PC W I CSS G + +I +++V LQ SLP +SL++L IS NLTG
Sbjct: 60 NWNSIDNTPCNNWTFITCSSQGFITDIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTG 119
Query: 117 TIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSL 176
T+P+ GD L +DLS N L G+IP + +LR LE+L LN+N L G+IP DI S L
Sbjct: 120 TLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKL 179
Query: 177 AYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSIS 236
L L+DN L+G IP +G LS L+V R GGN+ + G++P EIG+CSNL +LGLAETS+S
Sbjct: 180 KSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVS 239
Query: 237 GNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSK 296
GN+PSS+G L++++T++IYT+++SG IP ++GNCSEL +L+LY+NS+SG IP IG L+K
Sbjct: 240 GNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTK 299
Query: 297 LKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLS 356
L+ L LWQNSLVG IP+E+G+C+ L ++D S NLL+GSIP S G L L+E +S N+ S
Sbjct: 300 LEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFS 359
Query: 357 GTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQE 416
G+IP I+ C++L L++D N ISG IP+++G + LTLFFAW N+L G+IP L+ C +
Sbjct: 360 GSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTD 419
Query: 417 LQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLS 476
LQALD S N+L+G IP +F LRNLTKLLL+SN LSGFIP +IGNC++L RLRL NR++
Sbjct: 420 LQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRIT 479
Query: 477 GTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP--TS 534
G IPS +G+LK +NF+D S N L G +P + C L+ +DL +N L GS+P+ + +
Sbjct: 480 GEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSG 539
Query: 535 LQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFS 594
LQ++D+S N+ SG + S+G L L+KL+LSKN SG IP + C L LLD+G+N S
Sbjct: 540 LQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELS 599
Query: 595 GEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQN 654
GEIP ELG I +LEI+LNLSSN+ +G+IPS+ + L KL ILDLSHN L GDL LA+++N
Sbjct: 600 GEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAPLANIEN 659
Query: 655 LVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRGL-----------YISGGVVSPTDSLP 703
LVSLN+S+N FSG LP+ FR+L DL N+ L Y G + D
Sbjct: 660 LVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQDSCFLTYRKGNGLG--DDGD 717
Query: 704 AGQARSAMKLVMSILVSASAVLVLLAIYVLVRTRMANNSFTAD----DTWEMTLYQKLDF 759
A + R + ++ +++L A+ V+ R +N ++ W+ T +QKL+F
Sbjct: 718 ASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSELGETYKWQFTPFQKLNF 777
Query: 760 SIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESG-----------AFS 808
S+D ++R L NVIG G SGVVYR + NGE +AVKK+W + +G +FS
Sbjct: 778 SVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFS 837
Query: 809 SEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVV 868
+E++TLG+IRHKNIVR LG N+N +LL YDY+PNGSL SLLH DW+ RY ++
Sbjct: 838 AEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRGSSLDWDLRYRIL 897
Query: 869 LGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQ 928
LG A LAYLHHDC+PPI+H D+KA N+L+G ++ Y+ADFGLA++V CS T
Sbjct: 898 LGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNT-- 955
Query: 929 RPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWT 986
+AGSYGY+APE+ +ITEKSDVYS+GVV+LEVLTG+ P+DPT+P G LV W
Sbjct: 956 ---VAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWV 1010
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 899 bits (2322), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 478/1001 (47%), Positives = 666/1001 (66%), Gaps = 36/1001 (3%)
Query: 15 FSFTLLLISINFLFFSTCDALDEQGQALLTWKNSLNSSTDAL-SSWNPAETSPCKWFGIH 73
FS TL L F S+ A + AL++W +S NS ++ S WNP+++ PC+W I
Sbjct: 18 FSITLSLFLA--FFISSTSASTNEVSALISWLHSSNSPPPSVFSGWNPSDSDPCQWPYIT 75
Query: 74 CSS--NGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFI 131
CSS N V EI++ +V L P SL++L+IS+ NLTG I E GD EL I
Sbjct: 76 CSSSDNKLVTEINVVSVQLALPFPPNISSFTSLQKLVISNTNLTGAISSEIGDCSELIVI 135
Query: 132 DLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIP 191
DLS NSL GEIP+ + +L+ L+ L LN+N L G+IP ++G+ SL L ++DN LS +P
Sbjct: 136 DLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLP 195
Query: 192 KSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQT 251
+G +S L+ RAGGN L G++P EIGNC NL +LGLA T ISG++P S+G L ++Q+
Sbjct: 196 LELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQS 255
Query: 252 IAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAI 311
+++Y+++LSG IP+E+GNCSEL NL+LY N +SG +P +G L L+ +LLWQN+L G I
Sbjct: 256 LSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPI 315
Query: 312 PDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTH 371
P+E+G L +D S N +G+IP+SFGNL LQEL LS N ++G+IP ++ CT L
Sbjct: 316 PEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQ 375
Query: 372 LEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPI 431
+ID N ISG IP +IG + L +F W+NKL GNIP+ L+ CQ LQALD S N L+G +
Sbjct: 376 FQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSL 435
Query: 432 PKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNF 491
P +F LRNLTKLLL+SN +SG IP +IGNCT+L RLRL +NR++G IP +G L++L+F
Sbjct: 436 PAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSF 495
Query: 492 VDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSL 549
+D+SEN+L G +P + C+ L+ L+L +N L G +P +L T LQ++D+S N L+G +
Sbjct: 496 LDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKI 555
Query: 550 AHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEI 609
S+G L L++L+LSKN +G IP+ + C L LLD+ +N SG IP+EL I L+I
Sbjct: 556 PDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDI 615
Query: 610 SLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGEL 669
+LNLS N G IP S L +L +LD+SHN LSGDL AL+ L+NLVSLN+S N FSG L
Sbjct: 616 ALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDLSALSGLENLVSLNISHNRFSGYL 675
Query: 670 PNTPFFRKLPLSDLASNRGLYISG---GVVSPTDSLPA--GQARSAMKLVMSILVSASAV 724
P++ FR+L +++ N GL G VS + L G +++ + +L+S +AV
Sbjct: 676 PDSKVFRQLIGAEMEGNNGLCSKGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAV 735
Query: 725 LVLLAIYVLVRT----RMANNSFTADD--TWEMTLYQKLDFSIDDVVRNLTSANVIGTGS 778
L +L + ++R R N+S T ++ TW+ T +QKL+F+++ V++ L NVIG G
Sbjct: 736 LAVLGVLAVIRAKQMIRDDNDSETGENLWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGC 795
Query: 779 SGVVYRVTIPNGETLAVKKMW------------SSDESGAFSSEIQTLGSIRHKNIVRLL 826
SG+VY+ +PN E +AVKK+W SS +FS+E++TLGSIRHKNIVR L
Sbjct: 796 SGIVYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFL 855
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLH-GAGKGGADWEARYEVVLGVAHALAYLHHDCMPP 885
G NKN +LL YDY+ NGSL SLLH +G WE RY+++LG A LAYLHHDC+PP
Sbjct: 856 GCCWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPP 915
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945
I+H D+KA N+L+GP ++ Y+ DFGLA++V S T +AGSYGY+APE+
Sbjct: 916 IVHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNT-----IAGSYGYIAPEYGY 970
Query: 946 MQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWT 986
+ITEKSDVYS+GVV+LEVLTG+ P+DPT+P G +V W
Sbjct: 971 SMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWV 1011
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGF5|Y1341_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g34110 OS=Arabidopsis thaliana GN=At1g34110 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 763 bits (1971), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/979 (45%), Positives = 628/979 (64%), Gaps = 38/979 (3%)
Query: 34 ALDEQGQALLTWKNSLNSSTDALSSWNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQGS 93
+L GQALL+ K S SSW+P + +PC W+GI CS++ V+ +S+ L S
Sbjct: 26 SLSSDGQALLSLKRP---SPSLFSSWDPQDQTPCSWYGITCSADNRVISVSIPDTFLNLS 82
Query: 94 LPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLE 153
L SL+ L +SS NL+G IP FG L +DLS NSL G IP+E+ RL L+
Sbjct: 83 SIPDLSSLSSLQFLNLSSTNLSGPIPPSFGKLTHLRLLDLSSNSLSGPIPSELGRLSTLQ 142
Query: 154 SLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKG 213
L LN N L G IPS I NL +L L L DN L+G IP S G+L LQ FR GGN NL G
Sbjct: 143 FLILNANKLSGSIPSQISNLFALQVLCLQDNLLNGSIPSSFGSLVSLQQFRLGGNTNLGG 202
Query: 214 ELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSEL 273
+P ++G NL LG A + +SG++PS+ G L +QT+A+Y + +SG IP ++G CSEL
Sbjct: 203 PIPAQLGFLKNLTTLGFAASGLSGSIPSTFGNLVNLQTLALYDTEISGTIPPQLGLCSEL 262
Query: 274 QNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTG 333
+NLYL+ N ++G IP +G L K+ SLLLW NSL G IP E+ +C+ L V D S N LTG
Sbjct: 263 RNLYLHMNKLTGSIPKELGKLQKITSLLLWGNSLSGVIPPEISNCSSLVVFDVSANDLTG 322
Query: 334 SIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGL 393
IP G L+ L++LQLS N +G IP E++ C++L L++D N +SG IP+ IGN+ L
Sbjct: 323 DIPGDLGKLVWLEQLQLSDNMFTGQIPWELSNCSSLIALQLDKNKLSGSIPSQIGNLKSL 382
Query: 394 TLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSG 453
FF W+N ++G IP S C +L ALD S N L+G IP+E+F L+ L+KLLLL N LSG
Sbjct: 383 QSFFLWENSISGTIPSSFGNCTDLVALDLSRNKLTGRIPEELFSLKRLSKLLLLGNSLSG 442
Query: 454 FIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSL 513
+P + C +L RLR+ +N+LSG IP E+G L++L F+D+ NH GG+P + L
Sbjct: 443 GLPKSVAKCQSLVRLRVGENQLSGQIPKEIGELQNLVFLDLYMNHFSGGLPYEISNITVL 502
Query: 514 EFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSG 571
E LD+H+N +TG +P L +L+ +DLS N +G++ S G+L+ L+KL+L+ N L+G
Sbjct: 503 ELLDVHNNYITGDIPAQLGNLVNLEQLDLSRNSFTGNIPLSFGNLSYLNKLILNNNLLTG 562
Query: 572 RIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTK 631
+IP I + +KL LLD+ N SGEIP+ELGQ++SL I+L+LS N F+G IP FS LT+
Sbjct: 563 QIPKSIKNLQKLTLLDLSYNSLSGEIPQELGQVTSLTINLDLSYNTFTGNIPETFSDLTQ 622
Query: 632 LGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRGLYI 691
L LDLS N L GD+ L SL +L SLN+S N+FSG +P+TPFF+ + + N L
Sbjct: 623 LQSLDLSSNSLHGDIKVLGSLTSLASLNISCNNFSGPIPSTPFFKTISTTSYLQNTNLCH 682
Query: 692 S-GGVVSPTDSLPAGQARSAMKLVMSILVSASAVLVLLAIYVLVRTRMANNSF------- 743
S G+ + + +S + ++ ++ AS + +LA ++L+ + NN
Sbjct: 683 SLDGITCSSHTGQNNGVKSPKIVALTAVILASITIAILAAWLLI---LRNNHLYKTSQNS 739
Query: 744 -----TADD---TWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAV 795
TA+D W +QKL +++++V +LT NVIG G SG+VY+ IPNG+ +AV
Sbjct: 740 SSSPSTAEDFSYPWTFIPFQKLGITVNNIVTSLTDENVIGKGCSGIVYKAEIPNGDIVAV 799
Query: 796 KKMWSS---DESG-----AFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSL 847
KK+W + +E G +F++EIQ LG+IRH+NIV+LLG+ SNK++KLL Y+Y PNG+L
Sbjct: 800 KKLWKTKDNNEEGESTIDSFAAEIQILGNIRHRNIVKLLGYCSNKSVKLLLYNYFPNGNL 859
Query: 848 SSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLA 907
LL G DWE RY++ +G A LAYLHHDC+P ILH DVK N+LL Y+A LA
Sbjct: 860 QQLLQ--GNRNLDWETRYKIAIGAAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAILA 917
Query: 908 DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT 967
DFGLA+++ S + + N ++AGSYGY+APE+ ITEKSDVYS+GVVLLE+L+
Sbjct: 918 DFGLAKLMMNSPNYH----NAMSRVAGSYGYIAPEYGYTMNITEKSDVYSYGVVLLEILS 973
Query: 968 GRHPLDPTLPGGAPLVQWT 986
GR ++P + G +V+W
Sbjct: 974 GRSAVEPQIGDGLHIVEWV 992
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 646 bits (1666), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/1008 (38%), Positives = 576/1008 (57%), Gaps = 67/1008 (6%)
Query: 34 ALDEQGQALLTWKNSLNSSTDALSSWNPAETSPCKWFGIHCS---SNGEVVEISLKAVDL 90
L+ +GQ LL K+ + L +WN ++ PC W G+ CS S+ EV+ ++L ++ L
Sbjct: 26 GLNLEGQYLLEIKSKFVDAKQNLRNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVL 85
Query: 91 QGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLR 150
G L L LK+L +S L+G IPKE G+ L + L+ N GEIP E+ +L
Sbjct: 86 SGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLV 145
Query: 151 KLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQN 210
LE+L + N + G +P +IGNL SL+ L Y N +SG++P+SIG L +L FRAG N
Sbjct: 146 SLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNM- 204
Query: 211 LKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNC 270
+ G LP EIG C +LVMLGLA+ +SG +P IGML+++ + ++ + SG IP EI NC
Sbjct: 205 ISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNC 264
Query: 271 SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNL 330
+ L+ L LY+N + GPIP +G L L+ L L++N L G IP E+G+ + +DFS+N
Sbjct: 265 TSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENA 324
Query: 331 LTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNI 390
LTG IP GN+ L+ L L NQL+GTIP+E++T L+ L++ NA++G IP +
Sbjct: 325 LTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYL 384
Query: 391 NGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSND 450
GL + ++N L+G IP L +L LD S N+LSG IP + N+ L L +N+
Sbjct: 385 RGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNN 444
Query: 451 LSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGC 510
LSG IP I C TL +LRL N L G PS + ++ +++ +N G IP V C
Sbjct: 445 LSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNC 504
Query: 511 QSLEFLDLHSNGLTGSVPDTL--------------------PTS------LQLVDLSDNR 544
+L+ L L NG TG +P + P+ LQ +D+ N
Sbjct: 505 SALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNN 564
Query: 545 LSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQI 604
SG+L +GSL +L L LS N LSG IP + + +L L +G N F+G IP+ELG +
Sbjct: 565 FSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSL 624
Query: 605 SSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDL-DALASLQNLVSLNVSFN 663
+ L+I+LNLS N+ +GEIP E S L L L L++N LSG++ + A+L +L+ N S+N
Sbjct: 625 TGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYN 684
Query: 664 DFSGELPNTPFFRKLPLSDLASNRGL-------YISGGVVSPTDSL--PAGQARSA-MKL 713
+G + P R + +S N GL I +P+ S P G S + +
Sbjct: 685 SLTGPI---PLLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAI 741
Query: 714 VMSILVSASAVLVLLAIYVLVR-TRMANNSFTADDTWEMTLY----QKLDFSIDDVVR-- 766
+++ S +L+ L +Y++ R R +S EM+L K F+ D+V
Sbjct: 742 TAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAAT 801
Query: 767 -NLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESG-------AFSSEIQTLGSIR 818
N + V+G G+ G VY+ +P G TLAVKK+ S+ E G +F +EI TLG+IR
Sbjct: 802 DNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIR 861
Query: 819 HKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL 878
H+NIV+L G+ +++ LL Y+Y+P GSL +LH DW R+++ LG A LAYL
Sbjct: 862 HRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDP-SCNLDWSKRFKIALGAAQGLAYL 920
Query: 879 HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGY 938
HHDC P I H D+K+ N+LL ++A++ DFGLA+++ + + +AGSYGY
Sbjct: 921 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI------DMPHSKSMSAIAGSYGY 974
Query: 939 MAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWT 986
+APE+A ++TEKSD+YS+GVVLLE+LTG+ P+ P GG +V W
Sbjct: 975 IAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGD-VVNWV 1021
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 636 bits (1641), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/1045 (38%), Positives = 587/1045 (56%), Gaps = 84/1045 (8%)
Query: 11 SQNIFSFTLLLISINFLFFSTCDALDEQGQALLTWKNS-LNSSTDALSSWNPAETSPCKW 69
S+++F L L++ L T ++L+ GQ LL KN S + L +WN + +PC W
Sbjct: 12 SKSMFVGVLFLLT---LLVWTSESLNSDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNW 68
Query: 70 FGIHCSSNGE--------VVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKE 121
G++CSS G V + L +++L G + L +L L ++ LTG IP+E
Sbjct: 69 IGVNCSSQGSSSSSNSLVVTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPRE 128
Query: 122 FGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTL 181
G+ +L + L+ N G IP E+ +L +L S + N L G +P +IG+L +L L
Sbjct: 129 IGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVA 188
Query: 182 YDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPS 241
Y N L+G +P+S+G L+KL FRAG N + G +P EIG C NL +LGLA+ ISG +P
Sbjct: 189 YTNNLTGPLPRSLGNLNKLTTFRAGQN-DFSGNIPTEIGKCLNLKLLGLAQNFISGELPK 247
Query: 242 SIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLL 301
IGML ++Q + ++ + SG IP++IGN + L+ L LY NS+ GPIP IG + LK L
Sbjct: 248 EIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLY 307
Query: 302 LWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPI 361
L+QN L G IP ELG +++ +DFS+NLL+G IP + +L+ L L N+L+G IP
Sbjct: 308 LYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPN 367
Query: 362 EIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALD 421
E++ L L++ N+++G IP N+ + + N L+G IP+ L L +D
Sbjct: 368 ELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVD 427
Query: 422 FSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPS 481
FS N LSG IP I NL L L SN + G IPP + C +L +LR+ NRL+G P+
Sbjct: 428 FSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPT 487
Query: 482 EMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDL----------------------- 518
E+ L +L+ +++ +N G +PP + CQ L+ L L
Sbjct: 488 ELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFN 547
Query: 519 -HSNGLTGSVPDTLPTS--LQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPA 575
SN LTG +P + LQ +DLS N GSL +GSL +L L LS+N+ SG IP
Sbjct: 548 VSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPF 607
Query: 576 EILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGIL 635
I + L L +G N FSG IP +LG +SSL+I++NLS N FSGEIP E L L L
Sbjct: 608 TIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYL 667
Query: 636 DLSHNKLSGDL-DALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRGLYISGG 694
L++N LSG++ +L +L+ N S+N+ +G+LP+T F+ + L+ N+GL GG
Sbjct: 668 SLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGL--CGG 725
Query: 695 VVSPTD----------SLPAGQARSAMKLVMSILVSASAVLVLLAIYV-LVRTRMANNSF 743
+ D SL AG AR +++ V L+L+AI V +R + +
Sbjct: 726 HLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAP 785
Query: 744 TADDTW------EMTLYQKLDFSIDDVV---RNLTSANVIGTGSSGVVYRVTIPNGETLA 794
D ++ K F++ D++ + + ++G G+ G VY+ +P+G+T+A
Sbjct: 786 YVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIA 845
Query: 795 VKKM---------WSSDESGAFSSEIQTLGSIRHKNIVRLLGW----GSNKNLKLLFYDY 841
VKK+ S++ +F +EI TLG IRH+NIVRL + GSN N LL Y+Y
Sbjct: 846 VKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSN--LLLYEY 903
Query: 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG 901
+ GSL LLHG DW R+ + LG A LAYLHHDC P I+H D+K+ N+L+
Sbjct: 904 MSRGSLGELLHGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDEN 963
Query: 902 YQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVV 961
++A++ DFGLA+++ D SK+ +AGSYGY+APE+A ++TEK D+YSFGVV
Sbjct: 964 FEAHVGDFGLAKVI----DMPLSKSVS--AVAGSYGYIAPEYAYTMKVTEKCDIYSFGVV 1017
Query: 962 LLEVLTGRHPLDPTLPGGAPLVQWT 986
LLE+LTG+ P+ P L G L WT
Sbjct: 1018 LLELLTGKAPVQP-LEQGGDLATWT 1041
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 633 bits (1633), Expect = e-180, Method: Compositional matrix adjust.
Identities = 382/1020 (37%), Positives = 568/1020 (55%), Gaps = 59/1020 (5%)
Query: 15 FSFTLLLISINFLFFSTCDALDEQGQALLTWKNSLNSSTDALSSWNPAETSPCKWFGIHC 74
F ++L S +F+ + L+E+G+ LL +K LN S L+SWN +++PC W GI C
Sbjct: 7 FLAIVILCSFSFILVRS---LNEEGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIAC 63
Query: 75 SSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLS 134
+ V + L ++L G+L + L L++L +S+ ++G IP++ R L +DL
Sbjct: 64 THLRTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLC 123
Query: 135 GNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSI 194
N G IP ++ + L+ LYL N L G IP IGNLSSL L +Y N L+G IP S+
Sbjct: 124 TNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSM 183
Query: 195 GALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAI 254
L +L++ RAG N G +P EI C +L +LGLAE + G++P + L+ + + +
Sbjct: 184 AKLRQLRIIRAGRN-GFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLIL 242
Query: 255 YTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDE 314
+ + LSG IP +GN S L+ L L++N +G IP IG L+K+K L L+ N L G IP E
Sbjct: 243 WQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPRE 302
Query: 315 LGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEI 374
+G+ + +DFS+N LTG IP+ FG++L L+ L L N L G IP E+ T L L++
Sbjct: 303 IGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDL 362
Query: 375 DNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKE 434
N ++G IP ++ + L + N+L G IP + LD S N+LSGPIP
Sbjct: 363 SINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAH 422
Query: 435 IFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSE------------ 482
+ L L L SN LSG IP D+ C +L +L L DN+L+G++P E
Sbjct: 423 FCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALEL 482
Query: 483 ------------MGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDT 530
+G LK+L + ++ N+ G IPP + + ++ SN LTG +P
Sbjct: 483 HQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKE 542
Query: 531 LPT--SLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDI 588
L + ++Q +DLS N+ SG +A +G L L L LS N+L+G IP +L+ L +
Sbjct: 543 LGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQL 602
Query: 589 GNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDA 648
G N S IP ELG+++SL+ISLN+S N SG IP L L IL L+ NKLSG++ A
Sbjct: 603 GGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPA 662
Query: 649 -LASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRGLYISGG-----VVSPTDS- 701
+ +L +L+ N+S N+ G +P+T F+++ S+ A N GL S +V +DS
Sbjct: 663 SIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSK 722
Query: 702 ---LPAGQARSAMKLVMSILVSASAVLVLLAIYVLVRTR----MANNSFTADDTWEMTLY 754
L G R + + I++ + ++ L + ++ R +A T D + +
Sbjct: 723 LNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYF 782
Query: 755 QKLDFSID---DVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESG----AF 807
K F+ D RN + V+G G+ G VY+ + GE +AVKK+ S E +F
Sbjct: 783 PKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSF 842
Query: 808 SSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGG-ADWEARYE 866
+EI TLG IRH+NIV+L G+ ++N LL Y+Y+ GSL L K DW ARY
Sbjct: 843 RAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYR 902
Query: 867 VVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKT 926
+ LG A L YLHHDC P I+H D+K+ N+LL +QA++ DFGLA+++ + S +
Sbjct: 903 IALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLI------DLSYS 956
Query: 927 NQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWT 986
+AGSYGY+APE+A ++TEK D+YSFGVVLLE++TG+ P+ P L G LV W
Sbjct: 957 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQP-LEQGGDLVNWV 1015
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 559 bits (1440), Expect = e-158, Method: Compositional matrix adjust.
Identities = 342/960 (35%), Positives = 537/960 (55%), Gaps = 72/960 (7%)
Query: 90 LQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRL 149
L G++P+ L++L+ L +++ +LTG IP + G+ +L ++ L N L G IP + L
Sbjct: 227 LNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADL 286
Query: 150 RKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGAL-SKLQVFRAGGN 208
L++L L+ N L GEIP + N+S L L L +N LSG +PKSI + + L+ G
Sbjct: 287 GNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGT 346
Query: 209 QNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIG 268
Q L GE+P E+ C +L L L+ S++G++P ++ L + + ++ + L G + I
Sbjct: 347 Q-LSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSIS 405
Query: 269 NCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSD 328
N + LQ L LY N++ G +P I AL KL+ L L++N G IP E+G+CT L ++D
Sbjct: 406 NLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFG 465
Query: 329 NLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIG 388
N G IP S G L +L L L N+L G +P + C L L++ +N +SG IP+ G
Sbjct: 466 NHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFG 525
Query: 389 NINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLS 448
+ GL + N L GN+P+SL + L ++ S+N L+G I + G + + +
Sbjct: 526 FLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTI-HPLCGSSSYLSFDVTN 584
Query: 449 NDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVV 508
N IP ++GN L RLRL N+L+G IP +G ++ L+ +DMS N L G IP +V
Sbjct: 585 NGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLV 644
Query: 509 GCQSLEFLDLHSNGLTGSVP--------------------DTLP------TSLQLVDLSD 542
C+ L +DL++N L+G +P ++LP T L ++ L
Sbjct: 645 LCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDG 704
Query: 543 NRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELG 602
N L+GS+ IG+L L+ L L KNQ SG +P + KL L + N +GEIP E+G
Sbjct: 705 NSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIG 764
Query: 603 QISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDL-DALASLQNLVSLNVS 661
Q+ L+ +L+LS N F+G+IPS L+KL LDLSHN+L+G++ ++ +++L LNVS
Sbjct: 765 QLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVS 824
Query: 662 FNDFSGELPNTPFFRKLPLSDLASNRGLYISGGVVSPTDSLPAGQARSAMKLVMSILVSA 721
FN+ G+L F + P N GL G +S + + + + + +++SA
Sbjct: 825 FNNLGGKLKKQ--FSRWPADSFLGNTGL--CGSPLSRCNRVRSNNKQQGLSARSVVIISA 880
Query: 722 SAVLVLLAIYVLV-------------RTRMANNSFTADDTWEMTLYQKL--------DFS 760
+ L + + +LV + + ++T+ + ++ L D
Sbjct: 881 ISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIR 940
Query: 761 IDDVV---RNLTSANVIGTGSSGVVYRVTIPNGETLAVKK-MWSSD--ESGAFSSEIQTL 814
+D++ NL+ +IG+G SG VY+ + NGET+AVKK +W D + +FS E++TL
Sbjct: 941 WEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTL 1000
Query: 815 GSIRHKNIVRLLGWGSNKN--LKLLFYDYLPNGSLSSLLH------GAGKGGADWEARYE 866
G IRH+++V+L+G+ S+K+ L LL Y+Y+ NGS+ LH K DWEAR
Sbjct: 1001 GRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLR 1060
Query: 867 VVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKT 926
+ +G+A + YLHHDC+PPI+H D+K+ NVLL +A+L DFGLA++++ + D N T
Sbjct: 1061 IAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTN---T 1117
Query: 927 NQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWT 986
+ A SYGY+APE+A + TEKSDVYS G+VL+E++TG+ P D +V+W
Sbjct: 1118 DSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWV 1177
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 541 bits (1395), Expect = e-153, Method: Compositional matrix adjust.
Identities = 337/955 (35%), Positives = 526/955 (55%), Gaps = 68/955 (7%)
Query: 90 LQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRL 149
L GSLP+ LK+L+ L + + +G IP + GD + +++L GN L G IP + L
Sbjct: 228 LNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTEL 287
Query: 150 RKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGA--LSKLQVFRAGG 207
L++L L++N L G I + ++ L +L L N+LSG +PK+I + S Q+F +
Sbjct: 288 ANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLS-- 345
Query: 208 NQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEI 267
L GE+P EI NC +L +L L+ +++G +P S+ L + + + + L G + I
Sbjct: 346 ETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSI 405
Query: 268 GNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFS 327
N + LQ LY N++ G +P IG L KL+ + L++N G +P E+G+CT L +D+
Sbjct: 406 SNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWY 465
Query: 328 DNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADI 387
N L+G IP S G L L L L N+L G IP + C +T +++ +N +SG IP+
Sbjct: 466 GNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSF 525
Query: 388 GNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLL 447
G + L LF + N L GN+P+SL + L ++FS N +G I + G + +
Sbjct: 526 GFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSI-SPLCGSSSYLSFDVT 584
Query: 448 SNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSV 507
N G IP ++G T L RLRL N+ +G IP G + L+ +D+S N L G IP +
Sbjct: 585 ENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVEL 644
Query: 508 VGCQSLEFLDLHSNGLTGSVPD--------------------TLP------TSLQLVDLS 541
C+ L +DL++N L+G +P +LP T++ + L
Sbjct: 645 GLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLD 704
Query: 542 DNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKEL 601
N L+GS+ IG+L L+ L L +NQLSG +P+ I KL L + N +GEIP E+
Sbjct: 705 GNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEI 764
Query: 602 GQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDA-LASLQNLVSLNV 660
GQ+ L+ +L+LS N F+G IPS S L KL LDLSHN+L G++ + +++L LN+
Sbjct: 765 GQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNL 824
Query: 661 SFNDFSGELPNTPFFRKLPLSDLASNRGLYISGGVVSPTDSLPAGQARSAMKLVMSIL-- 718
S+N+ G+L F + N GL G +S + + RS + I+
Sbjct: 825 SYNNLEGKLKKQ--FSRWQADAFVGNAGL--CGSPLSHCNRAGSKNQRSLSPKTVVIISA 880
Query: 719 VSASAVLVLLAIYVLVRTRMANNSFTA-----------DDTWEMTLYQ----KLDFSIDD 763
+S+ A + L+ + +++ + ++ F + + L+ K D DD
Sbjct: 881 ISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDD 940
Query: 764 VVRN---LTSANVIGTGSSGVVYRVTIPNGETLAVKK-MWSSD--ESGAFSSEIQTLGSI 817
++ L +IG+G SG VY+ + NGET+AVKK +W D + +F+ E++TLG+I
Sbjct: 941 IMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTI 1000
Query: 818 RHKNIVRLLGWGSNK--NLKLLFYDYLPNGSLSSLLHG----AGKGGADWEARYEVVLGV 871
RH+++V+L+G+ S+K L LL Y+Y+ NGS+ LH K WE R ++ LG+
Sbjct: 1001 RHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGL 1060
Query: 872 AHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQ 931
A + YLH+DC+PPI+H D+K+ NVLL +A+L DFGLA+I++G+ D N T
Sbjct: 1061 AQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTN---TESNTM 1117
Query: 932 LAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWT 986
AGSYGY+APE+A + TEKSDVYS G+VL+E++TG+ P + +V+W
Sbjct: 1118 FAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWV 1172
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZ59|PEPR2_ARATH Leucine-rich repeat receptor-like protein kinase PEPR2 OS=Arabidopsis thaliana GN=PEPR2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 541 bits (1394), Expect = e-152, Method: Compositional matrix adjust.
Identities = 365/1017 (35%), Positives = 540/1017 (53%), Gaps = 56/1017 (5%)
Query: 14 IFSFTLLLISINFLFFSTCDALDEQGQALLTWKNSLNS-STDALSSW--NPAETSPCK-- 68
+ TLL + + +L+ G ALL+ + + S+W N +ET+PC
Sbjct: 6 LLEITLLCSLFVYFRIDSVSSLNSDGLALLSLLKHFDKVPLEVASTWKENTSETTPCNNN 65
Query: 69 WFGIHCSSNGEVVE-ISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRE 127
WFG+ C +G VVE ++L A L G L S LKSL L +S + +G +P G+
Sbjct: 66 WFGVICDLSGNVVETLNLSASGLSGQLGSEIGELKSLVTLDLSLNSFSGLLPSTLGNCTS 125
Query: 128 LTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLS 187
L ++DLS N GE+P L+ L LYL+ N L G IP+ +G L L L + N LS
Sbjct: 126 LEYLDLSNNDFSGEVPDIFGSLQNLTFLYLDRNNLSGLIPASVGGLIELVDLRMSYNNLS 185
Query: 188 GKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLE 247
G IP+ +G SKL+ + A N L G LP + NL L ++ S+ G + +
Sbjct: 186 GTIPELLGNCSKLE-YLALNNNKLNGSLPASLYLLENLGELFVSNNSLGGRLHFGSSNCK 244
Query: 248 RIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSL 307
++ ++ + + G +P EIGNCS L +L + + +++G IP +G L K+ + L N L
Sbjct: 245 KLVSLDLSFNDFQGGVPPEIGNCSSLHSLVMVKCNLTGTIPSSMGMLRKVSVIDLSDNRL 304
Query: 308 VGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCT 367
G IP ELG+C+ L + +DN L G IP + L KLQ L+L N+LSG IPI I
Sbjct: 305 SGNIPQELGNCSSLETLKLNDNQLQGEIPPALSKLKKLQSLELFFNKLSGEIPIGIWKIQ 364
Query: 368 ALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNL 427
+LT + + NN ++GE+P ++ + L + N G+IP SL + L+ +D N
Sbjct: 365 SLTQMLVYNNTLTGELPVEVTQLKHLKKLTLFNNGFYGDIPMSLGLNRSLEEVDLLGNRF 424
Query: 428 SGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSG---------- 477
+G IP + + L +L SN L G IP I C TL R+RL DN+LSG
Sbjct: 425 TGEIPPHLCHGQKLRLFILGSNQLHGKIPASIRQCKTLERVRLEDNKLSGVLPEFPESLS 484
Query: 478 -------------TIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLT 524
+IP +G+ K+L +D+S+N L G IPP + QSL L+L N L
Sbjct: 485 LSYVNLGSNSFEGSIPRSLGSCKNLLTIDLSQNKLTGLIPPELGNLQSLGLLNLSHNYLE 544
Query: 525 GSVPDTLPTSLQLV--DLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRK 582
G +P L +L+ D+ N L+GS+ S S LS L+LS N G IP + +
Sbjct: 545 GPLPSQLSGCARLLYFDVGSNSLNGSIPSSFRSWKSLSTLVLSDNNFLGAIPQFLAELDR 604
Query: 583 LILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKL 642
L L I N F G+IP +G + SL L+LS+N F+GEIP+ L L L++S+NKL
Sbjct: 605 LSDLRIARNAFGGKIPSSVGLLKSLRYGLDLSANVFTGEIPTTLGALINLERLNISNNKL 664
Query: 643 SGDLDALASLQNLVSLNVSFNDFSGELP-----NTPFFRKLPLSDLASNRGLYISGGVVS 697
+G L L SL++L ++VS+N F+G +P N+ F P DL +S +
Sbjct: 665 TGPLSVLQSLKSLNQVDVSYNQFTGPIPVNLLSNSSKFSGNP--DLCIQASYSVSAIIRK 722
Query: 698 PTDSLPAGQARSAMKLVMSILVSASAVLVLLAIYVLVRTRMANNSFTADDTWEMTLYQKL 757
S S K+ + S+ +VL LL LV R + T D + + L
Sbjct: 723 EFKSCKGQVKLSTWKIALIAAGSSLSVLALLFALFLVLCRCKRGTKTEDAN--ILAEEGL 780
Query: 758 DFSIDDVVR---NLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGA---FSSEI 811
++ V+ NL +IG G+ GVVYR ++ +GE AVKK+ ++ A EI
Sbjct: 781 SLLLNKVLAATDNLDDKYIIGRGAHGVVYRASLGSGEEYAVKKLIFAEHIRANQNMKREI 840
Query: 812 QTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGA--DWEARYEVVL 869
+T+G +RH+N++RL + K L+ Y Y+PNGSL +LH +G A DW AR+ + L
Sbjct: 841 ETIGLVRHRNLIRLERFWMRKEDGLMLYQYMPNGSLHDVLHRGNQGEAVLDWSARFNIAL 900
Query: 870 GVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR 929
G++H LAYLHHDC PPI+H D+K N+L+ + ++ DFGLARI+ DD+ T
Sbjct: 901 GISHGLAYLHHDCHPPIIHRDIKPENILMDSDMEPHIGDFGLARIL----DDSTVST--- 953
Query: 930 PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWT 986
+ G+ GY+APE+A +++SDVYS+GVVLLE++TG+ LD + P +V W
Sbjct: 954 ATVTGTTGYIAPENAYKTVRSKESDVYSYGVVLLELVTGKRALDRSFPEDINIVSWV 1010
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1001 | ||||||
| 224122130 | 1093 | predicted protein [Populus trichocarpa] | 0.984 | 0.901 | 0.787 | 0.0 | |
| 359494335 | 1093 | PREDICTED: probable LRR receptor-like se | 0.984 | 0.901 | 0.791 | 0.0 | |
| 224056849 | 1095 | predicted protein [Populus trichocarpa] | 0.984 | 0.899 | 0.795 | 0.0 | |
| 356566345 | 1090 | PREDICTED: probable LRR receptor-like se | 0.982 | 0.901 | 0.763 | 0.0 | |
| 356499463 | 1080 | PREDICTED: probable LRR receptor-like se | 0.983 | 0.911 | 0.733 | 0.0 | |
| 356524391 | 1092 | PREDICTED: probable LRR receptor-like se | 0.982 | 0.900 | 0.757 | 0.0 | |
| 255582798 | 1059 | receptor protein kinase, putative [Ricin | 0.941 | 0.889 | 0.731 | 0.0 | |
| 356553486 | 1093 | PREDICTED: probable LRR receptor-like se | 0.956 | 0.875 | 0.743 | 0.0 | |
| 356566347 | 953 | PREDICTED: probable LRR receptor-like se | 0.937 | 0.984 | 0.758 | 0.0 | |
| 79330883 | 1090 | leucine-rich receptor-like protein kinas | 0.950 | 0.872 | 0.708 | 0.0 |
| >gi|224122130|ref|XP_002330548.1| predicted protein [Populus trichocarpa] gi|222872106|gb|EEF09237.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1582 bits (4096), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 777/987 (78%), Positives = 879/987 (89%), Gaps = 2/987 (0%)
Query: 1 MPAALRHLLFSQNIFSFTLLLISINFLFFSTCDALDEQGQALLTWKNSLNSSTDALSSWN 60
MPA LR+LLFS +IFSFTLLL SIN LFF +C ++DEQGQALL WKNSLN+STD L+SWN
Sbjct: 1 MPAPLRNLLFSPSIFSFTLLL-SINSLFFRSCYSIDEQGQALLAWKNSLNTSTDVLNSWN 59
Query: 61 PAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPK 120
P ++SPCKWFG+HC+S+G ++EI+LKAVDLQG LPS FQPLKSLK LI+SS NLTG IP+
Sbjct: 60 PLDSSPCKWFGVHCNSDGNIIEINLKAVDLQGPLPSNFQPLKSLKSLILSSTNLTGAIPE 119
Query: 121 EFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLT 180
FGDY ELT IDLS NSL GEIP E+CRLRKLE+L LNTN LEG IPSDIGNLSSL LT
Sbjct: 120 AFGDYLELTLIDLSDNSLSGEIPEEICRLRKLETLSLNTNFLEGAIPSDIGNLSSLVNLT 179
Query: 181 LYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVP 240
L+DNQLSG+IP+SIGAL +LQ+FRAGGN+N+KGELP EIGNC+ LV+LGLAETSISG++P
Sbjct: 180 LFDNQLSGEIPQSIGALRRLQIFRAGGNKNVKGELPQEIGNCTELVVLGLAETSISGSLP 239
Query: 241 SSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSL 300
SSIGML+RIQTIAIY +LLSG IPE IG+CSELQNLYLYQNSISGPIP RIG LSKL+SL
Sbjct: 240 SSIGMLKRIQTIAIYATLLSGAIPEAIGDCSELQNLYLYQNSISGPIPRRIGELSKLQSL 299
Query: 301 LLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIP 360
LLWQNS+VGAIPDE+GSCTELTV+D S+NLL GSIPRSFGNLLKL+ELQLSVNQLSGTIP
Sbjct: 300 LLWQNSIVGAIPDEIGSCTELTVIDLSENLLAGSIPRSFGNLLKLEELQLSVNQLSGTIP 359
Query: 361 IEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQAL 420
+EI CTALTHLE+DNN ISGEIPA IGN+ LTLFFAWKN LTGNIPESLS+C LQAL
Sbjct: 360 VEITNCTALTHLEVDNNGISGEIPAGIGNLKSLTLFFAWKNNLTGNIPESLSECVNLQAL 419
Query: 421 DFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIP 480
D SYN+L G IPK++FGL+NLTKLL+LSN+LSGFIPPDIGNCT L RLRLN NRL GTIP
Sbjct: 420 DLSYNSLFGSIPKQVFGLQNLTKLLILSNELSGFIPPDIGNCTNLYRLRLNGNRLGGTIP 479
Query: 481 SEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDL 540
SE+ LK LNF+D+S N LVG IP SV GC++LEFLDLHSNG+TGSVPDTLP SLQ VD+
Sbjct: 480 SEIEKLKSLNFIDLSNNLLVGRIPSSVSGCENLEFLDLHSNGITGSVPDTLPKSLQYVDV 539
Query: 541 SDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKE 600
SDNRL+GSLAHSIGSL EL+KL L+KNQL+G IPAEILSC KL LL++G+N FSGEIPKE
Sbjct: 540 SDNRLTGSLAHSIGSLIELTKLNLAKNQLTGGIPAEILSCSKLQLLNLGDNGFSGEIPKE 599
Query: 601 LGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNV 660
LGQI +LEISLNLS NQFSG+IPS+FS L+KLG+LD+SHNKL G LD LA+LQNLV LNV
Sbjct: 600 LGQIPALEISLNLSCNQFSGKIPSQFSDLSKLGVLDISHNKLEGSLDVLANLQNLVFLNV 659
Query: 661 SFNDFSGELPNTPFFRKLPLSDLASNRGLYISGGVVSPTDSL-PAGQARSAMKLVMSILV 719
SFNDFSGELPNTPFFRKLP+SDLASN+GLYISGGV +P D L P RSAM+L+MS+L+
Sbjct: 660 SFNDFSGELPNTPFFRKLPISDLASNQGLYISGGVATPADHLGPGAHTRSAMRLLMSVLL 719
Query: 720 SASAVLVLLAIYVLVRTRMANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSS 779
SA VL+LL IY+LVR R+ N+ DDTWEM LYQKL+FS++D+V+NLTS+NVIGTGSS
Sbjct: 720 SAGVVLILLTIYMLVRARVDNHGLMKDDTWEMNLYQKLEFSVNDIVKNLTSSNVIGTGSS 779
Query: 780 GVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839
GVVYRVT+PN E +AVKKMWS +ESGAF+SEI+TLGSIRH+NIVRLLGW SNKNLKLLFY
Sbjct: 780 GVVYRVTLPNWEMIAVKKMWSPEESGAFNSEIRTLGSIRHRNIVRLLGWCSNKNLKLLFY 839
Query: 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG 899
DYLPNGSLSSLLHGAGKGGA+WEARY+V+LGVAHALAYLHHDC+PPILHGDVKAMNVLLG
Sbjct: 840 DYLPNGSLSSLLHGAGKGGAEWEARYDVLLGVAHALAYLHHDCVPPILHGDVKAMNVLLG 899
Query: 900 PGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFG 959
PGY+ YLADFGLAR+V+ DD+ K + RPQLAGSYGYMAPEHASMQRITEKSDVYSFG
Sbjct: 900 PGYEPYLADFGLARVVNNKSDDDLCKPSPRPQLAGSYGYMAPEHASMQRITEKSDVYSFG 959
Query: 960 VVLLEVLTGRHPLDPTLPGGAPLVQWT 986
VVLLEVLTGRHPLDPTLP GA LVQW
Sbjct: 960 VVLLEVLTGRHPLDPTLPDGAHLVQWV 986
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359494335|ref|XP_002267870.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g26540-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1581 bits (4094), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 782/988 (79%), Positives = 875/988 (88%), Gaps = 3/988 (0%)
Query: 1 MPAALRHLLFSQNIFSFTL-LLISINFLFFSTCDALDEQGQALLTWKNSLNSSTDALSSW 59
MPA LR+LL S NIFSF+ L+SIN LFFS C ++DEQGQALLTWKN LNSSTD L SW
Sbjct: 1 MPATLRNLLLSPNIFSFSFTFLLSINSLFFSCCFSIDEQGQALLTWKNGLNSSTDVLRSW 60
Query: 60 NPAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIP 119
NP++ SPC WFG+HC+ NGEVV+ISL++VDLQG LPS FQ L SLK LI+ S NLTGTIP
Sbjct: 61 NPSDPSPCNWFGVHCNPNGEVVQISLRSVDLQGPLPSNFQSLNSLKSLILPSANLTGTIP 120
Query: 120 KEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYL 179
KEFG+YREL IDLSGNS+ GEIP E+CRL KL+SL LNTN LEGEIPS+IGNLSSL YL
Sbjct: 121 KEFGEYRELALIDLSGNSITGEIPEEICRLSKLQSLSLNTNFLEGEIPSNIGNLSSLVYL 180
Query: 180 TLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNV 239
TLYDNQLSG+IPKSIG L+KL+VFRAGGNQNLKGELPWEIGNC+NLVM+GLAETSISG++
Sbjct: 181 TLYDNQLSGEIPKSIGELTKLEVFRAGGNQNLKGELPWEIGNCTNLVMIGLAETSISGSL 240
Query: 240 PSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKS 299
P SIGML+RIQTIAIYT+LLSGPIP+EIGNCSELQNLYLYQNSISGPIP IG L+KL+S
Sbjct: 241 PLSIGMLKRIQTIAIYTALLSGPIPQEIGNCSELQNLYLYQNSISGPIPRGIGELAKLRS 300
Query: 300 LLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTI 359
LLLWQNS VG IP E+G+C+ELTV+D S+NLL+GSIP SFGNLLKL+ELQLSVNQLSG I
Sbjct: 301 LLLWQNSFVGTIPSEIGACSELTVIDLSENLLSGSIPGSFGNLLKLRELQLSVNQLSGFI 360
Query: 360 PIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQA 419
P EI CTAL HLE+DNN ISGEIP IGN+ LTL FAW+NKLTG+IPESLS C+ LQA
Sbjct: 361 PSEITNCTALNHLEVDNNDISGEIPVLIGNLKSLTLLFAWQNKLTGSIPESLSNCENLQA 420
Query: 420 LDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTI 479
LD SYN+LSG IPK+IFGL+NLTK+LLLSN+LSGFIPPDIGNCT L R RLNDNRL+GTI
Sbjct: 421 LDLSYNHLSGSIPKQIFGLKNLTKVLLLSNELSGFIPPDIGNCTNLYRFRLNDNRLAGTI 480
Query: 480 PSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVD 539
PSE+GNLK LNF+DMS NHLVGGIPPS+ GCQ+LEFLDLHSNGL SVPDTLP SLQLVD
Sbjct: 481 PSEIGNLKSLNFLDMSNNHLVGGIPPSISGCQNLEFLDLHSNGLISSVPDTLPISLQLVD 540
Query: 540 LSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPK 599
+SDN L+G L IGSL EL+KL L KN+LSG IPAEILSC KL LLD+GNN FSGEIPK
Sbjct: 541 VSDNMLTGPLTPYIGSLVELTKLNLGKNRLSGTIPAEILSCSKLQLLDLGNNGFSGEIPK 600
Query: 600 ELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLN 659
ELGQ+ +LEISLNLS NQ +GEIPS+FS L+KLG+LDLSHNKL+G+L+ L SLQNLV LN
Sbjct: 601 ELGQLPALEISLNLSCNQLTGEIPSQFSSLSKLGVLDLSHNKLTGNLNILTSLQNLVFLN 660
Query: 660 VSFNDFSGELPNTPFFRKLPLSDLASNRGLYISGGVVSPTDSL-PAGQARSAMKLVMSIL 718
VS+NDFSGELP+TPFFR LP+SDLA NR LYIS GVV+ DS+ G +SAMKL MSIL
Sbjct: 661 VSYNDFSGELPDTPFFRNLPMSDLAGNRALYISNGVVARADSIGRGGHTKSAMKLAMSIL 720
Query: 719 VSASAVLVLLAIYVLVRTRMANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGS 778
VSASAVLVLLAIY+LVR R+AN +DTW+MTLYQKLDFSIDD++RNLTSANVIGTGS
Sbjct: 721 VSASAVLVLLAIYMLVRARVANR-LLENDTWDMTLYQKLDFSIDDIIRNLTSANVIGTGS 779
Query: 779 SGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838
SGVVYRV IP+G+TLAVKKMWSS+ESGAFSSEI+TLGSIRH+NIVRLLGWGSN++LKLLF
Sbjct: 780 SGVVYRVAIPDGQTLAVKKMWSSEESGAFSSEIRTLGSIRHRNIVRLLGWGSNRSLKLLF 839
Query: 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL 898
YDYLPNGSLSSLLHGAGKGGADWEARY+VVL VAHA+AYLHHDC+P ILHGDVKAMNVLL
Sbjct: 840 YDYLPNGSLSSLLHGAGKGGADWEARYDVVLDVAHAVAYLHHDCVPAILHGDVKAMNVLL 899
Query: 899 GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSF 958
GP +AYLADFGLAR+V+ SG+D+ SK QRP LAGSYGYMAPEHASMQRITEKSDVYSF
Sbjct: 900 GPKLEAYLADFGLARVVNNSGEDDFSKMGQRPHLAGSYGYMAPEHASMQRITEKSDVYSF 959
Query: 959 GVVLLEVLTGRHPLDPTLPGGAPLVQWT 986
GVVLLEVLTGRHPLDPTLPGGA LVQW
Sbjct: 960 GVVLLEVLTGRHPLDPTLPGGAHLVQWV 987
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224056849|ref|XP_002299054.1| predicted protein [Populus trichocarpa] gi|222846312|gb|EEE83859.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1571 bits (4067), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 785/987 (79%), Positives = 886/987 (89%), Gaps = 2/987 (0%)
Query: 1 MPAALRHLLFSQNIFSFTLLLISINFLFFSTCDALDEQGQALLTWKNSLNSSTDALSSWN 60
MPA LR+LL S NIFSFTLLL L +C ++DEQGQALL WKNSLN+STD L+SWN
Sbjct: 1 MPAPLRNLLLSPNIFSFTLLLSIN-SLLLRSCYSIDEQGQALLAWKNSLNTSTDVLNSWN 59
Query: 61 PAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPK 120
P ++SPCKWFG+HC+SNG ++EI+LKAV+LQG LPS FQPLKSLK LI+SS NLTG IPK
Sbjct: 60 PLDSSPCKWFGVHCNSNGNIIEINLKAVNLQGPLPSNFQPLKSLKSLILSSTNLTGAIPK 119
Query: 121 EFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLT 180
FGDY ELT IDLS NSL GEIP E+CRLRKL++L LNTN LEG IPSDIGNLSSL YLT
Sbjct: 120 AFGDYLELTLIDLSDNSLSGEIPEEICRLRKLQNLSLNTNFLEGAIPSDIGNLSSLVYLT 179
Query: 181 LYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVP 240
L+DNQLSG+IP+SIGALS+LQ+FRAGGN+NLKGE+P EIGNC+NLV+LGLAETSISG++P
Sbjct: 180 LFDNQLSGEIPQSIGALSRLQIFRAGGNKNLKGEVPQEIGNCTNLVVLGLAETSISGSLP 239
Query: 241 SSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSL 300
SSIG L+RIQT+AIYT+LLSG IPEEIG+CSELQNLYLYQNSISGPIP RIG LSKL+SL
Sbjct: 240 SSIGKLKRIQTVAIYTALLSGSIPEEIGDCSELQNLYLYQNSISGPIPRRIGKLSKLQSL 299
Query: 301 LLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIP 360
LLWQNS+VGAIPDELG CTELTV+D S+NLLTGSIPRSFGNLLKL+ELQLSVNQL+GTIP
Sbjct: 300 LLWQNSIVGAIPDELGRCTELTVIDLSENLLTGSIPRSFGNLLKLEELQLSVNQLTGTIP 359
Query: 361 IEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQAL 420
+EI CTAL+HLE+DNN ISGEIPA IG++ LTLFFAW+N LTGNIPESLS+C+ LQAL
Sbjct: 360 VEITNCTALSHLEVDNNEISGEIPAGIGSLKSLTLFFAWQNNLTGNIPESLSECENLQAL 419
Query: 421 DFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIP 480
D SYN+L G IPK+IFGL+NL+KLL+LSNDLSGFIPPDIGNCT L RLRLN NRL GTIP
Sbjct: 420 DLSYNSLFGSIPKQIFGLQNLSKLLILSNDLSGFIPPDIGNCTNLYRLRLNGNRLGGTIP 479
Query: 481 SEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDL 540
SE+GNLK LNFVD+S N LVGGIP S+ GCQ+LEFLDLHSNG+TGSVPDTLP SLQ VD+
Sbjct: 480 SEIGNLKILNFVDLSNNLLVGGIPLSISGCQNLEFLDLHSNGITGSVPDTLPKSLQYVDV 539
Query: 541 SDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKE 600
SDNRL+GSL H IGSLTEL+KL L+KNQLSG IPAEIL C KL LL++G+N FSGEIPKE
Sbjct: 540 SDNRLTGSLTHRIGSLTELTKLNLAKNQLSGGIPAEILLCSKLQLLNLGDNGFSGEIPKE 599
Query: 601 LGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNV 660
LGQI +LEISLNLS NQFSG+IPS+FS L+KLG+LD+SHNKL G LD LA+LQNLV LNV
Sbjct: 600 LGQIPALEISLNLSCNQFSGKIPSQFSDLSKLGVLDISHNKLEGSLDVLANLQNLVFLNV 659
Query: 661 SFNDFSGELPNTPFFRKLPLSDLASNRGLYISGGVVSPTDSL-PAGQARSAMKLVMSILV 719
SFNDFSGELPNTPFFRKLPLSDLASN+GLYI+GGVV+P L P RSAMKL+MS+L+
Sbjct: 660 SFNDFSGELPNTPFFRKLPLSDLASNQGLYIAGGVVTPGVHLGPGAHTRSAMKLLMSVLL 719
Query: 720 SASAVLVLLAIYVLVRTRMANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSS 779
SASAVL+LLAIY+LVR R+ ++ DDTWEMTLYQKL+FS+DD+V+NLTSANVIGTGSS
Sbjct: 720 SASAVLILLAIYMLVRARIGSHGLMEDDTWEMTLYQKLEFSVDDIVKNLTSANVIGTGSS 779
Query: 780 GVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839
GVVYRV +PNGE +AVKKMWSS+ESGAF+SEIQTLGSIRH+NIVRLLGW SNKNLKLLFY
Sbjct: 780 GVVYRVILPNGEMIAVKKMWSSEESGAFNSEIQTLGSIRHRNIVRLLGWCSNKNLKLLFY 839
Query: 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG 899
DYLP+GSLSSLLHGAGKGGA+WEARY+V+LGVAHALAYLHHDC+PPILHGDVKAMNVLLG
Sbjct: 840 DYLPHGSLSSLLHGAGKGGAEWEARYDVLLGVAHALAYLHHDCLPPILHGDVKAMNVLLG 899
Query: 900 PGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFG 959
PGY+ YLADFGLAR+V+ + DD+ K QRPQLAGSYGYMAPEHASMQRITEKSDVYSFG
Sbjct: 900 PGYEPYLADFGLARVVNNNSDDDFCKPTQRPQLAGSYGYMAPEHASMQRITEKSDVYSFG 959
Query: 960 VVLLEVLTGRHPLDPTLPGGAPLVQWT 986
VVLLEVLTGRHPLDPTLPGGA LVQW
Sbjct: 960 VVLLEVLTGRHPLDPTLPGGAHLVQWV 986
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356566345|ref|XP_003551393.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g26540-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1470 bits (3805), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 753/986 (76%), Positives = 864/986 (87%), Gaps = 3/986 (0%)
Query: 1 MPAALRHLLFSQNIFSFTLLLISINFLFFSTCDALDEQGQALLTWKNSLNSSTDALSSWN 60
MP +LR+L S IFSFTLLL + LFF C +LDEQGQAL+ WKNSLN ++D L+SWN
Sbjct: 1 MPGSLRNLSLSPKIFSFTLLLSLNSLLFFPCCYSLDEQGQALIAWKNSLNITSDVLASWN 60
Query: 61 PAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPK 120
P+ +SPC WFG++C+S GEV+EISLK+V+LQGSLPS FQPL+SLK L++SS NLTG+IPK
Sbjct: 61 PSASSPCNWFGVYCNSQGEVIEISLKSVNLQGSLPSNFQPLRSLKILVLSSTNLTGSIPK 120
Query: 121 EFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLT 180
E GDY EL F+DLSGNSL+GEIP E+C LRKL+SL L+TN L+G IPS+IGNL+SL LT
Sbjct: 121 EIGDYVELIFVDLSGNSLFGEIPEEICSLRKLQSLSLHTNFLQGNIPSNIGNLTSLVNLT 180
Query: 181 LYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVP 240
LYDN LSG+IPKSIG+L KLQVFRAGGN+NLKGE+PWEIG+C+NLVMLGLAETSISG++P
Sbjct: 181 LYDNHLSGEIPKSIGSLRKLQVFRAGGNKNLKGEIPWEIGSCTNLVMLGLAETSISGSLP 240
Query: 241 SSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSL 300
SI ML+ I+TIAIYT+LLSGPIPEEIGNCSELQNLYL+QNSISG IP +IG LSKLKSL
Sbjct: 241 YSIKMLKNIKTIAIYTTLLSGPIPEEIGNCSELQNLYLHQNSISGSIPSQIGELSKLKSL 300
Query: 301 LLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIP 360
LLWQN++VG IP+ELGSCTE+ V+D S+NLLTGSIPRSFGNL LQELQLSVNQLSG IP
Sbjct: 301 LLWQNNIVGTIPEELGSCTEIKVIDLSENLLTGSIPRSFGNLSNLQELQLSVNQLSGIIP 360
Query: 361 IEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQAL 420
EI+ CT+L LE+DNNA+SGEIP IGN+ LTLFFAWKNKLTGNIP+SLS+CQEL+A+
Sbjct: 361 PEISNCTSLNQLELDNNALSGEIPDLIGNMKDLTLFFAWKNKLTGNIPDSLSECQELEAI 420
Query: 421 DFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIP 480
D SYNNL GPIPK++FGLRNLTKLLLLSNDLSGFIPPDIGNCT+L RLRLN NRL+G IP
Sbjct: 421 DLSYNNLIGPIPKQLFGLRNLTKLLLLSNDLSGFIPPDIGNCTSLYRLRLNHNRLAGHIP 480
Query: 481 SEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDL 540
E+GNLK LNF+D+S NHL G IPP++ GCQ+LEFLDLHSN L+GSV D+LP SLQL+DL
Sbjct: 481 PEIGNLKSLNFMDLSSNHLYGEIPPTLSGCQNLEFLDLHSNSLSGSVSDSLPKSLQLIDL 540
Query: 541 SDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKE 600
SDNRL+G+L+H+IGSL EL+KL L NQLSGRIP+EILSC KL LLD+G+N F+GEIP E
Sbjct: 541 SDNRLTGALSHTIGSLVELTKLNLGNNQLSGRIPSEILSCSKLQLLDLGSNSFNGEIPNE 600
Query: 601 LGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNV 660
+G I SL ISLNLS NQFSG+IP + S LTKLG+LDLSHNKLSG+LDAL+ L+NLVSLNV
Sbjct: 601 VGLIPSLAISLNLSCNQFSGKIPPQLSSLTKLGVLDLSHNKLSGNLDALSDLENLVSLNV 660
Query: 661 SFNDFSGELPNTPFFRKLPLSDLASNRGLYISGGVVSPTDSLPAGQARSAMKLVMSILVS 720
SFN SGELPNT FF LPLS+LA N+GLYI+GGVV+P D G ARSAMK +MSIL+S
Sbjct: 661 SFNGLSGELPNTLFFHNLPLSNLAENQGLYIAGGVVTPGD---KGHARSAMKFIMSILLS 717
Query: 721 ASAVLVLLAIYVLVRTRMANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSG 780
SAVLVLL IYVLVRT MA+ ++TWEMTLYQKLDFSIDD+V NLTSANVIGTGSSG
Sbjct: 718 TSAVLVLLTIYVLVRTHMASKVLMENETWEMTLYQKLDFSIDDIVMNLTSANVIGTGSSG 777
Query: 781 VVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840
VVY+VTIPNGETLAVKKMWSS+ESGAF+SEIQTLGSIRHKNI+RLLGWGSNKNLKLLFYD
Sbjct: 778 VVYKVTIPNGETLAVKKMWSSEESGAFNSEIQTLGSIRHKNIIRLLGWGSNKNLKLLFYD 837
Query: 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP 900
YLPNGSLSSLL+G+GKG A+WE RY+V+LGVAHALAYLHHDC+P I+HGDVKAMNVLLGP
Sbjct: 838 YLPNGSLSSLLYGSGKGKAEWETRYDVILGVAHALAYLHHDCLPAIIHGDVKAMNVLLGP 897
Query: 901 GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGV 960
GYQ YLADFGLAR + +GD+ SK QR LAGSYGYMAPEHAS+Q ITEKSDVYSFG+
Sbjct: 898 GYQPYLADFGLARTATENGDNTDSKPLQRHYLAGSYGYMAPEHASLQPITEKSDVYSFGM 957
Query: 961 VLLEVLTGRHPLDPTLPGGAPLVQWT 986
VLLEVLTGRHPLDPTLP GA LVQW
Sbjct: 958 VLLEVLTGRHPLDPTLPRGAHLVQWV 983
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356499463|ref|XP_003518559.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g26540-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1447 bits (3746), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 723/986 (73%), Positives = 849/986 (86%), Gaps = 2/986 (0%)
Query: 1 MPAALRHLLFSQNIFSFTLLLISINFLFFSTCDALDEQGQALLTWKNSLNSSTDALSSWN 60
M L +L S IF F +L+ + L F C +L+EQGQALL WKNSLNS+ DAL+SWN
Sbjct: 1 MSVILWNLSLSPKIF-FLTMLLLLKSLLFPCCYSLNEQGQALLAWKNSLNSTLDALASWN 59
Query: 61 PAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPK 120
P++ SPC WFG+HC+ GEVVEI+LK+V+LQGSLPS FQPL+SLK L++S+ N+TG IPK
Sbjct: 60 PSKPSPCNWFGVHCNLQGEVVEINLKSVNLQGSLPSNFQPLRSLKTLVLSTANITGRIPK 119
Query: 121 EFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLT 180
E GDY+EL IDLSGNSL GEIP E+CRL KL++L L+ N LEG IPS+IG+LSSL LT
Sbjct: 120 EIGDYKELIVIDLSGNSLLGEIPQEICRLSKLQTLALHANFLEGNIPSNIGSLSSLVNLT 179
Query: 181 LYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVP 240
LYDN+LSG+IPKSIG+L+ LQV RAGGN NLKGE+PW+IGNC+NLV+LGLAETSISG++P
Sbjct: 180 LYDNKLSGEIPKSIGSLTALQVLRAGGNTNLKGEVPWDIGNCTNLVVLGLAETSISGSLP 239
Query: 241 SSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSL 300
SSIG L+RIQTIAIYT+LLSGPIPEEIG CSELQNLYLYQNSISG IP +IG LSKL++L
Sbjct: 240 SSIGKLKRIQTIAIYTTLLSGPIPEEIGKCSELQNLYLYQNSISGSIPSQIGELSKLQNL 299
Query: 301 LLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIP 360
LLWQN++VG IP+ELGSCT++ V+D S+NLLTGSIP SFG L LQ LQLSVN+LSG IP
Sbjct: 300 LLWQNNIVGTIPEELGSCTQIEVIDLSENLLTGSIPTSFGKLSNLQGLQLSVNKLSGIIP 359
Query: 361 IEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQAL 420
EI CT+LT LE+DNN ISGEIP IGN+ LTLFFAW+NKLTG IP+SLS+CQ+LQ
Sbjct: 360 PEITNCTSLTQLEVDNNDISGEIPPLIGNLRSLTLFFAWQNKLTGKIPDSLSRCQDLQEF 419
Query: 421 DFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIP 480
D SYNNL+G IPK++FGLRNLTKLLLLSNDLSGFIPP+IGNCT+L RLRLN NRL+GTIP
Sbjct: 420 DLSYNNLTGLIPKQLFGLRNLTKLLLLSNDLSGFIPPEIGNCTSLYRLRLNHNRLAGTIP 479
Query: 481 SEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDL 540
+E+ NLK+LNF+D+S NHLVG IPP++ CQ+LEFLDLHSN L GS+PD LP +LQL+DL
Sbjct: 480 TEITNLKNLNFLDVSSNHLVGEIPPTLSRCQNLEFLDLHSNSLIGSIPDNLPKNLQLIDL 539
Query: 541 SDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKE 600
+DNRL+G L+HSIGSLTEL+KL L KNQLSG IPAEILSC KL LLD+G+N FSG+IP+E
Sbjct: 540 TDNRLTGELSHSIGSLTELTKLSLGKNQLSGSIPAEILSCSKLQLLDLGSNSFSGQIPEE 599
Query: 601 LGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNV 660
+ QI SLEI LNLS NQFSGEIPS+FS L KLG+LDLSHNKLSG+LDAL+ LQNLVSLNV
Sbjct: 600 VAQIPSLEIFLNLSCNQFSGEIPSQFSSLKKLGVLDLSHNKLSGNLDALSDLQNLVSLNV 659
Query: 661 SFNDFSGELPNTPFFRKLPLSDLASNRGLYISGGVVSPTDSLPA-GQARSAMKLVMSILV 719
SFN+FSGELPNTPFFR+LPL+DL N G+YI GGV +P D A G AR AMK++MSIL+
Sbjct: 660 SFNNFSGELPNTPFFRRLPLNDLTGNDGVYIVGGVATPADRKEAKGHARLAMKIIMSILL 719
Query: 720 SASAVLVLLAIYVLVRTRMANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSS 779
+AVLVLL I+VL+R +A+ ++ W +TLYQK +FSIDD+VRNLTS+NVIGTGSS
Sbjct: 720 CTTAVLVLLTIHVLIRAHVASKILNGNNNWVITLYQKFEFSIDDIVRNLTSSNVIGTGSS 779
Query: 780 GVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839
GVVY+VT+PNG+TLAVKKMWS+ ESGAF+SEIQ LGSIRHKNI++LLGWGS+KN+KLLFY
Sbjct: 780 GVVYKVTVPNGQTLAVKKMWSTAESGAFTSEIQALGSIRHKNIIKLLGWGSSKNMKLLFY 839
Query: 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG 899
+YLPNGSLSSL+HG+GKG ++WE RY+V+LGVAHALAYLH+DC+P ILHGDVKAMNVLLG
Sbjct: 840 EYLPNGSLSSLIHGSGKGKSEWETRYDVMLGVAHALAYLHNDCVPSILHGDVKAMNVLLG 899
Query: 900 PGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFG 959
PGYQ YLADFGLA I S +GD SK+ QR LAGSYGYMAPEHASMQRITEKSDVYSFG
Sbjct: 900 PGYQPYLADFGLATIASENGDYTNSKSVQRTYLAGSYGYMAPEHASMQRITEKSDVYSFG 959
Query: 960 VVLLEVLTGRHPLDPTLPGGAPLVQW 985
VVLLEVLTGRHPLDPTLPGGA LVQW
Sbjct: 960 VVLLEVLTGRHPLDPTLPGGAHLVQW 985
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356524391|ref|XP_003530812.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g26540-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1444 bits (3739), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 748/988 (75%), Positives = 860/988 (87%), Gaps = 5/988 (0%)
Query: 1 MPAALRHLLFSQNIFSFTLLLISINFL-FFSTCDALDEQGQALLTWKNSLNSSTDALSSW 59
MP +LR+L IFSFTLLLI +N L FF C +LDEQGQAL+ WKN+LN ++D L+SW
Sbjct: 1 MPGSLRNLSLFPKIFSFTLLLILLNSLLFFPCCYSLDEQGQALIAWKNTLNITSDVLASW 60
Query: 60 NPAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLK-SLKRLIISSCNLTGTI 118
NP+ +SPC WFG++C+S GEVVE++LK+V+LQGSLPS FQPLK SLK L++SS NLTG++
Sbjct: 61 NPSASSPCNWFGVYCNSQGEVVELNLKSVNLQGSLPSNFQPLKGSLKILVLSSTNLTGSV 120
Query: 119 PKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAY 178
PKE DY EL F+DLSGNSL+GEIP E+C LRKL SL L+ N L+G IPS+IGNL+SL
Sbjct: 121 PKEIRDYVELIFVDLSGNSLFGEIPEEICSLRKLLSLSLHMNFLQGNIPSNIGNLTSLVN 180
Query: 179 LTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGN 238
LTLYDN LSG+IPKSIG+L KLQVFRAGGN+NLKGE+PWEIG+C+NLV LGLAETSISG+
Sbjct: 181 LTLYDNHLSGEIPKSIGSLRKLQVFRAGGNKNLKGEIPWEIGSCTNLVTLGLAETSISGS 240
Query: 239 VPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLK 298
+PSSI ML+RI TIAIYT+LLSGPIPEEIGNCSEL+NLYL+QNSISG IP +IG L KLK
Sbjct: 241 LPSSIKMLKRINTIAIYTTLLSGPIPEEIGNCSELENLYLHQNSISGSIPSQIGELGKLK 300
Query: 299 SLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGT 358
SLLLWQN++VG IP+ELGSCTE+ V+D S+NLLTGSIPRSFGNL LQELQLSVNQLSG
Sbjct: 301 SLLLWQNNIVGTIPEELGSCTEIEVIDLSENLLTGSIPRSFGNLSNLQELQLSVNQLSGI 360
Query: 359 IPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQ 418
IP EI+ CT+L LE+DNNA+SGEIP IGN+ LTLFFAWKNKLTGNIP+SLS+CQEL+
Sbjct: 361 IPPEISNCTSLNQLELDNNALSGEIPDLIGNLKDLTLFFAWKNKLTGNIPDSLSECQELE 420
Query: 419 ALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGT 478
A+D SYNNL GPIPK++FGLRNLTKLLLL NDLSGFIPPDIGNCT+L RLRLN NRL+G+
Sbjct: 421 AIDLSYNNLIGPIPKQLFGLRNLTKLLLLFNDLSGFIPPDIGNCTSLYRLRLNHNRLAGS 480
Query: 479 IPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLV 538
IP E+GNLK LNF+DMS NHL G IPP++ GCQ+LEFLDLHSN +TGSVPD+LP SLQL+
Sbjct: 481 IPPEIGNLKSLNFMDMSSNHLSGEIPPTLYGCQNLEFLDLHSNSITGSVPDSLPKSLQLI 540
Query: 539 DLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIP 598
DLSDNRL+G+L+H+IGSL EL+KL L NQLSGRIP+EILSC KL LLD+G+N F+GEIP
Sbjct: 541 DLSDNRLTGALSHTIGSLVELTKLNLGNNQLSGRIPSEILSCTKLQLLDLGSNSFNGEIP 600
Query: 599 KELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSL 658
E+G I SL ISLNLS NQFSG IPS+FS LTKLG+LDLSHNKLSG+LDAL+ L+NLVSL
Sbjct: 601 NEVGLIPSLAISLNLSCNQFSGRIPSQFSSLTKLGVLDLSHNKLSGNLDALSDLENLVSL 660
Query: 659 NVSFNDFSGELPNTPFFRKLPLSDLASNRGLYISGGVVSPTDSLPAGQARSAMKLVMSIL 718
NVSFN SGELPNT FF KLPLSDLA N+GLYI+GGV +P D G RSAMK +MSIL
Sbjct: 661 NVSFNGLSGELPNTLFFHKLPLSDLAENQGLYIAGGVATPGD---KGHVRSAMKFIMSIL 717
Query: 719 VSASAVLVLLAIYVLVRTRMANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGS 778
+S SAVLVLL +YVLVRT MAN ++TWEMTLYQKLDFSIDD+V NLTSANVIGTGS
Sbjct: 718 LSTSAVLVLLTVYVLVRTHMANKVLMENETWEMTLYQKLDFSIDDIVMNLTSANVIGTGS 777
Query: 779 SGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838
SGVVY+VTIPNGETLAVKKMW ++ESGAF+SEIQTLGSIRHKNI+RLLGWGSNK+LKLLF
Sbjct: 778 SGVVYKVTIPNGETLAVKKMWLAEESGAFNSEIQTLGSIRHKNIIRLLGWGSNKSLKLLF 837
Query: 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL 898
YDYLPNGSLSSLLHG+GKG A+WE RY+ +LGVAHALAYLHHDC+P I+HGDVKAMNVLL
Sbjct: 838 YDYLPNGSLSSLLHGSGKGKAEWETRYDAILGVAHALAYLHHDCLPAIIHGDVKAMNVLL 897
Query: 899 GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSF 958
GPG+Q YLADFGLAR + +G + SK QR LAGSYGYMAPEHAS+Q ITEKSDVYSF
Sbjct: 898 GPGHQPYLADFGLARTATENGCNTDSKPLQRHYLAGSYGYMAPEHASLQPITEKSDVYSF 957
Query: 959 GVVLLEVLTGRHPLDPTLPGGAPLVQWT 986
G+VLLEVLTGRHPLDPTLPGGA LVQW
Sbjct: 958 GMVLLEVLTGRHPLDPTLPGGAHLVQWV 985
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255582798|ref|XP_002532173.1| receptor protein kinase, putative [Ricinus communis] gi|223528141|gb|EEF30210.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1442 bits (3733), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 724/990 (73%), Positives = 823/990 (83%), Gaps = 48/990 (4%)
Query: 1 MPAALRHLLFSQNI--FSFTLLLISINFLFFSTC-DALDEQGQALLTWKNSLNSSTDALS 57
MPA L +L S NI FSFT L SINF+F +C ++DEQGQ LL WKNSLNSS D L+
Sbjct: 1 MPATLSNLFLSHNICSFSFTFFL-SINFVFLHSCYSSIDEQGQVLLAWKNSLNSSADELA 59
Query: 58 SWNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGT 117
SWNP +++PCKW G+HC+SNG V EISLKAVDLQ G+
Sbjct: 60 SWNPLDSTPCKWVGVHCNSNGMVTEISLKAVDLQ------------------------GS 95
Query: 118 IPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLA 177
+P F + L + LS +L G IP E R+L + L+ N L GEIP +I L L
Sbjct: 96 LPSNFQSLKFLKTLVLSSANLTGNIPKEFGEYRELSLIDLSDNSLSGEIPVEICRLKKLQ 155
Query: 178 YLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISG 237
L+L N F GGN+NLKGELP EIGNC+NLV+LGLAETSISG
Sbjct: 156 SLSLNTN------------------FLEGGNKNLKGELPLEIGNCTNLVVLGLAETSISG 197
Query: 238 NVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKL 297
++PSSIG L+RIQT+AIYTSLLSGPIPEEIG+CSELQNLYLYQNS+SG IP RIG L+KL
Sbjct: 198 SLPSSIGKLKRIQTLAIYTSLLSGPIPEEIGDCSELQNLYLYQNSLSGSIPKRIGELTKL 257
Query: 298 KSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSG 357
+SLLLWQNSLVG IPDELGSC ELTV+DFS NLLTG+IPRS GNLLKLQELQLSVNQL+G
Sbjct: 258 QSLLLWQNSLVGTIPDELGSCAELTVIDFSVNLLTGTIPRSLGNLLKLQELQLSVNQLTG 317
Query: 358 TIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQEL 417
TIP+EI CTALTHLE+DNNAISGEIPA IGN+N LTLFFAW+N LTGN+P+SLS CQ L
Sbjct: 318 TIPVEITNCTALTHLEVDNNAISGEIPASIGNLNSLTLFFAWQNNLTGNVPDSLSNCQNL 377
Query: 418 QALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSG 477
QA+D SYN+L G IPK+IFGL+NLTKLLL+SNDLSGFIPPDIGNCT L RLRL+ NRL+G
Sbjct: 378 QAVDLSYNHLFGSIPKQIFGLQNLTKLLLISNDLSGFIPPDIGNCTNLYRLRLSRNRLAG 437
Query: 478 TIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQL 537
TIPSE+GNLK LNF+D+S NH +GGIPPS+ GCQ+LEFLDLHSNG+TGS+PDTLP SLQ
Sbjct: 438 TIPSEIGNLKSLNFIDLSNNHFIGGIPPSISGCQNLEFLDLHSNGITGSLPDTLPESLQF 497
Query: 538 VDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEI 597
VD+SDNRL+G L HSIG LTEL+KL+L++NQLSGRIPAEILSC KL LL++G+N FSG+I
Sbjct: 498 VDVSDNRLAGPLTHSIGLLTELTKLVLARNQLSGRIPAEILSCSKLQLLNLGDNGFSGDI 557
Query: 598 PKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVS 657
PKELGQI +LEISLNLSSNQFSG IPSEFSGL+KL +LDLSHNKL G LD LA LQNLVS
Sbjct: 558 PKELGQIPALEISLNLSSNQFSGVIPSEFSGLSKLAVLDLSHNKLKGKLDVLADLQNLVS 617
Query: 658 LNVSFNDFSGELPNTPFFRKLPLSDLASNRGLYISGGVVSPTDSL-PAGQARSAMKLVMS 716
LNVSFNDFSGE PNTPFFRKLPLSDLASN+GL+IS G V+P D+L PA Q RSAMKL+MS
Sbjct: 618 LNVSFNDFSGEWPNTPFFRKLPLSDLASNQGLHIS-GTVTPVDTLGPASQTRSAMKLLMS 676
Query: 717 ILVSASAVLVLLAIYVLVRTRMANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGT 776
+L+SASAVLVLLAIY+L+R RMANN D W+MTLYQKLDFSI+D+VRNLTS+NVIGT
Sbjct: 677 VLLSASAVLVLLAIYMLIRVRMANNGLMEDYNWQMTLYQKLDFSIEDIVRNLTSSNVIGT 736
Query: 777 GSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836
GSSGVVY+VTIPNG+TLAVKKMWSS+ESGAFSSEIQTLGSIRH+NIVRLLGW SN+NLKL
Sbjct: 737 GSSGVVYKVTIPNGDTLAVKKMWSSEESGAFSSEIQTLGSIRHRNIVRLLGWASNRNLKL 796
Query: 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNV 896
LFYDYLPNGSLSSLLHGA KGGA+WE RY++VLGVAHALAYLHHDC+P ILHGDVKAMNV
Sbjct: 797 LFYDYLPNGSLSSLLHGAAKGGAEWETRYDIVLGVAHALAYLHHDCVPAILHGDVKAMNV 856
Query: 897 LLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVY 956
L+GPGY+ YLADFGLAR+V+ + D+ +K +QRP LAGSYGYMAPEHASMQRI EKSDVY
Sbjct: 857 LIGPGYEPYLADFGLARVVNSNFTDDVAKPSQRPHLAGSYGYMAPEHASMQRINEKSDVY 916
Query: 957 SFGVVLLEVLTGRHPLDPTLPGGAPLVQWT 986
SFGVVLLEVLTGRHPLDPTLPGGAPLVQW
Sbjct: 917 SFGVVLLEVLTGRHPLDPTLPGGAPLVQWV 946
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356553486|ref|XP_003545087.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g26540-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1441 bits (3731), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 712/958 (74%), Positives = 831/958 (86%), Gaps = 1/958 (0%)
Query: 29 FSTCDALDEQGQALLTWKNSLNSSTDALSSWNPAETSPCKWFGIHCSSNGEVVEISLKAV 88
F C +L+EQGQALL WKNSLNS++DAL+SWNP+ SPC WFG+ C+ GEVVE++LK+V
Sbjct: 28 FPCCYSLNEQGQALLAWKNSLNSTSDALASWNPSNPSPCNWFGVQCNLQGEVVEVNLKSV 87
Query: 89 DLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCR 148
+LQGSLP FQPL+SLK L++S+ N+TG IPKE GDY+EL IDLSGNSL+GEIP E+CR
Sbjct: 88 NLQGSLPLNFQPLRSLKTLVLSTTNITGMIPKEIGDYKELIVIDLSGNSLFGEIPEEICR 147
Query: 149 LRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGN 208
L KL++L L+ N LEG IPS+IGNLSSL LTLYDN++SG+IPKSIG+L++LQV R GGN
Sbjct: 148 LSKLQTLALHANFLEGNIPSNIGNLSSLVNLTLYDNKVSGEIPKSIGSLTELQVLRVGGN 207
Query: 209 QNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIG 268
NLKGE+PW+IGNC+NL++LGLAETSISG++PSSIGML++IQTIAIYT+ LSGPIPEEIG
Sbjct: 208 TNLKGEVPWDIGNCTNLLVLGLAETSISGSLPSSIGMLKKIQTIAIYTTQLSGPIPEEIG 267
Query: 269 NCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSD 328
CSELQNLYLYQNSISG IP +IG LSKL++LLLWQN++VG IP+ELGSCT+L V+D S+
Sbjct: 268 KCSELQNLYLYQNSISGSIPIQIGELSKLQNLLLWQNNIVGIIPEELGSCTQLEVIDLSE 327
Query: 329 NLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIG 388
NLLTGSIP SFG L LQ LQLSVN+LSG IP EI CT+LT LE+DNNAI GE+P IG
Sbjct: 328 NLLTGSIPTSFGKLSNLQGLQLSVNKLSGIIPPEITNCTSLTQLEVDNNAIFGEVPPLIG 387
Query: 389 NINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLS 448
N+ LTLFFAW+NKLTG IP+SLSQCQ+LQALD SYNNL+GPIPK++FGLRNLTKLLLLS
Sbjct: 388 NLRSLTLFFAWQNKLTGKIPDSLSQCQDLQALDLSYNNLNGPIPKQLFGLRNLTKLLLLS 447
Query: 449 NDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVV 508
NDLSGFIPP+IGNCT+L RLRLN NRL+GTIPSE+ NLK+LNF+D+S NHL+G IP ++
Sbjct: 448 NDLSGFIPPEIGNCTSLYRLRLNHNRLAGTIPSEITNLKNLNFLDVSSNHLIGEIPSTLS 507
Query: 509 GCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQ 568
CQ+LEFLDLHSN L GS+P+ LP +LQL DLSDNRL+G L+HSIGSLTEL+KL L KNQ
Sbjct: 508 RCQNLEFLDLHSNSLIGSIPENLPKNLQLTDLSDNRLTGELSHSIGSLTELTKLNLGKNQ 567
Query: 569 LSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSG 628
LSG IPAEILSC KL LLD+G+N FSGEIPKE+ QI SLEI LNLS NQFSGEIP++FS
Sbjct: 568 LSGSIPAEILSCSKLQLLDLGSNSFSGEIPKEVAQIPSLEIFLNLSCNQFSGEIPTQFSS 627
Query: 629 LTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRG 688
L KLG+LDLSHNKLSG+LDAL LQNLVSLNVSFNDFSGELPNTPFFRKLPL+DL N G
Sbjct: 628 LRKLGVLDLSHNKLSGNLDALFDLQNLVSLNVSFNDFSGELPNTPFFRKLPLNDLTGNDG 687
Query: 689 LYISGGVVSPTDSLPA-GQARSAMKLVMSILVSASAVLVLLAIYVLVRTRMANNSFTADD 747
LYI GGV +P D A G AR MK+++S L+ SA+LVLL I+VL+R +AN + ++
Sbjct: 688 LYIVGGVATPADRKEAKGHARLVMKIIISTLLCTSAILVLLMIHVLIRAHVANKALNGNN 747
Query: 748 TWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAF 807
W +TLYQK +FS+DD+VRNLTS+NVIGTGSSGVVY+VT+PNG+ LAVKKMWSS ESGAF
Sbjct: 748 NWLITLYQKFEFSVDDIVRNLTSSNVIGTGSSGVVYKVTVPNGQILAVKKMWSSAESGAF 807
Query: 808 SSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEV 867
+SEIQ LGSIRHKNI++LLGWGS+KN+KLLFY+YLPNGSLSSL+HG+GKG +WE RY+V
Sbjct: 808 TSEIQALGSIRHKNIIKLLGWGSSKNMKLLFYEYLPNGSLSSLIHGSGKGKPEWETRYDV 867
Query: 868 VLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTN 927
+LGVAHALAYLHHDC+P ILHGDVKAMNVLLGP YQ YLADFGLARI S +GD S+
Sbjct: 868 MLGVAHALAYLHHDCVPSILHGDVKAMNVLLGPSYQPYLADFGLARIASENGDYTNSEPV 927
Query: 928 QRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQW 985
QRP LAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGA LV W
Sbjct: 928 QRPYLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAHLVPW 985
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356566347|ref|XP_003551394.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g26540-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1388 bits (3593), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 714/941 (75%), Positives = 823/941 (87%), Gaps = 3/941 (0%)
Query: 1 MPAALRHLLFSQNIFSFTLLLISINFLFFSTCDALDEQGQALLTWKNSLNSSTDALSSWN 60
MP +LR+L S IFSFTLLL + LFF C +LDEQGQAL+ WKNSLN ++D L+SWN
Sbjct: 1 MPGSLRNLSLSPKIFSFTLLLSLNSLLFFPCCYSLDEQGQALIAWKNSLNITSDVLASWN 60
Query: 61 PAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPK 120
P+ +SPC WFG++C+S GEV+EISLK+V+LQGSLPS FQPL+SLK L++SS NLTG+IPK
Sbjct: 61 PSASSPCNWFGVYCNSQGEVIEISLKSVNLQGSLPSNFQPLRSLKILVLSSTNLTGSIPK 120
Query: 121 EFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLT 180
E GDY EL F+DLSGNSL+GEIP E+C LRKL+SL L+TN L+G IPS+IGNL+SL LT
Sbjct: 121 EIGDYVELIFVDLSGNSLFGEIPEEICSLRKLQSLSLHTNFLQGNIPSNIGNLTSLVNLT 180
Query: 181 LYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVP 240
LYDN LSG+IPKSIG+L KLQVFRAGGN+NLKGE+PWEIG+C+NLVMLGLAETSISG++P
Sbjct: 181 LYDNHLSGEIPKSIGSLRKLQVFRAGGNKNLKGEIPWEIGSCTNLVMLGLAETSISGSLP 240
Query: 241 SSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSL 300
SI ML+ I+TIAIYT+LLSGPIPEEIGNCSELQNLYL+QNSISG IP +IG LSKLKSL
Sbjct: 241 YSIKMLKNIKTIAIYTTLLSGPIPEEIGNCSELQNLYLHQNSISGSIPSQIGELSKLKSL 300
Query: 301 LLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIP 360
LLWQN++VG IP+ELGSCTE+ V+D S+NLLTGSIPRSFGNL LQELQLSVNQLSG IP
Sbjct: 301 LLWQNNIVGTIPEELGSCTEIKVIDLSENLLTGSIPRSFGNLSNLQELQLSVNQLSGIIP 360
Query: 361 IEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQAL 420
EI+ CT+L LE+DNNA+SGEIP IGN+ LTLFFAWKNKLTGNIP+SLS+CQEL+A+
Sbjct: 361 PEISNCTSLNQLELDNNALSGEIPDLIGNMKDLTLFFAWKNKLTGNIPDSLSECQELEAI 420
Query: 421 DFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIP 480
D SYNNL GPIPK++FGLRNLTKLLLLSNDLSGFIPPDIGNCT+L RLRLN NRL+G IP
Sbjct: 421 DLSYNNLIGPIPKQLFGLRNLTKLLLLSNDLSGFIPPDIGNCTSLYRLRLNHNRLAGHIP 480
Query: 481 SEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDL 540
E+GNLK LNF+D+S NHL G IPP++ GCQ+LEFLDLHSN L+GSV D+LP SLQL+DL
Sbjct: 481 PEIGNLKSLNFMDLSSNHLYGEIPPTLSGCQNLEFLDLHSNSLSGSVSDSLPKSLQLIDL 540
Query: 541 SDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKE 600
SDNRL+G+L+H+IGSL EL+KL L NQLSGRIP+EILSC KL LLD+G+N F+GEIP E
Sbjct: 541 SDNRLTGALSHTIGSLVELTKLNLGNNQLSGRIPSEILSCSKLQLLDLGSNSFNGEIPNE 600
Query: 601 LGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNV 660
+G I SL ISLNLS NQFSG+IP + S LTKLG+LDLSHNKLSG+LDAL+ L+NLVSLNV
Sbjct: 601 VGLIPSLAISLNLSCNQFSGKIPPQLSSLTKLGVLDLSHNKLSGNLDALSDLENLVSLNV 660
Query: 661 SFNDFSGELPNTPFFRKLPLSDLASNRGLYISGGVVSPTDSLPAGQARSAMKLVMSILVS 720
SFN SGELPNT FF LPLS+LA N+GLYI+GGVV+P D G ARSAMK +MSIL+S
Sbjct: 661 SFNGLSGELPNTLFFHNLPLSNLAENQGLYIAGGVVTPGD---KGHARSAMKFIMSILLS 717
Query: 721 ASAVLVLLAIYVLVRTRMANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSG 780
SAVLVLL IYVLVRT MA+ ++TWEMTLYQKLDFSIDD+V NLTSANVIGTGSSG
Sbjct: 718 TSAVLVLLTIYVLVRTHMASKVLMENETWEMTLYQKLDFSIDDIVMNLTSANVIGTGSSG 777
Query: 781 VVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840
VVY+VTIPNGETLAVKKMWSS+ESGAF+SEIQTLGSIRHKNI+RLLGWGSNKNLKLLFYD
Sbjct: 778 VVYKVTIPNGETLAVKKMWSSEESGAFNSEIQTLGSIRHKNIIRLLGWGSNKNLKLLFYD 837
Query: 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP 900
YLPNGSLSSLL+G+GKG A+WE RY+V+LGVAHALAYLHHDC+P I+HGDVKAMNVLLGP
Sbjct: 838 YLPNGSLSSLLYGSGKGKAEWETRYDVILGVAHALAYLHHDCLPAIIHGDVKAMNVLLGP 897
Query: 901 GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAP 941
GYQ YLADFGLAR + +GD+ SK QR LAGSYGYMAP
Sbjct: 898 GYQPYLADFGLARTATENGDNTDSKPLQRHYLAGSYGYMAP 938
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79330883|ref|NP_001032080.1| leucine-rich receptor-like protein kinase [Arabidopsis thaliana] gi|332009331|gb|AED96714.1| leucine-rich receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1347 bits (3485), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 680/960 (70%), Positives = 802/960 (83%), Gaps = 9/960 (0%)
Query: 32 CDALDEQGQALLTWKNSLNSSTDALSSWNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQ 91
C ++DEQG ALL+WK+ LN S DALSSW +E++PC+W GI C+ G+V EI L+ +D Q
Sbjct: 25 CFSIDEQGLALLSWKSQLNISGDALSSWKASESNPCQWVGIKCNERGQVSEIQLQVMDFQ 84
Query: 92 GSLPSI-FQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLR 150
G LP+ + +KSL L ++S NLTG+IPKE GD EL +DL+ NSL GEIP ++ +L+
Sbjct: 85 GPLPATNLRQIKSLTLLSLTSVNLTGSIPKELGDLSELEVLDLADNSLSGEIPVDIFKLK 144
Query: 151 KLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQN 210
KL+ L LNTN LEG IPS++GNL +L LTL+DN+L+G+IP++IG L L++FRAGGN+N
Sbjct: 145 KLKILSLNTNNLEGVIPSELGNLVNLIELTLFDNKLAGEIPRTIGELKNLEIFRAGGNKN 204
Query: 211 LKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNC 270
L+GELPWEIGNC +LV LGLAETS+SG +P+SIG L+++QTIA+YTSLLSGPIP+EIGNC
Sbjct: 205 LRGELPWEIGNCESLVTLGLAETSLSGRLPASIGNLKKVQTIALYTSLLSGPIPDEIGNC 264
Query: 271 SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNL 330
+ELQNLYLYQNSISG IP +G L KL+SLLLWQN+LVG IP ELG+C EL +VD S+NL
Sbjct: 265 TELQNLYLYQNSISGSIPVSMGRLKKLQSLLLWQNNLVGKIPTELGTCPELFLVDLSENL 324
Query: 331 LTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNI 390
LTG+IPRSFGNL LQELQLSVNQLSGTIP E+A CT LTHLEIDNN ISGEIP IG +
Sbjct: 325 LTGNIPRSFGNLPNLQELQLSVNQLSGTIPEELANCTKLTHLEIDNNQISGEIPPLIGKL 384
Query: 391 NGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSND 450
LT+FFAW+N+LTG IPESLSQCQELQA+D SYNNLSG IP IF +RNLTKLLLLSN
Sbjct: 385 TSLTMFFAWQNQLTGIIPESLSQCQELQAIDLSYNNLSGSIPNGIFEIRNLTKLLLLSNY 444
Query: 451 LSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGC 510
LSGFIPPDIGNCT L RLRLN NRL+G IP+E+GNLK+LNF+D+SEN L+G IPP + GC
Sbjct: 445 LSGFIPPDIGNCTNLYRLRLNGNRLAGNIPAEIGNLKNLNFIDISENRLIGNIPPEISGC 504
Query: 511 QSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLS 570
SLEF+DLHSNGLTG +P TLP SLQ +DLSDN L+GSL IGSLTEL+KL L+KN+ S
Sbjct: 505 TSLEFVDLHSNGLTGGLPGTLPKSLQFIDLSDNSLTGSLPTGIGSLTELTKLNLAKNRFS 564
Query: 571 GRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLT 630
G IP EI SCR L LL++G+N F+GEIP ELG+I SL ISLNLS N F+GEIPS FS LT
Sbjct: 565 GEIPREISSCRSLQLLNLGDNGFTGEIPNELGRIPSLAISLNLSCNHFTGEIPSRFSSLT 624
Query: 631 KLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRGLY 690
LG LD+SHNKL+G+L+ LA LQNLVSLN+SFN+FSGELPNT FFRKLPLS L SN+GL+
Sbjct: 625 NLGTLDVSHNKLAGNLNVLADLQNLVSLNISFNEFSGELPNTLFFRKLPLSVLESNKGLF 684
Query: 691 ISGGVVSPTDSLPAGQARSAMKLVMSILVSASAVLVLLAIYVLVRTRMANNSFTADDTWE 750
IS P + + + RSA+K+ MSILV+AS VLVL+A+Y LV+ + D+WE
Sbjct: 685 IS---TRPENGIQT-RHRSAVKVTMSILVAASVVLVLMAVYTLVKAQRITGKQEELDSWE 740
Query: 751 MTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSE 810
+TLYQKLDFSIDD+V+NLTSANVIGTGSSGVVYRVTIP+GETLAVKKMWS +E+ AF+SE
Sbjct: 741 VTLYQKLDFSIDDIVKNLTSANVIGTGSSGVVYRVTIPSGETLAVKKMWSKEENRAFNSE 800
Query: 811 IQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGK--GGADWEARYEVV 868
I TLGSIRH+NI+RLLGW SN+NLKLLFYDYLPNGSLSSLLHGAGK GGADWEARY+VV
Sbjct: 801 INTLGSIRHRNIIRLLGWCSNRNLKLLFYDYLPNGSLSSLLHGAGKGSGGADWEARYDVV 860
Query: 869 LGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG--DDNCSKT 926
LGVAHALAYLHHDC+PPILHGDVKAMNVLLG +++YLADFGLA+IVSG G D + SK
Sbjct: 861 LGVAHALAYLHHDCLPPILHGDVKAMNVLLGSRFESYLADFGLAKIVSGEGVTDGDSSKL 920
Query: 927 NQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWT 986
+ RP LAGSYGYMAPEHASMQ ITEKSDVYS+GVVLLEVLTG+HPLDP LPGGA LVQW
Sbjct: 921 SNRPPLAGSYGYMAPEHASMQHITEKSDVYSYGVVLLEVLTGKHPLDPDLPGGAHLVQWV 980
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1001 | ||||||
| TAIR|locus:2131518 | 1091 | AT4G26540 [Arabidopsis thalian | 0.950 | 0.871 | 0.662 | 0.0 | |
| TAIR|locus:2161825 | 1090 | AT5G56040 [Arabidopsis thalian | 0.949 | 0.871 | 0.654 | 0.0 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.651 | 0.571 | 0.462 | 6.6e-232 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.758 | 0.668 | 0.420 | 3.6e-231 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.636 | 0.566 | 0.351 | 1.9e-153 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.634 | 0.576 | 0.352 | 9.3e-152 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.642 | 0.514 | 0.340 | 3.3e-145 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.640 | 0.511 | 0.337 | 2.8e-142 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.658 | 0.588 | 0.333 | 2.8e-137 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.882 | 0.801 | 0.343 | 1.2e-131 |
| TAIR|locus:2131518 AT4G26540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3259 (1152.3 bits), Expect = 0., P = 0.
Identities = 637/962 (66%), Positives = 747/962 (77%)
Query: 32 CDALDEQGQALLTWKNSLNSSTDALSSWNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQ 91
C +LD+QGQALL+WK+ LN S DA SSW+ A+TSPC W G+ C+ GEV EI LK +DLQ
Sbjct: 22 CFSLDQQGQALLSWKSQLNISGDAFSSWHVADTSPCNWVGVKCNRRGEVSEIQLKGMDLQ 81
Query: 92 GSLP-SIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLR 150
GSLP + + LKSL L +SS NLTG IPKE GD+ EL +DLS NSL G+IP E+ RL+
Sbjct: 82 GSLPVTSLRSLKSLTSLTLSSLNLTGVIPKEIGDFTELELLDLSDNSLSGDIPVEIFRLK 141
Query: 151 KLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQN 210
KL++L LNTN LEG IP +IGNLS L L L+DN+LSG+IP+SIG L LQV RAGGN+N
Sbjct: 142 KLKTLSLNTNNLEGHIPMEIGNLSGLVELMLFDNKLSGEIPRSIGELKNLQVLRAGGNKN 201
Query: 211 LKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNC 270
L+GELPWEIGNC NLVMLGLAETS+SG +P+SIG L+R+QTIAIYTSLLSGPIP+EIG C
Sbjct: 202 LRGELPWEIGNCENLVMLGLAETSLSGKLPASIGNLKRVQTIAIYTSLLSGPIPDEIGYC 261
Query: 271 SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNL 330
+ELQNLYLYQNSISG IP IG L KL+SLLLWQN+LVG IP ELG+C EL ++DFS+NL
Sbjct: 262 TELQNLYLYQNSISGSIPTTIGGLKKLQSLLLWQNNLVGKIPTELGNCPELWLIDFSENL 321
Query: 331 LTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNI 390
LTG+IPRSFG L LQELQLSVNQ+SGTIP E+ CT LTHLEIDNN I+GEIP+ + N+
Sbjct: 322 LTGTIPRSFGKLENLQELQLSVNQISGTIPEELTNCTKLTHLEIDNNLITGEIPSLMSNL 381
Query: 391 NGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGXXXXXXXXXXXXX 450
LT+FFAW+NKLTGNIP+SLSQC+ELQA+D SYN+LSG IPKEIFG
Sbjct: 382 RSLTMFFAWQNKLTGNIPQSLSQCRELQAIDLSYNSLSGSIPKEIFGLRNLTKLLLLSND 441
Query: 451 XXGFIPPDIGNCTTXXXXXXXXXXXSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGC 510
GFIPPDIGNCT +G+IPSE+GNLK+LNFVD+SEN LVG IPP++ GC
Sbjct: 442 LSGFIPPDIGNCTNLYRLRLNGNRLAGSIPSEIGNLKNLNFVDISENRLVGSIPPAISGC 501
Query: 511 QSLEFLDLHSNGLTGSV-PDTLPTSLQLVDLSDNRLSGSLAHSIGSLTEXXXXXXXXNQL 569
+SLEFLDLH+N L+GS+ TLP SL+ +D SDN LS +L IG LTE N+L
Sbjct: 502 ESLEFLDLHTNSLSGSLLGTTLPKSLKFIDFSDNALSSTLPPGIGLLTELTKLNLAKNRL 561
Query: 570 SGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQXXXXXXXXXXXXXQFSGEIPSEFSGL 629
SG IP EI +CR L LL++G N FSGEIP ELGQ +F GEIPS FS L
Sbjct: 562 SGEIPREISTCRSLQLLNLGENDFSGEIPDELGQIPSLAISLNLSCNRFVGEIPSRFSDL 621
Query: 630 TKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRGL 689
LG+LD+SHN+L+G+L+ L LQNLVSLN+S+NDFSG+LPNTPFFR+LPLSDLASNRGL
Sbjct: 622 KNLGVLDVSHNQLTGNLNVLTDLQNLVSLNISYNDFSGDLPNTPFFRRLPLSDLASNRGL 681
Query: 690 YISGGVVSPTDSLPAGQARSAMKXXXXXXXXXXXXXXXXXXXXXXRTRMANNSFTAD--D 747
YIS + + D P + S ++ R R A + D
Sbjct: 682 YISNAISTRPD--PTTRNSSVVRLTILILVVVTAVLVLMAVYTLVRARAAGKQLLGEEID 739
Query: 748 TWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAF 807
+WE+TLYQKLDFSIDD+V+NLTSANVIGTGSSGVVYR+TIP+GE+LAVKKMWS +ESGAF
Sbjct: 740 SWEVTLYQKLDFSIDDIVKNLTSANVIGTGSSGVVYRITIPSGESLAVKKMWSKEESGAF 799
Query: 808 SSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGA-DWEARYE 866
+SEI+TLGSIRH+NIVRLLGW SN+NLKLLFYDYLPNGSLSS LHGAGKGG DWEARY+
Sbjct: 800 NSEIKTLGSIRHRNIVRLLGWCSNRNLKLLFYDYLPNGSLSSRLHGAGKGGCVDWEARYD 859
Query: 867 VVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG---SGDDNC 923
VVLGVAHALAYLHHDC+P I+HGDVKAMNVLLGP ++ YLADFGLAR +SG +G D
Sbjct: 860 VVLGVAHALAYLHHDCLPTIIHGDVKAMNVLLGPHFEPYLADFGLARTISGYPNTGIDLA 919
Query: 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLV 983
TN RP +AGSYGYMAPEHASMQRITEKSDVYS+GVVLLEVLTG+HPLDP LPGGA LV
Sbjct: 920 KPTN-RPPMAGSYGYMAPEHASMQRITEKSDVYSYGVVLLEVLTGKHPLDPDLPGGAHLV 978
Query: 984 QW 985
+W
Sbjct: 979 KW 980
|
|
| TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3219 (1138.2 bits), Expect = 0., P = 0.
Identities = 628/959 (65%), Positives = 743/959 (77%)
Query: 32 CDALDEQGQALLTWKNSLNSSTDALSSWNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQ 91
C ++DEQG ALL+WK+ LN S DALSSW +E++PC+W GI C+ G+V EI L+ +D Q
Sbjct: 25 CFSIDEQGLALLSWKSQLNISGDALSSWKASESNPCQWVGIKCNERGQVSEIQLQVMDFQ 84
Query: 92 GSLPSI-FQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLR 150
G LP+ + +KSL L ++S NLTG+IPKE GD EL +DL+ NSL GEIP ++ +L+
Sbjct: 85 GPLPATNLRQIKSLTLLSLTSVNLTGSIPKELGDLSELEVLDLADNSLSGEIPVDIFKLK 144
Query: 151 KLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQN 210
KL+ L LNTN LEG IPS++GNL +L LTL+DN+L+G+IP++IG L L++FRAGGN+N
Sbjct: 145 KLKILSLNTNNLEGVIPSELGNLVNLIELTLFDNKLAGEIPRTIGELKNLEIFRAGGNKN 204
Query: 211 LKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNC 270
L+GELPWEIGNC +LV LGLAETS+SG +P+SIG L+++QTIA+YTSLLSGPIP+EIGNC
Sbjct: 205 LRGELPWEIGNCESLVTLGLAETSLSGRLPASIGNLKKVQTIALYTSLLSGPIPDEIGNC 264
Query: 271 SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNL 330
+ELQNLYLYQNSISG IP +G L KL+SLLLWQN+LVG IP ELG+C EL +VD S+NL
Sbjct: 265 TELQNLYLYQNSISGSIPVSMGRLKKLQSLLLWQNNLVGKIPTELGTCPELFLVDLSENL 324
Query: 331 LTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNI 390
LTG+IPRSFGNL LQELQLSVNQLSGTIP E+A CT LTHLEIDNN ISGEIP IG +
Sbjct: 325 LTGNIPRSFGNLPNLQELQLSVNQLSGTIPEELANCTKLTHLEIDNNQISGEIPPLIGKL 384
Query: 391 NGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGXXXXXXXXXXXXX 450
LT+FFAW+N+LTG IPESLSQCQELQA+D SYNNLSG IP IF
Sbjct: 385 TSLTMFFAWQNQLTGIIPESLSQCQELQAIDLSYNNLSGSIPNGIFEIRNLTKLLLLSNY 444
Query: 451 XXGFIPPDIGNCTTXXXXXXXXXXXSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGC 510
GFIPPDIGNCT +G IP+E+GNLK+LNF+D+SEN L+G IPP + GC
Sbjct: 445 LSGFIPPDIGNCTNLYRLRLNGNRLAGNIPAEIGNLKNLNFIDISENRLIGNIPPEISGC 504
Query: 511 QSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTEXXXXXXXXNQLS 570
SLEF+DLHSNGLTG +P TLP SLQ +DLSDN L+GSL IGSLTE N+ S
Sbjct: 505 TSLEFVDLHSNGLTGGLPGTLPKSLQFIDLSDNSLTGSLPTGIGSLTELTKLNLAKNRFS 564
Query: 571 GRIPAEILSCRKLILLDIGNNRFSGEIPKELGQXXXXXXXXXXXXXQFSGEIPSEFSGLT 630
G IP EI SCR L LL++G+N F+GEIP ELG+ F+GEIPS FS LT
Sbjct: 565 GEIPREISSCRSLQLLNLGDNGFTGEIPNELGRIPSLAISLNLSCNHFTGEIPSRFSSLT 624
Query: 631 KLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRGLY 690
LG LD+SHNKL+G+L+ LA LQNLVSLN+SFN+FSGELPNT FFRKLPLS L SN+GL+
Sbjct: 625 NLGTLDVSHNKLAGNLNVLADLQNLVSLNISFNEFSGELPNTLFFRKLPLSVLESNKGLF 684
Query: 691 ISGGVVSPTDSLPAGQARSAMKXXXXXXXXXXXXXXXXXXXXXXRTRMANNSFTADDTWE 750
IS P + + + RSA+K + + D+WE
Sbjct: 685 IS---TRPENGIQT-RHRSAVKVTMSILVAASVVLVLMAVYTLVKAQRITGKQEELDSWE 740
Query: 751 MTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSE 810
+TLYQKLDFSIDD+V+NLTSANVIGTGSSGVVYRVTIP+GETLAVKKMWS +E+ AF+SE
Sbjct: 741 VTLYQKLDFSIDDIVKNLTSANVIGTGSSGVVYRVTIPSGETLAVKKMWSKEENRAFNSE 800
Query: 811 IQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKG--GADWEARYEVV 868
I TLGSIRH+NI+RLLGW SN+NLKLLFYDYLPNGSLSSLLHGAGKG GADWEARY+VV
Sbjct: 801 INTLGSIRHRNIIRLLGWCSNRNLKLLFYDYLPNGSLSSLLHGAGKGSGGADWEARYDVV 860
Query: 869 LGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG--DDNCSKT 926
LGVAHALAYLHHDC+PPILHGDVKAMNVLLG +++YLADFGLA+IVSG G D + SK
Sbjct: 861 LGVAHALAYLHHDCLPPILHGDVKAMNVLLGSRFESYLADFGLAKIVSGEGVTDGDSSKL 920
Query: 927 NQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQW 985
+ RP LAGSYGYMAPEHASMQ ITEKSDVYS+GVVLLEVLTG+HPLDP LPGGA LVQW
Sbjct: 921 SNRPPLAGSYGYMAPEHASMQHITEKSDVYSYGVVLLEVLTGKHPLDPDLPGGAHLVQW 979
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1551 (551.0 bits), Expect = 6.6e-232, Sum P(2) = 6.6e-232
Identities = 304/657 (46%), Positives = 426/657 (64%)
Query: 38 QGQALLTWKNSLNSSTDALS--SWNPAETSPCK-WFGIHCSSNGEVVEISLKAVDLQGSL 94
+ L +W +S + + +LS +WN + +PC W I CSS G + +I +++V LQ SL
Sbjct: 38 EASILYSWLHSSSPTPSSLSLFNWNSIDNTPCNNWTFITCSSQGFITDIDIESVPLQLSL 97
Query: 95 PSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLES 154
P +SL++L IS NLTGT+P+ GD L +DLS N L G+IP + +LR LE+
Sbjct: 98 PKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLET 157
Query: 155 LYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGE 214
L LN+N L G+IP DI S L L L+DN L+G IP +G LS L+V R GGN+ + G+
Sbjct: 158 LILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQ 217
Query: 215 LPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQ 274
+P EIG+CSNL +LGLAETS+SGN+PSS+G L++++T++IYT+++SG IP ++GNCSEL
Sbjct: 218 IPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELV 277
Query: 275 NLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGS 334
+L+LY+NS+SG IP IG L+KL+ L LWQNSLVG IP+E+G+C+ L ++D S NLL+GS
Sbjct: 278 DLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGS 337
Query: 335 IPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLT 394
IP S G L L+E +S N+ SG+IP I+ C++L L++D N ISG IP+++G + LT
Sbjct: 338 IPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLT 397
Query: 395 LFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGXXXXXXXXXXXXXXXGF 454
LFFAW N+L G+IP L+ C +LQALD S N+L+G IP +F GF
Sbjct: 398 LFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGF 457
Query: 455 IPPDIGNCTTXXXXXXXXXXXSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLE 514
IP +IGNC++ +G IPS +G+LK +NF+D S N L G +P + C L+
Sbjct: 458 IPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQ 517
Query: 515 FLDLHSNGLTGSVPDTLPT--SLQLVDLSDNRLSGSLAHSIGSLTEXXXXXXXXNQLSGR 572
+DL +N L GS+P+ + + LQ++D+S N+ SG + S+G L N SG
Sbjct: 518 MIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGS 577
Query: 573 IPAEILSCRKLILLDIGNNRFSGEIPKELGQXXXXXXXXXXXXXQFSGEIPSEFSGLTKL 632
IP + C L LLD+G+N SGEIP ELG + +G+IPS+ + L KL
Sbjct: 578 IPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKL 637
Query: 633 GILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRGL 689
ILDLSHN L GDL LA+++NLVSLN+S+N FSG LP+ FR+L DL N+ L
Sbjct: 638 SILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKL 694
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1561 (554.6 bits), Expect = 3.6e-231, Sum P(2) = 3.6e-231
Identities = 326/775 (42%), Positives = 464/775 (59%)
Query: 41 ALLTWKNSLNSSTDAL-SSWNPAETSPCKWFGIHCSS--NGEVVEISLKAVDLQGSLPSI 97
AL++W +S NS ++ S WNP+++ PC+W I CSS N V EI++ +V L P
Sbjct: 42 ALISWLHSSNSPPPSVFSGWNPSDSDPCQWPYITCSSSDNKLVTEINVVSVQLALPFPPN 101
Query: 98 FQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYL 157
SL++L+IS+ NLTG I E GD EL IDLS NSL GEIP+ + +L+ L+ L L
Sbjct: 102 ISSFTSLQKLVISNTNLTGAISSEIGDCSELIVIDLSSNSLVGEIPSSLGKLKNLQELCL 161
Query: 158 NTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPW 217
N+N L G+IP ++G+ SL L ++DN LS +P +G +S L+ RAGGN L G++P
Sbjct: 162 NSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNSELSGKIPE 221
Query: 218 EIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLY 277
EIGNC NL +LGLA T ISG++P S+G L ++Q++++Y+++LSG IP+E+GNCSEL NL+
Sbjct: 222 EIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLF 281
Query: 278 LYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPR 337
LY N +SG +P +G L L+ +LLWQN+L G IP+E+G L +D S N +G+IP+
Sbjct: 282 LYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPK 341
Query: 338 SFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFF 397
SFGNL LQEL LS N ++G+IP ++ CT L +ID N ISG IP +IG + L +F
Sbjct: 342 SFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFL 401
Query: 398 AWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGXXXXXXXXXXXXXXXGFIPP 457
W+NKL GNIP+ L+ CQ LQALD S N L+G +P +F G IP
Sbjct: 402 GWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPL 461
Query: 458 DIGNCTTXXXXXXXXXXXSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLD 517
+IGNCT+ +G IP +G L++L+F+D+SEN+L G +P + C+ L+ L+
Sbjct: 462 EIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLN 521
Query: 518 LHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHSIGSLTEXXXXXXXXNQLSGRIPA 575
L +N L G +P +L T LQ++D+S N L+G + S+G L N +G IP+
Sbjct: 522 LSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPS 581
Query: 576 EILSCRKLILLDIGNNRFSGEIPKELGQXXXXXXXXXXXXXQFSGEIPSEFSGLTKLGIL 635
+ C L LLD+ +N SG IP+EL G IP S L +L +L
Sbjct: 582 SLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVL 641
Query: 636 DLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRGLYISGG- 694
D+SHN LSGDL AL+ L+NLVSLN+S N FSG LP++ FR+L +++ N GL G
Sbjct: 642 DISHNMLSGDLSALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFR 701
Query: 695 --VVSPTDSLPAGQA------RSAMKXXXXXXXXXXXXXXXXXXXXXXRTRMANNSFTAD 746
VS + L + R A+ R N+S T +
Sbjct: 702 SCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGE 761
Query: 747 D--TWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMW 799
+ TW+ T +QKL+F+++ V++ L NVIG G SG+VY+ +PN E +AVKK+W
Sbjct: 762 NLWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGIVYKAEMPNREVIAVKKLW 816
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 999 (356.7 bits), Expect = 1.9e-153, Sum P(2) = 1.9e-153
Identities = 230/654 (35%), Positives = 352/654 (53%)
Query: 33 DALDEQGQALLTWKN-SLNSSTDALSSWNPAETSPCKWFGIHCSSNGE--------VVEI 83
++L+ GQ LL KN S + L +WN + +PC W G++CSS G V +
Sbjct: 31 ESLNSDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSSQGSSSSSNSLVVTSL 90
Query: 84 SLKAVDLQGSL-PSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEI 142
L +++L G + PSI L +L L ++ LTG IP+E G+ +L + L+ N G I
Sbjct: 91 DLSSMNLSGIVSPSI-GGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSI 149
Query: 143 PTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQV 202
P E+ +L +L S + N L G +P +IG+L +L L Y N L+G +P+S+G L+KL
Sbjct: 150 PVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTT 209
Query: 203 FRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGP 262
FRAG N + G +P EIG C NL +LGLA+ ISG +P IGML ++Q + ++ + SG
Sbjct: 210 FRAGQN-DFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGF 268
Query: 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELT 322
IP++IGN + L+ L LY NS+ GPIP IG + LK L L+QN L G IP ELG +++
Sbjct: 269 IPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVM 328
Query: 323 VVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGE 382
+DFS+NLL+G IP + +L+ L L N+L+G IP E++ L L++ N+++G
Sbjct: 329 EIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGP 388
Query: 383 IPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGXXXXX 442
IP N+ + + N L+G IP+ L L +DFS N LSG IP I
Sbjct: 389 IPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLI 448
Query: 443 XXXXXXXXXXGFIPPDIGNCTTXXXXXXXXXXXSGTIPSEMGNLKHLNFVDMSENHLVGG 502
G IPP + C + +G P+E+ L +L+ +++ +N G
Sbjct: 449 LLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGP 508
Query: 503 IPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLV--DLSDNRLSGSLAHSIGSLTEXX 560
+PP + CQ L+ L L +N + ++P+ + LV ++S N L+G + I +
Sbjct: 509 LPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQ 568
Query: 561 XXXXXXNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQXXXXXXXXXXXXXQFSG 620
N G +P E+ S +L +L + NRFSG IP +G FSG
Sbjct: 569 RLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNL-FSG 627
Query: 621 EIPSEFSGLTKLGI-LDLSHNKLSGDLDA-LASLQNLVSLNVSFNDFSGELPNT 672
IP + L+ L I ++LS+N SG++ + +L L+ L+++ N SGE+P T
Sbjct: 628 SIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTT 681
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 984 (351.4 bits), Expect = 9.3e-152, Sum P(2) = 9.3e-152
Identities = 226/641 (35%), Positives = 342/641 (53%)
Query: 34 ALDEQGQALLTWKNSLNSSTDALSSWNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQGS 93
+L+E+G+ LL +K LN S L+SWN +++PC W GI C+ V + L ++L G+
Sbjct: 23 SLNEEGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIACTHLRTVTSVDLNGMNLSGT 82
Query: 94 LPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLE 153
L + L L++L +S+ ++G IP++ R L +DL N G IP ++ + L+
Sbjct: 83 LSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLK 142
Query: 154 SLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKG 213
LYL N L G IP IGNLSSL L +Y N L+G IP S+ L +L++ RAG N G
Sbjct: 143 KLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRN-GFSG 201
Query: 214 ELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSEL 273
+P EI C +L +LGLAE + G++P + L+ + + ++ + LSG IP +GN S L
Sbjct: 202 VIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRL 261
Query: 274 QNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTG 333
+ L L++N +G IP IG L+K+K L L+ N L G IP E+G+ + +DFS+N LTG
Sbjct: 262 EVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTG 321
Query: 334 SIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGL 393
IP+ FG++L L+ L L N L G IP E+ T L L++ N ++G IP ++ + L
Sbjct: 322 FIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYL 381
Query: 394 TLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGXXXXXXXXXXXXXXXG 453
+ N+L G IP + LD S N+LSGPIP G
Sbjct: 382 VDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSG 441
Query: 454 FIPPDIGNCTTXXXXXXXXXXXSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSL 513
IP D+ C + +G++P E+ NL++L +++ +N L G I + ++L
Sbjct: 442 NIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNL 501
Query: 514 EFLDLHSNGLTGSVPDTLPTSLQLV--DLSDNRLSGSLAHSIGSLTEXXXXXXXXNQLSG 571
E L L +N TG +P + ++V ++S N+L+G + +GS N+ SG
Sbjct: 502 ERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSG 561
Query: 572 RIPAEILSCRKLILLDIGNNRFSGEIPKELGQXXXXXXXXXXXXXQFSGEIPSEFSGLTK 631
I E+ L +L + +NR +GEIP G S IP E LT
Sbjct: 562 YIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNL-LSENIPVELGKLTS 620
Query: 632 LGI-LDLSHNKLSGDL-DALASLQNLVSLNVSFNDFSGELP 670
L I L++SHN LSG + D+L +LQ L L ++ N SGE+P
Sbjct: 621 LQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIP 661
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 921 (329.3 bits), Expect = 3.3e-145, Sum P(2) = 3.3e-145
Identities = 225/660 (34%), Positives = 343/660 (51%)
Query: 40 QALLTWKNSLNSST---DALSSWNPAETSPCKWFGIHCSSNG--EVVEISLKAVDLQGSL 94
Q LL K SL ++ D L WN + C W G+ C + G V+ ++L + L GS+
Sbjct: 28 QTLLEVKKSLVTNPQEDDPLRQWNSDNINYCSWTGVTCDNTGLFRVIALNLTGLGLTGSI 87
Query: 95 PSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLES 154
F +L L +SS NL G IP + L + L N L GEIP+++ L + S
Sbjct: 88 SPWFGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQLTGEIPSQLGSLVNIRS 147
Query: 155 LYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGE 214
L + N L G+IP +GNL +L L L +L+G IP +G L ++Q N L+G
Sbjct: 148 LRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLVRVQSLILQDNY-LEGP 206
Query: 215 LPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQ 274
+P E+GNCS+L + AE ++G +P+ +G LE ++ + + + L+G IP ++G S+LQ
Sbjct: 207 IPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQ 266
Query: 275 NLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGS 334
L L N + G IP + L L++L L N+L G IP+E + ++L + ++N L+GS
Sbjct: 267 YLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGS 326
Query: 335 IPRSF-GNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGL 393
+P+S N L++L LS QLSG IP+E++ C +L L++ NN+++G IP + + L
Sbjct: 327 LPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVEL 386
Query: 394 TLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGXXXXXXXXXXXXXXXG 453
T + N L G + S+S LQ L +NNL G +PKEI G
Sbjct: 387 TDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSG 446
Query: 454 FIPPDIGNCTTXXXXXXXXXXXSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSL 513
IP +IGNCT+ G IP +G LK LN + + +N LVGG+P S+ C L
Sbjct: 447 EIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQL 506
Query: 514 EFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHSIGSLTEXXXXXXXXNQLSG 571
LDL N L+GS+P + L+ + L +N L G+L S+ SL N+L+G
Sbjct: 507 NILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNG 566
Query: 572 RIPAEILSCRKLILLDIGNNRFSGEIPKELGQXXXXXXXXXXXXXQFSGEIPSEFSGLTK 631
I + + D+ NN F EIP ELG Q +G+IP + +
Sbjct: 567 TIHP-LCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKN-QLTGKIPWTLGKIRE 624
Query: 632 LGILDLSHNKLSGDLDA-LASLQNLVSLNVSFNDFSGELPNTPFFRKLP-LSDL--ASNR 687
L +LD+S N L+G + L + L ++++ N SG +P P+ KL L +L +SN+
Sbjct: 625 LSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIP--PWLGKLSQLGELKLSSNQ 682
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 893 (319.4 bits), Expect = 2.8e-142, Sum P(2) = 2.8e-142
Identities = 223/660 (33%), Positives = 340/660 (51%)
Query: 40 QALLTWKNSLNSST---DALSSWNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSL-P 95
Q LL KNS ++ D L WN S C W G+ C E++ ++L + L GS+ P
Sbjct: 31 QTLLELKNSFITNPKEEDVLRDWNSGSPSYCNWTGVTCGGR-EIIGLNLSGLGLTGSISP 89
Query: 96 SIFQPLKSLKRLIISSCNLTGTIPKEFGDYRE-LTFIDLSGNSLWGEIPTEVCRLRKLES 154
SI + +L + +SS L G IP + L + L N L G+IP+++ L L+S
Sbjct: 90 SIGR-FNNLIHIDLSSNRLVGPIPTTLSNLSSSLESLHLFSNLLSGDIPSQLGSLVNLKS 148
Query: 155 LYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGE 214
L L N L G IP GNL +L L L +L+G IP G L +LQ N+ L+G
Sbjct: 149 LKLGDNELNGTIPETFGNLVNLQMLALASCRLTGLIPSRFGRLVQLQTLILQDNE-LEGP 207
Query: 215 LPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQ 274
+P EIGNC++L + A ++G++P+ + L+ +QT+ + + SG IP ++G+ +Q
Sbjct: 208 IPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQ 267
Query: 275 NLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGS 334
L L N + G IP R+ L+ L++L L N+L G I +E +L + + N L+GS
Sbjct: 268 YLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGS 327
Query: 335 IPRSF-GNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGL 393
+P++ N L++L LS QLSG IP EI+ C +L L++ NN ++G+IP + + L
Sbjct: 328 LPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVEL 387
Query: 394 TLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGXXXXXXXXXXXXXXXG 453
T + N L G + S+S LQ +NNL G +PKEI G
Sbjct: 388 TNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSG 447
Query: 454 FIPPDIGNCTTXXXXXXXXXXXSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSL 513
+P +IGNCT SG IPS +G LK L + + EN LVG IP S+ C +
Sbjct: 448 EMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQM 507
Query: 514 EFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHSIGSLTEXXXXXXXXNQLSG 571
+DL N L+GS+P + T+L+L + +N L G+L S+ +L N+ +G
Sbjct: 508 TVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNG 567
Query: 572 RIPAEILSCRKLILLDIGNNRFSGEIPKELGQXXXXXXXXXXXXXQFSGEIPSEFSGLTK 631
I + + + D+ N F G+IP ELG+ QF+G IP F +++
Sbjct: 568 SI-SPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKN-QFTGRIPRTFGKISE 625
Query: 632 LGILDLSHNKLSGDLDA-LASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSD---LASNR 687
L +LD+S N LSG + L + L ++++ N SG +P + KLPL L+SN+
Sbjct: 626 LSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPT--WLGKLPLLGELKLSSNK 683
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 969 (346.2 bits), Expect = 2.8e-137, Sum P(2) = 2.8e-137
Identities = 225/674 (33%), Positives = 345/674 (51%)
Query: 38 QGQALLTWKNSLNSSTDALSSW-NPAETSP---C-KWFGIHCSSNGEVVEISLKAVDLQG 92
+ ALL WK++ +S+ LSSW + A T+ C W+G+ C+S G + E++L ++G
Sbjct: 33 EANALLKWKSTFTNSSK-LSSWVHDANTNTSFSCTSWYGVSCNSRGSIEELNLTNTGIEG 91
Query: 93 SLPSI-FQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRK 151
+ F L +L + +S L+GTIP +FG+ +L + DLS N L GEI + L+
Sbjct: 92 TFQDFPFISLSNLAYVDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHLTGEISPSLGNLKN 151
Query: 152 LESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNL 211
L LYL+ N L IPS++GN+ S+ L L N+L+G IP S+G L L V N L
Sbjct: 152 LTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYENY-L 210
Query: 212 KGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCS 271
G +P E+GN ++ L L++ ++G++PS++G L+ + + +Y + L+G IP EIGN
Sbjct: 211 TGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGNME 270
Query: 272 ELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLL 331
+ NL L QN ++G IP +G L L L L+QN L G IP +LG+ + ++ S+N L
Sbjct: 271 SMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKL 330
Query: 332 TGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNIN 391
TGSIP S GNL L L L N L+G IP E+ ++ L+++NN ++G IP+ GN+
Sbjct: 331 TGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLK 390
Query: 392 GLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGXXXXXXXXXXXXXX 451
LT + + N LTG IP+ L + + LD S N L+G +P
Sbjct: 391 NLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHL 450
Query: 452 XGFIPPDIGNCTTXXXXXXXXXXXSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQ 511
G IPP + N + +G P + + L + + NHL G IP S+ C+
Sbjct: 451 SGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCK 510
Query: 512 SLEFLDLHSNGLTGSVPDT--LPTSLQLVDLSDNRLSGSLAHSIGSLTEXXXXXXXXNQL 569
SL N TG + + + L +D S N+ G ++ + + N +
Sbjct: 511 SLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNI 570
Query: 570 SGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQXXXXXXXXXXXXXQFSGEIPSEFSGL 629
+G IP EI + +L+ LD+ N GE+P+ +G Q SG +P+ S L
Sbjct: 571 TGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGN-QLSGRVPAGLSFL 629
Query: 630 TKLGILDLSHNKLSGDL-DALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRG 688
T L LDLS N S ++ S L +N+S N F G +P +L DL+ N+
Sbjct: 630 TNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIPRLSKLTQLTQLDLSHNQ- 688
Query: 689 LYISGGVVSPTDSL 702
+ G + S SL
Sbjct: 689 --LDGEIPSQLSSL 700
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1291 (459.5 bits), Expect = 1.2e-131, P = 1.2e-131
Identities = 320/932 (34%), Positives = 491/932 (52%)
Query: 73 HCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFID 132
+CSS E+++++ D G +P L SL+ LII + ++G++P E G+ L+ +
Sbjct: 119 NCSSL-EILKLNNNQFD--GEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLV 175
Query: 133 LSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPK 192
N++ G++P + L++L S N++ G +PS+IG SL L L NQLSG++PK
Sbjct: 176 TYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPK 235
Query: 193 SIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTI 252
IG L KL N+ G +P EI NC++L L L + + G +P +G L+ ++ +
Sbjct: 236 EIGMLKKLSQVILWENE-FSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFL 294
Query: 253 AIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIP 312
+Y + L+G IP EIGN S + +N+++G IP +G + L+ L L++N L G IP
Sbjct: 295 YLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIP 354
Query: 313 DELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHL 372
EL + L+ +D S N LTG IP F L L LQL N LSGTIP ++ + L L
Sbjct: 355 VELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVL 414
Query: 373 EIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIP 432
++ +N +SG IP+ + + + + N L+GNIP ++ C+ L L + NNL G P
Sbjct: 415 DMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFP 474
Query: 433 KEIFGXXXXXXXXXXXXXXXGFIPPDIGNCTTXXXXXXXXXXXSGTIPSEMGNLKHLNFV 492
+ G IP ++GNC+ +G +P E+G L L +
Sbjct: 475 SNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTL 534
Query: 493 DMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPT--SLQLVDLSDNRLSGSLA 550
++S N L G +P + C+ L+ LD+ N +G++P + + L+L+ LS+N LSG++
Sbjct: 535 NISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIP 594
Query: 551 HSIGSLTEXXXXXXXXNQLSGRIPAEILSCRKL-ILLDIGNNRFSGEIPKELGQXXXXXX 609
++G+L+ N +G IP E+ S L I L++ N+ +GEIP EL
Sbjct: 595 VALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEF 654
Query: 610 XXXXXXXQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGEL 669
SGEIPS F+ L+ L + S+N L+G + L N+S + F G
Sbjct: 655 LLLNNN-NLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLLR--------NISMSSFIG-- 703
Query: 670 PNTPFFRKLPLSDLASNRGLYISGGVVSPTDSLPAGQARSAMKXXXXXXXXXXXXXXXXX 729
N PL N+ + S + P G S +
Sbjct: 704 -NEGLCGP-PL-----NQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIAL 756
Query: 730 XXXXXRTRMANNSFTADDTW--EMTL--Y--QKLDFSIDDVVR---NLTSANVIGTGSSG 780
R + + +A D EM+L Y K F+ D+V N + V+G G+ G
Sbjct: 757 IVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACG 816
Query: 781 VVYRVTIPNGETLAVKKMWSSDESG-------AFSSEIQTLGSIRHKNIVRLLGWGSNKN 833
VY+ +P G TLAVKK+ S+ E G +F +EI TLG+IRH+NIV+L G+ +++
Sbjct: 817 TVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQG 876
Query: 834 LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKA 893
LL Y+Y+P GSL +LH DW R+++ LG A LAYLHHDC P I H D+K+
Sbjct: 877 SNLLLYEYMPKGSLGEILHDPSCN-LDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKS 935
Query: 894 MNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKS 953
N+LL ++A++ DFGLA+++ D SK+ +AGSYGY+APE+A ++TEKS
Sbjct: 936 NNILLDDKFEAHVGDFGLAKVI----DMPHSKSMSA--IAGSYGYIAPEYAYTMKVTEKS 989
Query: 954 DVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQW 985
D+YS+GVVLLE+LTG+ P+ P GG +V W
Sbjct: 990 DIYSYGVVLLELLTGKAPVQPIDQGG-DVVNW 1020
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGR3 | Y4265_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7154 | 0.9510 | 0.8725 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_scaffold_140000048 | hypothetical protein (1093 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1001 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-160 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-38 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-30 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-28 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-20 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-17 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-10 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-05 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-05 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 7e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.002 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 0.002 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.003 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.003 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 0.003 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 497 bits (1281), Expect = e-160
Identities = 330/981 (33%), Positives = 498/981 (50%), Gaps = 114/981 (11%)
Query: 19 LLLISINFLFFSTCDALDEQGQALLTWKNSLNSSTDALSSWNPAETSPCKWFGIHCSSNG 78
L+ + FLF + E+ + LL++K+S+N LS+WN + C W GI C+++
Sbjct: 11 YLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSADV-CLWQGITCNNSS 69
Query: 79 EVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKE-FGDYRELTFIDLSGNS 137
VV I L ++ G + S L ++ + +S+ L+G IP + F L +++LS N+
Sbjct: 70 RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNN 129
Query: 138 LWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGAL 197
G IP + LE+L L+ N+L GEIP+DIG+ SSL L L N L GKIP S+ L
Sbjct: 130 FTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187
Query: 198 SKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTS 257
+ L+ NQ L G++P E+G +L + L ++SG +P IG L + + + +
Sbjct: 188 TSLEFLTLASNQ-LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246
Query: 258 LLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGS 317
L+GPIP +GN LQ L+LYQN +SGPIP I +L KL SL L NSL G IP+ +
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 318 CTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNN 377
L ++ N TG IP + +L +LQ LQL
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL--------------------------- 339
Query: 378 AISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFG 437
W NK +G IP++L + L LD S NNL+G IP+ +
Sbjct: 340 ---------------------WSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
Query: 438 LRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSEN 497
NL KL+L SN L G IP +G C +LRR+RL DN SG +PSE L + F+D+S N
Sbjct: 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNN 438
Query: 498 HLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTS-LQLVDLSDNRLSGSLAHSIGSL 556
+L G I SL+ L L N G +PD+ + L+ +DLS N+ SG++ +GSL
Sbjct: 439 NLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSL 498
Query: 557 TELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSN 616
+EL +L LS+N+LSG IP E+ SC+KL +SL+LS N
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKL-------------------------VSLDLSHN 533
Query: 617 QFSGEIPSEFSGLTKLGILDLSHNKLSGDLDA-LASLQNLVSLNVSFNDFSGELPNTPFF 675
Q SG+IP+ FS + L LDLS N+LSG++ L ++++LV +N+S N G LP+T F
Sbjct: 534 QLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAF 593
Query: 676 RKLPLSDLASNRGLYISGGVVSPTDSLPAGQARSAMKLVMSILVSASAVLVLLAI--YVL 733
+ S +A N L GG T LP + + ++LA+ +
Sbjct: 594 LAINASAVAGNIDL--CGG--DTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGF 649
Query: 734 VRTRMANNS-----FTADDTWEMTLYQK---LDFSIDDVVRNLTSANVIGTGSSGVVYR- 784
V R NN D TWE+ + +I+D++ +L NVI G G Y+
Sbjct: 650 VFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKG 709
Query: 785 VTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844
+I NG VK++ +D + SSEI +G ++H NIV+L+G ++ L ++Y+
Sbjct: 710 KSIKNGMQFVVKEI--NDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767
Query: 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQA 904
+LS +L WE R ++ +G+A AL +LH C P ++ G++ +++ +
Sbjct: 768 KNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEP 822
Query: 905 YLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLE 964
+L L ++ C+ T A Y+APE + ITEKSD+Y FG++L+E
Sbjct: 823 HLR-LSLPGLL-------CTDTKCFISSA----YVAPETRETKDITEKSDIYGFGLILIE 870
Query: 965 VLTGRHPLDPTLPGGAPLVQW 985
+LTG+ P D +V+W
Sbjct: 871 LLTGKSPADAEFGVHGSIVEW 891
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 61/197 (30%), Positives = 93/197 (47%), Gaps = 17/197 (8%)
Query: 774 IGTGSSGVVYRVTIPN-GETLAVKKM---WSSDESGAFSSEIQTLGSIRHKNIVRLLGWG 829
+G G G VY G+ +A+K + SS EI+ L + H NIV+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 830 SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHG 889
++N L +Y GSL LL +G + ++L + L YLH + I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 890 DVKAMNVLLG-PGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE-HASMQ 947
D+K N+LL + LADFGL+++++ + G+ YMAPE
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-------VGTPAYMAPEVLLGKG 169
Query: 948 RITEKSDVYSFGVVLLE 964
+EKSD++S GV+L E
Sbjct: 170 YYSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMW----SSDESGAFSSEIQTLGSIRHKNIVRLLG 827
+G+GS G VY+ G+ +AVK + S + EI+ L + H NIVRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
+K+ L +Y G L L G ++ EA+ + L + L YLH + I+
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKK-IALQILRGLEYLHSN---GII 120
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE-HASM 946
H D+K N+LL +ADFGLA+ + S + G+ YMAPE
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-------FVGTPWYMAPEVLLGG 173
Query: 947 QRITEKSDVYSFGVVLLEVLTGRHP 971
K DV+S GV+L E+LTG+ P
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 69/213 (32%), Positives = 104/213 (48%), Gaps = 29/213 (13%)
Query: 772 NVIGTGSSGVVYRVTIP-NGETLAVKKM----WSSDESGAFSSEIQTLGSIRHKNIVRLL 826
++G GS G VY GE +AVK + S +E A EI+ L S++H NIVR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 827 G--WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEA---RY--EVVLGVAHALAYLH 879
G KN +F +Y+ GSLSSLL K G E +Y +++ G LAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLK---KFGKLPEPVIRKYTRQILEG----LAYLH 118
Query: 880 -HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGY 938
+ I+H D+K N+L+ LADFG A+ + + + + G+ +
Sbjct: 119 SNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS-----VRGTPYW 169
Query: 939 MAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
MAPE + +D++S G ++E+ TG+ P
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESG---AFSSEIQTLGSIRHKNIVRLLG 827
+G GS G VY G+ +A+K + EI+ L ++H NIVRL
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
+++ L +Y G L LL ++ EAR+ + + AL YLH I+
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLK-KRGRLSEDEARF-YLRQILSALEYLHSKG---IV 119
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ 947
H D+K N+LL LADFGLAR + T G+ YMAPE +
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLD---PGEKLTT-----FVGTPEYMAPEVLLGK 171
Query: 948 RITEKSDVYSFGVVLLEVLTGRHPLD 973
+ D++S GV+L E+LTG+ P
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFP 197
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 25/208 (12%)
Query: 773 VIGTGSSGVVYR----VTIPNGETL-AVKKMW---SSDESGAFSSEIQTLGSIRHKNIVR 824
+G G+ G VY+ ET AVK + S +E F E + + H NIVR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCM 883
LLG + + +Y+P G L L + ++ L +A + YL +
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEYLESKNF- 123
Query: 884 PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD---DNCSKTNQRPQLAGSYGYMA 940
+H D+ A N L+ ++DFGL+R + K + +MA
Sbjct: 124 ---VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK--------WMA 172
Query: 941 PEHASMQRITEKSDVYSFGVVLLEVLTG 968
PE + T KSDV+SFGV+L E+ T
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 768 LTSANVIGTGSSGVVYR-----VTIPNGETLAVKKM---WSSDESGAFSSEIQTLGSIRH 819
LT +G G+ G VY+ +AVK + S + F E + + + H
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 820 KNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH 879
NIV+LLG + + ++ +Y+P G L L L +A + YL
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
+H D+ A N L+G ++DFGL+R + D K + P +M
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLP-----IRWM 171
Query: 940 APEHASMQRI-TEKSDVYSFGVVLLEVLT-GRHP 971
APE + + T KSDV+SFGV+L E+ T G P
Sbjct: 172 APE-SLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 61/216 (28%), Positives = 88/216 (40%), Gaps = 25/216 (11%)
Query: 772 NVIGTGSSGVVYR---VTIPNGETL-AVKKMWSSDESG---AFSSEIQTLGSIRHKNIVR 824
+G G+ G VY+ T AVK + F E + + + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY-------EVVLGVAHALAY 877
LLG + + L +Y+ G L L + E + +A + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 878 LHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR-PQLAGSY 936
L +H D+ A N L+G ++DFGL+R V D KT + P
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY-DDDYYRKKTGGKLP-----I 171
Query: 937 GYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+MAPE T KSDV+SFGV+L E+ T G P
Sbjct: 172 RWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 767 NLTSANVIGTGSSGVVYR-VTIPNGETLAVKKM----WSSDESGAFSSEIQTLGSIRHKN 821
N ++IG G+ GVVY+ + + G+ +A+K++ + + EI L +++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 822 IVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHD 881
IV+ +G + + +Y NGSL ++ G A Y V V LAYLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY--VYQVLQGLAYLHEQ 118
Query: 882 CMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAP 941
++H D+KA N+L LADFG+A ++ D + G+ +MAP
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-------DASVVGTPYWMAP 168
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLTGRHP---LDPT 975
E M + SD++S G ++E+LTG P L+P
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM 205
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMW--SSDESGAFSSEIQTLGSIRHKNIVRLLG-W 828
IG G G VY+ G+ +A+K + S ++ +EIQ L +H NIV+ G +
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 829 GSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH--HDCMPPI 886
L ++ ++ GSL LL + + + Y V + L YLH I
Sbjct: 67 LKKDELWIVM-EFCSGGSLKDLLKSTNQTLTESQIAY-VCKELLKGLEYLHSNG-----I 119
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM 946
+H D+KA N+LL + L DFGL+ +S T R + G+ +MAPE +
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLS--------DTKARNTMVGTPYWMAPEVING 171
Query: 947 QRITEKSDVYSFGVVLLEVLTGRHPL 972
+ K+D++S G+ +E+ G+ P
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPPY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 23/215 (10%)
Query: 768 LTSANVIGTGSSGVVYR-----VTIPNGETLAVKKMWSSDESGA---FSSEIQTLGSIRH 819
LT +G G+ G VY+ +AVK + F E + + + H
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 820 KNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH 879
N+V+LLG + + + +Y+ G L S L + L +A + YL
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN-RPKLSLSDLLSFALQIARGMEYLE 119
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR-PQLAGSYGY 938
+H D+ A N L+G ++DFGL+R + DD K + P +
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL--YDDDYYRKRGGKLP-----IRW 169
Query: 939 MAPEHASMQRI-TEKSDVYSFGVVLLEVLT-GRHP 971
MAPE + + T KSDV+SFGV+L E+ T G P
Sbjct: 170 MAPE-SLKEGKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 43/220 (19%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESG---AFSSEIQTLGSIRHKNIVRLLGW 828
V+G GSSGVVY+V P G+ A+KK+ + E++TL S +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG- 66
Query: 829 GSNKNLKLLFYD---------YLPNGSLSSLLHGAGKGGADWEARYEVVLG-----VAHA 874
FY Y+ GSL+ LL GK E VL +
Sbjct: 67 --------AFYKEGEISIVLEYMDGGSLADLLKKVGKIP-------EPVLAYIARQILKG 111
Query: 875 LAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAG 934
L YLH I+H D+K N+L+ + +ADFG+++++ + D + G
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT-------FVG 162
Query: 935 SYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974
+ YM+PE + + +D++S G+ LLE G+ P P
Sbjct: 163 TVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLP 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 72/233 (30%), Positives = 106/233 (45%), Gaps = 28/233 (12%)
Query: 772 NVIGTGSSGVVYR-VTIPNGETLAVKKMWSSDESGAF----SSEIQTLGSIRHKNIVRLL 826
VIG G++ VVY + +PN E +A+K++ ++ E+Q + H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLL-HGAGKGGADWEARYEVVL-GVAHALAYLHHDCMP 884
+ L YL GSL ++ +GG D EA VL V L YLH +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD-EAIIATVLKEVLKGLEYLHSNGQ- 123
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS-GDDNCSKTNQRPQLAGSYGYMAPEH 943
+H D+KA N+LLG +ADFG VS S D R G+ +MAPE
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFG----VSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 944 ASMQR-ITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLMLNL 995
K+D++SFG+ +E+ TG AP ++ P+ LML L
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGA----------APYSKYPPMKVLMLTL 220
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-23
Identities = 70/210 (33%), Positives = 101/210 (48%), Gaps = 13/210 (6%)
Query: 773 VIGTGSSGVVYRVT---IPNGETLAVKKMWSSDESGAFSSEIQTLGSIRH-KNIVRLLGW 828
+G GS G VY + + LA K S E F EIQ L S+ H NIV+L +
Sbjct: 7 KLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDF 66
Query: 829 GSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR-YEVVLGVAHALAYLHHDCMPPIL 887
++ L +Y+ GSL LL G+ G E+ ++ + AL YLH I+
Sbjct: 67 FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---II 123
Query: 888 HGDVKAMNVLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE---H 943
H D+K N+LL G L DFGLA+++ G + + G+ GYMAPE
Sbjct: 124 HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGYMAPEVLLG 182
Query: 944 ASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
S+ + SD++S G+ L E+LTG P +
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFE 212
|
Length = 384 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 772 NVIGTGSSGVVYR-VTIPNGETLAVKKMWSSDESG----AFSSEIQTLGSIRHKNIVRLL 826
N IG G+ G VY V + GE +AVK++ D + E++ L ++H N+V+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEA---RYEVVLGVAHALAYLHHDCM 883
G ++ +F +Y G+L LL G E Y L + LAYLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEH---GRILDEHVIRVY--TLQLLEGLAYLH---S 117
Query: 884 PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG---YMA 940
I+H D+K N+ L L DFG A + + T ++ G YMA
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT------TTMGEEVQSLAGTPAYMA 171
Query: 941 PEHASMQRITEK---SDVYSFGVVLLEVLTGRHP 971
PE + + +D++S G V+LE+ TG+ P
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 68/212 (32%), Positives = 111/212 (52%), Gaps = 20/212 (9%)
Query: 773 VIGTGSSGVVY-RVTIPNGETLAVKKMW--SSDESG---------AFSSEIQTLGSIRHK 820
+IG+GS G VY + +GE +AVK++ S S A + EI L ++H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 821 NIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYE-VVLGVAHALAYLH 879
NIV+ LG + + +F +Y+P GS+++LL+ G A E V + L YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLH 123
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
I+H D+K N+L+ ++DFG+++ + + + RP L GS +M
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN-SLSTKTNGARPSLQGSVFWM 179
Query: 940 APEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
APE T K+D++S G +++E+LTG+HP
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 4e-22
Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 18/214 (8%)
Query: 769 TSANVIGTGSSGVVYRVTIPNGETLAVK--------KMWSSDESGAFSSEIQTLGSIRHK 820
T V+G G+ G VY G+ +AVK + + E E+ L S++H
Sbjct: 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHV 62
Query: 821 NIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY--EVVLGVAHALAYL 878
NIV+ LG + N +F +++P GS+SS+L+ G +Y +++ GV AYL
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGV----AYL 118
Query: 879 HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGY 938
H++C ++H D+K NV+L P L DFG AR ++ G + + +N + G+ +
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG-LHGTHSNMLKSMHGTPYW 174
Query: 939 MAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
MAPE + KSD++S G + E+ TG+ PL
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (240), Expect = 6e-22
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKM----WSSDESGAFSSEIQTLGSIRHKNIVRLL 826
IG GS G VY V +G+ +K++ S E +E++ L + H NI++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 827 G-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLG----VAHALAYL 878
+ L + +Y G LS + K G + E +L + AL YL
Sbjct: 66 ESFEEKGKL-CIVMEYADGGDLSQKIKKQKKEG-----KPFPEEQILDWFVQLCLALKYL 119
Query: 879 H--HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSY 936
H ILH D+K N+ L L DFG+++++S + D +KT + G+
Sbjct: 120 HSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKT-----VVGTP 167
Query: 937 GYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
Y++PE + KSD++S G VL E+ T +HP
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 69/214 (32%), Positives = 107/214 (50%), Gaps = 25/214 (11%)
Query: 773 VIGTGSSGVVY-RVTIPNGETLAVKKM----WSSDESG--------AFSSEIQTLGSIRH 819
+IG G+ G VY + + GE +AVK++ + A SEI+TL + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 820 KNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH 879
NIV+ LG+ + + +F +Y+P GS+ S L G+ + + V LAYLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR--FEEQLVRFFTEQVLEGLAYLH 125
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
ILH D+KA N+L+ ++DFG+++ S DN + + GS +M
Sbjct: 126 SK---GILHRDLKADNLLVDADGICKISDFGISK-KSDDIYDNDQNMSMQ----GSVFWM 177
Query: 940 APE--HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
APE H+ Q + K D++S G V+LE+ GR P
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRL 825
N IG GS GVV++V + A+K KM + A E + L + I+R
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSSYIIRY 64
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPP 885
+K + +Y NG L LL + + + + LA+LH
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---K 121
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945
ILH D+K++N+ L + D G+A+++S + N + T + G+ Y++PE
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFANT-----IVGTPYYLSPELCE 174
Query: 946 MQRITEKSDVYSFGVVLLEVLTGRHPLD 973
+ EKSDV++ GVVL E TG+HP D
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 7e-21
Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 14/202 (6%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSN 831
+G GS G VY+ G+ +A+K + ++ EI L IV+ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69
Query: 832 KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVL-GVAHALAYLHHDCMPPILHGD 890
+ +Y GS+S ++ K E +L L YLH + +H D
Sbjct: 70 NTDLWIVMEYCGAGSVSDIMKITNKTLT--EEEIAAILYQTLKGLEYLHSN---KKIHRD 124
Query: 891 VKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRIT 950
+KA N+LL QA LADFG++ ++ + +R + G+ +MAPE
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSGQLTDTMA-------KRNTVIGTPFWMAPEVIQEIGYN 177
Query: 951 EKSDVYSFGVVLLEVLTGRHPL 972
K+D++S G+ +E+ G+ P
Sbjct: 178 NKADIWSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 9e-21
Identities = 62/223 (27%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 766 RNLTSANVIGTGSSGVVY--RVTIPN---GETLAVKKMWSSDESGA---FSSEIQTLGSI 817
R+L +G G G V R GE +AVK + S E F EI+ L ++
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 818 RHKNIVRLLGW---GSNKNLKLLFYDYLPNGSLSSLLHG-AGKGGADWEARYEVVLGVAH 873
H+NIV+ G ++L+L+ +YLP+GSL L + + +
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIM-EYLPSGSLRDYLQRHRDQINLKRLLLFS--SQICK 120
Query: 874 ALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKT-NQRPQL 932
+ YL +H D+ A N+L+ ++DFGLA+++ D K + P
Sbjct: 121 GMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 933 AGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDP 974
+ APE + + SDV+SFGV L E+ T G P
Sbjct: 178 -----WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 36/220 (16%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKM----WSSDESGAFSSEIQTLGSIRHKNIVRLL 826
IG GS G V +V +G+ L K++ + E SE+ L ++H NIVR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 827 GWGSNKNLKLLF--YDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGV----AHALAY 877
+++ + L+ +Y G L+ L+ K E +Y E + + AL
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKK-----ERKYIEEEFIWRILTQLLLALYE 120
Query: 878 LHH--DCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGS 935
H+ D +LH D+K N+ L L DFGLA+I+ A +
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-----------GHDSSFAKT 169
Query: 936 Y-G---YMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
Y G YM+PE + EKSD++S G ++ E+ P
Sbjct: 170 YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 49/236 (20%)
Query: 752 TLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYR-VTIPNGETLAVKKM---WSSDESGAF 807
+LYQ+L+ +IG G+ G VYR +P G +A+K + D+
Sbjct: 1 SLYQRLE--------------LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDI 46
Query: 808 SSEIQTLGSIRH---KNIVRLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEA 863
E+ L +R NI + G + L ++ +Y GS+ +L+ K G E
Sbjct: 47 QREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM-EYAEGGSVRTLM----KAGPIAEK 101
Query: 864 RYEVVL-GVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922
V++ V AL Y+H ++H D+KA N+L+ L DFG+A +++
Sbjct: 102 YISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN------ 152
Query: 923 CSKTNQRPQLAGSYGYMAPEHASMQRITE------KSDVYSFGVVLLEVLTGRHPL 972
+++R G+ +MAPE ITE K+D++S G+ + E+ TG P
Sbjct: 153 -QNSSKRSTFVGTPYWMAPE-----VITEGKYYDTKADIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 64/207 (30%), Positives = 92/207 (44%), Gaps = 16/207 (7%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWS---SDESGAFSSEIQTLGSIRHKNIVRLLG 827
+G G+SGVV +V P G+ +AVK + E+ L IV G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
N + +Y+ GSL +L +G ++ + V L YLH I+
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILK-EVQGRIPERILGKIAVAVLKGLTYLHEKH--KII 123
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ 947
H DVK N+L+ Q L DFG VSG ++ +KT G+ YMAPE
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFG----VSGQLVNSLAKTF-----VGTSSYMAPERIQGN 174
Query: 948 RITEKSDVYSFGVVLLEVLTGRHPLDP 974
+ KSD++S G+ L+E+ TGR P P
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 774 IGTGSSGVVYRVTIPNGETLAVKKMWSSDES--GAFSSEIQTLGSIRHKNIVRLLGWGSN 831
+G+G G V+ N +A+K + S D F E+Q L +RHK+++ L S
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 832 KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDV 891
+ + + GSL + L + ++ VA +AYL +H D+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDL 130
Query: 892 KAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR-PQLAGSYGYMAPEHASMQRIT 950
A N+L+G +ADFGLAR++ +D ++++ P Y + APE AS +
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIK---EDVYLSSDKKIP-----YKWTAPEAASHGTFS 182
Query: 951 EKSDVYSFGVVLLEVLT 967
KSDV+SFG++L E+ T
Sbjct: 183 TKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (220), Expect = 2e-19
Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 28/209 (13%)
Query: 774 IGTGSSGVVYRVTIPN-GETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRLL- 826
+G GS G V V + G+ A+K K+ E +E L I H IV+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY--EVVLGVAHALAYLH-HDCM 883
+ + + L L+ +Y P G L S L G+ + Y E+VL AL YLH
Sbjct: 61 AFQTEEKLYLVL-EYAPGGELFSHLSKEGRFSEERARFYAAEIVL----ALEYLHSLG-- 113
Query: 884 PPILHGDVKAMNVLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE 942
I++ D+K N+LL G+ L DFGLA+ +S S + G+ Y+APE
Sbjct: 114 --IIYRDLKPENILLDADGH-IKLTDFGLAKELS-SEGSRTN------TFCGTPEYLAPE 163
Query: 943 HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ + D +S GV+L E+LTG+ P
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 774 IGTGSSGVVYRV--TIPNGETL--AVKKMWS---SDESGAFSSEIQTLGSIRHKNIVRLL 826
+G GS GVV R + G+ + AVK + S SD F E + S+ H+N++RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPI 886
G L ++ + P GSL L G + + +A+ + YL
Sbjct: 63 GVVLTHPLMMVT-ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRF 118
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM 946
+H D+ A N+LL + + DFGL R + + D + + + A + APE
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA----WCAPESLRT 174
Query: 947 QRITEKSDVYSFGVVLLEVLT-GRHP 971
+ + SDV+ FGV L E+ T G P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 767 NLTSANVIGTGSSGVVYRVT-IPNGETLAVKKM-----WSSDESGAFSS---EIQTLGSI 817
+GTG+ Y+ + G +AVK++ SS++ + EI+ + +
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 818 RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAY 877
H +I+R+LG + LF +++ GS+S LL G Y + L+Y
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY--TEQLLRGLSY 118
Query: 878 LHHDCMPPILHGDVKAMNVLL-GPGYQAYLADFG----LARIVSGSGDDNCSKTNQRPQL 932
LH + I+H DVK N+L+ G + +ADFG LA +G+G+ + QL
Sbjct: 119 LHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE-------FQGQL 168
Query: 933 AGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
G+ +MAPE ++ DV+S G V++E+ T + P
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 768 LTSANVIGTGSSGVVYRVTIPNGETLAVKKM---WSSDESGAFSSEIQTLGSIRHKNIVR 824
LT IG+G G+V+ +A+K + S+E F E Q + + H +V+
Sbjct: 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEED--FIEEAQVMMKLSHPKLVQ 63
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMP 884
L G + ++ L ++++ +G LS L A +G E + L V +AYL
Sbjct: 64 LYGVCTERSPICLVFEFMEHGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESSN-- 120
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG------Y 938
++H D+ A N L+G ++DFG+ R V DD Q S G +
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFVL---DD---------QYTSSTGTKFPVKW 167
Query: 939 MAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLD 973
+PE S + + KSDV+SFGV++ EV + G+ P +
Sbjct: 168 SSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 27/208 (12%)
Query: 774 IGTGSSGVVYRVTIPNGET-LAVKKMWSSDES-GAFSSEIQTLGSIRHKNIVRLLGWGSN 831
+G G G V+ T NG T +AVK + S AF E Q + +RH +V+L S
Sbjct: 14 LGAGQFGEVWMGTW-NGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 832 KNLKLLFYDYLPNGSLSSLLHGAGKGGA-------DWEARYEVVLGVAHALAYLHHDCMP 884
+ + +Y+ GSL L G+G D A+ +A +AYL
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKS-GEGKKLRLPQLVDMAAQ------IAEGMAYLESR--- 122
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHA 944
+H D+ A N+L+G +ADFGLAR++ D+ ++ + + + APE A
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIED--DEYTAREGAKFPIK----WTAPEAA 176
Query: 945 SMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ R T KSDV+SFG++L E++T GR P
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 766 RNLTSANVIGTGSSGVV----YRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKN 821
+ L IG G G V YR G +AVK + + + AF +E + +RH N
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDATAQAFLAEASVMTQLRHSN 60
Query: 822 IVRLLGWGSNKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHH 880
+V+LLG + L + +Y+ GSL L G+ + + L V A+ YL
Sbjct: 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120
Query: 881 DCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMA 940
+ +H D+ A NVL+ A ++DFGL + S + D T + P + A
Sbjct: 121 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLP-----VKWTA 167
Query: 941 PEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTLP 977
PE ++ + KSDV+SFG++L E+ + GR P P +P
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRIP 204
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 32/212 (15%)
Query: 774 IGTGSSGVVYR-VTIPNGETLAVKKMWSSDESGAFSS-------EIQTLGSIRHKNIVRL 825
+G+GS G VY + + +G+ AVK++ +D+ EI L ++H NIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWE---ARY--EVVLGVAHALAYLHH 880
LG ++ +F + +P GSL+ LL K G+ E Y +++LG L YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLL---KKYGSFPEPVIRLYTRQILLG----LEYLHD 120
Query: 881 DCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMA 940
+H D+K N+L+ LADFG+A+ V K GS +MA
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK--------GSPYWMA 169
Query: 941 PE-HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
PE A +D++S G +LE+ TG+ P
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGA---FSSEIQTLGSIRHKNI 822
+ L IG G G V G+ +AVK + D+S A F +E + ++RH N+
Sbjct: 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCL--KDDSTAAQAFLAEASVMTTLRHPNL 62
Query: 823 VRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC 882
V+LLG N + +Y+ GSL L G+ + L V + YL
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK- 121
Query: 883 MPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE 942
+H D+ A NVL+ A ++DFGLA+ S D + + P + APE
Sbjct: 122 --NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLP-----VKWTAPE 169
Query: 943 HASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
++ + KSDV+SFG++L E+ + GR P
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 52/223 (23%), Positives = 91/223 (40%), Gaps = 33/223 (14%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESGAFSSEIQTLGSI-RHKNIVRL 825
+IG GS V + A+K ++ + E + L + H I++L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 826 LG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLHHD 881
+ +NL + +Y PNG L + G R+ E++ AL YLH
Sbjct: 68 YYTFQDEENLYFV-LEYAPNGELLQYIRKYGSLDEKC-TRFYAAEIL----LALEYLHSK 121
Query: 882 CMPPILHGDVKAMNVLLGPGYQAYLADFGLARI-------VSGSGDDNCSKTNQRPQLA- 933
I+H D+K N+LL + DFG A++ S GD +
Sbjct: 122 ---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 934 -----GSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
G+ Y++PE + + + SD+++ G ++ ++LTG+ P
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 774 IGTGSSGVVYRVTIPNGETLAVKKMW---SSDESGAFSSEIQTLGSIRHKNIVRLLGWGS 830
+G G+ G VY+ A K+ S +E F EI L +H NIV L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 831 NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGD 890
+N + ++ G+L S++ +G + + RY V + AL +LH ++H D
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIHRD 128
Query: 891 VKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRIT 950
+KA N+LL LADFG VS K R G+ +MAPE + +
Sbjct: 129 LKAGNILLTLDGDVKLADFG----VSAKNKSTLQK---RDTFIGTPYWMAPEVVACETFK 181
Query: 951 E-----KSDVYSFGVVLLEVLTGRHP 971
+ K+D++S G+ L+E+ P
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 16/215 (7%)
Query: 774 IGTGSSGVVYRVTIPNGETLAVKKMWS-SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNK 832
+G G G V+ N +AVK + + + F +E Q + +RH +++L + +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 833 NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL--HHDCMPPILHGD 890
+ + + GSL L G ++ VA +AYL + +H D
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN-----YIHRD 128
Query: 891 VKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRIT 950
+ A NVL+G +ADFGLAR++ +D R + APE A R +
Sbjct: 129 LAARNVLVGENNICKVADFGLARVI---KED---IYEAREGAKFPIKWTAPEAALYNRFS 182
Query: 951 EKSDVYSFGVVLLEVLT-GRHPLDPTLPGGAPLVQ 984
KSDV+SFG++L E++T GR P P + L Q
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMPY-PGMTNAEVLQQ 216
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 765 VRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVR 824
++ LT +IG G G V + G+ +AVK + + AF E + + HKN+VR
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVR 63
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMP 884
LLG + L ++ + + G+L + L G+ + L VA + YL
Sbjct: 64 LLGVILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK--- 119
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHA 944
++H D+ A N+L+ A ++DFGLAR+ S D ++ P + APE
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-----NSKLP-----VKWTAPEAL 169
Query: 945 SMQRITEKSDVYSFGVVLLEVLT-GRHP 971
++ + KSDV+S+GV+L EV + GR P
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 772 NVIGTGSSGVVYR--VTIPNGE--TLAVK--KMWSSDESGA-FSSEIQTLGSIRHKNIVR 824
VIG G G V R + +P + +A+K K SSD+ F +E +G H NI+R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLL-HGAGKGGADWEARYEVVLGVAHALAYLHHDCM 883
L G + ++ +Y+ NGSL L GK ++ G+A + YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 884 PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEH 943
+H D+ A N+L+ ++DFGL+R + S +K + P + APE
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR-----WTAPEA 179
Query: 944 ASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ ++ T SDV+SFG+V+ EV++ G P
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 774 IGTGSSGVVYR--VTIPNGE----TLAVKKMWSSDESGA---FSSEIQTLGSIRHKNIVR 824
+G G+ G VY+ +T PN ++A+K + + E F E + + ++H NIV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLL--------HGAGKGGADWEARYE------VVLG 870
LLG + + + ++YL +G L L GA G ++ + + +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 871 VAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQ 928
+A + YL HH +H D+ A N L+G G ++DFGL+R + + D ++
Sbjct: 133 IAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA--DYYRVQSK 185
Query: 929 RPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEV 965
+M PE + T +SD++SFGVVL E+
Sbjct: 186 SLL---PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 31/210 (14%)
Query: 773 VIGTGSSGVVYRV-TIPNGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLL 826
+GTGS G V V +G+ A+K + + + +E + L SIRH +V L
Sbjct: 8 TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLY 67
Query: 827 G-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLHHDC 882
G + + NL L+ +Y+P G L S L +G+ AR+ +VVL AL YLH
Sbjct: 68 GSFQDDSNLYLVM-EYVPGGELFSHLRKSGRFPEPV-ARFYAAQVVL----ALEYLHSL- 120
Query: 883 MPPILHGDVKAMNVLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAP 941
I++ D+K N+LL GY + DFG A+ V G + T L G+ Y+AP
Sbjct: 121 --DIVYRDLKPENLLLDSDGYIK-ITDFGFAKRVKGR-----TYT-----LCGTPEYLAP 167
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
E + + D ++ G+++ E+L G P
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 30/231 (12%)
Query: 767 NLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSS----EIQTLGSIRHKNI 822
+ + +G G+ G V + + N + K ++D + E++ S + I
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 823 VRLLGW---GSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY-EVVLG-----VAH 873
V+ G S+ ++ + +Y GSL S+ K G R E VLG V
Sbjct: 62 VKYYGAFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGG----RIGEKVLGKIAESVLK 116
Query: 874 ALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLA 933
L+YLH I+H D+K N+LL Q L DFG VSG ++ + T
Sbjct: 117 GLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG----VSGELVNSLAGT-----FT 164
Query: 934 GSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQ 984
G+ YMAPE + + SDV+S G+ LLEV R P P ++
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIE 215
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 4e-16
Identities = 64/230 (27%), Positives = 96/230 (41%), Gaps = 57/230 (24%)
Query: 774 IGTGSSGVVYRV-TIPNGETLAVKKMWSSDESGAFS----SEIQTLGSIRHKNIVRLLGW 828
IG G+ G VY+ GE +A+KK+ +E F EI+ L +RH NIVRL
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 829 GSNKNLKLLF--YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAH----------ALA 876
++K ++ ++Y+ + L+ LL EV + L
Sbjct: 67 VTSKGKGSIYMVFEYMDH-DLTGLLD-----------SPEVKFTESQIKCYMKQLLEGLQ 114
Query: 877 YLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQ------RP 930
YLH + ILH D+K N+L+ LADFGLAR + + TN+ RP
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY--TNRVITLWYRP 169
Query: 931 Q--LAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978
L G+ Y + D++S G +L E+ G+ P G
Sbjct: 170 PELLLGATRY-----------GPEVDMWSVGCILAELFLGK----PIFQG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 67/206 (32%), Positives = 90/206 (43%), Gaps = 21/206 (10%)
Query: 773 VIGTGSSGVVYR-VTIPNGETLAVKKM---WSSDESGAFSSEIQTLGSIRHKNIVRLLGW 828
IG GS G VY+ + + +A+K + + DE EIQ L R I + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG- 66
Query: 829 GSNKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVL-GVAHALAYLHHDCMPPI 886
K KL + +Y GS LL K G E +L V L YLH +
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEE---GK 119
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM 946
+H D+KA N+LL LADFG VSG SK N G+ +MAPE
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFG----VSGQLTSTMSKRNT---FVGTPFWMAPEVIKQ 172
Query: 947 QRITEKSDVYSFGVVLLEVLTGRHPL 972
EK+D++S G+ +E+ G PL
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPL 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 7e-16
Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 19/223 (8%)
Query: 768 LTSANVIGTGSSGVVYR-VTIPNGETL----AVKKM--WSSDES-GAFSSEIQTLGSIRH 819
L ++G+G G V++ + IP G+++ A+K + S ++ + + +GS+ H
Sbjct: 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDH 68
Query: 820 KNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH 879
IVRLLG +L+L+ P GSL + + D + + +A + YL
Sbjct: 69 AYIVRLLGICPGASLQLV-TQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLE 126
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
M +H ++ A N+LL +ADFG+A ++ DD K + +M
Sbjct: 127 EHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYP--DD---KKYFYSEHKTPIKWM 178
Query: 940 APEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTLPGGAP 981
A E R T +SDV+S+GV + E+++ G P P P
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP 221
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 768 LTSANVIGTGSSGVVYRVTIPNGETLAVKKM----WSSDESGAFSSEIQTLGSIRHKNIV 823
LT +G+G GVV+ +A+K + S D+ F E + + + H N+V
Sbjct: 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD---FIEEAKVMMKLSHPNLV 62
Query: 824 RLLGWGSNKNLKLLFYDYLPNGSLSSLLHG-AGKGGADWEARYEVVLGVAHALAYLHHDC 882
+L G + + + +Y+ NG L + L GK G +W ++ V A+ YL +
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG 120
Query: 883 MPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN--CSKTNQRPQLAGSYGYMA 940
+H D+ A N L+G ++DFGLAR V DD S+ + P +
Sbjct: 121 ---FIHRDLAARNCLVGEDNVVKVSDFGLARYVL---DDQYTSSQGTKFP-----VKWAP 169
Query: 941 PEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLD 973
PE R + KSDV+SFGV++ EV + G+ P +
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 774 IGTGSSGVVYR-VTIPNGETLAVKKM-------WSSDESGAFSSEIQTLGSIRHKNIVRL 825
+G G+ G VY + G LAVK++ + E A EIQ L +++H+ IV+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLL--HGAGKGGADWEARYEVVLGVAHALAYLHHDCM 883
G + +F +Y+P GS+ L +GA + +++ + YLH +
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLHSN-- 123
Query: 884 PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEH 943
I+H D+K N+L L DFG ++ + CS + G+ +M+PE
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI----CSSGTGMKSVTGTPYWMSPEV 178
Query: 944 ASMQRITEKSDVYSFGVVLLEVLTGRHP 971
S + K+DV+S G ++E+LT + P
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 33/217 (15%)
Query: 773 VIGTGSSGVVYR-VTIPNGET----LAVKKMWSSDESGAFSS-----EIQTLGSIRHKNI 822
V+G+G+ G VY+ V IP GE +A+K + +E+ ++ E + S+ H ++
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL--REETSPKANKEILDEAYVMASVDHPHV 71
Query: 823 VRLLGWGSNKNLKLLFYDYLPNGSLSSLLHG-AGKGGA----DWEARYEVVLGVAHALAY 877
VRLLG + ++L+ +P G L + G+ +W + +A ++Y
Sbjct: 72 VRLLGICLSSQVQLI-TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSY 124
Query: 878 LHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG 937
L ++H D+ A NVL+ + DFGLA+++ + ++ + P
Sbjct: 125 LE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP-----IK 176
Query: 938 YMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLD 973
+MA E + T KSDV+S+GV + E++T G P +
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 774 IGTGSSGVVYRVTIPNGETLAVKKMWSSDES-GAFSSEIQTLGSIRHKNIVRLLGWGSNK 832
+G G G V+ T +A+K + S AF E Q + +RH+ +V+L S +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 833 NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVK 892
+ ++ +Y+ GSL L G ++ +A +AY+ +H D++
Sbjct: 74 PIYIV-TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLR 129
Query: 893 AMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEK 952
A N+L+G +ADFGLAR++ +DN Q + + APE A R T K
Sbjct: 130 AANILVGENLVCKVADFGLARLI----EDNEYTARQGAKF--PIKWTAPEAALYGRFTIK 183
Query: 953 SDVYSFGVVLLEVLT-GRHP 971
SDV+SFG++L E+ T GR P
Sbjct: 184 SDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 768 LTSANVIGTGSSGVVYR--VTIPNGETLAV-----KKMWSSDESGAFSSEIQTLGSIRHK 820
+T VIG G G V+R + +P + +AV K ++ + F SE +G H
Sbjct: 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHH 66
Query: 821 NIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWE-ARYEVV---LGVAHALA 876
NI+RL G + ++ +Y+ NG+L L D E + Y++V G+A +
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDH-----DGEFSSYQLVGMLRGIAAGMK 121
Query: 877 YLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSY 936
YL +H D+ A N+L+ + ++DFGL+R++ + + + + +
Sbjct: 122 YLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR--- 175
Query: 937 GYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ APE + ++ T SDV+SFG+V+ EV++ G P
Sbjct: 176 -WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 56/198 (28%), Positives = 87/198 (43%), Gaps = 12/198 (6%)
Query: 774 IGTGSSGVVYRVTIPNGETLAVKKMWSS---DESGAFSSEIQTLGSIRHKNIVRLLGWGS 830
IG G+ G VY+ + +AVK S+ D F E + L H NIV+L+G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 831 NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGD 890
K + + +P GSL + L K + ++ L A + YL +H D
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118
Query: 891 VKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRIT 950
+ A N L+G ++DFG++R G Q P + APE + R T
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP-----IKWTAPEALNYGRYT 173
Query: 951 EKSDVYSFGVVLLEVLTG 968
+SDV+S+G++L E +
Sbjct: 174 SESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 774 IGTGSSGVVYRVTIPNGETLAVKKMWSSDES-GAFSSEIQTLGSIRHKNIVRLLGWGSNK 832
+G G G V+ T +AVK + S +F E Q + +RH +V+L S +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 833 NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY-------EVVLGVAHALAYLHHDCMPP 885
+ ++ +Y+ GSL L D E R ++ VA +AY+ M
Sbjct: 74 PIYIV-TEYMSKGSLLDFLK-------DGEGRALKLPNLVDMAAQVAAGMAYIER--MNY 123
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945
I H D+++ N+L+G G +ADFGLAR++ +DN Q + + APE A
Sbjct: 124 I-HRDLRSANILVGDGLVCKIADFGLARLI----EDNEYTARQGAKF--PIKWTAPEAAL 176
Query: 946 MQRITEKSDVYSFGVVLLEVLT-GRHP 971
R T KSDV+SFG++L E++T GR P
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 57/234 (24%), Positives = 101/234 (43%), Gaps = 42/234 (17%)
Query: 766 RNLTSANVIGTGSSGVVYRVTIPNGET------LAVKKMWSSDESGA---FSSEIQTLGS 816
+ +G G+ G V+ + E +AVK + + + A F E + L +
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64
Query: 817 IRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLL--HG----------AGKGGADWEAR 864
+H+NIV+ G + + ++ ++Y+ +G L+ L HG + G
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 865 YEVVLGVAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922
++ + +A + YL H +H D+ N L+G + DFG++R V
Sbjct: 125 LQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVY------ 173
Query: 923 CSKTNQRPQLAGS----YGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
T ++ G +M PE ++ T +SDV+SFGVVL E+ T G+ P
Sbjct: 174 ---TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 773 VIGTGSSGVVYRV-TIPNGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWG 829
V+G G+ G+VY + +A+K++ D EI ++H+NIV+ LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 830 SNKNLKLLFYDYLPNGSLSSLLH---GAGKGGADWEARYEVVLGVAHALAYLHHDCMPPI 886
S +F + +P GSLS+LL G K Y + L YLH + I
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFY--TKQILEGLKYLHDN---QI 129
Query: 887 LHGDVKAMNVLLGPGYQAYL--ADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE-- 942
+H D+K NVL+ Y + +DFG ++ ++G + C++T G+ YMAPE
Sbjct: 130 VHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGI--NPCTET-----FTGTLQYMAPEVI 181
Query: 943 HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ +D++S G ++E+ TG+ P
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 8e-15
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 29/225 (12%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKM-WSSDESGAFSSEIQTLGSIRHKNIVRLLGWGS 830
IG G+SG VY+ T G+ +A+KKM +EI + +H NIV S
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD--S 83
Query: 831 NKNLKLLF--YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILH 888
L+ +Y+ GSL+ ++ + + Y V V L YLH ++H
Sbjct: 84 YLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-VCREVLQGLEYLHSQ---NVIH 139
Query: 889 GDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR 948
D+K+ N+LL LADFG A ++ + ++R + G+ +MAPE +
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLT-------KEKSKRNSVVGTPYWMAPEVIKRKD 192
Query: 949 ITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPL--MFL 991
K D++S G++ +E+ G +P P ++ PL +FL
Sbjct: 193 YGPKVDIWSLGIMCIEMAEG----EP------PYLREPPLRALFL 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 70/256 (27%), Positives = 104/256 (40%), Gaps = 48/256 (18%)
Query: 767 NLTSANVIGTGSSGVVYRVT------IPNGETLAVK---KMWSSDESGAFSSEIQTLGSI 817
NL +G G G V + T T+AVK + SS E SE L +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 818 RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAY 877
H ++++L G S LL +Y GSL S L + K G + + +Y
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSY-----LGSDGNRNSSY 115
Query: 878 LHHDCMPPI------------------------LHGDVKAMNVLLGPGYQAYLADFGLAR 913
L + + +H D+ A NVL+ G + ++DFGL+R
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPL 972
V +D+ K R + +MA E T +SDV+SFGV+L E++T G +P
Sbjct: 176 DVYE--EDSYVK---RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP- 229
Query: 973 DPTLPGGAPLVQWTPL 988
PG AP + L
Sbjct: 230 ---YPGIAPERLFNLL 242
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 767 NLTSANVIGTGSSGVVYR-VTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVR 824
++T + +G G G VY V T+AVK + E F E + I+H N+V+
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 66
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMP 884
LLG + + + +++ G+L L + + + ++ A+ YL
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK--- 123
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGS---YGYMAP 941
+H D+ A N L+G + +ADFGL+R+++G + T AG+ + AP
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAH----AGAKFPIKWTAP 174
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLT 967
E + + + KSDV++FGV+L E+ T
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVKKM----WSSDESGAFSSEIQTLGSIRHKNIVR---- 824
+G GS G VY+V + + + A+K++ S E +EI+ L S+ H NI+
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 825 -LLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGG------ADWEARYEVVLGVAHALAY 877
L G N + +Y P G LS + K W +++ G L
Sbjct: 68 FLDG-----NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG----LQA 118
Query: 878 LHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG 937
LH ILH D+K+ N+LL + D G+++++ N +KT G+
Sbjct: 119 LHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQ-----IGTPH 166
Query: 938 YMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
YMAPE + + KSD++S G +L E+ T P +
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 36/91 (39%), Positives = 58/91 (63%), Gaps = 2/91 (2%)
Query: 468 LRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSV 527
L L++ L G IP+++ L+HL +++S N + G IPPS+ SLE LDL N GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 528 PDTLP--TSLQLVDLSDNRLSGSLAHSIGSL 556
P++L TSL++++L+ N LSG + ++G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 36/217 (16%)
Query: 773 VIGTGSSGVVY----RVTIPNGETLAVKKMWSSDESGAFSS----EIQTLGSIRHKNIVR 824
V+G G+ GVV + T GE +A+KK S++ E++ L +RH+NIV
Sbjct: 8 VVGEGAYGVVLKCRNKAT---GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVN 64
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCM 883
L K L ++Y+ L L A GG +A + + A+AY H H+
Sbjct: 65 LKEAFRRKGRLYLVFEYVERTLLELL--EASPGGLPPDAVRSYIWQLLQAIAYCHSHN-- 120
Query: 884 PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC-----SKTNQRPQ-LAGSYG 937
I+H D+K N+L+ L DFG AR + ++ + P+ L G
Sbjct: 121 --IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 938 YMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974
Y P DV++ G ++ E+L G PL P
Sbjct: 179 YGKP-----------VDVWAIGCIMAELLDGE-PLFP 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-14
Identities = 52/168 (30%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 807 FSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF--YDYLPNGSLSSLLHGAGKGGADWEAR 864
F E + H NIV LL G LLF ++Y+P +L +L G A R
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYVPGRTLREVLAADGALPAGETGR 83
Query: 865 YEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDD 921
++L V ALA H+ I+H D+K N+++ G A + DFG+ ++ G D
Sbjct: 84 --LMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138
Query: 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGR 969
+ + + ++ G+ Y APE + +T SD+Y++G++ LE LTG+
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 4e-14
Identities = 67/237 (28%), Positives = 106/237 (44%), Gaps = 42/237 (17%)
Query: 768 LTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGA---FSSEIQTLGSIRHKNIV 823
L N IG+G+ G VY+V P G A+K ++ + E EI+ L + H N+V
Sbjct: 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVV 135
Query: 824 RLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC 882
+ + N +++L +++ GSL G AD + +V + +AYLH
Sbjct: 136 KCHDMFDHNGEIQVLL-EFMDGGSLE------GTHIADEQFLADVARQILSGIAYLHRR- 187
Query: 883 MPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE 942
I+H D+K N+L+ +ADFG++RI++ + D C+ + G+ YM+PE
Sbjct: 188 --HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP-CNSS------VGTIAYMSPE 238
Query: 943 HASMQRITEK----------SDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLM 989
RI D++S GV +LE GR P G W LM
Sbjct: 239 -----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-----DWASLM 285
|
Length = 353 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 67/239 (28%), Positives = 99/239 (41%), Gaps = 43/239 (17%)
Query: 768 LTSANVIGTGSSGVVYR---VTIPNGE---TLAVKKMWSSDESGAFS---SEIQTLGSI- 817
LT +G G+ G V + V + N T+AVK + S SE++ + I
Sbjct: 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 73
Query: 818 RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG------- 870
+HKNI+ LLG + + + +Y +G+L L G
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 871 -------VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923
VA + +L +H D+ A NVL+ + +ADFGLAR + D
Sbjct: 134 LVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIH-HIDYYR 189
Query: 924 SKTNQR-PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAP 981
TN R P +MAPE + T +SDV+SFGV+L E+ T GG+P
Sbjct: 190 KTTNGRLP-----VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---------LGGSP 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 5e-14
Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 21/219 (9%)
Query: 768 LTSANVIGTGSSGVVYR-VTIPNGETL----AVKKMWSSDESGA---FSSEIQTLGSIRH 819
L V+G+G+ G VY+ + +P GET+ A+K + + A F E + S+ H
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68
Query: 820 KNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH 879
++VRLLG + ++L+ +P+G L +H K + + +A + YL
Sbjct: 69 PHLVRLLGVCLSPTIQLV-TQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
++H D+ A NVL+ + DFGLAR++ G + + + P +M
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP-----IKWM 178
Query: 940 APEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLD--PT 975
A E ++ T +SDV+S+GV + E++T G P D PT
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 767 NLTSANVIGTGSSGVVYRV-TIPNGETLAVKKMW-------SSDESGAFSSEIQTLGSIR 818
N ++G G+ G VY + G LA K++ +S E A EIQ L +++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 819 HKNIVRLLGWGSNKNLKLL--FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALA 876
H+ IV+ G ++ K L F +Y+P GS+ L G +Y + ++
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY--TRQILEGMS 120
Query: 877 YLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR-----IVSGSGDDNCSKTNQRPQ 931
YLH + I+H D+K N+L L DFG ++ +SG+G +
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS--------- 168
Query: 932 LAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ G+ +M+PE S + K+DV+S G ++E+LT + P
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-14
Identities = 67/223 (30%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 759 FSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGA-----FSSEIQ 812
FS DD + T IG GS G VY + E +A+KKM S + E++
Sbjct: 8 FSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 813 TLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVA 872
L +RH N + G ++ L +Y GS S +L K + E + G
Sbjct: 68 FLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIA-AICHGAL 125
Query: 873 HALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQL 932
LAYLH +H D+KA N+LL LADFG A +VS +
Sbjct: 126 QGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-----------SF 171
Query: 933 AGSYGYMAPEHA-SMQ--RITEKSDVYSFGVVLLEVLTGRHPL 972
G+ +MAPE +M + K DV+S G+ +E+ + PL
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 65/241 (26%), Positives = 102/241 (42%), Gaps = 40/241 (16%)
Query: 754 YQKLDFSIDDVVRNLTSANVIGTGSSGVVYRV-TIPNGETLAVKKMWSSDESGAFSS--- 809
YQKL IG G+ GVVY+ GE +A+KK+ ES
Sbjct: 1 YQKLGK--------------IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL 46
Query: 810 -EIQTLGSIRHKNIVRLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEV 867
EI+ L + H NI++LL + +L L+F +++ + L L+ +G + +
Sbjct: 47 REIKLLKELNHPNIIKLLDVFRHKGDLYLVF-EFM-DTDLYKLIKDRQRGLPESLIKS-Y 103
Query: 868 VLGVAHALAYLH-HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKT 926
+ + LA+ H H ILH D+K N+L+ LADFGLAR
Sbjct: 104 LYQLLQGLAFCHSHG----ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR------ 153
Query: 927 NQRPQLAGSYGYMAPE-HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQW 985
+ + Y APE + + D++S G + E+L+ R P PG + + Q
Sbjct: 154 PYTHYVVTRW-YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR----PLFPGKSEIDQL 208
Query: 986 T 986
Sbjct: 209 F 209
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 774 IGTGSSGVVYRVTIPNGETLAVKKMWSSDES-GAFSSEIQTLGSIRHKNIVRLLGWGSNK 832
+G G G V+ N +AVK + S AF E + +++H +VRL + +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 833 NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVK 892
+ +Y+ GSL L G + +A +AY+ +H D++
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLR 130
Query: 893 AMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEK 952
A NVL+ +ADFGLAR++ +DN + R + APE + T K
Sbjct: 131 AANVLVSESLMCKIADFGLARVI----EDN--EYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 953 SDVYSFGVVLLEVLT-GRHP 971
SDV+SFG++L E++T G+ P
Sbjct: 185 SDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 8e-14
Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 760 SIDDVVRNLTSANVIGTGSSGVVYR-VTIPNGETLAVKKMWSSDESGA--FSSEIQTLGS 816
S+ D + T IG G+SG VY + + G+ +A+K+M + +EI +
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 817 IRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALA 876
+H NIV L + + +YL GSL+ ++ A V AL
Sbjct: 73 NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---VCRECLQALE 129
Query: 877 YLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSY 936
+LH + ++H D+K+ N+LLG L DFG ++ + ++R + G+
Sbjct: 130 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-------PEQSKRSTMVGTP 179
Query: 937 GYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+MAPE + + K D++S G++ +E++ G P
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 59/216 (27%), Positives = 87/216 (40%), Gaps = 33/216 (15%)
Query: 774 IGTGSSGVVY----RVTIPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRHK-NIV 823
I G+ G VY R T G+ A+K M + ++ +E + +
Sbjct: 4 ISKGAFGSVYLAKKRST---GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 824 RLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY--EVVLGVAHALAYLHHD 881
+L +K+ L +YL G +SL+ G DW +Y EVVLGV LH
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVED----LHQR 116
Query: 882 CMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAP 941
I+H D+K N+L+ L DFGL+R + + G+ Y+AP
Sbjct: 117 ---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL-----------ENKKFVGTPDYLAP 162
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977
E + SD +S G V+ E L G P P
Sbjct: 163 ETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 767 NLTSANVIGTGSSGVVYRV-TIPNGETLAVKKM-------WSSDESGAFSSEIQTLGSIR 818
N ++G G+ G VY G LAVK++ +S E A EIQ L ++R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 819 HKNIVRLLGWGSNKNLKLL--FYDYLPNGSLSSLLHGAGKGGADWEARY--EVVLGVAHA 874
H IV+ G + K L F +Y+P GS+ L G + RY +++ GV+
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS-- 120
Query: 875 LAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV-----SGSGDDNCSKTNQR 929
YLH + I+H D+K N+L L DFG ++ + SG+G +
Sbjct: 121 --YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS------- 168
Query: 930 PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ G+ +M+PE S + K+DV+S ++E+LT + P
Sbjct: 169 --VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-13
Identities = 38/103 (36%), Positives = 59/103 (57%), Gaps = 1/103 (0%)
Query: 403 LTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNC 462
L G IP +S+ + LQ+++ S N++ G IP + + +L L L N +G IP +G
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 463 TTLRRLRLNDNRLSGTIPSEMGN-LKHLNFVDMSENHLVGGIP 504
T+LR L LN N LSG +P+ +G L H + ++N + GIP
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 772 NVIGTGSSGVVYR-VTIPNGETLAVK--KMWSSDESGAFSSEIQTLGSIRHKNIVRLLG- 827
IG+G+ G VY+ I GE +A+K K+ D+ EI L RH NIV G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLHHDCMP 884
+ L ++ +Y GSL + ++ + Y E + G LAYLH
Sbjct: 69 YLRRDKLWIVM-EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKG----LAYLHET--- 120
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHA 944
+H D+K N+LL LADFG VS +K R G+ +MAPE A
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFG----VSAQLTATIAK---RKSFIGTPYWMAPEVA 173
Query: 945 SMQRI---TEKSDVYSFGVVLLEVLTGRHPL 972
+++R K D+++ G+ +E+ + P+
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 773 VIGTGSSGVVY--RVTIPNGE--TLAVKKM---WSSDESGAFSSEIQTLGSIRHKNIVRL 825
VIG G G V R+ +P +A+K + ++ + F SE +G H NI+ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVL------GVAHALAYLH 879
G + ++ +++ NG+L S L + ++ V+ G+A + YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQN-------DGQFTVIQLVGMLRGIAAGMKYLS 123
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG-- 937
+H D+ A N+L+ ++DFGL+R + +D+ S L G
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL----EDDTSDPTYTSSLGGKIPIR 176
Query: 938 YMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ APE + ++ T SDV+S+G+V+ EV++ G P
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGA---FSSEIQTLGSIRHKNIVRLLGWG 829
+G G+ G V +V IP G +A K + +S E+Q + R IV G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 830 SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL---HHDCMPPI 886
N+N + +++ GSL + G + + + + V L YL H I
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR-----I 125
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM 946
+H D+K N+L+ Q L DFG VSG ++ + T G+ YM+PE
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFG----VSGELINSIADT-----FVGTSTYMSPERIQG 176
Query: 947 QRITEKSDVYSFGVVLLEVLTGRHPLD 973
+ T KSDV+S G+ ++E+ G+ P
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 28/211 (13%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFS-----SEIQTLGSIRHKNIVRLLG 827
IG G VVY+ + +G +A+KK+ + A + EI L + H N+++ L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR--YEVVLGVAHALAYLHHDCMPP 885
N + + G LS ++ K R ++ + + AL ++H
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---R 126
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945
I+H D+K NV + L D GL R S SKT L G+ YM+PE
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFS-------SKTTAAHSLVGTPYYMSPE--- 176
Query: 946 MQRITE-----KSDVYSFGVVLLEVLTGRHP 971
RI E KSD++S G +L E+ + P
Sbjct: 177 --RIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-13
Identities = 33/90 (36%), Positives = 54/90 (60%), Gaps = 1/90 (1%)
Query: 131 IDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKI 190
+ L L G IP ++ +LR L+S+ L+ N + G IP +G+++SL L L N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 191 PKSIGALSKLQVFRAGGNQNLKGELPWEIG 220
P+S+G L+ L++ GN +L G +P +G
Sbjct: 483 PESLGQLTSLRILNLNGN-SLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 66/213 (30%), Positives = 95/213 (44%), Gaps = 24/213 (11%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHK----NIVRLLGW 828
+G G+ G VY+V P G T+A+K++ + F+ I L I HK IV G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMEL-DILHKAVSPYIVDFYGA 67
Query: 829 GSNKNLKLLFYDYLPNGSLSSLLHGAGK-GGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
+ + +Y+ GSL L G G + + V L +L + I+
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ 947
H DVK NVL+ Q L DFG VSG+ + +KTN G YMAPE
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFG----VSGNLVASLAKTN-----IGCQSYMAPERIKSG 176
Query: 948 RITE------KSDVYSFGVVLLEVLTGRHPLDP 974
+ +SDV+S G+ +LE+ GR+P P
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 35/215 (16%)
Query: 774 IGTGSSGVVYRV-TIPNGETLAVKKMWSSDESGAFSS----EIQTLGSIRHKNIVRLLG- 827
IG GS GVV++ G+ +A+KK S++ EI+ L ++H N+V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKG--GADWEARYEVVLGVAHALAYLH-HDCMP 884
+ + L L+F +Y + ++L+ K G +++ A+ + H H+C
Sbjct: 69 FRRKRKLHLVF-EYCDH----TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC-- 121
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR----PQL-AGSYGYM 939
+H DVK N+L+ Q L DFG ARI++G GDD R P+L G Y
Sbjct: 122 --IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYG 179
Query: 940 APEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974
P DV++ G V E+LTG+ PL P
Sbjct: 180 PP-----------VDVWAIGCVFAELLTGQ-PLWP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 41/112 (36%), Positives = 58/112 (51%), Gaps = 14/112 (12%)
Query: 866 EVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSK 925
++ + + AL YLH ++H DVK NVL+ Q L DFG +SG D+ +K
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFG----ISGYLVDSVAK 160
Query: 926 TNQRPQLAGSYGYMAPEH----ASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
T AG YMAPE + + KSDV+S G+ ++E+ TGR P D
Sbjct: 161 TID----AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 63/239 (26%), Positives = 94/239 (39%), Gaps = 47/239 (19%)
Query: 774 IGTGSSGVVYR-VTIPNGETLAVKKMWSSDESGAFS----SEIQTLGSIRHKNIVRLLGW 828
+G G+ G VY+ I G +A+KK+ +E F EI+ L ++H N+V L+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 829 -----GSNKNLKLLFYDYLP--NGSLSSLLHGAGKGGADWEARYEV------VLGVAHAL 875
+K + Y P + LS LL + +L + +
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP-------SVKLTESQIKCYMLQLLEGI 128
Query: 876 AYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAG- 934
YLH + ILH D+KA N+L+ +ADFGLAR G + G
Sbjct: 129 NYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDG-----PPPNPKGGGGGGT 180
Query: 935 -SYG-------YMAPEH-ASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQ 984
Y Y PE +R T D++ G V E+ T R P L G + + Q
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR----PILQGKSDIDQ 235
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 63/214 (29%), Positives = 90/214 (42%), Gaps = 35/214 (16%)
Query: 772 NVIGTGSSGVVYRVTI-PNGETLAVKKMWSSD--ESGAFSS---EIQTLGSIRHKNIVRL 825
VIG G+ G V V + A+K M E G+ + E + L + H +V L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 826 LGWGS---NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY-----EVVLGVAHALAY 877
W S +N+ L+ D L G L L + E + E+VL AL Y
Sbjct: 66 --WYSFQDEENMYLVV-DLLLGGDLRYHL---SQKVKFSEEQVKFWICEIVL----ALEY 115
Query: 878 LHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG 937
LH I+H D+K N+LL ++ DF +A V+ + T +G+ G
Sbjct: 116 LHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD-----TLTTST---SGTPG 164
Query: 938 YMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
YMAPE Q + D +S GV E L G+ P
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 70/222 (31%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 765 VRNLTSANVIGTGSSGVVYRV-TIPNGETLAVKKMWSSDESGAF--SS--EIQTLGSIRH 819
V N IG G+ G+VYR +GE +A+KK+ +E SS EI L ++RH
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH 65
Query: 820 KNIVRLLGWGSNKNLKLLF--YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAY 877
NIV L K+L +F +Y L+SLL ++ + + ++L + L Y
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKC-LMLQLLRGLQY 123
Query: 878 LHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG 937
LH + I+H D+K N+LL +ADFGLAR G T P++ +
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY---GLPAKPMT---PKVV-TLW 173
Query: 938 YMAPEHA-SMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978
Y APE T D+++ G +L E+L + P LPG
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK----PLLPG 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 4e-13
Identities = 48/149 (32%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVKKM-WSSDESGAFSS---EIQTLGSIRHKNIVRLLG- 827
+G G+ GVVY+ GE +A+KK+ ++E G S+ EI L ++H NIV+LL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
+ + L L+F +Y L L + + ++ + LAY H IL
Sbjct: 67 IHTERKLYLVF-EYCDM-DLKKYLDKRPGPLSPNLIKS-IMYQLLRGLAYCHSHR---IL 120
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLARIVS 916
H D+K N+L+ LADFGLAR
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 767 NLTSANVIGTGSSGVVYRV-TIPNGETLAVKKMW-------SSDESGAFSSEIQTLGSIR 818
N ++G G+ G VY G LAVK++ +S E A EIQ L ++
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 819 HKNIVRLLGWGSNKNLKLL--FYDYLPNGSLSSLLHGAGKGGADWEARY--EVVLGVAHA 874
H+ IV+ G + + L F +++P GS+ L G + +Y +++ GV+
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS-- 120
Query: 875 LAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR-----IVSGSGDDNCSKTNQR 929
YLH + I+H D+K N+L L DFG ++ +SG+G
Sbjct: 121 --YLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG---------M 166
Query: 930 PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ G+ +M+PE S + K+D++S G ++E+LT + P
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-13
Identities = 37/76 (48%), Positives = 44/76 (57%)
Query: 285 GPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLK 344
G IP I L L+S+ L NS+ G IP LGS T L V+D S N GSIP S G L
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 345 LQELQLSVNQLSGTIP 360
L+ L L+ N LSG +P
Sbjct: 492 LRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 9e-13
Identities = 62/208 (29%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVKKM-------WSSDESGAFSSEIQTLGSIRHKNIVRL 825
+G G G V V T A+K + E SE + L H IV+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEH--IFSEKEILEECNHPFIVKL 58
Query: 826 L-GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMP 884
+ K + +L +Y G L ++L G ++ AR+ + V A YLH+
Sbjct: 59 YRTFKDKKYIYMLM-EYCLGGELWTILRDRGLFD-EYTARF-YIACVVLAFEYLHNR--- 112
Query: 885 PILHGDVKAMNVLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEH 943
I++ D+K N+LL GY L DFG A+ + SG KT G+ Y+APE
Sbjct: 113 GIIYRDLKPENLLLDSNGY-VKLVDFGFAKKL-KSG----QKTWT---FCGTPEYVAPEI 163
Query: 944 ASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ D +S G++L E+LTGR P
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 774 IGTGSSGVVYRVTIPNGETLAVKKMWSSDES-GAFSSEIQTLGSIRHKNIVRLLGWGSNK 832
+G G G V+ T +AVK M S AF +E + +++H +V+L + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73
Query: 833 NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVK 892
+ ++ +++ GSL L + +A +A++ +H D++
Sbjct: 74 PIYII-TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLR 129
Query: 893 AMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEK 952
A N+L+ +ADFGLAR++ +DN + R + APE + T K
Sbjct: 130 AANILVSASLVCKIADFGLARVI----EDN--EYTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 953 SDVYSFGVVLLEVLT-GRHP 971
SDV+SFG++L+E++T GR P
Sbjct: 184 SDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 1e-12
Identities = 67/241 (27%), Positives = 100/241 (41%), Gaps = 67/241 (27%)
Query: 774 IGTGSSGVVY--RVTIPNGETLAVKKMWSSDESGA-----FSS--EIQTLGSIRHKNIVR 824
+G G+ VVY R G +A+KK+ + A F++ EI+ L ++H NI+
Sbjct: 8 LGEGTYAVVYKARDKE-TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 825 LLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAH---------- 873
LL +G N+ L+F +++ L ++ +VL A
Sbjct: 67 LLDVFGHKSNINLVF-EFME-TDLEKVIK-----------DKSIVLTPADIKSYMLMTLR 113
Query: 874 ALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQ----- 928
L YLH + ILH D+K N+L+ LADFGLAR G N T+Q
Sbjct: 114 GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF---GSPNRKMTHQVVTRW 167
Query: 929 -R-PQL---AGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLV 983
R P+L A YG D++S G + E+L P LPG + +
Sbjct: 168 YRAPELLFGARHYGVGV-------------DMWSVGCIFAELLLRV----PFLPGDSDID 210
Query: 984 Q 984
Q
Sbjct: 211 Q 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 36/223 (16%)
Query: 774 IGTGSSGVVYRVT----IPNGETL--AVKKMWSSDESGA--FSSEIQTLGSIRHKNIVRL 825
+G G+ G V+ +P + + AVK + + ES F E + L ++H++IVR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLL--HG-------AGKGGADWEARYEVVLGVAHA-- 874
G + L+ ++Y+ +G L+ L HG G+ A + +L +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 875 -----LAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR 929
LA LH +H D+ N L+G G + DFG++R + + + + R
Sbjct: 133 SGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST---DYYRVGGR 183
Query: 930 PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
L +M PE ++ T +SD++SFGVVL E+ T G+ P
Sbjct: 184 TMLP--IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 56/185 (30%), Positives = 88/185 (47%), Gaps = 18/185 (9%)
Query: 790 GETLAVKKMWSSDESGA--FSSEIQTLGSIRHKNIVRLLGWG---SNKNLKLLFYDYLPN 844
GE +AVKK+ S F EI+ L S++H NIV+ G +NL+L+ +YLP
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM-EYLPY 91
Query: 845 GSLSSLLHGAGKGGADWEARYEVVLG--VAHALAYLHHDCMPPILHGDVKAMNVLLGPGY 902
GSL L K + R ++ + + YL +H D+ N+L+
Sbjct: 92 GSLRDYLQ---KHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESEN 145
Query: 903 QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVL 962
+ + DFGL +++ D + P + + Y APE + + + SDV+SFGVVL
Sbjct: 146 RVKIGDFGLTKVLP---QDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVL 201
Query: 963 LEVLT 967
E+ T
Sbjct: 202 YELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 35/84 (41%), Positives = 47/84 (55%)
Query: 114 LTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNL 173
L G IP + R L I+LSGNS+ G IP + + LE L L+ N G IP +G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 174 SSLAYLTLYDNQLSGKIPKSIGAL 197
+SL L L N LSG++P ++G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 72/254 (28%), Positives = 114/254 (44%), Gaps = 28/254 (11%)
Query: 737 RMANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT----IPNGET 792
+ N + D ++ K +F + NL+ +G G+ G V T +
Sbjct: 10 SINGNEYVYIDPTQLPYDLKWEFPRN----NLSFGKTLGAGAFGKVVEATAYGLSKSDAV 65
Query: 793 L--AVKKMWS---SDESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPNGS 846
+ AVK + S E A SE++ + + H+NIV LLG + L+ +Y G
Sbjct: 66 MKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125
Query: 847 LSSLLHGAGKGGADWEARYEVVLGVAHALAYL-HHDCMPPILHGDVKAMNVLLGPGYQAY 905
L + L + E VA +A+L +C +H D+ A NVLL G
Sbjct: 126 LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVK 181
Query: 906 LADFGLAR-IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLE 964
+ DFGLAR I++ S + K N R + +MAPE T +SDV+S+G++L E
Sbjct: 182 ICDFGLARDIMNDS--NYVVKGNARLPVK----WMAPESIFNCVYTFESDVWSYGILLWE 235
Query: 965 VLT-GRHPLDPTLP 977
+ + G +P P +P
Sbjct: 236 IFSLGSNPY-PGMP 248
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 774 IGTGSSGVVYRVTIPNGETLAVKKMWSSDES-GAFSSEIQTLGSIRHKNIVRLLGWGSNK 832
+G G G V+ T +A+K + AF E Q + +RH +V L S +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 833 NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVK 892
+ ++ +++ GSL L ++ +A +AY+ +H D++
Sbjct: 74 PIYIV-TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLR 129
Query: 893 AMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEK 952
A N+L+G +ADFGLAR++ +DN Q + + APE A R T K
Sbjct: 130 AANILVGDNLVCKIADFGLARLI----EDNEYTARQGAKF--PIKWTAPEAALYGRFTIK 183
Query: 953 SDVYSFGVVLLEVLT-GRHP 971
SDV+SFG++L E++T GR P
Sbjct: 184 SDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 67/223 (30%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 759 FSIDDVVRNLTSANVIGTGSSGVVYRVTIPN-GETLAVKKM-WSSDESGA----FSSEIQ 812
F DD + IG GS G VY T + E +AVKKM +S ++ E++
Sbjct: 14 FYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK 73
Query: 813 TLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVA 872
L ++H N + G ++ L +Y GS S LL K + E + G
Sbjct: 74 FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGAL 131
Query: 873 HALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQL 932
LAYLH M +H D+KA N+LL Q LADFG A S +
Sbjct: 132 QGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASKSSPAN-----------SF 177
Query: 933 AGSYGYMAPE---HASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
G+ +MAPE + K DV+S G+ +E+ + PL
Sbjct: 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 59/214 (27%), Positives = 104/214 (48%), Gaps = 32/214 (14%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS----EIQTLGSIRHKNIVRLL-- 826
IG G+ G+V++ GET+A+KK+ G + EI+ L + +H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 827 ---GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR-YEVVLGVAHALAYLHHDC 882
G G L+ +Y+P LS +L + + + + Y +L +AY+H +
Sbjct: 68 FPHGSG----FVLVM-EYMP-SDLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMHAN- 118
Query: 883 MPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE 942
I+H D+K N+L+ +ADFGLAR+ S ++ ++Q + Y APE
Sbjct: 119 --GIMHRDLKPANLLISADGVLKIADFGLARLF--SEEEPRLYSHQ----VATRWYRAPE 170
Query: 943 --HASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974
+ + ++ D+++ G + E+L G PL P
Sbjct: 171 LLYGA-RKYDPGVDLWAVGCIFAELLNGS-PLFP 202
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 16/215 (7%)
Query: 760 SIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKK--MWSSDESGAFSSEIQTLGS 816
SI D + T IG G+SG V+ + G+ +A+K+ + + +EI +
Sbjct: 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 817 IRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALA 876
+++ NIV L + + +YL GSL+ ++ A A V AL
Sbjct: 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA---VCRECLQALE 129
Query: 877 YLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSY 936
+LH + ++H D+K+ NVLLG L DFG ++ + ++R + G+
Sbjct: 130 FLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT-------PEQSKRSTMVGTP 179
Query: 937 GYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+MAPE + + K D++S G++ +E++ G P
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 773 VIGTGSSGVVY--RVTIPNGETLAV-----KKMWSSDESGAFSSEIQTLGSIRHKNIVRL 825
VIG G G V R+ +P + V K ++ + F SE +G H NI+ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVL------GVAHALAYLH 879
G + ++ +Y+ NGSL + L + ++ V+ G+A + YL
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKH-------DGQFTVIQLVGMLRGIASGMKYLS 123
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
+H D+ A N+L+ ++DFGL+R++ + + + + +
Sbjct: 124 D---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR----WT 176
Query: 940 APEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
APE + ++ T SDV+S+G+V+ EV++ G P
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 24/230 (10%)
Query: 773 VIGTGSSGVVYRVTIPN-GETLAVKKMWSSDESGAFSS----EIQTLGSIRHKNIVRLLG 827
++G GS G+V + G+ +A+KK S++ EI+ L +RH+N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCMPPI 886
K L ++++ + L L G D + + + + + H H+ I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHN----I 121
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEH-AS 945
+H D+K N+L+ L DFG AR ++ G+ R Y APE
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-------WYRAPELLVG 174
Query: 946 MQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLMLNL 995
+ D+++ G ++ E+LTG +P PG + + Q ++ + NL
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTG----EPLFPGDSDIDQLYHIIKCLGNL 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 773 VIGTGSSG--VVYRVTIPNGETLAVKK---MWSSDESGAFSS--EIQTLGSIRHKNIVRL 825
V+G G+ G +YR T + +L V K + E + EI L ++H NI+
Sbjct: 7 VLGKGAFGEATLYRRTEDD--SLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPP 885
+ N L+ +Y G+L + + E + + A++Y+H
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---G 121
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945
ILH D+K +N+ L L DFG+++I+ S+ + + G+ YM+PE
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILG-------SEYSMAETVVGTPYYMSPELCQ 174
Query: 946 MQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977
+ KSD+++ G VL E+LT + D T P
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 26/214 (12%)
Query: 774 IGTGSSGVVYRVTIPNGET--LAVKKMW---SSDESGAFSSEIQTLGSIRHKNIVRLLGW 828
+G G+ G VY+ N ET LA K+ S +E + EI+ L + H IV+LLG
Sbjct: 20 LGDGAFGKVYKAK--NKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 829 GSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILH 888
+ ++ P G++ +++ +G + + + + + AL YLH I+H
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEALQYLHSM---KIIH 133
Query: 889 GDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR 948
D+KA NVLL LADFG++ N +R G+ +MAPE +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSA-------KNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 949 ITE-----KSDVYSFGVVLLE---VLTGRHPLDP 974
+ + K+D++S G+ L+E + H L+P
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-12
Identities = 72/213 (33%), Positives = 109/213 (51%), Gaps = 8/213 (3%)
Query: 461 NCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHS 520
N L L LN NRL I SE+ L +L +D+ N++ P + +L+ LDL
Sbjct: 91 NLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSD 149
Query: 521 NGL-TGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILS 579
N + + P +L+ +DLS N LS L + +L+ L+ L LS N++S +P EI
Sbjct: 150 NKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIEL 207
Query: 580 CRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSH 639
L LD+ NN E+ L + +L L LS+N+ ++P L+ L LDLS+
Sbjct: 208 LSALEELDLSNNSII-ELLSSLSNLKNLSG-LELSNNKLE-DLPESIGNLSNLETLDLSN 264
Query: 640 NKLSGDLDALASLQNLVSLNVSFNDFSGELPNT 672
N++S + +L SL NL L++S N S LP
Sbjct: 265 NQIS-SISSLGSLTNLRELDLSGNSLSNALPLI 296
|
Length = 394 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 68/223 (30%), Positives = 97/223 (43%), Gaps = 25/223 (11%)
Query: 759 FSIDDVVRNLTSANVIGTGSSGVVYRV-TIPNGETLAVKKM-WSSDESGA----FSSEIQ 812
F DD + + IG GS G VY + N E +A+KKM +S +S E++
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 813 TLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVA 872
L +RH N ++ G ++ L +Y GS S LL K + E V G
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AVTHGAL 125
Query: 873 HALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQL 932
LAYLH M +H DVKA N+LL L DFG A I++ +
Sbjct: 126 QGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-----------XF 171
Query: 933 AGSYGYMAPE---HASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
G+ +MAPE + K DV+S G+ +E+ + PL
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-11
Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 1/92 (1%)
Query: 538 VDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEI 597
+ L + L G + + I L L + LS N + G IP + S L +LD+ N F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 598 PKELGQISSLEISLNLSSNQFSGEIPSEFSGL 629
P+ LGQ++SL I LNL+ N SG +P+ G
Sbjct: 483 PESLGQLTSLRI-LNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 774 IGTGSSGVVYRVTIPNGETLAVKKMWS-SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNK 832
+G G G V+ +A+K + S AF +E + ++H +VRL + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 833 NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVK 892
+ + +Y+ NGSL L ++ +A +A++ +H D++
Sbjct: 74 PI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLR 129
Query: 893 AMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGS---YGYMAPEHASMQRI 949
A N+L+ +ADFGLAR++ + N+ G+ + APE +
Sbjct: 130 AANILVSETLCCKIADFGLARLI---------EDNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 950 TEKSDVYSFGVVLLEVLT-GRHP 971
T KSDV+SFG++L E++T GR P
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 28/220 (12%)
Query: 767 NLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDESGAFSSEIQTLGSI-RH 819
++ +VIG G+ G V R I N +K+ S ++ F+ E++ L + H
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 820 KNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGA-----------GKGGADWEARYEVV 868
NI+ LLG N+ + +Y P G+L L + G A +++
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 869 LGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD-NCSKTN 927
+ + + +H D+ A NVL+G + +ADFGL+R G++ KT
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTM 177
Query: 928 QRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT 967
R + +MA E + T KSDV+SFGV+L E+++
Sbjct: 178 GRLPVR----WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-11
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 773 VIGTGSSG-VVYRVTIPNGETLAVKKM----WSSDESGAFSSEIQTLGSIRHKNIVRL-- 825
V+G+G++G V+ + +GE AVK + S + +E+ L + +IV+
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 826 -LGWGSNKN-----LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH 879
+N + L DY G L + K + +E L L +H
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTF-REHEAGLLFIQVLLAVH 157
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
H ++H D+K+ N+LL L DFG +++ + + D+ +T G+ Y+
Sbjct: 158 HVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-----FCGTPYYV 212
Query: 940 APEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
APE + ++K+D++S GV+L E+LT + P D
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 38/90 (42%), Positives = 50/90 (55%), Gaps = 1/90 (1%)
Query: 559 LSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQF 618
+ L L L G IP +I R L +++ N G IP LG I+SLE+ L+LS N F
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEV-LDLSYNSF 478
Query: 619 SGEIPSEFSGLTKLGILDLSHNKLSGDLDA 648
+G IP LT L IL+L+ N LSG + A
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-11
Identities = 33/85 (38%), Positives = 50/85 (58%)
Query: 259 LSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSC 318
L G IP +I LQ++ L NSI G IP +G+++ L+ L L NS G+IP+ LG
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 319 TELTVVDFSDNLLTGSIPRSFGNLL 343
T L +++ + N L+G +P + G L
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 59/211 (27%), Positives = 87/211 (41%), Gaps = 29/211 (13%)
Query: 772 NVIGTGSSGVVYRVTI----PNGETLAVK---KMWSSDESGAFSSEIQTLGSIRHKNIVR 824
VIG G G VY T+ AVK ++ +E F E + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 825 LLGWG-SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVV-------LGVAHALA 876
LLG ++ L+ Y+ +G L + + E V L VA +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRS--------ETHNPTVKDLIGFGLQVAKGME 112
Query: 877 YLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSY 936
YL +H D+ A N +L + +ADFGLAR + D +
Sbjct: 113 YLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIY---DKEYYSVHNHTGAKLPV 166
Query: 937 GYMAPEHASMQRITEKSDVYSFGVVLLEVLT 967
+MA E Q+ T KSDV+SFGV+L E++T
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 32/217 (14%)
Query: 772 NVIGTGSSGVVYRVTI-PNGETL--AVKKM---WSSDESGAFSSEIQTLGSI-RHKNIVR 824
+VIG G+ G V + I +G + A+K+M S D+ F+ E++ L + H NI+
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLLHG------------AGKGGADWEARYEVVLG-- 870
LLG ++ L +Y P+G+L L A + ++ +
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
VA + YL +H D+ A N+L+G Y A +ADFGL+R + KT R
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRL 185
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT 967
+ +MA E + T SDV+S+GV+L E+++
Sbjct: 186 PVR----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 762 DDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKM--WSSDESGAFSSEIQTLGSIR 818
D L + IG GS+G+V T G +AVKKM +E+ + +
Sbjct: 15 GDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ 74
Query: 819 HKNIVRLLGWGS---NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHAL 875
H NIV + + S L ++ ++L G+L+ ++ + E V L V AL
Sbjct: 75 HPNIVEM--YSSYLVGDELWVVM-EFLEGGALTDIV---THTRMNEEQIATVCLAVLKAL 128
Query: 876 AYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGS 935
++LH ++H D+K+ ++LL + L+DFG VS + +R L G+
Sbjct: 129 SFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS-------KEVPRRKSLVGT 178
Query: 936 YGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
+MAPE S + D++S G++++E++ G P
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 760 SIDDVVRNLTSANVIGTGSSGVVYR-VTIPNGETLAVKKM--WSSDESGAFSSEIQTLGS 816
S+ D + T IG G+SG VY + + G+ +A+++M + +EI +
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 817 IRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALA 876
++ NIV L + + +YL GSL+ ++ A V AL
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---VCRECLQALE 130
Query: 877 YLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSY 936
+LH + ++H D+K+ N+LLG L DFG ++ + ++R + G+
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-------PEQSKRSTMVGTP 180
Query: 937 GYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+MAPE + + K D++S G++ +E++ G P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 30/219 (13%)
Query: 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKM----WSSDESGAFSSEIQTLGSIRHKN 821
++LT +GTG GVV +A+K + S DE F E + + + H+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE---FIEEAKVMMKLSHEK 60
Query: 822 IVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHD 881
+V+L G + + + +Y+ NG L + L GK + E+ V +AYL
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEGMAYLESK 119
Query: 882 CMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG---- 937
+H D+ A N L+ ++DFGL+R V DD + S G
Sbjct: 120 ---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL---DD---------EYTSSVGSKFP 164
Query: 938 --YMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLD 973
+ PE + + KSDV++FGV++ EV + G+ P +
Sbjct: 165 VRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 29/213 (13%)
Query: 774 IGTGSSGVVYR---VTIPNGE---TLAVKKMW---SSDESGAFSSEIQTLGSIRHKNIVR 824
+G GS G+VY + GE +A+K + S E F +E + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLL--------HGAGKGGADWEARYEVVLGVAHALA 876
LLG S L+ + + G L S L + G G + ++ +A +A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 877 YLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR--PQLAG 934
YL +H D+ A N ++ + DFG+ R + + D K + P
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET--DYYRKGGKGLLP---- 184
Query: 935 SYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT 967
+MAPE T KSDV+SFGVVL E+ T
Sbjct: 185 -VRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 774 IGTGSSGVVYRV-TIPNGETLAVK--KMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGS 830
+G+G+ G VY+ + GE AVK K+ D+ EI + +H NIV G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 831 NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGD 890
++ + +Y GSL + H G ++ + Y V LAYLH +H D
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPL-SELQIAY-VCRETLQGLAYLHSKGK---MHRD 131
Query: 891 VKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR-- 948
+K N+LL LADFG+A ++ + +R G+ +MAPE A++++
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITAT-------IAKRKSFIGTPYWMAPEVAAVEKNG 184
Query: 949 -ITEKSDVYSFGVVLLEVLTGRHPL 972
+ D+++ G+ +E+ + P+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 773 VIGTGSSGVVYRVTIPNGETLAVKKM---WSSDESGAFSSEIQTLGSIRHKNIVRLLGWG 829
++G G+ G V++ T+ + +AVK + F SE + L H NIV+L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 830 SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCMPPILH 888
+ + + + +P G S L K + + L A +AYL +C +H
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESKNC----IH 116
Query: 889 GDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR 948
D+ A N L+G ++DFG++R DD ++ Q+ + APE + R
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR----QEDDGIYSSSGLKQI--PIKWTAPEALNYGR 170
Query: 949 ITEKSDVYSFGVVLLEVLT 967
+ +SDV+S+G++L E +
Sbjct: 171 YSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 760 SIDDVVRNLTSANVIGTGSSGVVYR-VTIPNGETLAVKKM--WSSDESGAFSSEIQTLGS 816
S+ D + T IG G+SG VY + I G+ +A+K+M + +EI +
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 817 IRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALA 876
++ NIV L + + +YL GSL+ ++ A V AL
Sbjct: 73 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---VCRECLQALD 129
Query: 877 YLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSY 936
+LH + ++H D+K+ N+LLG L DFG ++ + ++R + G+
Sbjct: 130 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-------PEQSKRSTMVGTP 179
Query: 937 GYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+MAPE + + K D++S G++ +E++ G P
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-11
Identities = 29/82 (35%), Positives = 49/82 (59%)
Query: 307 LVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATC 366
L G IP+++ L ++ S N + G+IP S G++ L+ L LS N +G+IP +
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 367 TALTHLEIDNNAISGEIPADIG 388
T+L L ++ N++SG +PA +G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-11
Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 759 FSIDDVVRNLTSANVIGTGSSGVVYRV-TIPNGETLAVKKM-WSSDESGA----FSSEIQ 812
F +D + T IG GS G VY + E +A+KKM +S +S E++
Sbjct: 18 FFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK 77
Query: 813 TLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVA 872
L I+H N + G ++ L +Y GS S LL K + E + G
Sbjct: 78 FLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGAL 135
Query: 873 HALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQL 932
LAYLH M +H D+KA N+LL Q LADFG A I S +
Sbjct: 136 QGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASIASPAN-----------SF 181
Query: 933 AGSYGYMAPE---HASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
G+ +MAPE + K DV+S G+ +E+ + PL
Sbjct: 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 17/137 (12%)
Query: 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH--HDCMPPILHGDVKAMNVL 897
+++ GSL +L AG+ + + + + V L YL H I+H DVK N+L
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILGK--ISIAVLRGLTYLREKHK----IMHRDVKPSNIL 132
Query: 898 LGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYS 957
+ + L DFG VSG D+ + + G+ YM+PE T +SD++S
Sbjct: 133 VNSRGEIKLCDFG----VSGQLIDSMANS-----FVGTRSYMSPERLQGTHYTVQSDIWS 183
Query: 958 FGVVLLEVLTGRHPLDP 974
G+ L+E+ GR+P+ P
Sbjct: 184 LGLSLVEMAIGRYPIPP 200
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 7e-11
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 772 NVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDESGAFSSEIQTLGSI-RHKNIVR 824
+VIG G+ G V + I + +K+ S D+ F+ E++ L + H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLLHGA-----------GKGGADWEARYEVVLGVAH 873
LLG ++ L +Y P+G+L L + A + +++ A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 874 ALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD-NCSKTNQRPQL 932
+ + +H D+ A N+L+G Y A +ADFGL+R G + KT R +
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPV 175
Query: 933 AGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT 967
+MA E + T SDV+S+GV+L E+++
Sbjct: 176 R----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 63/208 (30%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKM----WSSDESGAFSSEIQTLGSIRHKNIVRLL- 826
V+G GS G V V +G+ +KK+ S E A E Q L ++H NIV
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR-YEVVLGVAHALAYLHHDCMPP 885
W L + + G L L KG E + E + +A AL YLH
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLK-EQKGKLLPENQVVEWFVQIAMALQYLHEK---H 122
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945
ILH D+K NV L + D G+AR++ D L G+ YM+PE S
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-------MASTLIGTPYYMSPELFS 175
Query: 946 MQRITEKSDVYSFGVVLLEVLTGRHPLD 973
+ KSDV++ G + E+ T +H +
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-11
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 764 VVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFS-SEIQTLGSIRHKNI 822
V RN T+A + T R + P + +A M + + A++ SE+ L + H I
Sbjct: 75 VGRNPTTAAFVAT-------RGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGI 127
Query: 823 VRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVL---GVAHALAYLH 879
V+ + + LL +Y G L+ + K ++ YEV L + AL +H
Sbjct: 128 VKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVGLLFYQIVLALDEVH 186
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
M +H D+K+ N+ L P L DFG ++ S S + + + G+ Y+
Sbjct: 187 SRKM---MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS-----FCGTPYYL 238
Query: 940 APEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
APE +R ++K+D++S GV+L E+LT P
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 48/143 (33%), Positives = 70/143 (48%), Gaps = 11/143 (7%)
Query: 832 KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY--EVVLGVAHALAYLHHDCMPPILHG 889
KNL L +YLP G L+SLL G D Y E+VL AL YLH + I+H
Sbjct: 66 KNL-YLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVL----ALEYLHSN---GIIHR 117
Query: 890 DVKAMNVLLGPGYQAYLADFGLARI-VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR 948
D+K N+L+ L DFGL+++ + + + ++ G+ Y+APE Q
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177
Query: 949 ITEKSDVYSFGVVLLEVLTGRHP 971
++ D +S G +L E L G P
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-11
Identities = 41/130 (31%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 216 PWEIGNC------SNLVM--LGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEI 267
PW +C + LGL + G +P+ I L +Q+I + + + G IP +
Sbjct: 403 PWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL 462
Query: 268 GNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGS-CTELTVVDF 326
G+ + L+ L L NS +G IP +G L+ L+ L L NSL G +P LG +F
Sbjct: 463 GSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF 522
Query: 327 SDNLLTGSIP 336
+DN IP
Sbjct: 523 TDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 58/237 (24%), Positives = 103/237 (43%), Gaps = 34/237 (14%)
Query: 766 RNLTSANVIGTGSSGVV-----YRVTIPNGETL-AVKKMWSSDESGA--FSSEIQTLGSI 817
R++ +G G+ G V Y ++ + L AVK + + F E + L ++
Sbjct: 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 64
Query: 818 RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKG------GADWEARYEVVLG- 870
+H++IV+ G + + ++ ++Y+ +G L+ L G G +A+ E+ L
Sbjct: 65 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 871 -------VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923
+A + YL +H D+ N L+G + DFG++R V +
Sbjct: 125 MLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP---LDPTL 976
P +M PE ++ T +SDV+SFGV+L E+ T G+ P L T
Sbjct: 182 GGHTMLP-----IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 67/225 (29%), Positives = 101/225 (44%), Gaps = 30/225 (13%)
Query: 767 NLTSANVIGTGSSGVVY------RVTIPNGETLAVKKMWSS----DESGAFSSEIQTLGS 816
++T +G G+ G VY R +AVK + S DES F E +
Sbjct: 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD-FLMEALIMSK 65
Query: 817 IRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLL-HGAGKGGADWEARYEVVLGVAHAL 875
H+NIVRL+G + + + + + G L S L + + +L A +
Sbjct: 66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 876 A----YLHHDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQ 928
A YL + +H D+ A N LL GPG A +ADFG+AR + + + +
Sbjct: 126 AKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA---SYYRKGG 179
Query: 929 RPQLAGSYGYMAPEHASMQRI-TEKSDVYSFGVVLLEVLT-GRHP 971
R L +M PE A + I T K+DV+SFGV+L E+ + G P
Sbjct: 180 RAML--PIKWMPPE-AFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 46/146 (31%), Positives = 68/146 (46%), Gaps = 11/146 (7%)
Query: 774 IGTGSSGVVYRV-TIPNGETLAVKKMWSSDESGAFSS----EIQTLGSIRHKNIVRLLGW 828
IG G+ GVVY+ GE +A+KK+ E+ S EI L + H NIV+LL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 829 GSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCMPPIL 887
+N L +++L + L + + G + + LA+ H H +L
Sbjct: 68 IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR----VL 122
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLAR 913
H D+K N+L+ LADFGLAR
Sbjct: 123 HRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 66/222 (29%), Positives = 95/222 (42%), Gaps = 40/222 (18%)
Query: 766 RNLTSANVIGTGSSGVV--YRVTIPN---GETLAVKKMWS----SDESGAFSSEIQTLGS 816
R L V+G G G V Y N GE +AVK + + SG + EI L +
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSG-WKKEINILKT 62
Query: 817 IRHKNIVRLLGWGSNKNLK--LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG---- 870
+ H+NIV+ G S + K L +Y+P GSL D+ ++++ L
Sbjct: 63 LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLR-----------DYLPKHKLNLAQLLL 111
Query: 871 ----VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV-SGSGDDNCSK 925
+ +AYLH +H D+ A NVLL + DFGLA+ V G +
Sbjct: 112 FAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 168
Query: 926 TNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT 967
P + A E + + SDV+SFGV L E+LT
Sbjct: 169 DGDSPVF-----WYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 63/219 (28%), Positives = 92/219 (42%), Gaps = 32/219 (14%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWS-SDESGAFSSEIQTLGSI-RHKNIVRLLGWG 829
VIG G+ G VY+ G+ +A+K M DE E L H NI G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 830 SNKNL-----KLLF-YDYLPNGSLSSLLHGAGKGGA----DWEARYEVVLGVAHALAYLH 879
KN +L + GS++ L+ G K G +W A Y ++ LAYLH
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA-Y-ILRETLRGLAYLH 130
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQ-LAGSYGY 938
++H D+K N+LL + L DFG++ + T R G+ +
Sbjct: 131 ---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--------DSTLGRRNTFIGTPYW 179
Query: 939 MAPE--HASMQR---ITEKSDVYSFGVVLLEVLTGRHPL 972
MAPE Q +SDV+S G+ +E+ G+ PL
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-10
Identities = 69/221 (31%), Positives = 115/221 (52%), Gaps = 9/221 (4%)
Query: 445 LLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIP 504
L LS++ +P + +L L + S + NL L +D++ N L I
Sbjct: 52 LNLSSNTLLLLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSNIS 110
Query: 505 PSVVGCQSLEFLDLHSNGLTG--SVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKL 562
++ +L LDL +N +T + L ++L+ +DLSDN++ SL + +L L L
Sbjct: 111 E-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNL 168
Query: 563 LLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEI 622
LS N LS +P + + L LD+ N+ S ++P E+ +S+LE L+LS+N E+
Sbjct: 169 DLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALE-ELDLSNNSII-EL 224
Query: 623 PSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFN 663
S S L L L+LS+NKL +++ +L NL +L++S N
Sbjct: 225 LSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNN 265
|
Length = 394 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 55/193 (28%), Positives = 87/193 (45%), Gaps = 23/193 (11%)
Query: 789 NGETLAVKKMWSSDES----GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844
+ L K+ D S F E++ L + NI RLLG + + +Y+ N
Sbjct: 44 DAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103
Query: 845 GSLSSLL--HGAGKGGADWEAR---YEVVLGVAHALA----YL-HHDCMPPILHGDVKAM 894
G L+ L H A G ++ + +L +A +A YL + +H D+
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN----FVHRDLATR 159
Query: 895 NVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSD 954
N L+G Y +ADFG++R + S + + R L +MA E + + T KSD
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSS---DYYRVQGRAPL--PIRWMAWESVLLGKFTTKSD 214
Query: 955 VYSFGVVLLEVLT 967
V++FGV L E+LT
Sbjct: 215 VWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-10
Identities = 20/42 (47%), Positives = 28/42 (66%), Gaps = 1/42 (2%)
Query: 35 LDEQGQALLTWKNSLNS-STDALSSWNPAETSPCKWFGIHCS 75
L++ ALL +K+SLN + ALSSWNP+ + PC W G+ C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 57/214 (26%), Positives = 88/214 (41%), Gaps = 37/214 (17%)
Query: 774 IGTGSSGVVY----RVTIPNGETLAVKKM-----WSSDESGAFSSEIQTLGSIRHKNIVR 824
+G G G V+ + T GE +A+K+M + +E +E L + + + +V+
Sbjct: 9 VGQGGYGQVFLAKKKDT---GEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVA--HALAYLH 879
LL + L +Y+P G +LL+ G D AR+ E+ V H L Y+H
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-HARFYMAEMFEAVDALHELGYIH 124
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
D P N L+ L DFGL++ + + N + GS YM
Sbjct: 125 RDLKPE---------NFLIDASGHIKLTDFGLSKGI-------VTYAN---SVVGSPDYM 165
Query: 940 APEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
APE + D +S G +L E L G P
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-10
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 774 IGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSS----EIQTLGSIRHKNIVRLLGWG 829
+G G+ GVV +V + +K+ + A + E+Q L IV G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 830 SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHG 889
+ + +++ GSL +L A + E +V + V LAYL I+H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKHQ--IMHR 128
Query: 890 DVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRI 949
DVK N+L+ + L DFG VSG D+ + + G+ YM+PE
Sbjct: 129 DVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANS-----FVGTRSYMSPERLQGTHY 179
Query: 950 TEKSDVYSFGVVLLEVLTGRHPLDP 974
+ +SD++S G+ L+E+ GR+P+ P
Sbjct: 180 SVQSDIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 774 IGTGSSGVVYRV-TIPNGETLAVK--KMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGS 830
IG+G+ G VY+ + GE A+K K+ ++ EI + +H NIV G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 831 NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGD 890
++ + ++ GSL + H G ++ + Y V L YLH +H D
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPL-SESQIAY-VSRETLQGLYYLHSKGK---MHRD 131
Query: 891 VKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR-- 948
+K N+LL LADFG++ ++ + +R G+ +MAPE A+++R
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITAT-------IAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 949 -ITEKSDVYSFGVVLLEVLTGRHPL 972
+ D+++ G+ +E+ + P+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 774 IGTGSSGVVYRVTIPNGETLAVKKMW---SSDESGAFSSEIQTLGSIRHKNIVRLLGWGS 830
+G G+ G VY+ LA K+ S +E + EI L S H NIV+LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 831 NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGD 890
+N + ++ G++ +++ + + + R V AL YLH + I+H D
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHEN---KIIHRD 128
Query: 891 VKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE----HASM 946
+KA N+L LADFG++ N +R G+ +MAPE S
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSA-------KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 947 QRITE-KSDVYSFGVVLLE---VLTGRHPLDP 974
R + K+DV+S G+ L+E + H L+P
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 774 IGTGSSGVVYRVTI-PNGETLAVKKM--WSSDESGAFSSEIQTLGSIRHKNIVRLLGWGS 830
IG GS+G+V T+ +G+ +AVKKM +E+ + +H+N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 831 NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGD 890
+ + ++L G+L+ ++ + E V L V AL+ LH ++H D
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLHAQ---GVIHRD 141
Query: 891 VKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRIT 950
+K+ ++LL + L+DFG VS + +R L G+ +MAPE S
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVS-------KEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 951 EKSDVYSFGVVLLEVLTGRHP 971
+ D++S G++++E++ G P
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 63/212 (29%), Positives = 90/212 (42%), Gaps = 19/212 (8%)
Query: 768 LTSANVIGTGSSGVVYR--VTIPNGETLAV-----KKMWSSDESGAFSSEIQTLGSIRHK 820
+T IG G G VY+ P E +AV K S F E + H
Sbjct: 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHP 67
Query: 821 NIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHH 880
+IV+L+G + + ++ + P G L S L K D + ++ ALAYL
Sbjct: 68 HIVKLIGVITENPVWIVM-ELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLES 125
Query: 881 DCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMA 940
+H D+ A NVL+ L DFGL+R + SK + P +MA
Sbjct: 126 KRF---VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG-KLP-----IKWMA 176
Query: 941 PEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
PE + +R T SDV+ FGV + E+L G P
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-10
Identities = 45/147 (30%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 35 LDEQGQALLTWKNSLNSSTDALSSWNPAETSPC-----KWFGIHC-----SSNGEVVEIS 84
L E+ AL T K+SL WN PC W G C + +
Sbjct: 370 LLEEVSALQTLKSSL--GLPLRFGWN---GDPCVPQQHPWSGADCQFDSTKGKWFIDGLG 424
Query: 85 LKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPT 144
L L+G +P+ L+ L+ + +S ++ G IP G L +DLS NS G IP
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 145 EVCRLRKLESLYLNTNLLEGEIPSDIG 171
+ +L L L LN N L G +P+ +G
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 36/220 (16%)
Query: 773 VIGTGSSGVVYR-VTIPNGETLAVKKM-WSSDESGAFSSEIQTLGSI-RHKNIVRLLGW- 828
V+G G+ G VY+ + G+ A+K M + DE EI L H+NI G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 829 ------GSNKNLKLLFYDYLPNGSLSSLLHGAGKGGA---DWEARY--EVVLGVAHALAY 877
G + L L+ ++ GS++ L+ KG A DW A E++ G+AH +
Sbjct: 83 IKKSPPGHDDQLWLVM-EFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHL--H 138
Query: 878 LHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG 937
H ++H D+K NVLL + L DFG VS D + N G+
Sbjct: 139 AHK-----VIHRDIKGQNVLLTENAEVKLVDFG----VSAQLDRTVGRRN---TFIGTPY 186
Query: 938 YMAPEHASMQRITE-----KSDVYSFGVVLLEVLTGRHPL 972
+MAPE + + +SD++S G+ +E+ G PL
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS----EIQTLGSIRHKNIVRLLGW 828
+G G+ GVV++V+ P+G +A +K+ + A + E+Q L IV G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMA-RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 829 GSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILH 888
+ + +++ GSL +L AG+ + +V + V L YL I+H
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK--HKIMH 127
Query: 889 GDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR 948
DVK N+L+ + L DFG VSG D+ + + G+ YM+PE
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANS-----FVGTRSYMSPERLQGTH 178
Query: 949 ITEKSDVYSFGVVLLEVLTGRHPLDP 974
+ +SD++S G+ L+E+ GR+P+ P
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 62/244 (25%), Positives = 96/244 (39%), Gaps = 61/244 (25%)
Query: 755 QKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQT 813
QK ++D L + IG+G+ G VY++ G +AVK+M + +
Sbjct: 8 QKYPADLND----LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMD 63
Query: 814 LG----SIRHKNIVRLLG-WGSNKN--------------LKLLFYDYLPNGSLSSLLHGA 854
L S IV+ G + ++ + L +P
Sbjct: 64 LDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPE-------DIL 116
Query: 855 GKGGADWEARYEVVLGVAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLA 912
GK + + + AL YL H ++H DVK N+LL L DFG++
Sbjct: 117 GK----------MTVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGIS 162
Query: 913 -RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEK----SDVYSFGVVLLEVLT 967
R+V D+ +KT AG YMAPE K +DV+S G+ L+E+ T
Sbjct: 163 GRLV-----DSKAKTRS----AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT 213
Query: 968 GRHP 971
G+ P
Sbjct: 214 GQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-10
Identities = 29/87 (33%), Positives = 50/87 (57%)
Query: 208 NQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEI 267
NQ L+G +P +I +L + L+ SI GN+P S+G + ++ + + + +G IPE +
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 268 GNCSELQNLYLYQNSISGPIPGRIGAL 294
G + L+ L L NS+SG +P +G
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 64/214 (29%), Positives = 86/214 (40%), Gaps = 19/214 (8%)
Query: 763 DVVRNLTSANVIGTGSSGVVYR-VTIPNGETLAVKKM---WSSDESGAFSSEIQTLGSIR 818
D T IG GS G VY+ + E +A+K + + DE EI L
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 819 HKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVL-GVAHALAY 877
I R G + +YL GS LL K G E +L + L Y
Sbjct: 61 SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDY 116
Query: 878 LHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG 937
LH + +H D+KA NVLL LADFG V+G D K N G+
Sbjct: 117 LHSERK---IHRDIKAANVLLSEQGDVKLADFG----VAGQLTDTQIKRN---TFVGTPF 166
Query: 938 YMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+MAPE K+D++S G+ +E+ G P
Sbjct: 167 WMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 774 IGTGSSGVVYRVTIPN-GETLAVKKM--WSSDESGAFSSEIQTLGSIRHKNIVRLLGWGS 830
IG GS+G+V T + G+ +AVKKM +E+ + H+N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 831 NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGD 890
+ + ++L G+L+ ++ + E V L V AL+YLH+ ++H D
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQ---GVIHRD 143
Query: 891 VKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRIT 950
+K+ ++LL + L+DFG VS + +R L G+ +MAPE S
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVS-------KEVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 951 EKSDVYSFGVVLLEVLTGRHP 971
+ D++S G++++E++ G P
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-10
Identities = 37/127 (29%), Positives = 53/127 (41%), Gaps = 46/127 (36%)
Query: 451 LSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGC 510
L GFIP DI L+ + L+ N + G IP +G++
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSI------------------------ 465
Query: 511 QSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLS 570
TSL+++DLS N +GS+ S+G LT L L L+ N LS
Sbjct: 466 ----------------------TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS 503
Query: 571 GRIPAEI 577
GR+PA +
Sbjct: 504 GRVPAAL 510
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-10
Identities = 31/86 (36%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 586 LDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGD 645
L + N G IP ++ ++ L+ S+NLS N G IP +T L +LDLS+N +G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQ-SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 646 L-DALASLQNLVSLNVSFNDFSGELP 670
+ ++L L +L LN++ N SG +P
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-09
Identities = 32/87 (36%), Positives = 47/87 (54%), Gaps = 1/87 (1%)
Query: 353 NQ-LSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESL 411
NQ L G IP +I+ L + + N+I G IP +G+I L + N G+IPESL
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 412 SQCQELQALDFSYNNLSGPIPKEIFGL 438
Q L+ L+ + N+LSG +P + G
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 32/91 (35%), Positives = 50/91 (54%)
Query: 419 ALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGT 478
L L G IP +I LR+L + L N + G IPP +G+ T+L L L+ N +G+
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 479 IPSEMGNLKHLNFVDMSENHLVGGIPPSVVG 509
IP +G L L ++++ N L G +P ++ G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 74/264 (28%), Positives = 103/264 (39%), Gaps = 57/264 (21%)
Query: 745 ADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSG-VVYRVTI------PNGETLAVKK 797
AD WE++ + LT +G G G VV I PN K
Sbjct: 3 ADPKWELSRTR------------LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVK 50
Query: 798 MWSSDESGA----FSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLH 852
M D + SE++ + I +HKNI+ LLG + + +Y G+L L
Sbjct: 51 MLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLR 110
Query: 853 GAGKGGADW--------------EARYEVVLGVAHALAYL-HHDCMPPILHGDVKAMNVL 897
G D+ + VA + YL C +H D+ A NVL
Sbjct: 111 ARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKC----IHRDLAARNVL 166
Query: 898 LGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYS 957
+ +ADFGLAR V D TN R + +MAPE + T +SDV+S
Sbjct: 167 VTEDNVMKIADFGLARDVHNI-DYYKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWS 221
Query: 958 FGVVLLEVLTGRHPLDPTLPGGAP 981
FGV+L E+ T GG+P
Sbjct: 222 FGVLLWEIFT---------LGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 1e-09
Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 52/229 (22%)
Query: 774 IGTGSSGVVYR-VTIPNGETLAVKKMWSSDESGAFSS---------EI---QTLGSIRHK 820
+G G+ G+V++ + E +A+KK++ AF + EI Q LG H
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIF-----DAFRNATDAQRTFREIMFLQELGD--HP 67
Query: 821 NIVRLLG---WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGG--ADWEARYEVVLGVAHAL 875
NIV+LL ++K++ L+F +Y+ + LH + D RY ++ + AL
Sbjct: 68 NIVKLLNVIKAENDKDIYLVF-EYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKAL 120
Query: 876 AYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGS 935
Y+H ++H D+K N+LL + LADFGLAR +S ++ + P L
Sbjct: 121 KYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN-----PENPVLT-D 171
Query: 936 Y----GYMAPE--HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978
Y Y APE S R T+ D++S G +L E+L G+ P PG
Sbjct: 172 YVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGK----PLFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 60/236 (25%), Positives = 92/236 (38%), Gaps = 49/236 (20%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLL 826
VIG G+ G V+ V G+ A+K + SD + +E L IV+L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 827 -GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGV--AHALAYLHH 880
+ ++L L+ +Y+P G L +LL + AR+ E+VL + H L ++H
Sbjct: 68 YSFQDEEHLYLVM-EYMPGGDLMNLLIRKDVFPEET-ARFYIAELVLALDSVHKLGFIHR 125
Query: 881 DCMPPILHGDVKAMNVLLGPGYQAYLADFGLA-RIVSGSGDDNCSKTNQRPQLA------ 933
D +K N+L+ LADFGL ++ D N L
Sbjct: 126 D---------IKPDNILIDADGHIKLADFGLCKKM--NKAKDREYYLNDSHNLLFRDNVL 174
Query: 934 -----------------GSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
G+ Y+APE + D +S GV+L E+L G P
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 41/113 (36%), Positives = 54/113 (47%), Gaps = 23/113 (20%)
Query: 867 VVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKT 926
+ + AL YL + I+H DVK N+LL L DFG +SG D+ +KT
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFG----ISGQLVDSIAKT 165
Query: 927 NQRPQLAGSYGYMAPEHASMQRITE--------KSDVYSFGVVLLEVLTGRHP 971
+ AG YMAPE RI +SDV+S G+ L EV TG+ P
Sbjct: 166 ----RDAGCRPYMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 68/256 (26%), Positives = 114/256 (44%), Gaps = 8/256 (3%)
Query: 315 LGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEI 374
L + L +D + N L +I L L L L N ++ P+ + L L++
Sbjct: 89 LLNLLPLPSLDLNLNRLRSNISELL-ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDL 147
Query: 375 DNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKE 434
+N I +P+ + N+ L N L+ ++P+ LS L LD S N +S +P E
Sbjct: 148 SDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPE 204
Query: 435 IFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDM 494
I L L +L L +N + + + N L L L++N+L +P +GNL +L +D+
Sbjct: 205 IELLSALEELDLSNNSIIE-LLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDL 262
Query: 495 SENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIG 554
S N + S+ +L LDL N L+ ++P L L L + L+
Sbjct: 263 SNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKL 320
Query: 555 SLTELSKLLLSKNQLS 570
+ L+ +LS + S
Sbjct: 321 NSILLNNNILSNGETS 336
|
Length = 394 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 51/201 (25%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 773 VIGTGSSGVVYRVTIPNGETLAVKKM-----WSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
V+G G+ G+V+ + L + K + DE A +E Q L + H NI+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
++ +Y P G+L+ + D + ++ L LHH IL
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDED---TILHFFVQILLALHHVHTKLIL 123
Query: 888 HGDVKAMNVLLGPGYQAY-LADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM 946
H D+K N+LL + DFG+++I+S SK+ + G+ Y++PE
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILS-------SKSKAY-TVVGTPCYISPELCEG 175
Query: 947 QRITEKSDVYSFGVVLLEVLT 967
+ +KSD+++ G VL E+ +
Sbjct: 176 KPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 49/193 (25%), Positives = 87/193 (45%), Gaps = 22/193 (11%)
Query: 793 LAVKKMWSSDESGA--FSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSL 850
+AVK + + ++ F E + L +++H++IV+ G + ++ ++Y+ +G L+
Sbjct: 38 VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97
Query: 851 LHGAG-------KGGADWEARYEVVLGVAHALA----YLHHDCMPPILHGDVKAMNVLLG 899
L G +G E +L +A +A YL +H D+ N L+G
Sbjct: 98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVG 154
Query: 900 PGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFG 959
+ DFG++R V + P +M PE ++ T +SDV+S G
Sbjct: 155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP-----IRWMPPESIMYRKFTTESDVWSLG 209
Query: 960 VVLLEVLT-GRHP 971
VVL E+ T G+ P
Sbjct: 210 VVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 41/215 (19%)
Query: 774 IGTGSSGVVYRV-TIPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRLL- 826
IG GS G V + +G+ +K KM S E E+ L +++H NIV+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGA-------DWEARYEVVLGVAHALAYLH 879
+ N NL ++ DY G L ++ +G DW ++ L + H
Sbjct: 67 SFEENGNLYIVM-DYCEGGDLYKKINAQ-RGVLFPEDQILDWFV--QICLALKHV----- 117
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLA----GS 935
HD ILH D+K+ N+ L L DFG+AR++ N +LA G+
Sbjct: 118 HD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-----------NSTVELARTCIGT 164
Query: 936 YGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRH 970
Y++PE + KSD+++ G VL E+ T +H
Sbjct: 165 PYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 56/223 (25%), Positives = 89/223 (39%), Gaps = 37/223 (16%)
Query: 774 IGTGSSGVVYRVTIP-----NGETLAVKKMW----SSDESGAFSSEIQTLGSIRHKNIVR 824
IG G+ G V++ P T+ KM S+D F E + H NIV+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLL--------HGAGKGGADWEA------------R 864
LLG + L ++Y+ G L+ L + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 865 YEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924
+ VA +AYL +H D+ N L+G +ADFGL+R + + D
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA--DYY- 186
Query: 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT 967
K ++ + +M PE R T +SDV+++GVVL E+ +
Sbjct: 187 KASENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 3e-09
Identities = 46/162 (28%), Positives = 72/162 (44%), Gaps = 29/162 (17%)
Query: 819 HKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL 878
+ N ++L + +L DY+ +G L LL GK E + ++ + AL L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEA-EVKK-IIRQLVEALNDL 125
Query: 879 H-HDCMPPILHGDVKAMNVLLGPGY-----QAYLADFGLARIV-SGSGDDNCSKTNQRPQ 931
H H+ I+H D+K NVL Y + YL D+GL +I+ + S D
Sbjct: 126 HKHN----IIHNDIKLENVL----YDRAKDRIYLCDYGLCKIIGTPSCYD---------- 167
Query: 932 LAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
G+ Y +PE D ++ GV+ E+LTG+HP
Sbjct: 168 --GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207
|
Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 25/205 (12%)
Query: 774 IGTGSSGVV----YRVTIPNGETLAVK-KMWSSDESGAFSSEI----QTLGSIRHKNIVR 824
+G G+ G V Y + +G+ + V K + A E + + H IVR
Sbjct: 3 LGHGNFGSVVKGVYL--MKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMP 884
L+G + L +L + P G L L + E+ VA +AYL
Sbjct: 61 LIGVCKGEPL-MLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESK--- 114
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSY--GYMAPE 942
+H D+ A NVLL +QA ++DFG++R + G+G D R AG + + APE
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRAL-GAGSDY-----YRATTAGRWPLKWYAPE 168
Query: 943 HASMQRITEKSDVYSFGVVLLEVLT 967
+ + + KSDV+S+GV L E +
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 35/227 (15%)
Query: 768 LTSANVIGTGSSGVVYRVTIPNGET----LAVKKM----WSSDESGAFSSEIQTLGSIRH 819
L ++G G G V + + +AVK M + E F SE + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 820 KNIVRLLG---WGSNKN---LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVL---- 869
N+++L+G S+ ++ ++ +G L S L + GG + + +L
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 870 GVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD----DNCSK 925
+A + YL + +H D+ A N +L +ADFGL++ + SGD +K
Sbjct: 121 DIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIY-SGDYYRQGRIAK 176
Query: 926 TNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ ++A E + + T KSDV++FGV + E+ T G+ P
Sbjct: 177 MPVK--------WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 27/207 (13%)
Query: 774 IGTGSSGVVYRVTIPNGET-LAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLL- 826
+GTG+ G V+ V E A+K M + + +E + L + H I+RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY--EVVLGVAHALAYLHHDCMP 884
+ L +L +Y+P G L S L +G+ Y E+V AL YLH
Sbjct: 69 TEHDQRFLYMLM-EYVPGGELFSYLRNSGRFSNSTGLFYASEIVC----ALEYLHSK--- 120
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHA 944
I++ D+K N+LL L DFG A+ + ++ L G+ Y+APE
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR----------DRTWTLCGTPEYLAPEVI 170
Query: 945 SMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ + D ++ G+++ E+L G P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 27/211 (12%)
Query: 780 GVVYRVTIPNGETLAVKKMW---SSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836
G +Y + + + +A+K + + + G F E + + H NIV LLG + +
Sbjct: 24 GHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83
Query: 837 LFYDYLPNGSLSSLL---------------HGAGKGGADWEARYEVVLGVAHALAYLHHD 881
+ ++YL G L L G K D + + +A + YL
Sbjct: 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH 143
Query: 882 CMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAP 941
+H D+ A N+L+G ++D GL+R + + + P +M P
Sbjct: 144 FF---VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP-----IRWMPP 195
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
E + + SD++SFGVVL E+ + G P
Sbjct: 196 EAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 54/220 (24%), Positives = 85/220 (38%), Gaps = 31/220 (14%)
Query: 767 NLTSANVIGTGSSGVVYRVTIP-----NGETL-AVKKMWSSDESG---AFSSEIQTLGSI 817
NL +G G G V+ GETL VK + + + F E+ +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 818 RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWE--------ARYEVVL 869
HKN+VRLLG + +Y G L L A K + + +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLR-ATKSKDEKLKPPPLSTKQKVALCT 124
Query: 870 GVAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTN 927
+A + +L +H D+ A N L+ + ++ L++ V S + N
Sbjct: 125 QIALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS--EYYKLRN 177
Query: 928 QRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT 967
L ++APE + KSDV+SFGV++ EV T
Sbjct: 178 ALIPLR----WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 65/211 (30%), Positives = 91/211 (43%), Gaps = 31/211 (14%)
Query: 788 PNGETLAVKKMWSSDES----GAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYL 842
PN T KM SD + SE++ + I +HKNI+ LLG + + +Y
Sbjct: 47 PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 106
Query: 843 PNGSLSSLLHGAGKGGADW--------------EARYEVVLGVAHALAYLHHDCMPPILH 888
G+L L G ++ + VA + YL +H
Sbjct: 107 SKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIH 163
Query: 889 GDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR 948
D+ A NVL+ +ADFGLAR + D TN R + +MAPE A R
Sbjct: 164 RDLAARNVLVTEDNVMKIADFGLARDIHHI-DYYKKTTNGRLPVK----WMAPE-ALFDR 217
Query: 949 I-TEKSDVYSFGVVLLEVLT-GRHPLDPTLP 977
I T +SDV+SFGV+L E+ T G P P +P
Sbjct: 218 IYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 57/188 (30%), Positives = 85/188 (45%), Gaps = 31/188 (16%)
Query: 809 SEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEV 867
SE++ + I +HKNI+ LLG + + +Y G+L L G ++ Y++
Sbjct: 69 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS--YDI 126
Query: 868 ----------------VLGVAHALAYL-HHDCMPPILHGDVKAMNVLLGPGYQAYLADFG 910
VA + YL C +H D+ A NVL+ +ADFG
Sbjct: 127 ARVPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFG 182
Query: 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GR 969
LAR V+ D TN R + +MAPE + T +SDV+SFGV++ E+ T G
Sbjct: 183 LARDVNNI-DYYKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 237
Query: 970 HPLDPTLP 977
P P +P
Sbjct: 238 SPY-PGIP 244
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 34/208 (16%)
Query: 792 TLAVK--KMWSSDESGA-FSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPNGSL 847
T+AVK K ++D+ A SE++ + I +HKNI+ LLG + + + +Y G+L
Sbjct: 46 TVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL 105
Query: 848 SSLLHGAGKGGAD--------------WEARYEVVLGVAHALAYLH-HDCMPPILHGDVK 892
L G D ++ VA + YL C +H D+
Sbjct: 106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC----IHRDLA 161
Query: 893 AMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKT-NQRPQLAGSYGYMAPEHASMQRI-T 950
A NVL+ +ADFGLAR V D KT N R + +MAPE A R+ T
Sbjct: 162 ARNVLVTEDNVMKIADFGLARGVHDI--DYYKKTSNGRLPVK----WMAPE-ALFDRVYT 214
Query: 951 EKSDVYSFGVVLLEVLT-GRHPLDPTLP 977
+SDV+SFG+++ E+ T G P P +P
Sbjct: 215 HQSDVWSFGILMWEIFTLGGSPY-PGIP 241
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 34/219 (15%)
Query: 773 VIGTGSSGVVYR-VTIPNGETLAVKKM-WSSDESGAFSSEIQTLGSI-RHKNIVRLLGWG 829
++G G+ G VY+ + G+ A+K M + DE EI L H+NI G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 830 SNKNLK------LLFYDYLPNGSLSSLLHGAGKGGA---DWEARY--EVVLGVAHALAYL 878
KN L ++ GS++ L+ KG +W A E++ G++H L
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSH----L 127
Query: 879 HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGY 938
H ++H D+K NVLL + L DFG VS D + N G+ +
Sbjct: 128 HQH---KVIHRDIKGQNVLLTENAEVKLVDFG----VSAQLDRTVGRRN---TFIGTPYW 177
Query: 939 MAPEHASMQRITE-----KSDVYSFGVVLLEVLTGRHPL 972
MAPE + + KSD++S G+ +E+ G PL
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 55/208 (26%), Positives = 84/208 (40%), Gaps = 18/208 (8%)
Query: 773 VIGTGSSGVVYRVTIPNGETLAVKK-----MWSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
IG GS G +Y + V K E A E+ L ++H NIV
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCMPPI 886
+ +Y G L ++ + G + + V +L H HD I
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHD--RKI 122
Query: 887 LHGDVKAMNVLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945
LH D+K+ N+ L G A L DFG+AR ++ S G+ Y++PE
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS-------MELAYTCVGTPYYLSPEICQ 175
Query: 946 MQRITEKSDVYSFGVVLLEVLTGRHPLD 973
+ K+D++S G VL E+ T +HP +
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-08
Identities = 27/81 (33%), Positives = 42/81 (51%)
Query: 331 LTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNI 390
L G IP L LQ + LS N + G IP + + T+L L++ N+ +G IP +G +
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 391 NGLTLFFAWKNKLTGNIPESL 411
L + N L+G +P +L
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 50/148 (33%), Positives = 73/148 (49%), Gaps = 13/148 (8%)
Query: 774 IGTGSSGVVYRV-TIPNGETLAVKKM-WSSDESGAFSS---EIQTLGSIRHKNIVRLLG- 827
IG G+ GVVY+ GE +A+KK+ +++ G S+ EI L + H NIVRLL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCMPPI 886
S L L+F ++L + L + + G D + + +AY H H +
Sbjct: 67 VHSENKLYLVF-EFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR----V 120
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARI 914
LH D+K N+L+ LADFGLAR
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 61/210 (29%), Positives = 89/210 (42%), Gaps = 21/210 (10%)
Query: 768 LTSANVIGTGSSGVVYR-VTIPNGETLAVKKM---WSSDESGAFSSEIQTLGSIRHKNIV 823
T IG GS G V++ + + +A+K + + DE EI L +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 824 RLLGWGSNKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG-VAHALAYLHHD 881
+ G K KL + +YL GS LL + G E + +L + L YLH +
Sbjct: 66 KYYG-SYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 882 CMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAP 941
+H D+KA NVLL LADFG V+G D K R G+ +MAP
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFG----VAGQLTDTQIK---RNTFVGTPFWMAP 170
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
E K+D++S G+ +E+ G P
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 60/209 (28%), Positives = 89/209 (42%), Gaps = 19/209 (9%)
Query: 768 LTSANVIGTGSSGVVYR-VTIPNGETLAVKKM---WSSDESGAFSSEIQTLGSIRHKNIV 823
T IG GS G V++ + + +A+K + + DE EI L +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 824 RLLGWGSNKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC 882
+ G K+ KL + +YL GS LL G D ++ + L YLH +
Sbjct: 66 KYYG-SYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSE- 120
Query: 883 MPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE 942
+H D+KA NVLL + LADFG V+G D K N G+ +MAPE
Sbjct: 121 --KKIHRDIKAANVLLSEHGEVKLADFG----VAGQLTDTQIKRN---TFVGTPFWMAPE 171
Query: 943 HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
K+D++S G+ +E+ G P
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 53/186 (28%), Positives = 86/186 (46%), Gaps = 19/186 (10%)
Query: 790 GETLAVKKMWSSDESGA-----FSSEIQTLGSIRHKNIVRLLGW---GSNKNLKLLFYDY 841
GE +AVK + ESG EI+ L ++ H+NIV+ G +KL+ ++
Sbjct: 33 GEQVAVKSL--KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM-EF 89
Query: 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG 901
LP+GSL L K + + + + + + + YL +H D+ A NVL+
Sbjct: 90 LPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESE 145
Query: 902 YQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVV 961
+Q + DFGL + + + + + L + APE + SDV+SFGV
Sbjct: 146 HQVKIGDFGLTKAI----ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVT 201
Query: 962 LLEVLT 967
L E+LT
Sbjct: 202 LYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 774 IGTGSSGVVYRVTIP-NGETLAVKKM--WSSDESGAFSSEIQTLGSIRHKNIVRLLGWGS 830
IG GS+G+V +G +AVK M +E+ + +H+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 831 NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGD 890
+ ++L G+L+ ++ + + E V V AL YLH ++H D
Sbjct: 89 VGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRD 142
Query: 891 VKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRIT 950
+K+ ++LL + L+DFG +S +R L G+ +MAPE S
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQIS-------KDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 951 EKSDVYSFGVVLLEVLTGRHP 971
+ D++S G++++E++ G P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 53/207 (25%), Positives = 85/207 (41%), Gaps = 18/207 (8%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVKK-----MWSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
IG G VYR T + + + +A+KK M + EI L + H N+++ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR--YEVVLGVAHALAYLHHDCMPP 885
N + + G LS ++ K R ++ + + A+ ++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---R 126
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945
++H D+K NV + L D GL R S SKT L G+ YM+PE
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFS-------SKTTAAHSLVGTPYYMSPERIH 179
Query: 946 MQRITEKSDVYSFGVVLLEVLTGRHPL 972
KSD++S G +L E+ + P
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 32/209 (15%)
Query: 772 NVIGTGSSGVVYR-VTIPNGETLAVKKM---WSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
++G G+ G VY+ + LAVK + + + SE++ L I+ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG-----VAHALAYLHHDC 882
+N + +++ GSL + E VLG V L YL
Sbjct: 67 AFFVENRISICTEFMDGGSLDV-----------YRKIPEHVLGRIAVAVVKGLTYLWS-- 113
Query: 883 MPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE 942
ILH DVK N+L+ Q L DFG++ + S +KT G+ YMAPE
Sbjct: 114 -LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKT-----YVGTNAYMAPE 163
Query: 943 HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
S ++ SDV+S G+ +E+ GR P
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 67/221 (30%), Positives = 97/221 (43%), Gaps = 29/221 (13%)
Query: 772 NVIGTGSSGVVYRVTIPN------GET-LAVK---KMWSSDESGAFSSEIQTLGSIRHKN 821
N +G+G+ G VY T + G +AVK K + E F E + + H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 822 IVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGA-----GKGGADWEARYEVVLGVAHALA 876
IV+LLG + + + + G L S L A G + ++ L VA
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 877 YLHHDCMPPILHGDVKAMNVLLG-PGYQA----YLADFGLARIVSGSGDDNCSKTNQRPQ 931
YL +H D+ A N L+ GY A + DFGLAR + S D K +
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS--DYYRKEGEGLL 175
Query: 932 LAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+MAPE + T +SDV+SFGV++ E+LT G+ P
Sbjct: 176 ---PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 21/216 (9%)
Query: 768 LTSANVIGTGSSGVVYR-VTIPNGETLAVK---KMWSSDESGAFSSEI----QTLGSIRH 819
L V+G+G+ G VY+ + IP+GE + + K+ + S + EI + +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 820 KNIVRLLGWGSNKNLKLLFYDYLPNGSL-SSLLHGAGKGGADWEARYEVVLGVAHALAYL 878
+ RLLG ++L+ +P G L + + G+ + V +A ++YL
Sbjct: 69 PYVCRLLGICLTSTVQLV-TQLMPYGCLLDYVRENKDRIGSQDLLNWCV--QIAKGMSYL 125
Query: 879 HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGY 938
++H D+ A NVL+ + DFGLAR++ + + + P +
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP-----IKW 177
Query: 939 MAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLD 973
MA E +R T +SDV+S+GV + E++T G P D
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 773 VIGTGSSGVVYR-VTIPNGETL----AVKKMWSSDESGA---FSSEIQTLGSIRHKNIVR 824
V+G+G+ G VY+ + IP GE + A+K++ + A E + S+ + ++ R
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLL-HGAGKGGADWEARYEVVLGVAHALAYLHHDCM 883
LLG ++L+ +P G L + G+ + + V +A + YL
Sbjct: 74 LLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYLLNWCV--QIAKGMNYLEER-- 128
Query: 884 PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEH 943
++H D+ A NVL+ + DFGLA+++ + ++ + P +MA E
Sbjct: 129 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP-----IKWMALES 182
Query: 944 ASMQRITEKSDVYSFGVVLLEVLT-GRHPLD 973
+ T +SDV+S+GV + E++T G P D
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 18/207 (8%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFS-----SEIQTLGSIRHKNIVRLLG 827
IG G VYR T + +G +A+KK+ D A + EI L + H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR--YEVVLGVAHALAYLHHDCMPP 885
N + + G LS ++ K + ++ + + AL ++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---R 126
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945
++H D+K NV + L D GL R S SKT L G+ YM+PE
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFS-------SKTTAAHSLVGTPYYMSPERIH 179
Query: 946 MQRITEKSDVYSFGVVLLEVLTGRHPL 972
KSD++S G +L E+ + P
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 40/222 (18%)
Query: 768 LTSANVIGTGSSGVV----YRVTIPNGETLAVKK-----MWSSDESGAFSSEIQTLGSIR 818
LT +G+G GVV +R I +A+K M D F E + + +
Sbjct: 6 LTFMKELGSGQFGVVHLGKWRAQI----KVAIKAINEGAMSEED----FIEEAKVMMKLS 57
Query: 819 HKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL 878
H +V+L G + + + +++ NG L + L +G + + V + YL
Sbjct: 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLR-QRQGKLSKDMLLSMCQDVCEGMEYL 116
Query: 879 HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG- 937
+ +H D+ A N L+ ++DFG+ R V DD + S G
Sbjct: 117 ERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVL---DD---------EYTSSSGA 161
Query: 938 -----YMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLD 973
+ PE + + + KSDV+SFGV++ EV T G+ P +
Sbjct: 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 774 IGTGSSGVVYRVTIPNG--ETLAVKKM-----------WSSDES-GAFSSEIQTLG-SIR 818
+G+G+ G VY+V N LA+K++ D+S G SE+ + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 819 HKNIVRLL-GWGSNKNLKLLFYDYLPNGSLSSLLHGAG-KGGADWEAR-YEVVLGVAHAL 875
H NIVR + N L ++ D + L + K E R + + + + AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVM-DLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 876 AYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGS 935
YLH + I+H D+ N++LG + + DFGLA+ ++ + G+
Sbjct: 127 RYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--------QKQPESKLTSVVGT 176
Query: 936 YGYMAPEHASMQRITEKSDVYSFGVVLLEVLT 967
Y PE + EK+DV++FG +L ++ T
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 46/182 (25%), Positives = 85/182 (46%), Gaps = 18/182 (9%)
Query: 797 KMWSSDESGAFSSEIQTLGSIRHK----NIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLH 852
K+ ++ + E+ I H+ IVR++G + L +L + G L+ L
Sbjct: 28 KVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEAL-MLVMEMASGGPLNKFL- 85
Query: 853 GAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLA 912
K E++ V+ + YL +H D+ A NVLL + A ++DFGL+
Sbjct: 86 SGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLS 142
Query: 913 RIVSGSGDDNCSKTNQRPQLAGSY--GYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GR 969
+ + DD+ K + AG + + APE + ++ + +SDV+S+G+ + E + G+
Sbjct: 143 KALGA--DDSYYKA----RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQ 196
Query: 970 HP 971
P
Sbjct: 197 KP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 50/147 (34%), Positives = 73/147 (49%), Gaps = 14/147 (9%)
Query: 774 IGTGSSGVVYR-VTIPNGETLAVKKM-WSSDESGAFSS---EIQTLGSIRHKNIVRLLG- 827
IG G+ G V++ E +A+K++ D+ G SS EI L ++HKNIVRL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCMPPI 886
S+K L L+F +Y + L G D E + + LA+ H H+ +
Sbjct: 68 LHSDKKLTLVF-EYC-DQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN----V 120
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLAR 913
LH D+K N+L+ + LADFGLAR
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 28/217 (12%)
Query: 772 NVIGTGSSGVVYR-VTIPNGETLAVKKMWSSDESGAFS----SEIQTLGSIRHKNIVRL- 825
IG G+ G VY+ GE +A+KK+ +E F EI+ L + H+NIV L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 826 ---------LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALA 876
L + +K L ++Y+ + L LL +G + + + L
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLE-SGLVHFSEDHIKSFMKQLLEGLN 130
Query: 877 YLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSY 936
Y H LH D+K N+LL Q LADFGLAR+ + +++ TN+ L
Sbjct: 131 YCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLY--NSEESRPYTNKVITL---- 181
Query: 937 GYMAPE-HASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
Y PE +R DV+S G +L E+ T + P+
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 9e-08
Identities = 58/215 (26%), Positives = 88/215 (40%), Gaps = 39/215 (18%)
Query: 772 NVIGTGSSGVVYRVTI----PNGETLAVK--------KMWSSDESGAFSSEIQTLGSIRH 819
+GTGS G RV I GE A+K KM + E L + H
Sbjct: 24 ETLGTGSFG---RVRIAKHKGTGEYYAIKCLKKREILKMKQVQH---VAQEKSILMELSH 77
Query: 820 KNIVRLL-GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY--EVVLGVAHALA 876
IV ++ + + L +++ G L + L AG+ D Y E+VL A
Sbjct: 78 PFIVNMMCSFQDENRVYFLL-EFVVGGELFTHLRKAGRFPNDVAKFYHAELVL----AFE 132
Query: 877 YLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSY 936
YLH I++ D+K N+LL + DFG A+ V ++ L G+
Sbjct: 133 YLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----------PDRTFTLCGTP 179
Query: 937 GYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
Y+APE + + D ++ GV+L E + G P
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 74/267 (27%), Positives = 112/267 (41%), Gaps = 59/267 (22%)
Query: 751 MTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYR-VTIPNGETLAVKKMWSSDESGA-FS 808
+ Y+KLD +G GS VY+ + G+ +A+K++ E GA F+
Sbjct: 4 LETYKKLD--------------KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFT 49
Query: 809 S--EIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR-- 864
+ E L ++H NIV L K L ++YL + L + G G + R
Sbjct: 50 AIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLF 108
Query: 865 -YEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923
++++ G LAY H +LH D+K N+L+ + LADFGLAR S
Sbjct: 109 LFQLLRG----LAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP----- 156
Query: 924 SKT--NQ------RPQ--LAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
SKT N+ RP L GS Y + D++ G + E+ TGR
Sbjct: 157 SKTYSNEVVTLWYRPPDVLLGSTEY-----------STSLDMWGVGCIFYEMATGR---- 201
Query: 974 PTLPGGAPLVQWTPLMFLMLNLEAEQT 1000
P PG + +F +L E+T
Sbjct: 202 PLFPGSTDVEDQLHKIFRVLGTPTEET 228
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 17/158 (10%)
Query: 772 NVIGTGSSGVVYRVTIPN-GETLAVKKM-WSSDESGAFSSEIQTLGSIR------HKNIV 823
IG G+ G VY+ N G +A+KK+ E G S ++ + ++ H NIV
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 824 RLL----GWGSNKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL 878
RLL G +++ LKL L ++++ + L++ L K G E +++ + + +L
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL 123
Query: 879 HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916
H I+H D+K N+L+ Q +ADFGLARI S
Sbjct: 124 HSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 33/107 (30%), Positives = 52/107 (48%), Gaps = 14/107 (13%)
Query: 866 EVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSK 925
++ LGV H H+ +LH D+K+ N+ L + L DFG AR+++ G C+
Sbjct: 108 QMCLGVQHI-----HE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT- 159
Query: 926 TNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
G+ Y+ PE KSD++S G +L E+ T +HP
Sbjct: 160 ------YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 64/237 (27%), Positives = 101/237 (42%), Gaps = 33/237 (13%)
Query: 755 QKLDFSIDDVVRNLTSANVIGTGSSGVVYRV-TIPNGETLAVKKMWSSDESGAFS----S 809
+ +F D V IG G+ G V++ + +A+KK+ +E F
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR 60
Query: 810 EIQTLGSIRHKNIVRLLGWGSNK-----NLKLLFY------DYLPNGSLSSLLHGAGKGG 858
EI+ L ++H+N+V L+ K K FY ++ L+ LL
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH----DLAGLLSNKNVKF 116
Query: 859 ADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918
E + +V+ + + L Y+H + ILH D+KA N+L+ LADFGLAR S S
Sbjct: 117 TLSEIK-KVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLS 172
Query: 919 --GDDNCSKTNQRPQLAGSYGYMAPEHASMQR-ITEKSDVYSFGVVLLEVLTGRHPL 972
N TN+ L Y PE +R D++ G ++ E+ T R P+
Sbjct: 173 KNSKPNRY-TNRVVTL----WYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 774 IGTGSSGVVYRVTIPN-GETLAVKKMW-SSDESGAFSSEIQTLGSIR------HKNIVRL 825
IG G+ G VY+ P+ G +A+K + ++E G S ++ + ++ H NIVRL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 826 L----GWGSNKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHH 880
+ +++ K+ L ++++ + L + L G E +++ L +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 881 DCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMA 940
+C I+H D+K N+L+ G Q LADFGLARI S + P + + Y A
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYS-------CQMALTPVVVTLW-YRA 175
Query: 941 PEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
PE D++S G + E+ R PL
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 772 NVIGTGSSGVVYR-VTIPNGETLAVK--KMWSSDESGAFSS--EIQTLGSIRHKNIVRL- 825
N I G+ GVVYR GE +A+K KM E +S EI L ++H NIV +
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVK 70
Query: 826 -LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMP 884
+ GSN + + +Y+ + L SL+ + E + ++L + +A+LH +
Sbjct: 71 EVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKC-LMLQLLSGVAHLHDNW-- 126
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE-H 943
ILH D+K N+LL + DFGLAR S QL + Y APE
Sbjct: 127 -ILHRDLKTSNLLLNNRGILKICDFGLAREYG-------SPLKPYTQLVVTLWYRAPELL 178
Query: 944 ASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQ 984
+ + D++S G + E+LT P PG + + Q
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTK----KPLFPGKSEIDQ 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 61/227 (26%), Positives = 92/227 (40%), Gaps = 53/227 (23%)
Query: 774 IGTGSSGVVYRVT---IPNGETLAVKKMWSSDESGAFSSEIQTLGSIR----------HK 820
+G G+ G+V ET+A+KK+ + FS +I ++R HK
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKI-----TNVFSKKILAKRALRELKLLRHFRGHK 62
Query: 821 NIVRLLG----WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAH--- 873
NI L + N N +L Y+ L L ++ L AH
Sbjct: 63 NITCLYDMDIVFPGNFN-ELYLYEELMEADLHQIIRS------------GQPLTDAHFQS 109
Query: 874 -------ALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKT 926
L Y+H +LH D+K N+L+ + + DFGLAR S + +N
Sbjct: 110 FIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166
Query: 927 NQRPQLAGSYGYMAPE-HASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
+ + Y APE S Q T+ DV+S G +L E+L GR P+
Sbjct: 167 T---EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-07
Identities = 58/235 (24%), Positives = 95/235 (40%), Gaps = 49/235 (20%)
Query: 773 VIGTGSSGVVYR-VTIPNGETLAVKKMWSSDESGAFSS---------EIQTLGSIRHKNI 822
IG+G+ GVV + +G+ +A+KK+ AF E++ L +H NI
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKI-----PHAFDVPTLAKRTLRELKILRHFKHDNI 66
Query: 823 VRLLG-WGSNKNLKLLFYD-YLPNGSLSSLLHGAGKGGADWEAR------YEVVLGVAHA 874
+ + F D Y+ + S LH Y+++ G
Sbjct: 67 IAIRDILRPPGAD---FKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRG---- 119
Query: 875 LAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQ----RP 930
L Y+H ++H D+K N+L+ + + DFG+AR +S S ++ + R
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 931 QLAGSYGYMAPE-HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQ 984
Y APE S+ T D++S G + E+L GR L PG + Q
Sbjct: 177 -------YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL---FPGKNYVHQ 220
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 773 VIGTGSSGVV-YRVTIPNGETLAVKKMWSSDESGAFSS----EIQTLGSIRHKNIVRLLG 827
VIG GS GVV + GE +A+KK+ E + ++ EI+ L +RH +IV +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI-- 64
Query: 828 WGSNKNLKL-----LFYD-YLPNGSLSSLLHGAGKGGADWEA-RYEVVL-GVAHALAYLH 879
K++ L F D Y+ + S LH K D ++ L + AL Y+H
Sbjct: 65 ----KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG-------DDNCSKTNQRPQL 932
+ H D+K N+L + + DFGLAR+ D ++ + P+L
Sbjct: 121 ---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 933 AGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978
GS+ + T D++S G + EVLTG+ P PG
Sbjct: 178 CGSF---------FSKYTPAIDIWSIGCIFAEVLTGK----PLFPG 210
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 50/224 (22%), Positives = 82/224 (36%), Gaps = 38/224 (16%)
Query: 764 VVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIV 823
V++ LT GS G V+ T P V K+ + G E L ++ H +++
Sbjct: 70 VIKTLTP------GSEGRVFVATKPGQPDPVVLKI---GQKGTTLIEAMLLQNVNHPSVI 120
Query: 824 RLLGWGSNKNLKLL--------FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHAL 875
R+ + + + Y YL S + A + + L
Sbjct: 121 RMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALI----------IEKQILEGL 170
Query: 876 AYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGS 935
YLH I+H DVK N+ + Q + D G A+ + LAG+
Sbjct: 171 RYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF--------LGLAGT 219
Query: 936 YGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGG 979
APE + + K+D++S G+VL E+L + P
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPST 263
|
Length = 357 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 59/221 (26%), Positives = 87/221 (39%), Gaps = 46/221 (20%)
Query: 773 VIGTGSSGVVYR--VTIPNGETLAV-----KKMWSSDESGAFSSEIQTLGSIRHKNIVRL 825
++GTG G + R + +P+ L V + S + F +E TLG H NIVRL
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPP 885
G + N ++ +Y+ NG+L S L ++E L +
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLR-----------KHEGQLVAGQLMG--------- 111
Query: 886 ILHGDVKAMNVLLGPGY-QAYLADFGLARIVSGSGDDNCSKTN----QRPQLAGSYGYM- 939
+L G M L GY LA A V + D C + Q + Y M
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLA----AHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMS 167
Query: 940 --------APEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
APE + SDV+SFG+V+ EV++ G P
Sbjct: 168 GKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 35/109 (32%), Positives = 52/109 (47%), Gaps = 16/109 (14%)
Query: 866 EVVLGVAHALAYLH-HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924
E+VLG L +LH I++ D+K NVLL +ADFG+ + G +
Sbjct: 104 EIVLG----LQFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTT 153
Query: 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
T G+ Y+APE S Q D ++ GV+L E+L G+ P +
Sbjct: 154 ST-----FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 29/210 (13%)
Query: 774 IGTGSSGVVYRVTIPN-GETLAVKKM------WSSDESGAFSSEIQTLGSIRHKNIVRLL 826
+G G G V + G+ A KK+ E A + E + L + + IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN-EKKILEKVSSRFIVSLA 59
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY-----EVVLGVAHALAYLHHD 881
K+ L + G L ++ G+ G EAR +++ G+ H LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP-EARAIFYAAQIICGLEH----LHQR 114
Query: 882 CMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAP 941
I++ D+K NVLL ++D GLA + G K R AG+ GYMAP
Sbjct: 115 ---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-----KKIKGR---AGTPGYMAP 163
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
E + D ++ G L E++ GR P
Sbjct: 164 EVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 65/233 (27%), Positives = 102/233 (43%), Gaps = 35/233 (15%)
Query: 760 SIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWS--SDESGAFSSEIQTLGSI 817
S+ D IG G+ G VY+VT +LA K+ SD +E L S+
Sbjct: 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSL 75
Query: 818 -RHKNIVRLLG--WGSNKNLK---LLFYDYLPNGSLSSLLHGAGKGGADWEAR------Y 865
H N+V+ G + ++K + L + GS++ L+ G G + Y
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 866 EVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGL-ARIVSGSGDDNCS 924
+LG+ H LH++ I+H DVK N+LL L DFG+ A++ S N S
Sbjct: 136 GALLGLQH----LHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188
Query: 925 KTNQRPQLAGSYGYMAPEHASMQRITEKS-----DVYSFGVVLLEVLTGRHPL 972
G+ +MAPE + ++ + S DV+S G+ +E+ G PL
Sbjct: 189 --------VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 51/194 (26%), Positives = 82/194 (42%), Gaps = 21/194 (10%)
Query: 787 IPNGETLAVKKMWSSDES----GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842
N L KM D + F EI+ + ++ NI+RLL + + +Y+
Sbjct: 42 SGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYM 101
Query: 843 PNGSLSSLL--HGAGKGGADWEARY-------EVVLGVAHALAYLHHDCMPPILHGDVKA 893
NG L+ L H + + + +A + YL +H D+
Sbjct: 102 ENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLAT 158
Query: 894 MNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKS 953
N L+G Y +ADFG++R + SGD + R L +M+ E + + T S
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLY-SGD--YYRIQGRAVL--PIRWMSWESILLGKFTTAS 213
Query: 954 DVYSFGVVLLEVLT 967
DV++FGV L E+LT
Sbjct: 214 DVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-07
Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 35/213 (16%)
Query: 774 IGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSS---------EIQTLGSIRHKNIV 823
IG G+ GVV+ VT P +G+ +A+KKM F + E++ L +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKM-----PNVFQNLVSCKRVFRELKMLCFFKHDNVL 62
Query: 824 RLLGWGSNKNLKLLFYDYLPNGSLSSLLHG---AGKGGADWEAR---YEVVLGVAHALAY 877
L ++ Y+ + S LH + + + + Y+++ G L Y
Sbjct: 63 SALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG----LKY 118
Query: 878 LHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG 937
LH ILH D+K N+L+ + DFGLAR+ D++ T ++ Y
Sbjct: 119 LHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV--EEPDESKHMTQ---EVVTQY- 169
Query: 938 YMAPE-HASMQRITEKSDVYSFGVVLLEVLTGR 969
Y APE + T D++S G + E+L R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 25/177 (14%)
Query: 807 FSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSS------LLHGAGKGGA- 859
F E++ L ++ NI+RLLG +++ + +Y+ NG L+ L G
Sbjct: 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125
Query: 860 ----------DWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADF 909
+ + V L +A + YL +H D+ N L+G +ADF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADF 182
Query: 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVL 966
G++R + +GD + R L +MA E M + T SDV++FGV L E+L
Sbjct: 183 GMSRNLY-AGD--YYRIQGRAVLP--IRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 45/167 (26%), Positives = 67/167 (40%), Gaps = 17/167 (10%)
Query: 809 SEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVV 868
EI L +I H+ I+ L+ K+ + +P + G E +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQ 191
Query: 869 LGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQ 928
+ ALAYLH I+H DVK N+ L A L DFG A + D
Sbjct: 192 RRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD-------- 240
Query: 929 RPQLAGSYGYM---APEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
PQ G G + +PE ++ K+D++S G+VL E+ L
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 808 SSEIQ---------TLGSIRHKNIVRLLGWGSNKNLK-LLFYDYLPNGSLSSLL----HG 853
+SEIQ L + H+NI+ +L + Y Y+ G+L L G
Sbjct: 47 ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLG 106
Query: 854 AGKGGADWEARYEVVLG--VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGL 911
+ V + +A ++YLH ++H D+ A N ++ Q + D L
Sbjct: 107 EANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNAL 163
Query: 912 ARIVSGSGDDNCSKTNQ-RPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GR 969
+R + D +C N+ RP +MA E + + SDV+SFGV+L E++T G+
Sbjct: 164 SRDLF-PMDYHCLGDNENRP-----VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ 217
Query: 970 HP---LDP 974
P +DP
Sbjct: 218 TPYVEIDP 225
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 45/141 (31%), Positives = 68/141 (48%), Gaps = 22/141 (15%)
Query: 837 LFY--DYLPNGSLSSLLHGAGKGGADWE-ARY---EVVLGVAHALAYLHHDCMPPILHGD 890
LF+ +YL G L + H G D AR+ E++ G L +LH I++ D
Sbjct: 71 LFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICG----LQFLHKK---GIIYRD 121
Query: 891 VKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRIT 950
+K NVLL +ADFG+ + +N + + G+ Y+APE Q+
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMCK-------ENMNGEGKASTFCGTPDYIAPEILKGQKYN 174
Query: 951 EKSDVYSFGVVLLEVLTGRHP 971
E D +SFGV+L E+L G+ P
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-07
Identities = 28/97 (28%), Positives = 47/97 (48%), Gaps = 11/97 (11%)
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS-KTNQRP----------QLAG 934
+LH D+K N+LLG + + D+G A +D ++R ++ G
Sbjct: 134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG 193
Query: 935 SYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ YMAPE +E +D+Y+ GV+L ++LT P
Sbjct: 194 TPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 13/198 (6%)
Query: 774 IGTGSSGVVYRVTIPNGETL-AVKKMWSS---DESGAFSSEIQTLGSIRHKNIVRLLGWG 829
IG G+ G V+ + T AVK + D F E + L H NIVRL+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 830 SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHG 889
+ K + + + G + L G + ++V A + YL +H
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH---CIHR 118
Query: 890 DVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRI 949
D+ A N L+ ++DFG++R D + T Q+ + APE + R
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIP--VKWTAPEALNYGRY 173
Query: 950 TEKSDVYSFGVVLLEVLT 967
+ +SDV+SFG++L E +
Sbjct: 174 SSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 5e-07
Identities = 61/249 (24%), Positives = 108/249 (43%), Gaps = 42/249 (16%)
Query: 756 KLDFSIDDVVRNLTSANVIGTGSSGVV-YRVTIPNGETLAVKKMWSSDESGAFSS----E 810
K + + D R+L +G+G+ G V + G +A+KK++ +S F+ E
Sbjct: 8 KTIWEVPDRYRDLKQ---VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRE 64
Query: 811 IQTLGSIRHKNIVRLLG-WGSNKNLKLL--FYDYLP--NGSLSSLLHGAGKGGADWEARY 865
++ L ++H+N++ LL + + +L FY +P L L+ E R
Sbjct: 65 LRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS----EDRI 120
Query: 866 E-VVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924
+ +V + L Y+H I+H D+K N+ + + + DFGLAR
Sbjct: 121 QFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----------- 166
Query: 925 KTNQRPQLAG---SYGYMAPEHA-SMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGA 980
++ G + Y APE + T+ D++S G ++ E+LTG+ P G
Sbjct: 167 --QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK----PLFKGHD 220
Query: 981 PLVQWTPLM 989
L Q +M
Sbjct: 221 HLDQLMEIM 229
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 64/243 (26%), Positives = 100/243 (41%), Gaps = 48/243 (19%)
Query: 747 DTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRV-TIPNGETLAVKKMWSSDESG 805
DTWE+ IG G+ G V++V NG AVK + D
Sbjct: 18 DTWEII-------------------ETIGKGTYGKVFKVLNKKNGSKAAVKIL---DPIH 55
Query: 806 AFSSEIQTLGSI-----RHKNIVRLLGWGSNKNLK-----LLFYDYLPNGSLSSLLHGAG 855
EI+ +I H N+V+ G K++K L + GS++ L+ G
Sbjct: 56 DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFL 115
Query: 856 KGGADWEARYEVVLGVAH-ALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914
K G E ++ + H AL L H + +H DVK N+LL L DFG++
Sbjct: 116 KRGERMEE--PIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173
Query: 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR-----ITEKSDVYSFGVVLLEVLTGR 969
++ S +R G+ +MAPE + ++ + DV+S G+ +E+ G
Sbjct: 174 LT-------STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGD 226
Query: 970 HPL 972
PL
Sbjct: 227 PPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-07
Identities = 57/244 (23%), Positives = 98/244 (40%), Gaps = 54/244 (22%)
Query: 763 DVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS----EIQTLGSI 817
++ +G G+ G+V G+ +A+KK+ + + E++ L +
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 818 RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR-----------YE 866
RH+NI+ L + + F L L LL +R Y+
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELLGTDLHRLL----------TSRPLEKQFIQYFLYQ 116
Query: 867 VVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKT 926
++ G L Y+H ++H D+K N+L+ + DFGLARI
Sbjct: 117 ILRG----LKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI------------ 157
Query: 927 NQRPQLAGSYG---YMAPE-HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPL 982
Q PQ+ G Y APE + Q+ + D++S G + E+L G+ P PG +
Sbjct: 158 -QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK----PLFPGKDHV 212
Query: 983 VQWT 986
Q++
Sbjct: 213 NQFS 216
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 25/217 (11%)
Query: 768 LTSANVIGTGSSGVVYR-----VTIPNGET-LAVKKM---WSSDESGAFSSEIQTLGSIR 818
+T + +G GS G+VY V ET +A+K + S E F +E +
Sbjct: 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 67
Query: 819 HKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHG--------AGKGGADWEARYEVVLG 870
++VRLLG S L+ + + G L S L + + ++
Sbjct: 68 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
+A +AYL+ + +H D+ A N ++ + + DFG+ R + + P
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT 967
+M+PE T SDV+SFGVVL E+ T
Sbjct: 185 -----VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 51/188 (27%), Positives = 84/188 (44%), Gaps = 21/188 (11%)
Query: 793 LAVKKMWSSDESGA---FSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSL-- 847
+AVK + + A F EI+ + +++ NI+RLLG + + + +Y+ NG L
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 848 --------SSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG 899
S+ H + + +A + YL +H D+ N L+G
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163
Query: 900 PGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFG 959
Y +ADFG++R + SGD + R L +MA E + + T SDV++FG
Sbjct: 164 NHYTIKIADFGMSRNLY-SGD--YYRIQGRAVLP--IRWMAWESILLGKFTTASDVWAFG 218
Query: 960 VVLLEVLT 967
V L E+ T
Sbjct: 219 VTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 774 IGTGSSGVVYRV-TIPNG-ETLAVKKMW-SSDESGAFSSEIQTLGSIR------HKNIVR 824
IG G+ G V++ + NG +A+K++ + E G S I+ + +R H N+VR
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 825 LLG----WGSNKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH 879
L +++ KL L ++++ + L++ L + G E +++ + L +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
++H D+K N+L+ Q LADFGLARI S + + Y
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--------ALTSVVVTLWYR 176
Query: 940 APEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
APE D++S G + E+ R PL
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 66/220 (30%), Positives = 95/220 (43%), Gaps = 38/220 (17%)
Query: 774 IGTGSSGVVY----RVTIPNGETLAVKKMWSSDESGAFSS----EIQTLGSIRHKNIVRL 825
IG G+ GVVY RVT ET+A+KK+ E S EI L ++H NIVRL
Sbjct: 10 IGEGTYGVVYKARDRVT---NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
Query: 826 LG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMP 884
S K L L+F +YL + L + + + + + +AY H
Sbjct: 67 QDVVHSEKRLYLVF-EYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH--- 121
Query: 885 PILHGDVKAMNVLLGPGYQAY-LADFGLARI----VSGSGDDNCSKTNQRPQ-LAGSYGY 938
+LH D+K N+L+ A LADFGLAR V + + + P+ L GS Y
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHY 181
Query: 939 MAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978
P D++S G + E++ + P PG
Sbjct: 182 STP-----------VDIWSVGCIFAEMVNQK----PLFPG 206
|
Length = 294 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 9e-07
Identities = 39/104 (37%), Positives = 55/104 (52%), Gaps = 13/104 (12%)
Query: 871 VAHALAYL-HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN-CSKTNQ 928
VA + +L +C +H DV A NVLL G A + DFGLAR + D N K N
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDI--MNDSNYVVKGNA 274
Query: 929 RPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
R + +MAPE T +SDV+S+G++L E+ + G+ P
Sbjct: 275 RLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 10/101 (9%)
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
+A AL +LH I++ D+K N+LL L DFGL S D+ K
Sbjct: 107 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL----SKESIDHEKKAYS-- 157
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
G+ YMAPE + + T+ +D +SFGV++ E+LTG P
Sbjct: 158 -FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 28/211 (13%)
Query: 774 IGTGSSGVV---YRVTIPNGETLAVKKMWSSDESGAFSSEI----QTLGSIRHKNIVRLL 826
+G+G+ G V + +T+AVK + + + A E+ + + + IVR++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPI 886
G ++ +L + G L+ L + E+V V+ + YL
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLEET---NF 116
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG-----YMAP 941
+H D+ A NVLL + A ++DFGL++ + D+N K A ++G + AP
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGA--DENYYK-------AKTHGKWPVKWYAP 167
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
E + + + KSDV+SFGV++ E + G+ P
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-06
Identities = 50/191 (26%), Positives = 85/191 (44%), Gaps = 37/191 (19%)
Query: 810 EIQTLGSIRHKNIVRLLGWGSNK-NLKL-LFYDYLPNGSLSSLLHGAGK--GGADWEARY 865
E+ + ++HKNIVR + NK N KL + ++ G LS + K G + A
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 866 EVVLGVAHALAYLHHDCMPP----ILHGDVKAMNVLLGPGYQ-----------------A 904
++ + HALAY H+ P +LH D+K N+ L G + A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 905 YLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE---HASMQRITEKSDVYSFGVV 961
+ DFGL++ N + G+ Y +PE H + + +KSD+++ G +
Sbjct: 182 KIGDFGLSK--------NIGIESMAHSCVGTPYYWSPELLLHET-KSYDDKSDMWALGCI 232
Query: 962 LLEVLTGRHPL 972
+ E+ +G+ P
Sbjct: 233 IYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 35/216 (16%)
Query: 774 IGTGSSGVVYR---VTIPNGET---LAVKKMWSS---DESGAFSSEIQTLGSIRHKNIVR 824
+G GS G+VY I GE +AVK + S E F +E + ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLL--------HGAGKGGADWEARYEVVLGVAHALA 876
LLG S L+ + + +G L S L + G+ + ++ +A +A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 877 YLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSY 936
YL+ +H D+ A N ++ + + DFG+ R + + D K G
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET--DYYRK--------GGK 180
Query: 937 G-----YMAPEHASMQRITEKSDVYSFGVVLLEVLT 967
G +MAPE T SD++SFGVVL E+ +
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 58/214 (27%), Positives = 88/214 (41%), Gaps = 32/214 (14%)
Query: 773 VIGTGSSGVVYRVTIPNGETLAVKKMWSSDE------SGAFSSEIQTLGSIRHKNIVRL- 825
VIG G+ G V V + + + K+ S E S F E + + IV+L
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH 109
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY--EVVLGVA--HALAYLHHD 881
+ +K L ++ +Y+P G L +L+ W Y EVVL + H++ ++H D
Sbjct: 110 YAFQDDKYLYMVM-EYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLALDAIHSMGFIHRD 167
Query: 882 CMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAP 941
VK N+LL LADFG + +G C G+ Y++P
Sbjct: 168 ---------VKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA------VGTPDYISP 212
Query: 942 EHASMQRIT----EKSDVYSFGVVLLEVLTGRHP 971
E Q + D +S GV L E+L G P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 70/321 (21%), Positives = 127/321 (39%), Gaps = 18/321 (5%)
Query: 158 NTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPW 217
++ +PS + L SL L+ S +++ L L N+
Sbjct: 54 LSSNTLLLLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSNISE- 111
Query: 218 EIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLY 277
+ +NL L L +I+ P + ++ + + + + +P + N L+NL
Sbjct: 112 -LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLD 169
Query: 278 LYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPR 337
L N +S +P + LS L +L L + + +P E+ + L +D S+N + +
Sbjct: 170 LSFNDLSD-LPKLLSNLSNLNNLDL-SGNKISDLPPEIELLSALEELDLSNNSII-ELLS 226
Query: 338 SFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFF 397
S NL L L+LS N+L +P I + L L++ NN IS I + +G++ L
Sbjct: 227 SLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELD 283
Query: 398 AWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGF--I 455
N L+ +P L+ + + L+ + LL + +G
Sbjct: 284 LSGNSLSNALPLIALLL------LLLELLLNLLLTLKALELKLNSILLNNNILSNGETSS 337
Query: 456 PPDIGNCTTLRRLRLNDNRLS 476
P + +L L DN L
Sbjct: 338 PEALSILESLNNLWTLDNALD 358
|
Length = 394 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 29/211 (13%)
Query: 774 IGTGSSGVVYRVT---IPNGETLAVKKMWS-----SDESGAFSSEIQTLGSIRHKNIVRL 825
+G GS G VY V E L V K +E+ + E Q L + H IV+
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADW------EARYEVVLGVAHALAYLH 879
++ + +Y L L G E +++LGV Y+H
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH----YMH 123
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
ILH D+KA N+ L + DFG++R++ GS D + T G+ YM
Sbjct: 124 QR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT-------GTPYYM 172
Query: 940 APEHASMQRITEKSDVYSFGVVLLEVLTGRH 970
+PE Q KSD++S G +L E+ H
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEMCCLAH 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 773 VIGTGSSGVV----YRVTIPNGETLAVKKM-----WSSDESGAFSSE---IQTLGSIRHK 820
V+G G G V Y+ T GE A+K + + DE + E +T S RH
Sbjct: 6 VLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 821 NIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAY 877
+V L ++ +Y G L ++H ++ A + VVLG L Y
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLG----LQY 116
Query: 878 LHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG 937
LH + I++ D+K N+LL +ADFGL + G GD +T+ G+
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD----RTST---FCGTPE 166
Query: 938 YMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
++APE + T D + GV++ E+L G P
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 4e-06
Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 41/232 (17%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRLL 826
++G G G V+ V G+ A+K +M ++ +E + L ++ H + L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 827 G-WGSNKNLKLLFYDYLPNGSLSSLLHG-AGKGGADWEARY---EVVLGVAHALAYLHHD 881
+ + L L+ DY P G L LL GK ++ AR+ EV+L AL YLH
Sbjct: 68 ASFQTETYLCLVM-DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL----ALEYLH-- 120
Query: 882 CMPPILHGDVKAMNVLLGPGYQAYLADFGLA-----------RIVSGSGDDNCSKTNQRP 930
+ I++ D+K N+LL L+DF L+ + + + +
Sbjct: 121 LLG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 931 QLA-----------GSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ G+ Y+APE S D ++ G++L E+L G P
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 774 IGTGSSGVVY----RVTIPNGETLAVKKMWSSDESGAFSS---EIQTLGSIRHKNIVRLL 826
+G G+ VY R T GE +A+K++ E G S+ EI + ++H+NIVRL
Sbjct: 8 LGEGTYATVYKGRNRTT---GEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLH 64
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGA-DWEARYEVVLGVAHALAYLHHDCMPP 885
+N +L ++Y+ + L + G GA D + +A+ H +
Sbjct: 65 DVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---R 120
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945
+LH D+K N+L+ + LADFGLAR G + +N+ L Y AP+
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAF---GIPVNTFSNEVVTL----WYRAPDVLL 173
Query: 946 MQRITEKS-DVYSFGVVLLEVLTGRHPLDPTLPG 978
R S D++S G ++ E++TGR P PG
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR----PLFPG 203
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 44/142 (30%), Positives = 68/142 (47%), Gaps = 22/142 (15%)
Query: 837 LFY--DYLPNGSLSSLLHGAGKGGAD-WEARY---EVVLGVAHALAYLHHDCMPPILHGD 890
LF+ ++L G L + H KG D + A + E+V G L +LH I++ D
Sbjct: 71 LFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCG----LQFLHSK---GIIYRD 121
Query: 891 VKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRIT 950
+K NV+L +ADFG+ + +N N+ G+ Y+APE + T
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCK-------ENVFGDNRASTFCGTPDYIAPEILQGLKYT 174
Query: 951 EKSDVYSFGVVLLEVLTGRHPL 972
D +SFGV+L E+L G+ P
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 20/234 (8%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS----EIQTLGSIRHKNIVRLLG 827
V+G G+ GVV + E +A+KK S+E+ E++ L +++ +NIV L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
+ L ++Y+ L LL G + R + + A+ + H + I+
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVR-SYIYQLIKAIHWCHKN---DIV 122
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ 947
H D+K N+L+ L DFG AR +S + N + + + Y +PE
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT------EYVATRWYRSPELLLGA 176
Query: 948 RITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLMLNLEAEQTQ 1001
+ D++S G +L E+ G+ P PG + + Q + ++ L AEQ +
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQ----PLFPGESEIDQLFTIQKVLGPLPAEQMK 226
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 24/210 (11%)
Query: 774 IGTGSSGVVYRVTIPNGETLA---VKKMWSS---DESGAFSSEIQTLGSIRHKNIVRLLG 827
IG G G V G + A VK++ +S DE F E+Q + H N+++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLL---HGAGKGGADWEARYEVVLGVAHALAYLHHDCMP 884
LL ++ P G L + L G A + + VA L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE-- 942
+H D+ N L + D+GLA + +D + A ++APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDC---HAVPLRWLAPELV 174
Query: 943 ---HASM--QRITEKSDVYSFGVVLLEVLT 967
+ + T+KS+++S GV + E+ T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 60/214 (28%), Positives = 89/214 (41%), Gaps = 27/214 (12%)
Query: 773 VIGTGSSGVVYRVTIPNGETLAVKK------MWSSDESGAFSSEIQTLGSIRHKNIVRLL 826
VIG G+ G V V + + E + K M E+ F E L + + I L
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLHHDCM 883
++N L DY G L +LL + AR+ E+VL + H++ LH+
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI-HSIHQLHY--- 123
Query: 884 PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE- 942
+H D+K NVLL LADFG ++ G T Q G+ Y++PE
Sbjct: 124 ---VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG------TVQSSVAVGTPDYISPEI 174
Query: 943 ----HASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
M + + D +S GV + E+L G P
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 46/146 (31%), Positives = 70/146 (47%), Gaps = 10/146 (6%)
Query: 774 IGTGSSGVVYR-VTIPNGETLAVKKM-WSSDESGAFSS---EIQTLGSIRHKNIVRLLGW 828
IG G+ GVVY+ G+ +A+KK+ S+E G S+ EI L ++H NIV L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 829 GSNKNLKLLFYDYLPNGSLSSLLHGAGKGGA-DWEARYEVVLGVAHALAYLHHDCMPPIL 887
++ L +++L + L L KG D E + + + + H +L
Sbjct: 68 LMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVL 123
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLAR 913
H D+K N+L+ LADFGLAR
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 30/236 (12%)
Query: 774 IGTGSSGVVYRVTIPNGETL-AVKKMWSSDESGAFSS---EIQTLGSIRHKNIVRLLGWG 829
+G G+ V++ E L A+K++ E GA + E+ L +++H NIV L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 830 SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHG 889
+ L ++YL + L L G + + + + L+Y H ILH
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCHKR---KILHR 127
Query: 890 DVKAMNVLLGPGYQAYLADFGLAR---IVSGSGDDNCSKTNQRPQ--LAGSYGYMAPEHA 944
D+K N+L+ + LADFGLAR + + + + RP L GS Y P
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTP--- 184
Query: 945 SMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLMLNLEAEQT 1000
D++ G +L E+ TGR P P G+ + + L+F +L E+T
Sbjct: 185 --------IDMWGVGCILYEMATGR----PMFP-GSTVKEELHLIFRLLGTPTEET 227
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
+A L +LH I++ D+K NV+L +ADFG+ + ++T
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRT---- 160
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
G+ Y+APE + Q + D ++FGV+L E+L G+ P D
Sbjct: 161 -FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 1e-05
Identities = 62/241 (25%), Positives = 88/241 (36%), Gaps = 71/241 (29%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS---------EIQTLGSIRHKN 821
IG+G+ GVV G +A+KK+ S F EI+ L +RH+N
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI-----SNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 822 IVRLLGWGSNKNLKLLFYDYLPNGSLSS---------LLHGAGKGGADWEA--RYEVVLG 870
I+ LL D L S L+ D + L
Sbjct: 61 IIGLL-------------DILRPPSPEDFNDVYIVTELME------TDLHKVIKSPQPLT 101
Query: 871 VAH----------ALAYLH--HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918
H L YLH + ++H D+K N+L+ + DFGLAR V
Sbjct: 102 DDHIQYFLYQILRGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGV--- 153
Query: 919 GDDNCSKTNQRPQLAGSYGYMAPE-HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977
D K + + Y APE S R T+ D++S G + E+LT + P P
Sbjct: 154 DPDEDEKGFLTEYVVTRW-YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK----PLFP 208
Query: 978 G 978
G
Sbjct: 209 G 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 30/81 (37%), Positives = 43/81 (53%), Gaps = 5/81 (6%)
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM 946
+H D+ A N+LL + DFGLAR + D K + R L +MAPE
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIY-KDPDYVRKGSARLPLK----WMAPESIFD 250
Query: 947 QRITEKSDVYSFGVVLLEVLT 967
+ T +SDV+SFGV+L E+ +
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 1e-05
Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 61/228 (26%)
Query: 774 IGTGSSGVVYR-VTIPNGETLAVKKMWSSDESGAFSS--------EIQTLGSI-RHKNIV 823
+G G+ G VY GE +A+KKM F S E+++L + H NIV
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-----KKKFYSWEECMNLREVKSLRKLNEHPNIV 61
Query: 824 RLLG-WGSNKNLKLLFYDYLPNGSLSSLL-HGAGKGGADWEARYEVVLGVAHALAYLHHD 881
+L + N L +F +Y+ G+L L+ GK ++ R ++ + LA++H
Sbjct: 62 KLKEVFRENDELYFVF-EYM-EGNLYQLMKDRKGKPFSESVIRS-IIYQILQGLAHIHK- 117
Query: 882 CMPPILHG----DVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSY- 936
HG D+K N+L+ +ADFGLAR + RP Y
Sbjct: 118 ------HGFFHRDLKPENLLVSGPEVVKIADFGLAR-----------EIRSRPPYT-DYV 159
Query: 937 ---GYMAPEHASMQRITEKSDVYS-------FGVVLLEVLTGRHPLDP 974
Y APE I +S YS G ++ E+ T R PL P
Sbjct: 160 STRWYRAPE------ILLRSTSYSSPVDIWALGCIMAELYTLR-PLFP 200
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 56/175 (32%), Positives = 91/175 (52%), Gaps = 11/175 (6%)
Query: 75 SSNGEVVEISLKAVDLQG----SLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTF 130
+++ +LK +DL SLPS + L +LK L +S +L+ +PK + L
Sbjct: 132 PPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNN 190
Query: 131 IDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKI 190
+DLSGN + ++P E+ L LE L L+ N + E+ S + NL +L+ L L +N+L +
Sbjct: 191 LDLSGNKI-SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DL 247
Query: 191 PKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGM 245
P+SIG LS L+ NQ +G+ +NL L L+ S+S +P +
Sbjct: 248 PESIGNLSNLETLDLSNNQISSIS---SLGSLTNLRELDLSGNSLSNALPLIALL 299
|
Length = 394 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 23/111 (20%)
Query: 866 EVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSK 925
E++LG+ H +H+ +++ D+K N+LL ++D GLA C
Sbjct: 105 EIILGLEH----MHNRF---VVYRDLKPANILLDEHGHVRISDLGLA----------CDF 147
Query: 926 TNQRPQLA-GSYGYMAPEHASMQRIT---EKSDVYSFGVVLLEVLTGRHPL 972
+ ++P + G++GYMAPE +Q+ T +D +S G +L ++L G P
Sbjct: 148 SKKKPHASVGTHGYMAPE--VLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-05
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 39/225 (17%)
Query: 773 VIGTGSSGVVYRVTIPNG-------------ETLAVKKMWSSDESGAFSSEIQTLGSIRH 819
V+GTG+ G V+ V G + V+K + + + +E L +R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHT---RTERNVLEHVRQ 63
Query: 820 KNIVRLLGWGSNKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHAL 875
+ L + KL L DY+ G + + L+ D E R+ E++L AL
Sbjct: 64 SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED-EVRFYSGEIIL----AL 118
Query: 876 AYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP-QLAG 934
+LH I++ D+K N+LL L DFGL++ + S+ +R G
Sbjct: 119 EHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSK-------EFLSEEKERTYSFCG 168
Query: 935 SYGYMAPEHASMQRITEKS-DVYSFGVVLLEVLTGRHPLDPTLPG 978
+ YMAPE + K+ D +S G+++ E+LTG P TL G
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF--TLEG 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 29/212 (13%)
Query: 773 VIGTGSSGVVYRVTI-PNGETLAVKKMWSS------DESGAFSSEIQTLGSIRHKNIVRL 825
V+G G G V + G+ A KK+ ES A + E Q L + + +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSRFVVSL 65
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY-----EVVLGVAHALAYLHH 880
K+ L + G L ++ G+ G + E R E+ G+ LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE-EGRAVFYAAEICCGLED----LHQ 120
Query: 881 DCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMA 940
+ I++ D+K N+LL ++D GLA V + K G+ GYMA
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGR-----VGTVGYMA 169
Query: 941 PEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
PE +R T D ++ G +L E++ G+ P
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 25/215 (11%)
Query: 764 VVRNLTSANVIGTGSSGVV-YRVTIPNGETLAVKKMWSSDESGAFSS----EIQTLGSIR 818
V++ IG+G+ G+V G +AVKK+ ++ + E+ L +
Sbjct: 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN 78
Query: 819 HKNIVRLLG-WGSNKNLK----LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAH 873
HKNI+ LL + K+L+ + L + +L ++H Y+++ G+ H
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKH 138
Query: 874 ALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLA 933
LH I+H D+K N+++ + DFGLAR C+ P +
Sbjct: 139 ----LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-------CTNFMMTPYVV 184
Query: 934 GSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTG 968
Y Y APE E D++S G ++ E++ G
Sbjct: 185 TRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 41/142 (28%), Positives = 64/142 (45%), Gaps = 17/142 (11%)
Query: 840 DYLPNGSLSSLLHGAGKGGADWEARY--EVVLGVAHALAYLHHDCMPPILHGDVKAMNVL 897
+Y+ G ++LL G D Y E VL AL YLH+ I+H D+K N+L
Sbjct: 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVL----ALEYLHN---YGIVHRDLKPDNLL 133
Query: 898 LGPGYQAYLADFGLARI--------VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRI 949
+ L DFGL++I + + ++ Q+ G+ Y+APE Q
Sbjct: 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY 193
Query: 950 TEKSDVYSFGVVLLEVLTGRHP 971
+ D ++ G++L E L G P
Sbjct: 194 GKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 53/229 (23%), Positives = 106/229 (46%), Gaps = 34/229 (14%)
Query: 755 QKLDFSIDDVVRNLTSANVIGTGSSG-VVYRVTIPNGETLAVKKMWSSDESGAFSS---- 809
++++ ++ ++ TS +G+G+ G V + GE +A+KK+ +S F+
Sbjct: 4 EEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63
Query: 810 EIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY---LP--NGSLSSLLHGAGKGGADWEAR 864
E+ L ++H+N++ LL ++ F D+ +P L ++ G ++ + +
Sbjct: 64 ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM---GHPLSEDKVQ 120
Query: 865 YEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924
Y +V + L Y+H I+H D+K N+ + + + DFGLAR D
Sbjct: 121 Y-LVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR----HAD---- 168
Query: 925 KTNQRPQLAG---SYGYMAPEHA-SMQRITEKSDVYSFGVVLLEVLTGR 969
++ G + Y APE + + D++S G ++ E+LTG+
Sbjct: 169 -----AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 43/175 (24%), Positives = 70/175 (40%), Gaps = 53/175 (30%)
Query: 774 IGTGSSGVVYRV---TIPNGETLAVKKMWSSDESGAFSS-----EIQTLGSIRHKNIVRL 825
IG G+ G VY+ +G+ A+KK E S EI L ++H+N+V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 826 LGWGSNKNLKLLF--YDY-------------------LPNGSLSSLLHGAGKGGADWEAR 864
+ K ++ +DY +P + SLL W+
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL---------WQ-- 116
Query: 865 YEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL-GPGYQ---AYLADFGLARIV 915
+ + + YLH + +LH D+K N+L+ G G + + D GLAR+
Sbjct: 117 ------ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 29/236 (12%)
Query: 774 IGTGSSGVVYR-VTIPNGETLAVKKMWSSDESGA-FSS--EIQTLGSIRHKNIVRLLGWG 829
+G GS VY+ ++ NG+ +A+K + E G F++ E L ++H NIV L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 830 SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHG 889
K ++Y+ ++ G G + R + + LAY+H ILH
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPG-GLHPYNVRL-FMFQLLRGLAYIHGQ---HILHR 127
Query: 890 DVKAMNVLLGPGYQAYLADFGLAR---IVSGSGDDNCSKTNQRPQ--LAGSYGYMAPEHA 944
D+K N+L+ + LADFGLAR I S + RP L G+ Y
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDY------ 181
Query: 945 SMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLMLNLEAEQT 1000
+ D++ G + +E+L G+ P PG + + + ++ +L + E T
Sbjct: 182 -----SSALDIWGAGCIFIEMLQGQ----PAFPGVSDVFEQLEKIWTVLGVPTEDT 228
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 66/253 (26%), Positives = 112/253 (44%), Gaps = 39/253 (15%)
Query: 737 RMANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYR-VTIPNGETLAV 795
R NN+ D+ E + ++ S + ++ N+IG GS GVVY + I E +A+
Sbjct: 40 RSHNNNAGEDEDEEKMIDNDINRSPN---KSYKLGNIIGNGSFGVVYEAICIDTSEKVAI 96
Query: 796 KKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGW----GSNKNLKLLF----YDYLPNGSL 847
KK+ + + E+ + ++ H NI+ L + KN K +F +++P
Sbjct: 97 KKVLQDPQYK--NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVH 154
Query: 848 SSLLHGAGKGGADWEARYEVVL---GVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQA 904
+ H A A + V L + ALAY+H I H D+K N+L+ P
Sbjct: 155 KYMKHYARNNHA--LPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHT 209
Query: 905 Y-LADFGLARIVSG---SGDDNCSKTNQRPQLA-GSYGYMAPEHASMQRITEKSDVYSFG 959
L DFG A+ + S CS+ + P+L G+ Y T D++S G
Sbjct: 210 LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNY-----------TTHIDLWSLG 258
Query: 960 VVLLEVLTGRHPL 972
++ E++ G +P+
Sbjct: 259 CIIAEMILG-YPI 270
|
Length = 440 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 47/201 (23%), Positives = 77/201 (38%), Gaps = 30/201 (14%)
Query: 791 ETLAVKKMWSSDESG---AFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSL 847
+ +A+K + E F E ++H NIV LLG + + + + Y + L
Sbjct: 36 QAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 848 SSLL------HGAGKGGADWEAR--------YEVVLGVAHALAYL--HHDCMPPILHGDV 891
L G D + +V +A + +L HH H D+
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVV-----HKDL 150
Query: 892 KAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITE 951
NVL+ ++D GL R V + + P +M+PE + +
Sbjct: 151 ATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP-----IRWMSPEAIMYGKFSI 205
Query: 952 KSDVYSFGVVLLEVLT-GRHP 971
SD++S+GVVL EV + G P
Sbjct: 206 DSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 32/223 (14%)
Query: 767 NLTSANVIGTGSSGVVYRVTIPNG-------------ETLAVKKMWSSDESGAFSSEIQT 813
N V+GTG+ G V+ V +G + V+K +++ + +E Q
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHT---RTERQV 57
Query: 814 LGSIRHKNIVRLLGWGSNKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVA 872
L IR + L + + KL L DY+ G L + L + EV +
Sbjct: 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF-----KEQEVQIYSG 112
Query: 873 HALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP-Q 931
+ L H I++ D+K N+LL L DFGL++ + +R
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-------EFHEDEVERAYS 165
Query: 932 LAGSYGYMAPE--HASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
G+ YMAP+ + D +S GV++ E+LTG P
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 19/207 (9%)
Query: 773 VIGTGSSGVVYRVTI-PNGETLAVKKMWSS------DESGAFSSEIQTLGSIRHKNIVRL 825
V+G G G V + G+ A K++ ES A + E Q L + + +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQFVVNL 65
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPP 885
K+ L + G L ++ G G + E + A L L
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE---RALFYAAEILCGLEDLHREN 122
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945
++ D+K N+LL ++D GLA + G+ + G+ GYMAPE +
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRV-------GTVGYMAPEVLN 174
Query: 946 MQRITEKSDVYSFGVVLLEVLTGRHPL 972
QR T D + G ++ E++ G+ P
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 52/184 (28%), Positives = 77/184 (41%), Gaps = 36/184 (19%)
Query: 809 SEIQTLGSIRHKNIVRLLGWGSNKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARY-- 865
+E Q L ++R + L + + KL L DY+ G L + L+ E R
Sbjct: 53 TERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYI 111
Query: 866 -EVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI-VSGSGDDNC 923
E+VL AL +LH I++ D+K N+LL L DFGL++ ++ +
Sbjct: 112 AEIVL----ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY 164
Query: 924 SKTNQRPQLAGSYGYMAPE--------HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975
S G+ YMAPE H D +S GV+ E+LTG P T
Sbjct: 165 S-------FCGTIEYMAPEVIRGGSGGHDKA------VDWWSLGVLTFELLTGASPF--T 209
Query: 976 LPGG 979
+ G
Sbjct: 210 VDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 30/81 (37%), Positives = 43/81 (53%), Gaps = 5/81 (6%)
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM 946
+H D+ A N+LL + DFGLAR + D K + R L +MAPE
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIY-KDPDYVRKGDARLPLK----WMAPESIFD 249
Query: 947 QRITEKSDVYSFGVVLLEVLT 967
+ T +SDV+SFGV+L E+ +
Sbjct: 250 KVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 55/206 (26%), Positives = 83/206 (40%), Gaps = 19/206 (9%)
Query: 774 IGTGSSGVVYRVTIPN-GETLAVKKM------WSSDESGAFSSEIQTLGSIRHKNIVRLL 826
+G G G V V + N G+ A KK+ S E A E + L + IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL-EKEILEKVNSPFIVNLA 59
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPI 886
+K L + G L ++ G+ G + E + + +LH I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDI 116
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM 946
++ D+K NVLL L+D GLA + QR AG+ GYMAPE
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-----KTITQR---AGTNGYMAPEILKE 168
Query: 947 QRITEKSDVYSFGVVLLEVLTGRHPL 972
+ + D ++ G + E++ GR P
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 40/214 (18%)
Query: 486 LKHLNFVDMSENHLVGGIPPSVVGCQS-------LEFLDLHSNGLT----GSVPDTL-PT 533
LK L S N G IP + L+ LDL N L G + L +
Sbjct: 53 LKELCL---SLNET-GRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSS 108
Query: 534 SLQLVDLSDNRLSGS-LAHSIGSLTE----LSKLLLSKNQLSGRIPAEIL----SCRKLI 584
SLQ + L++N L L L + L KL+L +N+L G + + R L
Sbjct: 109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLK 168
Query: 585 LLDIGNNRFSGEIPKELGQI----SSLEISLNLSSNQFSGEIPSEFSG----LTKLGILD 636
L++ NN + L + +LE+ L+L++N + E S + L L +L+
Sbjct: 169 ELNLANNGIGDAGIRALAEGLKANCNLEV-LDLNNNGLTDEGASALAETLASLKSLEVLN 227
Query: 637 LSHNKL-SGDLDALAS-----LQNLVSLNVSFND 664
L N L ALAS +L++L++S ND
Sbjct: 228 LGDNNLTDAGAAALASALLSPNISLLTLSLSCND 261
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 14/107 (13%)
Query: 866 EVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSK 925
E++ G L +LH I++ D+K N+LL +ADFG+ + + GD +K
Sbjct: 104 EIICG----LQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK-ENMLGD---AK 152
Query: 926 TNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
T G+ Y+APE Q+ D +SFGV+L E+L G+ P
Sbjct: 153 TCT---FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 46/194 (23%), Positives = 77/194 (39%), Gaps = 36/194 (18%)
Query: 784 RVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843
R+ GE +A+ +E Q L + + +V L K+ L +
Sbjct: 37 RIKKRKGEAMAL-------------NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83
Query: 844 NGSLSSLLHGAGKGGADWEARY-----EVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL 898
G L ++ G G D E R E+ G+ LH + I++ D+K N+LL
Sbjct: 84 GGDLKFHIYNMGNPGFD-EERAVFYAAEITCGLED----LHRE---RIVYRDLKPENILL 135
Query: 899 GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQ-LAGSYGYMAPEHASMQRITEKSDVYS 957
++D GLA + + + G+ GYMAPE +R T D +
Sbjct: 136 DDYGHIRISDLGLAVEI---------PEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWG 186
Query: 958 FGVVLLEVLTGRHP 971
G ++ E++ G+ P
Sbjct: 187 LGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 30/81 (37%), Positives = 43/81 (53%), Gaps = 5/81 (6%)
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM 946
+H D+ A N+LL + DFGLAR + D K + R L +MAPE
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIY-KDPDYVRKGDARLPLK----WMAPETIFD 255
Query: 947 QRITEKSDVYSFGVVLLEVLT 967
+ T +SDV+SFGV+L E+ +
Sbjct: 256 RVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 49/228 (21%), Positives = 83/228 (36%), Gaps = 31/228 (13%)
Query: 769 TSANVIGTGSSGV----VYRVTIPNGETLAVKKM----WSSDESGAFSSEIQTLGSIRHK 820
+IG + + + P +AVKK+ S ++ EI T ++H
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 821 NIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHH 880
NI+ + + + + GS LL G A ++ V +AL Y+H
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119
Query: 881 DCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR-IVSGSGDDNC------SKTNQRPQLA 933
+H VKA ++LL + L+ + ++ S P L+
Sbjct: 120 K---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176
Query: 934 GSYGYMAPE--HASMQRITEKSDVYSFGVVLLEVLTGRHP---LDPTL 976
PE ++Q EKSD+YS G+ E+ G P + T
Sbjct: 177 -------PEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 6e-05
Identities = 38/110 (34%), Positives = 57/110 (51%), Gaps = 14/110 (12%)
Query: 871 VAHALAYL-HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN-CSKTNQ 928
VA +++L +C +H D+ A N+LL G + DFGLAR + D N K N
Sbjct: 223 VAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI--RNDSNYVVKGNA 276
Query: 929 RPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTLP 977
R + +MAPE T +SDV+S+G++L E+ + G P P +P
Sbjct: 277 RLPVK----WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY-PGMP 321
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 6e-05
Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 47/237 (19%)
Query: 763 DVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFS----SEIQTLGSI 817
DV + + IG G+ G+V T P G +A+KK+ S E F EI+ L
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-SPFEHQTFCQRTLREIKILRRF 60
Query: 818 RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSL-------------LHGAGKGG--ADWE 862
+H+NI+ +L D + S S L+ K ++
Sbjct: 61 KHENIIGIL-------------DIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDH 107
Query: 863 ARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922
+Y + + L Y+H +LH D+K N+LL + DFGLARI D
Sbjct: 108 IQY-FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH- 162
Query: 923 CSKTNQRPQLAGSYGYMAPE-HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978
T + + Y APE + + T+ D++S G +L E+L+ R P PG
Sbjct: 163 ---TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR----PLFPG 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 57/216 (26%), Positives = 88/216 (40%), Gaps = 31/216 (14%)
Query: 773 VIGTGSSGVVYRVTIPNGETLAVKK------MWSSDESGAFSSEIQTLGSIRHKNIVRLL 826
VIG G+ G V V + N + + K M E+ F E L + ++ I L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGV--AHALAYLHHD 881
++N L DY G L +LL + AR+ E+V+ + H L Y+H D
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRD 127
Query: 882 CMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAP 941
+K N+L+ LADFG + G T Q G+ Y++P
Sbjct: 128 ---------IKPDNILMDMNGHIRLADFGSCLKLMEDG------TVQSSVAVGTPDYISP 172
Query: 942 E-HASMQ----RITEKSDVYSFGVVLLEVLTGRHPL 972
E +M+ + + D +S GV + E+L G P
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 31/108 (28%), Positives = 54/108 (50%), Gaps = 19/108 (17%)
Query: 866 EVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSK 925
E++LG+ H +H+ +++ D+K N+LL ++D GLA C
Sbjct: 105 EIILGLEH----MHNRF---VVYRDLKPANILLDEHGHVRISDLGLA----------CDF 147
Query: 926 TNQRPQLA-GSYGYMAPEHASMQRITEKS-DVYSFGVVLLEVLTGRHP 971
+ ++P + G++GYMAPE + S D +S G +L ++L G P
Sbjct: 148 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-05
Identities = 67/254 (26%), Positives = 104/254 (40%), Gaps = 49/254 (19%)
Query: 431 IPKEIFGLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLNDNRLSGTIPS--EMGNLK 487
IP++I T L+L +N+L +P ++ GN TL + T+P + L
Sbjct: 197 IPEQI------TTLILDNNELKS-LPENLQGNIKTLYANSNQLTSIPATLPDTIQEMELS 249
Query: 488 HLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSG 547
++ E L PS +L+ LDL N ++ +P+ LP L+ + + DN +
Sbjct: 250 INRITELPE-RL-----PS-----ALQSLDLFHNKIS-CLPENLPEELRYLSVYDNSIRT 297
Query: 548 SLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFS---GEIPKELGQI 604
AH +T L+ S L +P L L+ G N + +P EL
Sbjct: 298 LPAHLPSGITHLNVQSNSLTALPETLPP------GLKTLEAGENALTSLPASLPPELQ-- 349
Query: 605 SSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDAL--------ASLQNLV 656
L++S NQ + +P + LD+S N L+ + L AS NLV
Sbjct: 350 -----VLDVSKNQIT-VLPETLP--PTITTLDVSRNALTNLPENLPAALQIMQASRNNLV 401
Query: 657 SLNVSFNDFSGELP 670
L S F GE P
Sbjct: 402 RLPESLPHFRGEGP 415
|
Length = 754 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 45/173 (26%), Positives = 68/173 (39%), Gaps = 35/173 (20%)
Query: 840 DYLPNGSLSSLLHGAGKGGADWEARY---EVVLGV--AHALAYLHHDCMPP-IL---HGD 890
DY+P G + SLL G D AR+ E+ + H + ++H D P IL G
Sbjct: 81 DYIPGGDMMSLLIRLGIFEEDL-ARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH 139
Query: 891 VKAMNVLLGPGYQ-----AYLADFGLARIVSGSGDDNCSKTNQRP--------------- 930
+K + L G++ Y R S + S+ ++
Sbjct: 140 IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRC 199
Query: 931 ---QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP-LDPTLPGG 979
L G+ Y+APE T+ D +S GV+L E+L G+ P L T P
Sbjct: 200 LAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADT-PAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 65/240 (27%), Positives = 109/240 (45%), Gaps = 38/240 (15%)
Query: 774 IGTGSSGVVYRVTIPNGETL-AVKKMWSSDESGAFSS---EIQTLGSIRHKNIVRLLGW- 828
+G G+ V++ E L A+K++ E GA + E+ L ++H NIV L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 829 GSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR---YEVVLGVAHALAYLHHDCMPP 885
++K+L L+F +YL + L + G + + Y+++ G LAY H
Sbjct: 74 HTDKSLTLVF-EYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRG----LAYCHRR---K 124
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLAR---IVSGSGDDNCSKTNQRPQ--LAGSYGYMA 940
+LH D+K N+L+ + LADFGLAR + + + + RP L GS Y
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY-- 182
Query: 941 PEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLMLNLEAEQT 1000
+ + D++ G + E+ +GR PL P G+ + L+F +L E+T
Sbjct: 183 ---------STQIDMWGVGCIFFEMASGR-PLFP----GSTVEDELHLIFRLLGTPTEET 228
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 9e-05
Identities = 56/231 (24%), Positives = 87/231 (37%), Gaps = 62/231 (26%)
Query: 774 IGTGSSGVVYRV-TIPNGETLAVKKM---WSSDESGAFSSEIQTLGSIR-HKNIVRLLGW 828
IG G+ V + + G+ A+K M + S E EIQ L + H NI+RL+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 829 ---GSNKNLKLLF-------YD-------YLPNGSLSSLLHGAGKGGADWEARYEVVLGV 871
L L+F Y+ LP + S + Y+++ +
Sbjct: 67 LFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYM-------------YQLLKSL 113
Query: 872 AHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQ 931
H +H + I H D+K N+L+ LADFG +C +P
Sbjct: 114 DH----MHRN---GIFHRDIKPENILI-KDDILKLADFG-----------SCRGIYSKPP 154
Query: 932 LA---GSYGYMAPE-HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978
+ Y APE + K D+++ G V E+L+ L P PG
Sbjct: 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS----LFPLFPG 201
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 10/103 (9%)
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
++ L +LH I++ D+K NV+L +ADFG+ + D ++T
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRT---- 160
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
G+ Y+APE + Q + D +++GV+L E+L G+ P D
Sbjct: 161 -FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 30/100 (30%), Positives = 47/100 (47%), Gaps = 10/100 (10%)
Query: 874 ALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLA 933
AL +LH I++ D+K NVLL L D+G+ + G GD +
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-------FC 157
Query: 934 GSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
G+ Y+APE + D ++ GV++ E++ GR P D
Sbjct: 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 62/239 (25%), Positives = 102/239 (42%), Gaps = 36/239 (15%)
Query: 774 IGTGSSGVVYRVTIPNGETL-AVKKMWSSDESGAFSS---EIQTLGSIRHKNIVRLLGWG 829
+G G+ VY+ + L A+K++ E GA + E+ L ++H NIV L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 830 SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR---YEVVLGVAHALAYLHHDCMPPI 886
+ L ++YL + L L G + ++++ G L Y H +
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRG----LNYCHRR---KV 125
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLAR---IVSGSGDDNCSKTNQRPQ--LAGSYGYMAP 941
LH D+K N+L+ + LADFGLAR I + + + RP L GS Y
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDY--- 182
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLMLNLEAEQT 1000
+ + D++ G + E+ TGR PL P G+ + + +F +L E+T
Sbjct: 183 --------STQIDMWGVGCIFYEMSTGR-PLFP----GSTVEEQLHFIFRILGTPTEET 228
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 11/88 (12%)
Query: 886 ILHGDVKAMNVLLGPGYQAYLA--DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEH 943
+++ D+K N+LL YQ ++A DFGL ++ N ++ G+ Y+APE
Sbjct: 114 VIYRDLKPENILLD--YQGHIALCDFGLCKL-------NMKDDDKTNTFCGTPEYLAPEL 164
Query: 944 ASMQRITEKSDVYSFGVVLLEVLTGRHP 971
T+ D ++ GV+L E+LTG P
Sbjct: 165 LLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 37/93 (39%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN-CSKTNQRPQLAGSYGYMAPEHAS 945
+H D+ A NVL+ G + DFGLAR + D N SK + L +MAPE
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMR--DSNYISKGSTFLPLK----WMAPESIF 314
Query: 946 MQRITEKSDVYSFGVVLLEVLT-GRHPLDPTLP 977
T SDV+SFG++L E+ T G P P LP
Sbjct: 315 NNLYTTLSDVWSFGILLWEIFTLGGTPY-PELP 346
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 1e-04
Identities = 23/60 (38%), Positives = 26/60 (43%)
Query: 296 KLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQL 355
LKSL L N L L V+D S N LT P +F L L+ L LS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 8/88 (9%)
Query: 611 LNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDA-LASLQNLVSLNVSFNDFSGEL 669
L L + G IP++ S L L ++LS N + G++ L S+ +L L++S+N F+G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 670 PNTPFFRKLPLSDLASNRGLYISGGVVS 697
P + L L S R L ++G +S
Sbjct: 483 PES-------LGQLTSLRILNLNGNSLS 503
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 2e-04
Identities = 22/57 (38%), Positives = 34/57 (59%), Gaps = 1/57 (1%)
Query: 610 SLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSG-DLDALASLQNLVSLNVSFNDF 665
SL+LS+N+ + F GL L +LDLS N L+ +A + L +L SL++S N+
Sbjct: 4 SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 55/214 (25%), Positives = 82/214 (38%), Gaps = 30/214 (14%)
Query: 773 VIGTGSSGVVYRVTIPNGETLAVKKMWSSDE------SGAFSSEIQTLGSIRHKNIVRLL 826
VIG G+ G V V + + K+ S E S F E + +V+L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY--EVVLGV--AHALAYLHHDC 882
+ + +Y+P G L +L+ W Y EVVL + H++ ++H D
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLALDAIHSMGFIHRD- 167
Query: 883 MPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE 942
VK N+LL LADFG ++ G C G+ Y++PE
Sbjct: 168 --------VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA------VGTPDYISPE 213
Query: 943 HASMQ----RITEKSDVYSFGVVLLEVLTGRHPL 972
Q + D +S GV L E+L G P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 26/222 (11%)
Query: 768 LTSANVIGTGSSGVVYRVTIPNGETL---AVKKM----WSSDESGAFSSEIQTLGSIRHK 820
L +G G G V + +++ AVK M + E F SE + H
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 821 NIVRLLG---WGSNKN---LKLLFYDYLPNGSLSSLLHGAGKGGADW----EARYEVVLG 870
N++RL+G ++ ++ +G L S L + G + + +
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
+A + YL +H D+ A N +L +ADFGL++ + + + P
Sbjct: 121 IASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
++A E + + T KSDV+SFGV + E+ T G+ P
Sbjct: 178 -----VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 60/222 (27%), Positives = 87/222 (39%), Gaps = 32/222 (14%)
Query: 763 DVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE------SGAFSSEIQTLGS 816
DVV+ VIG G+ G V V + + + K+ S E S F E +
Sbjct: 46 DVVK------VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 817 IRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY--EVVLGVAHA 874
+V+L + + +Y+P G L +L+ W Y EVVL A
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVP-EKWAKFYTAEVVL----A 154
Query: 875 LAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAG 934
L +H ++H DVK N+LL LADFG + +G C G
Sbjct: 155 LDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA------VG 205
Query: 935 SYGYMAPEHASMQ----RITEKSDVYSFGVVLLEVLTGRHPL 972
+ Y++PE Q + D +S GV L E+L G P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 10/103 (9%)
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
+A L +LH I++ D+K NV+L +ADFG+ + D +KT
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKT---- 160
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
G+ Y+APE + Q + D ++FGV+L E+L G+ P +
Sbjct: 161 -FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 42/222 (18%)
Query: 772 NVIGTGSSG----VVYRVTIPNGETLAVKKMWSS----DESGAFSSEIQTLGSIRHKN-I 822
+++G G G V + T G+ A+K M S E+ +F E + + SI + I
Sbjct: 7 SLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWI 63
Query: 823 VRLL-GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGV--AHALA 876
+L + NL L+ +Y P G L SLL+ + A++ E+VL + H +
Sbjct: 64 PQLQYAFQDKDNLYLVM-EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 877 YLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQL-AGS 935
Y+H D+K NVL+ LADFG A ++ + N +L G+
Sbjct: 123 YVHR---------DIKPENVLIDRTGHIKLADFGSAARLTANKMVN-------SKLPVGT 166
Query: 936 YGYMAPEHASMQRITEKS------DVYSFGVVLLEVLTGRHP 971
Y+APE + K D +S GV+ E++ GR P
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 58/212 (27%), Positives = 87/212 (41%), Gaps = 29/212 (13%)
Query: 773 VIGTGSSGVV-----------YRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKN 821
VIG GS G V Y V + +T+ KK +++ + L +++H
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKK----EQNHIMAERNVLLKNLKHPF 57
Query: 822 IVRLLGWGSNKNLKLLF-YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHH 880
+V L + KL F DY+ G L L + + AR+ VA A+ YLH
Sbjct: 58 LVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRARFYAA-EVASAIGYLHS 114
Query: 881 DCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMA 940
I++ D+K N+LL L DFGL + G + + T G+ Y+A
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTST-----FCGTPEYLA 164
Query: 941 PEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
PE + D + G VL E+L G P
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 36/130 (27%), Positives = 55/130 (42%), Gaps = 10/130 (7%)
Query: 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL-HHDCMPPILHGDVKAMNVL 897
Y + + +LL G G VA + +L +C +H D+ A NVL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVL 269
Query: 898 LGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYS 957
L G + DFGLAR + + + P +MAPE T SDV+S
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP-----VKWMAPESIFDNLYTTLSDVWS 324
Query: 958 FGVVLLEVLT 967
+G++L E+ +
Sbjct: 325 YGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-04
Identities = 62/242 (25%), Positives = 95/242 (39%), Gaps = 54/242 (22%)
Query: 773 VIGTGSSGVVYRV-TIPNGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLL 826
VIG G+ G V V G A+KK+ S+ + +E L + +V+L
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 827 -GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGV--AHALAYLHH 880
+ L L+ +YLP G + +LL + E R+ E +L + H L Y+H
Sbjct: 68 YSFQDENYLYLIM-EYLPGGDMMTLLMKKDTFTEE-ETRFYIAETILAIDSIHKLGYIHR 125
Query: 881 DCMPPILHGDVKAMNVLLGPGYQAYLADFGL------------ARIVSGSGDDNCSKTNQ 928
D +K N+LL L+DFGL RI+S + N
Sbjct: 126 D---------IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176
Query: 929 RP---------------QLA----GSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGR 969
+P LA G+ Y+APE ++ D +S GV++ E+L G
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236
Query: 970 HP 971
P
Sbjct: 237 PP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 59/214 (27%), Positives = 91/214 (42%), Gaps = 32/214 (14%)
Query: 773 VIGTGSSGVVYRVTI----PNGETLAVKKM------WSSDESGAFSSEIQTLGSIRHKNI 822
V+G G G V++V G+ A+K + + ++ +E L +++H I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 823 VRLLGWGSNKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARY--EVVLGVAHALAYLH 879
V L+ + KL L +YL G L L G D Y E+ L AL +LH
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISL----ALEHLH 117
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR--IVSGSGDDNCSKTNQRPQLAGSYG 937
I++ D+K N+LL L DFGL + I G + T+ G+
Sbjct: 118 QQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG------TVTH---TFCGTIE 165
Query: 938 YMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
YMAPE + D +S G ++ ++LTG P
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 31/102 (30%), Positives = 46/102 (45%), Gaps = 10/102 (9%)
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
+A AL YLH I++ D+K N+LL L DFGL + + ++++
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK-------EGIAQSDTTT 154
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
G+ Y+APE Q D + G VL E+L G P
Sbjct: 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 32/102 (31%), Positives = 43/102 (42%), Gaps = 10/102 (9%)
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
+A AL YLH I++ D+K N+LL L DFGL + +N
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK-------ENIEHNGTTS 154
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
G+ Y+APE Q D + G VL E+L G P
Sbjct: 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 9/147 (6%)
Query: 774 IGTGSSGVVYR-VTIPNGETLAVKKMWSSDESGA-FSS--EIQTLGSIRHKNIVRLLGWG 829
+G GS VY+ + NG+ +A+K + +E G F++ E L ++H NIV L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 830 SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHG 889
K L ++Y+ + GG E + + L+Y+H ILH
Sbjct: 73 HTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHR 127
Query: 890 DVKAMNVLLGPGYQAYLADFGLARIVS 916
D+K N+L+ + LADFGLAR S
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKS 154
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 42/141 (29%), Positives = 65/141 (46%), Gaps = 21/141 (14%)
Query: 837 LFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLH-HDCMPPILHGDVK 892
L DY+ G L L G+ D A++ E+VL AL +LH +D I++ D+K
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSED-RAKFYIAELVL----ALEHLHKYD----IVYRDLK 123
Query: 893 AMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR-ITE 951
N+LL L DFGL++ N + G+ Y+APE ++ T+
Sbjct: 124 PENILLDATGHIALCDFGLSK-------ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176
Query: 952 KSDVYSFGVVLLEVLTGRHPL 972
D +S GV++ E+ G P
Sbjct: 177 HVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 33/107 (30%), Positives = 50/107 (46%), Gaps = 14/107 (13%)
Query: 866 EVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSK 925
+++ G+ H LH I++ D+K NVLL ++D GLA + D SK
Sbjct: 105 QIISGLEH----LHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK----DGQSK 153
Query: 926 TNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
T AG+ G+MAPE + D ++ GV L E++ R P
Sbjct: 154 TK---GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 51/195 (26%), Positives = 75/195 (38%), Gaps = 17/195 (8%)
Query: 778 SSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837
+SG Y + I E + K DE +E + L + RH + L K+
Sbjct: 18 ASGKYYAMKILKKEVIIAK-----DEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCF 72
Query: 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVL 897
+Y+ G L L D Y + AL YLH I++ D+K N++
Sbjct: 73 VMEYVNGGELFFHLSRERVFSEDRTRFYGA--EIVSALDYLHSG---KIVYRDLKLENLM 127
Query: 898 LGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYS 957
L + DFGL + G D KT G+ Y+APE D +
Sbjct: 128 LDKDGHIKITDFGLCK--EGITDAATMKT-----FCGTPEYLAPEVLEDNDYGRAVDWWG 180
Query: 958 FGVVLLEVLTGRHPL 972
GVV+ E++ GR P
Sbjct: 181 LGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 30/103 (29%), Positives = 47/103 (45%), Gaps = 10/103 (9%)
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
++ AL YLH I++ D+K NVLL L D+G+ + GD
Sbjct: 105 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-------S 154
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
G+ Y+APE + D ++ GV++ E++ GR P D
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-04
Identities = 57/234 (24%), Positives = 87/234 (37%), Gaps = 59/234 (25%)
Query: 791 ETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSL 850
+TL K + ++ +E L ++ +VRL +K+ DY+P G + SL
Sbjct: 32 KTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSL 91
Query: 851 LHGAGKGGADWEARY--EVVLGV--AHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYL 906
L G D Y E+ V H + ++H D +K N+L+ L
Sbjct: 92 LIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD---------IKPDNILIDRDGHIKL 142
Query: 907 ADFGLARIVSG-----------SGD----------------DNC-------------SKT 926
DFGL +G SGD NC ++
Sbjct: 143 TDFGLC---TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQ 199
Query: 927 NQR---PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977
+QR L G+ Y+APE T+ D +S GV+L E+L G+ P P
Sbjct: 200 HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTP 253
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 7e-04
Identities = 18/59 (30%), Positives = 28/59 (47%)
Query: 321 LTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAI 379
L +D S+N LT +F L L+ L LS N L+ P + +L L++ N +
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 7e-04
Identities = 58/238 (24%), Positives = 102/238 (42%), Gaps = 33/238 (13%)
Query: 764 VVRNLTSANVIGTGSSGVV---YRVTIPNGETLAVKKMWSSDESGAFSS----EIQTLGS 816
V++ + IG+G+ G+V Y + +A+KK+ ++ + E+ +
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 817 IRHKNIVRLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR----YEVVLGV 871
+ HKNI+ LL + K+L+ YL + + L + D E Y+++ G+
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 872 AHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQ 931
H LH I+H D+K N+++ + DFGLAR S P
Sbjct: 133 KH----LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-------FMMTPY 178
Query: 932 LAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLM 989
+ Y Y APE E D++S G ++ E++ RH + PG + QW ++
Sbjct: 179 VVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV--RHKI--LFPGRDYIDQWNKVI 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 0.001
Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 47/233 (20%)
Query: 773 VIGTGSSGVV----YRVTIPNGETLAVKKMWSSDESGAFSS---------EIQTLGSIRH 819
IG+G+ G+V VT G+ +A+KK+ S F + E+ + + H
Sbjct: 23 PIGSGAQGIVCAAYDTVT---GQNVAIKKL-----SRPFQNVTHAKRAYRELVLMKLVNH 74
Query: 820 KNIVRLLG-WGSNKNLKLLFYD-YLPNGSLSSLLHGAGKGGADWEAR----YEVVLGVAH 873
KNI+ LL + K+L+ F D YL + + L + D E Y+++ G+ H
Sbjct: 75 KNIIGLLNVFTPQKSLEE-FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKH 133
Query: 874 ALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLA 933
LH I+H D+K N+++ + DFGLAR S P +
Sbjct: 134 ----LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-------FMMTPYVV 179
Query: 934 GSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWT 986
Y Y APE E D++S G ++ E++ G PG + QW
Sbjct: 180 TRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT----VLFPGTDHIDQWN 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 0.001
Identities = 45/186 (24%), Positives = 82/186 (44%), Gaps = 39/186 (20%)
Query: 809 SEIQTLGSIRHKNIVRL---LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR- 864
+EI LG + H+NI+++ L +N + YD+ L S ++ DW+ R
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMY---DEAFDWKDRP 264
Query: 865 -----YEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919
++ + A+ Y+H + +H D+K N+ L + L DFG A
Sbjct: 265 LLKQTRAIMKQLLCAVEYIHDKKL---IHRDIKLENIFLNCDGKIVLGDFGTA------- 314
Query: 920 DDNCSKTNQRPQLAGSYGYM------APEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
++ + A YG++ +PE + E +D++S G++LL++L+ H
Sbjct: 315 -----MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS--HDFC 367
Query: 974 PTLPGG 979
P GG
Sbjct: 368 PIGDGG 373
|
Length = 501 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 43/221 (19%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS---------EIQTLGSIRHKNIV 823
IG G+ G+V E +A+KK+ + AF + EI+ L + H+N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI-----ANAFDNRIDAKRTLREIKLLRHLDHENVI 67
Query: 824 RLLGWGSNK-----NLKLLFYD-YLPNGSLSSLLHG---AGKGGADWEARYEVVLGVAHA 874
+ K + F D Y+ + + LH + + +D +Y + +
Sbjct: 68 AI------KDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQY-FLYQLLRG 120
Query: 875 LAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAG 934
L Y+H +LH D+K N+LL + DFGLAR S GD R
Sbjct: 121 LKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR----- 172
Query: 935 SYGYMAPEHA-SMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974
Y APE + T DV+S G + E+L GR PL P
Sbjct: 173 --WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFP 210
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 63/218 (28%), Positives = 90/218 (41%), Gaps = 37/218 (16%)
Query: 773 VIGTGSSGVVYRVTIPN-GETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRL- 825
VIG G+ G V V + N G+ A+K +M E+ F E L + + I L
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGV--AHALAYLHH 880
+ NL L+ DY G L +LL + AR+ E+VL + H L Y+H
Sbjct: 68 YAFQDENNLYLVM-DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHR 126
Query: 881 DCMPPILHGDVKAMNVLLGPGYQAYLADFG--LARIVSGSGDDNCSKTNQRPQLAGSYGY 938
D +K NVLL LADFG L + G+ N + G+ Y
Sbjct: 127 D---------IKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--------VGTPDY 169
Query: 939 MAPE-----HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
++PE R + D +S GV + E+L G P
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 29/100 (29%), Positives = 46/100 (46%), Gaps = 10/100 (10%)
Query: 874 ALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLA 933
AL +LH I++ D+K NVLL L D+G+ + GD +
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-------FC 157
Query: 934 GSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
G+ Y+APE + D ++ GV++ E++ GR P D
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 21/61 (34%), Positives = 27/61 (44%), Gaps = 2/61 (3%)
Query: 392 GLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSND 450
L N+LT + L+ LD S NNL+ I E F GL +L L L N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGNN 59
Query: 451 L 451
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 58/231 (25%), Positives = 92/231 (39%), Gaps = 56/231 (24%)
Query: 791 ETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSL 850
+TL K + + ++ +E L ++ +V+L +K+ DY+P G + SL
Sbjct: 32 KTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSL 91
Query: 851 LHGAGKGGADWEARY---EVVLGV--AHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAY 905
L + AR+ E+ L + H + ++H D +K N+L+
Sbjct: 92 LIRMEVF-PEVLARFYIAELTLAIESVHKMGFIHRD---------IKPDNILIDLDGHIK 141
Query: 906 LADFGLA---RIVSGSG-------------------DD--NC-------------SKTNQ 928
L DFGL R S DD NC +K +Q
Sbjct: 142 LTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQ 201
Query: 929 R---PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP-LDPT 975
R L G+ Y+APE + T+ D +S GV+L E+L G+ P L PT
Sbjct: 202 RCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPT 252
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 30/102 (29%), Positives = 46/102 (45%), Gaps = 9/102 (8%)
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
+ AL YLH + +++ D+K N++L + DFGL + G D KT
Sbjct: 104 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKT---- 155
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
G+ Y+APE D + GVV+ E++ GR P
Sbjct: 156 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 29/104 (27%), Positives = 49/104 (47%), Gaps = 12/104 (11%)
Query: 871 VAHALAYLH-HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR 929
V AL +LH H +++ D+K N+LL LADFG+ + G + + T
Sbjct: 105 VTLALMFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTT--- 155
Query: 930 PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
G+ Y+APE D ++ GV++ E++ G+ P +
Sbjct: 156 --FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 30/102 (29%), Positives = 45/102 (44%), Gaps = 10/102 (9%)
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
+ AL YLH +++ D+K N++L + DFGL + G D KT
Sbjct: 104 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKT---- 154
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
G+ Y+APE D + GVV+ E++ GR P
Sbjct: 155 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.003
Identities = 28/78 (35%), Positives = 40/78 (51%), Gaps = 5/78 (6%)
Query: 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNV 896
L +YL G + SLLH G + +Y + VA AL YLH I+H D+K N+
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKY--ISEVALALDYLHRH---GIIHRDLKPDNM 135
Query: 897 LLGPGYQAYLADFGLARI 914
L+ L DFGL+++
Sbjct: 136 LISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.003
Identities = 58/257 (22%), Positives = 103/257 (40%), Gaps = 50/257 (19%)
Query: 755 QKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSS---- 809
K + + D +NL + +G+G+ G V G +A+KK+ +S +
Sbjct: 7 NKTVWEVPDRYQNL---SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR 63
Query: 810 EIQTLGSIRHKNIVRLL-----GWGSNKNLKLLFYD-YLPNGSLSSLLHGAGKGGA--DW 861
E++ L + H+N++ LL F D YL + + L+ K D
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLED-----FQDVYLVTHLMGADLNNIVKCQKLSDD 118
Query: 862 EARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921
++ +V + L Y+H I+H D+K N+ + + + DFGLAR
Sbjct: 119 HIQF-LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-------- 166
Query: 922 NCSKTNQRPQLAGSYGYMAPE------HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975
++ + Y APE H + D++S G ++ E+LTG+
Sbjct: 167 --HTDDEMTGYVATRWYRAPEIMLNWMH-----YNQTVDIWSVGCIMAELLTGK----TL 215
Query: 976 LPGGAPLVQWTPLMFLM 992
PG + Q +M L+
Sbjct: 216 FPGSDHIDQLKRIMNLV 232
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 30/98 (30%), Positives = 44/98 (44%), Gaps = 10/98 (10%)
Query: 874 ALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLA 933
AL YLH +++ D+K N++L + DFGL + G D KT
Sbjct: 107 ALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKT-----FC 156
Query: 934 GSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
G+ Y+APE D + GVV+ E++ GR P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.004
Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 465 LRRLRLNDNRLSGTIPSEM-GNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGL 523
L+ L L++NRL+ IP L +L +D+S N+L P + G SL LDL N L
Sbjct: 2 LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.004
Identities = 25/62 (40%), Positives = 32/62 (51%), Gaps = 3/62 (4%)
Query: 582 KLILLDIGNNRFSGEIPKE-LGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHN 640
L LD+ NNR + IP + +L+ L+LS N + P FSGL L LDLS N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLK-VLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
Query: 641 KL 642
L
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.004
Identities = 22/60 (36%), Positives = 26/60 (43%), Gaps = 2/60 (3%)
Query: 128 LTFIDLSGNSLWGEIPTEVCR-LRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQL 186
L +DLS N L IP + L L+ L L+ N L P L SL L L N L
Sbjct: 2 LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 56/238 (23%), Positives = 100/238 (42%), Gaps = 33/238 (13%)
Query: 764 VVRNLTSANVIGTGSSGVV---YRVTIPNGETLAVKKMWSSDESGAFSS----EIQTLGS 816
V++ + IG+G+ G+V Y + +A+KK+ ++ + E+ +
Sbjct: 22 VLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 817 IRHKNIVRLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR----YEVVLGV 871
+ HKNI+ LL + K+L+ Y+ + + L + D E Y+++ G+
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 872 AHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQ 931
H LH I+H D+K N+++ + DFGLAR S P
Sbjct: 140 KH----LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-------FMMTPY 185
Query: 932 LAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLM 989
+ Y Y APE E D++S G ++ E++ G PG + QW ++
Sbjct: 186 VVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHIDQWNKVI 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1001 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.98 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.98 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.98 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.98 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.98 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.98 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.98 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.98 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.98 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.65 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.43 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.13 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.12 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.11 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.1 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.09 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.08 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.99 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.98 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.97 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.94 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.93 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.82 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.69 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.69 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.69 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.66 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.61 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.53 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.51 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.5 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.45 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.43 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.42 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.29 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-113 Score=1098.32 Aligned_cols=857 Identities=36% Similarity=0.594 Sum_probs=607.1
Q ss_pred cHHHHHHHHHHHHhCCCCCCccCCCCCCCCCCCccceEEeCCCCcEEEEEeccccccccCCcccccCCCCcEEeccCCcc
Q 001873 35 LDEQGQALLTWKNSLNSSTDALSSWNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNL 114 (1001)
Q Consensus 35 ~~~~~~aLl~~k~~~~~~~~~l~sW~~~~~~~c~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~~~l 114 (1001)
.++|++||++||+++.+|.+.+.+|+. +.+||.|.||+|+..++|+++++.++.+.|.+|+.+..+++|+.|+|++|++
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~-~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~ 105 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNS-SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQL 105 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCC-CCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCcc
Confidence 568999999999999888888999985 6799999999999778999988877777776666666777777777777777
Q ss_pred cCCCCcccC-CccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccCCC
Q 001873 115 TGTIPKEFG-DYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKS 193 (1001)
Q Consensus 115 ~g~~p~~~~-~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~ 193 (1001)
+|.+|..+. .+++|++|||++|+++|.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.+|..
T Consensus 106 ~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 183 (968)
T PLN00113 106 SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183 (968)
T ss_pred CCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChh
Confidence 666666544 666777777777776666664 34666667777776666666666666666666666666666666666
Q ss_pred ccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCcccccCCCCC
Q 001873 194 IGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSEL 273 (1001)
Q Consensus 194 ~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L 273 (1001)
++++++|++|++++| .+. +.+|+.++++++|
T Consensus 184 ~~~l~~L~~L~L~~n-~l~------------------------------------------------~~~p~~l~~l~~L 214 (968)
T PLN00113 184 LTNLTSLEFLTLASN-QLV------------------------------------------------GQIPRELGQMKSL 214 (968)
T ss_pred hhhCcCCCeeeccCC-CCc------------------------------------------------CcCChHHcCcCCc
Confidence 666555555555555 222 2334444444444
Q ss_pred ceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccc
Q 001873 274 QNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVN 353 (1001)
Q Consensus 274 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 353 (1001)
++|+|++|++++.+|..++++++|++|++++|++++.+|..++++++|+.|++++|.+++.+|..+.++++|++|+|++|
T Consensus 215 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n 294 (968)
T PLN00113 215 KWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294 (968)
T ss_pred cEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCC
Confidence 44444444444444444555555555555555554445555555555555555555555455555555555555555555
Q ss_pred cccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCc
Q 001873 354 QLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPK 433 (1001)
Q Consensus 354 ~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~ 433 (1001)
++.+.+|..+..+++|+.|++++|.+.+..|..+..+++|+.|++++|.+++.+|..++.+++|+.|++++|++++.+|.
T Consensus 295 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~ 374 (968)
T PLN00113 295 SLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374 (968)
T ss_pred eeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCCh
Confidence 55555555555555555555555555555555555555555555556666666666666777777777777777777777
Q ss_pred ccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccC
Q 001873 434 EIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSL 513 (1001)
Q Consensus 434 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 513 (1001)
.+..+++|+.|++++|++.+.+|..+..+++|+.|++++|++++.+|..+.+++.|+.|++++|++++.+|..+..+++|
T Consensus 375 ~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 454 (968)
T PLN00113 375 GLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSL 454 (968)
T ss_pred hHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCC
Confidence 77777777777777777777777777778888888888888888888888888888888888888888888777788888
Q ss_pred ceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccc
Q 001873 514 EFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRF 593 (1001)
Q Consensus 514 ~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 593 (1001)
+.|++++|++.+.+|..+ ..++|+.|++++|++++.+|..+..+++|+.|+|++|++
T Consensus 455 ~~L~L~~n~~~~~~p~~~-----------------------~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 511 (968)
T PLN00113 455 QMLSLARNKFFGGLPDSF-----------------------GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKL 511 (968)
T ss_pred cEEECcCceeeeecCccc-----------------------ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcc
Confidence 888888888776555422 124667777777777777777777777777777777777
Q ss_pred cCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCC-ChhhhhcccccceeEcccCCCCCCCCCC
Q 001873 594 SGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSG-DLDALASLQNLVSLNVSFNDFSGELPNT 672 (1001)
Q Consensus 594 ~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~ls~N~l~~~~p~~ 672 (1001)
++.+|..+..+++|+. |+|++|++++.+|..|..+++|+.|||++|++++ .+..+..+++|++|++++|+++|.+|..
T Consensus 512 ~~~~p~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~ 590 (968)
T PLN00113 512 SGEIPDELSSCKKLVS-LDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590 (968)
T ss_pred eeeCChHHcCccCCCE-EECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc
Confidence 7777777777777775 7777777777788888888888888888888876 4566778888889999999999999998
Q ss_pred ccccCCCCCCCCCCCcccccCCC--CCCCCCCCccccccchhhhHHHHHHHHHHHHHHHhhhhhhhcccC---CccCCCC
Q 001873 673 PFFRKLPLSDLASNRGLYISGGV--VSPTDSLPAGQARSAMKLVMSILVSASAVLVLLAIYVLVRTRMAN---NSFTADD 747 (1001)
Q Consensus 673 ~~~~~~~~~~~~~n~~lc~~~~~--~s~~~~~~~~~~~~~~~iv~~i~v~~~~ilvl~~~~~~~r~r~~~---~~~~~~~ 747 (1001)
.++.++..+++.+|+++|+.+.+ .++|... .. ....+.++++++++++++++++++++++|+|+.. +......
T Consensus 591 ~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (968)
T PLN00113 591 GAFLAINASAVAGNIDLCGGDTTSGLPPCKRV-RK-TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDG 668 (968)
T ss_pred chhcccChhhhcCCccccCCccccCCCCCccc-cc-cceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccc
Confidence 88889998999999999985422 2233211 11 1111222222222222233333333333333211 1111222
Q ss_pred chhhhhhcc---ccccHHHHHhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCCchhhHHHHHHHhhccCCCcee
Q 001873 748 TWEMTLYQK---LDFSIDDVVRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIV 823 (1001)
Q Consensus 748 ~~~~~~~~~---~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv 823 (1001)
.|+...+.. ..++.+++.+.++..++||+|+||+||+|+. .++..||||++..... ...+|++.+++++|||||
T Consensus 669 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~l~~l~HpnIv 746 (968)
T PLN00113 669 TWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--IPSSEIADMGKLQHPNIV 746 (968)
T ss_pred cccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--ccHHHHHHHhhCCCCCcc
Confidence 344332221 2356677788899999999999999999997 4789999999854332 234578999999999999
Q ss_pred eEEeeeecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCc
Q 001873 824 RLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQ 903 (1001)
Q Consensus 824 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 903 (1001)
++++++.+.+..++|||||++|+|.++++. ++|..+.+|+.|+|+|++|||+.+.++|+||||||+||+++.++.
T Consensus 747 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~ 821 (968)
T PLN00113 747 KLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE 821 (968)
T ss_pred eEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc
Confidence 999999999999999999999999999963 789999999999999999999766679999999999999999988
Q ss_pred EEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcc
Q 001873 904 AYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLV 983 (1001)
Q Consensus 904 ~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~ 983 (1001)
+++. ||.+..... .....||++|||||++.+..++.++|||||||++|||+||+.||+........++
T Consensus 822 ~~~~-~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~ 889 (968)
T PLN00113 822 PHLR-LSLPGLLCT-----------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV 889 (968)
T ss_pred eEEE-ecccccccc-----------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHH
Confidence 8876 665443211 1122688999999999999999999999999999999999999987766666677
Q ss_pred cchhh
Q 001873 984 QWTPL 988 (1001)
Q Consensus 984 ~~~~~ 988 (1001)
+|...
T Consensus 890 ~~~~~ 894 (968)
T PLN00113 890 EWARY 894 (968)
T ss_pred HHHHH
Confidence 76654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-62 Score=628.33 Aligned_cols=512 Identities=37% Similarity=0.567 Sum_probs=424.9
Q ss_pred CCcEEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhh-cccccceEEccCCcccCCCCccccCCccccceec
Q 001873 103 SLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVC-RLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTL 181 (1001)
Q Consensus 103 ~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~-~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L 181 (1001)
+++.|+|++|+++|.+|+.+..+++|++|||++|+++|.+|..+. .+++|++|+|++|.++|.+|. +.+++|++|+|
T Consensus 70 ~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~L 147 (968)
T PLN00113 70 RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDL 147 (968)
T ss_pred cEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEEC
Confidence 566777777777777777777777777777777777777777655 777777777777777777764 45677777777
Q ss_pred cccccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccc
Q 001873 182 YDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSG 261 (1001)
Q Consensus 182 ~~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g 261 (1001)
++|.+++.+|..++++++|++|++++| .+.+
T Consensus 148 s~n~~~~~~p~~~~~l~~L~~L~L~~n-------------------------------------------------~l~~ 178 (968)
T PLN00113 148 SNNMLSGEIPNDIGSFSSLKVLDLGGN-------------------------------------------------VLVG 178 (968)
T ss_pred cCCcccccCChHHhcCCCCCEEECccC-------------------------------------------------cccc
Confidence 777776666665555555555555544 3445
Q ss_pred cCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCccccc
Q 001873 262 PIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGN 341 (1001)
Q Consensus 262 ~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 341 (1001)
.+|..++++++|++|+|++|++.+.+|..++++++|+.|+|++|++++.+|..++++++|++|++++|.+++.+|..|++
T Consensus 179 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~ 258 (968)
T PLN00113 179 KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN 258 (968)
T ss_pred cCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhC
Confidence 67777888889999999999999999999999999999999999999899999999999999999999999889989999
Q ss_pred ccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEe
Q 001873 342 LLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALD 421 (1001)
Q Consensus 342 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~ 421 (1001)
+++|++|+|++|++.+.+|..+..+++|++|++++|.+.+.+|..+.++++|+.|++++|.+++.+|..+..+++|+.|+
T Consensus 259 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~ 338 (968)
T PLN00113 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQ 338 (968)
T ss_pred CCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEE
Confidence 99999999999999888888899999999999999999888888888888888888888888888888888888888888
Q ss_pred CcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCccccc
Q 001873 422 FSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVG 501 (1001)
Q Consensus 422 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 501 (1001)
+++|.+++.+|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|++++|++++
T Consensus 339 L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~ 418 (968)
T PLN00113 339 LWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSG 418 (968)
T ss_pred CcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeee
Confidence 88888888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccc
Q 001873 502 GIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCR 581 (1001)
Q Consensus 502 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 581 (1001)
.+|..+..+++|+.|++++|++++. ++..+..+++|+.|++++|++.+.+|..+ ..+
T Consensus 419 ~~p~~~~~l~~L~~L~Ls~N~l~~~----------------------~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~ 475 (968)
T PLN00113 419 ELPSEFTKLPLVYFLDISNNNLQGR----------------------INSRKWDMPSLQMLSLARNKFFGGLPDSF-GSK 475 (968)
T ss_pred ECChhHhcCCCCCEEECcCCcccCc----------------------cChhhccCCCCcEEECcCceeeeecCccc-ccc
Confidence 7888788888887777777777654 34445668899999999999998888766 458
Q ss_pred cccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCC-ChhhhhcccccceeEc
Q 001873 582 KLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSG-DLDALASLQNLVSLNV 660 (1001)
Q Consensus 582 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l 660 (1001)
+|+.||+++|++++.+|..+..+++|+. |+|++|++++.+|+.+.++++|++|+|++|.+++ .+..+..+++|++|||
T Consensus 476 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 554 (968)
T PLN00113 476 RLENLDLSRNQFSGAVPRKLGSLSELMQ-LKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL 554 (968)
T ss_pred cceEEECcCCccCCccChhhhhhhccCE-EECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEEC
Confidence 9999999999999999999999999996 9999999999999999999999999999999998 4678899999999999
Q ss_pred ccCCCCCCCCCCc-cccCCCCCCCCCCCcc
Q 001873 661 SFNDFSGELPNTP-FFRKLPLSDLASNRGL 689 (1001)
Q Consensus 661 s~N~l~~~~p~~~-~~~~~~~~~~~~n~~l 689 (1001)
++|+++|.+|... .+..+...++.+|+-.
T Consensus 555 s~N~l~~~~p~~l~~l~~L~~l~ls~N~l~ 584 (968)
T PLN00113 555 SQNQLSGEIPKNLGNVESLVQVNISHNHLH 584 (968)
T ss_pred CCCcccccCChhHhcCcccCEEeccCCcce
Confidence 9999999999642 2444555566677643
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=399.81 Aligned_cols=484 Identities=29% Similarity=0.395 Sum_probs=305.2
Q ss_pred ccceEEccCCcccCCCCccccCCccccceeccccccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccc
Q 001873 151 KLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGL 230 (1001)
Q Consensus 151 ~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l 230 (1001)
.|+.|++++|.+. .+-+.+.+|..|.+|++++|+++ ..|+++|.+.+++.+++++|+ ++ ++|++++++.+|..|++
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~-ls-~lp~~i~s~~~l~~l~~ 121 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNK-LS-ELPEQIGSLISLVKLDC 121 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccch-Hh-hccHHHhhhhhhhhhhc
Confidence 4555555555555 44445555555555555555555 555555555555555555552 22 45555555555555555
Q ss_pred cccccccccCCccccccccceeccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCccccc
Q 001873 231 AETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGA 310 (1001)
Q Consensus 231 ~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~ 310 (1001)
+.|.+. ++|++++.+-.++.++..+|+++ .+|+.++++.+|..|++.+|++....|..+. |+.|++||..+|-+. .
T Consensus 122 s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-t 197 (565)
T KOG0472|consen 122 SSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-T 197 (565)
T ss_pred ccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-c
Confidence 554444 33444444444444444444444 4566666666666666666666644444443 666666666666665 5
Q ss_pred CCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhc-cccccCEEeccCCcccCccCccccc
Q 001873 311 IPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIA-TCTALTHLEIDNNAISGEIPADIGN 389 (1001)
Q Consensus 311 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~ 389 (1001)
+|..++.+.+|+.|+|.+|++. ..| .|..+..|++|+++.|+|. .+|.+.. +++++..|||.+|+++ +.|..+.-
T Consensus 198 lP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~cl 273 (565)
T KOG0472|consen 198 LPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICL 273 (565)
T ss_pred CChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHH
Confidence 6666666666666666666665 445 5666666666666666665 4444443 5666666666666665 44555555
Q ss_pred cCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCccccccc---ccceEEc--cCCcCCCCCCCCCCCCCC
Q 001873 390 INGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLR---NLTKLLL--LSNDLSGFIPPDIGNCTT 464 (1001)
Q Consensus 390 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~---~L~~L~L--~~N~l~~~~p~~l~~l~~ 464 (1001)
+.+|..|++++|.++ ..|..++++ .|+.|.+.+|.+.. +...+-+.. -|++|.= ..-.++..
T Consensus 274 LrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrT-iRr~ii~~gT~~vLKyLrs~~~~dglS~s---------- 340 (565)
T KOG0472|consen 274 LRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRT-IRREIISKGTQEVLKYLRSKIKDDGLSQS---------- 340 (565)
T ss_pred hhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHH-HHHHHHcccHHHHHHHHHHhhccCCCCCC----------
Confidence 555555555555555 334445555 55555555555442 111111100 0111110 00000000
Q ss_pred cceEEccccccccCCCcccCCCCCcceeeccCcccccCCccccccccc---CceEEcccccCcccCCCCccc---ccccc
Q 001873 465 LRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQS---LEFLDLHSNGLTGSVPDTLPT---SLQLV 538 (1001)
Q Consensus 465 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~---~l~~L 538 (1001)
+.=.-+.=......-.....+.+.+.|+++.-+++ .+|..+..... ....+++.|++. .+|..+.. .+..+
T Consensus 341 -e~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l 417 (565)
T KOG0472|consen 341 -EGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDL 417 (565)
T ss_pred -cccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHH
Confidence 00000000000011112334567888999999998 56665555444 778999999998 77776653 34448
Q ss_pred cCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcc
Q 001873 539 DLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQF 618 (1001)
Q Consensus 539 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l 618 (1001)
++++|.++ .+|..++.+++|..|+|++|.+. .+|.+++.+..|+.||+|+|+|. .+|+..-.+..++. +--++|++
T Consensus 418 ~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEt-llas~nqi 493 (565)
T KOG0472|consen 418 VLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLET-LLASNNQI 493 (565)
T ss_pred HhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHH-HHhccccc
Confidence 88988887 88889999999999999999998 78999999999999999999998 89999888888885 77778999
Q ss_pred cccccccccccccccEEEecCCcCCCChhhhhcccccceeEcccCCCC
Q 001873 619 SGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFS 666 (1001)
Q Consensus 619 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ls~N~l~ 666 (1001)
..+.|+.+.++.+|.+|||.+|.+...|+.++++++|++|+++||++.
T Consensus 494 ~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 494 GSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 988888899999999999999999999999999999999999999997
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=369.98 Aligned_cols=200 Identities=33% Similarity=0.490 Sum_probs=179.8
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
...+|...+.||+|+||+||+|+++ ++..||||.+.... ..+-+..|+.+++.++|||||.+++++..++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4567888889999999999999976 68999999986553 235578899999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC------CcEEEeccccc
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG------YQAYLADFGLA 912 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~------~~~ki~Dfgla 912 (1001)
||||.||+|.+|++..+ .+++.+++.++.|+|.|+++||++ +||||||||+|||++.. -.+||+|||+|
T Consensus 88 MEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999999754 589999999999999999999999 99999999999999764 46899999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+.+.+ .....+.+|+|-|||||++...+|+.|+|+||+|+|+|+|++|+.||+..+
T Consensus 163 R~L~~--------~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 163 RFLQP--------GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhCCc--------hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 98752 344556799999999999999999999999999999999999999999543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=393.53 Aligned_cols=485 Identities=28% Similarity=0.422 Sum_probs=285.9
Q ss_pred CcEEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccc
Q 001873 104 LKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYD 183 (1001)
Q Consensus 104 L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~ 183 (1001)
++.|++++|.++ .+.+.+.+|..|++|++++|+++ ++|++++.+..++.|+.++|+++ ++|++++.+.+|+.|+.++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 445666666665 45555666667777777777766 66667777777777777777776 6777777777777777777
Q ss_pred cccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccC
Q 001873 184 NQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPI 263 (1001)
Q Consensus 184 n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~i 263 (1001)
|.+. .+|++++.+..|..++..+|+ .. ++|..++++++|..+++.+|.+....|..+. +++|++++.-+|.++ .+
T Consensus 124 n~~~-el~~~i~~~~~l~dl~~~~N~-i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tl 198 (565)
T KOG0472|consen 124 NELK-ELPDSIGRLLDLEDLDATNNQ-IS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TL 198 (565)
T ss_pred ccee-ecCchHHHHhhhhhhhccccc-cc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cC
Confidence 7766 666677777777777766663 22 5666667777777777766666644343333 666666666666555 66
Q ss_pred cccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCcc-CCCCCCEEeccCCCCCCCCCcccccc
Q 001873 264 PEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELG-SCTELTVVDFSDNLLTGSIPRSFGNL 342 (1001)
Q Consensus 264 p~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l 342 (1001)
|+.++.+.+|+.|||+.|+|. ..| .|.+++.|++|+++.|++. .+|.+.. ++.++.+|||.+|+++ ..|..+.-+
T Consensus 199 P~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clL 274 (565)
T KOG0472|consen 199 PPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLL 274 (565)
T ss_pred ChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHh
Confidence 667777777777777777766 445 6666666777777776666 5555544 6666677777777766 566666666
Q ss_pred cCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccc------cCcccEEEeecCccCCCCCcccccCcc
Q 001873 343 LKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGN------INGLTLFFAWKNKLTGNIPESLSQCQE 416 (1001)
Q Consensus 343 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~------l~~L~~L~l~~n~l~~~~p~~l~~l~~ 416 (1001)
++|++||+|+|.|+ ..|..++++ .|+.|-+.+|.+.. +-..+-+ ++.|+. .+..-.++..
T Consensus 275 rsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrT-iRr~ii~~gT~~vLKyLrs-~~~~dglS~s---------- 340 (565)
T KOG0472|consen 275 RSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRT-IRREIISKGTQEVLKYLRS-KIKDDGLSQS---------- 340 (565)
T ss_pred hhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHH-HHHHHHcccHHHHHHHHHH-hhccCCCCCC----------
Confidence 66667777776666 455566666 66666666666542 1111100 011111 0000000000
Q ss_pred cceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCC---cceEEccccccccCCCcccCCCCCcce-e
Q 001873 417 LQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTT---LRRLRLNDNRLSGTIPSEMGNLKHLNF-V 492 (1001)
Q Consensus 417 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~---L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L 492 (1001)
+.=.-+.-............+.+.+.|+++.-+++ .+|+....... ....+++.|++. .+|..+..++.+.. +
T Consensus 341 -e~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l 417 (565)
T KOG0472|consen 341 -EGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDL 417 (565)
T ss_pred -cccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHH
Confidence 00000000000001111223334444444444444 22332222222 455666666665 55655555554433 3
Q ss_pred eccCcccccCCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCcccccc
Q 001873 493 DMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGR 572 (1001)
Q Consensus 493 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 572 (1001)
.+++|.+. .+|..++.+++|..|+|++|-+. .+|.+++.+..|++||+|.|++. .
T Consensus 418 ~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-----------------------~LP~e~~~lv~Lq~LnlS~NrFr-~ 472 (565)
T KOG0472|consen 418 VLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-----------------------DLPEEMGSLVRLQTLNLSFNRFR-M 472 (565)
T ss_pred HhhcCccc-cchHHHHhhhcceeeecccchhh-----------------------hcchhhhhhhhhheecccccccc-c
Confidence 34444443 56666666666666666666654 34555666666677777777666 5
Q ss_pred chhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCC
Q 001873 573 IPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSG 644 (1001)
Q Consensus 573 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 644 (1001)
.|..+..+..|+.+-.++|++....|..+.+++.|.+ |||.+|.+. .+|+.++++++|++|+|.+|+|..
T Consensus 473 lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~t-LDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr~ 542 (565)
T KOG0472|consen 473 LPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTT-LDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFRQ 542 (565)
T ss_pred chHHHhhHHHHHHHHhccccccccChHHhhhhhhcce-eccCCCchh-hCChhhccccceeEEEecCCccCC
Confidence 6666666666666666667776555555777777775 777777777 667778888888888888888884
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=350.03 Aligned_cols=211 Identities=28% Similarity=0.463 Sum_probs=183.3
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCC-ceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN-LKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~-~~~lv~e~ 841 (1001)
+.+..++||+|..|+|||++++ +++.+|+|.+.... ..+++.+|++++++++||+||+++|.|...+ ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4556788999999999999987 68889999984332 3478999999999999999999999999888 59999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
|++|||+++++.. ..+++...-+|+.++++||.|||++ ++||||||||+|||++..|++||||||.++.+...
T Consensus 160 MDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred cCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 9999999999875 4489999999999999999999974 29999999999999999999999999999987432
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhhhhccc
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLML 993 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~~~~~~ 993 (1001)
...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.||-+. ..+-..|...+..+.
T Consensus 233 ------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~---~~~~~~~~~Ll~~Iv 295 (364)
T KOG0581|consen 233 ------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP---NPPYLDIFELLCAIV 295 (364)
T ss_pred ------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc---CCCCCCHHHHHHHHh
Confidence 345679999999999999999999999999999999999999999886 334445555554433
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=370.88 Aligned_cols=222 Identities=43% Similarity=0.795 Sum_probs=193.2
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc--hhhHHHHHHHhhccCCCceeeEEeeeecCC-ceEEE
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE--SGAFSSEIQTLGSIRHKNIVRLLGWGSNKN-LKLLF 838 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~-~~~lv 838 (1001)
...++.|...++||+|+||.||+|..+++..||||++..... .++|.+|+.++.+++|||+|+++|||.+.+ ..++|
T Consensus 71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 71 RKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred HHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 445678999999999999999999999899999998866554 467999999999999999999999999998 49999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
||||++|+|.++++......++|.+|++||.++|+|++|||..+.++||||||||+|||+|+++++||+|||+|+.....
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 99999999999998754326899999999999999999999998889999999999999999999999999999754320
Q ss_pred CCCCCCCCCCCCcc-cccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC-CCCcCcccchhhhh
Q 001873 919 GDDNCSKTNQRPQL-AGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL-PGGAPLVQWTPLMF 990 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~-~~~~~l~~~~~~~~ 990 (1001)
....... .||.+|+|||+...+..+.|+|||||||++.|++||+.|.+... .+...+++|.....
T Consensus 231 -------~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 231 -------DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred -------ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 1111111 79999999999999999999999999999999999999999765 33455899875543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=368.20 Aligned_cols=424 Identities=22% Similarity=0.211 Sum_probs=358.4
Q ss_pred ccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCC
Q 001873 257 SLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIP 336 (1001)
Q Consensus 257 n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 336 (1001)
..+.|.+| +.-+.||+++|+++.+.+..|.++++|+.+++.+|.++ .||..-+...+|+.|+|.+|.|+..-.
T Consensus 70 ~~l~g~lp------~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~s 142 (873)
T KOG4194|consen 70 SRLKGFLP------SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTS 142 (873)
T ss_pred cccCCcCc------cceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccH
Confidence 34555555 33567999999999888888999999999999999998 788766677779999999999987777
Q ss_pred cccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcc
Q 001873 337 RSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQE 416 (1001)
Q Consensus 337 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~ 416 (1001)
+.+..++.|+.||||.|.|+.+.-..|..-.++++|+|++|.|+......|.++.+|..|.|++|+++...+..|+++++
T Consensus 143 e~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~ 222 (873)
T KOG4194|consen 143 EELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPK 222 (873)
T ss_pred HHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcch
Confidence 88888999999999999998665567777788999999999999888889999999999999999999887888999999
Q ss_pred cceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccC
Q 001873 417 LQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSE 496 (1001)
Q Consensus 417 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 496 (1001)
|+.|+|..|+|.-.---.|.++++|+.|.|..|++.......|-.+.++++|+|+.|+++..-..++-+|+.|+.|+||+
T Consensus 223 L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~ 302 (873)
T KOG4194|consen 223 LESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSY 302 (873)
T ss_pred hhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccch
Confidence 99999999999844466788999999999999999998889999999999999999999988888999999999999999
Q ss_pred cccccCCcccccccccCceEEcccccCcccCCCCcc--cccccccCCCCcCCCCcccccccccccceeeccCccccccch
Q 001873 497 NHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIP 574 (1001)
Q Consensus 497 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 574 (1001)
|.|..+.+.+..-+++|++|||++|+|+...+..+. ..++.|+|++|+|+..-...|..+++|++|||++|.|+..+.
T Consensus 303 NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IE 382 (873)
T KOG4194|consen 303 NAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIE 382 (873)
T ss_pred hhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEe
Confidence 999998899999999999999999999966565554 567789999999997777889999999999999999987554
Q ss_pred ---hhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCChhhhhc
Q 001873 575 ---AEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALAS 651 (1001)
Q Consensus 575 ---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 651 (1001)
..|..+++|+.|++-+|+|....-..|..+..|+. |||.+|.|..+-|.+|..+ .|++|-+..-.+-||++.-+-
T Consensus 383 Daa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~-LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~Wl 460 (873)
T KOG4194|consen 383 DAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEH-LDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKWL 460 (873)
T ss_pred cchhhhccchhhhheeecCceeeecchhhhccCcccce-ecCCCCcceeecccccccc-hhhhhhhcccceEEeccHHHH
Confidence 35778999999999999999666678999999997 9999999999999999999 999999999999999887777
Q ss_pred ccccceeEcccCCCCCCCCCCccccCCCCCCCCCCCccc
Q 001873 652 LQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRGLY 690 (1001)
Q Consensus 652 l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc 690 (1001)
.+||.-..+.. .....|.-++.+......+.+...-.|
T Consensus 461 ~qWl~~~~lq~-sv~a~CayPe~Lad~~i~svd~~~lvC 498 (873)
T KOG4194|consen 461 AQWLYRRKLQS-SVIAKCAYPEPLADQSIVSVDTANLVC 498 (873)
T ss_pred HHHHHhccccc-ceeeeccCCcccccceeEeechhhcee
Confidence 78877666652 233344444444444444444333444
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=361.10 Aligned_cols=200 Identities=38% Similarity=0.571 Sum_probs=175.4
Q ss_pred ccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCC-ceEEEEEcc
Q 001873 768 LTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKN-LKLLFYDYL 842 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~-~~~lv~e~~ 842 (1001)
....+.+|+|+||+||+|.++....||||++..... .++|.+|+.++++++|||||+++|+|.+.. ..++|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 344456999999999999996544599999865331 358999999999999999999999999887 789999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-eEEeCCCCCCeEECCCC-cEEEecccccccccCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPP-ILHGDVKAMNVLLGPGY-QAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~-ivH~Dlkp~NIll~~~~-~~ki~Dfgla~~~~~~~~ 920 (1001)
++|+|.++++...+..+++..+.+++.|||+||+|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999875566799999999999999999999998 7 99999999999999997 99999999998764321
Q ss_pred CCCCCCCCCCcccccccccCccccc--cCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHAS--MQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
...+...||++|||||++. ...|+.|+||||||+++|||+||+.||....+
T Consensus 199 ------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 199 ------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred ------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 2233368999999999999 67999999999999999999999999998765
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.04 Aligned_cols=200 Identities=25% Similarity=0.392 Sum_probs=174.2
Q ss_pred HHhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCC---------chhhHHHHHHHhhccCCCceeeEEeeeecCC
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSD---------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN 833 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~ 833 (1001)
+.+.|.+.+.+|+|+||.|-+|.. ++|++||||++.+.. ......+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 567889999999999999999875 479999999985421 1134579999999999999999999999999
Q ss_pred ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC---CcEEEeccc
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG---YQAYLADFG 910 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~ki~Dfg 910 (1001)
+.|||||||+||+|.+++-.. ..+.+...+.+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999999999764 3467777788999999999999999 99999999999999765 789999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCccccccCCCC---CccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRIT---EKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+|+... ....+.+.+|||.|.|||++.++.+. .++||||+||++|-+++|.+||.+..
T Consensus 325 lAK~~g--------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 325 LAKVSG--------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred hhhccc--------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 999863 34567788999999999999765543 47899999999999999999998754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=358.18 Aligned_cols=198 Identities=25% Similarity=0.397 Sum_probs=182.5
Q ss_pred hcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecC-----CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWS-----SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|...++||+|+|+.||.++. ..|+.||+|++.+ ....+...+||++.+.++|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999997 7899999999854 345578999999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
|+|+.++|..++++ .+.+++.+++.+++||+.|+.|||+. +|+|||||..|++++++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~- 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD- 171 (592)
T ss_pred EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc-
Confidence 99999999999985 56699999999999999999999998 9999999999999999999999999999987533
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.....+.+|||.|.|||++....++..+||||+|||||-|+.|++||+..
T Consensus 172 ------~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 172 ------GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred ------ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 24456789999999999999999999999999999999999999999865
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.29 Aligned_cols=200 Identities=29% Similarity=0.378 Sum_probs=178.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.+.|++.++||+|+||+||.++.+ +++.+|+|++++.. +.+...+|..++.+++||+||+++-.|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 357899999999999999999865 58999999885432 346688899999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
+||+.||.|..++++. ..+++..+.-++.+|+.|+.|||++ +|||||+||+|||+|++|+++|+|||+++.....
T Consensus 104 ld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999999999874 4589998888999999999999999 9999999999999999999999999999864322
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.....+.+||+.|||||++....|+.++|-||+|+++|||++|..||....
T Consensus 179 -------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 179 -------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred -------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 223345799999999999999999999999999999999999999998753
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=331.93 Aligned_cols=203 Identities=27% Similarity=0.392 Sum_probs=176.7
Q ss_pred HhcccCCCeEeecCCeeEEEEE-eCCCCEEEEEEecC----CCchhhHHHHHHHhhccCCCceeeEEee-eecC-CceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWS----SDESGAFSSEIQTLGSIRHKNIVRLLGW-GSNK-NLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~-~~~~-~~~~l 837 (1001)
...|++.++||+|.||+||+++ ..+|..||.|++.- ..+.++...|+.++++++|||||+++++ +.++ ...+|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 4568899999999999999998 45899999998852 2234678899999999999999999994 3333 44789
Q ss_pred EEEccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEeCCCCCCeEECCCCcEEEecccccc
Q 001873 838 FYDYLPNGSLSSLLHG--AGKGGADWEARYEVVLGVAHALAYLHHDCMPP--ILHGDVKAMNVLLGPGYQAYLADFGLAR 913 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~ki~Dfgla~ 913 (1001)
|||||..|+|.+.++. .+.+.+++.++++++.|++.|+.++|++. +. |+||||||.||+++.+|.+|++|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999875 33556899999999999999999999942 24 8999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.+.. .+......+|||.||+||.+.+.+|+.+|||||+||++|||+.-+.||.+.
T Consensus 177 ~l~s-------~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 177 FLSS-------KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred Hhcc-------hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 8853 345566789999999999999999999999999999999999999999875
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=328.12 Aligned_cols=218 Identities=26% Similarity=0.395 Sum_probs=187.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCch----hhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDES----GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
++|+...++|+|+||.||+.+.+ +|+.||||++....+. +-..|||+++++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888889999999999999977 5999999999655442 557799999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
||+..-|.. +... ..+.+.+...++..|++.|+.|+|++ ++|||||||+|||++.+|.+|+||||.|+.+..++
T Consensus 82 ~~dhTvL~e-Le~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg- 155 (396)
T KOG0593|consen 82 YCDHTVLHE-LERY-PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG- 155 (396)
T ss_pred ecchHHHHH-HHhc-cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc-
Confidence 998644444 4433 45689999999999999999999999 99999999999999999999999999999986432
Q ss_pred CCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhhhhcccchhhhc
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLMLNLEAEQ 999 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~~~~~~~~~~~~ 999 (1001)
...+..+.|++|+|||.+.+ ..|+.++||||+||++.||++|. +..|+..+++|.-.+....|+..+..
T Consensus 156 ------d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~----pL~PG~SDiDQLy~I~ktLG~L~prh 225 (396)
T KOG0593|consen 156 ------DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE----PLWPGRSDIDQLYLIRKTLGNLIPRH 225 (396)
T ss_pred ------chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC----cCCCCcchHHHHHHHHHHHcccCHHH
Confidence 23345689999999998866 89999999999999999999998 45567788888888888788776654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=316.89 Aligned_cols=217 Identities=24% Similarity=0.364 Sum_probs=189.3
Q ss_pred hcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCCch----hhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSDES----GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
++|...+++|+|.||.||+|++ ++|+.||||+++..+.. ....|||+.++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999985 57999999999765433 457899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
||+ .+|+..+++. ...++..++..++.++++|++|+|++ .|+||||||.|+|++++|.+||+|||+|+.+.+...
T Consensus 82 fm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred ecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 997 7999999875 55678999999999999999999998 999999999999999999999999999998864422
Q ss_pred CCCCCCCCCCcccccccccCcccc-ccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhhhhcccchhhh
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHA-SMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLMLNLEAE 998 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~~~~~~~~~~~ 998 (1001)
..+..+-|.+|+|||.+ ..+.|+..+||||.|||+.||+-|. |.++|+.+++|..+++...|.+.++
T Consensus 157 -------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~----P~fpG~sDidQL~~If~~LGTP~~~ 224 (318)
T KOG0659|consen 157 -------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV----PFFPGDSDIDQLSKIFRALGTPTPD 224 (318)
T ss_pred -------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC----CCCCCCchHHHHHHHHHHcCCCCcc
Confidence 22333789999999976 5588999999999999999999998 4567889999999998777755444
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=320.25 Aligned_cols=198 Identities=28% Similarity=0.394 Sum_probs=179.7
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|+..+.||.|+||+|.+++.+ +|..+|+|++..... .+...+|..+++.+.||+++++++.+.+.+..++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 356888999999999999999976 689999999865442 24567899999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||++||.|..++++.+ .+++..++-+|.||+.|++|||+. +|++||+||+|||+|++|++||+|||.|+.+..
T Consensus 123 meyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred EeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 99999999999999854 489999999999999999999998 999999999999999999999999999998642
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
...+.+|||.|+|||++..++|+.++|-|||||++|||+.|++||....+
T Consensus 197 ---------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 197 ---------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ---------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 24567999999999999999999999999999999999999999987654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=354.53 Aligned_cols=301 Identities=26% Similarity=0.284 Sum_probs=225.1
Q ss_pred ccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccC
Q 001873 265 EEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLK 344 (1001)
Q Consensus 265 ~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 344 (1001)
++++.++.|+.|||+.|.|+.+.-.+|..-.++++|+|++|.|+..--..|.++.+|..|.|++|+++...+..|.+|++
T Consensus 143 e~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~ 222 (873)
T KOG4194|consen 143 EELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPK 222 (873)
T ss_pred HHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcch
Confidence 34556677888888888888766677777778888888888888777777777888888888888888666667777888
Q ss_pred ccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcC
Q 001873 345 LQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSY 424 (1001)
Q Consensus 345 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~ 424 (1001)
|+.|+|..|+|.-..-..|.++++|+.|.|..|.|+. ..-..|..+.++++|+|+.
T Consensus 223 L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~k------------------------L~DG~Fy~l~kme~l~L~~ 278 (873)
T KOG4194|consen 223 LESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISK------------------------LDDGAFYGLEKMEHLNLET 278 (873)
T ss_pred hhhhhccccceeeehhhhhcCchhhhhhhhhhcCccc------------------------ccCcceeeecccceeeccc
Confidence 8888888887764334566677777777777666653 3334566777788888888
Q ss_pred ccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCc
Q 001873 425 NNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIP 504 (1001)
Q Consensus 425 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 504 (1001)
|+++..-..++++++.|+.|+|++|.|..+.++.+..+++|++|+|++|+|+...+..|..|..|+.|+|++|.++...-
T Consensus 279 N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e 358 (873)
T KOG4194|consen 279 NRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAE 358 (873)
T ss_pred chhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHh
Confidence 88887777788888888888888888888888888888888888888888888888888888888888888888887777
Q ss_pred ccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhcccccc
Q 001873 505 PSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLI 584 (1001)
Q Consensus 505 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 584 (1001)
..|..+++|+.|||++|.|++.+.++ ...|.+++.|++|+|.+|+|..+...+|.+++.|+
T Consensus 359 ~af~~lssL~~LdLr~N~ls~~IEDa-------------------a~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE 419 (873)
T KOG4194|consen 359 GAFVGLSSLHKLDLRSNELSWCIEDA-------------------AVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALE 419 (873)
T ss_pred hHHHHhhhhhhhcCcCCeEEEEEecc-------------------hhhhccchhhhheeecCceeeecchhhhccCcccc
Confidence 78888888888888888888665542 22455566666666666666655555666666666
Q ss_pred EEecccccccCCCCCccccccchhh
Q 001873 585 LLDIGNNRFSGEIPKELGQISSLEI 609 (1001)
Q Consensus 585 ~L~Ls~N~l~~~~p~~~~~l~~L~~ 609 (1001)
+|||.+|.|...-|+.|..+ .|+.
T Consensus 420 ~LdL~~NaiaSIq~nAFe~m-~Lk~ 443 (873)
T KOG4194|consen 420 HLDLGDNAIASIQPNAFEPM-ELKE 443 (873)
T ss_pred eecCCCCcceeecccccccc-hhhh
Confidence 66666666666666666665 5543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.88 Aligned_cols=219 Identities=26% Similarity=0.341 Sum_probs=187.4
Q ss_pred HhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCCch----hhHHHHHHHhhccCCCceeeEEeeeecC--CceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSDES----GAFSSEIQTLGSIRHKNIVRLLGWGSNK--NLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~Ei~~l~~l~h~nIv~l~~~~~~~--~~~~l 837 (1001)
.+.|+.+++||+|.||.||+|+. .+|+.||+|++.-+.+. .-..|||.++++++||||+++.+...+. +.+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 34677788999999999999985 57999999999655433 4567899999999999999999976655 78999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
|+|||+ -||.-++... .-.+++.++..++.|++.|++|+|++ +|+|||||.+|||||.+|.+||+|||+|+++..
T Consensus 196 VFeYMd-hDL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMD-HDLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEeccc-chhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999998 5898888754 34689999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhhhhcccchh
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLMLNLE 996 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~~~~~~~~~ 996 (1001)
.. ....+..+-|.+|+|||.+.+ ..|+.++|+||.||||.||++|++.|. +..++.|..+++.+.|.+.
T Consensus 271 ~~------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~----G~tEveQl~kIfklcGSP~ 340 (560)
T KOG0600|consen 271 SG------SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ----GRTEVEQLHKIFKLCGSPT 340 (560)
T ss_pred CC------CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC----CccHHHHHHHHHHHhCCCC
Confidence 43 223566788999999998765 789999999999999999999996555 5567888888888888666
Q ss_pred hh
Q 001873 997 AE 998 (1001)
Q Consensus 997 ~~ 998 (1001)
++
T Consensus 341 e~ 342 (560)
T KOG0600|consen 341 ED 342 (560)
T ss_pred hh
Confidence 54
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=379.50 Aligned_cols=503 Identities=30% Similarity=0.347 Sum_probs=365.0
Q ss_pred EeccCCcccCCCCcccCCccccccccccCCccCCCCChh-hhcccccceEEccCCcccCCCCccccCCccccceeccccc
Q 001873 107 LIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTE-VCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQ 185 (1001)
Q Consensus 107 L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~-~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~ 185 (1001)
+|++..+++ .||..+..-..++.|+++.|.+. ..|-+ +.+.-+|+.|||++|+++ ..|..+..+.+|+.|+++.|.
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 466667776 77777766666888888888876 44433 334555899999988887 788888888999999999988
Q ss_pred cccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCcc
Q 001873 186 LSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPE 265 (1001)
Q Consensus 186 l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~ 265 (1001)
+. .+|.+++++.+|++|.|.+|. ...+|.++..+++|++|+++.|.+. .+|.
T Consensus 80 i~-~vp~s~~~~~~l~~lnL~~n~--l~~lP~~~~~lknl~~LdlS~N~f~-------------------------~~Pl 131 (1081)
T KOG0618|consen 80 IR-SVPSSCSNMRNLQYLNLKNNR--LQSLPASISELKNLQYLDLSFNHFG-------------------------PIPL 131 (1081)
T ss_pred Hh-hCchhhhhhhcchhheeccch--hhcCchhHHhhhcccccccchhccC-------------------------CCch
Confidence 88 788888888888888888873 3357777777777777777765544 6777
Q ss_pred cccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCc
Q 001873 266 EIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKL 345 (1001)
Q Consensus 266 ~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 345 (1001)
.+..++.++.+..++|.... .++... .+.++|..|.+.+.++..+.+++. .|||.+|.+. . -.+.++.+|
T Consensus 132 ~i~~lt~~~~~~~s~N~~~~----~lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l 201 (1081)
T KOG0618|consen 132 VIEVLTAEEELAASNNEKIQ----RLGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANL 201 (1081)
T ss_pred hHHhhhHHHHHhhhcchhhh----hhcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhhccch
Confidence 77777777788888772221 222222 777788888888777777777666 6888888876 2 235567788
Q ss_pred cEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCc
Q 001873 346 QELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYN 425 (1001)
Q Consensus 346 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N 425 (1001)
+.|....|+++.. ....++|+.|+.++|.++...+ -..-.+|+++++++|+++ .+|++++.+.+|+.++..+|
T Consensus 202 ~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N 274 (1081)
T KOG0618|consen 202 EVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDV--HPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHN 274 (1081)
T ss_pred hhhhhhhcccceE----EecCcchheeeeccCcceeecc--ccccccceeeecchhhhh-cchHHHHhcccceEecccch
Confidence 8888888887632 2244678888888888762222 223367788888888887 44588888888888888888
Q ss_pred cccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCC-cceeeccCcccccCCc
Q 001873 426 NLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKH-LNFVDMSENHLVGGIP 504 (1001)
Q Consensus 426 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p 504 (1001)
+++ .+|..+..+++|+.|.+.+|++. .+|+....++.|+.|+|..|+|....+..+.-+.. |+.|+.+.|++....-
T Consensus 275 ~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~ 352 (1081)
T KOG0618|consen 275 RLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPS 352 (1081)
T ss_pred hHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccccc
Confidence 885 67778888888888888888887 55667777888888888888887444444444443 7777777777764332
Q ss_pred ccccccccCceEEcccccCcccCCCCc--ccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhcccc
Q 001873 505 PSVVGCQSLEFLDLHSNGLTGSVPDTL--PTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRK 582 (1001)
Q Consensus 505 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 582 (1001)
..=...+.|+.|++.+|+|+...-..+ ...|+.|+|++|+|.......+.++..|++|+||+|+|+ .+|+++..+..
T Consensus 353 ~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~ 431 (1081)
T KOG0618|consen 353 YEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGR 431 (1081)
T ss_pred ccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhh
Confidence 222235677788888888875332222 356777888888887666777788888888888888888 77888888888
Q ss_pred ccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCC-CChhhhhcccccceeEcc
Q 001873 583 LILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLS-GDLDALASLQNLVSLNVS 661 (1001)
Q Consensus 583 L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~ls 661 (1001)
|++|...+|++. ..| ++.+++.|++ +|+|.|+|+...-..-..-++|++|||++|... -+...+..+..+...+++
T Consensus 432 L~tL~ahsN~l~-~fP-e~~~l~qL~~-lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~ 508 (1081)
T KOG0618|consen 432 LHTLRAHSNQLL-SFP-ELAQLPQLKV-LDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDIT 508 (1081)
T ss_pred hHHHhhcCCcee-ech-hhhhcCcceE-EecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecc
Confidence 888888888887 667 7888888887 888888888654333333378899999998843 366777778888888877
Q ss_pred cC
Q 001873 662 FN 663 (1001)
Q Consensus 662 ~N 663 (1001)
-|
T Consensus 509 ~~ 510 (1081)
T KOG0618|consen 509 LN 510 (1081)
T ss_pred cC
Confidence 66
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=346.49 Aligned_cols=201 Identities=28% Similarity=0.442 Sum_probs=176.6
Q ss_pred cccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc-hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCC
Q 001873 767 NLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE-SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNG 845 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 845 (1001)
.++.++.||+|.||+||.|++.....||+|.++.... .++|.+|+++|++++|++||+++|+|..++.++||||||+.|
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 4556778999999999999998777999999977543 488999999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCC
Q 001873 846 SLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSK 925 (1001)
Q Consensus 846 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 925 (1001)
+|.+|++..+...+...+...++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+.+..+. +. ..
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~-~~ 361 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YT-AS 361 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc-ee-ec
Confidence 999999986667789999999999999999999999 99999999999999999999999999999543222 11 11
Q ss_pred CCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 926 TNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 926 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.. ..-...|.|||.+....++.|||||||||+||||+| |+.|+..+.
T Consensus 362 ~~----~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms 409 (468)
T KOG0197|consen 362 EG----GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS 409 (468)
T ss_pred CC----CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC
Confidence 11 123357999999999999999999999999999999 999988764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=338.90 Aligned_cols=206 Identities=25% Similarity=0.400 Sum_probs=181.1
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC-----CCchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS-----SDESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.+|...++||+|+|++|++|+.. .++.||||++.+ +...+.+.+|-.+|.++ .||.|++++..|+++..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 46888899999999999999854 699999998743 33346788899999999 899999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
+||+++|+|.++|++.+ .+++...+.++.+|+.|++|||+. |||||||||+|||+|+||++||+|||.|+.+.+.
T Consensus 153 Le~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999999999864 489999999999999999999998 9999999999999999999999999999998764
Q ss_pred CCC------CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 919 GDD------NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 919 ~~~------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
... .......+...+||..|.+||++.....++.+|+|+||||+|+|+.|.+||.+..
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 322 1112222366899999999999999999999999999999999999999997653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=340.60 Aligned_cols=216 Identities=23% Similarity=0.329 Sum_probs=189.8
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCch---hhHHHHHHHhhccC-CCceeeEEeeeecCC-ce
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDES---GAFSSEIQTLGSIR-HKNIVRLLGWGSNKN-LK 835 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~-~~ 835 (1001)
-.+.++|+..++||.|+||+||+|+.. +++.||||+++..-.. ..-.||++.++++. |||||++.+++.+.+ ..
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 346789999999999999999999854 6899999998765433 34668999999998 999999999998887 99
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
++|||||+ .+|++.+++. ++.+++.+++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.+
T Consensus 86 ~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 86 YFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 99999997 6999999987 77899999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCCCCCCCCCCcccccccccCcccc-ccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhhhhcccc
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHA-SMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLMLN 994 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~~~~~~~ 994 (1001)
... ...+..+.|++|+|||++ +...|+.+.||||+|||++|+.+-+ +.+||..+++|..++-..+|.
T Consensus 161 ~Sk--------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLr----PLFPG~sE~Dqi~KIc~VLGt 228 (538)
T KOG0661|consen 161 RSK--------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLR----PLFPGASEIDQIYKICEVLGT 228 (538)
T ss_pred ccC--------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhc----ccCCCCcHHHHHHHHHHHhCC
Confidence 532 334556899999999986 5688899999999999999999987 577788888888888766663
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.54 Aligned_cols=200 Identities=29% Similarity=0.481 Sum_probs=165.5
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhh--ccCCCceeeEEeeeecCC----ceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLG--SIRHKNIVRLLGWGSNKN----LKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~--~l~h~nIv~l~~~~~~~~----~~~lv 838 (1001)
.+..+..+.+|+|.||+||||+. +++.||||++.. .+.+.|.+|-.+.+ .|+|+||++|+++..... .+++|
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~-~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE-QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc-cCceeEEEecCH-HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 34566677899999999999998 469999999843 34556776666654 568999999999876555 88999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeEEeCCCCCCeEECCCCcEEEeccccc
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC------MPPILHGDVKAMNVLLGPGYQAYLADFGLA 912 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~------~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla 912 (1001)
+||.+.|+|.+|++. ...+|....+|+..+++||+|||+.. .|+|+|||||++|||+.+|+++.|+|||+|
T Consensus 287 t~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999999985 45899999999999999999999863 478999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCccccccCC------CCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR------ITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
..+.+.... ......+||.+|||||++.+.- .-.+.||||+|.++|||+++..-+++
T Consensus 364 l~~~p~~~~-----~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~ 426 (534)
T KOG3653|consen 364 LRLEPGKPQ-----GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP 426 (534)
T ss_pred EEecCCCCC-----cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC
Confidence 998754322 2223369999999999986632 22478999999999999998766543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=340.64 Aligned_cols=196 Identities=32% Similarity=0.436 Sum_probs=177.1
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
++|.+.+.||+|+||+||||+.+ +.+.||+|.+.+.. +.+.+.+|++++++++|||||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777888999999999999865 68899999885433 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+.| +|..++.+. +.++++.++.++.+++.|+.|||+. +|+|||+||+||+++..|++|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST--- 152 (808)
T ss_pred hhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc---
Confidence 9985 999999875 4499999999999999999999998 999999999999999999999999999998753
Q ss_pred CCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
.+...+.+.|||-|||||...+++|+..+|+||+|||+||+++|++||-.
T Consensus 153 ----~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 153 ----NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred ----CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 34455667899999999999999999999999999999999999999964
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=313.34 Aligned_cols=218 Identities=28% Similarity=0.336 Sum_probs=188.4
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchh----hHHHHHHHhhccCCCceeeEEeeee--cCCceE
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESG----AFSSEIQTLGSIRHKNIVRLLGWGS--NKNLKL 836 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~Ei~~l~~l~h~nIv~l~~~~~--~~~~~~ 836 (1001)
-+++|+....|++|+||.||+|+++ +++.||+|+++.+.+.. --.|||.++.+++|||||.+-++.. +-+..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3567888999999999999999975 68999999998766553 3579999999999999999998764 445789
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
+|||||+ .+|...++... ..+...+++.++.|+++|++|||+. .|+||||||+|+|+...|.+||+|||+|+.+.
T Consensus 154 ~VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 154 IVMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999997 69999998764 5688899999999999999999998 99999999999999999999999999999886
Q ss_pred CCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhhhhcccch
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLMLNL 995 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~~~~~~~~ 995 (1001)
.+ ....+..+-|.+|+|||.+.+ ..|+.+.||||+|||+.|+++++ |.++|...++|..+++..+|-+
T Consensus 229 sp-------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~k----Plf~G~sE~dQl~~If~llGtP 297 (419)
T KOG0663|consen 229 SP-------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQK----PLFPGKSEIDQLDKIFKLLGTP 297 (419)
T ss_pred CC-------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcC----CCCCCCchHHHHHHHHHHhCCC
Confidence 43 334566788999999998765 67999999999999999999999 4667778888888887777754
Q ss_pred hh
Q 001873 996 EA 997 (1001)
Q Consensus 996 ~~ 997 (1001)
.+
T Consensus 298 te 299 (419)
T KOG0663|consen 298 SE 299 (419)
T ss_pred cc
Confidence 43
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=322.45 Aligned_cols=224 Identities=29% Similarity=0.426 Sum_probs=185.3
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHH-HHHHHhhccCCCceeeEEeeeecCC----ceE
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFS-SEIQTLGSIRHKNIVRLLGWGSNKN----LKL 836 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~-~Ei~~l~~l~h~nIv~l~~~~~~~~----~~~ 836 (1001)
..+.++.++.+.||+|.||+||+|+| .|+.||||+|.+.++...|. .||..-..++|+||+.|++....+. ..|
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 34557788899999999999999999 59999999998776654443 4666667789999999999764332 679
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeEEeCCCCCCeEECCCCcEEEecccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHD-----CMPPILHGDVKAMNVLLGPGYQAYLADFGL 911 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgl 911 (1001)
+|.+|.+.|||+||+.+ ..++.+..+++++.+|.||++||.+ ..|.|.|||||++|||+..++.+.|+|+|+
T Consensus 286 LvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 99999999999999985 4589999999999999999999975 458999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCcccccccccCccccccC----CC--CCccchHHHHHHHHHHHhC----------CCCCCCC
Q 001873 912 ARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ----RI--TEKSDVYSFGVVLLEVLTG----------RHPLDPT 975 (1001)
Q Consensus 912 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~--~~~~Dv~SlG~il~elltg----------~~Pf~~~ 975 (1001)
|.......+.-. ......+||.+|||||++... .+ -..+||||||.|+||+..+ ..||.+.
T Consensus 363 Av~h~~~t~~id---i~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 363 AVRHDSDTDTID---IPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred eEEecccCCccc---CCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 988766544332 344556999999999998542 22 2578999999999999763 4689988
Q ss_pred CCCCcCcccchhhhhcc
Q 001873 976 LPGGAPLVQWTPLMFLM 992 (1001)
Q Consensus 976 ~~~~~~l~~~~~~~~~~ 992 (1001)
.+.+....+.++++...
T Consensus 440 Vp~DPs~eeMrkVVCv~ 456 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVCVQ 456 (513)
T ss_pred CCCCCCHHHHhcceeec
Confidence 88888888888887543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=326.12 Aligned_cols=218 Identities=24% Similarity=0.341 Sum_probs=183.8
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.++||+|+||+||+++-+ +|+.+|+|++++.. +.+.+..|=.+|...++|+||+++..|++.++.|+|
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 467899999999999999999865 69999999986543 335677899999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||++||+...+|... ..+++..++.++.+++.|++-+|+. |+|||||||+|+|||..|++|++|||++.-+...
T Consensus 220 MEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999999874 4588888899999999999999998 9999999999999999999999999998644220
Q ss_pred -------------------CCCCCCC------C---------------CCCCcccccccccCccccccCCCCCccchHHH
Q 001873 919 -------------------GDDNCSK------T---------------NQRPQLAGSYGYMAPEHASMQRITEKSDVYSF 958 (1001)
Q Consensus 919 -------------------~~~~~~~------~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~Sl 958 (1001)
....... . ......+|||.|||||++.+..|+..+|.||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000000 0 01234689999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCC--cCcccchh
Q 001873 959 GVVLLEVLTGRHPLDPTLPGG--APLVQWTP 987 (1001)
Q Consensus 959 G~il~elltg~~Pf~~~~~~~--~~l~~~~~ 987 (1001)
|||||||+.|.+||....+.+ ..+..|..
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~ 405 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRE 405 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh
Confidence 999999999999999876544 35555554
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=361.91 Aligned_cols=480 Identities=29% Similarity=0.330 Sum_probs=394.3
Q ss_pred cccccCCccCCCCChhhhcccccceEEccCCcccCCCC-ccccCCccccceeccccccccccCCCccchhhhhhhhhccC
Q 001873 130 FIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIP-SDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGN 208 (1001)
Q Consensus 130 ~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip-~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~n 208 (1001)
.+|.|..++. .||..+..-..|+.|+++.|.+- ..| +.+.+.-+|+.|||++|+++ ..|..|..+.+|+.|+++.|
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n 78 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRN 78 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchh
Confidence 4788888888 89988877777999999999876 444 34455566999999999997 89999999999999999988
Q ss_pred cCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCcccccCCCCCceEeeecCcccCCCC
Q 001873 209 QNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIP 288 (1001)
Q Consensus 209 ~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p 288 (1001)
. -..+|.+++++++|++|.|.. |.+. ..|.++..+.+|+.|+++.|++. .+|
T Consensus 79 ~--i~~vp~s~~~~~~l~~lnL~~------------------------n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~P 130 (1081)
T KOG0618|consen 79 Y--IRSVPSSCSNMRNLQYLNLKN------------------------NRLQ-SLPASISELKNLQYLDLSFNHFG-PIP 130 (1081)
T ss_pred h--HhhCchhhhhhhcchhheecc------------------------chhh-cCchhHHhhhcccccccchhccC-CCc
Confidence 2 235566666666666666655 4443 68999999999999999999997 889
Q ss_pred cccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccc
Q 001873 289 GRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTA 368 (1001)
Q Consensus 289 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 368 (1001)
..+..++.+..+..++|..... ++... ++.++|..|.+.+.++..+..+.. .|+|++|.+. -.....+.+
T Consensus 131 l~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~ 200 (1081)
T KOG0618|consen 131 LVIEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLAN 200 (1081)
T ss_pred hhHHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccc
Confidence 9999999999999999933222 33333 889999999999998888877776 7999999986 345678899
Q ss_pred cCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccC
Q 001873 369 LTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLS 448 (1001)
Q Consensus 369 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 448 (1001)
|+.|....|+++... -.-++|+.|+..+|.++...+. ..-.+|+++++++|+++ .+|+++..+.+|+.+...+
T Consensus 201 l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~ 273 (1081)
T KOG0618|consen 201 LEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANH 273 (1081)
T ss_pred hhhhhhhhcccceEE----ecCcchheeeeccCcceeeccc--cccccceeeecchhhhh-cchHHHHhcccceEecccc
Confidence 999999999987322 2347899999999999843332 22358999999999999 5679999999999999999
Q ss_pred CcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccc-cCceEEcccccCcccC
Q 001873 449 NDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQ-SLEFLDLHSNGLTGSV 527 (1001)
Q Consensus 449 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~ 527 (1001)
|+++ .+|..+...++|+.|++..|.++ -+|.....++.|+.|+|..|+|....+..+.-.. +|+.|+.+.|++.. .
T Consensus 274 N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~-l 350 (1081)
T KOG0618|consen 274 NRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLST-L 350 (1081)
T ss_pred hhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccc-c
Confidence 9996 77888999999999999999999 7888889999999999999999854444444443 37889999999873 3
Q ss_pred CC---CcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccc
Q 001873 528 PD---TLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQI 604 (1001)
Q Consensus 528 p~---~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 604 (1001)
|. .....++.|++.+|.++...-..+.++.+|+.|+|++|+|.......+.++..|++|+||+|+|+ .+|..+.++
T Consensus 351 p~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~ 429 (1081)
T KOG0618|consen 351 PSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANL 429 (1081)
T ss_pred ccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhh
Confidence 32 22356788999999999877778999999999999999998555556788999999999999998 889999999
Q ss_pred cchhhhhhcCCCcccccccccccccccccEEEecCCcCCCCh-hhhhcccccceeEcccCC
Q 001873 605 SSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDL-DALASLQNLVSLNVSFND 664 (1001)
Q Consensus 605 ~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~ls~N~ 664 (1001)
+.|++ |...+|++. ..| ++..+++|+.+|+|.|.++... +.-..-++|++||++||.
T Consensus 430 ~~L~t-L~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 430 GRLHT-LRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred hhhHH-HhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 99997 999999998 566 8999999999999999998732 322233899999999997
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=316.89 Aligned_cols=222 Identities=26% Similarity=0.383 Sum_probs=191.5
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC----CCchhhHHHHHHHhhccCCCceeeEEeeeec-----CC
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS----SDESGAFSSEIQTLGSIRHKNIVRLLGWGSN-----KN 833 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~-----~~ 833 (1001)
+.+.|...+.||+|+||.|+.+..+ +|+.||||++.. ....++..||++++++++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456666789999999999999865 799999999853 2334788899999999999999999998754 44
Q ss_pred ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccc
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~ 913 (1001)
..|+|+|+|+ .+|.+.++.. ..++...+.-+++|+++|++|+|+. +|+|||+||+|++++.+..+||||||+|+
T Consensus 100 DvYiV~elMe-tDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence 6799999994 7999999864 3388888999999999999999998 99999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCcccc-ccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhhhhcc
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHA-SMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLM 992 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~~~~~ 992 (1001)
..... ......+..+.|.+|.|||++ ....|+.+.||||.|||+.||++|+ +.++|.+.+.|...++...
T Consensus 174 ~~~~~-----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gk----plFpG~d~v~Ql~lI~~~l 244 (359)
T KOG0660|consen 174 YLDKF-----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGK----PLFPGKDYVHQLQLILELL 244 (359)
T ss_pred ecccc-----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCC----CCCCCCchHHHHHHHHHhc
Confidence 87543 344566778999999999986 4588999999999999999999999 5777889999999999999
Q ss_pred cchhhhcc
Q 001873 993 LNLEAEQT 1000 (1001)
Q Consensus 993 ~~~~~~~~ 1000 (1001)
|.+++|..
T Consensus 245 GtP~~e~l 252 (359)
T KOG0660|consen 245 GTPSEEDL 252 (359)
T ss_pred CCCCHHHH
Confidence 87776653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=316.99 Aligned_cols=209 Identities=29% Similarity=0.414 Sum_probs=185.3
Q ss_pred HhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
.+.|+...+||.|..++||+|+. +.++.||||++.-+. +.+.+.+|++.|+.++||||++++..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 46799999999999999999984 578999999995443 23778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
||.+||+.++++......+++..+..|.+++++||.|||.+ |.||||||+.|||++.+|.|||+|||.+..+...+.
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999988888899999999999999999999999 999999999999999999999999998877766552
Q ss_pred CCCCCCCCCCcccccccccCcccc--ccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHA--SMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGG 979 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~ 979 (1001)
.. .... ...+||+.|||||++ ....|+.|+||||||++..|+.+|..||....|-+
T Consensus 182 R~--~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk 239 (516)
T KOG0582|consen 182 RQ--VTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK 239 (516)
T ss_pred ee--eEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH
Confidence 21 2222 667999999999994 34789999999999999999999999998876443
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=316.93 Aligned_cols=217 Identities=27% Similarity=0.392 Sum_probs=180.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecCC-----ceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN-----LKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~ 839 (1001)
-.|+..+++|+|+||.||+|... +++.||||+++.+...+ .+|+++|++++|||||++..+|.... +..+||
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 35777889999999999999965 57999999997765533 37999999999999999998775322 345899
Q ss_pred EccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC-CcEEEeccccccccc
Q 001873 840 DYLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG-YQAYLADFGLARIVS 916 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ki~Dfgla~~~~ 916 (1001)
|||| .+|+++++.. .+..++...++-++.||.+|+.|||+. +|+||||||+|+|+|.+ |.+||||||.|+.+.
T Consensus 102 eymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred Hhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 9998 6999998852 244577778888999999999999997 99999999999999965 999999999999875
Q ss_pred CCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhhhhcccch
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLMLNL 995 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~~~~~~~~ 995 (1001)
.. .......-|+.|+|||.+.+ ..|+.+.||||.|||+.||+-|++ .++|+...+|.+++.-..|.+
T Consensus 178 ~~--------epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~p----lFpG~s~~dQL~eIik~lG~P 245 (364)
T KOG0658|consen 178 KG--------EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQP----LFPGDSSVDQLVEIIKVLGTP 245 (364)
T ss_pred cC--------CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCc----ccCCCCHHHHHHHHHHHhCCC
Confidence 33 23344567899999998754 789999999999999999999995 566778888889988888877
Q ss_pred hhhcc
Q 001873 996 EAEQT 1000 (1001)
Q Consensus 996 ~~~~~ 1000 (1001)
.+|++
T Consensus 246 t~e~I 250 (364)
T KOG0658|consen 246 TREDI 250 (364)
T ss_pred CHHHH
Confidence 77654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=331.55 Aligned_cols=200 Identities=30% Similarity=0.422 Sum_probs=177.2
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-------CchhhHHHHHHHhhccC-CCceeeEEeeeecCCc
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-------DESGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNL 834 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~ 834 (1001)
..+.|.+.+.||+|+||+|+.|++. +++.||+|.+... ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4578999999999999999999754 6899999966443 12356778999999998 9999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC-CcEEEecccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG-YQAYLADFGLAR 913 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ki~Dfgla~ 913 (1001)
+++||||+.||+|.+++.+ ...+.+..+.+++.|++.|++|+|+. +|+||||||+||+++.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999987 34588899999999999999999998 99999999999999999 999999999998
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCccccccCC-CC-CccchHHHHHHHHHHHhCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR-IT-EKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+..
T Consensus 170 ~~~-------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~ 226 (370)
T KOG0583|consen 170 ISP-------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS 226 (370)
T ss_pred ccC-------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc
Confidence 763 1223455679999999999999877 85 8999999999999999999999974
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=310.48 Aligned_cols=217 Identities=27% Similarity=0.349 Sum_probs=182.8
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCc-eeeEEeeeecCC-----
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKN-IVRLLGWGSNKN----- 833 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~n-Iv~l~~~~~~~~----- 833 (1001)
...|+.+++||+|+||+||+|+.+ +|+.||+|++..+.+ .....+|+.++++++|+| ||.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345677778999999999999965 789999999965543 245789999999999999 999999988776
Q ss_pred -ceEEEEEccCCCCHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccc
Q 001873 834 -LKLLFYDYLPNGSLSSLLHGAGK--GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFG 910 (1001)
Q Consensus 834 -~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfg 910 (1001)
..++|+||++ -+|.+++..... ...+...++.++.||++|++|||++ +|+||||||+||+++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 7889999997 699999988654 3577788999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhhh
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLM 989 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~~ 989 (1001)
+|+...- .....+..++|.+|+|||++.+ ..|+...||||+|||+.||++++.-|. ++.+.+|...++
T Consensus 166 lAra~~i-------p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFp----G~se~~ql~~If 234 (323)
T KOG0594|consen 166 LARAFSI-------PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFP----GDSEIDQLFRIF 234 (323)
T ss_pred hHHHhcC-------CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCC----CCcHHHHHHHHH
Confidence 9996542 2233455689999999999866 489999999999999999999986554 555677877777
Q ss_pred hcccchh
Q 001873 990 FLMLNLE 996 (1001)
Q Consensus 990 ~~~~~~~ 996 (1001)
..+|-+.
T Consensus 235 ~~lGtP~ 241 (323)
T KOG0594|consen 235 RLLGTPN 241 (323)
T ss_pred HHcCCCC
Confidence 6666443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=328.37 Aligned_cols=200 Identities=25% Similarity=0.390 Sum_probs=179.1
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.+-...|+..++||+|+.|.||.++. .+++.||||++.... ..+-+.+|+.+|+..+|+|||.+++.+..++..|+|
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 44457788889999999999999874 478999999985443 335688999999999999999999988888999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
||||+||+|.|.+... .+++.++..|.+++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+...
T Consensus 349 MEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred EeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999999999999853 489999999999999999999999 9999999999999999999999999999887543
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
...+.+.+|||.|||||+.....|++|+||||||++++||+-|++||--
T Consensus 423 -------~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 423 -------QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred -------cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 2256677999999999999999999999999999999999999999863
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.71 Aligned_cols=196 Identities=33% Similarity=0.495 Sum_probs=169.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++..+...||+|.||+||+|+|. -.||||++.... ..++|++|+.++++-+|.||+-|.|||..++. .||+.|
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred HHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 34566778999999999999984 479999885432 34789999999999999999999999998887 999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
|+|-+|+.+++.. +..++..+...||.|||+||.|||.+ +|||||||..||++.++++|||+|||++..-.-
T Consensus 469 CeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~---- 540 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR---- 540 (678)
T ss_pred ccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeee----
Confidence 9999999999976 45689999999999999999999999 999999999999999999999999999975321
Q ss_pred CCCCCCCCCcccccccccCcccccc---CCCCCccchHHHHHHHHHHHhCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASM---QRITEKSDVYSFGVVLLEVLTGRHPLD 973 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~il~elltg~~Pf~ 973 (1001)
...........|..-|||||++.. .+|++.+||||||+|+|||+||..||.
T Consensus 541 -w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 541 -WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred -eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 122233334457889999999854 678999999999999999999999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=317.57 Aligned_cols=202 Identities=34% Similarity=0.522 Sum_probs=172.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc--hhhHHHHHHHhhccCCCceeeEEeeeecCC--ceEEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE--SGAFSSEIQTLGSIRHKNIVRLLGWGSNKN--LKLLFYD 840 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~--~~~lv~e 840 (1001)
.+|...+.||+|+||.||++... +|+.+|||.+..... .+.+.+|+.++++++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35777889999999999999975 489999998854421 456899999999999999999999744444 6899999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC-CCcEEEecccccccccCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP-GYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~ki~Dfgla~~~~~~~ 919 (1001)
|+++|+|.+++.+.+. .+++..+..+++||++|++|||++ +||||||||+|||++. ++.+||+|||+++.....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~- 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK- 171 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc-
Confidence 9999999999998765 799999999999999999999998 9999999999999999 799999999999876531
Q ss_pred CCCCCCCCCCCcccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQ-RITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
...........||+.|||||++..+ ....++||||+||++.||+||+.||...
T Consensus 172 ---~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 172 ---GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred ---cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 1122334456899999999999853 3345999999999999999999999873
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=321.32 Aligned_cols=185 Identities=29% Similarity=0.480 Sum_probs=166.1
Q ss_pred CCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCCHHHH
Q 001873 771 ANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSL 850 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 850 (1001)
.+-+|.|+-|.||.|+.+ ++.||||+++.- -+.+|+-+++++||||+.|.|+|.....+|||||||..|-|+..
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el-----kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL-----KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhh-----hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 456999999999999994 799999998432 23578899999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCCCCC
Q 001873 851 LHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930 (1001)
Q Consensus 851 l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~ 930 (1001)
++.. ..+.......+..+||.||.|||.+ .|||||||.-||||..+..|||+|||-++.... .....
T Consensus 203 Lka~--~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~--------~STkM 269 (904)
T KOG4721|consen 203 LKAG--RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSD--------KSTKM 269 (904)
T ss_pred Hhcc--CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhh--------hhhhh
Confidence 9874 4578888889999999999999998 999999999999999999999999999987532 22344
Q ss_pred cccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 931 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
.++||..|||||++...+.++|+||||||||+|||+||..||..
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence 57899999999999999999999999999999999999999874
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=338.23 Aligned_cols=368 Identities=26% Similarity=0.370 Sum_probs=234.1
Q ss_pred EeeecCccc-CCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEccccc
Q 001873 276 LYLYQNSIS-GPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQ 354 (1001)
Q Consensus 276 L~L~~N~i~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 354 (1001)
.|+++|.++ +..|.....|++++.|.|...++. .+|+.++.+.+|+.|.+++|++. .+-..+..++.|+.+++..|+
T Consensus 12 vDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~ 89 (1255)
T KOG0444|consen 12 VDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNN 89 (1255)
T ss_pred ccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccc
Confidence 344444444 233444444444444444444443 34444444444444444444444 233334444444444444444
Q ss_pred ccC-cCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCc
Q 001873 355 LSG-TIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPK 433 (1001)
Q Consensus 355 l~~-~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~ 433 (1001)
+.. -+|..+..+..|+.|||++|++. +.|..+...+++..|++++|+|..+....|.+++.|-.||||+|++. .+|.
T Consensus 90 LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPP 167 (1255)
T KOG0444|consen 90 LKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPP 167 (1255)
T ss_pred cccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCH
Confidence 431 13444444444444444444444 33444444444444444444444222233455556666666666665 4455
Q ss_pred ccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccc-cCCCcccCCCCCcceeeccCcccccCCccccccccc
Q 001873 434 EIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLS-GTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQS 512 (1001)
Q Consensus 434 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 512 (1001)
.+..+.+|++|.|++|.+...--..+..+++|+.|.+++.+=+ ..+|.++..+.+|..+|+|+|.+. .+|+.+.++++
T Consensus 168 Q~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~ 246 (1255)
T KOG0444|consen 168 QIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRN 246 (1255)
T ss_pred HHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhh
Confidence 5566666666666666655433334445666777777765533 356777777777777777777777 67777777777
Q ss_pred CceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEeccccc
Q 001873 513 LEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNR 592 (1001)
Q Consensus 513 L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 592 (1001)
|+.|+||+|+|+. ..-..+.-.+|++|+||+|+++ .+|++++.+++|+.|++.+|+
T Consensus 247 LrrLNLS~N~ite-----------------------L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~Nk 302 (1255)
T KOG0444|consen 247 LRRLNLSGNKITE-----------------------LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNK 302 (1255)
T ss_pred hheeccCcCceee-----------------------eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCc
Confidence 7777777777762 1112344568888999999998 888999999999999999999
Q ss_pred ccC-CCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCChhhhhcccccceeEcccCCCCCCCCC
Q 001873 593 FSG-EIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPN 671 (1001)
Q Consensus 593 l~~-~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p~ 671 (1001)
|+. -+|..++.+..|++ +..++|.+. .+|+.++.+.+|+.|.|++|++...|+++..|+.|++|||..|+---.+|.
T Consensus 303 L~FeGiPSGIGKL~~Lev-f~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 303 LTFEGIPSGIGKLIQLEV-FHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred ccccCCccchhhhhhhHH-HHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCCCC
Confidence 873 48999999999997 999999998 899999999999999999999999999999999999999999988777776
Q ss_pred Ccc
Q 001873 672 TPF 674 (1001)
Q Consensus 672 ~~~ 674 (1001)
+..
T Consensus 381 P~d 383 (1255)
T KOG0444|consen 381 PND 383 (1255)
T ss_pred cch
Confidence 643
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=309.00 Aligned_cols=199 Identities=23% Similarity=0.380 Sum_probs=179.6
Q ss_pred HHhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
..-+|++.+.||+|.||+|-++.. ..|+.||||.+++.. +.-.+.+||++|+.++||||+.++++|...+...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 445788888999999999999984 689999999875433 22357899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||..+|.|+||+.+.+ .+++.++..+++||..|+.|+|.+ +++|||||.+|||+|+++++||+|||++..+.
T Consensus 131 vMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~- 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA- 204 (668)
T ss_pred EEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc-
Confidence 999999999999999854 489999999999999999999999 99999999999999999999999999998763
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRI-TEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......+++|+|-|.+||++.+.+| ++.+|.||+||++|-+..|.+||++.
T Consensus 205 -------~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~ 256 (668)
T KOG0611|consen 205 -------DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR 256 (668)
T ss_pred -------cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc
Confidence 3456677899999999999999999 48899999999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=341.06 Aligned_cols=203 Identities=26% Similarity=0.427 Sum_probs=175.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCch---hhHHHHHHHhhccCCCceeeEEeeeecCCceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDES---GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~---~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
.+....+.||+|+||+||+|+.. +..-||||.++...+. ++|+||+++++.++|||||+++|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34455678999999999999843 3567999999776543 68999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhhcCCC------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcE
Q 001873 837 LFYDYLPNGSLSSLLHGAGK------------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQA 904 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 904 (1001)
+|+|||..|||.+|++.... ..++..+.+.||.|||.||+||-++ .+|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 99999999999999975321 2267889999999999999999998 99999999999999999999
Q ss_pred EEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 905 YLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 905 ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
||+|||+++.+...++++.... ..=..+|||||.+..++|+.+||||||||+|||+++ |+.||.+..
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~-----t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS 710 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGN-----TLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS 710 (774)
T ss_pred EecccccchhhhhhhhhcccCC-----ceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence 9999999998876655443211 123478999999999999999999999999999998 999999875
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.67 Aligned_cols=368 Identities=27% Similarity=0.406 Sum_probs=261.0
Q ss_pred CCccccccccccCCccC-CCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccCCCccchhhhh
Q 001873 123 GDYRELTFIDLSGNSLW-GEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQ 201 (1001)
Q Consensus 123 ~~l~~L~~L~Ls~n~l~-g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~ 201 (1001)
+-|+..+-.|+|+|.|+ +..|..+..|++++.|.|...++. .+|+.++.|.+|++|.+++|++. .+-.++..|+.|+
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR 81 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR 81 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence 34567788889999988 578999999999999999999988 89999999999999999999988 7788888899999
Q ss_pred hhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCccc-ccCCCCCceEeeec
Q 001873 202 VFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEE-IGNCSELQNLYLYQ 280 (1001)
Q Consensus 202 ~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~-l~~l~~L~~L~L~~ 280 (1001)
.+.+..|+.-...+|..|..|..|+.|+||+|++. ++|..+..-+++-+|++++|++. .||.. +-+++.|-.|||++
T Consensus 82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~ 159 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSN 159 (1255)
T ss_pred HHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhcccc
Confidence 99999885555668888888888888888887776 56666666666667777777666 45543 45677777777777
Q ss_pred CcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCC-CCCCcccccccCccEEEcccccccCcC
Q 001873 281 NSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLT-GSIPRSFGNLLKLQELQLSVNQLSGTI 359 (1001)
Q Consensus 281 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 359 (1001)
|++. .+|..+..|..|++|.|++|.+....-.-+..+++|++|.+|+.+=+ ..+|.++..+.+|..+|||.|.+. ..
T Consensus 160 NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~v 237 (1255)
T KOG0444|consen 160 NRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IV 237 (1255)
T ss_pred chhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cc
Confidence 7776 56666777777777777777665433344555667777777766533 346667777777777777777776 66
Q ss_pred ChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCcccc-CCCCcccccc
Q 001873 360 PIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLS-GPIPKEIFGL 438 (1001)
Q Consensus 360 p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l 438 (1001)
|..+.++++|+.|+|++|+|+ .+....+...+|+.|+++.|+++ .+|+++++++.|+.|.+.+|+++ .-+|..++++
T Consensus 238 Pecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL 315 (1255)
T KOG0444|consen 238 PECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKL 315 (1255)
T ss_pred hHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhh
Confidence 777777777777777777776 34444445556666666666666 55666666666666666666655 2356666666
Q ss_pred cccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccc
Q 001873 439 RNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLV 500 (1001)
Q Consensus 439 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 500 (1001)
.+|+.+..++|.+. .+|..++.|..|+.|.|+.|++. ++|+.+.-++.|+.||+.+|.--
T Consensus 316 ~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 316 IQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred hhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 66666666666665 56666666666666666666665 56666666666666666666543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=333.27 Aligned_cols=220 Identities=25% Similarity=0.399 Sum_probs=183.1
Q ss_pred cccCCCeEeecCCeeEEEEEeC----CCCEEEEEEecCC---CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP----NGETLAVKKMWSS---DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
..++.++||.|.||+||+|+++ ....||||.++.. ....+|..|+.||.+++||||+++.|+.......+||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3567789999999999999875 2467999999763 34578999999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
|||++|+|..|+++.. ..+.+.+...+.++||.||+||.+. ++|||||.++|||++.+-.+|++|||+++.+.++.
T Consensus 710 EyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999999999874 4588999999999999999999998 99999999999999999999999999999875543
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCcCcccchhhhhcccchh
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTLPGGAPLVQWTPLMFLMLNLE 996 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~~~~~~l~~~~~~~~~~~~~~ 996 (1001)
.... .+ ... .-..+|.|||.+..++++.++||||||++|||.++ |+.||..+. ++++..-++....+-|+|
T Consensus 786 ~~~y-tt-~GG--KIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS--NQdVIkaIe~gyRLPpPm 857 (996)
T KOG0196|consen 786 EAAY-TT-LGG--KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVIKAIEQGYRLPPPM 857 (996)
T ss_pred Cccc-cc-cCC--ccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc--hHHHHHHHHhccCCCCCC
Confidence 2111 11 111 12368999999999999999999999999999887 999998774 344455555544444444
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=322.13 Aligned_cols=198 Identities=29% Similarity=0.401 Sum_probs=178.1
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
...|+..+.||.|+.|.|-.|++. +|+.+|||++.... ....+.+||-+|+-+.||||+++++++.+..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 456888899999999999999965 79999999985542 235788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
.||++||.|.+++-+.+ .+++.++.+++.||+.|+.|+|+. +|+|||+||+|+|+|..+++||+|||+|..-.
T Consensus 91 lEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-- 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV-- 163 (786)
T ss_pred EEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence 99999999999998754 489999999999999999999998 99999999999999999999999999998643
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCC-CccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRIT-EKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......+.||+|.|.|||++.+.+|. .++||||.|||+|.++||+.||+++
T Consensus 164 ------~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd 215 (786)
T KOG0588|consen 164 ------PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD 215 (786)
T ss_pred ------CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc
Confidence 23445567999999999999999995 8999999999999999999999943
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=288.82 Aligned_cols=199 Identities=28% Similarity=0.430 Sum_probs=182.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|-||.||.|+.+ ++-.||+|++.+.+ ...++.+|+++-+.++||||+++++||.++...|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 56889999999999999999965 67889999885533 3468999999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||.+.|++...+++.....+++.....++.|+|.|+.|+|.. +|+||||||+|+|++.++..||+|||.+...
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~---- 174 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA---- 174 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec----
Confidence 999999999999977777889999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
....+.+.+||..|.|||...+..++..+|+|++|+..||++.|.+||+...
T Consensus 175 -----p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 175 -----PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred -----CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 2455677899999999999999999999999999999999999999999765
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=324.72 Aligned_cols=201 Identities=25% Similarity=0.365 Sum_probs=177.4
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~l 837 (1001)
.++|+..++||+|+||+|+++..+ +++.+|||.+++. ++.+....|.+++... +||.++.++..|..+++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 357889999999999999999976 6889999988654 3446778888888777 59999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||+.||++..+.+ ...+++..+.-++..++.||.|||++ +|||||||.+|||+|.+|++||+|||+++.-..
T Consensus 447 vmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC
Confidence 999999999555544 35589999999999999999999999 999999999999999999999999999986432
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~ 978 (1001)
......+.+|||.|||||++.+..|+.++|-|||||+||||+.|..||.+..++
T Consensus 521 -------~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe 574 (694)
T KOG0694|consen 521 -------QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE 574 (694)
T ss_pred -------CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 234556789999999999999999999999999999999999999999977544
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=308.32 Aligned_cols=206 Identities=23% Similarity=0.334 Sum_probs=170.1
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----------------chhhHHHHHHHhhccCCCceeeE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----------------ESGAFSSEIQTLGSIRHKNIVRL 825 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----------------~~~~~~~Ei~~l~~l~h~nIv~l 825 (1001)
....+|++.+.||+|.||+|-+|+.. +++.||||++.+.. ..+...+||.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34678999999999999999999865 78999999884321 11468899999999999999999
Q ss_pred Eeeeec--CCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCc
Q 001873 826 LGWGSN--KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQ 903 (1001)
Q Consensus 826 ~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 903 (1001)
+++..+ .+..|||+|||..|.+...-.+ ...+++.++++++++++.||+|||.+ +||||||||+|+|++++|+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d--~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD--KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCC--cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence 999875 4578999999999887655432 22289999999999999999999999 9999999999999999999
Q ss_pred EEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccC---C-CCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 904 AYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ---R-ITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 904 ~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~-~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+||+|||.+.......+.. ........+|||.|+|||...++ . .+.+.||||+||++|.++.|+.||.+.
T Consensus 249 VKIsDFGVs~~~~~~~~~~--~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEG--SDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred EEeeccceeeecccCCccc--cHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 9999999988764432211 11223336899999999988652 2 357899999999999999999999765
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=326.14 Aligned_cols=206 Identities=24% Similarity=0.324 Sum_probs=175.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||+||+++.. +++.||||++.... ....+.+|+.++++++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888999999999999999865 68999999985422 2256788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++|+|.+++.+. ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++++||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999999864 4589999999999999999999998 99999999999999999999999999998653221
Q ss_pred CCCC----------------------------CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCC
Q 001873 920 DDNC----------------------------SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971 (1001)
Q Consensus 920 ~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~P 971 (1001)
.... .........+||+.|+|||++.+..++.++||||+||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 1000 000111345799999999999999999999999999999999999999
Q ss_pred CCCCC
Q 001873 972 LDPTL 976 (1001)
Q Consensus 972 f~~~~ 976 (1001)
|.+..
T Consensus 236 f~~~~ 240 (363)
T cd05628 236 FCSET 240 (363)
T ss_pred CCCCC
Confidence 98654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.21 Aligned_cols=198 Identities=23% Similarity=0.312 Sum_probs=173.3
Q ss_pred ccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 768 LTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
|+..+.||+|+||+||++... +++.||||++.... ....+.+|+.++++++|++|+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 677889999999999999864 78999999875432 224577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++|+|.+++.......+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 9999999988765555689999999999999999999998 99999999999999999999999999998653211
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 157 ------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 157 ------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred ------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 1123468999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=309.42 Aligned_cols=204 Identities=26% Similarity=0.374 Sum_probs=176.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
+...+.++||+|-||+|.+.+...+..||||+++.... ..+|.+|+++|.+++|||||+++|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 34566789999999999999987789999999976543 378999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
++|+|.+|+.++......-....+|+.||+.||+||.+- .+||||+.++|+|++.++++||+|||+++-+..++.+.
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999887544445556678999999999999997 99999999999999999999999999999765544332
Q ss_pred CCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh--CCCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT--GRHPLDPTLP 977 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt--g~~Pf~~~~~ 977 (1001)
. ....+-..+|||||.+..++++.++|||+||+++||+++ +..||.....
T Consensus 695 v-----qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 695 V-----QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred e-----ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 2 222345679999999999999999999999999999865 8889987653
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=316.08 Aligned_cols=201 Identities=25% Similarity=0.347 Sum_probs=181.0
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCc-eEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNL-KLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~-~~lv 838 (1001)
.++|..++.+|+|+||.++.++++ +++.||+|++.-.. +++...+|+.++++++|||||.+.+.|.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357888999999999999998876 67899999985433 33567889999999999999999999988887 8999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|+|++||++.+.+.+.+...++++.+.+++.|++.|+.|||++ +|+|||||+.||+++.++.|||+|||+|+.+.+.
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999999988767789999999999999999999988 9999999999999999999999999999987543
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. ....+.+||+.||.||.+.+.+|+.|+||||+||++|||++=+.+|...
T Consensus 160 ~-------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~ 209 (426)
T KOG0589|consen 160 D-------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS 209 (426)
T ss_pred h-------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc
Confidence 2 2445679999999999999999999999999999999999999999764
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=319.59 Aligned_cols=217 Identities=26% Similarity=0.307 Sum_probs=191.1
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCch-hhHHHHHHHhhccC-C-----CceeeEEeeeecCCceE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDES-GAFSSEIQTLGSIR-H-----KNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~Ei~~l~~l~-h-----~nIv~l~~~~~~~~~~~ 836 (1001)
..+|.+.++||+|+||.|.++.+. +++.||||+++..... .+-..|+.++..++ | -|+|+++++|...++.|
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 348999999999999999999854 6999999999776543 66778999999996 4 38999999999999999
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC--CcEEEeccccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG--YQAYLADFGLARI 914 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~ki~Dfgla~~ 914 (1001)
||+|.++ .+|+++++.....+++...++.|+.||+.||.+||+. +|||+||||+|||+.+- ..+||+|||.|..
T Consensus 265 iVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999995 7999999998888899999999999999999999998 99999999999999743 4899999999987
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhhhhcccc
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLMLN 994 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~~~~~~~ 994 (1001)
.... ....+.++.|+|||++.+.+|+.+.||||||||+.||++|. +.++|+...+|...++...|.
T Consensus 341 ~~q~----------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~----PLfpG~ne~DQl~~I~e~lG~ 406 (586)
T KOG0667|consen 341 ESQR----------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGE----PLFPGDNEYDQLARIIEVLGL 406 (586)
T ss_pred cCCc----------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCc----cccCCCCHHHHHHHHHHHhCC
Confidence 5321 22457889999999999999999999999999999999996 567788899999999999997
Q ss_pred hhhhc
Q 001873 995 LEAEQ 999 (1001)
Q Consensus 995 ~~~~~ 999 (1001)
++++.
T Consensus 407 Pp~~m 411 (586)
T KOG0667|consen 407 PPPKM 411 (586)
T ss_pred CCHHH
Confidence 77653
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=323.62 Aligned_cols=206 Identities=26% Similarity=0.335 Sum_probs=175.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||+||+++.. +++.||||++... .....+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999999999999975 6899999998542 22356788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999999764 3489999999999999999999998 99999999999999999999999999987653321
Q ss_pred CCCCCC-------------------------------CCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhC
Q 001873 920 DDNCSK-------------------------------TNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTG 968 (1001)
Q Consensus 920 ~~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg 968 (1001)
...... .......+||+.|+|||++....++.++||||+||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 100000 0011234799999999999989999999999999999999999
Q ss_pred CCCCCCCC
Q 001873 969 RHPLDPTL 976 (1001)
Q Consensus 969 ~~Pf~~~~ 976 (1001)
+.||....
T Consensus 236 ~~Pf~~~~ 243 (364)
T cd05599 236 YPPFCSDN 243 (364)
T ss_pred CCCCCCCC
Confidence 99997653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=313.32 Aligned_cols=196 Identities=26% Similarity=0.383 Sum_probs=173.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ..+.+.+|+.++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999975 68999999985432 2356888999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++|+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999999999764 3478899999999999999999998 9999999999999999999999999999865321
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~ 202 (291)
T cd05612 155 ---------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202 (291)
T ss_pred ---------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 123468999999999999899999999999999999999999997653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=296.76 Aligned_cols=209 Identities=24% Similarity=0.296 Sum_probs=180.4
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCC-CCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPN-GETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.+.|+..+.||+|.-|+||+++.++ +..+|+|++.++. ...+...|-+|++.++||.++++++.++.++..|+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3567788899999999999999764 6899999985433 225677799999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
||||+||+|...++++..+.+++..++-++.+++-||+|||.. |||+|||||+||||.++|++.++||.++......
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999999999888899999999999999999999998 9999999999999999999999999997654221
Q ss_pred CC--------------------------------CC-----------------CCCCCCCCcccccccccCccccccCCC
Q 001873 919 GD--------------------------------DN-----------------CSKTNQRPQLAGSYGYMAPEHASMQRI 949 (1001)
Q Consensus 919 ~~--------------------------------~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~~ 949 (1001)
.. .. ..........+||.+|.|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00 00 011122345689999999999999999
Q ss_pred CCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 950 TEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 950 ~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+.++|-|+|||++|||+.|+.||.+..
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~ 339 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSN 339 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCC
Confidence 999999999999999999999998764
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=324.52 Aligned_cols=206 Identities=24% Similarity=0.324 Sum_probs=173.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.++||+|+||+||+++.. +++.||||++... ...+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888999999999999999864 7899999988542 22356788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999999764 4478889999999999999999998 99999999999999999999999999997442211
Q ss_pred CCCC---------CC-------------------------------CCCCCcccccccccCccccccCCCCCccchHHHH
Q 001873 920 DDNC---------SK-------------------------------TNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFG 959 (1001)
Q Consensus 920 ~~~~---------~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG 959 (1001)
.... .. .......+||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0000 00 0001134799999999999989999999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 001873 960 VVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 960 ~il~elltg~~Pf~~~~ 976 (1001)
|++|||++|+.||....
T Consensus 236 vil~elltG~~Pf~~~~ 252 (377)
T cd05629 236 AIMFECLIGWPPFCSEN 252 (377)
T ss_pred hhhhhhhcCCCCCCCCC
Confidence 99999999999997644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=323.30 Aligned_cols=205 Identities=23% Similarity=0.293 Sum_probs=173.2
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
.|+.++.||+|+||+||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999864 68899999985432 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++|+|.+++.+. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++++||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999999764 3478888899999999999999998 999999999999999999999999999864321100
Q ss_pred CCC----------------------------------------CCCCCCCcccccccccCccccccCCCCCccchHHHHH
Q 001873 921 DNC----------------------------------------SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGV 960 (1001)
Q Consensus 921 ~~~----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ 960 (1001)
... .........+||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 000 0000112457999999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 001873 961 VLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 961 il~elltg~~Pf~~~~ 976 (1001)
++|||++|+.||....
T Consensus 237 il~elltG~~Pf~~~~ 252 (381)
T cd05626 237 ILFEMLVGQPPFLAPT 252 (381)
T ss_pred HHHHHHhCCCCCcCCC
Confidence 9999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=317.98 Aligned_cols=197 Identities=24% Similarity=0.309 Sum_probs=173.4
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCC--CCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPN--GETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
.++|++.+.||+|+||.||+|+.+. +..||+|++... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568999999999999999998543 368999988432 233568889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||+++|+|.+++.+. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++++||+|||+++.+..
T Consensus 109 v~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999864 3588999999999999999999998 999999999999999999999999999986532
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 184 ~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 184 R----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred C----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 1 123479999999999998889999999999999999999999997643
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=323.74 Aligned_cols=205 Identities=24% Similarity=0.315 Sum_probs=173.0
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
.|+.+++||+|+||+||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999864 68899999985432 23568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++|+|.+++.+. ..+++..+..++.||+.|++|||++ +|+||||||+|||++.++++||+|||+|+.+.....
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999999764 3478888899999999999999998 999999999999999999999999999864321100
Q ss_pred CCC----------------------------------------CCCCCCCcccccccccCccccccCCCCCccchHHHHH
Q 001873 921 DNC----------------------------------------SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGV 960 (1001)
Q Consensus 921 ~~~----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ 960 (1001)
... .........+||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 000 0000112357999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 001873 961 VLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 961 il~elltg~~Pf~~~~ 976 (1001)
++|||++|+.||....
T Consensus 237 il~elltG~~Pf~~~~ 252 (382)
T cd05625 237 ILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=316.98 Aligned_cols=196 Identities=25% Similarity=0.342 Sum_probs=174.1
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.+.||+|+||+||+|+.. +++.||||++... ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 357889999999999999999975 6899999988542 2235688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++|+|.+++.+. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 97 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999999864 3478888899999999999999998 9999999999999999999999999999865321
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 172 ----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 172 ----------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred ----------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 12347999999999999999999999999999999999999999754
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=322.90 Aligned_cols=206 Identities=25% Similarity=0.339 Sum_probs=173.8
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
.|++.+.||+|+||+||+++.. +++.||||++... ...+.+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6889999999999999999865 6899999998542 233568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++|+|.+++.+. ..+++..+..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+|..+.....
T Consensus 82 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999999764 3478888889999999999999998 999999999999999999999999999854321100
Q ss_pred CCC------------------------------------CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHH
Q 001873 921 DNC------------------------------------SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLE 964 (1001)
Q Consensus 921 ~~~------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~e 964 (1001)
... .........+||+.|||||++.+..++.++||||+||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000 00001123579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCC
Q 001873 965 VLTGRHPLDPTLP 977 (1001)
Q Consensus 965 lltg~~Pf~~~~~ 977 (1001)
|++|+.||....+
T Consensus 237 ll~G~~Pf~~~~~ 249 (376)
T cd05598 237 MLVGQPPFLADTP 249 (376)
T ss_pred hhhCCCCCCCCCH
Confidence 9999999987643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=313.45 Aligned_cols=192 Identities=23% Similarity=0.285 Sum_probs=168.2
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCC
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNG 845 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 845 (1001)
+.||+|+||+||+++.. +++.||||++... .....+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 6899999988643 22356778999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCC
Q 001873 846 SLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSK 925 (1001)
Q Consensus 846 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 925 (1001)
+|.+++... ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~------- 148 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-------
Confidence 999999764 4578999999999999999999998 9999999999999999999999999998753211
Q ss_pred CCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 926 TNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 926 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 11223457999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=318.15 Aligned_cols=199 Identities=25% Similarity=0.316 Sum_probs=171.8
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.+.||+|+||.||+++.. +++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999976 5889999988531 2235678899999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++|+|.+++... .+++..+..++.||+.|++|||+. +|+||||||+||++++++.+||+|||+|..+...
T Consensus 122 ~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 122 MEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 9999999999999753 478888999999999999999998 9999999999999999999999999999875322
Q ss_pred CCCCCCCCCCCCcccccccccCccccccC----CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQ----RITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.. .......||+.|+|||++... .++.++||||+||++|||++|+.||...
T Consensus 196 ~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 196 GM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred Cc------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 11 112345799999999998653 3788999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=316.02 Aligned_cols=196 Identities=26% Similarity=0.364 Sum_probs=174.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999976 5899999998543 23356888999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++|+|.+++... ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999764 3478899999999999999999998 999999999999999999999999999976432
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 202 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202 (333)
T ss_pred --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence 2234579999999999998899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=316.38 Aligned_cols=205 Identities=26% Similarity=0.346 Sum_probs=171.4
Q ss_pred cCCCeEeecCCeeEEEEEeCC--C---CEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 769 TSANVIGTGSSGVVYRVTIPN--G---ETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 769 ~~~~~lG~G~fg~Vy~~~~~~--~---~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
...++||+|+||+||+|+.+. + .+||||..+.+. ...+|.+|+++|+.++|||||+++|++..+.++++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 344899999999999998643 2 238999887522 336899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
||+|+||+|.+++++.+. .++..++.+++.+.|+||+|||++ ++|||||.++|+|++.++.+||+|||+++.-.
T Consensus 240 mEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~-- 313 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS-- 313 (474)
T ss_pred EEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc--
Confidence 999999999999998643 689999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCcCcccch
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTLPGGAPLVQWT 986 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~~~~~~l~~~~ 986 (1001)
........ ..-..+|+|||.+....|+.++|||||||++||+++ |..||.+.... ++.+|+
T Consensus 314 -~~~~~~~~----~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI 375 (474)
T KOG0194|consen 314 -QYVMKKFL----KKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKI 375 (474)
T ss_pred -ceeecccc----ccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHH
Confidence 01100101 123468999999999999999999999999999998 88899887533 344444
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=318.19 Aligned_cols=207 Identities=24% Similarity=0.331 Sum_probs=175.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|+..+.||+|+||+||+++.. +++.||||++... .....+.+|+.++..++||+|+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999865 6899999998532 22356788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++|+|.+++.+. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++++||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999999764 3478999999999999999999998 99999999999999999999999999987653221
Q ss_pred CCCC----------------------------CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCC
Q 001873 920 DDNC----------------------------SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971 (1001)
Q Consensus 920 ~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~P 971 (1001)
.... .........+||+.|+|||++.+..++.++||||+||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 1000 000111245799999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 001873 972 LDPTLP 977 (1001)
Q Consensus 972 f~~~~~ 977 (1001)
|....+
T Consensus 236 f~~~~~ 241 (360)
T cd05627 236 FCSETP 241 (360)
T ss_pred CCCCCH
Confidence 976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=313.09 Aligned_cols=203 Identities=29% Similarity=0.395 Sum_probs=168.5
Q ss_pred hcccCCCeEeecCCeeEEEEEe------CCCCEEEEEEecCCCc---hhhHHHHHHHhhcc-CCCceeeEEeeeecC-Cc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI------PNGETLAVKKMWSSDE---SGAFSSEIQTLGSI-RHKNIVRLLGWGSNK-NL 834 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~-~~ 834 (1001)
++|++.++||+|+||.||+|.+ .+++.||||++..... .+.+.+|+.+++++ +||||+++++++... +.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 5789999999999999999974 2356899999865332 35688999999999 899999999987654 46
Q ss_pred eEEEEEccCCCCHHHHhhcCCC----------------------------------------------------------
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGK---------------------------------------------------------- 856 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 856 (1001)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 7899999999999999975321
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCCCCCcccc
Q 001873 857 --GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAG 934 (1001)
Q Consensus 857 --~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~g 934 (1001)
..+++.++.+++.|+++|++|||++ +|+||||||+||+++.++.+||+|||+++.+...... .......+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-----~~~~~~~~ 238 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-----VRKGSARL 238 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcch-----hcccCCCC
Confidence 2367788889999999999999998 9999999999999999999999999999865322111 11122346
Q ss_pred cccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 935 SYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 935 t~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
++.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 688999999998899999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=309.45 Aligned_cols=192 Identities=24% Similarity=0.295 Sum_probs=167.6
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCC
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNG 845 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 845 (1001)
+.||+|+||.||+++.. +++.||+|++... .....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999865 6899999998542 22356778999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCC
Q 001873 846 SLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSK 925 (1001)
Q Consensus 846 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 925 (1001)
+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~------- 148 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-------
Confidence 999998764 3578999999999999999999998 9999999999999999999999999998753211
Q ss_pred CCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 926 TNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 926 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 11122357999999999999899999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=331.11 Aligned_cols=203 Identities=31% Similarity=0.438 Sum_probs=171.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC--C----CEEEEEEecCC---CchhhHHHHHHHhhccCCCceeeEEeeeecCCceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN--G----ETLAVKKMWSS---DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~--~----~~vavK~~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
+..+..+.||+|+||.||.|...+ + .+||||.+... .+..+|.+|..+|+.++|||||+++|+|-+.+..+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 345567789999999999998643 3 35999988543 34478999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccc
Q 001873 837 LFYDYLPNGSLSSLLHGAG-----KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGL 911 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgl 911 (1001)
|++|||++|+|..||++.+ ...++..+...++.|||+|++||+++ ++|||||..+|+|++....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999998753 33468889999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 912 ARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 912 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
|+.+....++.... .. .-..+|||||.+..+.++.|+|||||||++||++| |..||....
T Consensus 849 ArDiy~~~yyr~~~-~a----~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~ 909 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHG-EA----MLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS 909 (1025)
T ss_pred hHhhhhchheeccC-cc----ccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc
Confidence 99654433322111 11 12358999999999999999999999999999999 888887653
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=303.36 Aligned_cols=200 Identities=28% Similarity=0.386 Sum_probs=176.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC---CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS---DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
..|+..++||+|.||.||+|.+. .++.||+|++.-+ .+.+++++|+.++..++++||.++++.+..+...|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35677789999999999999854 6899999998543 3447889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
|.||++.+.++.. ..+++..+..|++++..|+.|+|.+ +.+|||||+.||++..+|.+|++|||.+.++...
T Consensus 93 ~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--- 164 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--- 164 (467)
T ss_pred hcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech---
Confidence 9999999999853 2247777778899999999999999 9999999999999999999999999999877532
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
...+.+.+|||.|||||++....|+.|+||||||++.+||.+|.+|+....|
T Consensus 165 ----~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 165 ----VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred ----hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 2233677999999999999999999999999999999999999999987654
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=308.99 Aligned_cols=192 Identities=24% Similarity=0.303 Sum_probs=168.1
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCC
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNG 845 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 845 (1001)
+.||+|+||.||+++.. +++.||||++... .....+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 6899999998643 23356788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCC
Q 001873 846 SLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSK 925 (1001)
Q Consensus 846 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 925 (1001)
+|.+++... ..+++..+..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~------- 148 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD------- 148 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-------
Confidence 999998764 3588999999999999999999998 9999999999999999999999999998753211
Q ss_pred CCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 926 TNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 926 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence 11223357999999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=307.38 Aligned_cols=190 Identities=26% Similarity=0.309 Sum_probs=166.6
Q ss_pred EeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCCH
Q 001873 774 IGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSL 847 (1001)
Q Consensus 774 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 847 (1001)
||+|+||+||+|+.. +++.||+|++... .....+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999875 5889999988532 2335678899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCC
Q 001873 848 SSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTN 927 (1001)
Q Consensus 848 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 927 (1001)
.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..... ..
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-------~~ 148 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-------DD 148 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC-------CC
Confidence 9999764 3488999999999999999999998 9999999999999999999999999998753221 11
Q ss_pred CCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 928 QRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 928 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 223457999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=314.24 Aligned_cols=199 Identities=25% Similarity=0.306 Sum_probs=171.7
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.+.||+|+||.||+++.+ +++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 368999999999999999999976 6889999987532 2234578899999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++|+|.++++.. .+++..+..++.||+.|++|||++ +|+||||||+||+++.++++||+|||+++.....
T Consensus 122 ~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 122 MEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 9999999999999753 478888889999999999999998 9999999999999999999999999999875422
Q ss_pred CCCCCCCCCCCCcccccccccCccccccC----CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQ----RITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.. .......||+.|+|||++... .++.++||||+||++|||++|+.||...
T Consensus 196 ~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 196 GM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred Cc------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 11 112345799999999998653 3789999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=313.64 Aligned_cols=200 Identities=26% Similarity=0.310 Sum_probs=171.5
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.+.||+|+||+||+++.. +++.||+|++... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 357899999999999999999875 6889999998532 2234577899999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++|+|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.....
T Consensus 122 ~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 122 MEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999753 478888889999999999999998 9999999999999999999999999999865422
Q ss_pred CCCCCCCCCCCCcccccccccCccccccC----CCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQ----RITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.. .......||+.|+|||++... .++.++||||+||++|||++|+.||....
T Consensus 196 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 196 GM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred Cc------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 11 112234799999999988643 47889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=312.56 Aligned_cols=200 Identities=30% Similarity=0.415 Sum_probs=172.6
Q ss_pred ccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecC---CCchhhHHHHHHHhhccCCCceeeEEeeeecC------CceEE
Q 001873 768 LTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWS---SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNK------NLKLL 837 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~------~~~~l 837 (1001)
|...+.||+|+||.||+|+. ..|+.||||.+.. ....+...+|++++++++|||||+.++.-... ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44556799999999999995 4799999999866 44557788999999999999999999976543 35689
Q ss_pred EEEccCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC--CCC--cEEEeccccc
Q 001873 838 FYDYLPNGSLSSLLHGAG-KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG--PGY--QAYLADFGLA 912 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~--~~~--~~ki~Dfgla 912 (1001)
|||||.||||+..+++.. ..++++.+.+.+..+++.||.|||++ +|+||||||.||++- ++| .-||+|||+|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999998753 35689999999999999999999988 999999999999983 334 5799999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCccccc-cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS-MQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~ 978 (1001)
+.++.+ ......+||+.|.|||... .+.|+..+|.|||||++|+..||..||.|...+
T Consensus 172 rel~d~--------s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 172 RELDDN--------SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccCCCC--------CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 987532 3556789999999999998 489999999999999999999999999987544
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=282.53 Aligned_cols=199 Identities=26% Similarity=0.351 Sum_probs=171.3
Q ss_pred CeEeecCCeeEEEEE-eCCCCEEEEEEecCCC--chhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEEEccCCCCH
Q 001873 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWSSD--ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPNGSL 847 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 847 (1001)
+.||+|+||.|-... ..+|..||||++.+.. ...+..+|++++..+ .|+||+++++||.++...|+|||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 469999999998755 6789999999985543 346788999999999 499999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC---cEEEecccccccccCCCCCCCC
Q 001873 848 SSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY---QAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 848 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
..+|+++ ..+++.++.+++.+|+.|+++||.+ ||.|||+||+|||..+.. -+|||||.++..+....+-...
T Consensus 164 LshI~~~--~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 164 LSHIQKR--KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred HHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 9999874 4589999999999999999999999 999999999999997544 5899999998766544433344
Q ss_pred CCCCCCcccccccccCcccc-----ccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHA-----SMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.+....+.+|+..|||||+. ....|+.+.|.||+|||+|-|++|+.||-+.
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 44555677899999999975 2357899999999999999999999999875
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=306.04 Aligned_cols=198 Identities=24% Similarity=0.301 Sum_probs=170.0
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCC-CceeeEEeeeecCCceEEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRH-KNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h-~nIv~l~~~~~~~~~~~lv~ 839 (1001)
+|++.+.||+|+||+||+|+.. +++.||||++... ...+.+..|+++++.++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999865 5789999988542 233567889999999976 56888999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++|+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG- 154 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence 999999999999764 3478899999999999999999998 9999999999999999999999999998743211
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
........||+.|+|||++.+..++.++||||+||++|||+||+.||....
T Consensus 155 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 155 ------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred ------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 112234579999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=314.63 Aligned_cols=206 Identities=26% Similarity=0.339 Sum_probs=177.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999975 6899999998542 23457889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++++|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999864 4588999999999999999999998 99999999999999999999999999998765432
Q ss_pred CC----------------------CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DD----------------------NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~----------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.. ............||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 00 0000112234579999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=306.21 Aligned_cols=192 Identities=27% Similarity=0.379 Sum_probs=166.5
Q ss_pred CeEeecCCeeEEEEEe----CCCCEEEEEEecCC------CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 772 NVIGTGSSGVVYRVTI----PNGETLAVKKMWSS------DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~------~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+.||+|+||.||+++. ..++.||||.+... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 35789999988542 1224577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++|+|.+++.+. ..+.+..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-- 154 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence 9999999999764 3478888889999999999999998 99999999999999999999999999987542211
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 155 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~ 203 (323)
T cd05584 155 -----TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203 (323)
T ss_pred -----CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence 1123357999999999999888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=307.87 Aligned_cols=200 Identities=27% Similarity=0.316 Sum_probs=171.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||+||+++.. +++.||||++... ...+.+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36889999999999999999965 5899999998531 22356888999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++|+|.+++.+. ...+++..+..++.||+.|++|||++ +|+||||||+||+++.++++||+|||++..+....
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999753 33578899999999999999999998 99999999999999999999999999987654321
Q ss_pred CCCCCCCCCCCcccccccccCcccccc-----CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASM-----QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......||+.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 157 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 157 T------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred C------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 1 11122469999999999863 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=300.37 Aligned_cols=199 Identities=23% Similarity=0.329 Sum_probs=170.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++|++.++||+|+||+||+|+.+ +++.||+|++.... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46899999999999999999865 68999999886432 234678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
++ |+|.+++...+ ...++..+..++.||+.|++|||++ +|+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-- 157 (288)
T cd07871 85 LD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-- 157 (288)
T ss_pred CC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence 97 59999987542 3468889999999999999999998 99999999999999999999999999997643211
Q ss_pred CCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......|++.|+|||++.+ ..++.++||||+||++|||+||+.||....
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred -----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223468999999998865 568999999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=305.78 Aligned_cols=196 Identities=26% Similarity=0.351 Sum_probs=168.1
Q ss_pred ccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHh---hccCCCceeeEEeeeecCCceEEE
Q 001873 768 LTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTL---GSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l---~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
|++.+.||+|+||.||+|+.. +++.||||++... ...+.+.+|++++ ++++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 667889999999999999865 6899999998642 2234566676655 566899999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++|+|..++++ ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999998864 3589999999999999999999998 9999999999999999999999999998753221
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 155 -------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 155 -------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred -------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 112234579999999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=308.63 Aligned_cols=200 Identities=26% Similarity=0.302 Sum_probs=171.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||+||+++.. +++.||+|.+... .....+.+|+.+++.++|++|+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36889999999999999999975 6789999988532 22345788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++|+|.+++.+. ...+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999864 23578889999999999999999998 99999999999999999999999999998654321
Q ss_pred CCCCCCCCCCCcccccccccCcccccc-----CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASM-----QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......||+.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 157 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 157 T------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred c------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 1 11123469999999998865 56788999999999999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=305.20 Aligned_cols=198 Identities=23% Similarity=0.302 Sum_probs=169.8
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
+|++.+.||+|+||+||+|+.. +++.||||.+.... ..+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999875 57899999886432 224566788888777 5899999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999999999764 3478999999999999999999998 99999999999999999999999999987542211
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 156 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 156 -------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred -------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 11234579999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=301.75 Aligned_cols=198 Identities=25% Similarity=0.344 Sum_probs=169.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+|+.++++++||||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 57999999999999999999976 689999999864322 24678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
++ ++|.+++.+. ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 157 (303)
T cd07869 85 VH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-- 157 (303)
T ss_pred CC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence 96 6888888754 34578889999999999999999998 99999999999999999999999999987542211
Q ss_pred CCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 158 -----HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred -----ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11223468999999998765 56889999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=305.63 Aligned_cols=191 Identities=23% Similarity=0.308 Sum_probs=166.8
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++||+|+||+||+++.. +++.||||+++... ..+.+.+|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 68899999986421 234578899999888 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++.+. ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~------ 149 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP------ 149 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC------
Confidence 9999998754 4589999999999999999999998 9999999999999999999999999998743211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
........||+.|+|||++.+..++.++||||+||++|||++|+.||+.
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 150 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred -CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 1122345799999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=303.25 Aligned_cols=192 Identities=27% Similarity=0.387 Sum_probs=164.5
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
+.||+|+||+||+|+.. +++.||||.++.. ...+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 5889999988642 2234556677776654 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~----- 150 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----- 150 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-----
Confidence 9999999764 3488899999999999999999998 99999999999999999999999999997542211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 1223457999999999999889999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=287.99 Aligned_cols=197 Identities=26% Similarity=0.379 Sum_probs=178.4
Q ss_pred ccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCC
Q 001873 768 LTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGS 846 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 846 (1001)
|.++.+||+|+||.||++.++ .|+.||+|++.-+.+-+++..|+.+|++++.|+||+++|.+......|+|||||--|+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 456678999999999999876 6999999999888888999999999999999999999998777778999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCC
Q 001873 847 LSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKT 926 (1001)
Q Consensus 847 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~ 926 (1001)
..|.++.. ++.+++.++..+.+..++|++|||.. .-||||||+.|||++.+|++|++|||.|..+.. ..
T Consensus 115 iSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-------TM 183 (502)
T KOG0574|consen 115 ISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-------TM 183 (502)
T ss_pred HHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh-------hH
Confidence 99999864 56789999999999999999999997 789999999999999999999999999987642 12
Q ss_pred CCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 927 NQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 927 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
..+.++.|||.|||||++..-.|+.++||||+|+...||..|++||..-
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI 232 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI 232 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc
Confidence 3456678999999999999999999999999999999999999998754
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=301.00 Aligned_cols=198 Identities=24% Similarity=0.339 Sum_probs=170.9
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+|++.+.||+|+||+||+++.+ +++.||||++.... ..+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 6889999999999999999976 58899999886432 235678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
++++.+..+... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 155 (287)
T cd07848 82 VEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN- 155 (287)
T ss_pred CCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence 998777665543 34588999999999999999999998 999999999999999999999999999987532211
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 156 -----ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred -----ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 1122346899999999998888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=304.18 Aligned_cols=193 Identities=24% Similarity=0.325 Sum_probs=166.8
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
+.||+|+||+||+|+.+ +++.||||++... ...+.+.+|..+++.. +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 5889999988532 2335677888888776 699999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++.+. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~------ 149 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN------ 149 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC------
Confidence 9999999764 3488999999999999999999998 9999999999999999999999999998753211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
........||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 150 -GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred -CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 112233579999999999998999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=304.53 Aligned_cols=197 Identities=27% Similarity=0.397 Sum_probs=173.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++|++.+.||+|+||.||+++.+ ++..||+|.+..... ...+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 57899999999999999999976 688899998865422 25788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++|+|.+++... ..+++..+..++.|++.|+.|||+++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 85 MDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 9999999999764 34789999999999999999999852 6999999999999999999999999998765321
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 158 ------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 158 ------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 122346899999999999989999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=304.50 Aligned_cols=201 Identities=25% Similarity=0.354 Sum_probs=180.5
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-----hhhHHHHHHHhhccC-CCceeeEEeeeecCCc
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-----SGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNL 834 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~ 834 (1001)
.++...|++.+.||+|.||.||+++.+ +|+.+|+|.+.+... ...+.+|+.+|+++. |||||.+++++.+...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 456678999999999999999999976 499999999865432 357899999999998 9999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC----CCcEEEeccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP----GYQAYLADFG 910 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~ki~Dfg 910 (1001)
+++|||++.||.|.+.+.+. ..++.++..++.|++.|++|+|+. +|+|||+||+|+++.. ++.+|++|||
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 99999999999999999865 389999999999999999999998 9999999999999963 3589999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+|..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+..
T Consensus 185 la~~~~~--------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 185 LAKFIKP--------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred CceEccC--------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 9998643 234556799999999999999999999999999999999999999999875
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=307.07 Aligned_cols=192 Identities=24% Similarity=0.296 Sum_probs=166.9
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCC
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNG 845 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 845 (1001)
+.||+|+||+||+++.. +++.||+|++... .....+.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 6899999998643 22356778999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 846 SLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHH-DCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 846 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
+|.+++... ..+++..+..++.|++.|++|||+ . +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~----- 150 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG----- 150 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-----
Confidence 999998754 358999999999999999999997 5 99999999999999999999999999987532211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 151 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred --cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 1122346999999999999899999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=278.53 Aligned_cols=197 Identities=28% Similarity=0.389 Sum_probs=170.7
Q ss_pred HhcccCCCeEeecCCeeEEEEE-eCCCCEEEEEEec----CCCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMW----SSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~----~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
.++|++.++||+|.|+.||+.. .++|+++|+|.+. .....+++.+|+++-+.++|||||++.+...+.+..|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4678888999999999999854 4579999998763 2335578999999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC---CCcEEEeccccccccc
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP---GYQAYLADFGLARIVS 916 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~Dfgla~~~~ 916 (1001)
|+|+|++|..=+-+. ...++..+-..++||+.|+.|+|.+ +|||||+||+|+++.. .--+|++|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999996654332 3358888889999999999999999 9999999999999953 3469999999999875
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
. .......+|||+|||||+++..+|+.++|||+.|||+|-++.|+.||.+
T Consensus 165 ~--------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 165 D--------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred C--------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 1 2334456899999999999999999999999999999999999999987
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=298.20 Aligned_cols=198 Identities=25% Similarity=0.332 Sum_probs=173.1
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
.|++.++||+|+||+||++... +++.||||++.... ....+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3778899999999999999864 68999999885422 12457789999999999999999999999899999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++|+|.+++.......+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++.+....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 99999999998765555689999999999999999999998 99999999999999999999999999998653211
Q ss_pred CCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......|++.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 157 -------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred -------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 112346899999999998888999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=306.93 Aligned_cols=198 Identities=25% Similarity=0.313 Sum_probs=169.3
Q ss_pred cccCCCeEeecCCeeEEEEEe----CCCCEEEEEEecCC------CchhhHHHHHHHhhcc-CCCceeeEEeeeecCCce
Q 001873 767 NLTSANVIGTGSSGVVYRVTI----PNGETLAVKKMWSS------DESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~------~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~ 835 (1001)
+|++.+.||+|+||+||+++. .+++.||+|++... ...+.+.+|+.+++++ +||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999875 25789999988532 1234678899999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
++||||+++|+|.+++.+. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999999764 3488999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ-RITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
..... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 156 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 156 LSEEK------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred cccCC------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 32211 112235799999999998764 4788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=293.68 Aligned_cols=213 Identities=24% Similarity=0.273 Sum_probs=183.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC-----CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS-----SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
..|+.-++||+|+||.||-.+.+ +|+.||.|++.+ ........+|-++++++..+.||.+--.|...+..|+|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 34666789999999999998755 699999997633 233345778999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
..|.||+|.-+|...++..+++..+.-++.+|+.||++||.+ +||+||+||+|||+|+.|+++|+|.|+|..+..
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~-- 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE-- 339 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC--
Confidence 999999999999999888999999999999999999999999 999999999999999999999999999998743
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhhhhccc
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLML 993 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~~~~~~ 993 (1001)
.......+||.+|||||++.+..|+...|-||+||++|||+.|+.||.... ..+.|.++...+.
T Consensus 340 ------g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K----eKvk~eEvdrr~~ 403 (591)
T KOG0986|consen 340 ------GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK----EKVKREEVDRRTL 403 (591)
T ss_pred ------CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh----hhhhHHHHHHHHh
Confidence 233445599999999999999999999999999999999999999998543 3344444443333
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=276.02 Aligned_cols=201 Identities=25% Similarity=0.405 Sum_probs=174.1
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCC------ch----hhHHHHHHHhhcc-CCCceeeEEeee
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSD------ES----GAFSSEIQTLGSI-RHKNIVRLLGWG 829 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~----~~~~~Ei~~l~~l-~h~nIv~l~~~~ 829 (1001)
++.-.+|...+++|+|..++|-+..+ ++|+++|+|++.... .. ++-.+|+.+++++ .||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 45567788889999999999987654 478999999883211 11 4566799999998 699999999999
Q ss_pred ecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecc
Q 001873 830 SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADF 909 (1001)
Q Consensus 830 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Df 909 (1001)
..+...++|+|.|+.|.|.|++.. ...++++...+|++|+..|++|||.+ .|||||+||+|||++++.++||+||
T Consensus 93 es~sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 999999999999999999999986 45689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCCcccccccccCcccccc------CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM------QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 910 gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
|.|..+.+ .......+|||+|.|||.+.. ..|+..+|+||.|||||-++.|..||...
T Consensus 168 GFa~~l~~--------GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR 231 (411)
T KOG0599|consen 168 GFACQLEP--------GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR 231 (411)
T ss_pred ceeeccCC--------chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH
Confidence 99988753 334556799999999997743 56888999999999999999999999753
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=304.29 Aligned_cols=191 Identities=24% Similarity=0.324 Sum_probs=165.6
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
+.||+|+||+||+|+.+ +++.||+|++.... ....+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 68899999986431 224577888888776 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~----- 150 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG----- 150 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-----
Confidence 9999988764 4589999999999999999999998 99999999999999999999999999987532211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||+.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred --CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 122345799999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=304.44 Aligned_cols=193 Identities=23% Similarity=0.329 Sum_probs=166.7
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++||+|+||+||+|+.. +++.||||++... ...+.+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 5789999998542 2234577888888866 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++.+. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~------ 149 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN------ 149 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccC------
Confidence 9999998764 3478899999999999999999998 9999999999999999999999999998754221
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
........||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 150 -GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred -CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 112234579999999999998899999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=305.36 Aligned_cols=200 Identities=25% Similarity=0.298 Sum_probs=170.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.++||+|+||+||+++.+ +++.||+|.+... .....+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999976 5788999988432 22345788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++|+|.+++++. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999764 23578889999999999999999998 99999999999999999999999999987653221
Q ss_pred CCCCCCCCCCCcccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHAS-----MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 157 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 157 T------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred c------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 1 1122347999999999885 356789999999999999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=324.78 Aligned_cols=207 Identities=25% Similarity=0.342 Sum_probs=174.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.++||+|+||.||+|+.. +++.||||++.... ..+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999875 58999999986432 1356889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccc
Q 001873 840 DYLPNGSLSSLLHGAG---------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFG 910 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfg 910 (1001)
||++||+|.+++.... ....++..+.+++.||++|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 12346677889999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCC-----------CCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 911 LARIVSGSGDDN-----------CSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 911 la~~~~~~~~~~-----------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+|+......... ..........+||+.|||||++.+..++.++||||+||++|||+||+.||...
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 998762211100 00111223457999999999999999999999999999999999999999763
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=301.56 Aligned_cols=192 Identities=27% Similarity=0.361 Sum_probs=165.8
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++||+|+||+||+|+.+ +++.||||.+... ...+....|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 6889999998642 2335567788887654 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------ 149 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG------ 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC------
Confidence 9999999764 3478899999999999999999998 9999999999999999999999999998743211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 150 -DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred -CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 12233457999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=302.74 Aligned_cols=197 Identities=23% Similarity=0.306 Sum_probs=169.3
Q ss_pred ccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccC-CCceeeEEeeeecCCceEEEEE
Q 001873 768 LTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
|+..+.||+|+||+||+|+.. +++.||+|++... ...+.+..|..+++.+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 667789999999999999865 6899999988542 22345778888888885 5788889999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++|+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||+++......
T Consensus 82 y~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 82 YVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 99999999999764 3489999999999999999999998 99999999999999999999999999987542211
Q ss_pred CCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 156 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 156 ------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred ------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 11233469999999999998899999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=302.56 Aligned_cols=192 Identities=24% Similarity=0.322 Sum_probs=166.9
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
+.||+|+||+||+|+.. +++.||||++.... ..+.+.+|+.++.++ +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 57899999986432 235578899998888 699999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------ 149 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP------ 149 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC------
Confidence 9999998754 3589999999999999999999998 9999999999999999999999999998753211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||+..
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 150 -GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred -CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 11223457999999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=300.75 Aligned_cols=192 Identities=24% Similarity=0.346 Sum_probs=165.1
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhc-cCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGS-IRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~-l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
+.||+|+||+||+|+.. +++.||||++... ...+.+..|..+++. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 5789999988543 233456678888776 4899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++.+. ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~------ 149 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG------ 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCC------
Confidence 9999999763 3478889999999999999999998 9999999999999999999999999998753211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 150 -DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred -CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 11123456999999999999989999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=302.61 Aligned_cols=192 Identities=28% Similarity=0.332 Sum_probs=164.0
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHH-HhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQ-TLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
+.||+|+||+||+|+.. +++.||||++.... ....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 68999999985421 2234455554 46789999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++... ..+++..+..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~------ 149 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH------ 149 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC------
Confidence 9999999763 4578899999999999999999998 9999999999999999999999999998753211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 150 -SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred -CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 11223457999999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-33 Score=318.72 Aligned_cols=209 Identities=27% Similarity=0.367 Sum_probs=172.0
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCC-CEEEEEEecCCCch--hhHHHHHHHhhccC-CCceeeEEee-ee---c---CCc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNG-ETLAVKKMWSSDES--GAFSSEIQTLGSIR-HKNIVRLLGW-GS---N---KNL 834 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~--~~~~~Ei~~l~~l~-h~nIv~l~~~-~~---~---~~~ 834 (1001)
-++++.++|.+|||+.||.|+...+ .+||+|++...++. +...+||++|+.++ |+|||.+++. .. . .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3577889999999999999997655 99999998766443 67889999999996 9999999993 21 1 236
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
+++.||||.||.|-|++.......+++.++++|+.|+++|+.+||. +.++|||||||-+|||++.+|+.||||||.|..
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 6899999999999999987666679999999999999999999998 467899999999999999999999999999865
Q ss_pred ccCCCCC--CCCCCCCCCcccccccccCcccc---ccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 915 VSGSGDD--NCSKTNQRPQLAGSYGYMAPEHA---SMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 915 ~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
....... ........-...-|+-|+|||++ .+...++|+||||+||++|-++....||++.
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 4322110 00000111122478999999976 6788999999999999999999999999876
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=296.68 Aligned_cols=199 Identities=24% Similarity=0.350 Sum_probs=168.0
Q ss_pred hcccCCCeEeecCCeeEEEEEeC--CCCEEEEEEecCCC----chhhHHHHHHHhhcc---CCCceeeEEeeee-----c
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP--NGETLAVKKMWSSD----ESGAFSSEIQTLGSI---RHKNIVRLLGWGS-----N 831 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l---~h~nIv~l~~~~~-----~ 831 (1001)
++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36899999999999999999863 46889999885432 224566788777665 6999999999875 3
Q ss_pred CCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccc
Q 001873 832 KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGL 911 (1001)
Q Consensus 832 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgl 911 (1001)
....++||||++ ++|.+++.......+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 6999999876556689999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 912 ARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 912 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
++..... .......||+.|+|||++....++.++||||+||++|||++|+.||....
T Consensus 157 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 157 ARIYSFQ--------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred eEeccCC--------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 9865321 12234468999999999988899999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=302.31 Aligned_cols=197 Identities=27% Similarity=0.418 Sum_probs=172.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++|++.++||+|+||.||++++. ++..||+|.+..... ...+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 57899999999999999999976 688899998754322 25688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++|+|.++++.. ..+++..+..++.|++.|+.|||+.+ +|+||||||+||++++++.+||+|||++..+...
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 85 MDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 9999999999764 34788899999999999999999752 7999999999999999999999999998765321
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 158 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 ------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 112346899999999999888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=308.26 Aligned_cols=201 Identities=26% Similarity=0.306 Sum_probs=173.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||+||+++.. +++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999865 68999999986432 2356888999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++|+|.+++.+. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999999865 24588999999999999999999998 99999999999999999999999999998764321
Q ss_pred CCCCCCCCCCCcccccccccCccccc------cCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHAS------MQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.. ......||+.|+|||++. ...++.++||||+||++|||++|+.||....
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 157 MV------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred ce------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 11 122346899999999886 4567899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=295.11 Aligned_cols=192 Identities=24% Similarity=0.289 Sum_probs=166.3
Q ss_pred EeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCCH
Q 001873 774 IGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSL 847 (1001)
Q Consensus 774 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 847 (1001)
||+|+||+||+++.. +++.||||++.... ..+.+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 68999999985432 124567899999999999999999999999999999999999999
Q ss_pred HHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCC
Q 001873 848 SSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSK 925 (1001)
Q Consensus 848 ~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 925 (1001)
.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+..+....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~------ 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ------ 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCC------
Confidence 9888542 234578999999999999999999998 99999999999999999999999999997654321
Q ss_pred CCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 926 TNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 926 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 152 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 152 -SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred -ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 1122346899999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=301.45 Aligned_cols=192 Identities=27% Similarity=0.317 Sum_probs=163.2
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHH-HhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQ-TLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++||+|+||+||+|+.. +++.||+|++.... ....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 68899999885422 2234555554 57889999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++... ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~------ 149 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP------ 149 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC------
Confidence 9999988753 4478888889999999999999998 9999999999999999999999999998753211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 150 -EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred -CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 11223457999999999999889999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=307.52 Aligned_cols=193 Identities=23% Similarity=0.302 Sum_probs=168.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
.+|++.+.||+|+||.||++... +++.||+|+.. .+.+.+|++++++++||||+++++++......++|+|++.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~- 166 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK- 166 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence 56999999999999999999864 68999999753 3457899999999999999999999999999999999995
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
++|..++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+......
T Consensus 167 ~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~----- 236 (391)
T PHA03212 167 TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN----- 236 (391)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc-----
Confidence 7899888764 3578999999999999999999998 99999999999999999999999999997532211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
........||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 237 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 237 -ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred -ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 1122345799999999999988999999999999999999999988754
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=314.99 Aligned_cols=202 Identities=24% Similarity=0.317 Sum_probs=173.1
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-C-CCEEEEEEecCCCch--hhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-N-GETLAVKKMWSSDES--GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~--~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
..|.+.+.||+|+||.||+|... + ++.||+|++...... ..+.+|+.+++.++|||||++++++...+..++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34889999999999999999754 3 678888876543322 4677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 842 LPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 842 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
+++|+|.+++++. ....+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988642 233578889999999999999999998 99999999999999999999999999998764321
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......+||++|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 224 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 224 S-----LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred c-----cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 11233457999999999999999999999999999999999999999754
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=303.20 Aligned_cols=192 Identities=27% Similarity=0.329 Sum_probs=164.2
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHH-HhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQ-TLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
+.||+|+||+||+++.. +|+.||||++... .....+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999865 6899999988543 22244555655 46778999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|..++... ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~------ 149 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ------ 149 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC------
Confidence 9999998753 4588999999999999999999998 9999999999999999999999999998753211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 150 -SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred -CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 11223457999999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=293.07 Aligned_cols=190 Identities=19% Similarity=0.318 Sum_probs=164.6
Q ss_pred CeEeecCCeeEEEEEeCCCCEEEEEEecCCCc-----hhhHHHHHHHhhccCCCceeeEEeeeec----CCceEEEEEcc
Q 001873 772 NVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE-----SGAFSSEIQTLGSIRHKNIVRLLGWGSN----KNLKLLFYDYL 842 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e~~ 842 (1001)
..||+|++|.||+|++ +|+.||||++..... .+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 689999999865322 2567799999999999999999998866 34678999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
++|+|.+++++. ..+++....+++.|++.|+.|+|+.. +++||||||+||++++++.+||+|||+++.+...
T Consensus 105 ~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---- 176 (283)
T PHA02988 105 TRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---- 176 (283)
T ss_pred CCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccc----
Confidence 999999999864 45889999999999999999999842 7889999999999999999999999999865321
Q ss_pred CCCCCCCCcccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASM--QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||+...
T Consensus 177 ------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 177 ------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred ------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 112368899999999876 689999999999999999999999998654
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=301.36 Aligned_cols=192 Identities=28% Similarity=0.306 Sum_probs=162.7
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHH-HhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQ-TLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
+.||+|+||+||+|+.. +++.||+|++.... ....+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 57889999985421 2234444444 46788999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++... ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~------ 149 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH------ 149 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC------
Confidence 9999999763 3477888888999999999999998 9999999999999999999999999998754221
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 150 -NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred -CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence 11223457999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=297.57 Aligned_cols=202 Identities=26% Similarity=0.396 Sum_probs=168.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC-----------------CCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN-----------------GETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRL 825 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l 825 (1001)
++|++.++||+|+||.||++.+++ +..||+|.+..... ..++.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999997532 34699998865432 2578899999999999999999
Q ss_pred EeeeecCCceEEEEEccCCCCHHHHhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEE
Q 001873 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGK-----------------GGADWEARYEVVLGVAHALAYLHHDCMPPILH 888 (1001)
Q Consensus 826 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH 888 (1001)
++++.+.+..++||||+++|+|.+++..... ..+++..+.+++.|++.|++|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 9999999999999999999999999864311 2357788899999999999999998 9999
Q ss_pred eCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-
Q 001873 889 GDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT- 967 (1001)
Q Consensus 889 ~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt- 967 (1001)
|||||+||+++.++.+||+|||+++.+...... .......++..|+|||++....++.++||||||+++|||++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYY-----RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCcee-----EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 999999999999999999999999865432111 11122346788999999988889999999999999999986
Q ss_pred -CCCCCCCC
Q 001873 968 -GRHPLDPT 975 (1001)
Q Consensus 968 -g~~Pf~~~ 975 (1001)
+..||...
T Consensus 237 ~~~~p~~~~ 245 (304)
T cd05096 237 CKEQPYGEL 245 (304)
T ss_pred cCCCCCCcC
Confidence 56788754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=303.14 Aligned_cols=199 Identities=25% Similarity=0.372 Sum_probs=167.2
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC----CchhhHHHHHHHhhccCCCceeeEEeeeecC-----CceE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNK-----NLKL 836 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~-----~~~~ 836 (1001)
+|++.+.||+|+||.||+|+.. +++.||||++... ....++.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5788899999999999999865 6899999988532 2235688999999999999999999987533 2479
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
+||||+. ++|.+++.+. ..+++..+..++.|+++|+.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 7999998764 3489999999999999999999998 99999999999999999999999999998643
Q ss_pred CCCCCCCCCCCCCCcccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASM--QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
..... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 155 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 155 NDTPT----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred cccCc----cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 22111 112234579999999999865 67899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=305.79 Aligned_cols=203 Identities=32% Similarity=0.412 Sum_probs=169.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc---hhhHHHHHHHhhcc-CCCceeeEEeeeecCCce
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE---SGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~ 835 (1001)
++|++.+.||+|+||.||+|++. +++.||||++..... .+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 47889999999999999998742 345899999865432 35688999999999 899999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCC------------------------------------------------------------
Q 001873 836 LLFYDYLPNGSLSSLLHGAG------------------------------------------------------------ 855 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 855 (1001)
++||||+++|+|.++++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999986421
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCC
Q 001873 856 --------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTN 927 (1001)
Q Consensus 856 --------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 927 (1001)
...+++..+.+++.||+.|++|||++ +|+||||||+||++++++++||+|||+++.+...... .
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~-----~ 269 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-----V 269 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-----e
Confidence 12367788899999999999999998 9999999999999999999999999999865432111 1
Q ss_pred CCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 928 QRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 928 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
......++..|||||++....++.++|||||||++|||++ |+.||....
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 1112235678999999988899999999999999999997 999997653
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=303.89 Aligned_cols=193 Identities=28% Similarity=0.476 Sum_probs=163.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++|+..+.||+|+||+||+|+.. +++.||||++..... .+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677889999999999999865 689999999865432 35788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++|+|.+.. ..++..+..++.||+.|++|||+. +|+||||||+||++++++.+||+|||+++.+....
T Consensus 154 ~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-- 222 (353)
T PLN00034 154 MDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-- 222 (353)
T ss_pred CCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc--
Confidence 9999986542 245677888999999999999998 99999999999999999999999999998754221
Q ss_pred CCCCCCCCCcccccccccCcccccc-----CCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASM-----QRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||..
T Consensus 223 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 223 -----DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred -----ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 11223479999999998743 2345689999999999999999999984
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=290.90 Aligned_cols=191 Identities=26% Similarity=0.327 Sum_probs=166.6
Q ss_pred EeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCCH
Q 001873 774 IGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSL 847 (1001)
Q Consensus 774 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 847 (1001)
||+|+||+||+++.+ +|+.||+|++.... ..+.+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 68999999885321 224556799999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCC
Q 001873 848 SSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTN 927 (1001)
Q Consensus 848 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 927 (1001)
.+++........++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-------- 149 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-------- 149 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--------
Confidence 9998766556688999999999999999999998 99999999999999999999999999987653221
Q ss_pred CCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 928 QRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 928 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 112346899999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=303.04 Aligned_cols=192 Identities=29% Similarity=0.354 Sum_probs=167.6
Q ss_pred CeEeecCCeeEEEEEe----CCCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccC
Q 001873 772 NVIGTGSSGVVYRVTI----PNGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
+.||+|+||+||+++. .+++.||+|++.... ....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 358999999986432 23457789999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+|+|.+++.+. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---- 152 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---- 152 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC----
Confidence 99999999753 3589999999999999999999998 99999999999999999999999999987643211
Q ss_pred CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 153 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 153 ---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred ---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 1123357999999999999888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=297.82 Aligned_cols=192 Identities=26% Similarity=0.359 Sum_probs=166.5
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
+.||+|+||+||+|+.. +++.||||++... .....+.+|+++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 5789999988642 2335677898998887 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++.+. ..+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~------ 149 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG------ 149 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcC------
Confidence 9999998764 3589999999999999999999998 9999999999999999999999999998753211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 150 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 150 -GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred -CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 11122346899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=303.50 Aligned_cols=208 Identities=24% Similarity=0.328 Sum_probs=172.9
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC----CchhhHHHHHHHhhccCCCceeeEEeeeecCC----
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN---- 833 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~---- 833 (1001)
.+.++|++.+.||+|+||.||+++.. +++.||||++... .....+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 46789999999999999999999865 6899999998543 22356789999999999999999999876443
Q ss_pred --ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccc
Q 001873 834 --LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGL 911 (1001)
Q Consensus 834 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgl 911 (1001)
..++||||++ +++.+.++. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 98 FQDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred cceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 4689999997 467776643 378888899999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhhhh
Q 001873 912 ARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMF 990 (1001)
Q Consensus 912 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~~~ 990 (1001)
++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ...+|.....
T Consensus 170 a~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~----~~~~~~~~~~ 236 (359)
T cd07876 170 ARTACTN--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD----HIDQWNKVIE 236 (359)
T ss_pred ccccccC--------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHH
Confidence 9754221 12234578999999999999999999999999999999999999998642 3344544443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=290.21 Aligned_cols=201 Identities=24% Similarity=0.369 Sum_probs=170.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeC----CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP----NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
++|++.+.||+|+||.||+|.+. .+..||+|.+..... ...+.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888999999999999999753 467899999876532 25688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++|+|.+++... ...+++..++.++.|++.|++|||++ +++||||||+||+++.++.+|++|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999999764 23578999999999999999999998 9999999999999999999999999987653211
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
. ........++..|+|||.+.+..++.++|||||||++||+++ |+.||....
T Consensus 161 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~ 213 (266)
T cd05064 161 A------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred c------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 1 011112245678999999998999999999999999999875 999997653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=288.31 Aligned_cols=202 Identities=23% Similarity=0.337 Sum_probs=178.6
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
.+..-|...+.||+|.|+.|-++++- +|+.||||++.+.. ....+.+|++.|+.++|||||++|++...+...|+
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 34566888899999999999999854 79999999985432 23678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE-CCCCcEEEeccccccccc
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL-GPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~ki~Dfgla~~~~ 916 (1001)
|+|.=++|+|+|||-++ +..+.+..+.+++.||+.|+.|+|+- ++|||||||+||.+ ..-|-+|++|||++..+.
T Consensus 95 iLELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 99999999999999877 45689999999999999999999997 89999999999876 567899999999987664
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccccCCCC-CccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRIT-EKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+ .....+.+|+..|-|||++.+..|+ +++||||+|||+|.+.+|+.||+...
T Consensus 171 P--------G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN 223 (864)
T KOG4717|consen 171 P--------GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN 223 (864)
T ss_pred C--------cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc
Confidence 3 3445667999999999999999997 68999999999999999999998764
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=303.82 Aligned_cols=204 Identities=29% Similarity=0.385 Sum_probs=170.6
Q ss_pred HhcccCCCeEeecCCeeEEEEEe------CCCCEEEEEEecCCC---chhhHHHHHHHhhcc-CCCceeeEEeeeecCCc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI------PNGETLAVKKMWSSD---ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNL 834 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~ 834 (1001)
.++|++.+.||+|+||.||+|++ .++..||||++.... ..+.+.+|+++++.+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688999999999999999863 235689999986433 235688999999999 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhcCC-----------------------------------------------------------
Q 001873 835 KLLFYDYLPNGSLSSLLHGAG----------------------------------------------------------- 855 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 855 (1001)
.++||||+++|+|.+++++..
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986532
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 856 --------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 856 --------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
...+++..+.+++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++.+......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 12367888899999999999999998 9999999999999999999999999999876432211
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 271 -----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 271 -----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred -----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 11112235678999999999999999999999999999998 899997653
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=275.60 Aligned_cols=227 Identities=21% Similarity=0.239 Sum_probs=185.7
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC---C--CCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeec-CC
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP---N--GETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSN-KN 833 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~--~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~-~~ 833 (1001)
....|+.+..||+|.||.||+|..+ + ...+|+|+++.+. .+....||+..++.++||||+.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 4567999999999999999998532 2 3479999997763 34567899999999999999999998766 78
Q ss_pred ceEEEEEccCCCCHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC----CcEEE
Q 001873 834 LKLLFYDYLPNGSLSSLLHGA---GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG----YQAYL 906 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~ki 906 (1001)
..++++||.+ -+|.+.|+-+ ..+.++...+..|..||+.|+.|||++ -|+||||||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence 8999999998 5899888643 234578889999999999999999999 89999999999999766 89999
Q ss_pred ecccccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCC-----c
Q 001873 907 ADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGG-----A 980 (1001)
Q Consensus 907 ~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~-----~ 980 (1001)
+|+|+|+.+...-.+. .....++-|.+|+|||.+.+ +.|+.+.||||.|||+.||+|-++-|.+....- -
T Consensus 178 aDlGlaR~~~~plkpl----~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pf 253 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPL----ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPF 253 (438)
T ss_pred ecccHHHHhhcccccc----ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCc
Confidence 9999999986553322 23345678999999998765 778999999999999999999998887654321 2
Q ss_pred Ccccchhhhhcccchhhh
Q 001873 981 PLVQWTPLMFLMLNLEAE 998 (1001)
Q Consensus 981 ~l~~~~~~~~~~~~~~~~ 998 (1001)
+.+|..+++.++|-+.++
T Consensus 254 q~dQl~rIf~vLG~Pt~~ 271 (438)
T KOG0666|consen 254 QHDQLDRIFEVLGTPTDK 271 (438)
T ss_pred hHHHHHHHHHHcCCCccc
Confidence 556777888888755443
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=290.89 Aligned_cols=198 Identities=25% Similarity=0.330 Sum_probs=172.5
Q ss_pred ccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 768 LTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
|+..+.||+|+||+||++... +++.||||++.... ....+.+|+.++++++|++|+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999865 68999999875432 124577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++++|.+++...+...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 9999999999765556689999999999999999999998 99999999999999999999999999987643211
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......|++.|+|||++....++.++||||+|+++|||++|+.||....
T Consensus 157 ------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 157 ------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred ------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 1123468999999999998899999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=288.73 Aligned_cols=202 Identities=27% Similarity=0.432 Sum_probs=176.0
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccC
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
.++|++.++||+|+||.||+|...++..||+|++.... ..+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 35788999999999999999998888899999876533 34688999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+++|.+++++......++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--- 158 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY--- 158 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce---
Confidence 99999999876556688999999999999999999998 999999999999999999999999999987532211
Q ss_pred CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
.......++..|+|||+.....++.++|||||||++|||+| |+.||...
T Consensus 159 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 159 ---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred ---eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 11122345678999999988889999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=286.08 Aligned_cols=201 Identities=24% Similarity=0.382 Sum_probs=173.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++|++.+.||+|+||.||+++++++..+|+|.+.... ..+++.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 4578889999999999999999888899999876433 346889999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.......
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~---- 155 (256)
T cd05114 84 GCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY---- 155 (256)
T ss_pred CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce----
Confidence 99999997542 3578999999999999999999998 999999999999999999999999999886532211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~ 206 (256)
T cd05114 156 --TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206 (256)
T ss_pred --eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 11112235668999999988889999999999999999999 999997653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=300.57 Aligned_cols=192 Identities=27% Similarity=0.429 Sum_probs=165.5
Q ss_pred CCCeEeecCCeeEEEEEeC-CCCEEE---EE---EecCCCchhhHHHHHHHhhccCCCceeeEEeeeecCCc--eEEEEE
Q 001873 770 SANVIGTGSSGVVYRVTIP-NGETLA---VK---KMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNL--KLLFYD 840 (1001)
Q Consensus 770 ~~~~lG~G~fg~Vy~~~~~-~~~~va---vK---~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~--~~lv~e 840 (1001)
...+||+|+|-+||+|-+. +|-.|| || ..+++...++|..|+.+++.++||||++++.+|.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3457999999999999864 466666 33 22444555889999999999999999999998876554 678999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC-CCCcEEEecccccccccCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG-PGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ki~Dfgla~~~~~~~ 919 (1001)
.|..|+|..|+++.+. ++....+.|++||++||.|||++ .|+|||||||-+||||+ ..|.|||+|.|+|+....
T Consensus 124 L~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~-- 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK-- 198 (632)
T ss_pred cccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc--
Confidence 9999999999998654 88899999999999999999996 58999999999999997 568999999999998632
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
.....++|||.|||||+.. ..|++.+||||||++|.||.|+..||..
T Consensus 199 -------s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE 245 (632)
T KOG0584|consen 199 -------SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE 245 (632)
T ss_pred -------cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh
Confidence 2334478999999999998 7899999999999999999999999864
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=312.76 Aligned_cols=204 Identities=24% Similarity=0.340 Sum_probs=172.6
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCC-----
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN----- 833 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~----- 833 (1001)
..++|++.+.||+|+||+||+++.. +++.||||++.... ....+.+|+..+..++|+||+++.+.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3468999999999999999999854 68999999985432 2356788999999999999999988664322
Q ss_pred ---ceEEEEEccCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEec
Q 001873 834 ---LKLLFYDYLPNGSLSSLLHGAG--KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLAD 908 (1001)
Q Consensus 834 ---~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~D 908 (1001)
..++||||+++|+|.++++... ...+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 3679999999999999997532 34578899999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 909 FGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 909 fgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 187 FGls~~~~~~~~-----~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~ 248 (496)
T PTZ00283 187 FGFSKMYAATVS-----DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248 (496)
T ss_pred cccCeecccccc-----ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999987643211 11223457999999999999999999999999999999999999999764
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=290.05 Aligned_cols=197 Identities=24% Similarity=0.323 Sum_probs=172.2
Q ss_pred ccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 768 LTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
|+..+.||+|+||+||+|+.. +++.||+|.+.... ....+.+|++++++++|++|+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667788999999999999865 68999999885432 124577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++++|.+++...+...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--- 155 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--- 155 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC---
Confidence 9999999998765555689999999999999999999998 9999999999999999999999999998764321
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......|++.|+|||++.+..++.++|+||+|+++|||++|+.||...
T Consensus 156 -----~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 156 -----ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred -----CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 1112346899999999998889999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=290.87 Aligned_cols=201 Identities=28% Similarity=0.400 Sum_probs=174.5
Q ss_pred CCeEeecCCeeEEEEEeC-CCCEEEEEEecC----CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCC
Q 001873 771 ANVIGTGSSGVVYRVTIP-NGETLAVKKMWS----SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNG 845 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 845 (1001)
.++||+|.||+||-|+++ +|+.||||.+.+ .....++++|+.+++.++||.||.+-..|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 578999999999999865 799999998854 334478999999999999999999999999999999999999755
Q ss_pred CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC---CCcEEEecccccccccCCCCCC
Q 001873 846 SLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP---GYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 846 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
-|+-++.. ....+++....-++.||+.|++|||.+ +|+|+||||+|||+.+ .-++||||||.|+++.
T Consensus 649 MLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg------ 718 (888)
T KOG4236|consen 649 MLEMILSS-EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG------ 718 (888)
T ss_pred HHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecc------
Confidence 55555543 456688888888899999999999998 9999999999999964 3489999999999874
Q ss_pred CCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcc
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLV 983 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~ 983 (1001)
....+..++|||.|.|||++..+.|+..-|+||+|||+|--++|..||..+..-.++++
T Consensus 719 --EksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ 777 (888)
T KOG4236|consen 719 --EKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ 777 (888)
T ss_pred --hhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhh
Confidence 34567788999999999999999999999999999999999999999998765555443
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=276.77 Aligned_cols=198 Identities=23% Similarity=0.277 Sum_probs=174.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|...++||+|.||+|.+++-+ .++.||+|+++++. +...-..|-++++..+||.+..+.-.|...+..|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 56777889999999999998865 68999999886643 2244567999999999999999988899999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||..||.|.-++.+ .+.+++...+-+...|+.|+.|||++ +||+||+|.+|.++|.+|++||+|||+++.--
T Consensus 248 eyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--- 319 (516)
T KOG0690|consen 248 EYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--- 319 (516)
T ss_pred EEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc---
Confidence 99999999998876 45578888888889999999999998 99999999999999999999999999998532
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......+.+|||.|.|||++....|+.++|-|.+||+||||++|+.||...
T Consensus 320 ----~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 320 ----KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred ----cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 2334456789999999999999999999999999999999999999999753
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=268.05 Aligned_cols=216 Identities=24% Similarity=0.347 Sum_probs=174.3
Q ss_pred hcccCCCeEeecCCeeEEEEE-eCCCCEEEEEEecCC--CchhhHHHHHHHhhccCCCceeeEEeeeec-----CCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSS--DESGAFSSEIQTLGSIRHKNIVRLLGWGSN-----KNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~-----~~~~~l 837 (1001)
++|++.+.+|+|||+-||.++ ..+++.||+|++.-. ++.+...+|++..++++||||++++++... ....|+
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 689999999999999999998 557899999998543 345778899999999999999999987543 335899
Q ss_pred EEEccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 838 FYDYLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
+++|+..|+|.+.+... +...+++.++++|+.++++|+++||+. .++++||||||.||++.+.+.+++.|||.+...
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 99999999999998764 334589999999999999999999996 346999999999999999999999999998765
Q ss_pred cCCCCCC--CCCCCCCCcccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCc
Q 001873 916 SGSGDDN--CSKTNQRPQLAGSYGYMAPEHAS---MQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPL 982 (1001)
Q Consensus 916 ~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l 982 (1001)
.-.-... ....+....-..|..|+|||.+. +...++++|||||||++|+|+.|..||+.....++.+
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 3221110 00001111223678899999874 4566899999999999999999999999766544433
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=307.32 Aligned_cols=197 Identities=24% Similarity=0.335 Sum_probs=162.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecC--------CceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNK--------NLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~--------~~~~ 836 (1001)
++|++.++||+|+||+||+|... +++.||||++.... ....+|+.+++.++||||+++++++... ...+
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 57999999999999999999865 68999999885432 3456799999999999999998876321 2467
Q ss_pred EEEEccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC-cEEEecccccc
Q 001873 837 LFYDYLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY-QAYLADFGLAR 913 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~Dfgla~ 913 (1001)
+||||++ +++.+++... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||+|+
T Consensus 144 lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 8999997 5787776532 234578999999999999999999998 999999999999999664 79999999998
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.+... .......||+.|+|||++.+ ..|+.++||||+||++|||++|+.||.+..
T Consensus 220 ~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 275 (440)
T PTZ00036 220 NLLAG--------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275 (440)
T ss_pred hccCC--------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 76422 11223478999999998765 478999999999999999999999997653
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=301.27 Aligned_cols=204 Identities=27% Similarity=0.366 Sum_probs=170.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc---hhhHHHHHHHhhccC-CCceeeEEeeeecCCc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE---SGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNL 834 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~ 834 (1001)
.++|++.++||+|+||.||+|+.. .+..||||++..... .+.+.+|++++++++ ||||+++++++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457889999999999999999753 234799999864332 357889999999996 9999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhcCC-----------------------------------------------------------
Q 001873 835 KLLFYDYLPNGSLSSLLHGAG----------------------------------------------------------- 855 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 855 (1001)
.++||||+++|+|.+++++..
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999986531
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC
Q 001873 856 -----------------------------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP 900 (1001)
Q Consensus 856 -----------------------------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 900 (1001)
...+++..+.+++.|++.|++|||+. +|+||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 12367778889999999999999998 9999999999999999
Q ss_pred CCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 901 GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 901 ~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
++.+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 273 ~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSN-----YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred CCEEEEEeCCcceecccccc-----ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 99999999999986533211 111223357788999999988899999999999999999997 999997653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=284.37 Aligned_cols=201 Identities=26% Similarity=0.381 Sum_probs=173.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++|++.+.||+|+||+||+|+..++..||||.+.... ..+.+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 4688889999999999999998777789999886543 246789999999999999999999999988899999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++..... .+++..+++++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.++.......
T Consensus 84 ~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~---- 155 (256)
T cd05113 84 GCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY---- 155 (256)
T ss_pred CcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce----
Confidence 999999976433 579999999999999999999998 999999999999999999999999999886532211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.......++..|+|||...+..++.++||||||+++|||++ |+.||....
T Consensus 156 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 206 (256)
T cd05113 156 --TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN 206 (256)
T ss_pred --eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 11112235678999999988889999999999999999999 999997643
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=283.80 Aligned_cols=202 Identities=28% Similarity=0.422 Sum_probs=175.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++|++.+.||+|+||.||+|...+++.||+|.+.... ..+++.+|+.++++++||||+++++++...+..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKY 85 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccC
Confidence 5688899999999999999998778899999986543 346799999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
++|.+++.+.....+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 86 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--- 159 (261)
T cd05068 86 GSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE--- 159 (261)
T ss_pred CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc---
Confidence 9999999876545689999999999999999999998 9999999999999999999999999999876422111
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.......+..|+|||+..+..++.++||||||+++|||+| |+.||.+..
T Consensus 160 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 160 ---AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred ---ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 1111123457999999998899999999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=297.97 Aligned_cols=195 Identities=32% Similarity=0.480 Sum_probs=168.4
Q ss_pred eEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCCHHH
Q 001873 773 VIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSS 849 (1001)
Q Consensus 773 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 849 (1001)
++|+|.||+||.|++. +..++|||.+.... ..+.+..||..-++++|.|||+++|.+.+.++.-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999976 46789999985443 44778999999999999999999999999999999999999999999
Q ss_pred HhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC-CCCcEEEecccccccccCCCCCCCCCCC
Q 001873 850 LLHGA-GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG-PGYQAYLADFGLARIVSGSGDDNCSKTN 927 (1001)
Q Consensus 850 ~l~~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 927 (1001)
+++.. +.-.-.+.++--+.+||++|+.|||++ .|||||||-+||+++ -.|.+||+|||-++.+..- ..
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-------nP 731 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-------NP 731 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-------Cc
Confidence 99763 222236778888899999999999999 999999999999996 6799999999999887532 22
Q ss_pred CCCcccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 928 QRPQLAGSYGYMAPEHASM--QRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 928 ~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
...+..||..|||||++.. +.|+.++|||||||++.||.||++||-..-.
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs 783 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS 783 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC
Confidence 3345679999999999854 6799999999999999999999999987643
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=293.42 Aligned_cols=198 Identities=21% Similarity=0.301 Sum_probs=163.6
Q ss_pred CCeEeecCCeeEEEEEeC---CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeec--CCceEEEEEccCCC
Q 001873 771 ANVIGTGSSGVVYRVTIP---NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSN--KNLKLLFYDYLPNG 845 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~~g 845 (1001)
.++||+|+||+||+|+.+ +++.||+|++........+.+|+.++++++||||+++++++.. +...++||||+. +
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence 357999999999999864 4688999998766656678899999999999999999998753 456789999996 6
Q ss_pred CHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE----CCCCcEEEeccccccc
Q 001873 846 SLSSLLHGAG-------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL----GPGYQAYLADFGLARI 914 (1001)
Q Consensus 846 sL~~~l~~~~-------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~ki~Dfgla~~ 914 (1001)
+|.+++.... ...+++..+..++.|++.|++|||++ +|+||||||+||++ +.++.+||+|||+|+.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 8888875321 22478889999999999999999998 99999999999999 4567999999999987
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+..... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 162 ~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 162 FNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCCc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 643211 1122234578999999999876 568999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=293.09 Aligned_cols=200 Identities=25% Similarity=0.405 Sum_probs=167.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCC----EEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGE----TLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
.+|+..+.||+|+||+||+|++. +++ .||||++.... ..+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999864 333 48999986433 236788999999999999999999998765 4679
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
|+||+++|+|.+++.+. ...+++..+++++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.+..
T Consensus 86 v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999999999864 33478889999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
..... ......++..|+|||++....++.++|||||||++||+++ |+.||+..
T Consensus 162 ~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 162 DEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred CCcce-----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 22110 1111234678999999999999999999999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=293.58 Aligned_cols=216 Identities=25% Similarity=0.377 Sum_probs=184.2
Q ss_pred cccCCCeEeecCCeeEEEEEeCC-CCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 767 NLTSANVIGTGSSGVVYRVTIPN-GETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
+.++..+||-|.||.||.|.|+. .-.||||.++.+. +.++|..|+.+|+.++|||+|+++|+|..+..+|||+|||.+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 45667889999999999999874 6789999987654 348999999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+|+++.....++....+.++.||+.||+||..+ ++|||||..+|+|+.++..+|++|||+++.+..+.+....
T Consensus 348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence 9999999998887788888899999999999999998 9999999999999999999999999999999866543322
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCcCcccchhhhhccc
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTLPGGAPLVQWTPLMFLML 993 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~~~~~~l~~~~~~~~~~~ 993 (1001)
.. .-...|.|||.+....++.|+|||+|||++||+.| |..||-+- +-.+++...+....|.
T Consensus 425 GA------KFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi--dlSqVY~LLEkgyRM~ 486 (1157)
T KOG4278|consen 425 GA------KFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYGLLEKGYRMD 486 (1157)
T ss_pred Cc------cCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc--cHHHHHHHHhcccccc
Confidence 21 23357999999999999999999999999999998 77777553 2234445555545544
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=282.87 Aligned_cols=200 Identities=28% Similarity=0.415 Sum_probs=171.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
.+|++.+.||+|+||.||+|+++++..+|+|.+.... ...++.+|+.++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 3578889999999999999998877899999886433 345788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
++|.+++.... ..+++..+.+++.|++.|++|||+. +|+||||||+||++++++.+||+|||.++.......
T Consensus 84 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~---- 155 (256)
T cd05059 84 GCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY---- 155 (256)
T ss_pred CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc----
Confidence 99999997643 3578999999999999999999998 999999999999999999999999999876532110
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
.......++..|+|||.+.+..++.++||||||+++||+++ |+.||+..
T Consensus 156 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 156 --TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred --cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 01111124457999999998899999999999999999999 89999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=287.43 Aligned_cols=203 Identities=26% Similarity=0.463 Sum_probs=172.0
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC------CCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN------GETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
.+|++.+.||+|+||.||+|+... ...||+|.+..... ..++.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998642 25799998865432 256889999999999999999999999989999
Q ss_pred EEEEccCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC
Q 001873 837 LFYDYLPNGSLSSLLHGAGK--------------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY 902 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 902 (1001)
++|||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999975421 3468888999999999999999998 999999999999999999
Q ss_pred cEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 903 QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 903 ~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.+||+|||+++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05048 162 TVKISDFGLSRDIYSADYY-----RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231 (283)
T ss_pred cEEECCCcceeeccccccc-----cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999865332111 11222356789999999988899999999999999999998 999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=299.56 Aligned_cols=197 Identities=22% Similarity=0.299 Sum_probs=168.2
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecC-----
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK----- 832 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~----- 832 (1001)
.+.++|++.+.||+|+||.||++... .++.||||++.... ..+.+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 45688999999999999999999865 68899999986432 235678899999999999999999977543
Q ss_pred -CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccc
Q 001873 833 -NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGL 911 (1001)
Q Consensus 833 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgl 911 (1001)
...++||||++ +++.+++.. .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 35699999997 578777753 378888999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 912 ARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 912 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 173 a~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 173 ARTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred ccccCCC--------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 9864321 1123347899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=291.75 Aligned_cols=199 Identities=21% Similarity=0.310 Sum_probs=169.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++|++.+.||+|+||+||+|+.+ +++.||+|++.... ....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999865 67889999886432 224678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
++ ++|.+++.+. ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 158 (309)
T cd07872 86 LD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-- 158 (309)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence 97 5888888754 23478889999999999999999998 99999999999999999999999999987543211
Q ss_pred CCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......+|+.|+|||++.+ ..++.++||||+||++|||+||+.||....
T Consensus 159 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 159 -----KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred -----cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223367899999998754 568899999999999999999999997653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=283.18 Aligned_cols=201 Identities=29% Similarity=0.426 Sum_probs=172.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc-hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE-SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
.+|++.++||+|+||.||+|+..+...||+|++..... .+.+.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCC
Confidence 56899999999999999999987777899999875433 4678999999999999999999998754 557899999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++.+.....+++..+..++.|++.|++|+|+. +++||||||+||++++++.+||+|||.++.+......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~--- 158 (262)
T cd05071 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--- 158 (262)
T ss_pred CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc---
Confidence 9999999865445678999999999999999999998 9999999999999999999999999999866432111
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
......++..|+|||+.....++.++||||||+++|||+| |+.||....
T Consensus 159 ---~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~ 208 (262)
T cd05071 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 208 (262)
T ss_pred ---cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 1112346678999999988899999999999999999999 888987653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=288.84 Aligned_cols=198 Identities=29% Similarity=0.453 Sum_probs=170.8
Q ss_pred ccCCCeEeecCCeeEEEEEeC---CCC--EEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 768 LTSANVIGTGSSGVVYRVTIP---NGE--TLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~---~~~--~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
.+..++||.|-||.||+|..- .|+ .||||..+.+. ..+.|.+|..+|+.++|||||+++|+|.+. ..||||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 445578999999999999753 233 48889876643 347899999999999999999999999865 579999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
|.++.|.|..|++.. +..++..+...++.||+.|+.|||+. ..|||||..+|||+....-+|++|||+++.+..+.
T Consensus 470 EL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 470 ELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred ecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 999999999999875 45688888899999999999999998 99999999999999999999999999999997766
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.+..+... -...|||||.+..++++.++|||.|||+|||++. |..||.+-.
T Consensus 546 yYkaS~~k------LPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk 597 (974)
T KOG4257|consen 546 YYKASRGK------LPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK 597 (974)
T ss_pred hhhccccc------cceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc
Confidence 55543222 2357999999999999999999999999999986 999998764
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=286.97 Aligned_cols=197 Identities=26% Similarity=0.365 Sum_probs=166.4
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhcc---CCCceeeEEeeeec-----CC
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSI---RHKNIVRLLGWGSN-----KN 833 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l---~h~nIv~l~~~~~~-----~~ 833 (1001)
+|++.+.||+|+||+||+|+.. +++.||+|.+.... ....+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888899999999999999875 68999999885432 123566788877665 69999999998754 34
Q ss_pred ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccc
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~ 913 (1001)
..++||||++ ++|.+++.......+++..+..++.|++.|++|+|++ +|+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 5789999997 5899998876555689999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 157 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 157 IYSCQ--------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cccCc--------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 65321 1122346899999999998889999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=294.86 Aligned_cols=193 Identities=32% Similarity=0.403 Sum_probs=168.4
Q ss_pred hcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCC----c-hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSD----E-SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~----~-~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
+.|.-.+.||.|+||.||.+++ ++.+.||||++.-.. + ..++..|+..+++++|||++.+.|+|-.+...|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 4566677899999999999985 478999999984322 1 257899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
|||- |+-.|++.-+ ++++.+..+..|..+.++|+.|||+. +.||||||+.|||+++.|.||++|||.|..+.+.
T Consensus 106 EYCl-GSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 106 EYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HHHh-ccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 9996 7888887655 45678888999999999999999998 9999999999999999999999999999876533
Q ss_pred CCCCCCCCCCCcccccccccCcccc---ccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHA---SMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
..++|||.|||||++ ..+.|+-++||||+|++..|+.-+++|+-.
T Consensus 180 ----------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn 227 (948)
T KOG0577|consen 180 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 227 (948)
T ss_pred ----------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC
Confidence 346899999999986 458899999999999999999999999643
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=298.72 Aligned_cols=198 Identities=25% Similarity=0.341 Sum_probs=167.9
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCC-----ceE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN-----LKL 836 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~-----~~~ 836 (1001)
+|++.+.||+|+||+||+++.. +++.||||++.... ..+++.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999864 78999999885432 2357889999999999999999999988766 789
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
+||||+. ++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+|+...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 6888888653 4589999999999999999999998 99999999999999999999999999998653
Q ss_pred CCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
... ........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..
T Consensus 155 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 155 PDE------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred cCc------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 221 112223468899999999876 457899999999999999999999997653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=286.97 Aligned_cols=202 Identities=26% Similarity=0.448 Sum_probs=172.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC------CCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN------GETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
+.|.+.+.||+|+||.||+|+..+ ++.||||.+..... .+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 467888999999999999998643 47899999865433 367899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcE
Q 001873 837 LFYDYLPNGSLSSLLHGAG------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQA 904 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 904 (1001)
+||||+++++|.++++..+ ...+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999997543 23467888999999999999999998 99999999999999999999
Q ss_pred EEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 905 YLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 905 ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
||+|||.++.+...... .......+++.|+|||++.+..++.++||||+||++|||++ |+.||...
T Consensus 162 kl~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 162 KIGDFGMSRDVYTTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred EECCcccceecccCcce-----ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999765322111 11122346788999999999999999999999999999999 99998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=300.72 Aligned_cols=199 Identities=26% Similarity=0.292 Sum_probs=171.4
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC---CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP---NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
..+|++.+.||+|+||.||++... .+..||||.+... +...+|++++++++||||+++++++......++|||+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 457999999999999999998753 3678999987543 3467899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+. ++|.+++.. ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 168 ~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~- 240 (392)
T PHA03207 168 YK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD- 240 (392)
T ss_pred cC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccc-
Confidence 96 789998854 34589999999999999999999998 999999999999999999999999999976543211
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
........||+.|+|||++....++.++||||+||++|||++|+.||.+...
T Consensus 241 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 241 ----TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred ----cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 1122345799999999999999999999999999999999999999976543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=313.26 Aligned_cols=200 Identities=26% Similarity=0.307 Sum_probs=176.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC-----CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS-----SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|.++++||+|+||.|..++++ +++.||+|++.+ ..+..-|..|=.+|..-+.+-|+.++-.|.++.+.|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 367999999999999999999976 588999998854 34556799999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
||||+||+|-.++.+.+ .+++..++-++..|+-|+.-+|+. |+|||||||+|||+|..|++|++|||.+-.+..+
T Consensus 154 MdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 99999999999999865 588888888899999999999998 9999999999999999999999999998877654
Q ss_pred CCCCCCCCCCCCcccccccccCccccc----c-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHAS----M-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+.- .....+|||.|.+||++. + +.|+..+|-||+||++|||+.|..||...
T Consensus 229 G~V------~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 229 GTV------RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred CcE------EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 332 233458999999999874 2 67899999999999999999999999643
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=297.74 Aligned_cols=197 Identities=22% Similarity=0.290 Sum_probs=168.1
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecC-----
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK----- 832 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~----- 832 (1001)
.+.++|++.+.||+|+||.||++... .++.||||++.... ..+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 46789999999999999999999864 68999999986432 235677899999999999999999987543
Q ss_pred -CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccc
Q 001873 833 -NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGL 911 (1001)
Q Consensus 833 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgl 911 (1001)
...++||||++ +++.+.+.. .+++..+..++.|+++|++|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 34689999997 567777653 378888999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 912 ARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 912 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 166 ~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 166 ARTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred cccCCCc--------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9864321 1223347899999999999989999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=281.83 Aligned_cols=201 Identities=27% Similarity=0.426 Sum_probs=173.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
.+|++.+.||+|+||.||+|..+ .++.||+|.+.... ..+++.+|++++++++||||+++++++..++..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 45778889999999999999865 58899999886543 23678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+++|.+++.......+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+.........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-- 160 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-- 160 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee--
Confidence 99999999876556689999999999999999999998 9999999999999999999999999999876432111
Q ss_pred CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 161 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 209 (263)
T cd05052 161 ----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 209 (263)
T ss_pred ----ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 1112234678999999988899999999999999999998 99998754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=291.57 Aligned_cols=203 Identities=23% Similarity=0.260 Sum_probs=167.6
Q ss_pred CCCeEeec--CCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 770 SANVIGTG--SSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 770 ~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
+.++||+| +|++||+++.+ +++.||||++.... ..+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 78899999864 78999999986542 2246778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
++|+|.+++.......+++..+.+++.|++.|++|||+. +|+||||||+||+++.++.++++||+.+......+...
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999765445689999999999999999999998 99999999999999999999999998765443221111
Q ss_pred CCCCCCCCcccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASM--QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
...........++..|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 111111223357788999999865 46889999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=280.54 Aligned_cols=200 Identities=30% Similarity=0.429 Sum_probs=175.1
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+|++.+.||+|+||.||+|+.+ +++.||+|.+... ...+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3677889999999999999875 6899999987532 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++++|.++++......+++..+.+++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.++.+....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-- 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-- 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence 9999999999876455688999999999999999999998 99999999999999999999999999988664321
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......|++.|+|||+..+..++.++|+||||+++|||++|+.||....
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 156 -----NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred -----chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 11223468889999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=247.84 Aligned_cols=217 Identities=25% Similarity=0.359 Sum_probs=179.3
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+|...++||+|.||+||+|+.+ +++.||+|++.-+++ .....+||.+++.++|.|||+++++...++..-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556678999999999999954 689999999865433 25688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
|+ .+|..|.... +..++.+.++.++.|+++|+.++|++ ++.|||+||+|.+++.+|+.|++|||+|+-+.-+
T Consensus 83 cd-qdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip--- 154 (292)
T KOG0662|consen 83 CD-QDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--- 154 (292)
T ss_pred hh-HHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc---
Confidence 96 6899998765 45689999999999999999999998 9999999999999999999999999999876422
Q ss_pred CCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCcCcccchhhhhcccchhhhc
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLT-GRHPLDPTLPGGAPLVQWTPLMFLMLNLEAEQ 999 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~~~~~~l~~~~~~~~~~~~~~~~~ 999 (1001)
.......+-|.+|.+|+++-+ +-|+...|+||-|||+.|+.. |+ +.+|+.+-.+|..+++...|.+.+|+
T Consensus 155 ----vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagr----plfpg~dvddqlkrif~~lg~p~ed~ 226 (292)
T KOG0662|consen 155 ----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR----PLFPGNDVDDQLKRIFRLLGTPTEDQ 226 (292)
T ss_pred ----eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCC----CCCCCCcHHHHHHHHHHHhCCCcccc
Confidence 122223367899999998865 568899999999999999986 65 34555566666666666666555543
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=280.23 Aligned_cols=202 Identities=26% Similarity=0.404 Sum_probs=173.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccC
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
.+.|++.++||+|+||.||+|..++++.||+|.+.... ..+++.+|+.++++++|+||+++++++. .+..++||||++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 35788999999999999999998889999999886543 3468999999999999999999999874 456799999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+++|.+++.......+++.++..++.|++.|++|||+. +++||||||+||++++++.++++|||.+........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--- 157 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY--- 157 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc---
Confidence 99999999876556689999999999999999999998 999999999999999999999999999976542111
Q ss_pred CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.......++..|+|||++....++.++||||||+++||+++ |+.||....
T Consensus 158 ---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 158 ---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred ---ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 11112245678999999988889999999999999999999 999997543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=296.83 Aligned_cols=190 Identities=26% Similarity=0.308 Sum_probs=160.1
Q ss_pred EeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhcc---CCCceeeEEeeeecCCceEEEEEccCC
Q 001873 774 IGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSI---RHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 774 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l---~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
||+|+||+||+|+.. +++.||||++.... +...+..|..++.+. +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 68999999985321 223445566666655 699999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++.+. ..+++..+..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~------ 149 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTD------ 149 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC------
Confidence 9999998763 4589999999999999999999998 9999999999999999999999999998753211
Q ss_pred CCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 150 -NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred -CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 112234579999999999865 45889999999999999999999999764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=279.85 Aligned_cols=200 Identities=30% Similarity=0.454 Sum_probs=172.1
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++|++.++||+|+||.||+|...++..||+|.+.... ..+.+.+|+.++++++|+||+++++++.. ...+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCC
Confidence 5788999999999999999998888899999986543 34679999999999999999999998754 557899999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
++|.+++++.....+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|||.+..+......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~--- 158 (260)
T cd05070 85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT--- 158 (260)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc---
Confidence 9999999875555689999999999999999999998 9999999999999999999999999999865432111
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
......++..|+|||......++.++||||||+++|||++ |+.||...
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 207 (260)
T cd05070 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred ---cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 1112235568999999988889999999999999999999 89999764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=268.54 Aligned_cols=199 Identities=23% Similarity=0.345 Sum_probs=169.4
Q ss_pred HHhcccCC-CeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhcc-CCCceeeEEeeee----cCCceE
Q 001873 764 VVRNLTSA-NVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSI-RHKNIVRLLGWGS----NKNLKL 836 (1001)
Q Consensus 764 ~~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~----~~~~~~ 836 (1001)
++++|++. ++||-|-.|+|-....+ +++++|+|++. +....++|++.--+. .|||||.+++++. ......
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~---Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL---DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh---cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 45566654 57999999999886654 79999999984 344567888874444 7999999999764 456778
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC---CCCcEEEecccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG---PGYQAYLADFGLAR 913 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~ki~Dfgla~ 913 (1001)
+|||.|+||.|.+.+++++...+++.++.+|+.||+.|+.|||+. .|.||||||+|+|.. .+..+|++|||+|+
T Consensus 136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccccc
Confidence 999999999999999999888899999999999999999999998 999999999999996 45689999999998
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.-.. .....+.+-||.|.|||++...+|+...|+||+||+||-|++|.+||....
T Consensus 213 ~t~~--------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h 267 (400)
T KOG0604|consen 213 ETQE--------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_pred ccCC--------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC
Confidence 6432 233445588999999999999999999999999999999999999997653
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=295.12 Aligned_cols=198 Identities=22% Similarity=0.316 Sum_probs=168.7
Q ss_pred HHHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecC---
Q 001873 761 IDDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK--- 832 (1001)
Q Consensus 761 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~--- 832 (1001)
..++.++|++.+.||+|+||+||+|... +++.||||++.... ..+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 3456788999999999999999999864 68899999986432 225677899999999999999999877532
Q ss_pred ---CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecc
Q 001873 833 ---NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADF 909 (1001)
Q Consensus 833 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Df 909 (1001)
...++++|++ +++|.++++. ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+||
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3568999988 7899988863 3589999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 910 gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
|+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 163 g~~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 163 GLARQADDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred ccceecCCC----------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 999865321 223468999999999876 57889999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=279.05 Aligned_cols=196 Identities=30% Similarity=0.455 Sum_probs=171.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeee-ecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWG-SNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~-~~~~~~~lv~e~~~~ 844 (1001)
++|++.+.||+|+||.||+++.+ +..||+|.+......+.+.+|+.++++++|+||+++++++ ...+..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 46888999999999999999874 7889999987766667899999999999999999999975 455678999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
++|.+++++.+....++..+.+++.|++.|++|||++ +++||||||+||++++++.+|++|||+++......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----- 156 (256)
T cd05082 85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 156 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-----
Confidence 9999999876555688999999999999999999998 99999999999999999999999999987643211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
....++..|+|||++....++.++|||||||++|||++ |+.||...
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~ 203 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 11234568999999988889999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=306.39 Aligned_cols=197 Identities=19% Similarity=0.257 Sum_probs=163.1
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-chhhHHHHHHHhhccCC------CceeeEEeeeecC-Cce
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-ESGAFSSEIQTLGSIRH------KNIVRLLGWGSNK-NLK 835 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h------~nIv~l~~~~~~~-~~~ 835 (1001)
.++|++.++||+|+||+||+|... .++.||||++.... ..+.+..|+++++.++| ++++++++++... +..
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 468999999999999999999865 57899999985432 23456678887777654 4588999988654 578
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC-------------
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY------------- 902 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~------------- 902 (1001)
++|||++ +++|.+++.+. ..+++..+..|+.||+.||+|||++ .+||||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred EEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 8999988 78999998764 3588999999999999999999973 2999999999999998665
Q ss_pred ---cEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 903 ---QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 903 ---~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.+||+|||.+.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||++..
T Consensus 283 ~~~~vkl~DfG~~~~~~----------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER----------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred CCceEEECCCCccccCc----------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999875421 12234579999999999999999999999999999999999999998643
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=254.33 Aligned_cols=207 Identities=25% Similarity=0.339 Sum_probs=167.5
Q ss_pred ccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEEEcc
Q 001873 768 LTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
......||+|+||.|-+.++. +|..+|||++.... +.++..+|+.+..+. .+|.+|.|+|...+++..|+.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 344567999999999998864 79999999986543 346677888885554 7999999999998999999999999
Q ss_pred CCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 843 PNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 843 ~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
+ .||..+-++. ....+++...-+||..+.+|+.|||++ ..|+|||+||+|||++.+|++||||||.+..+...
T Consensus 128 ~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS-- 202 (282)
T KOG0984|consen 128 D-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS-- 202 (282)
T ss_pred h-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhh--
Confidence 6 6887776542 234578888889999999999999998 48999999999999999999999999999876432
Q ss_pred CCCCCCCCCCcccccccccCccccc----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccc
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHAS----MQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQW 985 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~ 985 (1001)
-..+...|...|||||.+. ...|+.++||||+|+.+.||.+++.||+.-..+=.++.|-
T Consensus 203 ------iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 203 ------IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred ------hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 1222235778999999873 3589999999999999999999999998655443444333
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=281.93 Aligned_cols=201 Identities=29% Similarity=0.427 Sum_probs=176.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc--hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE--SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
.+|++.++||+|+||.||+|+..+++.||+|.+..... ..++.+|+.+++.++||||+++++++...+..++||||++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 46888999999999999999988899999999865543 4678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+++|.+++++.....+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||.+........
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~--- 159 (261)
T cd05148 86 KGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY--- 159 (261)
T ss_pred cCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc---
Confidence 99999999876556689999999999999999999998 999999999999999999999999999986532211
Q ss_pred CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
......++..|+|||......++.++||||||+++|+|++ |+.||....
T Consensus 160 ----~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 160 ----LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred ----cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 1112245678999999988899999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=287.95 Aligned_cols=205 Identities=26% Similarity=0.409 Sum_probs=177.3
Q ss_pred ccHHHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCce
Q 001873 759 FSIDDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 759 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~ 835 (1001)
.++.+..++|+..+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|+.+++.++||||+++++.+......
T Consensus 13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 344555678999999999999999999864 68999999886433 336788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
++||||+++++|.+++.+ ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 93 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred EEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 999999999999999974 3478889999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.... .......|++.|+|||.+....++.++|||||||++|+|++|+.||....
T Consensus 167 ~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 167 TPEQ-------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred cccc-------cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 3221 11223468899999999988888999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=284.09 Aligned_cols=202 Identities=25% Similarity=0.446 Sum_probs=170.5
Q ss_pred hcccCCCeEeecCCeeEEEEEe-----CCCCEEEEEEecCCCch---hhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI-----PNGETLAVKKMWSSDES---GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~---~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
+.|++.+.||+|+||+||+|+. ..+..||+|.+...... +++.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4578889999999999999974 24688999998653322 568899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC
Q 001873 838 FYDYLPNGSLSSLLHGAG---------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY 902 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 902 (1001)
||||+++++|.+++.... ...+++.++..++.|++.|++|||++ +|+||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999985321 12467888899999999999999998 999999999999999999
Q ss_pred cEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 903 QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 903 ~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||.+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 162 HVKISDLGLSREIYSADYY-----RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred cEEeccccccccccCCcce-----ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999876432211 11222345678999999988889999999999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=283.04 Aligned_cols=204 Identities=25% Similarity=0.373 Sum_probs=170.6
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCce
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~ 835 (1001)
.++|++.+.||+|+||.||+|.+. .+..||||++.... ...++.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 467999999999999999998753 35679999885433 235688999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCC--------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEe
Q 001873 836 LLFYDYLPNGSLSSLLHGAGK--------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLA 907 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~ 907 (1001)
++||||+++|+|.+++++... ...++..+..++.|++.|++|||+. +++||||||+||++++++.+|++
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEEC
Confidence 999999999999999975321 2357788899999999999999998 99999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 908 DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 908 Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
|||+++......... ......+++.|+|||++....++.++|||||||++|||++ |..||.+..
T Consensus 162 dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 162 DFGMTRDIYETDYYR-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred CCCCccccCCcceee-----cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999987653321111 1112345788999999988889999999999999999999 788987653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=283.55 Aligned_cols=198 Identities=36% Similarity=0.572 Sum_probs=166.2
Q ss_pred CCCeEeecCCeeEEEEEeC-----CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 770 SANVIGTGSSGVVYRVTIP-----NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 770 ~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
..+.||+|+||.||+|++. .+..|+||.+..... .+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4568999999999999975 367899999965433 36899999999999999999999999988889999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++|+|.++++......+++..+.+|+.||+.||.|||++ +++|+||+++||++++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~- 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK- 158 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-
T ss_pred cccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc-
Confidence 9999999999987556789999999999999999999998 999999999999999999999999999987622111
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
........+...|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 159 ----~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 159 ----YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp ----EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred ----ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 111222346778999999998889999999999999999999 78898654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=281.96 Aligned_cols=192 Identities=27% Similarity=0.361 Sum_probs=168.0
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
+|+..+.||+|+||.||+|... +++.||+|.+.... ..+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5788899999999999999864 68999999885432 2256889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
++++|..+. ..++..+..++.|++.|+.|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 999997653 267888889999999999999998 9999999999999999999999999999765321
Q ss_pred CCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......||..|+|||++.+..++.++||||+|+++|+|++|+.||....
T Consensus 149 -----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 197 (279)
T cd06619 149 -----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQ 197 (279)
T ss_pred -----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhc
Confidence 1223478999999999998899999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=291.50 Aligned_cols=203 Identities=28% Similarity=0.381 Sum_probs=168.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc---hhhHHHHHHHhhcc-CCCceeeEEeeeec-CCc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE---SGAFSSEIQTLGSI-RHKNIVRLLGWGSN-KNL 834 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~-~~~ 834 (1001)
++|++.+.||+|+||.||+|... +++.||+|++..... .+.+.+|+.+++++ +|+||+++++++.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 47899999999999999998632 357899999865432 24677899999999 89999999998764 456
Q ss_pred eEEEEEccCCCCHHHHhhcCCC----------------------------------------------------------
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGK---------------------------------------------------------- 856 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 856 (1001)
.+++|||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999999864321
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCCCCCccccc
Q 001873 857 -GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGS 935 (1001)
Q Consensus 857 -~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt 935 (1001)
..+++..+.+++.||+.|++|||+. +|+||||||+||++++++++||+|||+++.+...... .......++
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-----~~~~~~~~~ 238 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-----VRKGDARLP 238 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-----hhccCCCCC
Confidence 2568889999999999999999998 9999999999999999999999999999876432211 112233566
Q ss_pred ccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 936 YGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 936 ~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
..|+|||++.+..++.++||||+||++|||++ |+.||.+..
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~ 280 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence 78999999999999999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=285.54 Aligned_cols=205 Identities=27% Similarity=0.423 Sum_probs=178.1
Q ss_pred cHHHHHhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceE
Q 001873 760 SIDDVVRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 760 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
+..+..++|++.+.||+|+||.||++.. .+++.||+|.+.... ..+.+.+|+.+++.++||||+++++++...+..+
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence 4456678999999999999999999986 479999999886433 3356888999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
+||||+++++|.+++.+ ...++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.+....
T Consensus 93 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred EeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999999999974 3478889999999999999999998 99999999999999999999999999987653
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
... .......+++.|+|||...+..++.++||||+||++|++++|+.||....+
T Consensus 167 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 167 PEQ-------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred CCc-------cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 221 112234688999999999988899999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=279.24 Aligned_cols=199 Identities=23% Similarity=0.317 Sum_probs=174.3
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
+|++.+.||+|+||.||+++.. +++.||+|.+.... ..+.+.+|+.+++.++||||+++++.+.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999865 68999999875432 3367888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
++|+|.+++.......+++..+..++.|++.|+.|||+. +|+|+||||+||++++++.++++|||.++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 999999998765555678999999999999999999998 999999999999999999999999999976543211
Q ss_pred CCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......|++.|+|||++.+..++.++|+||+|+++|+|++|+.||...
T Consensus 156 -----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 203 (255)
T cd08219 156 -----YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203 (255)
T ss_pred -----ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC
Confidence 122346889999999998888999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=287.96 Aligned_cols=196 Identities=21% Similarity=0.306 Sum_probs=162.1
Q ss_pred CeEeecCCeeEEEEEeC---CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeee--cCCceEEEEEccCCCC
Q 001873 772 NVIGTGSSGVVYRVTIP---NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGS--NKNLKLLFYDYLPNGS 846 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~--~~~~~~lv~e~~~~gs 846 (1001)
.+||+|+||+||+|+.+ ++..||+|++........+.+|+.++++++||||+++++++. .+...++||||++ ++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~ 85 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HD 85 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-Cc
Confidence 57999999999999864 457899999876665667889999999999999999999874 3557789999996 58
Q ss_pred HHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE----CCCCcEEEecccccccc
Q 001873 847 LSSLLHGA-------GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL----GPGYQAYLADFGLARIV 915 (1001)
Q Consensus 847 L~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~ki~Dfgla~~~ 915 (1001)
|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||++ +.++++||+|||+++..
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 88877532 122468889999999999999999998 99999999999999 56679999999999876
Q ss_pred cCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
..... .........||+.|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus 163 ~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 163 NSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCcc----cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 43221 1112234578999999999866 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=283.79 Aligned_cols=203 Identities=24% Similarity=0.424 Sum_probs=171.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc--hhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE--SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
.+|.+.+.||+|+||+||++... ++..||+|.+..... .+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46888999999999999999742 345689998865432 3578999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEE
Q 001873 838 FYDYLPNGSLSSLLHGAG-----------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYL 906 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki 906 (1001)
||||+++++|.+++...+ ...+++..+..++.|++.|++|||++ +++||||||+||++++++.+|+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999997542 12478999999999999999999998 9999999999999999999999
Q ss_pred ecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 907 ADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 907 ~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 162 ~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 162 GDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred ccCCccccccCCcee-----ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999865332111 11122345778999999998899999999999999999998 999997653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=286.17 Aligned_cols=196 Identities=27% Similarity=0.400 Sum_probs=171.1
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
+|++.+.||+|+||.||+++.. ++..||+|.+..... ..++.+|++++++++||||+++++++.+++..++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 5888999999999999999865 578899998754422 256889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
++++|.++++.. ..+++..+..++.|++.|+.|||+.+ +++||||||+||+++.++.+||+|||.+......
T Consensus 82 ~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 153 (308)
T cd06615 82 DGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 153 (308)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc----
Confidence 999999999864 44788999999999999999999742 8999999999999999999999999998754321
Q ss_pred CCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 154 -----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred -----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 122346889999999998888999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=278.55 Aligned_cols=203 Identities=32% Similarity=0.475 Sum_probs=174.0
Q ss_pred cccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC--------chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD--------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
+|+..+.||+|+||+||+|...+++.||||.+.... ..+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999998889999999875432 124588899999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++++|.+++.+. ..+++..+..++.|++.|++|+|+. +|+|+||||+||++++++.++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999999764 3478889999999999999999998 9999999999999999999999999998865322
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.... ..........|+..|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus 156 ~~~~-~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 211 (265)
T cd06631 156 GLHG-THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211 (265)
T ss_pred cccc-cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence 1111 1112223446899999999999888999999999999999999999999754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=279.44 Aligned_cols=199 Identities=26% Similarity=0.352 Sum_probs=171.4
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 357999999999999999999964 68899999885432 335688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++++|.+++++. ..+++..+..++.|++.|++|||+. +|+|||+||+||+++.++.+||+|||+++.+....
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06646 88 CGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-- 160 (267)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence 9999999998753 3578999999999999999999998 99999999999999999999999999998763221
Q ss_pred CCCCCCCCCcccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHAS---MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......|++.|+|||.+. ...++.++||||+||++|||++|+.||...
T Consensus 161 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 161 -----AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred -----cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 1122346889999999874 455788999999999999999999998644
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=312.46 Aligned_cols=204 Identities=25% Similarity=0.372 Sum_probs=167.9
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeec--CCceE
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSN--KNLKL 836 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~--~~~~~ 836 (1001)
...+|++.+.||+|+||+||+++.. .++.||+|.+.... ....+.+|+.++++++|||||++++++.. ...+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 4568999999999999999999975 57789999875432 23578899999999999999999998754 45689
Q ss_pred EEEEccCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeEEeCCCCCCeEECC----------
Q 001873 837 LFYDYLPNGSLSSLLHGAG--KGGADWEARYEVVLGVAHALAYLHHDCM----PPILHGDVKAMNVLLGP---------- 900 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~yLH~~~~----~~ivH~Dlkp~NIll~~---------- 900 (1001)
+||||+++|+|.+++.... ...+++..++.|+.||+.||.|||+... .+||||||||+|||++.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999997532 2458999999999999999999998421 25999999999999964
Q ss_pred -------CCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCC
Q 001873 901 -------GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM--QRITEKSDVYSFGVVLLEVLTGRHP 971 (1001)
Q Consensus 901 -------~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~elltg~~P 971 (1001)
.+.+||+|||++..+... .......||+.|+|||++.. ..++.++||||||||+|||+||+.|
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~--------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIE--------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccCCCCceEEccCCcccccccc--------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 235899999999865321 11223479999999998853 5688999999999999999999999
Q ss_pred CCCC
Q 001873 972 LDPT 975 (1001)
Q Consensus 972 f~~~ 975 (1001)
|...
T Consensus 243 F~~~ 246 (1021)
T PTZ00266 243 FHKA 246 (1021)
T ss_pred CCcC
Confidence 9753
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=277.57 Aligned_cols=201 Identities=28% Similarity=0.420 Sum_probs=171.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++|++.+.||+|+||.||+|+...+..||+|++.... ..+.+.+|++++++++|||++++++++.. +..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCC
Confidence 4688889999999999999998777789999876533 34678999999999999999999998754 567899999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
++|.+++++......++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||.++.......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~---- 157 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY---- 157 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc----
Confidence 9999999875555678999999999999999999998 999999999999999999999999999976532211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.......++..|+|||...+..++.++||||||+++|||+| |+.||....
T Consensus 158 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 208 (260)
T cd05069 158 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV 208 (260)
T ss_pred --cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 11112245678999999988889999999999999999999 999997653
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=280.92 Aligned_cols=201 Identities=25% Similarity=0.379 Sum_probs=166.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCC----EEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGE----TLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
++|++.+.||+|+||+||+|.+. +++ .||+|.+..... ..++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46788899999999999999864 344 477887753322 2567778889999999999999998764 45678
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
++||+++|+|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.++....
T Consensus 86 i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 99999999999999764 24579999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.... .......++..|+|||.+....++.++||||||+++||+++ |+.||.+..
T Consensus 162 ~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 162 DDKK-----YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred CCcc-----cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 2211 11123356778999999988899999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=281.03 Aligned_cols=201 Identities=26% Similarity=0.371 Sum_probs=170.7
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-chhhHHHHHHHhhcc-CCCceeeEEeeeecC------Cce
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNK------NLK 835 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~------~~~ 835 (1001)
...|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 456888889999999999999865 58899999885433 346788999999998 799999999987642 457
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
++||||+++++|.+++.......+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||++...
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 8999999999999999876556688999999999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHAS-----MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.... .......|++.|+|||++. ...++.++||||+||++|||++|+.||+..
T Consensus 162 ~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 162 DRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred cccc-------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 3211 1223456899999999885 346788999999999999999999999754
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=277.92 Aligned_cols=201 Identities=28% Similarity=0.425 Sum_probs=171.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC----CCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN----GETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
++|++.+.||+|+||+||+|+++. ...||||.+..... ..++.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 468899999999999999998742 45799998865432 25688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++++|.+++.... ..+++..+.+++.|++.|++|||+. +|+||||||+||++++++.+|++|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999997643 3579999999999999999999998 9999999999999999999999999999876421
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 160 ~~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~ 212 (266)
T cd05033 160 EATY-----TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred ccce-----eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence 1110 1112235678999999998899999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=278.07 Aligned_cols=202 Identities=30% Similarity=0.446 Sum_probs=175.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccC
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
.++|++.++||+|+||.||+|..++++.||||.+.... ..+++.+|+.++++++|+||+++++++......++||||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 46789999999999999999998888899999986543 34689999999999999999999999998889999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+++|.+++.+.....+++..+..++.|++.|+.|||+. +++||||||+||++++++.+|++|||.++.+.....
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~--- 158 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY--- 158 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh---
Confidence 99999999876556689999999999999999999998 999999999999999999999999999886542111
Q ss_pred CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
.......++..|+|||.+.+..++.++||||+|+++||+++ |+.||.+.
T Consensus 159 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 159 ---TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred ---hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11111234568999999998889999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=280.63 Aligned_cols=196 Identities=33% Similarity=0.509 Sum_probs=171.5
Q ss_pred ccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchh----hHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 768 LTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESG----AFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
|++.+.||+|+||+||+++.. +++.||+|++....... ...+|+.++++++||||+++++++.++...++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 677889999999999999976 46689999997765442 2345999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
++++|.+++.. ...+++..+..++.|+++|++|||+. +|+||||||+||++++++.++|+|||.+.....
T Consensus 81 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~----- 150 (260)
T PF00069_consen 81 PGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE----- 150 (260)
T ss_dssp TTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-----
T ss_pred ccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-----
Confidence 99999999983 34579999999999999999999998 999999999999999999999999999875411
Q ss_pred CCCCCCCCcccccccccCccccc-cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHAS-MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.........++..|+|||++. ...++.++||||+|+++|+|++|+.||...
T Consensus 151 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 151 --NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp --TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred --cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 112233457899999999998 888999999999999999999999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=276.91 Aligned_cols=201 Identities=27% Similarity=0.418 Sum_probs=172.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-------chhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
+.|+..+.||+|+||.||.+... ++++||+|.+.... ..+.+.+|+.++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999864 68999999875332 12468889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
|+||+++++|.+++... ..+++..+.+++.|++.|+.|||+. +|+||||||+||++++++.++|+|||.++....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999999764 3478888999999999999999998 999999999999999999999999999976533
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
... .........|+..|+|||+..+..++.++||||+|+++|||++|+.||...
T Consensus 157 ~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 157 ICS----SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred ccc----ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 211 111112345788999999999888999999999999999999999999653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=297.35 Aligned_cols=194 Identities=25% Similarity=0.312 Sum_probs=167.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
..|.+.+.||+|+||.||++.+. .++.||||... ...+.+|++++++++|+|||++++++...+..++|||++.
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 46889999999999999999976 57899999642 2356789999999999999999999999999999999995
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 244 ~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~---- 315 (461)
T PHA03211 244 SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS---- 315 (461)
T ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc----
Confidence 7899888653 23589999999999999999999998 999999999999999999999999999986543211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~ 973 (1001)
........||+.|+|||++.+..++.++|||||||++|||++|..|+-
T Consensus 316 -~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 316 -TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred -cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 111224579999999999999999999999999999999999887653
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=287.52 Aligned_cols=199 Identities=26% Similarity=0.362 Sum_probs=176.5
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
+..|.+.+.||+|.|++|.+|++. ++..||+|.+.+..- .+.+.+|+++|..++|||||+++.+...+...|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467889999999999999999865 699999998855431 245889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+.+|.+++|+.+++. ..+..+..++.|+.+|++|+|++ .|||||||++||+++.++++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~- 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG- 208 (596)
T ss_pred EeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc-
Confidence 99999999999998654 45577888899999999999999 9999999999999999999999999999887532
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRI-TEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
....+.+|++.|.|||++.+..| ++++|+||+|+++|-++.|..||++..
T Consensus 209 -------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 209 -------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred -------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 33445689999999999998877 489999999999999999999999754
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=281.76 Aligned_cols=196 Identities=29% Similarity=0.377 Sum_probs=173.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||.||++... +++.||+|++... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888999999999999999865 6899999988542 22356889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999999764 4588999999999999999999998 9999999999999999999999999998865322
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||....
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 223468899999999988888999999999999999999999997543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=279.26 Aligned_cols=200 Identities=25% Similarity=0.337 Sum_probs=172.0
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+|++++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999865 68999999874321 2246889999999999999999999999889999999
Q ss_pred EccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 840 DYLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||+++|+|.+++... ....+++..+..++.|++.|++|||++ +++||||||+||+++.++.++|+|||.+..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988642 234478899999999999999999998 999999999999999999999999999887532
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.. .......|++.|+|||.+.+..++.++||||+|+++|||++|+.||...
T Consensus 159 ~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 159 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hh-------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 21 1112346888999999998888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=281.55 Aligned_cols=203 Identities=25% Similarity=0.452 Sum_probs=171.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCch--hhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDES--GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
++|.+.+.||+|+||.||+|+.. ++..||+|.+...... +.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999742 3456899988654432 578999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCc
Q 001873 838 FYDYLPNGSLSSLLHGAG--------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQ 903 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 903 (1001)
||||+++++|.+++.... ...+++..+.+++.|++.|++|||++ +|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999997542 23478899999999999999999998 9999999999999999999
Q ss_pred EEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 904 AYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 904 ~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
+||+|||++........ ........++..|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 162 ~~l~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 162 VKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred EEECCCCcccccCCCce-----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999976533211 111223356789999999998899999999999999999999 999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=274.83 Aligned_cols=199 Identities=25% Similarity=0.347 Sum_probs=174.3
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+|+..++||+|+||.||.++.. +++.||+|++... ...+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4888999999999999998854 6899999987533 2335788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++++|.+++.+.....+++..+..++.|++.|+.|||+. +++||||||+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999875445679999999999999999999998 999999999999999999999999999986543221
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......|++.|+|||...+..++.++||||+|+++|||++|+.||+..
T Consensus 157 ------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08221 157 ------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204 (256)
T ss_pred ------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence 122346899999999998888899999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=276.37 Aligned_cols=201 Identities=26% Similarity=0.433 Sum_probs=173.2
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccC
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
.++|++.+.||+|+||.||+|+..++..||+|.+.... ..+.+.+|++++++++|+||+++++.+.+ ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 36788999999999999999998778889999886543 34678999999999999999999998877 67899999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+++|.+++........++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 157 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY--- 157 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc---
Confidence 99999999876555678899999999999999999998 999999999999999999999999999976532211
Q ss_pred CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
.......++..|+|||++....++.++|+|||||++|+++| |+.||...
T Consensus 158 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 158 ---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred ---ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 11112245678999999988889999999999999999999 99999764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=276.35 Aligned_cols=200 Identities=26% Similarity=0.371 Sum_probs=176.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC-CCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN-GETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++|+..+.||+|+||.||+|+..+ ++.||+|.+......+++.+|++++++++||||+++++++.+....++++||+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 468889999999999999999764 7899999987655567899999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
++|.+++... ...+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||++........
T Consensus 83 ~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 154 (256)
T cd06612 83 GSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA---- 154 (256)
T ss_pred CcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc----
Confidence 9999999754 34579999999999999999999998 999999999999999999999999999987643211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 155 ---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred ---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 1223457889999999988899999999999999999999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=275.85 Aligned_cols=196 Identities=31% Similarity=0.467 Sum_probs=171.1
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNG 845 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 845 (1001)
++|++.+.||+|+||.||++.. .++.||+|++......+.+.+|+.++++++||||+++++++...+ .++||||++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCC
Confidence 5688999999999999999875 688999999876666678999999999999999999999887654 68999999999
Q ss_pred CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCC
Q 001873 846 SLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSK 925 (1001)
Q Consensus 846 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 925 (1001)
+|.+++.......+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.+||+|||.++......
T Consensus 84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~------ 154 (254)
T cd05083 84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV------ 154 (254)
T ss_pred CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC------
Confidence 999999876555689999999999999999999998 99999999999999999999999999987642211
Q ss_pred CCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 926 TNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 926 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.....+..|+|||.+.+..++.++||||+|+++|||++ |+.||....
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 202 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence 11123467999999988899999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=279.35 Aligned_cols=199 Identities=25% Similarity=0.358 Sum_probs=171.2
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 356888889999999999999864 68999999886543 234678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++++|.+++... ..+++.++..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.+.......
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 88 CGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 9999999998764 3588999999999999999999998 99999999999999999999999999987653211
Q ss_pred CCCCCCCCCcccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHAS---MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......|++.|+|||++. ...++.++||||+||++|||++|+.||...
T Consensus 161 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 161 -----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred -----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence 1123346899999999874 456889999999999999999999998644
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=275.86 Aligned_cols=203 Identities=32% Similarity=0.520 Sum_probs=172.9
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-----------hhhHHHHHHHhhccCCCceeeEEeeeecCCc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-----------SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNL 834 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----------~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~ 834 (1001)
+|.+.+.||+|+||.||+|... +++.||+|.+..... .+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778889999999999999864 588999998854321 1457889999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999764 3478888999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......... .........|+..|+|||.+.+..++.++||||+|+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 156 LEANSLSTK-TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred cccccccCC-ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 653221111 111223346889999999998888999999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=276.41 Aligned_cols=201 Identities=26% Similarity=0.388 Sum_probs=169.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-------chhhHHHHHHHhhccCCCceeeEEeeeecC--Cce
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK--NLK 835 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~--~~~ 835 (1001)
.+|++.+.||+|+||.||.|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999865 58999999874321 124678899999999999999999987653 467
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
++||||+++++|.+++.+.. .+++..+.+++.|++.|++|||+. +|+|+||||+||+++.++.+||+|||.++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999997643 378888899999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
...... ........|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 157 QTICLS----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred cccccc----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 422111 11122346889999999998888999999999999999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=284.54 Aligned_cols=208 Identities=24% Similarity=0.325 Sum_probs=176.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|+..+.||+|+||.||++... +++.||+|.+.... ..+.+.+|++++++++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999876 48999999886543 2356888999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++++|.+++.+.....+++..+..++.|+++|++|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999999865556689999999999999999999998 99999999999999999999999999987654322
Q ss_pred CCCCC----------------------CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCS----------------------KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
..... .........||..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11100 0011223468999999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=274.13 Aligned_cols=197 Identities=30% Similarity=0.465 Sum_probs=173.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc-hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE-SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++|++.+.||+|+||.||+|... ++.||+|++..... .+++.+|+.++++++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 46888899999999999999874 89999999976654 57899999999999999999999999988999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
++|.++++......+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.++.......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---- 157 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---- 157 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc----
Confidence 9999999876555689999999999999999999998 999999999999999999999999999987532111
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
...++..|+|||.+....++.++||||||+++||+++ |+.||....
T Consensus 158 ------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 204 (256)
T cd05039 158 ------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 1234567999999988889999999999999999997 999987653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=282.79 Aligned_cols=199 Identities=22% Similarity=0.320 Sum_probs=169.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++|++.+.||+|+||.||+|+.+ +++.||+|.+.... ....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57899999999999999999865 68899999885432 234678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
++ ++|.+++.+. ...+++..+..++.|+++|++|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 97 6999988764 33578899999999999999999998 99999999999999999999999999987543211
Q ss_pred CCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 159 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 159 -----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred -----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11122357889999998765 457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=279.38 Aligned_cols=199 Identities=29% Similarity=0.383 Sum_probs=166.8
Q ss_pred cc-cCCCeEeecCCeeEEEEEe-----CCCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecC--Cce
Q 001873 767 NL-TSANVIGTGSSGVVYRVTI-----PNGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK--NLK 835 (1001)
Q Consensus 767 ~~-~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~--~~~ 835 (1001)
+| +..+.||+|+||+||++.. .+++.||+|.+.... ..+.+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 44 8889999999999988652 357899999986543 236788999999999999999999987653 457
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
++||||+++++|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.+
T Consensus 84 ~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 8999999999999999753 489999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
....... .......++..|+|||......++.++||||||+++|||+||+.||...
T Consensus 158 ~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 158 PEGHEYY----RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred CCcchhh----ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 4322110 1112224566799999998888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=281.75 Aligned_cols=204 Identities=28% Similarity=0.368 Sum_probs=173.1
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc---hhhHHHHHHHhhcc-CCCceeeEEeeeecCCc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE---SGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNL 834 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~ 834 (1001)
.++|++.+.||+|+||.||+++.. .+..||||++..... .+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357889999999999999998741 355899998865432 25688999999999 79999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.++||||+++|+|.+++++.....+++.++..++.|++.|++|||++ +|+|+||||+||+++.++.+|++|||.++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccc
Confidence 99999999999999999865444579999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
....... .......++..|+|||.+....++.++||||+||++|||++ |+.||....
T Consensus 191 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 191 IMNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred ccCCCce-----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 5432211 01112346778999999988889999999999999999998 999987644
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=279.03 Aligned_cols=201 Identities=26% Similarity=0.402 Sum_probs=167.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCC----EEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGE----TLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
++|+..++||+|+||+||+|++. +++ +||+|.+..... .+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 46888899999999999999853 444 489998864432 35788999999999999999999998754 4678
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
++||+++|+|.+++++. ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.+..
T Consensus 86 ~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 99999999999999764 34589999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.... .......+++.|+|||...+..++.++|||||||++|||++ |..||+...
T Consensus 162 ~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 216 (279)
T cd05109 162 DETE-----YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216 (279)
T ss_pred ccce-----eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 2111 01111235678999999988899999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=277.07 Aligned_cols=197 Identities=25% Similarity=0.335 Sum_probs=161.5
Q ss_pred CeEeecCCeeEEEEEeC---CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCC
Q 001873 772 NVIGTGSSGVVYRVTIP---NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNG 845 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 845 (1001)
+.||+|+||.||+|+.. .+..+|+|++..... ...+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999864 346799998865432 246888999999999999999999999989999999999999
Q ss_pred CHHHHhhcCCC---CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 846 SLSSLLHGAGK---GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 846 sL~~~l~~~~~---~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
+|.+++++... ...++..+..++.|++.|++|||+. +++||||||+||+++.++++|++|||.++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-- 155 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-- 155 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce--
Confidence 99999975322 2356778888999999999999998 999999999999999999999999999875432111
Q ss_pred CCCCCCCCcccccccccCccccccC-------CCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASMQ-------RITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
........|+..|+|||++... .++.++||||||+++|||++ |+.||....
T Consensus 156 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 214 (269)
T cd05087 156 ---YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214 (269)
T ss_pred ---eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 1112234578899999987532 35789999999999999996 999997543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=279.32 Aligned_cols=199 Identities=26% Similarity=0.325 Sum_probs=169.1
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999875 68999999885432 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 842 LPNGSLSSLLHGAGK-GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
++ ++|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 689988875432 5578999999999999999999998 99999999999999999999999999987543211
Q ss_pred CCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......+++.|+|||++.+ ..++.++||||+|+++|||+||+.||.+..
T Consensus 156 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 156 ------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred ------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 11122357889999998765 457889999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=274.05 Aligned_cols=199 Identities=29% Similarity=0.369 Sum_probs=171.6
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeec-CCceEEEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSN-KNLKLLFYD 840 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e 840 (1001)
.|++.+.||+|+||.||+++.+ +++.||+|++.... ..+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999865 57899999985432 23568889999999999999999998764 446789999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++++|.+++.......+++.++..++.|++.|++|+|+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 99999999999875455689999999999999999999998 99999999999999999999999999998764321
Q ss_pred CCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......|++.|+|||+..+..++.++||||+|+++|++++|+.||+..
T Consensus 157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 157 ------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred ------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 1223346889999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=294.48 Aligned_cols=199 Identities=27% Similarity=0.433 Sum_probs=169.4
Q ss_pred ccCCCeEeecCCeeEEEEEe-CCC----CEEEEEEecCC---CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 768 LTSANVIGTGSSGVVYRVTI-PNG----ETLAVKKMWSS---DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~-~~~----~~vavK~~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
.+..++||+|+||+||+|.| +.| -+||+|++... ....++.+|+..|.+++|||+++++|+|..+. ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34567899999999999885 333 46888887443 23478999999999999999999999998766 68999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
+||+.|.|.+|++.+ +..+..+..+.|..|||+||.|||.+ ++|||||..+|||+.+-.++||+|||+|+...++.
T Consensus 777 q~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999999976 34577788899999999999999998 99999999999999999999999999999887664
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
....... ..-.+.|||-|.+..+.|+.++|||||||++||++| |..|+++..
T Consensus 853 ~ey~~~~-----gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~ 905 (1177)
T KOG1025|consen 853 KEYSAPG-----GKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP 905 (1177)
T ss_pred ccccccc-----cccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC
Confidence 4332221 123467999999999999999999999999999998 999998764
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=273.47 Aligned_cols=196 Identities=24% Similarity=0.355 Sum_probs=165.2
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCCH
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSL 847 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 847 (1001)
+.||+|+||.||+|+.. +++.||+|.+..... ...+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999875 689999998754332 35688999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCC
Q 001873 848 SSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTN 927 (1001)
Q Consensus 848 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 927 (1001)
.+++... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+|++|||.+......... .
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-----~ 151 (252)
T cd05084 81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA-----S 151 (252)
T ss_pred HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccc-----c
Confidence 9999754 23578999999999999999999998 9999999999999999999999999998764321110 0
Q ss_pred CCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 928 QRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 928 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
......++..|+|||.+.+..++.++||||+|+++|||++ |..||+...
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 0111123457999999988889999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=273.65 Aligned_cols=195 Identities=24% Similarity=0.399 Sum_probs=162.1
Q ss_pred eEeecCCeeEEEEEeC---CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCC
Q 001873 773 VIGTGSSGVVYRVTIP---NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGS 846 (1001)
Q Consensus 773 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 846 (1001)
.||+|+||.||+|.++ .+..||+|++..... .+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999754 355799998865432 2568899999999999999999998864 56799999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCC
Q 001873 847 LSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKT 926 (1001)
Q Consensus 847 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~ 926 (1001)
|.+++... ...+++..+.+++.|++.|++|||++ +++||||||+||+++.++.+||+|||+++.........
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~---- 152 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY---- 152 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce----
Confidence 99999753 34579999999999999999999998 99999999999999999999999999998654322111
Q ss_pred CCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 927 NQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 927 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.......++..|+|||.+....++.++|||||||++||+++ |+.||....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 11112234578999999988889999999999999999996 999997653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=259.18 Aligned_cols=196 Identities=25% Similarity=0.415 Sum_probs=165.1
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCch---hhHHHHHHHhhccC-CCceeeEEeeeecCCceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDES---GAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+.+.+..||.|+.|.||+++.+ .|..+|||.+...... +++...+.++.+.+ .|+||+.+|||..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3455677999999999999976 5899999999765544 56667777766654 89999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
|. ...+.++++. ...+++..+-++...+++|+.||..++ +|+|||+||+|||+|+.|++|+||||.+.++...
T Consensus 173 Ms-~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--- 245 (391)
T KOG0983|consen 173 MS-TCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--- 245 (391)
T ss_pred HH-HHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc---
Confidence 94 5666666654 345788888899999999999999986 9999999999999999999999999999877432
Q ss_pred CCCCCCCCCcccccccccCcccccc---CCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASM---QRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
...+...|-+.|||||.+.. ..|+.++||||||+.++|+.||+.||.+
T Consensus 246 -----kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 246 -----KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred -----cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 23344578999999998853 5789999999999999999999999987
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=279.00 Aligned_cols=199 Identities=27% Similarity=0.357 Sum_probs=170.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc--hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE--SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
+.|++.+.||+|+||.||+|+.. +++.||+|.+..... .+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56889999999999999999975 588999999865432 367888999999999999999999999899999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
++++|..++.+. ...+++..+..++.|++.|++|||+. +++||||||+||+++.++++||+|||.+......
T Consensus 92 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---- 163 (292)
T cd06644 92 PGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT---- 163 (292)
T ss_pred CCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc----
Confidence 999999888654 24578999999999999999999998 9999999999999999999999999988754221
Q ss_pred CCCCCCCCcccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHAS-----MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
........+++.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 164 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 164 ---LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred ---ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 11122346888999999874 355778999999999999999999999754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=271.95 Aligned_cols=195 Identities=26% Similarity=0.389 Sum_probs=166.6
Q ss_pred CeEeecCCeeEEEEEeCCCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCCHH
Q 001873 772 NVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLS 848 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 848 (1001)
++||+|+||.||+|..++++.||+|.+..... ...+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999998865432 246889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCCC
Q 001873 849 SLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQ 928 (1001)
Q Consensus 849 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~ 928 (1001)
+++.... ..+++..+.+++.|++.|+.|+|+. +++||||||+||+++.++.+|++|||++........ ..
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~------~~ 150 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY------SS 150 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccc------cc
Confidence 9987542 3478999999999999999999998 999999999999999999999999999875432111 01
Q ss_pred CCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 929 RPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 929 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.....++..|+|||++....++.++||||||+++||+++ |..||.+..
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~ 199 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT 199 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence 111234568999999988889999999999999999998 999997653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=280.13 Aligned_cols=200 Identities=26% Similarity=0.412 Sum_probs=174.7
Q ss_pred HHhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
..++|+..+.||.|+||.||+|.. .+++.||+|.+.... ..+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 346799999999999999999985 478999999885433 33678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++++|.+++.+ ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 97 ~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 97 YLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred ecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 9999999999874 3478999999999999999999998 999999999999999999999999999876543211
Q ss_pred CCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......|++.|+|||.+....++.++|||||||++|++++|+.||....
T Consensus 171 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 171 -------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred -------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1123468899999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=281.52 Aligned_cols=203 Identities=29% Similarity=0.392 Sum_probs=170.2
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC--------CCCEEEEEEecCCC---chhhHHHHHHHhhcc-CCCceeeEEeeeecC
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP--------NGETLAVKKMWSSD---ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNK 832 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~ 832 (1001)
.++|++.+.||+|+||.||+|+.. ++..||+|.+.... ..+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 457889999999999999998741 24579999886432 235788999999999 899999999999999
Q ss_pred CceEEEEEccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE
Q 001873 833 NLKLLFYDYLPNGSLSSLLHGAG--------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL 898 (1001)
Q Consensus 833 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll 898 (1001)
+..++||||+++|+|.+++.+.. ...+++.++..++.|++.|+.|||+. +|+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 99999999999999999997642 13467888999999999999999998 99999999999999
Q ss_pred CCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 899 GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 899 ~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
++++.+||+|||.++.+...... .......+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred cCCCcEEECCCccceeccccccc-----ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999876432211 11122245678999999988889999999999999999998 88888654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=278.72 Aligned_cols=203 Identities=27% Similarity=0.365 Sum_probs=168.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC------CCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN------GETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
++|++.+.||+|+||.||+|.+.+ +..||+|.+..... ...+.+|+.++++++|+||+++++++.+.+..+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 568889999999999999998753 56789998754332 246889999999999999999999999888999
Q ss_pred EEEEccCCCCHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC---cEEEec
Q 001873 837 LFYDYLPNGSLSSLLHGAGK-----GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY---QAYLAD 908 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~ki~D 908 (1001)
+||||+++++|.++++..+. ..+++..+.+++.||+.|++|||+. +++||||||+||+++.++ .+|++|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEecc
Confidence 99999999999999976432 2478999999999999999999998 999999999999998654 699999
Q ss_pred ccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 909 FGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 909 fgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 163 fg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 163 FGMARDIYRASYY-----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred CccccccCCccce-----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999876322110 01111234568999999988899999999999999999997 999998654
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=290.13 Aligned_cols=203 Identities=29% Similarity=0.387 Sum_probs=169.6
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc---hhhHHHHHHHhhccC-CCceeeEEeeeecCCc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE---SGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNL 834 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~ 834 (1001)
.++|.+.+.||+|+||.||+|+++ .++.||||++..... .+.+.+|+.++.++. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 356788899999999999999853 346899999965432 246889999999997 9999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhcCCC----------------------------------------------------------
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGK---------------------------------------------------------- 856 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 856 (1001)
.++||||+++|+|.+++++.+.
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999975321
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE
Q 001873 857 --------------------------------------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL 898 (1001)
Q Consensus 857 --------------------------------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll 898 (1001)
..+++..+.+++.|++.|++|||+. +|+||||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 1346677888999999999999998 99999999999999
Q ss_pred CCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 899 GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 899 ~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
++++.+|++|||+++.+...... .......+++.|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNY-----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred eCCCEEEEEecCcceeccccccc-----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999865322111 11122357889999999988889999999999999999998 89998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=279.80 Aligned_cols=203 Identities=25% Similarity=0.371 Sum_probs=169.1
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCce
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~ 835 (1001)
.++|++.++||+|+||.||+|..+ .+..||+|.+..... ..++.+|+.++++++||||+++++++.+....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 467999999999999999998753 245899998764432 24578899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCC--------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEe
Q 001873 836 LLFYDYLPNGSLSSLLHGAGK--------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLA 907 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~ 907 (1001)
++||||+++|+|.+++++.+. ...++..+.+++.|++.|+.|||++ +|+||||||+||++++++.+|++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999975321 2346677889999999999999998 99999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 908 DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 908 Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.
T Consensus 162 Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 162 DFGMTRDIYETDYY-----RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred cCCccccccccccc-----cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999865432211 11112245678999999988899999999999999999998 78898754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=278.04 Aligned_cols=203 Identities=26% Similarity=0.375 Sum_probs=171.5
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCC------CCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCce
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPN------GETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~ 835 (1001)
.++|++.+.||+|+||.||+|...+ +..||+|.+..... ...+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578889999999999999988642 46899999864432 24688999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCC--------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEe
Q 001873 836 LLFYDYLPNGSLSSLLHGAGK--------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLA 907 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~ 907 (1001)
++||||+++|+|.+++..... ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 999999999999999975321 2367888999999999999999998 99999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 908 DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 908 Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
|||+++.+...... .......++..|+|||.+....++.++|||||||++||++| |+.||...
T Consensus 162 dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 225 (277)
T cd05032 162 DFGMTRDIYETDYY-----RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225 (277)
T ss_pred CcccchhhccCccc-----ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC
Confidence 99999865432211 11223356789999999988889999999999999999998 99998654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=275.70 Aligned_cols=203 Identities=26% Similarity=0.412 Sum_probs=170.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeC----CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP----NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.+|++.+.||+|+||.||+|+.. .+..||+|.+.... ..+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999863 23479999886433 235788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||++..+...
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999997643 3578999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.... .......++..|+|||.+.+..++.++|+||||+++||+++ |+.||....
T Consensus 160 ~~~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 160 PEAA----YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred ccee----eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 2111 01111234568999999998899999999999999999887 999997653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=283.36 Aligned_cols=199 Identities=29% Similarity=0.459 Sum_probs=166.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCC--EEEEEEecCCC---chhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGE--TLAVKKMWSSD---ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~~~~~~---~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.+|++.+.||+|+||.||+|+++ ++. .+|+|++.... ..+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46888899999999999999865 344 46777765432 235788999999999 899999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcE
Q 001873 839 YDYLPNGSLSSLLHGAGK--------------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQA 904 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 904 (1001)
|||+++|+|.+++++.+. ..+++.+++.++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999975421 2468899999999999999999998 99999999999999999999
Q ss_pred EEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 905 YLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 905 ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
||+|||+++..... .......++..|+|||++....++.++|||||||++|||+| |..||...
T Consensus 164 kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 164 KIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred EeCccccCcccchh--------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 99999998642110 01111234567999999988889999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=282.26 Aligned_cols=203 Identities=28% Similarity=0.374 Sum_probs=169.4
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC--------CCCEEEEEEecCCC---chhhHHHHHHHhhcc-CCCceeeEEeeeecC
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP--------NGETLAVKKMWSSD---ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNK 832 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~ 832 (1001)
.++|.+.+.||+|+||.||+++.. +...||+|.+.... ...++.+|+.+++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357999999999999999998752 23579999986543 224688899999999 799999999999999
Q ss_pred CceEEEEEccCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE
Q 001873 833 NLKLLFYDYLPNGSLSSLLHGAGK--------------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL 898 (1001)
Q Consensus 833 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll 898 (1001)
+..++||||+++|+|.+++..... ..+++.++.+++.|++.|++|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999976422 2478899999999999999999998 99999999999999
Q ss_pred CCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 899 GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 899 ~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
+.++.+||+|||.++........ .......+++.|+|||++.+..++.++||||+||++|||++ |+.||...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred cCCCcEEECCCcccccccccchh-----hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 99999999999998765321110 01111234568999999988889999999999999999998 88888654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=288.43 Aligned_cols=202 Identities=26% Similarity=0.399 Sum_probs=172.7
Q ss_pred cccCCCeEeecCCeeEEEEEeCC--C--CEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIPN--G--ETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
+.+..++||+|+||.|++|.|.. | -.||||.+.... ...+|.+|+.+|.+++|||++++||+..+ ....+||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 34556789999999999999752 3 469999986543 44789999999999999999999999887 5678999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
|.++.|+|.+.+++.....+-......++.|||.||.||.++ +.||||+..+|+++-....|||+|||+.+-+....
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999999985566677788889999999999999999 99999999999999999999999999999887655
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
+.+..... ..-...|+|||.+..+.++.++|||+|||++|||+| |+.||-+-.
T Consensus 267 d~Yvm~p~----rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~ 320 (1039)
T KOG0199|consen 267 DMYVMAPQ----RKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR 320 (1039)
T ss_pred cceEecCC----CcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence 44322222 223457999999999999999999999999999998 899997653
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=276.82 Aligned_cols=196 Identities=24% Similarity=0.330 Sum_probs=159.3
Q ss_pred CeEeecCCeeEEEEEeCC---CCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCC
Q 001873 772 NVIGTGSSGVVYRVTIPN---GETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNG 845 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 845 (1001)
+.||+|+||+||+|+..+ ...||+|.+..... ...+.+|+..++.++||||+++++++......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999997543 45788887754322 246889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCC---CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 846 SLSSLLHGAGK---GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 846 sL~~~l~~~~~---~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
+|.+++..... ...++.....++.|++.|++|||+. +|+||||||+||++++++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 2246778889999999999999998 99999999999999999999999999987543221110
Q ss_pred CCCCCCCCcccccccccCcccccc-------CCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASM-------QRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
......+++.|+|||+... ..++.++||||+||++|||++ |+.||...
T Consensus 158 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 158 -----TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred -----ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 1122346778999998643 456789999999999999999 78888654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=275.15 Aligned_cols=200 Identities=26% Similarity=0.352 Sum_probs=173.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||.||+|... +++.||+|.++.. ...+.+.+|++++++++|++|+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 47889999999999999999976 7899999987532 12467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 840 DYLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||+++|+|.+++... ....+++..+..++.|+++|+.|||+. +|+||||||+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998653 234478899999999999999999998 999999999999999999999999999876532
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.. .......|++.|+|||.+.+..++.++||||+||++|+|++|+.||...
T Consensus 159 ~~-------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 159 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CC-------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 21 1122346888999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=278.57 Aligned_cols=202 Identities=26% Similarity=0.455 Sum_probs=170.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc--hhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE--SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
++|...++||+|+||.||+++.. ++..||+|.+..... .+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56778899999999999998632 356899998764432 3679999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcE
Q 001873 838 FYDYLPNGSLSSLLHGAGK-------------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQA 904 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 904 (1001)
||||+++++|.+++...+. ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999976432 2468899999999999999999998 99999999999999999999
Q ss_pred EEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 905 YLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 905 ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
||+|||++..+...... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 162 kL~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 228 (280)
T cd05092 162 KIGDFGMSRDIYSTDYY-----RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228 (280)
T ss_pred EECCCCceeEcCCCcee-----ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence 99999999765322110 11122345688999999998899999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=281.09 Aligned_cols=200 Identities=30% Similarity=0.433 Sum_probs=166.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC-C--CEEEEEEecCCC---chhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN-G--ETLAVKKMWSSD---ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~-~--~~vavK~~~~~~---~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv 838 (1001)
++|++.+.||+|+||+||+|..++ + ..+|+|.++... ..+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998653 3 347888876422 235688999999999 799999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcE
Q 001873 839 YDYLPNGSLSSLLHGAGK--------------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQA 904 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 904 (1001)
|||+++++|.++++.... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999975321 2468889999999999999999998 99999999999999999999
Q ss_pred EEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 905 YLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 905 ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
||+|||++....... .......+..|+|||+.....++.++|||||||++|||++ |+.||....
T Consensus 159 kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~ 223 (297)
T cd05089 159 KIADFGLSRGEEVYV--------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223 (297)
T ss_pred EECCcCCCcccccee--------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999986421110 0111123457999999988889999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=289.09 Aligned_cols=190 Identities=23% Similarity=0.303 Sum_probs=163.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
..|++.+.||+|+||.||+|+.. +++.||+|.... .....|+.++++++||||+++++++......++||||+.
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 140 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK----GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS- 140 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc----cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-
Confidence 46999999999999999999975 578899997532 234579999999999999999999999999999999995
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
++|.+++... ...+++..+..++.||+.|+.|||++ +|+||||||+||+++.++.+||+|||.++.....
T Consensus 141 ~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~------ 210 (357)
T PHA03209 141 SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA------ 210 (357)
T ss_pred CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC------
Confidence 6898888654 34589999999999999999999998 9999999999999999999999999998753211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf 972 (1001)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1122346899999999999999999999999999999999865554
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=275.50 Aligned_cols=200 Identities=24% Similarity=0.357 Sum_probs=166.0
Q ss_pred ccCCCeEeecCCeeEEEEEeCC----CCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCc-----
Q 001873 768 LTSANVIGTGSSGVVYRVTIPN----GETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNL----- 834 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~----- 834 (1001)
|++.+.||+|+||.||+|+... +..||||++..+.. ...+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998642 47899999865432 2568899999999999999999998765443
Q ss_pred -eEEEEEccCCCCHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecc
Q 001873 835 -KLLFYDYLPNGSLSSLLHGA----GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADF 909 (1001)
Q Consensus 835 -~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Df 909 (1001)
.++||||+++|+|..++... ....+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 68999999999999998543 223578999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 910 gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
|+++.+....... ......++..|+|||.+....++.++|||||||++|||++ |..||...
T Consensus 158 g~~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~ 219 (273)
T cd05035 158 GLSKKIYSGDYYR-----QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219 (273)
T ss_pred cceeecccccccc-----ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 9998764332211 1111235678999999988899999999999999999999 88998654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=280.69 Aligned_cols=219 Identities=25% Similarity=0.375 Sum_probs=181.6
Q ss_pred ccCCCeEeecCCeeEEEEE-eCCCCEEEEEEecCCCc-----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 768 LTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDE-----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~-----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
|..++.||-|+||+|.+++ ..+...||+|.+.+.+. ......|-.||+..+.+-||+++-.|.+++.+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 5567789999999999987 44577899998865443 24467789999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
++||++..++-+. ..+.+..++-++.++.+|+++.|.. |+|||||||+|||||.+|++|++|||++.-+....+.
T Consensus 711 IPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred cCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999999998764 3478888888899999999999998 9999999999999999999999999998644221111
Q ss_pred CCCCC-----------------------------------CCCCcccccccccCccccccCCCCCccchHHHHHHHHHHH
Q 001873 922 NCSKT-----------------------------------NQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVL 966 (1001)
Q Consensus 922 ~~~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ell 966 (1001)
..... ......+||+.|+|||++....|+..+|-||.|||+|||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 00000 0123467999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCC--cCcccchhhhhc
Q 001873 967 TGRHPLDPTLPGG--APLVQWTPLMFL 991 (1001)
Q Consensus 967 tg~~Pf~~~~~~~--~~l~~~~~~~~~ 991 (1001)
.|+.||-..++++ ..+..|....+.
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~ 892 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINWRNFLHI 892 (1034)
T ss_pred hCCCCccCCCCCcceeeeeehhhcccc
Confidence 9999999888776 467788876543
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=279.13 Aligned_cols=199 Identities=27% Similarity=0.340 Sum_probs=171.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc--hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE--SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
++|++.+.||+|+||.||+|+.. +++.||+|.+..... .+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 46888899999999999999875 689999998865432 357889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
++++|.+++.+.+ ..+++..+..++.|++.|+.|||++ +|+||||||+||+++.++.++|+|||.+.......
T Consensus 85 ~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--- 157 (280)
T cd06611 85 DGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--- 157 (280)
T ss_pred CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc---
Confidence 9999999987642 3589999999999999999999998 99999999999999999999999999887643211
Q ss_pred CCCCCCCCcccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHAS-----MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......|++.|+|||.+. ...++.++||||+|+++|||++|+.||...
T Consensus 158 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 158 ----QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred ----cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 1122346889999999874 345778999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=279.74 Aligned_cols=199 Identities=29% Similarity=0.414 Sum_probs=169.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++|++.+.||+|+||.||+++.. +++.||+|.+..... ...+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999976 789999998864322 35788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 842 LPNGSLSSLLHGAG-KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
+++++|.++++... ...+++..+..++.|+++|+.|||+++ +|+||||||+||+++.++.+||+|||.+..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 99999999987532 235799999999999999999999742 8999999999999999999999999998765321
Q ss_pred CCCCCCCCCCcccccccccCccccccC------CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQ------RITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......|++.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 157 -------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred -------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 11223578899999988543 3578999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=277.41 Aligned_cols=198 Identities=27% Similarity=0.337 Sum_probs=168.7
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccC
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
.|++.+.||+|+||.||+|+.. ++..+|+|.+.... ..+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3677889999999999999976 57788999875433 23578899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+++|..++.+. ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++++||+|||++.......
T Consensus 86 ~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---- 157 (282)
T cd06643 86 GGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 157 (282)
T ss_pred CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc----
Confidence 99999988653 34589999999999999999999998 99999999999999999999999999987643211
Q ss_pred CCCCCCCcccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHAS-----MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......|++.|+|||++. ...++.++||||+||++|||++|+.||...
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 158 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred ---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 1122346889999999873 455778999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=280.17 Aligned_cols=212 Identities=24% Similarity=0.374 Sum_probs=173.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC----chhhHHHHHHHhhccC-CCceeeEEeeeecCCceEEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD----ESGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
+.|++.+.||+||.++||++...+.+.||+|++.... ....|.+|+..+.+++ |.+||++++|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 5688999999999999999998888999999874322 2367999999999995 9999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|=+ .+|.+++++.......| -++.+..||+.|+.++|.+ ||||.||||.|+++-. |.+||+|||.|..+.++..
T Consensus 441 ~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred ccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 865 69999999765544445 5566889999999999999 9999999999999875 6999999999998866533
Q ss_pred CCCCCCCCCCcccccccccCccccccC-----------CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhhh
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQ-----------RITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLM 989 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~~ 989 (1001)
. -.+...+||+.|||||.+... +.+.++||||+|||+|+|+.|+.||.... ..|.+..
T Consensus 515 s-----I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------n~~aKl~ 583 (677)
T KOG0596|consen 515 S-----IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------NQIAKLH 583 (677)
T ss_pred c-----eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH------HHHHHHH
Confidence 2 223445899999999987432 25679999999999999999999997542 2455554
Q ss_pred hcccc
Q 001873 990 FLMLN 994 (1001)
Q Consensus 990 ~~~~~ 994 (1001)
..+.|
T Consensus 584 aI~~P 588 (677)
T KOG0596|consen 584 AITDP 588 (677)
T ss_pred hhcCC
Confidence 44443
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=279.30 Aligned_cols=202 Identities=29% Similarity=0.383 Sum_probs=168.7
Q ss_pred cccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
+|++.+.||+|+||.||+|+.. ....||+|.+..... .+++.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999753 235788888765433 2568899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCC
Q 001873 838 FYDYLPNGSLSSLLHGAG----------------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMN 895 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~N 895 (1001)
||||+++|+|.+++.... ...+++..++.++.|++.|++|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999986421 12467889999999999999999998 99999999999
Q ss_pred eEECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCC
Q 001873 896 VLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDP 974 (1001)
Q Consensus 896 Ill~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~ 974 (1001)
|++++++.+||+|||+++........ .......++..|+|||...+..++.++||||||+++|||++ |+.||.+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred EEEcCCCcEEeccccccccccCccch-----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999865432211 01122245678999999988889999999999999999999 9999976
Q ss_pred CC
Q 001873 975 TL 976 (1001)
Q Consensus 975 ~~ 976 (1001)
..
T Consensus 233 ~~ 234 (290)
T cd05045 233 IA 234 (290)
T ss_pred CC
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=273.41 Aligned_cols=210 Identities=25% Similarity=0.360 Sum_probs=176.1
Q ss_pred HHhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCC---------chhhHHHHHHHhhccCCCceeeEEeeee-cC
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSD---------ESGAFSSEIQTLGSIRHKNIVRLLGWGS-NK 832 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~-~~ 832 (1001)
+-++|-....||+|+|++||++-+ ...+.||||+-.-.. -.+...+|.++-+.++||-||++++|+. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 346788888999999999999864 457889999652211 1134668999999999999999999885 56
Q ss_pred CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC---CCCcEEEecc
Q 001873 833 NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG---PGYQAYLADF 909 (1001)
Q Consensus 833 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~ki~Df 909 (1001)
+.+|-|+|||+|.+|.-|++++ +.+++.+++.|+.||+.|+.||... .++|||-||||.|||+. .-|.+||+||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 6789999999999999999875 4589999999999999999999985 57999999999999995 3478999999
Q ss_pred cccccccCCCCCCCCCCCCCCcccccccccCccccc----cCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS----MQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 910 gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
|+++++..+.+.............||.+|++||.+. ..+.+.|+||||+|||+|+.+.|+.||...-
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 999999877665544555556678999999999763 2456789999999999999999999998764
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=279.44 Aligned_cols=201 Identities=23% Similarity=0.336 Sum_probs=168.4
Q ss_pred cccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
.|++.+.||+|+||+||+|+.. +++.||+|++..... .+.+.+|+.+++.++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4677888999999999999853 257899999865433 2568889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCc
Q 001873 838 FYDYLPNGSLSSLLHGAG--------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQ 903 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 903 (1001)
++||+++++|.+++.... ...+++..+.+++.|++.|++|+|+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999985321 22467888899999999999999998 9999999999999999999
Q ss_pred EEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 904 AYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 904 ~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
+||+|||+++........ .......+++.|+|||++....++.++||||+||++|||++ |..||.+.
T Consensus 163 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 163 VKISDLGLFREVYAADYY-----KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred eEecccccccccccchhe-----eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999998865432111 11122346788999999988889999999999999999998 88888764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=276.98 Aligned_cols=200 Identities=26% Similarity=0.351 Sum_probs=172.6
Q ss_pred hcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||.||+++. .+++.||||.+.... ..+++.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 478999999875322 2257889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 840 DYLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||+++++|.+++... ....+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998742 234578999999999999999999998 999999999999999999999999999876532
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.. .......|+..|+|||...+..++.++||||||+++|+|++|..||...
T Consensus 159 ~~-------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 159 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CC-------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 21 1112346889999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=272.33 Aligned_cols=193 Identities=25% Similarity=0.384 Sum_probs=162.2
Q ss_pred eEeecCCeeEEEEEeC---CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCC
Q 001873 773 VIGTGSSGVVYRVTIP---NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNG 845 (1001)
Q Consensus 773 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 845 (1001)
+||+|+||.||+|.++ +++.||+|++..... .+++.+|+.++++++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999653 578899998864432 2578899999999999999999998864 4568999999999
Q ss_pred CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCC
Q 001873 846 SLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSK 925 (1001)
Q Consensus 846 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 925 (1001)
+|.+++... ..+++..+.+++.|++.|++|+|++ +|+||||||+||++++++.+||+|||.++.+......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~---- 151 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY---- 151 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe----
Confidence 999999754 3588999999999999999999998 9999999999999999999999999999876432211
Q ss_pred CCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 926 TNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 926 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
........++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 011122234678999999988889999999999999999998 99999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=280.55 Aligned_cols=202 Identities=28% Similarity=0.394 Sum_probs=168.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC--------CCCEEEEEEecCCCc---hhhHHHHHHHhhcc-CCCceeeEEeeeecCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP--------NGETLAVKKMWSSDE---SGAFSSEIQTLGSI-RHKNIVRLLGWGSNKN 833 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~ 833 (1001)
++|.+.+.||+|+||.||+|+.. ....||+|.+..... ...+.+|+.+++++ +||||+++++++.+.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57889999999999999998742 245799998865432 24678899999999 6999999999999999
Q ss_pred ceEEEEEccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAG--------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG 899 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~ 899 (1001)
..++||||+++|+|.+++.... ...+++.++.+++.|++.|++|||++ +|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 9999999999999999997532 13478889999999999999999998 999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 900 PGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 900 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
+++.+||+|||.++......... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYK-----KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred CCCcEEEcccccccccccccccc-----ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999998654321110 1111234467999999988899999999999999999999 89998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=276.48 Aligned_cols=199 Identities=28% Similarity=0.406 Sum_probs=170.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
++|+..+.||+|+||.||+|+.+ +++.||+|++.... ..+.+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888999999999999999976 58999999875432 22567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|++++.+..+.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++++||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99998888887653 3489999999999999999999998 999999999999999999999999999987643221
Q ss_pred CCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.+..
T Consensus 156 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 156 -------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred -------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1122357889999998865 567899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=277.44 Aligned_cols=199 Identities=26% Similarity=0.371 Sum_probs=169.0
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++|++.+.||+|+||.||+|+.+ +++.||+|.+..... ...+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57889999999999999999976 689999998854322 24577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
++ ++|.+++.+.. ..+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 85 LD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred CC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 98 59999987653 3578999999999999999999998 99999999999999999999999999987532111
Q ss_pred CCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......++..|+|||++.+ ..++.++||||+|+++|||++|+.||....
T Consensus 158 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred -----ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 11112246789999998865 568899999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=276.08 Aligned_cols=197 Identities=28% Similarity=0.384 Sum_probs=173.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++|+..+.||.|+||.||+|+.. +++.||+|.+.... ....+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999865 68999999886443 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++++|.+++... .+++..+..++.|++.|+.|||++ +++||||+|+||++++++.++|+|||.++.+....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 152 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-- 152 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence 9999999999853 579999999999999999999998 99999999999999999999999999998764321
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......|++.|+|||.+.+..++.++||||||+++|||+||+.||+..
T Consensus 153 -----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 153 -----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred -----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 1122346888999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=271.63 Aligned_cols=200 Identities=27% Similarity=0.454 Sum_probs=172.0
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
.+|++.+.||+|+||.||++.+.+++.+|+|.+.... ...++.+|++++++++||||+++++++......++||||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 3578889999999999999998778899999886543 346799999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.......
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~---- 155 (256)
T cd05112 84 GCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY---- 155 (256)
T ss_pred CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc----
Confidence 99999997542 3478899999999999999999998 999999999999999999999999999876532211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
.......++.+|+|||.+.+..++.++||||+|+++|||++ |+.||...
T Consensus 156 --~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 205 (256)
T cd05112 156 --TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205 (256)
T ss_pred --cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 11112235678999999988889999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=276.48 Aligned_cols=203 Identities=22% Similarity=0.309 Sum_probs=171.2
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCC-----CCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeec-CCce
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPN-----GETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSN-KNLK 835 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~-~~~~ 835 (1001)
.++|++.++||+|+||.||+|.+.+ +..||+|++..... .+.+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 3578889999999999999999765 68899998864432 3568899999999999999999998765 5678
Q ss_pred EEEEEccCCCCHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGK------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADF 909 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Df 909 (1001)
++++||+++|+|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999976432 3578999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 910 gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
|+++.+....... ......++..|+|||++....++.++||||||+++||+++ |+.||...
T Consensus 162 g~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 162 ALSRDLFPMDYHC-----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223 (280)
T ss_pred CCcccccCCceEE-----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence 9998654322110 0112245678999999988889999999999999999999 99999764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=272.70 Aligned_cols=196 Identities=29% Similarity=0.425 Sum_probs=167.5
Q ss_pred CeEeecCCeeEEEEEeCC--C--CEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIPN--G--ETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
+.||+|+||.||+|.+.+ + ..||||.+..... .+.+.+|+.++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 2 3699999866543 3678899999999999999999999888 888999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
++|.+++.+.....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-- 154 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY-- 154 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce--
Confidence 9999999875435679999999999999999999998 99999999999999999999999999998764432111
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
.......++..|+|||.+....++.++|||||||++|||++ |+.||+..
T Consensus 155 --~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 155 --VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred --ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 11123457789999999998899999999999999999999 99999654
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=272.48 Aligned_cols=200 Identities=27% Similarity=0.379 Sum_probs=174.1
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
++|++.+.||+|+||.||+|+.. +++.+|+|.+.... ..+.+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999875 57889999886443 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
++++|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+.......
T Consensus 83 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 155 (262)
T cd06613 83 GGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--- 155 (262)
T ss_pred CCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh---
Confidence 999999998764 24588999999999999999999998 99999999999999999999999999987654321
Q ss_pred CCCCCCCCcccccccccCccccccC---CCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASMQ---RITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......++..|+|||.+... .++.++||||+|+++|||++|+.||....
T Consensus 156 ----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 156 ----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred ----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 112234688899999998776 88899999999999999999999997643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-32 Score=266.85 Aligned_cols=194 Identities=29% Similarity=0.369 Sum_probs=161.9
Q ss_pred CCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHh-hccCCCceeeEEeeeecCCceEEEEEccCCC
Q 001873 771 ANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTL-GSIRHKNIVRLLGWGSNKNLKLLFYDYLPNG 845 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l-~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 845 (1001)
...||.|+||+|+|..++ .|+.+|||++..... .+++..|.+.. +.-+.||||+++|.+..++..||.||.|+ .
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 457999999999998865 699999999976543 46788888874 44479999999999888888999999996 5
Q ss_pred CHHHH---hhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 846 SLSSL---LHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 846 sL~~~---l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
|+..+ +....+..+++...-+|+...+.|++||-.+. .|||||+||+|||++..|.+|+||||.+..+...
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---- 221 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---- 221 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH----
Confidence 66544 44445566888888899999999999999974 9999999999999999999999999998776432
Q ss_pred CCCCCCCCcccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASM--QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
-..+.-+|...|||||.+.. ..|+.+|||||+|+++||+.||+.|+.+-
T Consensus 222 ----iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w 272 (361)
T KOG1006|consen 222 ----IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW 272 (361)
T ss_pred ----HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence 22333468889999998853 46899999999999999999999998764
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-31 Score=287.67 Aligned_cols=198 Identities=27% Similarity=0.339 Sum_probs=168.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC-CCEEEEEEec--CCCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN-GETLAVKKMW--SSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
+.|.++..||.|+||+||++..++ +--.|.|.+. ...+-+++.-||++++.++||+||++++.|..++..||+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 456778889999999999998764 3345567663 3344578999999999999999999999888888999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
.||-...++-+. ...+.+.++..+.+|++.|+.|||++ .|||||||+.|||++-+|.++++|||.+....
T Consensus 112 ~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~------ 181 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK------ 181 (1187)
T ss_pred CCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch------
Confidence 999998888765 35688999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCCCCCCcccccccccCcccc-----ccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHA-----SMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
.....+..+.|||+|||||++ ...+|++++||||||+++.||..+.+|-..
T Consensus 182 -~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 182 -STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred -hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 222345567899999999976 458999999999999999999999988643
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=273.69 Aligned_cols=205 Identities=27% Similarity=0.417 Sum_probs=170.1
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC-C---CEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN-G---ETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
..|++.+.||+|+||.||+|+... + ..||||.+.... ..++|..|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357888999999999999998652 3 369999986542 235799999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++|+|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+..+...
T Consensus 84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999999764 34578999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.... ..........+..|+|||.+....++.++||||+||++||+++ |..||....
T Consensus 160 ~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 160 TSDP--TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred cccc--ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 2111 0011111112457999999998899999999999999999886 999997643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=272.16 Aligned_cols=200 Identities=27% Similarity=0.421 Sum_probs=168.8
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-------chhhHHHHHHHhhccCCCceeeEEeeeec--CCceE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-------ESGAFSSEIQTLGSIRHKNIVRLLGWGSN--KNLKL 836 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~--~~~~~ 836 (1001)
.|+..+.||+|+||.||+|... ++..||+|++.... ....+.+|+.++++++||||+++++++.+ ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 5888899999999999999864 68999999875321 12468889999999999999999998765 35678
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
++|||+++++|.+++.... .+++.....++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 83 l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999999997643 478888899999999999999998 99999999999999999999999999987653
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.... .........++..|+|||.+.+..++.++||||+||++||+++|+.||...
T Consensus 158 ~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 158 TICM----SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccc----cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 2211 111112345888999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=277.69 Aligned_cols=202 Identities=26% Similarity=0.387 Sum_probs=170.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC-----------------CCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN-----------------GETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRL 825 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l 825 (1001)
++|++.+.||+|+||.||+|+... +..||+|++.... ..+.+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 578999999999999999987542 2468999886543 23578899999999999999999
Q ss_pred EeeeecCCceEEEEEccCCCCHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCe
Q 001873 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAG---------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNV 896 (1001)
Q Consensus 826 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NI 896 (1001)
++++..++..++||||+++++|.+++.+.. ...+++..++.++.|++.|++|||+. +|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 999999999999999999999999997643 12578999999999999999999998 999999999999
Q ss_pred EECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh--CCCCCCC
Q 001873 897 LLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT--GRHPLDP 974 (1001)
Q Consensus 897 ll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt--g~~Pf~~ 974 (1001)
+++.++.++|+|||.++........ .......+++.|+|||.+....++.++|||||||++|||++ |..||..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYY-----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eecCCCceEEccccceeecccCcce-----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999998765332111 11223356788999999988889999999999999999998 7788865
Q ss_pred C
Q 001873 975 T 975 (1001)
Q Consensus 975 ~ 975 (1001)
.
T Consensus 237 ~ 237 (296)
T cd05051 237 L 237 (296)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=278.29 Aligned_cols=203 Identities=28% Similarity=0.381 Sum_probs=170.1
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc---hhhHHHHHHHhhcc-CCCceeeEEeeeecCCc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE---SGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNL 834 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~ 834 (1001)
.++|++.+.||+|+||.||+++.. ....||+|.+..... ..++.+|+.+++++ +||||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 356888899999999999999864 236799998865432 24688899999999 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC
Q 001873 835 KLLFYDYLPNGSLSSLLHGA--------------GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP 900 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 900 (1001)
.+++|||+++|+|.++++.. ....+++..+.+++.|++.|++|||+. +|+||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 99999999999999999652 134578899999999999999999998 9999999999999999
Q ss_pred CCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 901 GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 901 ~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
++.+|++|||.++.+....... ......++..|+|||+..+..++.++|||||||++||+++ |..||...
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYR-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred CCeEEeCcccccccccccccee-----ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 9999999999998764322111 1111234578999999988899999999999999999998 99998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=271.65 Aligned_cols=196 Identities=29% Similarity=0.446 Sum_probs=170.8
Q ss_pred CeEeecCCeeEEEEEeCC----CCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIPN----GETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
+.||+|+||.||+|.... +..||+|.+..... .+++.+|++.+++++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998753 88999999865543 46888999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 845 GSLSSLLHGAG-------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 845 gsL~~~l~~~~-------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
++|.+++.... ...+++..+.+++.|+++|++|||++ +++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999998642 25579999999999999999999998 999999999999999999999999999987653
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
... ........++..|+|||.+....++.++||||+|+++|||++ |+.||...
T Consensus 158 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 158 DDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred ccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 321 112233457889999999988889999999999999999999 69999865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=275.51 Aligned_cols=201 Identities=28% Similarity=0.406 Sum_probs=166.7
Q ss_pred hcccCCCeEeecCCeeEEEEEe-----CCCCEEEEEEecCCCc--hhhHHHHHHHhhccCCCceeeEEeeeec--CCceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI-----PNGETLAVKKMWSSDE--SGAFSSEIQTLGSIRHKNIVRLLGWGSN--KNLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~~~~~~--~~~~~ 836 (1001)
.+|++.+.||+|+||+||++.. .+++.||+|++..... .+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688899999999999999874 2578999999865433 3578899999999999999999997643 34678
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
+||||+++|+|.+++.+. ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 999999999999999754 23478999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
...... .......++..|+|||+..+..++.++||||+||++|||++|..|+..
T Consensus 160 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 160 QDKEYY----KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred CCCcce----eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 332111 011112344569999999888899999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-31 Score=313.01 Aligned_cols=209 Identities=30% Similarity=0.428 Sum_probs=176.1
Q ss_pred cHHHHHhcccCCCeEeecCCeeEEEEE-eCCCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCc
Q 001873 760 SIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNL 834 (1001)
Q Consensus 760 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~ 834 (1001)
....+.-+|....+||.|.||.||.+. ..+|+-.|||-++-.. ..+...+|..++..++|||+|+++|+-...+.
T Consensus 1229 ~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1229 SLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred HhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence 344455678888899999999999977 4579999999774322 23678899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.+|.||||++|+|.+.+...+ ..++.....+..|++.|+.|||+. |||||||||.||+++.+|.+|.+|||.|..
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeE
Confidence 999999999999999997542 256666677889999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCcccccc---CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM---QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+.+..+... .......||+.|||||++.+ +....+.||||+|||+.||+||+.||....
T Consensus 1384 i~~~~~~~~---~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d 1445 (1509)
T KOG4645|consen 1384 IKNNAQTMP---GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD 1445 (1509)
T ss_pred ecCchhcCC---HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc
Confidence 876533222 22234589999999999865 445678999999999999999999998654
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=273.49 Aligned_cols=199 Identities=25% Similarity=0.347 Sum_probs=162.6
Q ss_pred cCCCeEeecCCeeEEEEEeCC-CC--EEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeec------CCce
Q 001873 769 TSANVIGTGSSGVVYRVTIPN-GE--TLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSN------KNLK 835 (1001)
Q Consensus 769 ~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~------~~~~ 835 (1001)
.+.+.||+|+||.||+|+..+ ++ .||+|.+.... ..+.+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 466889999999999998754 32 68999875432 23568889999999999999999997642 2246
Q ss_pred EEEEEccCCCCHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccc
Q 001873 836 LLFYDYLPNGSLSSLLHGA----GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGL 911 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgl 911 (1001)
++||||+++|+|.+++... ....+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999987432 123478999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 912 ARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 912 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
++.+...... .......+++.|+|||......++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 218 (272)
T cd05075 159 SKKIYNGDYY-----RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218 (272)
T ss_pred ccccCcccce-----ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9876432211 11122346678999999998999999999999999999999 88999754
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=284.25 Aligned_cols=202 Identities=28% Similarity=0.371 Sum_probs=166.2
Q ss_pred hcccCCCeEeecCCeeEEEEEe------CCCCEEEEEEecCCCc---hhhHHHHHHHhhcc-CCCceeeEEeeeec-CCc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI------PNGETLAVKKMWSSDE---SGAFSSEIQTLGSI-RHKNIVRLLGWGSN-KNL 834 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~-~~~ 834 (1001)
++|++.+.||+|+||+||+|.+ .+++.||||++..... ...+.+|+.++.++ +||||+++++++.. ...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5799999999999999999973 3478899999865332 35688899999999 68999999998765 446
Q ss_pred eEEEEEccCCCCHHHHhhcCCC----------------------------------------------------------
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGK---------------------------------------------------------- 856 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 856 (1001)
.++||||+++|+|.++++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999999865321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCCCC
Q 001873 857 -------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR 929 (1001)
Q Consensus 857 -------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~ 929 (1001)
..+++..+.+++.|++.|++|||++ +|+||||||+||++++++++||+|||++......... ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-----~~~ 238 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-----VRK 238 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcch-----hhc
Confidence 1256778889999999999999998 9999999999999999999999999999865322111 111
Q ss_pred CcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 930 PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 930 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
....++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 12245678999999988899999999999999999997 99998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=271.15 Aligned_cols=197 Identities=30% Similarity=0.434 Sum_probs=171.6
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-------chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
+|+..+.||+|+||+||+|... +++.||+|.+.... ..+.+.+|+.++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999876 78999999875432 235788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++++|.+++.+. ..+++..+..++.|++.|++|||+. +|+|+||+|+||+++.++.+||+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999999764 3478899999999999999999998 9999999999999999999999999998765322
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQR-ITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
. ......|+..|+|||.+.... ++.++|+||+|+++|+|++|+.||....
T Consensus 156 ~--------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 156 S--------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred c--------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 1 122346889999999987666 8999999999999999999999997654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=275.62 Aligned_cols=199 Identities=25% Similarity=0.319 Sum_probs=167.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+.|++.+.||+|+||.||+|... +++.||+|++..... ...+.+|+.+++.++|+||+++.+++..++..++||||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 57899999999999999999864 689999999864332 24678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+. +++.+++... ....++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 157 (291)
T cd07870 85 MH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-- 157 (291)
T ss_pred cc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC--
Confidence 96 7887777543 23467888888999999999999998 99999999999999999999999999987543211
Q ss_pred CCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||+...
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 158 -----QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred -----CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 11122357889999999865 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=277.34 Aligned_cols=199 Identities=27% Similarity=0.390 Sum_probs=172.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++|++.+.||+|+||+||+++.. +++.||+|++.... ..+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46888899999999999999865 58899999875432 236788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++++|.+++.+. ..+++..+..++.+++.|+.|||+.+ +++||||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 9999999998764 34789999999999999999999742 8999999999999999999999999998754221
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
......|+..|+|||++.+..++.++|||||||++|++++|+.||....+
T Consensus 158 ------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 158 ------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred ------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 11234689999999999888899999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=278.49 Aligned_cols=203 Identities=25% Similarity=0.364 Sum_probs=168.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC---------------CCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEe
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN---------------GETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLG 827 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~ 827 (1001)
++|++.+.||+|+||.||+++... ...||+|++..... ...+.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578999999999999999987532 23589998865322 256889999999999999999999
Q ss_pred eeecCCceEEEEEccCCCCHHHHhhcCCC----------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeE
Q 001873 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGK----------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVL 897 (1001)
Q Consensus 828 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIl 897 (1001)
++...+..++||||+++++|.+++..... ...++..+..++.|++.|++|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 99999999999999999999999965321 2357888899999999999999998 9999999999999
Q ss_pred ECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh--CCCCCCCC
Q 001873 898 LGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT--GRHPLDPT 975 (1001)
Q Consensus 898 l~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt--g~~Pf~~~ 975 (1001)
+++++.+|++|||++........ ........++..|+|||+.....++.++|||||||++|||++ |..||...
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred EcCCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 99999999999999976532211 111122345678999999988889999999999999999998 66788764
Q ss_pred C
Q 001873 976 L 976 (1001)
Q Consensus 976 ~ 976 (1001)
.
T Consensus 237 ~ 237 (295)
T cd05097 237 S 237 (295)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=273.12 Aligned_cols=201 Identities=28% Similarity=0.441 Sum_probs=172.1
Q ss_pred cccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCC--------chhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSD--------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
+|+..+.||+|+||.||+|+. .+++.||+|++.... ..+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 478999999885432 23578899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC-cEEEeccccccccc
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY-QAYLADFGLARIVS 916 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~Dfgla~~~~ 916 (1001)
||||+++++|.+++.+. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++ .+||+|||.+..+.
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999999764 3478899999999999999999998 999999999999998776 69999999998765
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
...... ........|+..|+|||.+.+..++.++||||+|+++|++++|+.||...
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 156 AKGTGA---GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred cccccC---CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 432111 11222346889999999998888999999999999999999999999743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=271.90 Aligned_cols=189 Identities=24% Similarity=0.361 Sum_probs=158.0
Q ss_pred CeEeecCCeeEEEEEeCC-------------CCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceE
Q 001873 772 NVIGTGSSGVVYRVTIPN-------------GETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
+.||+|+||+||+|+... ...||+|.+.... ....+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999997532 2358888875433 2357888999999999999999999999988999
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCc-------EEEecc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQ-------AYLADF 909 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~-------~ki~Df 909 (1001)
+||||+++|+|..++... ...+++..+.+++.||++|++|||++ +|+||||||+||+++.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999998754 23478999999999999999999998 9999999999999986654 899999
Q ss_pred cccccccCCCCCCCCCCCCCCcccccccccCccccc-cCCCCCccchHHHHHHHHHHH-hCCCCCCCC
Q 001873 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS-MQRITEKSDVYSFGVVLLEVL-TGRHPLDPT 975 (1001)
Q Consensus 910 gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~il~ell-tg~~Pf~~~ 975 (1001)
|.+..... .....++..|+|||.+. ...++.++|||||||++|||+ +|+.||...
T Consensus 157 g~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 157 GIPITVLS-----------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred CCCccccC-----------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 99875421 11235778899999886 567899999999999999997 588888754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=271.35 Aligned_cols=205 Identities=29% Similarity=0.443 Sum_probs=176.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++|++.+.||+|+||+||+|... +++.||+|++.... ..+.+.+|+++++.++|+||+++++.+..+...++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36889999999999999999865 68899999885433 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 842 LPNGSLSSLLHGAGK-GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
+++++|.++++.... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976433 4578999999999999999999998 999999999999999999999999999987654322
Q ss_pred CCCCCCCCCCcccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQ-RITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.. ........|+..|+|||++... .++.++|+|||||++|||++|+.||....
T Consensus 158 ~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 158 RT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred cc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 11 1223445689999999998766 78899999999999999999999997653
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=275.63 Aligned_cols=200 Identities=28% Similarity=0.395 Sum_probs=168.0
Q ss_pred hcccCCCeEeecCCeeEEEEEe-----CCCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecC--Cce
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI-----PNGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK--NLK 835 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~--~~~ 835 (1001)
+.|++.+.||+|+||.||.++. .++..||+|.+.... ..+++.+|++++++++||||+++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3578889999999999999874 357889999986443 235788999999999999999999988765 567
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
++||||+++++|.+++.+.. ...++..+..++.|++.|++|+|++ +|+||||||+||+++.++.+||+|||+++.+
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence 89999999999999997542 3579999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~ 973 (1001)
...... ........++..|+|||++.+..++.++||||||+++||++|++.|+.
T Consensus 160 ~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 160 ETDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred ccCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 432211 111223457778999999988889999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=277.60 Aligned_cols=204 Identities=25% Similarity=0.325 Sum_probs=170.8
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
+|+..+.||+|+||.||+++.. .++.||+|.+.... ..+.+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999875 57899999885432 23567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++++|.+++... ..+++..+..++.|++.|++|+|+. +++||||||+||+++.++.+|++|||.++.......
T Consensus 82 ~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 82 YVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999999999764 3478899999999999999999998 999999999999999999999999999874211100
Q ss_pred CC--------CCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 921 DN--------CSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 921 ~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.. ...........|+..|+|||.+....++.++|+||||+++||+++|+.||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 00 00001112346788999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=271.66 Aligned_cols=202 Identities=28% Similarity=0.473 Sum_probs=169.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CC---CEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NG---ETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~---~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.+|+..+.||+|+||.||+|+.+ ++ ..||+|++.... ..+.+.+|++++++++||||+++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46777889999999999999865 23 379999886442 235788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++++|.+++.+. ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999999999764 24578999999999999999999998 9999999999999999999999999999866432
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
.... ........+..|+|||++....++.++|||||||++||+++ |+.||...
T Consensus 161 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 161 PEGT----YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred cccc----eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 1111 01111223467999999988889999999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=270.03 Aligned_cols=199 Identities=24% Similarity=0.305 Sum_probs=171.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.+|..+.+||+|+||+|-++..+ +.+-||||+++++. +.+--..|-++++.- +-|.++++..++..-+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 45778889999999999999865 57889999876543 233345577777666 578999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+.||+|.-.+++.++ +.+..+.-+|.+||-|+-+||++ +||+||||.+|||++.+|++||+|||+++.-.
T Consensus 429 MEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-- 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-- 501 (683)
T ss_pred EEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc--
Confidence 999999999999988655 66777777899999999999999 99999999999999999999999999998532
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......+.+|||.|+|||++...+|+.++|-|||||++|||+.|..||++..
T Consensus 502 -----~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD 554 (683)
T KOG0696|consen 502 -----FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 554 (683)
T ss_pred -----cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 23334556799999999999999999999999999999999999999999864
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=269.34 Aligned_cols=195 Identities=28% Similarity=0.377 Sum_probs=163.6
Q ss_pred CeEeecCCeeEEEEEeCC----CCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIPN----GETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++||+|+||.||+|.+.. +..||+|.+..... .+++.+|++++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 469999999999997532 36899999865543 3578899999999999999999998764 457999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~-- 152 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY-- 152 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc--
Confidence 99999998653 578999999999999999999998 99999999999999999999999999998764332211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.......++..|+|||......++.++||||||+++|||++ |+.||+...
T Consensus 153 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~ 203 (257)
T cd05060 153 --RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203 (257)
T ss_pred --ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence 11111224567999999988899999999999999999998 999997653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=276.85 Aligned_cols=197 Identities=26% Similarity=0.360 Sum_probs=167.0
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999975 68999999885432 225678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
++ ++|.+++... ...+++..+..++.||++|+.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 153 (284)
T cd07839 81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-- 153 (284)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence 97 5888887654 23489999999999999999999998 99999999999999999999999999997653221
Q ss_pred CCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......+++.|+|||++.+ ..++.++||||+||++|||+||+.||.+.
T Consensus 154 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~ 203 (284)
T cd07839 154 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 203 (284)
T ss_pred -----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 11123357889999998865 44789999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=270.37 Aligned_cols=199 Identities=25% Similarity=0.359 Sum_probs=173.2
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+|+..+.||+|+||.||+++.. +++.||+|++... ...+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999864 6899999988532 2335788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++++|.+++........++.++.+++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999999865455678999999999999999999998 999999999999999999999999999976532211
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......|++.|+|||+..+..++.++|+|||||++|+|++|+.||...
T Consensus 157 ------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 157 ------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred ------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 112235788999999998888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=273.93 Aligned_cols=201 Identities=26% Similarity=0.405 Sum_probs=169.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCC----EEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGE----TLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
++|++.+.||+|+||.||+|..+ +++ .||+|....... ..++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56888999999999999999864 233 689998765432 2578899999999999999999999887 67899
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.++....
T Consensus 86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999998643 3478999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
..... ......++..|+|||......++.++|+||||+++||+++ |+.||+...
T Consensus 162 ~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 162 DEKEY-----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred cccce-----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 22111 0111224568999999988899999999999999999999 999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=273.47 Aligned_cols=198 Identities=27% Similarity=0.366 Sum_probs=172.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
..|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+|+.++++++||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45778889999999999999865 58899999886433 235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++|+|.+++.. ..+++.....++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06640 84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc--
Confidence 999999999874 3478888899999999999999998 99999999999999999999999999997654321
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......++..|+|||++.+..++.++|+|||||++|||++|+.||....
T Consensus 156 -----~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 156 -----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred -----cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 11223467889999999988889999999999999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=277.62 Aligned_cols=198 Identities=28% Similarity=0.370 Sum_probs=170.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+.|+..+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45667788999999999999864 57899999876433 235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++++|.+++.. ..+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++++|||++..+....
T Consensus 84 ~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06642 84 LGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred cCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence 999999999864 3578899999999999999999998 99999999999999999999999999997654321
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......|+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 156 -----IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred -----hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence 11122357889999999998889999999999999999999999997543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=276.71 Aligned_cols=202 Identities=25% Similarity=0.374 Sum_probs=168.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-----------------CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-----------------NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRL 825 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l 825 (1001)
++|++.+.||+|+||.||+++.. ++..||+|++..... ..++.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999998532 234689998864432 3578899999999999999999
Q ss_pred EeeeecCCceEEEEEccCCCCHHHHhhcCCC---------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCe
Q 001873 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGK---------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNV 896 (1001)
Q Consensus 826 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NI 896 (1001)
++++...+..++||||+++|+|.+++.+... ..+++.++..++.|++.|++|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999976421 2356788999999999999999998 999999999999
Q ss_pred EECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh--CCCCCCC
Q 001873 897 LLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT--GRHPLDP 974 (1001)
Q Consensus 897 ll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt--g~~Pf~~ 974 (1001)
+++.++.++++|||.++.+...... .......++..|+|||......++.++|||||||++|||++ |..||..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYY-----RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcce-----eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999999865432211 11112234678999999888889999999999999999998 7788865
Q ss_pred C
Q 001873 975 T 975 (1001)
Q Consensus 975 ~ 975 (1001)
.
T Consensus 237 ~ 237 (296)
T cd05095 237 L 237 (296)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=275.65 Aligned_cols=204 Identities=25% Similarity=0.343 Sum_probs=170.0
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-chhhHHHHHHHhhcc-CCCceeeEEeeee-----cCCc
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-ESGAFSSEIQTLGSI-RHKNIVRLLGWGS-----NKNL 834 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~-----~~~~ 834 (1001)
+..++|++.+.||+|+||.||+++.. +++.||+|+..... ...++.+|+.+++++ +||||+++++++. .++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 35678999999999999999999865 58899999875433 236788899999999 6999999999873 3456
Q ss_pred eEEEEEccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLA 912 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla 912 (1001)
.++||||+++++|.+++... ....+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+|++|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCce
Confidence 89999999999999988642 234578888999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS-----MQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+.+.... .......|++.|+|||++. ...++.++||||+||++|||++|+.||....
T Consensus 172 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 172 AQLTSTR-------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred eecccCC-------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 8654221 1122336899999999875 3457889999999999999999999997653
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=269.43 Aligned_cols=198 Identities=23% Similarity=0.378 Sum_probs=172.2
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+|+..+.||+|+||.||++... +++.||||.+.... ..+++.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999998864 68899999885432 346788999999999999999999999888999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC-CcEEEecccccccccCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG-YQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ki~Dfgla~~~~~~~~ 920 (1001)
+++++|.+++.+.....+++..+.+++.|++.|++|||++ +++||||||+||+++++ +.+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 9999999999876555689999999999999999999998 99999999999999855 468999999998753221
Q ss_pred CCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......|+..|+|||.+....++.++||||+|+++|+|++|+.||+..
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 157 -------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred -------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 112346888999999998888899999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=269.05 Aligned_cols=204 Identities=24% Similarity=0.348 Sum_probs=166.2
Q ss_pred HHHhcccCCCeE--eecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEE
Q 001873 763 DVVRNLTSANVI--GTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 763 ~~~~~~~~~~~l--G~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv 838 (1001)
+..++|++.+.+ |+|+||.||+++.+ +++.+|+|.+...... .. |+.....+ +||||+++++++...+..++|
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AI--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-hh--hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 344667777766 99999999999864 6888999987543211 11 22222222 799999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC-cEEEecccccccccC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY-QAYLADFGLARIVSG 917 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~Dfgla~~~~~ 917 (1001)
|||+++++|.+++.... .+++..+..++.|+++|+.|||+. +++||||||+||+++.++ .++|+|||.++....
T Consensus 88 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 88 MDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 99999999999998643 689999999999999999999998 999999999999999988 999999999876532
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccc
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQW 985 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~ 985 (1001)
. ....|+..|+|||++....++.++||||+|+++|||++|+.||...........+|
T Consensus 163 ~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~ 219 (267)
T PHA03390 163 P-----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL 219 (267)
T ss_pred C-----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH
Confidence 1 12357899999999998889999999999999999999999998654433333333
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=273.75 Aligned_cols=203 Identities=25% Similarity=0.361 Sum_probs=171.1
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-chhhHHHHHHHhhcc-CCCceeeEEeeeec------CCc
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-ESGAFSSEIQTLGSI-RHKNIVRLLGWGSN------KNL 834 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~------~~~ 834 (1001)
..+.|++.+.||+|+||.||+|+.. +++.||+|.+.... ...++..|+.+++++ +||||+++++++.. ...
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 3467899999999999999999974 68899999875443 345788899999998 79999999998742 457
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.+++|||+++|+|.+++........++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++..
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 79999999999999999876555678888899999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS-----MQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
..... .......|++.|+|||.+. ...++.++||||+||++|||++|+.||....
T Consensus 171 ~~~~~-------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 171 LDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred hhccc-------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 53211 1123346899999999875 3567889999999999999999999997543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=271.27 Aligned_cols=193 Identities=30% Similarity=0.469 Sum_probs=160.7
Q ss_pred CeEeecCCeeEEEEEeCC-CC--EEEEEEecCCC---chhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIPN-GE--TLAVKKMWSSD---ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~---~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
+.||+|+||.||+|+.++ +. .+|+|.++... ..+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998753 43 56888876432 235788999999999 799999999999999999999999999
Q ss_pred CCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccc
Q 001873 845 GSLSSLLHGAG--------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFG 910 (1001)
Q Consensus 845 gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfg 910 (1001)
|+|.+++++.. ...+++..+.+++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999997532 12468889999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
++...... ........+..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 158 l~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 158 LSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred Cccccchh--------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 98632110 01111133567999999988889999999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=269.99 Aligned_cols=201 Identities=27% Similarity=0.407 Sum_probs=169.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-------CchhhHHHHHHHhhccCCCceeeEEeeeecC--Cce
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-------DESGAFSSEIQTLGSIRHKNIVRLLGWGSNK--NLK 835 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~--~~~ 835 (1001)
.+|++.+.||+|+||.||+|+.. +++.||+|.+... .....+.+|++++++++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 36888999999999999999864 6899999987422 1225788999999999999999999988653 457
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
++|+||+++++|.+++...+ .+++..+.+++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999997643 378888999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
..... .........|+..|+|||.+.+..++.++|+|||||++||+++|+.||...
T Consensus 157 ~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 157 QTICM----SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred ccccc----cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 32111 111122346889999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=278.76 Aligned_cols=197 Identities=26% Similarity=0.381 Sum_probs=169.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
+.|+....||+|+||.||++... +++.||+|.+.... ..+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 33445557999999999999864 68999999885432 3457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--- 171 (297)
T cd06659 101 QGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--- 171 (297)
T ss_pred CCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc---
Confidence 99999998864 3478999999999999999999998 99999999999999999999999999987653221
Q ss_pred CCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 172 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 220 (297)
T cd06659 172 ----PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220 (297)
T ss_pred ----ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1122346889999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=277.80 Aligned_cols=197 Identities=28% Similarity=0.411 Sum_probs=169.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
+.|.....||+|+||.||++... ++..||||++.... ..+.+.+|+.++++++||||+++++.+...+..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 44555567999999999999864 68899999875432 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
++++|.+++.. ..+++..+..++.||+.|++|||++ +|+||||||+||++++++.+||+|||++.......
T Consensus 102 ~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--- 172 (292)
T cd06658 102 EGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--- 172 (292)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc---
Confidence 99999999864 3478899999999999999999998 99999999999999999999999999987653221
Q ss_pred CCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......|+..|+|||......++.++||||+|+++|||++|+.||...
T Consensus 173 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 221 (292)
T cd06658 173 ----PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 221 (292)
T ss_pred ----ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1122346889999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=274.64 Aligned_cols=202 Identities=28% Similarity=0.424 Sum_probs=169.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
++|++.+.||+|+||.||+|+.. ++..||+|++..... .+++.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 56888999999999999999853 467899998865432 356889999999999999999999999989999
Q ss_pred EEEEccCCCCHHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCe
Q 001873 837 LFYDYLPNGSLSSLLHGAG--------------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNV 896 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~--------------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NI 896 (1001)
+||||+++|+|.+++.... ...+++..++.++.|++.|++|+|+. +++||||||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhhe
Confidence 9999999999999997431 12367888899999999999999998 999999999999
Q ss_pred EECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 897 LLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 897 ll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
++++++.+||+|||.++.+....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYK-----ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred EecCCCceEECccccceecccCcccc-----ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999987653322111 1111234567999999988899999999999999999998 88898654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=275.21 Aligned_cols=205 Identities=19% Similarity=0.280 Sum_probs=156.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC----CCEEEEEEecCCCch-------------hhHHHHHHHhhccCCCceeeEEee
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN----GETLAVKKMWSSDES-------------GAFSSEIQTLGSIRHKNIVRLLGW 828 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-------------~~~~~Ei~~l~~l~h~nIv~l~~~ 828 (1001)
++|++.+.||+|+||+||+|+..+ +..+|+|+.....+. .....+...++.++|++|++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 689999999999999999998754 345666653222211 011223344566789999999987
Q ss_pred eecCC----ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcE
Q 001873 829 GSNKN----LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQA 904 (1001)
Q Consensus 829 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 904 (1001)
+.... ..++++|++. .++.+.+... ...++..+..++.|++.|++|||+. +|+||||||+||+++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence 65443 3467788774 5777776643 2257788889999999999999998 99999999999999999999
Q ss_pred EEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 905 YLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 905 ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
||+|||+|+.+...+..............||+.|+|||+..+..++.++||||+||++|||++|+.||....
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 999999998765432221111122333469999999999999999999999999999999999999998763
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=280.06 Aligned_cols=202 Identities=29% Similarity=0.390 Sum_probs=168.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeC--------CCCEEEEEEecCCCc---hhhHHHHHHHhhcc-CCCceeeEEeeeecCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP--------NGETLAVKKMWSSDE---SGAFSSEIQTLGSI-RHKNIVRLLGWGSNKN 833 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~ 833 (1001)
.+|++.+.||+|+||.||+|+.. .+..||+|.+..... .+++.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46899999999999999999742 123689998765332 35788999999999 7999999999999999
Q ss_pred ceEEEEEccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAG--------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG 899 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~ 899 (1001)
..+++|||+++|+|.+++.+.. ...+++.++..++.|++.|++|||+. +|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999999997532 23467888999999999999999998 999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 900 PGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 900 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred CCCcEEECCcccceeccccccc-----ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999865432111 11112234567999999998899999999999999999998 88888754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=274.95 Aligned_cols=201 Identities=27% Similarity=0.415 Sum_probs=174.2
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
+..++|++.+.||+|+||.||++... +++.||+|.+.... ..+.+.+|+.++++++||||+++++++...+..++|+
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 33578999999999999999999854 68899999885432 3367889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++++|.+++.+ ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 96 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 96 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred ecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 99999999999974 3478889999999999999999998 99999999999999999999999999887653321
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......|++.|+|||.+....++.++||||||+++|++++|+.||....
T Consensus 170 -------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 170 -------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred -------cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223468889999999988889999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=271.78 Aligned_cols=190 Identities=23% Similarity=0.255 Sum_probs=158.2
Q ss_pred eEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhc---cCCCceeeEEeeeecCCceEEEEEccC
Q 001873 773 VIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGS---IRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 773 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~---l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
+||+|+||.||++... +++.||+|.+.... ....+.+|..+++. .+||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999865 58999999875432 11234455544433 479999999999998899999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.++++|||++......
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----- 150 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----- 150 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc-----
Confidence 99999998764 3489999999999999999999998 9999999999999999999999999998754321
Q ss_pred CCCCCCCcccccccccCccccc-cCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHAS-MQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......||+.|+|||... +..++.++||||+||++|||++|+.||....
T Consensus 151 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 151 ----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred ----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 112236899999999886 4568899999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=272.12 Aligned_cols=192 Identities=26% Similarity=0.309 Sum_probs=166.8
Q ss_pred EeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCCH
Q 001873 774 IGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSL 847 (1001)
Q Consensus 774 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 847 (1001)
||+|+||+||++... +++.||+|.+.... ....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 68999999885321 234567899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCC
Q 001873 848 SSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTN 927 (1001)
Q Consensus 848 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 927 (1001)
.+++.......+++..+..++.|++.|+.|||+. +++||||+|+||++++++.+||+|||.+...... .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--------~ 149 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--------K 149 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--------C
Confidence 9999876555689999999999999999999998 9999999999999999999999999998765321 1
Q ss_pred CCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 928 QRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 928 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......++..|+|||++.+..++.++||||+|+++|+|++|+.||....
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 1123357889999999988889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=270.08 Aligned_cols=188 Identities=26% Similarity=0.402 Sum_probs=160.3
Q ss_pred CeEeecCCeeEEEEEeCCCC-----------EEEEEEecCCCc-hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 772 NVIGTGSSGVVYRVTIPNGE-----------TLAVKKMWSSDE-SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~-~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
+.||+|+||.||+|...+.. .|++|.+..... ...+.+|+.++++++||||+++++++.. +..++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999976433 578887654433 5789999999999999999999999887 7789999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC-------cEEEeccccc
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY-------QAYLADFGLA 912 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~-------~~ki~Dfgla 912 (1001)
||+++|+|.+++..... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++ .+|++|||++
T Consensus 80 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 80 EYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999986532 578999999999999999999998 999999999999999887 7999999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCccccccC--CCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ--RITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
..... .....++..|+|||++... .++.++||||+|+++||+++ |..||...
T Consensus 156 ~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 156 ITVLS-----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred ccccc-----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 86532 1123466789999998776 78899999999999999999 57888665
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=297.67 Aligned_cols=201 Identities=19% Similarity=0.285 Sum_probs=160.1
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeCC--CCEEEEE------------------EecCC-CchhhHHHHHHHhhccCCC
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIPN--GETLAVK------------------KMWSS-DESGAFSSEIQTLGSIRHK 820 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK------------------~~~~~-~~~~~~~~Ei~~l~~l~h~ 820 (1001)
+.+.++|++.+.||+|+||+||++..+. +..+++| ++... .....+.+|+.++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 3456889999999999999999986532 2222222 11111 1235688999999999999
Q ss_pred ceeeEEeeeecCCceEEEEEccCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeE
Q 001873 821 NIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAG---KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVL 897 (1001)
Q Consensus 821 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIl 897 (1001)
||+++++++...+..++|+|++. +++.+++.... ........+..++.|++.||+|||++ +||||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 99999999999999999999995 67877775422 11234566778999999999999998 9999999999999
Q ss_pred ECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 001873 898 LGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972 (1001)
Q Consensus 898 l~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf 972 (1001)
++.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKERE------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccc------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999987643211 1223357999999999999999999999999999999999987644
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=271.72 Aligned_cols=201 Identities=24% Similarity=0.375 Sum_probs=170.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
++|+..+.||+|+||+||+|+.+ +.+.||+|.+..... .+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999864 346799998754433 367899999999999999999999999989999
Q ss_pred EEEEccCCCCHHHHhhcCCCC-------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKG-------GADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADF 909 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Df 909 (1001)
+||||+++|+|.++++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999865421 579999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 910 gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
|+++...... ........++..|+|||.+....++.++||||||+++|++++ |..||...
T Consensus 162 ~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~ 222 (275)
T cd05046 162 SLSKDVYNSE------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL 222 (275)
T ss_pred ccccccCccc------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 9987543211 111223356778999999988888999999999999999998 88898643
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=273.54 Aligned_cols=199 Identities=26% Similarity=0.383 Sum_probs=164.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHH-hhccCCCceeeEEeeeecCCceEEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQT-LGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~-l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
++|++.+.||+|+||.||+|+.. +|+.||+|++..... ..++..|+.. ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999875 699999998865432 2455566665 566789999999999999999999999
Q ss_pred ccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 841 YLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|++ |+|.+++... ....+++..+..++.|++.|++|||+++ +++||||||+||+++.++.+||+|||.++.+...
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 7888887642 2345799999999999999999999853 8999999999999999999999999998865321
Q ss_pred CCCCCCCCCCCCcccccccccCcccccc----CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASM----QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......|+..|+|||.+.+ ..++.++|+||+||++|||++|+.||...
T Consensus 158 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 158 --------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred --------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 11122468889999998754 45688999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=267.20 Aligned_cols=199 Identities=29% Similarity=0.448 Sum_probs=171.1
Q ss_pred ccCCCeEeecCCeeEEEEEeCC-----CCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 768 LTSANVIGTGSSGVVYRVTIPN-----GETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
+++.+.||+|+||.||+++..+ +..||+|++.... ..+.+.+|+..++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999998753 4889999986544 3468889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++++|.+++.......+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||.++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999865443389999999999999999999998 99999999999999999999999999998764331
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
... .....+++.|+|||......++.++||||+|+++|+|++ |+.||+..
T Consensus 158 ~~~------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 158 YYK------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred ccc------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 111 001236789999999988889999999999999999998 88888753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=272.39 Aligned_cols=198 Identities=25% Similarity=0.345 Sum_probs=170.8
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999965 68999999986543 235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+ +++|.+++.... ..+++.++..++.|+++|++|||+. +++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 999999987643 5589999999999999999999998 999999999999999999999999999987643221
Q ss_pred CCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......|+.+|+|||.+.+ ..++.++||||+|+++|||++|+.||.+.
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 155 -----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred -----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 11223468899999998865 45689999999999999999998888654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=273.38 Aligned_cols=203 Identities=27% Similarity=0.369 Sum_probs=169.6
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-chhhHHHHHHHhhcc-CCCceeeEEeeeecC-----Cce
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNK-----NLK 835 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~-----~~~ 835 (1001)
..++|++.+.||+|+||.||++... ++++||+|.+.... ...++.+|+.+++++ +||||+++++++... +..
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 3578999999999999999999874 68899999885533 346788899999998 899999999987643 357
Q ss_pred EEEEEccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~ 913 (1001)
++||||+++++|.++++.. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 9999999999999988642 234578999999999999999999998 99999999999999999999999999988
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCccccccC-----CCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ-----RITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
....... ......|+..|+|||++... .++.++||||+||++|||++|+.||....
T Consensus 177 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 177 QLTSTRL-------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred hcccccc-------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 6542211 11223688899999987543 36789999999999999999999997653
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=274.16 Aligned_cols=197 Identities=25% Similarity=0.317 Sum_probs=168.0
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-------hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-------SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
+|+..+.||+|+||.||+|... +++.||||++..... ...+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999865 689999999864332 24567899999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+ +|+|.+++.... ..+++..+.+++.|+++|+.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 899999998643 3589999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.. ......+++.|+|||.+.+ ..++.++|||||||++|||++|..||...
T Consensus 156 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~ 206 (298)
T cd07841 156 NR-------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD 206 (298)
T ss_pred Cc-------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC
Confidence 11 1122356788999998754 56789999999999999999998777643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=276.55 Aligned_cols=204 Identities=23% Similarity=0.306 Sum_probs=169.7
Q ss_pred cccCCCeEeecCCeeEEEEEeC---CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecC--CceE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP---NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNK--NLKL 836 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~--~~~~ 836 (1001)
+|++.++||+|+||.||+|+.. +++.||+|.+... ...+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778889999999999999975 4789999998762 2346788899999999999999999999887 7899
Q ss_pred EEEEccCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC----CCcEEEecc
Q 001873 837 LFYDYLPNGSLSSLLHGAG---KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP----GYQAYLADF 909 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~ki~Df 909 (1001)
+||||++ +++.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999997 47777765432 23578899999999999999999998 9999999999999999 899999999
Q ss_pred cccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001873 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978 (1001)
Q Consensus 910 gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~ 978 (1001)
|+++........ ........+++.|+|||++.+ ..++.++||||||+++|||++|+.||......
T Consensus 157 g~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 157 GLARLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred ccccccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence 999876432211 112233468899999998765 46789999999999999999999999866543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=271.67 Aligned_cols=189 Identities=23% Similarity=0.340 Sum_probs=156.4
Q ss_pred eEeecCCeeEEEEEeCC-------------------------CCEEEEEEecCCCc--hhhHHHHHHHhhccCCCceeeE
Q 001873 773 VIGTGSSGVVYRVTIPN-------------------------GETLAVKKMWSSDE--SGAFSSEIQTLGSIRHKNIVRL 825 (1001)
Q Consensus 773 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l 825 (1001)
.||+|+||.||+|.... ...||+|.+..... ..++.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999987421 23588888754322 3568889999999999999999
Q ss_pred EeeeecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC---
Q 001873 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY--- 902 (1001)
Q Consensus 826 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~--- 902 (1001)
++++.+....++||||+++|+|.+++.+. ...+++..+.+++.|+++|++|||++ +|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999998753 34578899999999999999999998 999999999999997543
Q ss_pred ----cEEEecccccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHH-hCCCCCCCCC
Q 001873 903 ----QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVL-TGRHPLDPTL 976 (1001)
Q Consensus 903 ----~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ell-tg~~Pf~~~~ 976 (1001)
.+|++|||.+..... .....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~-----------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS-----------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred CccceeeecCCcccccccc-----------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 489999998764321 112357788999998865 66899999999999999995 7999997654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=267.16 Aligned_cols=201 Identities=30% Similarity=0.455 Sum_probs=172.8
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+|+..+.||+|+||.||+|... +++.||+|.+..... .+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999864 689999999865433 36788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++++|.+++... ...++..+..++.|+++|++|||+. +|+||||+|+||++++++.+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999999864 3478888999999999999999998 9999999999999999999999999999876443221
Q ss_pred CCCCCCCCCcccccccccCccccccCC---CCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQR---ITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.. .......+++.|+|||++.... ++.++||||||+++||+++|+.||...
T Consensus 156 ~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 156 MG---EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cc---ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 11 1012346788999999987765 889999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=269.01 Aligned_cols=200 Identities=28% Similarity=0.381 Sum_probs=167.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC----CCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN----GETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
++|++.+.||+|+||.||+|.+.+ ...||||...... ..+.+.+|+.++++++||||+++++++.+. ..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEE
Confidence 457888999999999999998643 3468999886543 235788999999999999999999988754 56899
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++|+|.+++.... ..+++..+..++.|++.|++|+|+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999997643 3579999999999999999999998 9999999999999999999999999999866432
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.... .....++..|+|||.+....++.++||||||+++||+++ |+.||.+..
T Consensus 161 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 161 SYYK------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred ccee------cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 1111 112234568999999988889999999999999999986 999997654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=272.46 Aligned_cols=198 Identities=27% Similarity=0.385 Sum_probs=169.4
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 3788899999999999999875 68999999885432 225688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+. ++|.+++.......+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-- 154 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 154 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence 96 6899998776556689999999999999999999998 99999999999999999999999999987653221
Q ss_pred CCCCCCCCCcccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQ-RITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......+++.|+|||.+.+. .++.++||||||+++|||+||+.||.+.
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 155 -----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred -----cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 111223568899999988654 4688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=269.16 Aligned_cols=197 Identities=27% Similarity=0.382 Sum_probs=170.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+-|+..+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34778889999999999999864 68899999875433 225688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++..+....
T Consensus 84 ~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 84 LGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 999999999874 3478999999999999999999998 99999999999999999999999999987654321
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......|+..|+|||.+.+..++.++|+||+||++|+|++|..||...
T Consensus 156 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 156 -----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204 (277)
T ss_pred -----hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 1112246788999999998888899999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=274.92 Aligned_cols=200 Identities=29% Similarity=0.461 Sum_probs=166.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCC----EEEEEEecCCCch---hhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGE----TLAVKKMWSSDES---GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~---~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
.+|+..+.||+|+||.||+|++. +++ .||+|.+...... .++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45778889999999999999864 344 5788887654332 3688999999999999999999988754 4678
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
++||+++|+|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 86 v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence 99999999999999764 33478899999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
.... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||...
T Consensus 162 ~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 162 DEKE-----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred cccc-----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2111 11112345678999999998899999999999999999997 99999764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=281.15 Aligned_cols=196 Identities=23% Similarity=0.318 Sum_probs=167.8
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecC------
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK------ 832 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~------ 832 (1001)
+.++|+..+.||+|+||.||+|+.. +++.||+|++.... ..+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 5688999999999999999999865 68999999885421 235677899999999999999999987543
Q ss_pred CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccc
Q 001873 833 NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLA 912 (1001)
Q Consensus 833 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla 912 (1001)
...++||||++ ++|.+.+... +++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35699999996 5888888642 78888999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+...... ......+++.|+|||.+.+..++.++||||+||++|+|++|+.||...
T Consensus 166 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 166 RTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred eeCCCCC--------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 8653211 122346889999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=270.87 Aligned_cols=197 Identities=27% Similarity=0.314 Sum_probs=173.7
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
+|++.+.||+|+||.||+|+.. +++.||+|.+.... ..+.+.+|++++++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999976 58999999885432 34678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++++|.+++... ..+++..+..++.|+++|+.|||+. +++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999764 4588999999999999999999998 99999999999999999999999999987654321
Q ss_pred CCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......|+..|+|||.+....++.++|+||+|+++|+|++|+.||....
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 1123457889999999988889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=267.01 Aligned_cols=198 Identities=29% Similarity=0.485 Sum_probs=175.8
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
+|++.+.||+|++|.||+|+.. +++.||||++..... .+++.+|+..+++++|+||+++++++...+..++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5788899999999999999976 599999999866543 478999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHH-DCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
++++|.+++... ..+++..+.+++.|+++|++|+|+ . +++||||+|+||+++.++.++++|||.+........
T Consensus 82 ~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 155 (264)
T cd06623 82 DGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD- 155 (264)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC-
Confidence 999999999864 458999999999999999999999 8 999999999999999999999999999887643211
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......++..|+|||.+....++.++|+||||+++|+|++|+.||....
T Consensus 156 ------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 156 ------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred ------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 1123467889999999988899999999999999999999999997764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=270.14 Aligned_cols=201 Identities=28% Similarity=0.407 Sum_probs=170.6
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-chhhHHHHHHHhhcc-CCCceeeEEeeeecCC------ce
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKN------LK 835 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~------~~ 835 (1001)
.++|++.+.||+|+||.||+|+.+ +++.||+|.+.... ..+++.+|+.+++++ +|+||+++++++.... ..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 478999999999999999999975 57899999886543 346789999999999 7999999999986544 48
Q ss_pred EEEEEccCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAG--KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~ 913 (1001)
++||||+++++|.++++... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.+|++|||.+.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccce
Confidence 99999999999999987543 45678999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCcccccc-----CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-----QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
...... .......|+..|+|||++.. ..++.++||||+|+++|+|++|+.||...
T Consensus 162 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 162 QLDSTL-------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred ecccch-------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 653221 11223468899999998743 45678999999999999999999999754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=267.73 Aligned_cols=196 Identities=21% Similarity=0.302 Sum_probs=156.8
Q ss_pred CeEeecCCeeEEEEEeCCC---CEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCC
Q 001873 772 NVIGTGSSGVVYRVTIPNG---ETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNG 845 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 845 (1001)
++||+|+||+||+++..++ ..+++|.+.... ..+.+.+|+..++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3589999999999975433 356677664332 2367899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 846 SLSSLLHGAGK--GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 846 sL~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+|.+++++... ...++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~--- 154 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY--- 154 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchh---
Confidence 99999976422 3356677788999999999999998 999999999999999999999999999864321110
Q ss_pred CCCCCCCcccccccccCcccccc-------CCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASM-------QRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
........|+..|+|||++.. ..++.++||||||+++|||++ |..||...
T Consensus 155 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 212 (268)
T cd05086 155 --IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL 212 (268)
T ss_pred --hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence 111123467889999998743 345779999999999999997 56788643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=267.38 Aligned_cols=196 Identities=29% Similarity=0.399 Sum_probs=158.5
Q ss_pred CeEeecCCeeEEEEEeC----CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeee-cCCceEEEEEccC
Q 001873 772 NVIGTGSSGVVYRVTIP----NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGS-NKNLKLLFYDYLP 843 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~-~~~~~~lv~e~~~ 843 (1001)
+.||+|+||+||+|+.. ++..||+|++..... .+.+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 245799998754332 357888999999999999999999765 4556789999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+|+|.+++.+.. ...++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~-- 154 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY-- 154 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce--
Confidence 999999997642 3357778888999999999999998 9999999999999999999999999999765322110
Q ss_pred CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhC-CCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTG-RHPLDP 974 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg-~~Pf~~ 974 (1001)
.........++..|+|||.+....++.++|||||||++|||++| ..||..
T Consensus 155 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 155 -SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred -eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 01111223467789999999888999999999999999999995 555653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=274.28 Aligned_cols=210 Identities=26% Similarity=0.342 Sum_probs=172.4
Q ss_pred cccHHHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecC
Q 001873 758 DFSIDDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNK 832 (1001)
Q Consensus 758 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~ 832 (1001)
++++.+..++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 4 EFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred cCcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 4556677789999999999999999999865 689999998854322 23567899999999999999999987654
Q ss_pred C--------ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcE
Q 001873 833 N--------LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQA 904 (1001)
Q Consensus 833 ~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 904 (1001)
+ ..++||||+. +++.+++... ...+++.++..++.|++.|++|||++ +++||||||+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~ 158 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGIL 158 (310)
T ss_pred cccccCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcE
Confidence 4 4499999996 5888888654 23579999999999999999999998 99999999999999999999
Q ss_pred EEecccccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 905 YLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 905 ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
||+|||.+..+....... ........++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.+.
T Consensus 159 kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 159 KLADFGLARAFSLSKNSK---PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred EECcCCCcccccCCcccC---CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999998764332211 111223467889999998765 44788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=274.40 Aligned_cols=198 Identities=24% Similarity=0.402 Sum_probs=169.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
++|++.+.||+|+||.||+|.++ +++.||+|++.... ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888899999999999999976 58999999875432 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|++++++..+.... ..+++..+..++.|+++|++|||+. +++||||+|+||++++++.++++|||++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999998887643 3479999999999999999999998 99999999999999999999999999988654321
Q ss_pred CCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 155 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 155 ------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred ------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 11122457889999998865 45788999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=266.97 Aligned_cols=197 Identities=27% Similarity=0.431 Sum_probs=164.7
Q ss_pred cCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCC
Q 001873 769 TSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNG 845 (1001)
Q Consensus 769 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 845 (1001)
.....||+|+||.||+|+.. ++..||+|.+.... ..+.+.+|+.++++++|+||+++++++..++..++|+||++++
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 90 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG 90 (268)
T ss_pred CceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence 34457999999999999865 57889999876543 3367899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC-CCcEEEecccccccccCCCCCCC
Q 001873 846 SLSSLLHGAG-KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP-GYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 846 sL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+|.++++... ....++..+..++.|++.|++|||++ +|+||||||+||+++. ++.+||+|||.+.......
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~---- 163 (268)
T cd06624 91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN---- 163 (268)
T ss_pred CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCC----
Confidence 9999998642 21227788888999999999999998 9999999999999986 6799999999987653211
Q ss_pred CCCCCCCcccccccccCccccccC--CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASMQ--RITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......|++.|+|||++... .++.++||||+|+++|+|++|+.||...
T Consensus 164 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 164 ---PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred ---CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 111223578999999998653 4788999999999999999999999754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=264.21 Aligned_cols=196 Identities=28% Similarity=0.409 Sum_probs=166.6
Q ss_pred CeEeecCCeeEEEEEeCCCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCCHH
Q 001873 772 NVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLS 848 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 848 (1001)
++||+|+||.||++...+++.||+|++..... .+.+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46899999999999987799999998865432 357889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCCC
Q 001873 849 SLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQ 928 (1001)
Q Consensus 849 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~ 928 (1001)
+++.+. ....++..+..++.+++.|++|||++ +++||||||+||+++.++.+||+|||.+......... ..
T Consensus 81 ~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-----~~ 151 (251)
T cd05041 81 TFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT-----VS 151 (251)
T ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcce-----ec
Confidence 999764 23578899999999999999999998 9999999999999999999999999999865321110 00
Q ss_pred CCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 929 RPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 929 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.....++..|+|||.+.+..++.++||||+|+++|||+| |+.||....
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 111234567999999988889999999999999999999 888886543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=270.64 Aligned_cols=197 Identities=30% Similarity=0.437 Sum_probs=172.6
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
+|+..+.||+|+||.||++..+ +++.||+|++.... ..+++.+|++++++++||||+++++++......++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777889999999999999976 68999999886543 2357889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHH-DCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
++++|.+++.... ..+++..+.+++.|++.|++|+|+ . +++||||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 9999999998653 557889999999999999999999 7 999999999999999999999999999876532211
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
....++..|+|||.+.+..++.++||||+|+++|+|++|+.||....
T Consensus 157 --------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 203 (265)
T cd06605 157 --------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEN 203 (265)
T ss_pred --------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence 11468889999999988899999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=269.30 Aligned_cols=197 Identities=26% Similarity=0.422 Sum_probs=169.9
Q ss_pred cccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCC---chhhHHHHHHHhhccC---CCceeeEEeeeecCCceEEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSD---ESGAFSSEIQTLGSIR---HKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~---h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
.|+..+.||+|+||.||+|.+ .+++.||+|.+.... ..+++.+|+.++++++ ||||+++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999986 478999999885432 3357889999999996 999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++++|.++++.. .+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998752 578999999999999999999998 99999999999999999999999999998764322
Q ss_pred CCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||+...
T Consensus 156 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 206 (277)
T cd06917 156 -------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206 (277)
T ss_pred -------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223468899999998865 456899999999999999999999997653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=270.29 Aligned_cols=196 Identities=30% Similarity=0.422 Sum_probs=164.2
Q ss_pred CeEeecCCeeEEEEEeCC-------CCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 772 NVIGTGSSGVVYRVTIPN-------GETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+.||+|+||.||+|+..+ ++.||+|.+.... ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999875432 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC-----cEEEecccc
Q 001873 842 LPNGSLSSLLHGAG-----KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY-----QAYLADFGL 911 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~-----~~ki~Dfgl 911 (1001)
+++++|.+++++.. ...+++.++..++.|++.|++|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 23468899999999999999999998 999999999999999877 899999999
Q ss_pred cccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 912 ARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 912 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
++.+...... .......++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 158 ARDIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred cccccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 9865432111 11122345778999999998899999999999999999998 99998644
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=271.27 Aligned_cols=199 Identities=25% Similarity=0.334 Sum_probs=167.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
++|++.+.||+|++|.||+|+.. ++++||+|++.... ..+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999875 68999999885432 22568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC-CCcEEEecccccccccCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP-GYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~ki~Dfgla~~~~~~~ 919 (1001)
|++ +++.+++........++..+..++.||+.|++|||++ +++||||||+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 6888888665444568888889999999999999998 9999999999999985 5679999999997643211
Q ss_pred CCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......+++.|+|||++.+ ..++.++||||+|+++|+|+||+.||...
T Consensus 158 -------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 158 -------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred -------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11122357889999998865 46789999999999999999999999754
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=270.79 Aligned_cols=197 Identities=26% Similarity=0.319 Sum_probs=167.5
Q ss_pred cccCCCeEeecCCeeEEEEEe----CCCCEEEEEEecCCC------chhhHHHHHHHhhcc-CCCceeeEEeeeecCCce
Q 001873 767 NLTSANVIGTGSSGVVYRVTI----PNGETLAVKKMWSSD------ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~------~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~ 835 (1001)
.|++.+.||+|+||.||.|+. .+|+.||+|++.... ..+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 377889999999999999885 368999999885422 225678899999999 599999999999988899
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
++||||+++++|.+++... ..+++..+..++.|++.|+.|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999999764 3478888899999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCCCCCCCCCCCcccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASM--QRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
..... .......|+..|+|||.+.. ..++.++||||||+++|+|++|+.||..
T Consensus 156 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 156 HEDEV------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ccccc------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 32211 11223468899999999865 3467899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=267.04 Aligned_cols=199 Identities=33% Similarity=0.495 Sum_probs=168.8
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC------------chhhHHHHHHHhhccCCCceeeEEeeeecCC
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD------------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN 833 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~------------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~ 833 (1001)
+|...+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778889999999999999854 68999999874311 0135778999999999999999999999999
Q ss_pred ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccc
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~ 913 (1001)
..++||||+++++|.+++++. ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999865 3578888999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCccccccCC--CCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR--ITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
....... ........|+..|+|||...... ++.++|+||+|+++||+++|+.||...
T Consensus 157 ~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 157 KSDDIYD-----NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred ccccccc-----ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 6432111 11123346889999999987644 789999999999999999999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=279.29 Aligned_cols=200 Identities=26% Similarity=0.345 Sum_probs=166.8
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecC-----Cce
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK-----NLK 835 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~-----~~~ 835 (1001)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999864 68999999985322 235688899999999999999999876544 357
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
++|+||++ +++.+++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 89999996 588888763 4589999999999999999999998 9999999999999999999999999999875
Q ss_pred cCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
...... ........||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 157 DPEHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred cccccc----cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 432211 112233568999999998654 56889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=271.42 Aligned_cols=198 Identities=28% Similarity=0.394 Sum_probs=170.4
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+|++.+.||+|+||.||+|..+ +++.||||++... ...+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 6888999999999999999876 5889999987542 2236788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
++++.+..+.... ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.+||+|||.+........
T Consensus 82 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 82 VERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 9987777666542 3478999999999999999999998 999999999999999999999999999987643321
Q ss_pred CCCCCCCCCcccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQ-RITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......++..|+|||++.+. .++.++||||+|+++|+|++|+.||...
T Consensus 156 -----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 156 -----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred -----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 112234678899999999877 8899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=272.70 Aligned_cols=197 Identities=31% Similarity=0.384 Sum_probs=168.0
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
+..+.|+..+.||+|+||+||+|+.. +++.||+|++.... ..+++.+|++++++++||||+++.+++.+.+..+
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 34467899999999999999999865 68999999885332 1246889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
+||||++ |++.+++... ...+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||++....
T Consensus 92 lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 92 LVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred EEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9999997 6777777543 23479999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHAS---MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.. ....|++.|+|||++. ...++.++||||||+++|||+||+.||...
T Consensus 167 ~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 167 PA-----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred CC-----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 21 1235788999999874 466889999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=268.57 Aligned_cols=197 Identities=28% Similarity=0.399 Sum_probs=170.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
..|...+.||+|++|.||++... +++.||+|++.... ..+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 34556679999999999999864 68999999875433 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+.......
T Consensus 99 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--- 169 (285)
T cd06648 99 EGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--- 169 (285)
T ss_pred CCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC---
Confidence 99999999976 3478899999999999999999998 99999999999999999999999999887543211
Q ss_pred CCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......|++.|+|||...+..++.++||||+|+++|||++|+.||...
T Consensus 170 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~ 218 (285)
T cd06648 170 ----PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218 (285)
T ss_pred ----cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence 1122346889999999998888999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-31 Score=257.36 Aligned_cols=210 Identities=27% Similarity=0.348 Sum_probs=173.8
Q ss_pred ccHHHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCch----hhHHHHHHHhhccCCCceeeEEeeeec--
Q 001873 759 FSIDDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDES----GAFSSEIQTLGSIRHKNIVRLLGWGSN-- 831 (1001)
Q Consensus 759 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~Ei~~l~~l~h~nIv~l~~~~~~-- 831 (1001)
++..+....|+...+||+|.||+||+|+.+ .|+.||+|++..+.+. ....+|+.++..++|+|++.+++.|..
T Consensus 10 ~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 10 EPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred CCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 344455667888889999999999999976 5788999987554433 467799999999999999999987642
Q ss_pred ------CCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEE
Q 001873 832 ------KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAY 905 (1001)
Q Consensus 832 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 905 (1001)
....|+||++|+ .+|.-++... ...++..++.+++.++..|+.|+|+. .|+|||+||.|++|+.+|.+|
T Consensus 90 Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilk 164 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILK 164 (376)
T ss_pred CCcccccceeeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEE
Confidence 345799999997 6899888754 45689999999999999999999998 999999999999999999999
Q ss_pred EecccccccccCCCCCCCCCCCCCCcccccccccCccccc-cCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 906 LADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS-MQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 906 i~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
|+|||+|+.+....+.. ....+..+-|.+|++||.+. .+.|+.+.|||+-||||.||+||.+-+.+..
T Consensus 165 lADFGlar~fs~~~n~~---kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt 233 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVV---KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT 233 (376)
T ss_pred eeccccccceecccccC---CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh
Confidence 99999998776543322 22344567799999999875 4789999999999999999999987666543
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=270.47 Aligned_cols=202 Identities=27% Similarity=0.383 Sum_probs=176.6
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
+..+.|+..+.+|+|+||.||+|.++ +++.||+|++..... .+.+.+|++.+++++|+||+++++++...+..++|+|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 44567888899999999999999976 689999999865443 5678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++++|.+++.... ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999998753 3689999999999999999999998 999999999999999999999999999876532211
Q ss_pred CCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 172 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~ 219 (286)
T cd06614 172 -------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE 219 (286)
T ss_pred -------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 122335788999999998888999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=266.83 Aligned_cols=189 Identities=23% Similarity=0.256 Sum_probs=157.8
Q ss_pred eEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-----hhhHHHHHHH---hhccCCCceeeEEeeeecCCceEEEEEccC
Q 001873 773 VIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-----SGAFSSEIQT---LGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 773 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~Ei~~---l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
.||+|+||+||++... +++.||+|.+..... ...+..|..+ ++...||+|+++.+++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 588999998754321 1223444433 444579999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
||+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----- 150 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----- 150 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-----
Confidence 99999998753 4589999999999999999999998 9999999999999999999999999998754321
Q ss_pred CCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......|+..|+|||.+.+ ..++.++||||+|+++|||++|+.||...
T Consensus 151 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 151 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred ----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 1123468999999999874 46889999999999999999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=275.57 Aligned_cols=198 Identities=25% Similarity=0.326 Sum_probs=173.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCC-EEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGE-TLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
.+++++..||-|+||.|-+++..+.. .+|+|.+++.. ..+....|-.+|..++.|.||++|..|.++++.|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666778999999999999875433 38888775432 2355778999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
|-|-||.++..+++.+ .++..+..-++..+..|++|||++ +||+|||||+|.+++.+|-+|+.|||.|+.+...
T Consensus 500 EaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g- 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG- 573 (732)
T ss_pred HhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence 9999999999999754 488888888999999999999999 9999999999999999999999999999987543
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
...-+.+|||.|.|||++.++..+.++|.||+|+.+||+++|++||.+..
T Consensus 574 -------~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d 623 (732)
T KOG0614|consen 574 -------RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD 623 (732)
T ss_pred -------CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence 22345699999999999999999999999999999999999999998764
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=275.33 Aligned_cols=201 Identities=22% Similarity=0.268 Sum_probs=164.1
Q ss_pred eEeec--CCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCC
Q 001873 773 VIGTG--SSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNG 845 (1001)
Q Consensus 773 ~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 845 (1001)
.||+| +||+||++++. +++.||||.+..... .+.+.+|+.+++.++||||+++++++..++..++||||++++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 99999999875 799999999864331 256888999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCC
Q 001873 846 SLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSK 925 (1001)
Q Consensus 846 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 925 (1001)
++.+++.+.....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++||+.+.............
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 999999876556689999999999999999999998 99999999999999999999999998664432221111111
Q ss_pred CCCCCcccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 926 TNQRPQLAGSYGYMAPEHASM--QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 926 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
........++..|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 111112235677999999866 457899999999999999999999997653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=268.98 Aligned_cols=197 Identities=27% Similarity=0.395 Sum_probs=168.6
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeec--CCceEEEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSN--KNLKLLFYD 840 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e 840 (1001)
+|+..+.||.|++|.||++... +++.||+|.+..... ..++.+|++++++++||||+++++++.+ .+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5777889999999999999975 588999998864332 3678899999999999999999998754 346799999
Q ss_pred ccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 841 YLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|+++++|.+++... ....+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 99999999987642 234478889999999999999999998 9999999999999999999999999998764321
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||+..
T Consensus 159 ~---------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 159 L---------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred c---------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1 11235788999999999889999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=268.87 Aligned_cols=199 Identities=26% Similarity=0.400 Sum_probs=169.3
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
+|+..+.||+|++|.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999975 68999999886432 2356778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 843 PNGSLSSLLHGAG-KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 843 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+ ++|.+++.... ...+++..+.+++.|++.|++|||+. +++||||||+||++++++.++++|||+++......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 8 58999887543 24579999999999999999999998 99999999999999999999999999997653211
Q ss_pred CCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+..
T Consensus 155 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 155 -----NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred -----cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11122357889999998755 457889999999999999999999997653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=269.39 Aligned_cols=203 Identities=28% Similarity=0.408 Sum_probs=171.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-----CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeec--CCce
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-----NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSN--KNLK 835 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~--~~~~ 835 (1001)
+.|+..+.||+|+||.||+|++. +++.||||.+..... .+++.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45778899999999999999853 368899999865544 4689999999999999999999999877 5578
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
++||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999998653 2489999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
....... .......++..|+|||......++.++||||||+++|||+||+.||....
T Consensus 160 ~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 160 PEDKDYY----YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred ccCCcce----eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 5322111 11112245567999999988889999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=266.53 Aligned_cols=199 Identities=25% Similarity=0.368 Sum_probs=172.2
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+|+..+.||+|+||.||+|... ++..||+|.+... .+.+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778889999999999999875 5889999988543 3446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC-cEEEecccccccccCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY-QAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~Dfgla~~~~~~~~ 920 (1001)
+++++|.+++.+.....+++..+..++.|+++|+.|||+. +++|+||||+||++++++ .+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999875555679999999999999999999998 999999999999999875 569999999876543211
Q ss_pred CCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......|++.|+|||+.....++.++|+||||+++|||++|+.||...
T Consensus 158 -------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 158 -------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred -------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 112235889999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=270.06 Aligned_cols=199 Identities=28% Similarity=0.316 Sum_probs=168.7
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecC--CceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNK--NLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~--~~~~l 837 (1001)
.++|+..+.||+|+||.||+|+.+ +++.||+|+++.... ...+.+|+.++++++||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357889999999999999999976 588999998864332 23567899999999999999999988776 88999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||++ ++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 84 v~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 84 VMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred EehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999997 59999987643 3589999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.. .......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||...
T Consensus 159 ~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 159 PL-------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred Cc-------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 21 11122357889999998865 44688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=252.63 Aligned_cols=198 Identities=22% Similarity=0.321 Sum_probs=174.3
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~l 837 (1001)
...|...++||+|+|++|..++++ +.+.||+|+++++ .+....+.|-.+.... +||.+|-+..+|..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467889999999999999999865 6788999988643 2335677788887666 79999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
|.||++||+|.-+++++ +.++++.++-+...|+-|+.|||++ |||+||+|.+||++|..|++|++|+|+++.--.
T Consensus 329 vieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999998888764 4589999998999999999999999 999999999999999999999999999986322
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
......+.+|||.|.|||++.+..|+..+|-|++||+|+||+.|+.||+.
T Consensus 404 -------~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 404 -------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred -------CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 23345667999999999999999999999999999999999999999984
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=264.72 Aligned_cols=190 Identities=28% Similarity=0.363 Sum_probs=167.0
Q ss_pred EeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCCH
Q 001873 774 IGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSL 847 (1001)
Q Consensus 774 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 847 (1001)
||+|+||.||+++.. +++.||+|++.... ..+.+.+|+.++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 48999999885432 236788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCC
Q 001873 848 SSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTN 927 (1001)
Q Consensus 848 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 927 (1001)
.+++.+. ..+++..+..++.|+++|++|+|+. +++|+||||+||+++.++.++|+|||.++......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-------- 147 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-------- 147 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--------
Confidence 9999764 3478899999999999999999998 99999999999999999999999999998764321
Q ss_pred CCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 928 QRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 928 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......|++.|+|||.+....++.++|+||+|+++|+|++|+.||....
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 1223468899999999988889999999999999999999999998664
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=265.05 Aligned_cols=199 Identities=27% Similarity=0.418 Sum_probs=169.2
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeec--CCceEEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSN--KNLKLLFY 839 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~--~~~~~lv~ 839 (1001)
+|++.+.||.|+||.||++... +++.||+|.+.... ..+++.+|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999854 68899999885432 23568889999999999999999997753 45678999
Q ss_pred EccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeEEeCCCCCCeEECCCCcEEEeccccc
Q 001873 840 DYLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLH-----HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLA 912 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH-----~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla 912 (1001)
||+++++|.+++... ....+++..+..++.|++.|++|+| +. +++||||||+||++++++.+|++|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999753 2345789999999999999999999 65 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
........ ......|++.|+|||++....++.++|+||||+++|+|++|+.||+..
T Consensus 158 ~~~~~~~~-------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 158 KILGHDSS-------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred ccccCCcc-------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 87643211 122346889999999998888999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=269.46 Aligned_cols=199 Identities=22% Similarity=0.266 Sum_probs=165.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccC-CCceeeEEeeeecCCc-----
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNL----- 834 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~----- 834 (1001)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888999999999999999965 68999999875432 2256888999999995 6999999998876655
Q ss_pred eEEEEEccCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC-CCcEEEeccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAG---KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP-GYQAYLADFG 910 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~ki~Dfg 910 (1001)
.++||||+++ +|.+++.... ...+++..+..++.||+.|+.|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 8988886542 23579999999999999999999998 9999999999999998 8899999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.++.+.... .......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...
T Consensus 157 ~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 157 LGRAFSIPV-------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cceecCCCc-------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 987653221 11122356889999998754 56789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=268.09 Aligned_cols=188 Identities=24% Similarity=0.342 Sum_probs=156.9
Q ss_pred CeEeecCCeeEEEEEeCC--------CCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 772 NVIGTGSSGVVYRVTIPN--------GETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+.||+|+||+||+|..+. ..+||+|.+.... ..+++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999997632 2348888775432 235788899999999999999999999988889999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCc--------EEEecccccc
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQ--------AYLADFGLAR 913 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~ki~Dfgla~ 913 (1001)
+++|+|.++++..+ ..+++..+.+++.||+.|++|||+. +|+||||||+||+++.++. ++++|||.+.
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999998653 3578999999999999999999998 9999999999999987765 6899999886
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCC-CCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGR-HPLDP 974 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~-~Pf~~ 974 (1001)
.... .....+++.|+|||++.+ ..++.++||||||+++|||++|. .||..
T Consensus 157 ~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 157 TVLP-----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred ccCC-----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 5421 122357889999999876 45789999999999999999985 56554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=270.90 Aligned_cols=199 Identities=31% Similarity=0.369 Sum_probs=167.2
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecC--CceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNK--NLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~--~~~~l 837 (1001)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999975 689999998854322 23467899999999999999999988654 46799
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||++ ++|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 86 v~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999997 5898888754 24589999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.. .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 161 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 161 PA-------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred cc-------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 11122346788999998865 56789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=269.77 Aligned_cols=198 Identities=27% Similarity=0.353 Sum_probs=163.5
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccC-CCceeeEEeeeecCCceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+|+..+.||+|+||.||++... +++.||+|++.... ....+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999865 68999999886432 2356889999999996 99999999999888899999999
Q ss_pred cCCCCHHHHh---hcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 842 LPNGSLSSLL---HGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 842 ~~~gsL~~~l---~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
+. +++.++. .......+++..+.+++.|++.|++|||+.+ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 86 4655543 3333456899999999999999999999742 8999999999999999999999999999765322
Q ss_pred CCCCCCCCCCCCcccccccccCccccccC---CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQ---RITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. ......|++.|+|||++... .++.++||||+||++|||++|+.||...
T Consensus 162 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 162 I--------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred C--------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 1 11223578899999998765 6889999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-28 Score=259.23 Aligned_cols=197 Identities=28% Similarity=0.423 Sum_probs=174.7
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccC
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
.|+..+.||+|++|.||++... +++.||+|++.... ..+.+.+|++++++++||+|+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3777889999999999999975 68999999986655 45789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+++|.+++.... ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999997642 4589999999999999999999998 999999999999999999999999999887643211
Q ss_pred CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.....|+..|+|||.+....++.++||||+|+++|+|++|+.||...
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23346888999999998888999999999999999999999999765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=266.55 Aligned_cols=197 Identities=27% Similarity=0.372 Sum_probs=168.4
Q ss_pred ccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 768 LTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
|++.+.||+|++|+||+|... +|+.||+|++.... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999865 79999999885433 2256888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
+ ++|.+++.......+++..+.+++.|+++|++|||+. +++||||+|+||+++.++.++|+|||.++......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--- 153 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--- 153 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc---
Confidence 5 7999999876545689999999999999999999998 99999999999999999999999999997643211
Q ss_pred CCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||...
T Consensus 154 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 154 ----RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred ----cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11122356889999998765 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=264.44 Aligned_cols=201 Identities=22% Similarity=0.365 Sum_probs=163.4
Q ss_pred ccCCCeEeecCCeeEEEEEeC----CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCC------
Q 001873 768 LTSANVIGTGSSGVVYRVTIP----NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN------ 833 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~------ 833 (1001)
|++.+.||+|+||.||+|.++ +++.||||++.... ..+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 36889999886532 2356889999999999999999999875432
Q ss_pred ceEEEEEccCCCCHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecc
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAG----KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADF 909 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Df 909 (1001)
..++++||+++|+|.+++.... ...+++..+.+++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999998875321 22468888999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 910 gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
|.++....... ........+++.|++||......++.++||||||+++|||++ |+.||....
T Consensus 158 g~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 158 GLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred cccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence 99986532211 011112245678999999988889999999999999999999 889987553
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=291.89 Aligned_cols=201 Identities=24% Similarity=0.393 Sum_probs=159.4
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeec-------
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSN------- 831 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~------- 831 (1001)
....+|+..+.||+||||.||+++.+ ||+.||||++.... ....+.+|+..+++++|||||+++..|.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34456777889999999999999977 89999999996553 22568899999999999999998731100
Q ss_pred --------------------------------------------------------------------------------
Q 001873 832 -------------------------------------------------------------------------------- 831 (1001)
Q Consensus 832 -------------------------------------------------------------------------------- 831 (1001)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 001873 832 ------------------------K--------NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH 879 (1001)
Q Consensus 832 ------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH 879 (1001)
+ ...||-||||+...+.+++++... .-.....++++++|+.|+.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~-~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF-NSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc-chhhHHHHHHHHHHHHHHHHHH
Confidence 0 124678999998788888875321 1146778899999999999999
Q ss_pred hCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc----C-------CCCCCCCCCCCCCcccccccccCccccccC-
Q 001873 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS----G-------SGDDNCSKTNQRPQLAGSYGYMAPEHASMQ- 947 (1001)
Q Consensus 880 ~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~----~-------~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~- 947 (1001)
++ |||||||||.||++++++.|||+|||+|.... . .+..........+..+||.-|+|||++.+.
T Consensus 715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 99 99999999999999999999999999998732 0 111122222355677999999999998664
Q ss_pred --CCCCccchHHHHHHHHHHHh
Q 001873 948 --RITEKSDVYSFGVVLLEVLT 967 (1001)
Q Consensus 948 --~~~~~~Dv~SlG~il~ellt 967 (1001)
.|+.|+||||+|+|++||+.
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc
Confidence 59999999999999999974
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=271.79 Aligned_cols=201 Identities=21% Similarity=0.217 Sum_probs=164.1
Q ss_pred CCeEeecCCeeEEEEEeCCCCEEEEEEecCC----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCC
Q 001873 771 ANVIGTGSSGVVYRVTIPNGETLAVKKMWSS----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGS 846 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 846 (1001)
.+.+|.|+++.||+++. +++.||||++... ...+.+.+|++++++++||||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 33445555555555544 6899999998643 223678999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCC
Q 001873 847 LSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKT 926 (1001)
Q Consensus 847 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~ 926 (1001)
|.+++.......+++.....++.|+++|++|||++ +|+||||||+||+++.++.+||+|||.+..+...........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999876555688999999999999999999998 999999999999999999999999999876543322111111
Q ss_pred CCCCcccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 927 NQRPQLAGSYGYMAPEHASM--QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 927 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......++..|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 22233457889999999865 45889999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=274.73 Aligned_cols=202 Identities=22% Similarity=0.304 Sum_probs=169.0
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeec----CCce
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSN----KNLK 835 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~----~~~~ 835 (1001)
.++|++.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999865 69999999886432 23567789999999999999999987653 3467
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
++||||+. ++|.+++... ..+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||.+...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999996 6899998754 3489999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
...... .........|+..|+|||.+.. ..++.++||||+||++|||++|+.||.+.
T Consensus 158 ~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 158 SSSPTE---HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred cccCcC---CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 432211 1112233478999999998755 56889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=262.44 Aligned_cols=216 Identities=20% Similarity=0.264 Sum_probs=182.0
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCch-hhHHHHHHHhhccC-C-Cc----eeeEEeeeecCCce
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDES-GAFSSEIQTLGSIR-H-KN----IVRLLGWGSNKNLK 835 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~Ei~~l~~l~-h-~n----Iv~l~~~~~~~~~~ 835 (1001)
+..+|++.+.+|+|.||+|....+. .+..||||+++.-... ++..-|+++++++. + |+ +|++.+||+..++.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 3789999999999999999987643 5789999999764433 56777999999993 3 32 78899999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC---------------
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP--------------- 900 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~--------------- 900 (1001)
|||+|.+ |-|+++++.......++...++.|+.|++++++|||+. +++|.||||+||++.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999998 56999999998888899999999999999999999998 9999999999999832
Q ss_pred -----CCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 901 -----GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 901 -----~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+..+|++|||.|+... .....++.|..|+|||++.+-++++++||||+|||++|+.||...|...
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~----------e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDH----------EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred eccCCCcceEEEecCCcceec----------cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 2358999999998642 2335678999999999999999999999999999999999999877654
Q ss_pred CCCCcCcccchhhhhcccchhh
Q 001873 976 LPGGAPLVQWTPLMFLMLNLEA 997 (1001)
Q Consensus 976 ~~~~~~l~~~~~~~~~~~~~~~ 997 (1001)
++..+..+.-...||+|.
T Consensus 313 ----en~EHLaMMerIlGp~P~ 330 (415)
T KOG0671|consen 313 ----ENLEHLAMMERILGPIPS 330 (415)
T ss_pred ----CcHHHHHHHHHhhCCCcH
Confidence 355555555566666664
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-28 Score=259.39 Aligned_cols=200 Identities=33% Similarity=0.460 Sum_probs=175.3
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecC--CceEEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK--NLKLLFY 839 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~--~~~~lv~ 839 (1001)
+|+..+.||+|++|.||+|... +++.|++|++.... ..+.+.+|+.++++++||||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999976 68999999986554 246789999999999999999999999888 8899999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++++|.+++.+.. .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999998653 689999999999999999999998 99999999999999999999999999998765432
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.. .......++..|+|||......++.++||||+|+++|+|++|+.||....
T Consensus 156 ~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 156 TG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11 01233468889999999988889999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-28 Score=258.80 Aligned_cols=197 Identities=30% Similarity=0.456 Sum_probs=173.4
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+|++.+.||+|++|.||+++.. ++++||+|.+.... ..+.+.+|++++++++|||++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 67899999986554 336788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++++|.+++... ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK- 154 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence 9999999999764 4589999999999999999999998 999999999999999999999999999987643221
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......++..|+|||......++.++||||+|+++|+|++|+.||...
T Consensus 155 ------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~ 202 (254)
T cd06627 155 ------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL 202 (254)
T ss_pred ------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence 123346888999999988878899999999999999999999999753
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=273.51 Aligned_cols=204 Identities=26% Similarity=0.410 Sum_probs=169.5
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC----CchhhHHHHHHHhhcc-CCCceeeEEeeeecC--Cc
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS----DESGAFSSEIQTLGSI-RHKNIVRLLGWGSNK--NL 834 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~--~~ 834 (1001)
.+.++|++.+.||+|+||.||+|... +++.||||++... .....+.+|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 35678999999999999999999875 5889999987432 2235677899999999 999999999987643 36
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.++||||++ ++|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 799999997 6999998753 578888899999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
........ .........||+.|+|||.+.. ..++.++||||||+++|+|++|+.||...
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 157 LSELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred cccccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 64432211 1112233568999999998754 56788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=263.17 Aligned_cols=199 Identities=27% Similarity=0.422 Sum_probs=167.3
Q ss_pred cccCCCeEeecCCeeEEEEEeCC--CCEEEEEEecCCC------------chhhHHHHHHHhhc-cCCCceeeEEeeeec
Q 001873 767 NLTSANVIGTGSSGVVYRVTIPN--GETLAVKKMWSSD------------ESGAFSSEIQTLGS-IRHKNIVRLLGWGSN 831 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~------------~~~~~~~Ei~~l~~-l~h~nIv~l~~~~~~ 831 (1001)
.|++.+.||+|+||.||+|.... ++.+|||.+.... ...++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37788899999999999999764 7889999874221 12456778888765 799999999999999
Q ss_pred CCceEEEEEccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecc
Q 001873 832 KNLKLLFYDYLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADF 909 (1001)
Q Consensus 832 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Df 909 (1001)
++..++||||+++++|.+++... ....+++..+++++.|++.|+.|||+.. +++||||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988542 2345788999999999999999999631 8999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 910 gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
|.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 g~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 159 GLAKQKQPES--------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred cceeeccccc--------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 9998653221 122346888999999998888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-30 Score=255.17 Aligned_cols=215 Identities=27% Similarity=0.353 Sum_probs=174.3
Q ss_pred ccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecC-----CceEE
Q 001873 768 LTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK-----NLKLL 837 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~-----~~~~l 837 (1001)
.+..+.||.|+||.||.++++ +|+.||.|++..-. ..+.+.+|++++..++|+||+..++..... .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 455678999999999999875 79999999985432 237889999999999999999888765432 34578
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
++|.|. .+|.+++-.. ..++...++-+.+||++|++|||+. +|.||||||.|.+++.+..+||||||+|+....
T Consensus 135 ~TELmQ-SDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHH-hhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 899996 6888888653 4467777778899999999999998 999999999999999999999999999997543
Q ss_pred CCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhhhhcccchh
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLMLNLE 996 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~~~~~~~~~ 996 (1001)
+ ....++..+-|..|+|||++.+ +.|+.+.||||+|||+.|++.++..|. ...++.|...+..+.|.++
T Consensus 209 d------~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ----Aq~PiqQL~lItdLLGTPs 278 (449)
T KOG0664|consen 209 R------DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ----AAGPIEQLQMIIDLLGTPS 278 (449)
T ss_pred h------hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh----ccChHHHHHHHHHHhCCCc
Confidence 2 1223344467899999998865 789999999999999999999998666 4567777777777777554
Q ss_pred hh
Q 001873 997 AE 998 (1001)
Q Consensus 997 ~~ 998 (1001)
-|
T Consensus 279 ~E 280 (449)
T KOG0664|consen 279 QE 280 (449)
T ss_pred HH
Confidence 43
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=267.01 Aligned_cols=192 Identities=28% Similarity=0.402 Sum_probs=166.4
Q ss_pred CCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCCH
Q 001873 771 ANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSL 847 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 847 (1001)
..+||+|+||.||++..+ +++.||||++.... ....+.+|+.++++++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 357999999999999874 68999999875432 235688999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCC
Q 001873 848 SSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTN 927 (1001)
Q Consensus 848 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 927 (1001)
.+++.. ..+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||.+....... .
T Consensus 105 ~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-------~ 171 (292)
T cd06657 105 TDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-------P 171 (292)
T ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-------c
Confidence 998864 3478899999999999999999998 99999999999999999999999999887653211 1
Q ss_pred CCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 928 QRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 928 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......|++.|+|||......++.++|+||+|+++|||++|+.||...
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 122346889999999998888899999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=272.19 Aligned_cols=198 Identities=24% Similarity=0.333 Sum_probs=166.7
Q ss_pred HHHHHhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecC---
Q 001873 761 IDDVVRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK--- 832 (1001)
Q Consensus 761 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~--- 832 (1001)
+..+.++|++.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 455668899999999999999999985 468999999986432 235678899999999999999999987532
Q ss_pred ---CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecc
Q 001873 833 ---NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADF 909 (1001)
Q Consensus 833 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Df 909 (1001)
...+++++++ +++|.++++. ..+++..+..++.|+++|++|||+. +|+||||||+||++++++.+||+||
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~df 164 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 164 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecc
Confidence 3467888887 7899988864 3488999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 910 gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
|+++.... ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 165 g~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 165 GLARHTDD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred cccccccc----------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99875421 1123467889999998765 56888999999999999999999999643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=272.23 Aligned_cols=199 Identities=23% Similarity=0.333 Sum_probs=168.7
Q ss_pred cHHHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCC-
Q 001873 760 SIDDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKN- 833 (1001)
Q Consensus 760 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~- 833 (1001)
++.++.++|++.+.||+|+||.||++... +++.||||++..... .+.+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 45556788999999999999999999854 789999998854321 246789999999999999999999876543
Q ss_pred -----ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEec
Q 001873 834 -----LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLAD 908 (1001)
Q Consensus 834 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~D 908 (1001)
..++||||+ +++|.+++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 458999999 7899988864 3588999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 909 FGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 909 fgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
||.+...... .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||...
T Consensus 162 fg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 162 FGLARQTDSE----------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred cccccccccC----------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999764321 122357889999998865 46889999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=270.59 Aligned_cols=207 Identities=21% Similarity=0.261 Sum_probs=168.4
Q ss_pred HHhcccC-CCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCch----------------hhHHHHHHHhhccCCCceeeE
Q 001873 764 VVRNLTS-ANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDES----------------GAFSSEIQTLGSIRHKNIVRL 825 (1001)
Q Consensus 764 ~~~~~~~-~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~----------------~~~~~Ei~~l~~l~h~nIv~l 825 (1001)
+.++|.. .+.||+|+||+||+|... +++.||||++...... ..+.+|++++++++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3456654 467999999999999865 6899999988543221 147789999999999999999
Q ss_pred EeeeecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEE
Q 001873 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAY 905 (1001)
Q Consensus 826 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 905 (1001)
++++...+..++||||++ |+|.+++... ..+++.....++.|++.|++|||+. +|+||||||+||+++.++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 999999999999999997 6999998753 3478999999999999999999998 999999999999999999999
Q ss_pred EecccccccccCCCCC-------CCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 906 LADFGLARIVSGSGDD-------NCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 906 i~Dfgla~~~~~~~~~-------~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
++|||.++........ ............+++.|+|||.+.+ ..++.++||||+||++|||++|+.||....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999866421110 0001112223357889999998865 346899999999999999999999997553
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=264.28 Aligned_cols=197 Identities=27% Similarity=0.343 Sum_probs=166.8
Q ss_pred ccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhcc---CCCceeeEEeeeecCCc-----
Q 001873 768 LTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSI---RHKNIVRLLGWGSNKNL----- 834 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l---~h~nIv~l~~~~~~~~~----- 834 (1001)
|++.+.||+|+||.||+|+.+ +++.||+|++..... ...+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999986 489999999864322 24566788777666 59999999999887776
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.+++|||+. ++|.+++.......+++..+..++.|+++|+.|||+. +++|+||+|+||+++.++.+||+|||.+..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999997 5899998765445689999999999999999999998 999999999999999999999999999977
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+.... ......++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 157 YSFEM--------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred ccCCc--------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 53221 1122357889999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-28 Score=259.17 Aligned_cols=199 Identities=28% Similarity=0.403 Sum_probs=174.6
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+|++.+.||+|+||.||++... ++++||+|++... ...+.+.+|+++++.++|||++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999975 6899999998654 2346788999999999999999999999988999999999
Q ss_pred cCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 842 LPNGSLSSLLHGAG--KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
+++++|.+++.+.. ...+++..+..++.+++.|+.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999998653 35689999999999999999999998 99999999999999999999999999997653321
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......|++.|+|||......++.++||||+|+++|+|++|+.||+..
T Consensus 158 -------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 158 -------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred -------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 1222346889999999998888999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=259.89 Aligned_cols=189 Identities=26% Similarity=0.349 Sum_probs=159.9
Q ss_pred CeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-----hhhHHHHHHHh-hccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-----SGAFSSEIQTL-GSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~Ei~~l-~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
+.||+|+||.||+|+.. +++.||||.+..... ...+..|..++ ...+|+||+++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 689999999854321 12344455443 445899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
++|.++++.. ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.+||+|||.++....
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 9999999764 3478899999999999999999998 999999999999999999999999999875421
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.....|++.|+|||.+.+..++.++||||+|+++|||++|..||....
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 122357889999999988888999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=268.82 Aligned_cols=206 Identities=28% Similarity=0.385 Sum_probs=167.7
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecC-------
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNK------- 832 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~------- 832 (1001)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999865 689999998853322 24678899999999999999999876433
Q ss_pred -CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccc
Q 001873 833 -NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGL 911 (1001)
Q Consensus 833 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgl 911 (1001)
...++||||++ +++...+... ...+++..+..++.|+++|++|||+. +|+||||||+||++++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 34689999997 5777777653 34589999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCC----CCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 912 ARIVSGSGDDNCS----KTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 912 a~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
++........... .........|++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 9876443221110 1122234567899999998754 45889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=263.10 Aligned_cols=194 Identities=25% Similarity=0.280 Sum_probs=162.4
Q ss_pred ccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccC-CCceeeEEeeeecC--CceEEEEE
Q 001873 768 LTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIR-HKNIVRLLGWGSNK--NLKLLFYD 840 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~e 840 (1001)
|++.+.||+|+||.||+|+.. +++.||+|++.... ......+|+.+++++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999865 68999999886432 2234557888998885 99999999998877 88999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|++ |++.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++. +.+||+|||.++.......
T Consensus 81 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 997 5888888754 24579999999999999999999998 9999999999999999 9999999999986532211
Q ss_pred CCCCCCCCCCcccccccccCccccc-cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHAS-MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.....+++.|+|||++. +..++.++||||+||++|||++|+.||...
T Consensus 155 --------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~ 202 (282)
T cd07831 155 --------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT 202 (282)
T ss_pred --------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence 12235788999999764 456788999999999999999999999764
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=266.54 Aligned_cols=194 Identities=32% Similarity=0.392 Sum_probs=165.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
..|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+|++++++++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 44777889999999999999864 68999999885322 1246888999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||++ |++.+.+... ...+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 105 EYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred eCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9997 5888877543 34478999999999999999999998 999999999999999999999999998875421
Q ss_pred CCCCCCCCCCCcccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHAS---MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.....|++.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 178 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 178 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred ---------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 12235888999999873 466889999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=269.36 Aligned_cols=194 Identities=23% Similarity=0.331 Sum_probs=169.0
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----------hhhHHHHHHHhhccC---CCceeeEEeeeec
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----------SGAFSSEIQTLGSIR---HKNIVRLLGWGSN 831 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~Ei~~l~~l~---h~nIv~l~~~~~~ 831 (1001)
..|+..+.+|+|+||.|+.+.++ +...|+||.+++++- -...-.||++|+.++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35889999999999999999876 467788998865431 134667999999997 9999999999999
Q ss_pred CCceEEEEEcc-CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccc
Q 001873 832 KNLKLLFYDYL-PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFG 910 (1001)
Q Consensus 832 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfg 910 (1001)
++++|++||-. +|.+|.+++... ..+++..+.-|++|++.|+++||++ +|||||||-+||.++.+|-+|++|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeecc
Confidence 99999999985 456999999864 4589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRI-TEKSDVYSFGVVLLEVLTGRHPLD 973 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~elltg~~Pf~ 973 (1001)
.|..... ......+||.+|.|||++.+.+| +...|||++|+++|-++..+.||.
T Consensus 716 saa~~ks---------gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKS---------GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcC---------CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9986533 23345689999999999999888 578899999999999999998875
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=265.34 Aligned_cols=205 Identities=22% Similarity=0.379 Sum_probs=175.3
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccC-CCceeeEEeeeecCCceEEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
+|++.+.||+|+||.||+|+.. +++.||+|.+... ...+.+.+|+.++++++ ||||+++++++...+..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 6888999999999999999865 6899999987542 22356888999999998 999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++++|.+++.+.+ .+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++++|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 82 EYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999998643 589999999999999999999998 99999999999999999999999999998765432
Q ss_pred CCCCC-------------CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCS-------------KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
..... .........|+..|+|||+.....++.++||||+|+++|++++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 21100 0122334468899999999988889999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=263.59 Aligned_cols=198 Identities=28% Similarity=0.366 Sum_probs=168.4
Q ss_pred ccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecC--CceEEEEE
Q 001873 768 LTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK--NLKLLFYD 840 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e 840 (1001)
|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+|++++++++|||++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999976 58999999986542 235688999999999999999999999887 88999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|++ ++|.+++.... ..+++..+..++.|++.|++|||+. +++|+||||+||++++++.+||+|||.+........
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 997 58999887542 4689999999999999999999998 999999999999999999999999999987643321
Q ss_pred CCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 156 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 156 ------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred ------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223356789999997754 567899999999999999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=261.29 Aligned_cols=198 Identities=28% Similarity=0.414 Sum_probs=167.8
Q ss_pred EeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCCH
Q 001873 774 IGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSL 847 (1001)
Q Consensus 774 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 847 (1001)
||+|+||.||+++.. +++.||+|.+.... ..+.+.+|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999976 49999999885442 235788899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC-CCCC
Q 001873 848 SSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN-CSKT 926 (1001)
Q Consensus 848 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~ 926 (1001)
.+++++.+ .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++.......... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99998753 589999999999999999999998 99999999999999999999999999987643221100 0001
Q ss_pred CCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 927 NQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 927 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......++..|+|||......++.++||||||+++||+++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 12234468889999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=263.97 Aligned_cols=201 Identities=28% Similarity=0.363 Sum_probs=167.4
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCC-----
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN----- 833 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~----- 833 (1001)
..++|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999976 58999999885432 2246778999999999999999999886544
Q ss_pred -----ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEec
Q 001873 834 -----LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLAD 908 (1001)
Q Consensus 834 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~D 908 (1001)
..++|+||+++ ++.+.+... ...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999985 777777654 34589999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 909 FGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 909 fgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
||.+........ .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 fg~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 160 FGLARLYNSEES------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred ccccccccCCcc------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999987643221 11112246778999998754 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=271.34 Aligned_cols=196 Identities=23% Similarity=0.320 Sum_probs=164.8
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecC----
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK---- 832 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~---- 832 (1001)
.++.++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+|+.++++++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred hccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 344578999999999999999999864 68999999986432 224678999999999999999999987644
Q ss_pred --CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccc
Q 001873 833 --NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFG 910 (1001)
Q Consensus 833 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfg 910 (1001)
..+++|+||+. .++.++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 91 EFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred CCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence 24689999996 57777653 3478899999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+++..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 163 ~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 163 LARHADAE----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred CCcCCCCC----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 98754211 123367889999998865 56889999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=258.80 Aligned_cols=198 Identities=26% Similarity=0.371 Sum_probs=172.1
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+|++.++||+|+||.||+++.. +++.+|+|++.... ....+.+|++++++++|+||+++.+++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999865 68899999885432 235678899999999999999999999888999999999
Q ss_pred cCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 842 LPNGSLSSLLHGAG--KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
+++++|.+++.+.. ...+++..++.++.|++.|++|||+. +++||||+|+||++++++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999987622 24578899999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......+++.|+|||...+..++.++|+||+|+++|||++|+.||....
T Consensus 157 --------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 157 --------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred --------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1122357889999999998899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=270.01 Aligned_cols=199 Identities=24% Similarity=0.345 Sum_probs=167.4
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC----CchhhHHHHHHHhhccCCCceeeEEeeeecC-----C
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNK-----N 833 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~-----~ 833 (1001)
+.++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+|+.++++++||||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3467999999999999999999864 6899999987542 2235677899999999999999999977543 3
Q ss_pred ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccc
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~ 913 (1001)
..++||||+. ++|.+++... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 4799999996 7899998764 4589999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
...... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...
T Consensus 157 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 157 TTSEKG-------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred ccCCCc-------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 653221 11223467889999998764 56889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=263.05 Aligned_cols=197 Identities=26% Similarity=0.446 Sum_probs=164.1
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC-CCEEEEEEecCCC---chhhHHHHHHHhhccC-CCceeeEEeeeecCCceEEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN-GETLAVKKMWSSD---ESGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
++|++.+.||+|+||+||+|++.+ ++.||||++.... ....+.+|+.++.+.. ||||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 568889999999999999999864 8999999986433 2245667777776664 9999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+. +++.+++... ...+++..+..++.|+++|++|||+.+ +|+||||+|+||++++++.+||+|||.+..+....
T Consensus 95 ~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~- 169 (296)
T cd06618 95 LMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK- 169 (296)
T ss_pred ccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC-
Confidence 985 5787777653 236889999999999999999999732 89999999999999999999999999987653221
Q ss_pred CCCCCCCCCCcccccccccCccccccCC----CCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQR----ITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 170 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 170 -------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred -------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 112235778999999987543 78899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=269.53 Aligned_cols=200 Identities=25% Similarity=0.338 Sum_probs=171.1
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCC-----ceE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN-----LKL 836 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~-----~~~ 836 (1001)
+|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.+++.++||||+++.+++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999975 48999999886532 3467899999999999999999999887765 789
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
+||||++ ++|.+++.+.. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||.+....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 58999987643 689999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ-RITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
..... ........+++.|+|||++.+. .++.++|+||+|+++|+|++|+.||....
T Consensus 155 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 155 PDEDE----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred ccccc----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 43211 1112334678999999999877 88999999999999999999999997553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=263.30 Aligned_cols=197 Identities=27% Similarity=0.329 Sum_probs=166.8
Q ss_pred cccCCCeEeecCCeeEEEEEe----CCCCEEEEEEecCCC------chhhHHHHHHHhhcc-CCCceeeEEeeeecCCce
Q 001873 767 NLTSANVIGTGSSGVVYRVTI----PNGETLAVKKMWSSD------ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~------~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~ 835 (1001)
+|++.+.||+|+||.||+++. .+++.||||.+.... ..+.+.+|+++++++ +||||+++.+.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 377888999999999999874 257889999885421 235688899999999 599999999999989999
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
++||||+++|+|.+++... ..+++..+..++.|+++|++|||+. +++||||||+||+++.++.++++|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999998753 3478889999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccccCC--CCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR--ITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
..... .......|+..|+|||...+.. ++.++||||+|+++|||++|+.||..
T Consensus 156 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 156 LAEEE------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccc------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 43211 1112345889999999987654 78899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=288.56 Aligned_cols=145 Identities=31% Similarity=0.362 Sum_probs=130.6
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.++||+|+||+||+|... +++.||||++..... ...+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367899999999999999999976 689999999864321 25788899999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
|||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++.
T Consensus 83 mEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 83 MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999999764 3478888999999999999999998 999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=261.55 Aligned_cols=194 Identities=32% Similarity=0.387 Sum_probs=164.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
+.|...+.||+|+||+||+|+.. +++.||+|++.... ..+.+.+|++++++++|||++++++++.+....++||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 34677788999999999999864 68899999885322 1246788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+. |++.+++... ...+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+....
T Consensus 101 e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--- 172 (313)
T cd06633 101 EYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS--- 172 (313)
T ss_pred ecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence 9996 6888887653 34578999999999999999999998 99999999999999999999999999886421
Q ss_pred CCCCCCCCCCCcccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHAS---MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......|+..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 173 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 173 --------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred --------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 112346889999999874 456888999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=264.64 Aligned_cols=195 Identities=23% Similarity=0.340 Sum_probs=165.9
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC----CchhhHHHHHHHhhccCCCceeeEEeeeec-CCceEE
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS----DESGAFSSEIQTLGSIRHKNIVRLLGWGSN-KNLKLL 837 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~-~~~~~l 837 (1001)
+.++|++.+.||+|+||.||+|+.. +++.||||++... ...+.+.+|++++++++||||+++.+++.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 4578999999999999999999865 7899999987432 234678899999999999999999998765 557889
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
|+||+ +++|.++++. ..+++..+..++.|+++|++|||+. +|+||||||+||++++++.+||+|||.++....
T Consensus 88 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 88 VTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred Eeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 99999 5789988874 3467888888999999999999998 999999999999999999999999999875421
Q ss_pred CCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .....+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||...
T Consensus 161 ~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 161 Q----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred C----------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 122357889999998765 67899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=260.45 Aligned_cols=196 Identities=23% Similarity=0.334 Sum_probs=167.5
Q ss_pred ccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHhhccC-CCceeeEEeeeecCCceEEEEEcc
Q 001873 768 LTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
|++.+.||+|+||+||+|+.. +++.||||++..... .....+|+..+++++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999976 578999998854432 234567999999998 999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
+|+|.+++.......+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||.++......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 78999998875545689999999999999999999998 99999999999999999999999999998653221
Q ss_pred CCCCCCCCcccccccccCccccc-cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHAS-MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......++..|+|||++. ...++.++|+||||+++|||++|+.||...
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 154 -----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred -----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 112346788999999874 456789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=271.04 Aligned_cols=203 Identities=26% Similarity=0.387 Sum_probs=175.8
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-chhhHHHHHHHhhcc-CCCceeeEEeeee-----cCCceE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-ESGAFSSEIQTLGSI-RHKNIVRLLGWGS-----NKNLKL 836 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~-----~~~~~~ 836 (1001)
.+.|++.++||.|.+|.||+++.. +++.+|||+..... ..++.+.|..+++.. +|||++.++|++. .++.+|
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 356888899999999999999854 68889999875443 346788899998877 6999999999875 356889
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
+|||||-+||..|+++......+.|..+..|.+.++.|+.+||.. .++|||||-.||+++.++.||++|||.+.+++
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 999999999999999987777789999999999999999999998 99999999999999999999999999998775
Q ss_pred CCCCCCCCCCCCCCcccccccccCcccccc-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASM-----QRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
. ....+.+.+|||.|||||++.. ..|+.++|+||+|++..||--|.+|+..+.|
T Consensus 175 s-------T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP 233 (953)
T KOG0587|consen 175 S-------TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP 233 (953)
T ss_pred c-------ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence 3 3345566789999999998843 4677899999999999999999999877643
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=265.42 Aligned_cols=200 Identities=24% Similarity=0.310 Sum_probs=164.2
Q ss_pred cccCCCeEeecCCeeEEEEEeC-C--CCEEEEEEecCCC----chhhHHHHHHHhhcc-CCCceeeEEeeeec----CCc
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-N--GETLAVKKMWSSD----ESGAFSSEIQTLGSI-RHKNIVRLLGWGSN----KNL 834 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~--~~~vavK~~~~~~----~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~----~~~ 834 (1001)
+|++.+.||+|+||.||+++.. . +..||+|++.... ..+.+.+|+.+++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778889999999999999965 3 7899999885422 235678899999999 59999999986432 245
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.++++||+. ++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 688899986 6899998753 4588999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
....... .........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus 155 ~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 155 FSENPGE---NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred ccccccc---ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 6433221 1112234578999999998765 56889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=259.05 Aligned_cols=196 Identities=28% Similarity=0.362 Sum_probs=168.3
Q ss_pred ccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 768 LTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
|++.+.||+|++|.||++... +++.+|+|++..... ...+.+|++++++++|+||+++++++.++...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999865 689999998854332 357888999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
+ +++.+++.... ..+++..+..++.|++.|+.|||+. +|+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 81 D-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred C-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 7 48888887642 4689999999999999999999998 99999999999999999999999999998764332
Q ss_pred CCCCCCCCcccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASMQ-RITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......++..|+|||.+.+. .++.++||||+|+++|+|+||+.||...
T Consensus 153 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 202 (283)
T cd05118 153 ----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK 202 (283)
T ss_pred ----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 111223578899999998766 7899999999999999999999999654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=284.29 Aligned_cols=217 Identities=28% Similarity=0.379 Sum_probs=173.9
Q ss_pred ccCCCeEeecCCeeEEEEEeC----C----CCEEEEEEecCCC---chhhHHHHHHHhhcc-CCCceeeEEeeeecCCce
Q 001873 768 LTSANVIGTGSSGVVYRVTIP----N----GETLAVKKMWSSD---ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~----~----~~~vavK~~~~~~---~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~ 835 (1001)
..+.+.+|+|+||.|++|... . ...||||..+... +.+.+..|+++|+.+ +||||+.++|+|..++..
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 345568999999999998732 1 4579999986544 347899999999999 699999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCC------------C--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC
Q 001873 836 LLFYDYLPNGSLSSLLHGAG------------K--GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG 901 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~------------~--~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 901 (1001)
++|+||++.|+|.++++..+ . ..++..+.+.++.|||.||+||++. ++||||+..+||++.++
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKN 454 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCC
Confidence 99999999999999998764 0 1277889999999999999999998 99999999999999999
Q ss_pred CcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 001873 902 YQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTLPGGA 980 (1001)
Q Consensus 902 ~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~~~~~ 980 (1001)
..+||+|||+|+.......+.......+ -...|||||.+....|+.++|||||||++||++| |..||.+ .+...
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~----LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-~~~~~ 529 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGT----LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-IPPTE 529 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCc----cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC-CCcHH
Confidence 9999999999997654433221111100 1245999999999999999999999999999999 8888865 22233
Q ss_pred Ccccchhhhhcc
Q 001873 981 PLVQWTPLMFLM 992 (1001)
Q Consensus 981 ~l~~~~~~~~~~ 992 (1001)
++.++.+....+
T Consensus 530 ~l~~~l~~G~r~ 541 (609)
T KOG0200|consen 530 ELLEFLKEGNRM 541 (609)
T ss_pred HHHHHHhcCCCC
Confidence 334444444433
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=267.76 Aligned_cols=200 Identities=24% Similarity=0.342 Sum_probs=163.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecC---------
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK--------- 832 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~--------- 832 (1001)
..+|++.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367999999999999999999864 68999999885433 335688999999999999999999865543
Q ss_pred -----CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC-CCCcEEE
Q 001873 833 -----NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG-PGYQAYL 906 (1001)
Q Consensus 833 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ki 906 (1001)
...++||||++ ++|.+++.. ..+++..+..++.||+.|++|||+. +|+||||||+||+++ +++.+|+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 689988864 3478999999999999999999998 999999999999997 4567899
Q ss_pred ecccccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 907 ADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 907 ~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+|||.++....... .........|+..|+|||.+.. ..++.++||||+||++|||++|+.||...
T Consensus 157 ~dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 157 GDFGLARIVDPHYS----HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred CCcccceecCCccc----cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999976532211 1111122357889999997643 56788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=260.00 Aligned_cols=194 Identities=32% Similarity=0.397 Sum_probs=164.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
+.|+..+.||+|+||.||+|+.. +++.||+|.+.... ..+++.+|+++++.++|+|++++.+++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777788999999999999965 57899999875321 1246788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+. |++.+++... ...+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+|++|||++......
T Consensus 95 e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9996 6888877543 33478899999999999999999998 9999999999999999999999999998764321
Q ss_pred CCCCCCCCCCCcccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHAS---MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
....|++.|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 169 ----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred ----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 1235788999999874 356788999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=249.95 Aligned_cols=181 Identities=25% Similarity=0.220 Sum_probs=154.6
Q ss_pred cCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCCHHHHhhcCC
Q 001873 777 GSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAG 855 (1001)
Q Consensus 777 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 855 (1001)
|.||+||+++.. +++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF- 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-
Confidence 899999999865 68999999986543 3344555555667999999999999999999999999999999998764
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCCCCCccccc
Q 001873 856 KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGS 935 (1001)
Q Consensus 856 ~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt 935 (1001)
..+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.++++|||.+....... ....++
T Consensus 80 -~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----------~~~~~~ 145 (237)
T cd05576 80 -LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----------DGEAVE 145 (237)
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----------ccCCcC
Confidence 3488999999999999999999998 99999999999999999999999999886653211 122456
Q ss_pred ccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 936 YGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 936 ~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
..|+|||......++.++||||+|+++|||++|+.||+..
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 7899999998888999999999999999999999887643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-27 Score=257.19 Aligned_cols=196 Identities=28% Similarity=0.371 Sum_probs=168.3
Q ss_pred ccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 768 LTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
|+..+.||+|+||.||+|+.. +++.||+|++.... ..+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999976 58999999886532 2356788999999999999999999999989999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
+ ++|.+++.+.. ..+++..+.+++.|++.|++|||+. +|+||||+|+||++++++.+||+|||.++.......
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 7 59999998642 3589999999999999999999998 999999999999999999999999999886533211
Q ss_pred CCCCCCCCcccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASMQ-RITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......++..|+|||.+.+. .++.++||||+|+++||+++|+.||...
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 154 -----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred -----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 11223467789999998765 8889999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=254.42 Aligned_cols=197 Identities=25% Similarity=0.348 Sum_probs=163.9
Q ss_pred cccCCCeEeecCCeeEEEEEeCC-CCEEEEEEecC-------CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIPN-GETLAVKKMWS-------SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~-------~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
+|.+.+.||+|+||+||+++... +..+++|..+. ..+..++.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999998653 44555555432 12234577899999999999999999999988899999
Q ss_pred EEccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 839 YDYLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
|||+++++|.+++.+. ....+++..+..++.|++.|+.|||+. +++|+||||+||++++ +.+|++|||.++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988652 234579999999999999999999998 9999999999999975 579999999987654
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
.... ......|++.|+|||......++.++|+||+|+++|+|++|+.||..
T Consensus 157 ~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 157 GSCD-------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred CCcc-------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3211 12234578899999999888889999999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=264.00 Aligned_cols=196 Identities=27% Similarity=0.318 Sum_probs=166.1
Q ss_pred HhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCCchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEEEcc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSDESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
.+.|.....+|.|+|+.|-.... .+++..+||++... ..+..+|+.++.+. +||||++..+.+.+..+.|+|||.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc--ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 35677777899999999988764 46899999998655 34556788776666 6999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE-CCCCcEEEecccccccccCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL-GPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
.|+-+.+.+..... .. ..+..|+.+|+.|++|||++ ||||||+||+|||+ ++.++++|+|||.++.....
T Consensus 399 ~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 399 DGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred cccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 99988888775322 23 67778999999999999998 99999999999999 69999999999999876433
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~ 978 (1001)
..+.+-|..|.|||+.....|++++|+||+|+++|+|++|+.||.....+
T Consensus 470 -------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 470 -------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred -------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 12235688999999999999999999999999999999999999976544
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=266.62 Aligned_cols=197 Identities=22% Similarity=0.320 Sum_probs=167.5
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCc--
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNL-- 834 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~-- 834 (1001)
.++.++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++.+++...+.
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 345678999999999999999999975 58899999885432 23567789999999999999999987765554
Q ss_pred ----eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccc
Q 001873 835 ----KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFG 910 (1001)
Q Consensus 835 ----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfg 910 (1001)
.++|+||+ +++|.+++.. ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999999 6799999874 3589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
++...... .....++..|+|||.+.+ ..++.++||||+|+++||+++|+.||...
T Consensus 164 ~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 164 LARHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred cccccccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99865321 123357889999998755 46789999999999999999999999654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=249.97 Aligned_cols=190 Identities=32% Similarity=0.396 Sum_probs=166.1
Q ss_pred EeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCCH
Q 001873 774 IGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSL 847 (1001)
Q Consensus 774 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 847 (1001)
||+|+||.||++... ++++||+|.+.... ....+.+|+.++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999875 58999999875433 235788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCC
Q 001873 848 SSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTN 927 (1001)
Q Consensus 848 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 927 (1001)
.+++.... .+++.....++.|+++|+.|+|+. +++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-------~ 148 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-------S 148 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-------C
Confidence 99998643 478999999999999999999998 99999999999999999999999999987653321 1
Q ss_pred CCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 928 QRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 928 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......++..|+|||...+..++.++|+||||+++|++++|+.||...
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 196 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 123346788999999998888899999999999999999999999654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-28 Score=239.33 Aligned_cols=220 Identities=21% Similarity=0.328 Sum_probs=177.9
Q ss_pred cccHHHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-hhhHHHHHHHhhcc-CCCceeeEEe-eeecCC
Q 001873 758 DFSIDDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-SGAFSSEIQTLGSI-RHKNIVRLLG-WGSNKN 833 (1001)
Q Consensus 758 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~Ei~~l~~l-~h~nIv~l~~-~~~~~~ 833 (1001)
+...-++.+.|.+.+.+|+|.||.+-+++++ ....+|+|-+..+.. .++|.+|...--.+ .|.||+.-++ .|...+
T Consensus 16 el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 16 ELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 3444556789999999999999999999987 577899998876654 47899999886666 5899998877 467788
Q ss_pred ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC--CCCcEEEecccc
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG--PGYQAYLADFGL 911 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~ki~Dfgl 911 (1001)
.+++++||++.|+|..-+.. .++-+....+++.|+++|++|||++ .+||||||.+||||- +..++|+||||.
T Consensus 96 ~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred eEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccc
Confidence 88999999999999998875 4577888899999999999999999 999999999999993 445899999999
Q ss_pred cccccCCCCCCCCCCCCCCcccccccccCcccccc-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccch
Q 001873 912 ARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-----QRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWT 986 (1001)
Q Consensus 912 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~ 986 (1001)
.+..+..- ...--+-.|.|||.... -...+.+|||.||+++|.++||+.||...-..+.+.+.|.
T Consensus 170 t~k~g~tV----------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~ 239 (378)
T KOG1345|consen 170 TRKVGTTV----------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE 239 (378)
T ss_pred ccccCcee----------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence 87543210 11123456899996533 2346789999999999999999999998777788888887
Q ss_pred hhhhccc
Q 001873 987 PLMFLML 993 (1001)
Q Consensus 987 ~~~~~~~ 993 (1001)
.+....-
T Consensus 240 ~w~~rk~ 246 (378)
T KOG1345|consen 240 QWLKRKN 246 (378)
T ss_pred HHhcccC
Confidence 7754443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=241.66 Aligned_cols=212 Identities=22% Similarity=0.304 Sum_probs=177.6
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecC------
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK------ 832 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~------ 832 (1001)
+..+|.-.+.+|.|+- .|..+-+. .+++||+|+...+. ..++..+|...+..+.|+||++++.++...
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3456777788899988 55555432 58999999885542 236778999999999999999999988543
Q ss_pred CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccc
Q 001873 833 NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLA 912 (1001)
Q Consensus 833 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla 912 (1001)
...|+|||||. ++|...+. ...+-+++..|..|+++|++|+|+. +|+||||||+||++..++.+||.|||+|
T Consensus 94 ~e~y~v~e~m~-~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 94 QEVYLVMELMD-ANLCQVIL----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HhHHHHHHhhh-hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 35689999996 79999887 2367888999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhhhhcc
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLM 992 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~~~~~ 992 (1001)
+.... .-..+..+.|+.|.|||++.+..|.+.+||||+||++.||++|+.-|. |++.++||.++....
T Consensus 166 r~e~~--------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~~l 233 (369)
T KOG0665|consen 166 RTEDT--------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIEQL 233 (369)
T ss_pred cccCc--------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHHHh
Confidence 86321 125567789999999999988889999999999999999999997554 889999999998777
Q ss_pred cchh
Q 001873 993 LNLE 996 (1001)
Q Consensus 993 ~~~~ 996 (1001)
|.+-
T Consensus 234 gtpd 237 (369)
T KOG0665|consen 234 GTPD 237 (369)
T ss_pred cCCC
Confidence 7543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=230.26 Aligned_cols=207 Identities=22% Similarity=0.281 Sum_probs=170.4
Q ss_pred HhcccCCCeEeecCCeeEEEEE-eCCCCEEEEEEecCCCchhhHHHHHHHhhccC-CCceeeEEeeeecC--CceEEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSIR-HKNIVRLLGWGSNK--NLKLLFYD 840 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~e 840 (1001)
.++|++.+++|+|-|++||.|. ..++++++||.++ +...+.+.+|+.+++.++ ||||+++++...+. ....+|+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec-hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 4689999999999999999998 4578889999874 455678999999999997 99999999987664 45579999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC-CcEEEecccccccccCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG-YQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ki~Dfgla~~~~~~~ 919 (1001)
|+.+.+...+-.. ++..++..++.++++|+.|+|++ ||+|||+||.|+++|.. -.++++|+|+|.++.+..
T Consensus 116 ~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 116 YVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 9998887776542 56667778899999999999999 99999999999999954 579999999999886543
Q ss_pred CCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhh
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPL 988 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~ 988 (1001)
. -...+.+..|--||.+.. ..|+.+-|+|||||++..|+..+.||-......+++++.+++
T Consensus 188 e--------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV 249 (338)
T KOG0668|consen 188 E--------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV 249 (338)
T ss_pred e--------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence 2 223467788999998754 678999999999999999999999998765555555544443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=246.02 Aligned_cols=138 Identities=28% Similarity=0.350 Sum_probs=119.3
Q ss_pred cccHHHHH--hcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCCch-hhHHHHHHHhhccC-----C---CceeeE
Q 001873 758 DFSIDDVV--RNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSDES-GAFSSEIQTLGSIR-----H---KNIVRL 825 (1001)
Q Consensus 758 ~~~~~~~~--~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~Ei~~l~~l~-----h---~nIv~l 825 (1001)
...+.|+. .+|-+.++||-|.|++||++.+ .+.+.||+|+.++.... +....||+++++++ | .+||++
T Consensus 68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred eeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 33444443 5899999999999999999875 46788999999876654 67889999999983 3 379999
Q ss_pred Eeeeec----CCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE
Q 001873 826 LGWGSN----KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL 898 (1001)
Q Consensus 826 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll 898 (1001)
++.|.. ..++|||+|++ |.+|..+|.+...+.++...+++|++||+.||.|||.+| +|||.||||+|||+
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 998864 55889999999 789999999988889999999999999999999999998 99999999999997
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=262.83 Aligned_cols=201 Identities=20% Similarity=0.255 Sum_probs=151.1
Q ss_pred HhcccCCCeEeecCCeeEEEEEe-----------------CCCCEEEEEEecCCCc--h--------------hhHHHHH
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI-----------------PNGETLAVKKMWSSDE--S--------------GAFSSEI 811 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~--~--------------~~~~~Ei 811 (1001)
.++|++.++||+|+||+||+|.. ..++.||||++..... . +....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 45799999999999999999863 2356899999854321 1 2234477
Q ss_pred HHhhccCCCce-----eeEEeeeec--------CCceEEEEEccCCCCHHHHhhcCCC----------------------
Q 001873 812 QTLGSIRHKNI-----VRLLGWGSN--------KNLKLLFYDYLPNGSLSSLLHGAGK---------------------- 856 (1001)
Q Consensus 812 ~~l~~l~h~nI-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------- 856 (1001)
.++.+++|.++ ++++++|.. ++..++||||+++++|.++++....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 667777643 4567999999999999999874211
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccc
Q 001873 857 GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSY 936 (1001)
Q Consensus 857 ~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~ 936 (1001)
...++..+..++.|++.|+.|+|+. +|+||||||+||+++.++.+||+|||+++.+..... .......+|+
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~------~~~~~g~~tp 374 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN------FNPLYGMLDP 374 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc------cCccccCCCc
Confidence 1235677889999999999999998 999999999999999999999999999976532211 0111223578
Q ss_pred cccCccccccCC--------------------CC--CccchHHHHHHHHHHHhCCC-CCCC
Q 001873 937 GYMAPEHASMQR--------------------IT--EKSDVYSFGVVLLEVLTGRH-PLDP 974 (1001)
Q Consensus 937 ~y~aPE~~~~~~--------------------~~--~~~Dv~SlG~il~elltg~~-Pf~~ 974 (1001)
.|+|||.+.... |+ .+.||||+||++|||++|.. ||..
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 999999875321 12 24799999999999999875 7754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=271.15 Aligned_cols=199 Identities=19% Similarity=0.254 Sum_probs=143.0
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-C----CCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEee------eecCC
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-N----GETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGW------GSNKN 833 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~------~~~~~ 833 (1001)
.++|++.+.||+|+||+||+|++. + +..||||++......+....| .+++..+.+++.+... .....
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 467999999999999999999975 4 689999997544332222222 1122222222222221 24566
Q ss_pred ceEEEEEccCCCCHHHHhhcCCCC------------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCC
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAGKG------------------GADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMN 895 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~N 895 (1001)
..++||||+++++|.++++..... ......+..++.|++.|++|||++ +|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHH
Confidence 789999999999999998753211 011234567899999999999998 99999999999
Q ss_pred eEECC-CCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccC----------------------CCCCc
Q 001873 896 VLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ----------------------RITEK 952 (1001)
Q Consensus 896 Ill~~-~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~ 952 (1001)
||+++ ++.+||+|||+|+.+..... .......+|++|||||.+... .++.+
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccc------cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99985 67999999999986543211 122345789999999965321 23456
Q ss_pred cchHHHHHHHHHHHhCCCCCCC
Q 001873 953 SDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 953 ~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
+||||+||++|||+++..|++.
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~ 381 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDS 381 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCch
Confidence 7999999999999998777654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=237.53 Aligned_cols=197 Identities=32% Similarity=0.435 Sum_probs=171.0
Q ss_pred ccCCCeEeecCCeeEEEEEeCC-CCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccC
Q 001873 768 LTSANVIGTGSSGVVYRVTIPN-GETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
|+..+.||+|++|+||++...+ ++++|+|.+.... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667889999999999999764 8999999986543 35688899999999999999999999998899999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+++|.+++..... ..++.....++.+++.++.|+|+. +++|+|++|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~---- 152 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL---- 152 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc----
Confidence 9999999986432 178899999999999999999998 99999999999999999999999999998764332
Q ss_pred CCCCCCCcccccccccCcccc-ccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHA-SMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
........++..|++||.. ....++.++|+|++|+++|||++|+.||..
T Consensus 153 --~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 --AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0122334678899999998 677788899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=262.12 Aligned_cols=200 Identities=29% Similarity=0.447 Sum_probs=163.1
Q ss_pred CCeEeecCCee-EEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEEEccCCCCHH
Q 001873 771 ANVIGTGSSGV-VYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLS 848 (1001)
Q Consensus 771 ~~~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 848 (1001)
.+++|.|+.|+ ||+|.. +|+.||||++..+. .....+|+..++.- +|||||++++...+++..||..|.|. .+|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~-~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~ 590 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF-FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQ 590 (903)
T ss_pred HHHcccCCCCcEEEEEee-CCceehHHHHhhHh-HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHH
Confidence 45689999985 688988 58999999984432 34567899999988 59999999999999999999999996 7999
Q ss_pred HHhhcCC-CCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC---C--CcEEEecccccccccCCCCC
Q 001873 849 SLLHGAG-KGG-ADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP---G--YQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 849 ~~l~~~~-~~~-~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~---~--~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++...+ ... ..-...+.+..|+++|+++||+- +||||||||+||||+. + .+++|+|||+++.+..+...
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 9998741 111 11134467788999999999996 9999999999999975 3 47899999999998755332
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhC-CCCCCCCCCCCc
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTG-RHPLDPTLPGGA 980 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg-~~Pf~~~~~~~~ 980 (1001)
. .......||-+|+|||++....-..++||||+||++|+.++| .+||+.....+.
T Consensus 668 ~----~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~ 723 (903)
T KOG1027|consen 668 F----SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA 723 (903)
T ss_pred h----hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh
Confidence 2 225567899999999999988888899999999999999985 999987655433
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=232.72 Aligned_cols=205 Identities=23% Similarity=0.292 Sum_probs=166.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC------CCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeec-CCce
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN------GETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSN-KNLK 835 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~-~~~~ 835 (1001)
.+++....+.+|.||+||.|.|++ .+.|.||.++.... ...+.+|...+..+.|||+.++.+++.+ ....
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 456666779999999999997643 34567787755433 2568889999999999999999998754 4466
Q ss_pred EEEEEccCCCCHHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecc
Q 001873 836 LLFYDYLPNGSLSSLLHGAG------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADF 909 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Df 909 (1001)
+++|.++--|+|..++...+ .+.++..+...++.|++.|++|||+. +|||.||..+|.+||+.-++||+|=
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccc
Confidence 88999999999999998432 23356677788999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCC
Q 001873 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTLPG 978 (1001)
Q Consensus 910 gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~~~ 978 (1001)
.+++.+.+.++ .+-..+.. ....||+||.+....|+.++|||||||+||||+| |+.|+..-.|.
T Consensus 441 aLSRDLFP~DY-hcLGDnEn----RPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf 505 (563)
T KOG1024|consen 441 ALSRDLFPGDY-HCLGDNEN----RPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF 505 (563)
T ss_pred hhccccCcccc-cccCCCCC----CcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH
Confidence 99998876543 33333322 2357999999999999999999999999999998 99998765443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=231.77 Aligned_cols=184 Identities=33% Similarity=0.463 Sum_probs=163.4
Q ss_pred CCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCCHHHHhhc
Q 001873 778 SSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHG 853 (1001)
Q Consensus 778 ~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 853 (1001)
+||.||+|+.. +++.||+|++..... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 489999999865543 57899999999999999999999999988999999999999999999976
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCCCCCccc
Q 001873 854 AGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLA 933 (1001)
Q Consensus 854 ~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~ 933 (1001)
... .++..+..++.+++.++.|||+. +++|+||+|+||++++++.++++|||.+....... ......
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~ 147 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------LLTTFV 147 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--------cccccc
Confidence 433 78999999999999999999998 99999999999999999999999999998764321 223346
Q ss_pred ccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 934 GSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 934 gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
++..|+|||......++.++||||+|+++|++++|+.||..
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 78899999999888889999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-24 Score=273.84 Aligned_cols=336 Identities=24% Similarity=0.333 Sum_probs=175.6
Q ss_pred cCCccccccccccCCc------cCCCCChhhhccc-ccceEEccCCcccCCCCccccCCccccceeccccccccccCCCc
Q 001873 122 FGDYRELTFIDLSGNS------LWGEIPTEVCRLR-KLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSI 194 (1001)
Q Consensus 122 ~~~l~~L~~L~Ls~n~------l~g~~p~~~~~l~-~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~ 194 (1001)
|.++++|++|.+..+. +...+|..+..++ +|+.|++.+|.+. .+|..+ .+.+|++|+|.+|++. .+|..+
T Consensus 554 F~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~ 630 (1153)
T PLN03210 554 FKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGV 630 (1153)
T ss_pred HhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccccc
Confidence 4445555555443332 2223444444442 3555555555554 455544 3455555555555554 455555
Q ss_pred cchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCcccccCCCCCc
Q 001873 195 GALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQ 274 (1001)
Q Consensus 195 ~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~ 274 (1001)
..+++|+.|++++|..+ +.+| .++++++|+.|++++|.....+|.+++++.+|+.|++++|..-+.+|..+ ++++|+
T Consensus 631 ~~l~~Lk~L~Ls~~~~l-~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~ 707 (1153)
T PLN03210 631 HSLTGLRNIDLRGSKNL-KEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLY 707 (1153)
T ss_pred ccCCCCCEEECCCCCCc-CcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCC
Confidence 55555555555554222 2333 24444455555554444333334444333334443333333222333332 344444
Q ss_pred eEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEccccc
Q 001873 275 NLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQ 354 (1001)
Q Consensus 275 ~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 354 (1001)
.|++++|. ..+.+|.. .++|+.|++++|.++ .+|..+ .+++|++|++.++.
T Consensus 708 ~L~Lsgc~------------------------~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~ 758 (1153)
T PLN03210 708 RLNLSGCS------------------------RLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMK 758 (1153)
T ss_pred EEeCCCCC------------------------Cccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccc
Confidence 44444443 32233321 223444444444443 233322 24444444444322
Q ss_pred c-------cCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccc
Q 001873 355 L-------SGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNL 427 (1001)
Q Consensus 355 l-------~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l 427 (1001)
. ....+..+...++|+.|++++|...+.+|..++++++|+.|++++|...+.+|... .+++|+.|++++|..
T Consensus 759 ~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~ 837 (1153)
T PLN03210 759 SEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSR 837 (1153)
T ss_pred hhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCc
Confidence 1 11112222334566666666666665666666666667777766665444556554 567777777777654
Q ss_pred cCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccc-cccccCCCcccCCCCCcceeeccCcc
Q 001873 428 SGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLND-NRLSGTIPSEMGNLKHLNFVDMSENH 498 (1001)
Q Consensus 428 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~ 498 (1001)
...+|.. ..+|+.|+|++|.++ .+|.++..+++|+.|+|++ |++. .+|..+..+++|+.+++++|.
T Consensus 838 L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 838 LRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred ccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 4344432 356778888888887 4677788888888888887 4555 567777888888888887763
|
syringae 6; Provisional |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=234.15 Aligned_cols=215 Identities=27% Similarity=0.367 Sum_probs=176.3
Q ss_pred HHHHHhcccCCCeEeecCCeeEEEEEeC----CCCEEEEEEecCCCchhhHHHHHHHhhcc-CCCceeeEEeeeecCCce
Q 001873 761 IDDVVRNLTSANVIGTGSSGVVYRVTIP----NGETLAVKKMWSSDESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 761 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~ 835 (1001)
...+...|..+++||+|.|++||++... .++.||+|.+.......++.+|++++..+ .+.||+++.+++...+..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 3445678999999999999999998743 46889999998877778899999999999 589999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC-CCCcEEEeccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG-PGYQAYLADFGLARI 914 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ki~Dfgla~~ 914 (1001)
.+|+||++...-.++... ++...+..+.+.+..||.++|++ |||||||||+|++.+ ..+.-.|+|||+|..
T Consensus 111 ~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred EEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHH
Confidence 999999999998888764 66888889999999999999999 999999999999997 556788999999973
Q ss_pred ccCCC----------------------------------CC---CCCCCCCCCcccccccccCccccc-cCCCCCccchH
Q 001873 915 VSGSG----------------------------------DD---NCSKTNQRPQLAGSYGYMAPEHAS-MQRITEKSDVY 956 (1001)
Q Consensus 915 ~~~~~----------------------------------~~---~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~ 956 (1001)
.+... .. ............||+||.|||++. ...-+.++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 21110 00 001112234567999999999875 45667899999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCcCcc
Q 001873 957 SFGVVLLEVLTGRHPLDPTLPGGAPLV 983 (1001)
Q Consensus 957 SlG~il~elltg~~Pf~~~~~~~~~l~ 983 (1001)
|.|||+..+++++.||-....+-+.+.
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ 289 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALA 289 (418)
T ss_pred eccceeehhhccccccccCccccchHH
Confidence 999999999999999986654433333
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=275.01 Aligned_cols=339 Identities=19% Similarity=0.240 Sum_probs=247.3
Q ss_pred cccccCCCCcEEeccCCc------ccCCCCcccCCcc-ccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCc
Q 001873 96 SIFQPLKSLKRLIISSCN------LTGTIPKEFGDYR-ELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPS 168 (1001)
Q Consensus 96 ~~~~~l~~L~~L~l~~~~------l~g~~p~~~~~l~-~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~ 168 (1001)
..|..+++|+.|.+..+. ....+|+.+..++ +|+.|++.++.+. .+|..+ .+.+|++|+|++|++. .+|.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 457889999999997653 3456788777764 6999999999987 889887 6799999999999998 7999
Q ss_pred cccCCccccceeccccccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccc
Q 001873 169 DIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLER 248 (1001)
Q Consensus 169 ~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~ 248 (1001)
.++.+++|++|+|++|...+.+|. ++.+++|++|++++|..+ ..+|..++++++|+.|++++|...+.+|..+ ++++
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L-~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s 705 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSL-VELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS 705 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCc-cccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence 999999999999999876668884 889999999999999544 5899999999999999999998778888877 7999
Q ss_pred cceeccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccc-------cCCCCccCCCCC
Q 001873 249 IQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVG-------AIPDELGSCTEL 321 (1001)
Q Consensus 249 L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~-------~~p~~l~~l~~L 321 (1001)
|+.|++++|...+.+|.. .++|++|++++|.+. .+|..+ .+++|++|++.++.... ..+......++|
T Consensus 706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL 780 (1153)
T PLN03210 706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSL 780 (1153)
T ss_pred CCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccc
Confidence 999999999776666653 467889999999987 556555 57788888887654321 111111223345
Q ss_pred CEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecC
Q 001873 322 TVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKN 401 (1001)
Q Consensus 322 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n 401 (1001)
+.|+|++|...+.+|..++++++|+.|++++|. .-+.+|..+ ++++|+.|++++|
T Consensus 781 ~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~------------------------~L~~LP~~~-~L~sL~~L~Ls~c 835 (1153)
T PLN03210 781 TRLFLSDIPSLVELPSSIQNLHKLEHLEIENCI------------------------NLETLPTGI-NLESLESLDLSGC 835 (1153)
T ss_pred hheeCCCCCCccccChhhhCCCCCCEEECCCCC------------------------CcCeeCCCC-CccccCEEECCCC
Confidence 555555554444455555555555555555543 222333333 3445555555544
Q ss_pred ccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccc
Q 001873 402 KLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNR 474 (1001)
Q Consensus 402 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 474 (1001)
.....+|.. .++|+.|+|++|.++ .+|..+..+++|+.|++++|+--..+|..+..+++|+.+++++|.
T Consensus 836 ~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 836 SRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred Ccccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 333334432 246788888888887 577788888888888888743333567777888888888888774
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-26 Score=235.34 Aligned_cols=274 Identities=23% Similarity=0.254 Sum_probs=141.5
Q ss_pred ccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccc-cccccccC-CCccchhhhhhhhhc
Q 001873 129 TFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYD-NQLSGKIP-KSIGALSKLQVFRAG 206 (1001)
Q Consensus 129 ~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~-n~l~g~~p-~~~~~l~~L~~L~l~ 206 (1001)
+.++|..|+|+...|..|+.+++||.||||+|.|+..-|..|.+|.+|-.|-+.+ |+|+ .+| ..|++|.+|+.|.+.
T Consensus 70 veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllN 148 (498)
T KOG4237|consen 70 VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLN 148 (498)
T ss_pred eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcC
Confidence 4455555555544444555666666666666666655555666666665555544 5555 333 345566666666554
Q ss_pred cCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCcccccCCCCCceEeeecCcccCC
Q 001873 207 GNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGP 286 (1001)
Q Consensus 207 ~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~ 286 (1001)
-|. + .-...+.|..+++|..|.+.+|.+..+
T Consensus 149 an~-i------------------------------------------------~Cir~~al~dL~~l~lLslyDn~~q~i 179 (498)
T KOG4237|consen 149 ANH-I------------------------------------------------NCIRQDALRDLPSLSLLSLYDNKIQSI 179 (498)
T ss_pred hhh-h------------------------------------------------cchhHHHHHHhhhcchhcccchhhhhh
Confidence 441 1 111223344445555555555555533
Q ss_pred CCcccCCCCCCcEEEcCCCccc------------ccCCCCccCCCCCCEEeccCCCCCCCCCcccccc-cCccEEEcccc
Q 001873 287 IPGRIGALSKLKSLLLWQNSLV------------GAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNL-LKLQELQLSVN 353 (1001)
Q Consensus 287 ~p~~~~~l~~L~~L~L~~N~l~------------~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N 353 (1001)
-..+|..+..++.+.+..|.+. ...|..++...-..-..+.++++..+-+..|... ..+.+=..+.+
T Consensus 180 ~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d 259 (498)
T KOG4237|consen 180 CKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSED 259 (498)
T ss_pred ccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhcccc
Confidence 3335555555555555555421 1233334444444444445555543333333221 11111111222
Q ss_pred cccCcCC-hhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCC
Q 001873 354 QLSGTIP-IEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIP 432 (1001)
Q Consensus 354 ~l~~~~p-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 432 (1001)
...+.-| ..|..+++|+.|+|++|+|++..+.+|..+..+++|++..|++...-...|.++..|+.|+|.+|+|+..-|
T Consensus 260 ~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~ 339 (498)
T KOG4237|consen 260 FPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAP 339 (498)
T ss_pred CcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEec
Confidence 2222223 345666666666666666666666666666666666666666654444556666666666666666666666
Q ss_pred cccccccccceEEccCCcCC
Q 001873 433 KEIFGLRNLTKLLLLSNDLS 452 (1001)
Q Consensus 433 ~~~~~l~~L~~L~L~~N~l~ 452 (1001)
.+|..+..|.+|.|-.|.+.
T Consensus 340 ~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 340 GAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred ccccccceeeeeehccCccc
Confidence 66666666666666666553
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-27 Score=242.20 Aligned_cols=383 Identities=21% Similarity=0.246 Sum_probs=217.0
Q ss_pred eccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCC-CcccccCCCCccCCCCCCEEeccCCC
Q 001873 252 IAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQ-NSLVGAIPDELGSCTELTVVDFSDNL 330 (1001)
Q Consensus 252 L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~ 330 (1001)
+++..|+++...|.+|+.+.+|+.|||++|+|+.+-|++|.++.+|..|-+-+ |+|+....+.|+.+.+|+.|.+.-|+
T Consensus 72 irLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~ 151 (498)
T KOG4237|consen 72 IRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANH 151 (498)
T ss_pred EEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhh
Confidence 34444555544444555555555555555555555555555555555554444 55554444455555555555555555
Q ss_pred CCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCccc------------CccCccccccCcccEEEe
Q 001873 331 LTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAIS------------GEIPADIGNINGLTLFFA 398 (1001)
Q Consensus 331 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~------------~~~~~~~~~l~~L~~L~l 398 (1001)
+.-...+.|..+++|..|.+..|.+..+--..|..+.+++.+.+..|.+. ...|..++...-..-..+
T Consensus 152 i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl 231 (498)
T KOG4237|consen 152 INCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRL 231 (498)
T ss_pred hcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHH
Confidence 55444455555555555555555555222235555555555555555521 112222222222222222
Q ss_pred ecCccCCCCCcccccC-cccc-eEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccc
Q 001873 399 WKNKLTGNIPESLSQC-QELQ-ALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLS 476 (1001)
Q Consensus 399 ~~n~l~~~~p~~l~~l-~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 476 (1001)
.++++..+.+..|... ..+. .+....+...--..+.|.++++|++|+|++|+++++.+.+|..+..+++|.|..|+|.
T Consensus 232 ~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~ 311 (498)
T KOG4237|consen 232 YYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLE 311 (498)
T ss_pred HHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHH
Confidence 3333332222222211 1111 1111222222122346778888888888888888888888888888888888888888
Q ss_pred cCCCcccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCc------------------ccCCCCcccccccc
Q 001873 477 GTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLT------------------GSVPDTLPTSLQLV 538 (1001)
Q Consensus 477 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~------------------~~~p~~~~~~l~~L 538 (1001)
.+-...|.++..|+.|+|.+|+|+...|.+|..+.+|..|+|-.|.+. |.+|-.-|..++.+
T Consensus 312 ~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~ 391 (498)
T KOG4237|consen 312 FVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQI 391 (498)
T ss_pred HHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCchhccc
Confidence 666677888888888889899888888888888888888888888663 12222223334444
Q ss_pred cCCCCcCCCCcccccccccccceeeccCccccccchhhhh---------cccccc-EEecccccccCCCCCccccccchh
Q 001873 539 DLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEIL---------SCRKLI-LLDIGNNRFSGEIPKELGQISSLE 608 (1001)
Q Consensus 539 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---------~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~ 608 (1001)
.++.+.+... +...|++.+ .++-+. +.-.|++.++ .+|..+.. ...
T Consensus 392 ~~~dv~~~~~---------------------~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP~--d~t 447 (498)
T KOG4237|consen 392 PISDVAFGDF---------------------RCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIPV--DVT 447 (498)
T ss_pred cchhcccccc---------------------ccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCCc--hhH
Confidence 4444433211 111222211 112222 2334555554 55554421 222
Q ss_pred hhhhcCCCcccccccccccccccccEEEecCCcCCCCh-hhhhcccccceeEcccC
Q 001873 609 ISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDL-DALASLQNLVSLNVSFN 663 (1001)
Q Consensus 609 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~ls~N 663 (1001)
.+++.+|.++ .+|.+ .+..| .+||++|+|+..- ..|.++..|.+|-+++|
T Consensus 448 -elyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 448 -ELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred -HHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 4888888888 45554 56677 8888888888743 56788888888888876
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=211.32 Aligned_cols=226 Identities=21% Similarity=0.262 Sum_probs=189.3
Q ss_pred HhcccCCCeEeecCCeeEEEEE-eCCCCEEEEEEecCCCchhhHHHHHHHhhccCC-CceeeEEeeeecCCceEEEEEcc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSIRH-KNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
..+|+++++||.|+||.+|.|. ..+|+.||+|.-.+.....++..|..+.+.+++ ..|..+..+..+..+..+|||..
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL 93 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL 93 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence 4789999999999999999998 568999999998777777889999999999975 67888888888999999999998
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC---CCcEEEecccccccccCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP---GYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~Dfgla~~~~~~~ 919 (1001)
|-+|+++..-+ .+.++..+++-.+-|++.-++|+|.+ ++|||||||+|+|+.- -..+.++|||+|+.+.+..
T Consensus 94 -GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 94 -GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred -CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 78999988754 45689999999999999999999998 9999999999999963 3468899999999887666
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhhhhcccchh
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLMLNLE 996 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~~~~~~~~~ 996 (1001)
.....+........||.+|.+-....+..-+.+.|+-|+|.++.+.-.|..||.+..+. ...+.+.++.+...+++
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~-tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA-TKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh-hHHHHHHHHHHhhcCCC
Confidence 55556666677789999999988887777788999999999999999999999987533 33344444444433333
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-25 Score=236.87 Aligned_cols=222 Identities=23% Similarity=0.236 Sum_probs=180.7
Q ss_pred ccHHHHH-hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-hhhHHHHHHHhhccC------CCceeeEEeee
Q 001873 759 FSIDDVV-RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-SGAFSSEIQTLGSIR------HKNIVRLLGWG 829 (1001)
Q Consensus 759 ~~~~~~~-~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~Ei~~l~~l~------h~nIv~l~~~~ 829 (1001)
+.+.++. .+|.+....|+|-|++|..|.+. .|+.||||+|..... .+.=..|+++|+++. .-|.++++..|
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 3444443 67999999999999999999865 588999999976543 366778999999994 34789999999
Q ss_pred ecCCceEEEEEccCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC-CcEEEe
Q 001873 830 SNKNLKLLFYDYLPNGSLSSLLHGAGK-GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG-YQAYLA 907 (1001)
Q Consensus 830 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ki~ 907 (1001)
....++|+|+|-+. .+|.+++++.+. .++....+..++.|+.-||..|-.- +|+|.||||.|||+++. ..+|||
T Consensus 504 ~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 504 KHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred hhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeec
Confidence 99999999999885 799999988653 4678888999999999999999985 99999999999999865 578999
Q ss_pred cccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchh
Q 001873 908 DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTP 987 (1001)
Q Consensus 908 Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~ 987 (1001)
|||.|.... .+..+++.-+..|.|||++.+.+|+...|+||+||++||+.||+..|-+.+ .=+....
T Consensus 580 DfGSA~~~~---------eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T----NN~MLrl 646 (752)
T KOG0670|consen 580 DFGSASFAS---------ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT----NNQMLRL 646 (752)
T ss_pred cCccccccc---------cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC----cHHHHHH
Confidence 999998753 233444556778999999999999999999999999999999998776543 3334444
Q ss_pred hhhcccchhh
Q 001873 988 LMFLMLNLEA 997 (1001)
Q Consensus 988 ~~~~~~~~~~ 997 (1001)
+|.+-|+.|.
T Consensus 647 ~me~KGk~p~ 656 (752)
T KOG0670|consen 647 FMELKGKFPN 656 (752)
T ss_pred HHHhcCCCcH
Confidence 5555555553
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=215.00 Aligned_cols=208 Identities=20% Similarity=0.293 Sum_probs=186.6
Q ss_pred hcccCCCeEeecCCeeEEEEE-eCCCCEEEEEEecCCCchhhHHHHHHHhhccC-CCceeeEEeeeecCCceEEEEEccC
Q 001873 766 RNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
-.|++.++||+|+||+++.|+ .-++++||||.-....+..++..|.+..+.+. .++|..++-+.....+-.+|+|.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 368999999999999999998 45899999998877777788999999999885 699999998888888889999988
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC-----CCcEEEecccccccccCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP-----GYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~ki~Dfgla~~~~~~ 918 (1001)
|-||+|+..-+ .+.++.+++..||.|++.-++|+|++ ..|+|||||+|+||.. ...+.|+|||+|+.+..+
T Consensus 107 GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 78999998766 45689999999999999999999998 9999999999999963 346899999999999888
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~ 978 (1001)
......+........||.+||+-.-..++.-+.+.|+-|+|-++++.+.|..||.+...+
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 777777788888899999999999999999999999999999999999999999987543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-25 Score=243.58 Aligned_cols=195 Identities=27% Similarity=0.385 Sum_probs=168.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC--CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS--DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
.++|+....+|.|.||.|||+++. .++..|||.++-+ ++.+-..+|+-+++.++|||||.++|.+...+..|++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 467899999999999999999965 6899999988654 3456788999999999999999999999888899999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
|.+|+|++.-+-.+ .+++.++..+.+...+|++|+|++ +-+|||||-.||++++.|.+|++|||.+..+..
T Consensus 94 cgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita---- 164 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA---- 164 (829)
T ss_pred cCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh----
Confidence 99999999887654 478888888999999999999998 889999999999999999999999999877642
Q ss_pred CCCCCCCCCcccccccccCcccc---ccCCCCCccchHHHHHHHHHHHhCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHA---SMQRITEKSDVYSFGVVLLEVLTGRHP 971 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~il~elltg~~P 971 (1001)
....+....||+.|||||+. +.+.|...+|||+.|+...|+---..|
T Consensus 165 ---ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp 214 (829)
T KOG0576|consen 165 ---TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP 214 (829)
T ss_pred ---hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence 22345567899999999976 457899999999999999887654444
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=209.57 Aligned_cols=181 Identities=33% Similarity=0.533 Sum_probs=158.4
Q ss_pred EeecCCeeEEEEEeCC-CCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCCHHH
Q 001873 774 IGTGSSGVVYRVTIPN-GETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSS 849 (1001)
Q Consensus 774 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 849 (1001)
||+|.+|.||+++... ++++++|++..... .+.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 89999999976655 3789999999999999999999999998899999999999999999
Q ss_pred HhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC-CCcEEEecccccccccCCCCCCCCCCCC
Q 001873 850 LLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQ 928 (1001)
Q Consensus 850 ~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~ki~Dfgla~~~~~~~~~~~~~~~~ 928 (1001)
++.... ...++..+..++.++++++.|||+. +++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-------~ 149 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-------L 149 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-------h
Confidence 998642 3578999999999999999999998 9999999999999999 89999999999986543211 1
Q ss_pred CCcccccccccCccccccC-CCCCccchHHHHHHHHHH
Q 001873 929 RPQLAGSYGYMAPEHASMQ-RITEKSDVYSFGVVLLEV 965 (1001)
Q Consensus 929 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~el 965 (1001)
.....+...|++||..... .++.++|+|++|++++++
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 2223577899999998876 888999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-23 Score=226.23 Aligned_cols=167 Identities=22% Similarity=0.203 Sum_probs=129.6
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC--CCCEEEEEEecCCC-------chhhHHHHHHHhhccCCCceee-EEeeeecCC
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP--NGETLAVKKMWSSD-------ESGAFSSEIQTLGSIRHKNIVR-LLGWGSNKN 833 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-------~~~~~~~Ei~~l~~l~h~nIv~-l~~~~~~~~ 833 (1001)
+...|++.+.||+|+||+||+|+++ +++.||||++.... ..+.+.+|++++++++|+||++ ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 4578999999999999999999865 57778999864321 1356899999999999999985 4432 4
Q ss_pred ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCC-CCCCeEECCCCcEEEeccccc
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDV-KAMNVLLGPGYQAYLADFGLA 912 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~ki~Dfgla 912 (1001)
..++||||++|++|... .. . . ...++.|+++|+.|+|+. +|+|||| ||+||+++.++++||+|||+|
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~--~---~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RP--H---G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cc--c---c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 57999999999999732 11 1 1 145788999999999998 9999999 999999999999999999999
Q ss_pred ccccCCCCCCCC-CCCCCCcccccccccCcccccc
Q 001873 913 RIVSGSGDDNCS-KTNQRPQLAGSYGYMAPEHASM 946 (1001)
Q Consensus 913 ~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~ 946 (1001)
+.+......... ....-....+++.|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 987554322111 1112245678999999998854
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=240.68 Aligned_cols=268 Identities=28% Similarity=0.386 Sum_probs=158.5
Q ss_pred CCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEc
Q 001873 271 SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQL 350 (1001)
Q Consensus 271 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 350 (1001)
.+-..|+|++|.++ .+|..+. ++|+.|++++|+++ .+|.. .++|++|+|++|+|+ .+|.. .++|+.|+|
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~L 269 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSI 269 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeec
Confidence 44667888888888 5677665 37888888888888 45542 467888888888887 44542 356777788
Q ss_pred ccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCC
Q 001873 351 SVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGP 430 (1001)
Q Consensus 351 s~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 430 (1001)
++|+++ .+|.. .++|+.|++++|+++. +|.. +++ |+.|++++|+|++
T Consensus 270 s~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt~-LP~~---p~~------------------------L~~LdLS~N~L~~- 316 (788)
T PRK15387 270 FSNPLT-HLPAL---PSGLCKLWIFGNQLTS-LPVL---PPG------------------------LQELSVSDNQLAS- 316 (788)
T ss_pred cCCchh-hhhhc---hhhcCEEECcCCcccc-cccc---ccc------------------------cceeECCCCcccc-
Confidence 877776 33332 2456667777777662 3321 233 4445555554442
Q ss_pred CCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCccccccc
Q 001873 431 IPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGC 510 (1001)
Q Consensus 431 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 510 (1001)
+|.. ..+|+.|++++|++++ +|.. ..+|+.|+|++|+|+ .+|... .+|+.|++++|+|++ +|.. .
T Consensus 317 Lp~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~~-LP~l---~ 381 (788)
T PRK15387 317 LPAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLTS-LPAL---P 381 (788)
T ss_pred CCCC---cccccccccccCcccc-cccc---ccccceEecCCCccC-CCCCCC---cccceehhhcccccc-Cccc---c
Confidence 2221 1234445555555543 2221 134556666666665 233322 345555666666653 4432 2
Q ss_pred ccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEeccc
Q 001873 511 QSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGN 590 (1001)
Q Consensus 511 ~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 590 (1001)
.+|+.|++++|+|++ +|. .+..++.|++++|+|++ +|.. ..+|+.|++++|+|+ .+|..+..+++|+.|+|++
T Consensus 382 ~~L~~LdLs~N~Lt~-LP~-l~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~ 454 (788)
T PRK15387 382 SGLKELIVSGNRLTS-LPV-LPSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 454 (788)
T ss_pred cccceEEecCCcccC-CCC-cccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence 356666666666663 332 23456666666666664 3432 235677777777777 6677777777777888888
Q ss_pred ccccCCCCCccccc
Q 001873 591 NRFSGEIPKELGQI 604 (1001)
Q Consensus 591 N~l~~~~p~~~~~l 604 (1001)
|+|++..|..+..+
T Consensus 455 N~Ls~~~~~~L~~l 468 (788)
T PRK15387 455 NPLSERTLQALREI 468 (788)
T ss_pred CCCCchHHHHHHHH
Confidence 87777666655433
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=238.65 Aligned_cols=266 Identities=26% Similarity=0.357 Sum_probs=187.6
Q ss_pred cceeccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccC
Q 001873 249 IQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSD 328 (1001)
Q Consensus 249 L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 328 (1001)
-..|+++.+.++ .+|+.+. ++|+.|++.+|+++. +|. .+++|++|+|++|+++ .+|.. .++|+.|++++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 467889999998 7898876 489999999999994 554 3589999999999999 45653 46899999999
Q ss_pred CCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCC
Q 001873 329 NLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIP 408 (1001)
Q Consensus 329 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p 408 (1001)
|.++ .+|..+ .+|+.|++++|+++ .+|. ..++|+.|++++|+|++ +|... .+|+.|++++|++++ +|
T Consensus 272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~---~p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP 338 (788)
T PRK15387 272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPV---LPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LP 338 (788)
T ss_pred Cchh-hhhhch---hhcCEEECcCCccc-cccc---cccccceeECCCCcccc-CCCCc---ccccccccccCcccc-cc
Confidence 9998 456533 57889999999998 4554 34789999999999985 34321 234455555555542 33
Q ss_pred cccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCC
Q 001873 409 ESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKH 488 (1001)
Q Consensus 409 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 488 (1001)
.. . .+|+.|+|++|+|++ +|.. ..+|+.|++++|+|+ .+|... .+
T Consensus 339 ~l---p------------------------~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l~---~~ 383 (788)
T PRK15387 339 TL---P------------------------SGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPALP---SG 383 (788)
T ss_pred cc---c------------------------cccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCcccc---cc
Confidence 21 1 234455555555543 2221 134555666666666 344322 35
Q ss_pred cceeeccCcccccCCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCcc
Q 001873 489 LNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQ 568 (1001)
Q Consensus 489 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 568 (1001)
|+.|++++|+|++ +|.. .++|+.|++++|+|++ +|. ++..++.|++++|+|+ .+|..+..+++|+.|+|++|+
T Consensus 384 L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~-l~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~ 456 (788)
T PRK15387 384 LKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPM-LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 456 (788)
T ss_pred cceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCc-chhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCC
Confidence 6677777777763 4432 2567788888888874 554 3456777899999998 678889999999999999999
Q ss_pred ccccchhhhhcc
Q 001873 569 LSGRIPAEILSC 580 (1001)
Q Consensus 569 l~~~~p~~~~~l 580 (1001)
|++..|..+..+
T Consensus 457 Ls~~~~~~L~~l 468 (788)
T PRK15387 457 LSERTLQALREI 468 (788)
T ss_pred CCchHHHHHHHH
Confidence 999888877443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=241.66 Aligned_cols=246 Identities=29% Similarity=0.458 Sum_probs=125.5
Q ss_pred ccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccCCCccchhhhhhhhhc
Q 001873 127 ELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAG 206 (1001)
Q Consensus 127 ~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~ 206 (1001)
+.+.|++++++++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|++|++++|+++ .+|..+. .+|+.|+++
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 4556666666666 4565543 45666666666666 5665543 36666666666666 5565443 356666666
Q ss_pred cCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCcccccCCCCCceEeeecCcccCC
Q 001873 207 GNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGP 286 (1001)
Q Consensus 207 ~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~ 286 (1001)
+| .+. .+|..+. ++|+.|++++|.+. . +|..+. ++|+.|++++|++++
T Consensus 250 ~N-~L~-~LP~~l~--s~L~~L~Ls~N~L~-~------------------------LP~~l~--~sL~~L~Ls~N~Lt~- 297 (754)
T PRK15370 250 IN-RIT-ELPERLP--SALQSLDLFHNKIS-C------------------------LPENLP--EELRYLSVYDNSIRT- 297 (754)
T ss_pred CC-ccC-cCChhHh--CCCCEEECcCCccC-c------------------------cccccC--CCCcEEECCCCcccc-
Confidence 66 333 4554432 24555555554444 2 333222 245555555555553
Q ss_pred CCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccc
Q 001873 287 IPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATC 366 (1001)
Q Consensus 287 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 366 (1001)
+|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+.
T Consensus 298 LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp-- 366 (754)
T PRK15370 298 LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP-- 366 (754)
T ss_pred Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--
Confidence 333222 245556666666552 343332 356666666666653 444442 45666666666665 3444332
Q ss_pred cccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCc----ccccCcccceEeCcCcccc
Q 001873 367 TALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPE----SLSQCQELQALDFSYNNLS 428 (1001)
Q Consensus 367 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~----~l~~l~~L~~L~Ls~N~l~ 428 (1001)
++|+.|++++|+++ .+|..+. ..|+.|++++|+++ .+|. .+..++.+..|++.+|.++
T Consensus 367 ~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 367 PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 45666666666655 2333221 13344444444443 2222 2222344455555555544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=216.86 Aligned_cols=206 Identities=26% Similarity=0.347 Sum_probs=169.0
Q ss_pred cccCCCeEeecCCeeEEEEEeCCC--CEEEEEEecCCCch--hhHHHHHHHhhccCC----CceeeEEeee-ecCCceEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIPNG--ETLAVKKMWSSDES--GAFSSEIQTLGSIRH----KNIVRLLGWG-SNKNLKLL 837 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~--~~~~~Ei~~l~~l~h----~nIv~l~~~~-~~~~~~~l 837 (1001)
+|++.+.||+|+||.||.|..... ..+|+|........ ..+..|+.++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997543 47888877554332 268889999988862 6899999888 57778899
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC-----CcEEEeccccc
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG-----YQAYLADFGLA 912 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~-----~~~ki~Dfgla 912 (1001)
||+.+ |.+|.++........++..+..+|+.|++.+|+++|+. |++||||||.|+.+... ..+.+.|||+|
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 78999998776667799999999999999999999998 99999999999999854 46999999999
Q ss_pred cccc--CCCCCC-CCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 913 RIVS--GSGDDN-CSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 913 ~~~~--~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+.+. ...... ...........||.+|+++++..+...+.+.|+||++.++.|+..|..||....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 9332 222111 111111234569999999999999999999999999999999999999997654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4e-21 Score=230.10 Aligned_cols=247 Identities=28% Similarity=0.493 Sum_probs=137.3
Q ss_pred CCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEc
Q 001873 271 SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQL 350 (1001)
Q Consensus 271 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 350 (1001)
.+.+.|+++++.++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|++++|+++ .+|..+. .+|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 35678888888887 4566553 47888888888887 4565543 47888888888877 4565443 36777777
Q ss_pred ccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCC
Q 001873 351 SVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGP 430 (1001)
Q Consensus 351 s~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 430 (1001)
++|++. .+|..+. ++|+.|++++|+|+ .+|..+ . ++|+.|++++|++++
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l------------------------~--~sL~~L~Ls~N~Lt~- 297 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENL------------------------P--EELRYLSVYDNSIRT- 297 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccC-cccccc------------------------C--CCCcEEECCCCcccc-
Confidence 777776 4555443 35666666666665 233322 1 245555555555552
Q ss_pred CCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCccccccc
Q 001873 431 IPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGC 510 (1001)
Q Consensus 431 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 510 (1001)
+|..+. ++|+.|++++|+++. +|..+ .++|+.|++++|.+++ +|..+. ++|+.|++++|+|+ .+|..+ .
T Consensus 298 LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l--p 366 (754)
T PRK15370 298 LPAHLP--SGITHLNVQSNSLTA-LPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL--P 366 (754)
T ss_pred Ccccch--hhHHHHHhcCCcccc-CCccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh--c
Confidence 232221 245555555555553 23222 1456666666666653 444332 45666666666665 344433 2
Q ss_pred ccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccc----cccccccceeeccCcccc
Q 001873 511 QSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHS----IGSLTELSKLLLSKNQLS 570 (1001)
Q Consensus 511 ~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~Ls~N~l~ 570 (1001)
++|+.|++++|+|+ .+|..++..++.|++++|+|++ +|.. ++.++++..|++.+|+++
T Consensus 367 ~~L~~LdLs~N~Lt-~LP~~l~~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 367 PTITTLDVSRNALT-NLPENLPAALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CCcCEEECCCCcCC-CCCHhHHHHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCcc
Confidence 45666666666666 3444444455555555555552 2222 222344455555555544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-20 Score=185.38 Aligned_cols=196 Identities=15% Similarity=0.113 Sum_probs=144.7
Q ss_pred cCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc------hhhHHHHHHHhhccC-CCceeeEEeeeecCCceEEEEEc
Q 001873 769 TSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE------SGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 769 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
.+...|++|+||+||.+.. .+.+++.+.+..... ...+.+|++++++++ |++|++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999998766 678888777644332 125789999999995 5889999886 346899999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCC-CCCCeEECCCCcEEEecccccccccCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDV-KAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
++|.+|.+.... ....++.|++.+++++|+. ||+|||| ||+||+++.++.++|+|||+|........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999999765421 1134678999999999999 9999999 79999999999999999999986432211
Q ss_pred C------CCCCCCCCCcccccccccCcccccc-CCCC-CccchHHHHHHHHHHHhCCCCCCCCCCCCcC
Q 001873 921 D------NCSKTNQRPQLAGSYGYMAPEHASM-QRIT-EKSDVYSFGVVLLEVLTGRHPLDPTLPGGAP 981 (1001)
Q Consensus 921 ~------~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~ 981 (1001)
- .....-.......++.|++|+.-.. ...+ ...+-++-|+.+|.++||+.|..++.++..+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~~~~ 216 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEGQGP 216 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCCCCC
Confidence 0 0000000111236788888885432 2333 5678889999999999999999888776543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-20 Score=235.17 Aligned_cols=154 Identities=17% Similarity=0.170 Sum_probs=115.3
Q ss_pred ccCC-CceeeEEeee-------ecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 001873 816 SIRH-KNIVRLLGWG-------SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887 (1001)
Q Consensus 816 ~l~h-~nIv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iv 887 (1001)
.++| +||+++++++ ...+..+.++||+ +++|.+++++. ...+++..++.++.||++||+|||++ +|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 4556 6888888877 2334567788988 57999999754 34589999999999999999999998 999
Q ss_pred EeCCCCCCeEECCCC-------------------cEEEecccccccccCCCCC---CC------CCCCCCCccccccccc
Q 001873 888 HGDVKAMNVLLGPGY-------------------QAYLADFGLARIVSGSGDD---NC------SKTNQRPQLAGSYGYM 939 (1001)
Q Consensus 888 H~Dlkp~NIll~~~~-------------------~~ki~Dfgla~~~~~~~~~---~~------~~~~~~~~~~gt~~y~ 939 (1001)
||||||+|||++..+ .+|++|||+++........ .. .........+||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996544 4555566655432110000 00 0000112246899999
Q ss_pred CccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 940 APEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 940 aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
|||++.+..|+.++|||||||++|||++|..|+..
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 99999999999999999999999999999988764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.4e-19 Score=198.97 Aligned_cols=203 Identities=32% Similarity=0.471 Sum_probs=169.1
Q ss_pred ccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc-----hhhHHHHHHHhhccCCC-ceeeEEeeeecCCceEEEEEc
Q 001873 768 LTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE-----SGAFSSEIQTLGSIRHK-NIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~Ei~~l~~l~h~-nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
|+..+.+|.|+||.||++... ..+|+|.+..... ...+.+|+.+++.+.|+ +|+++.+.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667788999999999999986 8899998854432 45689999999999988 799999999777778999999
Q ss_pred cCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC-cEEEecccccccccCCC
Q 001873 842 LPNGSLSSLLHGAGK-GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY-QAYLADFGLARIVSGSG 919 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~Dfgla~~~~~~~ 919 (1001)
+.++++.+++..... ...+......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999987775432 2578889999999999999999998 999999999999999988 79999999998654332
Q ss_pred CCCCCCCCCCCcccccccccCcccccc---CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASM---QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
...... .......||..|+|||.... ..+....|+||+|++++++++|+.||....
T Consensus 157 ~~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred cccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 111000 13455689999999999987 678899999999999999999999976554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.9e-20 Score=186.15 Aligned_cols=137 Identities=20% Similarity=0.201 Sum_probs=107.5
Q ss_pred CCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc-----------hhhH-----------------HHHHHHhhccCCCce
Q 001873 771 ANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE-----------SGAF-----------------SSEIQTLGSIRHKNI 822 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~-----------------~~Ei~~l~~l~h~nI 822 (1001)
...||+|+||.||+|..++|++||||+++.... ...| .+|++.++++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 467999999999999988899999999864321 1122 349999999988776
Q ss_pred eeEEeeeecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEEeCCCCCCeEECCC
Q 001873 823 VRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL-HHDCMPPILHGDVKAMNVLLGPG 901 (1001)
Q Consensus 823 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yL-H~~~~~~ivH~Dlkp~NIll~~~ 901 (1001)
.....+... ..++||||++++++...... ...++..++.+++.|++.++.|+ |+. +|+||||||+||+++ +
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence 443332222 23899999998877655332 23578899999999999999999 677 999999999999998 4
Q ss_pred CcEEEecccccccc
Q 001873 902 YQAYLADFGLARIV 915 (1001)
Q Consensus 902 ~~~ki~Dfgla~~~ 915 (1001)
+.++++|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.9e-20 Score=190.21 Aligned_cols=169 Identities=12% Similarity=0.139 Sum_probs=131.9
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCch--h---------hHHHHHHHhhccCCCceeeEEeeeecC
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDES--G---------AFSSEIQTLGSIRHKNIVRLLGWGSNK 832 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~---------~~~~Ei~~l~~l~h~nIv~l~~~~~~~ 832 (1001)
+..+|+..+++|.|+||.||.+.. ++..+|||.+...... + .+.+|++.++++.||+|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 457899999999999999999766 5778999998543211 1 268999999999999999998875432
Q ss_pred --------CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcE
Q 001873 833 --------NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQA 904 (1001)
Q Consensus 833 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 904 (1001)
+..++||||++|.+|.++.. .+. ....+++.++..+|+. +++|||+||+||+++++| +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-E
Confidence 35789999999999988742 222 2456899999999998 999999999999999988 9
Q ss_pred EEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHH
Q 001873 905 YLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVL 966 (1001)
Q Consensus 905 ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ell 966 (1001)
+++|||.++...... ........+.|+.++|+||||+.+....
T Consensus 174 ~liDfg~~~~~~e~~-------------------a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRK-------------------AKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchh-------------------hHHHHHHHhHhcccccccceeEeehHHH
Confidence 999999886542110 0011344556778999999999887543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-20 Score=185.98 Aligned_cols=193 Identities=23% Similarity=0.307 Sum_probs=156.1
Q ss_pred ccCCCeEeecCCeeEEEEEeCCCCEEEEEEecC----CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccC
Q 001873 768 LTSANVIGTGSSGVVYRVTIPNGETLAVKKMWS----SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
.....+|.+...|+.|+|+|+ |..+++|++.- ...+++|..|.-.++.+.||||++++|.|.......++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 344567899999999999995 56666776533 3345789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEe--cccccccccCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLA--DFGLARIVSGSGDD 921 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~--Dfgla~~~~~~~~~ 921 (1001)
.|+|+..+++......+..++.+++.++|+|+.|||+- .+-|-.--+.++.+++|++.+++|. |--.+.+.
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe------ 343 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE------ 343 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec------
Confidence 99999999987766678889999999999999999994 2334444688999999999988764 43333221
Q ss_pred CCCCCCCCCcccccccccCccccccCCCC---CccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRIT---EKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......|.||+||.++.++-+ .++|+|||++++||+.|++.||....
T Consensus 344 --------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls 393 (448)
T KOG0195|consen 344 --------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS 393 (448)
T ss_pred --------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence 112456889999999776544 57999999999999999999997653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.9e-19 Score=180.27 Aligned_cols=137 Identities=21% Similarity=0.235 Sum_probs=109.6
Q ss_pred CCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc----------------------------hhhHHHHHHHhhccCCCce
Q 001873 771 ANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE----------------------------SGAFSSEIQTLGSIRHKNI 822 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------------~~~~~~Ei~~l~~l~h~nI 822 (1001)
.+.||+|+||+||+|+..+|+.||||++..... ...+.+|++.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999987899999998864321 0123578999999999987
Q ss_pred eeEEeeeecCCceEEEEEccCCCCHHHH-hhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCeEECC
Q 001873 823 VRLLGWGSNKNLKLLFYDYLPNGSLSSL-LHGAGKGGADWEARYEVVLGVAHALAYLHH-DCMPPILHGDVKAMNVLLGP 900 (1001)
Q Consensus 823 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NIll~~ 900 (1001)
.....+.... .++||||++|+++... +.+ ...+.....+++.|++.++.|+|+ . +|+||||||+||+++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 5444443322 4899999998855443 432 346788889999999999999999 7 999999999999999
Q ss_pred CCcEEEeccccccccc
Q 001873 901 GYQAYLADFGLARIVS 916 (1001)
Q Consensus 901 ~~~~ki~Dfgla~~~~ 916 (1001)
++.++|+|||+|+.+.
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.5e-20 Score=170.90 Aligned_cols=164 Identities=27% Similarity=0.518 Sum_probs=127.2
Q ss_pred ccCCCCcEEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccc
Q 001873 99 QPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAY 178 (1001)
Q Consensus 99 ~~l~~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~ 178 (1001)
-.++..+.|.|+.|.++ .+|+.++.|.+|+.|++++|++. ++|.++++|++|+.|+++-|++. .+|..||.++.|+.
T Consensus 30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 34567778888888888 78888888889999999988888 88888888888999998888888 78888888888888
Q ss_pred eecccccccc-ccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccc
Q 001873 179 LTLYDNQLSG-KIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTS 257 (1001)
Q Consensus 179 L~L~~n~l~g-~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n 257 (1001)
|||++|++.. .+|..|..++.|+.|+++.| .+. .+|..++++++|+.|.+.+|.+.
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dn-dfe-~lp~dvg~lt~lqil~lrdndll--------------------- 163 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDN-DFE-ILPPDVGKLTNLQILSLRDNDLL--------------------- 163 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCC-Ccc-cCChhhhhhcceeEEeeccCchh---------------------
Confidence 8888888774 47888888888888888888 443 66777777777777777666554
Q ss_pred cccccCcccccCCCCCceEeeecCcccCCCCcccCC
Q 001873 258 LLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGA 293 (1001)
Q Consensus 258 ~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~ 293 (1001)
.+|.+++.+++|++|++++|+++ .+|..+++
T Consensus 164 ----~lpkeig~lt~lrelhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 164 ----SLPKEIGDLTRLRELHIQGNRLT-VLPPELAN 194 (264)
T ss_pred ----hCcHHHHHHHHHHHHhcccceee-ecChhhhh
Confidence 46666666666777777777766 45544444
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=176.62 Aligned_cols=108 Identities=31% Similarity=0.287 Sum_probs=94.9
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++++. ...+++..++.++.|++.|++|||++ + ||+||+++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc------
Confidence 7899999864 34589999999999999999999997 5 999999999999999 9998865321
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
...||+.|||||++.+..++.++|||||||++|||+||+.||....
T Consensus 63 ------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 63 ------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred ------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 1158899999999999999999999999999999999999997654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-19 Score=167.85 Aligned_cols=181 Identities=28% Similarity=0.444 Sum_probs=148.1
Q ss_pred cCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccCCCccchhhhh
Q 001873 122 FGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQ 201 (1001)
Q Consensus 122 ~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~ 201 (1001)
+.++++.+.|.||+|+++ .+|+.|..|.+|+.|++++|+++ ++|.+++.|++|+.|++.-|++. ..|..||.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 456778899999999999 88999999999999999999999 89999999999999999999998 8899999999999
Q ss_pred hhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCcccccCCCCCceEeeecC
Q 001873 202 VFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQN 281 (1001)
Q Consensus 202 ~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N 281 (1001)
.||+.+|+.-...+|..+.-++.|+-|++++ |.+. .+|..++++++|+.|.+.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~d------------------------ndfe-~lp~dvg~lt~lqil~lrdn 160 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGD------------------------NDFE-ILPPDVGKLTNLQILSLRDN 160 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcC------------------------CCcc-cCChhhhhhcceeEEeeccC
Confidence 9999998433344555555555555555555 4444 78999999999999999999
Q ss_pred cccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCC---CCCEEeccCCCCC
Q 001873 282 SISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCT---ELTVVDFSDNLLT 332 (1001)
Q Consensus 282 ~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~---~L~~L~Ls~N~l~ 332 (1001)
.+- .+|..++.+++|+.|.+.+|+++ .+|.+++++. +=+++.+.+|...
T Consensus 161 dll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 161 DLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred chh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 987 78999999999999999999999 7787777643 2233444455443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-18 Score=205.76 Aligned_cols=203 Identities=22% Similarity=0.295 Sum_probs=160.0
Q ss_pred cCCCeEeecCCeeEEEEEeC-CCCEEEEEEec----CCCch----hhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 769 TSANVIGTGSSGVVYRVTIP-NGETLAVKKMW----SSDES----GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 769 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~----~~~~~----~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
...+++|.|++|.|+.+... ..+..+.|.+. ..... ..+..|+.+-..++|||++.......+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999988876643 34445555432 21111 12556888888899999988877666665555569
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
|||++ +|..++... ..+...++..++.|+..|++|+|+. ||.|||+|++|+++..+|.+||+|||.+....-+.
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 999999864 3477788888999999999999998 99999999999999999999999999998764433
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCC-CccchHHHHHHHHHHHhCCCCCCCCCCCCc
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRIT-EKSDVYSFGVVLLEVLTGRHPLDPTLPGGA 980 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~il~elltg~~Pf~~~~~~~~ 980 (1001)
.. ........+|+..|+|||.+.+..|+ ...||||.|+++..|.+|+.||......++
T Consensus 475 e~---~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 475 EK---NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred ch---hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 22 12345567899999999999999987 568999999999999999999987765544
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.3e-20 Score=204.02 Aligned_cols=286 Identities=26% Similarity=0.324 Sum_probs=142.7
Q ss_pred EEeccCCCCC-CCCCcccccccCccEEEcccccccCc----CChhhccccccCEEeccCCcccCccCccccccCcccEEE
Q 001873 323 VVDFSDNLLT-GSIPRSFGNLLKLQELQLSVNQLSGT----IPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFF 397 (1001)
Q Consensus 323 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 397 (1001)
.|+|+.+.++ +..+..|..+.+|+.|++++|.++.. ++..+...+++++|+++++.+.+ .+..+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~---------- 70 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGL---------- 70 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHH----------
Confidence 4667777776 33444556666777777777776432 34445556667777777666542 01100
Q ss_pred eecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccc---cceEEccCCcCCC----CCCCCCCCC-CCcceEE
Q 001873 398 AWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRN---LTKLLLLSNDLSG----FIPPDIGNC-TTLRRLR 469 (1001)
Q Consensus 398 l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~p~~l~~l-~~L~~L~ 469 (1001)
..++..+..+++|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|++|+
T Consensus 71 -------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~ 143 (319)
T cd00116 71 -------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLV 143 (319)
T ss_pred -------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEE
Confidence 112233444555666666666555444444443333 5555555555442 111122233 4555555
Q ss_pred ccccccccC----CCcccCCCCCcceeeccCcccccC----CcccccccccCceEEcccccCcccCCCCcccccccccCC
Q 001873 470 LNDNRLSGT----IPSEMGNLKHLNFVDMSENHLVGG----IPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLS 541 (1001)
Q Consensus 470 Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls 541 (1001)
+++|.+++. ++..+..+++|++|++++|.+++. ++..+..+++|+.|++++|.+++....
T Consensus 144 L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~------------ 211 (319)
T cd00116 144 LGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS------------ 211 (319)
T ss_pred cCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH------------
Confidence 555555421 222334444555555555555421 122223334455555555544321110
Q ss_pred CCcCCCCcccccccccccceeeccCccccccchhhhhc-----cccccEEecccccccCCCCCccccccchhhhhhcCCC
Q 001873 542 DNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILS-----CRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSN 616 (1001)
Q Consensus 542 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N 616 (1001)
.++..+..+++|+.|++++|++++.....+.. .++|+.|++++|.+++.-.
T Consensus 212 ------~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~------------------ 267 (319)
T cd00116 212 ------ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGA------------------ 267 (319)
T ss_pred ------HHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHH------------------
Confidence 11223344556666666666665432322222 2456666666665541100
Q ss_pred cccccccccccccccccEEEecCCcCCCCh-----hhhhcc-cccceeEcccCCC
Q 001873 617 QFSGEIPSEFSGLTKLGILDLSHNKLSGDL-----DALASL-QNLVSLNVSFNDF 665 (1001)
Q Consensus 617 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-----~~~~~l-~~L~~L~ls~N~l 665 (1001)
..+.+.+..+++|+.+|+++|.++... .++... +.|+++|+.+|++
T Consensus 268 ---~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 268 ---KDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred ---HHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 112233445578888888888888642 233444 6788888888764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.3e-18 Score=202.58 Aligned_cols=218 Identities=22% Similarity=0.248 Sum_probs=170.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccC---CCceeeEEeeeecCCceEEEEEcc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIR---HKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
..|.+.+.+|+|+||+||+|...+|+.||+|+-+... ..+|.--.+++.|++ -+.|..+.......+.-++|+||.
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~-~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~ 776 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN-PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYS 776 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC-ceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecc
Confidence 4677888999999999999998889999999865443 455555566677776 233444444444556668999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC-------CCCcEEEecccccccc
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG-------PGYQAYLADFGLARIV 915 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~-------~~~~~ki~Dfgla~~~ 915 (1001)
++|+|.+++. ..+.+++.....++.|++..+++||.. +|||+||||+|+++. ....++|+|||.+-.+
T Consensus 777 ~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 777 PYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred ccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 9999999998 356689999999999999999999998 999999999999994 2346899999999776
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCC--CCCC-------CCCCcCcccch
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP--LDPT-------LPGGAPLVQWT 986 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~P--f~~~-------~~~~~~l~~~~ 986 (1001)
.--.+ .......++|-.+-.+|+..++.+++..|.|.++.+++-|+.|+.. +++. ++.--..+-|.
T Consensus 852 ~lfp~-----~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~~~~~~~~Ry~~~~~W~ 926 (974)
T KOG1166|consen 852 KLFPD-----GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSWMVKTNFPRYWKRDMWN 926 (974)
T ss_pred eEcCC-----CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcceeccccchhhhhHHHHH
Confidence 43322 2234456789999999999999999999999999999999998742 1111 23334567788
Q ss_pred hhhhcccc
Q 001873 987 PLMFLMLN 994 (1001)
Q Consensus 987 ~~~~~~~~ 994 (1001)
+++..+++
T Consensus 927 ~~F~~lLN 934 (974)
T KOG1166|consen 927 KFFDLLLN 934 (974)
T ss_pred HHHHHHhC
Confidence 88877776
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.1e-17 Score=167.96 Aligned_cols=136 Identities=17% Similarity=0.267 Sum_probs=104.8
Q ss_pred ccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCC--CchhhHHHHHHHhhcc-----CCCceeeEEeeeecCC---ceE-
Q 001873 768 LTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSS--DESGAFSSEIQTLGSI-----RHKNIVRLLGWGSNKN---LKL- 836 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~Ei~~l~~l-----~h~nIv~l~~~~~~~~---~~~- 836 (1001)
+...+.||+|+||.||. +++....+||++... ...+.+.+|+.+++.+ .||||++++|++..+. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34467899999999996 544344479987543 2346799999999999 5799999999988763 433
Q ss_pred EEEEc--cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeEEeCCCCCCeEECC----CCcEEEec-
Q 001873 837 LFYDY--LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHAL-AYLHHDCMPPILHGDVKAMNVLLGP----GYQAYLAD- 908 (1001)
Q Consensus 837 lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l-~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~ki~D- 908 (1001)
+|+|| +++|+|.+++++. .+++. ..++.|++.++ +|||++ +|+||||||+||+++. +++++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 6679999999753 24444 34577878777 999999 9999999999999974 34899999
Q ss_pred ccccc
Q 001873 909 FGLAR 913 (1001)
Q Consensus 909 fgla~ 913 (1001)
||...
T Consensus 154 ~G~~~ 158 (210)
T PRK10345 154 IGEST 158 (210)
T ss_pred CCCcc
Confidence 55443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=1e-19 Score=203.18 Aligned_cols=240 Identities=24% Similarity=0.271 Sum_probs=103.6
Q ss_pred ccccCCCCCceEeeecCcccCC----CCcccCCCCCCcEEEcCCCcccc------cCCCCccCCCCCCEEeccCCCCCCC
Q 001873 265 EEIGNCSELQNLYLYQNSISGP----IPGRIGALSKLKSLLLWQNSLVG------AIPDELGSCTELTVVDFSDNLLTGS 334 (1001)
Q Consensus 265 ~~l~~l~~L~~L~L~~N~i~~~----~p~~~~~l~~L~~L~L~~N~l~~------~~p~~l~~l~~L~~L~Ls~N~l~~~ 334 (1001)
..+..+++|++|+++++.++.. ++..+...++|++|+++++.+.+ .++..+..+++|+.|++++|.+.+.
T Consensus 17 ~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~ 96 (319)
T cd00116 17 ELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPD 96 (319)
T ss_pred HHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChh
Confidence 3344444455555555554321 23333344445555555554431 1223344455555555555555543
Q ss_pred CCcccccccC---ccEEEcccccccC----cCChhhccc-cccCEEeccCCcccCccCccccccCcccEEEeecCccCCC
Q 001873 335 IPRSFGNLLK---LQELQLSVNQLSG----TIPIEIATC-TALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGN 406 (1001)
Q Consensus 335 ~p~~~~~l~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~ 406 (1001)
.+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++.... .
T Consensus 97 ~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~--------------------~ 156 (319)
T cd00116 97 GCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE--------------------A 156 (319)
T ss_pred HHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHH--------------------H
Confidence 4444433333 5555555555542 112223333 4555555555555422111 0
Q ss_pred CCcccccCcccceEeCcCccccCC----CCcccccccccceEEccCCcCCCC----CCCCCCCCCCcceEEccccccccC
Q 001873 407 IPESLSQCQELQALDFSYNNLSGP----IPKEIFGLRNLTKLLLLSNDLSGF----IPPDIGNCTTLRRLRLNDNRLSGT 478 (1001)
Q Consensus 407 ~p~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~ 478 (1001)
++..+..+++|++|++++|.+++. ++..+..+++|++|++++|.+++. ++..+..+++|++|++++|.+++.
T Consensus 157 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~ 236 (319)
T cd00116 157 LAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDA 236 (319)
T ss_pred HHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchH
Confidence 111223333444444444444321 111222223444444444444321 122233445555555555555432
Q ss_pred CCcccC-----CCCCcceeeccCccccc----CCcccccccccCceEEcccccCc
Q 001873 479 IPSEMG-----NLKHLNFVDMSENHLVG----GIPPSVVGCQSLEFLDLHSNGLT 524 (1001)
Q Consensus 479 ~p~~~~-----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 524 (1001)
....+. ..+.|+.|++++|.+++ .+...+..+++|+++++++|.++
T Consensus 237 ~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 237 GAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred HHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 111111 12456666666665541 12233344456666666666665
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.5e-18 Score=193.29 Aligned_cols=184 Identities=29% Similarity=0.293 Sum_probs=154.2
Q ss_pred eEeecCCeeEEEEE----eCCCCEEEEEEecCCCch----hhHHHHHHHhhccC-CCceeeEEeeeecCCceEEEEEccC
Q 001873 773 VIGTGSSGVVYRVT----IPNGETLAVKKMWSSDES----GAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 773 ~lG~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~----~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
++|+|+||.|+.++ ...++-+|+|..+..... .....|-.++..++ ||.+|++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36999999999754 335778888877543321 23445777888886 9999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
||++...+.+. ..+++.....+...++-+++++|+. +|+|||+|++||+++.+|++|+.|||.++......
T Consensus 81 gg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred cchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 99999988763 3467777777788999999999998 99999999999999999999999999998764221
Q ss_pred CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
..+||..|||||++. ....++|.||||++++||+||..||.+
T Consensus 152 -------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 -------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 118999999999998 667889999999999999999999998
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.1e-17 Score=173.07 Aligned_cols=203 Identities=23% Similarity=0.350 Sum_probs=132.9
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-----hhhHHHHHHHhhccCC----------Cce------ee
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-----SGAFSSEIQTLGSIRH----------KNI------VR 824 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~Ei~~l~~l~h----------~nI------v~ 824 (1001)
.+...+.||.|+++.||.+++. +++++|||.+....+ .+++.+|......+.+ -.+ ++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455678999999999999976 589999998854332 2566677665555322 111 22
Q ss_pred EEe---eeecC---C-----ceEEEEEccCCCCHHHHhhc---CCCC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEE
Q 001873 825 LLG---WGSNK---N-----LKLLFYDYLPNGSLSSLLHG---AGKG--GADWEARYEVVLGVAHALAYLHHDCMPPILH 888 (1001)
Q Consensus 825 l~~---~~~~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~--~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH 888 (1001)
+-+ +.... . ..+++|+-+. ++|.+++.. .... ......+..+..|+++.+++||+. |+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 111 11111 1 2267788775 788887642 1111 123445567779999999999999 9999
Q ss_pred eCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCcccccc--------CCCCCccchHHHHH
Q 001873 889 GDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM--------QRITEKSDVYSFGV 960 (1001)
Q Consensus 889 ~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlG~ 960 (1001)
+||||+|++++++|.++++||+........ .. ....+..|.+||.... ..++.+.|.|++|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~---------~~-~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR---------YR-CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEE---------EE-GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCce---------ee-ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 999999999999999999999987653211 00 0234577999997643 35788999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcCcc
Q 001873 961 VLLEVLTGRHPLDPTLPGGAPLV 983 (1001)
Q Consensus 961 il~elltg~~Pf~~~~~~~~~l~ 983 (1001)
++|.|++|+.||+...++...-.
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~~~ 261 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADPEW 261 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTSGG
T ss_pred HHHHHHHccCCCCCCCccccccc
Confidence 99999999999998765554433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.1e-17 Score=169.75 Aligned_cols=139 Identities=17% Similarity=0.240 Sum_probs=109.9
Q ss_pred cccCCCeEeecCCeeEEEEE--eCCCCEEEEEEecCCCc--------------------------hhhHHHHHHHhhccC
Q 001873 767 NLTSANVIGTGSSGVVYRVT--IPNGETLAVKKMWSSDE--------------------------SGAFSSEIQTLGSIR 818 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~--------------------------~~~~~~Ei~~l~~l~ 818 (1001)
-|++.+.||+|+||.||+|. ..+|++||||++..... ...+.+|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37788999999999999998 56899999998864321 012567999999997
Q ss_pred CC--ceeeEEeeeecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-eEEeCCCCCC
Q 001873 819 HK--NIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPP-ILHGDVKAMN 895 (1001)
Q Consensus 819 h~--nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~-ivH~Dlkp~N 895 (1001)
+. .+.+++++ ...++||||++|+++..+... .......+...++.|++.++.|+|+. + |+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence 53 34455543 234899999999888776532 22345566778999999999999998 8 9999999999
Q ss_pred eEECCCCcEEEecccccccc
Q 001873 896 VLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 896 Ill~~~~~~ki~Dfgla~~~ 915 (1001)
|+++ ++.++++|||.|...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 889999999998754
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.9e-17 Score=193.08 Aligned_cols=152 Identities=36% Similarity=0.548 Sum_probs=99.3
Q ss_pred CcHHHHHHHHHHHHhCCCCCCccCCCCCCCCCCC----ccceEEeCC---CC--cEEEEEeccccccccCCcccccCCCC
Q 001873 34 ALDEQGQALLTWKNSLNSSTDALSSWNPAETSPC----KWFGIHCSS---NG--EVVEISLKAVDLQGSLPSIFQPLKSL 104 (1001)
Q Consensus 34 ~~~~~~~aLl~~k~~~~~~~~~l~sW~~~~~~~c----~w~gv~c~~---~~--~v~~l~l~~~~l~~~~~~~~~~l~~L 104 (1001)
+.++|.+||+++|+++.++.. .+|+. ..|| .|.||+|+. .+ +|+.
T Consensus 369 t~~~~~~aL~~~k~~~~~~~~--~~W~g--~~C~p~~~~w~Gv~C~~~~~~~~~~v~~---------------------- 422 (623)
T PLN03150 369 TLLEEVSALQTLKSSLGLPLR--FGWNG--DPCVPQQHPWSGADCQFDSTKGKWFIDG---------------------- 422 (623)
T ss_pred cCchHHHHHHHHHHhcCCccc--CCCCC--CCCCCcccccccceeeccCCCCceEEEE----------------------
Confidence 456799999999999976542 48973 3332 799999962 12 3444
Q ss_pred cEEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceecccc
Q 001873 105 KRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDN 184 (1001)
Q Consensus 105 ~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n 184 (1001)
|+|++|+++|.+|+.++.+++|+.|+|++|++.|.+|..++.+++|++|+|++|+++|.+|+.+++|++|++|+|++|
T Consensus 423 --L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N 500 (623)
T PLN03150 423 --LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500 (623)
T ss_pred --EECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCC
Confidence 555566666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred ccccccCCCccch-hhhhhhhhccCcCCCC
Q 001873 185 QLSGKIPKSIGAL-SKLQVFRAGGNQNLKG 213 (1001)
Q Consensus 185 ~l~g~~p~~~~~l-~~L~~L~l~~n~~l~~ 213 (1001)
.++|.+|..++.+ .++..+++++|..++|
T Consensus 501 ~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~ 530 (623)
T PLN03150 501 SLSGRVPAALGGRLLHRASFNFTDNAGLCG 530 (623)
T ss_pred cccccCChHHhhccccCceEEecCCccccC
Confidence 6666666666543 3455566666654443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.9e-16 Score=163.97 Aligned_cols=132 Identities=21% Similarity=0.344 Sum_probs=112.7
Q ss_pred CeEeecCCeeEEEEEeCCCCEEEEEEecCCCc----------hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 772 NVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE----------SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+.||+|++|.||+|.. .+..|+||+...... ...+.+|+.++..++|++|+....++.+....++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 678899998653221 13577899999999999988777777677778999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
++|++|.+++.... . .+..++.+++.++.++|+. +++|||++|+||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986431 2 7788999999999999998 999999999999999 78999999999875
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.8e-16 Score=185.56 Aligned_cols=135 Identities=21% Similarity=0.340 Sum_probs=111.0
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEe-cCC-C--------chhhHHHHHHHhhccCCCceeeEEeeeecCCce
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKM-WSS-D--------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~-~~~-~--------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~ 835 (1001)
..|...+.||+|+||+||+|.+... .+++|+. ... . ..+++.+|++++++++|++|+....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 4456788999999999999987543 4444432 111 0 124578999999999999998888777777778
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
++||||+++++|.+++. ...+++.++++++.|+|+. +++|||+||+||++ .++.++|+|||+++..
T Consensus 412 ~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999999885 3467899999999999998 99999999999999 6789999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.2e-16 Score=161.60 Aligned_cols=133 Identities=21% Similarity=0.304 Sum_probs=107.2
Q ss_pred ccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc------------------------hhhHHHHHHHhhccCCC--c
Q 001873 768 LTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE------------------------SGAFSSEIQTLGSIRHK--N 821 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------------~~~~~~Ei~~l~~l~h~--n 821 (1001)
|.+.+.||+|+||.||++..++|+.||||++..... .....+|+.++..+.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 677889999999999999988899999998653220 01356788899988777 4
Q ss_pred eeeEEeeeecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC
Q 001873 822 IVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG 901 (1001)
Q Consensus 822 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 901 (1001)
+++.++. ...++||||++|++|.+.... .....++.+++.++.++|+. +|+||||||+||+++++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCC
Confidence 4444442 345899999999998776431 23456888999999999998 99999999999999999
Q ss_pred CcEEEecccccccc
Q 001873 902 YQAYLADFGLARIV 915 (1001)
Q Consensus 902 ~~~ki~Dfgla~~~ 915 (1001)
+.++|+|||.+...
T Consensus 162 ~~~~liDfg~~~~~ 175 (198)
T cd05144 162 EKIYIIDWPQMVST 175 (198)
T ss_pred CcEEEEECCccccC
Confidence 99999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.9e-16 Score=162.33 Aligned_cols=129 Identities=20% Similarity=0.394 Sum_probs=105.7
Q ss_pred eEeecCCeeEEEEEeCCCCEEEEEEecCCC----c------hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 773 VIGTGSSGVVYRVTIPNGETLAVKKMWSSD----E------SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 773 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~------~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
.||+|+||.||+|.+ ++.+|++|+..... + ..++.+|+++++.++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999986 57899999864321 1 145678999999999887655555555566678999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
+|++|.+++..... .++.+++.++.++|+. +++|||++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999998764211 7889999999999998 999999999999999 789999999998763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.4e-17 Score=190.85 Aligned_cols=199 Identities=20% Similarity=0.205 Sum_probs=148.2
Q ss_pred cccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCch---hhHHH---HHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDES---GAFSS---EIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~---Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
++...+.+|++.|=+|.+++++.|. |+||++...... +.|.+ |++ ...++|||.+++.-+-..++.-|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5666788999999999999998777 999988655422 34444 444 555689999999888777777788989
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC-CC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG-SG 919 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~-~~ 919 (1001)
|.. -+|+|.+.- +..+...+.+.|+.|++.|+..+|.. +|+|||||.+|||++.-+=+.|+||..-+...- .+
T Consensus 102 yvk-hnLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 102 YVK-HNLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHh-hhhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 884 699999874 33457777888999999999999998 999999999999999988899999986543211 11
Q ss_pred CCCCCCCCCCCcccccccccCccccccC----------C-CCCccchHHHHHHHHHHHh-CCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQ----------R-ITEKSDVYSFGVVLLEVLT-GRHPLDP 974 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~SlG~il~ellt-g~~Pf~~ 974 (1001)
++.....-..+ ...-.-|.|||.+... . .+++.||||+||++.|+++ |++||+-
T Consensus 176 NPadf~fFFDT-SrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 176 NPADFTFFFDT-SRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred CcccceEEEec-CCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 11000000000 1112359999976431 2 4578899999999999998 7999863
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.9e-16 Score=162.41 Aligned_cols=149 Identities=24% Similarity=0.293 Sum_probs=110.1
Q ss_pred CCCceeeEEeeeec---------------------------CCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 001873 818 RHKNIVRLLGWGSN---------------------------KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG 870 (1001)
Q Consensus 818 ~h~nIv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ 870 (1001)
+|||||+++++|.+ ....|+||..++ .+|..|+.. ...+.....-|..|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~---~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT---RHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc---CCCchHHHHHHHHH
Confidence 69999999886532 235588888886 589999974 33566777778999
Q ss_pred HHHHHHHHhhCCCCCeEEeCCCCCCeEEC--CCC--cEEEecccccccccCCCCCCCCCCCCCCcccccccccCcccccc
Q 001873 871 VAHALAYLHHDCMPPILHGDVKAMNVLLG--PGY--QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM 946 (1001)
Q Consensus 871 i~~~l~yLH~~~~~~ivH~Dlkp~NIll~--~~~--~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 946 (1001)
++.|+.|||++ ||.|||+|++||++. +|+ .+.|+|||++---...+-... -....-...|...-||||+...
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlp-y~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLP-YESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccc-cccccccCCCcceecchhhhhc
Confidence 99999999998 999999999999994 444 578999998753222111100 0011122347778899998754
Q ss_pred CC------CCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 947 QR------ITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 947 ~~------~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
.+ -..|+|.|+.|.+.||+++...||..
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 22 12589999999999999999999987
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2e-16 Score=184.59 Aligned_cols=174 Identities=26% Similarity=0.356 Sum_probs=124.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
..|..++.|..|+||.||.++++ ..+++|+|.- +... +.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~l---ilRn--ilt~a~npfvv--------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL---ILRN--ILTFAGNPFVV--------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhccc-ccch---hhhc--cccccCCccee---------------------
Confidence 45788899999999999999886 4788888442 2211 1110 22222333333
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC----
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD---- 920 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~---- 920 (1001)
|+=...++..+. ++. +++.+++|+|+- +|+|||+||+|.+|+.-|++|++|||+++..--...
T Consensus 136 gDc~tllk~~g~--lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 GDCATLLKNIGP--LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred chhhhhcccCCC--Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 444444443322 221 227789999998 999999999999999999999999999864311100
Q ss_pred ----CCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 001873 921 ----DNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGG 979 (1001)
Q Consensus 921 ----~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~ 979 (1001)
......-....++|||.|.|||++....|+..+|-|++|+|+||.+-|..||.++++++
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 01111112345689999999999999999999999999999999999999999997663
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.6e-14 Score=141.93 Aligned_cols=135 Identities=20% Similarity=0.289 Sum_probs=114.4
Q ss_pred CCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccCC--CceeeEEeeeecCCceEEEEEccCCCCH
Q 001873 770 SANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRH--KNIVRLLGWGSNKNLKLLFYDYLPNGSL 847 (1001)
Q Consensus 770 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~~gsL 847 (1001)
+.+.+|+|.++.||+++..+ ..+++|..........+.+|+..++.++| ..+++++++....+..+++|||++++.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 35679999999999999854 88999998655444678999999999976 5899999988888889999999998777
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 848 SSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 848 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
..+ +......++.+++++++++|....++++|+|++|+||++++.+.++++|||.++.
T Consensus 81 ~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 654 4456677889999999999986434799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.5e-16 Score=169.81 Aligned_cols=129 Identities=23% Similarity=0.372 Sum_probs=110.1
Q ss_pred CCceEEEEEccCCCCHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccc
Q 001873 832 KNLKLLFYDYLPNGSLSSLLHG-AGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFG 910 (1001)
Q Consensus 832 ~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfg 910 (1001)
..+.+|.|++|...+|.+|+.. ......++.....++.|++.|++| + +.+|||+||.||+...+.++||.|||
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence 3467899999999999999974 334456888899999999999999 5 89999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT 967 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt 967 (1001)
+.......... .......+..+||..||+||.+.+..|+.++||||+|++++|++.
T Consensus 402 l~ts~~~~~~~-~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETV-APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcc-cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99876554421 123344566789999999999999999999999999999999988
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2e-14 Score=146.96 Aligned_cols=133 Identities=21% Similarity=0.317 Sum_probs=96.9
Q ss_pred CCeEeecCCeeEEEEEeCCCCEEEEEEecCCCch----hhH----------------------HHHHHHhhccCCCc--e
Q 001873 771 ANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDES----GAF----------------------SSEIQTLGSIRHKN--I 822 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~----------------------~~Ei~~l~~l~h~n--I 822 (1001)
.+.||+|+||+||+|...++++||||++...... ... ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999987543211 111 34555666654432 4
Q ss_pred eeEEeeeecCCceEEEEEccCCCCHHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCeEECC
Q 001873 823 VRLLGWGSNKNLKLLFYDYLPNGSLSS-LLHGAGKGGADWEARYEVVLGVAHALAYLHH-DCMPPILHGDVKAMNVLLGP 900 (1001)
Q Consensus 823 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NIll~~ 900 (1001)
.+.+++ ...++||||++++.+.. .+.... .. ..+..++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 444443 23589999999854321 121110 11 5567889999999999999 6 999999999999999
Q ss_pred CCcEEEecccccccc
Q 001873 901 GYQAYLADFGLARIV 915 (1001)
Q Consensus 901 ~~~~ki~Dfgla~~~ 915 (1001)
++.++++|||.|...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999999764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=7.1e-14 Score=147.41 Aligned_cols=133 Identities=22% Similarity=0.331 Sum_probs=104.3
Q ss_pred CCeEe-ecCCeeEEEEEeCCCCEEEEEEecCC---------------CchhhHHHHHHHhhccCCCce--eeEEeeeecC
Q 001873 771 ANVIG-TGSSGVVYRVTIPNGETLAVKKMWSS---------------DESGAFSSEIQTLGSIRHKNI--VRLLGWGSNK 832 (1001)
Q Consensus 771 ~~~lG-~G~fg~Vy~~~~~~~~~vavK~~~~~---------------~~~~~~~~Ei~~l~~l~h~nI--v~l~~~~~~~ 832 (1001)
..+|| .|+.|+||.++.. +..+|||++... .....+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45688 8999999999884 788999977421 112467889999999998775 6667654332
Q ss_pred -Cc---eEEEEEccCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEe
Q 001873 833 -NL---KLLFYDYLPN-GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLA 907 (1001)
Q Consensus 833 -~~---~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~ 907 (1001)
.. .++||||++| .+|.+++.+. .++.. .+.+++.++.++|+. ||+||||||+|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 22 2599999997 6999988642 23433 356899999999998 99999999999999998999999
Q ss_pred ccccccc
Q 001873 908 DFGLARI 914 (1001)
Q Consensus 908 Dfgla~~ 914 (1001)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998875
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.9e-14 Score=160.05 Aligned_cols=158 Identities=26% Similarity=0.469 Sum_probs=128.0
Q ss_pred hhccCCCceeeEEeeeecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe-EEeCCC
Q 001873 814 LGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPI-LHGDVK 892 (1001)
Q Consensus 814 l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~i-vH~Dlk 892 (1001)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+... ...+++.=...++++|+.|+.|+|.. +| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence 45789999999999999999999999999999999999863 44577777888899999999999997 55 999999
Q ss_pred CCCeEECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCC-------CCCccchHHHHHHHHHH
Q 001873 893 AMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR-------ITEKSDVYSFGVVLLEV 965 (1001)
Q Consensus 893 p~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~SlG~il~el 965 (1001)
+.|.++|....+|++|||+........ .........-..-|.|||.+.... .+.+.||||||++++|+
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~-----~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETA-----EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccc-----cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 999999999999999999987764311 111111122345699999886631 45679999999999999
Q ss_pred HhCCCCCCCCCCCCc
Q 001873 966 LTGRHPLDPTLPGGA 980 (1001)
Q Consensus 966 ltg~~Pf~~~~~~~~ 980 (1001)
++++.||+......+
T Consensus 152 ~~r~~~~~~~~~~~~ 166 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVED 166 (484)
T ss_pred HhccCccccccccCC
Confidence 999999997543333
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.7e-14 Score=170.32 Aligned_cols=216 Identities=26% Similarity=0.312 Sum_probs=170.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeC--CCCEEEEEEecCCC----chhhHHHHHHHhhccC-CCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP--NGETLAVKKMWSSD----ESGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~~lv 838 (1001)
..|...+.||+|+|+.|-..... ....+|+|.+.... .......|..+-+.+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 35777788999999999887643 34556777664332 1234445777777776 99999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEEeCCCCCCeEECCCC-cEEEeccccccccc
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCMPPILHGDVKAMNVLLGPGY-QAYLADFGLARIVS 916 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH-~~~~~~ivH~Dlkp~NIll~~~~-~~ki~Dfgla~~~~ 916 (1001)
.+|.+++++.+.+........+...+..+..|+..++.|+| .. ++.|||+||+|.+++..+ ..|++|||+|..+.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999984222224555666778999999999999 66 999999999999999999 99999999998875
Q ss_pred CCCCCCCCCCCCCCcccc-cccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhh
Q 001873 917 GSGDDNCSKTNQRPQLAG-SYGYMAPEHASMQ-RITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPL 988 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~ 988 (1001)
.-. .........+| ++.|+|||...+. ......|+||.|+++.-+++|..||+-..........|...
T Consensus 177 ~~~----g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~ 246 (601)
T KOG0590|consen 177 NKN----GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN 246 (601)
T ss_pred ccC----CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc
Confidence 411 12223344567 9999999998774 45688999999999999999999999877777777777665
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.1e-13 Score=152.06 Aligned_cols=148 Identities=17% Similarity=0.253 Sum_probs=104.2
Q ss_pred cHHHHHhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCch-----------------------------------
Q 001873 760 SIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDES----------------------------------- 804 (1001)
Q Consensus 760 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------------------------- 804 (1001)
+++++...|. .+.||+|++|.||+|+.++|+.||||+.+.....
T Consensus 112 ~~~~~F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~ 190 (437)
T TIGR01982 112 PLEELFAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEF 190 (437)
T ss_pred CHHHHHhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHH
Confidence 4455555555 3679999999999999999999999987432100
Q ss_pred -------hhHHHHHHHhhccC-----CCceeeEEe-eeecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHH
Q 001873 805 -------GAFSSEIQTLGSIR-----HKNIVRLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGV 871 (1001)
Q Consensus 805 -------~~~~~Ei~~l~~l~-----h~nIv~l~~-~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i 871 (1001)
-+|.+|++.+.+++ +++| .+-. +.......++||||++|++|.++...... ..+ ..+++.++
T Consensus 191 ~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~ 265 (437)
T TIGR01982 191 EKTLRRELDLRREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENL 265 (437)
T ss_pred HHHHHHHHCHHHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHH
Confidence 02445666555552 3333 2222 22334456999999999999888653211 122 34566666
Q ss_pred HH-HHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 872 AH-ALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 872 ~~-~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
+. .+..+|.. |++|+|+||.||+++++++++++|||++..+.
T Consensus 266 ~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 266 ARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 65 46788987 99999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.4e-14 Score=158.34 Aligned_cols=175 Identities=35% Similarity=0.534 Sum_probs=92.7
Q ss_pred CccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccCCCccchhhhhhh
Q 001873 124 DYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVF 203 (1001)
Q Consensus 124 ~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L 203 (1001)
.|+--...||+.|++. ++|.+++.+..|+.|.|..|.+. .||..+++|..|.+|||+.|+++ .+|..++.|+ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 3444455566666665 56666666666666666666665 56666666666666666666665 5566555554 5555
Q ss_pred hhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCcccccCCCCCceEeeecCcc
Q 001873 204 RAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSI 283 (1001)
Q Consensus 204 ~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i 283 (1001)
-+++|+ ++ .+|++++-+..|.+|+.+.|.+. .+|..++++.+|+.|.++.|.+. .+|++++.| .|..||++.|++
T Consensus 149 i~sNNk-l~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNki 223 (722)
T KOG0532|consen 149 IVSNNK-LT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKI 223 (722)
T ss_pred EEecCc-cc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCce
Confidence 555552 22 45666665566666666665554 33333344444444444444443 344444422 245555555555
Q ss_pred cCCCCcccCCCCCCcEEEcCCCccc
Q 001873 284 SGPIPGRIGALSKLKSLLLWQNSLV 308 (1001)
Q Consensus 284 ~~~~p~~~~~l~~L~~L~L~~N~l~ 308 (1001)
+ .+|-.|.+|+.|++|-|.+|-+.
T Consensus 224 s-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 224 S-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred e-ecchhhhhhhhheeeeeccCCCC
Confidence 4 44444444444444444444444
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.4e-15 Score=160.57 Aligned_cols=174 Identities=30% Similarity=0.490 Sum_probs=108.2
Q ss_pred cceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCcccCCCCcc-cccccccCCCC
Q 001873 465 LRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP-TSLQLVDLSDN 543 (1001)
Q Consensus 465 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~l~~L~Ls~N 543 (1001)
-...||+.|++. .+|..+..+..|+.+.|.+|.+. .+|..++++..|++|||+.|+++ ..|..++ --|+.|.+++|
T Consensus 77 t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lpLkvli~sNN 153 (722)
T KOG0532|consen 77 TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLPLKVLIVSNN 153 (722)
T ss_pred hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCcceeEEEecC
Confidence 345555556655 55555555555555666666655 45555666666666666666665 3333332 23555666666
Q ss_pred cCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCccccccc
Q 001873 544 RLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIP 623 (1001)
Q Consensus 544 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p 623 (1001)
+++ .+|..++.+..|..||.+.|.+. .+|..++.+.+|+.|++..|++. .+|.++..|+-.+ ||+|.|+++ .+|
T Consensus 154 kl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~--lDfScNkis-~iP 227 (722)
T KOG0532|consen 154 KLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIR--LDFSCNKIS-YLP 227 (722)
T ss_pred ccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceee--eecccCcee-ecc
Confidence 665 45666666667777777777776 55666777777777777777776 5566666555443 677777776 566
Q ss_pred ccccccccccEEEecCCcCCCChh
Q 001873 624 SEFSGLTKLGILDLSHNKLSGDLD 647 (1001)
Q Consensus 624 ~~~~~l~~L~~L~Ls~N~l~~~~~ 647 (1001)
-.|..|+.|++|-|.+|+++..+.
T Consensus 228 v~fr~m~~Lq~l~LenNPLqSPPA 251 (722)
T KOG0532|consen 228 VDFRKMRHLQVLQLENNPLQSPPA 251 (722)
T ss_pred hhhhhhhhheeeeeccCCCCCChH
Confidence 677777777777777777776543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=6.7e-13 Score=152.66 Aligned_cols=182 Identities=35% Similarity=0.502 Sum_probs=97.1
Q ss_pred CCccccccccccCCccCCCCChhhhccc-ccceEEccCCcccCCCCccccCCccccceeccccccccccCCCccchhhhh
Q 001873 123 GDYRELTFIDLSGNSLWGEIPTEVCRLR-KLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQ 201 (1001)
Q Consensus 123 ~~l~~L~~L~Ls~n~l~g~~p~~~~~l~-~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~ 201 (1001)
..++.++.|++.+|.++ .+|...+.++ +|++|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.+++|+
T Consensus 113 ~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~ 189 (394)
T COG4886 113 LELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLN 189 (394)
T ss_pred hcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhh
Confidence 33445555555555555 4555555553 5555555555555 44445555555555555555555 4554444555555
Q ss_pred hhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCcccccCCCCCceEeeecC
Q 001873 202 VFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQN 281 (1001)
Q Consensus 202 ~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N 281 (1001)
.|++++|+ +. .+|..++.+..|+++.++.|. .. .++..+.+++++..|.+.+|
T Consensus 190 ~L~ls~N~-i~-~l~~~~~~~~~L~~l~~~~N~------------------------~~-~~~~~~~~~~~l~~l~l~~n 242 (394)
T COG4886 190 NLDLSGNK-IS-DLPPEIELLSALEELDLSNNS------------------------II-ELLSSLSNLKNLSGLELSNN 242 (394)
T ss_pred heeccCCc-cc-cCchhhhhhhhhhhhhhcCCc------------------------ce-ecchhhhhcccccccccCCc
Confidence 55555552 21 333333333334444444432 11 34455566666666666666
Q ss_pred cccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCc
Q 001873 282 SISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPR 337 (1001)
Q Consensus 282 ~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 337 (1001)
++. ..+..++.+++++.|++++|+++. ++. ++.+.+++.|++++|.+....|.
T Consensus 243 ~~~-~~~~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 243 KLE-DLPESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred eee-eccchhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchh
Confidence 665 235566666667777777776663 333 66666777777777766654443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.5e-12 Score=149.86 Aligned_cols=199 Identities=33% Similarity=0.449 Sum_probs=112.0
Q ss_pred EEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCccccccc-CccEEEcccccccCcCChhhccccccCEEeccCC
Q 001873 299 SLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLL-KLQELQLSVNQLSGTIPIEIATCTALTHLEIDNN 377 (1001)
Q Consensus 299 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 377 (1001)
.+++..|.+.. .+..+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 46666666542 2233444566666666666666 4555555553 6666666666665 44445566666666666666
Q ss_pred cccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCC
Q 001873 378 AISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPP 457 (1001)
Q Consensus 378 ~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 457 (1001)
+++ .+|... +..+.|+.|++++|+++ .+|........|++|.+++|++. ..+.
T Consensus 174 ~l~-~l~~~~------------------------~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~ 226 (394)
T COG4886 174 DLS-DLPKLL------------------------SNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLS 226 (394)
T ss_pred hhh-hhhhhh------------------------hhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecch
Confidence 665 233333 24455555555555555 34444344444555566555432 2344
Q ss_pred CCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCcccCCCC
Q 001873 458 DIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDT 530 (1001)
Q Consensus 458 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 530 (1001)
.+..+.++..+.+.+|++. ..+..++.+..+++|++++|+++...+ +..+.+++.|++++|.++...|..
T Consensus 227 ~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 227 SLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hhhhcccccccccCCceee-eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhh
Confidence 5555666666666666665 335566666666666666666663322 666666677777776666544443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.9e-12 Score=153.99 Aligned_cols=106 Identities=40% Similarity=0.572 Sum_probs=67.9
Q ss_pred ccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEe
Q 001873 558 ELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDL 637 (1001)
Q Consensus 558 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 637 (1001)
.++.|+|++|.+++.+|..+..+++|+.|+|++|+|+|.+|..++.++.|+. |+|++|+++|.+|+.++++++|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~-LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEV-LDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCE-EECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 3566777777777777777777777777777777777777777777777765 777777777777776666666666666
Q ss_pred cCCcCCCC-hhhhhcc-cccceeEcccCC
Q 001873 638 SHNKLSGD-LDALASL-QNLVSLNVSFND 664 (1001)
Q Consensus 638 s~N~l~~~-~~~~~~l-~~L~~L~ls~N~ 664 (1001)
++|++++. |..+..+ .++..+++++|.
T Consensus 498 s~N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 498 NGNSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred cCCcccccCChHHhhccccCceEEecCCc
Confidence 66666653 3333321 233444444443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.2e-11 Score=143.01 Aligned_cols=153 Identities=12% Similarity=0.137 Sum_probs=99.7
Q ss_pred cccHHHHHhcccCCCeEeecCCeeEEEEEeCC-CCEEEEEEecCCCch--------------------------------
Q 001873 758 DFSIDDVVRNLTSANVIGTGSSGVVYRVTIPN-GETLAVKKMWSSDES-------------------------------- 804 (1001)
Q Consensus 758 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-------------------------------- 804 (1001)
..+.+++...|+. +.+|+|++|+||+|+.++ |+.||||+.......
T Consensus 112 G~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v 190 (537)
T PRK04750 112 GGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVV 190 (537)
T ss_pred CCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHH
Confidence 3456666777877 789999999999999887 999999988533100
Q ss_pred ----------hhHHHHHHHhhccC----CCceeeEEeee-ecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 001873 805 ----------GAFSSEIQTLGSIR----HKNIVRLLGWG-SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVL 869 (1001)
Q Consensus 805 ----------~~~~~Ei~~l~~l~----h~nIv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~ 869 (1001)
-++.+|+..+.+++ +...+.+-.++ ......++||||++|+.+.++-.-. ....+.....+..
T Consensus 191 ~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~~g~d~~~la~~~- 268 (537)
T PRK04750 191 AEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-AAGTDMKLLAERG- 268 (537)
T ss_pred HHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-hcCCCHHHHHHHH-
Confidence 02444555555542 43334433333 2355678999999999998753211 1122222211111
Q ss_pred HHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC----cEEEecccccccccC
Q 001873 870 GVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY----QAYLADFGLARIVSG 917 (1001)
Q Consensus 870 ~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~ki~Dfgla~~~~~ 917 (1001)
+..-+..++.. |++|+|+||.||+++.++ +++++|||++..++.
T Consensus 269 -v~~~~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 269 -VEVFFTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -HHHHHHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 11112233445 999999999999999888 999999999987743
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.2e-11 Score=122.21 Aligned_cols=130 Identities=18% Similarity=0.165 Sum_probs=96.8
Q ss_pred CCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCcee-eEEeeeecCCceEEEEEccCCCCHH
Q 001873 771 ANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIV-RLLGWGSNKNLKLLFYDYLPNGSLS 848 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv-~l~~~~~~~~~~~lv~e~~~~gsL~ 848 (1001)
++.++.|.++.||+++.. ++.|++|...... ....+.+|+.+++.+.+.+++ +++.+.. ...++||||++|.++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 356899999999999875 7889999875543 234578899999998655544 4554433 2348999999998776
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 849 SLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC--MPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 849 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
+. . . ....++.++++++..||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~-~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE-D------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc-c------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 43 0 0 11245678999999999972 11259999999999999 67899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.3e-11 Score=148.92 Aligned_cols=127 Identities=28% Similarity=0.371 Sum_probs=87.3
Q ss_pred CCCcEEeccCCcccCCCCcccCCccccccccccCCc--cCCCCCh-hhhcccccceEEccCCcccCCCCccccCCccccc
Q 001873 102 KSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNS--LWGEIPT-EVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAY 178 (1001)
Q Consensus 102 ~~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~--l~g~~p~-~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~ 178 (1001)
...++..+.+|.+. .++.+..+ +.|++|-+..|. +. .++. .|..|+.|++|||++|.=-+++|++|++|-+|++
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred hheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 45556666666654 33333322 257777777775 44 4444 3667888888888887655688888888888888
Q ss_pred eeccccccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhcccccc
Q 001873 179 LTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAET 233 (1001)
Q Consensus 179 L~L~~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~ 233 (1001)
|+|++..++ .+|..+++|++|.+|++..+..+. .+|..+..|++|++|.+...
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~-~~~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLE-SIPGILLELQSLRVLRLPRS 652 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheeccccccccc-cccchhhhcccccEEEeecc
Confidence 888888887 788888888888888888774433 33555556777777777654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.4e-10 Score=128.28 Aligned_cols=163 Identities=21% Similarity=0.303 Sum_probs=126.1
Q ss_pred CCCCEEEEEEecCCCc--hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHH
Q 001873 788 PNGETLAVKKMWSSDE--SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY 865 (1001)
Q Consensus 788 ~~~~~vavK~~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~ 865 (1001)
.++.+|.|...+.... .+...+-++.++.++||||+++++.+..++..|+|+|-+ ..|..++++.+ .....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~~v~ 107 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KEEVC 107 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HHHHH
Confidence 3688888888765544 355778888899999999999999999999999999998 47888888643 34445
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccc
Q 001873 866 EVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945 (1001)
Q Consensus 866 ~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 945 (1001)
..+.||++||.+||..| +++|++|.-..|++++.|+.||++|.++......+. ......---.|..|+.+.
T Consensus 108 ~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-------~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-------PAKSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-------ccccchhhhcccChhhcC
Confidence 56889999999999876 999999999999999999999999998875432211 011111122456666543
Q ss_pred cCCCCCccchHHHHHHHHHHHhC
Q 001873 946 MQRITEKSDVYSFGVVLLEVLTG 968 (1001)
Q Consensus 946 ~~~~~~~~Dv~SlG~il~elltg 968 (1001)
... ...|.|.||+++||++.|
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCc
Confidence 322 356999999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.4e-10 Score=106.21 Aligned_cols=141 Identities=21% Similarity=0.298 Sum_probs=106.7
Q ss_pred CCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC----------chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 770 SANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD----------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 770 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
....+-+|+-+.|+++.+ .|+.+.||.-.... ..++..+|++.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456789999999999998 58888888543322 1256778999999987555544333444445557999
Q ss_pred EccCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC---cEEEeccccccc
Q 001873 840 DYLPN-GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY---QAYLADFGLARI 914 (1001)
Q Consensus 840 e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~ki~Dfgla~~ 914 (1001)
||++| .++.+++................+.+|-+.+.-||.. +|+|+||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99986 3889998876554444444467888899999999999 999999999999997654 458999999875
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.3e-11 Score=131.93 Aligned_cols=209 Identities=22% Similarity=0.239 Sum_probs=112.4
Q ss_pred cccccceEEccCCcCCCCCC-CCCCCCCCcceEEccccccccCC--CcccCCCCCcceeeccCcccccCCcccc-ccccc
Q 001873 437 GLRNLTKLLLLSNDLSGFIP-PDIGNCTTLRRLRLNDNRLSGTI--PSEMGNLKHLNFVDMSENHLVGGIPPSV-VGCQS 512 (1001)
Q Consensus 437 ~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~ 512 (1001)
++.+|+++.|.+........ .....|++++.||||.|-+.... ..-...+++|+.|+|+.|++........ ..++.
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 46667777777777652211 24556777777777777666321 2233456667777777776653222111 12455
Q ss_pred CceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEeccccc
Q 001873 513 LEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNR 592 (1001)
Q Consensus 513 L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 592 (1001)
|+.|.++.|.|+-. .+......+++|+.|+|+.|..-..-.....-+..|++|||++|+
T Consensus 199 lK~L~l~~CGls~k---------------------~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~ 257 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWK---------------------DVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNN 257 (505)
T ss_pred hheEEeccCCCCHH---------------------HHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCc
Confidence 55566666655411 111112234555555555553211222223334455555555555
Q ss_pred ccCCC-CCccccccchhhhhhcCCCccccccccc------ccccccccEEEecCCcCCC--ChhhhhcccccceeEcccC
Q 001873 593 FSGEI-PKELGQISSLEISLNLSSNQFSGEIPSE------FSGLTKLGILDLSHNKLSG--DLDALASLQNLVSLNVSFN 663 (1001)
Q Consensus 593 l~~~~-p~~~~~l~~L~~~L~Ls~N~l~~~~p~~------~~~l~~L~~L~Ls~N~l~~--~~~~~~~l~~L~~L~ls~N 663 (1001)
+-... -...+.++.|+. |+++.+.+..+--.. ...+++|+.|+++.|++.. ....+..+++|+.|....|
T Consensus 258 li~~~~~~~~~~l~~L~~-Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n 336 (505)
T KOG3207|consen 258 LIDFDQGYKVGTLPGLNQ-LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLN 336 (505)
T ss_pred ccccccccccccccchhh-hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccc
Confidence 44221 123344555554 555555555432222 2456788888888888854 4566777788888888888
Q ss_pred CCCC
Q 001873 664 DFSG 667 (1001)
Q Consensus 664 ~l~~ 667 (1001)
.++.
T Consensus 337 ~ln~ 340 (505)
T KOG3207|consen 337 YLNK 340 (505)
T ss_pred cccc
Confidence 7754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1e-10 Score=131.67 Aligned_cols=200 Identities=25% Similarity=0.267 Sum_probs=157.2
Q ss_pred hcccCCCeEee--cCCeeEEEEEe---CCCCEEEEEEecCC----CchhhHHHHHHHhhccC-CCceeeEEeeeecCCce
Q 001873 766 RNLTSANVIGT--GSSGVVYRVTI---PNGETLAVKKMWSS----DESGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 766 ~~~~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~~~~~----~~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~ 835 (1001)
..+.+.+.+|. |.+|.||.+.. .+++.+|+|+-+.. .....=.+|+..-++++ |++.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 44566778999 99999999876 36889999974332 23344556777777774 99999988899999999
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeEEeCCCCCCeEECCC-CcEEEeccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAH----ALAYLHHDCMPPILHGDVKAMNVLLGPG-YQAYLADFG 910 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~----~l~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ki~Dfg 910 (1001)
++-+|++. .++.++.+.. ...++....+.+..+..+ |+.++|+. +++|-|+||.||+...+ ..++.+|||
T Consensus 194 fiqtE~~~-~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeecccc-chhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 99999884 7888887754 233667777888888888 99999998 99999999999999998 899999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~ 973 (1001)
+...+....-....... ....|...|++||... ..++..+|+||+|.+..+..++-.+.-
T Consensus 269 ~v~~i~~~~~~~~~~~~--~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVS--KRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred eeEEccCCccccceeee--ecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc
Confidence 99988765432222211 2225777899999886 467789999999999999988766544
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.5e-11 Score=123.02 Aligned_cols=131 Identities=28% Similarity=0.283 Sum_probs=66.1
Q ss_pred CCCcceeeccCcccccCCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeecc
Q 001873 486 LKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLS 565 (1001)
Q Consensus 486 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 565 (1001)
...|+.+|||+|.|+ .+.++..-++.++.|++|+|.|.. ...+..+++|+.||||
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~------------------------v~nLa~L~~L~~LDLS 337 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT------------------------VQNLAELPQLQLLDLS 337 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceee------------------------ehhhhhcccceEeecc
Confidence 344555555555555 344444444555555555555441 1125556666777777
Q ss_pred CccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccc-cccccccccccEEEecCCcCCC
Q 001873 566 KNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEI-PSEFSGLTKLGILDLSHNKLSG 644 (1001)
Q Consensus 566 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~ 644 (1001)
+|.++ .+-.+-..+.+++.|.|+.|.+. .-..++.+.+|.. ||+++|+|...- -..+++|+-|+++.|.+|++..
T Consensus 338 ~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE--~LSGL~KLYSLvn-LDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 338 GNLLA-ECVGWHLKLGNIKTLKLAQNKIE--TLSGLRKLYSLVN-LDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred cchhH-hhhhhHhhhcCEeeeehhhhhHh--hhhhhHhhhhhee-ccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 77666 33344445566666666666653 1223344444443 555555554211 1224455555555555555554
Q ss_pred C
Q 001873 645 D 645 (1001)
Q Consensus 645 ~ 645 (1001)
.
T Consensus 414 ~ 414 (490)
T KOG1259|consen 414 S 414 (490)
T ss_pred c
Confidence 3
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.9e-11 Score=123.77 Aligned_cols=135 Identities=26% Similarity=0.279 Sum_probs=81.5
Q ss_pred cccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCC
Q 001873 409 ESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKH 488 (1001)
Q Consensus 409 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 488 (1001)
......+.|+++|||+|.|+ .+.....-.+.++.|++++|.+... ..+..+++|+.||||+|.++ .+..+-..+.+
T Consensus 278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGN 353 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGN 353 (490)
T ss_pred EecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcC
Confidence 34444566777777777776 4555555566777777777777633 23666677777777777776 44445555666
Q ss_pred cceeeccCcccccCCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCcc
Q 001873 489 LNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQ 568 (1001)
Q Consensus 489 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 568 (1001)
++.|.|++|.|... ..+..+-+|..||+++|+|... .-...+++++-|+++.|.+|.
T Consensus 354 IKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~l---------------------deV~~IG~LPCLE~l~L~~NP 410 (490)
T KOG1259|consen 354 IKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEEL---------------------DEVNHIGNLPCLETLRLTGNP 410 (490)
T ss_pred EeeeehhhhhHhhh--hhhHhhhhheeccccccchhhH---------------------HHhcccccccHHHHHhhcCCC
Confidence 66667777766521 3344555566666666665411 112345666666666666666
Q ss_pred cc
Q 001873 569 LS 570 (1001)
Q Consensus 569 l~ 570 (1001)
+.
T Consensus 411 l~ 412 (490)
T KOG1259|consen 411 LA 412 (490)
T ss_pred cc
Confidence 66
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.2e-09 Score=109.79 Aligned_cols=133 Identities=14% Similarity=0.183 Sum_probs=96.3
Q ss_pred CeEeecCCeeEEEEEeCC-------CCEEEEEEecCCC------------c------------hhhH----HHHHHHhhc
Q 001873 772 NVIGTGSSGVVYRVTIPN-------GETLAVKKMWSSD------------E------------SGAF----SSEIQTLGS 816 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~------------~------------~~~~----~~Ei~~l~~ 816 (1001)
..||.|--+.||.|...+ +..+|||..+... + .+.+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999997543 4799999652100 0 1122 379999999
Q ss_pred cCC--CceeeEEeeeecCCceEEEEEccCCCCHHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEEeCCC
Q 001873 817 IRH--KNIVRLLGWGSNKNLKLLFYDYLPNGSLSS-LLHGAGKGGADWEARYEVVLGVAHALAYL-HHDCMPPILHGDVK 892 (1001)
Q Consensus 817 l~h--~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~~i~~~l~yL-H~~~~~~ivH~Dlk 892 (1001)
+.. -++.+.+++ ...++||||+.++.+.. .+++ ...+..+..++..+++.++.++ |+. ++||||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 853 456666664 34589999997654422 2322 2244556667789999999999 776 99999999
Q ss_pred CCCeEECCCCcEEEecccccccc
Q 001873 893 AMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 893 p~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
+.||+++ ++.++|+|||.|...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 468999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.5e-11 Score=139.80 Aligned_cols=175 Identities=33% Similarity=0.394 Sum_probs=84.5
Q ss_pred cccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcc
Q 001873 411 LSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLN 490 (1001)
Q Consensus 411 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 490 (1001)
+..+++|+.|++..|+|.. +...+..+++|++|++++|.|+.+. .+..++.|+.|++++|.|+.. ..+..+..|+
T Consensus 91 l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~ 165 (414)
T KOG0531|consen 91 LSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLK 165 (414)
T ss_pred cccccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhhheeccCcchhc--cCCccchhhh
Confidence 3444455555555555542 1212444555555555555555432 233444566666666666522 2344456666
Q ss_pred eeeccCcccccCCc-ccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCccccccccc--ccceeeccCc
Q 001873 491 FVDMSENHLVGGIP-PSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLT--ELSKLLLSKN 567 (1001)
Q Consensus 491 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~Ls~N 567 (1001)
.+++++|+++..-+ . ...+.+++.+++++|.+...-.......+..+++..|+++..-+ +..+. .|+.+++++|
T Consensus 166 ~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n 242 (414)
T KOG0531|consen 166 LLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGN 242 (414)
T ss_pred cccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccC
Confidence 66666666654333 1 34555666666666665522222222233334555555543221 11122 2556666666
Q ss_pred cccccchhhhhccccccEEeccccccc
Q 001873 568 QLSGRIPAEILSCRKLILLDIGNNRFS 594 (1001)
Q Consensus 568 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 594 (1001)
++. ..+..+..+.++..|++++|++.
T Consensus 243 ~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 243 RIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred ccc-cccccccccccccccchhhcccc
Confidence 655 32234444555555555555554
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.7e-11 Score=147.08 Aligned_cols=128 Identities=29% Similarity=0.379 Sum_probs=101.2
Q ss_pred CCCcEEeccCCc--ccCCCCc-ccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccc
Q 001873 102 KSLKRLIISSCN--LTGTIPK-EFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAY 178 (1001)
Q Consensus 102 ~~L~~L~l~~~~--l~g~~p~-~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~ 178 (1001)
+.|+.|-+.+|. +. .++. .|..++.|++||||+|.=-+.+|.+|+.|-+||+|+|++..++ .+|..+++|..|.+
T Consensus 545 ~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~ 622 (889)
T KOG4658|consen 545 PKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIY 622 (889)
T ss_pred CccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhe
Confidence 367788888886 44 4554 4788999999999998877899999999999999999999999 99999999999999
Q ss_pred eeccccccccccCCCccchhhhhhhhhccCc-CCCCCCCcccccCccchhcccc
Q 001873 179 LTLYDNQLSGKIPKSIGALSKLQVFRAGGNQ-NLKGELPWEIGNCSNLVMLGLA 231 (1001)
Q Consensus 179 L~L~~n~l~g~~p~~~~~l~~L~~L~l~~n~-~l~~~lp~~l~~l~~L~~L~l~ 231 (1001)
|++..+.....+|..+..|++|++|.+..-. ..++..-.++.+|.+|+.+...
T Consensus 623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~ 676 (889)
T KOG4658|consen 623 LNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSIT 676 (889)
T ss_pred eccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheee
Confidence 9999998877788888889999999987652 1222222344455555555543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=1e-09 Score=115.50 Aligned_cols=140 Identities=21% Similarity=0.271 Sum_probs=109.3
Q ss_pred CeEeecCCeeEEEEEeCCCCEEEEEEecCCCc---hhhHHHHHHHhhccCC--CceeeEEeeeecC---CceEEEEEccC
Q 001873 772 NVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE---SGAFSSEIQTLGSIRH--KNIVRLLGWGSNK---NLKLLFYDYLP 843 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h--~nIv~l~~~~~~~---~~~~lv~e~~~ 843 (1001)
+.+|.|.++.||+++..+|+.+++|....... ..++.+|+++++.+++ ..+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987678999998765432 4678999999999975 4467777776654 25689999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------------
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC----------------------------------------- 882 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~----------------------------------------- 882 (1001)
|.++.+.+.. ...+......++.++++++.+||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9888776531 23567777778888888888888521
Q ss_pred ------------CCCeEEeCCCCCCeEECC--CCcEEEeccccccc
Q 001873 883 ------------MPPILHGDVKAMNVLLGP--GYQAYLADFGLARI 914 (1001)
Q Consensus 883 ------------~~~ivH~Dlkp~NIll~~--~~~~ki~Dfgla~~ 914 (1001)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 145799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.5e-11 Score=139.78 Aligned_cols=247 Identities=28% Similarity=0.329 Sum_probs=112.9
Q ss_pred CCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEE
Q 001873 293 ALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHL 372 (1001)
Q Consensus 293 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 372 (1001)
.+..++.+++..|.+.. +-..+..+++|+.|++.+|+|.. +...+..+++|++|+|++|+|+... .+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhhh
Confidence 34444455555555542 22334455555555555555552 2222444555555555555554332 22333334445
Q ss_pred eccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCC
Q 001873 373 EIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLS 452 (1001)
Q Consensus 373 ~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 452 (1001)
++++|.|+.. ..+..+..|+.+++++|++....+.....+.+++.+.+.+|.+.
T Consensus 146 ~l~~N~i~~~--------------------------~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 146 NLSGNLISDI--------------------------SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIR 199 (414)
T ss_pred eeccCcchhc--------------------------cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchh
Confidence 5555444310 12222445555555555554322200244455555555555554
Q ss_pred CCCCCCCCCCCCcceEEccccccccCCCcccCCCC--CcceeeccCcccccCCcccccccccCceEEcccccCcccCCCC
Q 001873 453 GFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLK--HLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDT 530 (1001)
Q Consensus 453 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 530 (1001)
.. ..+..+..+..+++..|+++..-+ +..+. +|+.+++++|.+. ..+..+..+..+..|++++|++...-.
T Consensus 200 ~i--~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~~-- 272 (414)
T KOG0531|consen 200 EI--EGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLEG-- 272 (414)
T ss_pred cc--cchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccccc--
Confidence 22 223333444444555555542211 11112 2555666666655 222344455555555555555543221
Q ss_pred cccccccccCCCCcCCCCcccccccccccceeeccCccccc---cchhh-hhccccccEEecccccccCCCC
Q 001873 531 LPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSG---RIPAE-ILSCRKLILLDIGNNRFSGEIP 598 (1001)
Q Consensus 531 ~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---~~p~~-~~~l~~L~~L~Ls~N~l~~~~p 598 (1001)
+.....+..+.+..|++.. ..... ....+.+..+.+..|.+....+
T Consensus 273 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 273 ----------------------LERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred ----------------------ccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 2233444455555555431 11111 3445666677777776664444
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.7e-10 Score=118.95 Aligned_cols=155 Identities=23% Similarity=0.393 Sum_probs=115.2
Q ss_pred HHhhccCCCceeeEEeeeecCC-----ceEEEEEccCCCCHHHHhhcCCCC--CCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 001873 812 QTLGSIRHKNIVRLLGWGSNKN-----LKLLFYDYLPNGSLSSLLHGAGKG--GADWEARYEVVLGVAHALAYLHHDCMP 884 (1001)
Q Consensus 812 ~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~i~~~i~~~l~yLH~~~~~ 884 (1001)
.-+-.+.|.|+|+++.|+.+.+ ...++.|||..|++.+++++.... .+....-.++.-||..|+.|||+ |.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 3344557999999999886544 457889999999999999875433 34666667899999999999999 789
Q ss_pred CeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHH
Q 001873 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLE 964 (1001)
Q Consensus 885 ~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~e 964 (1001)
+|+|+++..+-|++..+|-+||.--.-..... ............-.+-++|.|||.-.....+-++|||+||++..|
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~---s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHP---SVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccch---hhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 99999999999999999988875211111000 000011111222246689999998877778889999999999999
Q ss_pred HHhCCC
Q 001873 965 VLTGRH 970 (1001)
Q Consensus 965 lltg~~ 970 (1001)
|.-+..
T Consensus 275 mailEi 280 (458)
T KOG1266|consen 275 MAILEI 280 (458)
T ss_pred HHHhee
Confidence 988765
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=8.5e-11 Score=115.71 Aligned_cols=124 Identities=25% Similarity=0.263 Sum_probs=36.0
Q ss_pred cccccCceEEcccccCcccCCCC-cccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhh-hccccccE
Q 001873 508 VGCQSLEFLDLHSNGLTGSVPDT-LPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEI-LSCRKLIL 585 (1001)
Q Consensus 508 ~~l~~L~~L~Ls~N~l~~~~p~~-~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~ 585 (1001)
.+..+++.|+|++|+|+..-.-. ....++.|+||+|.|+... .+..+++|++|++++|+|+.. ++.+ ..+++|++
T Consensus 16 ~n~~~~~~L~L~~n~I~~Ie~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQISTIENLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQE 92 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS---S--CHHHHHH-TT--E
T ss_pred ccccccccccccccccccccchhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCcc-ccchHHhCCcCCE
Confidence 34445566666666665211111 1123444555555554321 244445555555555555422 2222 23445555
Q ss_pred EecccccccCCCCCccccccchhhhhhcCCCccccccc-ccccccccccEEEecCCcCCCCh----hhhhcccccceeE
Q 001873 586 LDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIP-SEFSGLTKLGILDLSHNKLSGDL----DALASLQNLVSLN 659 (1001)
Q Consensus 586 L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~l~~L~~L~ 659 (1001)
|++++|+|. .... ..+..+++|+.|+|.+|+++... ..+..+|+|+.||
T Consensus 93 L~L~~N~I~-------------------------~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 93 LYLSNNKIS-------------------------DLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp EE-TTS----------------------------SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred EECcCCcCC-------------------------ChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 555555543 2111 23556788888899999887643 3567888888887
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.7e-09 Score=104.32 Aligned_cols=129 Identities=23% Similarity=0.411 Sum_probs=97.3
Q ss_pred CeEeecCCeeEEEEEeCCCCEEEEEEecCCC----------chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 772 NVIGTGSSGVVYRVTIPNGETLAVKKMWSSD----------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
..+++|+-+.+|.+.+. |.++++|.-..+. ...+-.+|++++++++--.|....=++.+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999874 4556676432211 114566799999998765555555555566667899999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
++|..|.+.+... ...++..+-.-+.-||.. +|+|+|+.++||.+..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999998753 134555666667789998 999999999999998765 99999999975
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.2e-11 Score=126.80 Aligned_cols=91 Identities=26% Similarity=0.316 Sum_probs=54.9
Q ss_pred ccccCCCCcEEeccCCcccC----CCCcccCCccccccccccCC---ccCCCCChhh-------hcccccceEEccCCcc
Q 001873 97 IFQPLKSLKRLIISSCNLTG----TIPKEFGDYRELTFIDLSGN---SLWGEIPTEV-------CRLRKLESLYLNTNLL 162 (1001)
Q Consensus 97 ~~~~l~~L~~L~l~~~~l~g----~~p~~~~~l~~L~~L~Ls~n---~l~g~~p~~~-------~~l~~L~~L~L~~n~l 162 (1001)
.+.++..+++++|++|.+.- .+.+.+.+.++|+.-++|+- ++..++|+.+ -..++|++||||.|-|
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~ 104 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAF 104 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccccc
Confidence 34456677777777776641 23455667777777777762 2333556543 3345777777777776
Q ss_pred cCCCCcc----ccCCccccceeccccccc
Q 001873 163 EGEIPSD----IGNLSSLAYLTLYDNQLS 187 (1001)
Q Consensus 163 ~~~ip~~----l~~L~~L~~L~L~~n~l~ 187 (1001)
.-.-+.. |.+++.|++|.|.+|.+.
T Consensus 105 G~~g~~~l~~ll~s~~~L~eL~L~N~Glg 133 (382)
T KOG1909|consen 105 GPKGIRGLEELLSSCTDLEELYLNNCGLG 133 (382)
T ss_pred CccchHHHHHHHHhccCHHHHhhhcCCCC
Confidence 5433332 345566777777766654
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.4e-10 Score=82.70 Aligned_cols=40 Identities=48% Similarity=1.057 Sum_probs=31.0
Q ss_pred HHHHHHHHHHHHhCC-CCCCccCCCCCCC-CCCCccceEEeC
Q 001873 36 DEQGQALLTWKNSLN-SSTDALSSWNPAE-TSPCKWFGIHCS 75 (1001)
Q Consensus 36 ~~~~~aLl~~k~~~~-~~~~~l~sW~~~~-~~~c~w~gv~c~ 75 (1001)
++|++||++||+++. +|.+.+.+|+..+ .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 579999999999996 6779999998643 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.3e-10 Score=112.74 Aligned_cols=110 Identities=31% Similarity=0.359 Sum_probs=42.6
Q ss_pred cccccccceeeccCccccccchhhhh-ccccccEEecccccccCCCCCccccccchhhhhhcCCCccccccccccccccc
Q 001873 553 IGSLTELSKLLLSKNQLSGRIPAEIL-SCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTK 631 (1001)
Q Consensus 553 ~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~ 631 (1001)
+.+..++++|+|.+|+|+.+ +.++ .+.+|+.||||+|.|+. ++ .+..++.|+. |++++|+|+.+.+.....+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~-L~L~~N~I~~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKT-LDLSNNRISSISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--E-EE--SS---S-CHHHHHH-TT
T ss_pred cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhh-cccCCCCCCccccchHHhCCc
Confidence 44455778888888888733 3455 47788888888888874 32 5777888886 889999888643322346899
Q ss_pred ccEEEecCCcCCC--ChhhhhcccccceeEcccCCCCC
Q 001873 632 LGILDLSHNKLSG--DLDALASLQNLVSLNVSFNDFSG 667 (1001)
Q Consensus 632 L~~L~Ls~N~l~~--~~~~~~~l~~L~~L~ls~N~l~~ 667 (1001)
|++|+|++|+|.. +...+..+++|++|++.+|+++.
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 9999999999987 56788999999999999999863
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.6e-10 Score=123.57 Aligned_cols=209 Identities=22% Similarity=0.245 Sum_probs=105.9
Q ss_pred CCCCCCcEEEcCCCcccccCC--CCccCCCCCCEEeccCCCCCCCCC--cccccccCccEEEcccccccCcCChh-hccc
Q 001873 292 GALSKLKSLLLWQNSLVGAIP--DELGSCTELTVVDFSDNLLTGSIP--RSFGNLLKLQELQLSVNQLSGTIPIE-IATC 366 (1001)
Q Consensus 292 ~~l~~L~~L~L~~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l 366 (1001)
.++++|+...|.+.... ..+ .....|++++.||||+|-+..-.| .....|++|+.|+|+.|++....... -..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 45778888888888776 333 245667888888888887763222 22345777777777777765221111 1133
Q ss_pred cccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEc
Q 001873 367 TALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLL 446 (1001)
Q Consensus 367 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 446 (1001)
+.|+.|.|+.|.++.. .+-..+..+++|+.|+|.+|..-..-......+..|+.|+|
T Consensus 197 ~~lK~L~l~~CGls~k-----------------------~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdL 253 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWK-----------------------DVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDL 253 (505)
T ss_pred hhhheEEeccCCCCHH-----------------------HHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccc
Confidence 4444444444444311 11112334555666666666422222223334455556666
Q ss_pred cCCcCCCCCC-CCCCCCCCcceEEccccccccCC-Ccc-----cCCCCCcceeeccCcccccC-CcccccccccCceEEc
Q 001873 447 LSNDLSGFIP-PDIGNCTTLRRLRLNDNRLSGTI-PSE-----MGNLKHLNFVDMSENHLVGG-IPPSVVGCQSLEFLDL 518 (1001)
Q Consensus 447 ~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~-p~~-----~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L 518 (1001)
++|++..+.- ...+.++.|+.|+++.+.++..- |+. ...+++|++|+++.|++... .-..+..+++|+.|.+
T Consensus 254 s~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~ 333 (505)
T KOG3207|consen 254 SNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRI 333 (505)
T ss_pred cCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhc
Confidence 6655543221 23445555666666666555321 111 23345566666666665421 0112233344455555
Q ss_pred ccccCc
Q 001873 519 HSNGLT 524 (1001)
Q Consensus 519 s~N~l~ 524 (1001)
..|.|+
T Consensus 334 ~~n~ln 339 (505)
T KOG3207|consen 334 TLNYLN 339 (505)
T ss_pred cccccc
Confidence 555554
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=6.7e-11 Score=123.31 Aligned_cols=248 Identities=22% Similarity=0.277 Sum_probs=112.2
Q ss_pred ccccCCCCCceEeeecCcccCC----CCcccCCCCCCcEEEcCCC---cccccCCCC-------ccCCCCCCEEeccCCC
Q 001873 265 EEIGNCSELQNLYLYQNSISGP----IPGRIGALSKLKSLLLWQN---SLVGAIPDE-------LGSCTELTVVDFSDNL 330 (1001)
Q Consensus 265 ~~l~~l~~L~~L~L~~N~i~~~----~p~~~~~l~~L~~L~L~~N---~l~~~~p~~-------l~~l~~L~~L~Ls~N~ 330 (1001)
+.+-.+..+++++|++|.+... +...+.+.++|+..++++= ++...+|+. +..+++|++||||+|.
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 3455667777777777777633 2233445566666666532 122233332 2334456666666666
Q ss_pred CCCCCCccc----ccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCC
Q 001873 331 LTGSIPRSF----GNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGN 406 (1001)
Q Consensus 331 l~~~~p~~~----~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~ 406 (1001)
|....++.| .+...|++|+|.+|.+...--..++ ..|..|. .|+ -.++-+.|+.+...+|++...
T Consensus 104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~--~al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen~ 172 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLG--RALFELA--VNK-------KAASKPKLRVFICGRNRLENG 172 (382)
T ss_pred cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHH--HHHHHHH--HHh-------ccCCCcceEEEEeeccccccc
Confidence 653333332 2334455555555544311101100 0111111 111 112234455555555555422
Q ss_pred C----CcccccCcccceEeCcCccccCC----CCcccccccccceEEccCCcCCCC----CCCCCCCCCCcceEEccccc
Q 001873 407 I----PESLSQCQELQALDFSYNNLSGP----IPKEIFGLRNLTKLLLLSNDLSGF----IPPDIGNCTTLRRLRLNDNR 474 (1001)
Q Consensus 407 ~----p~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~ 474 (1001)
. ...|...+.|+.+.++.|.|... +...+..+++|+.|+|..|-++.. +...++.+++|++|++++|.
T Consensus 173 ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcl 252 (382)
T KOG1909|consen 173 GATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCL 252 (382)
T ss_pred cHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccc
Confidence 1 12344555666666666666421 122344555555555555555422 22334445555555555555
Q ss_pred cccCCCccc-----CCCCCcceeeccCcccccC----CcccccccccCceEEcccccC
Q 001873 475 LSGTIPSEM-----GNLKHLNFVDMSENHLVGG----IPPSVVGCQSLEFLDLHSNGL 523 (1001)
Q Consensus 475 l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l 523 (1001)
++..-...| ...+.|+.|.|.+|.|+.. +...+...+.|+.|+|++|++
T Consensus 253 l~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 253 LENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred cccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 543222221 1234555555555555421 112222344455555555544
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.4e-08 Score=105.30 Aligned_cols=139 Identities=15% Similarity=0.149 Sum_probs=101.1
Q ss_pred CeEeecCCeeEEEEEeCCCCEEEEEEecCCCch-------------hhHHHHHHHhhccCCCce--eeEEeeeec-----
Q 001873 772 NVIGTGSSGVVYRVTIPNGETLAVKKMWSSDES-------------GAFSSEIQTLGSIRHKNI--VRLLGWGSN----- 831 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------------~~~~~Ei~~l~~l~h~nI--v~l~~~~~~----- 831 (1001)
+.+-+.....|+++.+ +|+.|.||+....... ..+.+|...+.++...+| ++.+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455555555777776 5789999976433211 147789999988854333 344444432
Q ss_pred CCceEEEEEccCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC-------CCc
Q 001873 832 KNLKLLFYDYLPNG-SLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP-------GYQ 903 (1001)
Q Consensus 832 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~-------~~~ 903 (1001)
...-++|+|++++. +|.+++.+......+......++.+++..+.-||.. ||+|+|++++|||++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 23468999999876 899998643233456667778999999999999998 9999999999999975 468
Q ss_pred EEEeccccccc
Q 001873 904 AYLADFGLARI 914 (1001)
Q Consensus 904 ~ki~Dfgla~~ 914 (1001)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998754
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.2e-10 Score=131.16 Aligned_cols=126 Identities=31% Similarity=0.327 Sum_probs=79.5
Q ss_pred cccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcC
Q 001873 535 LQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLS 614 (1001)
Q Consensus 535 l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls 614 (1001)
+...+.++|++. ....++.-++.|+.|||++|+++.. +.+..+++|++|||++|+|+ .+|..-..--.|.. |+++
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~-L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQL-LNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhhhee-eeec
Confidence 444555556555 3444555667777777777777644 36677777777777777776 44432222222665 7777
Q ss_pred CCcccccccccccccccccEEEecCCcCCC--ChhhhhcccccceeEcccCCCCC
Q 001873 615 SNQFSGEIPSEFSGLTKLGILDLSHNKLSG--DLDALASLQNLVSLNVSFNDFSG 667 (1001)
Q Consensus 615 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~l~~L~~L~ls~N~l~~ 667 (1001)
+|-++.. ..+.+|.+|+.|||+.|-|.+ ....++.|..|+.|+|.||++..
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 7777633 235667777777777777766 34556777777777777777754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.9e-09 Score=121.48 Aligned_cols=191 Identities=19% Similarity=0.164 Sum_probs=142.5
Q ss_pred HhcccCCCeEeecCCeeEEEEEe--CCCCEEEEEEecCCCc----hhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI--PNGETLAVKKMWSSDE----SGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~l 837 (1001)
..+|..+..||.|.|+.|++... .++..|++|....... ...-..|+.+...+ -|.+++..+..+..-...++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 35677788999999999998764 3678899997644321 12234567676666 48888888776666666679
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC-CcEEEeccccccccc
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG-YQAYLADFGLARIVS 916 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ki~Dfgla~~~~ 916 (1001)
--||+++++....+.- ...+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||++..+.
T Consensus 344 p~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred chhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccc
Confidence 9999999988776632 22356777888999999999999997 99999999999999876 788899999986432
Q ss_pred CCCCCCCCCCCCCCccccccccc--CccccccCCCCCccchHHHHHHHHHHHhCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYM--APEHASMQRITEKSDVYSFGVVLLEVLTGRH 970 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~SlG~il~elltg~~ 970 (1001)
-. . ....++.+++ +|+......+..+.|+||||.-+.|..++..
T Consensus 419 ~~---------~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 419 FS---------S-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ee---------c-ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 10 0 0011233444 5556667788899999999999999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.8e-09 Score=127.39 Aligned_cols=209 Identities=25% Similarity=0.279 Sum_probs=146.0
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
+.+.+.+-+.+|.++.++.++-. .|...+.|..... .+.+...++-.+.-..++|.++..+..+......++|+
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 34555667888999999876532 3433333322111 11122222222222335677877776666667789999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
+|..++++...++..+. .+.+........+.++.+|||+. .+.|||++|.|++...+++.+++|||.......-.
T Consensus 884 ~~~~~~~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGC--LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred HHhccCCchhhhhcCCC--cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccccc
Confidence 99999999999987542 45555556677788999999997 69999999999999999999999998443221100
Q ss_pred -------C---------------CCCCC--CCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 -------D---------------DNCSK--TNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 -------~---------------~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. ..... ........||+.|.|||...+......+|.|+.|++++|.++|..||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 00000 01234567999999999999999999999999999999999999999876
Q ss_pred CCCC
Q 001873 976 LPGG 979 (1001)
Q Consensus 976 ~~~~ 979 (1001)
++.+
T Consensus 1039 tpq~ 1042 (1205)
T KOG0606|consen 1039 TPQQ 1042 (1205)
T ss_pred chhh
Confidence 5443
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.2e-08 Score=82.48 Aligned_cols=60 Identities=33% Similarity=0.542 Sum_probs=34.8
Q ss_pred CcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccCceEEcccccC
Q 001873 464 TLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGL 523 (1001)
Q Consensus 464 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 523 (1001)
+|++|++++|+++...+..|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544445555566666666666666555555566666666666666553
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=6.3e-08 Score=99.15 Aligned_cols=132 Identities=20% Similarity=0.282 Sum_probs=94.9
Q ss_pred cCCCeEeecCCeeEEEEEeCCCCEEEEEEecC----------CC--------------chhhHHHHHHHhhccCCC--ce
Q 001873 769 TSANVIGTGSSGVVYRVTIPNGETLAVKKMWS----------SD--------------ESGAFSSEIQTLGSIRHK--NI 822 (1001)
Q Consensus 769 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~----------~~--------------~~~~~~~Ei~~l~~l~h~--nI 822 (1001)
.+...||-|--+.||.|..+.|.++|||.=+. .. .....++|.++|+++... .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 45678999999999999999999999993210 00 012466899999999655 77
Q ss_pred eeEEeeeecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC
Q 001873 823 VRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY 902 (1001)
Q Consensus 823 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 902 (1001)
.+.+++ +..++||||++|-.|...--+ ..... .+...|+.-+.-.-.. ||||+|+.+-||+++++|
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~~----~en~~---~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRLD----VENPD---EILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccCc----ccCHH---HHHHHHHHHHHHHHHc---CccccCCchheEEEecCC
Confidence 777776 345899999998776654311 11222 2333333333333344 999999999999999999
Q ss_pred cEEEeccccccc
Q 001873 903 QAYLADFGLARI 914 (1001)
Q Consensus 903 ~~ki~Dfgla~~ 914 (1001)
.+.++||-.+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999987654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.69 E-value=1e-07 Score=95.67 Aligned_cols=123 Identities=23% Similarity=0.362 Sum_probs=80.8
Q ss_pred eEEEEEeCCCCEEEEEEecCCC--------------c--------------hhhHHHHHHHhhccCCC--ceeeEEeeee
Q 001873 781 VVYRVTIPNGETLAVKKMWSSD--------------E--------------SGAFSSEIQTLGSIRHK--NIVRLLGWGS 830 (1001)
Q Consensus 781 ~Vy~~~~~~~~~vavK~~~~~~--------------~--------------~~~~~~Ei~~l~~l~h~--nIv~l~~~~~ 830 (1001)
.||.|...+|..+|||..+... . .....+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998899999999653210 0 02466799999999755 466666552
Q ss_pred cCCceEEEEEccC--CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeEEeCCCCCCeEECCCCcEEEe
Q 001873 831 NKNLKLLFYDYLP--NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL-HHDCMPPILHGDVKAMNVLLGPGYQAYLA 907 (1001)
Q Consensus 831 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yL-H~~~~~~ivH~Dlkp~NIll~~~~~~ki~ 907 (1001)
..++||||++ |..+..+.... .+......++.+++..+..+ |.. ||+|+|+.+.||+++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 3479999998 65554443321 11233455667777766664 566 99999999999999987 99999
Q ss_pred cccccccc
Q 001873 908 DFGLARIV 915 (1001)
Q Consensus 908 Dfgla~~~ 915 (1001)
|||.|...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.9e-08 Score=81.38 Aligned_cols=59 Identities=29% Similarity=0.412 Sum_probs=29.2
Q ss_pred CCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCC
Q 001873 272 ELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNL 330 (1001)
Q Consensus 272 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 330 (1001)
+|++|++++|+++...++.|..+++|++|++++|+++...|..|..+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34455555555554444445555555555555555544444444455555555555444
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.61 E-value=4.6e-07 Score=99.85 Aligned_cols=166 Identities=18% Similarity=0.266 Sum_probs=125.1
Q ss_pred CCeeEEEEEe-CCCCEEEEEEecCCCch--hhHHHHHHHhhccCCCceeeEEeeee----cCCceEEEEEccCC-CCHHH
Q 001873 778 SSGVVYRVTI-PNGETLAVKKMWSSDES--GAFSSEIQTLGSIRHKNIVRLLGWGS----NKNLKLLFYDYLPN-GSLSS 849 (1001)
Q Consensus 778 ~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~Ei~~l~~l~h~nIv~l~~~~~----~~~~~~lv~e~~~~-gsL~~ 849 (1001)
...+.|++.. .+|..|++|++...+.. ..-..-+++++++.|+|||++.+++. .+...++||+|+++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 4456788874 48999999998332221 23345678899999999999999775 34577899999986 47777
Q ss_pred HhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 850 LLHGAG-------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 850 ~l~~~~-------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
+-.... +...++...|.++.|+..|+.++|+. |..-+-+.|++|+++.+.+++|...|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 653221 22357889999999999999999999 99999999999999999999999988876654
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRH 970 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~ 970 (1001)
.+. + |-+. --.+-|.-.||.++..+.||..
T Consensus 445 ~d~--------------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDP--------------T-------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC--------------C-------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 321 0 1111 1135599999999999999954
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.6e-06 Score=87.42 Aligned_cols=137 Identities=16% Similarity=0.099 Sum_probs=102.4
Q ss_pred EeecCCeeEEEEEeCCCCEEEEEEecC--------CCchhhHHHHHHHhhccCCCc--eeeEEeeee--cC--CceEEEE
Q 001873 774 IGTGSSGVVYRVTIPNGETLAVKKMWS--------SDESGAFSSEIQTLGSIRHKN--IVRLLGWGS--NK--NLKLLFY 839 (1001)
Q Consensus 774 lG~G~fg~Vy~~~~~~~~~vavK~~~~--------~~~~~~~~~Ei~~l~~l~h~n--Iv~l~~~~~--~~--~~~~lv~ 839 (1001)
-|+||-+-|+..... |+.+-+|+... +.....|.+|+..++++..-+ +.++..+.. .. -.-++|+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 367888899998874 55788997531 233467999999999995322 444442211 11 1346999
Q ss_pred EccCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCc--EEEeccccccc
Q 001873 840 DYLPN-GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQ--AYLADFGLARI 914 (1001)
Q Consensus 840 e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~ki~Dfgla~~ 914 (1001)
|-+++ .+|.+++.+......+...+..+..++++.+.-||+. ++.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97754 4899998765444567777889999999999999998 9999999999999986666 99999987654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=5.2e-07 Score=104.14 Aligned_cols=150 Identities=19% Similarity=0.257 Sum_probs=98.1
Q ss_pred cHHHHHhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCch--------------------------------h--
Q 001873 760 SIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDES--------------------------------G-- 805 (1001)
Q Consensus 760 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------------------------------~-- 805 (1001)
.+++...+|.. +-|+.++-|.||+|+.++|+.||||+....-.. +
T Consensus 120 ~iee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~ 198 (517)
T COG0661 120 PIEELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEF 198 (517)
T ss_pred CHHHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHH
Confidence 34444454443 579999999999999999999999976321100 0
Q ss_pred --------hHHHHHHHhhccC-----CCceeeEEeeeecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 001873 806 --------AFSSEIQTLGSIR-----HKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVA 872 (1001)
Q Consensus 806 --------~~~~Ei~~l~~l~-----h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~ 872 (1001)
++.+|..-+.+++ .|.|.-..=|++......++|||++|..+.+...-. ....+... ++..++
T Consensus 199 ~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~-~~g~d~k~---ia~~~~ 274 (517)
T COG0661 199 EKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK-SAGIDRKE---LAELLV 274 (517)
T ss_pred HHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH-hcCCCHHH---HHHHHH
Confidence 2444666555552 344432223344456679999999999888874221 12344333 333333
Q ss_pred HH-HHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 873 HA-LAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 873 ~~-l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
++ +..+=.. |++|.|..|.||+++.+|++.+.|||+...+.+
T Consensus 275 ~~f~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 275 RAFLRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 32 2222223 899999999999999999999999999887643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=2e-06 Score=92.40 Aligned_cols=193 Identities=17% Similarity=0.257 Sum_probs=126.2
Q ss_pred cCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhcc-CCCceeeEEee------eec-CCceEEEEE
Q 001873 769 TSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSI-RHKNIVRLLGW------GSN-KNLKLLFYD 840 (1001)
Q Consensus 769 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~~~------~~~-~~~~~lv~e 840 (1001)
...+.||+|+-+.+|.... -...+.|+...+....+ .+.+..|... .||-+-.-+.| .-+ +....++|.
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~-aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQ-AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHH-HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 4567899999999997432 12224455544332211 1222333333 46544331222 112 223567888
Q ss_pred ccCCC-CHHHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 841 YLPNG-SLSSLLHG----AGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 841 ~~~~g-sL~~~l~~----~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
.+++. ...++..- +......|.-..+.++.++.+...||.. |.+-+|+.++|+|+++++.+.+.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence 87765 22222221 1123357888999999999999999998 9999999999999999999999886543332
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhC-CCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHAS-----MQRITEKSDVYSFGVVLLEVLTG-RHPLDPT 975 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~elltg-~~Pf~~~ 975 (1001)
. ........+|...|.+||... +..-+...|-|.+|+++++++.| +.||.+-
T Consensus 168 ~--------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 168 A--------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred c--------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 1 112223347999999999653 44556789999999999999875 9999764
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=5.5e-09 Score=118.03 Aligned_cols=124 Identities=28% Similarity=0.314 Sum_probs=85.2
Q ss_pred cccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCc-ccCCCCCcceee
Q 001873 415 QELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPS-EMGNLKHLNFVD 493 (1001)
Q Consensus 415 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ 493 (1001)
..|...+.++|.+. .....+.-++.|+.|+|++|+++.. ..+..++.|++|||+.|.+. .+|. ....++ |+.|.
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~ 238 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLN 238 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeee
Confidence 35777888888887 4556677778888888888888754 37788888888888888888 4443 334444 88888
Q ss_pred ccCcccccCCcccccccccCceEEcccccCccc---CCCCcccccccccCCCCcC
Q 001873 494 MSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGS---VPDTLPTSLQLVDLSDNRL 545 (1001)
Q Consensus 494 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~~l~~L~Ls~N~l 545 (1001)
+++|.++.. ..+.++++|+.||+++|-|.+. .|-+....++.|+|.+|.+
T Consensus 239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL 291 (1096)
T ss_pred ecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence 888888743 3467788888888888887642 1212223344455555544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.2e-06 Score=90.48 Aligned_cols=105 Identities=27% Similarity=0.410 Sum_probs=82.4
Q ss_pred hhHHHHHHHhhccCCCc--eeeEEeeeecC----CceEEEEEccCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 001873 805 GAFSSEIQTLGSIRHKN--IVRLLGWGSNK----NLKLLFYDYLPNG-SLSSLLHGAGKGGADWEARYEVVLGVAHALAY 877 (1001)
Q Consensus 805 ~~~~~Ei~~l~~l~h~n--Iv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~y 877 (1001)
....+|...+.++..-. +++.+++.... ...++|+|++++. +|.+++.+... .+......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 46778998888885333 44555554432 2347999999874 89999986322 5566677889999999999
Q ss_pred HhhCCCCCeEEeCCCCCCeEECCCC---cEEEeccccccc
Q 001873 878 LHHDCMPPILHGDVKAMNVLLGPGY---QAYLADFGLARI 914 (1001)
Q Consensus 878 LH~~~~~~ivH~Dlkp~NIll~~~~---~~ki~Dfgla~~ 914 (1001)
||.. ||+|+|+++.|||++.++ .+.++||+-++.
T Consensus 134 lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 999999999999999877 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.7e-06 Score=88.99 Aligned_cols=138 Identities=15% Similarity=0.182 Sum_probs=87.7
Q ss_pred CeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccCCCc--eeeEEeeeecCCceEEEEEccCCCC-HH
Q 001873 772 NVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKN--IVRLLGWGSNKNLKLLFYDYLPNGS-LS 848 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~gs-L~ 848 (1001)
..||+|..+.||+. .+..+++|............+|.++++.+..-. +.+++++..+.+...+|||+++|.. +.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~ 83 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFS 83 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchh
Confidence 46899999999983 255788898766555567899999999986433 5677888777777889999999863 11
Q ss_pred HH---------------------hhcCCCCCCCHHHHH-HHHH----------HHHH-HHHHHhhC-CCCCeEEeCCCCC
Q 001873 849 SL---------------------LHGAGKGGADWEARY-EVVL----------GVAH-ALAYLHHD-CMPPILHGDVKAM 894 (1001)
Q Consensus 849 ~~---------------------l~~~~~~~~~~~~~~-~i~~----------~i~~-~l~yLH~~-~~~~ivH~Dlkp~ 894 (1001)
.. ++............. ++.. .+.. ..++|... ..+.++|+|+.|.
T Consensus 84 ~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~ 163 (226)
T TIGR02172 84 RIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIG 163 (226)
T ss_pred hhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCC
Confidence 11 121111111111110 0000 0111 12222211 1235789999999
Q ss_pred CeEECCCCcEEEecccccc
Q 001873 895 NVLLGPGYQAYLADFGLAR 913 (1001)
Q Consensus 895 NIll~~~~~~ki~Dfgla~ 913 (1001)
||++++++ +.|+||+.+.
T Consensus 164 Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 164 NLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cEEEcCCC-cEEEechhcC
Confidence 99999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=2e-07 Score=106.64 Aligned_cols=104 Identities=24% Similarity=0.398 Sum_probs=79.7
Q ss_pred HHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCCCC--CcccccccccCccccc
Q 001873 868 VLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR--PQLAGSYGYMAPEHAS 945 (1001)
Q Consensus 868 ~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~--~~~~gt~~y~aPE~~~ 945 (1001)
+.+++.|+.|+|.. +++||++|.|++|.++.++..||+.|+.+....+..+..+...... .-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34556999999987 6999999999999999999999999998876655333222222221 2223556899999999
Q ss_pred cCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 001873 946 MQRITEKSDVYSFGVVLLEVLT-GRHPLD 973 (1001)
Q Consensus 946 ~~~~~~~~Dv~SlG~il~ellt-g~~Pf~ 973 (1001)
+...+.++|+||+|+.+|.+.. |+.-++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~ 211 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIA 211 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhh
Confidence 8888899999999999999984 444343
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1001 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 9e-46 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-45 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-34 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-33 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-21 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 9e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-11 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 8e-11 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 4e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-10 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-10 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 5e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-10 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 8e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-10 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 6e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-10 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 8e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-10 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 9e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-08 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 5e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-06 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 1e-06 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 2e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 7e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-05 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 1e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-05 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 2e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-04 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-04 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 565 bits (1459), Expect = 0.0
Identities = 179/623 (28%), Positives = 298/623 (47%), Gaps = 25/623 (4%)
Query: 81 VEISLKAVDLQGSLP-SIFQPLKSLKRLIISSCNLTGTIPKEF---GDYRELTFIDLSGN 136
+++ + L S L SL+ L +S+ +++G + EL + +SGN
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188
Query: 137 SLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGA 196
+ G++ V R LE L +++N IP +G+ S+L +L + N+LSG ++I
Sbjct: 189 KISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAIST 245
Query: 197 LSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSI-GMLERIQTIAIY 255
++L++ N G +P +L L LAE +G +P + G + + + +
Sbjct: 246 CTELKLLNISSN-QFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLS 302
Query: 256 TSLLSGPIPEEIGNCSELQNLYLYQNSISGPIP-GRIGALSKLKSLLLWQNSLVGAIPDE 314
+ G +P G+CS L++L L N+ SG +P + + LK L L N G +P+
Sbjct: 303 GNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362
Query: 315 LGSCT-ELTVVDFSDNLLTGSIPRSFGNLLK--LQELQLSVNQLSGTIPIEIATCTALTH 371
L + + L +D S N +G I + K LQEL L N +G IP ++ C+ L
Sbjct: 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 422
Query: 372 LEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPI 431
L + N +SG IP+ +G+++ L W N L G IP+ L + L+ L +N+L+G I
Sbjct: 423 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEI 482
Query: 432 PKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNF 491
P + NL + L +N L+G IP IG L L+L++N SG IP+E+G+ + L +
Sbjct: 483 PSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIW 542
Query: 492 VDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP--TSLQLVDLSDN--RLSG 547
+D++ N G IP ++ + +N + G + + + N G
Sbjct: 543 LDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQG 598
Query: 548 SLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSL 607
+ + L+ + ++ G + ++ LD+ N SG IPKE+G + L
Sbjct: 599 IRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYL 658
Query: 608 EISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDL-DALASLQNLVSLNVSFNDFS 666
LNL N SG IP E L L ILDLS NKL G + A+++L L +++S N+ S
Sbjct: 659 F-ILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717
Query: 667 GELPNTPFFRKLPLSDLASNRGL 689
G +P F P + +N GL
Sbjct: 718 GPIPEMGQFETFPPAKFLNNPGL 740
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 552 bits (1426), Expect = 0.0
Identities = 186/688 (27%), Positives = 306/688 (44%), Gaps = 56/688 (8%)
Query: 27 LFFSTCDALDEQGQALLTWKNSLNSSTDALSSWNPAETSPCKWFGIHCSSNGEVVEISLK 86
S +L + L+++K+ L L W+ +PC + G+ C + +V I L
Sbjct: 2 FQASPSQSLYREIHQLISFKDVLPDKN-LLPDWSSN-KNPCTFDGVTCR-DDKVTSIDLS 58
Query: 87 AVDLQGSLPSI--------------------------FQPLKSLKRLIISSCNLTGTIP- 119
+ L ++ F+ SL L +S +L+G +
Sbjct: 59 SKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTT 118
Query: 120 -KEFGDYRELTFIDLSGNSLWGEIPTE-VCRLRKLESLYLNTNLLEGEIPSDI---GNLS 174
G L F+++S N+L +L LE L L+ N + G
Sbjct: 119 LTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCG 178
Query: 175 SLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETS 234
L +L + N++SG + + L+ N N +P+ +G+CS L L ++
Sbjct: 179 ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSN-NFSTGIPF-LGDCSALQHLDISGNK 234
Query: 235 ISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRI-GA 293
+SG+ +I ++ + I ++ GPIP LQ L L +N +G IP + GA
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 294 LSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPR-SFGNLLKLQELQLSV 352
L L L N GA+P GSC+ L + S N +G +P + + L+ L LS
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 352
Query: 353 NQLSGTIPIEIATCTA-LTHLEIDNNAISGEIPADIGNI--NGLTLFFAWKNKLTGNIPE 409
N+ SG +P + +A L L++ +N SG I ++ N L + N TG IP
Sbjct: 353 NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 412
Query: 410 SLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLR 469
+LS C EL +L S+N LSG IP + L L L L N L G IP ++ TL L
Sbjct: 413 TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI 472
Query: 470 LNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPD 529
L+ N L+G IPS + N +LN++ +S N L G IP + ++L L L +N +G++P
Sbjct: 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532
Query: 530 TLP--TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLD 587
L SL +DL+ N +G++ ++ + ++ N ++G+ I +
Sbjct: 533 ELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECH 588
Query: 588 IGNN--RFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGD 645
N F G ++L ++S+ N++S + G F + LD+S+N LSG
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNP-CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 647
Query: 646 L-DALASLQNLVSLNVSFNDFSGELPNT 672
+ + S+ L LN+ ND SG +P+
Sbjct: 648 IPKEIGSMPYLFILNLGHNDISGSIPDE 675
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 455 bits (1172), Expect = e-147
Identities = 155/553 (28%), Positives = 255/553 (46%), Gaps = 25/553 (4%)
Query: 146 VCRLRKLESLYLNTNLLE---GEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQV 202
CR K+ S+ L++ L + S + +L+ L L L ++ ++G + + L
Sbjct: 46 TCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTS 104
Query: 203 FRAGGNQNLKGELPW--EIGNCSNLVMLGLAETSISGNVPSSIGM-LERIQTIAIYTSLL 259
N +L G + +G+CS L L ++ ++ S G+ L ++ + + + +
Sbjct: 105 LDLSRN-SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSI 163
Query: 260 SGPIPEEI---GNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELG 316
SG C EL++L + N ISG + + L+ L + N+ IP LG
Sbjct: 164 SGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLG 220
Query: 317 SCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDN 376
C+ L +D S N L+G R+ +L+ L +S NQ G IP +L +L +
Sbjct: 221 DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAE 278
Query: 377 NAISGEIPADI-GNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEI 435
N +GEIP + G + LT N G +P C L++L S NN SG +P +
Sbjct: 279 NKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT 338
Query: 436 FG-LRNLTKLLLLSNDLSGFIPPDIGNCTT-LRRLRLNDNRLSGTIPSEMGN--LKHLNF 491
+R L L L N+ SG +P + N + L L L+ N SG I + L
Sbjct: 339 LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398
Query: 492 VDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSL 549
+ + N G IPP++ C L L L N L+G++P +L + L+ + L N L G +
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458
Query: 550 AHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEI 609
+ + L L+L N L+G IP+ + +C L + + NNR +GEIPK +G++ +L I
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI 518
Query: 610 SLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDL-DALASLQNLVSLNVSFNDFSGE 668
L LS+N FSG IP+E L LDL+ N +G + A+ ++ N
Sbjct: 519 -LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVY 577
Query: 669 LPNTPFFRKLPLS 681
+ N ++ +
Sbjct: 578 IKNDGMKKECHGA 590
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 6e-86
Identities = 107/385 (27%), Positives = 177/385 (45%), Gaps = 18/385 (4%)
Query: 316 GSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEID 375
T + + N+ ++ S +L L+ L LS + ++G++ +LT L++
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 376 NNAISGEIPAD--IGNINGLTLFFAWKNKLTGNIP-ESLSQCQELQALDFSYNNLSGPIP 432
N++SG + +G+ +GL N L + L+ LD S N++SG
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 433 KEIFGLRNLTKLLLL---SNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHL 489
+L L N +SG + + C L L ++ N S IP +G+ L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSAL 225
Query: 490 NFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSL 549
+D+S N L G ++ C L+ L++ SN G +P SLQ + L++N+ +G +
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEI 285
Query: 550 AHSI-GSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKE-LGQISSL 607
+ G+ L+ L LS N G +P SC L L + +N FSGE+P + L ++ L
Sbjct: 286 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGL 345
Query: 608 EISLNLSSNQFSGEIPSEFSGLT-KLGILDLSHNKLSGDL---DALASLQNLVSLNVSFN 663
+ L+LS N+FSGE+P + L+ L LDLS N SG + L L + N
Sbjct: 346 K-VLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNN 404
Query: 664 DFSGELPNTPF-FRKLPLSDLASNR 687
F+G++P T +L L+ N
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNY 429
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-26
Identities = 44/193 (22%), Positives = 71/193 (36%), Gaps = 15/193 (7%)
Query: 46 KNSLNSSTDALSSWNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLK 105
K S + + ++ + + ++ QG L +
Sbjct: 560 KQSGKIAANFIAGKRYVYIKND--------GMKKECHGAGNLLEFQGIRSEQLNRLSTRN 611
Query: 106 RLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGE 165
I+S G F + + F+D+S N L G IP E+ + L L L N + G
Sbjct: 612 PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGS 671
Query: 166 IPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNL 225
IP ++G+L L L L N+L G+IP+++ AL+ L N NL G +P
Sbjct: 672 IPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN-NLSGPIP------EMG 724
Query: 226 VMLGLAETSISGN 238
N
Sbjct: 725 QFETFPPAKFLNN 737
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 355 bits (913), Expect = e-110
Identities = 127/634 (20%), Positives = 213/634 (33%), Gaps = 46/634 (7%)
Query: 83 ISLKAVDLQG-SLPSIFQPL-KSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWG 140
+S + D L + L ++ L ++ L F Y +LT +D+ N++
Sbjct: 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 141 EIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKL 200
P +L L+ L L N L ++L L L N + L
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123
Query: 201 QVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLE--RIQTIAIYTSL 258
N L NL L L+ I + + ++ + + ++
Sbjct: 124 ITLDLSHN-GLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182
Query: 259 LSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIG---ALSKLKSLLLWQNSLVGAIPDEL 315
+ P L L+L + + ++ A + +++L L + L
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 316 GSC--TELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLE 373
T LT++D S N L SF L +L+ L N + + + +L
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN 302
Query: 374 IDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPK 433
+ + I L S + L+ L+ N++ G
Sbjct: 303 LKRSFTKQSIS---------------LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN 347
Query: 434 EIFGLRNLTKLLLLSNDLSGFIPPDIG----NCTTLRRLRLNDNRLSGTIPSEMGNLKHL 489
GL NL L L ++ S + + L L L N++S L HL
Sbjct: 348 MFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHL 407
Query: 490 NFVDMSENHLVGGIPPSV-VGCQSLEFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLS 546
+D+ N + + G +++ + L N ++ SLQ + L L
Sbjct: 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467
Query: 547 G--SLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFS--------GE 596
S L L+ L LS N ++ + KL +LD+ +N + G
Sbjct: 468 NVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGG 527
Query: 597 IPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSG-DLDALASLQNL 655
L +S L I LNL SN F F L +L I+DL N L+ + +L
Sbjct: 528 PIYFLKGLSHLHI-LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSL 586
Query: 656 VSLNVSFNDFSGELPNT--PFFRKLPLSDLASNR 687
SLN+ N + P FR L D+ N
Sbjct: 587 KSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNP 620
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 311 bits (800), Expect = 6e-94
Identities = 111/590 (18%), Positives = 199/590 (33%), Gaps = 39/590 (6%)
Query: 89 DLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCR 148
+ P + Q L LK L + L+ K F LT + L NS+ +
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 149 LRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGAL--SKLQVFRAG 206
+ L +L L+ N L L +L L L +N++ + + S L+
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 207 GNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGM---LERIQTIAIYTSLLSGPI 263
N +K P L L L + ++ + + I+ +++ S LS
Sbjct: 180 SN-QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS 238
Query: 264 PEEIGNC--SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTEL 321
+ L L L N+++ L +L+ L N++ L +
Sbjct: 239 NTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNV 298
Query: 322 TVVDFSDNL---------LTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHL 372
++ + L SF L L+ L + N + G L +L
Sbjct: 299 RYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYL 358
Query: 373 EIDNNAIS-----GEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNL 427
+ N+ S E + + L NK++ ++ S L+ LD N +
Sbjct: 359 SLSNSFTSLRTLTNETFVSLAHSPLHILNLTK-NKISKIESDAFSWLGHLEVLDLGLNEI 417
Query: 428 SGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSG--TIPSEMG 484
+ + + GL N+ ++ L N +L+RL L L + PS
Sbjct: 418 GQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
Query: 485 NLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP----------TS 534
L++L +D+S N++ + G + LE LDL N L P +
Sbjct: 478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH 537
Query: 535 LQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFS 594
L +++L N L EL + L N L+ + + L L++ N +
Sbjct: 538 LHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLIT 597
Query: 595 GEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSG 644
K G L++ N F S + ++ +H +
Sbjct: 598 SVEKKVFGPAFRNLTELDMRFNPFDCTCE---SIAWFVNWINETHTNIPE 644
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = 3e-91
Identities = 110/591 (18%), Positives = 202/591 (34%), Gaps = 66/591 (11%)
Query: 82 EISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGE 141
E+ L + +Q + F K+L L +S L+ T L + LS N +
Sbjct: 101 ELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160
Query: 142 IPTE--VCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSK 199
E + L+ L L++N ++ P + L L L + QL + + +
Sbjct: 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELA 220
Query: 200 LQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLE--RIQTIAIYTS 257
+++ L L+ + +S ++ L+ + + + +
Sbjct: 221 N----------------------TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258
Query: 258 LLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGS 317
L+ + +L+ +L N+I + L ++ L L ++
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS------------ 306
Query: 318 CTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNN 377
T S L SF L L+ L + N + G L +L + N+
Sbjct: 307 ---FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 378 AIS-----GEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIP 432
S E + + L NK++ ++ S L+ LD N + +
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTK-NKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422
Query: 433 KEIF-GLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSG--TIPSEMGNLKHL 489
+ + GL N+ ++ L N +L+RL L L + PS L++L
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482
Query: 490 NFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSL 549
+D+S N++ + G + LE LDL N L L + G
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHN--------------NLARLWKHANPGGP 528
Query: 550 AHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEI 609
+ + L+ L L L N +L ++D+G N + SL+
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK- 587
Query: 610 SLNLSSNQFSGEIPSEFS-GLTKLGILDLSHNKLSGDLDALASLQNLVSLN 659
SLNL N + F L LD+ N +++A N ++
Sbjct: 588 SLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINET 638
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-55
Identities = 70/332 (21%), Positives = 133/332 (40%), Gaps = 17/332 (5%)
Query: 369 LTHLEIDNNAISGEIPADI-GNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNL 427
+ + ++ ++P D+ NI L L N+L + ++ +L +LD +N +
Sbjct: 6 HEVADCSHLKLT-QVPDDLPTNITVLNLTH---NQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 428 SGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLK 487
S P+ L L L L N+LS CT L L L N + + K
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 488 HLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTL----PTSLQLVDLSDN 543
+L +D+S N L + V ++L+ L L +N + + L +SL+ ++LS N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 544 RLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEI---LSCRKLILLDIGNNRFSGEIPKE 600
++ ++ L L L+ QL + ++ L+ + L + N++ S
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 601 LG--QISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSG-DLDALASLQNLVS 657
+ ++L + L+LS N + F+ L +L L +N + +L L N+
Sbjct: 242 FLGLKWTNLTM-LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300
Query: 658 LNVSFNDFSGELPNTPFFRKLPLSDLASNRGL 689
LN+ + + K+ + L
Sbjct: 301 LNLKRSFTKQSISLA-SLPKIDDFSFQWLKCL 331
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 345 bits (888), Expect = e-107
Identities = 89/679 (13%), Positives = 187/679 (27%), Gaps = 103/679 (15%)
Query: 26 FLFFSTCDALDEQGQALLTWKNSLNSSTDALSS-WNPAETSPCKWFGIHCSSNGEVVEIS 84
F D L+ AL W+ G
Sbjct: 5 FTVKDNALTDDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGT---------- 54
Query: 85 LKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPT 144
+ +T + L G G +P
Sbjct: 55 ---------------QPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPD 99
Query: 145 EVCRLRKLESLYLNTNLLEG----EIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKL 200
+ +L +LE L L ++ + P I S
Sbjct: 100 AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFS 159
Query: 201 QVFRAGGNQN-LKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLL 259
+ + N + + + +G +I+
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF---------------------- 197
Query: 260 SGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCT 319
+ + + ++L+ Y+ + ++ + +
Sbjct: 198 ---VSKAVMRLTKLRQFYMGNSPFVAENI-----CEAWENENSEYAQQYKTEDLKWDNLK 249
Query: 320 ELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQL--------SGTIPIEIATCTALTH 371
+LT V+ + +P L ++Q + ++ N+ + +
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 372 LEIDNNAI-SGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGP 430
+ I N + + + + + L + N+L G + +L +L+ +YN ++
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITE- 367
Query: 431 IPKEIFG-LRNLTKLLLLSNDLSGFIPP-DIGNCTTLRRLRLNDNRLSG-------TIPS 481
IP G + L N L D + + + + + N + +
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427
Query: 482 EMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP--------- 532
+++ +++S N + L ++L N LT ++L
Sbjct: 428 TPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNT 487
Query: 533 TSLQLVDLSDNRLSG-SLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGN- 590
L +DL N+L+ S +L L + LS N S P + L+ L I N
Sbjct: 488 YLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546
Query: 591 -----NRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSG- 644
NR E P+ + SL L + SN ++ + + +LD+ N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLT-QLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISI 602
Query: 645 DLDALASLQNLVSLNVSFN 663
DL + + ++
Sbjct: 603 DLSYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-102
Identities = 86/565 (15%), Positives = 191/565 (33%), Gaps = 52/565 (9%)
Query: 170 IGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQ---NLKGELPWEIGNCSNLV 226
+ + + L+L SG++P +IG L++L+V G + N + P I +
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 227 MLGLAETSISGNVPSSIGMLE--RIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSIS 284
+ + I + I + + + N+I+
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 285 GPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLK 344
+ + L+KL+ + + V E + + NL
Sbjct: 197 F-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDLKWDNLKD 250
Query: 345 LQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAI--------SGEIPADIGNINGLTLF 396
L ++++ +P + + + + N + AD + +
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310
Query: 397 FAWKNKL-TGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFI 455
+ N L T + SL + ++L L+ YN L G +P L L L N ++
Sbjct: 311 YIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIP 369
Query: 456 PPDIGNCTTLRRLRLNDNRLSGTIPS--EMGNLKHLNFVDMSENHLVG-------GIPPS 506
G + L N+L IP+ + ++ ++ +D S N + + P+
Sbjct: 370 ANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428
Query: 507 VVGCQSLEFLDLHSNGLTGSVPDTL--PTSLQLVDLSDNRLSG-------SLAHSIGSLT 557
++ ++L +N ++ + + L ++L N L+ + +
Sbjct: 429 PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTY 488
Query: 558 ELSKLLLSKNQLSGRIPAEI--LSCRKLILLDIGNNRFSGEIPKELGQISSLEI-----S 610
L+ + L N+L+ + + + L+ +D+ N FS P + S+L+
Sbjct: 489 LLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546
Query: 611 LNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELP 670
+ N+ E P + L L + N + + + N+ L++ N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI--TPNISVLDIKDNPNISIDL 604
Query: 671 NTPF-FRKLPLSDLASNRGLYISGG 694
+ + + + L ++ I G
Sbjct: 605 SYVCPYIEAGMYMLFYDKTQDIRGC 629
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 8e-86
Identities = 83/527 (15%), Positives = 167/527 (31%), Gaps = 82/527 (15%)
Query: 84 SLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIP 143
+ + Q S+ + ++ S N+T + K +L + + E
Sbjct: 165 CINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENI 223
Query: 144 TEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVF 203
E E NL L + +Y+ K+P + AL ++Q+
Sbjct: 224 CEAWENENSEYAQQYKT-----EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLI 278
Query: 204 RAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPI 263
N+ + GE
Sbjct: 279 NVACNRGISGEQL-----------------------------------------KDDWQA 297
Query: 264 PEEIGNCSELQNLYLYQNSI-SGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELT 322
+ ++Q +Y+ N++ + P+ + + KL L N L G GS +L
Sbjct: 298 LADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLA 356
Query: 323 VVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIP--IEIATCTALTHLEIDNNAIS 380
++ + N +T G +++ L + N+L IP + + + ++ ++ N I
Sbjct: 357 SLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIG 415
Query: 381 G-------EIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSG---- 429
+ ++ N+++ E S L +++ N L+
Sbjct: 416 SVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKN 475
Query: 430 ---PIPKEIFGLRNLTKLLLLSNDLSGFIPPDI--GNCTTLRRLRLNDNRLSGTIPSEMG 484
+ LT + L N L+ + D L + L+ N S P++
Sbjct: 476 SLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPL 533
Query: 485 NLKHL------NFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLV 538
N L N D N + P + C SL L + SN + V + + ++ ++
Sbjct: 534 NSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNISVL 592
Query: 539 DLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLIL 585
D+ DN + E +L ++ +I C L +
Sbjct: 593 DIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ-----DIRGCDALDI 634
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 2e-79
Identities = 72/458 (15%), Positives = 157/458 (34%), Gaps = 45/458 (9%)
Query: 266 EIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVG----AIPDELGSCTEL 321
+ + + L L SG +P IG L++L+ L L + P + +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 322 TVVDFSDNLLTGSIPRSFG--NLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAI 379
+ + L + ++ + +I T + +N I
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 380 SGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLR 439
+ + + + L F+ + + + + Y + L+
Sbjct: 196 TF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKWDNLK 249
Query: 440 NLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRL--------SGTIPSEMGNLKHLNF 491
+LT + + + +P + ++ + + NR ++ + +
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 492 VDMSENHLVGG-IPPSVVGCQSLEFLDLHSNGLTGSVPD-TLPTSLQLVDLSDNRLSGSL 549
+ + N+L + S+ + L L+ N L G +P L ++L+ N+++
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIP 369
Query: 550 AHSIGSLTELSKLLLSKNQLSGRIPA--EILSCRKLILLDIGNNRFSG-------EIPKE 600
A+ G ++ L + N+L IP + S + +D N +
Sbjct: 370 ANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428
Query: 601 LGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSG--------DLDALASL 652
+ ++ S+NLS+NQ S FS + L ++L N L+ + + +
Sbjct: 429 PFKGINVS-SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNT 487
Query: 653 QNLVSLNVSFNDFSGELPNTPFFRKLP-LS--DLASNR 687
L S+++ FN + L + LP L DL+ N
Sbjct: 488 YLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNS 524
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 330 bits (849), Expect = e-102
Identities = 121/601 (20%), Positives = 192/601 (31%), Gaps = 52/601 (8%)
Query: 103 SLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLL 162
S K L +S L F + EL +DLS + L L +L L N +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 163 EGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNC 222
+ LSSL L + L+ IG L L+ N +LP N
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 223 SNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPI---PEEIGNCSELQNLYLY 279
+NL L L+ I + + +L ++ + + L P+ L L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 280 QNSISGPIP-GRIGALSKLKSLLLWQNSLVGA------IPDELGSCTELTVVDFSDNLLT 332
N S + I L+ L+ L L LT+ +F L
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 333 GS---IPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGN 389
I F L + L + + HLE+ N + +
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKS 326
Query: 390 INGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLS--GPIPKEIFGLRNLTKLLLL 447
+ LT G S L+ LD S N LS G + FG +L L L
Sbjct: 327 LKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 448 SNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEM-GNLKHLNFVDMSENHLVGGIPPS 506
N + + + L L + L + +L++L ++D+S H
Sbjct: 382 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 507 VVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSK 566
G SLE L + N + L L+ L LS+
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFL---------------------PDIFTELRNLTFLDLSQ 479
Query: 567 NQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEF 626
QL P S L +L++ +N F ++SL++ L+ S N E
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV-LDYSLNHIMTSKKQEL 538
Query: 627 SGL-TKLGILDLSHNKLSGDLDA---LASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSD 682
+ L L+L+ N + + L +++ L V P + +P+
Sbjct: 539 QHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP--SDKQGMPVLS 596
Query: 683 L 683
L
Sbjct: 597 L 597
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 1e-67
Identities = 101/529 (19%), Positives = 180/529 (34%), Gaps = 55/529 (10%)
Query: 82 EISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGT-IPKEFGDYRELTFIDLSGNSLWG 140
++ +L LK+LK L ++ + +P+ F + L +DLS N +
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 141 EIPTEVCRLRKLE----SLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPK-SIG 195
T++ L ++ SL L+ N + P + L LTL +N S + K I
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQ 222
Query: 196 ALSKLQVFRAGGNQ-----NLKGELPWEIGNCSNLVMLGLAETSIS---GNVPSSIGMLE 247
L+ L+V R + NL+ + NL + + ++ L
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282
Query: 248 RIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSL 307
+ + ++ + + Q+L L L LK L N
Sbjct: 283 NVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKG 337
Query: 308 VGAIPDELGSCTELTVVDFSDNLLT--GSIPRSFGNLLKLQELQLSVNQLSGTIPIEIAT 365
A L +D S N L+ G +S L+ L LS N + T+
Sbjct: 338 GNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG 394
Query: 366 CTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYN 425
L HL+ ++ + + L LD S+
Sbjct: 395 LEQLEHLDFQHSNLKQMSE-----------------------FSVFLSLRNLIYLDISHT 431
Query: 426 NLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLNDNRLSGTIPSEMG 484
+ GL +L L + N PDI L L L+ +L P+
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 485 NLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDT---LPTSLQLVDLS 541
+L L ++MS N+ SL+ LD N + S P+SL ++L+
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551
Query: 542 DNRLSGSLAHS--IGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDI 588
N + + H + + + +LL+ ++ P++ ++ L+I
Sbjct: 552 QNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD-KQGMPVLSLNI 599
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-51
Identities = 83/438 (18%), Positives = 131/438 (29%), Gaps = 65/438 (14%)
Query: 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELT 322
IP+ + +NL L N + + +L+ L L + + S + L+
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 323 VVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGE 382
+ + N + +F L LQ+L L+ I L L + +N I
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS- 138
Query: 383 IPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLT 442
+PE S L+ LD S N + ++ L +
Sbjct: 139 ----------------------FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 443 KLLLLSNDLSG----FIPPDIGNCTTLRRLRLNDNRLSGTIPSE-MGNLKHLNFVDMSEN 497
LL LS DLS FI P L +L L +N S + + L L +
Sbjct: 177 -LLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLG 235
Query: 498 HLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGS---LAHS 552
L L +L + + L +
Sbjct: 236 EFRN------------------EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277
Query: 553 IGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLN 612
LT +S L + L++ N +F +L + L + N
Sbjct: 278 FNCLTNVSSFSLVSVTIERVKDFSYNF--GWQHLELVNCKFGQFPTLKLKSLKRLTFTSN 335
Query: 613 LSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGD---LDALASLQNLVSLNVSFNDFSGEL 669
N FS L L LDLS N LS + +L L++SFN
Sbjct: 336 KGGNAFS------EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMS 389
Query: 670 PNTPFFRKLPLSDLASNR 687
N +L D +
Sbjct: 390 SNFLGLEQLEHLDFQHSN 407
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 305 bits (782), Expect = 1e-89
Identities = 97/670 (14%), Positives = 198/670 (29%), Gaps = 106/670 (15%)
Query: 44 TWKNSLNSSTDALSSWNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKS 103
+ + ++T +WN W
Sbjct: 287 RYYSGTINNTIHSLNWNF-NKELDMWGDQPGVD---------------------LDNNGR 324
Query: 104 LKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLE 163
+ L ++ G +P G EL + +S + + +
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384
Query: 164 GEIPSDIG----NLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEI 219
L+ L N+ P + L+ + G N + I
Sbjct: 385 MHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAI 444
Query: 220 GNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLY 279
+ L ++ A + + + + + + N +L ++ LY
Sbjct: 445 QRLTKLQIIYFANSPFTYDNIAVDW-----EDANSDYAKQYENEELSWSNLKDLTDVELY 499
Query: 280 QNSISGPIPGRIGALSKLKSLLLWQNSLVG---------AIPDELGSCTELTVVDFSDNL 330
+P + L +L+SL + N + + D+ + ++ + N
Sbjct: 500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN 559
Query: 331 LTG-SIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIG- 388
L S ++KL L N++ + T LT L++D N I EIP D
Sbjct: 560 LEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCA 616
Query: 389 NINGLTLFFAWKNKLTGNIPE--SLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLL 446
+ + NKL IP + + ++DFSYN + + I
Sbjct: 617 FTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGS-EGRNI----------- 663
Query: 447 LSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPS 506
D + L+ N + ++ + +S N + IP +
Sbjct: 664 -------SCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM-TSIPEN 715
Query: 507 VVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSG-SLAHSIGSLTELSKLLLS 565
+ + + + L +DL N+L+ S +L LS + +S
Sbjct: 716 SLKPKDGNYKNT--------------YLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVS 761
Query: 566 KNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSE 625
N S P + L+ +L I + + N+ + P+
Sbjct: 762 YNCFSS-FPTQPLNSSQLKAFGIRHQ-------------------RDAEGNRILRQWPTG 801
Query: 626 FSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDF-SGELPNTPFFRKLPLSDLA 684
+ L L + N + + L L L+++ N S ++ + + + + L
Sbjct: 802 ITTCPSLIQLQIGSNDIRKVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLL 859
Query: 685 SNRGLYISGG 694
++ I G
Sbjct: 860 YDKTQDIRGC 869
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-55
Identities = 58/436 (13%), Positives = 136/436 (31%), Gaps = 41/436 (9%)
Query: 84 SLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIP 143
L+ + S + + + + ++LT ++L ++P
Sbjct: 449 KLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLP 508
Query: 144 TEVCRLRKLESLYLNTNLLEG---------EIPSDIGNLSSLAYLTLYDNQLSG-KIPKS 193
+ L +L+SL + N + D + + N L S
Sbjct: 509 DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASAS 568
Query: 194 IGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIG-MLERIQTI 252
+ + KL + N+ ++ L G L L L I +P ++++ +
Sbjct: 569 LQKMVKLGLLDCVHNK-VR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGL 624
Query: 253 AIYTSLLSG-PIPEEIGNCSELQNLYLYQNSISG-----PIPGRIGALSKLKSLLLWQNS 306
+ L P + + ++ N I ++ L N
Sbjct: 625 GFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE 684
Query: 307 LVGAIPDELGSCTELTVVDFSDNLLT-------GSIPRSFGNLLKLQELQLSVNQLSGTI 359
+ + + + ++ + S+NL+T ++ N L + L N+L+ ++
Sbjct: 685 IQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SL 743
Query: 360 PIEIATC--TALTHLEIDNNAISGEIPADIGNINGLTLF------FAWKNKLTGNIPESL 411
+ L+++++ N S P N + L F A N++ P +
Sbjct: 744 SDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802
Query: 412 SQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLN 471
+ C L L N++ + +++ L L + N + L
Sbjct: 803 TTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLL 859
Query: 472 DNRLSGTIPSEMGNLK 487
++ + ++
Sbjct: 860 YDKTQDIRGCDALGIE 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 1e-10
Identities = 17/153 (11%), Positives = 48/153 (31%), Gaps = 2/153 (1%)
Query: 516 LDLHSNGLTGSVPDTLPTSLQL-VDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIP 574
LD + + SL + + + + ++ L L+ GR+P
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP 340
Query: 575 AEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGI 634
I +L +L G + + + + ++S +L +
Sbjct: 341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNL 400
Query: 635 LDLSHNKLSGDLDALASLQNLVSLNVSFNDFSG 667
DL + ++ + + + ++ +++
Sbjct: 401 SDLLQDAINRNPE-MKPIKKDSRISLKDTQIGN 432
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 3e-83
Identities = 113/615 (18%), Positives = 193/615 (31%), Gaps = 45/615 (7%)
Query: 86 KAVDLQG-SLPSIFQPL-KSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIP 143
K + + L I L S + L S L F LTF+DL+ ++
Sbjct: 15 KTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHE 74
Query: 144 TEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVF 203
+L++L L N L + + +L +L +S + L+
Sbjct: 75 DTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESL 134
Query: 204 RAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLS-GP 262
G N + + L +L +I + L++ +++ +
Sbjct: 135 YLGSNH-ISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
Query: 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIG--ALSKLKSLLLWQNSLVGAIPDELGSCTE 320
I + + Q+L I + + L P E
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253
Query: 321 LTVV--DFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNA 378
++V + + +F LQEL L+ LS +P + + L L +
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA-- 310
Query: 379 ISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF-G 437
NK S S L L N +
Sbjct: 311 ----------------------NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN 348
Query: 438 LRNLTKLLLLSNDL--SGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMS 495
L NL +L L +D+ S + N + L+ L L+ N L +D++
Sbjct: 349 LENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA 408
Query: 496 ENHLVGGIPPSV-VGCQSLEFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHS 552
L S L+ L+L + L S +LQ ++L N
Sbjct: 409 FTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQK 468
Query: 553 IGS---LTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEI 609
S L L L+LS LS S + + +D+ +NR + + L + +
Sbjct: 469 TNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY- 527
Query: 610 SLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGEL 669
LNL+SN S +PS L++ ++L N L + L+ D L
Sbjct: 528 -LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKENMQKLEDTEDTL 586
Query: 670 PNTP-FFRKLPLSDL 683
P R + LSD+
Sbjct: 587 CENPPLLRGVRLSDV 601
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 7e-76
Identities = 99/592 (16%), Positives = 184/592 (31%), Gaps = 77/592 (13%)
Query: 131 IDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKI 190
+ L EIP + E L + N+L + L +L +L L Q+
Sbjct: 17 YNCENLGL-NEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 191 PKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQ 250
+ + +L N
Sbjct: 74 EDTFQSQHRLDTLVLTANP----------------------------------------- 92
Query: 251 TIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGA 310
L + L++L+ Q IS + L+SL L N +
Sbjct: 93 --------LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144
Query: 311 IPDELGSCTELTVVDFSDNLLTGSIPRSFGNL--LKLQELQLSVNQLSGTIPIEIATCTA 368
+ +L V+DF +N + +L L L+ N ++ I
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAV 203
Query: 369 LTHLEIDNNAISGEIP-----ADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFS 423
L I + I ++ T ++ + E L + +++++
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS-VESINLQ 262
Query: 424 YNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEM 483
+ L +L L + LS +P + +TL++L L+ N+
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISA 321
Query: 484 GNLKHLNFVDMSENHLVGGIPPSVV-GCQSLEFLDLHSNGLTGSVPDTLP----TSLQLV 538
N L + + N + + ++L LDL + + S L + LQ +
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL 381
Query: 539 DLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILS-CRKLILLDIGNNRFSGEI 597
+LS N + +L L L+ +L + L +L++ ++
Sbjct: 382 NLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISS 441
Query: 598 PKELGQISSLEISLNLSSNQFSGEI---PSEFSGLTKLGILDLSHNKLSG-DLDALASLQ 653
+ + +L+ LNL N F + L +L IL LS LS D A SL+
Sbjct: 442 EQLFDGLPALQH-LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK 500
Query: 654 NLVSLNVSFNDFSGELPNTPFFRKLPLS--DLASNRGLYISGGVVSPTDSLP 703
+ +++S N + L +LASN I ++
Sbjct: 501 MMNHVDLSHNRLTSSSIEA--LSHLKGIYLNLASNHISIILPSLLPILSQQR 550
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 9e-58
Identities = 79/405 (19%), Positives = 142/405 (35%), Gaps = 23/405 (5%)
Query: 298 KSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSG 357
K+ L IP L + ++FS N+L +F L+ L L L+ Q+
Sbjct: 15 KTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 358 TIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQEL 417
+ L L + N + + L F + ++ L + L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 418 QALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRR--LRLNDNRL 475
++L N++S + F L L +N + D+ + L LN N +
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 476 SGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGC--QSLEFLDLHSNGLTGSVPDTLP- 532
+ I + ++ + I + QSL P
Sbjct: 192 A-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250
Query: 533 ---TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIG 589
S++ ++L + +++ + L +L L+ LS +P+ ++ L L +
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLS 309
Query: 590 NNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSE-FSGLTKLGILDLSHNKLSG---D 645
N+F SL L++ N E+ + L L LDLSH+ +
Sbjct: 310 ANKFENLCQISASNFPSLT-HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC 368
Query: 646 LDALASLQNLVSLNVSFNDFSGELPNTPFFRKLP-LS--DLASNR 687
L +L +L SLN+S+N+ F++ P L DLA R
Sbjct: 369 NLQLRNLSHLQSLNLSYNEPLSLKTEA--FKECPQLELLDLAFTR 411
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 3e-78
Identities = 73/270 (27%), Positives = 124/270 (45%), Gaps = 9/270 (3%)
Query: 401 NKLTGNIPESLSQCQELQALDFSYNNLSG--PIPKEIFGLRNLTKLLLLS-NDLSGFIPP 457
G + ++ +Q + LD S NL PIP + L L L + N+L G IPP
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 458 DIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLD 517
I T L L + +SG IP + +K L +D S N L G +PPS+ +L +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 518 LHSNGLTGSVPDT---LPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIP 574
N ++G++PD+ + +S NRL+G + + +L L+ + LS+N L G
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDAS 214
Query: 575 AEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGI 634
S + + + N + ++ ++G +L L+L +N+ G +P + L L
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLN-GLDLRNNRIYGTLPQGLTQLKFLHS 272
Query: 635 LDLSHNKLSGDLDALASLQNLVSLNVSFND 664
L++S N L G++ +LQ + N
Sbjct: 273 LNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 3e-78
Identities = 77/273 (28%), Positives = 127/273 (46%), Gaps = 7/273 (2%)
Query: 236 SGNVPSSIGMLERIQTIAIYTSLLSG--PIPEEIGNCSELQNLYLY-QNSISGPIPGRIG 292
G + + R+ + + L PIP + N L LY+ N++ GPIP I
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 293 ALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSV 352
L++L L + ++ GAIPD L L +DFS N L+G++P S +L L +
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 353 NQLSGTIPIEIATCTAL-THLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESL 411
N++SG IP + + L T + I N ++G+IP N+N L +N L G+
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLF 217
Query: 412 SQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLN 471
+ Q + + N+L+ + ++ +NL L L +N + G +P + L L ++
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276
Query: 472 DNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIP 504
N L G IP GNL+ + + N + G P
Sbjct: 277 FNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 255 bits (655), Expect = 9e-78
Identities = 91/338 (26%), Positives = 141/338 (41%), Gaps = 54/338 (15%)
Query: 310 AIPDELGSCTEL----TVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIAT 365
I +LG+ T L D + G + + ++ L LS L PI
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPI---- 68
Query: 366 CTALTHLEIDNNAISGEIPADIGNINGLT-LFFAWKNKLTGNIPESLSQCQELQALDFSY 424
P+ + N+ L L+ N L G IP ++++ +L L ++
Sbjct: 69 ------------------PSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 425 NNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMG 484
N+SG IP + ++ L L N LSG +PP I + L + + NR+SG IP G
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 485 NLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPT-SLQLVDLSDN 543
+ L + + N LTG +P T +L VDLS N
Sbjct: 171 SFSKL-----------------------FTSMTISRNRLTGKIPPTFANLNLAFVDLSRN 207
Query: 544 RLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQ 603
L G + GS K+ L+KN L+ + ++ + L LD+ NNR G +P+ L Q
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQ 266
Query: 604 ISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNK 641
+ L SLN+S N GEIP + L + + ++NK
Sbjct: 267 LKFLH-SLNVSFNNLCGEIPQGGN-LQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 248 bits (637), Expect = 3e-75
Identities = 81/315 (25%), Positives = 125/315 (39%), Gaps = 34/315 (10%)
Query: 153 ESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSG--KIPKSIGALSKLQVFRAGGNQN 210
+ G + + L L L IP S+ L L GG N
Sbjct: 29 PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88
Query: 211 LKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNC 270
L G +P I + L L + T++SG +P + ++ + T+ + LSG +P I +
Sbjct: 89 LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148
Query: 271 SELQNLYLYQNSISGPIPGRIGALSKL-KSLLLWQNSLVGAIPDELGSCTELTVVDFSDN 329
L + N ISG IP G+ SKL S+ + +N L G IP + L VD S N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN 207
Query: 330 LLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGN 389
+L G FG+ Q++ L+ N L+ + +G
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-------------------------KVGL 242
Query: 390 INGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSN 449
L N++ G +P+ L+Q + L +L+ S+NNL G IP+ L+ +N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301
Query: 450 D-LSGFIPPDIGNCT 463
L G P CT
Sbjct: 302 KCLCGSPLP---ACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 6e-75
Identities = 89/333 (26%), Positives = 141/333 (42%), Gaps = 35/333 (10%)
Query: 36 DEQGQALLTWKNSLNSSTDALSSWNPAET-SPCKWFGIHCSSNGE---VVEISLKAVDLQ 91
+ QALL K L + T LSSW P W G+ C ++ + V + L ++L
Sbjct: 5 PQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 92 GS--LPSIFQPLKSLKRLIISSCN-LTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCR 148
+PS L L L I N L G IP +L ++ ++ ++ G IP + +
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 149 LRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGN 208
++ L +L + N L G +P I +L +L +T N++SG IP S G+ SKL
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 209 QNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIG 268
L G++P N NL + L S N +L G G
Sbjct: 184 NRLTGKIPPTFANL-NLAFVDL-----SRN-------------------MLEGDASVLFG 218
Query: 269 NCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSD 328
+ Q ++L +NS++ + ++G L L L N + G +P L L ++ S
Sbjct: 219 SDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 329 NLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPI 361
N L G IP+ GNL + + N+ P+
Sbjct: 278 NNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPL 309
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 6e-65
Identities = 71/315 (22%), Positives = 116/315 (36%), Gaps = 56/315 (17%)
Query: 407 IPESLSQCQELQ----ALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSG--FIPPDIG 460
I + L L D G + + L L +L IP +
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 461 NCTTLRRLRL-NDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLH 519
N L L + N L G IP + L L+++ ++ ++ G IP + ++L LD
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 520 SNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILS 579
N L+G++P SI SL L + N++SG IP S
Sbjct: 134 YNALSGTLP----------------------PSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 580 CRKLI-LLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLS 638
KL + I NR +G+IP ++ L ++LS N G+ F + L+
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLN-LAF-VDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 639 HNKLSGDLDALASLQNLVSLNVSFN------------------------DFSGELPNTPF 674
N L+ DL + +NL L++ N + GE+P
Sbjct: 230 KNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289
Query: 675 FRKLPLSDLASNRGL 689
++ +S A+N+ L
Sbjct: 290 LQRFDVSAYANNKCL 304
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 1e-72
Identities = 83/252 (32%), Positives = 136/252 (53%), Gaps = 17/252 (6%)
Query: 745 ADDTWEMTLYQKLDFSIDDVV---RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSS 801
A++ E+ L Q FS+ ++ N ++ N++G G G VY+ + +G +AVK++
Sbjct: 6 AEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE 65
Query: 802 DESGA---FSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGG 858
G F +E++ + H+N++RL G+ +LL Y Y+ NGS++S L +
Sbjct: 66 RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 859 A--DWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916
DW R + LG A LAYLH C P I+H DVKA N+LL ++A + DFGLA++
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-- 183
Query: 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976
D + + G+ G++APE+ S + +EK+DV+ +GV+LLE++TG+ D
Sbjct: 184 --MDYKDTHVTTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239
Query: 977 PGG---APLVQW 985
L+ W
Sbjct: 240 LANDDDVMLLDW 251
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 5e-71
Identities = 111/595 (18%), Positives = 200/595 (33%), Gaps = 42/595 (7%)
Query: 103 SLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLL 162
S K + +S L F ++ EL ++DLS + L L +L L N +
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 163 EGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNC 222
+ P L+SL L + +L+ IG L L+ N +LP N
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL 152
Query: 223 SNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPI---PEEIGNCSELQNLYLY 279
+NLV + L+ I + + L + + + PI ++ +L L L
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212
Query: 280 QNSISGPIPGR-IGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRS 338
N S I + L+ L L + L P
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEF------------------KDERNLEIFEPSI 254
Query: 339 FGNL--LKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLF 396
L + + E +L+ ++ ++ + + +I + + +L
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLS 313
Query: 397 FAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIP 456
+ +L L L++L + N S I + L +L+ L L N LS F
Sbjct: 314 II-RCQLKQFPTLDLPF---LKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALS-FSG 366
Query: 457 PDI---GNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSV-VGCQS 512
+LR L L+ N + + L+ L +D + L S + +
Sbjct: 367 CCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425
Query: 513 LEFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHSI-GSLTELSKLLLSKNQL 569
L +LD+ TSL + ++ N + ++ + T L+ L LSK QL
Sbjct: 426 LLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQL 485
Query: 570 SGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGL 629
+ +L LL++ +N Q+ SL +L+ S N+
Sbjct: 486 EQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLS-TLDCSFNRIETSKGILQHFP 544
Query: 630 TKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTP-FFRKLPLSDL 683
L +L++N ++ + LQ + + TP + D
Sbjct: 545 KSLAFFNLTNNSVACICEHQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLDF 599
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 3e-64
Identities = 93/525 (17%), Positives = 161/525 (30%), Gaps = 30/525 (5%)
Query: 90 LQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRL 149
L+ F L+ L +S C + K + L+ + L+GN + P L
Sbjct: 44 LKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGL 103
Query: 150 RKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSG-KIPKSIGALSKLQVFRAGGN 208
LE+L L IG L +L L + N + K+P L+ L N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163
Query: 209 QNLKGELPWEIGNCSNL----VMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIP 264
++ ++ + L ++ I + ++ + + + S I
Sbjct: 164 Y-IQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIM 221
Query: 265 EE-IGNCSELQNLYLYQNSISGPIPGRIGALSKLKSL--------LLWQNSLVGAIPDEL 315
+ + N + L L I S ++ L L + +
Sbjct: 222 KTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKF 281
Query: 316 GSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEID 375
++ + + + K Q L + QL L L +
Sbjct: 282 HCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLT 336
Query: 376 NNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQ--CQELQALDFSYNNLSGPIPK 433
N S I + L+ +N L+ + S S L+ LD S+N +
Sbjct: 337 MNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSA 393
Query: 434 EIFGLRNLTKLLLLSNDLSGFIPPD-IGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFV 492
GL L L + L + L L ++ L LN +
Sbjct: 394 NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTL 453
Query: 493 DMSENHLVGGIPPSVV-GCQSLEFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSL 549
M+ N +V +L FLDL L LQL+++S N L
Sbjct: 454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLD 513
Query: 550 AHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFS 594
+ L LS L S N++ + L ++ NN +
Sbjct: 514 SSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-44
Identities = 83/438 (18%), Positives = 143/438 (32%), Gaps = 31/438 (7%)
Query: 84 SLKAVDLQG------SLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTF----IDL 133
+LK +++ LP+ F L +L + +S + + RE +D+
Sbjct: 129 TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188
Query: 134 SGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSD-IGNLSSLAYLTLYDNQLSGKI-- 190
S N + I + + KL L L N I + NL+ L L + +
Sbjct: 189 SLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL 247
Query: 191 ----PKSIGALSKLQVFRAGGNQN-LKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGM 245
P + L + + + + +N+ + LA SI +
Sbjct: 248 EIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPK 305
Query: 246 LERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQN 305
+ Q+++I L P + L++L L N S I + AL L L L +N
Sbjct: 306 HFKWQSLSIIRCQLKQ-FPT--LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRN 360
Query: 306 SL--VGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIE- 362
+L G L +D S N + +F L +LQ L + L
Sbjct: 361 ALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSA 419
Query: 363 IATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPES-LSQCQELQALD 421
+ L +L+I + + L N N + + L LD
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD 479
Query: 422 FSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPS 481
S L L L L + N+L +L L + NR+ +
Sbjct: 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI 539
Query: 482 EMGNLKHLNFVDMSENHL 499
K L F +++ N +
Sbjct: 540 LQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-40
Identities = 67/338 (19%), Positives = 118/338 (34%), Gaps = 24/338 (7%)
Query: 370 THLEIDNNAISGEIPADIG-NINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLS 428
+ + +S ++P DI + + L F N L S S ELQ LD S +
Sbjct: 14 ITYQCMDQKLS-KVPDDIPSSTKNIDLSF---NPLKILKSYSFSNFSELQWLDLSRCEIE 69
Query: 429 GPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKH 488
K GL +L+ L+L N + F P T+L L + +L+ +G L
Sbjct: 70 TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLIT 129
Query: 489 LNFVDMSENHLVG-GIPPSVVGCQSLEFLDLHSNGLTGSVPDT------LPTSLQLVDLS 541
L ++++ N + +P +L +DL N + + P +D+S
Sbjct: 130 LKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189
Query: 542 DNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILS-CRKLILLDIGNNRFSGEIPKE 600
N + + +L +L L N S I L L + + F E E
Sbjct: 190 LNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248
Query: 601 LGQISSLE-------ISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQ 653
+ + S +E L+ + +F L + + L+ + L+ +
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHF 307
Query: 654 NLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRGLYI 691
SL++ + P L L N+G
Sbjct: 308 KWQSLSIIRCQLK-QFPTL-DLPFLKSLTLTMNKGSIS 343
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-30
Identities = 65/403 (16%), Positives = 107/403 (26%), Gaps = 53/403 (13%)
Query: 5 LRHLLFSQNIFSFTLLLISINFLFFSTCDALDEQGQALLTWKNSLNSSTDALSSWNPAET 64
L L N S ++ + L E
Sbjct: 206 LHELTLRGNFNSSNIMKTCLQNLAGLH----------------VHRLILGEFKDERNLEI 249
Query: 65 SPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGD 124
C + E L + F L ++ + ++ ++ ++
Sbjct: 250 FEPSIMEGLCDVTID--EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPK 305
Query: 125 YRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDN 184
+ + + + L + PT L L+SL L N I L SL+YL L N
Sbjct: 306 HFKWQSLSIIRCQL-KQFPTL--DLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRN 360
Query: 185 QLSGKIPKS--IGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSS 242
LS S + L+ N + L L +++ S
Sbjct: 361 ALSFSGCCSYSDLGTNSLRHLDLSFNGA--IIMSANFMGLEELQHLDFQHSTLKRVTEFS 418
Query: 243 IGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLL 302
+ +L L + + G L+ L +L +
Sbjct: 419 A-----------------------FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKM 455
Query: 303 WQNSLVGAIPDE-LGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPI 361
NS + T LT +D S L F L +LQ L +S N L
Sbjct: 456 AGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSS 515
Query: 362 EIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLT 404
+L+ L+ N I L F N +
Sbjct: 516 HYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 2e-70
Identities = 83/259 (32%), Positives = 132/259 (50%), Gaps = 16/259 (6%)
Query: 735 RTRMANNSFTADDTWEMTLYQKLDFSIDDVV---RNLTSANVIGTGSSGVVYRVTIPNGE 791
++ N+ A + + ++ + D+ N +IG G G VY+ + +G
Sbjct: 5 YSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA 64
Query: 792 TLAVKKMWSSDESGA--FSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSS 849
+A+K+ G F +EI+TL RH ++V L+G+ +N +L Y Y+ NG+L
Sbjct: 65 KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR 124
Query: 850 LLHGAGKGGA--DWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLA 907
L+G+ WE R E+ +G A L YLH I+H DVK++N+LL + +
Sbjct: 125 HLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKIT 181
Query: 908 DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT 967
DFG+++ + + S T + G+ GY+ PE+ R+TEKSDVYSFGVVL EVL
Sbjct: 182 DFGISKKGTELDQTHLS-T----VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
Query: 968 GRHPLDPTLPGGAP-LVQW 985
R + +LP L +W
Sbjct: 237 ARSAIVQSLPREMVNLAEW 255
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-62
Identities = 76/224 (33%), Positives = 114/224 (50%), Gaps = 18/224 (8%)
Query: 769 TSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGA------FSSEIQTLGSIRHKNI 822
N +G G GVVY+ + N T+AVKK+ + + F EI+ + +H+N+
Sbjct: 34 VGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92
Query: 823 VRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGA-DWEARYEVVLGVAHALAYLHHD 881
V LLG+ S+ + L Y Y+PNGSL L W R ++ G A+ + +LH +
Sbjct: 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN 152
Query: 882 CMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAP 941
+H D+K+ N+LL + A ++DFGLAR +T ++ G+ YMAP
Sbjct: 153 H---HIHRDIKSANILLDEAFTAKISDFGLARA--SEKFA---QTVMTSRIVGTTAYMAP 204
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQW 985
E IT KSD+YSFGVVLLE++TG +D L+
Sbjct: 205 EALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLDI 246
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 6e-61
Identities = 102/422 (24%), Positives = 184/422 (43%), Gaps = 33/422 (7%)
Query: 265 EEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVV 324
+E L + +++ + L ++ +L + + D + LT +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 73
Query: 325 DFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIP 384
+FS+N LT P NL KL ++ ++ NQ++ P+ A T LT L + NN I+ P
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPL--ANLTNLTGLTLFNNQITDIDP 129
Query: 385 ADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKL 444
+ N+ L N ++ +LS LQ L F N ++ P + L L +L
Sbjct: 130 --LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERL 182
Query: 445 LLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIP 504
+ SN +S + T L L +N++S P +G L +L+ + ++ N L
Sbjct: 183 DISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--I 236
Query: 505 PSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLL 564
++ +L LDL +N ++ P + T L + L N++S + LT L+ L L
Sbjct: 237 GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNI--SPLAGLTALTNLEL 294
Query: 565 SKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPS 624
++NQL P I + + L L + N S P + ++ L+ L +N+ S S
Sbjct: 295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQ-RLFFYNNKVSD--VS 347
Query: 625 EFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLA 684
+ LT + L HN++S DL LA+L + L ++ ++ N + + + +
Sbjct: 348 SLANLTNINWLSAGHNQIS-DLTPLANLTRITQLGLNDQAWTNAPVN--YKANVSIPNTV 404
Query: 685 SN 686
N
Sbjct: 405 KN 406
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 3e-60
Identities = 100/521 (19%), Positives = 199/521 (38%), Gaps = 64/521 (12%)
Query: 152 LESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQ-- 209
L S + + +I +D L+ L ++ + L ++ +A
Sbjct: 3 LGSATITQDTPINQIFTD-TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59
Query: 210 NLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGN 269
++ G + +NL + + ++ + N
Sbjct: 60 SIDG-----VEYLNNLTQINFSNNQLTD--------------------------ITPLKN 88
Query: 270 CSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDN 329
++L ++ + N I+ P + L+ L L L+ N + P L + T L ++ S N
Sbjct: 89 LTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSN 144
Query: 330 LLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGN 389
++ + L LQ+L NQ++ P+ T L L+I +N +S + +
Sbjct: 145 TISD--ISALSGLTSLQQLSFG-NQVTDLKPLA--NLTTLERLDISSNKVSD--ISVLAK 197
Query: 390 INGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSN 449
+ L A N+++ P L L L + N L + L NLT L L +N
Sbjct: 198 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANN 253
Query: 450 DLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVG 509
+S P + T L L+L N++S P + L L ++++EN L +
Sbjct: 254 QISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISN 307
Query: 510 CQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQL 569
++L +L L+ N ++ P + T LQ + +N++S S+ +LT ++ L NQ+
Sbjct: 308 LKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQI 365
Query: 570 SGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGL 629
S P + + ++ L + + ++ +S N++ + P+ S
Sbjct: 366 SDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIA---PATISDG 420
Query: 630 TKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELP 670
D++ N S + + V++ FSG +
Sbjct: 421 GSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-55
Identities = 105/524 (20%), Positives = 185/524 (35%), Gaps = 67/524 (12%)
Query: 103 SLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLL 162
L I+ I E L ++ + L ++ +L + +
Sbjct: 2 PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 163 EGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNC 222
+ + L++L + +NQL+ P + L+KL NQ + P + N
Sbjct: 59 K--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ-IADITP--LANL 111
Query: 223 SNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNS 282
+NL L L I+ + + N + L L L N+
Sbjct: 112 TNLTGLTLFNNQITD--------------------------IDPLKNLTNLNRLELSSNT 145
Query: 283 ISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNL 342
IS + L+ L+ L N + P L + T L +D S N ++ L
Sbjct: 146 ISDISA--LSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKL 198
Query: 343 LKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNK 402
L+ L + NQ+S P+ T L L ++ N + + ++ LT N+
Sbjct: 199 TNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQ 254
Query: 403 LTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNC 462
++ P LS +L L N +S P + GL LT L L N L P I N
Sbjct: 255 ISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNL 308
Query: 463 TTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNG 522
L L L N +S P + +L L + N + S+ ++ +L N
Sbjct: 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQ 364
Query: 523 LTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRK 582
++ P T + + L+D + + + +++ + + L PA I
Sbjct: 365 ISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGS 422
Query: 583 LILLDIGNNRFSGEIPKELGQIS---SLEISLNLSSNQFSGEIP 623
DI N +P ++S S +++ + FSG +
Sbjct: 423 YTEPDITWN-----LPSYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-49
Identities = 107/441 (24%), Positives = 173/441 (39%), Gaps = 56/441 (12%)
Query: 84 SLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIP 143
+L+A L + L +L ++ S+ LT P + +L I ++ N + P
Sbjct: 50 TLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP 107
Query: 144 TEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVF 203
+ L L L L N + P + NL++L L L N +S ++ L+ LQ
Sbjct: 108 --LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQL 161
Query: 204 RAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPI 263
G + P + N + L L ++ +S
Sbjct: 162 SFGN--QVTDLKP--LANLTTLERLDISSNKVSD-------------------------- 191
Query: 264 PEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTV 323
+ + L++L N IS P +G L+ L L L N L L S T LT
Sbjct: 192 ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTD 247
Query: 324 VDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEI 383
+D ++N ++ P L KL EL+L NQ+S P+ TALT+LE++ N +
Sbjct: 248 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA--GLTALTNLELNENQLEDIS 303
Query: 384 PADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTK 443
P I N+ LT + N ++ P +S +LQ L F N +S + L N+
Sbjct: 304 P--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSS--LANLTNINW 357
Query: 444 LLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGI 503
L N +S P + N T + +L LND + + N+ N V L+
Sbjct: 358 LSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--A 413
Query: 504 PPSVVGCQSLEFLDLHSNGLT 524
P ++ S D+ N +
Sbjct: 414 PATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-34
Identities = 78/376 (20%), Positives = 135/376 (35%), Gaps = 52/376 (13%)
Query: 84 SLKAVDLQG---SLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWG 140
+L ++L S S L SL++L +T P + L +D+S N +
Sbjct: 135 NLNRLELSSNTISDISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKV-- 189
Query: 141 EIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKL 200
+ + +L LESL N + P +G L++L L+L NQL ++ +L+ L
Sbjct: 190 SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNL 245
Query: 201 QVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLS 260
NQ + P + + L L L IS
Sbjct: 246 TDLDLANNQ-ISNLAP--LSGLTKLTELKLGANQISN----------------------- 279
Query: 261 GPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTE 320
+ + L NL L +N + P I L L L L+ N++ P + S T+
Sbjct: 280 ---ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTK 332
Query: 321 LTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAIS 380
L + F +N ++ S NL + L NQ+S P+ T +T L +++ A +
Sbjct: 333 LQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA--NLTRITQLGLNDQAWT 388
Query: 381 GEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRN 440
N++ L P ++S D ++N S + +
Sbjct: 389 NAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSY-TNEVSYTFSQ 445
Query: 441 LTKLLLLSNDLSGFIP 456
+ + SG +
Sbjct: 446 PVTIGKGTTTFSGTVT 461
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 9e-58
Identities = 110/589 (18%), Positives = 194/589 (32%), Gaps = 89/589 (15%)
Query: 103 SLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCR-LRKLESLYLNTNL 161
S K L +S L F + EL +DLS + I + L L +L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 162 LEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGN 221
++ LSSL L + L+ IG L L+ N
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL------------ 135
Query: 222 CSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQN 281
+ S +PE N + L++L L N
Sbjct: 136 ------------------------------------IQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 282 SISGPIPGRIGALSKLKSLLLW----QNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPR 337
I + L ++ L L N + I L + +N + ++ +
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMK 218
Query: 338 -SFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLF 396
L L+ +L + + +E +AL L N+
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC---------------NLTIEEFR 263
Query: 397 FAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIP 456
A+ + +I + + + + + + + L L++ F
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSY-NFGWQHLELVNCKFGQFPT 321
Query: 457 PDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHL--VGGIPPSVVGCQSLE 514
+L+RL N+ SE+ +L L F+D+S N L G S G SL+
Sbjct: 322 ---LKLKSLKRLTFTSNKGG-NAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 515 FLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHSI-GSLTELSKLLLSKNQLSG 571
+LDL NG+ ++ L+ +D + L S+ SL L L +S
Sbjct: 377 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 572 RIPAEILS-CRKLILLDIGNNRFSGEIPKE-LGQISSLEISLNLSSNQFSGEIPSEFSGL 629
I + L +L + N F + ++ +L L+LS Q P+ F+ L
Sbjct: 436 -AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF-LDLSQCQLEQLSPTAFNSL 493
Query: 630 TKLGILDLSHNKLSG-DLDALASLQNLVSLNVSFNDFSGELPNTPFFRK 677
+ L +L+++ N+L L +L + + N + P + +
Sbjct: 494 SSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 542
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-43
Identities = 89/420 (21%), Positives = 150/420 (35%), Gaps = 29/420 (6%)
Query: 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELT 322
IP+ + +NL L N + + +L+ L L + + S + L+
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 323 VVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAI-SG 381
+ + N + +F L LQ+L L+ I L L + +N I S
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 382 EIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQA----LDFSYNNLSGPIPKEIFG 437
++P N+ L NK+ L ++ LD S N ++ I F
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFK 198
Query: 438 LRNLTKLLLLSNDLSGFIPPD-IGNCTTLRRLRL------NDNRLSGTIPSEMGNLKHLN 490
L KL L +N S + I L RL N+ L S + L +L
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 491 FVDMSENHL---VGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSG 547
+ +L + I ++ L S + + Q ++L + +
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQ 318
Query: 548 SLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNR--FSGEIPKELGQIS 605
L L +L + N+ +E+ L LD+ N F G + +
Sbjct: 319 ---FPTLKLKSLKRLTFTSNKGGN-AFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373
Query: 606 SLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSG--DLDALASLQNLVSLNVSFN 663
SL+ L+LS N + S F GL +L LD H+ L + SL+NL+ L++S
Sbjct: 374 SLK-YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-33
Identities = 76/423 (17%), Positives = 138/423 (32%), Gaps = 36/423 (8%)
Query: 84 SLKAVDLQG------SLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTF----IDL 133
+LK +++ LP F L +L+ L +SS + + ++ +DL
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 134 SGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSD-IGNLSSLAYLTLY------DNQL 186
S N + I + +L L L N + I L+ L L + L
Sbjct: 185 SLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243
Query: 187 SGKIPKSIGALSKLQV--FRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSI- 243
++ L L + FR ++ +N+ L +I S
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303
Query: 244 GMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLW 303
+ ++ + L+ L N L L+ L L
Sbjct: 304 FGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLS 355
Query: 304 QNSL--VGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPI 361
+N L G T L +D S N + ++ +F L +L+ L + L
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEF 414
Query: 362 EI-ATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNI-PESLSQCQELQA 419
+ + L +L+I + ++ L + N N P+ ++ + L
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474
Query: 420 LDFSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGT 478
LD S L + F L +L L + SN L T+L+++ L+ N +
Sbjct: 475 LDLSQCQLEQ-LSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533
Query: 479 IPS 481
P
Sbjct: 534 CPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-29
Identities = 71/334 (21%), Positives = 120/334 (35%), Gaps = 30/334 (8%)
Query: 382 EIPADI-GNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF-GLR 439
+IP ++ + L L F N L S ELQ LD S + I + L
Sbjct: 21 KIPDNLPFSTKNLDLSF---NPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLS 76
Query: 440 NLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHL 499
+L+ L+L N + ++L++L + L+ +G+LK L ++++ N +
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 500 -VGGIPPSVVGCQSLEFLDLHSNGLTGSVPDT------LPTSLQLVDLSDNRLSGSLAHS 552
+P +LE LDL SN + +P +DLS N ++ +
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPG 195
Query: 553 IGSLTELSKLLLSKNQLSGRIPAEI---LSCRKLILLDIGNNRFSGEIPK-ELGQISSLE 608
L KL L N S + L+ ++ L +G R G + K + + L
Sbjct: 196 AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255
Query: 609 ----ISLNLSSNQFSG-EIPSEFSGLTKLGILDLSHNKLSG--DLDALASLQNLVSLNVS 661
L+ + +I F+ LT + L + D Q+L +N
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCK 315
Query: 662 FNDFSGELPNTPFFRKLPLSDLASNRGLYISGGV 695
F F + L SN+G V
Sbjct: 316 FGQFPTL-----KLKSLKRLTFTSNKGGNAFSEV 344
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 5e-55
Identities = 63/252 (25%), Positives = 100/252 (39%), Gaps = 30/252 (11%)
Query: 757 LDFSIDDVV---RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESG-AFSSEIQ 812
+D +++ L V G G V++ E +AVK D+ E+
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEYEVY 70
Query: 813 TLGSIRHKNIVRLLG---WGSNKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVV 868
+L ++H+NI++ +G G++ ++ L L + GSLS L W +
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHIA 127
Query: 869 LGVAHALAYLHHDCM-------PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921
+A LAYLH D P I H D+K+ NVLL A +ADFGLA
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 922 NCSKTNQRPQLAGSYGYMAPE-----HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976
+ G+ YMAPE + + D+Y+ G+VL E+ + D +
Sbjct: 188 GDTHG-----QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 977 PGG-APLVQWTP 987
P +
Sbjct: 243 DEYMLPFEEEIG 254
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 2e-54
Identities = 120/627 (19%), Positives = 213/627 (33%), Gaps = 83/627 (13%)
Query: 74 CSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDL 133
CS +G + +L + Q L + +RL++S + F +L ++L
Sbjct: 2 CSFDGRIAFYRFC------NLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLEL 55
Query: 134 SGNSLWGEIPTEVCR-LRKLESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQLSGKI- 190
I E R L L L L ++ + + D L L L LY LS +
Sbjct: 56 GSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVL 114
Query: 191 -PKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERI 249
L L NQ L G ++L + + I + L+
Sbjct: 115 KDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGK 174
Query: 250 QTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRI-GALSKLKSLLLWQNSLV 308
L L NS+ + ++ ++++L +
Sbjct: 175 T----------------------LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDV- 211
Query: 309 GAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTA 368
G+ + + N ++ S S + + +
Sbjct: 212 ------SGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK------------ 253
Query: 369 LTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLS 428
+ D N +G + + L + + ++L+ L+ +YN ++
Sbjct: 254 ----DPDQNTFAG-----LARSSVRHLDLSH-GFVFSLNSRVFETLKDLKVLNLAYNKIN 303
Query: 429 GPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLK 487
I E F GL NL L L N L + + + L N ++ L+
Sbjct: 304 K-IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLE 362
Query: 488 HLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSG 547
L +D+ +N L ++ S+ + L N L + + L+ LS+NRL
Sbjct: 363 KLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTL--PKINLTANLIHLSENRLEN 415
Query: 548 -SLAHSIGSLTELSKLLLSKNQLSGRIPAEILS-CRKLILLDIGNNRFSGEIPKEL---- 601
+ + + + L L+L++N+ S + S L L +G N EL
Sbjct: 416 LDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDV 475
Query: 602 -GQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNV 660
+S L++ L L+ N + P FS LT L L L+ N+L+ L NL L++
Sbjct: 476 FEGLSHLQV-LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDI 533
Query: 661 SFNDFSGELPNTPFFRKLPLSDLASNR 687
S N PN F L + D+ N+
Sbjct: 534 SRNQLLA--PNPDVFVSLSVLDITHNK 558
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 7e-07
Identities = 44/211 (20%), Positives = 74/211 (35%), Gaps = 43/211 (20%)
Query: 5 LRHLLFSQNIFSFTLLLISINFLFFSTCDALDEQGQALLTWKNSLNSSTDALSSWNPAET 64
L+ L N + + SI +F S N L + + N
Sbjct: 364 LQTLDLRDNALTTIHFIPSIPDIFLS---------------GNKLVTLPKINLTANL--- 405
Query: 65 SPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKE-FG 123
IH S N L+ +D+ + L+ LI++ + +
Sbjct: 406 -------IHLSEN------RLENLDIL----YFLLRVPHLQILILNQNRFSSCSGDQTPS 448
Query: 124 DYRELTFIDLSGNSLWGEIPTEVCR-----LRKLESLYLNTNLLEGEIPSDIGNLSSLAY 178
+ L + L N L TE+C L L+ LYLN N L P +L++L
Sbjct: 449 ENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRG 508
Query: 179 LTLYDNQLSGKIPKSIGALSKLQVFRAGGNQ 209
L+L N+L+ + + + L++ NQ
Sbjct: 509 LSLNSNRLT-VLSHND-LPANLEILDISRNQ 537
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-54
Identities = 105/543 (19%), Positives = 181/543 (33%), Gaps = 99/543 (18%)
Query: 101 LKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTN 160
L+ + S NLT +P E + + T + + P R++ L
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 161 LLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIG 220
L L L + LS +P+ L L + N ELP
Sbjct: 69 L-----------DRQAHELELNNLGLS-SLPELPPHLESLVA-----SCNSLTELPELPQ 111
Query: 221 NCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQ 280
+ +L++ ++S P L+ L +
Sbjct: 112 SLKSLLVDNNNLKALSDLPPL-------------------------------LEYLGVSN 140
Query: 281 NSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFG 340
N + +P + S LK + + NSL +PD S L + +N L +P
Sbjct: 141 NQLEK-LPE-LQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE-ELP-ELQ 192
Query: 341 NLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWK 400
NL L + N L +P +L + NN + ++ N+ LT +A
Sbjct: 193 NLPFLTAIYADNNSLK-KLPDLP---LSLESIVAGNNILE--ELPELQNLPFLTTIYADN 246
Query: 401 NKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIG 460
N L +P+ L+AL+ N L+ +P+ L L + + LS P
Sbjct: 247 NLLK-TLPDLPPS---LEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPP---- 297
Query: 461 NCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHS 520
L L + N + ++ +L+ LN +S N L+ +P LE L
Sbjct: 298 ---NLYYLNASSNEIR-SLCDLPPSLEELN---VSNNKLI-ELPAL---PPRLERLIASF 346
Query: 521 NGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSC 580
N L VP+ LP +L+ + + N L S+ +L + L+ +P +
Sbjct: 347 NHLA-EVPE-LPQNLKQLHVEYNPLR-EFPDIPESVEDLRMN----SHLA-EVPELPQNL 398
Query: 581 RKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHN 640
++ L + N E P + L ++S + KL H+
Sbjct: 399 KQ---LHVETNPLR-EFPDIPESVE----DLRMNSERVVDPYEFAHETTDKLEDDVFEHH 450
Query: 641 KLS 643
Sbjct: 451 HHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 7e-54
Identities = 107/483 (22%), Positives = 184/483 (38%), Gaps = 72/483 (14%)
Query: 191 PKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQ 250
P+++ + R + NL E+P E N + A + N P G +
Sbjct: 5 PRNVSNTFLQEPLR--HSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 251 TIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGA 310
+ L L L +S +P L+SL+ NSL
Sbjct: 62 VSRLRDCLDRQ-----------AHELELNNLGLS-SLPELPP---HLESLVASCNSLT-E 105
Query: 311 IPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALT 370
+P+ S L V + + L+ P L+ L +S NQL +P E+ + L
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLK 156
Query: 371 HLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGP 430
+++DNN++ ++P ++ + N+L +PE L L A+ N+L
Sbjct: 157 IIDVDNNSLK-KLPDLPPSLEFIAAGN---NQLE-ELPE-LQNLPFLTAIYADNNSLKK- 209
Query: 431 IPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLN 490
+P +L ++ +N L P++ N L + ++N L T+P +L+ LN
Sbjct: 210 LPDLPL---SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN 263
Query: 491 FVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLA 550
D L P L+ + +GL+ LP +L ++ S N + SL
Sbjct: 264 VRDNYLTDL----PELPQSLTFLDVSENIFSGLS-----ELPPNLYYLNASSNEIR-SLC 313
Query: 551 HSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEIS 610
SL EL+ +S N+L +PA +L L N + E+P+ + L
Sbjct: 314 DLPPSLEELN---VSNNKLI-ELPALP---PRLERLIASFNHLA-EVPELPQNLKQL--- 362
Query: 611 LNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELP 670
++ N E P + L ++ L+ + QNL L+V N E P
Sbjct: 363 -HVEYNPLR-EFPDIPESVEDL----RMNSHLA---EVPELPQNLKQLHVETNPLR-EFP 412
Query: 671 NTP 673
+ P
Sbjct: 413 DIP 415
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 4e-49
Identities = 89/424 (20%), Positives = 158/424 (37%), Gaps = 63/424 (14%)
Query: 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGS----- 317
I + + LQ + ++++ +P + + P G
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 318 --------CTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTAL 369
+ ++ ++ L+ S+P +L + L S N L+ +P + +L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSL 116
Query: 370 THLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSG 429
+ A+S P L N+L +PE L L+ +D N+L
Sbjct: 117 LVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK 167
Query: 430 PIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHL 489
+P +L + +N L P++ N L + ++N L +P +L+ +
Sbjct: 168 -LPDL---PPSLEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSLK-KLPDLPLSLESI 220
Query: 490 NFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSL 549
N L P + L + +N L ++PD P SL+ +++ DN L+ L
Sbjct: 221 ---VAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPP-SLEALNVRDNYLT-DL 272
Query: 550 AHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEI 609
SLT L + LS P L L+ +N + SLE
Sbjct: 273 PELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLC---DLPPSLE- 320
Query: 610 SLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGEL 669
LN+S+N+ E+P+ L +L S N L+ ++ L QNL L+V +N E
Sbjct: 321 ELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPEL--PQNLKQLHVEYNPLR-EF 372
Query: 670 PNTP 673
P+ P
Sbjct: 373 PDIP 376
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-36
Identities = 86/478 (17%), Positives = 161/478 (33%), Gaps = 129/478 (26%)
Query: 93 SLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKL 152
LP + Q LKSL + L+ P L ++ +S N L ++P E+ L
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFL 155
Query: 153 ESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLK 212
+ + ++ N L+ ++P +L ++ +NQL
Sbjct: 156 KIIDVDNNSLK-KLPDLPPSLE---FIAAGNNQLE------------------------- 186
Query: 213 GELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSE 272
ELP E+ N L + S+ +P+ +
Sbjct: 187 -ELP-ELQNLPFLTAIYADNNSLKK-------------------------LPDLPLS--- 216
Query: 273 LQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLT 332
L+++ N + + L L ++ N L +PD S L + DN LT
Sbjct: 217 LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL---NVRDNYLT 270
Query: 333 GSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNING 392
+P +L L + + LS P L +L +N I
Sbjct: 271 -DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR------------ 310
Query: 393 LTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLS 452
++ + L+ L+ S N L +P L +L+ N L+
Sbjct: 311 -------------SLCDLPPS---LEELNVSNNKLIE-LPALP---PRLERLIASFNHLA 350
Query: 453 GFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQS 512
+P N L++L + N L P +++ L N + +P Q+
Sbjct: 351 -EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRM-----NSHLAEVPEL---PQN 397
Query: 513 LEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLS 570
L+ L + +N L PD +P S++ + ++ R+ + + +L + +
Sbjct: 398 LKQLHVETNPLR-EFPD-IPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-25
Identities = 53/234 (22%), Positives = 93/234 (39%), Gaps = 33/234 (14%)
Query: 454 FIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSV------ 507
FI P + T L+ + + L+ +P E N+K + + PP
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 508 -------VGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELS 560
+ L+L++ GL+ S+P+ P L+ + S N L+ L SL L
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPELPP-HLESLVASCNSLT-ELPELPQSLKSLL 117
Query: 561 KLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSG 620
+ LS P L L + NN+ ++P EL S L+I +++ +N
Sbjct: 118 VDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKI-IDVDNNSLK- 166
Query: 621 EIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTPF 674
++P L + +N+L +L L +L L ++ N +LP+ P
Sbjct: 167 KLPDLPPSLEF---IAAGNNQLE-ELPELQNLPFLTAIYADNNSLK-KLPDLPL 215
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-21
Identities = 55/298 (18%), Positives = 107/298 (35%), Gaps = 41/298 (13%)
Query: 84 SLKAVDLQG-SLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEI 142
L A+ SL + SL+ ++ + L E + LT I N L +
Sbjct: 196 FLTAIYADNNSLKKLPDLPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLL-KTL 252
Query: 143 PTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQV 202
P LE+L + N L ++P +L+ L + +N S + + L L
Sbjct: 253 PDL---PPSLEALNVRDNYLT-DLPELPQSLTF---LDVSENIFS-GLSELPPNLYYLNA 304
Query: 203 FRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGP 262
+ N L +L L ++ + +P+ LER+ IA + L
Sbjct: 305 -----SSNEIRSLC---DLPPSLEELNVSNNKLI-ELPALPPRLERL--IASFNHLAE-- 351
Query: 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELT 322
+PE N L+ L++ N + P ++ L+ NS + +P+ + +L
Sbjct: 352 VPELPQN---LKQLHVEYNPLRE-FPDIPESVEDLR-----MNSHLAEVPELPQNLKQL- 401
Query: 323 VVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAIS 380
N L P + +++L+++ ++ T L +++
Sbjct: 402 --HVETNPLR-EFPDIPES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 5e-54
Identities = 88/392 (22%), Positives = 159/392 (40%), Gaps = 51/392 (13%)
Query: 273 LQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLT 332
L I+ P L++ +L + S+ + +T + + +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 333 GSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNING 392
SI L L+ L L+ NQ++ P+ LT+L I N I+
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKIT------------ 101
Query: 393 LTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLS 452
+L L+ L + +N+S P + L + L L +N
Sbjct: 102 --------------DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL 145
Query: 453 GFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQS 512
+ P + N T L L + ++++ P + NL L + ++ N + P + S
Sbjct: 146 SDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTS 200
Query: 513 LEFLDLHSNGLTGSVP-DTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSG 571
L + + N +T P + T L + + +N+++ + +L++L+ L + NQ+S
Sbjct: 201 LHYFTAYVNQITDITPVANM-TRLNSLKIGNNKITDL--SPLANLSQLTWLEIGTNQISD 257
Query: 572 RIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTK 631
I A + KL +L++G+N+ S L +S L SL L++NQ E GLT
Sbjct: 258 -INA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLN-SLFLNNNQLGNEDMEVIGGLTN 312
Query: 632 LGILDLSHNKLSGDLDALASLQNLVSLNVSFN 663
L L LS N ++ D+ LASL + S + +
Sbjct: 313 LTTLFLSQNHIT-DIRPLASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 7e-49
Identities = 63/354 (17%), Positives = 136/354 (38%), Gaps = 27/354 (7%)
Query: 219 IGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYL 278
+ + + L + S++ + LE I + + ++ + I + L+ L L
Sbjct: 18 DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVASI--QGIEYLTNLEYLNL 73
Query: 279 YQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRS 338
N I+ P + L KL +L + N + L + T L + +++ ++ P
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP-- 127
Query: 339 FGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFA 398
NL K+ L L N + ++ T L +L + + + P I N+ L
Sbjct: 128 LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSL 184
Query: 399 WKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPD 458
N++ L+ L N ++ P + + L L + +N ++ P
Sbjct: 185 NYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-- 238
Query: 459 IGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDL 518
+ N + L L + N++S + + +L L +++ N + + L L L
Sbjct: 239 LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFL 294
Query: 519 HSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLS 570
++N L + + T+L + LS N ++ + SL+++ + +
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI--RPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-46
Identities = 72/349 (20%), Positives = 138/349 (39%), Gaps = 30/349 (8%)
Query: 345 LQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLT 404
L ++ P + +++ + + +T K+
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 405 GNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTT 464
+ + L+ L+ + N ++ P + L LT L + +N ++ + N T
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 465 LRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLT 524
LR L LN++ +S S + NL + +++ NH + + L +L + + +
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVK 168
Query: 525 GSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLI 584
P T L + L+ N++ + SLT L NQ++ P + + +L
Sbjct: 169 DVTPIANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITDITP--VANMTRLN 224
Query: 585 LLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSG 644
L IGNN+ + P L +S L L + +NQ S + LTKL +L++ N++S
Sbjct: 225 SLKIGNNKITDLSP--LANLSQLT-WLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS- 278
Query: 645 DLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRGLYISG 693
D+ L +L L SL ++ N E + L + L++S
Sbjct: 279 DISVLNNLSQLNSLFLNNNQLGNEDME-------VIGGLTNLTTLFLSQ 320
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 9e-46
Identities = 84/373 (22%), Positives = 147/373 (39%), Gaps = 28/373 (7%)
Query: 104 LKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLE 163
L + P D E L S+ + E L + L + +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA 57
Query: 164 GEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCS 223
I L++L YL L NQ++ P + L KL G N+ + ++ + N +
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNK-IT-DIS-ALQNLT 110
Query: 224 NLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSI 283
NL L L E +IS S + L ++ ++ + + + N + L L + ++ +
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKV 167
Query: 284 SGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLL 343
P I L+ L SL L N + P L S T L N +T P N+
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMT 221
Query: 344 KLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKL 403
+L L++ N+++ P+ + LT LEI N IS I A + ++ L + N++
Sbjct: 222 RLNSLKIGNNKITDLSPLA--NLSQLTWLEIGTNQISD-INA-VKDLTKLKMLNVGSNQI 277
Query: 404 TGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCT 463
+ L+ +L +L + N L + I GL NLT L L N ++ P + + +
Sbjct: 278 SD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLS 333
Query: 464 TLRRLRLNDNRLS 476
+ + +
Sbjct: 334 KMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 64/300 (21%), Positives = 124/300 (41%), Gaps = 23/300 (7%)
Query: 84 SLKAVDLQG---SLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWG 140
+L+ ++L G + S L L L I + +T + L + L+ +++
Sbjct: 67 NLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD 124
Query: 141 EIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKL 200
P + L K+ SL L N S + N++ L YLT+ ++++ P I L+ L
Sbjct: 125 ISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDL 179
Query: 201 QVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLS 260
NQ ++ P + + ++L I+ + + + R+ ++ I + ++
Sbjct: 180 YSLSLNYNQ-IEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKIT 234
Query: 261 GPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTE 320
P + N S+L L + N IS + L+KLK L + N + L + ++
Sbjct: 235 DLSP--LANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD--ISVLNNLSQ 288
Query: 321 LTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAIS 380
L + ++N L G L L L LS N ++ P +A+ + + + N I
Sbjct: 289 LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-50
Identities = 110/589 (18%), Positives = 207/589 (35%), Gaps = 81/589 (13%)
Query: 84 SLKAVDLQG-SLPSIFQPL-KSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGE 141
+ D + S SI L ++K L +S +T + L + L + +
Sbjct: 6 ASGVCDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NT 64
Query: 142 IPTEVCR-LRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSG-KIPKSIGALSK 199
I + L LE L L+ N L S G LSSL YL L N + L+
Sbjct: 65 IEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTN 124
Query: 200 LQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLL 259
LQ R G + + ++L L I ++
Sbjct: 125 LQTLRIGNVETFSEIRRIDFAGLTSLNEL-----EIKAL---------SLRNYQ------ 164
Query: 260 SGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCT 319
+ + + ++ +L L+ + + + LS ++ L L +L L
Sbjct: 165 ----SQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDE 220
Query: 320 ELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAI 379
+ + + SF LLKL L ++++ + T L +
Sbjct: 221 VSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE----FDDCTLNGLGDFNPSES-- 274
Query: 380 SGEIPADIGNINGLTLFFAW--KNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF- 436
++ +++G + +T+ + L ++ S ++++ + + + +P
Sbjct: 275 --DVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL-VPCSFSQ 331
Query: 437 GLRNLTKLLLLSNDLSGFIPPD---IGNCTTLRRLRLNDNRLSGTIPSEMG---NLKHLN 490
L++L L L N + + G +L+ L L+ N L ++ LK+L
Sbjct: 332 HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLT 390
Query: 491 FVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLA 550
+D+S N +P S + + FL+L S G+ V +P +L+++D+S+N L
Sbjct: 391 SLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLDSFSL 448
Query: 551 HSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEIS 610
L L +L +S+N+L +P L L +
Sbjct: 449 F----LPRLQELYISRNKLK-TLPDASLF-------------------------PVLLV- 477
Query: 611 LNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLN 659
+ +S NQ F LT L + L N + L ++ N
Sbjct: 478 MKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKN 526
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-42
Identities = 82/448 (18%), Positives = 157/448 (35%), Gaps = 37/448 (8%)
Query: 269 NCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSD 328
+C S + IP + + +KSL L N + +L +C L V+
Sbjct: 3 SCDASGVCDGRSRSFTS-IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 329 NLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISG-EIPADI 387
+ + +F +L L+ L LS N LS ++L +L + N + +
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119
Query: 388 GNINGL-TLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLL 446
N+ L TL + + L L+ +L + + +R++ L L
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 447 LSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMG-----------NLKHLNFVDMS 495
++ + + +++R L L D L+ S + + D S
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239
Query: 496 ENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPT----------SLQLVDLSDNRL 545
N L+ + ++ +EF D NGL P +++ + + L
Sbjct: 240 FNELLK-LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL 298
Query: 546 SGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILS-CRKLILLDIGNNRFSGEIPKE---L 601
L+ L ++ ++ + +++ +P + L LD+ N E K
Sbjct: 299 FYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357
Query: 602 GQISSLEISLNLSSNQFS--GEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLN 659
G SL+ L LS N + L L LD+S N D+ + + LN
Sbjct: 358 GAWPSLQT-LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLN 416
Query: 660 VSFNDFSGELPNTPFFRKLPLSDLASNR 687
+S + + L + D+++N
Sbjct: 417 LSSTGIR-VVKTC-IPQTLEVLDVSNNN 442
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-24
Identities = 68/446 (15%), Positives = 132/446 (29%), Gaps = 96/446 (21%)
Query: 82 EISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGE 141
E+ +KA+ L+ + ++ + L + +
Sbjct: 152 ELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFAD------------------ 193
Query: 142 IPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQ 201
L + L L L S + + + + S +S L K
Sbjct: 194 ------ILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK-- 245
Query: 202 VFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSG 261
L I S + + PS ++ + +
Sbjct: 246 -------------LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV--------- 283
Query: 262 PIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTEL 321
++ L++ Q + + L K+K + + + + L
Sbjct: 284 -------ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSL 336
Query: 322 TVVDFSDNLLTGSI---PRSFGNLLKLQELQLSVNQLS--GTIPIEIATCTALTHLEIDN 376
+D S+NL+ G LQ L LS N L + T LT L+I
Sbjct: 337 EFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISR 396
Query: 377 NAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF 436
N +P+S ++++ L+ S + + I
Sbjct: 397 NTFH-------------------------PMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP 430
Query: 437 GLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSE 496
+ L L + +N+L + L+ L ++ N+L T+P L + +S
Sbjct: 431 --QTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLK-TLPDA-SLFPVLLVMKISR 482
Query: 497 NHLVGGIPPSVV-GCQSLEFLDLHSN 521
N L +P + SL+ + LH+N
Sbjct: 483 NQL-KSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-21
Identities = 41/201 (20%), Positives = 78/201 (38%), Gaps = 10/201 (4%)
Query: 508 VGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKN 567
+ C + D S T S+P L +++ +DLS N+++ + + L L+L +
Sbjct: 2 LSCDASGVCDGRSRSFT-SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 568 QLSGRIPAEILSC-RKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSG-EIPSE 625
+++ I + L LD+ +N S G +SSL+ LNL N + + S
Sbjct: 61 RIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLK-YLNLMGNPYQTLGVTSL 118
Query: 626 FSGLTKLGILDLSHNKLSGDL--DALASLQNLVSLNVSFNDFSGELPNTPF--FRKLPLS 681
F LT L L + + + ++ A L +L L + + R +
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHL 177
Query: 682 DLASNRGLYISGGVVSPTDSL 702
L + ++ S+
Sbjct: 178 TLHLSESAFLLEIFADILSSV 198
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-49
Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 768 LTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
+ V+G G+ GVV + + +A+K++ S E AF E++ L + H NIV+L G
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGA-DWEARYEVVLGVAHALAYLHHDCMPPI 886
+ L+ +Y GSL ++LHGA L + +AYLH +
Sbjct: 69 A-CLNPVCLVM-EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 887 LHGDVKAMNVLLGPGYQAY-LADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945
+H D+K N+LL G + DFG A + TN GS +MAPE
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------MTNN----KGSAAWMAPEVFE 176
Query: 946 MQRITEKSDVYSFGVVLLEVLTGRHP 971
+EK DV+S+G++L EV+T R P
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKP 202
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 7e-49
Identities = 73/219 (33%), Positives = 106/219 (48%), Gaps = 16/219 (7%)
Query: 758 DFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESG----AFSSEIQT 813
D I +L IG GS G V+R +G +AVK + D F E+
Sbjct: 31 DMDIP--WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 814 LGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGA-DWEARYEVVLGVA 872
+ +RH NIV +G + + +YL GSL LLH +G D R + VA
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 873 HALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQL 932
+ YLH+ PPI+H ++K+ N+L+ Y + DFGL+R+ + S +
Sbjct: 148 KGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA---STFLSSKSA---- 199
Query: 933 AGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
AG+ +MAPE + EKSDVYSFGV+L E+ T + P
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 5e-47
Identities = 58/251 (23%), Positives = 106/251 (42%), Gaps = 43/251 (17%)
Query: 738 MANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVK 796
M + F L + + IG G G+V++ + + +A+K
Sbjct: 3 MGGSEFPKSRLPT------LADN------EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIK 50
Query: 797 KMWSSDESG---------AFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSL 847
+ D G F E+ + ++ H NIV+L G + +++ +++P G L
Sbjct: 51 SLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG-LMHNPPRMVM-EFVPCGDL 108
Query: 848 SSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAY-- 905
L W + ++L +A + Y+ + PPI+H D+++ N+ L +
Sbjct: 109 YHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPV 166
Query: 906 ---LADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE--HASMQRITEKSDVYSFGV 960
+ADFGL++ + G++ +MAPE A + TEK+D YSF +
Sbjct: 167 CAKVADFGLSQQ-----SVHSVSGL-----LGNFQWMAPETIGAEEESYTEKADTYSFAM 216
Query: 961 VLLEVLTGRHP 971
+L +LTG P
Sbjct: 217 ILYTILTGEGP 227
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 4e-46
Identities = 69/451 (15%), Positives = 140/451 (31%), Gaps = 45/451 (9%)
Query: 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELT 322
I E N + + + +S+ + + +K L L N L +L T+L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 323 VVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGE 382
+++ S N+L +L L+ L L+ N + E+ ++ L NN IS
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 383 IPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSG-PIPKEIFGLRNL 441
+ G G + NK+T +Q LD N + + L
Sbjct: 114 VSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 442 TKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVG 501
L L N + + + L+ L L+ N+L+ + E + + ++ + N LV
Sbjct: 172 EHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL 228
Query: 502 GIPPSVVGCQSLEFLDLHSNGL-TGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELS 560
I ++ Q+LE DL NG G++ D + ++ ++ + + T +
Sbjct: 229 -IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 561 KLLLSKNQLS----------------------------GRIPAEILSCRKLILLDIGNNR 592
R+ E + + +D +
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 593 FSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASL 652
+ + ++ +I+L ++ + +L A
Sbjct: 348 YR-TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQ 406
Query: 653 QNLVSLNVSFNDFSGELPNTPFFRKLPLSDL 683
L L + + + D
Sbjct: 407 SPLQLLRAIVKRYEEMYVEQQSVQNNAIRDW 437
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-42
Identities = 83/525 (15%), Positives = 159/525 (30%), Gaps = 45/525 (8%)
Query: 93 SLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKL 152
++ I Q K ++ +L + + +DLSGN L ++ KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 153 ESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLK 212
E L L++N+L D+ +LS+L L L +N + + ++ A N +
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN-IS 112
Query: 213 GELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSE 272
+ G + L + N +I + + G S
Sbjct: 113 -RVSCSRG--QGKKNIYL-----ANN---------KITML----------RDLDEGCRSR 145
Query: 273 LQNLYLYQNSISG-PIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLL 331
+Q L L N I + L+ L L N + + ++ +L +D S N L
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL 203
Query: 332 TGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADI--GN 389
+ F + + + L N+L I + L H ++ N D N
Sbjct: 204 A-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261
Query: 390 INGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLT-KLLLLS 448
T+ KLTG E + + +L P + L+ LL
Sbjct: 262 QRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQ 321
Query: 449 NDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVV 508
+ + + N R + + I + ++ + L +
Sbjct: 322 GSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRR 381
Query: 509 GCQSLEFLDLHSNGLTG-SVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKN 567
L+ + G + LQL+ R +
Sbjct: 382 AHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQ 441
Query: 568 QLSGRIPAEILSCRKLI-LLDIGNNRFSGEIPKELGQISSLEISL 611
++ E +KL D+ + + + + + +L L
Sbjct: 442 HKETQLAEENARLKKLNGEADLALASANATLQELVVREQNLASQL 486
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 7e-42
Identities = 59/400 (14%), Positives = 132/400 (33%), Gaps = 45/400 (11%)
Query: 310 AIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTAL 369
AI + + + +D+ L ++ + ++EL LS N LS ++A T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 370 THLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSG 429
L + +N + + ++ L+ L+ LD + N +
Sbjct: 61 ELLNLSSNVLY-----ETLDLESLS---------------------TLRTLDLNNNYVQ- 93
Query: 430 PIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHL 489
E+ ++ L +N++S + G + + L +N+++ + G +
Sbjct: 94 ----ELLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRV 146
Query: 490 NFVDMSENHLVGGIPPSVVG-CQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGS 548
++D+ N + + +LE L+L N + + L+ +DLS N+L+
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-F 205
Query: 549 LAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLE 608
+ S ++ + L N+L I + + L D+ N F ++ S +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQ 262
Query: 609 ISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLS----GDLDALASL--QNLVSLNVSF 662
++ T + D L +L + L+
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQG 322
Query: 663 NDFSGELPNTPFFRKLPLSDLASNRGLYISGGVVSPTDSL 702
++ + D + + V +
Sbjct: 323 SETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAK 362
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 46/451 (10%), Positives = 109/451 (24%), Gaps = 96/451 (21%)
Query: 84 SLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIP 143
+L+ +DL + S++ L ++ N++ + G + I L+ N +
Sbjct: 81 TLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRD 137
Query: 144 TEVCRLRKLESLYLNTNLLEG-EIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQV 202
+ +++ L L N ++ + +L +L L N + + +
Sbjct: 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-------- 188
Query: 203 FRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGP 262
+ L L L+ ++
Sbjct: 189 ------------------VFAKLKTLDLSSNKLAF------------------------- 205
Query: 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELT 322
+ E + + + + L N + I L L
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-------------------------LIEKALRFSQNLE 240
Query: 323 VVDFSDN-LLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISG 381
D N G++ F ++Q + + CT T
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTVPTLGHYGAYCCED 298
Query: 382 EIPADIGNINGLTLFFAWKNKLTGN----IPESLSQCQELQALDFSYNNLSGPIPKEIF- 436
+ L G+ + + +D + ++
Sbjct: 299 LPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRT-VIDQVTL 357
Query: 437 GLRNLTKLLLLSNDLSGFIP---PDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVD 493
+ L L + + + L E L+ L +
Sbjct: 358 RKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQH-ATEEQSPLQLLRAIV 416
Query: 494 MSENHLVGGIPPSVVGCQSLEFLDLHSNGLT 524
+ + V ++ D++ + T
Sbjct: 417 KRYEEMY--VEQQSVQNNAIRDWDMYQHKET 445
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 768 LTSANVIGTGSSGVVYRVTIPNGETLAVKKM-WSSDESGA-----FSSEIQTLGSIRHKN 821
LT +IG G G VYR G+ +AVK DE + E + ++H N
Sbjct: 9 LTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 822 IVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHD 881
I+ L G + L ++ G L+ +L G + + +A + YLH +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI---PPDILVNWAVQIARGMNYLHDE 124
Query: 882 CMPPILHGDVKAMNVLLGPGYQAY--------LADFGLARIVSGSGDDNCSKTNQRPQLA 933
+ PI+H D+K+ N+L+ + + DFGLAR +K + A
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-----HRTTKMSA----A 175
Query: 934 GSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
G+Y +MAPE ++ SDV+S+GV+L E+LTG P
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-45
Identities = 66/239 (27%), Positives = 97/239 (40%), Gaps = 23/239 (9%)
Query: 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFS-SEIQTLGSIRHKNIVR 824
R++T +G G G V+R + GE +AVK S DE F +E+ +RH+NI+
Sbjct: 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILG 66
Query: 825 LLGWGSNKNLKLLFY----DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHH 880
+ Y GSL L D + +VL +A LA+LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 881 D-----CMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGS 935
+ P I H D+K+ N+L+ Q +AD GLA + S S + N R G+
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR---VGT 180
Query: 936 YGYMAPE------HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPL 988
YMAPE ++ D+++FG+VL EV P P
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-45
Identities = 43/210 (20%), Positives = 80/210 (38%), Gaps = 25/210 (11%)
Query: 772 NVIGTGSSGVVYRVTIPNGETLAVKKM----WSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
+ SG +++ G + VK + WS+ +S F+ E L H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 828 WGSNKNLKLLFY---DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMP 884
++P GSL ++LH D + L +A +A+LH P
Sbjct: 75 A-CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEP 132
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE-- 942
I + + +V++ A ++ + G + ++APE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR------------MYAPAWVAPEAL 180
Query: 943 -HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+D++SF V+L E++T P
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 4e-45
Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 28/238 (11%)
Query: 758 DFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSE--IQTLG 815
+ S+D + NL +IG G G VY+ ++ + +AVK ++ F +E I +
Sbjct: 7 EPSLD--LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-FINEKNIYRVP 62
Query: 816 SIRHKNIVRLLG-----WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG 870
+ H NI R + + LL +Y PNGSL L +DW + +
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCRLAHS 119
Query: 871 VAHALAYLHHD------CMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924
V LAYLH + P I H D+ + NVL+ ++DFGL+ ++G+
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 925 KTNQRP-QLAGSYGYMAPE-------HASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974
+ + G+ YMAPE + ++ D+Y+ G++ E+ L P
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 9e-45
Identities = 53/364 (14%), Positives = 95/364 (26%), Gaps = 54/364 (14%)
Query: 92 GSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRK 151
GS + L ++ D +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 152 LESLYLNTNLLEGEIPSDIGNLSS--LAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQ 209
+ L+ + + + L L L + P LS LQ
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 210 NLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGN 269
L ELP + + L L LA + +P I +
Sbjct: 116 -LM-ELPDTMQQFAGLETLTLARNPLRA-------------------------LPASIAS 148
Query: 270 CSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDN 329
+ L+ L + +P + + E L +
Sbjct: 149 LNRLRELSIRACPELTELPEPLASTD---------------ASGEHQGLVNLQSLRLEWT 193
Query: 330 LLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGN 389
+ S+P S NL L+ L++ + LS + I L L++ P G
Sbjct: 194 GIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGG 251
Query: 390 INGLT-LFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLS 448
L L + L +P + + +L+ LD +P I L +L+
Sbjct: 252 RAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP 310
Query: 449 NDLS 452
+ +
Sbjct: 311 HLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-44
Identities = 50/334 (14%), Positives = 99/334 (29%), Gaps = 32/334 (9%)
Query: 170 IGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLG 229
+ S L + + + W N +N +
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW-----HSAWRQANSNNPQIET 62
Query: 230 LAETSISGNVPSSIGMLERIQTIAIYTSLLSG----PIPEEIGNCSELQNLYLYQNSISG 285
++ + + +A+ L P++ S LQ++ + +
Sbjct: 63 RTGRALK-ATADLLEDATQPGRVALE---LRSVPLPQFPDQAFRLSHLQHMTIDAAGLME 118
Query: 286 PIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKL 345
+P + + L++L L +N L A+P + S L + +P +
Sbjct: 119 -LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST--- 173
Query: 346 QELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTG 405
E L L ++ I +PA I N+ L + L+
Sbjct: 174 ------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA 220
Query: 406 NIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTL 465
+ ++ +L+ LD P G L +L+L +P DI T L
Sbjct: 221 -LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQL 279
Query: 466 RRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHL 499
+L L +PS + L + + +
Sbjct: 280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-44
Identities = 57/335 (17%), Positives = 108/335 (32%), Gaps = 24/335 (7%)
Query: 213 GELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGP-IPEEIGNCS 271
G + S L ++ + +R Y + + N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRH-----YNADRNRWHSAWRQANSN 56
Query: 272 ELQNLYLYQNSISGPIPGRIGALS--KLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDN 329
Q ++ + + +L L L PD+ + L +
Sbjct: 57 NPQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114
Query: 330 LLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGN 389
L +P + L+ L L+ N L +P IA+ L L I E+P + +
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172
Query: 390 ING---------LTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRN 440
+ L + ++P S++ Q L++L + LS + I L
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPK 230
Query: 441 LTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLV 500
L +L L PP G L+RL L D T+P ++ L L +D+ +
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290
Query: 501 GGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSL 535
+P + + + + + L + P +
Sbjct: 291 SRLPSLIAQLPANCIILVPPH-LQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-43
Identities = 58/284 (20%), Positives = 109/284 (38%), Gaps = 17/284 (5%)
Query: 84 SLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRE--LTFIDLSGNSLWGE 141
D + Q + ++ + D + ++L L +
Sbjct: 37 RHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPL-PQ 95
Query: 142 IPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQ 201
P + RL L+ + ++ L E+P + + L LTL N L +P SI +L++L+
Sbjct: 96 FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLR 153
Query: 202 VFRAGGNQNLKGELPWEIGNCS---------NLVMLGLAETSISGNVPSSIGMLERIQTI 252
L ELP + + NL L L T I ++P+SI L+ ++++
Sbjct: 154 ELSIRACPELT-ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSL 211
Query: 253 AIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIP 312
I S LS + I + +L+ L L + P G + LK L+L S + +P
Sbjct: 212 KIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLP 270
Query: 313 DELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLS 356
++ T+L +D + +P L + + + +
Sbjct: 271 LDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-43
Identities = 53/330 (16%), Positives = 112/330 (33%), Gaps = 24/330 (7%)
Query: 333 GSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNING 392
GS + + L + ++ + + + N N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNN 57
Query: 393 LTLFFAWKNKLTGNIPESLSQCQE--LQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSND 450
+ L + L + AL+ L P + F L +L + + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAG 115
Query: 451 LSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSV--- 507
L +P + L L L N L +P+ + +L L + + + +P +
Sbjct: 116 LME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 508 ------VGCQSLEFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHSIGSLTEL 559
G +L+ L L G+ S+P ++ +L+ + + ++ LS +L +I L +L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL 231
Query: 560 SKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFS 619
+L L P L L + + +P ++ +++ LE L+L
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEK-LDLRGCVNL 290
Query: 620 GEIPSEFSGLTKLGILDLSHNKLSGDLDAL 649
+PS + L I+ + + +
Sbjct: 291 SRLPSLIAQLPANCIILVPPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-37
Identities = 59/315 (18%), Positives = 100/315 (31%), Gaps = 37/315 (11%)
Query: 394 TLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSG 453
L+F L + LSQ Q D + + N + +
Sbjct: 16 NLYFQGSTALR-PYHDVLSQWQRHYNADRN-------RWHSAWRQANSNNPQIETRTGRA 67
Query: 454 F--IPPDIGNCT--TLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVG 509
+ + T L L L P + L HL + + L+ +P ++
Sbjct: 68 LKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQ 125
Query: 510 CQSLEFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHSIGS---------LTE 558
LE L L N L ++P ++ L+ + + L + S L
Sbjct: 126 FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVN 184
Query: 559 LSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQF 618
L L L + +PA I + + L L I N+ S + + + LE L+L
Sbjct: 185 LQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEE-LDLRGCTA 241
Query: 619 SGEIPSEFSGLTKLGILDLSHNKLSGDL-DALASLQNLVSLNVSFNDFSGELPNTPFFRK 677
P F G L L L L + L L L++ LP+
Sbjct: 242 LRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL----- 296
Query: 678 LPLSDLASNRGLYIS 692
++ L +N + +
Sbjct: 297 --IAQLPANCIILVP 309
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 5e-43
Identities = 65/241 (26%), Positives = 98/241 (40%), Gaps = 25/241 (10%)
Query: 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFS-SEIQTLGSIRHKNIVR 824
R + IG G G V+R GE +AVK S +E F +EI +RH+NI+
Sbjct: 42 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 100
Query: 825 LLG-----WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH 879
+ G+ L L DY +GSL L+ + E ++ L A LA+LH
Sbjct: 101 FIAADNKDNGTWTQL-WLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLH 156
Query: 880 HDCM-----PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAG 934
+ + P I H D+K+ N+L+ +AD GLA + D N R G
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR---VG 213
Query: 935 SYGYMAPE------HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPL 988
+ YMAPE + +++D+Y+ G+V E+ P P
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273
Query: 989 M 989
Sbjct: 274 D 274
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 6e-43
Identities = 62/240 (25%), Positives = 96/240 (40%), Gaps = 25/240 (10%)
Query: 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFS-SEIQTLGSIRHKNIVR 824
+ + IG G G V+ GE +AVK ++++E+ F +EI +RH+NI+
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILG 95
Query: 825 LLG-----WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH 879
+ GS L L DY NGSL L D ++ ++ L +LH
Sbjct: 96 FIAADIKGTGSWTQL-YLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLH 151
Query: 880 -----HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAG 934
P I H D+K+ N+L+ +AD GLA ++ N R G
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR---VG 208
Query: 935 SYGYMAPE------HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPL 988
+ YM PE + + + +D+YSFG++L EV P P
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 9e-43
Identities = 69/237 (29%), Positives = 109/237 (45%), Gaps = 31/237 (13%)
Query: 742 SFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSS 801
S A D WE + +T IG+GS G VY+ +G+ AVK + +
Sbjct: 12 SRDAADDWE------IPDG------QITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVT 57
Query: 802 DESG----AFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKG 857
+ AF +E+ L RH NI+ +G+ + L ++ + SL LH +
Sbjct: 58 APTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVT-QWCEGSSLYHHLHA-SET 115
Query: 858 GADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917
+ + ++ A + YLH I+H D+K+ N+ L + DFGLA S
Sbjct: 116 KFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS- 171
Query: 918 SGDDNCSKTNQRPQLAGSYGYMAPE---HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
S ++Q QL+GS +MAPE + +SDVY+FG+VL E++TG+ P
Sbjct: 172 ----RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-42
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 16/221 (7%)
Query: 768 LTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESG--AFSSEIQTLGSIRHKNIVR 824
L V+G G G +VT GE + +K++ DE F E++ + + H N+++
Sbjct: 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 825 LLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCM 883
+G +K L + +Y+ G+L ++ W R +A +AYLH
Sbjct: 72 FIGVLYKDKRLNFIT-EYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHS--- 126
Query: 884 PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKT-------NQRPQLAGSY 936
I+H D+ + N L+ +ADFGLAR++ +R + G+
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 937 GYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977
+MAPE + + EK DV+SFG+VL E++ + LP
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 8e-42
Identities = 81/385 (21%), Positives = 148/385 (38%), Gaps = 43/385 (11%)
Query: 270 CSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDN 329
+ L + ++ ++ +P + + + +L++ N+L ++P L + S N
Sbjct: 39 NNGNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91
Query: 330 LLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGN 389
LT S+P LL+L + L + L L I N ++ +P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQLT-SLPVLPPG 142
Query: 390 INGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSN 449
+ L++ N+L ++P S+ L L N L+ +P L +L + N
Sbjct: 143 LQELSVSD---NQLA-SLPALPSE---LCKLWAYNNQLTS-LPMLP---SGLQELSVSDN 191
Query: 450 DLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVG 509
L+ +P L +L +NRL+ ++P+ LK L +S N L +P
Sbjct: 192 QLA-SLPTLPSE---LYKLWAYNNRLT-SLPALPSGLKEL---IVSGNRL-TSLPVL--- 239
Query: 510 CQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQL 569
L+ L + N LT S+P LP+ L + + N+L+ L S+ L+ + + L N L
Sbjct: 240 PSELKELMVSGNRLT-SLPM-LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296
Query: 570 SGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGL 629
S R + RF + +L ++ P+
Sbjct: 297 SERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRW 356
Query: 630 TKLGILDLSHNKLSGDLDALASLQN 654
G D + + S LD L+ +N
Sbjct: 357 HMFGQEDNA-DAFSLFLDRLSETEN 380
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-39
Identities = 76/338 (22%), Positives = 135/338 (39%), Gaps = 46/338 (13%)
Query: 318 CTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNN 377
V++ ++ LT ++P + L + N L+ ++P L LE+ N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALP---PELRTLEVSGN 91
Query: 378 AISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFG 437
++ +P + L++F L +P L L N L+ +P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGL------CKLWIFGNQLTS-LPVLP-- 140
Query: 438 LRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSEN 497
L +L + N L+ +P L +L +N+L+ ++P L+ L+ +S+N
Sbjct: 141 -PGLQELSVSDNQLAS-LPALPSE---LCKLWAYNNQLT-SLPMLPSGLQELS---VSDN 191
Query: 498 HLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLT 557
L +P L L ++N LT S+P LP+ L+ + +S NRL+ SL L
Sbjct: 192 QLAS-LPTLP---SELYKLWAYNNRLT-SLPA-LPSGLKELIVSGNRLT-SLPVLPSELK 244
Query: 558 ELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQ 617
EL +S N+L+ +P L+ L + N+ + +P+ L +SS ++NL N
Sbjct: 245 ELM---VSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSET-TVNLEGNP 295
Query: 618 FSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNL 655
S +T + A AS
Sbjct: 296 LSERTLQALREITS---APGYSGPIIRFDMAGASAPRE 330
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-38
Identities = 74/326 (22%), Positives = 136/326 (41%), Gaps = 44/326 (13%)
Query: 361 IEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQAL 420
+ L + + ++ +P + +T N LT ++P + L+ L
Sbjct: 34 MRACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPE---LRTL 86
Query: 421 DFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIP 480
+ S N L+ +P GL L+ L + L +L + N+L+ ++P
Sbjct: 87 EVSGNQLTS-LPVLPPGLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQLT-SLP 137
Query: 481 SEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDL 540
L+ L +S+N L +P L L ++N LT S+P LP+ LQ + +
Sbjct: 138 VLPPGLQEL---SVSDNQL-ASLPALP---SELCKLWAYNNQLT-SLPM-LPSGLQELSV 188
Query: 541 SDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKE 600
SDN+L+ SL L +L N+L+ +PA ++LI+ NR + +P
Sbjct: 189 SDNQLA-SLPTLPSELYKLW---AYNNRLT-SLPALPSGLKELIVS---GNRLT-SLPVL 239
Query: 601 LGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNV 660
++ L +S N+ + +P SGL L + N+L+ ++L L + ++N+
Sbjct: 240 PSELKEL----MVSGNRLT-SLPMLPSGLLSL---SVYRNQLTRLPESLIHLSSETTVNL 291
Query: 661 SFNDFSGELPNTPFFRKLPLSDLASN 686
N S E R++ + S
Sbjct: 292 EGNPLS-ERTL-QALREITSAPGYSG 315
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-36
Identities = 79/426 (18%), Positives = 138/426 (32%), Gaps = 84/426 (19%)
Query: 145 EVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFR 204
C L + + L +P + + L + DN L+ +P L L+V
Sbjct: 35 RACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTLEV-- 88
Query: 205 AGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIP 264
GNQ L LP L + T + P
Sbjct: 89 -SGNQ-LT-SLPVLPPGLLELSIFSNPLTHL----------------------------P 117
Query: 265 EEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVV 324
L L+++ N ++ +P L + L + N L ++P +L
Sbjct: 118 ALPSG---LCKLWIFGNQLTS-LPVLPPGL---QELSVSDNQL-ASLPALPSELCKLWA- 168
Query: 325 DFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIP 384
+N LT S+P L QEL +S NQL+ ++P + L L NN ++ +P
Sbjct: 169 --YNNQLT-SLPMLPSGL---QELSVSDNQLA-SLPTLPSE---LYKLWAYNNRLT-SLP 217
Query: 385 ADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKL 444
A + L + N+LT ++P S+ L+ L S N L+ +P L L
Sbjct: 218 ALPSGLKELIVSG---NRLT-SLPVLPSE---LKELMVSGNRLTS-LPMLP---SGLLSL 266
Query: 445 LLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIP 504
+ N L+ +P + + ++ + L N LS + +
Sbjct: 267 SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPII------- 318
Query: 505 PSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLL 564
+ + T ++ L + + H G L
Sbjct: 319 -------RFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRW-HMFGQEDNADAFSL 370
Query: 565 SKNQLS 570
++LS
Sbjct: 371 FLDRLS 376
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-31
Identities = 74/375 (19%), Positives = 130/375 (34%), Gaps = 51/375 (13%)
Query: 84 SLKAVDLQG----SLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLW 139
+++ +LP + L+I NLT ++P EL +++SGN L
Sbjct: 41 GNAVLNVGESGLTTLPDCL--PAHITTLVIPDNNLT-SLPALPP---ELRTLEVSGNQL- 93
Query: 140 GEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSK 199
+P L +L L S L L ++ NQL+ +P L +
Sbjct: 94 TSLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPVLPPGLQE 145
Query: 200 LQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLL 259
L V + N LP L TS+ P L+ + L
Sbjct: 146 LSV-----SDNQLASLPALPSELCKLWAYNNQLTSL----PMLPSGLQEL--SVSDNQLA 194
Query: 260 SGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCT 319
S +P L L+ Y N ++ +P LK L++ N L ++P
Sbjct: 195 S--LPTLPSE---LYKLWAYNNRLT-SLPALPS---GLKELIVSGNRL-TSLPVLPSE-- 242
Query: 320 ELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAI 379
L + S N LT S+P L L + NQL+ +P + ++ T + ++ N +
Sbjct: 243 -LKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296
Query: 380 SGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLR 439
S E + +T + + S +E +AL + + P +
Sbjct: 297 S-ERTLQ--ALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPA 353
Query: 440 NLTKLLLLSNDLSGF 454
+ + ++ F
Sbjct: 354 DRWHMFGQEDNADAF 368
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-31
Identities = 70/308 (22%), Positives = 124/308 (40%), Gaps = 61/308 (19%)
Query: 405 GNIPESLSQCQE--LQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNC 462
+ + + C L+ + L+ +P + ++T L++ N+L+ +P
Sbjct: 28 AAVVQKMRACLNNGNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLT-SLPALPPE- 82
Query: 463 TTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNG 522
LR L ++ N+L+ ++P L L+ HL L L + N
Sbjct: 83 --LRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQ 132
Query: 523 LTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRK 582
LT S+P LP LQ + +SDN+L+ SL L KL NQL+ +P
Sbjct: 133 LT-SLPV-LPPGLQELSVSDNQLA-SLPALPSELC---KLWAYNNQLT-SLPMLP---SG 182
Query: 583 LILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKL 642
L L + +N+ + +P ++ L +N+ + +P+ SGL +L +S N+L
Sbjct: 183 LQELSVSDNQLA-SLPTLPSELYKLW----AYNNRLT-SLPALPSGLKEL---IVSGNRL 233
Query: 643 S------GDLDAL-----------ASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLAS 685
+ +L L L+SL+V N + LP + L L+S
Sbjct: 234 TSLPVLPSELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPES-------LIHLSS 285
Query: 686 NRGLYISG 693
+ + G
Sbjct: 286 ETTVNLEG 293
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 3e-17
Identities = 53/300 (17%), Positives = 94/300 (31%), Gaps = 51/300 (17%)
Query: 84 SLKAVDLQG-SLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEI 142
L LP++ L +L I LT ++P L + +S N L +
Sbjct: 105 ELSIFSNPLTHLPAL---PSGLCKLWIFGNQLT-SLPVLPP---GLQELSVSDNQL-ASL 156
Query: 143 PTEVCRLRKL-----------------ESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQ 185
P L KL + L ++ N L +P+ L L Y+N+
Sbjct: 157 PALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLA-SLPTLPSELYKL---WAYNNR 212
Query: 186 LSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGM 245
L+ +P L +L V + N LP L L ++ ++ ++P
Sbjct: 213 LT-SLPALPSGLKELIV-----SGNRLTSLPVLPSE---LKELMVSGNRLT-SLPMLPSG 262
Query: 246 LERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQN 305
L + +Y + L+ +PE + + S + L N +S + ++
Sbjct: 263 LLSLS---VYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPII 318
Query: 306 SLVGAIPDELGSCTELTVVDF-------SDNLLTGSIPRSFGNLLKLQELQLSVNQLSGT 358
A L + FG L +++LS T
Sbjct: 319 RFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSET 378
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-40
Identities = 73/373 (19%), Positives = 138/373 (36%), Gaps = 33/373 (8%)
Query: 326 FSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPA 385
I + ++ + + E T + N+ + ++PA
Sbjct: 4 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPA 62
Query: 386 DI-GNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF-GLRNLTK 443
+ + + L ++ + + +Q L +N + +P +F + LT
Sbjct: 63 ALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTV 121
Query: 444 LLLLSNDLSGFIPPDI-GNCTTLRRLRLNDNRLSGTIPSEM-GNLKHLNFVDMSENHLVG 501
L+L NDLS +P I N L L +++N L I + L + +S N L
Sbjct: 122 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT- 178
Query: 502 GIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSK 561
+ S SL ++ N L+ ++ P +++ +D S N ++ + EL+
Sbjct: 179 HVDLS--LIPSLFHANVSYNLLS-TLAI--PIAVEELDASHNSIN-VV--RGPVNVELTI 230
Query: 562 LLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKE-LGQISSLEISLNLSSNQFSG 620
L L N L+ +L+ L+ +D+ N +I ++ LE L +S+N+
Sbjct: 231 LKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLE-RLYISNNRLV- 285
Query: 621 EIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPL 680
+ + L +LDLSHN L L +L + N L L
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV----------TLKL 335
Query: 681 SDLASNRGLYISG 693
S + + L +S
Sbjct: 336 STHHTLKNLTLSH 348
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-37
Identities = 83/430 (19%), Positives = 134/430 (31%), Gaps = 70/430 (16%)
Query: 239 VPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLK 298
+ S++ + I E + + + +++ + + +++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 299 SLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGT 358
L L + + + N + P F N+ L L L N LS
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-- 130
Query: 359 IPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQ 418
+P I +L
Sbjct: 131 -----------------------SLPRGI-----------------------FHNTPKLT 144
Query: 419 ALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSG 477
L S NNL I + F +L L L SN L+ D+ +L ++ N LS
Sbjct: 145 TLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS- 199
Query: 478 TIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP-TSLQ 536
T+ + ++ L D S N + + V L L L N LT L L
Sbjct: 200 TLAIPI-AVEEL---DASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLV 251
Query: 537 LVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGE 596
VDLS N L + H + L +L +S N+L + L +LD+ +N
Sbjct: 252 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-H 309
Query: 597 IPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLV 656
+ + Q LE +L L N + S L L LSHN + A +N+
Sbjct: 310 VERNQPQFDRLE-NLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN-SLRALFRNVA 364
Query: 657 SLNVSFNDFS 666
V D
Sbjct: 365 RPAVDDADQH 374
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-34
Identities = 69/376 (18%), Positives = 137/376 (36%), Gaps = 31/376 (8%)
Query: 82 EISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKE-FGDYRELTFIDLSGNSLWG 140
++ + L + K + + + +P +R++ ++L+ +
Sbjct: 25 DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI-E 82
Query: 141 EIPTEV-CRLRKLESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQLSGKIPKSI-GAL 197
EI T ++ LY+ N + +P + N+ L L L N LS +P+ I
Sbjct: 83 EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNT 140
Query: 198 SKLQVFRAGGNQNLKGELPWEI-GNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYT 256
KL N L+ + + ++L L L+ ++ S I L
Sbjct: 141 PKLTTLSMSNNN-LE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHAN------ 192
Query: 257 SLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELG 316
+S + + ++ L NSI+ + G +L L L N+L L
Sbjct: 193 --VSYNLLSTLAIPIAVEELDASHNSINV-VRG--PVNVELTILKLQHNNLTD--TAWLL 245
Query: 317 SCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDN 376
+ L VD S N L + F + +L+ L +S N+L + + L L++ +
Sbjct: 246 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSH 304
Query: 377 NAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF 436
N + + + + L + N + + S L+ L S+N+ + +F
Sbjct: 305 NHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWDCNSLRALF 360
Query: 437 GLRNLTKLLLLSNDLS 452
RN+ + + D
Sbjct: 361 --RNVARPAVDDADQH 374
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-34
Identities = 71/439 (16%), Positives = 153/439 (34%), Gaps = 69/439 (15%)
Query: 142 IPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSI-GALSKL 200
I + + ++++ + + L++ +T ++ + K+P ++ + ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 201 QVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLS 260
++ Q +E I
Sbjct: 72 ELLNLNDLQ------------------------------------IEEID---------- 85
Query: 261 GPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTE 320
+Q LY+ N+I P + L L+L +N L + +
Sbjct: 86 ---TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK 142
Query: 321 LTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAIS 380
LT + S+N L +F LQ LQLS N+L+ ++++ +L H + N +S
Sbjct: 143 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS 199
Query: 381 GEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRN 440
+ + A N + + + EL L +NNL+ +
Sbjct: 200 -----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPG 249
Query: 441 LTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLV 500
L ++ L N+L + L RL +++NRL + + L +D+S NHL+
Sbjct: 250 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308
Query: 501 GGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELS 560
+ + LE L L N + ++ + +L+ + LS N + ++ ++
Sbjct: 309 -HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVA 364
Query: 561 KLLLSKNQLSGRIPAEILS 579
+ + +I ++
Sbjct: 365 RPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-32
Identities = 68/389 (17%), Positives = 126/389 (32%), Gaps = 53/389 (13%)
Query: 93 SLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEV-CRLRK 151
+ S Q + I E + +++ ++P + R+
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQ 70
Query: 152 LESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQLSGKIPKSIGA-LSKLQVFRAGGNQ 209
+E L LN +E EI + ++ L + N + +P + + L V N
Sbjct: 71 VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 128
Query: 210 NLKGELPWEI-GNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIG 268
L LP I N L L + S N ++ I +
Sbjct: 129 -LS-SLPRGIFHNTPKLTTLSM-----SNN---------NLERIE----------DDTFQ 162
Query: 269 NCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSD 328
+ LQNL L N ++ + + + L + N L L + +D S
Sbjct: 163 ATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASH 214
Query: 329 NLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADI- 387
N + + ++L L+L N L+ + L +++ N + +I
Sbjct: 215 NSIN-VVRG--PVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPF 268
Query: 388 GNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLL 447
+ L + N+L + L+ LD S+N+L + + L L L
Sbjct: 269 VKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLD 326
Query: 448 SNDLSGFIPPDIGNCTTLRRLRLNDNRLS 476
N + + TL+ L L+ N
Sbjct: 327 HNSIVTL---KLSTHHTLKNLTLSHNDWD 352
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 56/282 (19%), Positives = 112/282 (39%), Gaps = 13/282 (4%)
Query: 407 IPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLR 466
I E + + ++L + N+ +L L N LS D+ T L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 467 RLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGS 526
L L+ N L ++ +L L +D++ N++ ++ S+E L +N ++
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 527 VPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSG-RIPAEILSCRKLIL 585
V + + + L++N+++ G + + L L N++ S L
Sbjct: 114 VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173
Query: 586 LDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGD 645
L++ N ++ ++ + L+ +L+LSSN+ + + EF + + L +NKL
Sbjct: 174 LNLQYNFIY-DVKGQV-VFAKLK-TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLI 229
Query: 646 LDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNR 687
AL QNL ++ N F F + + +A
Sbjct: 230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 58/350 (16%), Positives = 127/350 (36%), Gaps = 41/350 (11%)
Query: 310 AIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTAL 369
AI + + + +D+ L ++ + ++EL LS N LS ++A T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 370 THLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSG 429
L + +N + + ++ L+ L+ LD + N +
Sbjct: 61 ELLNLSSNVLY-----ETLDLESLS---------------------TLRTLDLNNNYVQ- 93
Query: 430 PIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHL 489
E+ ++ L +N++S + G + + L +N+++ + G +
Sbjct: 94 ----ELLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRV 146
Query: 490 NFVDMSENHLVGGIPPSVVG-CQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGS 548
++D+ N + + +LE L+L N + + L+ +DLS N+L+
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-F 205
Query: 549 LAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLE 608
+ S ++ + L N+L I + + L D+ N F ++ S +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQ 262
Query: 609 ISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSL 658
++ ++ + + L DL A L++L
Sbjct: 263 RVQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAP-FADRLIAL 310
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 52/352 (14%), Positives = 109/352 (30%), Gaps = 43/352 (12%)
Query: 291 IGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQL 350
++ K + +SL A+ S + +D S N L+ KL+ L L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 351 SVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPES 410
S N L ++ + + L L+++NN +
Sbjct: 66 SSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----------------------------E 94
Query: 411 LSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRL 470
L ++ L + NN+S + + + L +N ++ D G + ++ L L
Sbjct: 95 LLVGPSIETLHAANNNISR-VSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 471 NDNRLSG-TIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPD 529
N + + L +++ N + + V L+ LDL SN L +
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGP 208
Query: 530 TLP--TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLD 587
+ + L +N+L + ++ L L N + +
Sbjct: 209 EFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQT 266
Query: 588 IGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSH 639
+ ++ + + ++ + + L LG H
Sbjct: 267 VAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHHH 317
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 58/336 (17%), Positives = 112/336 (33%), Gaps = 49/336 (14%)
Query: 93 SLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKL 152
++ I Q K ++ +L + + +DLSGN L ++ KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 153 ESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLK 212
E L L++N+L D+ +LS+L L L +N + + ++ A N +
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN-IS 112
Query: 213 GELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSE 272
+ G + L + N +I + + G S
Sbjct: 113 -RVSCSRG--QGKKNIYL-----ANN---------KITMLR----------DLDEGCRSR 145
Query: 273 LQNLYLYQNSISG-PIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLL 331
+Q L L N I + L+ L L N + + ++ +L +D S N L
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL 203
Query: 332 TGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNIN 391
+ F + + + L N+L I + L H ++ N
Sbjct: 204 A-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH---------CG 252
Query: 392 GLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNL 427
L FF+ ++ +++ + + + L
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 56/291 (19%), Positives = 103/291 (35%), Gaps = 39/291 (13%)
Query: 90 LQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRL 149
L+ +L S+ Q ++K L +S L+ + + +L ++LS N L E ++ L
Sbjct: 22 LKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL-YETL-DLESL 79
Query: 150 RKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQ 209
L +L LN N + ++ S+ L +N +S ++ S + N+
Sbjct: 80 STLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNK 131
Query: 210 NLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGN 269
+ + G S + L L N I T+ E +
Sbjct: 132 -ITMLRDLDEGCRSRVQYLDL-----KLN---------EIDTV---------NFAELAAS 167
Query: 270 CSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDN 329
L++L L N I + G++ +KLK+L L N L + E S +T + +N
Sbjct: 168 SDTLEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNN 224
Query: 330 LLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAIS 380
L I ++ L+ L N + + +
Sbjct: 225 KLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 34/271 (12%), Positives = 84/271 (30%), Gaps = 38/271 (14%)
Query: 84 SLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIP 143
+L+ +DL + S++ L ++ N++ + G + I L+ N +
Sbjct: 81 TLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRD 137
Query: 144 TEVCRLRKLESLYLNTNLLEG-EIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQV 202
+ +++ L L N ++ + +L +L L N + + + +KL+
Sbjct: 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKT 195
Query: 203 FRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGP 262
N+ L + E + + + + L +
Sbjct: 196 LDLSSNK-LA-FMGPEFQSAAGVTWISLRNNKLVL------------------------- 228
Query: 263 IPEEIGNCSELQNLYLYQNSIS-GPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTEL 321
I + + L++ L N G + +++++ + +E + L
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288
Query: 322 TVVDFSDNLLTGSIPRSFG-NLLKLQELQLS 351
+P F L+ L
Sbjct: 289 GHY---GAYCCEDLPAPFADRLIALGHHHHH 316
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 53/248 (21%), Positives = 92/248 (37%), Gaps = 34/248 (13%)
Query: 737 RMANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVK 796
R A+ + W+ + F L +IG G G VY +GE A++
Sbjct: 16 RKASQTSIFLQEWD------IPFE------QLEIGELIGKGRFGQVYHGRW-HGEV-AIR 61
Query: 797 KMWSSDESG----AFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLH 852
+ ++ AF E+ RH+N+V +G + + +L S++
Sbjct: 62 LIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR 121
Query: 853 GAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLA 912
A K D ++ + + YLH ILH D+K+ NV G + + DFGL
Sbjct: 122 DA-KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDNG-KVVITDFGLF 176
Query: 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPE---------HASMQRITEKSDVYSFGVVLL 963
I + ++ G ++APE ++ SDV++ G +
Sbjct: 177 SISGVL--QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234
Query: 964 EVLTGRHP 971
E+ P
Sbjct: 235 ELHAREWP 242
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-37
Identities = 89/495 (17%), Positives = 178/495 (35%), Gaps = 33/495 (6%)
Query: 110 SSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSD 169
S L +PK+ ++ T +++S N + +++ L KL L ++ N ++ +
Sbjct: 8 SKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDIS 63
Query: 170 I-GNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVML 228
+ L YL L N+L KI L+ N + E GN S L L
Sbjct: 64 VFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL 120
Query: 229 GLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIP 288
GL+ T + + I L + + + E LQ+ I P
Sbjct: 121 GLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEG-----LQDFNTESLHIVFPTN 175
Query: 289 GRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQEL 348
+ L + ++ + E + ++L + L L +
Sbjct: 176 KEFHFI-----LDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNI 230
Query: 349 QLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNING-----LTLFFAWKNKL 403
+ + N +++ T + + I N + G++ + +G L++ +
Sbjct: 231 ETTWNSFIR--ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF 288
Query: 404 TGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCT 463
+ +F+ + + L +N L+ + + G+ T
Sbjct: 289 GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLT 348
Query: 464 TLRRLRLNDNRLSGTIPSEMG---NLKHLNFVDMSENHLVGGIPPSV-VGCQSLEFLDLH 519
L L L N+L + +K L +D+S+N + +SL L++
Sbjct: 349 ELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS 407
Query: 520 SNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEIL- 578
SN LT ++ LP ++++DL N++ S+ + L L +L ++ NQL +P I
Sbjct: 408 SNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFD 465
Query: 579 SCRKLILLDIGNNRF 593
L + + N +
Sbjct: 466 RLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-30
Identities = 89/553 (16%), Positives = 165/553 (29%), Gaps = 91/553 (16%)
Query: 129 TFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSG 188
+D S N L +P ++ +K L ++ N + SDI +LS L L + N++
Sbjct: 3 FLVDRSKNGL-IHVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ- 58
Query: 189 KIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLER 248
+ Q L L L+ + +
Sbjct: 59 YLDI--SVFKFNQ----------------------ELEYLDLSHNKLV-KISC------- 86
Query: 249 IQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSI-SGPIPGRIGALSKLKSLLLWQNSL 307
L++L L N+ + PI G +S+LK L L L
Sbjct: 87 -------------------HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHL 127
Query: 308 VGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCT 367
+ + V+ L L + + I +
Sbjct: 128 EKSSVLPIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFHFILDVS 185
Query: 368 ALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNL 427
T ++ + I + K +I L +L L +
Sbjct: 186 VKTVANLELSNIKC-------------VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIET 232
Query: 428 SGPIPKEIFGLRNLTKLLLLS------NDLSGFIPPDIGNC--TTLRRLRLNDNRLSGTI 479
+ I L T + S F D L ++ +
Sbjct: 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQ 292
Query: 480 PSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLT---GSVPDTLPTSLQ 536
++N + + + LD +N LT L T L+
Sbjct: 293 SYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL-TELE 351
Query: 537 LVDLSDNRLS--GSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSC-RKLILLDIGNNRF 593
+ L N+L +A + L +L +S+N +S S + L+ L++ +N
Sbjct: 352 TLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411
Query: 594 SGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSG-DLDALASL 652
+ I + L +++ L+L SN+ IP + L L L+++ N+L L
Sbjct: 412 TDTIFRCLP--PRIKV-LDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRL 467
Query: 653 QNLVSLNVSFNDF 665
+L + + N +
Sbjct: 468 TSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-25
Identities = 70/432 (16%), Positives = 138/432 (31%), Gaps = 43/432 (9%)
Query: 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELT 322
+P+++ + L + QN IS I +LSKL+ L++ N + EL
Sbjct: 15 VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72
Query: 323 VVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPI--EIATCTALTHLEIDNNAIS 380
+D S N L I + L+ L LS N +PI E + L L + +
Sbjct: 73 YLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 381 GEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRN 440
I ++N + E Q+ + I +
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSV 186
Query: 441 LTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLV 500
T L +++ + + + + L+ + + LN ++ + N +
Sbjct: 187 KTVANLELSNIKCVLEDN--------KCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238
Query: 501 GGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELS 560
+V ++ + + + L G + D S SL LS
Sbjct: 239 R--ILQLVWHTTVWYFSISNVKLQG------QLDFRDFDYSGT-----------SLKALS 279
Query: 561 KLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSG 620
+ + + + + + +IS L+ S+N +
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFL-HLDFSNNLLTD 338
Query: 621 EIPSEFSGLTKLGILDLSHNKLS---GDLDALASLQNLVSLNVSFNDFSGELPNTPFFR- 676
+ LT+L L L N+L + +++L L++S N S +
Sbjct: 339 TVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWT 398
Query: 677 -KLPLSDLASNR 687
L +++SN
Sbjct: 399 KSLLSLNMSSNI 410
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 6e-14
Identities = 57/310 (18%), Positives = 105/310 (33%), Gaps = 31/310 (10%)
Query: 401 NKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDI- 459
N L ++P+ LSQ + L+ S N +S +I L L L++ N + + +
Sbjct: 10 NGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVF 65
Query: 460 GNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGC-QSLEFLDL 518
L L L+ N+L I +L +D+S N G L+FL L
Sbjct: 66 KFNQELEYLDLSHNKLV-KISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGL 122
Query: 519 HSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEIL 578
+ L S + L + L + + L + + IL
Sbjct: 123 STTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFIL 182
Query: 579 -----SCRKLILLDIGNNRFSGEIPKELGQISSLEI-----SLNLSSNQFSGEIPSE--- 625
+ L L +I + L ++ L+ +L L++ + +
Sbjct: 183 DVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQ 242
Query: 626 FSGLTKLGILDLSHNKLSGDLD------ALASLQNLVSLNVSFNDFSGELPNTPF--FRK 677
T + +S+ KL G LD + SL+ L V + F + + F
Sbjct: 243 LVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG-FPQSYIYEIFSN 301
Query: 678 LPLSDLASNR 687
+ + + +
Sbjct: 302 MNIKNFTVSG 311
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 39/225 (17%), Positives = 66/225 (29%), Gaps = 37/225 (16%)
Query: 89 DLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCR 148
I++ ++ + +D S N L +
Sbjct: 287 VFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGH 346
Query: 149 LRKLESLYLNTNLLEGEIPSDIG---NLSSLAYLTLYDNQLSGKIPKSI-GALSKLQVFR 204
L +LE+L L N L+ E+ + SL L + N +S K L
Sbjct: 347 LTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405
Query: 205 AGGNQNLKGELPWEIGNC--SNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGP 262
N L I C + +L L N +I++
Sbjct: 406 MSSNI-----LTDTIFRCLPPRIKVLDL-----HSN---------KIKS----------- 435
Query: 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSL 307
IP+++ LQ L + N + G L+ L+ + L N
Sbjct: 436 IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-35
Identities = 104/628 (16%), Positives = 180/628 (28%), Gaps = 83/628 (13%)
Query: 239 VPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLK 298
+ S++ + I E + + + +++ + + +++
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 299 SLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGT 358
L L + + + N + P F N+ L L L N LS
Sbjct: 79 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-- 136
Query: 359 IPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQ 418
+P I +L
Sbjct: 137 -----------------------SLPRGI-----------------------FHNTPKLT 150
Query: 419 ALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSG 477
L S NNL I + F +L L L SN L+ D+ +L ++ N L
Sbjct: 151 TLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLL-- 204
Query: 478 TIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP-TSLQ 536
S + + +D S N + + V L L L N LT L L
Sbjct: 205 ---STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLV 257
Query: 537 LVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGE 596
VDLS N L + H + L +L +S N+L + L +LD+ +N
Sbjct: 258 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-H 315
Query: 597 IPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLV 656
+ + Q LE +L L N + S L L LSHN + A +N+
Sbjct: 316 VERNQPQFDRLE-NLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN-SLRALFRNVA 370
Query: 657 SLNVSFNDFSGELP-----------NTPFFRKLPLSDLASNRGLYISGGVVSPTDSLPAG 705
V D ++ + + L +A + +
Sbjct: 371 RPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTI 430
Query: 706 QARSAMKLVMSILVSASAVLVLLAIYVLVRTRMANNSFTADDTWEMTLYQKLDFSIDDVV 765
+ ++ ++ + R T + + L Q L ID +
Sbjct: 431 NSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNL 490
Query: 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRL 825
R SS + +V E A K + ++ + + +NI
Sbjct: 491 RRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALE 550
Query: 826 --LGWGSNKNLKLLFYDYLPNGSLSSLL 851
L K +L L + L
Sbjct: 551 KQLDNKRAKQAELRQETSLKRQKVKQLE 578
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-33
Identities = 91/620 (14%), Positives = 198/620 (31%), Gaps = 77/620 (12%)
Query: 82 EISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKE-FGDYRELTFIDLSGNSLWG 140
++ + L + K + + + +P +R++ ++L+ +
Sbjct: 31 DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI-E 88
Query: 141 EIPTEV-CRLRKLESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQLSGKIPKSI-GAL 197
EI T ++ LY+ N + +P + N+ L L L N LS +P+ I
Sbjct: 89 EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNT 146
Query: 198 SKLQVFRAGGNQNLKGELPWEI-GNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYT 256
KL N L+ + + ++L L L+ ++ +V + ++ + +
Sbjct: 147 PKLTTLSMSNNN-LE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSY 201
Query: 257 SLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELG 316
+LLS + ++ L NSI+ + G +L L L N+L L
Sbjct: 202 NLLS-----TLAIPIAVEELDASHNSINV-VRG--PVNVELTILKLQHNNLTD--TAWLL 251
Query: 317 SCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDN 376
+ L VD S N L + F + +L+ L +S N+L + + L L++ +
Sbjct: 252 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSH 310
Query: 377 NAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF 436
N + ++ + Q L+ L +N++ +
Sbjct: 311 NHLL-------------------------HVERNQPQFDRLENLYLDHNSIV-TLKLSTH 344
Query: 437 GLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGN----------L 486
L L L ND + + R ++D I ++ +
Sbjct: 345 --HTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPY 400
Query: 487 KHLNFVDMSENHLVGGIPPSVVGCQSLEFLDL--HSNGLTGSVPDTLPTSLQLVDLSDNR 544
++ +V + + C + + ++ + + ++ N
Sbjct: 401 LDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNE 460
Query: 545 LSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEIL-SCRKLILLDIGNNRFSGEIPKELGQ 603
L + +L+ + + QL + AEI + R+ L G R S + K
Sbjct: 461 LR-------AEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTH 513
Query: 604 ISSLEISLNLSSNQFSGEIPSEFSGL--TKLGILDLSHNKLSGDLDALASLQNLVSLNVS 661
+ + + E ++ + + L + Q
Sbjct: 514 LKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQK 573
Query: 662 FNDFSGELPNTPFFRKLPLS 681
+ P R++
Sbjct: 574 VKQLEAKKNRNPDTRRVSHH 593
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-32
Identities = 84/525 (16%), Positives = 183/525 (34%), Gaps = 80/525 (15%)
Query: 141 EIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSI-GALSK 199
I + + ++++ + + L++ +T ++ + K+P ++ + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76
Query: 200 LQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLL 259
+++ Q I+ I
Sbjct: 77 VELLNLNDLQ---------------------------------------IEEID------ 91
Query: 260 SGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCT 319
+Q LY+ N+I P + L L+L +N L +
Sbjct: 92 ----TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTP 147
Query: 320 ELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAI 379
+LT + S+N L +F LQ LQLS N+L+ ++++ +L H + N +
Sbjct: 148 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLL 204
Query: 380 SGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLR 439
S + + A N + + + EL L +NNL+ +
Sbjct: 205 S-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYP 254
Query: 440 NLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHL 499
L ++ L N+L + L RL +++NRL + + L +D+S NHL
Sbjct: 255 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 313
Query: 500 VGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTEL 559
+ + + LE L L N + ++ + +L+ + LS N + ++ +
Sbjct: 314 L-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNV 369
Query: 560 SKLLLSKNQLSGRIPAEI---LSCRKL-------ILLDIGNNRFSGEIPKELGQISSLEI 609
++ + +I ++ L C++ +L I ++ + G+ S+ +
Sbjct: 370 ARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATD- 428
Query: 610 SLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQN 654
++N + L L+ N+L ++ L + Q
Sbjct: 429 TINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQI 473
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 67/220 (30%), Positives = 92/220 (41%), Gaps = 14/220 (6%)
Query: 755 QKLDFSIDDVVRNLTSANVIGTGSSGVVYR-VTIPNGETLAVKKMWSSDESGAFSSEIQT 813
+ +D+ + V +T +G GS G V+R G AVKK+ E+
Sbjct: 47 KPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV---RLEVFRVEELVA 103
Query: 814 LGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG-VA 872
+ IV L G +F + L GSL L+ + G E R LG
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQAL 160
Query: 873 HALAYLHHDCMPPILHGDVKAMNVLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQ 931
L YLH ILHGDVKA NVLL G +A L DFG A + G
Sbjct: 161 EGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK--SLLTGDY 215
Query: 932 LAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ G+ +MAPE + K D++S ++L +L G HP
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-35
Identities = 94/523 (17%), Positives = 170/523 (32%), Gaps = 58/523 (11%)
Query: 84 SLKAVDLQG-SLPSIFQPL-KSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGE 141
VD +L + + L K L +S +++ + EL + LS N +
Sbjct: 32 LESMVDYSNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-S 90
Query: 142 IPTEVC-RLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQL-SGKIPKSIGALSK 199
+ V + LE L ++ N L+ I ++SL +L L N + K G L+K
Sbjct: 91 LDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTK 147
Query: 200 LQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLL 259
L + + +L + ++L L I G S+ +
Sbjct: 148 LTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN------------ 195
Query: 260 SGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCT 319
L+L + S +++ L L L L
Sbjct: 196 -------------TTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKL------------ 230
Query: 320 ELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAI 379
L+ + LQ ++ + + + +L I N I
Sbjct: 231 NDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF--QFFWPRPVEYLNIYNLTI 288
Query: 380 SGEIPADIGNINGLTLFFAW-----KNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKE 434
+ I + + L + S E+ S ++
Sbjct: 289 TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVC 348
Query: 435 IFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLS--GTIPSEMGNLKHLNFV 492
+ T L N + + L+ L L N L + N+ L +
Sbjct: 349 PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETL 408
Query: 493 DMSENHLVGGIPPSVVGC-QSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAH 551
D+S N L +S+ L+L SN LTGSV LP ++++DL +NR+ S+
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPK 467
Query: 552 SIGSLTELSKLLLSKNQLSGRIPAEIL-SCRKLILLDIGNNRF 593
+ L L +L ++ NQL +P + L + + +N +
Sbjct: 468 DVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-27
Identities = 79/471 (16%), Positives = 149/471 (31%), Gaps = 75/471 (15%)
Query: 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDEL-GSCTEL 321
+P+++ + L L QNSIS I LS+L+ L L N + ++ + +L
Sbjct: 46 VPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDL 102
Query: 322 TVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPI--EIATCTALTHLEIDNNAI 379
+D S N L +I + L+ L LS N +P+ E T LT L +
Sbjct: 103 EYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF 158
Query: 380 SGEIPADIGNINGLTLFFA-WKNKLTGNIPESL--------------------------- 411
+ +++ + + G ESL
Sbjct: 159 RQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVN 218
Query: 412 -SQCQELQALDFSYNNLSGP--IPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNC---TTL 465
+L + + N E+ L + L + + + +
Sbjct: 219 ALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV 278
Query: 466 RRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGG---IPPSVVGCQ--SLEFLDLHS 520
L + + ++ I E + H+ + + L
Sbjct: 279 EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSI 338
Query: 521 NGLTG--SVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLS--GRIPAE 576
+ V P+S ++ + N + S+ +L L L+L +N L ++
Sbjct: 339 SDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALM 398
Query: 577 ILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSG---------------- 620
+ L LD+ N + + + LNLSSN +G
Sbjct: 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLH 458
Query: 621 -----EIPSEFSGLTKLGILDLSHNKL-SGDLDALASLQNLVSLNVSFNDF 665
IP + + L L L+++ N+L S L +L + + N +
Sbjct: 459 NNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 5e-17
Identities = 50/181 (27%), Positives = 76/181 (41%), Gaps = 10/181 (5%)
Query: 510 CQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQL 569
+ +D + LT VP LP + + LS N +S I L+EL L LS N++
Sbjct: 30 NELESMVDYSNRNLT-HVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI 88
Query: 570 SGRIPAEI-LSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQF-SGEIPSEFS 627
+ + L + L LD+ +NR I ++SL L+LS N F + EF
Sbjct: 89 R-SLDFHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMASLRH-LDLSFNDFDVLPVCKEFG 143
Query: 628 GLTKLGILDLSHNKL-SGDLDALASLQ-NLVSLNVSFNDFSGELPNTPFFRKLPLSDLAS 685
LTKL L LS K DL +A L + + L++ G + + L
Sbjct: 144 NLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVF 203
Query: 686 N 686
+
Sbjct: 204 H 204
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-34
Identities = 82/375 (21%), Positives = 147/375 (39%), Gaps = 42/375 (11%)
Query: 298 KSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSG 357
+++L + V A+P+ + TE ++D N + F + L+EL+L+ N +S
Sbjct: 14 RAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS- 69
Query: 358 TIPIEI-ATCTALTHLEIDNNAISGEIPADI-GNINGLTLFFAWKNKLTGNIPESLSQCQ 415
+ L L + +N + IP + ++ LT +NK+ +
Sbjct: 70 AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY 128
Query: 416 ELQALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLNDN 473
L++L+ N+L I F GL +L +L L +L+ IP + + L LRL
Sbjct: 129 NLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHL 186
Query: 474 RLSGTIPSEM-GNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP 532
++ I L L +++S + + P+ + +L L + LT +VP
Sbjct: 187 NIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAV 244
Query: 533 ---TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIG 589
L+ ++LS N +S + L L ++ L QL+ +
Sbjct: 245 RHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA----------------VVE 288
Query: 590 NNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDAL 649
F G ++ L + LN+S NQ + S F + L L L N L+ D L
Sbjct: 289 PYAFRG--------LNYLRV-LNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLL 339
Query: 650 ASLQNLVSLNVSFND 664
+ LN +
Sbjct: 340 WVFRRRWRLNFNRQQ 354
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 53/313 (16%), Positives = 112/313 (35%), Gaps = 14/313 (4%)
Query: 82 EISLKAVDLQG-SLPSIFQPL-KSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLW 139
+AV ++ + + + L + + EF + L ++L+ N +
Sbjct: 10 SAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV- 68
Query: 140 GEIPTEVCR-LRKLESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQLSGKIPKSIGAL 197
+ L L +L L +N L+ IP + LS+L L + +N++ + L
Sbjct: 69 SAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDL 127
Query: 198 SKLQVFRAGGNQNLKGELPWEI-GNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYT 256
L+ G N L + ++L L L + +++ ++ L + + +
Sbjct: 128 YNLKSLEVGDND-LV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRH 185
Query: 257 SLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDE-L 315
++ L+ L + + L SL + +L A+P +
Sbjct: 186 LNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAV 244
Query: 316 GSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEI-ATCTALTHLEI 374
L ++ S N ++ LL+LQE+QL QL+ + L L +
Sbjct: 245 RHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNV 303
Query: 375 DNNAISGEIPADI 387
N ++ + +
Sbjct: 304 SGNQLT-TLEESV 315
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-34
Identities = 69/449 (15%), Positives = 151/449 (33%), Gaps = 66/449 (14%)
Query: 100 PLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNT 159
P + + ++ + T LT +D +S+ T + +L L L +
Sbjct: 16 PDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTS 73
Query: 160 NLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEI 219
N + + D+ ++L YL N+L+ + + L+KL N+ +L +
Sbjct: 74 NNIT-TL--DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNK--LTKLD--V 123
Query: 220 GNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLY 279
L L A ++ T + ++ + ++L L +
Sbjct: 124 SQNPLLTYLNCARNTL--------------------TEI-------DVSHNTQLTELDCH 156
Query: 280 QNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSF 339
N + + ++L +L N + ++ L ++ N +T +
Sbjct: 157 LNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--L 208
Query: 340 GNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAW 399
++L L S N+L+ I++ T LT+ + N ++ E+ + ++ LT
Sbjct: 209 NQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCI 262
Query: 400 KNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDI 459
+ L I L+ +L + ++ L L + ++ D+
Sbjct: 263 QTDLL-EID--LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGITEL---DL 314
Query: 460 GNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLH 519
L L LN+ L+ + + + L + H+ SV +L
Sbjct: 315 SQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD--FSSVGKIPALNNNFEA 369
Query: 520 SNGLTGSVPDTLPTSLQLVDLSDNRLSGS 548
+TL + + +S + L
Sbjct: 370 EGQTITMPKETLTNNSLTIAVSPDLLDQF 398
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-32
Identities = 74/367 (20%), Positives = 134/367 (36%), Gaps = 44/367 (11%)
Query: 327 SDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPAD 386
+ + + S L L L + ++ IE T LT L +N I+ D
Sbjct: 26 AAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIE--KLTGLTKLICTSNNITT---LD 80
Query: 387 IGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLL 446
+ LT NKLT N+ ++ +L L+ N L+ ++ LT L
Sbjct: 81 LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNC 134
Query: 447 LSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPS 506
N L+ D+ + T L L + N+ ++ L +D S N + + S
Sbjct: 135 ARNTLTEI---DVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKITE-LDVS 188
Query: 507 VVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSK 566
+ L L+ +N +T + L +D S N+L+ + + LT+L+ S
Sbjct: 189 --QNKLLNRLNCDTNNIT-KLDLNQNIQLTFLDCSSNKLT-EI--DVTPLTQLTYFDCSV 242
Query: 567 NQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEF 626
N L+ + LS KL L EI ++ + + +
Sbjct: 243 NPLT-ELDVSTLS--KLTTLHCIQTDLL-EID-----LTHNTQLIYFQAEGCRKIKELDV 293
Query: 627 SGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASN 686
+ T+L +LD ++ +LD L+ LV L ++ + + +L +S
Sbjct: 294 THNTQLYLLDCQAAGIT-ELD-LSQNPKLVYLYLNNTELT----------ELDVSHNTKL 341
Query: 687 RGLYISG 693
+ L
Sbjct: 342 KSLSCVN 348
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 84/502 (16%), Positives = 163/502 (32%), Gaps = 73/502 (14%)
Query: 82 EISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGE 141
A ++Q + + L +L L + ++T LT + + N++
Sbjct: 22 SEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNI-TT 78
Query: 142 IPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQ 201
+ + + L L ++N L D+ L+ L YL N+L+ + L
Sbjct: 79 LD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT---KLDVSQNPLLT 130
Query: 202 VFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSG 261
N L ++ + + L L
Sbjct: 131 YLNCARNT-LT---EIDVSHNTQLTELDCHLNKKIT------------------------ 162
Query: 262 PIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTEL 321
++ ++L L N I+ + + L L N++ +L +L
Sbjct: 163 --KLDVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQL 214
Query: 322 TVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISG 381
T +D S N LT I L +L SVN L+ ++++T + LT L +
Sbjct: 215 TFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL- 267
Query: 382 EIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNL 441
EI D+ + L F A + + ++ +L LD ++ ++ L
Sbjct: 268 EI--DLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---ELDLSQNPKL 320
Query: 442 TKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVG 501
L L + +L+ D+ + T L+ L + + +G + LN +E +
Sbjct: 321 VYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI- 374
Query: 502 GIPP------SVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGS 555
+P S+ S + LD N + D ++ LS +
Sbjct: 375 TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYT 434
Query: 556 LTELSKLLLSKNQLSGRIPAEI 577
T + ++ P I
Sbjct: 435 FTSENGAIVGTVTTPFEAPQPI 456
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 45/260 (17%), Positives = 97/260 (37%), Gaps = 30/260 (11%)
Query: 434 EIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVD 493
+ F N + + ++ TL L +++ ++ + + L L +
Sbjct: 13 DWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLI 70
Query: 494 MSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSI 553
+ N++ + S +L +L SN LT ++ T T L ++ N+L+ +
Sbjct: 71 CTSNNIT-TLDLS--QNTNLTYLACDSNKLT-NLDVTPLTKLTYLNCDTNKLT---KLDV 123
Query: 554 GSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNL 613
L+ L ++N L+ ++ +L LD N+ ++ + + L +L+
Sbjct: 124 SQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLT-TLDC 177
Query: 614 SSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTP 673
S N+ + + S L L+ N ++ LD L L L+ S N +
Sbjct: 178 SFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD-LNQNIQLTFLDCSSNKLT------- 225
Query: 674 FFRKLPLSDLASNRGLYISG 693
++ ++ L S
Sbjct: 226 ---EIDVTPLTQLTYFDCSV 242
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 66/311 (21%), Positives = 122/311 (39%), Gaps = 30/311 (9%)
Query: 369 LTHLEIDNNAISGEIPADI-GNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNL 427
L ++ + + ++P D+ + L L NK+T + L L N +
Sbjct: 33 LRVVQCSDLGLE-KVPKDLPPDTALLDLQN---NKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 428 SGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEM-GN 485
S I F L L +L L N L +P + TL+ LR+++N ++ + +
Sbjct: 89 SK-ISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEIT-KVRKSVFNG 143
Query: 486 LKHLNFVDMSENHL-VGGIPPSV-VGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDN 543
L + V++ N L GI G + L ++ + +T ++P LP SL + L N
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGN 202
Query: 544 RLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILS-CRKLILLDIGNNRFSGEIPKELG 602
+++ A S+ L L+KL LS N +S + L+ L L + NN+ ++P L
Sbjct: 203 KITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260
Query: 603 QISSLEISLNLSSNQFSGEIPSE-------FSGLTKLGILDLSHNKLSGDL---DALASL 652
++ + L +N S I S + + L N + +
Sbjct: 261 DHKYIQ-VVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 318
Query: 653 QNLVSLNVSFN 663
++ +
Sbjct: 319 YVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-28
Identities = 62/288 (21%), Positives = 118/288 (40%), Gaps = 18/288 (6%)
Query: 412 SQCQ-ELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRL 470
+CQ L+ + S L +PK++ + L L +N ++ D N L L L
Sbjct: 27 FRCQCHLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLIL 83
Query: 471 NDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDT 530
+N++S P L L + +S+N L +P + ++L+ L +H N +T
Sbjct: 84 INNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMP--KTLQELRVHENEITKVRKSV 140
Query: 531 LP--TSLQLVDLSDNRLSGSL--AHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILL 586
+ +V+L N L S + + +LS + ++ ++ IP + L L
Sbjct: 141 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP--SLTEL 197
Query: 587 DIGNNRFSGEIPKE-LGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGD 645
+ N+ + ++ L +++L L LS N S + L L L++NKL
Sbjct: 198 HLDGNKIT-KVDAASLKGLNNLA-KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV 255
Query: 646 LDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRGLYISG 693
LA + + + + N+ S + + F + AS G+ +
Sbjct: 256 PGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFS 302
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 62/339 (18%), Positives = 117/339 (34%), Gaps = 51/339 (15%)
Query: 269 NCS-ELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFS 327
C L+ + + +P + L L N + + + L +
Sbjct: 28 RCQCHLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILI 84
Query: 328 DNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADI 387
+N ++ P +F L+KL+ L LS NQL +P ++ L L + N I+ ++ +
Sbjct: 85 NNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--TLQELRVHENEIT-KVRKSV 140
Query: 388 -GNINGLTLFFAWKNKLT-GNIPE-SLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKL 444
+N + + N L I + ++L + + N++ IP+ + +LT+L
Sbjct: 141 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTEL 197
Query: 445 LLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIP 504
L N ++ + L +L L+ N +S +
Sbjct: 198 HLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-------------------------AVD 232
Query: 505 PSV-VGCQSLEFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSG------SLAHSIGS 555
L L L++N L VP L +Q+V L +N +S
Sbjct: 233 NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTK 291
Query: 556 LTELSKLLLSKNQLS-GRIPAEILSC-RKLILLDIGNNR 592
S + L N + I C + +GN +
Sbjct: 292 KASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 70/410 (17%), Positives = 128/410 (31%), Gaps = 127/410 (30%)
Query: 127 ELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQL 186
L + S L ++P ++ L L N + D NL +L L L +N++
Sbjct: 32 HLRVVQCSDLGL-EKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 187 SGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAE---TSISGNVPSSI 243
S KI GA + L L L L++ + +P +
Sbjct: 89 S-KISP--GAFAPL----------------------VKLERLYLSKNQLKELPEKMPKT- 122
Query: 244 GMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLW 303
LQ L +++N I+ + + L
Sbjct: 123 -----------------------------LQELRVHENEITK-VRK--SVFNGLNQ---- 146
Query: 304 QNSLVGAIPDELGSCTELTVVDFSDNLLTGSI--PRSFGNLLKLQELQLSVNQLSGTIPI 361
+ VV+ N L S +F + KL ++++ ++ I
Sbjct: 147 -----------------MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT---I 186
Query: 362 EIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALD 421
+LT L +D N I+ ++ SL L L
Sbjct: 187 PQGLPPSLTELHLDGNKIT-KVD-----------------------AASLKGLNNLAKLG 222
Query: 422 FSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIP 480
S+N++S + +L +L L +N L +P + + ++ + L++N +S I
Sbjct: 223 LSFNSISA-VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIG 279
Query: 481 SEM-------GNLKHLNFVDMSENHL-VGGIPPSVVGC-QSLEFLDLHSN 521
S + V + N + I PS C + L +
Sbjct: 280 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 59/301 (19%), Positives = 106/301 (35%), Gaps = 58/301 (19%)
Query: 95 PSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLES 154
F+ LK+L LI+ + ++ P F +L + LS N L E+P ++ + L+
Sbjct: 69 DGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL-KELPEKM--PKTLQE 125
Query: 155 LYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQL-SGKIPKSIGALSKLQVFRAGGNQNLK 212
L ++ N + ++ + L+ + + L N L S I GA +
Sbjct: 126 LRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIEN--GAFQGM------------ 170
Query: 213 GELPWEIGNCSNLVMLGLAE---TSISGNVPSSIGMLE----RIQTIAIYTSLLSGPIPE 265
L + +A+ T+I +P S+ L +I +
Sbjct: 171 ----------KKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVD----------AA 210
Query: 266 EIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVD 325
+ + L L L NSIS G + L+ L L N LV +P L + VV
Sbjct: 211 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 269
Query: 326 FSDNLLTGSIPRS-------FGNLLKLQELQLSVNQLSGT-IPIEIATC-TALTHLEIDN 376
+N ++ +I + + L N + I C +++ N
Sbjct: 270 LHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN 328
Query: 377 N 377
Sbjct: 329 Y 329
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 23/209 (11%)
Query: 773 VIGTGSSGVVYR-VTIPNGETLAVKKM----WSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
IG GS VY+ + +A ++ + E F E + L ++H NIVR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 828 -W--GSNKNLKLLFY-DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCM 883
W ++ + + +G+L + L + + L +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLH-TRT 149
Query: 884 PPILHGDVKAMNVLL-GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE 942
PPI+H D+K N+ + GP + D GLA + S + G+ +MAPE
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---------FAKAVIGTPEFMAPE 200
Query: 943 HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
++ E DVY+FG+ +LE+ T +P
Sbjct: 201 MYE-EKYDESVDVYAFGMCMLEMATSEYP 228
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 64/229 (27%), Positives = 101/229 (44%), Gaps = 32/229 (13%)
Query: 773 VIGTGSSGVVYR-VTIPNGETLAVK--KMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWG 829
V+G G+ G+VY + N +A+K S S EI ++HKNIV+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 830 SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWE---ARY--EVVLGVAHALAYLHHDCMP 884
S +F + +P GSLS+LL D E Y +++ G L YLH +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG----LKYLHDNQ-- 142
Query: 885 PILHGDVKAMNVLLGPGY-QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE- 942
I+H D+K NVL+ ++DFG ++ ++G G+ YMAPE
Sbjct: 143 -IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-------CTETFTGTLQYMAPEI 194
Query: 943 -HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMF 990
+ + +D++S G ++E+ TG+ P L + MF
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPPF-------YELGEPQAAMF 236
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 74/370 (20%), Positives = 136/370 (36%), Gaps = 57/370 (15%)
Query: 333 GSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCT-ALTHLEIDNNAISGEIPADI-GNI 390
S + + L L + + P C L ++ + + +P +I +
Sbjct: 4 ASGAETTSGIPDLDSLPPTYSA---MCP---FGCHCHLRVVQCSDLGLK-AVPKEISPDT 56
Query: 391 NGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSN 449
L L N ++ + Q L AL N +S I ++ F LR L KL + N
Sbjct: 57 TLLDLQN---NDISELRKDDFKGLQHLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKN 112
Query: 450 DLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEM-GNLKHLNFVDMSENHL-VGGIPPSV 507
L IPP++ ++L LR++DNR+ +P + L+++N ++M N L G P
Sbjct: 113 HLVE-IPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGA 168
Query: 508 VGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKN 567
L +L + LT +P LP +L + L N++ + ++L +L L N
Sbjct: 169 FDGLKLNYLRISEAKLT-GIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHN 227
Query: 568 QLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFS 627
Q+ I N S + +L L+L +N+ S +P+
Sbjct: 228 QIR----------------MIENGSLSF--------LPTLR-ELHLDNNKLS-RVPAGLP 261
Query: 628 GLTKLGILDLSHNKLS-------GDLDALASLQNLVSLNVSFNDFS-GELPNTPF--FRK 677
L L ++ L N ++ + +++ N E+ F
Sbjct: 262 DLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTD 321
Query: 678 LPLSDLASNR 687
+ +
Sbjct: 322 RLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 67/338 (19%), Positives = 114/338 (33%), Gaps = 50/338 (14%)
Query: 269 NCS-ELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFS 327
C L+ + + +P I L L N + D+ L +
Sbjct: 30 GCHCHLRVVQCSDLGLKA-VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLV 86
Query: 328 DNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADI 387
+N ++ ++F L KLQ+L +S N L IP + ++L L I +N I ++P
Sbjct: 87 NNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIR-KVP--- 139
Query: 388 GNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNL-SGPIPKEIFGLRNLTKLLL 446
S + + ++ N L + F L L +
Sbjct: 140 --------------------KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRI 179
Query: 447 LSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEM-GNLKHLNFVDMSENHLVGGIPP 505
L+G IP D+ TL L L+ N++ I E L + + N + I
Sbjct: 180 SEAKLTG-IPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQI-RMIEN 234
Query: 506 SV-VGCQSLEFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLS----GSLAH--SIGSL 556
+L L L +N L+ VP LP LQ+V L N ++
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKR 293
Query: 557 TELSKLLLSKNQLS-GRIPAEILSC-RKLILLDIGNNR 592
+ + L N + + C + + GN +
Sbjct: 294 AYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 61/329 (18%), Positives = 105/329 (31%), Gaps = 38/329 (11%)
Query: 127 ELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQL 186
L + S L +P E+ L L N + D L L L L +N++
Sbjct: 34 HLRVVQCSDLGL-KAVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 187 SGKIPKSIGALSKLQVFRAGGNQ--NLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIG 244
S K+ L KLQ N + LP S+LV L + + I
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLVEIPPNLP------SSLVELRIHDNRIRKVPKGVFS 144
Query: 245 MLERIQTIAIYT-SLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLW 303
L + I + L + + +L L + + ++G IP L L L
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPK--DLPETLNELHLD 201
Query: 304 QNSLVGAIPDE-LGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIE 362
N + AI E L ++L + N + S L L+EL L N+LS +P
Sbjct: 202 HNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259
Query: 363 IATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDF 422
+ L + + N I+ ++ + + +
Sbjct: 260 LPDLKLLQVVYLHTNNIT-KVGVND--FCPVGFGVKRAY---------------YNGISL 301
Query: 423 SYNNLS-GPIPKEIF-GLRNLTKLLLLSN 449
N + + F + + + +
Sbjct: 302 FNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 16/100 (16%), Positives = 35/100 (35%), Gaps = 9/100 (9%)
Query: 95 PSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLES 154
L RL + + L + L N L +P + L+ L+
Sbjct: 210 LEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL-SRVPAGLPDLKLLQV 268
Query: 155 LYLNTNLLEGEIPSDI-------GNLSSLAYLTLYDNQLS 187
+YL+TN + ++ + + ++L++N +
Sbjct: 269 VYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-30
Identities = 76/353 (21%), Positives = 120/353 (33%), Gaps = 68/353 (19%)
Query: 334 SIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGL 393
SI N L + N +S + + E A+ GE
Sbjct: 2 SIMLPINNNFSLSQN-SFYNTIS-GTYADYFSA--WDKWE--KQALPGEN---------- 45
Query: 394 TLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSG 453
+N+ + E L + L + NLS +P + +T L + N L
Sbjct: 46 ------RNEAVSLLKECL--INQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI- 93
Query: 454 FIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSL 513
+P + L L DNRLS T+P +LKHL+ + N L +P L
Sbjct: 94 SLPELPAS---LEYLDACDNRLS-TLPELPASLKHLD---VDNNQLTM-LPELP---ALL 142
Query: 514 EFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRI 573
E+++ +N LT +P+ LPTSL+++ + +N+L+ L SL L +S N L +
Sbjct: 143 EYINADNNQLT-MLPE-LPTSLEVLSVRNNQLT-FLPELPESLEALD---VSTNLLE-SL 195
Query: 574 PAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLG 633
PA + EI N+ + IP L
Sbjct: 196 PAVPVRNHHS---------------------EETEIFFRCRENRIT-HIPENILSLDPTC 233
Query: 634 ILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASN 686
+ L N LS + S Q + PL+D +
Sbjct: 234 TIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTA 286
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-30
Identities = 64/340 (18%), Positives = 129/340 (37%), Gaps = 35/340 (10%)
Query: 262 PIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLW---QNSLVGAIPDELGSC 318
I I N L Y N+ISG A K + L +N V + + L
Sbjct: 2 SIMLPINNNFSLSQNSFY-NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--I 58
Query: 319 TELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNA 378
+ + + + L+ S+P + ++ L+++ N L ++P +L +L+ +N
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELP---ASLEYLDACDNR 111
Query: 379 ISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGL 438
+S +P ++ L + N+LT +PE + L+ ++ N L+ +P+
Sbjct: 112 LS-TLPELPASLKHLDVDN---NQLT-MLPELPAL---LEYINADNNQLTM-LPELP--- 159
Query: 439 RNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHL----NFVDM 494
+L L + +N L+ F+P + L L ++ N L ++P+ H F
Sbjct: 160 TSLEVLSVRNNQLT-FLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRC 214
Query: 495 SENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIG 554
EN + IP +++ + L N L+ + ++L D R+ S++
Sbjct: 215 RENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
Query: 555 SLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFS 594
+ +++ + N FS
Sbjct: 274 NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS 313
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-27
Identities = 66/410 (16%), Positives = 122/410 (29%), Gaps = 66/410 (16%)
Query: 110 SSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEV--CRLRKLESLYLNTNLLEGEIP 167
++GT F + + L G + E + + C + + L LN L +P
Sbjct: 18 FYNTISGTYADYFSAWDKWEKQALPGENR-NEAVSLLKECLINQFSELQLNRLNLS-SLP 75
Query: 168 SDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVM 227
++ + L + N L +P+ +L L N LP + +L
Sbjct: 76 DNLP--PQITVLEITQNALI-SLPELPASLEYLDA-----CDNRLSTLPELPASLKHL-- 125
Query: 228 LGLAETSISGN----VPSSIGMLERIQTIAIYTSLLSG----PIPEEIGNCSELQNLYLY 279
+ N +P +LE I +PE + L+ L +
Sbjct: 126 ------DVDNNQLTMLPELPALLEYIN--------ADNNQLTMLPELPTS---LEVLSVR 168
Query: 280 QNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELT----VVDFSDNLLTGSI 335
N ++ +P L++L + N L ++P +N +T I
Sbjct: 169 NNQLTF-LP---ELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HI 222
Query: 336 PRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTL 395
P + +L + L N LS I ++ TA S N L
Sbjct: 223 PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPL 280
Query: 396 FFAWKNKLTGNIPESLSQC-----QELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSND 450
A N +SQ E A FS + +
Sbjct: 281 ADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAF------LDRLSDTVSARNTSGFREQ 334
Query: 451 LSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLV 500
++ ++ + LR ++ + L + ++ + LV
Sbjct: 335 VAAWLE----KLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLV 380
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-26
Identities = 61/340 (17%), Positives = 123/340 (36%), Gaps = 37/340 (10%)
Query: 242 SIGMLERIQTIAIYTSLLSGPIPEEIGNC-SELQNLYL---YQNSISGPIPGRIGALSKL 297
I + + Y ++ + + + + L +N + +++
Sbjct: 6 PINNNFSLSQNSFYNTISG--TYADYFSAWDKWEKQALPGENRNEAVSLLK--ECLINQF 61
Query: 298 KSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSG 357
L L + +L ++PD L ++TV++ + N L S+P +L + L N+LS
Sbjct: 62 SELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPASL---EYLDACDNRLS- 113
Query: 358 TIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQEL 417
T+P A+ L HL++DNN ++ +P + + N+LT +PE + L
Sbjct: 114 TLPELPAS---LKHLDVDNNQLT-MLPELPALLEYINADN---NQLT-MLPELPTS---L 162
Query: 418 QALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRR----LRLNDN 473
+ L N L+ +P+ +L L + +N L +P R +N
Sbjct: 163 EVLSVRNNQLTF-LPEL---PESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCREN 217
Query: 474 RLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPT 533
R++ IP + +L + + +N L I S+ + + S
Sbjct: 218 RIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTL 276
Query: 534 SLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRI 573
L D + + + + N S +
Sbjct: 277 HRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFL 316
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 5e-09
Identities = 41/270 (15%), Positives = 87/270 (32%), Gaps = 20/270 (7%)
Query: 84 SLKAVDLQG-SLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEI 142
L+ ++ L + + SL+ L + + LT +P+ L +D+S N L +
Sbjct: 141 LLEYINADNNQLTMLPELPTSLEVLSVRNNQLT-FLPELPES---LEALDVSTNLL-ESL 195
Query: 143 PTEVCRLRKLES----LYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALS 198
P R E N + IP +I +L + L DN LS +I +S+ +
Sbjct: 196 PAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254
Query: 199 KLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGML-ERIQTIAIYTS 257
+ + + N + + N S + + + +
Sbjct: 255 AQPDYH---GPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANT 311
Query: 258 LLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGA-IPDELG 316
+ + + + +N ++ ++ ++ A ++L+ + D +
Sbjct: 312 FSA--FLDRLSDTVSARNTSGFREQVAA-WLEKLSASAELRQQSFAVAADATESCEDRVA 368
Query: 317 SC-TELTVVDFSDNLLTGSIPRSFGNLLKL 345
L G G LL L
Sbjct: 369 LTWNNLRKTLLVHQASEGLFDNDTGALLSL 398
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-30
Identities = 89/481 (18%), Positives = 161/481 (33%), Gaps = 94/481 (19%)
Query: 74 CSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDL 133
CS G + + +P + + + +S ++ F ++L F+ +
Sbjct: 8 CSVIGYNAICINRGLH---QVPELP---AHVNYVDLSLNSIAELNETSFSRLQDLQFLKV 61
Query: 134 SGNSLWGEIPTEVCR-LRKLESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQL-SGKI 190
+ I R L L L L+ N ++ + L++L LTL L +
Sbjct: 62 EQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVL 120
Query: 191 PKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQ 250
L ++L ML L N +++IQ
Sbjct: 121 SG--NFFKPL----------------------TSLEMLVL-----RDN------NIKKIQ 145
Query: 251 TIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGA 310
+ + ++ L L N + I L + L
Sbjct: 146 PASFFLNM------------RRFHVLDLTFNKVKS-ICE--EDLLNFQGKHFTLLRL--- 187
Query: 311 IPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALT 370
+ +T+ D ++ L + + L LS N ++ A T
Sbjct: 188 --------SSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT 239
Query: 371 HLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGP 430
++ + S + + G+ N L + ++ D S + +
Sbjct: 240 KIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS---------GVKTCDLSKSKIFA- 289
Query: 431 IPKEIF-GLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLNDNRLSGTIPSEM-GNLK 487
+ K +F +L +L L N+++ I + T L +L L+ N L +I S M NL
Sbjct: 290 LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLD 347
Query: 488 HLNFVDMSENHLVGGIPPSV-VGCQSLEFLDLHSNGLTGSVP----DTLPTSLQLVDLSD 542
L +D+S NH+ + +G +L+ L L +N L SVP D L SLQ + L
Sbjct: 348 KLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLT-SLQKIWLHT 404
Query: 543 N 543
N
Sbjct: 405 N 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-30
Identities = 77/381 (20%), Positives = 123/381 (32%), Gaps = 65/381 (17%)
Query: 319 TELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEI-ATCTALTHLEIDNN 377
+ VD S N + SF L LQ L++ I ++L L++D N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 378 AISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNL-SGPIPKEIF 436
++ + L+ L + NL + F
Sbjct: 90 QFL-QLETGA-----------------------FNGLANLEVLTLTQCNLDGAVLSGNFF 125
Query: 437 -GLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLNDNRLSGTIPSEM----------- 483
L +L L+L N++ P N L L N++ +I E
Sbjct: 126 KPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTL 184
Query: 484 GNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDN 543
L + DM+E L + S+ LDL NG S+ ++ +
Sbjct: 185 LRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSL 244
Query: 544 RLSGSLAHSIG-----------------SLTELSKLLLSKNQLSGRIPAEILS-CRKLIL 585
LS S + + LSK+++ + + S L
Sbjct: 245 ILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQ 303
Query: 586 LDIGNNRFSGEIPKE-LGQISSLEISLNLSSNQFSGEIPSE-FSGLTKLGILDLSHNKLS 643
L + N + +I ++ L LNLS N I S F L KL +LDLS+N +
Sbjct: 304 LTLAQNEIN-KIDDNAFWGLTHLL-KLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR 360
Query: 644 G-DLDALASLQNLVSLNVSFN 663
+ L NL L + N
Sbjct: 361 ALGDQSFLGLPNLKELALDTN 381
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-14
Identities = 35/153 (22%), Positives = 61/153 (39%), Gaps = 10/153 (6%)
Query: 517 DLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAE 576
+ GL VP+ LP + VDLS N ++ S L +L L + + I
Sbjct: 16 ICINRGLH-QVPE-LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNN 73
Query: 577 IL-SCRKLILLDIGNNRFSGEIPKE-LGQISSLEISLNLSSNQF-SGEIPSE-FSGLTKL 632
LI+L + N+F ++ +++LE L L+ + F LT L
Sbjct: 74 TFRGLSSLIILKLDYNQFL-QLETGAFNGLANLE-VLTLTQCNLDGAVLSGNFFKPLTSL 131
Query: 633 GILDLSHNKLS--GDLDALASLQNLVSLNVSFN 663
+L L N + +++ L+++FN
Sbjct: 132 EMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 7e-14
Identities = 59/290 (20%), Positives = 102/290 (35%), Gaps = 33/290 (11%)
Query: 95 PSIFQPLKSLKRLIISSCNLTGTIPKE-FGDYRELTFIDLSGNSLWGEIPTEV------- 146
+ F+PL SL+ L++ N+ P F + R +DL+ N I E
Sbjct: 122 GNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK-VKSICEEDLLNFQGK 180
Query: 147 ----CRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSI---GALSK 199
RL + +N L E + +S+ L L N + K A +K
Sbjct: 181 HFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTK 240
Query: 200 LQVFRAGGNQNLKGELPW-EIGNCSNLVMLGLAETSI-----SGN----VPSSI-GMLER 248
+Q + N+ + N GL + + S + + S+
Sbjct: 241 IQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTD 300
Query: 249 IQTIAIYTSLLSGPIPEEI-GNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSL 307
++ + + + ++ I + + L L L QN + L KL+ L L N +
Sbjct: 301 LEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI 359
Query: 308 VGAIPDEL-GSCTELTVVDFSDNLLTGSIPRS-FGNLLKLQELQLSVNQL 355
A+ D+ L + N L S+P F L LQ++ L N
Sbjct: 360 -RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 15/67 (22%), Positives = 27/67 (40%), Gaps = 3/67 (4%)
Query: 610 SLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDL--DALASLQNLVSLNVSFNDFSG 667
++LS N + + FS L L L + + + L +L+ L + +N F
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL- 92
Query: 668 ELPNTPF 674
+L F
Sbjct: 93 QLETGAF 99
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 51/216 (23%), Positives = 82/216 (37%), Gaps = 23/216 (10%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESG--AFSSEIQTLGSIRHKNIVRLLGW- 828
+G G V V + +G A+K++ ++ E H NI+RL+ +
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 829 ----GSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADW---EARYEVVLGVAHALAYLHHD 881
G+ LL + G+L + + G + ++LG+ L +H
Sbjct: 96 LRERGAKHEAWLLL-PFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLGICRGLEAIHA- 152
Query: 882 CMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG---Y 938
H D+K N+LLG Q L D G + + A Y
Sbjct: 153 --KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC-IHVEGSRQALTLQDWAAQRCTISY 209
Query: 939 MAPEHASMQR---ITEKSDVYSFGVVLLEVLTGRHP 971
APE S+Q I E++DV+S G VL ++ G P
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 17/205 (8%)
Query: 773 VIGTGSSGVVYRVTIPN-GETLAVKKM---WSSDESGA--FSSEIQTLGSIRHKNIVRLL 826
++G G G VY +A+K M SSD E +T G ++ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPI 886
+G + + L+++L +G +V + AL H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAA---GA 155
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM 946
H DVK N+L+ AYL DFG+A + ++ G+ YMAPE S
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEK---LTQLGN---TVGTLYYMAPERFSE 209
Query: 947 QRITEKSDVYSFGVVLLEVLTGRHP 971
T ++D+Y+ VL E LTG P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP 234
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 22/212 (10%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMW----SSDESGAFSSEIQTLGSIRHKNIVRLLG 827
IGTGS G ++ +G+ L K++ + E SE+ L ++H NIVR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 828 WGSNKNLKLLFY--DYLPNGSLSSLLHGAGKGGADWEARYEVVLG----VAHALAYLH-- 879
++ L+ +Y G L+S++ K + E VL + AL H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE--EFVLRVMTQLTLALKECHRR 130
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
D +LH D+K NV L L DFGLARI++ +KT G+ YM
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKT-----FVGTPYYM 183
Query: 940 APEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+PE + EKSD++S G +L E+ P
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-29
Identities = 47/219 (21%), Positives = 83/219 (37%), Gaps = 30/219 (13%)
Query: 773 VIGTGSSGVVYRV--TIPNGETLAVKKMWSSDESGA---FSSEIQTLGSIRHKNIVRLLG 827
I G G +Y NG + +K + S ++ A +E Q L + H +IV++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 828 WGS--NKNLKLLFY---DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC 882
+ +++ + Y +Y+ SL +L + AL+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKL----PVAEAIAYLLEILPALSYLHSI- 201
Query: 883 MPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE 942
+++ D+K N++L Q L D G ++ G L G+ G+ APE
Sbjct: 202 --GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG-----------YLYGTPGFQAPE 247
Query: 943 HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAP 981
T +D+Y+ G L + + G P
Sbjct: 248 IV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP 285
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 24/210 (11%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKM-----WSSDESGAFSSEIQTLGSIRHKNIVRLL 826
IG G VYR + +G +A+KK+ + EI L + H N+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 827 G-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG----VAHALAYLHHD 881
+ + L ++ + G LS ++ K V + AL ++H
Sbjct: 99 ASFIEDNELNIVL-ELADAGDLSRMIKHFKKQKRLIPE--RTVWKYFVQLCSALEHMHSR 155
Query: 882 CMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAP 941
++H D+K NV + L D GL R S SKT L G+ YM+P
Sbjct: 156 R---VMHRDIKPANVFITATGVVKLGDLGLGRFFS-------SKTTAAHSLVGTPYYMSP 205
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
E KSD++S G +L E+ + P
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-29
Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 17/205 (8%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKM----WSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
IG GS G V +G +K++ SS E E+ L +++H NIV+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 828 -WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPI 886
+ N +L ++ DY G L ++ + + + + AL ++H I
Sbjct: 91 SFEENGSLYIVM-DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKI 146
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM 946
LH D+K+ N+ L L DFG+AR+++ + + ++ G+ Y++PE
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARA-----CIGTPYYLSPEICEN 199
Query: 947 QRITEKSDVYSFGVVLLEVLTGRHP 971
+ KSD+++ G VL E+ T +H
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 39/233 (16%)
Query: 755 QKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS---E 810
+ + DD + +G G+ GVV++V+ P+G +A K + + + E
Sbjct: 26 KVGELKDDD----FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE 81
Query: 811 IQTLGSIRHKNIVRLLGWGSNKNLKLLFYD---------YLPNGSLSSLLHGAGKGGADW 861
+Q L IV G FY ++ GSL +L AG+
Sbjct: 82 LQVLHECNSPYIVGFYG---------AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI 132
Query: 862 EARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921
+ V + V L YL I+H DVK N+L+ + L DFG VSG D
Sbjct: 133 LGK--VSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFG----VSGQLID 184
Query: 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974
+ + + G+ YM+PE + +SD++S G+ L+E+ GR+P+ P
Sbjct: 185 SMANSF-----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-28
Identities = 48/210 (22%), Positives = 90/210 (42%), Gaps = 22/210 (10%)
Query: 773 VIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTL-GSIRHKNIVRLLGWGSN 831
V+G G+ G + + + +AVK++ S A E+Q L S H N++R +
Sbjct: 31 VLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA-DREVQLLRESDEHPNVIRYFCTEKD 89
Query: 832 KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCMPPILHGD 890
+ + + + +L + E ++ LA+LH + I+H D
Sbjct: 90 RQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHSLN----IVHRD 143
Query: 891 VKAMNVLL-----GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE--- 942
+K N+L+ +A ++DFGL + + ++R + G+ G++APE
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGLCKKL----AVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 943 HASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ T D++S G V V++ G HP
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSHP 229
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 47/204 (23%), Positives = 82/204 (40%), Gaps = 17/204 (8%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVKKM---WSSDESGA--FSSEIQTLGSIRHKNIVRLLG 827
+G G VY +A+K + E F E+ + H+NIV ++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
+ L +Y+ +LS + G + + + + H I+
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM---RIV 133
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ 947
H D+K N+L+ + DFG+A+ +S + Q + G+ Y +PE A +
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETS------LTQTNHVLGTVQYFSPEQAKGE 187
Query: 948 RITEKSDVYSFGVVLLEVLTGRHP 971
E +D+YS G+VL E+L G P
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-27
Identities = 37/257 (14%), Positives = 61/257 (23%), Gaps = 51/257 (19%)
Query: 766 RNLTSANVIGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRH 819
R L + G VV+ V + E A+K S E +
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121
Query: 820 KNIVRLL-------------------------GWGSNKNLKLLFYDYLPNGSLSSLL--- 851
++ G L + L L
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181
Query: 852 --HGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADF 909
+G A + + + A L ++HG N+ + P + L D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE--HASMQRITEKSDVYSFGVVLLEVLT 967
V G + Y E +AS T + + G+ + V
Sbjct: 239 SALWKVGTRGPASS----------VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
Query: 968 GRHPLDPTLPGGAPLVQ 984
P PG +
Sbjct: 289 LFLPFGLVTPGIKGSWK 305
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 61/263 (23%), Positives = 102/263 (38%), Gaps = 36/263 (13%)
Query: 740 NNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYR-----VTIPNGETLA 794
+ D ++ R+L + +G G+ G V + G +A
Sbjct: 9 AQLYACQDPTI----------FEE--RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVA 56
Query: 795 VK--KMWSSDESGAFSSEIQTLGSIRHKNIVRLLG---WGSNKNLKLLFYDYLPNGSLSS 849
VK + D+ F EIQ L ++ IV+ G ++L+L+ +YLP+G L
Sbjct: 57 VKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVM-EYLPSGCLRD 115
Query: 850 LLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCMPPILHGDVKAMNVLLGPGYQAYLAD 908
L + D + + YL C +H D+ A N+L+ +AD
Sbjct: 116 FLQ-RHRARLDASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIAD 170
Query: 909 FGLARIVSGSGDDNCSKTNQR-PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT 967
FGLA+++ D + + P + APE S + +SDV+SFGVVL E+ T
Sbjct: 171 FGLAKLLPLDKDYYVVREPGQSP-----IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
Query: 968 -GRHPLDPTLPGGAPLVQWTPLM 989
P+ + +
Sbjct: 226 YCDKSCSPSAEFLRMMGCERDVP 248
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 42/218 (19%), Positives = 77/218 (35%), Gaps = 27/218 (12%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMW---SSDESGAFSSEIQTLGSIRHKNIVRLLG- 827
+G G GVV+ + A+K++ E++ L + H IVR
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 828 --------WGSNKNLKLLFY---DYLPNGSLSSLLHGAGKGGADWEARY--EVVLGVAHA 874
+ K+ Y +L ++ + E + L +A A
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERSVCLHIFLQIAEA 130
Query: 875 LAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD-----DNCSKTNQR 929
+ +LH ++H D+K N+ + DFGL + + +
Sbjct: 131 VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 930 PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT 967
G+ YM+PE + K D++S G++L E+L
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 63/267 (23%), Positives = 109/267 (40%), Gaps = 20/267 (7%)
Query: 412 SQCQ-ELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLR 469
S+C + + L+ +P I + T+L L SN L +P + T L +L
Sbjct: 3 SRCSCSGTEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLS 58
Query: 470 LNDNRLS--GTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSV 527
L+ N LS G L ++D+S N ++ + + +G + LE LD + L +
Sbjct: 59 LSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QM 116
Query: 528 PDTLP----TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILS-CRK 582
+ +L +D+S + L+ L L ++ N +I + R
Sbjct: 117 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 176
Query: 583 LILLDIGNNRFSGEIPKE-LGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNK 641
L LD+ + ++ +SSL+ LN+S N F + L L +LD S N
Sbjct: 177 LTFLDLSQCQLE-QLSPTAFNSLSSLQ-VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 234
Query: 642 LSG-DLDALASLQ-NLVSLNVSFNDFS 666
+ L +L LN++ NDF+
Sbjct: 235 IMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 53/248 (21%), Positives = 93/248 (37%), Gaps = 18/248 (7%)
Query: 310 AIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIAT---C 366
++P + + T ++ N L F L +L +L LS N LS +
Sbjct: 21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-FKGCCSQSDFGT 77
Query: 367 TALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESL-SQCQELQALDFSYN 425
T+L +L++ N + + ++ + L + L S+ + L LD S+
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 426 NLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLNDNRLSGTIPSEM 483
+ IF GL +L L + N PDI L L L+ +L +
Sbjct: 137 HTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA 194
Query: 484 -GNLKHLNFVDMSENHLVGGIPPSV-VGCQSLEFLDLHSNGLT---GSVPDTLPTSLQLV 538
+L L ++MS N+ + SL+ LD N + P+SL +
Sbjct: 195 FNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 253
Query: 539 DLSDNRLS 546
+L+ N +
Sbjct: 254 NLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 53/206 (25%), Positives = 82/206 (39%), Gaps = 14/206 (6%)
Query: 505 PSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLL 564
PS C S + +S GLT SVP +P+S ++L N+L LT+L+KL L
Sbjct: 2 PSRCSC-SGTEIRCNSKGLT-SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSL 59
Query: 565 SKNQLSGR-IPAEILS-CRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEI 622
S N LS + ++ L LD+ N + + LE L+ + ++
Sbjct: 60 SSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE-HLDFQHSNLK-QM 116
Query: 623 PSE--FSGLTKLGILDLSHNKLSG-DLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLP 679
F L L LD+SH L +L L ++ N F F +L
Sbjct: 117 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD-IFTELR 175
Query: 680 -LS--DLASNRGLYISGGVVSPTDSL 702
L+ DL+ + +S + SL
Sbjct: 176 NLTFLDLSQCQLEQLSPTAFNSLSSL 201
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 58/308 (18%), Positives = 96/308 (31%), Gaps = 65/308 (21%)
Query: 84 SLKAVDLQG----SLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSL- 138
S + S+P+ S RL + S L F +LT + LS N L
Sbjct: 8 SGTEIRCNSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 139 WGEIPTEVCR-LRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGAL 197
+ ++ L+ L L+ N + + S+ L L +L + L +
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK--------QM 116
Query: 198 SKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTS 257
S+ VF + NL+ L ++ T
Sbjct: 117 SEFSVFL----------------SLRNLIYLDISHTHTRV-------------------- 140
Query: 258 LLSGPIPEEI-GNCSELQNLYLYQNS-ISGPIPGRIGALSKLKSLLLWQNSLVGAIPDEL 315
I S L+ L + NS +P L L L L Q L +
Sbjct: 141 -----AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA 194
Query: 316 GSC-TELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEI--ATCTALTHL 372
+ + L V++ S N + L LQ L S+N + T + ++L L
Sbjct: 195 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFL 253
Query: 373 EIDNNAIS 380
+ N +
Sbjct: 254 NLTQNDFA 261
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVKKM---WSSDESGA--FSSEIQTLGSIRHKNIVRLLG 827
+G G V+ + + +AVK + + D S F E Q ++ H IV +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 828 WGSNKNLKLLFY----DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCM 883
G + +Y+ +L ++H G + EV+ AL + H +
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN-- 135
Query: 884 PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEH 943
I+H DVK N+++ + DFG+AR ++ SG + Q + G+ Y++PE
Sbjct: 136 -GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG----NSVTQTAAVIGTAQYLSPEQ 190
Query: 944 ASMQRITEKSDVYSFGVVLLEVLTGRHP 971
A + +SDVYS G VL EVLTG P
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-27
Identities = 55/210 (26%), Positives = 86/210 (40%), Gaps = 14/210 (6%)
Query: 767 NLTSANVIGTGSSGVVYRVTIPNGETL-AVKKM---WSSDESGAFSSEIQTLGSIRHKNI 822
+L IG G+ G V+ + TL AVK D F E + L H NI
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 823 VRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC 882
VRL+G + K + + + G + L G + ++V A + YL
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK- 232
Query: 883 MPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE 942
+H D+ A N L+ ++DFG++R + Q P + APE
Sbjct: 233 --CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVP-----VKWTAPE 285
Query: 943 HASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ R + +SDV+SFG++L E + G P
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASP 315
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 46/217 (21%), Positives = 90/217 (41%), Gaps = 30/217 (13%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLG--- 827
+IG+G G V++ +G+T +K++ ++E E++ L + H NIV G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK--AEREVKALAKLDHVNIVHYNGCWD 74
Query: 828 ----------WGSNKNLKLLFY---DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHA 874
S+++ + ++ G+L + D E+ +
Sbjct: 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKG 134
Query: 875 LAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAG 934
+ Y+H +++ D+K N+ L Q + DFGL + +R + G
Sbjct: 135 VDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLK--------NDGKRTRSKG 183
Query: 935 SYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ YM+PE S Q ++ D+Y+ G++L E+L
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 61/233 (26%), Positives = 103/233 (44%), Gaps = 36/233 (15%)
Query: 745 ADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDES 804
W ++ ++ L IG G G V G +AVK + + +
Sbjct: 12 YRSGWA----------LN--MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA 58
Query: 805 GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY---DYLPNGSLSSLLHGAGKGGADW 861
AF +E + +RH N+V+LLG + L Y +Y+ GSL L G+
Sbjct: 59 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL--YIVTEYMAKGSLVDYLRSRGRSVLGG 116
Query: 862 EARYEVVLGVAHALAYL-HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920
+ + L V A+ YL ++ +H D+ A NVL+ A ++DFGL + +
Sbjct: 117 DCLLKFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK------E 166
Query: 921 DNCSKTNQR-PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ ++ + P + APE ++ + KSDV+SFG++L E+ + GR P
Sbjct: 167 ASSTQDTGKLP-----VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 772 NVIGTGSSGVVYRVTIPNGETLAVK----KMWSSDESGAFSSEIQTLGSIRHKN--IVRL 825
IG+G S V++V + A+K + + ++ +EI L ++ + I+RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCMP 884
+ + + N L+S L WE + + A+ +H H
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSID-PWERKS-YWKNMLEAVHTIHQHG--- 147
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE-- 942
I+H D+K N L+ G L DFG+A + + + + G+ YM PE
Sbjct: 148 -IVHSDLKPANFLIVDG-MLKLIDFGIANQM-----QPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 943 ---------HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
S +I+ KSDV+S G +L + G+ P
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 772 NVIGTGSSGVVYRVTIPNGETLAVK----KMWSSDESGAFSSEIQTLGSIRHKN--IVRL 825
IG+G S V++V + A+K + + ++ +EI L ++ + I+RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCMP 884
+ + + N L+S L WE + + A+ +H H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSID-PWERKS-YWKNMLEAVHTIHQHG--- 128
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE-- 942
I+H D+K N L+ G L DFG+A + + + + G+ YM PE
Sbjct: 129 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQ-----PDTTSVVKDSQVGTVNYMPPEAI 181
Query: 943 ---------HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
S +I+ KSDV+S G +L + G+ P
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 772 NVIGTGSSGVVYRVTIPNGETLAVK----KMWSSDESGAFSSEIQTLGSIRHKN--IVRL 825
IG+G S V++V + A+K + + ++ +EI L ++ + I+RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCMP 884
+ + + N L+S L WE + + A+ +H H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSID-PWERKS-YWKNMLEAVHTIHQHG--- 175
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE-- 942
I+H D+K N L+ G L DFG+A + + + + G+ YM PE
Sbjct: 176 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQ-----PDTTSVVKDSQVGAVNYMPPEAI 228
Query: 943 ---------HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
S +I+ KSDV+S G +L + G+ P
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 52/219 (23%), Positives = 83/219 (37%), Gaps = 21/219 (9%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESG--AFSSEIQTLGSIR-HKNIVRLLGW 828
V+ G VY + +G A+K++ S++E A E+ + + H NIV+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 829 -------GSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR-YEVVLGVAHALAYLHH 880
+ L L G L L G ++ A+ ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 881 DCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP--QLAGSYG- 937
PPI+H D+K N+LL L DFG A +S D + S + +
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 938 --YMAPE---HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
Y PE S I EK D+++ G +L + +HP
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 746 DDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETL-AVK--KMWSSD 802
D WE ++ ++T + +G G G VY AVK K + +
Sbjct: 5 YDKWE----------ME--RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 52
Query: 803 ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWE 862
F E + I+H N+V+LLG + + + +++ G+L L +
Sbjct: 53 VE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV 111
Query: 863 ARYEVVLGVAHALAYL-HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921
+ ++ A+ YL + +H D+ A N L+G + +ADFGL+R+++G D
Sbjct: 112 VLLYMATQISSAMEYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMTG--DT 165
Query: 922 NCSKTNQR-PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ + P + APE + + + KSDV++FGV+L E+ T G P
Sbjct: 166 YTAHAGAKFP-----IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 63/273 (23%), Positives = 105/273 (38%), Gaps = 35/273 (12%)
Query: 727 LLAIYVLVRTRMANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYR-- 784
+ L ++F D + ++ R+L +G G+ G V
Sbjct: 14 IPTTENLYFQGAMGSAFEDRDPTQ----------FEE--RHLKFLQQLGKGNFGSVEMCR 61
Query: 785 ---VTIPNGETLAVK--KMWSSDESGAFSSEIQTLGSIRHKNIVRLLG---WGSNKNLKL 836
+ GE +AVK + + + F EI+ L S++H NIV+ G +NLKL
Sbjct: 62 YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121
Query: 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCMPPILHGDVKAMN 895
+ +YLP GSL L K D + + + YL +H D+ N
Sbjct: 122 IM-EYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTKRY----IHRDLATRN 175
Query: 896 VLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR-PQLAGSYGYMAPEHASMQRITEKSD 954
+L+ + + DFGL +++ + K P + APE + + + SD
Sbjct: 176 ILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP-----IFWYAPESLTESKFSVASD 230
Query: 955 VYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTP 987
V+SFGVVL E+ T ++
Sbjct: 231 VWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 263
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-26
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 767 NLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLL 826
L IG G G V G +AVK + + + AF +E + +RH N+V+LL
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLL 252
Query: 827 GWGSNKNLKLLFY---DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL-HHDC 882
G + K Y +Y+ GSL L G+ + + L V A+ YL ++
Sbjct: 253 GVIVEE--KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 310
Query: 883 MPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR-PQLAGSYGYMAP 941
+H D+ A NVL+ A ++DFGL + + + ++ + P + AP
Sbjct: 311 ----VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLP-----VKWTAP 355
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
E ++ + KSDV+SFG++L E+ + GR P
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 58/238 (24%), Positives = 93/238 (39%), Gaps = 25/238 (10%)
Query: 766 RNLTSANVIGTGSSGVVYR----VTIPNGETL-AVKKM---WSSDESGAFSSEIQTLGSI 817
R L +G G G V N AVK + + EI+ L ++
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 818 RHKNIVRLLG---WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHA 874
H+NIV+ G +KL+ ++LP+GSL L K + + + + + +
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIM-EFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKG 138
Query: 875 LAYLH-HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR-PQL 932
+ YL +H D+ A NVL+ +Q + DFGL + + + K ++ P
Sbjct: 139 MDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP-- 192
Query: 933 AGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTLPGGAPLVQWTPLM 989
+ APE + SDV+SFGV L E+LT P + M
Sbjct: 193 ---VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 19/215 (8%)
Query: 767 NLTSANVIGTGSSGVVYR--VTIPNGETL--AVK-----KMWSSDESGAFSSEIQTLGSI 817
+L +G GS GVV R P+G+T+ AVK + + F E+ + S+
Sbjct: 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 818 RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAY 877
H+N++RL G +K++ + P GSL L +G + VA + Y
Sbjct: 79 DHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGY 136
Query: 878 LHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG 937
L +H D+ A N+LL + DFGL R + +D+ + ++ +
Sbjct: 137 LESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQ--NDDHYVMQEHRKV--PFA 189
Query: 938 YMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ APE + + SD + FGV L E+ T G+ P
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 773 VIGTGSSGVVYR-VTIPNGETLAVKKM---WSSDESGAFSSEIQTLGSIRHKNIVRLLGW 828
VIG+G++ VV P E +A+K++ EIQ + H NIV
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT- 80
Query: 829 GS-NKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYE------VVLGVAHALAYLHH 880
S +L L L GS+ ++ G + ++ V L YLH
Sbjct: 81 -SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 881 DCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMA 940
+ +H DVKA N+LLG +ADFG++ ++ GD ++ R G+ +MA
Sbjct: 140 N---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI--TRNKVRKTFVGTPCWMA 194
Query: 941 PEHASMQRIT---EKSDVYSFGVVLLEVLTGRHPL 972
PE M+++ K+D++SFG+ +E+ TG P
Sbjct: 195 PE--VMEQVRGYDFKADIWSFGITAIELATGAAPY 227
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 51/226 (22%), Positives = 87/226 (38%), Gaps = 32/226 (14%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK---KMWSSDESGAFSSEIQTLGSIRHKNIVRLLG- 827
++G G++ V+R G+ A+K + E + L + HKNIV+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 828 -WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGA--DWEARYEVVLGVAHALAYLHHDCMP 884
+ K+L ++ P GSL ++L + E V+ V + +L +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLRENG-- 132
Query: 885 PILHGDVKAMNVLLGPGYQAY----LADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMA 940
I+H ++K N++ G L DFG AR + DD + L G+ Y+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVS-----LYGTEEYLH 183
Query: 941 PE--------HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978
P+ ++ D++S GV TG P P
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 60/234 (25%), Positives = 96/234 (41%), Gaps = 23/234 (9%)
Query: 766 RNLTSANVIGTGSSGVVYR-----VTIPNGETLAVK--KMWSSDESGAFSSEIQTLGSIR 818
R+L +G G+ G V + GE +AVK + + + F EI+ L S++
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 819 HKNIVRLLG---WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHAL 875
H NIV+ G +NLKL+ +YLP GSL L K D + + +
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGM 127
Query: 876 AYLH-HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR-PQLA 933
YL +H D+ N+L+ + + DFGL +++ + K P
Sbjct: 128 EYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP--- 180
Query: 934 GSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTP 987
+ APE + + + SDV+SFGVVL E+ T ++
Sbjct: 181 --IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-25
Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 767 NLTSANVIGTGSSGVVYR-VTIPNGETL----AVKKM---WSSDESGAFSSEIQTLGSIR 818
V+G+G+ G VY+ + IP GE + A+K++ S + E + S+
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 819 HKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL 878
+ ++ RLLG ++L+ +P G L + K + + +A + YL
Sbjct: 76 NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 879 HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG- 937
+ +H D+ A NVL+ + DFGLA+++ ++ G
Sbjct: 134 EDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEG--------GK 180
Query: 938 ----YMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+MA E + T +SDV+S+GV + E++T G P
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 37/248 (14%), Positives = 71/248 (28%), Gaps = 51/248 (20%)
Query: 766 RNLTSANVIGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIR- 818
R L V+G T GE+ V + S+ E+ L +R
Sbjct: 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 137
Query: 819 ------------------------HKNIVRLLGWGSNKNLKLLFYDY-LPNGSLSSLL-- 851
K ++R+ + + F+ Y +L +
Sbjct: 138 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 197
Query: 852 ---HGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLAD 908
H + AR ++ L V LA LHH ++H ++ ++++L +L
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTG 254
Query: 909 FGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR-----ITEKSDVYSFGVVLL 963
F S + A + +T D ++ G+ +
Sbjct: 255 FEHLVRDGASAVSPIG------RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308
Query: 964 EVLTGRHP 971
+ P
Sbjct: 309 WIWCADLP 316
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 52/278 (18%), Positives = 98/278 (35%), Gaps = 23/278 (8%)
Query: 409 ESLSQCQELQALDFSYNNLSGPIP-KEIFGLRNLTKLLLLSNDLSGFIPPD---IGNCTT 464
E + L+ L + + +I +L +L + + + I + +
Sbjct: 37 ELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISG 96
Query: 465 LRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVG------CQSLEFLDL 518
L+ L L + ++GT P + + ++ ++ + + L+ L +
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156
Query: 519 HSNGLTGSVPDTL--PTSLQLVDLSDNRLSG--SLAHSI--GSLTELSKLLLSKNQ---L 569
+ + +L +DLSDN G L ++ L L L
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216
Query: 570 SGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGL 629
SG A + +L LD+ +N S SLNLS ++P
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-- 273
Query: 630 TKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSG 667
KL +LDLS+N+L + L + +L++ N F
Sbjct: 274 AKLSVLDLSYNRLDR-NPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 5e-20
Identities = 60/284 (21%), Positives = 96/284 (33%), Gaps = 41/284 (14%)
Query: 422 FSYNNLSGPIPKEIF-GLRNLTKLLLLSN-DLSGFIPPDIGNCTTLRRLRLNDNRLSGTI 479
S N G E++ G R+L LL + + DI +L+RL + R+ I
Sbjct: 25 SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRI 84
Query: 480 PSEM---GNLKHLNFVDMSENHLVGGIPPSVVGCQ--SLEFLDLHSNGLTG------SVP 528
+ L + + + G PP ++ L L+L + +
Sbjct: 85 LFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQ 144
Query: 529 DTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDI 588
L L+++ ++ + LS L LS N G C
Sbjct: 145 QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC-------- 196
Query: 589 GNNRFSGEIPKELGQISSLEISLNLSSNQF---SGEIPSEFSGLTKLGILDLSHNKLSGD 645
+ +L+ L L + SG + + +L LDLSHN L
Sbjct: 197 ------------PLKFPTLQ-VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDA 243
Query: 646 LDAL--ASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNR 687
A L SLN+SF ++P KL + DL+ NR
Sbjct: 244 AGAPSCDWPSQLNSLNLSFTGLK-QVP-KGLPAKLSVLDLSYNR 285
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 51/277 (18%), Positives = 78/277 (28%), Gaps = 26/277 (9%)
Query: 292 GALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRS---FGNLLKLQEL 348
G S L ++ L + + I + LQEL
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 349 QLSVNQLSGTIPIEIA--TCTALTHLEIDNNAISGEIPADIGNIN-----GLTLFFAWKN 401
L +++GT P + T L L + N + + A + + GL + +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQA 159
Query: 402 KLTGNIPESLSQCQELQALDFSYNNLSGPIPKEI----FGLRNLTKLLLLSN---DLSGF 454
E + L LD S N G L L L + SG
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGV 219
Query: 455 IPPDIGNCTTLRRLRLNDNRLSGTIPSEM-GNLKHLNFVDMSENHLVGGIPPSVVGC--Q 511
L+ L L+ N L + LN +++S L V
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-----KQVPKGLPA 274
Query: 512 SLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGS 548
L LDL N L + + + L N S
Sbjct: 275 KLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 52/253 (20%), Positives = 87/253 (34%), Gaps = 22/253 (8%)
Query: 266 EIGNCSELQNLYLYQNSISGPIPG---RIGALSKLKSLLLWQNSLVGAIPDELGSCT--E 320
+I L+ L + I I R+ +S L+ L L + G P L T +
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPD 122
Query: 321 LTVVDFSDNLLTG--SIPRSFGNLLK--LQELQLSVNQLSGTIPIEIATCTALTHLEIDN 376
L +++ + + LK L+ L ++ ++ AL+ L++ +
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD 182
Query: 377 NAISGEI-------PADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSG 429
N GE P + L L A +G + +LQ LD S+N+L
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242
Query: 430 PIPKEIF-GLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKH 488
L L L L +P + L L L+ NRL PS L
Sbjct: 243 AAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLP--AKLSVLDLSYNRLD-RNPSP-DELPQ 297
Query: 489 LNFVDMSENHLVG 501
+ + + N +
Sbjct: 298 VGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 51/302 (16%), Positives = 90/302 (29%), Gaps = 36/302 (11%)
Query: 111 SCNLTGTIPKEF---------------GDYRELTFIDLSGNSLWGEIPTEVCRLRKLESL 155
SCN + P G + T++ + L+ L
Sbjct: 14 SCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRL 73
Query: 156 YLNTNLLEGEIPSD---IGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLK 212
+ + I + +S L LTL + +++G P + + +
Sbjct: 74 TVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133
Query: 213 GELPWEIGNCSNLVMLGLAETSISGNV-----PSSIGMLERIQTIAIYTSLLSGPIPEEI 267
+ + GL SI+ + + + T+ + + G
Sbjct: 134 ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193
Query: 268 GNC----SELQNLYLYQN---SISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGS-CT 319
C LQ L L + SG A +L+ L L NSL A +
Sbjct: 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253
Query: 320 ELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAI 379
+L ++ S L +P+ KL L LS N+L P + +L + N
Sbjct: 254 QLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPF 308
Query: 380 SG 381
Sbjct: 309 LD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 37/211 (17%), Positives = 58/211 (27%), Gaps = 39/211 (18%)
Query: 85 LKAVDLQGSLPSIFQPLK-SLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEI- 142
+ L + Q LK LK L I+ + ++ + L+ +DLS N GE
Sbjct: 131 VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 143 ------PTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGA 196
P + L+ L G + L L L N L
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250
Query: 197 -LSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIY 255
S+L ++P + + L +L L S N R+
Sbjct: 251 WPSQLNSLNLSFTGL--KQVPKGLP--AKLSVLDL-----SYN---------RLDRN--- 289
Query: 256 TSLLSGPIPEEIGNCSELQNLYLYQNSISGP 286
++ NL L N
Sbjct: 290 ---------PSPDELPQVGNLSLKGNPFLDS 311
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 33/222 (14%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKM-WSSDESGAFSSEIQTLGSIRHKNIVRLLG-WG 829
V+G G+ G V + + A+KK+ + ++ SE+ L S+ H+ +VR W
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 830 SNKNLKLLFY------------DYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHA 874
+N +Y NG+L L+H E +++ A
Sbjct: 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE----A 128
Query: 875 LAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLA- 933
L+Y+H I+H D+K MN+ + + DFGLA+ V S D + P +
Sbjct: 129 LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 934 ------GSYGYMAPE-HASMQRITEKSDVYSFGVVLLEVLTG 968
G+ Y+A E EK D+YS G++ E++
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 28/240 (11%)
Query: 736 TRMANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAV 795
D WE I +L +G G G V+ T +AV
Sbjct: 170 MSSKPQKPWEKDAWE----------IPR--ESLKLEKKLGAGQFGEVWMATYNKHTKVAV 217
Query: 796 KKMWSSDESG-AFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGA 854
K M S AF +E + +++H +V+L + + + ++ +++ GSL L
Sbjct: 218 KTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSD 276
Query: 855 GKGGADWEARYEVVLGVAHALAYL-HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913
+ +A +A++ + +H D++A N+L+ +ADFGLAR
Sbjct: 277 EGSKQPLPKLIDFSAQIAEGMAFIEQRNY----IHRDLRAANILVSASLVCKIADFGLAR 332
Query: 914 IVSGSGDDNCSKTNQR-PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
++ ++ ++ + P + APE + T KSDV+SFG++L+E++T GR P
Sbjct: 333 VIED--NEYTAREGAKFP-----IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 745 ADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVK--KMWSSD 802
+D WE + L +G G G V+ +AVK K S
Sbjct: 4 WEDEWE----------VP--RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS 51
Query: 803 ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWE 862
AF +E + ++H+ +VRL + + + + +Y+ NGSL L
Sbjct: 52 PD-AFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 863 ARYEVVLGVAHALAYL-HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921
++ +A +A++ + +H D++A N+L+ +ADFGLAR++ ++
Sbjct: 110 KLLDMAAQIAEGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLIED--NE 163
Query: 922 NCSKTNQR-PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
++ + P + APE + T KSDV+SFG++L E++T GR P
Sbjct: 164 YTAREGAKFP-----IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 58/223 (26%), Positives = 87/223 (39%), Gaps = 27/223 (12%)
Query: 766 RNLTSANVIGTGSSGVVYR-----VTIPNGETLAVKKM---WSSDESGAFSSEIQTLGSI 817
R L +G G G V GE +AVK + + EI L ++
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 818 RHKNIVRLLG---WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHA 874
H++I++ G +L+L+ +Y+P GSL L + +
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVM-EYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEG 146
Query: 875 LAYLH-HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR-PQL 932
+AYLH +H D+ A NVLL + DFGLA+ V + + + P
Sbjct: 147 MAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP-- 200
Query: 933 AGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDP 974
+ APE + SDV+SFGV L E+LT P
Sbjct: 201 ---VFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-25
Identities = 61/251 (24%), Positives = 96/251 (38%), Gaps = 23/251 (9%)
Query: 400 KNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPD 458
+ L+ +P+ + + L+ NN+ I + F L +L L L N + I
Sbjct: 63 RRGLS-EVPQGIPS--NTRYLNLMENNIQM-IQADTFRHLHHLEVLQLGRNSIR-QIEVG 117
Query: 459 I-GNCTTLRRLRLNDNRLSGTIPSEM-GNLKHLNFVDMSENHLVGGIPPSV-VGCQSLEF 515
+L L L DN L+ IPS L L + + N + IP SL
Sbjct: 118 AFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMR 175
Query: 516 LDL-HSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGR 572
LDL L +L+ ++L + ++ L L +L +S N
Sbjct: 176 LDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSGNHFP-E 232
Query: 573 IPAEILSC-RKLILLDIGNNRFSGEIPKE-LGQISSLEISLNLSSNQFSGEIPSE-FSGL 629
I L L + N++ S I + ++SL LNL+ N S +P + F+ L
Sbjct: 233 IRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLV-ELNLAHNNLS-SLPHDLFTPL 289
Query: 630 TKLGILDLSHN 640
L L L HN
Sbjct: 290 RYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 63/263 (23%), Positives = 110/263 (41%), Gaps = 25/263 (9%)
Query: 439 RNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENH 498
+K++ LS +P I + R L L +N + +L HL + + N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 499 LVGGIPPSV-VGCQSLEFLDLHSNGLTGSVPDTLP---TSLQLVDLSDNRLSGSLAHSIG 554
+ I G SL L+L N LT +P + L+ + L +N + +++
Sbjct: 111 I-RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFN 168
Query: 555 SLTELSKLLLSK-NQLSGRIPAEILS-CRKLILLDIGNNRFSGEIPKELGQISSLEISLN 612
+ L +L L + +L I L L++G ++P L + LE L
Sbjct: 169 RVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLE-ELE 224
Query: 613 LSSNQFSGEIPSE-FSGLTKLGILDLSHNKLSG-DLDALASLQNLVSLNVSFNDFSGELP 670
+S N F EI F GL+ L L + ++++S + +A L +LV LN++ N+ S LP
Sbjct: 225 MSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLP 282
Query: 671 NTPFFRKLPLSDLASNRGLYISG 693
+ F + L L++
Sbjct: 283 HDLF------TPLRYLVELHLHH 299
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 19/236 (8%)
Query: 271 SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNL 330
S + L L +N+I L L+ L L +NS+ L ++ DN
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134
Query: 331 LTGSIPR-SFGNLLKLQELQLSVNQLSGTIPIEI-ATCTALTHLEI-DNNAISGEIPADI 387
LT IP +F L KL+EL L N + +IP +L L++ + + I
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGA 191
Query: 388 ----GNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF-GLRNLT 442
N+ L L + ++P +L+ L+ L+ S N+ I F GL +L
Sbjct: 192 FEGLFNLKYLNLGM---CNIK-DMP-NLTPLVGLEELEMSGNHFPE-IRPGSFHGLSSLK 245
Query: 443 KLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEM-GNLKHLNFVDMSEN 497
KL ++++ +S +L L L N LS ++P ++ L++L + + N
Sbjct: 246 KLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 7e-19
Identities = 48/192 (25%), Positives = 78/192 (40%), Gaps = 18/192 (9%)
Query: 505 PSVVGCQS-LEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLL 563
PSV C + + GL+ VP +P++ + ++L +N + A + L L L
Sbjct: 47 PSVCSCSNQFSKVVCTRRGLS-EVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQ 105
Query: 564 LSKNQLSGRIPAEILS-CRKLILLDIGNNRFSGEIPKE-LGQISSLEISLNLSSNQFSGE 621
L +N + +I + L L++ +N + IP +S L L L +N
Sbjct: 106 LGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLR-ELWLRNNPIE-S 161
Query: 622 IPSE-FSGLTKLGILDLSH-NKLSG-DLDALASLQNLVSLNVSFNDFSGELPNTPFFRKL 678
IPS F+ + L LDL KL A L NL LN+ + + P L
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMC----NIKDMPNLTPL 217
Query: 679 P-LS--DLASNR 687
L +++ N
Sbjct: 218 VGLEELEMSGNH 229
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 63/308 (20%), Positives = 98/308 (31%), Gaps = 46/308 (14%)
Query: 55 ALSSWNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQG-SLPSIFQPL-KSLKRLIISSC 112
A+++ A C CS + + V L + Q + + + L +
Sbjct: 34 AIAAAASAGPQNC---PSVCSCSNQ-----FSKVVCTRRGLSEVPQGIPSNTRYLNLMEN 85
Query: 113 NLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEV-CRLRKLESLYLNTNLLEGEIPSDI- 170
N+ F L + L NS+ +I L L +L L N L IPS
Sbjct: 86 NIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAF 143
Query: 171 GNLSSLAYLTLYDNQLSGKIPKSI-GALSKLQVFRAGGNQNLKGELPWEI-GNCSNLVML 228
LS L L L +N + IP + L G + L+ + NL L
Sbjct: 144 EYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYL 201
Query: 229 GLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIP 288
L +I + + L+ L + N P
Sbjct: 202 NLGMCNIK-----------DMPNLT---------------PLVGLEELEMSGNHFPEIRP 235
Query: 289 GRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRS-FGNLLKLQE 347
G LS LK L + + + + L ++ + N L+ S+P F L L E
Sbjct: 236 GSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVE 294
Query: 348 LQLSVNQL 355
L L N
Sbjct: 295 LHLHHNPW 302
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 6e-25
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 768 LTSANVIGTGSSGVVYRVTIPNGETL-AVK--KMWSSDESGAFSSEIQTLGSIRHKNIVR 824
+T + +G G G VY AVK K + + F E + I+H N+V+
Sbjct: 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 280
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCM 883
LLG + + + +++ G+L L + + ++ A+ YL +
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF- 339
Query: 884 PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR-PQLAGSYGYMAPE 942
+H ++ A N L+G + +ADFGL+R+++G D + + P + APE
Sbjct: 340 ---IHRNLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP-----IKWTAPE 389
Query: 943 HASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ + + KSDV++FGV+L E+ T G P
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 56/234 (23%), Positives = 100/234 (42%), Gaps = 28/234 (11%)
Query: 755 QKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKM---WSSDESGAFSSE 810
Q+ I+D L + +G+G+ G V+++ G +AVK+M + +E+ +
Sbjct: 18 QRYQAEIND----LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD 73
Query: 811 IQTL-GSIRHKNIVRLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVV 868
+ + S IV+ G + +N ++ + + + + G + +
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFITNTDVFIAM-ELMGTCAEKLKKRMQGPIPERILGK--MT 130
Query: 869 LGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQ 928
+ + AL YL ++H DVK N+LL Q L DFG +SG D+ +K
Sbjct: 131 VAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFG----ISGRLVDDKAKDRS 184
Query: 929 RPQLAGSYGYMAPE-----HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977
AG YMAPE + ++DV+S G+ L+E+ TG+ P
Sbjct: 185 ----AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 44/285 (15%), Positives = 89/285 (31%), Gaps = 62/285 (21%)
Query: 735 RTRMANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETL 793
+ A +S + W +++ + + R L V+G T GE+
Sbjct: 42 YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 101
Query: 794 AVK-----KMWSSDESGAFSSEIQTLGSIR-------------------------HKNIV 823
V + S+ E+ L +R K ++
Sbjct: 102 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 161
Query: 824 RLLGWGSNKNLKLLFYDY-LPNGSLSSLL-----HGAGKGGADWEARYEVVLGVAHALAY 877
R+ + + F+ Y +L + H + AR ++ L V LA
Sbjct: 162 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221
Query: 878 LHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG 937
LHH ++H ++ ++++L +L F + R + S G
Sbjct: 222 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-----------RDGARVVSSVSRG 267
Query: 938 YMAPEHASMQ-----------RITEKSDVYSFGVVLLEVLTGRHP 971
+ PE + + +T D ++ G+V+ + P
Sbjct: 268 FEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-25
Identities = 49/217 (22%), Positives = 83/217 (38%), Gaps = 26/217 (11%)
Query: 772 NVIGTGSS--GVVYRVT-IPNGETLAVKKM----WSSDESGAFSSEIQTLGSIRHKNIVR 824
VIG G V P GE + V+++ S++ E+ H NIV
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 825 LLGWGS-NKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVL-GVAHALAYLHHD 881
+ + +L + ++ GS L+ G + E +L GV AL Y+HH
Sbjct: 91 Y--RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN-ELAIAYILQGVLKALDYIHHM 147
Query: 882 CMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSY-G--- 937
+H VKA ++L+ + YL+ + S + +
Sbjct: 148 ---GYVHRSVKASHILISVDGKVYLSGLR----SNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 938 YMAPE--HASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
+++PE ++Q KSD+YS G+ E+ G P
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 64/243 (26%), Positives = 96/243 (39%), Gaps = 43/243 (17%)
Query: 755 QKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKM---WSSDESGAFSSE 810
Q DF+ +D L IG G+ G V ++ P+G+ +AVK++ E +
Sbjct: 15 QHWDFTAED----LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD 70
Query: 811 IQT-LGSIRHKNIVRLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVV 868
+ + S IV+ G + + + + + S D E +
Sbjct: 71 LDVVMRSSDCPYIVQFYGALFREGDCWICM-ELM-STSFDKFYKYVYSVLDDVIP--EEI 126
Query: 869 LG-----VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923
LG AL +L + I+H D+K N+LL L DFG +SG D+
Sbjct: 127 LGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFG----ISGQLVDSI 180
Query: 924 SKTNQRPQLAGSYGYMAPEHASMQRI---------TEKSDVYSFGVVLLEVLTGRHPLDP 974
+KT AG YMAPE RI +SDV+S G+ L E+ TGR P
Sbjct: 181 AKTRD----AGCRPYMAPE-----RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231
Query: 975 TLP 977
Sbjct: 232 WNS 234
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 53/235 (22%), Positives = 101/235 (42%), Gaps = 31/235 (13%)
Query: 746 DDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYR--VTIPNGETL-AVKKM---W 799
D + ++ + I D+ +G G+ G V + + + A+K +
Sbjct: 1 DKKLFL---KRDNLLIADIE--------LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT 49
Query: 800 SSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGA 859
++ E Q + + + IVRL+G + L L+ + G L L G +
Sbjct: 50 EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVG-KREEI 107
Query: 860 DWEARYEVVLGVAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917
E++ V+ + YL + +H D+ A NVLL + A ++DFGL++ +
Sbjct: 108 PVSNVAELLHQVSMGMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162
Query: 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
DD+ + + APE + ++ + +SDV+S+GV + E L+ G+ P
Sbjct: 163 --DDSYYTARSAGKW--PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 22/217 (10%)
Query: 766 RNLTSANVIGTGSSGVVYR---VTIPNGETL-AVKKMW---SSDESGAFSSEIQTLGSIR 818
+ +IG+G SG V + A+K + + + F SE +G
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 819 HKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL 878
H NI+RL G + L ++ +Y+ NGSL + L G ++ GV + YL
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 879 --HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR-PQLAGS 935
+H D+ A NVL+ ++DFGL+R++ D + T + P
Sbjct: 168 SDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP----- 217
Query: 936 YGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ APE + + + SDV+SFGVV+ EVL G P
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 61/250 (24%), Positives = 96/250 (38%), Gaps = 21/250 (8%)
Query: 400 KNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPD 458
+ L +P+ +S + L+ N + I F LR+L L L N + I
Sbjct: 52 RKNLR-EVPDGIST--NTRLLNLHENQIQI-IKVNSFKHLRHLEILQLSRNHIR-TIEIG 106
Query: 459 I-GNCTTLRRLRLNDNRLSGTIPSEM-GNLKHLNFVDMSENHLVGGIPPSV-VGCQSLEF 515
L L L DNRL+ TIP+ L L + + N + IP SL
Sbjct: 107 AFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRR 164
Query: 516 LDL-HSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGR 572
LDL L+ ++L+ ++L+ L ++ L +L +L LS N LS
Sbjct: 165 LDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLS-A 221
Query: 573 IPAEILS-CRKLILLDIGNNRFSGEIPKE-LGQISSLEISLNLSSNQFSGEIPSEFSGLT 630
I L L + ++ I + + SL +NL+ N + F+ L
Sbjct: 222 IRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLV-EINLAHNNLTLLPHDLFTPLH 279
Query: 631 KLGILDLSHN 640
L + L HN
Sbjct: 280 HLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-24
Identities = 61/262 (23%), Positives = 114/262 (43%), Gaps = 23/262 (8%)
Query: 439 RNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENH 498
+K++ + +L +P I T R L L++N++ + +L+HL + +S NH
Sbjct: 43 NQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 499 LVGGIPPSV-VGCQSLEFLDLHSNGLTGSVPDTL--PTSLQLVDLSDNRLSGSLAHSIGS 555
+ I G +L L+L N LT + L+ + L +N + +++
Sbjct: 100 I-RTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNR 158
Query: 556 LTELSKLLLSK-NQLSGRIPAEILS-CRKLILLDIGNNRFSGEIPKELGQISSLEISLNL 613
+ L +L L + +LS I L L++ EIP L + L+ L+L
Sbjct: 159 IPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLD-ELDL 214
Query: 614 SSNQFSGEIPSE-FSGLTKLGILDLSHNKLSG-DLDALASLQNLVSLNVSFNDFSGELPN 671
S N S I F GL L L + +++ + +A +LQ+LV +N++ N+ + LP+
Sbjct: 215 SGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPH 272
Query: 672 TPFFRKLPLSDLASNRGLYISG 693
F + L +++
Sbjct: 273 DLF------TPLHHLERIHLHH 288
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 63/244 (25%), Positives = 102/244 (41%), Gaps = 21/244 (8%)
Query: 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELT 322
+P+ I + + L L++N I L L+ L L +N + L
Sbjct: 58 VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLN 115
Query: 323 VVDFSDNLLTGSIPR-SFGNLLKLQELQLSVNQLSGTIPIEI-ATCTALTHLEI-DNNAI 379
++ DN LT +IP +F L KL+EL L N + +IP +L L++ + +
Sbjct: 116 TLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRL 173
Query: 380 SGEIPADI----GNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEI 435
S I N+ L L L IP +L+ +L LD S N+LS I
Sbjct: 174 S-YISEGAFEGLSNLRYLNLAM---CNLR-EIP-NLTPLIKLDELDLSGNHLSA-IRPGS 226
Query: 436 F-GLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEM-GNLKHLNFVD 493
F GL +L KL ++ + + N +L + L N L+ +P ++ L HL +
Sbjct: 227 FQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIH 285
Query: 494 MSEN 497
+ N
Sbjct: 286 LHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 7e-19
Identities = 58/204 (28%), Positives = 87/204 (42%), Gaps = 12/204 (5%)
Query: 505 PSVVGCQS-LEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLL 563
PSV C + + L VPD + T+ +L++L +N++ +S L L L
Sbjct: 36 PSVCSCSNQFSKVICVRKNLR-EVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQ 94
Query: 564 LSKNQLSGRIPAEILS-CRKLILLDIGNNRFSGEIPKE-LGQISSLEISLNLSSNQFSGE 621
LS+N + I + L L++ +NR + IP +S L+ L L +N
Sbjct: 95 LSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLK-ELWLRNNPIE-S 150
Query: 622 IPSE-FSGLTKLGILDLSH-NKLSG-DLDALASLQNLVSLNVSFNDFSGELPNTPFFRKL 678
IPS F+ + L LDL +LS A L NL LN++ + E+PN KL
Sbjct: 151 IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKL 209
Query: 679 PLSDLASNRGLYISGGVVSPTDSL 702
DL+ N I G L
Sbjct: 210 DELDLSGNHLSAIRPGSFQGLMHL 233
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-17
Identities = 61/290 (21%), Positives = 99/290 (34%), Gaps = 39/290 (13%)
Query: 95 PSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEV-CRLRKLE 153
PS+ ++I NL +P ++L N + I LR LE
Sbjct: 36 PSVCSCSNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQ-IIKVNSFKHLRHLE 91
Query: 154 SLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQ--N 210
L L+ N + I L++L L L+DN+L+ + LSKL+ N +
Sbjct: 92 ILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES 150
Query: 211 LKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNC 270
+ +L L L E R+ I+
Sbjct: 151 IPSYAFN---RIPSLRRLDLGE----LK---------RLSYIS----------EGAFEGL 184
Query: 271 SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNL 330
S L+ L L ++ IP + L KL L L N L P L + +
Sbjct: 185 SNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ 242
Query: 331 LTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEI-ATCTALTHLEIDNNAI 379
+ +F NL L E+ L+ N L+ +P ++ L + + +N
Sbjct: 243 IQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 51/217 (23%), Positives = 83/217 (38%), Gaps = 8/217 (3%)
Query: 95 PSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCR-LRKLE 153
+ F+ L+ L+ L +S ++ F L ++L N L IP L KL+
Sbjct: 81 VNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLK 139
Query: 154 SLYLNTNLLEGEIPSDI-GNLSSLAYLTLYD-NQLSGKIPKSIGALSKLQVFRAGGNQNL 211
L+L N +E IPS + SL L L + +LS + LS L+ L
Sbjct: 140 ELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCN-L 197
Query: 212 KGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCS 271
+ E+P + L L L+ +S P S L +Q + + S + N
Sbjct: 198 R-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQ 255
Query: 272 ELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLV 308
L + L N+++ L L+ + L N
Sbjct: 256 SLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 62/310 (20%), Positives = 111/310 (35%), Gaps = 23/310 (7%)
Query: 365 TCTALTHLEIDNNAISGEIPADI-GNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFS 423
+C + + +++ IP+ + + L L N++T L +C LQAL +
Sbjct: 29 SCDRNGICKGSSGSLN-SIPSGLTEAVKSLDLSN---NRITYISNSDLQRCVNLQALVLT 84
Query: 424 YNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLNDNRLSGTIPS 481
N ++ I ++ F L +L L L N LS + ++L L L N +
Sbjct: 85 SNGINT-IEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGET 142
Query: 482 EM-GNLKHLNFVDMSENHLVGGIPPSV-VGCQSLEFLDLHSNGLTGSVPDTLP--TSLQL 537
+ +L L + + I G LE L++ ++ L P +L ++
Sbjct: 143 SLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSH 202
Query: 538 VDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILS--------CRKLILLDIG 589
+ L + L + + + L L L +E+ + + I
Sbjct: 203 LILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKIT 262
Query: 590 NNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDAL 649
+ ++ K L QIS L L S NQ F LT L + L N +
Sbjct: 263 DESLF-QVMKLLNQISGLL-ELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 320
Query: 650 ASLQNLVSLN 659
L ++ N
Sbjct: 321 DYLSRWLNKN 330
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 5e-21
Identities = 56/292 (19%), Positives = 114/292 (39%), Gaps = 31/292 (10%)
Query: 310 AIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEI-ATCTA 368
+IP L + +D S+N +T + LQ L L+ N ++ TI + ++ +
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101
Query: 369 LTHLEIDNNAISGEIPADI-GNINGLTLFFAWKNKLTGNIPESL-SQCQELQALDFSYNN 426
L HL++ N +S + + ++ LT N SL S +LQ L +
Sbjct: 102 LEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160
Query: 427 LSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEM-G 484
I ++ F GL L +L + ++DL + P + + + L L+ + +
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVD 219
Query: 485 NLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP--TSLQLVDLSD 542
+ +++ + L H + L+ ++L + + V ++D
Sbjct: 220 VTSSVECLELRDTDLDT----------------FHFSELSTGETNSLIKKFTFRNVKITD 263
Query: 543 NRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEIL-SCRKLILLDIGNNRF 593
L + + ++ L +L S+NQL +P I L + + N +
Sbjct: 264 ESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 64/298 (21%), Positives = 106/298 (35%), Gaps = 41/298 (13%)
Query: 93 SLPSIFQPL-KSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEV-CRLR 150
SL SI L +++K L +S+ +T + L + L+ N + I + L
Sbjct: 42 SLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLG 100
Query: 151 KLESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQLSGKIPKSI-GALSKLQVFRAGGN 208
LE L L+ N L + S LSSL +L L N S+ L+KLQ+ R G
Sbjct: 101 SLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNM 159
Query: 209 QNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIG 268
T I + + L + + I S L P+ +
Sbjct: 160 DTF---------------------TKIQRKDFAGLTFL---EELEIDASDLQSYEPKSLK 195
Query: 269 NCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQN--------SLVGAIPDELGSCTE 320
+ + +L L+ + + S ++ L L L + L
Sbjct: 196 SIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT 255
Query: 321 LTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEI-ATCTALTHLEIDNN 377
V +D L + + + L EL+ S NQL ++P I T+L + + N
Sbjct: 256 FRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 57/263 (21%), Positives = 101/263 (38%), Gaps = 24/263 (9%)
Query: 444 LLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEM-GNLKHLNFVDMSENHLVGG 502
+++S +C + + L+ +IPS + +K L D+S N +
Sbjct: 12 GVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGLTEAVKSL---DLSNNRI-TY 66
Query: 503 IPPSV-VGCQSLEFLDLHSNGLT---GSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTE 558
I S C +L+ L L SNG+ +L SL+ +DLS N LS + L+
Sbjct: 67 ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSL-GSLEHLDLSYNYLSNLSSSWFKPLSS 125
Query: 559 LSKLLLSKNQLSGRIPAEILS-CRKLILLDIGNNRFSGEIPKE-LGQISSLEISLNLSSN 616
L+ L L N + S KL +L +GN +I ++ ++ LE L + ++
Sbjct: 126 LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLE-ELEIDAS 184
Query: 617 QFSGEIPSEFSGLTKLGILDLSHNKLS----GDLDALASLQ--NLVSLNVSFNDFSGELP 670
P + + L L + +D +S++ L ++ FS EL
Sbjct: 185 DLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFS-ELS 243
Query: 671 NTPFFRKLPLSDLASNRGLYISG 693
L + R + I+
Sbjct: 244 TGETNS---LIKKFTFRNVKITD 263
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 58/352 (16%), Positives = 106/352 (30%), Gaps = 98/352 (27%)
Query: 127 ELTFIDLSGNSLWGEIPTEV-CRLRKLESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDN 184
+ +DLS N + I R L++L L +N + I D +L SL +L L N
Sbjct: 53 AVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110
Query: 185 QLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIG 244
LS + L S+L L L GN
Sbjct: 111 YLS-NLSS--SWFKPL----------------------SSLTFLNL-----LGN------ 134
Query: 245 MLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRI-GALSKLKSLLLW 303
+ + ++++ L LQ L + I + L+ L+ L +
Sbjct: 135 PYKTLGETSLFSHLTK------------LQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182
Query: 304 QNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPR-SFGNLLKLQELQLSVNQLSGTIPIE 362
+ L P L S ++ + + ++ L+L L T
Sbjct: 183 ASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLD-TFHF- 239
Query: 363 IATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDF 422
++L+ SL + + +
Sbjct: 240 --------------------------------------SELSTGETNSLIKKFTFRNVKI 261
Query: 423 SYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLNDN 473
+ +L + K + + L +L N L +P I T+L+++ L+ N
Sbjct: 262 TDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVK--KMWSSDESGAFSSEIQTLGSIRHKNIV 823
LT IG+G G+V+ N + +A+K + + E F E + + + H +V
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLV 66
Query: 824 RLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL--HHD 881
+L G + L +++ +G LS L +G E + L V +AYL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC- 124
Query: 882 CMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR-PQLAGSYGYMA 940
++H D+ A N L+G ++DFG+ R V D S T + P + +
Sbjct: 125 ----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQYTSSTGTKFP-----VKWAS 173
Query: 941 PEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
PE S R + KSDV+SFGV++ EV + G+ P
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 23/207 (11%)
Query: 773 VIGTGSSGVVYR-VTIPNGETLAVKKM---WSSDESGAFSSEIQTLGSIRHKNIVRLLGW 828
IG GS G V++ + + +A+K + + DE EI L + + G
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG- 87
Query: 829 GS-NKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVL-GVAHALAYLHHDCMPP 885
S K+ KL + +YL GS LL + G E + +L + L YLH +
Sbjct: 88 -SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---K 139
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945
+H D+KA NVLL + LADFG V+G D K R G+ +MAPE
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFG----VAGQLTDTQIK---RNTFVGTPFWMAPEVIK 192
Query: 946 MQRITEKSDVYSFGVVLLEVLTGRHPL 972
K+D++S G+ +E+ G P
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPPH 219
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 767 NLTSANVIGTGSSGVVYR-VTIPNGETL----AVKKM---WSSDESGAFSSEIQTLGSIR 818
L V+G+G G V++ V IP GE++ +K + A + + +GS+
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 819 HKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL 878
H +IVRLLG +L+L+ YLP GSL + +G + + +A + YL
Sbjct: 74 HAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 879 HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR-PQLAGSYG 937
M +H ++ A NVLL Q +ADFG+A ++ D + + P
Sbjct: 132 EEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLL-PPDDKQLLYSEAKTP-----IK 182
Query: 938 YMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+MA E + T +SDV+S+GV + E++T G P
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 58/217 (26%), Positives = 89/217 (41%), Gaps = 27/217 (12%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK---KMWSSDESGAFSSEIQTLGSIRHKNIVRLL-- 826
+GTG G V R GE +A+K + S + EIQ + + H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 827 ----GWGSNKNLKLLFYDYLPNGSLSSLL--HGAGKGGADWEARYEVVLGVAHALAYLHH 880
+ +L LL +Y G L L G + R ++ ++ AL YLH
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLHE 139
Query: 881 DCMPPILHGDVKAMNVLLGPGYQAY---LADFGLARIVSGSGDDNCSKTNQRPQLAGSYG 937
+ I+H D+K N++L PG Q + D G A+ + G+
Sbjct: 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTE-----FVGTLQ 188
Query: 938 YMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974
Y+APE ++ T D +SFG + E +TG P P
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVK--KMWSSDESGAFSSEIQTLGSIRHKNIV 823
+T +G+G GVV +AVK K S E F E QT+ + H +V
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLV 66
Query: 824 RLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL--HHD 881
+ G S + + +Y+ NG L + L G G + E+ V +A+L H
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ- 124
Query: 882 CMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR-PQLAGSYGYMA 940
+H D+ A N L+ ++DFG+ R V D S + P + A
Sbjct: 125 ----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD--DQYVSSVGTKFP-----VKWSA 173
Query: 941 PEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
PE + + KSDV++FG+++ EV + G+ P
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-24
Identities = 52/226 (23%), Positives = 88/226 (38%), Gaps = 32/226 (14%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK---KMWSSDESGAFSSEIQTLGSIRHKNIVRLLGW 828
++G G++ V+R G+ A+K + E + L + HKNIV+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 829 --GSNKNLKLLFYDYLPNGSLSSLL--HGAGKGGADWEARYEVVLGVAHALAYLHHDCMP 884
+ K+L ++ P GSL ++L G + E V+ V + +L +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLRENG-- 132
Query: 885 PILHGDVKAMNVLLGPGYQAY----LADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMA 940
I+H ++K N++ G L DFG AR + DD + L G+ Y+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVS-----LYGTEEYLH 183
Query: 941 PE--------HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978
P+ ++ D++S GV TG P P
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 49/209 (23%), Positives = 88/209 (42%), Gaps = 22/209 (10%)
Query: 773 VIGTGSSGVVYR--VTIPNGETL-AVKKM----WSSDESGAFSSEIQTLGSIRHKNIVRL 825
+G+G+ G V + + AVK + +E + + + IVR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL--HHDCM 883
+G ++ L+ + G L+ L V V+ + YL +
Sbjct: 84 IGICEAESWMLVM-EMAELGPLNKYLQQNRHVKDKNIIEL--VHQVSMGMKYLEESN--- 137
Query: 884 PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEH 943
+H D+ A NVLL + A ++DFGL++ + D+N K + + APE
Sbjct: 138 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKW--PVKWYAPEC 191
Query: 944 ASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ + + KSDV+SFGV++ E + G+ P
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
+G GS VYR I G +A+K M+ + +E++ ++H +I+ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
+ + N L + NG ++ L K ++ EAR+ + + + YLH IL
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH-FMHQIITGMLYLHSHG---IL 134
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ 947
H D+ N+LL +ADFGLA T L G+ Y++PE A+
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHYT-----LCGTPNYISPEIATRS 187
Query: 948 RITEKSDVYSFGVVLLEVLTGRHPLD 973
+SDV+S G + +L GR P D
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFD 213
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-24
Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 767 NLTSANVIGTGSSGVVYR--VTIPNGETL--AVKKMW---SSDESGAFSSEIQTLGSIRH 819
N++ V+G G G V + +P+ + + A+K + + + F E +G H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 820 KNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL- 878
NI+RL G + ++ +Y+ NGSL S L ++ G+A + YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 879 -HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG 937
+H D+ A N+L+ ++DFGL R++ D + T + ++
Sbjct: 165 DMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLED--DPEAAYTTRGGKI--PIR 215
Query: 938 YMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ +PE + ++ T SDV+S+G+VL EV++ G P
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 43/231 (18%)
Query: 772 NVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLG-SIRHKNIVRLLGWGS 830
++G GSSG V G +AVK+M A EI+ L S H N++R +
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA-LMEIKLLTESDDHPNVIRYYCSET 79
Query: 831 NKNLKLLFYDYLP----NGSLSSLLHGAGKGGADWEARYE-----VVLGVAHALAYLHHD 881
F Y+ N +L L+ + + + E ++ +A +A+LH
Sbjct: 80 TDR----FL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134
Query: 882 CMPPILHGDVKAMNVLLGPGYQAY-------------LADFGLARIVSGSGDDNCSKTNQ 928
I+H D+K N+L+ + ++DFGL + + S
Sbjct: 135 K---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL---DSGQSSFRTN 188
Query: 929 RPQLAGSYGYMAPE-------HASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+G+ G+ APE + +R+T D++S G V +L+ G+HP
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 26/230 (11%)
Query: 745 ADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDES 804
A D WE I +L +G G G V+ T +A+K + S
Sbjct: 175 AKDAWE----------IP--RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS 222
Query: 805 G-AFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEA 863
AF E Q + +RH+ +V+L S + + ++ +Y+ GSL L G
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQ 281
Query: 864 RYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923
++ +A +AY+ +H D++A N+L+G +ADFGLAR++ ++
Sbjct: 282 LVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED--NEYT 336
Query: 924 SKTNQR-PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
++ + P + APE A R T KSDV+SFG++L E+ T GR P
Sbjct: 337 ARQGAKFP-----IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 767 NLTSANVIGTGSSGVVYR-VTIPNGETL----AVKKM---WSSDESGAFSSEIQTLGSIR 818
V+G+G+ G VY+ + IP GE + A+K++ S + E + S+
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 819 HKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL 878
+ ++ RLLG ++L+ +P G L + K + + +A + YL
Sbjct: 76 NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 879 HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG- 937
+ +H D+ A NVL+ + DFGLA+++ ++ G
Sbjct: 134 EDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHA--------EGGK 180
Query: 938 ----YMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+MA E + T +SDV+S+GV + E++T G P
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 32/233 (13%)
Query: 745 ADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVK--KMWSSD 802
+WE ID ++LT +GTG GVV +A+K K S
Sbjct: 15 GYGSWE----------ID--PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS 62
Query: 803 ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWE 862
E F E + + ++ H+ +V+L G + + + +Y+ NG L + L + +
Sbjct: 63 ED-EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQ 120
Query: 863 ARYEVVLGVAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920
E+ V A+ YL LH D+ A N L+ ++DFGL+R V D
Sbjct: 121 QLLEMCKDVCEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--D 173
Query: 921 DNCSKTNQR-PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ S + P + PE + + KSD+++FGV++ E+ + G+ P
Sbjct: 174 EYTSSVGSKFP-----VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 65/271 (23%), Positives = 103/271 (38%), Gaps = 53/271 (19%)
Query: 722 SAVLVLLAIYVLVRTRMANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGV 781
+ +Y N T E I +T VIG G G
Sbjct: 12 YDIPTTENLYFQGAMGSDPNQAVLKFTTE----------IH--PSCVTRQKVIGAGEFGE 59
Query: 782 VYR--VTIPNGETL---AVKKMW---SSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN 833
VY+ + +G+ A+K + + + F E +G H NI+RL G S
Sbjct: 60 VYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119
Query: 834 LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKA 893
++ +Y+ NG+L L G ++ G+A + YL + +H D+ A
Sbjct: 120 PMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNY---VHRDLAA 175
Query: 894 MNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGY------------MAP 941
N+L+ ++DFGL+R++ DD AP
Sbjct: 176 RNILVNSNLVCKVSDFGLSRVL---EDD-------------PEATYTTSGGKIPIRWTAP 219
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
E S ++ T SDV+SFG+V+ EV+T G P
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 39/230 (16%)
Query: 767 NLTSANVIGTGSSGVVYRVTIPNGE---TLAVKKM---WSSDESGAFSSEIQTLGSI-RH 819
++ +VIG G+ G V + I A+K+M S D+ F+ E++ L + H
Sbjct: 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 85
Query: 820 KNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG--------- 870
NI+ LLG ++ L +Y P+G+L L + D
Sbjct: 86 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 871 -----VAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923
VA + YL +H D+ A N+L+G Y A +ADFGL+R +
Sbjct: 146 HFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV 196
Query: 924 SKTNQR-PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
KT R P +MA E + T SDV+S+GV+L E+++ G P
Sbjct: 197 KKTMGRLP-----VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-23
Identities = 49/208 (23%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 773 VIGTGSSGVVYR--VTIPNGETL-AVKKM---WSSDESGAFSSEIQTLGSIRHKNIVRLL 826
+G G+ G V + + + A+K + ++ E Q + + + IVRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL--HHDCMP 884
G + L L+ + G L L G + E++ V+ + YL +
Sbjct: 403 GVCQAEALMLVM-EMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---- 456
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHA 944
+H ++ A NVLL + A ++DFGL++ + DD+ + + APE
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWP--LKWYAPECI 511
Query: 945 SMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ ++ + +SDV+S+GV + E L+ G+ P
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 60/246 (24%), Positives = 99/246 (40%), Gaps = 60/246 (24%)
Query: 757 LDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKM---WSSDESGAFSSEIQ 812
++ DD L +G G+ GVV ++ +P+G+ +AVK++ +S E ++
Sbjct: 2 MEVKADD----LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD 57
Query: 813 -TLGSIRHKNIVRLLGWGSNKNLKLLFYD---------YLPNGSLSSLLHGAGKGGADWE 862
++ ++ V G + + + SL G
Sbjct: 58 ISMRTVDCPFTVTFYG---------ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIP 107
Query: 863 ARYEVVLG-----VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917
E +LG + AL +LH ++H DVK NVL+ Q + DFG +SG
Sbjct: 108 ---EDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFG----ISG 158
Query: 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRI---------TEKSDVYSFGVVLLEVLTG 968
D+ +K AG YMAPE RI + KSD++S G+ ++E+
Sbjct: 159 YLVDDVAKDID----AGCKPYMAPE-----RINPELNQKGYSVKSDIWSLGITMIELAIL 209
Query: 969 RHPLDP 974
R P D
Sbjct: 210 RFPYDS 215
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 16/208 (7%)
Query: 768 LTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESG-AFSSEIQTLGSIRHKNIVRLL 826
L +G G G V+ T +A+K + S AF E Q + +RH+ +V+L
Sbjct: 269 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLY 328
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCMPP 885
S + + ++ +Y+ GSL L G ++ +A +AY+ +
Sbjct: 329 AVVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY--- 384
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR-PQLAGSYGYMAPEHA 944
+H D++A N+L+G +ADFGLAR++ ++ ++ + P + APE A
Sbjct: 385 -VHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFP-----IKWTAPEAA 436
Query: 945 SMQRITEKSDVYSFGVVLLEVLT-GRHP 971
R T KSDV+SFG++L E+ T GR P
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 6e-23
Identities = 61/243 (25%), Positives = 92/243 (37%), Gaps = 45/243 (18%)
Query: 744 TADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYR--VTIPNGETL--AVKKMW 799
++ +E I + IG G G V++ P L A+K
Sbjct: 5 SSTRDYE----------IQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK 52
Query: 800 ---SSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGK 856
S F E T+ H +IV+L+G + + ++ + G L S L K
Sbjct: 53 NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ-VRK 110
Query: 857 GGADWEARYEVVLGVAHALAYL-HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915
D + ++ ALAYL +H D+ A NVL+ L DFGL+R +
Sbjct: 111 YSLDLASLILYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYM 166
Query: 916 SGSGDDNCSKTNQRPQLAGSYG------YMAPEHASMQRITEKSDVYSFGVVLLEVLT-G 968
D K + +MAPE + +R T SDV+ FGV + E+L G
Sbjct: 167 E---DSTYYKAS---------KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 214
Query: 969 RHP 971
P
Sbjct: 215 VKP 217
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 8e-23
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRL 825
+G G G VY + LA+K ++ + E++ +RH NI+RL
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 826 LGW-GSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCM 883
G+ + L+ +Y P G++ L K A Y + +A+AL+Y H
Sbjct: 75 YGYFHDATRVYLIL-EYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHSKR-- 129
Query: 884 PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEH 943
++H D+K N+LLG + +ADFG + +++R L G+ Y+ PE
Sbjct: 130 --VIHRDIKPENLLLGSAGELKIADFGWSVHA---------PSSRRTDLCGTLDYLPPEM 178
Query: 944 ASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
+ EK D++S GV+ E L G+ P +
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 9e-23
Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 16/220 (7%)
Query: 756 KLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTL 814
D +G GS G VY+ G+ +A+K++ + EI +
Sbjct: 19 DEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIM 78
Query: 815 GSIRHKNIVRLLGWGS-NKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVA 872
++V+ G S KN L + +Y GS+S ++ K + E ++
Sbjct: 79 QQCDSPHVVKYYG--SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-ILQSTL 135
Query: 873 HALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQL 932
L YLH +H D+KA N+LL A LADFG V+G D +K R +
Sbjct: 136 KGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFG----VAGQLTDTMAK---RNTV 185
Query: 933 AGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
G+ +MAPE +D++S G+ +E+ G+ P
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 68/252 (26%), Positives = 108/252 (42%), Gaps = 49/252 (19%)
Query: 746 DDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYR---VTIPNGE---TLAVKKM- 798
++ WE F + NL +G G+ G V + + +AVK +
Sbjct: 38 NEKWE--------FPRN----NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK 85
Query: 799 --WSSDESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAG 855
+DE A SE++ + + +H+NIV LLG ++ L+ +Y G L + L
Sbjct: 86 STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKS 145
Query: 856 KGGADWEARYEVV------------LGVAHALAYL--HHDCMPPILHGDVKAMNVLLGPG 901
+ A VA +A+L + +H DV A NVLL G
Sbjct: 146 RVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-----CIHRDVAARNVLLTNG 200
Query: 902 YQAYLADFGLARIVSGSGDDNCSKTNQR-PQLAGSYGYMAPEHASMQRITEKSDVYSFGV 960
+ A + DFGLAR + + + K N R P +MAPE T +SDV+S+G+
Sbjct: 201 HVAKIGDFGLARDIM-NDSNYIVKGNARLP-----VKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 961 VLLEVLT-GRHP 971
+L E+ + G +P
Sbjct: 255 LLWEIFSLGLNP 266
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 63/239 (26%), Positives = 97/239 (40%), Gaps = 49/239 (20%)
Query: 767 NLTSANVIGTGSSGVVYR---VTIPNGE-----TLAVKKM---WSSDESGAFSSEIQTLG 815
LT +G G+ G V V I + T+AVK + + + SE++ +
Sbjct: 36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 816 SI-RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG---- 870
I +HKNI+ LLG + + +Y G+L L G ++ V
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 871 ----------VAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918
+A + YL +H D+ A NVL+ +ADFGLAR ++
Sbjct: 156 FKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINN- 209
Query: 919 GDDNCSKTNQ-----RPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
D KT + +MAPE + T +SDV+SFGV++ E+ T G P
Sbjct: 210 -IDYYKKTTNGRLPVK--------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 57/243 (23%), Positives = 97/243 (39%), Gaps = 47/243 (19%)
Query: 745 ADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYR--VTIPNGETL--AVK--KM 798
+ I ++ ++G G G VY T GE + AVK K
Sbjct: 3 GGPQYG----------IAR--EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKK 50
Query: 799 WSSDES-GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKG 857
+ ++ F SE + ++ H +IV+L+G + ++ + P G L L K
Sbjct: 51 DCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYLE-RNKN 108
Query: 858 GADWEARYEVVLGVAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915
L + A+AYL + +H D+ N+L+ L DFGL+R +
Sbjct: 109 SLKVLTLVLYSLQICKAMAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYI 163
Query: 916 SGSGDDNCSKTNQRPQLAGSYG------YMAPEHASMQRITEKSDVYSFGVVLLEVLT-G 968
D++ K + +M+PE + +R T SDV+ F V + E+L+ G
Sbjct: 164 ---EDEDYYKAS---------VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFG 211
Query: 969 RHP 971
+ P
Sbjct: 212 KQP 214
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 64/256 (25%), Positives = 98/256 (38%), Gaps = 53/256 (20%)
Query: 746 DDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYR-----VTIPNGETL-AVKKM- 798
D WE F + L+ +G G+ G V + + AVK +
Sbjct: 15 DHKWE--------FPRN----RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62
Query: 799 --WSSDESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAG 855
E A SE++ L + H NIV LLG + L+ +Y G L + L
Sbjct: 63 PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122
Query: 856 KGGADWEARYEVVLG----------------VAHALAYL--HHDCMPPILHGDVKAMNVL 897
+ ++ VA +A+L + +H D+ A N+L
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAARNIL 177
Query: 898 LGPGYQAYLADFGLARIVSGSGDDNCSKTNQR-PQLAGSYGYMAPEHASMQRITEKSDVY 956
L G + DFGLAR + + + K N R P +MAPE T +SDV+
Sbjct: 178 LTHGRITKICDFGLARDI-KNDSNYVVKGNARLP-----VKWMAPESIFNCVYTFESDVW 231
Query: 957 SFGVVLLEVLT-GRHP 971
S+G+ L E+ + G P
Sbjct: 232 SYGIFLWELFSLGSSP 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 60/239 (25%), Positives = 93/239 (38%), Gaps = 49/239 (20%)
Query: 767 NLTSANVIGTGSSGVVYR---VTIPNGE-----TLAVKKM---WSSDESGAFSSEIQTLG 815
L +G G+ G V + + + +AVK + + + SE++ +
Sbjct: 70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 129
Query: 816 SI-RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG---- 870
I +HKNI+ LLG + + +Y G+L L G ++
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 871 ----------VAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918
VA + YL +H D+ A NVL+ +ADFGLAR +
Sbjct: 190 SKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLARDIHH- 243
Query: 919 GDDNCSKTNQ-----RPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
D KT + +MAPE + T +SDV+SFGV+L E+ T G P
Sbjct: 244 -IDYYKKTTNGRLPVK--------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 55/230 (23%), Positives = 86/230 (37%), Gaps = 30/230 (13%)
Query: 758 DFSIDDVVRNLTSANVIGTGSSGVVYR--VTIPNGETLAV-----KKMWSSDESGAFSSE 810
I + VIG G G VY + +G+ + ++ E F +E
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 811 IQTLGSIRHKNIVRLLGWGSNKNLKLLF-YDYLPNGSLSSLLHGAGKGGADWEARYEVVL 869
+ H N++ LLG L Y+ +G L + + + L
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 199
Query: 870 GVAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTN 927
VA + +L +H D+ A N +L + +ADFGLAR +
Sbjct: 200 QVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMY--------DKE 246
Query: 928 QRPQLAGSYG-----YMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ +MA E Q+ T KSDV+SFGV+L E++T G P
Sbjct: 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 56/230 (24%), Positives = 87/230 (37%), Gaps = 30/230 (13%)
Query: 758 DFSIDDVVRNLTSANVIGTGSSGVVYR--VTIPNGETLAV-----KKMWSSDESGAFSSE 810
I + VIG G G VY + +G+ + ++ E F +E
Sbjct: 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 76
Query: 811 IQTLGSIRHKNIVRLLGWGSNKNLKLLF-YDYLPNGSLSSLLHGAGKGGADWEARYEVVL 869
+ H N++ LLG L Y+ +G L + + + L
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 135
Query: 870 GVAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTN 927
VA + YL +H D+ A N +L + +ADFGLAR + +
Sbjct: 136 QVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK- 189
Query: 928 QRPQLAGSYG-----YMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ +MA E Q+ T KSDV+SFGV+L E++T G P
Sbjct: 190 -------TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 54/236 (22%), Positives = 95/236 (40%), Gaps = 45/236 (19%)
Query: 766 RNLTSANVIGTGSSGVVYR----VTIPNGETL--AVK--KMWSSDESGAFSSEIQTLGSI 817
R++ +G G+ G V+ P + + AVK K + F E + L ++
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 818 RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYE----------- 866
+H++IV+ G + + ++ ++Y+ +G L+ L G
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 867 ---VVLGVAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921
+ +A + YL H +H D+ N L+G + DFG++R V D
Sbjct: 135 MLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDV--YSTD 187
Query: 922 NCSKTNQ-----RPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
R +M PE ++ T +SDV+SFGV+L E+ T G+ P
Sbjct: 188 YYRVGGHTMLPIR--------WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 58/248 (23%), Positives = 95/248 (38%), Gaps = 41/248 (16%)
Query: 401 NKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDI 459
L +P + Q + N +S +P F RNLT L L SN L+ I
Sbjct: 21 QGLQ-AVPVGIPA--ASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLA-RIDAAA 75
Query: 460 -GNCTTLRRLRLNDNRLSGTIPSEM-GNLKHLNFVDMSENHLVGGIPPSV-VGCQSLEFL 516
L +L L+DN ++ L L+ + + L + P + G +L++L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYL 134
Query: 517 DLHSNGLTGSVPDTL---PTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRI 573
L N L ++PD +L + L NR+S + L L +LLL +N+++ +
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HV 192
Query: 574 PAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSE-FSGLTKL 632
F + L +L L +N S +P+E + L L
Sbjct: 193 HPHA---------------FRD--------LGRLM-TLYLFANNLS-ALPTEALAPLRAL 227
Query: 633 GILDLSHN 640
L L+ N
Sbjct: 228 QYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 61/248 (24%), Positives = 92/248 (37%), Gaps = 38/248 (15%)
Query: 423 SYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSE 482
L +P I ++ L N +S C L L L+ N L+ I +
Sbjct: 19 PQQGLQA-VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAA 74
Query: 483 M-GNLKHLNFVDMSENHLVGGIPPSV-VGCQSLEFLDLHSNGLTGSVPDTLP---TSLQL 537
L L +D+S+N + + P+ G L L L GL + L +LQ
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133
Query: 538 VDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEI 597
+ L DN L + L L+ L L N++S +P F G
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERA---------------FRG-- 175
Query: 598 PKELGQISSLEISLNLSSNQFSGEIPSE-FSGLTKLGILDLSHNKLSG-DLDALASLQNL 655
+ SL+ L L N+ + + F L +L L L N LS +ALA L+ L
Sbjct: 176 ------LHSLD-RLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL 227
Query: 656 VSLNVSFN 663
L ++ N
Sbjct: 228 QYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 51/195 (26%), Positives = 70/195 (35%), Gaps = 13/195 (6%)
Query: 515 FLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIP 574
GL +VP +P + Q + L NR+S A S + L+ L L N L+ RI
Sbjct: 15 TTSCPQQGLQ-AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RID 72
Query: 575 AEILSC-RKLILLDIGNNRFSGEIPKE-LGQISSLEISLNLSSNQFSGEIPSE-FSGLTK 631
A + L LD+ +N + + L +L+L E+ F GL
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLH-TLHLDRCGLQ-ELGPGLFRGLAA 130
Query: 632 LGILDLSHNKLSG-DLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLP-LS--DLASNR 687
L L L N L D L NL L + N S FR L L L NR
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA--FRGLHSLDRLLLHQNR 188
Query: 688 GLYISGGVVSPTDSL 702
++ L
Sbjct: 189 VAHVHPHAFRDLGRL 203
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 50/257 (19%), Positives = 79/257 (30%), Gaps = 56/257 (21%)
Query: 103 SLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEV-CRLRKLESLYLNTNL 161
+ +R+ + ++ F R LT + L N L I L LE L L+ N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNA 91
Query: 162 LEGEIPSDI-GNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIG 220
+ L L L L L ++ G L
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGP--GLFRGL-------------------- 128
Query: 221 NCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEI-GNCSELQNLYLY 279
+ L L L + ++ +P++ + L +L+L+
Sbjct: 129 --AALQYLYLQDNALQA-------------------------LPDDTFRDLGNLTHLFLH 161
Query: 280 QNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRS- 338
N IS L L LLL QN + P L + N L+ ++P
Sbjct: 162 GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEA 220
Query: 339 FGNLLKLQELQLSVNQL 355
L LQ L+L+ N
Sbjct: 221 LAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 47/266 (17%), Positives = 86/266 (32%), Gaps = 56/266 (21%)
Query: 124 DYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYD 183
L +P + + ++L+ N + + +L L L+
Sbjct: 9 YNEPKVTTSCPQQGL-QAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHS 65
Query: 184 NQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSI 243
N L+ +I A + L + L L L S N
Sbjct: 66 NVLA-RIDA--AAFTGL----------------------ALLEQLDL-----SDN----- 90
Query: 244 GMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLW 303
+++++ P L L+L + + PG L+ L+ L L
Sbjct: 91 ---AQLRSVD----------PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ 137
Query: 304 QNSLVGAIPDE-LGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIE 362
N+L A+PD+ LT + N ++ R+F L L L L N+++ +
Sbjct: 138 DNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPH 195
Query: 363 I-ATCTALTHLEIDNNAISGEIPADI 387
L L + N +S +P +
Sbjct: 196 AFRDLGRLMTLYLFANNLS-ALPTEA 220
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 54/253 (21%), Positives = 88/253 (34%), Gaps = 57/253 (22%)
Query: 84 SLKAVDLQG----SLPS-IFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSL 138
+ + + L G +P+ F+ ++L L + S L F L +DLS N+
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 139 WGEIPTEV-CRLRKLESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQLSGKIPKSIGA 196
+ L +L +L+L+ L+ E+ + L++L YL L DN L +P
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPD--DT 148
Query: 197 LSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYT 256
L NL L L GN RI ++
Sbjct: 149 FRDL----------------------GNLTHLFL-----HGN---------RISSVP--- 169
Query: 257 SLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELG 316
L L L+QN ++ P L +L +L L+ N+L + L
Sbjct: 170 -------ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALA 222
Query: 317 SCTELTVVDFSDN 329
L + +DN
Sbjct: 223 PLRALQYLRLNDN 235
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-22
Identities = 63/239 (26%), Positives = 96/239 (40%), Gaps = 49/239 (20%)
Query: 767 NLTSANVIGTGSSGVVYR---VTIPNGE-----TLAVKKM---WSSDESGAFSSEIQTLG 815
LT +G G G V V I + T+AVK + + + SE++ +
Sbjct: 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 141
Query: 816 SI-RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG---- 870
I +HKNI+ LLG + + +Y G+L L G ++ V
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 871 ----------VAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918
+A + YL +H D+ A NVL+ +ADFGLAR ++
Sbjct: 202 FKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINN- 255
Query: 919 GDDNCSKTNQ-----RPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
D KT + +MAPE + T +SDV+SFGV++ E+ T G P
Sbjct: 256 -IDYYKKTTNGRLPVK--------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 52/206 (25%), Positives = 78/206 (37%), Gaps = 22/206 (10%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKM----WSSDESGAFSSEIQTLGSI-RHKNIVRLL 826
+G GS G V++V +G AVK+ + +E+ + + +H VRL
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 827 G-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPP 885
W L L + SL G + + + ALA+LH
Sbjct: 124 QAWEEGGIL-YLQTELC-GPSLQQHCEAWGASLPEAQVWG-YLRDTLLALAHLHSQ---G 177
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945
++H DVK N+ LGP + L DFGL + + G YMAPE
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEV-----QEGDPRYMAPE-LL 228
Query: 946 MQRITEKSDVYSFGVVLLEVLTGRHP 971
+DV+S G+ +LEV
Sbjct: 229 QGSYGTAADVFSLGLTILEVACNMEL 254
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 773 VIGTGSSGVVYRV-TIPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRLL 826
+G G G VY N +A+K ++ EI+ +RH NI+R+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 827 GW-GSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPP 885
+ K + L+ ++ P G L L G+ A + + +A AL Y H
Sbjct: 81 NYFHDRKRIYLML-EFAPRGELYKELQKHGRFDEQRSATF--MEELADALHYCHERK--- 134
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945
++H D+K N+L+G + +ADFG + +T + G+ Y+ PE
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHA----PSLRRRT-----MCGTLDYLPPEMIE 185
Query: 946 MQRITEKSDVYSFGVVLLEVLTGRHPLD 973
+ EK D++ GV+ E L G P D
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFD 213
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 18/206 (8%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
+G G + ++ E A K + + S EI S+ H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
+ + + + + SL L + EARY + + YLH + ++
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKA-LTEPEARY-YLRQIVLGCQYLHRNR---VI 163
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ 947
H D+K N+ L + + DFGLA V D K L G+ Y+APE S +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKV-----LCGTPNYIAPEVLSKK 216
Query: 948 RITEKSDVYSFGVVLLEVLTGRHPLD 973
+ + DV+S G ++ +L G+ P +
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFE 242
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKM--WSSDESGAFSSEIQTLGSIRHKNIVRLLGW 828
+G G+ G VY+ G A K + S +E + EI+ L + H IV+LLG
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG- 83
Query: 829 GSNKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
+ KL + ++ P G++ +++ +G + + + V + AL +LH I+
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNFLHSK---RII 139
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ 947
H D+KA NVL+ LADFG VS K + G+ +MAPE +
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRD---SFIGTPYWMAPEVVMCE 192
Query: 948 RITE-----KSDVYSFGVVLLEVLTGRHPL 972
+ + K+D++S G+ L+E+ P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPH 222
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 54/236 (22%), Positives = 83/236 (35%), Gaps = 46/236 (19%)
Query: 767 NLTSANVIGTGSSGVVYR----VTIPNGETLAV-----KKMWSSDESGAFSSEIQTLGSI 817
+ +G G VY+ P +T AV K F E +
Sbjct: 10 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL 69
Query: 818 RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYE----------- 866
+H N+V LLG + + + Y +G L L +
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 867 ---VVLGVAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921
+V +A + YL HH ++H D+ NVL+ ++D GL R V + D
Sbjct: 130 FVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAA--D 182
Query: 922 NCSKTNQ-----RPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
R +MAPE + + SD++S+GVVL EV + G P
Sbjct: 183 YYKLLGNSLLPIR--------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 20/216 (9%)
Query: 767 NLTSANVIGTGSSGVVYR---VTIPNGETL-AVKKM---WSSDESGAFSSEIQTLGSIRH 819
S VIG G GVVY + A+K + + AF E + + H
Sbjct: 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH 81
Query: 820 KNIVRLLGWGSNKN-LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL 878
N++ L+G L + Y+ +G L + + + + L VA + YL
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYL 140
Query: 879 --HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSY 936
+H D+ A N +L + +ADFGLAR + + + ++ +L
Sbjct: 141 AEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQQHRHARL--PV 192
Query: 937 GYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ A E R T KSDV+SFGV+L E+LT G P
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 60/250 (24%), Positives = 93/250 (37%), Gaps = 44/250 (17%)
Query: 751 MTLYQKLDFSIDD---VVR-NLTSANVIGTGSSGVVYR----VTIPNGETLAV-----KK 797
+ D + D V R +T + +G GS G+VY + + V +
Sbjct: 6 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 65
Query: 798 MWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKG 857
S E F +E + ++VRLLG S L+ + + G L S L
Sbjct: 66 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 125
Query: 858 GADWEARYEVVLG--------VAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLA 907
A+ L +A +AYL + +H D+ A N ++ + +
Sbjct: 126 MANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIG 180
Query: 908 DFGLARIVSGSGDDNCSKTNQ-----RPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVL 962
DFG+ R + D K + R +M+PE T SDV+SFGVVL
Sbjct: 181 DFGMTRDI--YETDYYRKGGKGLLPVR--------WMSPESLKDGVFTTYSDVWSFGVVL 230
Query: 963 LEVLT-GRHP 971
E+ T P
Sbjct: 231 WEIATLAEQP 240
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 98.1 bits (244), Expect = 5e-22
Identities = 37/257 (14%), Positives = 79/257 (30%), Gaps = 40/257 (15%)
Query: 772 NVIGTGSSGVVYRVT------IPNGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIV 823
+++G G+ VY T N + +K ++ E + ++ L +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 824 RLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGK---GGADWEARYEVVLGVAHALAYLHH 880
+ +N +L + G+L + ++ + + + + +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 881 DCMPPILHGDVKAMNVLLGPGYQAY-----------LADFGLARIVSGSGDDNCSKTNQR 929
I+HGD+K N +LG G+ L D G + +
Sbjct: 191 C---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA--- 244
Query: 930 PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP----------LDPTLPGG 979
+ G+ E S + + D + + +L G + +
Sbjct: 245 --KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRL 302
Query: 980 APLVQWTPLMFLMLNLE 996
L W +MLN+
Sbjct: 303 PHLDMWNEFFHVMLNIP 319
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 26/215 (12%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKM-WSSDESGAFSSEIQTLGSI-RHKNIVRLLG-- 827
++G G+ G VY+ + G+ A+K M + DE EI L H+NI G
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 828 ---WGSNKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVL-GVAHALAYLHHDC 882
+ +L L ++ GS++ L+ E + + L++LH
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK-EEWIAYICREILRGLSHLHQHK 149
Query: 883 MPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE 942
++H D+K NVLL + L DFG VS D + N G+ +MAPE
Sbjct: 150 ---VIHRDIKGQNVLLTENAEVKLVDFG----VSAQLDRTVGRRN---TFIGTPYWMAPE 199
Query: 943 HASMQRITE-----KSDVYSFGVVLLEVLTGRHPL 972
+ + KSD++S G+ +E+ G PL
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 5e-22
Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 18/206 (8%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
+G G + ++ E A K + + S EI S+ H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
+ + + + + SL L + EARY + + YLH + ++
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKA-LTEPEARY-YLRQIVLGCQYLHRNR---VI 137
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ 947
H D+K N+ L + + DFGLA V D K L G+ Y+APE S +
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKV-----LCGTPNYIAPEVLSKK 190
Query: 948 RITEKSDVYSFGVVLLEVLTGRHPLD 973
+ + DV+S G ++ +L G+ P +
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 65/262 (24%), Positives = 99/262 (37%), Gaps = 60/262 (22%)
Query: 746 DDTWEMTLYQKLDFSIDDVVR-NLTSANVIGTGSSGVVYR---VTIPNGE---TLAVKKM 798
D WE R NL +G G G V + + T+AVK +
Sbjct: 15 DPKWE-------------FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML 61
Query: 799 ---WSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAG 855
S E SE L + H ++++L G S LL +Y GSL L +
Sbjct: 62 KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121
Query: 856 KGGADWEARYEVVLG----------------------VAHALAYL--HHDCMPPILHGDV 891
K G + ++ + YL ++H D+
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDL 176
Query: 892 KAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR-PQLAGSYGYMAPEHASMQRIT 950
A N+L+ G + ++DFGL+R V D ++ R P +MA E T
Sbjct: 177 AARNILVAEGRKMKISDFGLSRDVY-EEDSYVKRSQGRIP-----VKWMAIESLFDHIYT 230
Query: 951 EKSDVYSFGVVLLEVLT-GRHP 971
+SDV+SFGV+L E++T G +P
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNP 252
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 51/227 (22%), Positives = 93/227 (40%), Gaps = 33/227 (14%)
Query: 767 NLTSANVIGTGSSGVVYR--VTIPNGETL--AVKKM----WSSDESGAFSSEIQTLGSIR 818
T ++G G G V + +G + AVK + +S + F E +
Sbjct: 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 819 HKNIVRLLG---WGSNKNLKLLFY---DYLPNGSLSSLLHGAGKGGADWEARYEVVLG-- 870
H ++ +L+G K + ++ +G L + L + G + + ++
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 871 --VAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKT 926
+A + YL + +H D+ A N +L +ADFGL+R + SGD
Sbjct: 144 VDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIY-SGDYYRQGC 197
Query: 927 NQR-PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ P ++A E + T SDV++FGV + E++T G+ P
Sbjct: 198 ASKLP-----VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 38/218 (17%), Positives = 86/218 (39%), Gaps = 24/218 (11%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKK----MWSSDESGAFSSEIQTLGSI-RHKNIVRLL 826
IG+G G V++ +G A+K+ + S + E+ + +H ++VR
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 827 G-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY--EVVLGVAHALAYLHHDCM 883
W + ++ L+ +Y GSL+ + + + ++ +++L V L Y+H
Sbjct: 78 SAWAEDDHM-LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-- 134
Query: 884 PPILHGDVKAMNVLL-------GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQ-LAGS 935
++H D+K N+ + + D+ +++ GD PQ G
Sbjct: 135 -SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGD 193
Query: 936 YGYMAPE--HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
++A E + K+D+++ + ++
Sbjct: 194 SRFLANEVLQENYTH-LPKADIFALALTVVCAAGAEPL 230
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-22
Identities = 60/216 (27%), Positives = 89/216 (41%), Gaps = 25/216 (11%)
Query: 767 NLTSANVIGTGSSGVVYR--VTIPNGETLAV-----KKMWSSDESGAFSSEIQTLGSIRH 819
+ IG G G V++ P +AV K S F E T+ H
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450
Query: 820 KNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH 879
+IV+L+G + + ++ + G L S L K D + ++ ALAYL
Sbjct: 451 PHIVKLIGVITENPVWIIM-ELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLE 508
Query: 880 -HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR--PQLAGSY 936
+H D+ A NVL+ L DFGL+R + D K ++ P
Sbjct: 509 SKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYME---DSTYYKASKGKLP-----I 556
Query: 937 GYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+MAPE + +R T SDV+ FGV + E+L G P
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 32/226 (14%)
Query: 767 NLTSANVIGTGSSGVVYR--VTIPNGETL--AVKKM----WSSDESGAFSSEIQTLGSIR 818
L ++G G G V + +G +L AVK M S E F SE +
Sbjct: 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94
Query: 819 HKNIVRLLG-----WGSNKNLKLLFYDYLPNGSLSSLL--HGAGKGGADWEAR--YEVVL 869
H N++RLLG ++ ++ G L + L G + + ++
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 870 GVAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTN 927
+A + YL + LH D+ A N +L +ADFGL++ + SGD
Sbjct: 155 DIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIY-SGDYYRQGRI 208
Query: 928 QR-PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ P ++A E + + T KSDV++FGV + E+ T G P
Sbjct: 209 AKMP-----VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 8e-22
Identities = 63/234 (26%), Positives = 95/234 (40%), Gaps = 40/234 (17%)
Query: 767 NLTSANVIGTGSSGVVYR---VTIPNGE---TLAVKKM---WSSDESGAFSSEIQTLGSI 817
L +G G+ G V I T+AVK + + E A SE++ L I
Sbjct: 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 87
Query: 818 -RHKNIVRLLGWGSNKNLKLLF-YDYLPNGSLSSLLHGAGKGGADWEARYEVVLG----- 870
H N+V LLG + L+ ++ G+LS+ L ++ E +
Sbjct: 88 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 871 ---------VAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919
VA + +L +H D+ A N+LL + DFGLAR +
Sbjct: 148 EHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDIY-KD 201
Query: 920 DDNCSKTNQR-PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
D K + R P +MAPE + T +SDV+SFGV+L E+ + G P
Sbjct: 202 PDYVRKGDARLP-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 56/255 (21%), Positives = 107/255 (41%), Gaps = 19/255 (7%)
Query: 409 ESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRL 468
+ +N++ + + L +T L ++ + L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGL 68
Query: 469 RLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVP 528
L DN++ T + + NL + +++S N L ++ G QS++ LDL S +T P
Sbjct: 69 ELKDNQI--TDLAPLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 529 DTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDI 588
++LQ++ L N+++ + LT L L + Q+S P + + KL L
Sbjct: 125 LAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA 180
Query: 589 GNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDA 648
+N+ S +I L + +L ++L +NQ S S + + L I+ L++ ++
Sbjct: 181 DDNKIS-DIS-PLASLPNLI-EVHLKNNQISDV--SPLANTSNLFIVTLTNQTIT--NQP 233
Query: 649 LASLQNLVSLNVSFN 663
+ NLV NV
Sbjct: 234 VFYNNNLVVPNVVKG 248
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 56/272 (20%), Positives = 104/272 (38%), Gaps = 42/272 (15%)
Query: 221 NCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQ 280
+N + + +++++ + L+ I T++ + + ++ E + + L L L
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 281 NSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFG 340
N I+ P + L+K+ L L N L + + +D + +T P
Sbjct: 73 NQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LA 126
Query: 341 NLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWK 400
L LQ L L +NQ++ P +A T L +L I N +S D+
Sbjct: 127 GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-----DL------------- 166
Query: 401 NKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIG 460
L+ +L L N +S P + L NL ++ L +N +S P +
Sbjct: 167 --------TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LA 214
Query: 461 NCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFV 492
N + L + L + ++ NL N V
Sbjct: 215 NTSNLFIVTLTNQTITNQPVFYNNNLVVPNVV 246
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 55/306 (17%), Positives = 107/306 (34%), Gaps = 49/306 (16%)
Query: 127 ELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQL 186
I +++ + L + +L + I + L++L L L DNQ+
Sbjct: 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQI 75
Query: 187 SGKIPKSIGALSKLQVFRAGGNQ--NLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIG 244
+ + + L+K+ GN N+ I ++ L L +
Sbjct: 76 T-DLA-PLKNLTKITELELSGNPLKNVSA-----IAGLQSIKTLDL-----TST------ 117
Query: 245 MLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQ 304
+I + + S LQ LYL N I+ I + L+ L+ L +
Sbjct: 118 ---QITDV------------TPLAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGN 160
Query: 305 NSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIA 364
+ P L + ++LT + DN ++ I +L L E+ L NQ+S P+
Sbjct: 161 AQVSDLTP--LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSPLA-- 214
Query: 365 TCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSY 424
+ L + + N I+ + N+ + P ++S + + ++
Sbjct: 215 NTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI--APATISDNGTYASPNLTW 272
Query: 425 NNLSGP 430
N S
Sbjct: 273 NLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 43/263 (16%), Positives = 80/263 (30%), Gaps = 63/263 (23%)
Query: 96 SIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESL 155
+ + L + L +S L + + +DL+ + ++ + L L+ L
Sbjct: 79 APLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQI-TDVT-PLAGLSNLQVL 134
Query: 156 YLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGEL 215
YL+ N + I S + L++L YL++ + Q+S + L+ L
Sbjct: 135 YLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVS-----DLTPLANL--------------- 172
Query: 216 PWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQN 275
S L L + I S I + + L
Sbjct: 173 -------SKLTTLKADDNKI-----SDI---------------------SPLASLPNLIE 199
Query: 276 LYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSI 335
++L N IS P + S L + L ++ + VV
Sbjct: 200 VHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVV--KGPSGAPIA 255
Query: 336 PRSFGNLLKLQELQLSVNQLSGT 358
P + + L+ N S
Sbjct: 256 PATISDNGTYASPNLTWNLTSFI 278
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 9e-22
Identities = 51/266 (19%), Positives = 103/266 (38%), Gaps = 22/266 (8%)
Query: 408 PESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRR 467
+ C + + ++ IP ++ RN +L + L L +
Sbjct: 3 HHRICHCSN-RVFLCQESKVTE-IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEK 58
Query: 468 LRLNDNRLSGTIPSEM-GNLKHLNFVDMSENHLVGGIPPSV-VGCQSLEFLDLHSNGLTG 525
+ ++ N + I +++ NL L+ + + + + + I P +L++L + + G+
Sbjct: 59 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK- 117
Query: 526 SVPDTL---PTSLQLVDLSDNRLSGSLAH-SIGSLTELSKLL-LSKNQLSGRIPAEILS- 579
+PD L+D+ DN ++ S L+ S +L L+KN + I +
Sbjct: 118 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNG 176
Query: 580 CRKLILLDIGNNRFSGEIPKE-LGQISSLEISLNLSSNQFSGEIPSE-FSGLTKLGILDL 637
+ L NN E+P + S I L++S + +PS L KL
Sbjct: 177 TQLDELNLSDNNNLE-ELPNDVFHGASGPVI-LDISRTRIH-SLPSYGLENLKKLRARST 233
Query: 638 SHNKLSGDLDALASLQNLVSLNVSFN 663
+ K L L L L+ ++++
Sbjct: 234 YNLK---KLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 4e-17
Identities = 49/274 (17%), Positives = 91/274 (33%), Gaps = 37/274 (13%)
Query: 298 KSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSG 357
+ L ++ + IP +L + F L +F L+++++S N +
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 358 TIPIEI-ATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQE 416
I ++ + L + I+ N L PE+
Sbjct: 69 VIEADVFSNLPKLHEIRIEKA-----------------------NNLLYINPEAFQNLPN 105
Query: 417 LQALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDI--GNCTTLRRLRLNDN 473
LQ L S + +P L + N I + G L LN N
Sbjct: 106 LQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 164
Query: 474 RLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSV-VGCQSLEFLDLHSNGLTGSVPDTLP 532
+ I + N L+ +++S+N+ + +P V G LD+ + S+P
Sbjct: 165 GIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGL 222
Query: 533 TSL-QLVDLSDNRLSGSLAHSIGSLTELSKLLLS 565
+L +L S L ++ L L + L+
Sbjct: 223 ENLKKLRARSTYNL--KKLPTLEKLVALMEASLT 254
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 53/304 (17%), Positives = 92/304 (30%), Gaps = 67/304 (22%)
Query: 84 SLKAVDLQG----SLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLW 139
S + Q +PS ++ L L F + +L I++S N +
Sbjct: 10 SNRVFLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 67
Query: 140 GEIPTEV-CRLRKLESLYL-NTNLLEGEIPSDI-GNLSSLAYLTLYDNQLSGKIPKSIGA 196
I +V L KL + + N L I + NL +L YL + + + +P
Sbjct: 68 EVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKI 125
Query: 197 -LSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIY 255
+ + N N+ +I N
Sbjct: 126 HSLQKVLLDIQDNINI---------------------HTIERNSFV-------------- 150
Query: 256 TSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDE- 314
G E L+L +N I I ++L L L N+ + +P++
Sbjct: 151 ------------GLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDV 197
Query: 315 LGSCTELTVVDFSDNLLTGSIPR-SFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLE 373
+ ++D S + S+P NL KL+ L +E AL
Sbjct: 198 FHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--YNLKKLPTLE--KLVALMEAS 252
Query: 374 IDNN 377
+
Sbjct: 253 LTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 9e-13
Identities = 35/192 (18%), Positives = 70/192 (36%), Gaps = 13/192 (6%)
Query: 504 PPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLL 563
+ C S + +T +P LP + + +L + +L K+
Sbjct: 3 HHRICHC-SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIE 60
Query: 564 LSKNQLSGRIPAEILS-CRKLILLDIGNNRFSGEIPKE-LGQISSLEISLNLSSNQFSGE 621
+S+N + I A++ S KL + I I E + +L+ L +S+
Sbjct: 61 ISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQ-YLLISNTGIK-H 118
Query: 622 IPSE-FSGLTKLGILDLSHNKLSGDL--DALASLQ-NLVSLNVSFNDFSGELPNTPF--F 675
+P + +LD+ N + ++ L V L ++ N E+ N+ F
Sbjct: 119 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGT 177
Query: 676 RKLPLSDLASNR 687
+ L+ +N
Sbjct: 178 QLDELNLSDNNN 189
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 99.8 bits (248), Expect = 9e-22
Identities = 61/233 (26%), Positives = 106/233 (45%), Gaps = 20/233 (8%)
Query: 441 LTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHL- 499
+ + + +S + I PD + L ++ + L ++ + + + +
Sbjct: 1 MGETITVSTPIKQ-IFPD-DAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 56
Query: 500 -VGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTE 558
V GI ++ L L+ N LT P T +L + L +N++ L+ S+ L +
Sbjct: 57 SVQGIQ----YLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIK-DLS-SLKDLKK 110
Query: 559 LSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQF 618
L L L N +S I ++ +L L +GNN+ + L +++ L+ L+L NQ
Sbjct: 111 LKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDT-LSLEDNQI 165
Query: 619 SGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPN 671
S +I +GLTKL L LS N +S DL ALA L+NL L + + + N
Sbjct: 166 S-DI-VPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPIN 215
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 87.5 bits (216), Expect = 7e-18
Identities = 47/255 (18%), Positives = 106/255 (41%), Gaps = 16/255 (6%)
Query: 409 ESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRL 468
E + +++ + + L ++ +++ ++D+ I + +L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV--QGIQYLPNVTKL 70
Query: 469 RLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVP 528
LN N+L+ + NLK+L ++ + EN + + + + L+ L L NG++
Sbjct: 71 FLNGNKLTDI--KPLTNLKNLGWLFLDENKIKD-LSS-LKDLKKLKSLSLEHNGISDING 126
Query: 529 DTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDI 588
L+ + L +N+++ + LT+L L L NQ+S I + KL L +
Sbjct: 127 LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYL 182
Query: 589 GNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDA 648
N S ++ + L + +L++ L L S + + + S L + + L +
Sbjct: 183 SKNHIS-DL-RALAGLKNLDV-LELFSQECLNKPINHQSNLVVPNTVKNTDGSLV-TPEI 238
Query: 649 LASLQNLVSLNVSFN 663
++ + NV ++
Sbjct: 239 ISDDGDYEKPNVKWH 253
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.4 bits (208), Expect = 6e-17
Identities = 49/249 (19%), Positives = 89/249 (35%), Gaps = 19/249 (7%)
Query: 230 LAETSISGNVPSSIGMLER---IQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGP 286
+ ET I + + ++ + + + + + I
Sbjct: 1 MGETITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS- 57
Query: 287 IPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQ 346
+ G I L + L L N L P L + L + +N + + S +L KL+
Sbjct: 58 VQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DLS-SLKDLKKLK 112
Query: 347 ELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGN 406
L L N +S + L L + NN I+ +I + + L N+++ +
Sbjct: 113 SLSLEHNGISDINGLV--HLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-D 167
Query: 407 IPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLR 466
I L+ +LQ L S N++S + + GL+NL L L S + N
Sbjct: 168 I-VPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPN 224
Query: 467 RLRLNDNRL 475
++ D L
Sbjct: 225 TVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 82.1 bits (202), Expect = 4e-16
Identities = 56/327 (17%), Positives = 97/327 (29%), Gaps = 79/327 (24%)
Query: 152 LESLYLNTNLLEGEIPSDIGNLSSLA---YLTLYDNQLSGKIPKSIGALSKLQVFRAGGN 208
+ + + I + A L ++ + L+ + A +
Sbjct: 1 MGETITVSTPI-----KQIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS 53
Query: 209 Q--NLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEE 266
+++G I N+ L ++GN ++ I +
Sbjct: 54 DIKSVQG-----IQYLPNVTKL-----FLNGN---------KLTDI------------KP 82
Query: 267 IGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDF 326
+ N L L+L +N I + + L KLKSL L N + L +L +
Sbjct: 83 LTNLKNLGWLFLDENKIKD-LSS-LKDLKKLKSLSLEHNGISDING--LVHLPQLESLYL 138
Query: 327 SDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPAD 386
+N +T I L KL L L NQ+S I +A T L +L + N IS D
Sbjct: 139 GNNKIT-DIT-VLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-----D 189
Query: 387 IGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLL 446
+ + GL L L+ L +
Sbjct: 190 LRALAGLK---------------------NLDVLELFSQECLNKPINHQSNLVVPNTVKN 228
Query: 447 LSNDLSGFIPPDIGNCTTLRRLRLNDN 473
L P I + + + +
Sbjct: 229 TDGSL--VTPEIISDDGDYEKPNVKWH 253
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 78.6 bits (193), Expect = 4e-15
Identities = 42/185 (22%), Positives = 82/185 (44%), Gaps = 19/185 (10%)
Query: 509 GCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQ 568
+L +T +V S+ + +++ + S+ I L ++KL L+ N+
Sbjct: 19 AFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNK 76
Query: 569 LSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSG 628
L+ I + + + L L + N+ ++ L + L+ L+L N S +I
Sbjct: 77 LT-DIKP-LTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKS-LSLEHNGIS-DING-LVH 129
Query: 629 LTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRG 688
L +L L L +NK++ D+ L+ L L +L++ N S ++ PL+ L +
Sbjct: 130 LPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQIS-DIV--------PLAGLTKLQN 179
Query: 689 LYISG 693
LY+S
Sbjct: 180 LYLSK 184
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 64.4 bits (156), Expect = 1e-10
Identities = 40/209 (19%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 101 LKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTN 160
L S+ ++I ++ ++ ++ + +T + L+GN L +I + L+ L L+L+ N
Sbjct: 42 LNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKL-TDI-KPLTNLKNLGWLFLDEN 97
Query: 161 LLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQ--NLKGELPWE 218
++ ++ S + +L L L+L N +S I + L +L+ G N+ ++
Sbjct: 98 KIK-DL-SSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITDITV----- 148
Query: 219 IGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYL 278
+ + L L L + IS + L ++Q + + + +S + L L L
Sbjct: 149 LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLEL 204
Query: 279 YQNSISGPIPGRIGALSKLKSLLLWQNSL 307
+ L ++ SL
Sbjct: 205 FSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 8e-04
Identities = 17/98 (17%), Positives = 32/98 (32%), Gaps = 4/98 (4%)
Query: 96 SIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESL 155
++ L L L + ++ I +L + LS N + + L+ L+ L
Sbjct: 147 TVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVL 202
Query: 156 YLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKS 193
L + + + NL + D L S
Sbjct: 203 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 61/261 (23%), Positives = 99/261 (37%), Gaps = 58/261 (22%)
Query: 741 NSFTADDTWEMTLYQKLDFSIDDVVR-NLTSANVIGTGSSGVVYR-----VTIPNGETL- 793
F+ + R ++ +G G+ G V+ + + L
Sbjct: 28 QYFSDACVHH-------------IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLV 74
Query: 794 AVK--KMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLL 851
AVK K S F E + L ++H++IVR G + L+ ++Y+ +G L+ L
Sbjct: 75 AVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL 134
Query: 852 HGAGKGGADWEARYEVV-------------LGVAHALAYL--HHDCMPPILHGDVKAMNV 896
G +V VA + YL H +H D+ N
Sbjct: 135 RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNC 189
Query: 897 LLGPGYQAYLADFGLARIVSGSGDDNCSKTNQ-----RPQLAGSYGYMAPEHASMQRITE 951
L+G G + DFG++R + D + R +M PE ++ T
Sbjct: 190 LVGQGLVVKIGDFGMSRDI--YSTDYYRVGGRTMLPIR--------WMPPESILYRKFTT 239
Query: 952 KSDVYSFGVVLLEVLT-GRHP 971
+SDV+SFGVVL E+ T G+ P
Sbjct: 240 ESDVWSFGVVLWEIFTYGKQP 260
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 20/222 (9%)
Query: 756 KLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKM--WSSDESGAFSSEIQ 812
+ S+ D + T IG G+SG VY + G+ +A+++M + +EI
Sbjct: 10 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 813 TLGSIRHKNIVRLLGWGS-NKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG 870
+ ++ NIV L S +L + +YL GSL+ ++ A V
Sbjct: 70 VMRENKNPNIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAA--VCRE 124
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
AL +LH + ++H D+K+ N+LLG L DFG SK R
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSK---RS 174
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
+ G+ +MAPE + + K D++S G++ +E++ G P
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 45/233 (19%), Positives = 83/233 (35%), Gaps = 49/233 (21%)
Query: 766 RNLTSANVIGTGSSGVVYR-------VTIPNGETL-AVK--KMWSSDESGAFSSEIQTLG 815
+L +G G+ +++ ET +K + S +F +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 816 SIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHAL 875
+ HK++V G + +L +++ GSL + L K + + EV +A A+
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAM 126
Query: 876 AYL--HHDCMPPILHGDVKAMNVLL--------GPGYQAYLADFGLARIVSGSGDDNCSK 925
+L + ++HG+V A N+LL G L+D G++ V
Sbjct: 127 HFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------- 174
Query: 926 TNQRPQLAGSYGY-----MAPEHASMQRI-TEKSDVYSFGVVLLEVLT-GRHP 971
+ PE + +D +SFG L E+ + G P
Sbjct: 175 ---------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 4e-21
Identities = 66/240 (27%), Positives = 100/240 (41%), Gaps = 46/240 (19%)
Query: 767 NLTSANVIGTGSSGVVYR---VTIPNGE---TLAVKKM---WSSDESGAFSSEIQTLGSI 817
NL V+G+G+ G V I +AVK + S E A SE++ + +
Sbjct: 46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 818 -RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG------ 870
H+NIV LLG + L ++Y G L + L + ++ E YE
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 871 ---------------VAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913
VA + +L +H D+ A NVL+ G + DFGLAR
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLAR 220
Query: 914 IVSGSGDDNCSKTNQR-PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ S + + N R P +MAPE T KSDV+S+G++L E+ + G +P
Sbjct: 221 DIM-SDSNYVVRGNARLP-----VKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-21
Identities = 67/446 (15%), Positives = 138/446 (30%), Gaps = 87/446 (19%)
Query: 271 SELQNLYLYQNSISGPIPGRIG-ALSKLKSLLLWQNSL----VGAIPDELGSCTELTVVD 325
++Q+L + +S + L + + + L L I L L ++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 326 FSDNLLTGSIPRSFGNLLK-----LQELQLSVNQLSGT----IPIEIATCTALTHLEIDN 376
N L L+ +Q+L L L+G + + T L L + +
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 377 NAISGE----IPADIGNIN-GLTLFFAWKNKLT----GNIPESLSQCQELQALDFSYNNL 427
N + + + + L L+ + L + + L S N++
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 428 SGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLS----GTIPSEM 483
+ G+R L + L + L L+L ++ + +
Sbjct: 183 NEA------GVRVLCQGL-------------KDSPCQLEALKLESCGVTSDNCRDLCGIV 223
Query: 484 GNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDN 543
+ L + + N L VG L LH + + L+ + + +
Sbjct: 224 ASKASLRELALGSNKL------GDVGMAELCPGLLHPS-----------SRLRTLWIWEC 266
Query: 544 RLS----GSLAHSIGSLTELSKLLLSKNQLSGR-----IPAEILSCRKLILLDIGNNRFS 594
++ G L + + L +L L+ N+L + +L L + + F+
Sbjct: 267 GITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326
Query: 595 GEIPKELGQI----SSLEISLNLSSNQFSGEIPSEFS-----GLTKLGILDLSHNKLSGD 645
+ L L +S+N+ E + L +L L+ +S
Sbjct: 327 AACCSHFSSVLAQNRFLL-ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 385
Query: 646 -----LDALASLQNLVSLNVSFNDFS 666
L + +L L++S N
Sbjct: 386 SCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-16
Identities = 61/376 (16%), Positives = 115/376 (30%), Gaps = 76/376 (20%)
Query: 345 LQELQLSVNQLSGT-IPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKL 403
+Q L + +LS + + +D+ ++ DI
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDIS--------------- 49
Query: 404 TGNIPESLSQCQELQALDFSYNNLSGPIPKEIF-GLRN----LTKLLLLSNDLS----GF 454
+L L L+ N L + GL+ + KL L + L+ G
Sbjct: 50 -----SALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV 104
Query: 455 IPPDIGNCTTLRRLRLNDNR--------LSGTIPSEMGNLKHLNFVDMSENHL----VGG 502
+ + TL+ L L+DN L + L+ L L
Sbjct: 105 LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQL---EYCSLSAASCEP 161
Query: 503 IPPSVVGCQSLEFLDLHSNGLTGSVPDTL-------PTSLQLVDLSDNRLS----GSLAH 551
+ + + L + +N + + L P L+ + L ++ L
Sbjct: 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221
Query: 552 SIGSLTELSKLLLSKNQLSGR-----IPAEILSCRKLILLDIGNNRFSGEIPKELGQI-- 604
+ S L +L L N+L P + +L L I + + +L ++
Sbjct: 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR 281
Query: 605 --SSLEISLNLSSNQFSGE-----IPSEFSGLTKLGILDLSHNKLSGD-----LDALASL 652
SL+ L+L+ N+ E + +L L + + LA
Sbjct: 282 AKESLK-ELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 340
Query: 653 QNLVSLNVSFNDFSGE 668
+ L+ L +S N
Sbjct: 341 RFLLELQISNNRLEDA 356
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-15
Identities = 85/524 (16%), Positives = 160/524 (30%), Gaps = 123/524 (23%)
Query: 126 RELTFIDLSGNSLWGEIPTEVCR-LRKLESLYLNTNLLEGE----IPSDIGNLSSLAYLT 180
++ +D+ L E+ L++ + + L+ L I S + +LA L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 181 LYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVP 240
L N+L + LQ + L L ++G
Sbjct: 63 LRSNELGDVGVHCVL--QGLQT------------------PSCKIQKLSLQNCCLTG--- 99
Query: 241 SSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGAL-----S 295
++ + LQ L+L N + +
Sbjct: 100 ------AGCGVLS-----------STLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC 142
Query: 296 KLKSLLLWQNSL----VGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLK-----LQ 346
+L+ L L SL + L + + + S+N + + R LK L+
Sbjct: 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLE 202
Query: 347 ELQLSVNQLSGTIPIEIA----TCTALTHLEIDNNAISGE-----IPADIGNINGLTLFF 397
L+L ++ ++ + +L L + +N + P + + L +
Sbjct: 203 ALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 262
Query: 398 AWKNKLT----GNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSG 453
W+ +T G++ L + L+ L + N L G R L + LL
Sbjct: 263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE------GARLLCETLLEPG---- 312
Query: 454 FIPPDIGNCTTLRRLRLNDNRLSGT----IPSEMGNLKHLNFVDMSENHLVGGIPPSVVG 509
L L + + S + + L + +S N L G
Sbjct: 313 ---------CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRL------EDAG 357
Query: 510 CQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLS----GSLAHSIGSLTELSKLLLS 565
+ L + L+++ L+D +S SLA ++ + L +L LS
Sbjct: 358 VRELCQGLGQPG-----------SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLS 406
Query: 566 KNQLSGRIPAEILS------CRKLILLDIGNNRFSGEIPKELGQ 603
N L G L L L + + +S E+ L
Sbjct: 407 NNCL-GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQA 449
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-14
Identities = 70/457 (15%), Positives = 146/457 (31%), Gaps = 84/457 (18%)
Query: 84 SLKAVDLQGS------LPSIFQPLKSLKRLIISSCNLTGT----IPKEFGDYRELTFIDL 133
++++D+Q + L+ + + + C LT I L ++L
Sbjct: 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63
Query: 134 SGNSLWGEIPTEVCRL-----RKLESLYLNTNLLEGE----IPSDIGNLSSLAYLTLYDN 184
N L V + K++ L L L G + S + L +L L L DN
Sbjct: 64 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123
Query: 185 QLSGKIPKSIGAL-----SKLQVFRAGGNQNLKGELPWEIG----NCSNLVMLGLAETSI 235
L + + +L+ + +L + + L ++ I
Sbjct: 124 LLGDAGLQLLCEGLLDPQCRLEKLQLEYC-SLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 236 SGNVPSSIG-MLE----RIQTIAIYTSLLS----GPIPEEIGNCSELQNLYLYQNSISGP 286
+ + L+ +++ + + + ++ + + + + L+ L L N +
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 287 -----IPGRIGALSKLKSLLLWQNSL----VGAIPDELGSCTELTVVDFSDNLLTGSIPR 337
PG + S+L++L +W+ + G + L + L + + N L R
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302
Query: 338 SFGNLLK-----LQELQLSVNQLSGTIPIEIA----TCTALTHLEIDNNAISGE----IP 384
L L+ L + + + L L+I NN + +
Sbjct: 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 362
Query: 385 ADIGNIN-GLTLFFAWKNKLT----GNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLR 439
+G L + + ++ ++ +L L+ LD S N L G+
Sbjct: 363 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA------GIL 416
Query: 440 NLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLS 476
L + + L +L L D S
Sbjct: 417 QLVESVRQ-------------PGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-05
Identities = 25/146 (17%), Positives = 46/146 (31%), Gaps = 30/146 (20%)
Query: 533 TSLQLVDLSDNRLS-GSLAHSIGSLTELSKLLLSKNQLSGR----IPAEILSCRKLILLD 587
+Q +D+ LS A + L + + L L+ I + + L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 588 IGNNRFSGEIPKELGQI-----SSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKL 642
+ +N + Q ++ L+L + +G G LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQ-KLSLQNCCLTGA-----------GCGVLS---- 106
Query: 643 SGDLDALASLQNLVSLNVSFNDFSGE 668
L +L L L++S N
Sbjct: 107 ----STLRTLPTLQELHLSDNLLGDA 128
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 25/210 (11%), Positives = 46/210 (21%), Gaps = 53/210 (25%)
Query: 773 VIGTGSSGVVYR----VTIPNGETLAVKKM---WSSDESGA--FSSEIQTLGSIRHKNIV 823
G ++ +A+ + + S L I +
Sbjct: 38 FHGGVPPLQFWQALDTAL---DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 824 RLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCM 883
R+L + L+ +++ GSL + + +A A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRA-- 148
Query: 884 PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEH 943
+ V + LA M
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYPA---------------------------TMPDA- 179
Query: 944 ASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
+ D+ G L +L R PL
Sbjct: 180 ------NPQDDIRGIGASLYALLVNRWPLP 203
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 7e-21
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 20/218 (9%)
Query: 760 SIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKM--WSSDESGAFSSEIQTLGS 816
D L S IG GS+G+V +G +AVK M +E+ +
Sbjct: 39 DQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD 98
Query: 817 IRHKNIVRLLGWGS-NKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHA 874
+H N+V + S +L + ++L G+L+ ++ + + A V V A
Sbjct: 99 YQHFNVVEMYK--SYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIAT--VCEAVLQA 153
Query: 875 LAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAG 934
LAYLH ++H D+K+ ++LL + L+DFG + K R L G
Sbjct: 154 LAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPK---RKSLVG 203
Query: 935 SYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
+ +MAPE S + D++S G++++E++ G P
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 60/225 (26%), Positives = 92/225 (40%), Gaps = 30/225 (13%)
Query: 767 NLTSANVIGTGSSGVVYR---VTIPNGE---TLAVKKM---WSSDESGAFSSEIQTLGSI 817
N+T +G G+ G VY +PN +AVK + S + F E +
Sbjct: 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 818 RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVL-----GVA 872
H+NIVR +G + + + + G L S L + + + L +A
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 873 HALAYL--HHDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTN 927
YL +H +H D+ A N LL GPG A + DFG+AR + + +
Sbjct: 151 CGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY---RASYYRKG 202
Query: 928 QRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
L +M PE T K+D +SFGV+L E+ + G P
Sbjct: 203 GCAMLPVK--WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 40/229 (17%), Positives = 85/229 (37%), Gaps = 41/229 (17%)
Query: 773 VIGTGSSGVVYRVTIPNGETLAVK-------------------KMWSSDESGAFSSEIQT 813
+ G + + + A+K K+ + F +E+Q
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 814 LGSIRHKNIVRLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG-- 870
+ I+++ + G + + +++ +Y+ N S+ ++ + +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIY-EYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 871 ----VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKT 926
V ++ +Y+H++ I H DVK N+L+ + L+DFG + + D K
Sbjct: 156 IIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYM----VDKKIKG 209
Query: 927 NQRPQLAGSYGYMAPEHASMQRIT--EKSDVYSFGVVLLEVLTGRHPLD 973
G+Y +M PE S + K D++S G+ L + P
Sbjct: 210 -----SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 64/261 (24%), Positives = 97/261 (37%), Gaps = 52/261 (19%)
Query: 736 TRMANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYR---VTIPNGE- 791
A + + D E+ +N+T +G G+ G VY +PN
Sbjct: 53 YCFAGKTSSISDLKEVPR------------KNITLIRGLGHGAFGEVYEGQVSGMPNDPS 100
Query: 792 --TLAVKKM---WSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGS 846
+AVK + S + F E + H+NIVR +G + + + + G
Sbjct: 101 PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 160
Query: 847 LSSLL--HGAGKGGADWEARYEVV---LGVAHALAYL--HHDCMPPILHGDVKAMNVLL- 898
L S L A +++ +A YL +H +H D+ A N LL
Sbjct: 161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLT 215
Query: 899 --GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGY-----MAPEHASMQRITE 951
GPG A + DFG+AR + K G M PE T
Sbjct: 216 CPGPGRVAKIGDFGMARDI--YRAGYYRK--------GGCAMLPVKWMPPEAFMEGIFTS 265
Query: 952 KSDVYSFGVVLLEVLT-GRHP 971
K+D +SFGV+L E+ + G P
Sbjct: 266 KTDTWSFGVLLWEIFSLGYMP 286
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 49/232 (21%), Positives = 88/232 (37%), Gaps = 16/232 (6%)
Query: 269 NCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSD 328
+E L + S++ + L+ + ++ + + + +T + +
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNG 77
Query: 329 NLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIG 388
N LT I NL L L L N++ ++ L L +++N IS +I +
Sbjct: 78 NKLT-DIK-PLANLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSLEHNGIS-DING-LV 131
Query: 389 NINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLS 448
++ L + NK+T +I LS+ +L L N +S +P + GL L L L
Sbjct: 132 HLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 449 NDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLV 500
N +S + L L L + NL N V ++ LV
Sbjct: 188 NHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 18/223 (8%)
Query: 442 TKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIP-SEMGNLKHLNFVDMSENHLV 500
++ + + + + L ++ + +E+ ++ + + +
Sbjct: 5 SETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQ 62
Query: 501 GGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELS 560
G + ++ L L+ N LT P +L + L +N++ L+ S+ L +L
Sbjct: 63 G-----IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLK 115
Query: 561 KLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSG 620
L L N +S I ++ +L L +GNN+ + L +++ L+ L+L NQ S
Sbjct: 116 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDT-LSLEDNQIS- 169
Query: 621 EIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFN 663
+I +GLTKL L LS N +S DL ALA L+NL L +
Sbjct: 170 DI-VPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQ 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 53/300 (17%), Positives = 98/300 (32%), Gaps = 53/300 (17%)
Query: 341 NLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWK 400
+ + L ++ + ++ + +N+ I + I L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-----SVQGIQYLP------ 68
Query: 401 NKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKL--LLLSN----DLSGF 454
+ L + N L+ +I L NL L L L DLS
Sbjct: 69 ---------------NVTKLFLNGNKLT-----DIKPLANLKNLGWLFLDENKVKDLSSL 108
Query: 455 IPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLE 514
+ L+ L L N +S I + +L L + + N + + L+
Sbjct: 109 -----KDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLD 159
Query: 515 FLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIP 574
L L N ++ VP T LQ + LS N +S L ++ L L L L + +
Sbjct: 160 TLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPI 217
Query: 575 AEILSCRKLILL-DIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLG 633
+ + + + + EI + G + +L +F+ E+ F +G
Sbjct: 218 NHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHL--PEFTNEVSFIFYQPVTIG 275
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 46/230 (20%), Positives = 84/230 (36%), Gaps = 16/230 (6%)
Query: 246 LERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQN 305
+ ++ + + + + + I + G I L + L L N
Sbjct: 23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQG-IQYLPNVTKLFLNGN 78
Query: 306 SLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIAT 365
L P L + L + +N + + S +L KL+ L L N +S +
Sbjct: 79 KLTDIKP--LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISDINGLV--H 132
Query: 366 CTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYN 425
L L + NN I+ +I + + L N+++ +I L+ +LQ L S N
Sbjct: 133 LPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKN 188
Query: 426 NLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRL 475
++S + + GL+NL L L S + N ++ D L
Sbjct: 189 HISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 51/281 (18%), Positives = 93/281 (33%), Gaps = 43/281 (15%)
Query: 148 RLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGG 207
+ L + + L+S+ + ++ + + + I L + G
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77
Query: 208 NQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEI 267
N+ + + N NL L L E + + L+
Sbjct: 78 NKLTDIK---PLANLKNLGWLFLDENKV-----KDLSSLK-------------------- 109
Query: 268 GNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFS 327
+ +L++L L N IS I G + L +L+SL L N + L T+L +
Sbjct: 110 -DLKKLKSLSLEHNGISD-ING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLE 164
Query: 328 DNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADI 387
DN ++ I L KLQ L LS N +S + L LE+ + +
Sbjct: 165 DNQIS-DIV-PLAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQ 220
Query: 388 GNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLS 428
N+ L PE +S + + + ++
Sbjct: 221 SNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 58/314 (18%), Positives = 100/314 (31%), Gaps = 73/314 (23%)
Query: 168 SDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQ--NLKGELPWEIGNCSNL 225
+ L ++ + L+ + A + +++G I N+
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG-----IQYLPNV 70
Query: 226 VMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISG 285
L L +GN ++ I + + N L L+L +N +
Sbjct: 71 TKLFL-----NGN---------KLTDI------------KPLANLKNLGWLFLDENKVKD 104
Query: 286 PIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKL 345
+ + L KLKSL L N + + + L +L + +N +T I L KL
Sbjct: 105 -LSS-LKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKIT-DIT-VLSRLTKL 158
Query: 346 QELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTG 405
L L NQ+S I +A T L +L + N IS D+ + GL
Sbjct: 159 DTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-----DLRALAGLK----------- 200
Query: 406 NIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPD-IGNCTT 464
L L+ K I NL + N + P+ I +
Sbjct: 201 ----------NLDVLELFSQECLN---KPINHQSNLVVPNTVKNTDGSLVTPEIISDDGD 247
Query: 465 LRRLRLNDNRLSGT 478
+ + + T
Sbjct: 248 YEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 8e-08
Identities = 41/215 (19%), Positives = 89/215 (41%), Gaps = 19/215 (8%)
Query: 96 SIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESL 155
L S+ ++I ++ ++ ++ + +T + L+GN L +I + L+ L L
Sbjct: 40 VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKL-TDI-KPLANLKNLGWL 95
Query: 156 YLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQ--NLKG 213
+L+ N ++ ++ S + +L L L+L N +S I + L +L+ G N+ ++
Sbjct: 96 FLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITDITV 151
Query: 214 ELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSEL 273
+ + L L L + IS ++ + L ++Q + + + +S + L
Sbjct: 152 -----LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISDL--RALAGLKNL 202
Query: 274 QNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLV 308
L L+ L ++ SLV
Sbjct: 203 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 59/240 (24%), Positives = 92/240 (38%), Gaps = 46/240 (19%)
Query: 767 NLTSANVIGTGSSGVVYR----VTIPNGETLAV-----KKMWSSDESGAFSSEIQTLGSI 817
N+ IG G+ G V++ +P V K+ S+D F E +
Sbjct: 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 107
Query: 818 RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG------- 870
+ NIV+LLG + L ++Y+ G L+ L + ++
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 871 ---------------VAHALAYL--HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913
VA +AYL +H D+ N L+G +ADFGL+R
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 914 IVSGSGDDNCSKTNQR-PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ S D + N P +M PE R T +SDV+++GVVL E+ + G P
Sbjct: 223 NI-YSADYYKADGNDAIP-----IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 65/225 (28%), Positives = 92/225 (40%), Gaps = 29/225 (12%)
Query: 759 FSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKM-----WSSDESGAFSSEIQ 812
F DD + + IG GS G VY + N E +A+KKM S+++ E++
Sbjct: 47 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 106
Query: 813 TLGSIRHKNIVRLLGWGS-NKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG 870
L +RH N ++ G + L +Y GS S LL K + E V G
Sbjct: 107 FLQKLRHPNTIQYRG--CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA-VTHG 162
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
LAYLH ++H DVKA N+LL L DFG S
Sbjct: 163 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGS-----------ASIMAPAN 208
Query: 931 QLAGSYGYMAPEHASMQRITE---KSDVYSFGVVLLEVLTGRHPL 972
G+ +MAPE + K DV+S G+ +E+ + PL
Sbjct: 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 58/236 (24%), Positives = 86/236 (36%), Gaps = 40/236 (16%)
Query: 319 TELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEI-ATCTALTHLEIDNN 377
+D S N L SF + +LQ L LS ++ TI + + L+ L + N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 378 AISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF- 436
I + S LQ L NL+ +
Sbjct: 87 PIQ-SLALGA-----------------------FSGLSSLQKLVAVETNLAS-LENFPIG 121
Query: 437 GLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLNDNRLSGTIPSEM----GNLKHLNF 491
L+ L +L + N + F P+ N T L L L+ N++ +I + LN
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNL 180
Query: 492 V-DMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTL---PTSLQLVDLSDN 543
D+S N + I P L+ L L +N L SVPD + TSLQ + L N
Sbjct: 181 SLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 53/214 (24%), Positives = 83/214 (38%), Gaps = 19/214 (8%)
Query: 455 IPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSV-VGCQSL 513
IP ++ + + L L+ N L + L +D+S + I L
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHL 78
Query: 514 EFLDLHSNGLTGSVPDTLP---TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLS 570
L L N + S+ +SLQ + + L+ IG L L +L ++ N +
Sbjct: 79 STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 571 GRIPAEILS-CRKLILLDIGNNRFSGEIPKE----LGQISSLEISLNLSSNQFSGEIPSE 625
E S L LD+ +N+ I L Q+ L +SL+LS N + P
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196
Query: 626 FSGLTKLGILDLSHNKLS----GDLDALASLQNL 655
F + +L L L N+L G D L SLQ +
Sbjct: 197 FKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKI 229
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 52/246 (21%), Positives = 83/246 (33%), Gaps = 47/246 (19%)
Query: 406 NIPESLSQCQELQALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDI-GNCT 463
N+P S + LD S+N L + F L L L ++ I + +
Sbjct: 25 NLPFST------KNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS 76
Query: 464 TLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGL 523
L L L N + ++ G G SL+ L L
Sbjct: 77 HLSTLILTGNPIQ-SLAL--------------------GAF---SGLSSLQKLVAVETNL 112
Query: 524 TGSVPDTL---PTSLQLVDLSDNRL-SGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILS 579
S+ + +L+ ++++ N + S L +LT L L LS N++ I L
Sbjct: 113 A-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLR 170
Query: 580 C-----RKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGI 634
+ LD+ N + I + L+ L L +NQ F LT L
Sbjct: 171 VLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLK-ELALDTNQLKSVPDGIFDRLTSLQK 228
Query: 635 LDLSHN 640
+ L N
Sbjct: 229 IWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 56/247 (22%), Positives = 90/247 (36%), Gaps = 49/247 (19%)
Query: 142 IPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGA---LS 198
+P ++L L+ N L + L L L ++ I GA LS
Sbjct: 26 LPFS------TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIE--DGAYQSLS 76
Query: 199 KLQVFRAGGNQNLKGELPWEI-GNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTS 257
L GN ++ L S+L L ET++ S
Sbjct: 77 HLSTLILTGNP-IQ-SLALGAFSGLSSLQKLVAVETNL--------------------AS 114
Query: 258 LLSGPIPEEIGNCSELQNLYLYQNSI-SGPIPGRIGALSKLKSLLLWQNSLVGAIPDE-L 315
L + P IG+ L+ L + N I S +P L+ L+ L L N + +I L
Sbjct: 115 LENFP----IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDL 169
Query: 316 GSCTELTVV----DFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEI-ATCTALT 370
++ ++ D S N + I ++L+EL L NQL ++P I T+L
Sbjct: 170 RVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQ 227
Query: 371 HLEIDNN 377
+ + N
Sbjct: 228 KIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 38/164 (23%), Positives = 65/164 (39%), Gaps = 11/164 (6%)
Query: 505 PSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLL 564
P V ++ + +PD LP S + +DLS N L ++S S EL L L
Sbjct: 2 PCVEVVPNITY-QCMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 565 SKNQLSGRIPAEILSC-RKLILLDIGNNRFSGEIPKEL-GQISSLEISLNLSSNQFSGEI 622
S+ ++ I L L + N + +SSL+ L + +
Sbjct: 60 SRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQ-KLVAVETNLA-SL 115
Query: 623 PSE-FSGLTKLGILDLSHNKLS--GDLDALASLQNLVSLNVSFN 663
+ L L L+++HN + + ++L NL L++S N
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 9e-19
Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 22/208 (10%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVK----KMWSSDESGAFSSEIQTLGSIRHKNIVRLL 826
+G+G+ G V A+K S+ + E+ L + H NI++L
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPI 886
+ +K L + G L + K +A ++ V + YLH I
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEV-DAA-VIIKQVLSGVTYLHKHN---I 157
Query: 887 LHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEH 943
+H D+K N+LL + DFGL+ + + + G+ Y+APE
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--------NQKKMKERLGTAYYIAPE- 208
Query: 944 ASMQRITEKSDVYSFGVVLLEVLTGRHP 971
++ EK DV+S GV+L +L G P
Sbjct: 209 VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 23/209 (11%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRL 825
V+G GS G V G+ AVK ++ + + E+Q L + H NI++L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPP 885
+ +K L + G L + + +A ++ V + Y+H +
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAA-RIIRQVLSGITYMHKNK--- 146
Query: 886 ILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE 942
I+H D+K N+LL + DFGL+ + + G+ Y+APE
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--------ASKKMKDKIGTAYYIAPE 198
Query: 943 HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
EK DV+S GV+L +L+G P
Sbjct: 199 -VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 31/131 (23%), Positives = 57/131 (43%), Gaps = 5/131 (3%)
Query: 533 TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNR 592
SL + L++ ++ L I + L ++ + P I L L I
Sbjct: 44 NSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKD 99
Query: 593 FSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASL 652
+ + L ++SL L++S + I ++ + L K+ +DLS+N D+ L +L
Sbjct: 100 VTSDKIPNLSGLTSLT-LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTL 158
Query: 653 QNLVSLNVSFN 663
L SLN+ F+
Sbjct: 159 PELKSLNIQFD 169
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-18
Identities = 34/208 (16%), Positives = 76/208 (36%), Gaps = 34/208 (16%)
Query: 341 NLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWK 400
L + + I A +LT++ + N ++ D+ I
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-----DLTGIEYAH------ 66
Query: 401 NKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIG 460
++ L + + + P I GL NL +L ++ D++ P++
Sbjct: 67 ---------------NIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLS 109
Query: 461 NCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHS 520
T+L L ++ + +I +++ L +N +D+S N + I P + L+ L++
Sbjct: 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQF 168
Query: 521 NGLTGSVP-DTLPTSLQLVDLSDNRLSG 547
+G+ + L + + G
Sbjct: 169 DGVHDYRGIEDF-PKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 29/184 (15%), Positives = 70/184 (38%), Gaps = 9/184 (4%)
Query: 461 NCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHS 520
L + + ++M +L ++ +++ L G + +++ L +++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75
Query: 521 NGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSC 580
T P + ++L+ + + ++ ++ LT L+ L +S + I +I +
Sbjct: 76 IHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 581 RKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHN 640
K+ +D+ N +I L + L+ SLN+ + KL L
Sbjct: 136 PKVNSIDLSYNGAITDI-MPLKTLPELK-SLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
Query: 641 KLSG 644
+ G
Sbjct: 192 TIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 29/234 (12%), Positives = 66/234 (28%), Gaps = 53/234 (22%)
Query: 435 IFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDM 494
L S +L + L + ++ +L +
Sbjct: 16 NIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT--------DLTGIE---- 63
Query: 495 SENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIG 554
+++ L +++ T + + I
Sbjct: 64 --------------YAHNIKDLTINNIHAT--------------NYN----------PIS 85
Query: 555 SLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLS 614
L+ L +L + ++ + L LLDI ++ I ++ + + S++LS
Sbjct: 86 GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVN-SIDLS 144
Query: 615 SNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGE 668
N +I L +L L++ + + D + L L G+
Sbjct: 145 YNGAITDI-MPLKTLPELKSLNIQFDGVH-DYRGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 9e-15
Identities = 28/213 (13%), Positives = 61/213 (28%), Gaps = 39/213 (18%)
Query: 172 NLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQ--NLKGELPWEIGNCSNLVMLG 229
+ L + + + ++ L +L G I N+ L
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLT 72
Query: 230 LAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPG 289
+ + I S L+ L + ++
Sbjct: 73 INNIHATN--------------------------YNPISGLSNLERLRIMGKDVTSDKIP 106
Query: 290 RIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQ 349
+ L+ L L + ++ +I ++ + ++ +D S N I L +L+ L
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLN 165
Query: 350 LSVNQLSGTIPIEIATCTALTHLEIDNNAISGE 382
+ + + IE L L + I G+
Sbjct: 166 IQFDGVHDYRGIE--DFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 22/164 (13%), Positives = 52/164 (31%), Gaps = 7/164 (4%)
Query: 266 EIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVD 325
+ L + L +++ + G I +K L + P + + L +
Sbjct: 39 TEAQMNSLTYITLANINVTD-LTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94
Query: 326 FSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPA 385
+T + L L L +S + +I +I T + +++ N +I
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154
Query: 386 DIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSG 429
+ + L + + + + +L L + G
Sbjct: 155 -LKTLPELKSLNIQFDGVH-DY-RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 30/206 (14%), Positives = 65/206 (31%), Gaps = 32/206 (15%)
Query: 100 PLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNT 159
P + K + + T LT+I L+ ++ ++ T + ++ L +N
Sbjct: 18 PDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINV-TDL-TGIEYAHNIKDLTINN 75
Query: 160 NLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEI 219
+ I LS+L L + ++ ++ L+ L + + + L +I
Sbjct: 76 IHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT-KI 132
Query: 220 GNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLY 279
+ + +S N I I + EL++L +
Sbjct: 133 NTLPKVNSI-----DLSYN--------GAITDI------------MPLKTLPELKSLNIQ 167
Query: 280 QNSISGPIPGRIGALSKLKSLLLWQN 305
+ + I KL L +
Sbjct: 168 FDGVHDYRG--IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 27/185 (14%), Positives = 57/185 (30%), Gaps = 32/185 (17%)
Query: 101 LKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTN 160
+ SL + +++ N+T + + ++ + L LE L +
Sbjct: 43 MNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGK 98
Query: 161 LLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIG 220
+ + ++ L+SL L + + I I L K+ N + +P +
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP--LK 156
Query: 221 NCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQ 280
L L +I + + I + +L LY +
Sbjct: 157 TLPELKSL-----NIQFD---------GVHDY------------RGIEDFPKLNQLYAFS 190
Query: 281 NSISG 285
+I G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 25/114 (21%), Positives = 44/114 (38%), Gaps = 3/114 (2%)
Query: 96 SIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESL 155
+ L +L+RL I ++T LT +D+S ++ I T++ L K+ S+
Sbjct: 82 NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI 141
Query: 156 YLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQ 209
L+ N +I + L L L + + + I KL A
Sbjct: 142 DLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 22/107 (20%), Positives = 39/107 (36%), Gaps = 3/107 (2%)
Query: 82 EISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGE 141
+ + D+ L SL L IS +I + ++ IDLS N +
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 142 IPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSG 188
I + L +L+SL + + + I + L L + + G
Sbjct: 152 I-MPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGG 195
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 5e-18
Identities = 50/249 (20%), Positives = 79/249 (31%), Gaps = 56/249 (22%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK-------KMWSSDESGAFSSEIQTLGSIRHKNIVR 824
IG GS GVV A+K + + + +E++ + + H NI R
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG-------------- 870
L ++ L + G L L+ A V
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 871 ------------------------VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYL 906
+ AL YLH+ I H D+K N L +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209
Query: 907 --ADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE--HASMQRITEKSDVYSFGVVL 962
DFGL++ + AG+ ++APE + + + K D +S GV+L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTT---KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 963 LEVLTGRHP 971
+L G P
Sbjct: 267 HLLLMGAVP 275
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 53/227 (23%), Positives = 88/227 (38%), Gaps = 50/227 (22%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKM------WSSDESGAFSSEIQTLGSIRHKNIVRL 825
++G GS G V V AVK + + EIQ L +RHKN+++L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 826 ---LGWGSNKNLKL-----------LFYDYLPNGSLSSLLHGAGKGGADWEARY---EVV 868
L + + + + D +P +A +++
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEML-DSVPEKRFP-----------VCQAHGYFCQLI 119
Query: 869 LGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQ 928
G+ YLH I+H D+K N+LL G ++ G+A + D+ +T+Q
Sbjct: 120 DGL----EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 929 RPQLAGSYGYMAPEHASMQRITE--KSDVYSFGVVLLEVLTGRHPLD 973
GS + PE A+ K D++S GV L + TG +P +
Sbjct: 173 -----GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 45/255 (17%), Positives = 92/255 (36%), Gaps = 36/255 (14%)
Query: 413 QCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLN 471
+C + + + ++ IP + L L+ L IP N + R+ ++
Sbjct: 9 ECHQEEDFRVTCKDIQR-IPS---LPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVS 63
Query: 472 DNRLSGTIPSEM-GNLKHLNFVDMSENHLVGGIPPSV-VGCQSLEFLDLHSNGLTGSVPD 529
+ + S NL + +++ + I P L+FL + + GL PD
Sbjct: 64 IDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD 122
Query: 530 TLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILS--CRKLILLD 587
+ S L ++ N IP C + + L
Sbjct: 123 --------------------LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLK 162
Query: 588 IGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSE-FSGL-TKLGILDLSHNKLSG- 644
+ NN F+ + + L+ ++ L+ N++ I + F G+ + +LD+S ++
Sbjct: 163 LYNNGFT-SVQGYAFNGTKLD-AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL 220
Query: 645 DLDALASLQNLVSLN 659
L L+ L++ N
Sbjct: 221 PSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 35/228 (15%), Positives = 69/228 (30%), Gaps = 32/228 (14%)
Query: 271 SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDEL-GSCTELTVVDFSDN 329
Q L L + + L + + + + + + + +++T ++ +
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 330 LLTGSIPRS-FGNLLKLQELQLSVNQLSGTIP--IEIATCTALTHLEIDNNAISGEIPAD 386
I L L+ L + L P ++ + LEI +N IP +
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 387 IGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLL 446
GL E L N + + F L + L
Sbjct: 150 A--FQGLC--------------------NETLTLKLYNNGFTS-VQGYAFNGTKLDAVYL 186
Query: 447 LSNDLSGFIPPDI--GNCTTLRRLRLNDNRLSGTIPSE-MGNLKHLNF 491
N I D G + L ++ ++ +PS+ + +LK L
Sbjct: 187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIA 233
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 37/197 (18%), Positives = 74/197 (37%), Gaps = 15/197 (7%)
Query: 502 GIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSK 561
G C E + + +P +LP S Q + L + L +H+ +L +S+
Sbjct: 2 GCSSPPCECHQEEDFRVTCKDIQ-RIP-SLPPSTQTLKLIETHLRTIPSHAFSNLPNISR 59
Query: 562 LLLSKNQLSGRIPAEILS-CRKLILLDIGNNRFSGEIPKE-LGQISSLEISLNLSSNQFS 619
+ +S + ++ + K+ ++I N R I + L ++ L+ L + +
Sbjct: 60 IYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLK-FLGIFNTGLK 118
Query: 620 GEIPSE--FSGLTKLGILDLSHNKLSGDL--DALASLQN-LVSLNVSFNDFSGELPNTPF 674
P IL+++ N + +A L N ++L + N F+ +
Sbjct: 119 -MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY-A 175
Query: 675 FRKLPLS--DLASNRGL 689
F L L N+ L
Sbjct: 176 FNGTKLDAVYLNKNKYL 192
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 35/260 (13%), Positives = 77/260 (29%), Gaps = 47/260 (18%)
Query: 317 SCTELTVVDFSDNLLTG--SIPRSFGNLLKLQELQLSVNQLSGTIPIEI-ATCTALTHLE 373
C + + + S+P S Q L+L L TIP + ++ +
Sbjct: 9 ECHQEEDFRVTCKDIQRIPSLPPS------TQTLKLIETHLR-TIPSHAFSNLPNISRIY 61
Query: 374 IDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPK 433
+ + ++ + L+ ++ ++ I
Sbjct: 62 VSIDVTLQQLESHS--FYNLS---------------------KVTHIEIRNTRNLTYIDP 98
Query: 434 EIF-GLRNLTKLLLLSNDLSGFIPPD--IGNCTTLRRLRLNDNRLSGTIPSEM--GNLKH 488
+ L L L + + L P + + L + DN +IP G
Sbjct: 99 DALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE 157
Query: 489 LNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVP----DTLPTSLQLVDLSDNR 544
+ + N + L+ + L+ N + + + L+D+S
Sbjct: 158 TLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTS 216
Query: 545 LSGSLAHSIGSLTELSKLLL 564
++ +L L L +L+
Sbjct: 217 VT-ALPS--KGLEHLKELIA 233
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 46/275 (16%), Positives = 91/275 (33%), Gaps = 62/275 (22%)
Query: 84 SLKAVDLQG-SLPSIFQPLKSLKRLIISSCNLTGTIPKE-FGDYRELTFIDLSGNSLWGE 141
+ + + I S + L + +L TIP F + ++ I +S + +
Sbjct: 12 QEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQ 70
Query: 142 IPTEV-CRLRKLESLYL-NTNLLEGEIPSDI-GNLSSLAYLTLYDNQLSGKIP--KSIGA 196
+ + L K+ + + NT L I D L L +L +++ L P + +
Sbjct: 71 LESHSFYNLSKVTHIEIRNTRNLT-YIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYS 128
Query: 197 LSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYT 256
+ N + TSI N +
Sbjct: 129 TDIFFILEITDNPYM---------------------TSIPVNAFQGL------------- 154
Query: 257 SLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDEL- 315
C+E L LY N + + G +KL ++ L +N + I +
Sbjct: 155 -------------CNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAF 200
Query: 316 -GSCTELTVVDFSDNLLTGSIP-RSFGNLLKLQEL 348
G + +++D S +T ++P + +L +L
Sbjct: 201 GGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIAR 234
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 47/193 (24%), Positives = 71/193 (36%), Gaps = 22/193 (11%)
Query: 406 NIPESLSQCQELQALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDIGNCTT 464
++P+ L S N L LT+L L +L+ G
Sbjct: 28 DLPKDT------TILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELTKL--QVDGTLPV 78
Query: 465 LRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSV-VGCQSLEFLDLHSNGL 523
L L L+ N+L ++P L L +D+S N L +P G L+ L L N L
Sbjct: 79 LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNEL 136
Query: 524 TGSVP----DTLPTSLQLVDLSDNRLSGSLAHSI-GSLTELSKLLLSKNQLSGRIPAEIL 578
++P L+ + L++N L+ L + L L LLL +N L IP
Sbjct: 137 K-TLPPGLLTPT-PKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192
Query: 579 SCRKLILLDIGNN 591
L + N
Sbjct: 193 GSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 40/170 (23%), Positives = 77/170 (45%), Gaps = 10/170 (5%)
Query: 512 SLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSG 571
S ++ LT ++P LP ++ LS+N L ++ T L++L L + +L+
Sbjct: 11 SHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT- 68
Query: 572 RIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSE-FSGLT 630
++ + + L LD+ +N+ +P + +L + L++S N+ + +P GL
Sbjct: 69 KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTV-LDVSFNRLT-SLPLGALRGLG 124
Query: 631 KLGILDLSHNKLSG-DLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLP 679
+L L L N+L L L L+++ N+ + ELP L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAG-LLNGLE 172
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 54/206 (26%), Positives = 84/206 (40%), Gaps = 13/206 (6%)
Query: 319 TELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNA 378
V+ LT ++P L LS N L + T LT L +D
Sbjct: 10 ASHLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 379 ISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF-G 437
++ ++ D L N+L ++P L LD S+N L+ +P G
Sbjct: 67 LT-KLQVDGTLPV-LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRG 122
Query: 438 LRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLNDNRLSGTIPSEM-GNLKHLNFVDMS 495
L L +L L N+L +PP + L +L L +N L+ +P+ + L++L+ + +
Sbjct: 123 LGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQ 180
Query: 496 ENHLVGGIPPSVVGCQSLEFLDLHSN 521
EN L IP G L F LH N
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 48/208 (23%), Positives = 80/208 (38%), Gaps = 37/208 (17%)
Query: 440 NLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHL 499
+ ++ +L+ +PPD+ L L++N L + + L +++ L
Sbjct: 11 SHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 500 VGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHSI-GSL 556
L LDL N L S+P +L ++D+S NRL+ SL L
Sbjct: 68 --TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGL 123
Query: 557 TELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSN 616
EL +L L N+L +P +L L+ L+L++N
Sbjct: 124 GELQELYLKGNELK-TLPPGLL--TPTPKLEK----------------------LSLANN 158
Query: 617 QFSGEIPSE-FSGLTKLGILDLSHNKLS 643
+ E+P+ +GL L L L N L
Sbjct: 159 NLT-ELPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 51/252 (20%), Positives = 82/252 (32%), Gaps = 60/252 (23%)
Query: 128 LTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLS 187
++ +L +P ++ + L+L+ NLL + + + L L L +L+
Sbjct: 12 HLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 188 GKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLE 247
KLQV G L L L S N
Sbjct: 69 -----------KLQVD----------------GTLPVLGTLDL-----SHN--------- 87
Query: 248 RIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSL 307
++Q++ P L L + N ++ G + L +L+ L L N L
Sbjct: 88 QLQSL-----------PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136
Query: 308 VGAIPDEL-GSCTELTVVDFSDNLLTGSIPRS-FGNLLKLQELQLSVNQLSGTIPIEIAT 365
+P L +L + ++N LT +P L L L L N L TIP
Sbjct: 137 K-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG 193
Query: 366 CTALTHLEIDNN 377
L + N
Sbjct: 194 SHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 54/277 (19%), Positives = 87/277 (31%), Gaps = 89/277 (32%)
Query: 84 SLKAVDLQG----SLPS-IFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSL 138
S V+ +LP + K L +S L Y LT ++L L
Sbjct: 11 SHLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 139 WGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALS 198
++ + L L +L L+ N L+ +P L +L L + N+L+ +P GAL
Sbjct: 68 -TKLQVDG-TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPL--GALR 121
Query: 199 KLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTI--AIYT 256
L L L L GN ++T+ + T
Sbjct: 122 GL----------------------GELQELYL-----KGN---------ELKTLPPGLLT 145
Query: 257 SLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELG 316
+L+ L L N+++ +P G L+ L
Sbjct: 146 PT------------PKLEKLSLANNNLTE-LPA--GLLNGL------------------- 171
Query: 317 SCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVN 353
L + +N L +IP+ F L L N
Sbjct: 172 --ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 2e-17
Identities = 46/257 (17%), Positives = 86/257 (33%), Gaps = 26/257 (10%)
Query: 730 IYVLVRTRMANNSFTADDTW-EMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIP 788
Y + R R+ N + E+ KL+ +VR +
Sbjct: 33 NYAIKRIRLPNRELAREKVMREVKALAKLEHP--GIVRYFNAWLETPPEKWQEEMDEIWL 90
Query: 789 NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF--YDYLPNGS 846
E+ S A S +I+ + KN V + L+ +
Sbjct: 91 KDESTDWPLS-SPSPMDAPSVKIRRMDPFSTKNTVG--QLQPSSPKVYLYIQMQLCRKEN 147
Query: 847 LSSLLHGAGKGGADWEARYEVVLG----VAHALAYLHHDCMPPILHGDVKAMNVLLGPGY 902
L ++ + + + + V L +A A+ +LH ++H D+K N+
Sbjct: 148 LKDWMN---RRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDD 201
Query: 903 QAYLADFGLARIVSGSGDDNCSKTNQRPQLA-----GSYGYMAPEHASMQRITEKSDVYS 957
+ DFGL + ++ T G+ YM+PE + K D++S
Sbjct: 202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFS 261
Query: 958 FGVVLLEVLTGRHPLDP 974
G++L E+L +
Sbjct: 262 LGLILFELL---YSFST 275
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 45/212 (21%), Positives = 90/212 (42%), Gaps = 30/212 (14%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRLL 826
++G GS V + A+K + ++ + E + + H V+L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 827 GWGSNKNLKLLFY--DYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLH-H 880
+ + ++ + L++ Y NG L + G R+ E+V AL YLH
Sbjct: 96 -YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-CTRFYTAEIVS----ALEYLHGK 149
Query: 881 DCMPPILHGDVKAMNVLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
I+H D+K N+LL + + DFG A+++S + + G+ Y+
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQ-ITDFGTAKVLSPESKQARANS-----FVGTAQYV 199
Query: 940 APEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+PE + + + SD+++ G ++ +++ G P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-17
Identities = 47/214 (21%), Positives = 82/214 (38%), Gaps = 34/214 (15%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVK----KMWSSDESGAFSSEIQTLGSIRHKNIVRLL 826
++G GS G V + + AVK + ++ E++ L + H NI++L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY------EVVLGVAHALAYLHH 880
+ + + + G L + R+ ++ V + Y+H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRK--------RFSEHDAARIIKQVFSGITYMHK 139
Query: 881 DCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG 937
I+H D+K N+LL + DFGL+ + + G+
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--------QNTKMKDRIGTAY 188
Query: 938 YMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
Y+APE EK DV+S GV+L +L+G P
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-17
Identities = 46/216 (21%), Positives = 88/216 (40%), Gaps = 31/216 (14%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK----------KMWSSDESGAFSSEIQTLGSIRHKN 821
+G+G+ G V + +A++ +D + +EI+ L + H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 822 IVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHD 881
I+++ + ++ ++ + + G L + G + + + A+ YLH +
Sbjct: 202 IIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEA-TCK-LYFYQMLLAVQYLHEN 258
Query: 882 CMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGY 938
I+H D+K NVLL + DFG ++I+ G+ + +T L G+ Y
Sbjct: 259 G---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRT-----LCGTPTY 307
Query: 939 MAPE---HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+APE D +S GV+L L+G P
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 7e-17
Identities = 52/183 (28%), Positives = 78/183 (42%), Gaps = 19/183 (10%)
Query: 505 PSVVGCQSL-----EFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSG-SLAHSIGSLTE 558
SVV C + L L +VP +LP+ L+DLS N LS + LT
Sbjct: 7 RSVVSCPANCLCASNILSCSKQQLP-NVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTN 65
Query: 559 LSKLLLSKNQLSGRIPAEILS-CRKLILLDIGNNRFSGEIPKE-LGQISSLEISLNLSSN 616
L LLLS N L+ I +E L LD+ +N + + + +LE+ L L +N
Sbjct: 66 LHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEV-LLLYNN 122
Query: 617 QFSGEIPSE-FSGLTKLGILDLSHNKLS----GDLDALASLQNLVSLNVSFNDFSGELPN 671
+ F + +L L LS N++S + L L+ L++S N +LP
Sbjct: 123 HIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK-KLPL 180
Query: 672 TPF 674
T
Sbjct: 181 TDL 183
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 51/215 (23%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 455 IPPDIGNCTTLRRLRLNDNRLSGTIPSEM--GNLKHLNFVDMSENHLVGGIPPSV-VGCQ 511
+P + + T L L+ N LS + +E L +L+ + +S NHL I V
Sbjct: 33 VPQSLPSYTA--LLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVP 88
Query: 512 SLEFLDLHSNGLTGSVPDTL---PTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQ 568
+L +LDL SN L ++ + L +L+++ L +N + ++ + +L KL LS+NQ
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147
Query: 569 LSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSG 628
+S R P E++ + ++ L + L+LSSN+ ++
Sbjct: 148 IS-RFPVELIK--------------------DGNKLPKLML-LDLSSNKLKKLPLTDLQK 185
Query: 629 LTKLG--ILDLSHNKLSGDLDALASLQNLVSLNVS 661
L L L +N L D + +S
Sbjct: 186 LPAWVKNGLYLHNNPLECDCKLYQLFSHWQYRQLS 220
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 40/177 (22%), Positives = 66/177 (37%), Gaps = 20/177 (11%)
Query: 382 EIPADI-GNINGLTLFFAWKNKLTGNIPE-SLSQCQELQALDFSYNNLSGPIPKEIF-GL 438
+P + L L N L+ E + ++ L +L S+N+L+ I E F +
Sbjct: 32 NVPQSLPSYTALLDLSH---NNLSRLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPV 87
Query: 439 RNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLNDNRLSGTIPSEM-GNLKHLNFVDMSE 496
NL L L SN L + + + L L L +N + + ++ L + +S+
Sbjct: 88 PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQ 145
Query: 497 NHLVGGIPPSV----VGCQSLEFLDLHSNGLTGSVPDTLPT----SLQLVDLSDNRL 545
N + P + L LDL SN L L + L +N L
Sbjct: 146 NQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 26/114 (22%), Positives = 46/114 (40%), Gaps = 9/114 (7%)
Query: 95 PSIFQPLKSLKRLIISSCNLTGTIPKE-FGDYRELTFIDLSGNSLWGEIPTEV-CRLRKL 152
F P+ +L+ L +SS +L T+ + F D + L + L N + + + +L
Sbjct: 81 SEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQL 138
Query: 153 ESLYLNTNLLEGEIPSDI----GNLSSLAYLTLYDNQLSGKIPKSIGALSKLQV 202
+ LYL+ N + P ++ L L L L N+L + L
Sbjct: 139 QKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVK 191
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 32/145 (22%), Positives = 59/145 (40%), Gaps = 18/145 (12%)
Query: 271 SELQNLYLYQNSISGPIPGRIGA---LSKLKSLLLWQNSLVGAIPDE-LGSCTELTVVDF 326
+ L +L L N ++ I A + L+ L L N L + + L V+
Sbjct: 64 TNLHSLLLSHNHLNF-ISS--EAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 327 SDNLLTGSIPR-SFGNLLKLQELQLSVNQLSGTIPIEI----ATCTALTHLEIDNNAISG 381
+N + + R +F ++ +LQ+L LS NQ+S P+E+ L L++ +N +
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKK 177
Query: 382 EIPADIGNINGLTLFFAWKNKLTGN 406
D+ + + L N
Sbjct: 178 LPLTDLQKLPAWVKNGLY---LHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 44/212 (20%), Positives = 80/212 (37%), Gaps = 27/212 (12%)
Query: 54 DALSSWNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPL-KSLKRLIISSC 112
D L+S + P C ++ S + LP++ Q L L +S
Sbjct: 1 DKLASGRSVVSCPAN-----CLCASNILSCSKQ------QLPNVPQSLPSYTALLDLSHN 49
Query: 113 NLTGTIPKE--FGDYRELTFIDLSGNSLWGEIPTEV-CRLRKLESLYLNTNLLEGEIPSD 169
NL+ + E L + LS N L I +E + L L L++N L +
Sbjct: 50 NLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHLH-TLDEF 106
Query: 170 I-GNLSSLAYLTLYDNQLSGKIPKSI-GALSKLQVFRAGGNQNLKGELPWEI----GNCS 223
+ +L +L L LY+N + + ++ +++LQ NQ + P E+
Sbjct: 107 LFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQ-IS-RFPVELIKDGNKLP 163
Query: 224 NLVMLGLAETSISGNVPSSIGMLERIQTIAIY 255
L++L L+ + + + L +Y
Sbjct: 164 KLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 29/115 (25%), Positives = 57/115 (49%), Gaps = 14/115 (12%)
Query: 84 SLKAVDLQG----SLPS-IFQPLKSLKRLIISSCNLTGTIPKE-FGDYRELTFIDLSGNS 137
+L+ +DL +L +F L++L+ L++ + ++ + + F D +L + LS N
Sbjct: 89 NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQ 147
Query: 138 LWGEIPTEV----CRLRKLESLYLNTNLLEGEIPSDIGNLSSL--AYLTLYDNQL 186
+ P E+ +L KL L L++N L+ +D+ L + L L++N L
Sbjct: 148 I-SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 41/219 (18%), Positives = 67/219 (30%), Gaps = 65/219 (29%)
Query: 142 IPTEVCRLRKLESLYLNTNLLEGEIPSDI--GNLSSLAYLTLYDNQLSGKIPKSIGALSK 199
+P+ L L+ N L + ++ L++L L L N L+ I A
Sbjct: 37 LPSYTALLD------LSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISS--EAFVP 86
Query: 200 LQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLL 259
+ NL L L S N + T
Sbjct: 87 V----------------------PNLRYLDL-----SSN---------HLHT-------- 102
Query: 260 SGPIPEEI-GNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDE---- 314
+ E + + L+ L LY N I +++L+ L L QN + P E
Sbjct: 103 ---LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKD 158
Query: 315 LGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVN 353
+L ++D S N L L + L ++
Sbjct: 159 GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 8e-17
Identities = 48/226 (21%), Positives = 82/226 (36%), Gaps = 47/226 (20%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESGAFSS----------EIQTLG 815
+G+G+ G V A+K + S + EI L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 816 SIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY------EVVL 869
S+ H NI++L +K L ++ G L + ++ ++
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--------KFDECDAANIMK 153
Query: 870 GVAHALAYLHHDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKT 926
+ + YLH I+H D+K N+LL + DFGL+
Sbjct: 154 QILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---------SK 201
Query: 927 NQRP-QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ + G+ Y+APE ++ EK DV+S GV++ +L G P
Sbjct: 202 DYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 54/210 (25%), Positives = 84/210 (40%), Gaps = 39/210 (18%)
Query: 455 IPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSV-VGCQSL 513
IP +I ++L L N+LS L L + +++N L +P + ++L
Sbjct: 31 IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNL 87
Query: 514 EFLDLHSNGLTGSVPD---TLPTSLQLVDLSDNRLSGSLAHSI-GSLTELSKLLLSKNQL 569
E L + N L ++P +L + L N+L SL + SLT+L+ L L N+L
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145
Query: 570 SGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGL 629
+P + KL L L L +NQ F L
Sbjct: 146 Q-SLPKGVF--DKLTSLK----------------------ELRLYNNQLKRVPEGAFDKL 180
Query: 630 TKLGILDLSHNKLS----GDLDALASLQNL 655
T+L L L +N+L G D+L L+ L
Sbjct: 181 TELKTLKLDNNQLKRVPEGAFDSLEKLKML 210
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 50/189 (26%), Positives = 85/189 (44%), Gaps = 20/189 (10%)
Query: 319 TELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATC-TALTHLEIDNN 377
+ +D N L+ ++F L KL+ L L+ N+L T+P I L L + +N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 378 AISGEIPADI----GNINGLTLFFAWKNKLT---GNIPESLSQCQELQALDFSYNNLSGP 430
+ +P + N+ L L N+L + +SL++ L L YN L
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDR---NQLKSLPPRVFDSLTK---LTYLSLGYNELQS- 147
Query: 431 IPKEIF-GLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLNDNRLSGTIPSEMGNLKH 488
+PK +F L +L +L L +N L +P T L+ L+L++N+L +L+
Sbjct: 148 LPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEK 206
Query: 489 LNFVDMSEN 497
L + + EN
Sbjct: 207 LKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 66/289 (22%), Positives = 103/289 (35%), Gaps = 94/289 (32%)
Query: 74 CSSNGEVVEISLKAVDLQG----SLPS-IFQPLKSLKRLIISSCNLTGTIPKEFGDYREL 128
CS N + +VD ++PS I K+L + S L+ K F +L
Sbjct: 12 CSCNN-----NKNSVDCSSKKLTAIPSNIPA---DTKKLDLQSNKLSSLPSKAFHRLTKL 63
Query: 129 TFIDLSGNSLWGEIPTEVC-RLRKLESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQL 186
+ L+ N L +P + L+ LE+L++ N L+ +P + L +LA L L NQL
Sbjct: 64 RLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL 121
Query: 187 SGKIPKSI-GALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGM 245
+P + +L+KL G N+ L S+ V
Sbjct: 122 K-SLPPRVFDSLTKLTYLSLGYNE-L---------------------QSLPKGV------ 152
Query: 246 LERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQN 305
+ L + L+ L LY N + G L++LK+L L N
Sbjct: 153 ---------FDKL------------TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN 191
Query: 306 SLVGAIPDELGSCTELTVVDFSDNLLTGSIPR-SFGNLLKLQELQLSVN 353
L +P +F +L KL+ LQL N
Sbjct: 192 QLK-------------------------RVPEGAFDSLEKLKMLQLQEN 215
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 48/225 (21%), Positives = 86/225 (38%), Gaps = 49/225 (21%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK----------KMWSSDESGAFSSEIQTLGSIRHKN 821
+G+G+ G V + +A+K +D + +EI+ L + H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 822 IVRLLGWGSNKNLKL---------LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVA 872
I+++ + ++ + LF + N L + + +
Sbjct: 77 IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLK-----------EATCK-LYFYQML 124
Query: 873 HALAYLHHDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQR 929
A+ YLH + I+H D+K NVLL + DFG ++I+ G+ + +T
Sbjct: 125 LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRT--- 175
Query: 930 PQLAGSYGYMAPE---HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
L G+ Y+APE D +S GV+L L+G P
Sbjct: 176 --LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 54/215 (25%), Positives = 87/215 (40%), Gaps = 28/215 (13%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
IG G+ V I G +A+K ++ + F E++ + + H NIV+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLHHDCMP 884
+ L +Y G + L G+ EAR ++V A+ Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-EARSKFRQIV----SAVQYCHQKR-- 134
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHA 944
I+H D+KA N+LL +ADFG + + G+ Y APE
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGFSNEFT---VGGKLDA-----FCGAPPYAAPELF 185
Query: 945 SMQRIT-EKSDVYSFGVVLLEVLTGRHPLD-PTLP 977
++ + DV+S GV+L +++G P D L
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 81.3 bits (200), Expect = 6e-16
Identities = 47/258 (18%), Positives = 91/258 (35%), Gaps = 13/258 (5%)
Query: 403 LTGNIPESLSQCQELQALDFSYNNLS-GPIPKEIFGLRNLTKL--LLLSNDLSGFIPPDI 459
L +P+ + + L +L LS + S + ++
Sbjct: 309 LNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSEL 368
Query: 460 GNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLH 519
+C L+ L + TI M L L + + + +V ++ DL
Sbjct: 369 ESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFST--LKAVDPMRAAYLDDLR 426
Query: 520 SNGLTG-SVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEIL 578
S L SV ++++ L+ L+ L H + L ++ L LS N+L +P +
Sbjct: 427 SKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALA 483
Query: 579 SCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSG-EIPSEFSGLTKLGILDL 637
+ R L +L +N + + + L+ L L +N+ +L +L+L
Sbjct: 484 ALRCLEVLQASDNALE-NVD-GVANLPRLQE-LLLCNNRLQQSAAIQPLVSCPRLVLLNL 540
Query: 638 SHNKLSGDLDALASLQNL 655
N L + L +
Sbjct: 541 QGNSLCQEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 80.2 bits (197), Expect = 1e-15
Identities = 49/258 (18%), Positives = 94/258 (36%), Gaps = 15/258 (5%)
Query: 410 SLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLR 469
S +L A + G + + +LL + + D L R
Sbjct: 297 SHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW-CRDSATDEQLFRCE 355
Query: 470 LNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPD 529
L+ + + + SE+ + K L ++ + + ++ ++L+ L L
Sbjct: 356 LSVEKST-VLQSELESCKEL--QELEPENKWCLLT-IILLMRALDPLLYEKETLQYFSTL 411
Query: 530 TLPTSLQLVDLSDNRLSGSLAHSI--GSLTELSKLLLSKNQLSGRIPAEILSCRKLILLD 587
++ L D R L +S+ ++ L L+ L+ + + + LD
Sbjct: 412 KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLD 469
Query: 588 IGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSG--D 645
+ +NR +P L + LE+ L S N + + L +L L L +N+L
Sbjct: 470 LSHNRLR-ALPPALAALRCLEV-LQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAA 525
Query: 646 LDALASLQNLVSLNVSFN 663
+ L S LV LN+ N
Sbjct: 526 IQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 2e-12
Identities = 46/298 (15%), Positives = 89/298 (29%), Gaps = 37/298 (12%)
Query: 151 KLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQN 210
L + LN L + S L ++ + +L ++
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW-CRDSATDEQLFRCELSVEKS 361
Query: 211 LKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNC 270
L E+ +C L L E + + I ++ + + L + +
Sbjct: 362 TV--LQSELESCKELQEL---EPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDP 416
Query: 271 SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNL 330
L ++ + ++ L L L + L +T +D S N
Sbjct: 417 MRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNR 474
Query: 331 LTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNI 390
L ++P + L L+ LQ S N L + +A L L + NN +
Sbjct: 475 LR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ--------QS 523
Query: 391 NGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGP---IPKEIFGLRNLTKLL 445
+ + L C L L+ N+L + L +++ +L
Sbjct: 524 AAI---------------QPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.2 bits (145), Expect = 2e-09
Identities = 46/346 (13%), Positives = 90/346 (26%), Gaps = 25/346 (7%)
Query: 35 LDEQGQALLTWKNSLNSSTDALSSWNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSL 94
L + ++ LS + G E +
Sbjct: 236 LGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNR 295
Query: 95 PSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLES 154
PS + G + + L + +L
Sbjct: 296 PSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDR--PECWCRDSATDEQLFR 353
Query: 155 LYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGN--QNLK 212
L+ + S++ + L L + I + AL L + LK
Sbjct: 354 CELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLK 412
Query: 213 GELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLE----RIQTIAIYTSLLSGPIPEEIG 268
P +L L E S+ + + +L + + +
Sbjct: 413 AVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL------------CHLE 460
Query: 269 NCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSD 328
+ +L L N + +P + AL L+ L N+L + + + L + +
Sbjct: 461 QLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCN 517
Query: 329 NLLTG-SIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLE 373
N L + + + +L L L N L I+ L +
Sbjct: 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 563
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 3e-09
Identities = 40/208 (19%), Positives = 65/208 (31%), Gaps = 42/208 (20%)
Query: 99 QPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLN 158
PL K + L P +L L E + L+L
Sbjct: 396 DPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLL------ENSVLKMEYADVRVLHLA 449
Query: 159 TNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQ--NLKGELP 216
L + + L + +L L N+L +P ++ AL L+V +A N N+ G
Sbjct: 450 HKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDG--- 503
Query: 217 WEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNL 276
+ N L L + N R+Q + + +C L L
Sbjct: 504 --VANLPRLQEL-----LLCNN---------RLQQS---------AAIQPLVSCPRLVLL 538
Query: 277 YLYQNSISGPIPGR---IGALSKLKSLL 301
L NS+ + L + S+L
Sbjct: 539 NLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.8 bits (131), Expect = 1e-07
Identities = 51/269 (18%), Positives = 87/269 (32%), Gaps = 7/269 (2%)
Query: 419 ALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGT 478
++ FS G + + + L + G P L LND T
Sbjct: 258 SVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHT 317
Query: 479 IPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLV 538
+ ++ S + L +L T + L + +L
Sbjct: 318 FRVIWTGSDSQKECVLLKDRPECWCRDSAT-DEQLFRCELSVEKST-VLQSELESCKELQ 375
Query: 539 DLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIP 598
+L L I + L LL K L + + + LD ++F E
Sbjct: 376 ELEPENKWCLL-TIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENS 434
Query: 599 KELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSL 658
+ + + + L+L+ + + L + LDLSHN+L ALA+L+ L L
Sbjct: 435 VLKMEYADVRV-LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVL 491
Query: 659 NVSFNDFSGELPNTPFFRKLPLSDLASNR 687
S N + +L L +NR
Sbjct: 492 QASDNALE-NVDGVANLPRLQELLLCNNR 519
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 44/208 (21%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK---KMWSSDESGAFSSEIQTLGSIRHKNIVRLLGW 828
V+G+G+ V+ V G+ A+K K + +S + +EI L I+H+NIV L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS-SLENEIAVLKKIKHENIVTLEDI 74
Query: 829 -GSNKNLKL---------LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL 878
S + L LF L G + + +A V+ V A+ YL
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYT-----------EKDAS-LVIQQVLSAVKYL 122
Query: 879 H-HDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAG 934
H + I+H D+K N+L + + DFGL+++ + T G
Sbjct: 123 HENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMST-----ACG 169
Query: 935 SYGYMAPEHASMQRITEKSDVYSFGVVL 962
+ GY+APE + + ++ D +S GV+
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 51/218 (23%), Positives = 84/218 (38%), Gaps = 44/218 (20%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRLL 826
++G GS G V + + AVK + D S E++ L + H NI++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLF 87
Query: 827 GW-GSNKNLKL---------LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALA 876
+ + + LF + + S + +A ++ V +
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFS-----------EHDAA-RIIKQVFSGIT 135
Query: 877 YLHHDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLA 933
Y+H I+H D+K N+LL + DFGL+ + K
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKD-----RI 184
Query: 934 GSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
G+ Y+APE EK DV+S GV+L +L+G P
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 55/214 (25%), Positives = 84/214 (39%), Gaps = 27/214 (12%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESG--AFSSEIQTLGSIRHKNIVR 824
VIG G VV R G+ AVK K SS E ++H +IV
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADW---EARYEVVLGVAHALAYLH-H 880
LL S+ + + ++++ L + G + A + + AL Y H +
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS-HYMRQILEALRYCHDN 149
Query: 881 DCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG 937
+ I+H DVK VLL L FG+A + SG + G+
Sbjct: 150 N----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGG-----RVGTPH 198
Query: 938 YMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+MAPE + + DV+ GV+L +L+G P
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
+G G+ G V G +AVK K+ S D G EIQ L RH +I++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR---YEVVLGVAHALAYLHHDCMP 884
S + +Y+ G L + G+ EAR +++ V Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEM-EARRLFQQILSAVD----YCHRHM-- 131
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHA 944
++H D+K NVLL A +ADFGL+ ++S D +T+ GS Y APE
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRTS-----CGSPNYAAPEVI 182
Query: 945 SMQRIT-EKSDVYSFGVVLLEVLTGRHPLD 973
S + + D++S GV+L +L G P D
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 52/209 (24%), Positives = 80/209 (38%), Gaps = 43/209 (20%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK----KMWSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
+G G+ VV R G A K K S+ + E + ++H NIVRL
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 828 W-GSNKNLKL---------LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAY 877
L LF D + S + +A + + ++AY
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFYS-----------EADAS-HCIQQILESIAY 120
Query: 878 LH-HDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLA 933
H + I+H ++K N+LL G LADFGLA V D A
Sbjct: 121 CHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHG-----FA 168
Query: 934 GSYGYMAPEHASMQRITEKSDVYSFGVVL 962
G+ GY++PE ++ D+++ GV+L
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-15
Identities = 49/209 (23%), Positives = 79/209 (37%), Gaps = 42/209 (20%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK----KMWSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
+G G+ VV R + G+ A K S+ + E + ++H NIVRL
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 828 W-GSNKNLKL---------LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAY 877
+ L LF D + S + +A + + A+ +
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYS-----------EADAS-HCIQQILEAVLH 125
Query: 878 LH-HDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLA 933
H ++H ++K N+LL G LADFGLA V G A
Sbjct: 126 CHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-------FA 174
Query: 934 GSYGYMAPEHASMQRITEKSDVYSFGVVL 962
G+ GY++PE + D+++ GV+L
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 53/214 (24%), Positives = 87/214 (40%), Gaps = 39/214 (18%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSN 831
+G G++ +VYR + A+K + + + +EI L + H NI++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFET 119
Query: 832 KNLKLLFYDYLPNGSLSSLLHGAGKGGADW----------EARYEVVLGVAHALAYLH-H 880
L + + G L D +A + V + A+AYLH +
Sbjct: 120 PTEISLVLELVTGGEL-----------FDRIVEKGYYSERDAA-DAVKQILEAVAYLHEN 167
Query: 881 DCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYG 937
I+H D+K N+L P +ADFGL++IV KT + G+ G
Sbjct: 168 G----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKT-----VCGTPG 215
Query: 938 YMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
Y APE + D++S G++ +L G P
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 7e-15
Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 21/208 (10%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVK---KMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWG 829
+G G+ G V E +AVK + D EI + H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 830 SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLHHDCMPPI 886
N++ LF +Y G L + +A+ +++ GV YLH I
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEP-DAQRFFHQLMAGV----VYLHGIG---I 126
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM 946
H D+K N+LL ++DFGLA + + + + G+ Y+APE
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-----MCGTLPYVAPELLKR 181
Query: 947 QRIT-EKSDVYSFGVVLLEVLTGRHPLD 973
+ E DV+S G+VL +L G P D
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 8e-15
Identities = 46/232 (19%), Positives = 89/232 (38%), Gaps = 19/232 (8%)
Query: 746 DDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDES 804
+D W+ + Q ++ V +G+G+ GVV+R G K + +
Sbjct: 31 EDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL 90
Query: 805 G--AFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWE 862
+EI + + H ++ L +K +L ++L G L + ++ E
Sbjct: 91 DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE 150
Query: 863 ARYEVVLGVAHALAYLH-HDCMPPILHGDVKAMNVLLG--PGYQAYLADFGLARIVSGSG 919
+ L ++H H I+H D+K N++ + DFGLA +
Sbjct: 151 VI-NYMRQACEGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATKL---N 202
Query: 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
D K + + APE + + +D+++ GV+ +L+G P
Sbjct: 203 PDEIVKV-----TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK---KMWSSDESGAFSSEIQTLGSIRHKNIVRLLGW 828
+G+G+ G V+ V +G +K K S +EI+ L S+ H NI+++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 829 GSNKNLKLLFYDYLPNGSL-SSLLHGAGKGGA--DWEARYEVVLGVAHALAYLH-HDCMP 884
+ + + + G L ++ +G A + E++ + +ALAY H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-ELMKQMMNALAYFHSQH--- 144
Query: 885 PILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAP 941
++H D+K N+L P + DFGLA + D S AG+ YMAP
Sbjct: 145 -VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF---KSDEHSTN-----AAGTALYMAP 195
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
E + +T K D++S GVV+ +LTG P
Sbjct: 196 EVFK-RDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 52/209 (24%), Positives = 80/209 (38%), Gaps = 43/209 (20%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK----KMWSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
+G G+ VV R G A K K S+ + E + ++H NIVRL
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 828 W-GSNKNLKL---------LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAY 877
L LF D + S + +A + + ++AY
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREFYS-----------EADAS-HCIQQILESIAY 143
Query: 878 LH-HDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLA 933
H + I+H ++K N+LL G LADFGLA V D A
Sbjct: 144 CHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHG-----FA 191
Query: 934 GSYGYMAPEHASMQRITEKSDVYSFGVVL 962
G+ GY++PE ++ D+++ GV+L
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 27/216 (12%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK---KMWSSDESGAFSSEIQTLGSIR-HKNIVRLLG 827
V+G G+ V + + AVK K S F E++ L + H+N++ L+
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR-EVEMLYQCQGHRNVLELIE 78
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAG----KGGADWEARYEVVLGVAHALAYLHHDCM 883
+ ++ L ++ + GS+ S +H EA VV VA AL +LH+
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL-----EAS-VVVQDVASALDFLHN--- 129
Query: 884 PPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMA 940
I H D+K N+L + DF L + +GD + T + GS YMA
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 941 PE-----HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
PE ++ D++S GV+L +L+G P
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 57/238 (23%), Positives = 92/238 (38%), Gaps = 55/238 (23%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESGAFSS------------------ 809
IG GS GVV + A+K K+
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 810 -----EIQTLGSIRHKNIVRL---LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADW 861
EI L + H N+V+L L + +L ++F + + G + + D
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVF-ELVNQGPVMEVPT-LKPLSED- 137
Query: 862 EARY---EVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918
+AR+ +++ G+ YLH+ I+H D+K N+L+G +ADFG++ G
Sbjct: 138 QARFYFQDLIKGIE----YLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG- 189
Query: 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRIT---EKSDVYSFGVVLLEVLTGRHPLD 973
D S T G+ +MAPE S R + DV++ GV L + G+ P
Sbjct: 190 SDALLSNT------VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 21/208 (10%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVK---KMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWG 829
+G G+ G V E +AVK + D EI + H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 830 SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLHHDCMPPI 886
N++ LF +Y G L + +A+ +++ GV YLH I
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEP-DAQRFFHQLMAGV----VYLHGIG---I 126
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM 946
H D+K N+LL ++DFGLA + + + + G+ Y+APE
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-----MCGTLPYVAPELLKR 181
Query: 947 QRIT-EKSDVYSFGVVLLEVLTGRHPLD 973
+ E DV+S G+VL +L G P D
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 48/225 (21%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
+G GS G V T + +A+K + SD EI L +RH +I++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 828 -WGSNKNLKL--------LFYDYL-PNGSLSSLLHGAGKGGADWEARY---EVVLGVAHA 874
+ ++ + LF DY+ ++ + E R +++ +
Sbjct: 77 VITTPTDIVMVIEYAGGELF-DYIVEKKRMT-----------EDEGRRFFQQIICAI--- 121
Query: 875 LAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAG 934
Y H I+H D+K N+LL +ADFGL+ I++ D N KT+ G
Sbjct: 122 -EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT---DGNFLKTS-----CG 169
Query: 935 SYGYMAPEHASMQRIT-EKSDVYSFGVVLLEVLTGRHPLD-PTLP 977
S Y APE + + + DV+S G+VL +L GR P D +P
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP 214
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 37/238 (15%), Positives = 75/238 (31%), Gaps = 43/238 (18%)
Query: 265 EEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVV 324
+ L + S++ + + +L + +
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-----DLVSQKEL---------------------SGVQNF 46
Query: 325 DFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIP 384
+ ++ + S+ L+EL LS NQ+S P++ T L L ++ N +
Sbjct: 47 NGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSPLK--DLTKLEELSVNRNRLK---- 98
Query: 385 ADIGNINGLTL--FFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLT 442
++ I L F N+L +SL + L+ L N L + + L L
Sbjct: 99 -NLNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLE 153
Query: 443 KLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLV 500
L L N+++ + + + L + L N V + +
Sbjct: 154 VLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWI 209
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 37/159 (23%), Positives = 62/159 (38%), Gaps = 19/159 (11%)
Query: 509 GCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQ 568
G + +L +T V + +Q + ++ + SLA + T L +L LS NQ
Sbjct: 17 GLANAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQ 74
Query: 569 LSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLE----ISLNLSSNQFSGEIPS 624
+S + + KL L + NR L ++ + L L +N+
Sbjct: 75 IS-DLSP-LKDLTKLEELSVNRNR--------LKNLNGIPSACLSRLFLDNNELRD--TD 122
Query: 625 EFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFN 663
L L IL + +NKL + L L L L++ N
Sbjct: 123 SLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGN 160
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 43/227 (18%), Positives = 83/227 (36%), Gaps = 16/227 (7%)
Query: 409 ESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRL 468
S + +Q + +N+ + NL +L L N +S P + + T L L
Sbjct: 35 VSQKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90
Query: 469 RLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVP 528
+N NRL L L + N L S++ ++LE L + +N L V
Sbjct: 91 SVNRNRLKNLNGIPSACLSRLF---LDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVM 145
Query: 529 DTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKL--ILL 586
+ L+++DL N ++ + L +++ + L+ + P + + +
Sbjct: 146 LGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDLTGQKCV-NEPVKYQPELYITNTVK 202
Query: 587 DIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLG 633
D S G + L ++ E+ +FS +G
Sbjct: 203 DPDGRWISPYYISNGGSYVDGCVLWEL--PVYTDEVSYKFSEYINVG 247
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 36/230 (15%), Positives = 80/230 (34%), Gaps = 43/230 (18%)
Query: 433 KEIFGLRNLTKLLLLS---NDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHL 489
++F L + + ++ + + ++ +++ + ++ + M +L
Sbjct: 10 NQVFPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNL 65
Query: 490 NFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSL 549
+ +S N + + P + LE L ++ N L ++ L + L +N L
Sbjct: 66 KELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNNELRD-- 120
Query: 550 AHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEI 609
S+ L L L + N+L I + KL +LD+ N +I++
Sbjct: 121 TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGN-----------EITNT-- 165
Query: 610 SLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLN 659
+ L K+ +DL+ K + + L N
Sbjct: 166 --------------GGLTRLKKVNWIDLTGQKCV--NEPVKYQPELYITN 199
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 45/260 (17%), Positives = 81/260 (31%), Gaps = 41/260 (15%)
Query: 219 IGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYL 278
+N V L + S++ S L +Q S + + + L+ L+L
Sbjct: 15 DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELHL 70
Query: 279 YQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRS 338
N IS + L L T+L + + N L ++ +
Sbjct: 71 SHNQIS-----DLSPLKDL---------------------TKLEELSVNRNRLK-NL--N 101
Query: 339 FGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFA 398
L L L N+L T + L L I NN + I +G ++ L +
Sbjct: 102 GIPSACLSRLFLDNNELRDTDSLI--HLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDL 157
Query: 399 WKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPD 458
N++T N L++ +++ +D + K L + P
Sbjct: 158 HGNEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW--ISPYY 213
Query: 459 IGNCTTLRRLRLNDNRLSGT 478
I N + + T
Sbjct: 214 ISNGGSYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 40/218 (18%), Positives = 73/218 (33%), Gaps = 47/218 (21%)
Query: 168 SDIGNLSSLAYLT---LYDNQLSGKIPKSIGALSKLQVFRAGGNQ--NLKGELPWEIGNC 222
+ + LA L ++ S LS +Q F + +L G +
Sbjct: 10 NQVFPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSLAG-----MQFF 62
Query: 223 SNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNS 282
+NL L L+ I S + + + ++L+ L + +N
Sbjct: 63 TNLKELHLSHNQI-----SDL---------------------SPLKDLTKLEELSVNRNR 96
Query: 283 ISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNL 342
+ + G + L L L N L D L L ++ +N L SI G L
Sbjct: 97 LKN-LNG--IPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIV-MLGFL 149
Query: 343 LKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAIS 380
KL+ L L N+++ T + + +++
Sbjct: 150 SKLEVLDLHGNEITNTGGLT--RLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 33/257 (12%), Positives = 80/257 (31%), Gaps = 42/257 (16%)
Query: 124 DYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYD 183
+L S+ L +++ + + ++ + + + ++L L L
Sbjct: 17 GLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSH 72
Query: 184 NQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSI 243
NQ+S + + L+KL+ N+ + N + + L+ + N
Sbjct: 73 NQIS-DL-SPLKDLTKLEELSVNRNR---------LKNLNGIPSACLSRLFLDNN----- 116
Query: 244 GMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLW 303
++ + + + L+ L + N + I +G LSKL+ L L
Sbjct: 117 ----ELRDT------------DSLIHLKNLEILSIRNNKLKS-IVM-LGFLSKLEVLDLH 158
Query: 304 QNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEI 363
N + L ++ +D + + L ++ + P I
Sbjct: 159 GNEITNT--GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW--ISPYYI 214
Query: 364 ATCTALTHLEIDNNAIS 380
+ + +
Sbjct: 215 SNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 32/141 (22%), Positives = 55/141 (39%), Gaps = 16/141 (11%)
Query: 98 FQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYL 157
Q +LK L +S ++ P D +L + ++ N L L L+L
Sbjct: 59 MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRL---KNLNGIPSACLSRLFL 113
Query: 158 NTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQ--NLKGEL 215
+ N L + +L +L L++ +N+L I +G LSKL+V GN+ N G
Sbjct: 114 DNNELRD--TDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNTGG-- 167
Query: 216 PWEIGNCSNLVMLGLAETSIS 236
+ + + L
Sbjct: 168 ---LTRLKKVNWIDLTGQKCV 185
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 8e-14
Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 27/215 (12%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
+G G+ G V G +AVK K+ S D G EIQ L RH +I++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR---YEVVLGVAHALAYLHHDCMP 884
S + + +Y+ G L + G+ E+R +++ GV Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEK-ESRRLFQQILSGVD----YCHRHM-- 136
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHA 944
++H D+K NVLL A +ADFGL+ ++S D +T+ GS Y APE
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRTS-----CGSPNYAAPEVI 187
Query: 945 SMQR-ITEKSDVYSFGVVLLEVLTGRHPLD-PTLP 977
S + + D++S GV+L +L G P D +P
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP 222
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 36/215 (16%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKM-----WSSDESGAFSSEIQTLGSIRHKNIVRLL 826
IG GS G V V + A+K M +E E+Q + + H +V L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL- 80
Query: 827 GWGSNKNLKLLFY--DYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLH-H 880
W S ++ + +F D L G L L + + E+V+ AL YL
Sbjct: 81 -WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-TVKLFICELVM----ALDYLQNQ 134
Query: 881 DCMPPILHGDVKAMNVLL-GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
I+H D+K N+LL G+ ++ DF +A ++ + T +AG+ YM
Sbjct: 135 R----IIHRDMKPDNILLDEHGH-VHITDFNIAAMLP---RETQITT-----MAGTKPYM 181
Query: 940 APEHASMQRITE--KS-DVYSFGVVLLEVLTGRHP 971
APE S ++ + D +S GV E+L GR P
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 60/245 (24%), Positives = 96/245 (39%), Gaps = 57/245 (23%)
Query: 751 MTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS 809
M Y+KL+ IG G+ G V++ E +A+K++ D+ S
Sbjct: 1 MQKYEKLEK--------------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS 46
Query: 810 ----EIQTLGSIRHKNIVRLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR 864
EI L ++HKNIVRL S+K L L+F ++ L +
Sbjct: 47 SALREICLLKELKHKNIVRLHDVLHSDKKLTLVF-EFCDQ-DLKKYFDSCNGDLDPEIVK 104
Query: 865 ---YEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921
++++ G L + H +LH D+K N+L+ + LA+FGLAR G
Sbjct: 105 SFLFQLLKG----LGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF---GIP 154
Query: 922 NCSKTNQ------RP--QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
+ + RP L G+ Y + D++S G + E+ PL
Sbjct: 155 VRCYSAEVVTLWYRPPDVLFGAKLY-----------STSIDMWSAGCIFAELANAGRPL- 202
Query: 974 PTLPG 978
PG
Sbjct: 203 --FPG 205
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 48/207 (23%), Positives = 79/207 (38%), Gaps = 22/207 (10%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLG-SIRHKNIVRLLGWG 829
IG GS V R AVK + S + EI+ L +H NI+ L
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP--TEEIEILLRYGQHPNIITLKDVY 85
Query: 830 SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCMPPILH 888
+ + + + G L + ++ EA V+ + + YLH ++H
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKF-FSEREAS-AVLFTITKTVEYLHAQG----VVH 139
Query: 889 GDVKAMNVLL-GPGYQAY---LADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHA 944
D+K N+L + DFG A+ + ++ T + ++APE
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQL--RAENGLLMT-----PCYTANFVAPEVL 192
Query: 945 SMQRITEKSDVYSFGVVLLEVLTGRHP 971
Q D++S GV+L +LTG P
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 48/209 (22%), Positives = 80/209 (38%), Gaps = 26/209 (12%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSI-RHKNIVRLLGW-G 829
V+G G +G V G+ A+K + +S E+ +IV +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLL---YDSPKARQEVDHHWQASGGPHIVCILDVYE 92
Query: 830 SNKNLKLLFY---DYLPNGSLSSLLHGAGKGG-ADWEARYEVVLGVAHALAYLHHDCMPP 885
+ + K + + G L S + G + EA E++ + A+ +LH
Sbjct: 93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA-EIMRDIGTAIQFLHSHN--- 148
Query: 886 ILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE 942
I H DVK N+L L DFG A+ N + Y+APE
Sbjct: 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET---------TQNALQTPCYTPYYVAPE 199
Query: 943 HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
++ + D++S GV++ +L G P
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 35/146 (23%), Positives = 65/146 (44%), Gaps = 11/146 (7%)
Query: 517 DLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSI-GSLTELSKLLLSKNQLSGRIPA 575
D + L +P+ +P + L++N + A I L +L K+ S N+++ I
Sbjct: 17 DCSNQKLN-KIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEE 74
Query: 576 EIL-SCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSE-FSGLTKLG 633
+ + + +NR K + SL+ L L SN+ + + ++ F GL+ +
Sbjct: 75 GAFEGASGVNEILLTSNRLENVQHKMFKGLESLKT-LMLRSNRIT-CVGNDSFIGLSSVR 132
Query: 634 ILDLSHNKLS----GDLDALASLQNL 655
+L L N+++ G D L SL L
Sbjct: 133 LLSLYDNQITTVAPGAFDTLHSLSTL 158
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 38/173 (21%), Positives = 65/173 (37%), Gaps = 36/173 (20%)
Query: 74 CSSNGEVVE---ISLKAV-----------DLQG----SLPS--IFQPLKSLKRLIISSCN 113
C G V+ L + L L + IF+ L L+++ S+
Sbjct: 9 CRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNK 68
Query: 114 LTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVC-RLRKLESLYLNTNLLEGEIPSDI-G 171
+T F + I L+ N L + ++ L L++L L +N + + +D
Sbjct: 69 ITDIEEGAFEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFI 126
Query: 172 NLSSLAYLTLYDNQLSGKIPKSI-GALSKLQVFRAGGNQNLKGELPWEIGNCS 223
LSS+ L+LYDNQ++ + L L N P+ NC+
Sbjct: 127 GLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN-------PF---NCN 168
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 32/140 (22%), Positives = 58/140 (41%), Gaps = 12/140 (8%)
Query: 358 TIPIEIATCTALTHLEIDNNAISG-EIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQE 416
IP I T L ++NN + E + L NK+T +
Sbjct: 25 KIPEHIPQYT--AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 417 LQALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLNDNR 474
+ + + N L + ++F GL +L L+L SN ++ + D +++R L L DN+
Sbjct: 83 VNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
Query: 475 LSGTIP----SEMGNLKHLN 490
++ T+ + +L LN
Sbjct: 141 IT-TVAPGAFDTLHSLSTLN 159
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 22/121 (18%), Positives = 45/121 (37%), Gaps = 7/121 (5%)
Query: 263 IPEEIGNCSELQNLYLYQNSISG-PIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTEL 321
IPE I L L N + G L +L+ + N + + +
Sbjct: 26 IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 322 TVVDFSDNLLTGSIPRS-FGNLLKLQELQLSVNQLSGTIPIEI-ATCTALTHLEIDNNAI 379
+ + N L ++ F L L+ L L N+++ + + +++ L + +N I
Sbjct: 84 NEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI 141
Query: 380 S 380
+
Sbjct: 142 T 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 19/91 (20%), Positives = 37/91 (40%), Gaps = 12/91 (13%)
Query: 271 SELQNLYLYQNSISGPIPGRI-GALSKLKSLLLWQNSLVGAIP----DELGSCTELTVVD 325
S + + L N + + ++ L LK+L+L N + + L + + ++
Sbjct: 81 SGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGL---SSVRLLS 135
Query: 326 FSDNLLTGSIPR-SFGNLLKLQELQLSVNQL 355
DN +T ++ +F L L L L N
Sbjct: 136 LYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 43/216 (19%), Positives = 80/216 (37%), Gaps = 32/216 (14%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVK----------KMWSSDESGAFSSEIQTLGSIRHKNI 822
+G+G+ G V+ + + VK + G + EI L + H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 823 VRLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYL 878
+++L + + +L+ + L + + + A Y ++V V YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP-LASYIFRQLVSAV----GYL 146
Query: 879 HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGY 938
I+H D+K N+++ + L DFG A + T G+ Y
Sbjct: 147 RLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLE---RGKLFYT-----FCGTIEY 195
Query: 939 MAPEHASMQR-ITEKSDVYSFGVVLLEVLTGRHPLD 973
APE + +++S GV L ++ +P
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 64/241 (26%), Positives = 95/241 (39%), Gaps = 51/241 (21%)
Query: 751 MTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS 809
M Y KLD +G G+ VY+ +A+K++ E GA +
Sbjct: 1 METYIKLDK--------------LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT 46
Query: 810 ---EIQTLGSIRHKNIVRLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY 865
E+ L ++H NIV L + K+L L+F +YL L L G +
Sbjct: 47 AIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF-EYLDK-DLKQYLDDCGNIINMHNVKL 104
Query: 866 EVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSK 925
+ + LAY H +LH D+K N+L+ + LADFGLAR +
Sbjct: 105 -FLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAK---SIPTKTY 157
Query: 926 TNQ------RP--QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977
N+ RP L GS Y + + D++ G + E+ TGR P P
Sbjct: 158 DNEVVTLWYRPPDILLGSTDY-----------STQIDMWGVGCIFYEMATGR----PLFP 202
Query: 978 G 978
G
Sbjct: 203 G 203
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 60/246 (24%), Positives = 100/246 (40%), Gaps = 54/246 (21%)
Query: 750 EMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFS 808
+ +++L+ +G G+ VY+ G +A+K++ E G S
Sbjct: 3 SSSQFKQLEK--------------LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS 48
Query: 809 S---EIQTLGSIRHKNIVRLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR 864
+ EI + ++H+NIVRL + L L+F +++ N L + G
Sbjct: 49 TAIREISLMKELKHENIVRLYDVIHTENKLTLVF-EFMDN-DLKKYMDSRTVGNTPRGLE 106
Query: 865 YEVVLGVAH----ALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920
+V LA+ H + ILH D+K N+L+ Q L DFGLAR G
Sbjct: 107 LNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF---GI 160
Query: 921 DNCSKTNQ------RP--QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
+ +++ R L GS Y + D++S G +L E++TG+
Sbjct: 161 PVNTFSSEVVTLWYRAPDVLMGSRTY-----------STSIDIWSCGCILAEMITGK--- 206
Query: 973 DPTLPG 978
P PG
Sbjct: 207 -PLFPG 211
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 51/228 (22%), Positives = 85/228 (37%), Gaps = 50/228 (21%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFS--SEIQTLGSIRHKNIVRLL--- 826
+ G G+ G V G ++A+KK+ D +Q L + H NIV+L
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-DPRFRNRELQIMQDLAVLHHPNIVQLQSYF 88
Query: 827 ---GWGSNKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAH--------- 873
G +++ L + +Y+P+ +L +
Sbjct: 89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVA--------PPPILIKVFLFQLI 139
Query: 874 -ALAYLHHDCMPPILHGDVKAMNVLLGPG-YQAYLADFGLARIVSGSGDDN----CSKTN 927
++ LH + + H D+K NVL+ L DFG A+ +S + N CS+
Sbjct: 140 RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-PSEPNVAYICSR-- 195
Query: 928 QRPQLAGSYGYMAPEH-ASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974
Y Y APE Q T D++S G + E++ G P+
Sbjct: 196 --------Y-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PIFR 233
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 50/222 (22%), Positives = 84/222 (37%), Gaps = 46/222 (20%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESG---AFSSEIQTLGSIRHKNIV 823
+G+G +V + G A K + +S E+ L + H NI+
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 824 RLLG-WGSNKNLKL---------LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAH 873
L + + ++ L LF SLS EA + +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-----------EAT-SFIKQILD 126
Query: 874 ALAYLHHDCMPPILHGDVKAMNVLL----GPGYQAYLADFGLARIVSGSGDDNCSKTNQR 929
+ YLH I H D+K N++L P L DFGLA + D K
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKN--- 177
Query: 930 PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ G+ ++APE + + + ++D++S GV+ +L+G P
Sbjct: 178 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 68/244 (27%), Positives = 102/244 (41%), Gaps = 57/244 (23%)
Query: 751 MTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSS- 809
M YQKL +G G+ GVVY+ G +A+K++ E S
Sbjct: 20 MEKYQKL--------------EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPST 65
Query: 810 ---EIQTLGSIRHKNIVRLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR- 864
EI L + H NIV L+ S + L L+F +++ L +L G D + +
Sbjct: 66 AIREISLLKELHHPNIVSLIDVIHSERCLTLVF-EFMEK-DLKKVLDENKTGLQDSQIKI 123
Query: 865 --YEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922
Y+++ G +A+ H ILH D+K N+L+ LADFGLAR G
Sbjct: 124 YLYQLLRG----VAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF---GIPV 173
Query: 923 CSKTNQ------RP--QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974
S T++ R L GS Y + D++S G + E++TG+ P
Sbjct: 174 RSYTHEVVTLWYRAPDVLMGSKKY-----------STSVDIWSIGCIFAEMITGK----P 218
Query: 975 TLPG 978
PG
Sbjct: 219 LFPG 222
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 47/219 (21%), Positives = 81/219 (36%), Gaps = 52/219 (23%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK-----------KMWSSDESGAFSSEIQTLGSI-RH 819
++G G S VV R P + AVK + A E+ L + H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 820 KNIVRLLG-WGSNKNLKL---------LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVL 869
NI++L + +N L LF +LS + E R +++
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS-----------EKETR-KIMR 131
Query: 870 GVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR 929
+ + LH I+H D+K N+LL L DFG + + +
Sbjct: 132 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLRE--- 182
Query: 930 PQLAGSYGYMAPE------HASMQRITEKSDVYSFGVVL 962
+ G+ Y+APE + + ++ D++S GV++
Sbjct: 183 --VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 55/312 (17%), Positives = 96/312 (30%), Gaps = 76/312 (24%)
Query: 407 IPESLSQCQELQALDFSYNNLSGPIPKEI-FGLRN----LTKLLLLSNDLSGFIPPDIG- 460
+ E S + +LD S NNL E+ N +T L L N L
Sbjct: 14 VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLG-----FKNS 68
Query: 461 ---------NCTTLRRLRLNDNRLSGTIPSEMGN-LKHLNFVDMSENHLVGGIPPSVVGC 510
+ L L+ N LS E+ L +
Sbjct: 69 DELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIP-------------------- 108
Query: 511 QSLEFLDLHSNGLT-------GSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSL-----TE 558
++ LDL N + LP S+ ++L N L + + +
Sbjct: 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPAN 168
Query: 559 LSKLLLSKNQLS---GRIPAEILS--CRKLILLDIGNNRFSGEIPKELGQI-----SSLE 608
++ L L N L+ A+ L+ + LD+ N + EL I + +
Sbjct: 169 VNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVV 228
Query: 609 ISLNLSSNQFSGE----IPSEFSGLTKLGILDLSHNKLSGD--------LDALASLQNLV 656
SLNL N G + L L + L ++ + A ++Q ++
Sbjct: 229 -SLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKII 287
Query: 657 SLNVSFNDFSGE 668
++ + +
Sbjct: 288 LVDKNGKEIHPS 299
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 50/359 (13%), Positives = 97/359 (27%), Gaps = 79/359 (22%)
Query: 315 LGSCTELTVVDFSDNLLTGSIPRSFGNLLK-----LQELQLSVNQLSGTIPIEIA----- 364
+T +D S N L + L LS N L E+
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 365 TCTALTHLEIDNNAISGEIPADIGNI-----NGLTLFFAWKNKLTGN----IPESLSQC- 414
+T L + N +S + ++ +T+ N + ++ S
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 415 QELQALDFSYNNLSGPIPKEIF-GLR----NLTKLLLLSNDLSGFIPPDIG--------- 460
+ +L+ N+L E+ L N+ L L N+L+
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA-----SKNCAELAKFLA 192
Query: 461 -NCTTLRRLRLNDNR--------LSGTIPSEMGNLKHLNFVDMSENHL----VGGIPPSV 507
++ L L+ N L+ S ++ L ++ N L + +
Sbjct: 193 SIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSL---NLCLNCLHGPSLENLKLLK 249
Query: 508 VGCQSLEFLDLHSNGLTGSVPDTL---------PTSLQLVDLSDNRLSGSLAHSIGSLTE 558
+ L+ + L + + + + LVD + + S + I +L
Sbjct: 250 DSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIR 309
Query: 559 LSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQ 617
L + + I IP EL +
Sbjct: 310 ELSGKADVPSLLNQCLIFAQKHQTNIEDL--------NIPDEL-------RESIQTCKP 353
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 65/406 (16%), Positives = 121/406 (29%), Gaps = 109/406 (26%)
Query: 128 LTFIDLSGNSLWGEIPTEVCRL-----RKLESLYLNTNLLEGEIPSDIG-----NLSSLA 177
+T +DLS N+L+ E+ + + SL L+ N L + ++ +++
Sbjct: 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83
Query: 178 YLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISG 237
L L N LS KS L K L + +L L S
Sbjct: 84 SLNLSGNFLS---YKSSDELVKT----------LA-------AIPFTITVLDLGWNDFSS 123
Query: 238 NVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGAL--- 294
+ + + S + +L L N + G +
Sbjct: 124 K-----------SSSEFKQAFSN-------LPAS-ITSLNLRGNDL-----GIKSSDELI 159
Query: 295 -------SKLKSLLLWQNSL----VGAIPDELGSC-TELTVVDFSDNLLTGSIPRSFGNL 342
+ + SL L N+L + L S +T +D S NLL +
Sbjct: 160 QILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYI 219
Query: 343 LK-----LQELQLSVNQLSGTIPIEIA----TCTALTHLEIDNNAISGEIPADIGNINGL 393
+ L L +N L G + + L + +D + + ++
Sbjct: 220 FSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVK-----NMS----- 269
Query: 394 TLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSG 453
+ + + Q++ +D + + P + NL + L D+
Sbjct: 270 -------KEQCKALGAAFPNIQKIILVDKNGKEIH---PSHSIPISNLIRELSGKADV-- 317
Query: 454 FIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHL 499
P + N + + N IP E L+ + L
Sbjct: 318 ---PSLLNQCLIFAQKHQTNIEDLNIPDE---LRESI---QTCKPL 354
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 44/219 (20%), Positives = 82/219 (37%), Gaps = 36/219 (16%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK--------KMWSSDESGAFSSEIQTLGSIRHK--N 821
++G+G G VY + + +A+K E+ L +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 822 IVRLLGWGSNKNLKLLFYDY-LPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAY 877
++RLL W + +L + P L + G + AR +V+ A+ +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE-LARSFFWQVL----EAVRH 164
Query: 878 LHHDCMPPILHGDVKAMNVLLGPGY-QAYLADFGLARIVSGSG-DDNCSKTNQRPQLAGS 935
H+ +LH D+K N+L+ + L DFG ++ + D G+
Sbjct: 165 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----------GT 211
Query: 936 YGYMAPEHASMQRIT-EKSDVYSFGVVLLEVLTGRHPLD 973
Y PE R + V+S G++L +++ G P +
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 48/221 (21%), Positives = 83/221 (37%), Gaps = 26/221 (11%)
Query: 760 SIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSIR 818
+G GS + + + + AVK + E+ EI L
Sbjct: 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK-EITALKLCE 63
Query: 819 -HKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGG-ADWEARYEVVLGVAHALA 876
H NIV+L ++ L + L G L K ++ EA ++ + A++
Sbjct: 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGEL--FERIKKKKHFSETEAS-YIMRKLVSAVS 120
Query: 877 YLHHDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGD---DNCSKTNQRP 930
++H ++H D+K N+L + + DFG AR+ C
Sbjct: 121 HMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC------- 170
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ Y APE + E D++S GV+L +L+G+ P
Sbjct: 171 ---FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 4e-13
Identities = 68/244 (27%), Positives = 99/244 (40%), Gaps = 57/244 (23%)
Query: 751 MTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSS- 809
M Y L+ IG G+ GVVY+ GET A+KK+ E S
Sbjct: 1 MEKYHGLEK--------------IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPST 46
Query: 810 ---EIQTLGSIRHKNIVRLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR- 864
EI L ++H NIV+L + K L L+F ++L L LL G A+
Sbjct: 47 TIREISILKELKHSNIVKLYDVIHTKKRLVLVF-EHLDQ-DLKKLLDVCEGGLESVTAKS 104
Query: 865 --YEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922
+++ G +AY H +LH D+K N+L+ + +ADFGLAR G
Sbjct: 105 FLLQLLNG----IAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAF---GIPV 154
Query: 923 CSKTNQ------RP--QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974
T++ R L GS Y + D++S G + E++ G P
Sbjct: 155 RKYTHEIVTLWYRAPDVLMGSKKY-----------STTIDIWSVGCIFAEMVNGT----P 199
Query: 975 TLPG 978
PG
Sbjct: 200 LFPG 203
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 61/279 (21%), Positives = 97/279 (34%), Gaps = 80/279 (28%)
Query: 767 NLTSANVIGTGSSGVVYRVTI------PNGETLAVKKM---WSSDESGAFSSEIQTLGSI 817
L +G G+ G V T+AVK + + E A SE++ L I
Sbjct: 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 82
Query: 818 -RHKNIVRLLGWGS-NKNLKLLFYDYLPNGSLSSLLHGAGKG------------------ 857
H N+V LLG + ++ ++ G+LS+ L
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYV 142
Query: 858 ---GADWEARYEVVLGVAHA----------LAYLHHDCMPPILHGDVKAMNVLLGPGYQ- 903
D + R + + + L+ + + P L+ D + L+ +Q
Sbjct: 143 GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQV 202
Query: 904 ----AYLA-------------------------DFGLARIVSGSGDDNCSKTNQR-PQLA 933
+LA DFGLAR + D K + R P
Sbjct: 203 AKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY-KDPDYVRKGDARLP--- 258
Query: 934 GSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+MAPE + T +SDV+SFGV+L E+ + G P
Sbjct: 259 --LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 55/364 (15%), Positives = 110/364 (30%), Gaps = 86/364 (23%)
Query: 345 LQELQLSVNQLS--GTIPI--EIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWK 400
++ L ++ ++ + + ++ + + N I E +
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLS------------ 53
Query: 401 NKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIG 460
E+++ ++L+ +FS + LR L + LL
Sbjct: 54 --------ENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALL-------------- 91
Query: 461 NCTTLRRLRLNDNRLS-------GTIPSEMGNLKHLNFVDMSENHL-------------V 500
C L +RL+DN S+ L+HL + N L
Sbjct: 92 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL---YLHNNGLGPQAGAKIARALQE 148
Query: 501 GGIPPSVVGCQSLEFLDLHSNGLT-GSVPD-----TLPTSLQLVDLSDNRL-----SGSL 549
+ L + N L GS+ + L V + N + L
Sbjct: 149 LAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLL 208
Query: 550 AHSIGSLTELSKLLLSKNQLS---GRIPAEIL-SCRKLILLDIGNNRFSGE----IPKEL 601
+ EL L L N + A L S L L + + S +
Sbjct: 209 LEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAF 268
Query: 602 GQISSLEI-SLNLSSNQFSGE-----IPSEFSGLTKLGILDLSHNKLSGDLDALASLQNL 655
++ ++ + +L L N+ + + L L+L+ N+ S + D + ++ +
Sbjct: 269 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 328
Query: 656 VSLN 659
S
Sbjct: 329 FSTR 332
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 47/272 (17%), Positives = 78/272 (28%), Gaps = 58/272 (21%)
Query: 439 RNLTKLLLLSNDLSG----FIPPDIGNCTTLRRLRLNDNRLS-------GTIPSEMGNLK 487
++ L + ++ + + +++ + L+ N + + +L+
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 488 HLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSG 547
F D+ + IP + L L L V LSDN
Sbjct: 64 IAEFSDIFTGRVKDEIPE---ALRLL------LQALLKC------PKLHTVRLSDNAFGP 108
Query: 548 ----SLAHSIGSLTELSKLLLSKNQLS---GRIPAEILS----------CRKLILLDIGN 590
L + T L L L N L G A L L + G
Sbjct: 109 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR 168
Query: 591 NRFSGE----IPKELGQISSLEISLNLSSNQFSGE-----IPSEFSGLTKLGILDLSHNK 641
NR K L ++ + N E + + +L +LDL N
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLH-TVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT 227
Query: 642 LSGD----L-DALASLQNLVSLNVSFNDFSGE 668
+ L AL S NL L ++ S
Sbjct: 228 FTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 55/340 (16%), Positives = 106/340 (31%), Gaps = 84/340 (24%)
Query: 267 IGNCSELQNLYLYQNSISG----PIPGRIGALSKLKSLLLWQNSL----VGAIPDELGSC 318
+ S ++ L ++I+ + + +K ++L N++ + + + S
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 319 TELTVVDFSDNLL----------TGSIPRSFGNLLKLQELQLSVNQLS--GTIPIE--IA 364
+L + +FSD + ++ KL ++LS N P+ ++
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 365 TCTALTHLEIDNNAISGE-------------IPADIGNINGLTLFFAWKNKLTGN----I 407
T L HL + NN + + + N L +N+L
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179
Query: 408 PESLSQCQELQALDFSYNNLSGPIPKEIFGL-----RNLTKLLLLSNDLSGFIPPDIG-- 460
++ + L + N + + + + L L L N + +G
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT-----HLGSS 234
Query: 461 -------NCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSL 513
+ LR L LND LS +V S + L
Sbjct: 235 ALAIALKSWPNLRELGLNDCLLS----------------ARGAAAVVDAF--SKLENIGL 276
Query: 514 EFLDLHSNGLTGSVPDTL-------PTSLQLVDLSDNRLS 546
+ L L N + TL L ++L+ NR S
Sbjct: 277 QTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 56/330 (16%), Positives = 99/330 (30%), Gaps = 68/330 (20%)
Query: 102 KSLKRLIISSCNLTG----TIPKEFGDYRELTFIDLSGNSLWGE----IPTEVCRLRKLE 153
S++ + +T ++ + + I LSGN++ E + + + LE
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 154 SLYLN---TNLLEGEIPSDIGNLS-------SLAYLTLYDNQLSGKIPKSIGAL----SK 199
+ T ++ EIP + L L + L DN + + +
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123
Query: 200 LQVFRAGGNQ-------NLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTI 252
L+ N + L N L N + M +
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSM----KEW 179
Query: 253 AIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSK-------LKSLLLWQN 305
A + + L + + QN I G L + LK L L N
Sbjct: 180 A-----------KTFQSHRLLHTVKMVQNGIRP--EGIEHLLLEGLAYCQELKVLDLQDN 226
Query: 306 SL----VGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLK------LQELQLSVNQL 355
+ A+ L S L + +D LL+ + + LQ L+L N++
Sbjct: 227 TFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEI 286
Query: 356 SGTIPIEIAT-----CTALTHLEIDNNAIS 380
+ T L LE++ N S
Sbjct: 287 ELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 5e-13
Identities = 52/217 (23%), Positives = 78/217 (35%), Gaps = 44/217 (20%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK---KMWSSDESGAFSSEIQTLGSIRHKNIVRLLGW 828
IG GS G V A K K + D F EI+ + S+ H NI+RL
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKSLDHPNIIRLYET 74
Query: 829 -GSNKNLKL---------LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL 878
N ++ L LF + + +A ++ V A+AY
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVFR-----------ESDAA-RIMKDVLSAVAYC 122
Query: 879 H-HDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAG 934
H + + H D+K N L P L DFGLA +T G
Sbjct: 123 HKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF---KPGKMMRT-----KVG 170
Query: 935 SYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ Y++P+ + D +S GV++ +L G P
Sbjct: 171 TPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 7e-13
Identities = 63/261 (24%), Positives = 101/261 (38%), Gaps = 76/261 (29%)
Query: 750 EMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKK--MWSSDESGA 806
E++ Y+KL IG G+ G V++ G+ +A+KK M + E
Sbjct: 15 EVSKYEKL--------------AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP 60
Query: 807 FSS--EIQTLGSIRHKNIVRLLG-----WGSNKNLKLLFY---DYLPNGSLSSLLHGAGK 856
++ EI+ L ++H+N+V L+ K Y D+ + L+ LL
Sbjct: 61 ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL- 118
Query: 857 GGADWEARYEVVLGVAH----------ALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYL 906
V ++ L Y+H + ILH D+KA NVL+ L
Sbjct: 119 ----------VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKL 165
Query: 907 ADFGLARIVSGSGDDNCSK-TNQ------RP--QLAGSYGYMAPEHASMQRITEKSDVYS 957
ADFGLAR S + + ++ TN+ RP L G Y D++
Sbjct: 166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDY-----------GPPIDLWG 214
Query: 958 FGVVLLEVLTGRHPLDPTLPG 978
G ++ E+ T P + G
Sbjct: 215 AGCIMAEMWTRS----PIMQG 231
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 52/218 (23%), Positives = 85/218 (38%), Gaps = 51/218 (23%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK----------KMWSSDESGAFSSEIQTLGSIR-HK 820
VIG G S VV R G AVK + A E L + H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 821 NIVRLLG-WGSNKNLKL---------LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG 870
+I+ L+ + S+ + L LF +LS + E R ++
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALS-----------EKETR-SIMRS 208
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
+ A+++LH + I+H D+K N+LL Q L+DFG + + +
Sbjct: 209 LLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHL---EPGEKLRE---- 258
Query: 931 QLAGSYGYMAPE------HASMQRITEKSDVYSFGVVL 962
L G+ GY+APE + ++ D+++ GV+L
Sbjct: 259 -LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-13
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 35/212 (16%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMW-----SSDESGAFSSEIQTLGSIRHKNIVRLL 826
+GTGS G V V +G A+K + + +E + L ++ +V+L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL- 106
Query: 827 GWGSNKNLKLLFY--DYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLH-H 880
S K+ L+ +Y+ G + S L G+ AR+ ++VL YLH
Sbjct: 107 -EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYAAQIVL----TFEYLHSL 160
Query: 881 DCMPPILHGDVKAMNVLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
D +++ D+K N+L+ GY + DFG A+ V G +T L G+ +
Sbjct: 161 D----LIYRDLKPENLLIDQQGYIQ-VTDFGFAKRVKG-------RTWT---LCGTPEAL 205
Query: 940 APEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
APE + + D ++ GV++ E+ G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 48/222 (21%), Positives = 82/222 (36%), Gaps = 46/222 (20%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKM--------WSSDESGAFSSEIQTLGSIRHKNIV 823
+G+G +V + G A K + E+ L + H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 824 RLLG-WGSNKNLKL---------LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAH 873
L + + ++ L LF SLS EA + +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-----------EAT-SFIKQILD 126
Query: 874 ALAYLHHDCMPPILHGDVKAMNVLL----GPGYQAYLADFGLARIVSGSGDDNCSKTNQR 929
+ YLH I H D+K N++L P L DFGLA + D K
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKN--- 177
Query: 930 PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ G+ ++APE + + + ++D++S GV+ +L+G P
Sbjct: 178 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 9e-13
Identities = 61/244 (25%), Positives = 102/244 (41%), Gaps = 21/244 (8%)
Query: 735 RTRMANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETL 793
T +N D W+ Q ++ D V+ + +GTG+ GVV+RVT G
Sbjct: 126 GTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNF 185
Query: 794 AVK---KMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSL 850
A K SD+ EIQT+ +RH +V L + N ++ Y+++ G L
Sbjct: 186 AAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK 244
Query: 851 LHGAGKGGADWEAR-YEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG--PGYQAYLA 907
+ A + E E + V L ++H + +H D+K N++ + L
Sbjct: 245 V--ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLI 299
Query: 908 DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT 967
DFGL + K G+ + APE A + + +D++S GV+ +L+
Sbjct: 300 DFGLTAHLD---PKQSVKV-----TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351
Query: 968 GRHP 971
G P
Sbjct: 352 GLSP 355
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 9e-13
Identities = 61/242 (25%), Positives = 99/242 (40%), Gaps = 52/242 (21%)
Query: 751 MTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYR-VTIPNGETLAVKKM-WSSDESGAFS 808
M Y+K+ IG GS GVV++ G+ +A+KK S D+
Sbjct: 2 MEKYEKIG--------------KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKK 47
Query: 809 S---EIQTLGSIRHKNIVRLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR 864
EI+ L ++H N+V LL + + L L+F +Y + ++ L +G + +
Sbjct: 48 IALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF-EYCDH-TVLHELDRYQRGVPEHLVK 105
Query: 865 YEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924
+ A+ + H +H DVK N+L+ L DFG AR+++G D
Sbjct: 106 S-ITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY-- 159
Query: 925 KTNQ------RP--QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976
++ R L G Y P + DV++ G V E+L+G P
Sbjct: 160 -DDEVATRWYRSPELLVGDTQYGPP-------V----DVWAIGCVFAELLSGV----PLW 203
Query: 977 PG 978
PG
Sbjct: 204 PG 205
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 9e-13
Identities = 48/236 (20%), Positives = 87/236 (36%), Gaps = 57/236 (24%)
Query: 774 IGTGSSGVVYR---VTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLG--- 827
+G G+ G VY+ + + A+K++ + S + EI L ++H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAH----------ALAY 877
+++ + LLF DY + L ++ A+ + V L + Y
Sbjct: 89 SHADRKVWLLF-DYAEH-DLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHY 143
Query: 878 LHHDCMPPILHGDVKAMNVLLGPGYQAY----LADFGLARIVSGSGDDNCSKTNQRPQ-- 931
LH + +LH D+K N+L+ +AD G AR+ + P
Sbjct: 144 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF---NSPLKPLADLDPVVV 197
Query: 932 ---------LAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978
L G+ Y T+ D+++ G + E+LT P
Sbjct: 198 TFWYRAPELLLGARHY-----------TKAIDIWAIGCIFAELLTSE----PIFHC 238
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 54/242 (22%), Positives = 93/242 (38%), Gaps = 52/242 (21%)
Query: 751 MTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS 809
M Y+ L ++G GS G+V + G +A+KK SD+
Sbjct: 24 MEKYENL--------------GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK 69
Query: 810 ----EIQTLGSIRHKNIVRLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR 864
EI+ L +RH+N+V LL K L+F +++ + ++ L G +
Sbjct: 70 IAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF-EFVDH-TILDDLELFPNGLDYQVVQ 127
Query: 865 YEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924
+ + + + + H I+H D+K N+L+ L DFG AR ++ G+
Sbjct: 128 K-YLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---V 180
Query: 925 KTNQ------RP--QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976
++ R L G Y DV++ G ++ E+ G P
Sbjct: 181 YDDEVATRWYRAPELLVGDVKYGKA-----------VDVWAIGCLVTEMFMGE----PLF 225
Query: 977 PG 978
PG
Sbjct: 226 PG 227
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-12
Identities = 67/255 (26%), Positives = 99/255 (38%), Gaps = 75/255 (29%)
Query: 751 MTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKK--MWSSDES--G 805
Y+KLDF +G G VY+ + +A+KK + E+ G
Sbjct: 9 AKRYEKLDF--------------LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDG 54
Query: 806 AFSS---EIQTLGSIRHKNIVRLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADW 861
+ EI+ L + H NI+ LL +G N+ L+F D++ L ++
Sbjct: 55 INRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF-DFMET-DLEVIIKDNS------ 106
Query: 862 EARYEVVLGVAH----------ALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGL 911
+VL +H L YLH ILH D+K N+LL LADFGL
Sbjct: 107 -----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGL 158
Query: 912 ARIVSGSGDDNCSKTNQ------RP--QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLL 963
A+ G N + T+Q R L G+ Y D+++ G +L
Sbjct: 159 AKSF---GSPNRAYTHQVVTRWYRAPELLFGARMY-----------GVGVDMWAVGCILA 204
Query: 964 EVLTGRHPLDPTLPG 978
E+L P LPG
Sbjct: 205 ELLLRV----PFLPG 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 46/213 (21%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK-----KMWSSDESG---AFSSEIQTLGSIRHKNIV 823
+G+G +V + G+ A K ++ SS E+ L IRH NI+
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 824 RLLG-WGSNKNLKL---------LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAH 873
L + + ++ L LF SL+ EA + + +
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-----------EAT-QFLKQILD 119
Query: 874 ALAYLHHDCMPPILHGDVKAMNVLL----GPGYQAYLADFGLARIVSGSGDDNCSKTNQR 929
+ YLH I H D+K N++L P + L DFG+A + N K
Sbjct: 120 GVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI---EAGNEFKN--- 170
Query: 930 PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVL 962
+ G+ ++APE + + + ++D++S GV+
Sbjct: 171 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 48/210 (22%), Positives = 88/210 (41%), Gaps = 17/210 (8%)
Query: 767 NLTSANVIGTGSSGVVYRVT-IPNGETLAVK--KMWSSDESGAFSSEIQTLGSIRHKNIV 823
++ ++G G G V++ G LA K K + +EI + + H N++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 824 RLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCM 883
+L +KN +L +Y+ G L + + + + + + ++H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI-LFMKQICEGIRHMHQM-- 206
Query: 884 PPILHGDVKAMNVLLG--PGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAP 941
ILH D+K N+L Q + DFGLAR K N G+ ++AP
Sbjct: 207 -YILHLDLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVN-----FGTPEFLAP 257
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
E + ++ +D++S GV+ +L+G P
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 47/221 (21%), Positives = 83/221 (37%), Gaps = 38/221 (17%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK-------KMWSSDESGA-FSSEIQTLGSIR----H 819
++G G G V+ + + +A+K WS E+ L + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 820 KNIVRLLGWGSNKNLKLLFYDY-LPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHAL 875
++RLL W + +L + LP L + G G +R +VV A+
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG-PSRCFFGQVV----AAI 152
Query: 876 AYLHHDCMPPILHGDVKAMNVLLGPGYQAY-LADFGLARIVSGSG-DDNCSKTNQRPQLA 933
+ H ++H D+K N+L+ L DFG ++ D
Sbjct: 153 QHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---------- 199
Query: 934 GSYGYMAPEHASMQRIT-EKSDVYSFGVVLLEVLTGRHPLD 973
G+ Y PE S + + V+S G++L +++ G P +
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 68/228 (29%), Positives = 97/228 (42%), Gaps = 56/228 (24%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS-EIQTLGSIRHKNIVRLL---- 826
VIG GS GVVY+ +GE +A+KK+ F + E+Q + + H NIVRL
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 827 -GWGSNKNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAH----------A 874
+ L L DY+P ++ + + L V + +
Sbjct: 118 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQT--------LPVIYVKLYMYQLFRS 168
Query: 875 LAYLH-HDCMPPILHGDVKAMNVLLGPGYQAY-LADFGLARIVSGSGDDN----CSKTNQ 928
LAY+H I H D+K N+LL P L DFG A+ + G+ N CS+
Sbjct: 169 LAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSR--- 220
Query: 929 RPQLAGSYGYMAPE--HASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974
Y Y APE + T DV+S G VL E+L G+ P+ P
Sbjct: 221 -------Y-YRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQ-PIFP 258
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 38/217 (17%)
Query: 773 VIGTGSSGVVYRV-TIPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRLL 826
VIG G+ G V V + A+K +M +S F E + +V+L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 134
Query: 827 GWGSNKNLKLLFY--DYLPNGSLSSLLHGAGKGGADWE-ARY---EVVLGVAHALAYLH- 879
+ + ++ + L+ +Y+P G L +L+ + AR+ EVVL AL +H
Sbjct: 135 -FYAFQDDRYLYMVMEYMPGGDLVNLMS---NYDVPEKWARFYTAEVVL----ALDAIHS 186
Query: 880 HDCMPPILHGDVKAMNVLL-GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGY 938
+H DVK N+LL G+ LADFG ++ G C G+ Y
Sbjct: 187 MG----FIHRDVKPDNMLLDKSGHLK-LADFGTCMKMNKEGMVRCD------TAVGTPDY 235
Query: 939 MAPE----HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
++PE + D +S GV L E+L G P
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 49/223 (21%), Positives = 85/223 (38%), Gaps = 48/223 (21%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK--------KMWSSDESGAFSSEIQTLGSIRHKNIV 823
+G+G VV + G A K E+ L I+H N++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 824 RLLG-WGSNKNLKL---------LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAH 873
L + + ++ L LF SL+ EA E + + +
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-----------EAT-EFLKQILN 125
Query: 874 ALAYLH-HDCMPPILHGDVKAMNVLL----GPGYQAYLADFGLARIVSGSGDDNCSKTNQ 928
+ YLH I H D+K N++L P + + DFGLA + N K
Sbjct: 126 GVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKN-- 176
Query: 929 RPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ G+ ++APE + + + ++D++S GV+ +L+G P
Sbjct: 177 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 64/216 (29%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVK---KMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWG 829
IG+G+ GV + E +AVK + + DE+ EI S+RH NIVR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN--VQREIINHRSLRHPNIVRFKEVI 85
Query: 830 SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLHHDCMPPI 886
+ +Y G L + AG+ D EAR+ +++ GV +Y H I
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSED-EARFFFQQLLSGV----SYCHSMQ---I 137
Query: 887 LHGDVKAMNVLLGPGYQAYL--ADFGLARIVSGSGDDNCSKTNQRPQLA-GSYGYMAPEH 943
H D+K N LL L DFG + S + +P+ G+ Y+APE
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYS---------KSSVLHSQPKSTVGTPAYIAPEV 188
Query: 944 ASMQRIT-EKSDVYSFGVVLLEVLTGRHPL-DPTLP 977
Q + +DV+S GV L +L G +P DP P
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 224
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 9e-12
Identities = 53/247 (21%), Positives = 89/247 (36%), Gaps = 58/247 (23%)
Query: 751 MTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS 809
+ Y+++ +G G+ G VY+ ET+A+K++ E
Sbjct: 33 IDRYRRITK--------------LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPG 78
Query: 810 ----EIQTLGSIRHKNIVRLLG-WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR 864
E+ L ++H+NI+ L N L L+F +Y N L +
Sbjct: 79 TAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF-EYAEN-DLKKYMDKNPDVSMRVIKS 136
Query: 865 YEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAY-----LADFGLARIVSGSG 919
+ + + + + + H LH D+K N+LL + + DFGLAR G
Sbjct: 137 F--LYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF---G 188
Query: 920 DDNCSKTNQ------RP--QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
T++ RP L GS Y + D++S + E+L
Sbjct: 189 IPIRQFTHEIITLWYRPPEILLGSRHY-----------STSVDIWSIACIWAEMLMKT-- 235
Query: 972 LDPTLPG 978
P PG
Sbjct: 236 --PLFPG 240
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 56/217 (25%), Positives = 86/217 (39%), Gaps = 35/217 (16%)
Query: 773 VIGTGSSGVVYRV-TIPNGETLAVK-----KMWSSDESGAFSSEIQTLGSIRHKNIVRLL 826
VIG G+ G V V + A+K +M E+ F E L + K I L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL- 139
Query: 827 GWGSNKNLKLLFY--DYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLH-H 880
+ ++ L+ DY G L +LL + AR+ E+V+ A+ +H
Sbjct: 140 -HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI----AIDSVHQL 194
Query: 881 DCMPPILHGDVKAMNVLL-GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
+H D+K N+L+ G+ LADFG + G S G+ Y+
Sbjct: 195 H----YVHRDIKPDNILMDMNGHIR-LADFGSCLKLMEDGTVQSS------VAVGTPDYI 243
Query: 940 APE-----HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+PE R + D +S GV + E+L G P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 52/219 (23%), Positives = 82/219 (37%), Gaps = 37/219 (16%)
Query: 773 VIGTGSSGVVYRV-TIPNGETLAVKK-----MWSSDESGAFSSEIQTLGSIRHKNIVRLL 826
VIG G+ V V G+ A+K M E F E L + + I +L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL- 126
Query: 827 GWGSNKNLKLLFY--DYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLH-H 880
+ ++ L+ +Y G L +LL G+ AR+ E+V+ A+ +H
Sbjct: 127 -HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM----AIDSVHRL 181
Query: 881 DCMPPILHGDVKAMNVLL-GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
+H D+K N+LL G+ LADFG + G G+ Y+
Sbjct: 182 G----YVHRDIKPDNILLDRCGHIR-LADFGSCLKLRADGTVRSL------VAVGTPDYL 230
Query: 940 APEHASMQRITEKSDVY-------SFGVVLLEVLTGRHP 971
+PE + Y + GV E+ G+ P
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 40/177 (22%), Positives = 73/177 (41%), Gaps = 32/177 (18%)
Query: 751 MTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRV--TIPNGETLAVKKMWSSDESGAFS 808
Y+ + IG G+ G V++ G +A+K++
Sbjct: 10 DQQYECV--------------AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP 55
Query: 809 S----EI---QTLGSIRHKNIVRLL----GWGSNKNLKL-LFYDYLPNGSLSSLLHGAGK 856
E+ + L + H N+VRL +++ KL L ++++ L++ L +
Sbjct: 56 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPE 114
Query: 857 GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913
G E +++ + L +LH ++H D+K N+L+ Q LADFGLAR
Sbjct: 115 PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 42/216 (19%), Positives = 80/216 (37%), Gaps = 42/216 (19%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMW-SSDESGAFSSEIQTLGSIRHKNIVRLLGWGS 830
+G G G+V+R + +T K + + EI L RH+NI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 831 NKNLKLLFYDYLPNGSLSSLLHGAGKGG------ADWEARY------EVVLGVAHALAYL 878
+ ++ ++++ G V V AL +L
Sbjct: 72 SMEELVMIFEFI-------------SGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 879 H-HDCMPPILHGDVKAMNVLLG--PGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGS 935
H H+ I H D++ N++ + +FG AR + + + L +
Sbjct: 119 HSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---PGDNFRL-----LFTA 166
Query: 936 YGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
Y APE ++ +D++S G ++ +L+G +P
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 27/210 (12%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSI-RHKNIVRLLG--- 827
V+G G +G V ++ E A+K + + E++ + +IVR++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKML---QDCPKARREVELHWRASQCPHIVRIVDVYE 125
Query: 828 --WGSNKNLKLLFYDYLPNGSL-SSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMP 884
+ K L ++ + L G L S + + + EA E++ + A+ YLH
Sbjct: 126 NLYAGRKCLLIVM-ECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHSIN-- 181
Query: 885 PILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAP 941
I H DVK N+L P L DFG A+ + N T + Y+AP
Sbjct: 182 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---SHNSLTT-----PCYTPYYVAP 232
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
E ++ + D++S GV++ +L G P
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 45/221 (20%), Positives = 80/221 (36%), Gaps = 46/221 (20%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVK----KMWSSDESGAFSSEIQTLGSIRH-KNIVRLL 826
+G G VV + G+ A K + D EI L + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGG-------ADWEARY------EVVLGVAH 873
N + +L +Y GG + ++ +
Sbjct: 96 EVYENTSEIILILEYAA-------------GGEIFSLCLPELAEMVSENDVIRLIKQILE 142
Query: 874 ALAYLHHDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
+ YLH + I+H D+K N+LL P + DFG++R + G +
Sbjct: 143 GVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI---GHACELRE---- 192
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ G+ Y+APE + IT +D+++ G++ +LT P
Sbjct: 193 -IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 44/179 (24%), Positives = 78/179 (43%), Gaps = 34/179 (18%)
Query: 751 MTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS 809
+ Y+ + IG G+ G VY+ +G +A+K + + G
Sbjct: 8 TSRYEPV--------------AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGG 53
Query: 810 -------EI---QTLGSIRHKNIVRLL----GWGSNKNLKL-LFYDYLPNGSLSSLLHGA 854
E+ + L + H N+VRL+ +++ +K+ L ++++ L + L A
Sbjct: 54 LPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKA 112
Query: 855 GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913
G E +++ L +LH +C I+H D+K N+L+ G LADFGLAR
Sbjct: 113 PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 38/167 (22%), Positives = 64/167 (38%), Gaps = 30/167 (17%)
Query: 519 HSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEIL 578
GLT +P LP ++ + L N + + +L ++ LS NQ+S + +
Sbjct: 19 RGKGLT-EIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAF 76
Query: 579 SCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSE-FSGLTKLGILDL 637
+ SL SL L N+ + E+P F GL L +L L
Sbjct: 77 Q-----------------------GLRSLN-SLVLYGNKIT-ELPKSLFEGLFSLQLLLL 111
Query: 638 SHNKLSG-DLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDL 683
+ NK++ +DA L NL L++ N + F + +
Sbjct: 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTM 157
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 35/132 (26%), Positives = 57/132 (43%), Gaps = 16/132 (12%)
Query: 95 PSIFQPLKSLKRLIISSCNLTGTIPKE-FGDYRELTFIDLSGNSLWGEIPTEV-CRLRKL 152
P F P K L+R+ +S+ ++ + + F R L + L GN + E+P + L L
Sbjct: 49 PGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSL 106
Query: 153 ESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNL 211
+ L LN N + + D +L +L L+LYDN+L + L +Q N
Sbjct: 107 QLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN--- 162
Query: 212 KGELPWEIGNCS 223
P+ C
Sbjct: 163 ----PF---ICD 167
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 42/179 (23%), Positives = 71/179 (39%), Gaps = 37/179 (20%)
Query: 317 SCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDN 376
+C+ +VD LT IP + + E++L N + P + L +++ N
Sbjct: 10 TCSN-NIVDCRGKGLT-EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSN 65
Query: 377 NAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF 436
N IS E+ D F L L +L N ++ +PK +F
Sbjct: 66 NQIS-ELAPDA---------F---QGLR-----------SLNSLVLYGNKITE-LPKSLF 100
Query: 437 -GLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLNDNRLSGTIPSE----MGNLKHL 489
GL +L LLL +N ++ + D + L L L DN+L TI + ++ +
Sbjct: 101 EGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTM 157
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 26/113 (23%), Positives = 46/113 (40%), Gaps = 12/113 (10%)
Query: 274 QNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIP----DELGSCTELTVVDFSDN 329
+ L QN+I PG KL+ + L N + + L L + N
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGL---RSLNSLVLYGN 90
Query: 330 LLTGSIPRS-FGNLLKLQELQLSVNQLSGTIPIEI-ATCTALTHLEIDNNAIS 380
+T +P+S F L LQ L L+ N+++ + ++ L L + +N +
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 34/158 (21%), Positives = 56/158 (35%), Gaps = 30/158 (18%)
Query: 319 TELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEI-ATCTALTHLEIDNN 377
+T + N + P +F KL+ + LS NQ+S + + +L L + N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 378 AISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF- 436
I+ E+P + F L LQ L + N ++ + + F
Sbjct: 91 KIT-ELPKSL--------F----EGLF-----------SLQLLLLNANKINC-LRVDAFQ 125
Query: 437 GLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLNDN 473
L NL L L N L I ++ + L N
Sbjct: 126 DLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 32/144 (22%), Positives = 61/144 (42%), Gaps = 15/144 (10%)
Query: 502 GIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHSI-GSLTE 558
+P ++ + L N + P L+ +DLS+N++S LA L
Sbjct: 29 NLPETI------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 559 LSKLLLSKNQLSGRIPAEIL-SCRKLILLDIGNNRFSGEIPKELGQ-ISSLEISLNLSSN 616
L+ L+L N+++ +P + L LL + N+ + + + Q + +L L+L N
Sbjct: 82 LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLN-LLSLYDN 138
Query: 617 QFSGEIPSEFSGLTKLGILDLSHN 640
+ FS L + + L+ N
Sbjct: 139 KLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 23/95 (24%), Positives = 37/95 (38%), Gaps = 5/95 (5%)
Query: 93 SLPS-IFQPLKSLKRLIISSCNLTGTIPKE-FGDYRELTFIDLSGNSLWGEIPTEV-CRL 149
L FQ L+SL L++ +T +PK F L + L+ N + + + L
Sbjct: 70 ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDL 127
Query: 150 RKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDN 184
L L L N L+ L ++ + L N
Sbjct: 128 HNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 27/80 (33%), Positives = 39/80 (48%), Gaps = 4/80 (5%)
Query: 611 LNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSG-DLDALASLQNLVSLNVSFNDFSGEL 669
+ L N P FS KL +DLS+N++S DA L++L SL + N + EL
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-EL 95
Query: 670 PNTPFFR--KLPLSDLASNR 687
P + F L L L +N+
Sbjct: 96 PKSLFEGLFSLQLLLLNANK 115
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 4e-11
Identities = 52/238 (21%), Positives = 91/238 (38%), Gaps = 37/238 (15%)
Query: 763 DVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS---------EIQ 812
V++ + IG+G+ G+V +A+KK+ S F + E+
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-----SRPFQNQTHAKRAYRELV 113
Query: 813 TLGSIRHKNIVRLLGWGSNKNLKLLFYD-YLPNGSLSSLLHGAGKGGADWEARYEVVLGV 871
+ + HKNI+ LL + + F D YL + + L + D E ++ +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 173
Query: 872 AHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQ 931
+ +LH I+H D+K N+++ + DFGLAR S
Sbjct: 174 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-----------FM 219
Query: 932 LAGSYG---YMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWT 986
+ Y APE E D++S G ++ E++ + PG + QW
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWN 273
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 4e-11
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 37/213 (17%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKM-----WSSDESGAFSSEIQTLGSIRHKNIVRLL 826
+GTGS G V+ + NG A+K + + + E L + H I+R+
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM- 71
Query: 827 GWGS---NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLH- 879
WG+ + + ++ DY+ G L SLL + + A++ EV L AL YLH
Sbjct: 72 -WGTFQDAQQIFMIM-DYIEGGELFSLLRKSQRFPNP-VAKFYAAEVCL----ALEYLHS 124
Query: 880 HDCMPPILHGDVKAMNVLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGY 938
D I++ D+K N+LL G+ + DFG A+ V T L G+ Y
Sbjct: 125 KD----IIYRDLKPENILLDKNGHIK-ITDFGFAKYVPD-------VTYT---LCGTPDY 169
Query: 939 MAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+APE S + + D +SFG+++ E+L G P
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 43/221 (19%)
Query: 455 IPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHL--VGGIPPSVVGCQS 512
P D T + L ++ ++ L ++ + + + + V GI +
Sbjct: 13 FPDDAFAETI--KANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQGIQYLP----N 64
Query: 513 LEFLDLHSNGLTG-SVPDTLPTSLQLVDLSDNRLSGSLAHSI-GSLTELSKLLLSKNQLS 570
+ +L L N L S L T+L + L+ N+L SL + + LT L +L+L +NQL
Sbjct: 65 VRYLALGGNKLHDISALKEL-TNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ 122
Query: 571 GRIPAEIL-SCRKLILLDIGNNRFSGEIPKELGQISSLEI----------SLNLSSNQFS 619
+P + L L++ +N Q+ SL L+LS NQ
Sbjct: 123 -SLPDGVFDKLTNLTYLNLAHN-----------QLQSLPKGVFDKLTNLTELDLSYNQLQ 170
Query: 620 GEIPSE-FSGLTKLGILDLSHNKL----SGDLDALASLQNL 655
+P F LT+L L L N+L G D L SLQ +
Sbjct: 171 -SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYI 210
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 44/219 (20%)
Query: 358 TIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQEL 417
P + T + +++ + +N + A + + + + +
Sbjct: 12 IFPDDAFAET--IKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKS--VQGIQYLPNV 65
Query: 418 QALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDIGNC-TTLRRLRLNDNRL 475
+ L N L I L NLT L+L N L +P + + T L+ L L +N+L
Sbjct: 66 RYLALGGNKLH-DIS--ALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQL 121
Query: 476 SGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVP----DTL 531
++P G+ + +L +L+L N L S+P D L
Sbjct: 122 Q-SLPD--------------------GVFDKLT---NLTYLNLAHNQLQ-SLPKGVFDKL 156
Query: 532 PTSLQLVDLSDNRLSGSLAHSI-GSLTELSKLLLSKNQL 569
T+L +DLS N+L SL + LT+L L L +NQL
Sbjct: 157 -TNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 55/235 (23%), Positives = 88/235 (37%), Gaps = 49/235 (20%)
Query: 129 TFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSG 188
+L S+ + T+ L ++ + N + ++ L ++ YL L N+L
Sbjct: 22 IKANLKKKSV-TDAVTQN-ELNSIDQIIANNSDIKSVQGIQY--LPNVRYLALGGNKL-- 75
Query: 189 KIPKSIGA---LSKLQVFRAGGNQNLKGELPWEIGNC-SNLVMLGLAETSISGNVPSSIG 244
I A L+ L GNQ L+ LP + + +NL L L E +
Sbjct: 76 ---HDISALKELTNLTYLILTGNQ-LQ-SLPNGVFDKLTNLKELVLVENQL--------- 121
Query: 245 MLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQ 304
SL G + +++ + L L L N + G L+ L L L
Sbjct: 122 -----------QSLPDG-VFDKL---TNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSY 166
Query: 305 NSLVGAIP----DELGSCTELTVVDFSDNLLTGSIPR-SFGNLLKLQELQLSVNQ 354
N L ++P D+L T+L + N L S+P F L LQ + L N
Sbjct: 167 NQL-QSLPEGVFDKL---TQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDNP 216
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 35/111 (31%), Positives = 49/111 (44%), Gaps = 8/111 (7%)
Query: 271 SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQN---SLVGAIPDELGSCTELTVVDFS 327
+ L L L N + G L+ LK L+L +N SL + D+L T LT ++ +
Sbjct: 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKL---TNLTYLNLA 141
Query: 328 DNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEI-ATCTALTHLEIDNN 377
N L F L L EL LS NQL ++P + T L L + N
Sbjct: 142 HNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQN 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 53/230 (23%), Positives = 86/230 (37%), Gaps = 46/230 (20%)
Query: 228 LGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPI 287
L + S++ + + + Q IA + + S I ++ L L N +
Sbjct: 24 ANLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQ---GIQYLPNVRYLALGGNKLH--- 76
Query: 288 PGRIGA---LSKLKSLLLWQNSLV---GAIPDELGSCTELTVVDFSDNLLTGSIPRSFGN 341
I A L+ L L+L N L + D+L T L + +N L F
Sbjct: 77 --DISALKELTNLTYLILTGNQLQSLPNGVFDKL---TNLKELVLVENQLQSLPDGVFDK 131
Query: 342 LLKLQELQLSVNQLSGTIPIEI-ATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWK 400
L L L L+ NQL ++P + T LT L++ N + +P + F
Sbjct: 132 LTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGV--------F---- 177
Query: 401 NKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSN 449
+KLT +L+ L N L +P +F L +L + L N
Sbjct: 178 DKLT-----------QLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 45/195 (23%), Positives = 81/195 (41%), Gaps = 20/195 (10%)
Query: 287 IPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQ 346
P A + L + S+ A+ + + +++ + S+ L ++
Sbjct: 13 FPDDAFA--ETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQ-GIQYLPNVR 66
Query: 347 ELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADI-GNINGLTLFFAWKNKLT- 404
L L N+L I + T LT+L + N + +P + + L +N+L
Sbjct: 67 YLALGGNKLH-DISA-LKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQS 123
Query: 405 --GNIPESLSQCQELQALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDI-G 460
+ + L+ L L+ ++N L +PK +F L NLT+L L N L +P +
Sbjct: 124 LPDGVFDKLTN---LTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQS-LPEGVFD 178
Query: 461 NCTTLRRLRLNDNRL 475
T L+ LRL N+L
Sbjct: 179 KLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 35/109 (32%), Positives = 52/109 (47%), Gaps = 9/109 (8%)
Query: 84 SLKAVDLQG----SLPS-IFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSL 138
+LK + L SLP +F L +L L ++ L F LT +DLS N L
Sbjct: 110 NLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL 169
Query: 139 WGEIPTEVC-RLRKLESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQ 185
+P V +L +L+ L L N L+ +P + L+SL Y+ L+DN
Sbjct: 170 -QSLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDNP 216
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 33/122 (27%), Positives = 51/122 (41%), Gaps = 11/122 (9%)
Query: 93 SLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVC-RLRK 151
+ + L +L LI++ L F L + L N L +P V +L
Sbjct: 77 DIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL-QSLPDGVFDKLTN 134
Query: 152 LESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQLSGKIPKSIGA---LSKLQVFRAGG 207
L L L N L+ +P + L++L L L NQL +P+ G L++L+ R
Sbjct: 135 LTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPE--GVFDKLTQLKDLRLYQ 190
Query: 208 NQ 209
NQ
Sbjct: 191 NQ 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 47/169 (27%), Positives = 68/169 (40%), Gaps = 31/169 (18%)
Query: 505 PSVVGC---QSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSK 561
+V GC + + +D L SVP +P + +DL L+ + LT+L+
Sbjct: 5 ETVTGCTCNEGKKEVDCQGKSLD-SVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTW 63
Query: 562 LLLSKNQLSGRIPAEILSC-RKLILLDIGNNRFSGEIPKELGQISSLEI----------S 610
L L NQL + A + +L L + NN Q++SL +
Sbjct: 64 LNLDYNQLQT-LSAGVFDDLTELGTLGLANN-----------QLASLPLGVFDHLTQLDK 111
Query: 611 LNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLS----GDLDALASLQNL 655
L L NQ F LTKL L L+ N+L G D L +LQ L
Sbjct: 112 LYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTL 160
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 51/191 (26%), Positives = 70/191 (36%), Gaps = 35/191 (18%)
Query: 455 IPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVV-GCQSL 513
+P I T +L L L+ + L L ++++ N L + V L
Sbjct: 29 VPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85
Query: 514 EFLDLHSNGLT---GSVPDTLPTSLQLVDLSDNRLSGSLAHSI-GSLTELSKLLLSKNQL 569
L L +N L V D L T L + L N+L SL + LT+L +L L+ NQL
Sbjct: 86 GTLGLANNQLASLPLGVFDHL-TQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL 143
Query: 570 SGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGL 629
IPA KL L L+LS+NQ F L
Sbjct: 144 Q-SIPAGAF--DKLTNLQT----------------------LSLSTNQLQSVPHGAFDRL 178
Query: 630 TKLGILDLSHN 640
KL + L N
Sbjct: 179 GKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 48/182 (26%), Positives = 69/182 (37%), Gaps = 36/182 (19%)
Query: 274 QNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIP----DELGSCTELTVVDFSDN 329
+ L L ++ L+KL L L N L + D+L TEL + ++N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDL---TELGTLGLANN 93
Query: 330 LLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATC-TALTHLEIDNNAISGEIPADIG 388
L F +L +L +L L NQL ++P + T L L ++ N + IPA
Sbjct: 94 QLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGA- 150
Query: 389 NINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF-GLRNLTKLLLL 447
F +KLT LQ L S N L +P F L L + L
Sbjct: 151 -------F----DKLT-----------NLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLF 187
Query: 448 SN 449
N
Sbjct: 188 GN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 44/157 (28%), Positives = 67/157 (42%), Gaps = 10/157 (6%)
Query: 418 QALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNC-TTLRRLRLNDNRLS 476
+ LD L+ GL LT L L N L + + + T L L L +N+L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 477 GTIPSEMGNLKHLNFVDMSENHLVGGIPPSVV-GCQSLEFLDLHSNGLTGSVP----DTL 531
+L L+ + + N L +P V L+ L L++N L S+P D L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 532 PTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQ 568
T+LQ + LS N+L + L +L + L NQ
Sbjct: 155 -TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 42/179 (23%), Positives = 69/179 (38%), Gaps = 30/179 (16%)
Query: 298 KSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRS-FGNLLKLQELQLSVNQLS 356
+ L L L T+LT ++ N L ++ F +L +L L L+ NQL+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 357 GTIPIEI-ATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQ 415
++P+ + T L L + N + +P+ + F ++LT
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGV--------F----DRLT----------- 131
Query: 416 ELQALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDN 473
+L+ L + N L IP F L NL L L +N L L+ + L N
Sbjct: 132 KLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 42/164 (25%), Positives = 67/164 (40%), Gaps = 21/164 (12%)
Query: 221 NCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQ 280
+C L S+ +P+ L+ + ++ L+ ++L L L
Sbjct: 20 DCQGK---SL--DSVPSGIPADTEKLD------LQSTGLATLSDATFRGLTKLTWLNLDY 68
Query: 281 NSISGPIPGRIGALSKLKSLLLWQN---SLVGAIPDELGSCTELTVVDFSDNLLTGSIPR 337
N + G L++L +L L N SL + D L T+L + N L S+P
Sbjct: 69 NQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHL---TQLDKLYLGGNQLK-SLPS 124
Query: 338 S-FGNLLKLQELQLSVNQLSGTIPIEI-ATCTALTHLEIDNNAI 379
F L KL+EL+L+ NQL +IP T L L + N +
Sbjct: 125 GVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 41/135 (30%), Positives = 60/135 (44%), Gaps = 15/135 (11%)
Query: 93 SLPS-IFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVC-RLR 150
+L + +F L L L +++ L F +L + L GN L +P+ V RL
Sbjct: 73 TLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLT 131
Query: 151 KLESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQ 209
KL+ L LNTN L+ IP+ L++L L+L NQL + L KLQ GN
Sbjct: 132 KLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN- 189
Query: 210 NLKGELPWEIGNCSN 224
+ +CS
Sbjct: 190 ------QF---DCSR 195
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 55/218 (25%), Positives = 78/218 (35%), Gaps = 65/218 (29%)
Query: 142 IPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQ 201
IP + E L L + L + L+ L +L L NQL + G L
Sbjct: 33 IPADT------EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLS--AGVFDDL- 82
Query: 202 VFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSG 261
+ L LGLA ++ ++P + + L
Sbjct: 83 ---------------------TELGTLGLANNQLA-SLPLGV-----------FDHL--- 106
Query: 262 PIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIP----DELGS 317
++L LYL N + G L+KLK L L N L +IP D+L
Sbjct: 107 ---------TQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKL-- 154
Query: 318 CTELTVVDFSDNLLTGSIPR-SFGNLLKLQELQLSVNQ 354
T L + S N L S+P +F L KLQ + L NQ
Sbjct: 155 -TNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 6/108 (5%)
Query: 105 KRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEV-CRLRKLESLYLNTNLLE 163
++L + S L F +LT+++L N L + V L +L +L L N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96
Query: 164 GEIPSDI-GNLSSLAYLTLYDNQLSGKIPKSI-GALSKLQVFRAGGNQ 209
+P + +L+ L L L NQL +P + L+KL+ R NQ
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQ 142
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 9e-11
Identities = 56/211 (26%), Positives = 85/211 (40%), Gaps = 29/211 (13%)
Query: 773 VIGTGSSGVVYRVTI-PNGETLAVKKM-----WSSDESGAFSSEIQTLGSIRHKNIVRLL 826
V+G G G V + G+ A KK+ +E Q L + + +V L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 827 GWGSNKNLKLLF-YDYLPNGSLSSLLHGAGKGGADWEAR---Y--EVVLGVAHALAYLHH 880
K+ L + G L ++ G+ G EAR Y E+ L LH
Sbjct: 251 YAYETKD-ALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYAAEICC----GLEDLHR 304
Query: 881 DCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMA 940
+ I++ D+K N+LL ++D GLA V G R G+ GYMA
Sbjct: 305 ER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQ----TIKGR---VGTVGYMA 353
Query: 941 PEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
PE +R T D ++ G +L E++ G+ P
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 53/226 (23%)
Query: 773 VIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLG----W 828
VIG GS GVV++ + + +A+KK+ + E+Q + ++H N+V L
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK--NRELQIMRIVKHPNVVDLKAFFYSN 104
Query: 829 GSNKNLKLLF--YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAH----------ALA 876
G K+ L +Y+P ++ K + + +LA
Sbjct: 105 GDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQT--------MPMLLIKLYMYQLLRSLA 155
Query: 877 YLH-HDCMPPILHGDVKAMNVLLGPG-YQAYLADFGLARIVSGSGDDN----CSKTNQRP 930
Y+H I H D+K N+LL P L DFG A+I+ +G+ N CS+
Sbjct: 156 YIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-AGEPNVSYICSR----- 205
Query: 931 QLAGSYGYMAPE--HASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974
Y Y APE + T D++S G V+ E++ G+ PL P
Sbjct: 206 -----Y-YRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQ-PLFP 243
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 33/236 (13%)
Query: 763 DVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS---------EIQ 812
V++ + IG+G+ G+V +A+KK+ S F + E+
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-----SRPFQNQTHAKRAYRELV 76
Query: 813 TLGSIRHKNIVRLLGWGSNKNLKLLFYD-YLPNGSLSSLLHGAGKGGADWEARYEVVL-G 870
+ + HKNI+ LL + + F D Y+ + + L + D R +L
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYLLYQ 135
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
+ + +LH I+H D+K N+++ + DFGLAR + T P
Sbjct: 136 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMT---P 185
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWT 986
+ Y Y APE E D++S G ++ E++ G PG + QW
Sbjct: 186 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHIDQWN 236
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 35/136 (25%), Positives = 63/136 (46%), Gaps = 11/136 (8%)
Query: 532 PTSLQLVDL--SDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIG 589
T + V+L + + ++ +L L LS N + +I + + L +L +G
Sbjct: 22 ATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLG 78
Query: 590 NNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLS--GDLD 647
N +I +LE L +S NQ + + S L L +L +S+NK++ G++D
Sbjct: 79 RNLIK-KIENLDAVADTLEE-LWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEID 134
Query: 648 ALASLQNLVSLNVSFN 663
LA+L L L ++ N
Sbjct: 135 KLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 24/125 (19%), Positives = 50/125 (40%), Gaps = 6/125 (4%)
Query: 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELT 322
+ + ++L L N+I I + + L+ L L +N + I + L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 323 VVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIE-IATCTALTHLEIDNNAISG 381
+ S N + S+ L+ L+ L +S N+++ I+ +A L L + N +
Sbjct: 97 ELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154
Query: 382 EIPAD 386
+ +
Sbjct: 155 DYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 27/138 (19%), Positives = 49/138 (35%), Gaps = 12/138 (8%)
Query: 314 ELGSCTELTVVD--FSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIE-IATCTALT 370
+ TE V+ + + + L + L LS N + I ++ L
Sbjct: 18 KSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEK---ISSLSGMENLR 73
Query: 371 HLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGP 430
L + N I +I + L + N++ ++ + + L+ L S N ++
Sbjct: 74 ILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITN- 129
Query: 431 IPKEIFGLRNLTKLLLLS 448
EI L L KL L
Sbjct: 130 -WGEIDKLAALDKLEDLL 146
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 29/161 (18%), Positives = 64/161 (39%), Gaps = 21/161 (13%)
Query: 441 LTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLV 500
+L + + + + + L L+ N + I S + +++L + + N +
Sbjct: 27 KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK 83
Query: 501 GGIPPSVVGCQSLEFLDLHSNGLTGSVP--DTLPTSLQLVDLSDNRLS--GSLAHSIGSL 556
I +LE L + N + S+ + L +L+++ +S+N+++ G + + +L
Sbjct: 84 -KIENLDAVADTLEELWISYNQIA-SLSGIEKLV-NLRVLYMSNNKITNWGEIDK-LAAL 139
Query: 557 TELSKLLLSKNQLSGRIPAE----------ILSCRKLILLD 587
+L LLL+ N L + L LD
Sbjct: 140 DKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 49/212 (23%), Positives = 80/212 (37%), Gaps = 28/212 (13%)
Query: 773 VIGTGSSGVVYRV-TIPNGETLAVKKM-----WSSDESGAFSSEIQTLGSIRHKNIVRLL 826
V+G G G V+ G+ A KK+ E + L + + IV L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 827 GWGSNKNLKLLF-YDYLPNGSLSSLLHGAGKGGADWE---ARY---EVVLGVAHALAYLH 879
K L + G + ++ + ++ A + ++V L +LH
Sbjct: 252 YAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS----GLEHLH 306
Query: 880 HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
I++ D+K NVLL ++D GLA + KT AG+ G+M
Sbjct: 307 QRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT----KTKGY---AGTPGFM 356
Query: 940 APEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
APE + D ++ GV L E++ R P
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 41/107 (38%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 274 QNLYLYQNSISGPIPGRIGALSKLKSLLLWQN---SLVGAIPDELGSCTELTVVDFSDNL 330
Q LYL+ N I+ PG +L LK L L N +L + D L T+LTV+D N
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSL---TQLTVLDLGTNQ 99
Query: 331 LTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNN 377
LT F L+ L+EL + N+L+ +P I T LTHL +D N
Sbjct: 100 LTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 44/154 (28%), Positives = 66/154 (42%), Gaps = 29/154 (18%)
Query: 517 DLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAE 576
D S SVP +PT+ Q++ L DN+++ SL L +L L NQL +P
Sbjct: 25 DCRSKRHA-SVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVG 82
Query: 577 IL-SCRKLILLDIGNNRFSGEIPKELGQISSLEI----------SLNLSSNQFSGEIPSE 625
+ S +L +LD+G N Q++ L L + N+ + E+P
Sbjct: 83 VFDSLTQLTVLDLGTN-----------QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRG 130
Query: 626 FSGLTKLGILDLSHNKL----SGDLDALASLQNL 655
LT L L L N+L G D L+SL +
Sbjct: 131 IERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHA 164
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 37/122 (30%), Positives = 58/122 (47%), Gaps = 15/122 (12%)
Query: 455 IPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLV---GGIPPSVVGCQ 511
+P I T + L L+DN+++ P +L +L + + N L G+ S+
Sbjct: 34 VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLT--- 88
Query: 512 SLEFLDLHSNGLTGSVP----DTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKN 567
L LDL +N LT +P D L L+ + + N+L+ L I LT L+ L L +N
Sbjct: 89 QLTVLDLGTNQLT-VLPSAVFDRL-VHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
Query: 568 QL 569
QL
Sbjct: 146 QL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 41/135 (30%), Positives = 56/135 (41%), Gaps = 17/135 (12%)
Query: 418 QALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLNDNRLS 476
Q L N ++ P L NL +L L SN L +P + + T L L L N+L+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 477 GTIPS----EMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVP---- 528
+PS + +LK L M N L +P + L L L N L S+P
Sbjct: 102 -VLPSAVFDRLVHLKEL---FMCCNKL-TELPRGIERLTHLTHLALDQNQLK-SIPHGAF 155
Query: 529 DTLPTSLQLVDLSDN 543
D L +SL L N
Sbjct: 156 DRL-SSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 38/138 (27%), Positives = 58/138 (42%), Gaps = 10/138 (7%)
Query: 74 CSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDL 133
CS +G V+ K S+P+ + + L + +T P F L + L
Sbjct: 17 CSCSGTTVDCRSKRHA---SVPAGIPT--NAQILYLHDNQITKLEPGVFDSLINLKELYL 71
Query: 134 SGNSLWGEIPTEVC-RLRKLESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQLSGKIP 191
N L G +P V L +L L L TN L +PS + L L L + N+L+ ++P
Sbjct: 72 GSNQL-GALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELP 128
Query: 192 KSIGALSKLQVFRAGGNQ 209
+ I L+ L NQ
Sbjct: 129 RGIERLTHLTHLALDQNQ 146
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 24/84 (28%), Positives = 32/84 (38%), Gaps = 3/84 (3%)
Query: 272 ELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLL 331
+L L L N ++ L LK L + N L +P + T LT + N L
Sbjct: 89 QLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQL 147
Query: 332 TGSIPR-SFGNLLKLQELQLSVNQ 354
SIP +F L L L N
Sbjct: 148 K-SIPHGAFDRLSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 27/94 (28%), Positives = 39/94 (41%), Gaps = 2/94 (2%)
Query: 93 SLPS-IFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRK 151
+LP +F L L L + + LT F L + + N L E+P + RL
Sbjct: 78 ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTH 136
Query: 152 LESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQ 185
L L L+ N L+ LSSL + L+ N
Sbjct: 137 LTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 5e-10
Identities = 49/214 (22%), Positives = 83/214 (38%), Gaps = 34/214 (15%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKM-----WSSDESGAFSSE---IQTLGSIRHKNIV 823
+IG G G VY G+ A+K + +E + + + IV
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 824 RLLGWGSNKNLKLLFY--DYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYL 878
+ + L + D + G L L G + R+ E++L L ++
Sbjct: 256 CM--SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIIL----GLEHM 308
Query: 879 HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGY 938
H+ +++ D+K N+LL ++D GLA S K + G++GY
Sbjct: 309 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK------KPHAS---VGTHGY 356
Query: 939 MAPEHASMQRITEKS-DVYSFGVVLLEVLTGRHP 971
MAPE + S D +S G +L ++L G P
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 6e-10
Identities = 47/259 (18%), Positives = 87/259 (33%), Gaps = 51/259 (19%)
Query: 754 YQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS--- 809
F + +L +G G +G+V+ + +A+KK+ +
Sbjct: 2 MNIHGFDLGSRYMDL---KPLGCGGNGLVFSAVDNDCDKRVAIKKI-------VLTDPQS 51
Query: 810 ------EIQTLGSIRHKNIVRLL--------GWGSNKNLKLLFYD-YLPNGSLSSLLHGA 854
EI+ + + H NIV++ + Y+ + + L
Sbjct: 52 VKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANV 111
Query: 855 GKGGADWEARYEVVL-GVAHALAYLHHDCMPPILHGDVKAMNVLL-GPGYQAYLADFGLA 912
+ G E + + + L Y+H +LH D+K N+ + + DFGLA
Sbjct: 112 LEQGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLA 168
Query: 913 RIVSGSGDDNCSKTNQRPQLAGSY----GYMAPE-HASMQRITEKSDVYSFGVVLLEVLT 967
RI+ + Y +P S T+ D+++ G + E+LT
Sbjct: 169 RIMDPHYSHKGHLSE--------GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220
Query: 968 GRHPLDPTLPGGAPLVQWT 986
G+ G L Q
Sbjct: 221 GK----TLFAGAHELEQMQ 235
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 6e-10
Identities = 67/429 (15%), Positives = 135/429 (31%), Gaps = 55/429 (12%)
Query: 268 GNCSELQNLYL-YQNSISGPIPGRIGA-LSKLKSLLLWQNSLVGAIPDELG----SCTEL 321
+L+ L L + + I K+K+LL+ ++S L T L
Sbjct: 135 ARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL 194
Query: 322 TVVDFSDNLLTG----SIPRSFGNLLKLQELQLS-VNQLSGTIPIEIAT-CTALTHLEID 375
V++F + N L +++ L + A ++
Sbjct: 195 EVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLN 254
Query: 376 NNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEI 435
+ E ++ L +P +++ LD Y L +
Sbjct: 255 EDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTL 313
Query: 436 FGLRNLTKLLLLSNDLSGFIPPDIG------NCTTLRRLRLNDNRLSGTIPSEMGNLKHL 489
++ L +L + I D G C L+RLR+ + E G +
Sbjct: 314 --IQKCPNLEVL--ETRNVIG-DRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQR 368
Query: 490 NFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLT----GSVPDTLP--TSLQLVDLS-- 541
+ +++ GCQ LE++ ++ + +T S+ L +LV L
Sbjct: 369 GLIALAQ------------GCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDRE 416
Query: 542 ----DNRLSGSLAHSIGSLTELSKLLLSKN--QLSGRIPAEILS-CRKLILLDIGNNRFS 594
D L + + +L + L+ + I + + +G S
Sbjct: 417 ERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGES 476
Query: 595 GEIPKELGQI-SSLEISLNLSSNQFSGE-IPSEFSGLTKLGILDLSHNKLS-GDLDALAS 651
E E + +L+ L + FS I + + L L L + + S D +
Sbjct: 477 DEGLMEFSRGCPNLQ-KLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQM 535
Query: 652 LQNLVSLNV 660
+ ++ +
Sbjct: 536 ARPYWNIEL 544
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 40/272 (14%), Positives = 85/272 (31%), Gaps = 38/272 (13%)
Query: 437 GLRNLTKLLLLSNDLSGFIPPDI----GNCTTLRRLRLN-----DNRLSGTIPSEMGNLK 487
G L+ + G++ P + N L+ + D L + +L+
Sbjct: 82 GKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLE 141
Query: 488 HLNFVDMSENHLVG--GIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRL 545
L + + G+ V C+ ++ L + + + + L
Sbjct: 142 TLK---LDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFS--------------EKDGKWL 184
Query: 546 SGSLAHSIGSLTELSKLLLSKNQLSGR-IPAEILSCRKLILLDIGNNRFS--GEIPKELG 602
LA SL L+ + ++S + + +CR L+ + +G+ K
Sbjct: 185 H-ELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAA 243
Query: 603 QISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSF 662
+ +L+ + E KL L LS+ + + L++ +
Sbjct: 244 NLEEFC-GGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLY 302
Query: 663 NDFSGE-----LPNTPFFRKLPLSDLASNRGL 689
E + P L ++ +RGL
Sbjct: 303 ALLETEDHCTLIQKCPNLEVLETRNVIGDRGL 334
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 53/307 (17%), Positives = 97/307 (31%), Gaps = 35/307 (11%)
Query: 93 SLPSIFQPLKSLKRLIISSCNLT--GTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLR 150
L +I + +SL + + + K + E L+ + E + R
Sbjct: 211 DLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPR 270
Query: 151 KLESLYLNTNLLEGEIPSDIGNLSSLAYLTL-YDNQLSGKIPKSIGALSKLQVFRAGGNQ 209
KL L L + + E+P + + L L Y + I L+V
Sbjct: 271 KLCRLGL-SYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVI 329
Query: 210 NLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGML--ERIQTIAIYTSLLSGPIPEEI 267
+G L C L L + + + G++ + +A
Sbjct: 330 GDRG-LEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQ------------- 375
Query: 268 GNCSELQNLYLYQNSIS----GPIPGRIGALSKLKSLLLWQNSLVGAIPDELG------S 317
C EL+ + +Y + I+ I + L + +LL + + +P + G
Sbjct: 376 -GCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIG 434
Query: 318 CTELTVVDFSDN--LLTGSIPRSFGNLLK-LQELQLSVNQLSGTIPIEIAT-CTALTHLE 373
C +L F LT G ++ + L S +E + C L LE
Sbjct: 435 CKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLE 494
Query: 374 IDNNAIS 380
+ S
Sbjct: 495 MRGCCFS 501
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 9e-10
Identities = 20/101 (19%), Positives = 35/101 (34%), Gaps = 4/101 (3%)
Query: 448 SNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEM-GNLKHLNFVDMSENHLVGGIPPS 506
+ D + + L L + + + + L L + + ++ L + P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 507 V-VGCQSLEFLDLHSNGLTGSVPDTL-PTSLQLVDLSDNRL 545
L L+L N L T+ SLQ + LS N L
Sbjct: 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 2e-09
Identities = 22/113 (19%), Positives = 40/113 (35%), Gaps = 5/113 (4%)
Query: 414 CQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPP-DIGNCTTLRRLRLND 472
L + + + G NLT+L + + + D+ LR L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 473 NRLSGTIPSEM-GNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLT 524
+ L + + L+ +++S N L + V SL+ L L N L
Sbjct: 66 SGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 2e-09
Identities = 21/102 (20%), Positives = 34/102 (33%), Gaps = 4/102 (3%)
Query: 401 NKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDI 459
+ L + L L + GL L L ++ + L F+ PD
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75
Query: 460 -GNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLV 500
L RL L+ N L ++ + L + +S N L
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 20/160 (12%), Positives = 36/160 (22%), Gaps = 51/160 (31%)
Query: 317 SCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDN 376
+ + + + L EL + Q +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLE---------------- 48
Query: 377 NAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF 436
L EL+ L + L + + F
Sbjct: 49 -------------------------------LRDLRGLGELRNLTIVKSGLR-FVAPDAF 76
Query: 437 -GLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRL 475
L++L L N L + +L+ L L+ N L
Sbjct: 77 HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 17/92 (18%), Positives = 30/92 (32%), Gaps = 2/92 (2%)
Query: 287 IPGRIGALSKLKSLLLWQNSLVGAIPDE-LGSCTELTVVDFSDNLLTGSIPRSFGNLLKL 345
+ L L + + + L EL + + L P +F +L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 346 QELQLSVNQLSGTIPIEIATCTALTHLEIDNN 377
L LS N L ++ + +L L + N
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 25/113 (22%), Positives = 38/113 (33%), Gaps = 6/113 (5%)
Query: 532 PTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILS-CRKLILLDIGN 590
P + + + SL H + L++L + Q + L +L L I
Sbjct: 7 PHGSSGLRCTRDGALDSL-HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 591 NRFSGEIPKE-LGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKL 642
+ + + L LNLS N GL+ L L LS N L
Sbjct: 66 SGLR-FVAPDAFHFTPRLS-RLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 9e-05
Identities = 17/94 (18%), Positives = 27/94 (28%), Gaps = 4/94 (4%)
Query: 117 TIPKEFGDYRELTFIDLSGNSLWGEIPTEVCR-LRKLESLYLNTNLLEGEIPSDI-GNLS 174
LT + + + R L +L +L + + L + D
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 175 SLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGN 208
L+ L L N L + LQ GN
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 48/258 (18%), Positives = 77/258 (29%), Gaps = 71/258 (27%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS---------EIQTLGSIRHKNI 822
+IGTGS G V +A+KK+ F EI L + H ++
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKI-----LRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 823 VRLL------GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAH--- 873
V++L L ++ + + L V L H
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVL-EIADS-DFKKLFRT------------PVYLTELHIKT 160
Query: 874 -------ALAYLH-HDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSK 925
+ Y+H ILH D+K N L+ + DFGLAR V + N
Sbjct: 161 LLYNLLVGVKYVHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 926 TNQRPQLAGSYGYMAPEHASMQRITE--------------------KS-DVYSFGVVLLE 964
+ + +++T ++ DV+S G + E
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276
Query: 965 VLTGRHPLDPTLPGGAPL 982
+L PL
Sbjct: 277 LLNMIKENVAYHADRGPL 294
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 50/211 (23%), Positives = 82/211 (38%), Gaps = 26/211 (12%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSIRH-KNIVRLLGWGSN 831
IG+GS G +Y T I GE +A+K + E + ++ I + G+
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 76
Query: 832 KNLKLLFYDYLPNG-SLSSLLHGAGKGGADWEARYEVVLGVA----HALAYLHHDCMPPI 886
+ ++ + L G SL L + + + + VL +A + Y+H
Sbjct: 77 GDYNVMVMELL--GPSLEDLFNFCSRKFS-----LKTVLLLADQMISRIEYIHSKN---F 126
Query: 887 LHGDVKAMNVLLGPGYQA---YLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM---A 940
+H DVK N L+G G + Y+ DFGLA+ + + L G+ Y
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 186
Query: 941 PEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
R + D+ S G VL+ G P
Sbjct: 187 HLGIEQSR---RDDLESLGYVLMYFNLGSLP 214
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-09
Identities = 60/270 (22%), Positives = 99/270 (36%), Gaps = 77/270 (28%)
Query: 755 QKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS---- 809
+++ ++I + +++G G+ GVV T P GE +A+KK+ F
Sbjct: 3 KRIVYNISSDFQLK---SLLGEGAYGVVCSATHKPTGEIVAIKKI------EPFDKPLFA 53
Query: 810 -----EIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSL-------------L 851
EI+ L +H+NI+ + ++ S + L
Sbjct: 54 LRTLREIKILKHFKHENIITI-------------FNIQRPDSFENFNEVYIIQELMQTDL 100
Query: 852 HGAGKGGADWEARYEVVLGVAH----------ALAYLHHDCMPPILHGDVKAMNVLLGPG 901
H +L H A+ LH ++H D+K N+L+
Sbjct: 101 HRVISTQ---------MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSN 148
Query: 902 YQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSY----GYMAPE-HASMQRITEKSDVY 956
+ DFGLARI+ S DN T Q+ + + Y APE + + + DV+
Sbjct: 149 CDLKVCDFGLARIIDESAADNSEPTGQQSGMVE-FVATRWYRAPEVMLTSAKYSRAMDVW 207
Query: 957 SFGVVLLEVLTGRHPLDPTLPGGAPLVQWT 986
S G +L E+ R P PG Q
Sbjct: 208 SCGCILAELFLRR----PIFPGRDYRHQLL 233
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 50/210 (23%), Positives = 84/210 (40%), Gaps = 33/210 (15%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSIR-HKNIVRLL---GW 828
+G G V+ I N E + VK + + EI+ L ++R NI+ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR-EIKILENLRGGPNIITLADIVKD 102
Query: 829 GSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR---YEVVLGVAHALAYLH-HDCMP 884
++ L+F ++ N L D++ R YE++ AL Y H
Sbjct: 103 PVSRTPALVFE-HVNNTDFKQLYQTLT----DYDIRFYMYEIL----KALDYCHSMG--- 150
Query: 885 PILHGDVKAMNVLLGPGY-QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE- 942
I+H DVK NV++ + + L D+GLA + N ++A Y + PE
Sbjct: 151 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV-------RVASRY-FKGPEL 201
Query: 943 HASMQRITEKSDVYSFGVVLLEVLTGRHPL 972
Q D++S G +L ++ + P
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 30/110 (27%), Positives = 45/110 (40%), Gaps = 13/110 (11%)
Query: 274 QNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIP----DELGSCTELTVVDFSDN 329
LYL N + +P + L + L N + + + T+L + S N
Sbjct: 34 TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNM---TQLLTLILSYN 88
Query: 330 LLTGSIP-RSFGNLLKLQELQLSVNQLSGTIPIEI-ATCTALTHLEIDNN 377
L IP R+F L L+ L L N +S +P +AL+HL I N
Sbjct: 89 RLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 31/142 (21%), Positives = 55/142 (38%), Gaps = 33/142 (23%)
Query: 519 HSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEIL 578
+ GL +P +P + + L N+ + + + + L+ + LS N++S + +
Sbjct: 18 SNKGLK-VLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSF 74
Query: 579 SCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSE-FSGLTKLGILDL 637
S + L L LS N+ IP F GL L +L L
Sbjct: 75 S--NMTQLLT----------------------LILSYNRLR-CIPPRTFDGLKSLRLLSL 109
Query: 638 SHNKLS----GDLDALASLQNL 655
N +S G + L++L +L
Sbjct: 110 HGNDISVVPEGAFNDLSALSHL 131
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 47/156 (30%), Positives = 67/156 (42%), Gaps = 28/156 (17%)
Query: 74 CSSNGEVVEISLKAVDLQGSLPS-IFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFID 132
C+ VV S K L+ LP I P + + L + T +PKE +Y+ LT ID
Sbjct: 8 CTCLDTVVRCSNK--GLK-VLPKGI--P-RDVTELYLDGNQFT-LVPKELSNYKHLTLID 60
Query: 133 LSGNSLWGEIPTEVC-RLRKLESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQLSGKI 190
LS N + + + + +L +L L+ N L IP L SL L+L+ N +S +
Sbjct: 61 LSNNRI-STLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VV 117
Query: 191 PKSIGA---LSKLQVFRAGGNQNLKGELPWEIGNCS 223
P+ GA LS L G N P C
Sbjct: 118 PE--GAFNDLSALSHLAIGAN-------PL---YCD 141
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 26/98 (26%), Positives = 43/98 (43%), Gaps = 10/98 (10%)
Query: 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIP----DELGSC 318
+P+E+ N L + L N IS +++L +L+L N L IP D L
Sbjct: 46 VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL-RCIPPRTFDGL--- 101
Query: 319 TELTVVDFSDNLLTGSIPR-SFGNLLKLQELQLSVNQL 355
L ++ N ++ +P +F +L L L + N L
Sbjct: 102 KSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 27/84 (32%), Positives = 40/84 (47%), Gaps = 3/84 (3%)
Query: 298 KSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSG 357
L L N +P EL + LT++D S+N ++ +SF N+ +L L LS N+L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 358 TIPIEI-ATCTALTHLEIDNNAIS 380
IP +L L + N IS
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 33/132 (25%), Positives = 51/132 (38%), Gaps = 35/132 (26%)
Query: 418 QALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLNDNRLS 476
L N + +PKE+ ++LT + L +N +S + N T L L L+ NRL
Sbjct: 34 TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91
Query: 477 GTIPSEMGNLKHLNFVDMSENHLVGGIPPSVV-GCQSLEFLDLHSNGLTGSVP----DTL 531
IPP G +SL L LH N ++ VP + L
Sbjct: 92 -------------------------CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDL 125
Query: 532 PTSLQLVDLSDN 543
++L + + N
Sbjct: 126 -SALSHLAIGAN 136
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 55/262 (20%), Positives = 86/262 (32%), Gaps = 57/262 (21%)
Query: 758 DFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS------- 809
+ + D ++IG GS G VY + +A+KK+ + F
Sbjct: 21 NVHVPDNYIIK---HLIGRGSYGYVYLAYDKNTEKNVAIKKV-----NRMFEDLIDCKRI 72
Query: 810 --EIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD-YLPNGSLSSLLHGAGKGGADWEARYE 866
EI L ++ I+RL +L F + Y+ S L K
Sbjct: 73 LREITILNRLKSDYIIRLYDLIIPDDLLK-FDELYIVLEIADSDLKKLFKTPIF------ 125
Query: 867 VVLGVAH----------ALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916
L H ++H I+H D+K N LL + DFGLAR ++
Sbjct: 126 --LTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 917 GSGDDNCSKTNQRPQLAGSYG---------------YMAPE-HASMQRITEKSDVYSFGV 960
D N + + G + Y APE + T+ D++S G
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240
Query: 961 VLLEVLTGRHPLDPTLPGGAPL 982
+ E+L PL
Sbjct: 241 IFAELLNMLQSHINDPTNRFPL 262
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 773 VIGTGSSGVVYRV-TIPNGETLAVKKM-----WSSDESGAFSSEIQTLGSIRHKNIVRLL 826
++G G+ G V V G A+K + + DE +E + L + RH + L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 827 GWGSNKNLKLLF-YDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLHHDC 882
+ +L F +Y G L L D AR+ E+V AL YLH +
Sbjct: 215 YSFQTHD-RLCFVMEYANGGELFFHLSRERVFSED-RARFYGAEIVS----ALDYLHSEK 268
Query: 883 MPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE 942
+++ D+K N++L + DFGL + G D KT G+ Y+APE
Sbjct: 269 --NVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKT-----FCGTPEYLAPE 319
Query: 943 HASMQRITEKSDVYSFGVVLLEVLTGRHP 971
D + GVV+ E++ GR P
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 47/249 (18%), Positives = 80/249 (32%), Gaps = 66/249 (26%)
Query: 773 VIGTGSSGVVYRVTI-PNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLL----G 827
+GTGS G+V V +G+ A+KK+ D E+ + + H NI++L+
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKV-LQDPRYKNR-ELDIMKVLDHVNIIKLVDYFYT 71
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEV-------------------- 867
G + D +
Sbjct: 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSF 131
Query: 868 -----VLGVAH----------ALAYLH-HDCMPPILHGDVKAMNVLLGPG-YQAYLADFG 910
+ + A+ ++H I H D+K N+L+ L DFG
Sbjct: 132 IRSGRSIPMNLISIYIYQLFRAVGFIHSLG----ICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 911 LARIVSGSGDDN----CSKTNQRPQLAGSYGYMAPE-HASMQRITEKSDVYSFGVVLLEV 965
A+ + + + CS+ + Y APE T D++S G V E+
Sbjct: 188 SAKKLI-PSEPSVAYICSR----------F-YRAPELMLGATEYTPSIDLWSIGCVFGEL 235
Query: 966 LTGRHPLDP 974
+ G+ PL
Sbjct: 236 ILGK-PLFS 243
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 60/252 (23%), Positives = 102/252 (40%), Gaps = 46/252 (18%)
Query: 758 DFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS------- 809
+ + V R+L +G+G+ G V G +A+KK+ F S
Sbjct: 20 AWEVRAVYRDL---QPVGSGAYGAVCSAVDGRTGAKVAIKKL-----YRPFQSELFAKRA 71
Query: 810 --EIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD-YLPNGSLSSLLHGAGKGGADWEARYE 866
E++ L +RH+N++ LL + F D YL + + L K E R +
Sbjct: 72 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ 131
Query: 867 VVL-GVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSK 925
++ + L Y+H I+H D+K N+ + + + DFGLAR
Sbjct: 132 FLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--------- 179
Query: 926 TNQRPQLAGSYG----YMAPE-HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGA 980
++ G Y Y APE + R T+ D++S G ++ E++TG+ G
Sbjct: 180 ----SEMTG-YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK----TLFKGSD 230
Query: 981 PLVQWTPLMFLM 992
L Q +M +
Sbjct: 231 HLDQLKEIMKVT 242
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 42/157 (26%), Positives = 63/157 (40%), Gaps = 34/157 (21%)
Query: 505 PSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSI-GSLTELSKLL 563
P++ C+ +D GL +P +P + L+DN L + + G L L KL
Sbjct: 3 PAMCHCEGTT-VDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLE 60
Query: 564 LSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIP 623
L +NQL+ I F G I L L N+ EI
Sbjct: 61 LKRNQLT-GIEPNA---------------FEG-----ASHIQEL----QLGENKIK-EIS 94
Query: 624 SE-FSGLTKLGILDLSHNKLS----GDLDALASLQNL 655
++ F GL +L L+L N++S G + L SL +L
Sbjct: 95 NKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 27/109 (24%), Positives = 41/109 (37%), Gaps = 24/109 (22%)
Query: 122 FGDYRELTFIDLSGNSLWGEIPTEVC-RLRKLESLYLNTNLLEGEIPSDI-GNLSSLAYL 179
FG L ++L N L I ++ L L N ++ EI + + L L L
Sbjct: 50 FGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTL 107
Query: 180 TLYDNQLSGKIPKSI--GA---LSKLQVFRAGGNQNLKGELPWEIGNCS 223
LYDNQ+ + G+ L+ L N P+ NC+
Sbjct: 108 NLYDNQI-----SCVMPGSFEHLNSLTSLNLASN-------PF---NCN 141
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 22/87 (25%), Positives = 37/87 (42%), Gaps = 10/87 (11%)
Query: 272 ELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIP----DELGSCTELTVVDFS 327
L L L +N ++G P S ++ L L +N + I L +L ++
Sbjct: 55 HLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI-KEISNKMFLGL---HQLKTLNLY 110
Query: 328 DNLLTGSIPR-SFGNLLKLQELQLSVN 353
DN ++ + SF +L L L L+ N
Sbjct: 111 DNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 27/85 (31%), Positives = 37/85 (43%), Gaps = 3/85 (3%)
Query: 298 KSLLLWQNSLVGAIPDEL-GSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLS 356
LLL N L D L G L ++ N LTG P +F +QELQL N++
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 357 GTIPIEI-ATCTALTHLEIDNNAIS 380
I ++ L L + +N IS
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQIS 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 24/97 (24%), Positives = 40/97 (41%), Gaps = 10/97 (10%)
Query: 401 NKLTGNIPESL-SQCQELQALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPD 458
N+L + L + L L+ N L+G I F G ++ +L L N + I
Sbjct: 39 NELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIKE-ISNK 96
Query: 459 I-GNCTTLRRLRLNDNRLSGTIPS----EMGNLKHLN 490
+ L+ L L DN++S + + +L LN
Sbjct: 97 MFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLN 132
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 46/211 (21%), Positives = 79/211 (37%), Gaps = 50/211 (23%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSI-RHKNIVRLLG--- 827
V+G G +G V ++ E A+K + + E++ + +IVR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML---QDCPKARREVELHWRASQCPHIVRIVDVYE 81
Query: 828 --WGSNKNLKLLFYDYLPNGSL-SSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCM 883
+ K L ++ + L G L S + + + EA E++ + A+ YLH +
Sbjct: 82 NLYAGRKCLLIVM-ECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHSIN-- 137
Query: 884 PPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMA 940
I H DVK N+L P L DFG A+ Y
Sbjct: 138 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET----------------TGEKYD--- 176
Query: 941 PEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ D++S GV++ +L G P
Sbjct: 177 ----------KSCDMWSLGVIMYILLCGYPP 197
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 59/249 (23%), Positives = 104/249 (41%), Gaps = 48/249 (19%)
Query: 763 DVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS---------EIQ 812
++ + S +G+G+ G V +GE +A+KK+ S F S E+
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-----SRPFQSEIFAKRAYRELL 75
Query: 813 TLGSIRHKNIVRLLGWGSNKNLKLLFYD-YLPNGSLSSLLHGAGKGG-ADWEARYEV--V 868
L ++H+N++ LL + + FYD YL + + L ++ + +Y V +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM 135
Query: 869 LGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQ 928
L L Y+H ++H D+K N+ + + + DFGLAR
Sbjct: 136 L---KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD------------ 177
Query: 929 RPQLAGSYG----YMAPE-HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLV 983
++ G Y Y APE S + D++S G ++ E+LTG+ G L
Sbjct: 178 -AEMTG-YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKGKDYLD 231
Query: 984 QWTPLMFLM 992
Q T ++ +
Sbjct: 232 QLTQILKVT 240
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 31/130 (23%), Positives = 54/130 (41%), Gaps = 12/130 (9%)
Query: 538 VDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEI 597
V L+ + + ++ + +L L ++ I + + +D +N EI
Sbjct: 2 VKLTAELIEQAAQYT--NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN----EI 54
Query: 598 PKELGQISSLE--ISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLS--GDLDALASLQ 653
K L L +L +++N+ L L L L++N L GDLD LASL+
Sbjct: 55 RK-LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLK 113
Query: 654 NLVSLNVSFN 663
+L L + N
Sbjct: 114 SLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 7e-07
Identities = 26/158 (16%), Positives = 56/158 (35%), Gaps = 37/158 (23%)
Query: 294 LSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVN 353
+ + L L + I + + + +DFSDN + + F L +L+ L ++ N
Sbjct: 18 AVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNN 74
Query: 354 QLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQ 413
++ LT L + NN++ ++G++ + L+
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLV-----ELGDL------------------DPLAS 111
Query: 414 CQELQALDFSYNNLSGPIPKE-------IFGLRNLTKL 444
+ L L N P+ + I+ + + L
Sbjct: 112 LKSLTYLCILRN----PVTNKKHYRLYVIYKVPQVRVL 145
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 23/130 (17%), Positives = 45/130 (34%), Gaps = 15/130 (11%)
Query: 323 VVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGE 382
+V + L+ + + N ++ +EL L ++ I AT ++ +N I
Sbjct: 1 MVKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-- 55
Query: 383 IPADIGNINGL----TLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGL 438
+ L TL N++ +L L + N+L ++ L
Sbjct: 56 ---KLDGFPLLRRLKTLLVN-NNRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPL 109
Query: 439 RNLTKLLLLS 448
+L L L
Sbjct: 110 ASLKSLTYLC 119
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 26/136 (19%), Positives = 42/136 (30%), Gaps = 34/136 (25%)
Query: 366 CTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYN 425
L++ I I L + + A+DFS N
Sbjct: 18 AVRDRELDLRGYKIP--------VIENLG-----------------ATLDQFDAIDFSDN 52
Query: 426 NLS--GPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLS--GTIPS 481
+ P LR L LL+ +N + L L L +N L G +
Sbjct: 53 EIRKLDGFPL----LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-D 107
Query: 482 EMGNLKHLNFVDMSEN 497
+ +LK L ++ + N
Sbjct: 108 PLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 24/128 (18%), Positives = 45/128 (35%), Gaps = 9/128 (7%)
Query: 402 KLTGNI---PESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPD 458
KLT + + + LD + I L + N++
Sbjct: 3 KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DG 59
Query: 459 IGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHL--VGGIPPSVVGCQSLEFL 516
L+ L +N+NR+ L L + ++ N L +G + P + +SL +L
Sbjct: 60 FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYL 118
Query: 517 DLHSNGLT 524
+ N +T
Sbjct: 119 CILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 24/134 (17%), Positives = 45/134 (33%), Gaps = 30/134 (22%)
Query: 461 NCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHS 520
N R L L ++ + NL + +D
Sbjct: 17 NAVRDRELDLRGYKIP-----VIENLGAT--------------------LDQFDAIDFSD 51
Query: 521 NGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEIL 578
N + D P L+ + +++NR+ +L +L++L+L+ N L + L
Sbjct: 52 NEIR--KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPL 109
Query: 579 S-CRKLILLDIGNN 591
+ + L L I N
Sbjct: 110 ASLKSLTYLCILRN 123
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 3e-08
Identities = 114/650 (17%), Positives = 187/650 (28%), Gaps = 188/650 (28%)
Query: 361 IEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQAL 420
++ + L+ EID+ I + L LF+ +K E + Q + L
Sbjct: 38 VQDMPKSILSKEEIDH--IIMS-KDAVSGT--LRLFWTLLSK-----QEEMVQKFVEEVL 87
Query: 421 DFSYNNLSGPIPKEIFGLRNLTKLLL-----LSNDLSGFIPPDIGNCTTLRRLRLNDNRL 475
+Y L PI E +T++ + L ND F ++ +LR L
Sbjct: 88 RINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR---QAL 144
Query: 476 SGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVV---GCQSLEFLDLHSNG---LT-GSV- 527
L+ V + V G + V C S + L +
Sbjct: 145 L--------ELRPAKNVLI---DGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCN 193
Query: 528 -PDTLPTSLQ---------LVDLSDNRLSGSLAHSIGSL-TELSKLLLSKNQLSGRIPAE 576
P+T+ LQ SD+ S ++ I S+ EL +LL SK
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSDH--SSNIKLRIHSIQAELRRLLKSKPY-------- 243
Query: 577 ILSCRKLILLDIGNNRFSGEIPKELGQISSLEI--SLNLSSNQFSGEIPSEFSGLTKLGI 634
L++L + + + + NLS I
Sbjct: 244 ---ENCLLVLL---------------NVQNAKAWNAFNLSCK-----------------I 268
Query: 635 LDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRGLYISGG 694
L + K D L + ++S + S S L Y+
Sbjct: 269 LLTTRFKQVTD-----FLSAATTTHISLDHHSM-----TLTPDEVKSLLLK----YLD-- 312
Query: 695 VVSPTDSLPAGQARSAMKLVMSILVSASAVLVLLAIYVLVRTRMANNSFTADDTWEMTLY 754
P D LP + + +SI I +R +A D W+
Sbjct: 313 -CRPQD-LPR-EVLTTNPRRLSI------------IAESIRDGLATW-----DNWKHVNC 352
Query: 755 QKLDFSIDDVVRNLTSANVIGTGSSGVVYR--VTIPNGETLAVKKMWSSDESGAFSSEIQ 812
KL I+ + L A V+ IP L++ +W S++
Sbjct: 353 DKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPT-ILLSL--IWFDVI----KSDVM 405
Query: 813 TLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVA 872
+ + HK L+ K K +P+ L + E Y +
Sbjct: 406 VVVNKLHKY--SLV----EKQPKESTI-SIPSIYLELKVKL--------ENEYAL----- 445
Query: 873 HA---------LAYLHHDCMPPIL----------HGDVKAMNVLLGPGYQAYLADFGL-- 911
H + D +PP L H + +L DF
Sbjct: 446 HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL-DFRFLE 504
Query: 912 ARIVSGSGDDNC--SKTNQRPQLAGSY-GYMAPEHASMQRITEKSDVYSF 958
+I S N S N QL Y Y+ +R+ + + F
Sbjct: 505 QKIRHDSTAWNASGSILNTLQQLK-FYKPYICDNDPKYERLV--NAILDF 551
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 7e-06
Identities = 85/480 (17%), Positives = 153/480 (31%), Gaps = 134/480 (27%)
Query: 58 SWNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLI----ISSCN 113
+W + C + + C + ++ ++LK + S ++ + L+ L I S +
Sbjct: 164 TWVALDV--CLSYKVQCKMDFKIFWLNLKNCN---SPETVLEMLQKLLYQIDPNWTSRSD 218
Query: 114 LTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKL--ESLYLNTNLLEGEIPSDIG 171
+ I + LR+L Y N LL + ++
Sbjct: 219 HSSNIKLRIHSIQA--------------------ELRRLLKSKPYENC-LL---VLLNVQ 254
Query: 172 NLSSLAY--------LTLYD----NQLSGKIPKSI------GALSK---LQVFRAGGNQN 210
N + LT + LS I L+ + +
Sbjct: 255 NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCR 314
Query: 211 LKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQ----TIAIYTSL--LSGPIP 264
+ +LP E+ + + +AE SI + ++ + + T I +SL L P
Sbjct: 315 PQ-DLPREVLTTNPRRLSIIAE-SIR-DGLATWDNWKHVNCDKLTTIIESSLNVLE---P 368
Query: 265 EEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVV 324
E L ++ S IP LS L+W + + + + + ++V
Sbjct: 369 AEYRKM--FDRLSVFPPSA--HIP--TILLS-----LIWFDVIKSDVMVVVNKLHKYSLV 417
Query: 325 DFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEI----DNNAIS 380
+ T SIP L+L+ + L +I + H I D++ +
Sbjct: 418 EKQPKESTISIP---SIYLELKVKLENEYALHRSI---------VDHYNIPKTFDSDDLI 465
Query: 381 GEIPAD------IG-------NINGLTLF------FAW-KNKL---TGNIPESLSQCQEL 417
D IG + +TLF F + + K+ + S S L
Sbjct: 466 -PPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL 524
Query: 418 QALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIP---PDI--GNCTTLRRLRLND 472
Q L F Y I N K L N + F+P ++ T L R+ L
Sbjct: 525 QQLKF-YK-------PYIC--DNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMA 574
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 4e-05
Identities = 52/284 (18%), Positives = 84/284 (29%), Gaps = 79/284 (27%)
Query: 9 LFSQ--NIFSFTL--LLISINFLFFSTCDALDEQGQALLTWKNSLNSSTDALSS------ 58
L + + L +++ N S G A TW N + + D L++
Sbjct: 306 LLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLA--TWDNWKHVNCDKLTTIIESSL 363
Query: 59 --WNPAETSPC-KWFGIH---------------CSSNGEVVEISLK------AVDLQG-- 92
PAE + V + + V+ Q
Sbjct: 364 NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE 423
Query: 93 ---SLPSIFQPLK-------SLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLW--- 139
S+PSI+ LK +L R I+ N IPK F D +L L
Sbjct: 424 STISIPSIYLELKVKLENEYALHRSIVDHYN----IPKTF-DSDDLIPPYLDQYFYSHIG 478
Query: 140 ----GEIPTEVCRLRKLESLYLNTNLLEGEI---------PSDIGNLSSLAYLTLYDNQL 186
E R+ ++L+ LE +I I N L L Y +
Sbjct: 479 HHLKNIEHPE--RMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNT--LQQLKFYKPYI 534
Query: 187 SGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGL 230
PK ++ + F +NL ++L+ + L
Sbjct: 535 CDNDPKYERLVNAILDFLPKIEENLI------CSKYTDLLRIAL 572
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 44/155 (28%), Positives = 62/155 (40%), Gaps = 30/155 (19%)
Query: 517 DLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAE 576
+ +S G T SVP +P +DL N L LT L++L L N+L +P
Sbjct: 13 ECYSQGRT-SVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNG 70
Query: 577 IL-SCRKLILLDIGNNRFSGEIPKELGQISSLEI----------SLNLSSNQFSGEIPSE 625
+ L L++ N Q+ SL L L++NQ +P
Sbjct: 71 VFNKLTSLTYLNLSTN-----------QLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDG 118
Query: 626 -FSGLTKLGILDLSHNKL----SGDLDALASLQNL 655
F LT+L L L N+L G D L SLQ +
Sbjct: 119 VFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYI 153
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 33/108 (30%), Positives = 47/108 (43%), Gaps = 8/108 (7%)
Query: 274 QNLYLYQNSISGPIPGRIGALSKLKSLLLWQN---SLVGAIPDELGSCTELTVVDFSDNL 330
L L NS+ G L+ L L L N SL + ++L T LT ++ S N
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKL---TSLTYLNLSTNQ 87
Query: 331 LTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEI-ATCTALTHLEIDNN 377
L F L +L+EL L+ NQL ++P + T L L + N
Sbjct: 88 LQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQN 134
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 41/150 (27%), Positives = 66/150 (44%), Gaps = 16/150 (10%)
Query: 233 TSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIG 292
TS+ +P+ L+ SL S P + L LYL N + G
Sbjct: 20 TSVPTGIPAQTTYLD-----LETNSLKSLP-NGVFDELTSLTQLYLGGNKLQSLPNGVFN 73
Query: 293 ALSKLKSLLLWQN---SLVGAIPDELGSCTELTVVDFSDNLLTGSIP-RSFGNLLKLQEL 348
L+ L L L N SL + D+L T+L + + N L S+P F L +L++L
Sbjct: 74 KLTSLTYLNLSTNQLQSLPNGVFDKL---TQLKELALNTNQLQ-SLPDGVFDKLTQLKDL 129
Query: 349 QLSVNQLSGTIPIEI-ATCTALTHLEIDNN 377
+L NQL ++P + T+L ++ + +N
Sbjct: 130 RLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 36/123 (29%), Positives = 52/123 (42%), Gaps = 16/123 (13%)
Query: 455 IPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLV---GGIPPSVVGCQ 511
+P I L L N L L L + + N L G+ +
Sbjct: 22 VPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLT--- 76
Query: 512 SLEFLDLHSNGLTGSVP----DTLPTSLQLVDLSDNRLSGSLAHSI-GSLTELSKLLLSK 566
SL +L+L +N L S+P D L T L+ + L+ N+L SL + LT+L L L +
Sbjct: 77 SLTYLNLSTNQLQ-SLPNGVFDKL-TQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQ 133
Query: 567 NQL 569
NQL
Sbjct: 134 NQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 44/136 (32%), Positives = 63/136 (46%), Gaps = 18/136 (13%)
Query: 418 QALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNC-TTLRRLRLNDNRLS 476
LD N+L L +LT+L L N L +P + N T+L L L+ N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 477 GTIPS----EMGNLKHLNFVDMSENHLVGGIPPSVVG-CQSLEFLDLHSNGLTGSVP--- 528
++P+ ++ LK L ++ N L +P V L+ L L+ N L SVP
Sbjct: 90 -SLPNGVFDKLTQLKEL---ALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGV 143
Query: 529 -DTLPTSLQLVDLSDN 543
D L TSLQ + L DN
Sbjct: 144 FDRL-TSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 40/141 (28%), Positives = 61/141 (43%), Gaps = 15/141 (10%)
Query: 74 CSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDL 133
CS +G VE + S+P+ L + + +L F + LT + L
Sbjct: 5 CSCSGTTVECYSQGRT---SVPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYL 59
Query: 134 SGNSLWGEIPTEVC-RLRKLESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQLSGKIP 191
GN L +P V +L L L L+TN L+ +P+ + L+ L L L NQL +P
Sbjct: 60 GGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLP 116
Query: 192 KSIGA---LSKLQVFRAGGNQ 209
G L++L+ R NQ
Sbjct: 117 D--GVFDKLTQLKDLRLYQNQ 135
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 5/96 (5%)
Query: 93 SLPS-IFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVC-RLR 150
SLP+ +F L SL L +S+ L F +L + L+ N L +P V +L
Sbjct: 66 SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLT 124
Query: 151 KLESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQ 185
+L+ L L N L+ +P + L+SL Y+ L+DN
Sbjct: 125 QLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDNP 159
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 62/244 (25%), Positives = 96/244 (39%), Gaps = 45/244 (18%)
Query: 763 DVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS---------EIQ 812
DV T+ + IG G+ G+V N +A+KK+ F EI+
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI------SPFEHQTYCQRTLREIK 77
Query: 813 TLGSIRHKNIVRLLGWGSNKNLKLLFYD-YLPNGSLSSLLHGAGKGGA--DWEARYEV-- 867
L RH+NI+ + ++ D Y+ + + L+ K + Y +
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQ-MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 868 VLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTN 927
+L L Y+H +LH D+K N+LL + DFGLAR+ D T
Sbjct: 137 IL---RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 928 QRPQLAGSY----GYMAPE-HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPL 982
Y Y APE + + T+ D++S G +L E+L+ R P PG L
Sbjct: 191 --------YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR----PIFPGKHYL 238
Query: 983 VQWT 986
Q
Sbjct: 239 DQLN 242
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 12/110 (10%)
Query: 274 QNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIP----DELGSCTELTVVDFSDN 329
L L N + G L++L L L QN + ++P D+L T+LT++ +N
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKL---TKLTILYLHEN 86
Query: 330 LLTGSIPRS-FGNLLKLQELQLSVNQLSGTIPIEI-ATCTALTHLEIDNN 377
L S+P F L +L+EL L NQL ++P I T+L + + N
Sbjct: 87 KLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 44/144 (30%), Positives = 62/144 (43%), Gaps = 32/144 (22%)
Query: 517 DLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAE 576
+S GLT SVP +P+S ++L N+L LT+L+KL LS+NQ+ +P
Sbjct: 13 RCNSKGLT-SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDG 70
Query: 577 ILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSE-FSGLTKLGIL 635
+ KL L I L L N+ +P+ F LT+L L
Sbjct: 71 VFD--KLTKLTI----------------------LYLHENKLQ-SLPNGVFDKLTQLKEL 105
Query: 636 DLSHNKL----SGDLDALASLQNL 655
L N+L G D L SLQ +
Sbjct: 106 ALDTNQLKSVPDGIFDRLTSLQKI 129
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 8e-05
Identities = 47/158 (29%), Positives = 68/158 (43%), Gaps = 31/158 (19%)
Query: 74 CSSNGEVVEISLKAVDLQGSLPS-IFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFID 132
CS +G + + K + S+P+ I S RL + S L F +LT +
Sbjct: 5 CSCSGTEIRCNSKGLT---SVPTGIPS---SATRLELESNKLQSLPHGVFDKLTQLTKLS 58
Query: 133 LSGNSLWGEIPTEVC-RLRKLESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYDNQLSGKI 190
LS N + +P V +L KL LYL+ N L+ +P+ + L+ L L L NQL
Sbjct: 59 LSQNQI-QSLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQL---- 112
Query: 191 PKSI--GA---LSKLQVFRAGGNQNLKGELPWEIGNCS 223
KS+ G L+ LQ N PW +CS
Sbjct: 113 -KSVPDGIFDRLTSLQKIWLHTN-------PW---DCS 139
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 29/88 (32%), Positives = 40/88 (45%), Gaps = 10/88 (11%)
Query: 272 ELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIP----DELGSCTELTVVDFS 327
+L L L QN I G L+KL L L +N L ++P D+L T+L +
Sbjct: 53 QLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKL-QSLPNGVFDKL---TQLKELALD 108
Query: 328 DNLLTGSIPR-SFGNLLKLQELQLSVNQ 354
N L S+P F L LQ++ L N
Sbjct: 109 TNQLK-SVPDGIFDRLTSLQKIWLHTNP 135
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 4e-08
Identities = 61/435 (14%), Positives = 140/435 (32%), Gaps = 65/435 (14%)
Query: 269 NCSELQNLYLYQNSISGPIPGRIGA-LSKLKSLLLWQNSLVG--AIPDELGSCTELTVVD 325
+ + L+ + L + ++ I K L+L + +C L +D
Sbjct: 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELD 162
Query: 326 FSDNLLTGSIPRSFGNLLK----LQELQLS--VNQLSGTIPIEIAT-CTALTHLEIDNNA 378
++ + + L L +S +++S + + T C L L+++
Sbjct: 163 LRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAV 222
Query: 379 ISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGL 438
++ + L Y+ LS + G
Sbjct: 223 PLEKLATLLQRAPQLEEL-------------GTGGYTAEV-RPDVYSGLSVALS----GC 264
Query: 439 RNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGT----IPSEMGNLKHLNFVDM 494
+ L L + + ++P C+ L L L+ + + + L+ L +D
Sbjct: 265 KELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324
Query: 495 SENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPT------------SLQLVDLSD 542
E+ G+ C+ L L + + P+ T L+ V
Sbjct: 325 IEDA---GLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFC 381
Query: 543 NRLSG----SLAHSIGSLTELSKLLLSKNQLSGRIPAEIL---------SCRKLILLDIG 589
+++ ++A + ++T +L + + + + E L C+ L L +
Sbjct: 382 RQMTNAALITIARNRPNMTRF-RLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLS 440
Query: 590 NNRFSGEIPKELGQISSLEISLNLSSNQFSGE-IPSEFSGLTKLGILDLSHNKLSGD--L 646
+ ++ + +G + L+++ S + SG L L++ L
Sbjct: 441 GL-LTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALL 499
Query: 647 DALASLQNLVSLNVS 661
+ L+ + SL +S
Sbjct: 500 ANASKLETMRSLWMS 514
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 70/576 (12%), Positives = 173/576 (30%), Gaps = 103/576 (17%)
Query: 84 SLKAVDLQG------SLPSIFQPLKSLKRLIISSC-NLTGTIPKEFGDY-RELTFIDLSG 135
L+ + L+ L I + K+ K L++SSC + R L +DL
Sbjct: 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRE 165
Query: 136 NSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIG 195
+ + +L+ P +L SL ++ +++S ++
Sbjct: 166 -----------SDVDDVSGHWLS------HFPDTYTSLVSL-NISCLASEVSF---SALE 204
Query: 196 ALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIY 255
L C NL L L + + + +++ +
Sbjct: 205 RLVT---------------------RCPNLKSLKLNRAVPLEKLATLLQRAPQLEELG-- 241
Query: 256 TSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDEL 315
G + +Y + + +L+ L + +++ +P
Sbjct: 242 -----------TGGYTAEVRPDVYSG-----LSVALSGCKELRCLSGFWDAVPAYLPAVY 285
Query: 316 GSCTELTVVDFSD-NLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEI 374
C+ LT ++ S + + + + KLQ L + + + +TC L L +
Sbjct: 286 SVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRV 345
Query: 375 DNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQ-CQELQALDFSYNNLSGPIPK 433
+ + L S+S C +L+++ + ++
Sbjct: 346 FP--SEPFVMEPNVALTEQGL-------------VSVSMGCPKLESVLYFCRQMTN---- 386
Query: 434 EIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVD 493
L + + + L L + + + K L +
Sbjct: 387 --AALITIARNRPNMTRF------RLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLS 438
Query: 494 MSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP---TSLQLVDLSDNRLSG-SL 549
+S + +E L + G + + SL+ +++ D +L
Sbjct: 439 LSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKAL 498
Query: 550 AHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEI 609
+ L + L +S +S + + +++ + R + + E + + I
Sbjct: 499 LANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAPDSRPESCPVERVFI 558
Query: 610 SLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGD 645
++ ++P + + + S ++ +
Sbjct: 559 YRTVAGP--RFDMPGFVWNMDQDSTMRFSRQIITTN 592
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-08
Identities = 47/248 (18%), Positives = 81/248 (32%), Gaps = 54/248 (21%)
Query: 773 VIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSS-------------EIQTLGSIRH 819
I +GS G V G +A+K+++++ G + EI+ L H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 820 KNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAH------ 873
NI+ L + + YL + + L +V+ H
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQ-------RIVISPQHIQYFMY 141
Query: 874 ----ALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR 929
L LH ++H D+ N+LL + DF LAR +
Sbjct: 142 HILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDT-----------AD 187
Query: 930 PQLAGSYG----YMAPE-HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQ 984
Y Y APE + T+ D++S G V+ E+ + G Q
Sbjct: 188 ANKTH-YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK----ALFRGSTFYNQ 242
Query: 985 WTPLMFLM 992
++ ++
Sbjct: 243 LNKIVEVV 250
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 52/211 (24%), Positives = 84/211 (39%), Gaps = 26/211 (12%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSIR-HKNIVRLLGWGSN 831
IG+GS G +Y T I E +A+K + E + ++ I + +G
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE 74
Query: 832 KNLKLLFYDYLPNG-SLSSLLHGAGKGGADWEARYEVVLGVA----HALAYLHHDCMPPI 886
+ +L D L G SL L + + + + VL +A + + ++H
Sbjct: 75 GDYNVLVMDLL--GPSLEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHSKS---F 124
Query: 887 LHGDVKAMNVLLGPGYQA---YLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM---A 940
LH D+K N L+G G +A Y+ DFGLA+ + + L G+ Y
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNT 184
Query: 941 PEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
R + D+ S G VL+ L G P
Sbjct: 185 HLGIEQSR---RDDLESLGYVLMYFLRGSLP 212
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 8e-08
Identities = 58/252 (23%), Positives = 105/252 (41%), Gaps = 46/252 (18%)
Query: 758 DFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS------- 809
+ + + +NL + +G+G+ G V G +AVKK+ S F S
Sbjct: 24 IWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKL-----SRPFQSIIHAKRT 75
Query: 810 --EIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD-YLPNGSLSSLLHGAGKGGADWEARYE 866
E++ L ++H+N++ LL + F D YL + + L+ K + +
Sbjct: 76 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 135
Query: 867 VVL-GVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSK 925
++ + L Y+H I+H D+K N+ + + + DFGLAR +
Sbjct: 136 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--------- 183
Query: 926 TNQRPQLAGSY----GYMAPE-HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGA 980
++ G Y Y APE + + D++S G ++ E+LTGR PG
Sbjct: 184 ----DEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR----TLFPGTD 234
Query: 981 PLVQWTPLMFLM 992
+ Q ++ L+
Sbjct: 235 HIDQLKLILRLV 246
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 8e-08
Identities = 37/136 (27%), Positives = 63/136 (46%), Gaps = 20/136 (14%)
Query: 840 DYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLHHDCMPPILHGDVKAMNV 896
+Y+ G L + G+ A + E+ + L +L I++ D+K NV
Sbjct: 422 EYVNGGDLMYHIQQVGRFKEP-HAVFYAAEIAI----GLFFLQSK---GIIYRDLKLDNV 473
Query: 897 LLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDV 955
+L G+ +ADFG+ + D +KT G+ Y+APE + Q + D
Sbjct: 474 MLDSEGHIK-IADFGMCK--ENIWDGVTTKT-----FCGTPDYIAPEIIAYQPYGKSVDW 525
Query: 956 YSFGVVLLEVLTGRHP 971
++FGV+L E+L G+ P
Sbjct: 526 WAFGVLLYEMLAGQAP 541
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 30/123 (24%), Positives = 47/123 (38%), Gaps = 16/123 (13%)
Query: 549 LAHSIGSLTELSKLLLSKNQLS-GRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSL 607
L + + +L+L + + G+I L L + N L +S+L
Sbjct: 16 LELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINV--------GLISVSNL 67
Query: 608 E-----ISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLS--GDLDALASLQNLVSLNV 660
L LS N+ G + L L L+LS NKL L+ L L+ L SL++
Sbjct: 68 PKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDL 127
Query: 661 SFN 663
Sbjct: 128 FNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 34/156 (21%), Positives = 56/156 (35%), Gaps = 29/156 (18%)
Query: 293 ALSKLKSL-LLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLS 351
+ ++ L L S G I L + + L S+ + L KL++L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELS 79
Query: 352 VNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESL 411
N++ G + + LTHL + N + DI + E L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK-----DISTL------------------EPL 116
Query: 412 SQCQELQALDFSYN---NLSGPIPKEIFGLRNLTKL 444
+ + L++LD NL+ L LT L
Sbjct: 117 KKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 23/97 (23%), Positives = 36/97 (37%), Gaps = 9/97 (9%)
Query: 405 GNIPESLSQCQELQALDFSYNNLS--GPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNC 462
G I ++ L+ L L +PK L L KL L N + G +
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGLISVSNLPK----LPKLKKLELSENRIFGGLDMLAEKL 94
Query: 463 TTLRRLRLNDNRLS--GTIPSEMGNLKHLNFVDMSEN 497
L L L+ N+L T+ + L+ L +D+
Sbjct: 95 PNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 32/92 (34%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 503 IPPSVVGCQSLEFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHSIGSLTELS 560
I +LEFL L + GL SV + LP L+ ++LS+NR+ G L L L+
Sbjct: 41 IEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98
Query: 561 KLLLSKNQLSGRIPAEILS-CRKLILLDIGNN 591
L LS N+L E L L LD+ N
Sbjct: 99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 59/269 (21%), Positives = 99/269 (36%), Gaps = 67/269 (24%)
Query: 756 KLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTL 814
++D + + +G G+ G+V++ GE +AVKK+ AF +
Sbjct: 2 RVDRHVLRKYELV---KKLGKGAYGIVWKSIDRRTGEVVAVKKI-----FDAFQNSTDAQ 53
Query: 815 GSIR----------HKNIVRLLGWGSNKNLK--LLFYDYLPNGSLSSLLHGAGKGGADWE 862
+ R H+NIV LL N + L +DY+ L +++
Sbjct: 54 RTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN-------- 104
Query: 863 ARYEVVLGVAH----------ALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLA 912
+L H + YLH +LH D+K N+LL +ADFGL+
Sbjct: 105 -----ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLS 156
Query: 913 RIVSGSGDDNCSKTNQRPQLAGSYG--------------YMAPEHA-SMQRITEKSDVYS 957
R + + ++ Y APE + T+ D++S
Sbjct: 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWS 216
Query: 958 FGVVLLEVLTGRHPLDPTLPGGAPLVQWT 986
G +L E+L G+ P PG + + Q
Sbjct: 217 LGCILGEILCGK----PIFPGSSTMNQLE 241
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 25/114 (21%), Positives = 48/114 (42%), Gaps = 10/114 (8%)
Query: 555 SLTELSKLLLSKNQLS-GRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLE--ISL 611
+ +++ +L+L ++ + G++ +L L N + + L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----TSIANLPKLNKLKKL 69
Query: 612 NLSSNQFSGEIPSEFSGLTKLGILDLSHNKLS--GDLDALASLQNLVSLNVSFN 663
LS N+ SG + L L+LS NK+ ++ L L+NL SL++
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 38/160 (23%), Positives = 59/160 (36%), Gaps = 37/160 (23%)
Query: 293 ALSKLKSLLLWQNSL-VGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLS 351
S +K L+L + G + EL + + LT SI + L KL++L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72
Query: 352 VNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESL 411
N++SG + + C LTHL + N I D+ I E L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK-----DLSTI------------------EPL 109
Query: 412 SQCQELQALDFSYNNLSGPIPKE-------IFGLRNLTKL 444
+ + L++LD + L LT L
Sbjct: 110 KKLENLKSLDLFNC----EVTNLNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 22/94 (23%), Positives = 39/94 (41%), Gaps = 7/94 (7%)
Query: 407 IPESLSQCQELQALDFSYNNLS--GPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTT 464
+ + +EL+ L L+ +PK L L KL L N +SG + C
Sbjct: 34 LEGLTDEFEELEFLSTINVGLTSIANLPK----LNKLKKLELSDNRVSGGLEVLAEKCPN 89
Query: 465 LRRLRLNDNRLSG-TIPSEMGNLKHLNFVDMSEN 497
L L L+ N++ + + L++L +D+
Sbjct: 90 LTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 25/111 (22%), Positives = 51/111 (45%), Gaps = 7/111 (6%)
Query: 510 CQSLEFLDLHSNGLTGSVPDTLP---TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSK 566
++ L L ++ + L L+ + + L+ S+A+ + L +L KL LS
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSD 73
Query: 567 NQLSGRIPAEILSCRKLILLDIGNNRFSG-EIPKELGQISSLEISLNLSSN 616
N++SG + C L L++ N+ + L ++ +L+ SL+L +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLK-SLDLFNC 123
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 773 VIGTGSSGVVYRV-TIPNGETLAVKKM-----WSSDESGAFSSEIQTLGSIRHKNIVRLL 826
++G G+ G V V G A+K + + DE +E + L + RH + L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 827 GWGSNKNLKLLF-YDYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLH-HD 881
+ +L F +Y G L L + AR+ E+V AL YLH D
Sbjct: 72 YAFQTHD-RLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVS----ALEYLHSRD 125
Query: 882 CMPPILHGDVKAMNVLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMA 940
+++ D+K N++L G+ + DFGL + G D KT G+ Y+A
Sbjct: 126 ----VVYRDIKLENLMLDKDGHIK-ITDFGLCK--EGISDGATMKT-----FCGTPEYLA 173
Query: 941 PEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
PE D + GVV+ E++ GR P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 47/215 (21%), Positives = 84/215 (39%), Gaps = 32/215 (14%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSIRH-KNIVRLLGWGSN 831
IG GS GV++ T + N + +A+K ++ E +T + I + +G
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 77
Query: 832 KNLKLLFYDYLPNG-SLSSLLHGAGKGGADWEARY--EVVLGVA----HALAYLHHDCMP 884
+L D L G SL LL G+ ++ + V A + +H
Sbjct: 78 GLHNVLVIDLL--GPSLEDLLDLCGR-------KFSVKTVAMAAKQMLARVQSIHEKS-- 126
Query: 885 PILHGDVKAMNVLLGPGY-----QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYM 939
+++ D+K N L+G Y+ DFG+ + ++ L+G+ Y
Sbjct: 127 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY- 184
Query: 940 APEHASMQRITEKS---DVYSFGVVLLEVLTGRHP 971
+ + R E+S D+ + G V + L G P
Sbjct: 185 MSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 2e-07
Identities = 26/201 (12%), Positives = 61/201 (30%), Gaps = 28/201 (13%)
Query: 485 NLKHLNFVDMSENHL------VGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLV 538
+ + L + D+ + P + L L + P L+ +
Sbjct: 140 HFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPN-LKSL 198
Query: 539 DLSDNRLSGSLAHSIGS-----LTELSKLLLSKNQLSGRIPAEILS-------CRKLILL 586
++ L S+ I L +L L + + L L
Sbjct: 199 EIISGGLPDSVVEDILGSDLPNLEKL-VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWL 257
Query: 587 DIGNNRFSGEIPKELGQISSLE--ISLNLSSNQFSGE----IPSEFSGLTKLGILDLSHN 640
I + + + + L ++++S+ + E + + L +++ +N
Sbjct: 258 GIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317
Query: 641 KLSGD-LDALA-SLQNLVSLN 659
LS + L SL + ++
Sbjct: 318 YLSDEMKKELQKSLPMKIDVS 338
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.0 bits (118), Expect = 2e-06
Identities = 27/162 (16%), Positives = 55/162 (33%), Gaps = 19/162 (11%)
Query: 525 GSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSC---- 580
+ L L +L + + +L+ L L + L + +IL
Sbjct: 162 VDLSPVLDAMPLLNNLKI-KGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPN 220
Query: 581 -RKLILLDIGNNRFSGEIPKELGQISSLE-----ISLNLSSNQFSGEIPS---EFSGLTK 631
KL+L + + S + L + + + E L +
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280
Query: 632 LGILDLSHNKLSGD-----LDALASLQNLVSLNVSFNDFSGE 668
L +D+S L+ + LD + +++L +N+ +N S E
Sbjct: 281 LETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 1e-04
Identities = 21/162 (12%), Positives = 46/162 (28%), Gaps = 21/162 (12%)
Query: 333 GSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIG---- 388
+ + L L++ + I L LEI + + + DI
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 389 -NINGLTLFFAWKNKLTGNIPESLS------QCQELQALDFSYNNLSGPIPKEIFG---L 438
N+ L L+ ++ + L+ L + + L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 439 RNLTKLLLLSNDLSGF----IPPDIGNCTTLRRLRLNDNRLS 476
L + + + L+ + + L+ + + N LS
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 6e-07
Identities = 39/137 (28%), Positives = 58/137 (42%), Gaps = 22/137 (16%)
Query: 840 DYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLH-HDCMPPILHGDVKAMN 895
+YL G L L G D A + E+ + AL +LH I++ D+K N
Sbjct: 101 EYLSGGELFMQLEREGIFMED-TACFYLAEISM----ALGHLHQKG----IIYRDLKPEN 151
Query: 896 VLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSD 954
++L G+ L DFGL + D + T G+ YMAPE D
Sbjct: 152 IMLNHQGHVK-LTDFGLCKE--SIHDGTVTHT-----FCGTIEYMAPEILMRSGHNRAVD 203
Query: 955 VYSFGVVLLEVLTGRHP 971
+S G ++ ++LTG P
Sbjct: 204 WWSLGALMYDMLTGAPP 220
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 32/155 (20%), Positives = 56/155 (36%), Gaps = 28/155 (18%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSIRH-KNIVRLLGWGSN 831
IG G+ G + + E +A+K + E + + I ++ +G
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC 76
Query: 832 KNLKLLFYDYLPNG-SLSSLLHGAGKGGADWEAR---YEVVLGVA----HALAYLHHDCM 883
+ + L G SL L D R + VL +A + Y+H
Sbjct: 77 GKYNAMVLELL--GPSLEDLF--------DLCDRTFSLKTVLMIAIQLISRMEYVHSKN- 125
Query: 884 PPILHGDVKAMNVLLGPGY-----QAYLADFGLAR 913
+++ DVK N L+G ++ DF LA+
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 22/137 (16%)
Query: 840 DYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLH-HDCMPPILHGDVKAMN 895
+Y+ G L + G+ A + E+ + L +L I++ D+K N
Sbjct: 101 EYVNGGDLMYHIQQVGRFKEPH-AVFYAAEIAI----GLFFLQSKG----IIYRDLKLDN 151
Query: 896 VLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSD 954
V+L G+ +ADFG+ + D +KT G+ Y+APE + Q + D
Sbjct: 152 VMLDSEGHIK-IADFGMCK--ENIWDGVTTKT-----FCGTPDYIAPEIIAYQPYGKSVD 203
Query: 955 VYSFGVVLLEVLTGRHP 971
++FGV+L E+L G+ P
Sbjct: 204 WWAFGVLLYEMLAGQAP 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 1e-06
Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 22/137 (16%)
Query: 840 DYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLH-HDCMPPILHGDVKAMN 895
D+L G L + L + ++ E+ L AL +LH I++ D+K N
Sbjct: 106 DFLRGGDLFTRLSKEVMFTEED-VKFYLAELAL----ALDHLHSLG----IIYRDLKPEN 156
Query: 896 VLL-GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSD 954
+LL G+ L DFGL++ + + + G+ YMAPE + + T+ +D
Sbjct: 157 ILLDEEGHIK-LTDFGLSKE--SIDHEKKAYS-----FCGTVEYMAPEVVNRRGHTQSAD 208
Query: 955 VYSFGVVLLEVLTGRHP 971
+SFGV++ E+LTG P
Sbjct: 209 WWSFGVLMFEMLTGTLP 225
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 40/137 (29%), Positives = 62/137 (45%), Gaps = 22/137 (16%)
Query: 840 DYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLH-HDCMPPILHGDVKAMN 895
+YL G L + K A + E++L L +LH I++ D+K N
Sbjct: 98 EYLNGGDLMYHIQSCHKFDLS-RATFYAAEIIL----GLQFLHSKG----IVYRDLKLDN 148
Query: 896 VLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSD 954
+LL G+ +ADFG+ + D + T G+ Y+APE Q+ D
Sbjct: 149 ILLDKDGHIK-IADFGMCKE--NMLGDAKTNT-----FCGTPDYIAPEILLGQKYNHSVD 200
Query: 955 VYSFGVVLLEVLTGRHP 971
+SFGV+L E+L G+ P
Sbjct: 201 WWSFGVLLYEMLIGQSP 217
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 2e-06
Identities = 36/247 (14%), Positives = 62/247 (25%), Gaps = 69/247 (27%)
Query: 774 IGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSI---------------- 817
IG G G V++ + +A+K + S +T I
Sbjct: 28 IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 818 ---RHKNIVRLLGW----GSNKNLKLLFYDYLPNGSLS---------------------- 848
R + + L GS L L +D+ + S
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 849 -SLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP------- 900
L + ++ + +LA H D+ NVLL
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLH 204
Query: 901 -------------GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ 947
G Q + D+ L+R+ C + G Y + M+
Sbjct: 205 YTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMK 264
Query: 948 RITEKSD 954
+
Sbjct: 265 KENNNRW 271
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 37/137 (27%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 840 DYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLH-HDCMPPILHGDVKAMN 895
+++ G L + + + AR+ E++ AL +LH I++ D+K N
Sbjct: 104 EFVNGGDLMFHIQKSRRFDEAR-ARFYAAEIIS----ALMFLHDKG----IIYRDLKLDN 154
Query: 896 VLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSD 954
VLL G+ LADFG+ + G + + T G+ Y+APE D
Sbjct: 155 VLLDHEGHCK-LADFGMCK--EGICNGVTTAT-----FCGTPDYIAPEILQEMLYGPAVD 206
Query: 955 VYSFGVVLLEVLTGRHP 971
++ GV+L E+L G P
Sbjct: 207 WWAMGVLLYEMLCGHAP 223
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 36/286 (12%), Positives = 80/286 (27%), Gaps = 70/286 (24%)
Query: 417 LQALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSGFIPPDIG----------NCTTL 465
L ++ + L + + KL L N L + +
Sbjct: 103 LDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG-----PEACKDLRDLLLHDQCQI 157
Query: 466 RRLRLNDNRLS-------GTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDL 518
LRL++N L+ + ++ HL + L G + L
Sbjct: 158 TTLRLSNNPLTAAGVAVLMEGLAGNTSVTHL---SLLHTGL------GDEGLELL----- 203
Query: 519 HSNGLTGSVPDTLPTSLQLVDLSDNRLSGS----LAHSIGSLTELSKLLLSKNQLS---G 571
+ L LQ ++++ N + LA + L L L N+LS
Sbjct: 204 -AAQLDR------NRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGR 256
Query: 572 RIPAEIL----SCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFS 627
++ ++ ++++ + + S+ +S + +
Sbjct: 257 QVLRDLGGAAEGGARVVVSLTEGTA--------VSEYWSVILSEVQRNLNSWDR--ARVQ 306
Query: 628 GLTKLGILDLSHNKLSGD-----LDALASLQNLVSLNVSFNDFSGE 668
+L + DL ++ + L + +L
Sbjct: 307 RHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSGSP 352
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 49/322 (15%), Positives = 85/322 (26%), Gaps = 90/322 (27%)
Query: 269 NCSELQNLYLYQNSISGPIPGRIG-ALSKLKSLLLWQNSL----VGAIPDELGSCTELTV 323
L + L + + + + L L NSL + D L
Sbjct: 99 GRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH------ 152
Query: 324 VDFSDNLLTGSIPRSFGNLLKLQELQLSVNQL--SGTIPI--EIATCTALTHLEIDNNAI 379
+ ++ L+LS N L +G + +A T++THL + + +
Sbjct: 153 -----------------DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGL 195
Query: 380 SGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLR 439
E GL L + L + ++LQ L+ +YN
Sbjct: 196 GDE---------GLEL-----------LAAQLDRNRQLQELNVAYNGAGDT------AAL 229
Query: 440 NLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGT-------IPSEMGNLKHLNFV 492
L + +L L L N LS + +
Sbjct: 230 ALARAAR--------------EHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVS 275
Query: 493 DMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLS----GS 548
+ S L + + N + L DL D+R +
Sbjct: 276 LTEGTAV------SEYWSVILSEVQRNLNSWDRARVQRHLELLLR-DLEDSRGATLNPWR 328
Query: 549 LAHSIGSLTELSKLLLSKNQLS 570
A + E+ LL
Sbjct: 329 KAQLLRVEGEVRALLEQLGSSG 350
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 40/155 (25%), Positives = 64/155 (41%), Gaps = 20/155 (12%)
Query: 840 DYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLH-HDCMPPILHGDVKAMN 895
+Y+ G L + K + AR+ E+ L AL YLH I++ D+K N
Sbjct: 90 EYVNGGDLMFHMQRQRKLPEEH-ARFYSAEISL----ALNYLHERG----IIYRDLKLDN 140
Query: 896 VLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDV 955
VLL L D+G+ + G + + T G+ Y+APE + D
Sbjct: 141 VLLDSEGHIKLTDYGMCK--EGLRPGDTTST-----FCGTPNYIAPEILRGEDYGFSVDW 193
Query: 956 YSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMF 990
++ GV++ E++ GR P D P +F
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 228
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 40/137 (29%), Positives = 57/137 (41%), Gaps = 22/137 (16%)
Query: 840 DYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLH-HDCMPPILHGDVKAMN 895
DY+ G L L AR+ E+ AL YLH + I++ D+K N
Sbjct: 119 DYINGGELFYHLQRERCFLEPR-ARFYAAEIAS----ALGYLHSLN----IVYRDLKPEN 169
Query: 896 VLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSD 954
+LL G+ L DFGL + ++ + T G+ Y+APE Q D
Sbjct: 170 ILLDSQGHIV-LTDFGLCK--ENIEHNSTTST-----FCGTPEYLAPEVLHKQPYDRTVD 221
Query: 955 VYSFGVVLLEVLTGRHP 971
+ G VL E+L G P
Sbjct: 222 WWCLGAVLYEMLYGLPP 238
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 40/155 (25%), Positives = 64/155 (41%), Gaps = 20/155 (12%)
Query: 840 DYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLH-HDCMPPILHGDVKAMN 895
+Y+ G L + K + AR+ E+ L AL YLH I++ D+K N
Sbjct: 133 EYVNGGDLMFHMQRQRKLPEEH-ARFYSAEISL----ALNYLHERG----IIYRDLKLDN 183
Query: 896 VLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDV 955
VLL L D+G+ + G + + T G+ Y+APE + D
Sbjct: 184 VLLDSEGHIKLTDYGMCK--EGLRPGDTTST-----FCGTPNYIAPEILRGEDYGFSVDW 236
Query: 956 YSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMF 990
++ GV++ E++ GR P D P +F
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 271
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 46/234 (19%), Positives = 82/234 (35%), Gaps = 52/234 (22%)
Query: 774 IGTGSSGVVYRVTIPNGETLAVK-----KMWSSDESGAFS--------------SEIQTL 814
IG G G +Y + + E++ K+ SD F+ +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 815 GSIRHKNIVRLLGWGSNKNLKLLFY----DYLPNG-SLSSLLHGAGKGGADWEAR---YE 866
+++ + + G G + + D G L + + A+ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY--------EANAKRFSRK 152
Query: 867 VVLGVA----HALAYLHHDCMPPILHGDVKAMNVLLGPGY--QAYLADFGLARIVSGSGD 920
VL ++ L Y+H +HGD+KA N+LL Q YL D+GLA G
Sbjct: 153 TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209
Query: 921 DNCSKTNQRPQLAGSYGYM---APEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ + G+ + A + R + D+ G +++ LTG P
Sbjct: 210 HKAYAADPKRCHDGTIEFTSIDAHNGVAPSR---RGDLEILGYCMIQWLTGHLP 260
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 38/139 (27%), Positives = 59/139 (42%), Gaps = 23/139 (16%)
Query: 840 DYLPNGSLSSLLHGAGKGGADWEARY---EVVLGVAHALAYLH-HDCMPPILHGDVKAMN 895
DY+ G L + L + + E+VL AL +LH I++ D+K N
Sbjct: 139 DYINGGELFTHLSQRERFTEHE-VQIYVGEIVL----ALEHLHKLG----IIYRDIKLEN 189
Query: 896 VLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE--HASMQRITEK 952
+LL G+ L DFGL++ + G+ YMAP+ +
Sbjct: 190 ILLDSNGHVV-LTDFGLSKEFVADETERAY-D-----FCGTIEYMAPDIVRGGDSGHDKA 242
Query: 953 SDVYSFGVVLLEVLTGRHP 971
D +S GV++ E+LTG P
Sbjct: 243 VDWWSLGVLMYELLTGASP 261
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 42/231 (18%), Positives = 73/231 (31%), Gaps = 16/231 (6%)
Query: 273 LQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLT 332
+ ++ + P+ L V + L C++L + L+
Sbjct: 72 VIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLS 131
Query: 333 GSIPRSFGNLLKLQELQLS-VNQLSGTIPIEIAT-CTALTHL------EIDNNAISGEIP 384
I + L L LS + S + + C+ L L + + +
Sbjct: 132 DPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVA 191
Query: 385 ADIGNINGLTLFFAWKNKLTGNIPESLSQ-CQELQALDFSY-NNLSGPIPKEIFGLRNLT 442
I L L ++ L + +L + C L LD S L +E F L L
Sbjct: 192 HVSETITQLNL-SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 250
Query: 443 KLLLLSNDL---SGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLN 490
L L + ++G TL+ L++ GT+ L HL
Sbjct: 251 HLSLSRCYDIIPETLL--ELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 299
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 40/234 (17%), Positives = 70/234 (29%), Gaps = 22/234 (9%)
Query: 369 LTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLS 428
+ + + + + + + LSQC +LQ L LS
Sbjct: 72 VIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLS 131
Query: 429 GPIPKEIFGLRNLTKLLLLSNDLSG-------FIPPDIGNCTTLRRL------RLNDNRL 475
PI + NL +L +LSG + + +C+ L L + +
Sbjct: 132 DPIVNTLAKNSNLVRL-----NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHV 186
Query: 476 SGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDL-HSNGLTGSVPDTL--P 532
+ + LN +N + V C +L LDL S L
Sbjct: 187 QVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL 246
Query: 533 TSLQLVDLSD-NRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLIL 585
LQ + LS + +G + L L + G + + L +
Sbjct: 247 NYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 300
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 50/230 (21%), Positives = 82/230 (35%), Gaps = 44/230 (19%)
Query: 774 IGTGSSGVVYRVT---------IPNGETLAVK---------KMWSSDESGAFSSEIQ--- 812
+ G++Y P + ++K + + A ++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 813 TLGSIRHKNIVRLLGWGSNKNL-KLLFYDYLPNG-SLSSLLHGAGKGGADWEARYEVVLG 870
L S I +G+G +++ + L L G SL S L + K + VL
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERS----VLQ 163
Query: 871 VA----HALAYLHHDCMPPILHGDVKAMNVLLGPGY--QAYLADFGLARIVSGSGDDNCS 924
VA AL +LH + +HG+V A N+ + P Q LA +G A SG
Sbjct: 164 VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220
Query: 925 KTNQRPQLAGSYGYM---APEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
R G ++ + R +SD+ S G +L+ L G P
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGPSR---RSDLQSLGYCMLKWLYGFLP 267
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 50/229 (21%), Positives = 82/229 (35%), Gaps = 45/229 (19%)
Query: 774 IGTGSSGVVYRVT-IPNGETLAVK--KMWSSDES--------------GAFSSEIQTLGS 816
IG+G G++Y E A K+ + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 817 IRHKNIVRLLGWGSNKNLKLLFY----DYLPNG-SLSSLLHGAGKGGADWEARYEVVLGV 871
+ + I G G + + + L G L + G + VL +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGT------FKKSTVLQL 156
Query: 872 A----HALAYLHHDCMPPILHGDVKAMNVLLGPGY--QAYLADFGLARIVSGSGDDNCSK 925
L Y+H + +HGD+KA N+LLG Q YLAD+GL+ +G+ +
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213
Query: 926 TNQRPQLAGSYGYM---APEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
N R G+ + A + ++ R +SDV G +L L G+ P
Sbjct: 214 ENPRKGHNGTIEFTSLDAHKGVALSR---RSDVEILGYCMLRWLCGKLP 259
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 40/229 (17%), Positives = 63/229 (27%), Gaps = 70/229 (30%)
Query: 810 EIQTLGSIR--------HKNIVRLLGWGSNKNLKLLFYDYLPNG------------SLSS 849
EI+ L S+R + +V+LL F NG L
Sbjct: 83 EIRLLKSVRNSDPNDPNREMVVQLLDD---------FKISGVNGTHICMVFEVLGHHLLK 133
Query: 850 LLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADF 909
+ + G +++ V L YLH C I+H D+K N+LL Q
Sbjct: 134 WIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191
Query: 910 GLARIVSGSGDDNCSKTNQRPQLAGSYG-------------------------------- 937
A SG S + A +
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT 251
Query: 938 -------YMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGG 979
Y + E +D++S + E+ TG + +P
Sbjct: 252 EDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE 300
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 20/56 (35%), Positives = 33/56 (58%), Gaps = 3/56 (5%)
Query: 516 LDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSI-GSLTELSKLLLSKNQLS 570
+D L SVP +PT+ Q++ L DN+++ L + LT+L++L L NQL+
Sbjct: 14 VDCSGKSLA-SVPTGIPTTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT 67
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 17/67 (25%), Positives = 26/67 (38%), Gaps = 4/67 (5%)
Query: 505 PSVVGCQSLEFLDLHSNGLTG-SVPDTLPTSLQLVDLSDNRLSGSLAHSI-GSLTELSKL 562
P+ C +D GLT S+P P + L+ N L+ +L + +L L
Sbjct: 3 PAPCSCAGTL-VDCGRRGLTWASLPTAFPVDTTELVLTGNNLT-ALPPGLLDALPALRTA 60
Query: 563 LLSKNQL 569
L N
Sbjct: 61 HLGANPW 67
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 15/56 (26%), Positives = 30/56 (53%), Gaps = 3/56 (5%)
Query: 516 LDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSI-GSLTELSKLLLSKNQLS 570
++ + L SVP +PT Q + L++N+++ L + L L +L + N+L+
Sbjct: 17 VNCQNIRLA-SVPAGIPTDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT 70
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 24/103 (23%), Positives = 38/103 (36%), Gaps = 18/103 (17%)
Query: 874 ALAYLHHDCMPPILHGDVKAMNVLL-GPGYQAY-----LADFGLARIVSGSGDDNCSKTN 927
L Y+H C I+H D+K NVL+ +AD G A C
Sbjct: 143 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----------CWYDE 190
Query: 928 QRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRH 970
+ Y +PE +D++S ++ E++TG
Sbjct: 191 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1001 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.98 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.98 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.98 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.98 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.98 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.98 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.98 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.98 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.98 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.98 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.98 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.98 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.98 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.98 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.98 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.98 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.98 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.98 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.98 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.98 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.98 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.98 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.98 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.82 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.82 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.77 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.75 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.71 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.69 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.69 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.69 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.57 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.57 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.55 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.55 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.53 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.53 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.5 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.47 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.46 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.46 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.44 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.42 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.37 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.35 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.25 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.23 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.21 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.18 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.17 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.16 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.91 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.9 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.86 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.78 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.77 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.74 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.35 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.34 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.33 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.25 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.24 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.23 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.11 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.08 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.77 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.73 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.68 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.51 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.41 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.36 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.36 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.21 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.19 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.14 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.97 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.93 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.9 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.87 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.83 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.68 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.55 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.35 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.19 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.14 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.85 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.81 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 89.2 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.62 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.91 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 84.74 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 80.04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-91 Score=873.85 Aligned_cols=659 Identities=32% Similarity=0.503 Sum_probs=547.8
Q ss_pred ccCcCcHHHHHHHHHHHHhCCCCCCccCCCCCCCCCCCccceEEeCCCCcEEEEEecccccccc---CCcccccCCCCcE
Q 001873 30 STCDALDEQGQALLTWKNSLNSSTDALSSWNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQGS---LPSIFQPLKSLKR 106 (1001)
Q Consensus 30 ~~~~~~~~~~~aLl~~k~~~~~~~~~l~sW~~~~~~~c~w~gv~c~~~~~v~~l~l~~~~l~~~---~~~~~~~l~~L~~ 106 (1001)
++..+.++|++|||+||+++.||. .+++|+. ++|||.|.||+|+ +|||++++|++..+.|. +|+.+..+++|+.
T Consensus 5 ~~~~~~~~~~~all~~k~~~~~~~-~l~~W~~-~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~ 81 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLPDKN-LLPDWSS-NKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCSCTT-SSTTCCT-TSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCE
T ss_pred ccccCCHHHHHHHHHHHhhCCCcc-cccCCCC-CCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCcccc
Confidence 344557889999999999999988 9999984 7899999999999 89999999999999998 8888888888888
Q ss_pred EeccCCcccCCCCcccCCccccccccccCCccCCCCCh--hhhcccccceEEccCCcccCCCCccc-cCCccccceeccc
Q 001873 107 LIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPT--EVCRLRKLESLYLNTNLLEGEIPSDI-GNLSSLAYLTLYD 183 (1001)
Q Consensus 107 L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~--~~~~l~~L~~L~L~~n~l~~~ip~~l-~~L~~L~~L~L~~ 183 (1001)
++++.+++. .+|+.|+++++|++|||++|.++|.+|. .++.+++|++|+|++|.+++.+|..+ +++++|++|+|++
T Consensus 82 l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~ 160 (768)
T 3rgz_A 82 LFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160 (768)
T ss_dssp EECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCS
T ss_pred cCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCC
Confidence 888777765 3567888888888888888888888888 88888888888888888888888776 7888888888888
Q ss_pred cccccccCCC---ccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceecccccccc
Q 001873 184 NQLSGKIPKS---IGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLS 260 (1001)
Q Consensus 184 n~l~g~~p~~---~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~ 260 (1001)
|.+++..|.. ++++++|++|++++| .+++..|. +++++|++|++++|.+.+..|. ++++++|++|++++|.++
T Consensus 161 n~l~~~~~~~~~~~~~l~~L~~L~Ls~n-~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~ 236 (768)
T 3rgz_A 161 NSISGANVVGWVLSDGCGELKHLAISGN-KISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLS 236 (768)
T ss_dssp SCCEEETHHHHHHTTCCTTCCEEECCSS-EEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCC
T ss_pred CccCCcCChhhhhhccCCCCCEEECCCC-cccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCC
Confidence 8888877776 778888888888888 56666554 7788888888888888877776 888888888888888888
Q ss_pred ccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCC-CCCCEEeccCCCCCCCCCccc
Q 001873 261 GPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSC-TELTVVDFSDNLLTGSIPRSF 339 (1001)
Q Consensus 261 g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~~ 339 (1001)
+.+|..++++++|++|+|++|++++.+|.. .+++|++|+|++|++++.+|..+... ++|++|+|++|.+++.+|..|
T Consensus 237 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~ 314 (768)
T 3rgz_A 237 GDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314 (768)
T ss_dssp SCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGG
T ss_pred CcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHH
Confidence 888888888888888888888888777665 77888888888888888888777664 888888888888887888888
Q ss_pred ccccCccEEEcccccccCcCChh-hccccccCEEeccCCcccCccCccccccC-cccEEEeecCccCCCCCccccc--Cc
Q 001873 340 GNLLKLQELQLSVNQLSGTIPIE-IATCTALTHLEIDNNAISGEIPADIGNIN-GLTLFFAWKNKLTGNIPESLSQ--CQ 415 (1001)
Q Consensus 340 ~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~l~~n~l~~~~p~~l~~--l~ 415 (1001)
+++++|++|+|++|++.+.+|.. +..+++|++|++++|++++.+|..+.+++ +|+.|++++|++++.+|..+.. ++
T Consensus 315 ~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 394 (768)
T 3rgz_A 315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN 394 (768)
T ss_dssp GGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTC
T ss_pred hcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccC
Confidence 88888888888888887777765 77888888888888888877888887776 7888888888888777777666 67
Q ss_pred ccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeecc
Q 001873 416 ELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMS 495 (1001)
Q Consensus 416 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 495 (1001)
+|++|++++|++++.+|..+..+++|++|++++|++++.+|..+..+++|++|++++|++++.+|..+..+++|++|+++
T Consensus 395 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 474 (768)
T 3rgz_A 395 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474 (768)
T ss_dssp CCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred CccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEec
Confidence 78888888888877778888888888888888888887778788888888888888888887788888888888888888
Q ss_pred CcccccCCcccccccccCceEEcccccCcccCCCCcc--cccccccCCCCcCCCCcccccccccccceeeccCccccccc
Q 001873 496 ENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRI 573 (1001)
Q Consensus 496 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 573 (1001)
+|++++.+|..+.++++|++|++++|++++.+|..+. +.++.|+|++|++++.+|..++.+++|+.|++++|+++|.+
T Consensus 475 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~i 554 (768)
T 3rgz_A 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 554 (768)
T ss_dssp SSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBC
T ss_pred CCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcC
Confidence 8888877888888888888888888888877777654 45677888888888777878888888888888888877766
Q ss_pred hhhh----------------------------------------------------------------------hccccc
Q 001873 574 PAEI----------------------------------------------------------------------LSCRKL 583 (1001)
Q Consensus 574 p~~~----------------------------------------------------------------------~~l~~L 583 (1001)
|..+ ..+++|
T Consensus 555 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L 634 (768)
T 3rgz_A 555 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM 634 (768)
T ss_dssp CGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCC
T ss_pred ChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccc
Confidence 6544 335789
Q ss_pred cEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCC-ChhhhhcccccceeEccc
Q 001873 584 ILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSG-DLDALASLQNLVSLNVSF 662 (1001)
Q Consensus 584 ~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~ls~ 662 (1001)
++|||++|+++|.+|..+++++.|+. |+|++|+++|.+|+.|+++++|+.|||++|++++ .|..+..+++|++|||++
T Consensus 635 ~~LdLs~N~l~g~ip~~l~~l~~L~~-L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~ 713 (768)
T 3rgz_A 635 MFLDMSYNMLSGYIPKEIGSMPYLFI-LNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713 (768)
T ss_dssp CEEECCSSCCBSCCCGGGGGCTTCCE-EECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCS
T ss_pred cEEECcCCcccccCCHHHhccccCCE-EeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcC
Confidence 99999999999999999999999997 9999999999999999999999999999999998 567899999999999999
Q ss_pred CCCCCCCCCCccccCCCCCCCCCCCcccccCCCCCCCCC
Q 001873 663 NDFSGELPNTPFFRKLPLSDLASNRGLYISGGVVSPTDS 701 (1001)
Q Consensus 663 N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~s~~~~ 701 (1001)
|+++|.+|...++.+++..+|.||+++||.. ..+|..
T Consensus 714 N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~--l~~C~~ 750 (768)
T 3rgz_A 714 NNLSGPIPEMGQFETFPPAKFLNNPGLCGYP--LPRCDP 750 (768)
T ss_dssp SEEEEECCSSSSGGGSCGGGGCSCTEEESTT--SCCCCS
T ss_pred CcccccCCCchhhccCCHHHhcCCchhcCCC--CcCCCC
Confidence 9999999999999999999999999999753 445543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-74 Score=714.04 Aligned_cols=568 Identities=33% Similarity=0.518 Sum_probs=379.1
Q ss_pred cccccCCCCcEEeccCCcccCCCCc--ccCCccccccccccCCccCCCCChhh-hcccccceEEccCCcccCCCCcc---
Q 001873 96 SIFQPLKSLKRLIISSCNLTGTIPK--EFGDYRELTFIDLSGNSLWGEIPTEV-CRLRKLESLYLNTNLLEGEIPSD--- 169 (1001)
Q Consensus 96 ~~~~~l~~L~~L~l~~~~l~g~~p~--~~~~l~~L~~L~Ls~n~l~g~~p~~~-~~l~~L~~L~L~~n~l~~~ip~~--- 169 (1001)
+.++.+++|++|+|++|.++|.+|. .++++++|++|||++|.+.+.+|..+ .++++|++|+|++|++++..|..
T Consensus 94 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 173 (768)
T 3rgz_A 94 SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVL 173 (768)
T ss_dssp CCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHH
T ss_pred hhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhh
Confidence 4555555555555555555555555 55555555555555555555555544 45555555555555555544444
Q ss_pred ccCCc----------------------cccceeccccccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchh
Q 001873 170 IGNLS----------------------SLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVM 227 (1001)
Q Consensus 170 l~~L~----------------------~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~ 227 (1001)
+++++ +|++|+|++|.+++.+|. ++++++|++|++++| .+++.+|..++++++|++
T Consensus 174 ~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n-~l~~~~~~~l~~l~~L~~ 251 (768)
T 3rgz_A 174 SDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGN-KLSGDFSRAISTCTELKL 251 (768)
T ss_dssp TTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSS-CCCSCHHHHTTTCSSCCE
T ss_pred hccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCC-cCCCcccHHHhcCCCCCE
Confidence 44444 455555555555444444 455555555555555 344444555555555555
Q ss_pred ccccccccccccCCccccccccceeccccccccccCcccccCC-CCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCc
Q 001873 228 LGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNC-SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNS 306 (1001)
Q Consensus 228 L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l-~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~ 306 (1001)
|++++|.+.+..|.. .+++|++|++++|.++|.+|..+... ++|++|+|++|++++.+|..|+++++|++|+|++|+
T Consensus 252 L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~ 329 (768)
T 3rgz_A 252 LNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 329 (768)
T ss_dssp EECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSE
T ss_pred EECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCc
Confidence 555555554444443 44555555555555555555555443 555555555555555555555555556666666555
Q ss_pred ccccCCCC-ccCCCCCCEEeccCCCCCCCCCccccccc-CccEEEcccccccCcCChhhcc--ccccCEEeccCCcccCc
Q 001873 307 LVGAIPDE-LGSCTELTVVDFSDNLLTGSIPRSFGNLL-KLQELQLSVNQLSGTIPIEIAT--CTALTHLEIDNNAISGE 382 (1001)
Q Consensus 307 l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~--l~~L~~L~L~~N~i~~~ 382 (1001)
++|.+|.. +..+++|++|++++|.+++.+|..+.+++ +|++|++++|++++.+|..+.. +++|++|++++|++++.
T Consensus 330 l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~ 409 (768)
T 3rgz_A 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409 (768)
T ss_dssp EEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEE
T ss_pred ccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccc
Confidence 55555544 55555566666666655555555555554 5666666666665555555554 55666666666666666
Q ss_pred cCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCC
Q 001873 383 IPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNC 462 (1001)
Q Consensus 383 ~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 462 (1001)
+|..++++++|+.|++++|++++.+|..+..+++|+.|++++|.+++.+|..+..+++|++|++++|++++.+|..+..+
T Consensus 410 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 489 (768)
T 3rgz_A 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489 (768)
T ss_dssp CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred cCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcC
Confidence 66667777777777777777777777777777777777777777776777777777777777777777777777777777
Q ss_pred CCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCcccCCCCcccc--------
Q 001873 463 TTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTS-------- 534 (1001)
Q Consensus 463 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-------- 534 (1001)
++|++|+|++|++++.+|.+++++++|++|++++|++++.+|..+.++++|++|++++|+++|.+|..+...
T Consensus 490 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~ 569 (768)
T 3rgz_A 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANF 569 (768)
T ss_dssp TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCST
T ss_pred CCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhc
Confidence 777777777777777777777777777777777777777777777777777777777777776666543221
Q ss_pred ----------------------------------------cccccCCCCcCCCCcccccccccccceeeccCccccccch
Q 001873 535 ----------------------------------------LQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIP 574 (1001)
Q Consensus 535 ----------------------------------------l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 574 (1001)
...++++.|.++|.+|..++.+++|+.|||++|+++|.+|
T Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip 649 (768)
T 3rgz_A 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIP 649 (768)
T ss_dssp TCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCC
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCC
Confidence 1123445566666677777888999999999999999999
Q ss_pred hhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCChhhhhcccc
Q 001873 575 AEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQN 654 (1001)
Q Consensus 575 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~ 654 (1001)
.+++.+++|+.|||++|+++|.+|..+++++.|+. |||++|+++|.+|..+.+++.|++|||++|++++.++....+..
T Consensus 650 ~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~-LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~ 728 (768)
T 3rgz_A 650 KEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI-LDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFET 728 (768)
T ss_dssp GGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCE-EECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGG
T ss_pred HHHhccccCCEEeCcCCccCCCCChHHhCCCCCCE-EECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhcc
Confidence 99999999999999999999999999999999997 99999999999999999999999999999999997776666777
Q ss_pred cceeEcccCC-CCCC
Q 001873 655 LVSLNVSFND-FSGE 668 (1001)
Q Consensus 655 L~~L~ls~N~-l~~~ 668 (1001)
+....+.+|+ ++|.
T Consensus 729 ~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 729 FPPAKFLNNPGLCGY 743 (768)
T ss_dssp SCGGGGCSCTEEEST
T ss_pred CCHHHhcCCchhcCC
Confidence 7777888885 5553
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-63 Score=613.15 Aligned_cols=579 Identities=19% Similarity=0.195 Sum_probs=509.0
Q ss_pred ccccccCCcccccCCCCcEEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCC
Q 001873 88 VDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIP 167 (1001)
Q Consensus 88 ~~l~~~~~~~~~~l~~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip 167 (1001)
.++. .+|..+. +++++|+|++|++++..+..|+++++|++|||++|++++..|..|+.+++|++|+|++|.+++..+
T Consensus 14 ~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~ 90 (680)
T 1ziw_A 14 LKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSD 90 (680)
T ss_dssp SCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCT
T ss_pred CCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccCh
Confidence 4443 3565443 689999999999998777789999999999999999999999999999999999999999995444
Q ss_pred ccccCCccccceeccccccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccc--c
Q 001873 168 SDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIG--M 245 (1001)
Q Consensus 168 ~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~--~ 245 (1001)
..++++++|++|+|++|.+++..|..++++++|++|++++| .+++..|..++++++|++|++++|.+.+..+..++ .
T Consensus 91 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 169 (680)
T 1ziw_A 91 KTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHN-GLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFA 169 (680)
T ss_dssp TTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSS-CCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGT
T ss_pred hhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCC-cccccCchhhcccccCCEEEccCCcccccCHHHhhccc
Confidence 47999999999999999999777788999999999999999 78888888999999999999999999987777665 4
Q ss_pred ccccceeccccccccccCcccccCCCCCceEeeecCcccCCCCcccC---CCCCCcEEEcCCCcccccCCCCccCCCC--
Q 001873 246 LERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIG---ALSKLKSLLLWQNSLVGAIPDELGSCTE-- 320 (1001)
Q Consensus 246 l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~---~l~~L~~L~L~~N~l~~~~p~~l~~l~~-- 320 (1001)
+.+|++|++++|.+++..|..+..+++|+.|++++|.+.+.....+. ..++|+.|++++|++++..|.++..++.
T Consensus 170 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~ 249 (680)
T 1ziw_A 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTN 249 (680)
T ss_dssp TCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSC
T ss_pred cccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCC
Confidence 58999999999999999999999999999999999987643222221 3478999999999999999999988755
Q ss_pred CCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccC-----ccCc----cccccC
Q 001873 321 LTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISG-----EIPA----DIGNIN 391 (1001)
Q Consensus 321 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~-----~~~~----~~~~l~ 391 (1001)
|+.|++++|.+++..|..|+.+++|++|+|++|++.+..|..+..+++|++|++++|...+ .+|. .+..++
T Consensus 250 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~ 329 (680)
T 1ziw_A 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329 (680)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCT
T ss_pred CCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCC
Confidence 9999999999998888999999999999999999999999999999999999999886654 2332 788899
Q ss_pred cccEEEeecCccCCCCCcccccCcccceEeCcCccccC--CCCcccccc--cccceEEccCCcCCCCCCCCCCCCCCcce
Q 001873 392 GLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSG--PIPKEIFGL--RNLTKLLLLSNDLSGFIPPDIGNCTTLRR 467 (1001)
Q Consensus 392 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~--~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 467 (1001)
+|+.|++++|++++..+..|..+++|++|++++|.++. .....|..+ ++|+.|++++|++++..|..|..+++|++
T Consensus 330 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 409 (680)
T 1ziw_A 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEV 409 (680)
T ss_dssp TCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCE
Confidence 99999999999999999999999999999999998653 223344443 58999999999999999999999999999
Q ss_pred EEccccccccCCC-cccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCc--ccCCCCcc--cccccccCCC
Q 001873 468 LRLNDNRLSGTIP-SEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLT--GSVPDTLP--TSLQLVDLSD 542 (1001)
Q Consensus 468 L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~--~~l~~L~Ls~ 542 (1001)
|+|++|++++.+| ..|.++++|++|++++|++++..+..|..+++|+.|++++|.++ +.+|..+. ..++.|++++
T Consensus 410 L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~ 489 (680)
T 1ziw_A 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489 (680)
T ss_dssp EECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCS
T ss_pred EeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCC
Confidence 9999999987665 78999999999999999999999999999999999999999997 45666664 5688899999
Q ss_pred CcCCCCcccccccccccceeeccCccccccch--------hhhhccccccEEecccccccCCCCCccccccchhhhhhcC
Q 001873 543 NRLSGSLAHSIGSLTELSKLLLSKNQLSGRIP--------AEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLS 614 (1001)
Q Consensus 543 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls 614 (1001)
|+|++..+..|..+++|+.|+|++|++++..+ ..+..+++|++|+|++|+++...+..|..+++|+. |+|+
T Consensus 490 N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~-L~Ls 568 (680)
T 1ziw_A 490 NNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI-IDLG 568 (680)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE-EECC
T ss_pred CCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcce-eECC
Confidence 99999888889999999999999999986422 23788999999999999999555567999999997 9999
Q ss_pred CCcccccccccccccccccEEEecCCcCCCCh-hhhh-cccccceeEcccCCCCCCCCC
Q 001873 615 SNQFSGEIPSEFSGLTKLGILDLSHNKLSGDL-DALA-SLQNLVSLNVSFNDFSGELPN 671 (1001)
Q Consensus 615 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~-~l~~L~~L~ls~N~l~~~~p~ 671 (1001)
+|+|++..+..|.++++|+.|+|++|++++.+ ..+. .+++|+.|++++|++.+.|+.
T Consensus 569 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred CCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 99999888888999999999999999999965 4566 789999999999999999985
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-63 Score=613.14 Aligned_cols=580 Identities=19% Similarity=0.177 Sum_probs=508.7
Q ss_pred CccceEEeCC----------CCcEEEEEeccccccccCCcccccCCCCcEEeccCCcccCCCCcccCCccccccccccCC
Q 001873 67 CKWFGIHCSS----------NGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGN 136 (1001)
Q Consensus 67 c~w~gv~c~~----------~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n 136 (1001)
|.+.-|.|+. ..+++.++++++.+.+..+..+..+++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 4556677752 247899999999999877788999999999999999999999999999999999999999
Q ss_pred ccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccCCCccchhhhhhhhhccCcCCCCCCC
Q 001873 137 SLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELP 216 (1001)
Q Consensus 137 ~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp 216 (1001)
++++..+..|+.+++|++|+|++|++++..|..++++++|++|+|++|.+++..|..++++++|++|++++| .+++..|
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~ 162 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN-KIQALKS 162 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSS-CCCCBCH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCC-cccccCH
Confidence 999555557999999999999999999777789999999999999999999999999999999999999999 6776666
Q ss_pred cccc--cCccchhccccccccccccCCccccccccceeccccccccccCccccc---CCCCCceEeeecCcccCCCCccc
Q 001873 217 WEIG--NCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIG---NCSELQNLYLYQNSISGPIPGRI 291 (1001)
Q Consensus 217 ~~l~--~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~---~l~~L~~L~L~~N~i~~~~p~~~ 291 (1001)
..++ ++++|+.|++++|.+.+..|..+..+.+|+.+++.++.+.+.....+. ..++|++|++++|.+++..|..|
T Consensus 163 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~ 242 (680)
T 1ziw_A 163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242 (680)
T ss_dssp HHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTT
T ss_pred HHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHh
Confidence 6554 568999999999999999999999999999999998887654333322 35889999999999999999999
Q ss_pred CCCCC--CcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccC-----cCCh---
Q 001873 292 GALSK--LKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSG-----TIPI--- 361 (1001)
Q Consensus 292 ~~l~~--L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-----~~p~--- 361 (1001)
..++. |+.|+|++|++++..|..++.+++|++|++++|.+++..|..|.++++|++|++++|...+ .+|.
T Consensus 243 ~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~ 322 (680)
T 1ziw_A 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322 (680)
T ss_dssp GGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECT
T ss_pred hccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccCh
Confidence 98865 9999999999999888999999999999999999998889999999999999999886553 2332
Q ss_pred -hhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCC--CcccccC--cccceEeCcCccccCCCCcccc
Q 001873 362 -EIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNI--PESLSQC--QELQALDFSYNNLSGPIPKEIF 436 (1001)
Q Consensus 362 -~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~--p~~l~~l--~~L~~L~Ls~N~l~~~~~~~~~ 436 (1001)
.|..+++|++|++++|++++..+..+.++++|+.|++++|.+.... +..|..+ ++|+.|++++|++++..|..+.
T Consensus 323 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~ 402 (680)
T 1ziw_A 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS 402 (680)
T ss_dssp TTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTT
T ss_pred hhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhh
Confidence 7888999999999999999988889999999999999999865332 2234433 5899999999999988899999
Q ss_pred cccccceEEccCCcCCCCCC-CCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccc--cCCcccccccccC
Q 001873 437 GLRNLTKLLLLSNDLSGFIP-PDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLV--GGIPPSVVGCQSL 513 (1001)
Q Consensus 437 ~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L 513 (1001)
.+++|++|++++|++++.+| ..|..+++|++|++++|++++..+..|..+++|+.|++++|.++ +..|..+.++++|
T Consensus 403 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L 482 (680)
T 1ziw_A 403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482 (680)
T ss_dssp TCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTC
T ss_pred CCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCC
Confidence 99999999999999987655 67899999999999999999888999999999999999999987 5688899999999
Q ss_pred ceEEcccccCcccCCCCcc--cccccccCCCCcCCCCcc--------cccccccccceeeccCccccccchhhhhccccc
Q 001873 514 EFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLA--------HSIGSLTELSKLLLSKNQLSGRIPAEILSCRKL 583 (1001)
Q Consensus 514 ~~L~Ls~N~l~~~~p~~~~--~~l~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 583 (1001)
+.|++++|++++..+..+. +.++.|++++|++++..+ ..|..+++|+.|+|++|+++...+..|..+++|
T Consensus 483 ~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L 562 (680)
T 1ziw_A 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL 562 (680)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCc
Confidence 9999999999977666554 578889999999986432 347889999999999999996655679999999
Q ss_pred cEEecccccccCCCCCccccccchhhhhhcCCCccccccccccc-ccccccEEEecCCcCCCChhh
Q 001873 584 ILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFS-GLTKLGILDLSHNKLSGDLDA 648 (1001)
Q Consensus 584 ~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~ 648 (1001)
++|||++|++++..+..|..+++|+. |+|++|+|++..|..|. .+++|+.|+|++|++.|+++.
T Consensus 563 ~~L~Ls~N~l~~l~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 563 KIIDLGLNNLNTLPASVFNNQVSLKS-LNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCE-EECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred ceeECCCCCCCcCCHhHhCCCCCCCE-EECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 99999999999877778899999996 99999999999988887 899999999999999999875
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-60 Score=580.70 Aligned_cols=492 Identities=20% Similarity=0.273 Sum_probs=337.8
Q ss_pred cHHHHHHHHHHHHhCCCCCC--------ccCCCCCCCCCCCcc---ceEEeCCCCcEEEEEeccccccccCCcccccCCC
Q 001873 35 LDEQGQALLTWKNSLNSSTD--------ALSSWNPAETSPCKW---FGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKS 103 (1001)
Q Consensus 35 ~~~~~~aLl~~k~~~~~~~~--------~l~sW~~~~~~~c~w---~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~l~~ 103 (1001)
...|++||.+||+++.++.. ...+|+. +.+||.| .||+|+..|||++++|+++++.|.+|+.++.|++
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~ 106 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTE 106 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCcc
Confidence 45799999999999965532 2347985 7899999 9999997799999999999999999999999999
Q ss_pred CcEEeccCCcc------cC------CCCcccCCccccccccccCCccCCCCChhhhc-ccccceEEccCCcccCCCCccc
Q 001873 104 LKRLIISSCNL------TG------TIPKEFGDYRELTFIDLSGNSLWGEIPTEVCR-LRKLESLYLNTNLLEGEIPSDI 170 (1001)
Q Consensus 104 L~~L~l~~~~l------~g------~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~-l~~L~~L~L~~n~l~~~ip~~l 170 (1001)
|++|+|++|.+ .| .+|+.. +..|+ +++++|.+.+.+|..++. +.++..+++....+..
T Consensus 107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~------ 177 (636)
T 4eco_A 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK------ 177 (636)
T ss_dssp CCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC------
T ss_pred ceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc------
Confidence 99999999976 34 556555 67788 899999998888888763 3445555554222210
Q ss_pred cCCccccceecc--ccccccccCCCccchhhhhhhhhccCcCCCCC-----------------CCcccc--cCccchhcc
Q 001873 171 GNLSSLAYLTLY--DNQLSGKIPKSIGALSKLQVFRAGGNQNLKGE-----------------LPWEIG--NCSNLVMLG 229 (1001)
Q Consensus 171 ~~L~~L~~L~L~--~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~-----------------lp~~l~--~l~~L~~L~ 229 (1001)
.....++.+.+. .|+++| +|.+++++++|++|++++| .++|. +|..++ ++++|++|+
T Consensus 178 ~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n-~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~ 255 (636)
T 4eco_A 178 SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNS-PFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVE 255 (636)
T ss_dssp CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESC-CCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCC-ccccccccccccccccchhcccCchhhhhcccCCCCEEE
Confidence 011112222221 244444 4444444444444444444 24433 555555 566666666
Q ss_pred ccccccccccCCccccccccceecccccc-ccc-cCcccccCC------CCCceEeeecCcccCCCCc--ccCCCCCCcE
Q 001873 230 LAETSISGNVPSSIGMLERIQTIAIYTSL-LSG-PIPEEIGNC------SELQNLYLYQNSISGPIPG--RIGALSKLKS 299 (1001)
Q Consensus 230 l~~~~l~~~~p~~i~~l~~L~~L~l~~n~-l~g-~ip~~l~~l------~~L~~L~L~~N~i~~~~p~--~~~~l~~L~~ 299 (1001)
+++|.+.+.+|..++++++|++|++++|. ++| .+|..++++ ++|++|+|++|+++ .+|. .|+++++|++
T Consensus 256 L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~ 334 (636)
T 4eco_A 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGM 334 (636)
T ss_dssp EECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCE
T ss_pred ecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCE
Confidence 66666666666666666666666666665 666 666666655 67777777777777 6666 6777777777
Q ss_pred EEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccC-ccEEEcccccccCcCChhhcccc--ccCEEeccC
Q 001873 300 LLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLK-LQELQLSVNQLSGTIPIEIATCT--ALTHLEIDN 376 (1001)
Q Consensus 300 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~ 376 (1001)
|++++|+++|.+| .++.+++|++|++++|+++ .+|..+.++++ |++|++++|+++ .+|..+..++ +|++|++++
T Consensus 335 L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~ 411 (636)
T 4eco_A 335 LECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSY 411 (636)
T ss_dssp EECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCS
T ss_pred EeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcC
Confidence 7777777776677 6677777777777777777 66666777777 777777777776 5666655544 677777777
Q ss_pred CcccCccCcccc-------ccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCccccc-c-------ccc
Q 001873 377 NAISGEIPADIG-------NINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFG-L-------RNL 441 (1001)
Q Consensus 377 N~i~~~~~~~~~-------~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-l-------~~L 441 (1001)
|++++.+|..+. .+++|+.|++++|++++..+..+..+++|++|++++|+++ .+|..+.. . ++|
T Consensus 412 N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L 490 (636)
T 4eco_A 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLL 490 (636)
T ss_dssp SCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGC
T ss_pred CcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCc
Confidence 777777776666 6667777777777777443344555777777777777777 44443332 2 278
Q ss_pred ceEEccCCcCCCCCCCCCC--CCCCcceEEccccccccCCCcccCCCCCcceeec------cCcccccCCcccccccccC
Q 001873 442 TKLLLLSNDLSGFIPPDIG--NCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDM------SENHLVGGIPPSVVGCQSL 513 (1001)
Q Consensus 442 ~~L~L~~N~l~~~~p~~l~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L 513 (1001)
++|+|++|+++ .+|..+. .+++|++|+|++|++++ +|..+.++++|+.|+| ++|++.+.+|..+.++++|
T Consensus 491 ~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L 568 (636)
T 4eco_A 491 TSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSL 568 (636)
T ss_dssp CEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSC
T ss_pred cEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCC
Confidence 88888888887 5566665 77888888888888876 7777778888888887 5677888888888888888
Q ss_pred ceEEcccccCcccCCCCcccccccccCCCCcCC
Q 001873 514 EFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLS 546 (1001)
Q Consensus 514 ~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~ 546 (1001)
+.|++++|++ +.+|..+.+.++.|++++|++.
T Consensus 569 ~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 569 TQLQIGSNDI-RKVNEKITPNISVLDIKDNPNI 600 (636)
T ss_dssp CEEECCSSCC-CBCCSCCCTTCCEEECCSCTTC
T ss_pred CEEECCCCcC-CccCHhHhCcCCEEECcCCCCc
Confidence 8888888888 4667666566666666666655
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-58 Score=579.89 Aligned_cols=539 Identities=21% Similarity=0.232 Sum_probs=362.8
Q ss_pred eCCCCcEEEEEeccccccccCCcccccCCCCcEEeccCCcccCCCCcccCCccccccccccCCccCCCC-Chhhhccccc
Q 001873 74 CSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEI-PTEVCRLRKL 152 (1001)
Q Consensus 74 c~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~-p~~~~~l~~L 152 (1001)
|...|+++. +.+.+++. +|. -.+++++|+|++|.+++..|..|+++++|++|||++|.+.+.+ |..|++|++|
T Consensus 2 C~~~~~~~d--cs~~~L~~-vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L 75 (844)
T 3j0a_A 2 CSFDGRIAF--YRFCNLTQ-VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNL 75 (844)
T ss_dssp CBTTTEEEE--ESCCCSSC-CCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTC
T ss_pred ceEeceEEE--ccCCCCCC-CCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCC
Confidence 443444433 34455554 454 3478899999999999888899999999999999999777777 7789999999
Q ss_pred ceEEccCCcccCCCCccccCCccccceeccccccccccCCC--ccchhhhhhhhhccCcCCCCCCC-cccccCccchhcc
Q 001873 153 ESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKS--IGALSKLQVFRAGGNQNLKGELP-WEIGNCSNLVMLG 229 (1001)
Q Consensus 153 ~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~--~~~l~~L~~L~l~~n~~l~~~lp-~~l~~l~~L~~L~ 229 (1001)
++|+|++|.+++..|..++++++|++|+|++|.+++.+|.. ++++++|++|++++| .+++..| ..++++++|++|+
T Consensus 76 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N-~l~~~~~~~~~~~L~~L~~L~ 154 (844)
T 3j0a_A 76 RILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN-QIRSLYLHPSFGKLNSLKSID 154 (844)
T ss_dssp CEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESC-CCCCCCCCGGGGTCSSCCEEE
T ss_pred CEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCC-cccccccchhHhhCCCCCEEE
Confidence 99999999999888999999999999999999999877776 888999999999988 4555433 5678888888888
Q ss_pred ccccccccccCCccccc--cccceeccccccccccCcccccCCCC------CceEeeecCcccCCCCcccCCC---CCCc
Q 001873 230 LAETSISGNVPSSIGML--ERIQTIAIYTSLLSGPIPEEIGNCSE------LQNLYLYQNSISGPIPGRIGAL---SKLK 298 (1001)
Q Consensus 230 l~~~~l~~~~p~~i~~l--~~L~~L~l~~n~l~g~ip~~l~~l~~------L~~L~L~~N~i~~~~p~~~~~l---~~L~ 298 (1001)
+++|.+.+..|..+..+ .+|+.|+++.|.+.+..|..++.+++ |++|++++|.+++..+..+... .+++
T Consensus 155 Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~ 234 (844)
T 3j0a_A 155 FSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAF 234 (844)
T ss_dssp EESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBS
T ss_pred CCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCccccc
Confidence 88888877777777766 67777777777777777766666655 7777777777766666665542 4566
Q ss_pred EEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccc--cCccEEEcccccccCcCChhhccccccCEEeccC
Q 001873 299 SLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNL--LKLQELQLSVNQLSGTIPIEIATCTALTHLEIDN 376 (1001)
Q Consensus 299 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 376 (1001)
.|.++.+.+... +..|.+.+..+..|..+ ++|+.|+|++|.+.+..|..|..+++|+.|+|++
T Consensus 235 ~L~l~~~~~~~~---------------~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 299 (844)
T 3j0a_A 235 SLILAHHIMGAG---------------FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAY 299 (844)
T ss_dssp EEECCSSCCBCS---------------SSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEES
T ss_pred ceeccccccccc---------------ccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCC
Confidence 666653322110 11222222222233332 3455555555555544455555555555555555
Q ss_pred CcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCC
Q 001873 377 NAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIP 456 (1001)
Q Consensus 377 N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 456 (1001)
|++++..|..+..+++|+.|++++|++++..|..|..+++|+.|++++|++++..+..|..+++|++|+|++|.+++.
T Consensus 300 n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-- 377 (844)
T 3j0a_A 300 NKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-- 377 (844)
T ss_dssp CCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC--
T ss_pred CcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc--
Confidence 555555555555555555555555555555555555555555555555555555555555555555555555555532
Q ss_pred CCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCC-cccccccccCceEEcccccCcccCCCCc---c
Q 001873 457 PDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGI-PPSVVGCQSLEFLDLHSNGLTGSVPDTL---P 532 (1001)
Q Consensus 457 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~ 532 (1001)
..+++|+.|++++|+++ .+|.. ...++.|++++|++++.. +..+.++++|+.|++++|++++..+... .
T Consensus 378 ---~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 450 (844)
T 3j0a_A 378 ---HFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSEN 450 (844)
T ss_dssp ---SSCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSC
T ss_pred ---cCCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccC
Confidence 12455556666666655 33332 344555666666665432 1223455666666666666654332211 2
Q ss_pred cccccccCCCCcCC-----CCcccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccch
Q 001873 533 TSLQLVDLSDNRLS-----GSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSL 607 (1001)
Q Consensus 533 ~~l~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 607 (1001)
+.++.|+|++|.++ +..+..|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|+|++..|..+. ++|
T Consensus 451 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L 528 (844)
T 3j0a_A 451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANL 528 (844)
T ss_dssp TTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCC
T ss_pred CccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccc
Confidence 44555666666664 34456788899999999999999988888899999999999999999987777666 788
Q ss_pred hhhhhcCCCcccccccccccccccccEEEecCCcCCCChhhh
Q 001873 608 EISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDAL 649 (1001)
Q Consensus 608 ~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 649 (1001)
+. |+|++|+|++.+|..|. +|+.|++++|++.|+++..
T Consensus 529 ~~-L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np~~C~c~~~ 566 (844)
T 3j0a_A 529 EI-LDISRNQLLAPNPDVFV---SLSVLDITHNKFICECELS 566 (844)
T ss_dssp CE-EEEEEECCCCCCSCCCS---SCCEEEEEEECCCCSSSCC
T ss_pred cE-EECCCCcCCCCChhHhC---CcCEEEecCCCcccccccH
Confidence 86 99999999999887764 7889999999999987643
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=564.05 Aligned_cols=520 Identities=20% Similarity=0.210 Sum_probs=296.9
Q ss_pred CCcEEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceecc
Q 001873 103 SLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLY 182 (1001)
Q Consensus 103 ~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~ 182 (1001)
.+++|+|++|++++..|..|+++++|++|||++|++.+..|..|+.+++|++|+|++|++++..|..++++++|++|+|+
T Consensus 34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 113 (606)
T 3t6q_A 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113 (606)
T ss_dssp TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence 67888888888887778888888888888888888887778888888888888888888887778888888888888888
Q ss_pred ccccccccCCCccchhhhhhhhhccCcCCCC-CCCcccccCccchhccccccccccccCCccccccccceeccccccccc
Q 001873 183 DNQLSGKIPKSIGALSKLQVFRAGGNQNLKG-ELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSG 261 (1001)
Q Consensus 183 ~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~-~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g 261 (1001)
+|.+++..|..++++++|++|++++| .+++ ..|..+ .+++|++|++++|.+. +
T Consensus 114 ~n~i~~l~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~-~l~~L~~L~L~~n~l~------------------------~ 167 (606)
T 3t6q_A 114 QTGISSIDFIPLHNQKTLESLYLGSN-HISSIKLPKGF-PTEKLKVLDFQNNAIH------------------------Y 167 (606)
T ss_dssp TSCCSCGGGSCCTTCTTCCEEECCSS-CCCCCCCCTTC-CCTTCCEEECCSSCCC------------------------E
T ss_pred ccCcccCCcchhccCCcccEEECCCC-cccccCccccc-CCcccCEEEcccCccc------------------------c
Confidence 88888655677777777777777777 3443 223222 2555555555554444 4
Q ss_pred cCcccccCCCCCc--eEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCC-----CC
Q 001873 262 PIPEEIGNCSELQ--NLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLT-----GS 334 (1001)
Q Consensus 262 ~ip~~l~~l~~L~--~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-----~~ 334 (1001)
..|..++.+++|+ +|++++|.+++..|..|.. .+|+.|++++|.. ++..+..+.++....+..+.+. ..
T Consensus 168 ~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~---~~~~~~~l~~~~l~~l~~~~~~~~~~~~i 243 (606)
T 3t6q_A 168 LSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQN---LLVIFKGLKNSTIQSLWLGTFEDMDDEDI 243 (606)
T ss_dssp ECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSC---HHHHHHHTTTCEEEEEECCCCTTSCCCCC
T ss_pred cChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchh---HHHHhhhccccchhheechhhcccccccc
Confidence 4444455555555 4555555555444444333 3455555555431 1122222222222222111111 01
Q ss_pred CCccccccc--CccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccc
Q 001873 335 IPRSFGNLL--KLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLS 412 (1001)
Q Consensus 335 ~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~ 412 (1001)
.+..|..+. +|++|++++|++++..+..|..+++|++|++++|+++ .+|..+..+++|+.|++++|++++..|..+.
T Consensus 244 ~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~ 322 (606)
T 3t6q_A 244 SPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISAS 322 (606)
T ss_dssp CGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGG
T ss_pred ChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhh
Confidence 111222222 3444444444444444444444444444444444444 3444444444444444444444444444444
Q ss_pred cCcccceEeCcCccccCCCCc-ccccccccceEEccCCcCCCCC--CCCCCCCCCcceEEccccccccCCCcccCCCCCc
Q 001873 413 QCQELQALDFSYNNLSGPIPK-EIFGLRNLTKLLLLSNDLSGFI--PPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHL 489 (1001)
Q Consensus 413 ~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 489 (1001)
.+++|++|++++|.+.+.+|. .+..+++|++|++++|++++.. +..+..+++|++|++++|++++..|..|..+++|
T Consensus 323 ~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 402 (606)
T 3t6q_A 323 NFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQL 402 (606)
T ss_dssp GCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTC
T ss_pred ccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccC
Confidence 444444444444444433322 2444444444444444444333 3444444444444444444444444444444444
Q ss_pred ceeeccCcccccCCccc-ccccccCceEEcccccCcccCCCCcc--cccccccCCCCcCCCC---cccccccccccceee
Q 001873 490 NFVDMSENHLVGGIPPS-VVGCQSLEFLDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGS---LAHSIGSLTELSKLL 563 (1001)
Q Consensus 490 ~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~l~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~ 563 (1001)
++|++++|++++..|.. +..+++|++|++++|.+++..|..+. +.++.|++++|++++. .+..+..+++|+.|+
T Consensus 403 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~ 482 (606)
T 3t6q_A 403 ELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILV 482 (606)
T ss_dssp SEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEE
T ss_pred CeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEE
Confidence 44444444444433322 44444444444444444443333321 2333444444444331 224566777788888
Q ss_pred ccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCC
Q 001873 564 LSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLS 643 (1001)
Q Consensus 564 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 643 (1001)
+++|++++..|..+..+++|++|+|++|++++..|..+..++.| . |++++|++++.+|..+..+++|+.|++++|+++
T Consensus 483 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~-L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 560 (606)
T 3t6q_A 483 LSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-Y-LNLASNHISIILPSLLPILSQQRTINLRQNPLD 560 (606)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-E-EECCSSCCCCCCGGGHHHHHTSSEEECTTCCEE
T ss_pred CCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-E-EECcCCcccccCHhhcccCCCCCEEeCCCCCcc
Confidence 88888877777777777888888888888877777777777777 4 788888888777777777788888888888888
Q ss_pred CChhhhhccccc
Q 001873 644 GDLDALASLQNL 655 (1001)
Q Consensus 644 ~~~~~~~~l~~L 655 (1001)
|+++..+...|+
T Consensus 561 c~c~~~~~~~w~ 572 (606)
T 3t6q_A 561 CTCSNIYFLEWY 572 (606)
T ss_dssp CSGGGHHHHHHH
T ss_pred ccCCcHHHHHHH
Confidence 777654444433
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-58 Score=569.05 Aligned_cols=514 Identities=19% Similarity=0.233 Sum_probs=315.3
Q ss_pred cCcHHHHHHHHHHHHhCCCCCCccCCCCCCC----CCC--Ccc------------ceEEeCCCCcEEEEEeccccccccC
Q 001873 33 DALDEQGQALLTWKNSLNSSTDALSSWNPAE----TSP--CKW------------FGIHCSSNGEVVEISLKAVDLQGSL 94 (1001)
Q Consensus 33 ~~~~~~~~aLl~~k~~~~~~~~~l~sW~~~~----~~~--c~w------------~gv~c~~~~~v~~l~l~~~~l~~~~ 94 (1001)
.+..+|++||++||+++.+| +|+.++ .+| |.| .||+|+.++||++++|+++++.|.+
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~i 339 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEE
T ss_pred ccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcC
Confidence 34568999999999999776 887543 356 999 9999998899999999999999999
Q ss_pred CcccccCCCCcEEec-cCCcccCCCCcccCCc----c-----cccc------ccc-cCCccCCCC-----------Chhh
Q 001873 95 PSIFQPLKSLKRLII-SSCNLTGTIPKEFGDY----R-----ELTF------IDL-SGNSLWGEI-----------PTEV 146 (1001)
Q Consensus 95 ~~~~~~l~~L~~L~l-~~~~l~g~~p~~~~~l----~-----~L~~------L~L-s~n~l~g~~-----------p~~~ 146 (1001)
|+.++.|++|++|+| ++|.++|..|-.-... . .++. ++. ....+++.+ +...
T Consensus 340 p~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~ 419 (876)
T 4ecn_A 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419 (876)
T ss_dssp CGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCC
T ss_pred chHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccc
Confidence 999999999999999 8888988755331111 0 0000 000 000011000 1111
Q ss_pred hcccccceEEccC--CcccCCCCccccCCccccceecccccccc-ccCCCccchhhhhhhhhccCcCCCCCCCcccc--c
Q 001873 147 CRLRKLESLYLNT--NLLEGEIPSDIGNLSSLAYLTLYDNQLSG-KIPKSIGALSKLQVFRAGGNQNLKGELPWEIG--N 221 (1001)
Q Consensus 147 ~~l~~L~~L~L~~--n~l~~~ip~~l~~L~~L~~L~L~~n~l~g-~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~--~ 221 (1001)
.....++.+.+.. |+++| +|..+++|++|++|+|++|.++| .+|..+..+ +.| .++|.+|..++ +
T Consensus 420 ~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~--------s~n-~~~g~iP~~l~f~~ 489 (876)
T 4ecn_A 420 DSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDA--------NSD-YAKQYENEELSWSN 489 (876)
T ss_dssp CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCT--------TSH-HHHHHTTSCCCGGG
T ss_pred ccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCccccccccc--------ccc-cccccCChhhhhcc
Confidence 1222333344433 66665 66666666666666666666665 222221111 001 22233444433 4
Q ss_pred CccchhccccccccccccCCccccccccceecccccc-ccc-cCcccccCCC-------CCceEeeecCcccCCCCc--c
Q 001873 222 CSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSL-LSG-PIPEEIGNCS-------ELQNLYLYQNSISGPIPG--R 290 (1001)
Q Consensus 222 l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~-l~g-~ip~~l~~l~-------~L~~L~L~~N~i~~~~p~--~ 290 (1001)
+++|++|++++|.+.+.+|..++++++|+.|++++|+ ++| .+|..+++++ +|++|+|++|+++ .+|. .
T Consensus 490 L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~ 568 (876)
T 4ecn_A 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASAS 568 (876)
T ss_dssp CTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHH
T ss_pred CCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhh
Confidence 4444444444444444444444444444444444444 444 4454444443 6666666666666 5555 6
Q ss_pred cCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccC-ccEEEcccccccCcCChhhccccc-
Q 001873 291 IGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLK-LQELQLSVNQLSGTIPIEIATCTA- 368 (1001)
Q Consensus 291 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~- 368 (1001)
|+++++|+.|+|++|+++ .+| .++.+++|+.|+|++|.++ .+|..+.++++ |++|+|++|+++ .+|..+..++.
T Consensus 569 l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~ 644 (876)
T 4ecn_A 569 LQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVY 644 (876)
T ss_dssp HTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSS
T ss_pred hhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccC
Confidence 666666666666666666 555 5666666666666666666 56666666666 666666666666 55555554433
Q ss_pred -cCEEeccCCcccCccCccc---c--ccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCccccc-----
Q 001873 369 -LTHLEIDNNAISGEIPADI---G--NINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFG----- 437 (1001)
Q Consensus 369 -L~~L~L~~N~i~~~~~~~~---~--~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~----- 437 (1001)
|+.|++++|++.+.+|... . .+++|+.|++++|+++...+..+..+++|+.|+|++|+++ .+|..+..
T Consensus 645 ~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~ 723 (876)
T 4ecn_A 645 VMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGN 723 (876)
T ss_dssp CEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSC
T ss_pred CCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhcccccc
Confidence 6666666666665544322 2 2236667777777666332223346667777777777776 44443332
Q ss_pred ---ccccceEEccCCcCCCCCCCCCC--CCCCcceEEccccccccCCCcccCCCCCcceeeccC------cccccCCccc
Q 001873 438 ---LRNLTKLLLLSNDLSGFIPPDIG--NCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSE------NHLVGGIPPS 506 (1001)
Q Consensus 438 ---l~~L~~L~L~~N~l~~~~p~~l~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~ 506 (1001)
+++|++|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+.++++|+.|+|++ |++.+.+|..
T Consensus 724 l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~ 801 (876)
T 4ecn_A 724 YKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTG 801 (876)
T ss_dssp CTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTT
T ss_pred ccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHH
Confidence 226777777777777 5566665 77777777777777775 576777777777777765 7888888989
Q ss_pred ccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCcccc
Q 001873 507 VVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLS 570 (1001)
Q Consensus 507 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 570 (1001)
+.++++|+.|+|++|++ +.+|..+.+.++.|+|++|++....+..+.....+..+.|..|++.
T Consensus 802 l~~L~~L~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 802 ITTCPSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp GGGCSSCCEEECCSSCC-CBCCSCCCSSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred HhcCCCCCEEECCCCCC-CccCHhhcCCCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 99999999999999998 5777766666666666666666555555555555555556655554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-57 Score=550.11 Aligned_cols=533 Identities=18% Similarity=0.164 Sum_probs=449.3
Q ss_pred cEEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceecccc
Q 001873 105 KRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDN 184 (1001)
Q Consensus 105 ~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n 184 (1001)
+.++.++.+++ .+|..+.. .+++|||++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 15 ~~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 91 (606)
T 3t6q_A 15 KTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91 (606)
T ss_dssp TEEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred ceEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCC
Confidence 36888888888 78887764 7899999999999888889999999999999999999888999999999999999999
Q ss_pred ccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCc
Q 001873 185 QLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIP 264 (1001)
Q Consensus 185 ~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip 264 (1001)
.+++..|..++++++|++|++++| .+++..|.. ++++++|++|++++|.+++..+
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~L~~n-~i~~l~~~~------------------------~~~l~~L~~L~L~~n~l~~~~~ 146 (606)
T 3t6q_A 92 PLIFMAETALSGPKALKHLFFIQT-GISSIDFIP------------------------LHNQKTLESLYLGSNHISSIKL 146 (606)
T ss_dssp CCSEECTTTTSSCTTCCEEECTTS-CCSCGGGSC------------------------CTTCTTCCEEECCSSCCCCCCC
T ss_pred cccccChhhhcccccccEeecccc-CcccCCcch------------------------hccCCcccEEECCCCcccccCc
Confidence 999888888888888888888777 344322333 4444455555555555554332
Q ss_pred ccccCCCCCceEeeecCcccCCCCcccCCCCCCc--EEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccc
Q 001873 265 EEIGNCSELQNLYLYQNSISGPIPGRIGALSKLK--SLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNL 342 (1001)
Q Consensus 265 ~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~--~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 342 (1001)
+.+..+++|++|++++|.+++..|..|+.+++|+ .|++++|++++..|..+.. .+|+.|++++|. .++..+..+
T Consensus 147 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l 222 (606)
T 3t6q_A 147 PKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGL 222 (606)
T ss_dssp CTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHT
T ss_pred ccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhc
Confidence 3344488999999999999988888888999998 8899999999877776654 679999999886 344455555
Q ss_pred cCccEEEccccccc-----CcCChhhcccc--ccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCc
Q 001873 343 LKLQELQLSVNQLS-----GTIPIEIATCT--ALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQ 415 (1001)
Q Consensus 343 ~~L~~L~Ls~N~l~-----~~~p~~~~~l~--~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~ 415 (1001)
.+++...+..+.+. ...+..+..+. +|+.|++++|.+++..+..++.+++|+.|++++|+++ .+|..+..++
T Consensus 223 ~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~ 301 (606)
T 3t6q_A 223 KNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLS 301 (606)
T ss_dssp TTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCT
T ss_pred cccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccc
Confidence 55544444333222 22233444444 7999999999999888888999999999999999999 7888999999
Q ss_pred ccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCC-CCCCCCCcceEEccccccccCC--CcccCCCCCccee
Q 001873 416 ELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPP-DIGNCTTLRRLRLNDNRLSGTI--PSEMGNLKHLNFV 492 (1001)
Q Consensus 416 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L 492 (1001)
+|++|++++|.+++..|..+..+++|++|++++|.+.+.+|. .+..+++|++|++++|++++.. +..+.++++|++|
T Consensus 302 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L 381 (606)
T 3t6q_A 302 TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL 381 (606)
T ss_dssp TCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEE
T ss_pred cCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEE
Confidence 999999999999988889999999999999999999866655 5999999999999999999776 7889999999999
Q ss_pred eccCcccccCCcccccccccCceEEcccccCcccCCCC-c--ccccccccCCCCcCCCCcccccccccccceeeccCccc
Q 001873 493 DMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDT-L--PTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQL 569 (1001)
Q Consensus 493 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~--~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 569 (1001)
++++|++++..|..+..+++|++|++++|++++..|.. + .+.++.|++++|.+++..|..+..+++|++|++++|++
T Consensus 382 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 461 (606)
T 3t6q_A 382 NLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF 461 (606)
T ss_dssp ECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBC
T ss_pred ECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCC
Confidence 99999999999999999999999999999999876654 3 36788899999999999999999999999999999999
Q ss_pred ccc---chhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCCh
Q 001873 570 SGR---IPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDL 646 (1001)
Q Consensus 570 ~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 646 (1001)
++. .+..+..+++|++|++++|++++..|..+..++.|+. |+|++|++++..|+.+.+++.| .|+|++|++++.+
T Consensus 462 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~-L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~ 539 (606)
T 3t6q_A 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH-VDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIIL 539 (606)
T ss_dssp GGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCE-EECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCC
T ss_pred CccccccchhhccCCCccEEECCCCccCccChhhhccccCCCE-EECCCCccCcCChhHhCccccc-EEECcCCcccccC
Confidence 863 3367899999999999999999999999999999997 9999999999999999999999 9999999999854
Q ss_pred -hhhhcccccceeEcccCCCCCCCCCC
Q 001873 647 -DALASLQNLVSLNVSFNDFSGELPNT 672 (1001)
Q Consensus 647 -~~~~~l~~L~~L~ls~N~l~~~~p~~ 672 (1001)
..+..+++|++|++++|++++.|+..
T Consensus 540 ~~~~~~l~~L~~L~l~~N~~~c~c~~~ 566 (606)
T 3t6q_A 540 PSLLPILSQQRTINLRQNPLDCTCSNI 566 (606)
T ss_dssp GGGHHHHHTSSEEECTTCCEECSGGGH
T ss_pred HhhcccCCCCCEEeCCCCCccccCCcH
Confidence 56899999999999999999988743
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-57 Score=547.31 Aligned_cols=534 Identities=20% Similarity=0.186 Sum_probs=357.0
Q ss_pred eccccccccCCcccccCCCCcEEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccC
Q 001873 85 LKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEG 164 (1001)
Q Consensus 85 l~~~~l~~~~~~~~~~l~~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~ 164 (1001)
+.+.+++. +|..+. +++++|+|++|++++..|..|+++++|++|||++|++++..|..|+.+++|++|+|++|.+++
T Consensus 18 c~~~~l~~-ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~ 94 (606)
T 3vq2_A 18 CMDQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS 94 (606)
T ss_dssp CTTSCCSS-CCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCC
T ss_pred ccCCCccc-CCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccc
Confidence 33344432 454443 789999999999998888899999999999999999998888899999999999999999998
Q ss_pred CCCccccCCccccceeccccccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccc
Q 001873 165 EIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIG 244 (1001)
Q Consensus 165 ~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~ 244 (1001)
..|..++++++|++|+|++|.+++..|..++++++|++|++++|......+|..++++++|++|++++|.+.+..|..++
T Consensus 95 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 174 (606)
T 3vq2_A 95 FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174 (606)
T ss_dssp CCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTH
T ss_pred cChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhh
Confidence 88999999999999999999999777788999999999999999433347899999999999999999988888788888
Q ss_pred cccccc----eeccccccccccCcccccCCCCCceEeeecCccc-CCCCcccCCCCCCcEEEcCCCccccc------CCC
Q 001873 245 MLERIQ----TIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSIS-GPIPGRIGALSKLKSLLLWQNSLVGA------IPD 313 (1001)
Q Consensus 245 ~l~~L~----~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~-~~~p~~~~~l~~L~~L~L~~N~l~~~------~p~ 313 (1001)
.+.+|+ ++++++|.+++..+..+.. .+|++|++++|.++ +..|..+.++++|+.+++..+.+.+. .+.
T Consensus 175 ~l~~L~~~l~~L~l~~n~l~~~~~~~~~~-~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~ 253 (606)
T 3vq2_A 175 FLRENPQVNLSLDMSLNPIDFIQDQAFQG-IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPS 253 (606)
T ss_dssp HHHHCTTCCCEEECTTCCCCEECTTTTTT-CEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGG
T ss_pred hhhccccccceeeccCCCcceeCcccccC-ceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChH
Confidence 777765 5777777777544444443 37777777777775 34566677777777777654443321 111
Q ss_pred CccCCC--CCCEEec-cCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCcccccc
Q 001873 314 ELGSCT--ELTVVDF-SDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNI 390 (1001)
Q Consensus 314 ~l~~l~--~L~~L~L-s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l 390 (1001)
.+..+. +++.+++ ..|.+.+.+|. +..+++|+.|++++|.+. .+| .+..+++|++|++++|.+ +.+| .+ .+
T Consensus 254 ~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l 327 (606)
T 3vq2_A 254 IMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DL 327 (606)
T ss_dssp GGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCC-CC-CC
T ss_pred HhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cccc-cC-CC
Confidence 111111 2444555 55555555554 566666666666666664 334 555566666666666666 3455 33 55
Q ss_pred CcccEEEeecCccCCCCCcccccCcccceEeCcCccccCC--CCcccccccccceEEccCCcCCCCCCCCCCCCCCcceE
Q 001873 391 NGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGP--IPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRL 468 (1001)
Q Consensus 391 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 468 (1001)
++|+.|++++|+..+.. .+..+++|++|++++|.+++. .|..+..+++|++|++++|.+++ +|..+..+++|++|
T Consensus 328 ~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L 404 (606)
T 3vq2_A 328 PFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHL 404 (606)
T ss_dssp SSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEE
T ss_pred CccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCee
Confidence 66666666666443322 344556666666666665543 24555555566666666665553 33555555555556
Q ss_pred EccccccccCCC-cccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCC
Q 001873 469 RLNDNRLSGTIP-SEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSG 547 (1001)
Q Consensus 469 ~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~ 547 (1001)
++++|++++..| ..+.++++|++|++++|++++..|..+.++++|++|++++|++++.
T Consensus 405 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--------------------- 463 (606)
T 3vq2_A 405 DFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN--------------------- 463 (606)
T ss_dssp ECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGG---------------------
T ss_pred ECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCc---------------------
Confidence 665555555544 4555555555555555555555555555555555555555555431
Q ss_pred CcccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCccccccccccc
Q 001873 548 SLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFS 627 (1001)
Q Consensus 548 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~ 627 (1001)
.+|..|+.+++|+.|++++|++++..|..+..+++|++|++++|++++.+|..+..+++|+. |++++|+|+ .+|..+.
T Consensus 464 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~-L~l~~N~l~-~~p~~~~ 541 (606)
T 3vq2_A 464 TLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST-LDCSFNRIE-TSKGILQ 541 (606)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCE-EECTTSCCC-CEESCGG
T ss_pred chHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCE-EECCCCcCc-ccCHhHh
Confidence 23445666677777777777777666677777777777777777777666777777777765 777777776 4455566
Q ss_pred ccc-cccEEEecCCcCCCChhhhhcccc
Q 001873 628 GLT-KLGILDLSHNKLSGDLDALASLQN 654 (1001)
Q Consensus 628 ~l~-~L~~L~Ls~N~l~~~~~~~~~l~~ 654 (1001)
.++ +|+.|++++|++.|+++..+...+
T Consensus 542 ~l~~~L~~l~l~~N~~~c~c~~~~~~~~ 569 (606)
T 3vq2_A 542 HFPKSLAFFNLTNNSVACICEHQKFLQW 569 (606)
T ss_dssp GSCTTCCEEECCSCCCCCSSTTHHHHTT
T ss_pred hhcccCcEEEccCCCcccCCccHHHHHH
Confidence 665 477777777777776654333333
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-56 Score=543.46 Aligned_cols=530 Identities=19% Similarity=0.184 Sum_probs=413.6
Q ss_pred cEEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceecccc
Q 001873 105 KRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDN 184 (1001)
Q Consensus 105 ~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n 184 (1001)
+.++.++++++ .+|..+. ++|++|||++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n 90 (606)
T 3vq2_A 14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90 (606)
T ss_dssp TEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence 56899999998 7887765 78999999999999888889999999999999999999777888999999999999999
Q ss_pred ccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCc
Q 001873 185 QLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIP 264 (1001)
Q Consensus 185 ~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip 264 (1001)
.+++..|..|+++++|++|++++| .+++..|..++++++|++|++++|.+.+ ..+|
T Consensus 91 ~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~-----------------------~~lp 146 (606)
T 3vq2_A 91 PIQSFSPGSFSGLTSLENLVAVET-KLASLESFPIGQLITLKKLNVAHNFIHS-----------------------CKLP 146 (606)
T ss_dssp CCCCCCTTSSTTCTTCCEEECTTS-CCCCSSSSCCTTCTTCCEEECCSSCCCC-----------------------CCCC
T ss_pred cccccChhhcCCcccCCEEEccCC-ccccccccccCCCCCCCEEeCCCCcccc-----------------------eech
Confidence 999777888888888888888888 4554444556666666666666555442 1456
Q ss_pred ccccCCCCCceEeeecCcccCCCCcccCCCCCCc----EEEcCCCcccccCCCCccCCCCCCEEeccCCCCC-CCCCccc
Q 001873 265 EEIGNCSELQNLYLYQNSISGPIPGRIGALSKLK----SLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLT-GSIPRSF 339 (1001)
Q Consensus 265 ~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~~ 339 (1001)
..++++++|++|++++|++++..|..|+.+++|+ +|++++|.+++..+..+... +|+.|++++|.++ +..|..+
T Consensus 147 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~ 225 (606)
T 3vq2_A 147 AYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCL 225 (606)
T ss_dssp GGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHH
T ss_pred HhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHh
Confidence 6666666666666666666666666666555444 56666666665444444433 6667777776665 3445556
Q ss_pred ccccCccEEEcccccccCc------CChhhcccc--ccCEEec-cCCcccCccCccccccCcccEEEeecCccCCCCCcc
Q 001873 340 GNLLKLQELQLSVNQLSGT------IPIEIATCT--ALTHLEI-DNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPES 410 (1001)
Q Consensus 340 ~~l~~L~~L~Ls~N~l~~~------~p~~~~~l~--~L~~L~L-~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~ 410 (1001)
.++++|+.+++..+.+.+. .+..+..+. .++.+++ ..|.+.+.+|. +..+++|+.+++++|.+. .+| .
T Consensus 226 ~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~ 302 (606)
T 3vq2_A 226 QNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-D 302 (606)
T ss_dssp HTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-C
T ss_pred ccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-h
Confidence 6666666666655443321 111122222 4556666 66777777776 778888888888888886 345 7
Q ss_pred cccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccC--CCcccCCCCC
Q 001873 411 LSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGT--IPSEMGNLKH 488 (1001)
Q Consensus 411 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~ 488 (1001)
+..+++|++|++++|.+ +.+| .+ .+++|++|++++|+..+.. .+..+++|++|++++|++++. +|..+..+++
T Consensus 303 l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~ 377 (606)
T 3vq2_A 303 VPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNS 377 (606)
T ss_dssp CCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSC
T ss_pred ccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCc
Confidence 78888888888888888 4667 44 8888888888888655433 567888888888888888865 3778888888
Q ss_pred cceeeccCcccccCCcccccccccCceEEcccccCcccCC-CCcc--cccccccCCCCcCCCCcccccccccccceeecc
Q 001873 489 LNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVP-DTLP--TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLS 565 (1001)
Q Consensus 489 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~--~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 565 (1001)
|++|++++|.+++ +|..+..+++|+.|++++|++++..| ..+. +.++.|++++|++++..|..+..+++|++|+++
T Consensus 378 L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 456 (606)
T 3vq2_A 378 LRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMA 456 (606)
T ss_dssp CCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECT
T ss_pred ccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECC
Confidence 8999998888885 56788888889999999988887766 3332 567778999999888888899999999999999
Q ss_pred Cccccc-cchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCC
Q 001873 566 KNQLSG-RIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSG 644 (1001)
Q Consensus 566 ~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 644 (1001)
+|++++ .+|..+..+++|++|++++|++++..|..+..+++|+. |+|++|++++..|..|.++++|++|||++|+++.
T Consensus 457 ~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~-L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 535 (606)
T 3vq2_A 457 GNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL-LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET 535 (606)
T ss_dssp TCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE-EECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC
T ss_pred CCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCE-EECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc
Confidence 999997 47889999999999999999999999999999999997 9999999999999999999999999999999998
Q ss_pred Chhhhhccc-ccceeEcccCCCCCCCCCC
Q 001873 645 DLDALASLQ-NLVSLNVSFNDFSGELPNT 672 (1001)
Q Consensus 645 ~~~~~~~l~-~L~~L~ls~N~l~~~~p~~ 672 (1001)
.++.+..++ +|++|++++|++.+.|+..
T Consensus 536 ~p~~~~~l~~~L~~l~l~~N~~~c~c~~~ 564 (606)
T 3vq2_A 536 SKGILQHFPKSLAFFNLTNNSVACICEHQ 564 (606)
T ss_dssp EESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred cCHhHhhhcccCcEEEccCCCcccCCccH
Confidence 777788887 6999999999999988864
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-55 Score=550.14 Aligned_cols=526 Identities=22% Similarity=0.232 Sum_probs=419.7
Q ss_pred EEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCC-CccccCCccccceecccc
Q 001873 106 RLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEI-PSDIGNLSSLAYLTLYDN 184 (1001)
Q Consensus 106 ~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~i-p~~l~~L~~L~~L~L~~n 184 (1001)
..+.++++++ .+|. -.++|++|||++|++++..|..|..+++|++|+|++|.+.+.+ |..+++|++|++|+|++|
T Consensus 8 ~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 5788888998 6776 4578999999999999888999999999999999999777677 778999999999999999
Q ss_pred ccccccCCCccchhhhhhhhhccCcCCCCCCCcc--cccCccchhccccccccccccCCccccccccceecccccccccc
Q 001873 185 QLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWE--IGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGP 262 (1001)
Q Consensus 185 ~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~--l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ 262 (1001)
.+++..|..++++++|++|++++| .+++.+|.. ++++++|++|++++|.+.+..+
T Consensus 84 ~l~~~~p~~~~~l~~L~~L~Ls~n-~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~---------------------- 140 (844)
T 3j0a_A 84 KIYFLHPDAFQGLFHLFELRLYFC-GLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL---------------------- 140 (844)
T ss_dssp CCCEECTTSSCSCSSCCCEECTTC-CCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCC----------------------
T ss_pred cCcccCHhHccCCcccCEeeCcCC-CCCcccccCccccccCCCCEEECCCCccccccc----------------------
Confidence 999888999999999999988888 666666654 6677777777777766554322
Q ss_pred CcccccCCCCCceEeeecCcccCCCCcccCCC--CCCcEEEcCCCcccccCCCCccCCCC------CCEEeccCCCCCCC
Q 001873 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIGAL--SKLKSLLLWQNSLVGAIPDELGSCTE------LTVVDFSDNLLTGS 334 (1001)
Q Consensus 263 ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~l~~l~~------L~~L~Ls~N~l~~~ 334 (1001)
+..|+++++|++|+|++|.+++..+..+..+ ++|+.|++++|.+.+..|..++.+++ |+.|++++|.+++.
T Consensus 141 -~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~ 219 (844)
T 3j0a_A 141 -HPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVD 219 (844)
T ss_dssp -CGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTT
T ss_pred -chhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchh
Confidence 2345566666666666666666666666555 56666666666666655555554444 66666666666666
Q ss_pred CCcccccc---cCccEEEcc---------cccccCcCChhhccc--cccCEEeccCCcccCccCccccccCcccEEEeec
Q 001873 335 IPRSFGNL---LKLQELQLS---------VNQLSGTIPIEIATC--TALTHLEIDNNAISGEIPADIGNINGLTLFFAWK 400 (1001)
Q Consensus 335 ~p~~~~~l---~~L~~L~Ls---------~N~l~~~~p~~~~~l--~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~ 400 (1001)
.|..+... .+++.|.++ .|.+.+..+..|.++ ++|+.|++++|.+.+..+..+..+++|+.|++++
T Consensus 220 ~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 299 (844)
T 3j0a_A 220 ITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAY 299 (844)
T ss_dssp TTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEES
T ss_pred HHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCC
Confidence 66555432 456666655 333443444455554 7899999999999988899999999999999999
Q ss_pred CccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCC
Q 001873 401 NKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIP 480 (1001)
Q Consensus 401 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 480 (1001)
|++++..|..|..+++|++|+|++|.+++..|..|.++++|++|++++|++++..+..|..+++|+.|+|++|.+++.
T Consensus 300 n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-- 377 (844)
T 3j0a_A 300 NKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-- 377 (844)
T ss_dssp CCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC--
T ss_pred CcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc--
Confidence 999999999999999999999999999988899999999999999999999988888999999999999999999843
Q ss_pred cccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCcccCCCC---cccccccccCCCCcCCCCccc-ccccc
Q 001873 481 SEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDT---LPTSLQLVDLSDNRLSGSLAH-SIGSL 556 (1001)
Q Consensus 481 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~---~~~~l~~L~Ls~N~l~~~~~~-~~~~l 556 (1001)
..+++|+.|++++|+++ .+|.. ..+++.|++++|++++..... -.+.++.|+|++|++++..+. .+..+
T Consensus 378 ---~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 450 (844)
T 3j0a_A 378 ---HFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSEN 450 (844)
T ss_dssp ---SSCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSC
T ss_pred ---cCCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccC
Confidence 33889999999999998 45543 467899999999998642211 235788899999999975543 45668
Q ss_pred cccceeeccCcccc-----ccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCccccccccccccccc
Q 001873 557 TELSKLLLSKNQLS-----GRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTK 631 (1001)
Q Consensus 557 ~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~ 631 (1001)
++|+.|+|++|+++ +..+..|..+++|++|+|++|+|++.+|..+..+++|+. |+|++|+|++..|..+. ++
T Consensus 451 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~-L~Ls~N~l~~l~~~~~~--~~ 527 (844)
T 3j0a_A 451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRG-LSLNSNRLTVLSHNDLP--AN 527 (844)
T ss_dssp TTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSE-EEEESCCCSSCCCCCCC--SC
T ss_pred CccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhhe-eECCCCCCCccChhhhh--cc
Confidence 99999999999997 445567888999999999999999999999999999996 99999999988887776 89
Q ss_pred ccEEEecCCcCCCChhhhhcccccceeEcccCCCCCCCCCCc
Q 001873 632 LGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTP 673 (1001)
Q Consensus 632 L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~ 673 (1001)
|+.|||++|++++.++. .+.+|+.|++++|++.+.|+...
T Consensus 528 L~~L~Ls~N~l~~~~~~--~~~~L~~l~l~~Np~~C~c~~~~ 567 (844)
T 3j0a_A 528 LEILDISRNQLLAPNPD--VFVSLSVLDITHNKFICECELST 567 (844)
T ss_dssp CCEEEEEEECCCCCCSC--CCSSCCEEEEEEECCCCSSSCCS
T ss_pred ccEEECCCCcCCCCChh--HhCCcCEEEecCCCcccccccHH
Confidence 99999999999986543 24689999999999999888543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=508.11 Aligned_cols=508 Identities=17% Similarity=0.254 Sum_probs=386.1
Q ss_pred CcHHHHHHHHHHHHhCCCCCCccCCCCCCCC-C--CCccce-EEeCCC---CcEEEEEeccccccccCCcccccCCCCcE
Q 001873 34 ALDEQGQALLTWKNSLNSSTDALSSWNPAET-S--PCKWFG-IHCSSN---GEVVEISLKAVDLQGSLPSIFQPLKSLKR 106 (1001)
Q Consensus 34 ~~~~~~~aLl~~k~~~~~~~~~l~sW~~~~~-~--~c~w~g-v~c~~~---~~v~~l~l~~~~l~~~~~~~~~~l~~L~~ 106 (1001)
..+.+.+.-.++++-...-.+ .+|...+. . .|+|.. ..|..- ..|+. +-. .+++.
T Consensus 24 ~~~~~~~d~~aL~~~~~~~~~--~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C------~~~----------~~V~~ 85 (636)
T 4eco_A 24 RTAEYIKDYLALKEIWDALNG--KNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL------NSN----------GRVTG 85 (636)
T ss_dssp CCCHHHHHHHHHHHHHHHTTG--GGCCCCC------CCCCCSSCGGGTTCCTTEEE------CTT----------CCEEE
T ss_pred hhhhHHHHHHHHHHHHHHcCC--CCcccCCcCCccCCCCCCCCCcccccCCCCeEE------cCC----------CCEEE
Confidence 345566666676665444433 37874331 2 247952 223211 23443 101 35778
Q ss_pred EeccCCcccCCCCcccCCccccccccccCCcc------CC------CCChhhhcccccceEEccCCcccCCCCccccC-C
Q 001873 107 LIISSCNLTGTIPKEFGDYRELTFIDLSGNSL------WG------EIPTEVCRLRKLESLYLNTNLLEGEIPSDIGN-L 173 (1001)
Q Consensus 107 L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l------~g------~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~-L 173 (1001)
|+|++++++|.+|++|++|++|++|||++|.+ .| .+|.+. +.+|+ ++++.|.+.+.+|..++. +
T Consensus 86 L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~ 162 (636)
T 4eco_A 86 LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLI 162 (636)
T ss_dssp EECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHH
T ss_pred EEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHH
Confidence 89999999999999999999999999999876 44 566655 66777 888888888777777753 3
Q ss_pred ccccceeccccccccccCCCccchhhhhhhhhcc-CcCCCCCCCcccccCccchhccccccccccc--------------
Q 001873 174 SSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGG-NQNLKGELPWEIGNCSNLVMLGLAETSISGN-------------- 238 (1001)
Q Consensus 174 ~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~-n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~-------------- 238 (1001)
..+..+++....+.. .....++.+.++. +..++| +|.+++++++|++|++++|.+++.
T Consensus 163 ~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~ 235 (636)
T 4eco_A 163 KDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA 235 (636)
T ss_dssp HHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHH
T ss_pred HHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchh
Confidence 455666655443331 2223344444443 336787 899999999999999999999886
Q ss_pred ---cCCccc--cccccceeccccccccccCcccccCCCCCceEeeecCc-ccC-CCCcccCCC------CCCcEEEcCCC
Q 001873 239 ---VPSSIG--MLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNS-ISG-PIPGRIGAL------SKLKSLLLWQN 305 (1001)
Q Consensus 239 ---~p~~i~--~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~-i~~-~~p~~~~~l------~~L~~L~L~~N 305 (1001)
+|.+++ ++++|++|++++|.+.|.+|+.++++++|++|+|++|+ +++ .+|..++.+ ++|++|+|++|
T Consensus 236 ~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n 315 (636)
T 4eco_A 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315 (636)
T ss_dssp HHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSS
T ss_pred cccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCC
Confidence 888888 88888888888888888888888888888889988888 887 788888776 88888888888
Q ss_pred cccccCCC--CccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccc-cCEEeccCCcccCc
Q 001873 306 SLVGAIPD--ELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTA-LTHLEIDNNAISGE 382 (1001)
Q Consensus 306 ~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~i~~~ 382 (1001)
+++ .+|. .++++++|++|++++|.++|.+| .|+.+++|++|+|++|+++ .+|..+..+++ |++|++++|+++ .
T Consensus 316 ~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~ 391 (636)
T 4eco_A 316 NLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-Y 391 (636)
T ss_dssp CCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-S
T ss_pred cCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-c
Confidence 888 7887 88888888888888888888888 8888888888888888888 77888888888 888888888888 6
Q ss_pred cCccccccC--cccEEEeecCccCCCCCcccc-------cCcccceEeCcCccccCCCCcccccccccceEEccCCcCCC
Q 001873 383 IPADIGNIN--GLTLFFAWKNKLTGNIPESLS-------QCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSG 453 (1001)
Q Consensus 383 ~~~~~~~l~--~L~~L~l~~n~l~~~~p~~l~-------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 453 (1001)
+|..+..++ +|+.|++++|++++.+|..+. .+++|++|++++|++++..+..+..+++|++|+|++|+++.
T Consensus 392 lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~ 471 (636)
T 4eco_A 392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471 (636)
T ss_dssp CCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSB
T ss_pred cchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCC
Confidence 777777654 888888888888888888887 77788888888888884444445568888888888888884
Q ss_pred CCCCCCCCC-------CCcceEEccccccccCCCcccC--CCCCcceeeccCcccccCCcccccccccCceEEcccccCc
Q 001873 454 FIPPDIGNC-------TTLRRLRLNDNRLSGTIPSEMG--NLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLT 524 (1001)
Q Consensus 454 ~~p~~l~~l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 524 (1001)
..+..+... ++|++|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|++++|+
T Consensus 472 i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~-- 547 (636)
T 4eco_A 472 IPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR-- 547 (636)
T ss_dssp CCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCB--
T ss_pred cCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCc--
Confidence 433333333 28888888888888 6777776 88888888888888886 78888888888888888887
Q ss_pred ccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEeccccccc
Q 001873 525 GSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFS 594 (1001)
Q Consensus 525 ~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 594 (1001)
++++|++.+.+|..+..+++|++|+|++|+| +.+|..+. ++|+.||+++|+++
T Consensus 548 --------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 548 --------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNI 600 (636)
T ss_dssp --------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred --------------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCc
Confidence 5677888888888888888888888888888 46777655 78888888888776
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-52 Score=497.24 Aligned_cols=495 Identities=20% Similarity=0.215 Sum_probs=308.8
Q ss_pred CCccceEEeCCCCcEEEEEeccccccccCCcccccCCCCcEEeccCCcccCCCCcccCCccccccccccCCccCCCCChh
Q 001873 66 PCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTE 145 (1001)
Q Consensus 66 ~c~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~ 145 (1001)
.|.|.|| |+..+ .++. .+|..+. ++|++|+|++|++++..|..|+++++|++|+|++|++++..|..
T Consensus 3 ~C~~~~~-c~~~~---------~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~ 69 (549)
T 2z81_A 3 SCDASGV-CDGRS---------RSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69 (549)
T ss_dssp EECTTSE-EECTT---------SCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTT
T ss_pred cCCCCce-EECCC---------Cccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhh
Confidence 4999999 97322 2222 2455443 67888888888888777788888888888888888888777788
Q ss_pred hhcccccceEEccCCcccCCCCccccCCccccceecccccccc-ccCCCccchhhhhhhhhccCcCCCCCCCcccccCcc
Q 001873 146 VCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSG-KIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSN 224 (1001)
Q Consensus 146 ~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g-~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~ 224 (1001)
|+.+++|++|+|++|++++..|..++++++|++|+|++|.+++ .+|..++++++|++|++++|. +.+.+|
T Consensus 70 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~-~~~~~~-------- 140 (549)
T 2z81_A 70 FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE-TFSEIR-------- 140 (549)
T ss_dssp TTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS-SCCEEC--------
T ss_pred ccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCc-cccccC--------
Confidence 8888888888888888887666668888888888888888875 345566666666666666552 111111
Q ss_pred chhccccccccccccCCccccccccceeccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCC
Q 001873 225 LVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQ 304 (1001)
Q Consensus 225 L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~ 304 (1001)
+..+.++++|++|++++|.+++.+|..++++++|++|++++|.+....+..+..+++|++|++++
T Consensus 141 ---------------~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~ 205 (549)
T 2z81_A 141 ---------------RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRD 205 (549)
T ss_dssp ---------------TTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEES
T ss_pred ---------------HhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccC
Confidence 12233333333333333444444455555555555555555554422211223345555555555
Q ss_pred CcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCCh----hhccccccCEEeccCCccc
Q 001873 305 NSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPI----EIATCTALTHLEIDNNAIS 380 (1001)
Q Consensus 305 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~i~ 380 (1001)
|++++.... .......+++|+.|++++|++.+..+. .+..+++|+.+++++|.+.
T Consensus 206 n~l~~~~~~---------------------~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~ 264 (549)
T 2z81_A 206 TNLARFQFS---------------------PLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLN 264 (549)
T ss_dssp CBCTTCCCC---------------------CCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEE
T ss_pred Ccccccccc---------------------ccchhhhhhcccceeccccccchhHHHHHHHHhhhhcccccccccccccc
Confidence 555432100 001112234445555555544432222 2233445555555555544
Q ss_pred Ccc------CccccccCcccEEEeecCccCC-----CCCcccccCcccceEeCcCccccCCCCccc-ccccccceEEccC
Q 001873 381 GEI------PADIGNINGLTLFFAWKNKLTG-----NIPESLSQCQELQALDFSYNNLSGPIPKEI-FGLRNLTKLLLLS 448 (1001)
Q Consensus 381 ~~~------~~~~~~l~~L~~L~l~~n~l~~-----~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~ 448 (1001)
+.. ...+..+.+|+.+.+.++.+.. .++..+....+|+.|++++|.++ .+|..+ ..+++|++|++++
T Consensus 265 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~ 343 (549)
T 2z81_A 265 GLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSE 343 (549)
T ss_dssp CCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCS
T ss_pred ccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccC
Confidence 321 1223444555566665555432 12222334567778888888776 555555 4677888888888
Q ss_pred CcCCCCCC---CCCCCCCCcceEEccccccccCCC--cccCCCCCcceeeccCcccccCCcccccccccCceEEcccccC
Q 001873 449 NDLSGFIP---PDIGNCTTLRRLRLNDNRLSGTIP--SEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGL 523 (1001)
Q Consensus 449 N~l~~~~p---~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 523 (1001)
|++++.+| ..++.+++|++|+|++|++++..+ ..+..+++|++|++++|+++ .+|..+..+++|++|++++|++
T Consensus 344 N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l 422 (549)
T 2z81_A 344 NLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI 422 (549)
T ss_dssp SCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCC
T ss_pred CccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCc
Confidence 88776542 346777788888888888875432 45777888888888888887 5677777778888888888877
Q ss_pred cccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCcccc
Q 001873 524 TGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQ 603 (1001)
Q Consensus 524 ~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 603 (1001)
+ .+|..+++ +|+.|++++|+|++.+ ..+++|++|+|++|+|+ .+|. ...
T Consensus 423 ~-~l~~~~~~------------------------~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~ 471 (549)
T 2z81_A 423 R-VVKTCIPQ------------------------TLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASL 471 (549)
T ss_dssp S-CCCTTSCT------------------------TCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGG
T ss_pred c-cccchhcC------------------------CceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-ccc
Confidence 6 33333333 4556666666665432 35667777777777776 5555 356
Q ss_pred ccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCChhhhhcc
Q 001873 604 ISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASL 652 (1001)
Q Consensus 604 l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l 652 (1001)
+++|+. |+|++|++++.+|+.|..+++|+.|+|++|+++|+++.+..+
T Consensus 472 l~~L~~-L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~l 519 (549)
T 2z81_A 472 FPVLLV-MKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 519 (549)
T ss_dssp CTTCCE-EECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHHHHHH
T ss_pred CccCCE-EecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCccHHHH
Confidence 777775 888888888888888899999999999999999998755444
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=496.77 Aligned_cols=498 Identities=20% Similarity=0.201 Sum_probs=280.3
Q ss_pred CCCcEEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceec
Q 001873 102 KSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTL 181 (1001)
Q Consensus 102 ~~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L 181 (1001)
+++++|+|++|++++..+.+|+++++|++|||++|++++..|..|+.+++|++|+|++|++++..|..++++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 45777777777777666667777777777777777777655666777777777777777777655667777777777777
Q ss_pred cccccccccCCCccchhhhhhhhhccCcCCCC-CCCcccccCccchhccccccccccccCCccccccccceecccccccc
Q 001873 182 YDNQLSGKIPKSIGALSKLQVFRAGGNQNLKG-ELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLS 260 (1001)
Q Consensus 182 ~~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~-~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~ 260 (1001)
++|.+++..+..++++++|++|++++| .+++ .+|..++++++|++|++++|.+ +
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n-~l~~~~lp~~~~~l~~L~~L~l~~n~l------------------------~ 162 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHN-LIQSFKLPEYFSNLTNLEHLDLSSNKI------------------------Q 162 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSS-CCCCCCCCGGGGGCTTCCEEECTTSCC------------------------C
T ss_pred cccccccCCCccccccccccEEecCCC-ccceecChhhhcccCCCCEEeCcCCcc------------------------c
Confidence 777776433335666666666666655 2222 3344444444444444433333 3
Q ss_pred ccCcccccCCCCC----ceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccc-cCCCCccCCCCCCEEeccCCCCCCCC
Q 001873 261 GPIPEEIGNCSEL----QNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVG-AIPDELGSCTELTVVDFSDNLLTGSI 335 (1001)
Q Consensus 261 g~ip~~l~~l~~L----~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~ 335 (1001)
+..|..++.+++| +.|++++|.+++..|..|..+ +|+.|++++|.... .++..+..+++++.+++..+.+...
T Consensus 163 ~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~- 240 (570)
T 2z63_A 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE- 240 (570)
T ss_dssp EECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCC-
T ss_pred eecHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCc-
Confidence 3333333333333 444444444444444444333 44444444442211 1222233333443333322211100
Q ss_pred CcccccccCccEEEcccccccCcCChhhcccc--ccCEEeccCC-cccCccCccccccCcccEEEeecCccCCCCCcccc
Q 001873 336 PRSFGNLLKLQELQLSVNQLSGTIPIEIATCT--ALTHLEIDNN-AISGEIPADIGNINGLTLFFAWKNKLTGNIPESLS 412 (1001)
Q Consensus 336 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~ 412 (1001)
.+ +.......+..++ .++.+++++| .+.+..|..+..+++|+.|++++|.++ .+|..+.
T Consensus 241 -------~~----------l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~ 302 (570)
T 2z63_A 241 -------GN----------LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSY 302 (570)
T ss_dssp -------SS----------CEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCS
T ss_pred -------hh----------hhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhc
Confidence 00 0001111122222 2344555555 455555556666666666666666665 4555666
Q ss_pred cCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCC--CcccCCCCCcc
Q 001873 413 QCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTI--PSEMGNLKHLN 490 (1001)
Q Consensus 413 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~ 490 (1001)
.+ +|++|++++|.+. .+|. ..+++|++|++++|.+.+..+. ..+++|++|++++|++++.. |..+.++++|+
T Consensus 303 ~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~ 376 (570)
T 2z63_A 303 NF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376 (570)
T ss_dssp CC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCC
T ss_pred cC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccC
Confidence 66 7777777777776 3443 3567777777777777655544 66778888888888887543 66778888888
Q ss_pred eeeccCcccccCCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCcccc
Q 001873 491 FVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLS 570 (1001)
Q Consensus 491 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 570 (1001)
+|++++|++++..+. +..+++|++|++++|++++..|. ..+..+++|+.|++++|+++
T Consensus 377 ~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~---------------------~~~~~l~~L~~L~l~~n~l~ 434 (570)
T 2z63_A 377 YLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEF---------------------SVFLSLRNLIYLDISHTHTR 434 (570)
T ss_dssp EEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTS---------------------CTTTTCTTCCEEECTTSCCE
T ss_pred EEECCCCcccccccc-ccccCCCCEEEccCCccccccch---------------------hhhhcCCCCCEEeCcCCccc
Confidence 888888888865444 88888888888888888754432 12334445555555555555
Q ss_pred ccchhhhhccccccEEeccccccc-CCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCCh-hh
Q 001873 571 GRIPAEILSCRKLILLDIGNNRFS-GEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDL-DA 648 (1001)
Q Consensus 571 ~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~ 648 (1001)
+..|..+..+++|++|++++|+++ +.+|..+..+++|+. |++++|++++..|..|.++++|++|+|++|++++.+ ..
T Consensus 435 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~-L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 513 (570)
T 2z63_A 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF-LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGI 513 (570)
T ss_dssp ECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE-EECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred ccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCE-EECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHH
Confidence 445555555555555555555554 345555555555553 555555555555555555555555555555555533 23
Q ss_pred hhcccccceeEcccCCCCCCCCCCc
Q 001873 649 LASLQNLVSLNVSFNDFSGELPNTP 673 (1001)
Q Consensus 649 ~~~l~~L~~L~ls~N~l~~~~p~~~ 673 (1001)
+..+++|+.|++++|++++.||...
T Consensus 514 ~~~l~~L~~L~l~~N~~~~~~~~~~ 538 (570)
T 2z63_A 514 FDRLTSLQKIWLHTNPWDCSCPRID 538 (570)
T ss_dssp TTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred hhcccCCcEEEecCCcccCCCcchH
Confidence 4555555555555555555555443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=485.51 Aligned_cols=502 Identities=22% Similarity=0.227 Sum_probs=374.2
Q ss_pred cEEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceecccc
Q 001873 105 KRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDN 184 (1001)
Q Consensus 105 ~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n 184 (1001)
...+.++.+++ .+|..+. +++++|||++|++++..|..|..+++|++|+|++|++++..|..++++++|++|+|++|
T Consensus 10 ~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 86 (570)
T 2z63_A 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86 (570)
T ss_dssp TEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred cEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCC
Confidence 45777787887 6787664 57899999999999777888999999999999999998777778899999999999999
Q ss_pred ccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCc
Q 001873 185 QLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIP 264 (1001)
Q Consensus 185 ~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip 264 (1001)
.+++..|..|+++++|++|++++| .+++.. +
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~n-~l~~l~------------------------------------------------~ 117 (570)
T 2z63_A 87 PIQSLALGAFSGLSSLQKLVAVET-NLASLE------------------------------------------------N 117 (570)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTS-CCCCST------------------------------------------------T
T ss_pred cCCccCHhhhcCcccccccccccc-ccccCC------------------------------------------------C
Confidence 988766777877777777777777 232111 1
Q ss_pred ccccCCCCCceEeeecCcccC-CCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCC----CEEeccCCCCCCCCCccc
Q 001873 265 EEIGNCSELQNLYLYQNSISG-PIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTEL----TVVDFSDNLLTGSIPRSF 339 (1001)
Q Consensus 265 ~~l~~l~~L~~L~L~~N~i~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L----~~L~Ls~N~l~~~~p~~~ 339 (1001)
..++++++|++|++++|.+++ .+|..|+++++|++|++++|++++..|..++.+++| +.|++++|.+++..|..|
T Consensus 118 ~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~ 197 (570)
T 2z63_A 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197 (570)
T ss_dssp CSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT
T ss_pred ccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHh
Confidence 124444444555555554443 234445555555555555555544444444444444 455555555554444444
Q ss_pred ccccCccEEEcccccccC-cCChhhccccccCEEeccCCcc------cCccCccccccC--cccEEEeecC-ccCCCCCc
Q 001873 340 GNLLKLQELQLSVNQLSG-TIPIEIATCTALTHLEIDNNAI------SGEIPADIGNIN--GLTLFFAWKN-KLTGNIPE 409 (1001)
Q Consensus 340 ~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~i------~~~~~~~~~~l~--~L~~L~l~~n-~l~~~~p~ 409 (1001)
... +|+.|++++|.... .++..+..+++++.+.+..+.+ .......+..+. .++.+.+.++ .+.+..|.
T Consensus 198 ~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~ 276 (570)
T 2z63_A 198 KEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276 (570)
T ss_dssp TTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTT
T ss_pred ccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchh
Confidence 333 45555555543221 2233344444444444332211 111222333333 3677888888 78889999
Q ss_pred ccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCc
Q 001873 410 SLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHL 489 (1001)
Q Consensus 410 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 489 (1001)
.+..+++|+.|++++|.++ .+|..+..+ +|++|++++|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|
T Consensus 277 ~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L 349 (570)
T 2z63_A 277 LFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSL 349 (570)
T ss_dssp TTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTC
T ss_pred hhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCC
Confidence 9999999999999999998 588888888 9999999999998 4454 4789999999999999876665 789999
Q ss_pred ceeeccCcccccCC--cccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCc
Q 001873 490 NFVDMSENHLVGGI--PPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKN 567 (1001)
Q Consensus 490 ~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 567 (1001)
++|++++|++++.. |..+.++++|++|++++|++++ .+..+..+++|++|++++|
T Consensus 350 ~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~-----------------------~~~~~~~l~~L~~L~l~~n 406 (570)
T 2z63_A 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-----------------------MSSNFLGLEQLEHLDFQHS 406 (570)
T ss_dssp CEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEE-----------------------EEEEEETCTTCCEEECTTS
T ss_pred CEEeCcCCccCccccccccccccCccCEEECCCCcccc-----------------------ccccccccCCCCEEEccCC
Confidence 99999999998664 7788899999999999998873 2223778899999999999
Q ss_pred cccccch-hhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCccc-ccccccccccccccEEEecCCcCCCC
Q 001873 568 QLSGRIP-AEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFS-GEIPSEFSGLTKLGILDLSHNKLSGD 645 (1001)
Q Consensus 568 ~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~ 645 (1001)
++++..| ..+..+++|++|++++|++++..|..+..+++|+. |++++|+++ +.+|..+..+++|++|+|++|++++.
T Consensus 407 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~ 485 (570)
T 2z63_A 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV-LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485 (570)
T ss_dssp EEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE-EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEE
T ss_pred ccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcE-EECcCCcCccccchhhhhcccCCCEEECCCCccccC
Confidence 9997766 57889999999999999999999999999999997 999999998 68999999999999999999999985
Q ss_pred -hhhhhcccccceeEcccCCCCCCCCCC-ccccCCCCCCCCCCCccc
Q 001873 646 -LDALASLQNLVSLNVSFNDFSGELPNT-PFFRKLPLSDLASNRGLY 690 (1001)
Q Consensus 646 -~~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc 690 (1001)
+..+..+++|++|++++|++++.+|.. ..+..+...++.+|+-.|
T Consensus 486 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 532 (570)
T 2z63_A 486 SPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 532 (570)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccC
Confidence 678899999999999999999987753 345555666778887665
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=494.91 Aligned_cols=462 Identities=19% Similarity=0.267 Sum_probs=321.2
Q ss_pred CCcEEeccCCcccCCCCcccCCccccccccc-cCCccCCCCChhhhcc---------cccceEEcc-------CCcccCC
Q 001873 103 SLKRLIISSCNLTGTIPKEFGDYRELTFIDL-SGNSLWGEIPTEVCRL---------RKLESLYLN-------TNLLEGE 165 (1001)
Q Consensus 103 ~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~L-s~n~l~g~~p~~~~~l---------~~L~~L~L~-------~n~l~~~ 165 (1001)
+++.|+|++++++|.+|++|++|++|++||| ++|.++|..|-..... ..++...+. ...+++.
T Consensus 324 ~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l 403 (876)
T 4ecn_A 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDL 403 (876)
T ss_dssp CEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHH
T ss_pred CEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHH
Confidence 5666777777777777777777777777777 6676666544221111 000000000 0000000
Q ss_pred -----------CCccccCCccccceeccc--cccccccCCCccchhhhhhhhhccCcCCCC-CCCcccccCccchhcccc
Q 001873 166 -----------IPSDIGNLSSLAYLTLYD--NQLSGKIPKSIGALSKLQVFRAGGNQNLKG-ELPWEIGNCSNLVMLGLA 231 (1001)
Q Consensus 166 -----------ip~~l~~L~~L~~L~L~~--n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~-~lp~~l~~l~~L~~L~l~ 231 (1001)
.+....+...++.+.+.. |.++| +|..++++++|++|+|++| .++| .+|..+.. .+
T Consensus 404 ~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N-~Lsg~~i~~~~~~--------~s 473 (876)
T 4ecn_A 404 LQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANS-PFTYDNIAVDWED--------AN 473 (876)
T ss_dssp HHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESC-CCCGGGBSSSCSC--------TT
T ss_pred HHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCC-cCCCCcccccccc--------cc
Confidence 011112223344444433 55555 5656666666666666655 3443 22221111 11
Q ss_pred ccccccccCCccc--cccccceeccccccccccCcccccCCCCCceEeeecCc-ccC-CCCcccCCCC-------CCcEE
Q 001873 232 ETSISGNVPSSIG--MLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNS-ISG-PIPGRIGALS-------KLKSL 300 (1001)
Q Consensus 232 ~~~l~~~~p~~i~--~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~-i~~-~~p~~~~~l~-------~L~~L 300 (1001)
.+...+.+|..++ ++++|+.|++++|.+.|.+|..|+++++|++|+|++|+ +++ .+|..++.++ +|+.|
T Consensus 474 ~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L 553 (876)
T 4ecn_A 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553 (876)
T ss_dssp SHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEE
T ss_pred cccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEE
Confidence 1333446888888 89999999999998888899889999999999999998 887 7777666554 89999
Q ss_pred EcCCCcccccCCC--CccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccc-cCEEeccCC
Q 001873 301 LLWQNSLVGAIPD--ELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTA-LTHLEIDNN 377 (1001)
Q Consensus 301 ~L~~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N 377 (1001)
+|++|+++ .+|. .++++++|+.|+|++|.++ .+| .|+.+++|++|+|++|++. .+|..+..+++ |+.|+|++|
T Consensus 554 ~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N 629 (876)
T 4ecn_A 554 YMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHN 629 (876)
T ss_dssp ECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSS
T ss_pred EeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCC
Confidence 99999988 7888 8888899999999999888 777 7888889999999999888 78888888888 999999999
Q ss_pred cccCccCccccccCc--ccEEEeecCccCCCCCccc---c--cCcccceEeCcCccccCCCCccc-ccccccceEEccCC
Q 001873 378 AISGEIPADIGNING--LTLFFAWKNKLTGNIPESL---S--QCQELQALDFSYNNLSGPIPKEI-FGLRNLTKLLLLSN 449 (1001)
Q Consensus 378 ~i~~~~~~~~~~l~~--L~~L~l~~n~l~~~~p~~l---~--~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N 449 (1001)
+++ .+|..+..++. |+.|++++|++++.+|... . .+++|+.|++++|+++ .+|..+ ..+++|+.|+|++|
T Consensus 630 ~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N 707 (876)
T 4ecn_A 630 KLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNN 707 (876)
T ss_dssp CCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSC
T ss_pred CCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCC
Confidence 888 67877777654 8889999998888766432 2 3447888899988888 455544 47888888888888
Q ss_pred cCCCCCCCCCCC--------CCCcceEEccccccccCCCcccC--CCCCcceeeccCcccccCCcccccccccCceEEcc
Q 001873 450 DLSGFIPPDIGN--------CTTLRRLRLNDNRLSGTIPSEMG--NLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLH 519 (1001)
Q Consensus 450 ~l~~~~p~~l~~--------l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 519 (1001)
+++ .+|..+.. +++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+.++++|+.|+|+
T Consensus 708 ~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls 784 (876)
T 4ecn_A 708 LMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIR 784 (876)
T ss_dssp CCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECC
T ss_pred cCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECC
Confidence 888 44444332 238888888888888 6777776 88888888888888886 68788888888888888
Q ss_pred cccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCC
Q 001873 520 SNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPK 599 (1001)
Q Consensus 520 ~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 599 (1001)
+|+ ++++|++.+.+|..|..+++|+.|+|++|+| +.+|..+. ++|+.|||++|++....+.
T Consensus 785 ~N~----------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~ 845 (876)
T 4ecn_A 785 HQR----------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVT 845 (876)
T ss_dssp CCB----------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECG
T ss_pred CCC----------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChH
Confidence 887 5677777777777777777777777777777 46666554 4677777777766644444
Q ss_pred ccc
Q 001873 600 ELG 602 (1001)
Q Consensus 600 ~~~ 602 (1001)
.+.
T Consensus 846 ~~~ 848 (876)
T 4ecn_A 846 SVC 848 (876)
T ss_dssp GGH
T ss_pred Hcc
Confidence 333
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=483.17 Aligned_cols=480 Identities=19% Similarity=0.173 Sum_probs=336.5
Q ss_pred EeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceecccccc
Q 001873 107 LIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQL 186 (1001)
Q Consensus 107 L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l 186 (1001)
.++++++++ .+|+.+. ++|++|||++|++++..|..|+.+++|++|+|++|++++..|..++++++|++|+|++|.+
T Consensus 10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 86 (549)
T 2z81_A 10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86 (549)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence 456677777 6777665 7888888888888877788888888888888888888877777888888888888888888
Q ss_pred ccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccc-cCcc
Q 001873 187 SGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSG-PIPE 265 (1001)
Q Consensus 187 ~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g-~ip~ 265 (1001)
++..|..++++++|++|++++| . +++ .+|.
T Consensus 87 ~~~~~~~~~~l~~L~~L~Ls~n-------------------------~------------------------l~~~~~~~ 117 (549)
T 2z81_A 87 SSLSSSWFGPLSSLKYLNLMGN-------------------------P------------------------YQTLGVTS 117 (549)
T ss_dssp CSCCHHHHTTCTTCCEEECTTC-------------------------C------------------------CSSSCSSC
T ss_pred CccCHHHhccCCCCcEEECCCC-------------------------c------------------------ccccchhh
Confidence 8655555666666666666665 1 111 2345
Q ss_pred cccCCCCCceEeeecCcccCCC-CcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcc-ccccc
Q 001873 266 EIGNCSELQNLYLYQNSISGPI-PGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRS-FGNLL 343 (1001)
Q Consensus 266 ~l~~l~~L~~L~L~~N~i~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~ 343 (1001)
.++++++|++|++++|.+.+.+ +..|.++++|++|++++|++++.+|..++.+++|+.|++++|.+. .+|.. +..++
T Consensus 118 ~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~ 196 (549)
T 2z81_A 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILS 196 (549)
T ss_dssp SCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTT
T ss_pred hhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcc
Confidence 5667777777777777743333 457777888888888888888777888888888888888888776 34443 35578
Q ss_pred CccEEEcccccccCcC--C-hhhccccccCEEeccCCcccCccCc----cccccCcccEEEeecCccCCCC------Ccc
Q 001873 344 KLQELQLSVNQLSGTI--P-IEIATCTALTHLEIDNNAISGEIPA----DIGNINGLTLFFAWKNKLTGNI------PES 410 (1001)
Q Consensus 344 ~L~~L~Ls~N~l~~~~--p-~~~~~l~~L~~L~L~~N~i~~~~~~----~~~~l~~L~~L~l~~n~l~~~~------p~~ 410 (1001)
+|++|++++|++++.. | .....+++|+.|++++|.+++..+. .+..+++|+.+++++|.+.+.. ...
T Consensus 197 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~ 276 (549)
T 2z81_A 197 SVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDV 276 (549)
T ss_dssp TBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTC
T ss_pred cccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhh
Confidence 8888888888887642 1 2234578899999999988765443 3456678888888888776531 123
Q ss_pred cccCcccceEeCcCccccCC-----CCcccccccccceEEccCCcCCCCCCCCC-CCCCCcceEEccccccccCCC---c
Q 001873 411 LSQCQELQALDFSYNNLSGP-----IPKEIFGLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLNDNRLSGTIP---S 481 (1001)
Q Consensus 411 l~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~p---~ 481 (1001)
+..+.+|+.|+++++.+... ++..+...++|++|++++|++. .+|..+ ..+++|++|++++|++++.+| .
T Consensus 277 ~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 355 (549)
T 2z81_A 277 VSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSA 355 (549)
T ss_dssp CCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHT
T ss_pred hhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchh
Confidence 45566677777777665421 1111223445666666666655 333333 345566666666666655442 2
Q ss_pred ccCCCCCcceeeccCcccccCCc--ccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCccccccccccc
Q 001873 482 EMGNLKHLNFVDMSENHLVGGIP--PSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTEL 559 (1001)
Q Consensus 482 ~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L 559 (1001)
.++.+++|++|++++|++++..+ ..+..+++|++|++++|+++ .+|..+..+++|
T Consensus 356 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-----------------------~lp~~~~~~~~L 412 (549)
T 2z81_A 356 CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-----------------------PMPDSCQWPEKM 412 (549)
T ss_dssp CTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-----------------------CCCSCCCCCTTC
T ss_pred hhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-----------------------cCChhhcccccc
Confidence 24555566666666666554321 33555555555555555554 345567778899
Q ss_pred ceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecC
Q 001873 560 SKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSH 639 (1001)
Q Consensus 560 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 639 (1001)
+.|++++|+++ .+|..+ .++|++||+++|+|++.+ ..++.|+. |+|++|+|+ .+|. ...+++|++|||++
T Consensus 413 ~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~-L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~ 482 (549)
T 2z81_A 413 RFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQE-LYISRNKLK-TLPD-ASLFPVLLVMKISR 482 (549)
T ss_dssp CEEECTTSCCS-CCCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCE-EECCSSCCS-SCCC-GGGCTTCCEEECCS
T ss_pred cEEECCCCCcc-cccchh--cCCceEEECCCCChhhhc----ccCChhcE-EECCCCccC-cCCC-cccCccCCEEecCC
Confidence 99999999998 444443 268999999999999753 57888996 999999999 5665 56799999999999
Q ss_pred CcCCCChh-hhhcccccceeEcccCCCCCCCCCCc
Q 001873 640 NKLSGDLD-ALASLQNLVSLNVSFNDFSGELPNTP 673 (1001)
Q Consensus 640 N~l~~~~~-~~~~l~~L~~L~ls~N~l~~~~p~~~ 673 (1001)
|++++.++ .+..+++|++|++++|++++.||...
T Consensus 483 N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 517 (549)
T 2z81_A 483 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 517 (549)
T ss_dssp SCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHHHH
T ss_pred CccCCcCHHHHhcCcccCEEEecCCCccCCCccHH
Confidence 99999654 58999999999999999999998543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=475.10 Aligned_cols=460 Identities=20% Similarity=0.219 Sum_probs=312.9
Q ss_pred cEEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceecccc
Q 001873 105 KRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDN 184 (1001)
Q Consensus 105 ~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n 184 (1001)
++||+++|+++ .+|..+. ++|++|||++|++++..|..|..+++|++|+|++|++++..|..++++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 46888899998 6888776 88999999999998777788999999999999999998777889999999999999999
Q ss_pred ccccccCCCccchhhhhhhhhccCcCCCC-CCCcccccCccchhccccccccccccCCccccccccceeccccccccccC
Q 001873 185 QLSGKIPKSIGALSKLQVFRAGGNQNLKG-ELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPI 263 (1001)
Q Consensus 185 ~l~g~~p~~~~~l~~L~~L~l~~n~~l~~-~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~i 263 (1001)
+++ .+|.. .+++|++|++++| .+++ .+|..++++++|++|++++|.+ ++
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N-~l~~~~~p~~~~~l~~L~~L~L~~n~l------------------------~~-- 129 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFN-AFDALPICKEFGNMSQLKFLGLSTTHL------------------------EK-- 129 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSS-CCSSCCCCGGGGGCTTCCEEEEEESSC------------------------CG--
T ss_pred cee-ecCcc--ccCCccEEeccCC-ccccccchhhhccCCcceEEEecCccc------------------------ch--
Confidence 988 67766 6677777777766 3332 3444444444444444444333 22
Q ss_pred cccccCCCCC--ceEeeecCcc--cCCCCcccCCCC-CCcEEEcCCCcccccCCC-CccCCCCCCEEeccCCC-------
Q 001873 264 PEEIGNCSEL--QNLYLYQNSI--SGPIPGRIGALS-KLKSLLLWQNSLVGAIPD-ELGSCTELTVVDFSDNL------- 330 (1001)
Q Consensus 264 p~~l~~l~~L--~~L~L~~N~i--~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~------- 330 (1001)
..+..+++| ++|++++|.+ .+..|..+..+. +...+++++|++.+.+++ .+..+++|+.|++++|.
T Consensus 130 -~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 208 (520)
T 2z7x_B 130 -SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY 208 (520)
T ss_dssp -GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHH
T ss_pred -hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccce
Confidence 234444555 7777777776 566666666554 233455666665554443 34455666666666655
Q ss_pred CCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcc
Q 001873 331 LTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPES 410 (1001)
Q Consensus 331 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~ 410 (1001)
+.+.+| .|+.+++|+.|++++|.+++..+..+.. . ...++|+.|++++|+++|.+|..
T Consensus 209 ~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~--------------------~-~~~~~L~~L~l~~n~l~~~~p~~ 266 (520)
T 2z7x_B 209 FLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQ--------------------L-VWHTTVWYFSISNVKLQGQLDFR 266 (520)
T ss_dssp HHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHH--------------------H-HHTSSCSEEEEEEEEEESCCCCC
T ss_pred eecchh-hhccccchhhccccccccCHHHHHHHHH--------------------H-hhhCcccEEEeecccccCccccc
Confidence 443333 4555555555555555554322111110 0 01234555555555555555555
Q ss_pred c-----ccCcccceEeCcCccccCCCC-cccccc---cccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCc
Q 001873 411 L-----SQCQELQALDFSYNNLSGPIP-KEIFGL---RNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPS 481 (1001)
Q Consensus 411 l-----~~l~~L~~L~Ls~N~l~~~~~-~~~~~l---~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 481 (1001)
+ ..+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|++.... .+..+++|++|++++|++++.+|.
T Consensus 267 ~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~ 342 (520)
T 2z7x_B 267 DFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFE 342 (520)
T ss_dssp CCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTT
T ss_pred hhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhh
Confidence 5 6667777777777777 334 444444 56777788777776432 125778888888888888877888
Q ss_pred ccCCCCCcceeeccCccccc--CCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCccccccccccc
Q 001873 482 EMGNLKHLNFVDMSENHLVG--GIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTEL 559 (1001)
Q Consensus 482 ~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L 559 (1001)
.++++++|++|++++|++++ .+|..+..+++|++|++++|++++.+|. ..+..+++|
T Consensus 343 ~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~---------------------~~~~~l~~L 401 (520)
T 2z7x_B 343 NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK---------------------GDCSWTKSL 401 (520)
T ss_dssp TCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGG---------------------CSCCCCTTC
T ss_pred hhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCccccc---------------------chhccCccC
Confidence 88888888888888888886 4567788888888888888887753332 134556778
Q ss_pred ceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecC
Q 001873 560 SKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSH 639 (1001)
Q Consensus 560 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 639 (1001)
+.|++++|++++.+|..+. ++|++|++++|+++ .+|..+..+++|+. |+|++|+|++..+..|..+++|++|++++
T Consensus 402 ~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~-L~L~~N~l~~l~~~~~~~l~~L~~L~l~~ 477 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQE-LNVASNQLKSVPDGIFDRLTSLQKIWLHT 477 (520)
T ss_dssp CEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCE-EECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCE-EECCCCcCCccCHHHhccCCcccEEECcC
Confidence 8888888888776666554 67888888888887 77877778888886 88888888854444588899999999999
Q ss_pred CcCCCChhhh
Q 001873 640 NKLSGDLDAL 649 (1001)
Q Consensus 640 N~l~~~~~~~ 649 (1001)
|+++|+++..
T Consensus 478 N~~~c~c~~~ 487 (520)
T 2z7x_B 478 NPWDCSCPRI 487 (520)
T ss_dssp SCBCCCHHHH
T ss_pred CCCcccCCch
Confidence 9999987643
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=481.54 Aligned_cols=569 Identities=22% Similarity=0.187 Sum_probs=361.6
Q ss_pred CCCCCccCCCCCCCCCCCccceEEeCCCCcEEEEEeccccccccCCcccccCCCCcEEeccCCcccCCCCcccCCccccc
Q 001873 50 NSSTDALSSWNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELT 129 (1001)
Q Consensus 50 ~~~~~~l~sW~~~~~~~c~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~~~l~g~~p~~~~~l~~L~ 129 (1001)
.|+...+++|+. .-|..|..+.|...+..+ +..+.+|+ .+|..+. +++++|||++|++++..|.+|+++++|+
T Consensus 7 ~~~~~~~~~~~~--~~p~~~~~c~~~~~~~~~--~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~ 79 (635)
T 4g8a_A 7 KDDDDKLAAANS--SIPESWEPCVEVVPNITY--QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQ 79 (635)
T ss_dssp --------------------CCSEEEETTTEE--ECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred CCCcchhhcccC--CCCCCCCCccccCCCCEE--ECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCC
Confidence 455667888873 345567777776444433 34455555 3565443 4789999999999977777899999999
Q ss_pred cccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccCCCccchhhhhhhhhccCc
Q 001873 130 FIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQ 209 (1001)
Q Consensus 130 ~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~n~ 209 (1001)
+|||++|++++..|..|..|++|++|+|++|++++..|..|++|++|++|+|++|++++..|..|+++++|++|++++|.
T Consensus 80 ~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~ 159 (635)
T 4g8a_A 80 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 159 (635)
T ss_dssp EEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCc
Confidence 99999999997777789999999999999999996556678999999999999999997666679999999999999994
Q ss_pred CCCCCCCcccccCccchhccccccccccccCCccccccccc----eeccccccccccCcccccCCCCCceEeeecCcccC
Q 001873 210 NLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQ----TIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISG 285 (1001)
Q Consensus 210 ~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~----~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~ 285 (1001)
.-...+|..++++++|++|++++|.+.+..|..+..+.+++ .++++.|.++.. +........++.|++.+|....
T Consensus 160 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i-~~~~~~~~~~~~l~l~~n~~~~ 238 (635)
T 4g8a_A 160 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI-QPGAFKEIRLHKLTLRNNFDSL 238 (635)
T ss_dssp CCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEE-CTTTTTTCEEEEEEEESCCSSH
T ss_pred cccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCccccc-Ccccccchhhhhhhhhcccccc
Confidence 33446788888888899998888888877777777666544 344555555532 3333333445566666665432
Q ss_pred C-CCcccCCCCCCcEEEcCCCc------ccccCCCCccCCCCCCEEeccCCCCCC---CCCcccccccCccEEEcccccc
Q 001873 286 P-IPGRIGALSKLKSLLLWQNS------LVGAIPDELGSCTELTVVDFSDNLLTG---SIPRSFGNLLKLQELQLSVNQL 355 (1001)
Q Consensus 286 ~-~p~~~~~l~~L~~L~L~~N~------l~~~~p~~l~~l~~L~~L~Ls~N~l~~---~~p~~~~~l~~L~~L~Ls~N~l 355 (1001)
. .+..+..+..++...+..+. +....+..+..+..+...++..+.... ..+..+..+.+++.+++.+|.+
T Consensus 239 ~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 318 (635)
T 4g8a_A 239 NVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTI 318 (635)
T ss_dssp HHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEE
T ss_pred cccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccc
Confidence 2 23344455555554443222 122222333334444444444433221 1223344455555666555555
Q ss_pred cCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccC--CCCc
Q 001873 356 SGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSG--PIPK 433 (1001)
Q Consensus 356 ~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~--~~~~ 433 (1001)
... ..+....+|+.|++.+|.+.+..+. .+..|+.+.+..|..... .....+++|+.|++++|.+.. ..+.
T Consensus 319 ~~~--~~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~ 391 (635)
T 4g8a_A 319 ERV--KDFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQ 391 (635)
T ss_dssp EEC--GGGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCH
T ss_pred ccc--cccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhcccccccccccc
Confidence 422 2234445556666666655433222 234455555555554422 123345555555555555532 2333
Q ss_pred ccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCC-cccCCCCCcceeeccCcccccCCccccccccc
Q 001873 434 EIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIP-SEMGNLKHLNFVDMSENHLVGGIPPSVVGCQS 512 (1001)
Q Consensus 434 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 512 (1001)
.+..+.+|+.+++..|.... .+..+..+++|+.++++.|+.....+ ..+.++++++.+++++|++.+..+..+..+++
T Consensus 392 ~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~ 470 (635)
T 4g8a_A 392 SDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 470 (635)
T ss_dssp HHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTT
T ss_pred chhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchh
Confidence 44445555555555555442 23344455555555555554443322 23444555555555555555555555555555
Q ss_pred CceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEeccccc
Q 001873 513 LEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNR 592 (1001)
Q Consensus 513 L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 592 (1001)
|+.|++++|++. .+..|..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|+
T Consensus 471 L~~L~Ls~N~~~---------------------~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~ 529 (635)
T 4g8a_A 471 LEVLKMAGNSFQ---------------------ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 529 (635)
T ss_dssp CCEEECTTCEEG---------------------GGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred hhhhhhhhcccc---------------------cccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCc
Confidence 555555544432 23456778889999999999999999999999999999999999999
Q ss_pred ccCCCCCccccccchhhhhhcCCCccccccccccccc-ccccEEEecCCcCCCChhhhhcccccc
Q 001873 593 FSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGL-TKLGILDLSHNKLSGDLDALASLQNLV 656 (1001)
Q Consensus 593 l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~l~~L~ 656 (1001)
|++..|..|..+++|++ |+|++|+|++..|+.|..+ ++|+.|+|++|+|+|+++..+...|++
T Consensus 530 l~~l~~~~~~~l~~L~~-L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~~~wl~ 593 (635)
T 4g8a_A 530 FFSLDTFPYKCLNSLQV-LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIK 593 (635)
T ss_dssp CCBCCCGGGTTCTTCCE-EECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHHHHHHH
T ss_pred CCCCChhHHhCCCCCCE-EECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHHHHHHH
Confidence 99988999999999997 9999999999999999988 689999999999999988655555554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=464.21 Aligned_cols=451 Identities=18% Similarity=0.168 Sum_probs=342.4
Q ss_pred EEEeccccccccCCcccccCCCCcEEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCc
Q 001873 82 EISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNL 161 (1001)
Q Consensus 82 ~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~ 161 (1001)
.+++++++++ .+|..+. ++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+.+++|++|+|++|+
T Consensus 4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 80 (520)
T 2z7x_B 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80 (520)
T ss_dssp EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence 4678888888 4777665 899999999999998888899999999999999999998889999999999999999999
Q ss_pred ccCCCCccccCCccccceecccccccc-ccCCCccchhhhhhhhhccCcCCCCCCCcccccCccc--hhccccccccccc
Q 001873 162 LEGEIPSDIGNLSSLAYLTLYDNQLSG-KIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNL--VMLGLAETSISGN 238 (1001)
Q Consensus 162 l~~~ip~~l~~L~~L~~L~L~~n~l~g-~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L--~~L~l~~~~l~~~ 238 (1001)
++ .+|.. .+++|++|+|++|.+++ .+|..++++++|++|++++| .+++ ..++.+++| +.|++++|.+.+
T Consensus 81 l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n-~l~~---~~~~~l~~L~L~~L~l~~n~l~~- 152 (520)
T 2z7x_B 81 LV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTT-HLEK---SSVLPIAHLNISKVLLVLGETYG- 152 (520)
T ss_dssp CC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEES-SCCG---GGGGGGTTSCEEEEEEEECTTTT-
T ss_pred ee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCc-ccch---hhccccccceeeEEEeecccccc-
Confidence 99 78877 89999999999999997 58999999999999999999 4443 234455555 555555544410
Q ss_pred cCCccccccccceeccccccccccCcccccCCC-CCceEeeecCcccCCCCc-ccCCCCCCcEEEcCCCc-------ccc
Q 001873 239 VPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCS-ELQNLYLYQNSISGPIPG-RIGALSKLKSLLLWQNS-------LVG 309 (1001)
Q Consensus 239 ~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~-~L~~L~L~~N~i~~~~p~-~~~~l~~L~~L~L~~N~-------l~~ 309 (1001)
++..|..+.+++ +...+++++|++.+.++. .+..+++|+.|++++|. +.+
T Consensus 153 ---------------------~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~ 211 (520)
T 2z7x_B 153 ---------------------EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS 211 (520)
T ss_dssp ---------------------SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHH
T ss_pred ---------------------cccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeec
Confidence 455666666655 344678889998876654 67889999999999998 777
Q ss_pred cCCCCccCCCCCCEEeccCCCCCCCCCcccc---cccCccEEEcccccccCcCChhh-----ccccccCEEeccCCcccC
Q 001873 310 AIPDELGSCTELTVVDFSDNLLTGSIPRSFG---NLLKLQELQLSVNQLSGTIPIEI-----ATCTALTHLEIDNNAISG 381 (1001)
Q Consensus 310 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~N~i~~ 381 (1001)
.+| .++.+++|+.|++++|.+++..+..+. ..++|++|++++|++.+.+|..+ ..+++|+.+++++|.+
T Consensus 212 ~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-- 288 (520)
T 2z7x_B 212 ILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-- 288 (520)
T ss_dssp HHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--
T ss_pred chh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--
Confidence 776 789999999999999988754332221 13466777777776666666555 4455555555555444
Q ss_pred ccCccccccCcccEEEeecCccCCCCC-cccccC---cccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCC
Q 001873 382 EIPADIGNINGLTLFFAWKNKLTGNIP-ESLSQC---QELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPP 457 (1001)
Q Consensus 382 ~~~~~~~~l~~L~~L~l~~n~l~~~~p-~~l~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 457 (1001)
.+| ..+..+ .+|+.|++++|.+.... .+..+++|++|++++|++++..|.
T Consensus 289 ------------------------~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~ 342 (520)
T 2z7x_B 289 ------------------------GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFE 342 (520)
T ss_dssp ------------------------CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTT
T ss_pred ------------------------ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhh
Confidence 223 233332 45777777777665321 125677788888888888887888
Q ss_pred CCCCCCCcceEEcccccccc--CCCcccCCCCCcceeeccCcccccCCcc-cccccccCceEEcccccCcccCCCCcccc
Q 001873 458 DIGNCTTLRRLRLNDNRLSG--TIPSEMGNLKHLNFVDMSENHLVGGIPP-SVVGCQSLEFLDLHSNGLTGSVPDTLPTS 534 (1001)
Q Consensus 458 ~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 534 (1001)
.+..+++|++|+|++|++++ .+|..++.+++|++|++++|++++.+|. .+..+++|++|++++|++++.+|..+++.
T Consensus 343 ~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~ 422 (520)
T 2z7x_B 343 NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR 422 (520)
T ss_dssp TCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCCTT
T ss_pred hhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhccc
Confidence 88888888888888888886 4567788999999999999999875665 47788999999999999987777766667
Q ss_pred cccccCCCCcCCCCcccccccccccceeeccCccccccchhh-hhccccccEEecccccccC
Q 001873 535 LQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAE-ILSCRKLILLDIGNNRFSG 595 (1001)
Q Consensus 535 l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~ 595 (1001)
++.|++++|+|+ .+|..+..+++|+.|++++|+|++ +|.. +..+++|++|++++|++++
T Consensus 423 L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c 482 (520)
T 2z7x_B 423 IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDC 482 (520)
T ss_dssp CCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCcc
Confidence 777777777777 555556677777777777777774 4443 6777777777777777764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=447.21 Aligned_cols=459 Identities=21% Similarity=0.208 Sum_probs=299.6
Q ss_pred cEEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceecccc
Q 001873 105 KRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDN 184 (1001)
Q Consensus 105 ~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n 184 (1001)
+++++++|+++ .+|..+. ++|++|||++|++++..|..|..+++|++|+|++|++++..|..++++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 45666677777 3666554 67777777777777666677777777777777777777666777777777777777777
Q ss_pred ccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCc
Q 001873 185 QLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIP 264 (1001)
Q Consensus 185 ~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip 264 (1001)
+++ .+|.. .+++|++|++++|+ +++ + .+|
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~-l~~-l----------------------------------------------~~p 139 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFND-FDV-L----------------------------------------------PVC 139 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSC-CSB-C----------------------------------------------CCC
T ss_pred cCC-ccCcc--ccccCCEEECCCCC-ccc-c----------------------------------------------Cch
Confidence 776 56655 56666666666552 221 0 122
Q ss_pred ccccCCCCCceEeeecCcccCCCCcccCCCCCC--cEEEcCCCcc--cccCCCCccCCC-CCCEEeccCCCCCCCCCc-c
Q 001873 265 EEIGNCSELQNLYLYQNSISGPIPGRIGALSKL--KSLLLWQNSL--VGAIPDELGSCT-ELTVVDFSDNLLTGSIPR-S 338 (1001)
Q Consensus 265 ~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~-~ 338 (1001)
..|+++++|++|+|++|++++. .+..+++| +.|++++|++ ++..|..+..+. ..-.+++++|.+.+.++. .
T Consensus 140 ~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~ 216 (562)
T 3a79_B 140 KEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS 216 (562)
T ss_dssp GGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEE
T ss_pred HhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhc
Confidence 3344444444444444444321 22222222 4444444444 444444443332 111334555555443332 3
Q ss_pred cccccCccEEEccccc-----ccCcCChhhccccccCEEeccCCcccCcc----CccccccCcccEEEeecCccCCCCCc
Q 001873 339 FGNLLKLQELQLSVNQ-----LSGTIPIEIATCTALTHLEIDNNAISGEI----PADIGNINGLTLFFAWKNKLTGNIPE 409 (1001)
Q Consensus 339 ~~~l~~L~~L~Ls~N~-----l~~~~p~~~~~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~l~~n~l~~~~p~ 409 (1001)
+..+++|+.|++++|+ +.+ ....+..+++|+.|+++++.+++.. +..+ ..++|+.|++++|+++|.+|.
T Consensus 217 ~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~ 294 (562)
T 3a79_B 217 VNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDR 294 (562)
T ss_dssp ESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCC
T ss_pred ccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccc
Confidence 4455556666666553 111 1224555566666666655554321 1111 124677777777777777777
Q ss_pred cc-----ccCcccceEeCcCccccCCCC-cccccc---cccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCC
Q 001873 410 SL-----SQCQELQALDFSYNNLSGPIP-KEIFGL---RNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIP 480 (1001)
Q Consensus 410 ~l-----~~l~~L~~L~Ls~N~l~~~~~-~~~~~l---~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 480 (1001)
.+ ..++.|+.++++.|.+ .+| ..+..+ .+|++|++++|.+.... ....+++|++|++++|++++.+|
T Consensus 295 ~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~ 370 (562)
T 3a79_B 295 EEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVF 370 (562)
T ss_dssp CCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTT
T ss_pred hhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchh
Confidence 66 6677777777777776 344 333332 56888888888876432 12678889999999999998888
Q ss_pred cccCCCCCcceeeccCcccccC--CcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccc
Q 001873 481 SEMGNLKHLNFVDMSENHLVGG--IPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTE 558 (1001)
Q Consensus 481 ~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~ 558 (1001)
..++++++|++|++++|++++. +|..+.++++|++|++++|++++.+|. ..+..+++
T Consensus 371 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~---------------------~~~~~l~~ 429 (562)
T 3a79_B 371 QGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYD---------------------RTCAWAES 429 (562)
T ss_dssp TTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSS---------------------CCCCCCTT
T ss_pred hhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccCh---------------------hhhcCccc
Confidence 8899999999999999999863 356788888899888888888754443 23556778
Q ss_pred cceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEec
Q 001873 559 LSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLS 638 (1001)
Q Consensus 559 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 638 (1001)
|+.|++++|++++.+|..+. ++|++|+|++|+++ .+|..+..+++|+. |+|++|+|++..+..|..+++|+.|+|+
T Consensus 430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~-L~L~~N~l~~l~~~~~~~l~~L~~L~l~ 505 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQE-LNVASNQLKSVPDGVFDRLTSLQYIWLH 505 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSE-EECCSSCCCCCCTTSTTTCTTCCCEECC
T ss_pred CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCE-EECCCCCCCCCCHHHHhcCCCCCEEEec
Confidence 88888888888876665544 68889999999888 77777778888886 9999999985444448899999999999
Q ss_pred CCcCCCChhhhhc
Q 001873 639 HNKLSGDLDALAS 651 (1001)
Q Consensus 639 ~N~l~~~~~~~~~ 651 (1001)
+|+++|+++..+.
T Consensus 506 ~N~~~c~c~~~~~ 518 (562)
T 3a79_B 506 DNPWDCTCPGIRY 518 (562)
T ss_dssp SCCBCCCHHHHHH
T ss_pred CCCcCCCcchHHH
Confidence 9999998875444
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=451.64 Aligned_cols=529 Identities=22% Similarity=0.220 Sum_probs=380.6
Q ss_pred EEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccc
Q 001873 106 RLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQ 185 (1001)
Q Consensus 106 ~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~ 185 (1001)
..+.++.+++ .+|+.+. +.+++||||+|+|++..|.+|.++++|++|||++|+|++..|..|++|++|++|+|++|+
T Consensus 35 ~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~ 111 (635)
T 4g8a_A 35 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 111 (635)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCc
Confidence 4567777888 7887664 478999999999997667789999999999999999997667789999999999999999
Q ss_pred cccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCcc
Q 001873 186 LSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPE 265 (1001)
Q Consensus 186 l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~ 265 (1001)
+++..|..|+++++|++|++++| .+++..+..++++++|++|++++|.+.+. .+|.
T Consensus 112 l~~l~~~~f~~L~~L~~L~Ls~N-~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~-----------------------~~~~ 167 (635)
T 4g8a_A 112 IQSLALGAFSGLSSLQKLVAVET-NLASLENFPIGHLKTLKELNVAHNLIQSF-----------------------KLPE 167 (635)
T ss_dssp CCEECGGGGTTCTTCCEEECTTS-CCCCSTTCCCTTCTTCCEEECCSSCCCCC-----------------------CCCG
T ss_pred CCCCCHHHhcCCCCCCEEECCCC-cCCCCChhhhhcCcccCeeccccCccccC-----------------------CCch
Confidence 99655667888888888888888 56654444566677777776666655431 2445
Q ss_pred cccCCCCCceEeeecCcccCCCCcccCCCCCC----cEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCC-CCcccc
Q 001873 266 EIGNCSELQNLYLYQNSISGPIPGRIGALSKL----KSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGS-IPRSFG 340 (1001)
Q Consensus 266 ~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L----~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~ 340 (1001)
.++++++|++|+|++|++++..+..|..+.++ ..++++.|.++...+..+ ....++.+++++|..... .+..+.
T Consensus 168 ~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~ 246 (635)
T 4g8a_A 168 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQ 246 (635)
T ss_dssp GGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHH
T ss_pred hhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhc
Confidence 55555566666666666655555555444333 245566666654333332 233455566666554422 123344
Q ss_pred cccCccEEEccccc------ccCcCChhhccccccCEEeccCCcccC---ccCccccccCcccEEEeecCccCCCCCccc
Q 001873 341 NLLKLQELQLSVNQ------LSGTIPIEIATCTALTHLEIDNNAISG---EIPADIGNINGLTLFFAWKNKLTGNIPESL 411 (1001)
Q Consensus 341 ~l~~L~~L~Ls~N~------l~~~~p~~~~~l~~L~~L~L~~N~i~~---~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l 411 (1001)
.+..++...+..+. +.......+..+..+...++..+.... ..+..+....+++.+.+.++.+.+.. .+
T Consensus 247 ~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~ 324 (635)
T 4g8a_A 247 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DF 324 (635)
T ss_dssp TTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GG
T ss_pred CCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--cc
Confidence 45555554443332 222223344445555555554443321 22334455566777777777665432 24
Q ss_pred ccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccc--cCCCcccCCCCCc
Q 001873 412 SQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLS--GTIPSEMGNLKHL 489 (1001)
Q Consensus 412 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L 489 (1001)
.....|+.|++++|.+.+..+ ..+..|+.+++..|.+... .....+++|+.|++++|.+. +..+..+..+.+|
T Consensus 325 ~~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L 399 (635)
T 4g8a_A 325 SYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISL 399 (635)
T ss_dssp GSCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCC
T ss_pred ccchhhhhhhcccccccCcCc---ccchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhh
Confidence 555677888888887765433 3456777888888877643 33456788888888888875 3456666778888
Q ss_pred ceeeccCcccccCCcccccccccCceEEcccccCcccCCCCcc---cccccccCCCCcCCCCcccccccccccceeeccC
Q 001873 490 NFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP---TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSK 566 (1001)
Q Consensus 490 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 566 (1001)
++++++.|.+.. .+..+..+++|+.++++.|+.....+.... ..++.+++++|.+++..+..+..++.|+.|+|++
T Consensus 400 ~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~ 478 (635)
T 4g8a_A 400 KYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 478 (635)
T ss_dssp CEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTT
T ss_pred hhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence 888888888874 456677888888899888887765554332 4556688999999888888899999999999999
Q ss_pred cccc-ccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCC
Q 001873 567 NQLS-GRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGD 645 (1001)
Q Consensus 567 N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 645 (1001)
|++. +..|..+..+++|++|||++|+|++.+|..|..+++|+. |+|++|+|++..|..|.++++|++|||++|+|++.
T Consensus 479 N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~-L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~ 557 (635)
T 4g8a_A 479 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV-LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 557 (635)
T ss_dssp CEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE-EECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBC
T ss_pred cccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCE-EECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCC
Confidence 9854 467889999999999999999999999999999999997 99999999999999999999999999999999995
Q ss_pred -hhhhhcc-cccceeEcccCCCCCCCCC
Q 001873 646 -LDALASL-QNLVSLNVSFNDFSGELPN 671 (1001)
Q Consensus 646 -~~~~~~l-~~L~~L~ls~N~l~~~~p~ 671 (1001)
+..+..+ ++|++|+|++|++.+.|.-
T Consensus 558 ~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 558 KKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp CSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred CHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 4567777 6899999999999998874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=397.66 Aligned_cols=200 Identities=21% Similarity=0.346 Sum_probs=180.1
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC-----CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS-----SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||+||+|+.+ +++.||||++.. ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999975 699999999853 334467999999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
|||+||+|.+++++. ..+++..+..++.||+.|++|||++ +|+||||||+|||++.++++||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999999874 3589999999999999999999999 99999999999999999999999999999875332
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.
T Consensus 187 ~-----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 187 K-----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp T-----CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C-----cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 22334568999999999999999999999999999999999999999764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=406.71 Aligned_cols=200 Identities=25% Similarity=0.359 Sum_probs=174.1
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
++|++.+.||+|+||+||+|++. +|+.||||++.... ..+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 58999999999999999999975 69999999986443 23578999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
||+||+|.+++...+...+++..+..|+.||+.||+|||++ +||||||||+|||++++|++||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-- 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence 99999999999876666689999999999999999999998 9999999999999999999999999999875321
Q ss_pred CCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.
T Consensus 179 -----~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 228 (350)
T 4b9d_A 179 -----VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228 (350)
T ss_dssp -----HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -----cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 11223468999999999999999999999999999999999999999864
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=437.43 Aligned_cols=453 Identities=20% Similarity=0.190 Sum_probs=334.1
Q ss_pred EEEEeccccccccCCcccccCCCCcEEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCC
Q 001873 81 VEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTN 160 (1001)
Q Consensus 81 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n 160 (1001)
..++++++++++ +|..+. ++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+.+++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 566778888886 676554 79999999999999888889999999999999999999888999999999999999999
Q ss_pred cccCCCCccccCCccccceecccccccc-ccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhcccccccccccc
Q 001873 161 LLEGEIPSDIGNLSSLAYLTLYDNQLSG-KIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNV 239 (1001)
Q Consensus 161 ~l~~~ip~~l~~L~~L~~L~L~~n~l~g-~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~ 239 (1001)
+++ .+|.. .+++|++|+|++|++++ .+|..++++++|++|++++|. +++. .+..
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~-l~~~---~~~~------------------ 165 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAK-FRQL---DLLP------------------ 165 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSB-CCTT---TTGG------------------
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCc-cccC---chhh------------------
Confidence 999 78877 89999999999999996 456889999888888888872 2210 1111
Q ss_pred CCccccccccceeccccccccccCcccccCCCCCceEeeecCcc--cCCCCcccCCCC-CCcEEEcCCCcccccCCC-Cc
Q 001873 240 PSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSI--SGPIPGRIGALS-KLKSLLLWQNSLVGAIPD-EL 315 (1001)
Q Consensus 240 p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i--~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~-~l 315 (1001)
+.++ +|++|++++|.+ ++..|..+..+. +.-.+++++|.+.+.+++ .+
T Consensus 166 ---------------------------l~~L-~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~ 217 (562)
T 3a79_B 166 ---------------------------VAHL-HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217 (562)
T ss_dssp ---------------------------GTTS-CEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEE
T ss_pred ---------------------------hhhc-eeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcc
Confidence 1111 225555555555 555555555443 111345556665554443 23
Q ss_pred cCCCCCCEEeccCCC-----CCCCCCcccccccCccEEEcccccccCcCChh---hccccccCEEeccCCcccCccCccc
Q 001873 316 GSCTELTVVDFSDNL-----LTGSIPRSFGNLLKLQELQLSVNQLSGTIPIE---IATCTALTHLEIDNNAISGEIPADI 387 (1001)
Q Consensus 316 ~~l~~L~~L~Ls~N~-----l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~---~~~l~~L~~L~L~~N~i~~~~~~~~ 387 (1001)
..+++|+.|++++|. +.+. ...|..+++|+.|+++++.+.+..... ....++|++|++++|.++|.+|..+
T Consensus 218 ~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~ 296 (562)
T 3a79_B 218 NALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREE 296 (562)
T ss_dssp SSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCC
T ss_pred cccceEEEecccccccccchHHHH-HHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchh
Confidence 456666666666664 1211 224566677777777777665321111 1223478888888888888888777
Q ss_pred -----cccCcccEEEeecCccCCCCC-ccccc---CcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCC
Q 001873 388 -----GNINGLTLFFAWKNKLTGNIP-ESLSQ---CQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPD 458 (1001)
Q Consensus 388 -----~~l~~L~~L~l~~n~l~~~~p-~~l~~---l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 458 (1001)
.+++.|+.+++..|.+ .+| ..+.. ..+|+.|++++|.+.... ....+++|++|++++|++++.+|..
T Consensus 297 ~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~ 372 (562)
T 3a79_B 297 FTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQG 372 (562)
T ss_dssp CCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTT
T ss_pred hhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhh
Confidence 7777777888877777 344 23322 257999999999886322 1267899999999999999989999
Q ss_pred CCCCCCcceEEccccccccC--CCcccCCCCCcceeeccCcccccCCcc-cccccccCceEEcccccCcccCCCCccccc
Q 001873 459 IGNCTTLRRLRLNDNRLSGT--IPSEMGNLKHLNFVDMSENHLVGGIPP-SVVGCQSLEFLDLHSNGLTGSVPDTLPTSL 535 (1001)
Q Consensus 459 l~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l 535 (1001)
+..+++|++|+|++|++++. +|..+.++++|++|++++|++++.+|. .+..+++|++|++++|++++.+|..+++.+
T Consensus 373 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~~L 452 (562)
T 3a79_B 373 CSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKV 452 (562)
T ss_dssp CCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCCTTC
T ss_pred hcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhcCcC
Confidence 99999999999999999963 356799999999999999999985554 588899999999999999988877776677
Q ss_pred ccccCCCCcCCCCcccccccccccceeeccCccccccchhh-hhccccccEEecccccccCC
Q 001873 536 QLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAE-ILSCRKLILLDIGNNRFSGE 596 (1001)
Q Consensus 536 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~ 596 (1001)
+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++ +|.. +..+++|+.|++++|++++.
T Consensus 453 ~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~ 512 (562)
T 3a79_B 453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCT 512 (562)
T ss_dssp SEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred CEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCC
Confidence 77888888777 455555577777777777777773 4444 77777777777777777643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=399.57 Aligned_cols=197 Identities=27% Similarity=0.399 Sum_probs=178.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC--CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS--SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
+.|+..++||+|+||+||+|+++ +|+.||||++.. ....+.+.+|+.++++++|||||++++++.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56888999999999999999975 699999999853 234467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
+||+|.+++++ ..+++..+..++.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--- 224 (346)
T 4fih_A 154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--- 224 (346)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS---
T ss_pred CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC---
Confidence 99999999975 3489999999999999999999999 99999999999999999999999999998764321
Q ss_pred CCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus 225 ----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 273 (346)
T 4fih_A 225 ----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 273 (346)
T ss_dssp ----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ----CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 2234568999999999999999999999999999999999999999764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=413.29 Aligned_cols=424 Identities=25% Similarity=0.308 Sum_probs=233.0
Q ss_pred cccccceEEccCCcccCCCCccccCCccccceeccccccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchh
Q 001873 148 RLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVM 227 (1001)
Q Consensus 148 ~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~ 227 (1001)
..++|++|++++|.+ |.+|+++++|++|++|++++|.++|.+|.+++++++|+.++++.|. ..++++
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~------------~~~l~~ 75 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL------------DRQAHE 75 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHH------------HHTCSE
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhh------------ccCCCE
Confidence 457788888888888 6888888888888888888888888888888888888888887772 134555
Q ss_pred ccccccccccccCCccccccccceeccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcc
Q 001873 228 LGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSL 307 (1001)
Q Consensus 228 L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l 307 (1001)
|++++|.+++ +|.. .++|++|++++|.+++ +|.. +++|++|++++|++
T Consensus 76 L~l~~~~l~~-------------------------lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l 123 (454)
T 1jl5_A 76 LELNNLGLSS-------------------------LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNL 123 (454)
T ss_dssp EECTTSCCSC-------------------------CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCC
T ss_pred EEecCCcccc-------------------------CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCcc
Confidence 5555555442 2221 2456666666666665 4432 25666666666666
Q ss_pred cccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccc
Q 001873 308 VGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADI 387 (1001)
Q Consensus 308 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~ 387 (1001)
++ +|.. .++|++|++++|++++ +| .|+++++|++|++++|++++ +|..+ .+|++|++++|++++ +| .+
T Consensus 124 ~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~ 191 (454)
T 1jl5_A 124 KA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-EL 191 (454)
T ss_dssp SC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CC
T ss_pred Cc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cc
Confidence 63 2221 1466666777666664 55 46666667777777766664 34322 466777777777665 44 46
Q ss_pred cccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcce
Q 001873 388 GNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRR 467 (1001)
Q Consensus 388 ~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 467 (1001)
+++++|+.|++++|++++ +|... ++|++|++++|+++ .+| .+..+++|++|++++|++++ +|.. +++|+.
T Consensus 192 ~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~ 261 (454)
T 1jl5_A 192 QNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEA 261 (454)
T ss_dssp TTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCE
T ss_pred cCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCE
Confidence 666777777777777664 33322 46777888888777 455 37777888888888888775 3332 367888
Q ss_pred EEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCC
Q 001873 468 LRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSG 547 (1001)
Q Consensus 468 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~ 547 (1001)
|++++|++++ +|.. .++|++|++++|++++. |.. .++|++|++++|++++ ++ .++..++.|++++|++++
T Consensus 262 L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~-~~~~~L~~L~Ls~N~l~~ 331 (454)
T 1jl5_A 262 LNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC-DLPPSLEELNVSNNKLIE 331 (454)
T ss_dssp EECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC-CCCTTCCEEECCSSCCSC
T ss_pred EECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-cc-CCcCcCCEEECCCCcccc
Confidence 8888888875 4543 36788888888888752 211 2578888888888875 33 244577788888888886
Q ss_pred CcccccccccccceeeccCccccccchhhhhccccccEEecccccccC--CCCCccccccchhhhhhcCCCccccccccc
Q 001873 548 SLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSG--EIPKELGQISSLEISLNLSSNQFSGEIPSE 625 (1001)
Q Consensus 548 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~ 625 (1001)
+|.. +++|+.|++++|+++ .+|. .+++|++|++++|++++ .+|..++ +|+.|.+.+.+|..
T Consensus 332 -lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~---------~L~~n~~~~~i~~~ 394 (454)
T 1jl5_A 332 -LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVE---------DLRMNSHLAEVPEL 394 (454)
T ss_dssp -CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCC---------EEECCC--------
T ss_pred -cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHH---------hhhhcccccccccc
Confidence 4433 578889999999888 4555 46889999999999987 6676654 33456677777763
Q ss_pred ccccccccEEEecCCcCCCChhhhhcccccceeEcccCCCCCCCCC
Q 001873 626 FSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPN 671 (1001)
Q Consensus 626 ~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p~ 671 (1001)
+++|+.||+++|++++.+.. -++++.|.+.+|.+.+.+|.
T Consensus 395 ---~~~L~~L~ls~N~l~~~~~i---P~sl~~L~~~~~~~~~~~~~ 434 (454)
T 1jl5_A 395 ---PQNLKQLHVETNPLREFPDI---PESVEDLRMNSERVVDPYEF 434 (454)
T ss_dssp ----------------------------------------------
T ss_pred ---cCcCCEEECCCCcCCccccc---hhhHhheeCcCcccCCcccc
Confidence 57888889999988863211 13567777888887776653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=395.48 Aligned_cols=203 Identities=24% Similarity=0.423 Sum_probs=175.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc--hhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE--SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
++|.+.+.||+|+||+||+|++. ++..||||++..... .++|.+|++++++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46788899999999999999864 467899999965443 3679999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEE
Q 001873 838 FYDYLPNGSLSSLLHGAG-----------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYL 906 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki 906 (1001)
|||||++|+|.+++++.+ ...+++.++.+|+.|||+||+|||++ +||||||||+|||+++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999997643 34689999999999999999999998 9999999999999999999999
Q ss_pred ecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 907 ADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 907 ~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
+|||+|+....... ........||++|||||++.+..|+.++|||||||++|||+| |+.||....
T Consensus 170 ~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 170 GDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp CCCSCHHHHTGGGC-----EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CCcccceecCCCCc-----eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999987643211 112233469999999999999999999999999999999999 899998753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=397.61 Aligned_cols=203 Identities=30% Similarity=0.339 Sum_probs=174.1
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccC
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
...|+..++||+|+||+||+|+++ +|+.||||++..+.. ..+|+.++++++|||||++++++.+++..|+|||||+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 356788889999999999999975 699999999965432 3579999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC-cEEEecccccccccCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY-QAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~Dfgla~~~~~~~~~~ 922 (1001)
||+|.+++++. ..+++..+..++.||+.||+|||++ +||||||||+|||++.+| ++||+|||+|+.+.......
T Consensus 134 gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 134 GGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp TCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999999874 3489999999999999999999998 999999999999999887 69999999999875432211
Q ss_pred CCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
........+||+.|||||++.+..|+.++||||+||++|||+||+.||.....
T Consensus 209 --~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 261 (336)
T 4g3f_A 209 --SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred --ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 11122345899999999999999999999999999999999999999987543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=393.27 Aligned_cols=203 Identities=24% Similarity=0.332 Sum_probs=176.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
..+++.++||+|+||+||+|++. +++.||||++.... ..++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 35677889999999999999863 46789999986433 2468999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC
Q 001873 837 LFYDYLPNGSLSSLLHGAG--------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY 902 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 902 (1001)
+|||||++|+|.++++... ...+++..+.+|+.|||+||+|||++ +||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 9999999999999997532 23478999999999999999999998 999999999999999999
Q ss_pred cEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 903 QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 903 ~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
++||+|||+|+.+..... .......+||++|||||++.+..|+.++|||||||++|||+| |+.||.+..
T Consensus 183 ~~Ki~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp CEEECCSCCBCGGGGGGC-----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred CEEECCcccceeccCCCc-----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 999999999987654321 122334579999999999999999999999999999999998 899998754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=402.19 Aligned_cols=198 Identities=27% Similarity=0.393 Sum_probs=179.3
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC--CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS--DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
.+.|+..++||+|+||+||+|+++ +|+.||||++... ...+.+.+|+.+|++++|||||++++++.+++..|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 467999999999999999999975 6999999998543 3446799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
|+||+|.++++. ..+++..+..++.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-- 301 (423)
T 4fie_A 230 LEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 301 (423)
T ss_dssp CTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred CCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence 999999999975 3489999999999999999999999 99999999999999999999999999998764321
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus 302 -----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 350 (423)
T 4fie_A 302 -----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 350 (423)
T ss_dssp -----CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -----ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 2334568999999999999999999999999999999999999999764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=394.72 Aligned_cols=203 Identities=28% Similarity=0.451 Sum_probs=169.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc--hhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE--SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
++|.+.++||+|+||+||+|+++ +++.||||++..... .++|.+|++++++++|||||+++|+|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35677789999999999999864 478899999975443 3679999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcE
Q 001873 838 FYDYLPNGSLSSLLHGAGK-------------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQA 904 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 904 (1001)
|||||++|+|.+++++.+. ..+++.++.+|+.|||+||+|||++ +||||||||+|||+++++++
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 9999999999999976432 3579999999999999999999998 99999999999999999999
Q ss_pred EEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 905 YLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 905 ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
||+|||+|+.+..... .......+||++|||||++.+..|+.++|||||||++|||+| |+.||....
T Consensus 198 Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp EECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred EEcccccceeccCCCc-----ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 9999999987643321 112234579999999999999999999999999999999999 899998653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=395.43 Aligned_cols=291 Identities=29% Similarity=0.485 Sum_probs=197.5
Q ss_pred CcHHHHHHHHHHHHhCCCCCCccCCCCCCCCCCCc--cceEEeCCC---CcEEEEEeccccccc--cCCcccccCCCCcE
Q 001873 34 ALDEQGQALLTWKNSLNSSTDALSSWNPAETSPCK--WFGIHCSSN---GEVVEISLKAVDLQG--SLPSIFQPLKSLKR 106 (1001)
Q Consensus 34 ~~~~~~~aLl~~k~~~~~~~~~l~sW~~~~~~~c~--w~gv~c~~~---~~v~~l~l~~~~l~~--~~~~~~~~l~~L~~ 106 (1001)
|.++|++||++||+++.||. .+++|+. +.+||. |.||+|+.. ++|+++++.++.+.| .+|+.+..+++|++
T Consensus 3 c~~~~~~aL~~~k~~~~~~~-~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~ 80 (313)
T 1ogq_A 3 CNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHhcCCcc-cccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCe
Confidence 56889999999999998876 8999985 679998 999999843 789987777777766 66666666666666
Q ss_pred EeccC-CcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccc
Q 001873 107 LIISS-CNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQ 185 (1001)
Q Consensus 107 L~l~~-~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~ 185 (1001)
|+|++ |++++.+|+.|+++++|++|+|++|++++.+|..|+.+++|++|+|++|.+++.+|..++++++|++|+|++|.
T Consensus 81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc
Confidence 66663 66666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred cccccCCCccchh-hhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCc
Q 001873 186 LSGKIPKSIGALS-KLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIP 264 (1001)
Q Consensus 186 l~g~~p~~~~~l~-~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip 264 (1001)
++|.+|..++.++ +|++|++++| .+++.+|
T Consensus 161 l~~~~p~~l~~l~~~L~~L~L~~N-------------------------------------------------~l~~~~~ 191 (313)
T 1ogq_A 161 ISGAIPDSYGSFSKLFTSMTISRN-------------------------------------------------RLTGKIP 191 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSS-------------------------------------------------EEEEECC
T ss_pred ccCcCCHHHhhhhhcCcEEECcCC-------------------------------------------------eeeccCC
Confidence 6655555554443 3333333333 3344455
Q ss_pred ccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccC
Q 001873 265 EEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLK 344 (1001)
Q Consensus 265 ~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 344 (1001)
..++.++ |++|+|++|.+++..|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..|..+++
T Consensus 192 ~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 269 (313)
T 1ogq_A 192 PTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269 (313)
T ss_dssp GGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTT
T ss_pred hHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcC
Confidence 5555555 66666666666666666666666777777777766655544 566667777777777776666666767777
Q ss_pred ccEEEcccccccCcCChhhccccccCEEeccCCc
Q 001873 345 LQELQLSVNQLSGTIPIEIATCTALTHLEIDNNA 378 (1001)
Q Consensus 345 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 378 (1001)
|++|+|++|++++.+|.. ..+++|+.|++++|+
T Consensus 270 L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 270 LHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp CCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred CCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 777777777776666654 666667777777666
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=388.52 Aligned_cols=199 Identities=31% Similarity=0.453 Sum_probs=167.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+++++.++||+|+||+||+|+++ ..||||+++... ..++|.+|+.++++++|||||+++|++.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 46778889999999999999975 469999986432 23679999999999999999999999865 467999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
|++|+|.++++.. ...+++..+.+|+.|||+||+|||++ +||||||||+|||+++++++||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~- 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG- 187 (307)
T ss_dssp CSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc-
Confidence 9999999999764 34589999999999999999999998 999999999999999999999999999987643211
Q ss_pred CCCCCCCCCcccccccccCcccccc---CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASM---QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+..
T Consensus 188 ----~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 188 ----SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ----ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 122344589999999999853 468999999999999999999999998643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=390.09 Aligned_cols=198 Identities=28% Similarity=0.321 Sum_probs=170.1
Q ss_pred hcccCCCeEeecCCeeEEEEEeC----CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP----NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
++|++.+.||+|+||+||+|+.. .++.||||++.... ....+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 47899999985432 23568899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
|||||+||+|.+++++. ..+++..+..++.||+.||+|||++ +|+||||||+|||++++|++||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999874 3589999999999999999999998 999999999999999999999999999986532
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.
T Consensus 179 ~-------~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 179 H-------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp ---------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C-------CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 2 12234568999999999999999999999999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=379.72 Aligned_cols=197 Identities=27% Similarity=0.383 Sum_probs=163.2
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ..+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999965 69999999985432 235789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+ +|+|.+++.+. ..+++..+..++.||+.|++|||++ +|+||||||+|||+++++++||+|||+|+.....
T Consensus 92 mEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 9999 68999999874 4589999999999999999999999 9999999999999999999999999999875322
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRI-TEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......+||+.|||||++.+..| +.++||||+||++|||+||+.||.+.
T Consensus 166 --------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 166 --------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp -----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 22345689999999999988776 58999999999999999999999764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=382.36 Aligned_cols=193 Identities=26% Similarity=0.374 Sum_probs=167.3
Q ss_pred ccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeec----CCceEEE
Q 001873 768 LTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSN----KNLKLLF 838 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~----~~~~~lv 838 (1001)
|+..++||+|+||+||+|.+. +++.||||++.... ..+.|.+|++++++++|||||++++++.+ ++..++|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 356678999999999999975 68999999985432 23578999999999999999999998864 3467999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEeCCCCCCeEEC-CCCcEEEecccccccc
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPP--ILHGDVKAMNVLLG-PGYQAYLADFGLARIV 915 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NIll~-~~~~~ki~Dfgla~~~ 915 (1001)
||||+||+|.+++++. ..+++..+..++.||+.||+|||++ + ||||||||+|||++ .++++||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 9999999999999864 4589999999999999999999997 6 99999999999998 5799999999999863
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.. ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||...
T Consensus 183 ~~---------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 183 RA---------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp CT---------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CC---------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 21 22345689999999999865 6999999999999999999999999754
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=407.89 Aligned_cols=424 Identities=24% Similarity=0.291 Sum_probs=188.3
Q ss_pred CCCCcEEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCcccccee
Q 001873 101 LKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLT 180 (1001)
Q Consensus 101 l~~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~ 180 (1001)
.++|++|++++|++ |.+|++|+++++|++|++++|++.|.+|.+++.+++|++++++.|.. .+|++|+
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~ 77 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELE 77 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEE
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEE
Confidence 35555666666666 56666666666666666666666666666666555553333333321 2234444
Q ss_pred ccccccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceecccccccc
Q 001873 181 LYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLS 260 (1001)
Q Consensus 181 L~~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~ 260 (1001)
+++|.+++ +|.. .++|++|++++| .+.+ +|.. +.+|++|++++|.++
T Consensus 78 l~~~~l~~-lp~~---~~~L~~L~l~~n-------------------------~l~~-lp~~---~~~L~~L~l~~n~l~ 124 (454)
T 1jl5_A 78 LNNLGLSS-LPEL---PPHLESLVASCN-------------------------SLTE-LPEL---PQSLKSLLVDNNNLK 124 (454)
T ss_dssp CTTSCCSC-CCSC---CTTCSEEECCSS-------------------------CCSS-CCCC---CTTCCEEECCSSCCS
T ss_pred ecCCcccc-CCCC---cCCCCEEEccCC-------------------------cCCc-cccc---cCCCcEEECCCCccC
Confidence 44444442 2221 123344444433 3332 2221 133344444444444
Q ss_pred ccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccc
Q 001873 261 GPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFG 340 (1001)
Q Consensus 261 g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 340 (1001)
+ +|.. .++|++|++++|++++ +| .|+++++|++|++++|++++ +|..+ .+|++|++++|++++ +| .|+
T Consensus 125 ~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~ 192 (454)
T 1jl5_A 125 A-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQ 192 (454)
T ss_dssp C-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCT
T ss_pred c-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-ccc
Confidence 2 2211 1456666666666664 44 46666666666666666663 44432 356666666666664 44 466
Q ss_pred cccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceE
Q 001873 341 NLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQAL 420 (1001)
Q Consensus 341 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L 420 (1001)
++++|++|++++|++++ +|.. .++|++|++++|+++ .+| .++.+++|+.|++++|++++ +|.. .++|+.|
T Consensus 193 ~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L 262 (454)
T 1jl5_A 193 NLPFLTAIYADNNSLKK-LPDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEAL 262 (454)
T ss_dssp TCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEE
T ss_pred CCCCCCEEECCCCcCCc-CCCC---cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEE
Confidence 66666666666666664 3322 146666666666666 444 36666666666666666664 3332 2566667
Q ss_pred eCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCC-CCcceeeccCccc
Q 001873 421 DFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNL-KHLNFVDMSENHL 499 (1001)
Q Consensus 421 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l 499 (1001)
++++|++++ +|.. .++|++|++++|++++. |.. .++|+.|++++|++++ ++ .+ ++|++|++++|++
T Consensus 263 ~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l 329 (454)
T 1jl5_A 263 NVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKL 329 (454)
T ss_dssp ECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCC
T ss_pred ECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcc
Confidence 777776664 3332 25667777777766652 111 1466777777777664 22 22 4677777777777
Q ss_pred ccCCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCC--CcccccccccccceeeccCccccccchhhh
Q 001873 500 VGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSG--SLAHSIGSLTELSKLLLSKNQLSGRIPAEI 577 (1001)
Q Consensus 500 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 577 (1001)
++ +|.. +++|++|++++|+++ .+|. ....++.|++++|++++ .+|..+.. |+.|.+.+.+|..
T Consensus 330 ~~-lp~~---~~~L~~L~L~~N~l~-~lp~-~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~- 394 (454)
T 1jl5_A 330 IE-LPAL---PPRLERLIASFNHLA-EVPE-LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL- 394 (454)
T ss_dssp SC-CCCC---CTTCCEEECCSSCCS-CCCC-CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC---------
T ss_pred cc-cccc---CCcCCEEECCCCccc-cccc-hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc-
Confidence 64 4433 466777777777776 3444 45666667777777776 44544432 2345555555553
Q ss_pred hccccccEEecccccccC--CCCCccccccchhhhhhcCCCcccccccccccc
Q 001873 578 LSCRKLILLDIGNNRFSG--EIPKELGQISSLEISLNLSSNQFSGEIPSEFSG 628 (1001)
Q Consensus 578 ~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~ 628 (1001)
+++|+.||+++|++++ .+|..+ + .|.+++|.+.+..|.....
T Consensus 395 --~~~L~~L~ls~N~l~~~~~iP~sl------~-~L~~~~~~~~~~~~~~~~~ 438 (454)
T 1jl5_A 395 --PQNLKQLHVETNPLREFPDIPESV------E-DLRMNSERVVDPYEFAHET 438 (454)
T ss_dssp -----------------------------------------------------
T ss_pred --cCcCCEEECCCCcCCccccchhhH------h-heeCcCcccCCccccCHHH
Confidence 4678888888888876 555443 3 2666777777666654443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=405.66 Aligned_cols=364 Identities=20% Similarity=0.172 Sum_probs=186.3
Q ss_pred CCCcEEeccCCcccCCCCcccCCccccccccccCCccCCCC-ChhhhcccccceEEccCCcccCCCCccccCCcccccee
Q 001873 102 KSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEI-PTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLT 180 (1001)
Q Consensus 102 ~~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~-p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~ 180 (1001)
++|++|+|++|++++..|..|+++++|++|+|++|.+.+.+ |..|..+++|++|+|++|++++..|..++++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 45666666666666555556666666666666666655444 33455666666666666666555555566666666666
Q ss_pred ccccccccccCCC--ccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceecccccc
Q 001873 181 LYDNQLSGKIPKS--IGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSL 258 (1001)
Q Consensus 181 L~~n~l~g~~p~~--~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~ 258 (1001)
|++|.+++.+|.. ++.+++|++|++++ |.
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~-------------------------------------------------n~ 140 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRD-------------------------------------------------NN 140 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCS-------------------------------------------------SB
T ss_pred CCCCCCCccccCcccccCcccCCEEECCC-------------------------------------------------Cc
Confidence 6665555433222 22222222222222 22
Q ss_pred ccccCccc-ccCCCCCceEeeecCcccCCCCcccCCC--CCCcEEEcCCCcccccCCCCc--------cCCCCCCEEecc
Q 001873 259 LSGPIPEE-IGNCSELQNLYLYQNSISGPIPGRIGAL--SKLKSLLLWQNSLVGAIPDEL--------GSCTELTVVDFS 327 (1001)
Q Consensus 259 l~g~ip~~-l~~l~~L~~L~L~~N~i~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~l--------~~l~~L~~L~Ls 327 (1001)
+++..|.. ++++++|++|++++|++++..|..+..+ .+|+.|++++|.+.+..+..+ ..+++|+.|+++
T Consensus 141 l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls 220 (455)
T 3v47_A 141 IKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLS 220 (455)
T ss_dssp CCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECT
T ss_pred cCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecC
Confidence 33333333 5556666666666666666555555554 455666666666554333222 233445555555
Q ss_pred CCCCCCCCCcccccc---cCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCcccccc--CcccEEEeecCc
Q 001873 328 DNLLTGSIPRSFGNL---LKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNI--NGLTLFFAWKNK 402 (1001)
Q Consensus 328 ~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l--~~L~~L~l~~n~ 402 (1001)
+|.+++..|..+... .+|+.|++++|.+.+.. +..+.+.+..+..+..+ ++|+.|++++|+
T Consensus 221 ~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~ 286 (455)
T 3v47_A 221 GNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSK 286 (455)
T ss_dssp TSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSC
T ss_pred CCcccccchhhhhccccccceeeEeeccccccccc--------------cchhhhccCcccccccccccCceEEEecCcc
Confidence 555544444433332 44444444444433210 01111111111222222 345555555555
Q ss_pred cCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcc
Q 001873 403 LTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSE 482 (1001)
Q Consensus 403 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 482 (1001)
+++..|..+..+++|++|++++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..|..
T Consensus 287 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 366 (455)
T 3v47_A 287 IFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQS 366 (455)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTT
T ss_pred ccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhh
Confidence 55555555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred cCCCCCcceeeccCcccccCCcccccccccCceEEcccccCcccCC
Q 001873 483 MGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVP 528 (1001)
Q Consensus 483 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 528 (1001)
|.++++|++|++++|++++..+..+..+++|++|++++|++++..|
T Consensus 367 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 367 FLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 5555555555555555555444445555555555555555554443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=384.78 Aligned_cols=206 Identities=29% Similarity=0.354 Sum_probs=167.4
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCch-hhHHHHHHHhhccCCCceeeEEeeeecCC----ceEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDES-GAFSSEIQTLGSIRHKNIVRLLGWGSNKN----LKLLFY 839 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~----~~~lv~ 839 (1001)
.++|.+.++||+|+||+||+|++ +|+.||||++...... ..+++|+..+.+++|||||++++++.+++ ..++||
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 35688889999999999999998 5899999998654432 22345666677899999999999987654 579999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC-----MPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
|||++|+|.++++.. .+++..+.+++.|++.||+|||+++ .++||||||||+|||++.++++||+|||+|+.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999853 4899999999999999999999862 35899999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccccC------CCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ------RITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
........ .......+||++|||||++.+. .|+.++|||||||++|||+||+.||.....
T Consensus 158 ~~~~~~~~---~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~ 223 (303)
T 3hmm_A 158 HDSATDTI---DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223 (303)
T ss_dssp EETTTTEE---SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred ccCCCCce---eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccc
Confidence 75432211 1223345899999999998654 467899999999999999999887765443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=397.21 Aligned_cols=384 Identities=17% Similarity=0.236 Sum_probs=294.7
Q ss_pred CceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCC-CcccccccCccEEEcc
Q 001873 273 LQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSI-PRSFGNLLKLQELQLS 351 (1001)
Q Consensus 273 L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls 351 (1001)
-+.++.+++.++ .+|. +. ++|++|+|++|++++..|..|+++++|++|++++|.+.+.+ +..|.++++|++|+|+
T Consensus 12 ~~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls 87 (455)
T 3v47_A 12 GYNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87 (455)
T ss_dssp TTEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred ccccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence 346788888887 4555 32 78999999999999888889999999999999999987555 5678899999999999
Q ss_pred cccccCcCChhhccccccCEEeccCCcccCccCcc--ccccCcccEEEeecCccCCCCCcc-cccCcccceEeCcCcccc
Q 001873 352 VNQLSGTIPIEIATCTALTHLEIDNNAISGEIPAD--IGNINGLTLFFAWKNKLTGNIPES-LSQCQELQALDFSYNNLS 428 (1001)
Q Consensus 352 ~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~--~~~l~~L~~L~l~~n~l~~~~p~~-l~~l~~L~~L~Ls~N~l~ 428 (1001)
+|++++..|..|.++++|++|++++|++++..+.. ++.+++|+.|++++|++++..|.. +..+++|++|++++|+++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~ 167 (455)
T 3v47_A 88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167 (455)
T ss_dssp TCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred CCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence 99998888888999999999999999998755544 777788888888888887776665 677778888888888877
Q ss_pred CCCCcccccc--cccceEEccCCcCCCCCCCCC--------CCCCCcceEEccccccccCCCcccCCC---CCcceeecc
Q 001873 429 GPIPKEIFGL--RNLTKLLLLSNDLSGFIPPDI--------GNCTTLRRLRLNDNRLSGTIPSEMGNL---KHLNFVDMS 495 (1001)
Q Consensus 429 ~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~l--------~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls 495 (1001)
+..+..+..+ .+|+.|++++|.+.+..+..+ ..+++|++|++++|++++..|..+..+ ++|+.|+++
T Consensus 168 ~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~ 247 (455)
T 3v47_A 168 SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS 247 (455)
T ss_dssp CCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECT
T ss_pred ccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeec
Confidence 7777776665 567777777777775544432 244566666666666665555544332 556666666
Q ss_pred CcccccCCcccccccccCceEEcccccCcccCCCCc----ccccccccCCCCcCCCCcccccccccccceeeccCccccc
Q 001873 496 ENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTL----PTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSG 571 (1001)
Q Consensus 496 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 571 (1001)
+|.+.+... ..+.+.+..+..+ ...++.|++++|++++..|..|+.+++|+.|+|++|++++
T Consensus 248 ~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 313 (455)
T 3v47_A 248 NSYNMGSSF--------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK 313 (455)
T ss_dssp TCTTTSCCT--------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCE
T ss_pred ccccccccc--------------chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccc
Confidence 665443211 1111111111111 1457778888888888888888899999999999999998
Q ss_pred cchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCChh-hhh
Q 001873 572 RIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLD-ALA 650 (1001)
Q Consensus 572 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~ 650 (1001)
..|..+..+++|++|+|++|++++..|..+..+++|+. |+|++|++++..|..|.++++|++|+|++|++++.++ .+.
T Consensus 314 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~-L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 392 (455)
T 3v47_A 314 IDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEV-LDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFD 392 (455)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCE-EECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred cChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCE-EECCCCcccccChhhccccccccEEECCCCccccCCHhHhc
Confidence 88888999999999999999998888888999999996 9999999998889899999999999999999998654 568
Q ss_pred cccccceeEcccCCCCCCCCCCccc
Q 001873 651 SLQNLVSLNVSFNDFSGELPNTPFF 675 (1001)
Q Consensus 651 ~l~~L~~L~ls~N~l~~~~p~~~~~ 675 (1001)
.+++|++|++++|++++.||....+
T Consensus 393 ~l~~L~~L~l~~N~l~~~~~~~~~l 417 (455)
T 3v47_A 393 RLTSLQKIWLHTNPWDCSCPRIDYL 417 (455)
T ss_dssp TCTTCCEEECCSSCBCCCTTTTHHH
T ss_pred cCCcccEEEccCCCcccCCCcchHH
Confidence 8999999999999999999865443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=373.98 Aligned_cols=204 Identities=21% Similarity=0.398 Sum_probs=160.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCC-------
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKN------- 833 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~------- 833 (1001)
..+|++.+.||+|+||+||+|+++ +|+.||||++..... .+.+.+|++++++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 457999999999999999999975 699999999864332 257889999999999999999999886543
Q ss_pred -----ceEEEEEccCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEe
Q 001873 834 -----LKLLFYDYLPNGSLSSLLHGAGK-GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLA 907 (1001)
Q Consensus 834 -----~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~ 907 (1001)
..|+|||||++|+|.++++.... ...++..+..++.||+.|++|||++ +||||||||+|||++.++++||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 36899999999999999986533 2346677889999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCCCCC-----CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 908 DFGLARIVSGSGDDNCS-----KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 908 Dfgla~~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
|||+|+.+......... ........+||+.|||||++.+..|+.++||||+||++|||++ ||..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 99999987543221110 1122345689999999999999999999999999999999996 7754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=380.41 Aligned_cols=204 Identities=28% Similarity=0.357 Sum_probs=174.8
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCC------CCEEEEEEecCCCc---hhhHHHHHHHhhccCC-CceeeEEeeeecC-C
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPN------GETLAVKKMWSSDE---SGAFSSEIQTLGSIRH-KNIVRLLGWGSNK-N 833 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h-~nIv~l~~~~~~~-~ 833 (1001)
.++|++.+.||+|+||+||+|++.. ++.||||++..... .++|.+|++++++++| ||||+++|+|.++ +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 3678999999999999999998642 36899999865443 3579999999999965 8999999998664 5
Q ss_pred ceEEEEEccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAG--------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG 899 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~ 899 (1001)
..++|||||++|+|.++++... ...+++..+..++.|||+||+|||++ +||||||||+|||++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeC
Confidence 6899999999999999997532 23478999999999999999999998 999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 900 PGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 900 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
+++++||+|||+|+.+..... .......+||++|||||++.+..|+.++|||||||++|||+| |+.||.+..
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred CCCCEEECcchhhhhcccCCC-----ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 999999999999987643321 112334579999999999999999999999999999999998 999998654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=376.38 Aligned_cols=220 Identities=25% Similarity=0.329 Sum_probs=180.3
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC----CCCEEEEEEecCCCchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP----NGETLAVKKMWSSDESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~l 837 (1001)
++.++|++.+.||+|+||+||+|+.+ .++.||||++.......++.+|+++++.+ +|||||++++++.+.+..|+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 34578999999999999999999753 46889999998777777899999999988 69999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC-CcEEEeccccccccc
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG-YQAYLADFGLARIVS 916 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ki~Dfgla~~~~ 916 (1001)
||||+++|+|.++++ .+++.++..++.|++.|++|||++ +|+||||||+|||++.+ +++||+|||+|+...
T Consensus 98 vmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 98 AMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 999999999999995 278999999999999999999998 99999999999999876 899999999998654
Q ss_pred CCCCCC---------------------CCCCCCCCcccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 917 GSGDDN---------------------CSKTNQRPQLAGSYGYMAPEHASMQ-RITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 917 ~~~~~~---------------------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
...... ..........+||++|||||++.+. .|+.++||||+||++|||+||+.||.+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 321100 0011223456899999999998764 589999999999999999999999976
Q ss_pred CCCCCcCcccchhhhhccc
Q 001873 975 TLPGGAPLVQWTPLMFLML 993 (1001)
Q Consensus 975 ~~~~~~~l~~~~~~~~~~~ 993 (1001)
.. ++..+...+....|
T Consensus 250 ~~---~~~~~l~~I~~~~G 265 (361)
T 4f9c_A 250 AS---DDLTALAQIMTIRG 265 (361)
T ss_dssp CS---SHHHHHHHHHHHHC
T ss_pred CC---CHHHHHHHHHHhcC
Confidence 44 33344444433333
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=376.95 Aligned_cols=201 Identities=22% Similarity=0.323 Sum_probs=171.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeec------CCc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSN------KNL 834 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~------~~~ 834 (1001)
++|++.+.||+|+||+||+|++. +|+.||||++..... .+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 799999999965432 2568899999999999999999998653 467
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.|+|||||+ |+|.+++.+. ..+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999996 7899999864 4589999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ-RITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+..... .........+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+.
T Consensus 208 ~~~~~~---~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 208 LCTSPA---EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp C----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred cccCcc---ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 643221 122334567899999999998764 5689999999999999999999999764
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=377.36 Aligned_cols=357 Identities=19% Similarity=0.203 Sum_probs=202.6
Q ss_pred ccccCCCCcEEeccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccc
Q 001873 97 IFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSL 176 (1001)
Q Consensus 97 ~~~~l~~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L 176 (1001)
.++.+++|++|++++|++++. | .++.+++|++|+|++|++++ +| ++.+++|++|+|++|++++ +| ++++++|
T Consensus 37 ~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L 108 (457)
T 3bz5_A 37 SEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKL 108 (457)
T ss_dssp EHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTC
T ss_pred ChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcC
Confidence 345566666666666666643 3 56666666666666666664 33 6666666666666666664 33 6666666
Q ss_pred cceeccccccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceecccc
Q 001873 177 AYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYT 256 (1001)
Q Consensus 177 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~ 256 (1001)
++|++++|++++ +| ++.+++|++|++++| .+++ +| ++++++|++|++ ++
T Consensus 109 ~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N-~l~~-l~--l~~l~~L~~L~l------------------------~~ 157 (457)
T 3bz5_A 109 TYLNCDTNKLTK-LD--VSQNPLLTYLNCARN-TLTE-ID--VSHNTQLTELDC------------------------HL 157 (457)
T ss_dssp CEEECCSSCCSC-CC--CTTCTTCCEEECTTS-CCSC-CC--CTTCTTCCEEEC------------------------TT
T ss_pred CEEECCCCcCCe-ec--CCCCCcCCEEECCCC-ccce-ec--cccCCcCCEEEC------------------------CC
Confidence 666666666664 33 566666666666665 3443 22 444444444444 44
Q ss_pred ccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCC
Q 001873 257 SLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIP 336 (1001)
Q Consensus 257 n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 336 (1001)
|...+.+ .++.+++|++|++++|++++. | ++.+++|+.|++++|++++. .++.+++|+.|++++|++++ +|
T Consensus 158 n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip 228 (457)
T 3bz5_A 158 NKKITKL--DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID 228 (457)
T ss_dssp CSCCCCC--CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC
T ss_pred CCccccc--ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC
Confidence 4433344 355666666666666666652 3 56666666666666666643 25666666666666666665 34
Q ss_pred cccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcc
Q 001873 337 RSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQE 416 (1001)
Q Consensus 337 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~ 416 (1001)
++.+++|++|++++|++++.. +..+++|+.|++++|++ +.+++++|.+.+.+| ++.+++
T Consensus 229 --~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~L--------------~~L~l~~n~~~~~~~--~~~l~~ 287 (457)
T 3bz5_A 229 --VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTDL--------------LEIDLTHNTQLIYFQ--AEGCRK 287 (457)
T ss_dssp --CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCCC--------------SCCCCTTCTTCCEEE--CTTCTT
T ss_pred --ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCCC--------------CEEECCCCccCCccc--cccccc
Confidence 556666666666666666543 33455566666555533 334555555555554 345566
Q ss_pred cceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccC
Q 001873 417 LQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSE 496 (1001)
Q Consensus 417 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 496 (1001)
|+.|++++|...+.+|. ...+|+.|++++| ++|++|++++|++++. .++++++|+.|++++
T Consensus 288 L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~~ 348 (457)
T 3bz5_A 288 IKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL---DVSHNTKLKSLSCVN 348 (457)
T ss_dssp CCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC---CCTTCTTCSEEECCS
T ss_pred CCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc---ccccCCcCcEEECCC
Confidence 66666666665554442 2233333333322 4566666666666652 255666666666666
Q ss_pred cccccCCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccc
Q 001873 497 NHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHS 552 (1001)
Q Consensus 497 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~ 552 (1001)
|++++ ++.|+.|++++|.++|. .-...++.+++++|+++|.+|..
T Consensus 349 N~l~~--------l~~L~~L~l~~n~l~g~---~~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 349 AHIQD--------FSSVGKIPALNNNFEAE---GQTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp SCCCB--------CTTGGGSSGGGTSEEEE---EEEEECCCBCCBTTBEEEECCTT
T ss_pred CCCCC--------ccccccccccCCcEEec---ceeeecCccccccCcEEEEcChh
Confidence 66654 13444555666666554 11123444666666666655544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=384.95 Aligned_cols=197 Identities=21% Similarity=0.252 Sum_probs=171.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHH---HHHHhhccCCCceeeEEeeeecCCceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSS---EIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~---Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
++|++.++||+|+||+||+|+.+ +|+.||||++... .......+ ++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 56999999999999999999976 6999999998532 22223333 466677889999999999999999999
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
+|||||+||+|.+++.+. ..+++..+..++.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+.+.
T Consensus 269 lVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999874 3489999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccc-cCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHAS-MQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.. .....+||+.|||||++. +..|+.++|+||+||++|||++|+.||.+..
T Consensus 344 ~~---------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~ 395 (689)
T 3v5w_A 344 KK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395 (689)
T ss_dssp SC---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred CC---------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 233468999999999996 4689999999999999999999999997643
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=370.43 Aligned_cols=352 Identities=20% Similarity=0.224 Sum_probs=194.4
Q ss_pred CcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccc
Q 001873 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNL 342 (1001)
Q Consensus 263 ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 342 (1001)
.+..++++++|++|++++|.+++. | .++.+++|++|+|++|++++. | ++.+++|++|++++|.+++. | ++++
T Consensus 34 ~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l 105 (457)
T 3bz5_A 34 DTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPL 105 (457)
T ss_dssp SEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTC
T ss_pred cccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCC
Confidence 334444555555555555555543 2 345555555555555555532 2 44555555555555555532 2 4455
Q ss_pred cCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeC
Q 001873 343 LKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDF 422 (1001)
Q Consensus 343 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L 422 (1001)
++|++|++++|++++ +| +..+++|++|++++|++++. .++.+++|+.|++++|+..+.+ .+..+++|+.|++
T Consensus 106 ~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l 177 (457)
T 3bz5_A 106 TKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDC 177 (457)
T ss_dssp TTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEEC
T ss_pred CcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEEC
Confidence 555555555555553 22 44555555555555555542 1445555555555555433333 2455555555555
Q ss_pred cCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccC
Q 001873 423 SYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGG 502 (1001)
Q Consensus 423 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 502 (1001)
++|++++ +| +..+++|+.|++++|++++. .++.+++|++|++++|++++ +| ++.+++|++|++++|++++.
T Consensus 178 s~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~ 248 (457)
T 3bz5_A 178 SFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTEL 248 (457)
T ss_dssp CSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC
T ss_pred CCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCc
Confidence 5555554 22 45555566666666655543 25555566666666666654 33 55556666666666666543
Q ss_pred CcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhh------
Q 001873 503 IPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAE------ 576 (1001)
Q Consensus 503 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~------ 576 (1001)
. +..+++|+.|++++|+++ .|++++|.+.+.+| ++.+++|+.|++++|++.+.+|..
T Consensus 249 ~---~~~l~~L~~L~l~~n~L~------------~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~ 311 (457)
T 3bz5_A 249 D---VSTLSKLTTLHCIQTDLL------------EIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITE 311 (457)
T ss_dssp C---CTTCTTCCEEECTTCCCS------------CCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSC
T ss_pred C---HHHCCCCCEEeccCCCCC------------EEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceE
Confidence 2 233445555555544332 34455555444443 334455555555555444333321
Q ss_pred --hhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCChhhhhcccc
Q 001873 577 --ILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQN 654 (1001)
Q Consensus 577 --~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~ 654 (1001)
+..+++|++|++++|+|++. + ++.++.|+. |++++|+|++ ++.|..|++++|.+++. ..+..
T Consensus 312 L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~-L~l~~N~l~~--------l~~L~~L~l~~n~l~g~----~~~~~ 375 (457)
T 3bz5_A 312 LDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKS-LSCVNAHIQD--------FSSVGKIPALNNNFEAE----GQTIT 375 (457)
T ss_dssp CCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSE-EECCSSCCCB--------CTTGGGSSGGGTSEEEE----EEEEE
T ss_pred echhhcccCCEEECCCCccccc-c--cccCCcCcE-EECCCCCCCC--------ccccccccccCCcEEec----ceeee
Confidence 23336778888888888763 3 777778875 8888888775 24556667788887765 35567
Q ss_pred cceeEcccCCCCCCCCCC
Q 001873 655 LVSLNVSFNDFSGELPNT 672 (1001)
Q Consensus 655 L~~L~ls~N~l~~~~p~~ 672 (1001)
|..+++++|+++|.+|..
T Consensus 376 l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 376 MPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp CCCBCCBTTBEEEECCTT
T ss_pred cCccccccCcEEEEcChh
Confidence 888899999999999854
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=365.42 Aligned_cols=238 Identities=28% Similarity=0.396 Sum_probs=153.8
Q ss_pred ccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCcc
Q 001873 267 IGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQ 346 (1001)
Q Consensus 267 l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 346 (1001)
++++++|++|+++ |.+.+.. .+.++++|+.|++++|++++. ..+..+++|+.|++++|.+++..| ++.+++|+
T Consensus 152 ~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~ 224 (466)
T 1o6v_A 152 LSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLD 224 (466)
T ss_dssp GTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCC
T ss_pred hccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCC
Confidence 4455555555554 3333222 255555666666666655532 235556666666666666654433 45566666
Q ss_pred EEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCcc
Q 001873 347 ELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNN 426 (1001)
Q Consensus 347 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 426 (1001)
+|++++|++.+. ..+..+++|++|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|+
T Consensus 225 ~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~ 298 (466)
T 1o6v_A 225 ELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 298 (466)
T ss_dssp EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSC
T ss_pred EEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCc
Confidence 666666666532 245566666666666666664433 5666666666666666665433 6677777777777777
Q ss_pred ccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCccc
Q 001873 427 LSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPS 506 (1001)
Q Consensus 427 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 506 (1001)
+++..+ +..+++|++|++++|++++..| +..+++|++|++++|++++. ..+.++++|+.|++++|++++..|
T Consensus 299 l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-- 370 (466)
T 1o6v_A 299 LEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-- 370 (466)
T ss_dssp CSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--
T ss_pred ccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--
Confidence 775443 6677777777887777776655 66777888888888888754 467788888888888888887666
Q ss_pred ccccccCceEEcccccCcc
Q 001873 507 VVGCQSLEFLDLHSNGLTG 525 (1001)
Q Consensus 507 ~~~l~~L~~L~Ls~N~l~~ 525 (1001)
+..+++|+.|++++|++++
T Consensus 371 ~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 371 LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp GTTCTTCCEEECCCEEEEC
T ss_pred hhcCCCCCEEeccCCcccC
Confidence 7778888888888888875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=378.67 Aligned_cols=201 Identities=25% Similarity=0.385 Sum_probs=179.6
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc--hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE--SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
.+.++|++.+.||+|+||+||+|+.+ +|+.||||++..... .+.+.+|+.+|+.++|||||++++++.+++..++||
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 35678999999999999999999975 699999999866543 367889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC--CcEEEecccccccccC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG--YQAYLADFGLARIVSG 917 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~ki~Dfgla~~~~~ 917 (1001)
|||+||+|.+++.+. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 234 E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 234 EFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp ECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred eecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999999753 34589999999999999999999999 99999999999999854 8999999999998643
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus 310 ~--------~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~ 359 (573)
T 3uto_A 310 K--------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 359 (573)
T ss_dssp T--------SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred C--------CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 2 2234568999999999999999999999999999999999999999764
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=370.55 Aligned_cols=345 Identities=20% Similarity=0.199 Sum_probs=243.9
Q ss_pred cEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCC
Q 001873 298 KSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNN 377 (1001)
Q Consensus 298 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 377 (1001)
+.++.++++++ .+|..+. ++++.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 45566666665 4454443 35666666666666555555666666666666666665555555555555555555555
Q ss_pred cccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCC
Q 001873 378 AISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPP 457 (1001)
Q Consensus 378 ~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 457 (1001)
+++ +..+..|.++++|++|+|++|++++..+..|..+++|++|++++|++++..+.
T Consensus 91 ~l~------------------------~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 146 (477)
T 2id5_A 91 RLK------------------------LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHR 146 (477)
T ss_dssp CCC------------------------SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTT
T ss_pred cCC------------------------ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChh
Confidence 554 33344455566666666666666655566666666666666666666666666
Q ss_pred CCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCcccCCCCcc--ccc
Q 001873 458 DIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLP--TSL 535 (1001)
Q Consensus 458 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~~l 535 (1001)
.|..+++|++|+|++|++++..+..+.++++|+.|++++|++++..+..|..+++|+.|++++|.+.+.+|.... ..+
T Consensus 147 ~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L 226 (477)
T 2id5_A 147 AFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226 (477)
T ss_dssp SSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCC
T ss_pred hccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccc
Confidence 666677777777777777655555667777777777777777766666677777777777777766655554433 256
Q ss_pred ccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCC
Q 001873 536 QLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSS 615 (1001)
Q Consensus 536 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~ 615 (1001)
+.|++++|+|++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..+..+++|+. |+|++
T Consensus 227 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~-L~L~~ 305 (477)
T 2id5_A 227 TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRV-LNVSG 305 (477)
T ss_dssp SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCE-EECCS
T ss_pred cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCE-EECCC
Confidence 66777777777666667888999999999999999888888999999999999999999888999999999996 99999
Q ss_pred CcccccccccccccccccEEEecCCcCCCChhhhhcccccceeEcccCCCCCCCC
Q 001873 616 NQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELP 670 (1001)
Q Consensus 616 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p 670 (1001)
|+|++..+..|..+++|+.|+|++|+++|+++..+...++..+++.++...+..|
T Consensus 306 N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 306 NQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp SCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred CcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence 9999888888999999999999999999998876666666666666665554444
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=363.04 Aligned_cols=345 Identities=27% Similarity=0.380 Sum_probs=199.4
Q ss_pred CCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEE
Q 001873 270 CSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQ 349 (1001)
Q Consensus 270 l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 349 (1001)
+++++.|++++|.+.. +| .+..+++|++|+|++|++++..| +.++++|++|++++|.+++..+ +.++++|++|+
T Consensus 45 l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 45 LDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred hccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 4566666666666653 33 25666666666666666664333 6666666666666666664433 66666666666
Q ss_pred cccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccC
Q 001873 350 LSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSG 429 (1001)
Q Consensus 350 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 429 (1001)
+++|++++..+ +..+++|++|++++|.+++. + .++.+++|+.|+++ |.+.+.. .+..+++|+.|++++|.+++
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~ 191 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSD 191 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCC
Confidence 66666664432 66666666666666666542 2 35666666666664 3444332 26667777777777777664
Q ss_pred CCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccc
Q 001873 430 PIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVG 509 (1001)
Q Consensus 430 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 509 (1001)
. ..+..+++|++|++++|++++..| ++.+++|++|++++|++++. ..+..+++|+.|++++|++++..| +..
T Consensus 192 ~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~ 263 (466)
T 1o6v_A 192 I--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSG 263 (466)
T ss_dssp C--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTT
T ss_pred C--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhc
Confidence 3 236666777777777777765544 55666777777777776643 346666777777777777765443 666
Q ss_pred cccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecc
Q 001873 510 CQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIG 589 (1001)
Q Consensus 510 l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 589 (1001)
+++|+.|++++|++++..+ +..+++|+.|++++|++++..| +..+++|+.|+++
T Consensus 264 l~~L~~L~l~~n~l~~~~~------------------------~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~ 317 (466)
T 1o6v_A 264 LTKLTELKLGANQISNISP------------------------LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLY 317 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG------------------------GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECC
T ss_pred CCCCCEEECCCCccCcccc------------------------ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECc
Confidence 6666666666666654322 3334444444444444443322 4444444444444
Q ss_pred cccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCChhhhhcccccceeEcccCCCCC
Q 001873 590 NNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSG 667 (1001)
Q Consensus 590 ~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ls~N~l~~ 667 (1001)
+|++++..| +..+++|+. |++++|++++. ..+..+++|+.|++++|++++.++ +..+++|+.|++++|++++
T Consensus 318 ~n~l~~~~~--~~~l~~L~~-L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 318 FNNISDISP--VSSLTKLQR-LFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp SSCCSCCGG--GGGCTTCCE-EECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEEEC
T ss_pred CCcCCCchh--hccCccCCE-eECCCCccCCc--hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcccC
Confidence 444443333 344444443 45555544443 234555555555555555555443 5555555555555555555
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=355.96 Aligned_cols=321 Identities=20% Similarity=0.157 Sum_probs=196.2
Q ss_pred ccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccCCCccchhhhhhhhhccC
Q 001873 129 TFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGN 208 (1001)
Q Consensus 129 ~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~n 208 (1001)
+.++.++++++ .+|..+. ++|++|+|++|++++..|..++++++|++|+|++|.+++..|..+++++
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~---------- 80 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLF---------- 80 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT----------
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCc----------
Confidence 45666666666 5665443 4666777777776655566666666666666666666644444444444
Q ss_pred cCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCcccccCCCCCceEeeecCcccCCCC
Q 001873 209 QNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIP 288 (1001)
Q Consensus 209 ~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p 288 (1001)
+|++|+|++|++++..+
T Consensus 81 ---------------------------------------------------------------~L~~L~L~~n~l~~~~~ 97 (477)
T 2id5_A 81 ---------------------------------------------------------------NLRTLGLRSNRLKLIPL 97 (477)
T ss_dssp ---------------------------------------------------------------TCCEEECCSSCCCSCCT
T ss_pred ---------------------------------------------------------------cCCEEECCCCcCCccCc
Confidence 44444444444443333
Q ss_pred cccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccc
Q 001873 289 GRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTA 368 (1001)
Q Consensus 289 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 368 (1001)
..|.++++|++|+|++|++++..|..|..+++|+.|++++|.+++..|..|.++++|++|+|++|++++..+..+..+++
T Consensus 98 ~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~ 177 (477)
T 2id5_A 98 GVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHG 177 (477)
T ss_dssp TSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTT
T ss_pred ccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCC
Confidence 34444444444444444444444444444444444444444444444444444455555555555554444444455555
Q ss_pred cCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccC
Q 001873 369 LTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLS 448 (1001)
Q Consensus 369 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 448 (1001)
|+.|++++|.+.+..+..+..+++|+.|++++|.+.+.+|.......+|++|++++|++++..+..+..+++|++|+|++
T Consensus 178 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 257 (477)
T 2id5_A 178 LIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSY 257 (477)
T ss_dssp CCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCS
T ss_pred CcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCC
Confidence 55555555555544444555555555555555555555555444455777777777777755445677777777777777
Q ss_pred CcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCcc
Q 001873 449 NDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTG 525 (1001)
Q Consensus 449 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 525 (1001)
|++++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|+.|++++|.++.
T Consensus 258 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 258 NPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC 334 (477)
T ss_dssp SCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred CcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence 77777777777788888888888888887777888888888888888888887767777788888888888888764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=349.02 Aligned_cols=201 Identities=26% Similarity=0.303 Sum_probs=176.2
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC-----CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS-----SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.++||+|+||+||+|+.+ +++.||||++.. ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 468999999999999999999976 478999999853 22334589999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
||||++|+|.+++.+. ...+++..++.++.|++.|++|||+. +|+||||||+|||++.++++||+|||+|+.....
T Consensus 153 ~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp ECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 9999999999999864 34589999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCCCCCCCCCCcccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHAS-----MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.. ......+||++|+|||++. ...|+.++||||+||++|||++|+.||.+.
T Consensus 229 ~~------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 284 (437)
T 4aw2_A 229 GT------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284 (437)
T ss_dssp SC------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CC------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence 11 1223457999999999986 567899999999999999999999999764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=329.23 Aligned_cols=200 Identities=27% Similarity=0.418 Sum_probs=178.6
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCC--CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSS--DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
+..++|++.+.||+|+||+||+|+. .+++.||||++... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 4457899999999999999999986 47899999988533 33467899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++|+|.+++.+. .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp ECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999999863 489999999999999999999998 99999999999999999999999999998764322
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 171 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 219 (297)
T 3fxz_A 171 -------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (297)
T ss_dssp -------CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -------cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1233457999999999999999999999999999999999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=332.40 Aligned_cols=198 Identities=23% Similarity=0.289 Sum_probs=176.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC-----CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS-----SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||+||+|+.+ +++.||||++.. ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57899999999999999999976 689999999854 234467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++|+|.+++.+. ..+++..+..++.||+.|++|||++ +|+||||||+||+++.++++||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 999999999999864 3589999999999999999999998 9999999999999999999999999999864321
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 159 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 208 (337)
T 1o6l_A 159 ------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp ------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence 12234468999999999999999999999999999999999999999754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=333.23 Aligned_cols=198 Identities=24% Similarity=0.373 Sum_probs=176.1
Q ss_pred HhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
.++|++.+.||+|+||+||+|++ .+|+.||||++.... ..+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46799999999999999999997 479999999985432 2356889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++|+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp CCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred ECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 999999999999764 3489999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCC-CccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRIT-EKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......+||+.|+|||++.+..+. .++||||+||++|||++|+.||++.
T Consensus 168 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 168 -------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp -------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 123345799999999999887775 7999999999999999999999765
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=339.67 Aligned_cols=347 Identities=18% Similarity=0.205 Sum_probs=161.2
Q ss_pred ccCCCCCCCCCCCc-cceEEeCC-CCcEEEEEeccccccccCCcccccCCCCcEEeccCCcccCCCCcc-cCCccccccc
Q 001873 55 ALSSWNPAETSPCK-WFGIHCSS-NGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKE-FGDYRELTFI 131 (1001)
Q Consensus 55 ~l~sW~~~~~~~c~-w~gv~c~~-~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~~~l~g~~p~~-~~~l~~L~~L 131 (1001)
.+++|.+ +.+||. |.++.|.. .-+|.. ..........-..++++++|+++++.++ .+|+. +..+++|++|
T Consensus 2 ~~~~~~~-~~~C~~~~~~~~c~~~~~~i~~-----~~~~~~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L 74 (390)
T 3o6n_A 2 NVKPRQP-EYKCIDSNLQYDCVFYDVHIDM-----QTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELL 74 (390)
T ss_dssp -----CC-EECBCC------EEEESCEECS-----SCCCCEESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEE
T ss_pred CcCCCCC-ccceehhhhhhccceeeeeeec-----ccccccccccccccCCceEEEecCCchh-hCChhHhcccccCcEE
Confidence 3678985 677774 55555531 111111 1100001111123455566666666555 33332 4555556666
Q ss_pred cccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccCCC-ccchhhhhhhhhccCcC
Q 001873 132 DLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKS-IGALSKLQVFRAGGNQN 210 (1001)
Q Consensus 132 ~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~-~~~l~~L~~L~l~~n~~ 210 (1001)
+|++|++++..|..|..+++|++|+|++|.+++..|..++++++|++|+|++|.++ .+|.. ++++++|++|++++|
T Consensus 75 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n-- 151 (390)
T 3o6n_A 75 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNN-- 151 (390)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSS--
T ss_pred ECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCC--
Confidence 66666555444445555566666666666555544555555555555555555555 23322 233333333333333
Q ss_pred CCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCcccccCCCCCceEeeecCcccCCCCcc
Q 001873 211 LKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGR 290 (1001)
Q Consensus 211 l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~ 290 (1001)
.+++..|..++++++|++|++++|++++. .
T Consensus 152 -----------------------------------------------~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~ 181 (390)
T 3o6n_A 152 -----------------------------------------------NLERIEDDTFQATTSLQNLQLSSNRLTHV---D 181 (390)
T ss_dssp -----------------------------------------------CCCBCCTTTTSSCTTCCEEECCSSCCSBC---C
T ss_pred -----------------------------------------------ccCccChhhccCCCCCCEEECCCCcCCcc---c
Confidence 22222333444455555555555555432 2
Q ss_pred cCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccC
Q 001873 291 IGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALT 370 (1001)
Q Consensus 291 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 370 (1001)
+..+++|+.|++++|.+++. ...++|+.|++++|.++.. |..+ .++|++|++++|++++. ..+..+++|+
T Consensus 182 ~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~ 251 (390)
T 3o6n_A 182 LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTDT--AWLLNYPGLV 251 (390)
T ss_dssp GGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCS
T ss_pred cccccccceeeccccccccc-----CCCCcceEEECCCCeeeec-cccc--cccccEEECCCCCCccc--HHHcCCCCcc
Confidence 33445555555555554421 2223455555555555532 2211 24555555555555432 3455555555
Q ss_pred EEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCc
Q 001873 371 HLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSND 450 (1001)
Q Consensus 371 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 450 (1001)
+|++++|.+++..|..+..+++|+.|++++|++++ +|..+..+++|++|++++|+++ .+|..+..+++|++|++++|+
T Consensus 252 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~ 329 (390)
T 3o6n_A 252 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 329 (390)
T ss_dssp EEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSC
T ss_pred EEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCc
Confidence 55555555554445555555555555555555442 2333445555666666666555 344445555555555555555
Q ss_pred CCCCCCCCCCCCCCcceEEccccccc
Q 001873 451 LSGFIPPDIGNCTTLRRLRLNDNRLS 476 (1001)
Q Consensus 451 l~~~~p~~l~~l~~L~~L~Ls~N~l~ 476 (1001)
++.. + +..+++|+.|++++|+++
T Consensus 330 i~~~-~--~~~~~~L~~L~l~~N~~~ 352 (390)
T 3o6n_A 330 IVTL-K--LSTHHTLKNLTLSHNDWD 352 (390)
T ss_dssp CCCC-C--CCTTCCCSEEECCSSCEE
T ss_pred ccee-C--chhhccCCEEEcCCCCcc
Confidence 5432 1 334444455555555444
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=337.89 Aligned_cols=199 Identities=22% Similarity=0.306 Sum_probs=175.7
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~l 837 (1001)
.++|++.++||+|+||+||+|+.+ +++.||||++.... ..+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999976 57899999986432 235688999999887 89999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||+++|+|.+++.+. ..+++..+..++.||+.|++|||++ +|+||||||+||+++.++++||+|||+|+....
T Consensus 131 V~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999864 4589999999999999999999998 999999999999999999999999999985322
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus 206 ~-------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 206 P-------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp T-------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred C-------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 1 12234568999999999999999999999999999999999999999754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=333.86 Aligned_cols=200 Identities=23% Similarity=0.321 Sum_probs=178.0
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--------chhhHHHHHHHhhccCCCceeeEEeeeecCC
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN 833 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~ 833 (1001)
++.++|++.+.||+|+||+||+++.+ +|+.||||++.... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 45578999999999999999999976 68999999986432 2357899999999999999999999999999
Q ss_pred ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC----cEEEecc
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY----QAYLADF 909 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~ki~Df 909 (1001)
..++||||+++|+|.+++.+. ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++ .+||+||
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999999763 4589999999999999999999998 999999999999998776 7999999
Q ss_pred cccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 910 gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
|+++.+... ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.
T Consensus 164 G~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~ 221 (361)
T 2yab_A 164 GLAHEIEDG--------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (361)
T ss_dssp SSCEECCTT--------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCceEcCCC--------CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 999876432 1223457999999999999999999999999999999999999999764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=336.61 Aligned_cols=199 Identities=24% Similarity=0.332 Sum_probs=172.6
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~l 837 (1001)
.++|++.++||+|+||+||+|+.+ +++.||||++... ...+.+.+|..+++.+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999975 6899999998542 2345688899999988 79999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||+++|+|.+++.+. ..+++..++.++.||+.|++|||++ +|+||||||+||+++.++++||+|||+|+....
T Consensus 102 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 99999999999999864 4489999999999999999999998 999999999999999999999999999985322
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus 177 ~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 227 (353)
T 3txo_A 177 N-------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227 (353)
T ss_dssp ----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C-------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence 1 12234458999999999999889999999999999999999999999765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.68 Aligned_cols=196 Identities=28% Similarity=0.403 Sum_probs=176.2
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.+.||+|+||+||+|+.+ +++.||+|++... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357999999999999999999975 6899999998542 3346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++|+|.+++... ..+++..+..++.||+.|++|||++ +|+||||||+||+++.++++||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp ECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 9999999999999874 3489999999999999999999998 999999999999999999999999999987532
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 159 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 206 (318)
T 1fot_A 159 ---------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 206 (318)
T ss_dssp ---------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ---------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 123457999999999999999999999999999999999999999754
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=339.22 Aligned_cols=286 Identities=21% Similarity=0.256 Sum_probs=203.7
Q ss_pred CcHHHHHHHHHHHHhC-CCCCCccCCCC---CCCCCCCccceEEeCCCCcEEEEEeccccccccCCcccccCCCCcEEec
Q 001873 34 ALDEQGQALLTWKNSL-NSSTDALSSWN---PAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLII 109 (1001)
Q Consensus 34 ~~~~~~~aLl~~k~~~-~~~~~~l~sW~---~~~~~~c~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l 109 (1001)
+..+|++||++||+++ .|+.+++.+|. ....++|.|.|++|+..... +. -...+.+++|+|
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~---------l~------~~~~~~l~~L~L 88 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADL---------LE------DATQPGRVALEL 88 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHH---------HH------HHTSTTCCEEEE
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHH---------Hh------cccccceeEEEc
Confidence 5678999999999999 78888899993 34678999999999621100 00 012356778899
Q ss_pred cCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccccccc
Q 001873 110 SSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGK 189 (1001)
Q Consensus 110 ~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~ 189 (1001)
++|+++ .+|+.++++++|++|+|++|+++ .+|..++.+++|++|+|++|.++ .+|..++++++|++|+|++|.+.+.
T Consensus 89 ~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~ 165 (328)
T 4fcg_A 89 RSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTE 165 (328)
T ss_dssp ESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCC
T ss_pred cCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccc
Confidence 999998 88999999999999999999999 89999999999999999999999 8899999999999999999999999
Q ss_pred cCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCcccccC
Q 001873 190 IPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGN 269 (1001)
Q Consensus 190 ~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~ 269 (1001)
+|..++.. .++..++++++|++|++++|.+. .+|..+++
T Consensus 166 ~p~~~~~~----------------~~~~~~~~l~~L~~L~L~~n~l~-------------------------~lp~~l~~ 204 (328)
T 4fcg_A 166 LPEPLAST----------------DASGEHQGLVNLQSLRLEWTGIR-------------------------SLPASIAN 204 (328)
T ss_dssp CCSCSEEE----------------C-CCCEEESTTCCEEEEEEECCC-------------------------CCCGGGGG
T ss_pred cChhHhhc----------------cchhhhccCCCCCEEECcCCCcC-------------------------cchHhhcC
Confidence 99887651 12334566777777777766555 34444555
Q ss_pred CCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEE
Q 001873 270 CSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQ 349 (1001)
Q Consensus 270 l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 349 (1001)
+++|++|+|++|++++ +|..++.+++|++|+|++|++.+.+|..++.+++|++|+|++|.+.+.+|..+.++++|++|+
T Consensus 205 l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~ 283 (328)
T 4fcg_A 205 LQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLD 283 (328)
T ss_dssp CTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEE
T ss_pred CCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEe
Confidence 5555555555555553 344455556666666666555555565566666666666666655555665566666666666
Q ss_pred cccccccCcCChhhccccccCEEeccCCcc
Q 001873 350 LSVNQLSGTIPIEIATCTALTHLEIDNNAI 379 (1001)
Q Consensus 350 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i 379 (1001)
|++|++.+.+|..+..+++|+.+++..|.+
T Consensus 284 L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 284 LRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp CTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred CCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence 666666556666666666666666655544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=341.43 Aligned_cols=199 Identities=25% Similarity=0.316 Sum_probs=175.2
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC-----CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS-----SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.++||+|+||+||+|+.+ +++.||||++.. ....+.+.+|+.+++.++|||||++++++.+.+..++|
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 467999999999999999999976 589999999853 23345688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||++||+|.++++.. .+++..+..++.||+.|++|||++ +|+||||||+||+++.++++||+|||+|+.+...
T Consensus 148 ~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp ECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 9999999999999753 489999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCC----CCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQR----ITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......+||+.|+|||++.... |+.++||||+||++|||++|+.||.+.
T Consensus 222 ~------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 222 G------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp S------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred C------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 1 11223458999999999987655 789999999999999999999999764
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=354.92 Aligned_cols=350 Identities=17% Similarity=0.143 Sum_probs=154.6
Q ss_pred CCccCCCCCCCCCCCc----cceEEeCCCCcEEEEEeccccccccCCcccccCCCCcEEeccCCcccCCCCcccCCcccc
Q 001873 53 TDALSSWNPAETSPCK----WFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYREL 128 (1001)
Q Consensus 53 ~~~l~sW~~~~~~~c~----w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~~~l~g~~p~~~~~l~~L 128 (1001)
...+++|.+ +.+||. |.++.|+. ++.. ...+... +..--.+++++.|++++|.+++..+..++++++|
T Consensus 6 ~~~l~~~~~-~~~C~~~~~~~~c~~~~~--~i~~---~~~~~~~--~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L 77 (597)
T 3oja_B 6 RYNVKPRQP-EYKCIDSNLQYDCVFYDV--HIDM---QTQDVYF--GFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77 (597)
T ss_dssp -----CCCS-EECCCCC--CCSEEECSC--EECS---SCCCCEE--SCSSGGGCCCSEEEESSCEESEECTHHHHHCCCC
T ss_pred cccccCCCC-CCcCcccCcCceeEecCc--eecc---ccccccc--CcccccCCCceEEEeeCCCCCCcCHHHHccCCCC
Confidence 346789985 677773 77666652 1110 0011100 0011123455555555555543222234555555
Q ss_pred ccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccCCCccchhhhhhhhhccC
Q 001873 129 TFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGN 208 (1001)
Q Consensus 129 ~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~n 208 (1001)
++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..++++++|++|+|++|.+++..|..++++++|++|++++|
T Consensus 78 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N 157 (597)
T 3oja_B 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNN 157 (597)
T ss_dssp SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCC
Confidence 55555555555444445555555555555555555444444555555555555555554221112233333333333333
Q ss_pred cCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCcccccCCCCCceEeeecCcccCCCC
Q 001873 209 QNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIP 288 (1001)
Q Consensus 209 ~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p 288 (1001)
.+++..|..|+++++|++|+|++|.+++..
T Consensus 158 -------------------------------------------------~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~- 187 (597)
T 3oja_B 158 -------------------------------------------------NLERIEDDTFQATTSLQNLQLSSNRLTHVD- 187 (597)
T ss_dssp -------------------------------------------------CCCBCCTTTTTTCTTCCEEECTTSCCSBCC-
T ss_pred -------------------------------------------------cCCCCChhhhhcCCcCcEEECcCCCCCCcC-
Confidence 222223333444444444444444444321
Q ss_pred cccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccc
Q 001873 289 GRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTA 368 (1001)
Q Consensus 289 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 368 (1001)
++.+++|+.|++++|.+++ +...++|+.|++++|.++.. |..+ .++|+.|+|++|++++ +..+..+++
T Consensus 188 --~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~-~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~ 255 (597)
T 3oja_B 188 --LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTD--TAWLLNYPG 255 (597)
T ss_dssp --GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEE-ECSC--CSCCCEEECCSSCCCC--CGGGGGCTT
T ss_pred --hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCccccc-cccc--CCCCCEEECCCCCCCC--ChhhccCCC
Confidence 2333444444444444432 11223444444444444422 1111 1344444444444443 233444444
Q ss_pred cCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccC
Q 001873 369 LTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLS 448 (1001)
Q Consensus 369 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 448 (1001)
|+.|+|++|.+++.. |..|..+++|+.|+|++|.+++ +|..+..+++|+.|+|++
T Consensus 256 L~~L~Ls~N~l~~~~------------------------~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~ 310 (597)
T 3oja_B 256 LVEVDLSYNELEKIM------------------------YHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSH 310 (597)
T ss_dssp CSEEECCSSCCCEEE------------------------SGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCS
T ss_pred CCEEECCCCccCCCC------------------------HHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCC
Confidence 444444444444433 4444444444444444444442 233334444455555555
Q ss_pred CcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCccccc
Q 001873 449 NDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVG 501 (1001)
Q Consensus 449 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 501 (1001)
|.++ .+|..+..+++|+.|+|++|++++. | +..+++|+.|++++|++.+
T Consensus 311 N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~ 359 (597)
T 3oja_B 311 NHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC 359 (597)
T ss_dssp SCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred CCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCC
Confidence 5554 2344444455555555555555532 1 4555666666666666654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=337.60 Aligned_cols=332 Identities=19% Similarity=0.207 Sum_probs=206.2
Q ss_pred cCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeC
Q 001873 343 LKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDF 422 (1001)
Q Consensus 343 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L 422 (1001)
.+++.|++++|.++...+..+..+++|++|++++|.+++..+..+..+++|+.|++++|++++..|..|..+++|++|++
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 34444444444444322233344444444444444444433444444444445555555555455555555666666666
Q ss_pred cCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccC
Q 001873 423 SYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGG 502 (1001)
Q Consensus 423 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 502 (1001)
++|+++...+..|..+++|++|++++|++++..|..+..+++|++|++++|++++. .+..+++|+.|++++|.+++.
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~ 201 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL 201 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc
Confidence 66666543333445566666666666666665566666666666666666666643 244556666667776666532
Q ss_pred CcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhcccc
Q 001873 503 IPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRK 582 (1001)
Q Consensus 503 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 582 (1001)
...++|+.|++++|+++. +|......++.|++++|++++. ..+..+++|++|++++|++++..|..+..+++
T Consensus 202 -----~~~~~L~~L~l~~n~l~~-~~~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 273 (390)
T 3o6n_A 202 -----AIPIAVEELDASHNSINV-VRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR 273 (390)
T ss_dssp -----ECCSSCSEEECCSSCCCE-EECCCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSS
T ss_pred -----CCCCcceEEECCCCeeee-ccccccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHcccccc
Confidence 223467777777777763 3444556677777777777753 45777888888888888888777788888888
Q ss_pred ccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCChhhhhcccccceeEccc
Q 001873 583 LILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSF 662 (1001)
Q Consensus 583 L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ls~ 662 (1001)
|++|+|++|++++ +|..+..+++|+. |+|++|+++ .+|..+..+++|+.|+|++|+++..+ +..+++|+.|++++
T Consensus 274 L~~L~L~~n~l~~-~~~~~~~l~~L~~-L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~L~~L~l~~ 348 (390)
T 3o6n_A 274 LERLYISNNRLVA-LNLYGQPIPTLKV-LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSH 348 (390)
T ss_dssp CCEEECCSSCCCE-EECSSSCCTTCCE-EECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCS
T ss_pred CCEEECCCCcCcc-cCcccCCCCCCCE-EECCCCcce-ecCccccccCcCCEEECCCCccceeC--chhhccCCEEEcCC
Confidence 8888888888874 5666677788885 888888887 45556777888888888888887653 56677888888888
Q ss_pred CCCCCCCCCCccccCCCCCCCCCCCcccc
Q 001873 663 NDFSGELPNTPFFRKLPLSDLASNRGLYI 691 (1001)
Q Consensus 663 N~l~~~~p~~~~~~~~~~~~~~~n~~lc~ 691 (1001)
|++++.+... .+..+....+..+...|.
T Consensus 349 N~~~~~~~~~-~~~~~~~~~~~~~~~~c~ 376 (390)
T 3o6n_A 349 NDWDCNSLRA-LFRNVARPAVDDADQHCK 376 (390)
T ss_dssp SCEEHHHHHH-HTTTCCTTTBCCCCSCCC
T ss_pred CCccchhHHH-HHHHHHhhcccccCceec
Confidence 8887644321 233334444555555564
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=330.91 Aligned_cols=206 Identities=17% Similarity=0.233 Sum_probs=181.7
Q ss_pred hcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCCchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEEEccC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSDESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
++|++.+.||+|+||+||+|+. .+++.||||++......+.+.+|+++++++ +||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~- 87 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL- 87 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence 5789999999999999999996 478999999997766667899999999999 9999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCc-----EEEecccccccccCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQ-----AYLADFGLARIVSGS 918 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~ki~Dfgla~~~~~~ 918 (1001)
+++|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++. +||+|||+|+.+...
T Consensus 88 ~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 88 GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 89999999865 34689999999999999999999998 9999999999999998887 999999999876544
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
...............||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence 3322222223355689999999999999999999999999999999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=323.75 Aligned_cols=211 Identities=27% Similarity=0.464 Sum_probs=179.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
++|++.+.||+|+||+||+|++. +++.||+|++.... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 57889999999999999999975 68999999885543 2367899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
++|+|.++++.. ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.+.......
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999999999874 34589999999999999999999998 99999999999999999999999999998765432211
Q ss_pred C-------CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCc
Q 001873 923 C-------SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGA 980 (1001)
Q Consensus 923 ~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~ 980 (1001)
. ..........||+.|+|||++.+..++.++||||||+++|||++|..||....+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~ 230 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH
Confidence 0 011122245799999999999999999999999999999999999999987655443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=330.83 Aligned_cols=199 Identities=23% Similarity=0.347 Sum_probs=176.5
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~l 837 (1001)
.++|++.+.||+|+||+||+|+.+ +++.||||++... ...+.+.+|..+++.+ +||||+++++++.+.+..++
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 468999999999999999999976 6899999998542 3446688899999877 89999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||+++|+|.+++... ..+++..+..++.||+.|++|||++ +|+||||||+||+++.++++||+|||+|+....
T Consensus 96 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999864 3489999999999999999999998 999999999999999999999999999986432
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 171 ~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (345)
T 1xjd_A 171 G-------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221 (345)
T ss_dssp T-------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C-------CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence 1 11234568999999999999999999999999999999999999999764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=323.80 Aligned_cols=201 Identities=23% Similarity=0.410 Sum_probs=172.5
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.+.||+|+||+||+++.. +++.||+|++..... .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 367999999999999999999865 689999998854321 25788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++++|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++++||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999999864 3489999999999999999999998 9999999999999999999999999999875432
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
. ........||+.|+|||++.+..++.++||||+|+++|||++|+.||.+..
T Consensus 165 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 165 S------LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp ----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred c------ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 112234579999999999999999999999999999999999999998654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=331.97 Aligned_cols=198 Identities=27% Similarity=0.331 Sum_probs=175.7
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC-----CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS-----SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.+.||+|+||+||+|+.. +++.||+|++.. ....+.+.+|+.+++.++|||||++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367999999999999999999975 588999998853 23346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++|+|.+++... ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++++||+|||+|+.+...
T Consensus 94 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp ECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999999864 4589999999999999999999998 9999999999999999999999999999876422
Q ss_pred CCCCCCCCCCCCcccccccccCcccccc---CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASM---QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......+||+.|+|||++.. ..|+.++||||+||++|||++|+.||...
T Consensus 169 --------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 169 --------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp --------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred --------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 22344579999999999863 46899999999999999999999999754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=337.15 Aligned_cols=203 Identities=16% Similarity=0.147 Sum_probs=175.2
Q ss_pred hcccCCCeEeecCCeeEEEEE------eCCCCEEEEEEecCCCchhhHHHHHHHhhccC---CCceeeEEeeeecCCceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVT------IPNGETLAVKKMWSSDESGAFSSEIQTLGSIR---HKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~---h~nIv~l~~~~~~~~~~~ 836 (1001)
++|++.+.||+|+||+||+|. ..+++.||||++... ...++.+|++++++++ |+||+++++++...+..+
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~ 143 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV 143 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence 678999999999999999994 446899999998644 4567888998888886 999999999999999999
Q ss_pred EEEEccCCCCHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC-----------CC
Q 001873 837 LFYDYLPNGSLSSLLHGA---GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP-----------GY 902 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~-----------~~ 902 (1001)
+||||+++|+|.++++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++. ++
T Consensus 144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CT
T ss_pred EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccC
Confidence 999999999999999742 245689999999999999999999998 9999999999999998 89
Q ss_pred cEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 903 QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 903 ~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
.+||+|||+|+.+.... ........+||++|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 221 ~~kl~DFG~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFP-----KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp TEEECCCTTCEEGGGSC-----TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CEEEeeCchhhhhhccC-----CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 99999999997654221 11223445799999999999999999999999999999999999999975443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=338.56 Aligned_cols=202 Identities=24% Similarity=0.287 Sum_probs=176.6
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.++||+|+||+||+++.+ +++.||||++... ...+.+.+|..++..++||||+++++++.+.+..|+|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 467999999999999999999975 6999999998542 2335688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++|+|.+++.+.+ ..+++..++.++.||+.|++|||+. +|+||||||+||+++.++++||+|||+|+.....
T Consensus 140 mE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 99999999999998642 3589999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCCCCCCCCCCcccccccccCccccc-------cCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHAS-------MQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.. ......+||+.|+|||++. ...|+.++||||+||++|||++|+.||....
T Consensus 216 ~~------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 216 GT------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp SC------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred Cc------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 11 1123458999999999986 4578999999999999999999999997653
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=354.61 Aligned_cols=333 Identities=19% Similarity=0.203 Sum_probs=231.2
Q ss_pred cCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeC
Q 001873 343 LKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDF 422 (1001)
Q Consensus 343 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L 422 (1001)
.+++.|++++|.+....+..+..+++|++|+|++|.|++..|..|+.+++|+.|++++|.+++..|..|+.+++|++|+|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 34444444444444333333444444555555555554444444555555555555555555555555666666666666
Q ss_pred cCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccC
Q 001873 423 SYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGG 502 (1001)
Q Consensus 423 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 502 (1001)
++|.+++..+..|..+++|++|+|++|.+++..|..|..+++|++|+|++|.+++. .++.+++|+.|++++|.+++.
T Consensus 131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~l 207 (597)
T 3oja_B 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL 207 (597)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSEE
T ss_pred eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCccccc
Confidence 66666654444556666666667777766666666677777777777777777654 244566777777777777642
Q ss_pred CcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhcccc
Q 001873 503 IPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRK 582 (1001)
Q Consensus 503 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 582 (1001)
...++|+.|++++|.++. ++...+..++.|+|++|.+++ +..+..+++|+.|+|++|++++..|..+..+++
T Consensus 208 -----~~~~~L~~L~ls~n~l~~-~~~~~~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 279 (597)
T 3oja_B 208 -----AIPIAVEELDASHNSINV-VRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR 279 (597)
T ss_dssp -----ECCTTCSEEECCSSCCCE-EECSCCSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSS
T ss_pred -----cCCchhheeeccCCcccc-cccccCCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccC
Confidence 334567788888888773 344455677788888888876 356888999999999999999888899999999
Q ss_pred ccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCChhhhhcccccceeEccc
Q 001873 583 LILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSF 662 (1001)
Q Consensus 583 L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ls~ 662 (1001)
|+.|+|++|++++ +|..+..+++|+. |+|++|+++ .+|..+..+++|+.|+|++|+++..+ +..+++|+.|++++
T Consensus 280 L~~L~Ls~N~l~~-l~~~~~~l~~L~~-L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~L~~L~l~~ 354 (597)
T 3oja_B 280 LERLYISNNRLVA-LNLYGQPIPTLKV-LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSH 354 (597)
T ss_dssp CCEEECTTSCCCE-EECSSSCCTTCCE-EECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCS
T ss_pred CCEEECCCCCCCC-CCcccccCCCCcE-EECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC--hhhcCCCCEEEeeC
Confidence 9999999999985 5777788889986 999999998 56777888999999999999998764 66788999999999
Q ss_pred CCCCCCCCCCccccCCCCCCCCCCCccccc
Q 001873 663 NDFSGELPNTPFFRKLPLSDLASNRGLYIS 692 (1001)
Q Consensus 663 N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~ 692 (1001)
|++++.++.. .+..+....+.++...|+.
T Consensus 355 N~~~~~~~~~-~~~~~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 355 NDWDCNSLRA-LFRNVARPAVDDADQHCKI 383 (597)
T ss_dssp SCEEHHHHHH-HTTTCCTTTBCCCCCCCCT
T ss_pred CCCCChhHHH-HHHHHhhhccccccccCCc
Confidence 9998765422 3455555667788888864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=325.77 Aligned_cols=208 Identities=37% Similarity=0.642 Sum_probs=181.9
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
+..++|+..+.||+|+||+||+|++++++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 115 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence 3457899999999999999999998889999999986543 34678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 841 YLPNGSLSSLLHGAGK--GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|+++|+|.+++..... ..+++..+.+++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999976432 3479999999999999999999998 9999999999999999999999999999865322
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~ 978 (1001)
.. ........||+.|+|||++.+..++.++||||||+++|||++|+.||....+.
T Consensus 193 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~ 247 (321)
T 2qkw_B 193 DQ-----THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247 (321)
T ss_dssp SC-----CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS
T ss_pred cc-----cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH
Confidence 11 11223446999999999998889999999999999999999999999876543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=329.75 Aligned_cols=207 Identities=26% Similarity=0.368 Sum_probs=177.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ..+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999876 78999999985433 23678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 159 (323)
T 3tki_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN- 159 (323)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT-
T ss_pred cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC-
Confidence 99999999999753 3489999999999999999999998 99999999999999999999999999998654321
Q ss_pred CCCCCCCCCCcccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCCcC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQRI-TEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAP 981 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~ 981 (1001)
.........||+.|+|||++.+..+ +.++||||+||++|||++|+.||.........
T Consensus 160 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 217 (323)
T 3tki_A 160 ----RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217 (323)
T ss_dssp ----EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH
T ss_pred ----cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH
Confidence 1122234579999999999987765 67899999999999999999999876544333
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=334.15 Aligned_cols=211 Identities=22% Similarity=0.243 Sum_probs=182.5
Q ss_pred HhcccCCCeEeec--CCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 765 VRNLTSANVIGTG--SSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
.++|++.++||+| +||+||+|+.. +++.||||++..... .+.+.+|+.++++++|||||++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999976 699999999864332 2567889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
|||||++|+|.+++.......+++..+..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999876556789999999999999999999998 999999999999999999999999999876544
Q ss_pred CCCCCCCCCCCCCcccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASM--QRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~ 978 (1001)
.+..............||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 243 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 33222222223344579999999999977 68999999999999999999999999875433
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=328.14 Aligned_cols=201 Identities=20% Similarity=0.281 Sum_probs=177.8
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+.++|++.+.||+|+||+||+++.. +++.||+|.+..... ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 3578999999999999999999976 588999999865443 35688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC--CCcEEEecccccccccCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP--GYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~ki~Dfgla~~~~~~~ 919 (1001)
+++|+|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999999999754 33589999999999999999999998 9999999999999987 789999999999876432
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......||+.|+|||++.+..++.++||||+||++|+|++|+.||....
T Consensus 158 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 158 -------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp -------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -------CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 12234579999999999998889999999999999999999999997653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=328.85 Aligned_cols=198 Identities=23% Similarity=0.306 Sum_probs=175.1
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv 838 (1001)
++|++.+.||+|+||+||+|+.+ +++.||||++.... ..+.+.+|..+++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57899999999999999999976 58899999986432 124578899999887 899999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++|+|.+++.+. ..+++..++.++.||+.|++|||++ +|+||||||+||+++.++++||+|||+|+.....
T Consensus 89 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999999999864 3489999999999999999999998 9999999999999999999999999999864221
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 164 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 213 (345)
T 3a8x_A 164 -------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213 (345)
T ss_dssp -------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTT
T ss_pred -------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCc
Confidence 12234458999999999999999999999999999999999999999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=332.01 Aligned_cols=204 Identities=27% Similarity=0.381 Sum_probs=176.2
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC--------CCCEEEEEEecCCCch---hhHHHHHHHhhcc-CCCceeeEEeeeecC
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP--------NGETLAVKKMWSSDES---GAFSSEIQTLGSI-RHKNIVRLLGWGSNK 832 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~---~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~ 832 (1001)
.++|++.+.||+|+||+||+|++. ++..||||++...... +++.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 367899999999999999999852 3567999998755432 5688999999999 899999999999999
Q ss_pred CceEEEEEccCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE
Q 001873 833 NLKLLFYDYLPNGSLSSLLHGAGK--------------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL 898 (1001)
Q Consensus 833 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll 898 (1001)
+..++||||+++|+|.+++...+. ..+++..+..++.||+.||+|||++ +|+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999986532 3478999999999999999999998 99999999999999
Q ss_pred CCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 899 GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 899 ~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
+.++.+||+|||+|+.+...... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTT-----CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCCCEEEccccCCcccCcccce-----ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999876432211 12233467889999999999999999999999999999999 999998643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=329.24 Aligned_cols=199 Identities=23% Similarity=0.298 Sum_probs=176.4
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~l 837 (1001)
.++|++.+.||+|+||+||+|+.+ +++.||||++... ...+.+.+|..+++.+ +||+|+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467999999999999999999976 4789999998542 3446788999999988 79999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||++||+|.+++.+. ..+++..+..++.||+.|++|||++ +|+||||||+||+++.++++||+|||+|+....
T Consensus 99 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999864 3489999999999999999999998 999999999999999999999999999986422
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 174 ~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 174 D-------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp T-------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C-------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 1 11234458999999999999999999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=327.86 Aligned_cols=196 Identities=22% Similarity=0.282 Sum_probs=176.5
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.+.||+|+||+||+|+.. +++.||||++... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367999999999999999999975 6899999998532 2346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++|+|.+++.+. ..+++..+..++.||+.|++|||++ +|+||||||+||+++.++++||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 9999999999999864 3489999999999999999999998 9999999999999999999999999999875321
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 195 ----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 241 (350)
T 1rdq_E 195 ----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp ----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ----------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence 23457999999999999999999999999999999999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=324.82 Aligned_cols=200 Identities=24% Similarity=0.331 Sum_probs=177.8
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--------chhhHHHHHHHhhccCCCceeeEEeeeecCC
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN 833 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~ 833 (1001)
++.++|++.+.||+|+||+||+++.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45678999999999999999999975 68999999885432 2367899999999999999999999999999
Q ss_pred ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC----cEEEecc
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY----QAYLADF 909 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~ki~Df 909 (1001)
..++||||+++|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++ .+||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999999763 4589999999999999999999998 999999999999999877 8999999
Q ss_pred cccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 910 gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
|+++.+.... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.
T Consensus 163 g~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 220 (326)
T 2y0a_A 163 GLAHKIDFGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220 (326)
T ss_dssp TTCEECCTTS--------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCCeECCCCC--------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 9998764221 123457999999999999999999999999999999999999999764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=322.23 Aligned_cols=202 Identities=24% Similarity=0.364 Sum_probs=174.3
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.+.++|++.+.||+|+||+||+|+..+++.||||++..... .+.+.+|++++++++||||+++++++.+++..++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 35578999999999999999999998899999999864332 25788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||++ |+|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 98 FEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99998 5888888754 34589999999999999999999998 9999999999999999999999999999876422
Q ss_pred CCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
. .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..
T Consensus 173 ~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 224 (311)
T 3niz_A 173 V-------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224 (311)
T ss_dssp C-------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c-------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence 1 12233478999999999865 568999999999999999999999998654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=328.42 Aligned_cols=200 Identities=26% Similarity=0.366 Sum_probs=176.6
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
.+.++|++.+.||+|+||.||++..+ +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45678999999999999999999875 68999999986543 22568899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC---CcEEEeccccccc
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG---YQAYLADFGLARI 914 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~ki~Dfgla~~ 914 (1001)
||||+++|+|.+++... ..+++..+..++.||+.|++|||++ +|+||||||+||+++.+ +.+||+|||++..
T Consensus 106 v~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999999764 4589999999999999999999998 99999999999999864 4699999999987
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.... .......||+.|+|||++.+..|+.++||||+||++|+|++|+.||...
T Consensus 181 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 233 (362)
T 2bdw_A 181 VNDS--------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233 (362)
T ss_dssp CTTC--------CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCC--------cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 5422 1223457999999999999999999999999999999999999999764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=343.95 Aligned_cols=200 Identities=25% Similarity=0.327 Sum_probs=179.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC-----CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS-----SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.++||+|+||+||+|+.+ +|+.||||++.. ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56889999999999999999975 699999999843 233456889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||++||+|.+++...+...+++..+..++.||+.||+|||++ +|+||||||+||+++.++++||+|||+|+.+...
T Consensus 264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~- 339 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG- 339 (576)
T ss_dssp CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC-
Confidence 999999999999876666689999999999999999999998 9999999999999999999999999999876422
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||....
T Consensus 340 -------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 340 -------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp -------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred -------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 11233479999999999999899999999999999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=336.19 Aligned_cols=204 Identities=24% Similarity=0.312 Sum_probs=177.2
Q ss_pred cHHHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCc
Q 001873 760 SIDDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNL 834 (1001)
Q Consensus 760 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~ 834 (1001)
+...+.++|++.+.||+|+||+||++... +++.||+|++..... .+.+.+|+.++++++||||+++++++.+++.
T Consensus 5 ~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 84 (444)
T 3soa_A 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH 84 (444)
T ss_dssp --CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred ccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence 34567789999999999999999999864 789999999865442 3568899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC---CCCcEEEecccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG---PGYQAYLADFGL 911 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~ki~Dfgl 911 (1001)
.++||||+++|+|.+++... ..+++..+..++.||+.|++|||++ +|+||||||+||+++ .++.+||+|||+
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 99999999999999999874 4489999999999999999999998 999999999999998 567899999999
Q ss_pred cccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 912 ARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 912 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
|+...... .......||+.|+|||++.+..|+.++||||+||++|+|++|+.||...
T Consensus 160 a~~~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~ 216 (444)
T 3soa_A 160 AIEVEGEQ-------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE 216 (444)
T ss_dssp CBCCCTTC-------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eEEecCCC-------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc
Confidence 98764321 1223457999999999999999999999999999999999999999654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=325.13 Aligned_cols=199 Identities=25% Similarity=0.348 Sum_probs=167.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEe----CCCCEEEEEEecCCC------chhhHHHHHHHhhccCCCceeeEEeeeecCCc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI----PNGETLAVKKMWSSD------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNL 834 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~ 834 (1001)
.++|++.+.||+|+||+||+++. .+++.||||++.... ....+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36799999999999999999986 478999999986532 23567889999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.++||||+++|+|.+++... ..+++..+..++.||+.|++|||++ +|+||||||+||+++.++++||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999864 3478999999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 171 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 171 SIHDG-------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp ---------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCC-------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 43221 1223457999999999999999999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=323.42 Aligned_cols=201 Identities=34% Similarity=0.490 Sum_probs=168.1
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
..+|++.+.||+|+||+||+|+. +++.||||++..... .+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 46799999999999999999987 688999999865432 2568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 841 YLPNGSLSSLLHGAGK-GGADWEARYEVVLGVAHALAYLHHDCMPP--ILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
|+++|+|.+++.+.+. ..+++..+..++.|++.|++|||++ + |+||||||+||+++.++.+||+|||+++....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 9999999999986432 2378999999999999999999998 8 99999999999999999999999999976432
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 192 ~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 192 T-------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred c-------ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 112234579999999999999999999999999999999999999998653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=327.04 Aligned_cols=204 Identities=36% Similarity=0.666 Sum_probs=179.5
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
..++|++.+.||+|+||+||+|+.++++.||||++..... ...+.+|+.++++++||||+++++++...+..++|||
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 107 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 107 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEE
T ss_pred HhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEE
Confidence 3578999999999999999999988899999999865432 2478999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 841 YLPNGSLSSLLHGAGK--GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|+++|+|.++++.... ..+++..+..++.|++.|++|||+++.++|+||||||+||+++.++.+||+|||+++.....
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 187 (326)
T 3uim_A 108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187 (326)
T ss_dssp CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSS
T ss_pred eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcc
Confidence 9999999999987533 34899999999999999999999986679999999999999999999999999999876432
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~ 973 (1001)
. ........||+.|+|||++.+..++.++||||+|+++|||++|+.||+
T Consensus 188 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 188 D------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp S------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred c------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 1 122233469999999999988889999999999999999999999996
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=329.07 Aligned_cols=202 Identities=25% Similarity=0.310 Sum_probs=175.4
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-------CchhhHHHHHHHhhccCCCceeeEEeeeecCCce
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-------DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~ 835 (1001)
+.++|++.+.||+|+||+||+++.+ +++.||||++... ...+.+.+|+.+++.++||||+++++++.+++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3468999999999999999999875 6899999988421 1346799999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCc---EEEeccc
Q 001873 836 LLFYDYLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQ---AYLADFG 910 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~ki~Dfg 910 (1001)
++||||+++|+|.+++.+. ....+++..+..++.||+.|++|||++ +|+||||||+||+++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999999887643 233479999999999999999999998 9999999999999986554 9999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+++...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 179 ~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 179 VAIQLGESG-------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp TCEECCTTS-------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ceeEecCCC-------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 998764321 1123457999999999999999999999999999999999999999764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=324.45 Aligned_cols=198 Identities=27% Similarity=0.372 Sum_probs=174.6
Q ss_pred HhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.+.||+|+||+||+|++ .+++.||||++... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999997 47899999988532 2335789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+ +|+|.+++.+. ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp ECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999 68999998764 3489999999999999999999998 9999999999999999999999999999865422
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRI-TEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||+...
T Consensus 162 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 212 (336)
T 3h4j_B 162 --------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212 (336)
T ss_dssp --------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred --------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence 22334579999999999988776 689999999999999999999998653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=340.22 Aligned_cols=201 Identities=23% Similarity=0.279 Sum_probs=178.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|+..++||+|+||+||+|+.+ +|+.||||++... ...+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57888999999999999999975 6999999998532 23467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 840 DYLPNGSLSSLLHGAG--KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||++||+|.+++.... ...+++..+..++.||+.|++|||++ +|+||||||+||+++.+|++||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999997654 34589999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.. ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||....
T Consensus 342 ~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 342 GQ-------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp TC-------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CC-------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 21 11233589999999999999999999999999999999999999998753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=323.22 Aligned_cols=203 Identities=24% Similarity=0.360 Sum_probs=175.0
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCC--ceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN--LKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~--~~~lv~ 839 (1001)
++|++.++||+|+||+||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 57999999999999999999976 58999999986432 3467889999999999999999999987655 779999
Q ss_pred EccCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE----CCCCcEEEeccccccc
Q 001873 840 DYLPNGSLSSLLHGAGK-GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL----GPGYQAYLADFGLARI 914 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~ki~Dfgla~~ 914 (1001)
||+++|+|.+++..... ..+++..+..++.|++.|++|||++ +|+||||||+||++ +.++.+||+|||+|+.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999986432 2389999999999999999999998 99999999999999 7888899999999987
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccc--------cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS--------MQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGG 979 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~ 979 (1001)
..... ......||+.|+|||++. +..++.++||||+||++|||++|+.||.+.....
T Consensus 166 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 230 (319)
T 4euu_A 166 LEDDE--------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230 (319)
T ss_dssp CCTTC--------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG
T ss_pred cCCCC--------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence 64321 223347999999999875 5788999999999999999999999998654433
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=329.12 Aligned_cols=202 Identities=19% Similarity=0.284 Sum_probs=178.0
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++.++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 345678999999999999999999875 68999999986543 235788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC--CCcEEEeccccccccc
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP--GYQAYLADFGLARIVS 916 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~ki~Dfgla~~~~ 916 (1001)
|||+++|+|.+++... ...+++..+..++.||+.|++|||++ +|+||||||+||+++. ++.+||+|||+|+...
T Consensus 127 ~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 127 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 9999999999999754 33589999999999999999999998 9999999999999974 5789999999998764
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 203 ~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 253 (387)
T 1kob_A 203 PD--------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253 (387)
T ss_dssp TT--------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CC--------cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence 22 1223347999999999999999999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=316.41 Aligned_cols=207 Identities=20% Similarity=0.266 Sum_probs=182.5
Q ss_pred HhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCCchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEEEcc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSDESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
.++|++.+.||+|+||+||+|+. .+++.||||++......+.+.+|+.+++++ +|++|+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 35799999999999999999996 478999999997777778899999999999 7999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCc-----EEEecccccccccC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQ-----AYLADFGLARIVSG 917 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~ki~Dfgla~~~~~ 917 (1001)
+++|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++. +||+|||+++....
T Consensus 89 -~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 89 -GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp -CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred -CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 99999999865 33589999999999999999999998 9999999999999987765 99999999988765
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
................||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 43322222233455679999999999999999999999999999999999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=329.30 Aligned_cols=198 Identities=27% Similarity=0.294 Sum_probs=167.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHH-hhccCCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQT-LGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~-l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
++|++.+.||+|+||+||+|+.+ +++.||||++.... ....+.+|..+ ++.++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 57999999999999999999976 58899999985432 22456667776 5778999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||++||+|.+++.+. ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++++||+|||+++.....
T Consensus 118 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999999864 3488999999999999999999998 9999999999999999999999999999864322
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus 193 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 242 (373)
T 2r5t_A 193 N-------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242 (373)
T ss_dssp C-------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred C-------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 1 2234568999999999999999999999999999999999999999754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=319.40 Aligned_cols=196 Identities=27% Similarity=0.378 Sum_probs=174.4
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccC
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
.|+..+.||+|+||+||+|+.. +|+.||||++.... ..+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 3666778999999999999976 79999999986433 34678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+|+|.+++.+ ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 126 ~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 195 (321)
T 2c30_A 126 GGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV---- 195 (321)
T ss_dssp SCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS----
T ss_pred CCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc----
Confidence 9999999874 3589999999999999999999998 99999999999999999999999999998764321
Q ss_pred CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......||+.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus 196 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~ 244 (321)
T 2c30_A 196 ---PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244 (321)
T ss_dssp ---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ---cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1223457999999999999999999999999999999999999999764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=314.80 Aligned_cols=200 Identities=28% Similarity=0.432 Sum_probs=177.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++|++.+.||+|+||+||+|++.+++.||||++.... ..+++.+|++++++++||||+++++++.+++..++||||+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 5789999999999999999999889999999997544 457899999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
++|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----- 160 (269)
T 4hcu_A 90 GCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ----- 160 (269)
T ss_dssp CBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-----
T ss_pred CcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc-----
Confidence 9999999764 34589999999999999999999998 99999999999999999999999999998653321
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 161 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred -cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 112233457889999999998999999999999999999999 99999764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.71 Aligned_cols=198 Identities=28% Similarity=0.412 Sum_probs=170.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++|++.+.||+|+||+||+|+..+++.||||++..... .+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57899999999999999999998899999999864432 36788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
++ ++|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (288)
T 1ob3_A 82 LD-QDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (288)
T ss_dssp CS-EEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc--
Confidence 98 4999998764 34589999999999999999999998 99999999999999999999999999998764221
Q ss_pred CCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 155 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -----cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11223468999999999865 46899999999999999999999999764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=326.78 Aligned_cols=200 Identities=25% Similarity=0.345 Sum_probs=162.5
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
+.++|++.+.||+|+||+||+|+.. +++.||||++......+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 3467999999999999999999976 588999999987766678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC---CCcEEEecccccccccCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP---GYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~Dfgla~~~~~~~ 919 (1001)
++|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 131 ~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 131 TGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp CSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence 999999999764 4489999999999999999999998 9999999999999975 889999999999865321
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 205 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 205 -------VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred -------cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 12234579999999999999999999999999999999999999997643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=322.46 Aligned_cols=203 Identities=29% Similarity=0.443 Sum_probs=173.2
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC----CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP----NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
.++|++.+.||+|+||+||+|++. .+..||||++..... .+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 357899999999999999999974 345699999975432 3578999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||+++|+|.++++.. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 99999999999999754 34589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
..... .......+|++|+|||++.+..++.++||||+|+++|||++ |+.||...
T Consensus 204 ~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 204 DPDAA----YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp ---CC----EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred Cccce----eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 32211 11223356789999999998899999999999999999999 99999654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=329.27 Aligned_cols=201 Identities=24% Similarity=0.345 Sum_probs=166.4
Q ss_pred HHHhcccCC-CeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhc-cCCCceeeEEeeeec----CCce
Q 001873 763 DVVRNLTSA-NVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGS-IRHKNIVRLLGWGSN----KNLK 835 (1001)
Q Consensus 763 ~~~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~-l~h~nIv~l~~~~~~----~~~~ 835 (1001)
.+.++|.+. ++||+|+||+||++... +++.||||++.. ...+.+|+.++.+ .+||||+++++++.. .+..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc---chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 345677776 68999999999999875 689999999853 3567789988744 589999999998765 5678
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC---CCcEEEeccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP---GYQAYLADFGLA 912 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~Dfgla 912 (1001)
++||||+++|+|.+++.+.+...+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999999876556789999999999999999999998 9999999999999997 789999999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
+..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.....
T Consensus 212 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 212 KETTSH--------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp EECC-------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred cccCCC--------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 865321 122345799999999999999999999999999999999999999986543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.89 Aligned_cols=200 Identities=26% Similarity=0.379 Sum_probs=177.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++|++.+.||+|+||+||+|+++++..||||++.... ..+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN 87 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCC
Confidence 5789999999999999999999888899999986544 447799999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
++|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 88 ~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---- 159 (268)
T 3sxs_A 88 GCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---- 159 (268)
T ss_dssp CBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE----
T ss_pred CcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhh----
Confidence 9999999764 23489999999999999999999998 999999999999999999999999999987643211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
.......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||+..
T Consensus 160 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 160 --VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp --EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred --hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 11223356788999999998899999999999999999999 99999754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=334.71 Aligned_cols=197 Identities=29% Similarity=0.447 Sum_probs=175.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecCC-ceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN-LKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~-~~~lv~e~~~~ 844 (1001)
++|++.+.||+|+||+||+|++. ++.||||+++.....++|.+|+.++++++||||+++++++.+.+ ..++||||+++
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~ 271 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence 57888999999999999999985 78999999987777789999999999999999999999976655 78999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.++++..+...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 272 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~------ 342 (450)
T 1k9a_A 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------ 342 (450)
T ss_dssp CBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc------
Confidence 9999999876555579999999999999999999998 9999999999999999999999999999854211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.....+++.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 112257889999999999999999999999999999998 999998654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=318.10 Aligned_cols=201 Identities=24% Similarity=0.343 Sum_probs=160.7
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
.++|++.+.||+|+||+||+|+.+ +++.||||++.... ..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357999999999999999999865 68999999986433 23678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 841 YLPNGSLSSLLHGAG----KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
|++ |+|.+++.... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999986531 23578999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..
T Consensus 160 ~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 160 IPV-------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp SCC-------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCc-------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 12233478999999999876 568999999999999999999999997643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=327.10 Aligned_cols=200 Identities=26% Similarity=0.298 Sum_probs=165.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
.++|++.+.||+|+||+||+++.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 468999999999999999999976 78999999986543 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCc--EEEecccccccccCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQ--AYLADFGLARIVSGSGD 920 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~ki~Dfgla~~~~~~~~ 920 (1001)
++|+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++. +||+|||+|+.....
T Consensus 99 ~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 99 SGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp CSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 999999999764 3489999999999999999999998 9999999999999987765 999999999753221
Q ss_pred CCCCCCCCCCcccccccccCccccccCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQRITEK-SDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
.......||+.|+|||++.+..+..+ +||||+||++|||++|+.||.....
T Consensus 172 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 172 ------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred ------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 12234579999999999988777655 8999999999999999999986543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=329.18 Aligned_cols=207 Identities=27% Similarity=0.391 Sum_probs=164.5
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccC-CCceeeEEeeeecCC--
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIR-HKNIVRLLGWGSNKN-- 833 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~-- 833 (1001)
..+.++|++.+.||+|+||+||+|.+. +++.||||++.... ..+.+.+|+.+++++. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 346789999999999999999999865 68999999985432 2356789999999997 999999999987544
Q ss_pred ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccc
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~ 913 (1001)
..++|||||+ |+|.++++. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+|+
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 6899999997 699999985 3588999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCCC--------------CCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 914 IVSGSGDDN--------------CSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 914 ~~~~~~~~~--------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.+....... ..........+||++|+|||++.+ ..|+.++||||+||++|||++|+.||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 764321110 011122345689999999999876 67899999999999999999999999754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=315.15 Aligned_cols=198 Identities=24% Similarity=0.365 Sum_probs=170.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
++|++.+.||+|+||+||+|+.. +++.||||++..... .+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999975 689999999864332 2678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++ ++.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-- 154 (292)
T ss_dssp CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--
T ss_pred cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc--
Confidence 9985 666666543 34589999999999999999999998 9999999999999999999999999999876422
Q ss_pred CCCCCCCCCCcccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQR-ITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
........||+.|+|||++.+.. ++.++||||+||++|||++|..||...
T Consensus 155 -----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~ 205 (292)
T 3o0g_A 155 -----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp -----CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred -----cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC
Confidence 12223457899999999987655 899999999999999999998886543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=324.52 Aligned_cols=202 Identities=30% Similarity=0.419 Sum_probs=171.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc-hhhHHHHHHHhhccCCCceeeEEeeeecCC----ceEEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE-SGAFSSEIQTLGSIRHKNIVRLLGWGSNKN----LKLLFYD 840 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~----~~~lv~e 840 (1001)
++|++.++||+|+||+||+|++. ++.||||++..... ...+.+|+.++++++||||+++++++.+.. ..++|||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 57999999999999999999985 79999999865432 345677999999999999999999987744 3699999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhC-------CCCCeEEeCCCCCCeEECCCCcEEEecccccc
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHD-------CMPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~-------~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~ 913 (1001)
|+++|+|.++++.. .+++..+..++.|++.|++|||+. +.++|+||||||+||+++.++++||+|||+|+
T Consensus 103 ~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 103 FHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence 99999999999853 489999999999999999999985 12389999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCcccccc-----CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-----QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.+..... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+..
T Consensus 180 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 180 KFEAGKS-----AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp EECTTSC-----CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred ccccccC-----ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 7654321 112233579999999999876 355678899999999999999999998654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=319.99 Aligned_cols=208 Identities=18% Similarity=0.331 Sum_probs=171.4
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCC-----
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN----- 833 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~----- 833 (1001)
.+.++|++.+.||+|+||+||+|+++ +++.||||++.... ..+.+.+|++++++++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 35678999999999999999999976 79999999986433 3367999999999999999999999875543
Q ss_pred ----------------------------------------------------ceEEEEEccCCCCHHHHhhcCCC-CCCC
Q 001873 834 ----------------------------------------------------LKLLFYDYLPNGSLSSLLHGAGK-GGAD 860 (1001)
Q Consensus 834 ----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~-~~~~ 860 (1001)
..++||||+++|+|.+++..... ...+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 37999999999999999986533 2346
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC-----CCCCCCccccc
Q 001873 861 WEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS-----KTNQRPQLAGS 935 (1001)
Q Consensus 861 ~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~-----~~~~~~~~~gt 935 (1001)
+..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++........... .........||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 677899999999999999998 9999999999999999999999999999887544221110 01223445799
Q ss_pred ccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 001873 936 YGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973 (1001)
Q Consensus 936 ~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~ 973 (1001)
+.|+|||++.+..++.++||||+||++|||++|..|+.
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 99999999999999999999999999999999987653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=322.65 Aligned_cols=204 Identities=27% Similarity=0.444 Sum_probs=168.2
Q ss_pred HHhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCCc-----hhhHHHHHHHhhccCCCceeeEEeeeecCCc---
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSDE-----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNL--- 834 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~--- 834 (1001)
+.++|++.+.||+|+||+||+|++ .+++.||||++..... ...+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 457899999999999999999996 4789999999865432 2468899999999999999999998876543
Q ss_pred -eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccc
Q 001873 835 -KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913 (1001)
Q Consensus 835 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~ 913 (1001)
.++||||+++++|.++++.. ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred ccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 39999999999999999864 3489999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.+...... ........||+.|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 165 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 165 AIADSGNS----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp ---------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccc----cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 76433211 122234579999999999999999999999999999999999999998654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=315.73 Aligned_cols=198 Identities=24% Similarity=0.354 Sum_probs=167.8
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----------------------------chhhHHHHHHHhh
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----------------------------ESGAFSSEIQTLG 815 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----------------------------~~~~~~~Ei~~l~ 815 (1001)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367999999999999999999865 68899999985432 1256889999999
Q ss_pred ccCCCceeeEEeeeec--CCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCC
Q 001873 816 SIRHKNIVRLLGWGSN--KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKA 893 (1001)
Q Consensus 816 ~l~h~nIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp 893 (1001)
+++||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.|++.|++|||++ +|+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence 9999999999999876 567899999999999988764 34589999999999999999999998 999999999
Q ss_pred CCeEECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCC---CCCccchHHHHHHHHHHHhCCC
Q 001873 894 MNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR---ITEKSDVYSFGVVLLEVLTGRH 970 (1001)
Q Consensus 894 ~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~il~elltg~~ 970 (1001)
+||+++.++++||+|||+++...... .......||+.|+|||++.+.. ++.++||||+||++|||++|+.
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSD-------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSS-------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred HHEEECCCCCEEEecCCCcccccccc-------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999999999999999998764321 1123347999999999987655 4788999999999999999999
Q ss_pred CCCCC
Q 001873 971 PLDPT 975 (1001)
Q Consensus 971 Pf~~~ 975 (1001)
||...
T Consensus 239 pf~~~ 243 (298)
T 2zv2_A 239 PFMDE 243 (298)
T ss_dssp SSCCS
T ss_pred CCCCc
Confidence 99754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=327.74 Aligned_cols=203 Identities=26% Similarity=0.419 Sum_probs=164.0
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC----CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP----NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
.++|++.+.||+|+||+||+|+.. ++..||||++..... .+++.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999864 577899999865432 3578999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||+++|+|.+++++. ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 99999999999999864 34589999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 200 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 200 DPEAA----YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred CCccc----eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 32111 11122245788999999999999999999999999999998 99999754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=336.60 Aligned_cols=199 Identities=23% Similarity=0.275 Sum_probs=167.1
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 357999999999999999999865 6899999998532 2335678899999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHH-DCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+||+++.++++||+|||+|+....
T Consensus 227 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999999999764 358999999999999999999998 7 999999999999999999999999999986432
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......+||++|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus 302 ~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 302 D-------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp ------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C-------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 2 12233468999999999999999999999999999999999999999764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=337.77 Aligned_cols=212 Identities=21% Similarity=0.282 Sum_probs=174.0
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecC------
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK------ 832 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~------ 832 (1001)
+.++|++.+.||+|+||+||+|+.. +++.||||++.... ..+++.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999865 68999999986432 236788999999999999999999998654
Q ss_pred CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccc
Q 001873 833 NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLA 912 (1001)
Q Consensus 833 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla 912 (1001)
...++||||+++ ++.+.+.. .+++..+..++.|++.|++|||++ +|+||||||+||+++.++++||+|||+|
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 356999999975 57777653 388999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcCcccchhhhhcc
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTPLMFLM 992 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~~~l~~~~~~~~~~ 992 (1001)
+..... ......+||++|+|||++.+..|+.++||||+||++|||++|+.||.+. +...+|..+....
T Consensus 212 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~----~~~~~~~~i~~~l 279 (464)
T 3ttj_A 212 RTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR----DYIDQWNKVIEQL 279 (464)
T ss_dssp -----C--------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHH
T ss_pred eecCCC--------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHhc
Confidence 875321 2234468999999999999999999999999999999999999999653 4556666666555
Q ss_pred cch
Q 001873 993 LNL 995 (1001)
Q Consensus 993 ~~~ 995 (1001)
+.+
T Consensus 280 g~p 282 (464)
T 3ttj_A 280 GTP 282 (464)
T ss_dssp CSC
T ss_pred CCC
Confidence 543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=323.65 Aligned_cols=197 Identities=26% Similarity=0.285 Sum_probs=175.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-chhhHHHHHHHhhccC-----CCceeeEEeeeecCCceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-ESGAFSSEIQTLGSIR-----HKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~-----h~nIv~l~~~~~~~~~~~l 837 (1001)
.++|++.++||+|+||+||+|+.. +++.||||++.... ..+.+.+|+.++++++ ||||+++++++...+..++
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l 113 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL 113 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence 478999999999999999999974 68999999986533 2356788999999886 9999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC-----------------
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP----------------- 900 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~----------------- 900 (1001)
||||+ +++|.+++.......+++..+..++.||+.||+|||+. +|+||||||+||+++.
T Consensus 114 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 114 IFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred EEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccccc
Confidence 99999 89999999887666789999999999999999999998 9999999999999975
Q ss_pred --------CCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 001873 901 --------GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972 (1001)
Q Consensus 901 --------~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf 972 (1001)
++.+||+|||+|+.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSD----------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTS----------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccCCCCEEEEeccCceecCC----------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 78999999999986432 123457899999999999999999999999999999999999999
Q ss_pred CCC
Q 001873 973 DPT 975 (1001)
Q Consensus 973 ~~~ 975 (1001)
...
T Consensus 260 ~~~ 262 (360)
T 3llt_A 260 RTH 262 (360)
T ss_dssp CCS
T ss_pred CCC
Confidence 764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=317.31 Aligned_cols=201 Identities=22% Similarity=0.325 Sum_probs=178.4
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--------chhhHHHHHHHhhccCCCceeeEEeeeecC
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK 832 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~ 832 (1001)
..+.++|++.+.||+|+||.||+|+.. +++.||||++.... ..+++.+|+.++++++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 446678999999999999999999976 68999999885432 235789999999999999999999999999
Q ss_pred CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC----cEEEec
Q 001873 833 NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY----QAYLAD 908 (1001)
Q Consensus 833 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~ki~D 908 (1001)
+..++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++ .+||+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999999999863 4589999999999999999999998 999999999999999887 799999
Q ss_pred ccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 909 FGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 909 fgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
||+++...... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.+.
T Consensus 163 fg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 163 FGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp CTTCEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CccceecCccc--------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 99998764321 123346999999999999999999999999999999999999999764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=326.84 Aligned_cols=206 Identities=19% Similarity=0.312 Sum_probs=171.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC------CCEEEEEEecCCCch-------------hhHHHHHHHhhccCCCceeeEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN------GETLAVKKMWSSDES-------------GAFSSEIQTLGSIRHKNIVRLL 826 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-------------~~~~~Ei~~l~~l~h~nIv~l~ 826 (1001)
++|++.+.||+|+||+||+|++.. ++.||||++...... ..+.+|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 489999999999999999998754 478999998654321 1234466667778899999999
Q ss_pred eeeecC----CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC--C
Q 001873 827 GWGSNK----NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG--P 900 (1001)
Q Consensus 827 ~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~--~ 900 (1001)
+++... ...++||||+ +++|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+||+++ .
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSC
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCC
Confidence 988654 4579999999 99999999874 34589999999999999999999998 999999999999998 8
Q ss_pred CCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 901 GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 901 ~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
++.+||+|||+|+.+..................||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8999999999998875543332222333345679999999999999999999999999999999999999998643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=317.91 Aligned_cols=198 Identities=22% Similarity=0.302 Sum_probs=154.6
Q ss_pred hcccCC---CeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccC-CCceeeEEeeeecCCceEEEEE
Q 001873 766 RNLTSA---NVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 766 ~~~~~~---~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
++|++. +.||+|+||+||++++. +++.||||++... ....+.+|+.+++++. ||||+++++++.+++..++|||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 86 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME 86 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence 445543 78999999999999975 6899999998543 3467889999999997 9999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC---cEEEecccccccccC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY---QAYLADFGLARIVSG 917 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~ki~Dfgla~~~~~ 917 (1001)
|+++|+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++ .+||+|||+++....
T Consensus 87 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 87 LLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp CCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 99999999999874 4589999999999999999999998 999999999999997665 899999999986543
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 162 ~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 162 DN-------QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp -----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred CC-------CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 21 12234478999999999999999999999999999999999999998654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=321.11 Aligned_cols=201 Identities=21% Similarity=0.332 Sum_probs=177.0
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----------chhhHHHHHHHhhccCCCceeeEEeeee
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----------ESGAFSSEIQTLGSIRHKNIVRLLGWGS 830 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~ 830 (1001)
.++.++|++.+.||+|+||+||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 356789999999999999999999864 68999999986543 2346788999999999999999999999
Q ss_pred cCCceEEEEEccCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecc
Q 001873 831 NKNLKLLFYDYLPNG-SLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADF 909 (1001)
Q Consensus 831 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Df 909 (1001)
+.+..++||||+.+| +|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+||
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 999999999999777 999999864 3489999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCCcccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRI-TEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 910 gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
|+++..... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...
T Consensus 175 g~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 175 GSAAYLERG--------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp TTCEECCTT--------CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred ccceECCCC--------CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 999876432 12234579999999999988777 78999999999999999999999753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=328.33 Aligned_cols=202 Identities=24% Similarity=0.353 Sum_probs=174.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++|++.+.||+|+||+||+|++. +++.||||++..... .+++.+|++++++++||||+++++++.+++..++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 57888999999999999999986 789999999865432 25788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++|+|.++++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 194 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~- 268 (377)
T 3cbl_A 194 VQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY- 268 (377)
T ss_dssp CTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE-
T ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce-
Confidence 9999999999754 23478999999999999999999998 999999999999999999999999999986432110
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
........+++.|+|||++....++.++|||||||++|||+| |+.||....
T Consensus 269 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 269 ----AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp ----ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred ----eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 111122346788999999998899999999999999999998 999997653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=316.66 Aligned_cols=210 Identities=29% Similarity=0.418 Sum_probs=171.5
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhc--cCCCceeeEEeeeec----CCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGS--IRHKNIVRLLGWGSN----KNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~--l~h~nIv~l~~~~~~----~~~~~lv 838 (1001)
.++|++.+.||+|+||+||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++.. ....++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 46899999999999999999998 6899999998543 34556666666655 799999999998643 3457899
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEEeCCCCCCeEECCCCcEEEeccc
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH--------HDCMPPILHGDVKAMNVLLGPGYQAYLADFG 910 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfg 910 (1001)
|||+++|+|.++++. ..+++..+.+++.|++.|++||| +. +|+||||||+||+++.++++||+|||
T Consensus 85 ~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 85 THYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp ECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCT
T ss_pred hhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCC
Confidence 999999999999964 45899999999999999999999 76 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCccccccC------CCCCccchHHHHHHHHHHHhC----------CCCCCC
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ------RITEKSDVYSFGVVLLEVLTG----------RHPLDP 974 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~il~elltg----------~~Pf~~ 974 (1001)
+|+......... ........||+.|+|||++.+. .++.++|||||||++|||+|| +.||..
T Consensus 159 ~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 159 LAVMHSQSTNQL---DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp TCEEEETTTTEE---ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred Ceeecccccccc---cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 998765432211 1122344799999999998776 455799999999999999999 888876
Q ss_pred CCCCCcCcccc
Q 001873 975 TLPGGAPLVQW 985 (1001)
Q Consensus 975 ~~~~~~~l~~~ 985 (1001)
..+.+.....+
T Consensus 236 ~~~~~~~~~~~ 246 (301)
T 3q4u_A 236 VVPNDPSFEDM 246 (301)
T ss_dssp TSCSSCCHHHH
T ss_pred cCCCCcchhhh
Confidence 65554443333
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=314.44 Aligned_cols=307 Identities=22% Similarity=0.371 Sum_probs=206.8
Q ss_pred ccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCcc
Q 001873 267 IGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQ 346 (1001)
Q Consensus 267 l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 346 (1001)
+..+++|++|++++|.+... | .+..+++|++|++++|++++. +. +..+++|++|++++|.+++ +| .|.++++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred chhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCC
Confidence 44567777777777777643 3 367777777777777777743 33 7777777777777777774 33 577777777
Q ss_pred EEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCcc
Q 001873 347 ELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNN 426 (1001)
Q Consensus 347 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 426 (1001)
+|++++|++.+..+ +..+++|++|++++|.....++ .+..+++|+.|++++|.+.+..+ +..+++|++|++++|.
T Consensus 114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~ 188 (347)
T 4fmz_A 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ 188 (347)
T ss_dssp EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSC
T ss_pred EEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCc
Confidence 77777777774433 6777777777777775543333 36667777777777777664433 6677777777777777
Q ss_pred ccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCccc
Q 001873 427 LSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPS 506 (1001)
Q Consensus 427 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 506 (1001)
+++..+ +..+++|+.|++++|++++..+ +..+++|++|++++|++++..+ +..+++|++|++++|++++. +.
T Consensus 189 l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~ 260 (347)
T 4fmz_A 189 IEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NA 260 (347)
T ss_dssp CCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GG
T ss_pred cccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hh
Confidence 764333 6677777777777777775543 6677777777777777774433 77777777777777777653 35
Q ss_pred ccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEE
Q 001873 507 VVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILL 586 (1001)
Q Consensus 507 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 586 (1001)
+..+++|++|++++|++++. ..+..+++|+.|++++|++++..|..+..+++|++|
T Consensus 261 ~~~l~~L~~L~l~~n~l~~~------------------------~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 316 (347)
T 4fmz_A 261 VKDLTKLKMLNVGSNQISDI------------------------SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316 (347)
T ss_dssp GTTCTTCCEEECCSSCCCCC------------------------GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEE
T ss_pred HhcCCCcCEEEccCCccCCC------------------------hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEE
Confidence 66677777777777766531 135556677777777777776666777777777777
Q ss_pred ecccccccCCCCCccccccchhhhhhcCCCccc
Q 001873 587 DIGNNRFSGEIPKELGQISSLEISLNLSSNQFS 619 (1001)
Q Consensus 587 ~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~ 619 (1001)
++++|++++..| +..++.|+. |++++|+|+
T Consensus 317 ~L~~n~l~~~~~--~~~l~~L~~-L~l~~N~i~ 346 (347)
T 4fmz_A 317 FLSQNHITDIRP--LASLSKMDS-ADFANQVIK 346 (347)
T ss_dssp ECCSSSCCCCGG--GGGCTTCSE-ESSSCC---
T ss_pred EccCCccccccC--hhhhhccce-eehhhhccc
Confidence 777777775555 666777775 777777664
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=331.86 Aligned_cols=198 Identities=28% Similarity=0.414 Sum_probs=176.0
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.+.||+|+||+||+|++. +|+.||||++... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999976 7999999998532 2346789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++|+|.+++.+. ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 ~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 95 MEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999999764 4589999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRI-TEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||+..
T Consensus 170 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 219 (476)
T 2y94_A 170 --------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219 (476)
T ss_dssp --------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --------ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence 12234579999999999988766 68999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=314.23 Aligned_cols=201 Identities=25% Similarity=0.351 Sum_probs=172.5
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-------chhhHHHHHHHhhccC---CCceeeEEeeeecC
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-------ESGAFSSEIQTLGSIR---HKNIVRLLGWGSNK 832 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~Ei~~l~~l~---h~nIv~l~~~~~~~ 832 (1001)
+.++|++.+.||+|+||+||+|++. +++.||||++.... ....+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3578999999999999999999964 68999999885322 1246778888887775 99999999998765
Q ss_pred C-----ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEe
Q 001873 833 N-----LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLA 907 (1001)
Q Consensus 833 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~ 907 (1001)
. ..++||||+. |+|.+++.......+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 5 4789999997 6999999887666689999999999999999999998 99999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 908 DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 908 Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
|||+|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 163 Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 223 (308)
T 3g33_A 163 DFGLARIYSYQ--------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223 (308)
T ss_dssp SCSCTTTSTTC--------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred eCccccccCCC--------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999865321 22344579999999999999999999999999999999999999997643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=313.29 Aligned_cols=201 Identities=24% Similarity=0.384 Sum_probs=174.8
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccC
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
.++|++.+.||+|+||+||++++.++..||||++.... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 35789999999999999999999888899999997554 44789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+++|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 103 ~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 174 (283)
T 3gen_A 103 NGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---- 174 (283)
T ss_dssp TCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH----
T ss_pred CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc----
Confidence 99999999763 23589999999999999999999998 99999999999999999999999999998754321
Q ss_pred CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
........+|+.|+|||++.+..++.++||||+|+++|||+| |+.||...
T Consensus 175 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 175 --YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp --HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred --cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 111223357889999999998899999999999999999998 99999764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.41 Aligned_cols=201 Identities=25% Similarity=0.294 Sum_probs=176.4
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC--CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS--DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++.++|++.+.||+|+||+||+|+.. ++..||+|++... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 346788999999999999999999976 5789999998543 3457899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE---CCCCcEEEecccccccc
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIV 915 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~ki~Dfgla~~~ 915 (1001)
|||+++++|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||++ +.++.+||+|||++..+
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 85 MELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999999998764 3489999999999999999999998 99999999999999 78899999999999876
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
... .......||+.|+|||++.+. ++.++||||+|+++|||++|+.||....
T Consensus 160 ~~~--------~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 160 KPG--------KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp CTT--------SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCc--------cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 432 122334799999999998654 8999999999999999999999997643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=329.29 Aligned_cols=206 Identities=23% Similarity=0.279 Sum_probs=169.0
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecC-----C
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK-----N 833 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~-----~ 833 (1001)
+.++|++.+.||+|+||+||+|+.. +++.||||++.... ..+++.+|+.++++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3578999999999999999999875 58899999986532 226788999999999999999999998765 5
Q ss_pred ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccc
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~ 913 (1001)
..|+||||++ |+|.++++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|+
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 6899999996 6999999863 4589999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCCCCC---------------CCCCCCcccccccccCcccc-ccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 914 IVSGSGDDNCS---------------KTNQRPQLAGSYGYMAPEHA-SMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 914 ~~~~~~~~~~~---------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
........... ........+||++|+|||++ ....|+.++||||+||++|||++|..||...
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 76543221000 00123566899999999986 5677999999999999999999977766543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=320.53 Aligned_cols=212 Identities=24% Similarity=0.274 Sum_probs=175.4
Q ss_pred ccHHHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC-------CCchhhHHHHHHHhhccCCCceeeEEeeee
Q 001873 759 FSIDDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS-------SDESGAFSSEIQTLGSIRHKNIVRLLGWGS 830 (1001)
Q Consensus 759 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-------~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~ 830 (1001)
-++.++.++|++.+.||+|+||+||+|+.. +++.||+|++.. ....+.+.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 356778899999999999999999999875 688999998843 233467999999999999999999999999
Q ss_pred cCCceEEEEEccCCCCHHHHhhcCC--------------------------------------CCCCCHHHHHHHHHHHH
Q 001873 831 NKNLKLLFYDYLPNGSLSSLLHGAG--------------------------------------KGGADWEARYEVVLGVA 872 (1001)
Q Consensus 831 ~~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------~~~~~~~~~~~i~~~i~ 872 (1001)
+.+..++||||+++|+|.+++.... ...+++..++.++.|++
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 9999999999999999999985210 11125677888999999
Q ss_pred HHHHHHhhCCCCCeEEeCCCCCCeEECCCC--cEEEecccccccccCCCCCCCCCCCCCCcccccccccCcccccc--CC
Q 001873 873 HALAYLHHDCMPPILHGDVKAMNVLLGPGY--QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM--QR 948 (1001)
Q Consensus 873 ~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~--~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~ 948 (1001)
.|++|||++ +|+||||||+||+++.++ .+||+|||+++.+....... ........||+.|+|||++.. ..
T Consensus 179 ~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~ 252 (345)
T 3hko_A 179 SALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE---YYGMTTKAGTPYFVAPEVLNTTNES 252 (345)
T ss_dssp HHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSC
T ss_pred HHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccc---cccccccCCCccccCchhhccCCCC
Confidence 999999998 999999999999998776 89999999998764322211 112234579999999999865 67
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 949 ITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 949 ~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
++.++|||||||++|||++|+.||....
T Consensus 253 ~~~~~DiwslG~il~el~~g~~pf~~~~ 280 (345)
T 3hko_A 253 YGPKCDAWSAGVLLHLLLMGAVPFPGVN 280 (345)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 8999999999999999999999997643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=335.95 Aligned_cols=200 Identities=27% Similarity=0.444 Sum_probs=175.1
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++|++.+.||+|+||+||+|++.++..||||++.... ..+++.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~ 266 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAK 266 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCC
Confidence 5688899999999999999999888999999997543 4578999999999999999999999986 5568999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.++++.......++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 267 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~----- 338 (454)
T 1qcf_A 267 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----- 338 (454)
T ss_dssp CBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-----
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-----
Confidence 9999999864434578999999999999999999998 99999999999999999999999999998764211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
........+|+.|+|||++....++.++|||||||++|||+| |+.||.+.
T Consensus 339 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~ 389 (454)
T 1qcf_A 339 -YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389 (454)
T ss_dssp -HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred -eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 111223356789999999998999999999999999999999 99999764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=332.66 Aligned_cols=198 Identities=24% Similarity=0.284 Sum_probs=154.8
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeec-----CCc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSN-----KNL 834 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~-----~~~ 834 (1001)
.++|++.++||+|+||+||+|++. +++.||||++.... ..+++.+|+.++++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999865 68999999986532 23678899999999999999999999843 356
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.|+||||+. |+|.++++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+|+.
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeccc-cchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 899999985 7999999864 4589999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCCCCC--------------------CCCCCCcccccccccCcccc-ccCCCCCccchHHHHHHHHHHHhC
Q 001873 915 VSGSGDDNCS--------------------KTNQRPQLAGSYGYMAPEHA-SMQRITEKSDVYSFGVVLLEVLTG 968 (1001)
Q Consensus 915 ~~~~~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~il~elltg 968 (1001)
.......... ........+||++|+|||++ ....|+.++||||+||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 6533221100 01233456899999999976 567799999999999999999994
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=310.10 Aligned_cols=209 Identities=21% Similarity=0.282 Sum_probs=174.7
Q ss_pred HHhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeee-ecCCceEEEEEc
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWG-SNKNLKLLFYDY 841 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~-~~~~~~~lv~e~ 841 (1001)
+.++|++.+.||+|+||+||+|+. .+++.||||++......+++.+|+.++++++|++++..++++ ...+..++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 457899999999999999999996 478999999987776667899999999999988776666654 677788999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE---CCCCcEEEecccccccccCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~ki~Dfgla~~~~~~ 918 (1001)
+ +++|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||++ +.++.+||+|||+++.....
T Consensus 87 ~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 87 L-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp C-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred c-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 9 89999999854 34589999999999999999999998 99999999999999 78899999999999887654
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
...............||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 33222222334456899999999999999999999999999999999999999987543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=322.41 Aligned_cols=194 Identities=23% Similarity=0.314 Sum_probs=166.3
Q ss_pred CCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCCCH
Q 001873 771 ANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSL 847 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 847 (1001)
.+.||+|+||+||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999864 68999999987654 346799999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE--CCCCcEEEecccccccccCCCCCCCCC
Q 001873 848 SSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL--GPGYQAYLADFGLARIVSGSGDDNCSK 925 (1001)
Q Consensus 848 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll--~~~~~~ki~Dfgla~~~~~~~~~~~~~ 925 (1001)
.+++.+. ...+++..+..++.||+.|++|||+. +|+||||||+||++ +.++++||+|||+++.+....
T Consensus 174 ~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~------ 243 (373)
T 2x4f_A 174 FDRIIDE-SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE------ 243 (373)
T ss_dssp HHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC------
T ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc------
Confidence 9998754 23589999999999999999999998 99999999999999 677899999999998764321
Q ss_pred CCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 926 TNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 926 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......||+.|+|||++....++.++|||||||++|||++|+.||.+..
T Consensus 244 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 244 --KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp --BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred --ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223469999999999998899999999999999999999999998653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=320.20 Aligned_cols=203 Identities=27% Similarity=0.416 Sum_probs=175.6
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCce
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~ 835 (1001)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .+.+.+|+.++++++||||+++++++.+.+..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 367999999999999999999874 348899999875443 35788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCC
Q 001873 836 LLFYDYLPNGSLSSLLHGAGK----------------------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKA 893 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp 893 (1001)
++||||+++|+|.+++..... ..+++..++.++.||+.|++|||++ +|+||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCc
Confidence 999999999999999986431 4589999999999999999999998 999999999
Q ss_pred CCeEECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCC
Q 001873 894 MNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPL 972 (1001)
Q Consensus 894 ~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf 972 (1001)
+||+++.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||+| |+.||
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ceEEECCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 999999999999999999987643211 112233468899999999998899999999999999999999 99999
Q ss_pred CCC
Q 001873 973 DPT 975 (1001)
Q Consensus 973 ~~~ 975 (1001)
...
T Consensus 278 ~~~ 280 (343)
T 1luf_A 278 YGM 280 (343)
T ss_dssp TTS
T ss_pred CCC
Confidence 764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=320.02 Aligned_cols=199 Identities=23% Similarity=0.295 Sum_probs=172.9
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEEE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
.+.++|++.+.||+|+||+||+++.+ +++.||||++.... ....+|++++.++ +||||+++++++.+.+..++|||
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK--RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT--CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc--CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 35678999999999999999999976 68899999986543 3456788888888 79999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC----CcEEEeccccccccc
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG----YQAYLADFGLARIVS 916 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~ki~Dfgla~~~~ 916 (1001)
|+++|+|.+++.+. ..+++..+..++.||+.|++|||++ +|+||||||+||++.++ +.+||+|||+++...
T Consensus 97 ~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 97 LMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999864 4589999999999999999999998 99999999999998533 359999999998764
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
... ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus 172 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 172 AEN-------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp CTT-------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CCC-------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 321 1223457899999999998888999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=322.10 Aligned_cols=202 Identities=28% Similarity=0.370 Sum_probs=175.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeC--------CCCEEEEEEecCCCch---hhHHHHHHHhhcc-CCCceeeEEeeeecCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP--------NGETLAVKKMWSSDES---GAFSSEIQTLGSI-RHKNIVRLLGWGSNKN 833 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~---~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~ 833 (1001)
++|++.+.||+|+||+||+|++. .+..||||++...... +++.+|+++++++ +||||+++++++.+++
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 57899999999999999999852 2357999998765433 5688999999999 8999999999999999
Q ss_pred ceEEEEEccCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAGK--------------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG 899 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~ 899 (1001)
..++||||+++|+|.+++..... ..+++..+.+++.|++.||+|||++ +|+||||||+||+++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEc
Confidence 99999999999999999987542 3589999999999999999999998 999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 900 PGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 900 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
.++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCT-----TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCcEEEcccCcccccccccc-----cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999987643221 112233467899999999999999999999999999999999 99999764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=315.33 Aligned_cols=204 Identities=28% Similarity=0.392 Sum_probs=176.4
Q ss_pred HhcccCCCeEeecCCeeEEEEEe------CCCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCce
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI------PNGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~ 835 (1001)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46799999999999999999985 2458899999865433 25788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCC
Q 001873 836 LLFYDYLPNGSLSSLLHGAGK----------------------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKA 893 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp 893 (1001)
++||||+++|+|.+++..... ..+++..++.++.|++.|++|||++ +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999987533 2378999999999999999999998 999999999
Q ss_pred CCeEECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCC
Q 001873 894 MNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPL 972 (1001)
Q Consensus 894 ~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf 972 (1001)
+||+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDS-----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSC-----EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred heEEEcCCCCEEEcccccccccccccc-----ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999987643221 112233457889999999998899999999999999999999 99999
Q ss_pred CCCC
Q 001873 973 DPTL 976 (1001)
Q Consensus 973 ~~~~ 976 (1001)
....
T Consensus 254 ~~~~ 257 (314)
T 2ivs_A 254 PGIP 257 (314)
T ss_dssp TTCC
T ss_pred CCCC
Confidence 8654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=325.10 Aligned_cols=203 Identities=26% Similarity=0.359 Sum_probs=173.8
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCce
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~ 835 (1001)
.++|++.+.||+|+||+||+|++. +++.||||++..... ..++.+|+.++++++||||+++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367899999999999999999843 467899999865432 25688999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC---cEEEe
Q 001873 836 LLFYDYLPNGSLSSLLHGAGK-----GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY---QAYLA 907 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~ki~ 907 (1001)
++||||+++|+|.++++..+. ..+++..++.++.|+++|++|||++ +|+||||||+||+++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999976432 3478999999999999999999998 999999999999999554 59999
Q ss_pred cccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 908 DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 908 Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
|||+|+.+..... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 227 DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~ 290 (367)
T 3l9p_A 227 DFGMARDIYRAGY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290 (367)
T ss_dssp CCHHHHHHHHHSS-----CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCccccccccccc-----cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999986543211 112234468999999999999999999999999999999998 99999764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=315.36 Aligned_cols=208 Identities=25% Similarity=0.313 Sum_probs=169.3
Q ss_pred HhcccCC-CeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEE
Q 001873 765 VRNLTSA-NVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 765 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
.+.|++. +.||+|+||+||+|+.. +++.||||++.... ..+.+.+|++++.++ +||||+++++++.+++..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4578874 78999999999999864 78999999986543 346789999999885 7999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCc---EEEeccccccccc
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQ---AYLADFGLARIVS 916 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~ki~Dfgla~~~~ 916 (1001)
||+++|+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++. +||+|||+++...
T Consensus 91 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 999999999999864 3589999999999999999999998 9999999999999998765 9999999998764
Q ss_pred CCCCCCCCCCCCCCcccccccccCcccccc-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASM-----QRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
.................||+.|+|||++.. ..++.++||||+||++|||++|+.||.....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 231 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccc
Confidence 332211111222334569999999999865 5688999999999999999999999987653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=337.23 Aligned_cols=202 Identities=26% Similarity=0.416 Sum_probs=178.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC-CCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN-GETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
.+|++.+.||+|+||+||+|++.. +..||||++.... ..++|.+|+.++++++||||+++++++.+.+..++|||||+
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~ 299 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 299 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence 468888999999999999999864 8899999986543 45789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+|+|.++++......+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 300 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---- 372 (495)
T 1opk_A 300 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT---- 372 (495)
T ss_dssp TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC----
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc----
Confidence 99999999876666789999999999999999999998 99999999999999999999999999998764321
Q ss_pred CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
........+++.|+|||++....++.++|||||||++|||+| |+.||.+..
T Consensus 373 --~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~ 424 (495)
T 1opk_A 373 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424 (495)
T ss_dssp --EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred --eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence 111223356789999999998899999999999999999999 999998654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=312.68 Aligned_cols=200 Identities=26% Similarity=0.362 Sum_probs=170.3
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
.++|++.+.||+|+||+||+|+.. +++.||||++..... .+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999976 589999999865443 256788999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++++|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.++......
T Consensus 82 e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp ECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999999998754 4489999999999999999999998 99999999999999999999999999998764321
Q ss_pred CCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+..
T Consensus 157 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 157 -------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp ----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 11233478999999999865 678999999999999999999999997653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=313.28 Aligned_cols=197 Identities=33% Similarity=0.479 Sum_probs=166.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNG 845 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 845 (1001)
++|++.+.||+|+||+||+|++. ++.||||++......+.+.+|++++++++||||+++++++.+ ..++||||+++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~ 84 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG 84 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence 57889999999999999999984 789999999877777889999999999999999999998874 478999999999
Q ss_pred CHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCc-EEEecccccccccCCCCCCC
Q 001873 846 SLSSLLHGAGK-GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQ-AYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 846 sL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~-~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+|.++++.... ...++..+..++.|+++|++|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----- 159 (307)
T 2eva_A 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----- 159 (307)
T ss_dssp BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----
Confidence 99999986533 24688999999999999999999932228999999999999988876 799999999764321
Q ss_pred CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||+..
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 160 -----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred -----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 12236899999999999999999999999999999999999999864
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=311.91 Aligned_cols=308 Identities=22% Similarity=0.344 Sum_probs=241.0
Q ss_pred ccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhcccccc
Q 001873 290 RIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTAL 369 (1001)
Q Consensus 290 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 369 (1001)
.+..+++|+.|++++|.+.. +| .+..+++|++|++++|.+++. +. +..+++|++|++++|+++. + ..+..+++|
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L 112 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-I-SALQNLTNL 112 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTC
T ss_pred cchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-c-hHHcCCCcC
Confidence 35578899999999999984 44 488899999999999999854 44 8899999999999999985 3 368899999
Q ss_pred CEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCC
Q 001873 370 THLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSN 449 (1001)
Q Consensus 370 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 449 (1001)
++|++++|++++..+ +..+++|+.|++++|.....++. +..+++|++|++++|.+.+..+ +..+++|++|++++|
T Consensus 113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187 (347)
T ss_dssp SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred CEEECcCCcccCchh--hccCCceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence 999999999885433 77788888888888865544443 7777888888888887775433 667777777777777
Q ss_pred cCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCcccCCC
Q 001873 450 DLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPD 529 (1001)
Q Consensus 450 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 529 (1001)
++.+..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|++++..+ +..+++|++|++++|++++
T Consensus 188 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~---- 257 (347)
T 4fmz_A 188 QIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD---- 257 (347)
T ss_dssp CCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC----
T ss_pred ccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC----
Confidence 7765433 6677777777777777764433 6667777777777777764433 6666677777666666652
Q ss_pred CcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhh
Q 001873 530 TLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEI 609 (1001)
Q Consensus 530 ~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 609 (1001)
. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..|..+..+++|+.
T Consensus 258 ------------------~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 315 (347)
T 4fmz_A 258 ------------------I--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT 315 (347)
T ss_dssp ------------------C--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSE
T ss_pred ------------------C--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCE
Confidence 1 2467789999999999999965 46889999999999999999999999999999997
Q ss_pred hhhcCCCcccccccccccccccccEEEecCCcCC
Q 001873 610 SLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLS 643 (1001)
Q Consensus 610 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 643 (1001)
|++++|++++..| +..+++|+.|++++|+++
T Consensus 316 -L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 316 -LFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp -EECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred -EEccCCccccccC--hhhhhccceeehhhhccc
Confidence 9999999998777 889999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=311.44 Aligned_cols=197 Identities=25% Similarity=0.295 Sum_probs=166.0
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEE
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~l 837 (1001)
+.++|++.++||+|+||+||+|+.. +++.||||++..... ..++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 4578999999999999999999976 799999999855332 23455566665555 89999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||+ +++|.+++... ...+++..++.++.|++.|++|||++ +|+||||||+||+++.++++||+|||++.....
T Consensus 135 v~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 99999 67999988765 34589999999999999999999998 999999999999999999999999999987543
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
. .......||++|+|||++.+ .++.++|||||||++|||++|..||..
T Consensus 210 ~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 210 A--------GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp -------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred C--------CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2 12233469999999999875 789999999999999999999776643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=321.81 Aligned_cols=200 Identities=27% Similarity=0.330 Sum_probs=172.3
Q ss_pred hcccCCCeEeecCCeeEEEEEe----CCCCEEEEEEecCC------CchhhHHHHHHHhhcc-CCCceeeEEeeeecCCc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI----PNGETLAVKKMWSS------DESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNL 834 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~------~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~ 834 (1001)
++|++.+.||+|+||+||+++. .+++.||||++... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999987 36899999988542 2335678899999999 69999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++++||+|||+++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999864 3489999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM--QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 209 ~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 209 FVAD------ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp CCGG------GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred cccC------CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 5322 1122334579999999999875 457899999999999999999999998643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=307.99 Aligned_cols=207 Identities=21% Similarity=0.291 Sum_probs=177.8
Q ss_pred HhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeee-ecCCceEEEEEcc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWG-SNKNLKLLFYDYL 842 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~-~~~~~~~lv~e~~ 842 (1001)
.++|++.+.||+|+||+||+|+. .+++.||||++......+++.+|+.++++++|++++..++++ ...+..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 46899999999999999999996 478999999987777777899999999999988766666544 6677889999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC---CCCcEEEecccccccccCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG---PGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~ki~Dfgla~~~~~~~ 919 (1001)
+++|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++ .++.+||+|||+++......
T Consensus 88 -~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 88 -GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp -CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred -CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 89999999754 34589999999999999999999998 999999999999994 88899999999998876543
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
..............||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 322222223445679999999999999999999999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=313.39 Aligned_cols=203 Identities=28% Similarity=0.402 Sum_probs=169.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEe-----CCCCEEEEEEecCCCch--hhHHHHHHHhhccCCCceeeEEeeeec--CCce
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI-----PNGETLAVKKMWSSDES--GAFSSEIQTLGSIRHKNIVRLLGWGSN--KNLK 835 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~--~~~~~Ei~~l~~l~h~nIv~l~~~~~~--~~~~ 835 (1001)
.++|++.+.||+|+||+||++++ .+++.||||++...... +.+.+|++++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36799999999999999999984 36889999998655433 678999999999999999999998854 3558
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
++||||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++++||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999998652 3489999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
...... ........+|..|+|||++.+..++.++||||+|+++|||+||..||...
T Consensus 165 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 165 PQDKEF----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp ---------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred cCCcce----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 433211 11223345788899999999999999999999999999999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=323.75 Aligned_cols=204 Identities=28% Similarity=0.362 Sum_probs=173.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEe------CCCCEEEEEEecCCCch---hhHHHHHHHhhcc-CCCceeeEEeeeecCC-
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI------PNGETLAVKKMWSSDES---GAFSSEIQTLGSI-RHKNIVRLLGWGSNKN- 833 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~---~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~- 833 (1001)
.++|++.+.||+|+||.||+|++ .+++.||||++...... +.+.+|+++++++ +||||+++++++.+.+
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 46899999999999999999973 24689999999764433 5689999999999 7999999999987755
Q ss_pred ceEEEEEccCCCCHHHHhhcCCC---------------------------------------------------------
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAGK--------------------------------------------------------- 856 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 856 (1001)
..++||||+++|+|.++++....
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 48999999999999999986532
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCCCC
Q 001873 857 -------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR 929 (1001)
Q Consensus 857 -------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~ 929 (1001)
..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.+..... ....
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-----~~~~ 252 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-----YVRK 252 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-----CEEC
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-----chhc
Confidence 1178899999999999999999998 999999999999999999999999999987643221 1122
Q ss_pred CcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 930 PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 930 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+..
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 34568999999999999999999999999999999998 999997654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=328.32 Aligned_cols=203 Identities=24% Similarity=0.362 Sum_probs=174.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCC--ceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN--LKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~--~~~lv~ 839 (1001)
++|++.++||+|+||+||+|++. +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 57999999999999999999976 58999999986432 3467889999999999999999999987655 679999
Q ss_pred EccCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE----CCCCcEEEeccccccc
Q 001873 840 DYLPNGSLSSLLHGAGK-GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL----GPGYQAYLADFGLARI 914 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~ki~Dfgla~~ 914 (1001)
||+++|+|.++++.... ..+++..++.++.|++.|++|||++ +|+||||||+||++ +.++.+||+|||+|+.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999986432 2389999999999999999999998 99999999999999 7788899999999987
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCcccccc--------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM--------QRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGG 979 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~ 979 (1001)
.... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||.+.....
T Consensus 166 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~ 230 (396)
T 4eut_A 166 LEDD--------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230 (396)
T ss_dssp CCCG--------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT
T ss_pred ccCC--------CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc
Confidence 6432 12233579999999998864 567789999999999999999999998755443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=305.40 Aligned_cols=202 Identities=25% Similarity=0.398 Sum_probs=157.7
Q ss_pred HHhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
..++|++.+.||+|+||.||+|+. .+++.||||++... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346799999999999999999997 47899999998532 223678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||+++++|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.+.....
T Consensus 89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999999864 34589999999999999999999998 999999999999999999999999999987542
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.. .......||+.|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 165 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 165 PH-------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp ----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred CC-------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 21 11223478999999999998889999999999999999999999998654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=343.29 Aligned_cols=199 Identities=24% Similarity=0.311 Sum_probs=176.8
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC-----CCchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS-----SDESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~l 837 (1001)
.++|++.++||+|+||+||+|+.+ +++.||||++.. ....+.+.+|..++..+ +||+|+++++++.+.+..|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 467999999999999999999975 688999999853 23446788899999988 79999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||+++|+|.++++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 420 V~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999999874 3489999999999999999999998 999999999999999999999999999986432
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.. ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.
T Consensus 495 ~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 495 DG-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp TT-------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CC-------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 21 2234568999999999999999999999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=321.91 Aligned_cols=195 Identities=24% Similarity=0.352 Sum_probs=165.0
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCC-----
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKN----- 833 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~----- 833 (1001)
+.++|++.+.||+|+||+||+|... +|+.||||++..... .+++.+|++++++++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3468999999999999999999974 699999999854332 356889999999999999999999987653
Q ss_pred -ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccc
Q 001873 834 -LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLA 912 (1001)
Q Consensus 834 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla 912 (1001)
..++||||+ +++|.++++. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+|
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 7899999985 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+.... .....+||++|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 176 ~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 176 RQADS----------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp EECCS----------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccc----------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 87532 1234578999999999876 78999999999999999999999999764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=316.17 Aligned_cols=201 Identities=25% Similarity=0.403 Sum_probs=167.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCC----EEEEEEecCC---CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGE----TLAVKKMWSS---DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
++|++.++||+|+||+||+|++. +++ +||+|++... ...+++.+|+.++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 57899999999999999999864 344 3688877543 23467999999999999999999999998765 688
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
|+||+++|+|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++++||+|||+|+....
T Consensus 94 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 99999999999999875 34589999999999999999999998 999999999999999999999999999987754
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||+...
T Consensus 170 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 224 (327)
T 3poz_A 170 EEKE-----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp TCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred Cccc-----ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence 3221 12223457889999999999999999999999999999999 999998653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.93 Aligned_cols=206 Identities=26% Similarity=0.366 Sum_probs=178.6
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
+.++|++.+.||+|+||+||+|+.. +++.||||++.... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 4678999999999999999999976 68999999985432 3367889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+..+....
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 85 EYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp ECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999999753 4589999999999999999999998 99999999999999999999999999998654321
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRI-TEKSDVYSFGVVLLEVLTGRHPLDPTLPGG 979 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~elltg~~Pf~~~~~~~ 979 (1001)
. ........||+.|+|||++.+..+ +.++||||+|+++|||++|+.||+......
T Consensus 160 ~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 215 (276)
T 2yex_A 160 R-----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215 (276)
T ss_dssp E-----ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS
T ss_pred c-----hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 1 112234578999999999987665 678999999999999999999998765443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.73 Aligned_cols=200 Identities=28% Similarity=0.420 Sum_probs=177.0
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++|++.+.||+|+||.||++++.+++.||+|++.... ..+++.+|++++++++||||+++++++.+++..++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 5788999999999999999999888999999997654 346899999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
++|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~----- 158 (267)
T 3t9t_A 88 GCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ----- 158 (267)
T ss_dssp CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-----
T ss_pred CcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc-----
Confidence 9999999865 34579999999999999999999998 99999999999999999999999999998753211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 159 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred -ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 111223457889999999998899999999999999999999 89999764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=306.19 Aligned_cols=197 Identities=28% Similarity=0.473 Sum_probs=172.0
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 357999999999999999999865 5789999988432 2235788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 9999999999999864 3489999999999999999999998 9999999999999999999999999998654221
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......||+.|+|||++.+..++.++||||+|+++|+|++|+.||...
T Consensus 163 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 210 (279)
T 3fdn_A 163 ---------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210 (279)
T ss_dssp --------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ---------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence 223347899999999999999999999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=324.14 Aligned_cols=206 Identities=22% Similarity=0.311 Sum_probs=175.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC---------CCEEEEEEecCCCchhhHHHHHHHhhccCCCceee------------
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN---------GETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVR------------ 824 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~------------ 824 (1001)
++|++.+.||+|+||+||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 689999999999999999999763 789999998644 57889999999999999987
Q ss_pred ---EEeeeec-CCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC
Q 001873 825 ---LLGWGSN-KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP 900 (1001)
Q Consensus 825 ---l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 900 (1001)
+++++.. .+..++||||+ +++|.+++.......+++..+..++.|++.|++|||++ +|+||||||+||+++.
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDP 194 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEET
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcC
Confidence 5666665 67889999999 99999999876446689999999999999999999998 9999999999999999
Q ss_pred CC--cEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001873 901 GY--QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978 (1001)
Q Consensus 901 ~~--~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~ 978 (1001)
++ .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||++|+.||....+.
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 9999999999877544332222222334558999999999999999999999999999999999999999876533
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.76 Aligned_cols=194 Identities=22% Similarity=0.321 Sum_probs=170.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecC--CceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK--NLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~--~~~~lv~ 839 (1001)
++|++.+.||+|+||+||+|++. ++.||||++.... ..+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57899999999999999999984 8999999986543 235789999999999999999999999876 7889999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPP--ILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||+++|+|.++++......+++..+..++.|++.|++|||+. + |+||||||+||+++.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 999999999999976555689999999999999999999997 7 9999999999999999999999998875421
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCC---ccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITE---KSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.....||+.|+|||++.+..++. ++||||+|+++|||++|+.||...
T Consensus 165 -----------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 165 -----------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp -----------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred -----------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 12236899999999998765544 799999999999999999999754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=317.31 Aligned_cols=204 Identities=29% Similarity=0.398 Sum_probs=175.0
Q ss_pred HhcccCCCeEeecCCeeEEEEEe------CCCCEEEEEEecCCC---chhhHHHHHHHhhcc-CCCceeeEEeeeecCCc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI------PNGETLAVKKMWSSD---ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNL 834 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~ 834 (1001)
.++|++.+.||+|+||+||+|++ .+++.||||++.... ..+.+.+|+.+++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 36789999999999999999986 245689999986432 346799999999999 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCC
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGK---------------------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKA 893 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp 893 (1001)
.++||||+++|+|.+++..... ..+++..+..++.|++.|++|||++ +|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCh
Confidence 9999999999999999986532 2368999999999999999999998 999999999
Q ss_pred CCeEECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCC
Q 001873 894 MNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPL 972 (1001)
Q Consensus 894 ~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf 972 (1001)
+||+++.++.+||+|||++........ ........||+.|+|||++.+..++.++||||||+++|||+| |+.||
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred hhEEEcCCCcEEeCCCccCcccccCcc-----ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999987643321 112234467889999999988999999999999999999998 99999
Q ss_pred CCCC
Q 001873 973 DPTL 976 (1001)
Q Consensus 973 ~~~~ 976 (1001)
....
T Consensus 276 ~~~~ 279 (344)
T 1rjb_A 276 PGIP 279 (344)
T ss_dssp TTCC
T ss_pred ccCC
Confidence 8754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=306.26 Aligned_cols=199 Identities=26% Similarity=0.370 Sum_probs=174.7
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
+.++|++.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3478999999999999999999875 68999999985433 225688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCc---EEEecccccccc
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQ---AYLADFGLARIV 915 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~ki~Dfgla~~~ 915 (1001)
|||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++. +||+|||.+...
T Consensus 84 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999999988764 4489999999999999999999998 9999999999999986654 999999999865
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||...
T Consensus 159 ~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 210 (284)
T 3kk8_A 159 NDS--------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210 (284)
T ss_dssp CSS--------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccC--------ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence 422 1123357999999999999999999999999999999999999999654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=332.07 Aligned_cols=201 Identities=29% Similarity=0.435 Sum_probs=171.0
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++|++.+.||+|+||+||+|++.++..||||++.... ..+++.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~ 262 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 262 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcC
Confidence 5688889999999999999999888889999987543 34789999999999999999999999876 668999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.++++......+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 263 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---- 335 (452)
T 1fmk_A 263 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---- 335 (452)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCce----
Confidence 9999999764345589999999999999999999998 999999999999999999999999999987643211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.......+++.|+|||++....++.++||||||+++|||++ |+.||.+..
T Consensus 336 --~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 386 (452)
T 1fmk_A 336 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred --ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence 11223357789999999998999999999999999999999 999997653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=315.13 Aligned_cols=199 Identities=24% Similarity=0.330 Sum_probs=167.0
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCch---hhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDES---GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++|++.+.||+|+||+||+|+.. +++.||||++...... ..+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999976 7899999998643322 3566899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
++ |+|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--- 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP--- 153 (324)
T ss_dssp CS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC---
Confidence 97 6999998865 34589999999999999999999998 9999999999999999999999999999865322
Q ss_pred CCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..
T Consensus 154 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 154 ----TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ----ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 112233478999999999876 678999999999999999999999997653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=322.11 Aligned_cols=204 Identities=22% Similarity=0.344 Sum_probs=168.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeC----CCCEEEEEEecCCCc-------------hhhHHHHHHHhhccCCCceeeEEee
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP----NGETLAVKKMWSSDE-------------SGAFSSEIQTLGSIRHKNIVRLLGW 828 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-------------~~~~~~Ei~~l~~l~h~nIv~l~~~ 828 (1001)
++|++.+.||+|+||+||+|+.. ++..||||++..... ...+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57999999999999999999975 578899999865432 1346678889999999999999999
Q ss_pred eec----CCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC--
Q 001873 829 GSN----KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY-- 902 (1001)
Q Consensus 829 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~-- 902 (1001)
+.. ....++||||+ +++|.+++...+ .+++..++.++.||+.|++|||++ +|+||||||+||+++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence 877 77889999999 999999998653 689999999999999999999998 999999999999998877
Q ss_pred cEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 903 QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 903 ~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.+||+|||+|+.+..................||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9999999999877543322222222334567999999999999999999999999999999999999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=304.67 Aligned_cols=200 Identities=23% Similarity=0.353 Sum_probs=174.4
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--------chhhHHHHHHHhhccCCCceeeEEeeeecCCc
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNL 834 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~ 834 (1001)
+.++|++.+.||+|+||+||+++.. +++.||||.+.... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 3467999999999999999999976 68999999885432 24678999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC----cEEEeccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY----QAYLADFG 910 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~ki~Dfg 910 (1001)
.++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999999763 3589999999999999999999998 999999999999998877 89999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.+....... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||....
T Consensus 158 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 158 IAHKIEAGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp TCEECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cceeccCCC--------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 998754321 1233468999999999998999999999999999999999999998653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=307.65 Aligned_cols=196 Identities=28% Similarity=0.506 Sum_probs=169.0
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCch---------hhHHHHHHHhhccCCCceeeEEeeeecCCce
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDES---------GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~ 835 (1001)
++|++.+.||+|+||+||+|++. +++.||||++...... +.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 57899999999999999999974 7899999998543211 57889999999999999999999987655
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEeCCCCCCeEECCCCc-----EEEec
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPP--ILHGDVKAMNVLLGPGYQ-----AYLAD 908 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NIll~~~~~-----~ki~D 908 (1001)
++||||+++|+|.+++.+. ...+++..+..++.|++.|++|||++ + |+||||||+||+++.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 7999999999999998764 34689999999999999999999998 8 999999999999988776 99999
Q ss_pred ccccccccCCCCCCCCCCCCCCcccccccccCcccc--ccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 909 FGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHA--SMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 909 fgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
||+++.... ......||+.|+|||++ ....++.++||||+||++|||++|+.||.....
T Consensus 173 fg~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 173 FGLSQQSVH----------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp CTTCBCCSS----------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CCccccccc----------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 999975321 22335799999999998 445678999999999999999999999986543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.02 Aligned_cols=201 Identities=26% Similarity=0.363 Sum_probs=171.3
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
++.++|++.+.||+|+||+||+++.. +++.||+|++.... ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 45678999999999999999999875 68999999985433 347899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE---CCCCcEEEecccccc
Q 001873 839 YDYLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLAR 913 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~ki~Dfgla~ 913 (1001)
|||+++|+|.+++... ....+++..+..++.|++.|++|||++ +|+||||||+||++ +.++.+||+|||+++
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999998642 235589999999999999999999998 99999999999999 456889999999998
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
..... .......||+.|+|||++. ..++.++||||+|+++|||++|+.||.+.
T Consensus 176 ~~~~~--------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~ 228 (285)
T 3is5_A 176 LFKSD--------EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228 (285)
T ss_dssp C------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCc--------ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence 65432 1223457999999999886 56889999999999999999999999764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=311.88 Aligned_cols=205 Identities=21% Similarity=0.311 Sum_probs=176.9
Q ss_pred cHHHHHhcccCC-CeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccC-CCceeeEEeeeecC
Q 001873 760 SIDDVVRNLTSA-NVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIR-HKNIVRLLGWGSNK 832 (1001)
Q Consensus 760 ~~~~~~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~ 832 (1001)
..+.+.++|.+. +.||+|+||+||+|+.. +++.||||++.... ....+.+|+.++++++ ||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 346677888887 88999999999999876 68999999886432 2467889999999994 69999999999999
Q ss_pred CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC---CCcEEEecc
Q 001873 833 NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP---GYQAYLADF 909 (1001)
Q Consensus 833 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~Df 909 (1001)
+..++||||+++|+|.+++.......+++..+..++.|++.|++|||++ +|+||||||+||+++. ++.+||+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999999999766556789999999999999999999998 9999999999999987 789999999
Q ss_pred cccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 910 gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
|+++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus 179 g~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 179 GMSRKIGHAC--------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp GGCEEC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccCCcc--------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9998764221 123357999999999999999999999999999999999999999764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=315.70 Aligned_cols=195 Identities=32% Similarity=0.391 Sum_probs=170.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCCc-----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSDE-----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.+.|+..+.||+|+||+||+|+. .+++.||||++..... .+++.+|++++++++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45688999999999999999986 4789999999864321 25688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||++ |++.+++... ...+++..+..++.|+++|++|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 99997 6888888643 34589999999999999999999998 999999999999999999999999999986532
Q ss_pred CCCCCCCCCCCCcccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHAS---MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 207 ----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 207 ----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp ----------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ----------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 12347999999999884 577899999999999999999999999754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=311.82 Aligned_cols=203 Identities=30% Similarity=0.396 Sum_probs=176.8
Q ss_pred hcccCCCeEeecCCeeEEEEEe------CCCCEEEEEEecCCCc---hhhHHHHHHHhhcc-CCCceeeEEeeeecCCce
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI------PNGETLAVKKMWSSDE---SGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~ 835 (1001)
++|++.+.||+|+||+||+|++ .+++.||||++..... .+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 5789999999999999999984 3468899999875543 36788999999999 999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCCC----------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKG----------------GADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG 899 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~----------------~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~ 899 (1001)
++||||+++|+|.+++...... .+++..+.+++.|++.|++|||++ +|+||||||+||+++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEc
Confidence 9999999999999999865432 479999999999999999999998 999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 900 PGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 900 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||+|+++|||+| |+.||....
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CCCCEEEcccccccccccccc-----ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999999999999987643321 111233467889999999998999999999999999999999 999998654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.21 Aligned_cols=200 Identities=27% Similarity=0.423 Sum_probs=174.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++|++.+.||+|+||+||+|+..+++.||||++.... ..+.+.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 91 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCC
Confidence 5789999999999999999998888899999986543 45789999999999999999999999874 457999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
++|.+++.......+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||.+........
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 164 (279)
T 1qpc_A 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---- 164 (279)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE----
T ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc----
Confidence 9999999754333589999999999999999999998 999999999999999999999999999987643211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
.......+++.|+|||++.+..++.++||||+|+++|||++ |+.||...
T Consensus 165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 165 --TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp --ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred --ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 11223457889999999988889999999999999999999 99999764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=327.49 Aligned_cols=200 Identities=25% Similarity=0.273 Sum_probs=175.5
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-hhhHHHHHHHhhcc------CCCceeeEEeeeecCC
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-SGAFSSEIQTLGSI------RHKNIVRLLGWGSNKN 833 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~Ei~~l~~l------~h~nIv~l~~~~~~~~ 833 (1001)
+.+..+|++.++||+|+||+||+|+.. +++.||||++..... .+++.+|+++++.+ +|+||+++++++...+
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 345578999999999999999999865 589999999965433 35677888888877 5779999999999999
Q ss_pred ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCc--EEEecccc
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQ--AYLADFGL 911 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~ki~Dfgl 911 (1001)
..++||||+. ++|.+++.......+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999996 7999999887666789999999999999999999998 9999999999999999887 99999999
Q ss_pred cccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 912 ARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 912 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
|..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 249 a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 249 SCYEHQ----------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CEETTC----------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecCC----------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 976422 122347999999999999999999999999999999999999999765
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=316.94 Aligned_cols=198 Identities=25% Similarity=0.366 Sum_probs=166.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc----hhhHHHHHHHhhccCC--CceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE----SGAFSSEIQTLGSIRH--KNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h--~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||+||++...+++.||||++..... .+.+.+|+.++++++| |||+++++++.+++..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 56999999999999999999998899999999864432 2568899999999976 99999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
|+ .+++|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++ ++.+||+|||+|+.+....
T Consensus 89 e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 89 EC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp CC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred eC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 95 578999999874 4589999999999999999999998 999999999999997 5789999999998764322
Q ss_pred CCCCCCCCCCCcccccccccCcccccc-----------CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASM-----------QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 162 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 162 T-----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp -------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred c-----cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 1 112234579999999999864 67889999999999999999999999764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=310.32 Aligned_cols=203 Identities=26% Similarity=0.402 Sum_probs=179.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
.++|++.+.||+|+||+||+|++. +++.||||++..... .+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 91 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence 357899999999999999999976 488999999865543 477999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
++++|.+++.......+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.+.......
T Consensus 92 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 165 (288)
T 3kfa_A 92 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--- 165 (288)
T ss_dssp TTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS---
T ss_pred CCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc---
Confidence 999999999887667789999999999999999999998 99999999999999999999999999998764321
Q ss_pred CCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
........+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||....
T Consensus 166 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~ 217 (288)
T 3kfa_A 166 ---YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217 (288)
T ss_dssp ---SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ---cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 112233467889999999998999999999999999999999 999997643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=305.48 Aligned_cols=199 Identities=23% Similarity=0.369 Sum_probs=176.2
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.+.||+|+||+||+++.. +++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999976 58899999885432 235788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++++|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.++.....
T Consensus 94 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999998764 3589999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......||+.|+|||++.+..++.++||||+|+++|||++|+.||+..
T Consensus 169 ~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 218 (294)
T 2rku_A 169 G-------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218 (294)
T ss_dssp T-------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred c-------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1223357899999999999889999999999999999999999999764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=314.62 Aligned_cols=201 Identities=28% Similarity=0.418 Sum_probs=169.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCE----EEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGET----LAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~----vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
++|++.+.||+|+||+||+|++. +++. ||+|.+.... ..+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEE
Confidence 57889999999999999999864 3443 7888774432 23578899999999999999999999864 56789
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||+++|+|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++++||+|||+|+.+..
T Consensus 92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999999864 33578899999999999999999998 999999999999999999999999999998654
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.... .......||+.|+|||++.+..++.++||||+|+++|||+| |+.||....
T Consensus 168 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 168 DDKQ-----LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp CTTC-----CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccc-----ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 3221 12234468889999999998999999999999999999999 999998653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=304.39 Aligned_cols=197 Identities=30% Similarity=0.481 Sum_probs=163.0
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC------chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||.||+|++. ++.||||++.... ..+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57889999999999999999984 8999999885432 2367889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC--------CCcEEEecccc
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP--------GYQAYLADFGL 911 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~--------~~~~ki~Dfgl 911 (1001)
||+++++|.+++.. ..+++..+..++.|++.|++|||++...+|+||||||+||+++. ++.+||+|||.
T Consensus 86 e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 86 EFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp ECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999999999963 45899999999999999999999982222999999999999986 77899999999
Q ss_pred cccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 912 ARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 912 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
++..... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus 163 ~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 163 AREWHRT---------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp ----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred ccccccc---------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9865322 112346899999999999999999999999999999999999999764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=306.88 Aligned_cols=201 Identities=28% Similarity=0.375 Sum_probs=162.3
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCC----CCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPN----GETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
.++|++.+.||+|+||+||+|++.. +..||+|++..... .+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3679999999999999999998643 45699999865432 357889999999999999999999985 456799
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||+++|+|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCc
Confidence 99999999999999864 34589999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
... .......+|+.|+|||++....++.++||||+|+++|||++ |+.||....
T Consensus 169 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~ 222 (281)
T 1mp8_A 169 STY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccc------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence 211 11223357789999999998999999999999999999996 999998654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=323.84 Aligned_cols=201 Identities=21% Similarity=0.333 Sum_probs=165.6
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----------chhhHHHHHHHhhccCCCceeeEEeeee
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----------ESGAFSSEIQTLGSIRHKNIVRLLGWGS 830 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~ 830 (1001)
..+.++|++.+.||+|+||+||+|... +++.||||++.... ....+.+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 456789999999999999999999865 68999999985421 1235889999999999999999999986
Q ss_pred cCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC---CcEEEe
Q 001873 831 NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG---YQAYLA 907 (1001)
Q Consensus 831 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~ki~ 907 (1001)
.+ ..++||||+++|+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.+ +.+||+
T Consensus 211 ~~-~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AE-DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SS-EEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cC-ceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 54 578999999999999998764 4589999999999999999999998 99999999999999754 459999
Q ss_pred cccccccccCCCCCCCCCCCCCCcccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 908 DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS---MQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 908 Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
|||+|+..... ......+||+.|+|||++. ...|+.++||||+||++|||++|+.||....
T Consensus 285 DFG~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 285 DFGHSKILGET--------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp CSSTTTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred ecccceecCCC--------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 99999875321 2223457999999999985 3678889999999999999999999998653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-33 Score=314.42 Aligned_cols=201 Identities=27% Similarity=0.432 Sum_probs=176.2
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----------hhhHHHHHHHhhcc-CCCceeeEEeee
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----------SGAFSSEIQTLGSI-RHKNIVRLLGWG 829 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~Ei~~l~~l-~h~nIv~l~~~~ 829 (1001)
..+.++|++.+.||+|+||.||+|+.. +|+.||||++..... .+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 456678999999999999999999975 799999998854331 24678899999999 799999999999
Q ss_pred ecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecc
Q 001873 830 SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADF 909 (1001)
Q Consensus 830 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Df 909 (1001)
...+..++||||+++++|.+++.+. ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+||
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEec
Confidence 9999999999999999999999863 3589999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCCcccccccccCcccccc------CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 910 GLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM------QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 910 gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
|++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 245 G~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 245 GFSCHLEPGE--------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp TTCEECCTTC--------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcccccCCCc--------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 9998764321 2234579999999998853 36889999999999999999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=312.81 Aligned_cols=203 Identities=28% Similarity=0.386 Sum_probs=174.4
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC--------CCCEEEEEEecCCCc---hhhHHHHHHHhhcc-CCCceeeEEeeeecC
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP--------NGETLAVKKMWSSDE---SGAFSSEIQTLGSI-RHKNIVRLLGWGSNK 832 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~ 832 (1001)
.++|++.+.||+|+||+||+|++. +++.||||++..... .+.+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 368999999999999999999863 467899999875443 25688999999999 899999999999999
Q ss_pred CceEEEEEccCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE
Q 001873 833 NLKLLFYDYLPNGSLSSLLHGAGK--------------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL 898 (1001)
Q Consensus 833 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll 898 (1001)
+..++||||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999986532 2478999999999999999999998 99999999999999
Q ss_pred CCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 899 GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 899 ~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
+.++.+||+|||+++....... ........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSS-----EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cCCCCEEEcccccccccccccc-----ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 9999999999999987643211 112233457889999999988889999999999999999999 99999764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-33 Score=305.99 Aligned_cols=197 Identities=38% Similarity=0.621 Sum_probs=170.2
Q ss_pred CCeEeecCCeeEEEEEeCCCCEEEEEEecCCC------chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 771 ANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
.+.||+|+||+||+|+. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 36 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 114 (307)
T 2nru_A 36 GNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN 114 (307)
T ss_dssp CCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred CCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCC
Confidence 38999999999999987 68999999985422 236789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 845 GSLSSLLHGAG-KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 845 gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
|+|.+++.... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 115 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--- 188 (307)
T 2nru_A 115 GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ--- 188 (307)
T ss_dssp CBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS---
T ss_pred CcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeecccccccccccc---
Confidence 99999997532 34589999999999999999999998 999999999999999999999999999987543211
Q ss_pred CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
........||+.|+|||++.+ .++.++||||||+++|+|++|+.||+....
T Consensus 189 --~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 189 --TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp --CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred --cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 112233579999999998865 588999999999999999999999987543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=311.92 Aligned_cols=199 Identities=23% Similarity=0.369 Sum_probs=176.4
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999976 58899999885432 236788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++++|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999998763 4589999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 195 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 195 G-------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp T-------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred c-------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 1 1223357999999999999999999999999999999999999999764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=322.66 Aligned_cols=208 Identities=21% Similarity=0.288 Sum_probs=179.8
Q ss_pred HhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCCchhhHHHHHHHhhccCC-CceeeEEeeeecCCceEEEEEcc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSDESGAFSSEIQTLGSIRH-KNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
.++|++.++||+|+||+||+|++ .+++.||||++.......++.+|+++++.++| ++|+.+..++...+..++||||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 36899999999999999999996 46899999998777667789999999999976 56666667777888889999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE---CCCCcEEEecccccccccCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
+++|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+|+.+....
T Consensus 86 -g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 86 -GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp -CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred -CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 89999999864 34589999999999999999999998 99999999999999 588999999999999876543
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
..............||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 3222222334466899999999999999999999999999999999999999987654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=306.38 Aligned_cols=198 Identities=23% Similarity=0.404 Sum_probs=174.7
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeec----------
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSN---------- 831 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~---------- 831 (1001)
.+..+|++.+.||+|+||.||+|+.. +++.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 45678999999999999999999976 79999999986543 467899999999999999999998754
Q ss_pred ------CCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEE
Q 001873 832 ------KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAY 905 (1001)
Q Consensus 832 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 905 (1001)
....++||||+++|+|.+++.......+++..++.++.|++.|+.|||++ +|+||||||+||++++++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEE
Confidence 44579999999999999999865556689999999999999999999998 999999999999999999999
Q ss_pred EecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 001873 906 LADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973 (1001)
Q Consensus 906 i~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~ 973 (1001)
|+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|..||.
T Consensus 163 l~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 163 IGDFGLVTSLKNDG--------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp ECCCTTCEESSCCS--------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred ECcchhheeccccc--------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 99999998764321 1223468999999999999999999999999999999999998874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=315.11 Aligned_cols=205 Identities=26% Similarity=0.343 Sum_probs=173.5
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeec-------
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSN------- 831 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~------- 831 (1001)
..++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+|+.++++++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4578999999999999999999974 789999998854432 3578899999999999999999998876
Q ss_pred -CCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccc
Q 001873 832 -KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFG 910 (1001)
Q Consensus 832 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfg 910 (1001)
.+..++||||++ |++.+.+... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 95 CKGSIYLVFDFCE-HDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp --CEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCceEEEEEeccC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 446899999997 5788877654 34589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+|+.+...... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..
T Consensus 170 ~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 170 LARAFSLAKNS---QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp TCEECCCCSSS---SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hcccccccccc---cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99876533221 1223344578999999998865 568999999999999999999999998653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=314.62 Aligned_cols=203 Identities=22% Similarity=0.357 Sum_probs=159.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCC----CEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCce--
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNG----ETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLK-- 835 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~-- 835 (1001)
++|++.+.||+|+||+||+|++... ..||||++.... ..+++.+|++++++++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 5799999999999999999987543 279999986432 336789999999999999999999998877655
Q ss_pred ----EEEEEccCCCCHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEe
Q 001873 836 ----LLFYDYLPNGSLSSLLHGAG----KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLA 907 (1001)
Q Consensus 836 ----~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~ 907 (1001)
++||||+++|+|.+++.... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEEC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEe
Confidence 89999999999999986432 12489999999999999999999998 99999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 908 DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 908 Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
|||+|+....... ........+|+.|+|||++.+..++.++||||+||++|||++ |+.||....
T Consensus 180 Dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 180 DFGLSRKIYSGDY-----YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp CCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ecccccccccccc-----ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 9999987643321 112223357889999999999999999999999999999999 999998643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-33 Score=308.14 Aligned_cols=202 Identities=23% Similarity=0.340 Sum_probs=174.6
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
...++|++.+.||+|+||.||+|... +++.||||++......+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 34578999999999999999999876 58999999998777778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++++|.+++... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||.+.......
T Consensus 106 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-- 179 (314)
T 3com_A 106 CGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-- 179 (314)
T ss_dssp CTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--
T ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--
Confidence 9999999999743 34589999999999999999999998 99999999999999999999999999998764321
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......||+.|+|||++.+..++.++||||+|+++|+|++|+.||...
T Consensus 180 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 180 -----AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp -----SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -----cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 1223447899999999999999999999999999999999999999764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=312.06 Aligned_cols=249 Identities=31% Similarity=0.451 Sum_probs=156.9
Q ss_pred CCCceEeeecCcccC--CCCcccCCCCCCcEEEcCC-CcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccE
Q 001873 271 SELQNLYLYQNSISG--PIPGRIGALSKLKSLLLWQ-NSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQE 347 (1001)
Q Consensus 271 ~~L~~L~L~~N~i~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 347 (1001)
.++++|+|++|.+++ .+|..|+++++|++|+|++ |++.+.+|..++++++|++|+|++|.+++.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 356666666666666 5666666666666666663 6666666666666666666666666666666666666666666
Q ss_pred EEcccccccCcCChhhccccccCEEeccCCcccCccCccccccC-cccEEEeecCccCCCCCcccccCcccceEeCcCcc
Q 001873 348 LQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNIN-GLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNN 426 (1001)
Q Consensus 348 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 426 (1001)
|+|++|++++.+|..+..+++|++|++++|++++.+|..++.++ +|+.|++++|++++.+|..+..++ |++|++++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 66666666666666666666666666666666666666665554 556666666655555565565555 6666666666
Q ss_pred ccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCccc
Q 001873 427 LSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPS 506 (1001)
Q Consensus 427 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 506 (1001)
+++..|..+..+++|++|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|++|++++|++++.+|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 6666666666666666666666666544443 555666666666666666666666666666666666666666666654
Q ss_pred ccccccCceEEccccc
Q 001873 507 VVGCQSLEFLDLHSNG 522 (1001)
Q Consensus 507 ~~~l~~L~~L~Ls~N~ 522 (1001)
..+++|+.|++++|+
T Consensus 288 -~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 288 -GNLQRFDVSAYANNK 302 (313)
T ss_dssp -TTGGGSCGGGTCSSS
T ss_pred -ccccccChHHhcCCC
Confidence 556666666666665
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=308.51 Aligned_cols=203 Identities=25% Similarity=0.344 Sum_probs=166.1
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-----hhhHHHHHHHhhccCCCceeeEEeeeecCCce
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~ 835 (1001)
....++|++.+.||+|+||+||+|+.. +++.||||++..... .+.+.+|+.++++++||||+++++++..++..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 345688999999999999999999975 688999999864322 25688999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 110 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999999999864 3489999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.... ........||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 185 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 185 TDEK------LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp ------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred cccc------cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 4321 11223446899999999999999999999999999999999999999764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=312.98 Aligned_cols=201 Identities=21% Similarity=0.301 Sum_probs=165.7
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCceE
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
....++|++.+.||+|+||+||+|+.. +++.||||++..... .+.+.+|+.++++++||||+++++++.+++..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 344678999999999999999999865 789999999864432 246779999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE-----CCCCcEEEecccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL-----GPGYQAYLADFGL 911 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll-----~~~~~~ki~Dfgl 911 (1001)
+||||++ |+|.+++.... .+++..+..++.|++.|++|||++ +|+||||||+||++ +.++.+||+|||+
T Consensus 110 lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999998 59999998753 489999999999999999999998 99999999999999 4556699999999
Q ss_pred cccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 912 ARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 912 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
|+...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 184 a~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 184 ARAFGIPI-------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp HHHHC------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCCcc-------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 98764221 12233468999999999876 45899999999999999999999999764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=303.24 Aligned_cols=196 Identities=27% Similarity=0.442 Sum_probs=174.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||.||+|+.. +++.||||++... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999976 5788999988432 23467899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 999999999999864 3489999999999999999999998 9999999999999999999999999998764321
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......||+.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus 168 --------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 168 --------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp --------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 123347899999999999999999999999999999999999999764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=328.21 Aligned_cols=200 Identities=23% Similarity=0.340 Sum_probs=175.3
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC----CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceE
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS----SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
..+.++|++.+.||+|+||+||+++.. +++.||||++.. ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 457789999999999999999999975 789999999843 334578999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC---CCCcEEEecccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG---PGYQAYLADFGLAR 913 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~ki~Dfgla~ 913 (1001)
+||||+++|+|.+++... ..+++..+..++.|++.|+.|||++ +|+||||||+||+++ .++.+||+|||+|+
T Consensus 98 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999999998764 3589999999999999999999998 999999999999995 55689999999998
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.+... ......+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.
T Consensus 173 ~~~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 225 (486)
T 3mwu_A 173 CFQQN--------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (486)
T ss_dssp TBCCC------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ECCCC--------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 65432 12234579999999999875 5899999999999999999999999765
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=319.54 Aligned_cols=198 Identities=23% Similarity=0.330 Sum_probs=165.8
Q ss_pred HHhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeec-----------
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSN----------- 831 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~----------- 831 (1001)
..++|++.+.||+|+||+||+|+. .+++.||||++.... ....+|+++++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 356899999999999999999986 479999999986543 334589999999999999999998843
Q ss_pred ---------------------------CCceEEEEEccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 001873 832 ---------------------------KNLKLLFYDYLPNGSLSSLLHG--AGKGGADWEARYEVVLGVAHALAYLHHDC 882 (1001)
Q Consensus 832 ---------------------------~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~yLH~~~ 882 (1001)
....++||||++ |+|.+.+.. .....+++..+..++.|++.|++|||+.
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 160 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL- 160 (383)
T ss_dssp ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 334789999998 588777753 2245689999999999999999999998
Q ss_pred CCCeEEeCCCCCCeEEC-CCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHH
Q 001873 883 MPPILHGDVKAMNVLLG-PGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGV 960 (1001)
Q Consensus 883 ~~~ivH~Dlkp~NIll~-~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ 960 (1001)
+|+||||||+||+++ .++.+||+|||+|+.+.... ......||+.|+|||++.+ ..++.++||||+||
T Consensus 161 --gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 161 --GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--------PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp --TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred --cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--------CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 999999999999997 68899999999998764321 2234478999999998876 45899999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 001873 961 VLLEVLTGRHPLDPT 975 (1001)
Q Consensus 961 il~elltg~~Pf~~~ 975 (1001)
++|||++|+.||.+.
T Consensus 231 il~ell~g~~pf~~~ 245 (383)
T 3eb0_A 231 VFGELILGKPLFSGE 245 (383)
T ss_dssp HHHHHHHSSCSSCCS
T ss_pred HHHHHHhCCCCCCCC
Confidence 999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=319.17 Aligned_cols=198 Identities=25% Similarity=0.361 Sum_probs=167.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc----hhhHHHHHHHhhccC--CCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE----SGAFSSEIQTLGSIR--HKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~--h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||+||++...+++.||||++..... .+.+.+|+.++++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45999999999999999999988899999999864432 267889999999996 599999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
| +.+++|.+++.+.. .+++..+..++.||+.||+|||+. +|+||||||+||+++ ++.+||+|||+++.+....
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 56789999998753 578899999999999999999998 999999999999996 5899999999998764321
Q ss_pred CCCCCCCCCCCcccccccccCcccccc-----------CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASM-----------QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 209 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 209 T-----SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred c-----cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 1 112234579999999999864 46889999999999999999999999764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=313.66 Aligned_cols=203 Identities=24% Similarity=0.290 Sum_probs=168.0
Q ss_pred HHHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-------chhhHHHHHHHhhccCCCceeeEEeeeecC
Q 001873 761 IDDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK 832 (1001)
Q Consensus 761 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~ 832 (1001)
+....++|++.+.||+|+||+||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 3455688999999999999999999975 58999999985422 124688999999999999999999999999
Q ss_pred CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccc
Q 001873 833 NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLA 912 (1001)
Q Consensus 833 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla 912 (1001)
+..++||||+++ +|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred CceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 999999999985 899988764 34578889999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+.+.... .......||+.|+|||++.+ ..++.++||||+||++|||++|..||.+.
T Consensus 160 ~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 160 KSFGSPN-------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp STTTSCC-------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeccCCc-------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 8764321 12234578999999999865 45889999999999999999999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=307.08 Aligned_cols=199 Identities=26% Similarity=0.394 Sum_probs=175.0
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
.+.++|++.+.||+|+||+||+++.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 45678999999999999999999975 68999999986543 3356889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE---CCCCcEEEeccccccccc
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~ki~Dfgla~~~~ 916 (1001)
||+++++|.+++.+. ..+++..+..++.|++.|++|||+. +|+||||||+||++ +.++.+||+|||+++...
T Consensus 86 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 86 QLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999998764 3489999999999999999999998 99999999999999 788999999999987532
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......||+.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus 161 ~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 161 N---------GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp C---------BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred C---------CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 1 1223346999999999999999999999999999999999999999764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.93 Aligned_cols=198 Identities=30% Similarity=0.452 Sum_probs=167.4
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeec-CCceEEEEEccC
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSN-KNLKLLFYDYLP 843 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~~ 843 (1001)
.++|++.+.||+|+||+||+++. +++.||||++......+.+.+|+.++++++||||+++++++.+ .+..++||||++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 36799999999999999999988 4889999999877777889999999999999999999998654 457899999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+++|.+++...+...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 170 (278)
T 1byg_A 99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----- 170 (278)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc-----
Confidence 99999999865433478899999999999999999998 9999999999999999999999999998764321
Q ss_pred CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.....+++.|+|||++.+..++.++||||+|+++|||+| |+.||....
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 112357889999999998999999999999999999998 999997653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=327.20 Aligned_cols=200 Identities=24% Similarity=0.348 Sum_probs=172.0
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
.+.++|++.+.||+|+||+||+|+.+ +++.||||++... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45678999999999999999999976 6899999998643 234678999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC---CCcEEEeccccccc
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP---GYQAYLADFGLARI 914 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~Dfgla~~ 914 (1001)
||||+++|+|.+++... ..+++..+..++.||+.|++|||++ +|+||||||+||+++. ++.+||+|||+|+.
T Consensus 114 v~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999998764 3489999999999999999999998 9999999999999975 45699999999987
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+... ......+||+.|+|||++. ..|+.++||||+||++|+|++|+.||.+..
T Consensus 189 ~~~~--------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 189 FENQ--------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp CBTT--------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCC--------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 6432 1223457999999999886 569999999999999999999999998653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=328.55 Aligned_cols=199 Identities=26% Similarity=0.364 Sum_probs=176.2
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
+.++|++.++||+|+||+||+++.. +++.||||++... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5578999999999999999999976 7899999998543 234679999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE---CCCCcEEEeccccccc
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL---GPGYQAYLADFGLARI 914 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~ki~Dfgla~~ 914 (1001)
||||+++|+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||++ +.++.+||+|||+|+.
T Consensus 104 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999999764 4589999999999999999999998 99999999999999 5678999999999987
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+... ......+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+..
T Consensus 179 ~~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 179 FEAS--------KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp BCCC--------CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccc--------cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 6432 12234579999999999875 68999999999999999999999998653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=321.99 Aligned_cols=205 Identities=21% Similarity=0.287 Sum_probs=160.0
Q ss_pred HHhcccC-CCeEeecCCeeEEEEEeC---CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeee--cCCceEE
Q 001873 764 VVRNLTS-ANVIGTGSSGVVYRVTIP---NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGS--NKNLKLL 837 (1001)
Q Consensus 764 ~~~~~~~-~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~--~~~~~~l 837 (1001)
+.+.|++ .++||+|+||+||+|+++ +++.||||++........+.+|+.++++++||||+++++++. .....++
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 3456776 457999999999999965 578999999987766778999999999999999999999984 4678899
Q ss_pred EEEccCCCCHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE----CCCCcEEE
Q 001873 838 FYDYLPNGSLSSLLHGA-------GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL----GPGYQAYL 906 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~ki 906 (1001)
||||++ |+|.+++... ....+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999997 5888887532 122489999999999999999999998 99999999999999 67789999
Q ss_pred ecccccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 907 ADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 907 ~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+|||+|+.+..... ........+||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 174 ~Dfg~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 174 ADMGFARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CCTTCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EECCCceecCCCCc----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999987643211 1122344679999999999876 458999999999999999999999998654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=316.71 Aligned_cols=199 Identities=27% Similarity=0.404 Sum_probs=174.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
.++|++.+.||+|+||+||+|++. +++.||+|++..... .+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 367999999999999999999976 689999999865432 3578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++++|.++++.. ..+++..+..++.|++.|++|||+++ +|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 99999999999864 34899999999999999999999842 8999999999999999999999999999765321
Q ss_pred CCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 186 -------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 186 -------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp -------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred -------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223479999999999999999999999999999999999999998643
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-32 Score=302.99 Aligned_cols=286 Identities=23% Similarity=0.344 Sum_probs=219.2
Q ss_pred cCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccC
Q 001873 369 LTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLS 448 (1001)
Q Consensus 369 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 448 (1001)
++.+++++|.++ .+|..+. ++++.|++++|++++..|..|..+++|++|++++|++++..|..|.++++|++|++++
T Consensus 35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred CCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 444444444443 2333321 3455555555555555555666667777777777777766666777777777777777
Q ss_pred CcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccc--cCCcccccccccCceEEcccccCccc
Q 001873 449 NDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLV--GGIPPSVVGCQSLEFLDLHSNGLTGS 526 (1001)
Q Consensus 449 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~ 526 (1001)
|+++. +|..+. ++|++|++++|++++..+..|.++++|+.|++++|+++ +..|..+..+ +|++|++++|++++
T Consensus 112 n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~- 186 (332)
T 2ft3_A 112 NHLVE-IPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG- 186 (332)
T ss_dssp SCCCS-CCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-
T ss_pred CcCCc-cCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-
Confidence 77763 344333 67888888888888666667888888888888888885 3667777777 88888888888884
Q ss_pred CCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccc
Q 001873 527 VPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISS 606 (1001)
Q Consensus 527 ~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 606 (1001)
+|..+.+.++.|++++|++++..+..|..+++|+.|++++|++++..+..+..+++|++|++++|+++ .+|..+..++.
T Consensus 187 l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~ 265 (332)
T 2ft3_A 187 IPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKL 265 (332)
T ss_dssp CCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTT
T ss_pred cCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCcc
Confidence 67777788899999999999888889999999999999999999888889999999999999999998 88989999999
Q ss_pred hhhhhhcCCCccccccccccccc------ccccEEEecCCcCCC---ChhhhhcccccceeEcccCC
Q 001873 607 LEISLNLSSNQFSGEIPSEFSGL------TKLGILDLSHNKLSG---DLDALASLQNLVSLNVSFND 664 (1001)
Q Consensus 607 L~~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~~---~~~~~~~l~~L~~L~ls~N~ 664 (1001)
|+. |++++|+|++..+..|... ..|+.|++++|++.. .+.++..+++|+.+++++|+
T Consensus 266 L~~-L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 266 LQV-VYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CCE-EECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CCE-EECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 996 9999999998888887754 679999999999973 45678899999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-33 Score=327.13 Aligned_cols=200 Identities=25% Similarity=0.355 Sum_probs=173.2
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---------------chhhHHHHHHHhhccCCCceeeEE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---------------ESGAFSSEIQTLGSIRHKNIVRLL 826 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------------~~~~~~~Ei~~l~~l~h~nIv~l~ 826 (1001)
.+.++|++.++||+|+||+||+|+.+ +++.||||++.... ..+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35678999999999999999999975 58899999985432 235788999999999999999999
Q ss_pred eeeecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC---c
Q 001873 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY---Q 903 (1001)
Q Consensus 827 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~---~ 903 (1001)
+++.+.+..++||||+++|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++ .
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999999998764 4489999999999999999999998 999999999999998775 6
Q ss_pred EEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 904 AYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 904 ~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+||+|||+|+.+... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||.+..
T Consensus 188 ~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD--------YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp EEECCCTTCEECCTT--------SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEEECCCCEEcCCC--------CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999876432 1223457999999999987 469999999999999999999999998653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-33 Score=308.72 Aligned_cols=194 Identities=22% Similarity=0.263 Sum_probs=171.1
Q ss_pred hcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCCchhhHHHHHHHhhccC-CCceeeEEeeeec--CCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSDESGAFSSEIQTLGSIR-HKNIVRLLGWGSN--KNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~--~~~~~lv~e~ 841 (1001)
++|++.+.||+|+||+||+|+. .+++.||||++.. ...+.+.+|+.++++++ ||||+++++++.+ ....++||||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 6799999999999999999986 4789999999864 34578999999999997 9999999999987 6678999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC-cEEEecccccccccCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY-QAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~Dfgla~~~~~~~~ 920 (1001)
+++++|.++++. +++..+..++.|++.|++|||++ +|+||||||+||+++.++ .+||+|||+|+......
T Consensus 115 ~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~- 185 (330)
T 3nsz_A 115 VNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 185 (330)
T ss_dssp CCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred cCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence 999999999864 78899999999999999999998 999999999999999776 89999999998764321
Q ss_pred CCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 186 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 235 (330)
T 3nsz_A 186 -------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235 (330)
T ss_dssp -------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred -------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 1233478999999999876 678999999999999999999999996544
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=315.86 Aligned_cols=204 Identities=30% Similarity=0.397 Sum_probs=175.0
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCC------CCEEEEEEecCCCc---hhhHHHHHHHhhcc-CCCceeeEEeeeecCCc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPN------GETLAVKKMWSSDE---SGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNL 834 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~---~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~ 834 (1001)
.++|++.+.||+|+||+||+|+... ...||||++..... .+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 3678899999999999999998642 24899999866542 35788999999999 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC
Q 001873 835 KLLFYDYLPNGSLSSLLHGAG------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY 902 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 902 (1001)
.++||||+++|+|.+++.... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 999999999999999997532 23578999999999999999999998 999999999999999999
Q ss_pred cEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 903 QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 903 ~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus 202 ~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSN-----YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp EEEBCCCGGGCCGGGCTT-----SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred eEEECccccccccccccc-----eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 999999999987643321 111233467889999999998899999999999999999998 999998654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-33 Score=309.98 Aligned_cols=212 Identities=25% Similarity=0.411 Sum_probs=169.9
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhcc--CCCceeeEEeeeecC----Cce
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSI--RHKNIVRLLGWGSNK----NLK 835 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l--~h~nIv~l~~~~~~~----~~~ 835 (1001)
..+.++|++.+.||+|+||+||+|+.. ++.||||++.... ...+.+|.+++... +||||+++++++... ...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc-cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 345688999999999999999999985 8999999985443 34455566665554 899999999998876 678
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEEeCCCCCCeEECCCCcEEEeccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC-----MPPILHGDVKAMNVLLGPGYQAYLADFG 910 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~ki~Dfg 910 (1001)
++||||+++|+|.++++.. .+++..+..++.|++.|++|||+++ .++|+||||||+||+++.++.+||+|||
T Consensus 111 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 9999999999999999753 4899999999999999999999752 2489999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCc------cchHHHHHHHHHHHhC----------CCCCCC
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEK------SDVYSFGVVLLEVLTG----------RHPLDP 974 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~SlG~il~elltg----------~~Pf~~ 974 (1001)
+|+.+....... ........||+.|+|||++.+..+..+ +|||||||++|||+|| +.||..
T Consensus 188 ~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 188 LAVKFISDTNEV---DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp TCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred Cceeeccccccc---cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 998764332211 111234579999999999987766655 9999999999999999 667765
Q ss_pred CCCCCcC
Q 001873 975 TLPGGAP 981 (1001)
Q Consensus 975 ~~~~~~~ 981 (1001)
..+....
T Consensus 265 ~~~~~~~ 271 (337)
T 3mdy_A 265 LVPSDPS 271 (337)
T ss_dssp TSCSSCC
T ss_pred hcCCCCc
Confidence 5444433
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=315.31 Aligned_cols=196 Identities=22% Similarity=0.301 Sum_probs=162.6
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCC-----
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN----- 833 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~----- 833 (1001)
+.++|++.+.||+|+||+||+|+.. +++.||||++.... ..+.+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3478999999999999999999865 68899999986532 2256889999999999999999999987654
Q ss_pred -ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccc
Q 001873 834 -LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLA 912 (1001)
Q Consensus 834 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla 912 (1001)
..++||||++ |+|.+++.. .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+|
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred cceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 6799999997 578888863 378999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 175 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 175 RTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp -----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccc--------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 865321 1223457999999999999999999999999999999999999999764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=302.82 Aligned_cols=198 Identities=27% Similarity=0.376 Sum_probs=176.2
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
.+.|++.+.||+|+||+||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 357899999999999999999864 68999999986432 34778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++++|.+++.. ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||.+.......
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 173 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence 9999999999974 4589999999999999999999998 99999999999999999999999999998764321
Q ss_pred CCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 174 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 222 (303)
T 3a7i_A 174 ------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222 (303)
T ss_dssp ------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence 1223457899999999999999999999999999999999999999754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=318.13 Aligned_cols=195 Identities=24% Similarity=0.338 Sum_probs=153.7
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecC------
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK------ 832 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~------ 832 (1001)
+.++|++.+.||+|+||.||+|... +|+.||||++.... ..+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3478999999999999999999864 68999999986532 235788999999999999999999988654
Q ss_pred CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccc
Q 001873 833 NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLA 912 (1001)
Q Consensus 833 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla 912 (1001)
...++|+||+ +++|.++++. ..+++..+..++.||++|++|||+. +|+||||||+||+++.++.+||+|||+|
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred CeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 5679999999 6899999874 4589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+.... .....+||++|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 180 ~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 233 (367)
T 2fst_X 180 RHTAD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233 (367)
T ss_dssp ---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccc----------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 86432 1234579999999999876 78899999999999999999999999764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=310.81 Aligned_cols=200 Identities=25% Similarity=0.414 Sum_probs=170.2
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCch----hhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDES----GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
.++|++.+.||+|+||.||+|+.. +++.||||++...... +.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 468999999999999999999976 5899999998554332 45778999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++++|.++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 104 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999999887653 3489999999999999999999998 99999999999999999999999999998654321
Q ss_pred CCCCCCCCCCCcccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQ-RITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 179 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 179 -------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 122334689999999998765 78999999999999999999999997653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=321.08 Aligned_cols=196 Identities=31% Similarity=0.361 Sum_probs=163.1
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecC------CceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNK------NLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~------~~~~lv 838 (1001)
.+|++.++||+|+||+||+|++. +++.||||++.... ....+|++++++++|||||++++++... ...++|
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 46889999999999999999975 68999999986543 3345799999999999999999987432 236799
Q ss_pred EEccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC-CcEEEecccccccc
Q 001873 839 YDYLPNGSLSSLLHG--AGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG-YQAYLADFGLARIV 915 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~ki~Dfgla~~~ 915 (1001)
|||+++ ++.+.+.. .....+++..++.++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999985 66666543 1245689999999999999999999998 99999999999999955 67899999999876
Q ss_pred cCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.... .....+||+.|+|||++.+ ..|+.++||||+||++|||++|+.||.+.
T Consensus 208 ~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 208 VRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp CTTC--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCC--------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 4321 1233578999999999865 47899999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=335.12 Aligned_cols=201 Identities=29% Similarity=0.436 Sum_probs=175.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++|++.+.||+|+||+||+|++.++..||||++.... ..++|.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~ 345 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 345 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcC
Confidence 5688889999999999999999888889999997543 34789999999999999999999999876 668999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.++++......+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 346 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~----- 417 (535)
T 2h8h_A 346 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE----- 417 (535)
T ss_dssp EEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-----
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-----
Confidence 9999999764345589999999999999999999998 99999999999999999999999999998653211
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
........++..|+|||++....++.++|||||||++|||++ |+.||.+..
T Consensus 418 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~ 469 (535)
T 2h8h_A 418 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469 (535)
T ss_dssp -HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred -eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 111223357789999999998999999999999999999999 999997653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-32 Score=301.74 Aligned_cols=294 Identities=21% Similarity=0.266 Sum_probs=214.9
Q ss_pred CCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcc
Q 001873 272 ELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLS 351 (1001)
Q Consensus 272 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 351 (1001)
+++.+++++|.++ .+|..+. ++|+.|+|++|++++..|..|.++++|++|++++|.+++..|..|.++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 5677777777776 4555543 567777777777776666677777777777777777776667777777777777777
Q ss_pred cccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccC--CCCCcccccCcccceEeCcCccccC
Q 001873 352 VNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLT--GNIPESLSQCQELQALDFSYNNLSG 429 (1001)
Q Consensus 352 ~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~--~~~p~~l~~l~~L~~L~Ls~N~l~~ 429 (1001)
+|+++ .+|..+. ++|++|++++|++++..+..+.++++|+.|++++|.++ +..|..+..+ +|+.|++++|++++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 77776 4444443 67777777777777655566777777777777777775 3666777777 88888888888875
Q ss_pred CCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccc
Q 001873 430 PIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVG 509 (1001)
Q Consensus 430 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 509 (1001)
+|..+. ++|++|++++|++++..+..+..+++|++|+|++|++++..+..+..+++|++|++++|+++ .+|..+..
T Consensus 187 -l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 262 (332)
T 2ft3_A 187 -IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262 (332)
T ss_dssp -CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGG
T ss_pred -cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhc
Confidence 555443 68888888888888887788888888888888888888877778888888888899888888 67777888
Q ss_pred cccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCcccc--ccchhhhhccccccEEe
Q 001873 510 CQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLS--GRIPAEILSCRKLILLD 587 (1001)
Q Consensus 510 l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~ 587 (1001)
+++|++|++++|++++..+..+.... + -.....|+.|++++|++. +..|..|..+++|+.|+
T Consensus 263 l~~L~~L~l~~N~l~~~~~~~~~~~~--------------~--~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~ 326 (332)
T 2ft3_A 263 LKLLQVVYLHTNNITKVGVNDFCPVG--------------F--GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQ 326 (332)
T ss_dssp CTTCCEEECCSSCCCBCCTTSSSCSS--------------C--CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEE
T ss_pred CccCCEEECCCCCCCccChhHccccc--------------c--ccccccccceEeecCcccccccCcccccccchhhhhh
Confidence 88888888888888855444332110 0 011456788888888877 56777888888888888
Q ss_pred ccccc
Q 001873 588 IGNNR 592 (1001)
Q Consensus 588 Ls~N~ 592 (1001)
+++|+
T Consensus 327 l~~n~ 331 (332)
T 2ft3_A 327 FGNYK 331 (332)
T ss_dssp C----
T ss_pred ccccc
Confidence 88875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=307.57 Aligned_cols=200 Identities=28% Similarity=0.387 Sum_probs=171.1
Q ss_pred hcccCCCeEeecCCeeEEEEEe-----CCCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecC--Cce
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI-----PNGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNK--NLK 835 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~--~~~ 835 (1001)
++|++.+.||+|+||.||+|++ .+++.||||++.... ..+.+.+|++++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5688999999999999999983 368999999986443 336789999999999999999999998876 668
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
++||||+++|+|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 9999999999999999654 34589999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~ 973 (1001)
...... ........||..|+|||++.+..++.++||||+|+++|||++|+.|+.
T Consensus 177 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 177 ETDKEY----YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CTTCCE----EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cCCCcc----eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 543211 122334468889999999998899999999999999999999998864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=318.50 Aligned_cols=197 Identities=27% Similarity=0.355 Sum_probs=163.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeecCC------ceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKN------LKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~------~~~lv~ 839 (1001)
.+|++.++||+|+||+||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+ ..++||
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~--~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR--FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT--SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc--hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 57999999999999999999988777899999865432 3347999999999999999999885433 378999
Q ss_pred EccCCCCHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC-CCCcEEEecccccccccC
Q 001873 840 DYLPNGSLSSLLHG-AGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG-PGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 840 e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ki~Dfgla~~~~~ 917 (1001)
||++++.+...... .....+++..+..++.|++.|++|||++ +|+||||||+||+++ .++.+||+|||+|+....
T Consensus 118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 99986544333221 1234589999999999999999999998 999999999999998 799999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.. ......||+.|+|||++.+ ..|+.++||||+||++|||++|+.||.+.
T Consensus 195 ~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 245 (394)
T 4e7w_A 195 GE--------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245 (394)
T ss_dssp TC--------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CC--------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 2234578999999999865 46899999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.35 Aligned_cols=193 Identities=22% Similarity=0.324 Sum_probs=166.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC-C-------CEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCce
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN-G-------ETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~ 835 (1001)
++|++.+.||+|+||+||+|+... + ..||+|++.... ..+.+.+|+.++++++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 578999999999999999998653 3 479999985433 346799999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCc--------EEEe
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQ--------AYLA 907 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~ki~ 907 (1001)
++||||+++|+|.+++.+. ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++. +||+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred EEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeec
Confidence 9999999999999999864 23489999999999999999999998 9999999999999998876 9999
Q ss_pred cccccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCC
Q 001873 908 DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLD 973 (1001)
Q Consensus 908 Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~ 973 (1001)
|||.+..... .....||+.|+|||++.+ ..++.++||||+|+++|||++|..|+.
T Consensus 164 Dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~ 219 (289)
T 4fvq_A 164 DPGISITVLP-----------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219 (289)
T ss_dssp CCCSCTTTSC-----------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred cCcccccccC-----------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence 9999875421 123468899999999977 778999999999999999999554443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=316.53 Aligned_cols=203 Identities=29% Similarity=0.400 Sum_probs=159.8
Q ss_pred cccCCCeEeecCCeeEEEEEeC--C--CCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeee-cCCceEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP--N--GETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGS-NKNLKLLF 838 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~--~--~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~-~~~~~~lv 838 (1001)
.|++.+.||+|+||+||+|++. + +..||||.+.... ..+++.+|+.++++++||||+++++++. .++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677789999999999999864 2 2468999886433 2367899999999999999999999865 45678999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++|+|.++++.. ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 170 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999999764 34578999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
... .........+|+.|+|||++.+..++.++|||||||++|||+| |..||....
T Consensus 246 ~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~ 301 (373)
T 3c1x_A 246 EFD---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred ccc---cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence 211 1112233467889999999999999999999999999999999 677776543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=311.10 Aligned_cols=203 Identities=25% Similarity=0.368 Sum_probs=174.7
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCch---hhHHHHHHHhhccCCCceeeEEeeeecCCce
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDES---GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~---~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~ 835 (1001)
.++|++.+.||+|+||.||+|++. +++.||||++...... ..+.+|+.++++++||||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 467999999999999999999754 3688999998654432 4688999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEe
Q 001873 836 LLFYDYLPNGSLSSLLHGAG--------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLA 907 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~ 907 (1001)
++||||+++|+|.++++..+ ....++..+.+++.|++.|++|||++ +|+||||||+||+++.++.+||+
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEEC
Confidence 99999999999999997532 13468999999999999999999998 99999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 908 DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 908 Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
|||+++....... ........||+.|+|||++.+..++.++||||+|+++|||++ |+.||...
T Consensus 181 Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 181 DFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp CTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred cCccccccccccc-----cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 9999986543211 111223467899999999998999999999999999999999 89999764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-33 Score=301.93 Aligned_cols=202 Identities=26% Similarity=0.386 Sum_probs=172.1
Q ss_pred hcccCCC-eEeecCCeeEEEEEeC---CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSAN-VIGTGSSGVVYRVTIP---NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
++|.+.+ .||+|+||.||+|.+. +++.||||++..... .+++.+|++++++++||||+++++++. .+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEE
Confidence 4566666 8999999999999853 578899999976432 367889999999999999999999994 5568999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++++|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999999754 34589999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
... ........||+.|+|||++.+..++.++||||+|+++|||++ |+.||....
T Consensus 164 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 164 DSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp SCE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cce----eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 211 112233457899999999988889999999999999999998 999997653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=318.70 Aligned_cols=201 Identities=22% Similarity=0.252 Sum_probs=172.5
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-hhhHHHHHHHhhccC--------CCceeeEEeeee----
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-SGAFSSEIQTLGSIR--------HKNIVRLLGWGS---- 830 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~Ei~~l~~l~--------h~nIv~l~~~~~---- 830 (1001)
.++|++.++||+|+||+||+|+.. +++.||||++..... .+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 468999999999999999999864 688999999865432 367889999999985 788999999887
Q ss_pred cCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC--------
Q 001873 831 NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY-------- 902 (1001)
Q Consensus 831 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~-------- 902 (1001)
.....++||||+ ++++.+++.......+++..+..++.||+.||+|||+++ +|+||||||+||+++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhh
Confidence 556789999999 577777776655566899999999999999999999963 899999999999999775
Q ss_pred -----------------------------------------cEEEecccccccccCCCCCCCCCCCCCCcccccccccCc
Q 001873 903 -----------------------------------------QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAP 941 (1001)
Q Consensus 903 -----------------------------------------~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 941 (1001)
.+||+|||.|+..... .....||+.|+||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----------~~~~~gt~~y~aP 262 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----------FTEDIQTRQYRSL 262 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----------SCSCCSCGGGCCH
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----------CccCCCCCcccCC
Confidence 7999999999875321 2334789999999
Q ss_pred cccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001873 942 EHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978 (1001)
Q Consensus 942 E~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~ 978 (1001)
|++.+..++.++|||||||++|||++|+.||.+....
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 299 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGE 299 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCccc
Confidence 9999999999999999999999999999999876543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=309.21 Aligned_cols=201 Identities=25% Similarity=0.398 Sum_probs=165.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCC----EEEEEEecCC---CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGE----TLAVKKMWSS---DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
++|++.+.||+|+||+||+|++. +++ +||+|.+... ...+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 57999999999999999999864 444 3577776433 24478999999999999999999999998765 688
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
|+||+++|+|.+++... ...+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 94 v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 99999999999999875 34589999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
... ........||+.|+|||++.+..++.++||||+||++|||++ |+.||++..
T Consensus 170 ~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 224 (327)
T 3lzb_A 170 EEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccc-----cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 321 112223457889999999999999999999999999999999 999998653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=322.66 Aligned_cols=197 Identities=17% Similarity=0.263 Sum_probs=160.3
Q ss_pred HhcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCC-----CchhhHHHHHH---HhhccCCCceeeEE-------ee
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSS-----DESGAFSSEIQ---TLGSIRHKNIVRLL-------GW 828 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~Ei~---~l~~l~h~nIv~l~-------~~ 828 (1001)
.++|++.+.||+|+||+||+|++ .+++.||||++... ...+.+.+|+. .+++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 36788999999999999999996 46999999998532 23467889994 55556899999998 55
Q ss_pred eecCC-----------------ceEEEEEccCCCCHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 001873 829 GSNKN-----------------LKLLFYDYLPNGSLSSLLHGAGK-----GGADWEARYEVVLGVAHALAYLHHDCMPPI 886 (1001)
Q Consensus 829 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~yLH~~~~~~i 886 (1001)
+.+.+ ..++||||+ +|+|.+++...+. ..+++..+..|+.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 278999999 6899999986321 1123578888999999999999998 99
Q ss_pred EEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccC-----------CCCCccch
Q 001873 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ-----------RITEKSDV 955 (1001)
Q Consensus 887 vH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv 955 (1001)
+||||||+||+++.++.+||+|||+|+.... ......| +.|+|||++.+. .++.++||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----------cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 9999999999999999999999999985321 1223467 999999999877 89999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCC
Q 001873 956 YSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 956 ~SlG~il~elltg~~Pf~~~~ 976 (1001)
|||||++|||++|+.||....
T Consensus 297 wSlG~il~elltg~~Pf~~~~ 317 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDA 317 (377)
T ss_dssp HHHHHHHHHHHHSSCCC----
T ss_pred HHHHHHHHHHHHCCCCCcccc
Confidence 999999999999999997654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=303.41 Aligned_cols=204 Identities=28% Similarity=0.396 Sum_probs=168.6
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCC----CCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeee-ecCCceE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPN----GETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWG-SNKNLKL 836 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~-~~~~~~~ 836 (1001)
..+|++.++||+|+||+||+|++.+ ...||||++..... .+.+.+|+.++++++||||+++++++ ..++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568889999999999999998643 23589998865443 25688999999999999999999985 4566789
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
+||||+++|+|.++++.. ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 104 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccc
Confidence 999999999999999764 34578999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
.... ..........||+.|+|||.+.+..++.++||||+|+++|||++ |..||...
T Consensus 180 ~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 236 (298)
T 3f66_A 180 DKEY---YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236 (298)
T ss_dssp CGGG---CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred ccch---hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence 3221 11222334568899999999999999999999999999999999 55566543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-33 Score=302.97 Aligned_cols=199 Identities=31% Similarity=0.454 Sum_probs=159.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
.++|++.+.||+|+||+||+|+.. ..||||++..... .+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEE
Confidence 367999999999999999999864 4699999864432 256889999999999999999999764 456799999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++++|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 99999999999754 34589999999999999999999998 999999999999999999999999999986542211
Q ss_pred CCCCCCCCCCcccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHAS---MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
........||+.|+|||++. ...++.++||||+|+++|||++|+.||...
T Consensus 176 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 176 -----SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred -----cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 12223457999999999886 567888999999999999999999999764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=299.89 Aligned_cols=195 Identities=26% Similarity=0.380 Sum_probs=168.1
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeec----CCceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSN----KNLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~----~~~~~ 836 (1001)
+.|++.+.||+|+||+||+|... ++..||+|++.... ..+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45788889999999999999875 68899999885432 23568899999999999999999998764 45689
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEeCCCCCCeEEC-CCCcEEEecccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPP--ILHGDVKAMNVLLG-PGYQAYLADFGLAR 913 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NIll~-~~~~~ki~Dfgla~ 913 (1001)
+||||+++|+|.+++... ..+++..+..++.|++.|++|||++ + |+||||||+||+++ +++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999999864 4489999999999999999999998 7 99999999999998 78999999999997
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.... .......||+.|+|||++. ..++.++||||+|+++|+|++|+.||...
T Consensus 181 ~~~~---------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 181 LKRA---------SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp GCCT---------TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccc---------cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 5422 1223446999999999887 45899999999999999999999999764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=308.23 Aligned_cols=202 Identities=29% Similarity=0.449 Sum_probs=166.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC-----CCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN-----GETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
++|+..+.||+|+||+||+|+... +..||||++..... ..++.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 467788999999999999998642 23599999865432 2568899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||+++|+|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 99999999999999864 34589999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
.... ........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...
T Consensus 200 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 254 (333)
T 1mqb_A 200 DPEA----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccc----ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence 2211 111222356789999999998999999999999999999999 99999754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=302.14 Aligned_cols=203 Identities=25% Similarity=0.322 Sum_probs=170.7
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC------CchhhHHHHHHHhhccCCCceeeEEeee--ecCCc
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS------DESGAFSSEIQTLGSIRHKNIVRLLGWG--SNKNL 834 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~Ei~~l~~l~h~nIv~l~~~~--~~~~~ 834 (1001)
+.++|++.+.||+|+||.||++... +++.||||++... ...+.+.+|+.++++++||||+++++++ .+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4678999999999999999999975 6899999998542 3346789999999999999999999988 44567
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.++||||++++ +.+++.......+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.+..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999866 88888776666789999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccccCC--CCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR--ITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
...... ........||+.|+|||++.+.. ++.++||||+|+++|||++|+.||...
T Consensus 159 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 159 LHPFAA-----DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp CCTTCS-----SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCcccc-----ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 643211 11223346999999999987643 377999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-33 Score=307.24 Aligned_cols=201 Identities=22% Similarity=0.346 Sum_probs=170.6
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----------chhhHHHHHHHhhccCCCceeeEEeeee
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----------ESGAFSSEIQTLGSIRHKNIVRLLGWGS 830 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~ 830 (1001)
..+.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+|++++++++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 456788999999999999999999875 58899999985432 1245889999999999999999999987
Q ss_pred cCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCc---EEEe
Q 001873 831 NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQ---AYLA 907 (1001)
Q Consensus 831 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~ki~ 907 (1001)
.++ .++||||+++++|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++. +||+
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred CCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 665 79999999999999999753 4589999999999999999999998 9999999999999987654 9999
Q ss_pred cccccccccCCCCCCCCCCCCCCcccccccccCccccc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 908 DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS---MQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 908 Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
|||+++..... .......||+.|+|||++. ...++.++||||+||++|||++|+.||....
T Consensus 160 Dfg~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 160 DFGHSKILGET--------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp CCTTCEECCCC--------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred cCccceecccc--------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99999875321 1122346899999999873 5678899999999999999999999998654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=300.69 Aligned_cols=197 Identities=17% Similarity=0.268 Sum_probs=169.5
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhcc-CCCceeeEEeeeecCCceE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~ 836 (1001)
.+.++|++.+.||+|+||+||+|+.. +++.||||++.... ...++.+|+..+.++ +||||+++++++.+.+..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 35678999999999999999999976 79999999986532 235788899999999 9999999999999999999
Q ss_pred EEEEccCCCCHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC-------------
Q 001873 837 LFYDYLPNGSLSSLLHGAGK--GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG------------- 901 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~------------- 901 (1001)
+||||+++++|.+++..... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999976421 4589999999999999999999998 99999999999999844
Q ss_pred ------CcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCC
Q 001873 902 ------YQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ-RITEKSDVYSFGVVLLEVLTGRHPLD 973 (1001)
Q Consensus 902 ------~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~elltg~~Pf~ 973 (1001)
..+||+|||.+...... ....||+.|+|||++.+. .++.++||||+||++|||++|+.|+.
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP-----------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS-----------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred cccCCceEEEEcccccccccCCc-----------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 47999999999875321 123589999999998765 56689999999999999999987764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-33 Score=313.14 Aligned_cols=203 Identities=21% Similarity=0.274 Sum_probs=166.9
Q ss_pred HHHHHhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc-------------hhhHHHHHHHhhccCCCceeeEEe
Q 001873 761 IDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE-------------SGAFSSEIQTLGSIRHKNIVRLLG 827 (1001)
Q Consensus 761 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-------------~~~~~~Ei~~l~~l~h~nIv~l~~ 827 (1001)
...+.++|++.+.||+|+||.||+|...+++.||||++..... .+.+.+|++++++++||||+++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 3455689999999999999999999988899999998853221 167899999999999999999999
Q ss_pred eeec-----CCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC
Q 001873 828 WGSN-----KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY 902 (1001)
Q Consensus 828 ~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~ 902 (1001)
++.. ....++||||++ |+|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 171 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNN 171 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCC
Confidence 8843 346799999998 6888888754 34589999999999999999999998 999999999999999999
Q ss_pred cEEEecccccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 903 QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 903 ~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+..
T Consensus 172 ~~kl~Dfg~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 172 DITICDFNLAREDTAD--------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp CEEECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CEEEEecCcccccccc--------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999754322 12234578999999998876 778999999999999999999999998643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=306.91 Aligned_cols=202 Identities=26% Similarity=0.369 Sum_probs=169.3
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-CchhhHHHHHHHhhcc-CCCceeeEEeeeec------CCc
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-DESGAFSSEIQTLGSI-RHKNIVRLLGWGSN------KNL 834 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~------~~~ 834 (1001)
..++|++.+.||+|+||.||+|++. +++.||||++... ...+.+.+|+.+++++ +||||+++++++.. .+.
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 3578999999999999999999974 7899999998644 3457899999999999 79999999999876 467
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.++||||+++|+|.+++.......+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 89999999999999999876556689999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS-----MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
..... .......||+.|+|||++. ...++.++|||||||++|+|++|+.||...
T Consensus 179 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 179 LDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp -------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cCcCc-------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 53221 1223347999999999986 567889999999999999999999999754
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-32 Score=300.56 Aligned_cols=267 Identities=22% Similarity=0.299 Sum_probs=215.7
Q ss_pred cccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEcc
Q 001873 392 GLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLN 471 (1001)
Q Consensus 392 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 471 (1001)
.++.|++++|++++..+..|..+++|++|++++|++++..|..|..+++|++|++++|+++. +|..+. ++|++|+++
T Consensus 53 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~~~--~~L~~L~l~ 129 (330)
T 1xku_A 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMP--KTLQELRVH 129 (330)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSCC--TTCCEEECC
T ss_pred CCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCc-cChhhc--ccccEEECC
Confidence 44555555555555555566666777777777777776666677777777777777777763 344333 678888888
Q ss_pred ccccccCCCcccCCCCCcceeeccCccccc--CCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCc
Q 001873 472 DNRLSGTIPSEMGNLKHLNFVDMSENHLVG--GIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSL 549 (1001)
Q Consensus 472 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~ 549 (1001)
+|++++..+..+.++++|++|++++|+++. ..+..+.++++|++|++++|+++ .+|..+.+.++.|++++|++++..
T Consensus 130 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~L~~L~l~~n~l~~~~ 208 (330)
T 1xku_A 130 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVD 208 (330)
T ss_dssp SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCCTTCSEEECTTSCCCEEC
T ss_pred CCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCccccccCCEEECCCCcCCccC
Confidence 888887777788889999999999998863 67788888999999999999998 567777788999999999999888
Q ss_pred ccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCccccccccccccc
Q 001873 550 AHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGL 629 (1001)
Q Consensus 550 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l 629 (1001)
+..|..+++|+.|++++|++++..+..+..+++|++|++++|+++ .+|..+..++.|+. |++++|+|++..+..|...
T Consensus 209 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~-L~l~~N~i~~~~~~~f~~~ 286 (330)
T 1xku_A 209 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV-VYLHNNNISAIGSNDFCPP 286 (330)
T ss_dssp TGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCE-EECCSSCCCCCCTTSSSCS
T ss_pred HHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCE-EECCCCcCCccChhhcCCc
Confidence 899999999999999999999888889999999999999999998 88999999999996 9999999999888888643
Q ss_pred ------ccccEEEecCCcCCC---ChhhhhcccccceeEcccCC
Q 001873 630 ------TKLGILDLSHNKLSG---DLDALASLQNLVSLNVSFND 664 (1001)
Q Consensus 630 ------~~L~~L~Ls~N~l~~---~~~~~~~l~~L~~L~ls~N~ 664 (1001)
..|+.|++++|++.. .+..+..++.++.+++++|+
T Consensus 287 ~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 287 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred ccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 788999999999975 45678889999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=306.30 Aligned_cols=200 Identities=27% Similarity=0.375 Sum_probs=171.3
Q ss_pred hcc-cCCCeEeecCCeeEEEEEeC-----CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeec--CCc
Q 001873 766 RNL-TSANVIGTGSSGVVYRVTIP-----NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSN--KNL 834 (1001)
Q Consensus 766 ~~~-~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~--~~~ 834 (1001)
++| ++.+.||+|+||+||++.+. +++.||||++..... .+.+.+|++++++++||||+++++++.+ ...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 89999999999999988642 588999999976543 3568899999999999999999999877 457
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.++||||+++|+|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence 78999999999999999854 389999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
...... .........||+.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus 184 ~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 184 VPEGHE----YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp CCTTCS----EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccc----ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 643321 111223346888999999999888999999999999999999999998753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=6e-33 Score=308.12 Aligned_cols=204 Identities=28% Similarity=0.361 Sum_probs=174.1
Q ss_pred HhcccCCCeEeecCCeeEEEEEe------CCCCEEEEEEecCCCch---hhHHHHHHHhhcc-CCCceeeEEeeeecCC-
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI------PNGETLAVKKMWSSDES---GAFSSEIQTLGSI-RHKNIVRLLGWGSNKN- 833 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~---~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~- 833 (1001)
.++|++.+.||+|+||+||+|++ .+++.||||++...... +.+.+|+.+++++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999974 35689999998765432 5688999999999 7999999999987654
Q ss_pred ceEEEEEccCCCCHHHHhhcCCCC--------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAGKG--------------GADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG 899 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~ 899 (1001)
..++||||+++|+|.+++...... .+++..+..++.|++.|++|||++ +|+||||||+||+++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEEC
Confidence 589999999999999999865431 278999999999999999999998 999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 900 PGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 900 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.++++||+|||+++....... ........||+.|+|||++.+..++.++||||+|+++|||+| |+.||....
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCCEEECCCccccccccCcc-----ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999987643211 112233468899999999999999999999999999999998 999997654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=298.55 Aligned_cols=197 Identities=28% Similarity=0.408 Sum_probs=166.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||.||+|+.. +++.||||++... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57999999999999999999976 7999999998532 23457889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++++|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~- 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 164 (276)
T ss_dssp ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred eccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC-
Confidence 999999999999764 3489999999999999999999998 9999999999999999999999999999875422
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRI-TEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||+..
T Consensus 165 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 165 -------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp -------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -------cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 11223468999999999987765 58999999999999999999999764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-33 Score=312.85 Aligned_cols=200 Identities=21% Similarity=0.324 Sum_probs=176.1
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc-----h--------------hhHHHHHHHhhccCCCceeeE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE-----S--------------GAFSSEIQTLGSIRHKNIVRL 825 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----~--------------~~~~~Ei~~l~~l~h~nIv~l 825 (1001)
.++|++.+.||+|+||.||+|+. +++.||||++..... . +.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 899999998853211 1 789999999999999999999
Q ss_pred EeeeecCCceEEEEEccCCCCHHHH------hhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEEeCCCCCCeEE
Q 001873 826 LGWGSNKNLKLLFYDYLPNGSLSSL------LHGAGKGGADWEARYEVVLGVAHALAYLHH-DCMPPILHGDVKAMNVLL 898 (1001)
Q Consensus 826 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NIll 898 (1001)
++++.+.+..++||||+++|+|.++ +.......+++..+..++.|++.|++|||+ . +|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999999 665445678999999999999999999999 7 99999999999999
Q ss_pred CCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccC-CCCC-ccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 899 GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ-RITE-KSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 899 ~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+.++.+||+|||.+...... ......||+.|+|||++.+. .++. ++||||+|+++|||++|+.||....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCcEEEeccccccccccc---------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999875322 22334789999999999876 6666 9999999999999999999998654
Q ss_pred C
Q 001873 977 P 977 (1001)
Q Consensus 977 ~ 977 (1001)
.
T Consensus 257 ~ 257 (348)
T 2pml_X 257 S 257 (348)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.1e-33 Score=309.64 Aligned_cols=202 Identities=28% Similarity=0.366 Sum_probs=174.1
Q ss_pred hcccCCCeEeecCCeeEEEEEe-----CCCCEEEEEEecCCCch--hhHHHHHHHhhccCCCceeeEEeeee--cCCceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI-----PNGETLAVKKMWSSDES--GAFSSEIQTLGSIRHKNIVRLLGWGS--NKNLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~--~~~~~Ei~~l~~l~h~nIv~l~~~~~--~~~~~~ 836 (1001)
++|++.+.||+|+||+||++++ .+++.||||++...... +.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5799999999999999999984 36889999998665433 56899999999999999999999876 456688
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
+||||+++++|.+++.... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999997642 3489999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
..... ........||+.|+|||++.+..++.++||||+|+++|+|++|+.||...
T Consensus 179 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 179 LDKDY----YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp TTCSE----EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cCCcc----ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 33211 11233446889999999999888999999999999999999999998643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=310.52 Aligned_cols=201 Identities=25% Similarity=0.322 Sum_probs=171.5
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCch---hhHHHHHHHhhccCCCceeeEEeeeecC-----Cce
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDES---GAFSSEIQTLGSIRHKNIVRLLGWGSNK-----NLK 835 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~Ei~~l~~l~h~nIv~l~~~~~~~-----~~~ 835 (1001)
.++|++.+.||+|+||+||+|+.. +++.||||++...... +.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 358999999999999999999865 6889999998643322 6788999999999999999999988654 467
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
++||||++ |+|.++++. ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999997 699999975 3489999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccc-cCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHAS-MQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
..... .........||+.|+|||++. ...++.++||||+||++|||++|+.||.+..
T Consensus 179 ~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 179 DPDHD----HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp CGGGC----BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCC----ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 43211 112234457999999999865 4558999999999999999999999997653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=299.95 Aligned_cols=200 Identities=26% Similarity=0.376 Sum_probs=168.8
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCC----CCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPN----GETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
.++|++.+.||+|+||+||+|++.+ +..||||++.... ..+.+.+|+.++++++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 3578999999999999999998542 3469999986543 236788999999999999999999998754 4689
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||+++++|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 90 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 99999999999999764 34589999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 166 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 166 EDY------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp -------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccc------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 211 11223457889999999998999999999999999999998 99999754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.6e-33 Score=307.01 Aligned_cols=207 Identities=28% Similarity=0.406 Sum_probs=158.7
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ..+++.+|+.++++++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 468999999999999999999864 68999999885432 33678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 841 YLPNGSLSSLLHG------AGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 841 ~~~~gsL~~~l~~------~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
|+++++|.+++.. .....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999874 1234579999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
....... ..........||+.|+|||++.. ..++.++||||+|+++|||++|+.||....
T Consensus 171 ~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 231 (303)
T 2vwi_A 171 LATGGDI--TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231 (303)
T ss_dssp CC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred eccCCCc--cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence 6433211 11122334579999999999865 678999999999999999999999998643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=304.26 Aligned_cols=201 Identities=25% Similarity=0.348 Sum_probs=163.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ..+++.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 467999999999999999999864 78999999986422 235688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 839 YDYLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
|||+++++|.+++... ....+++..++.++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998642 244589999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.
T Consensus 188 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 188 SKT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp ------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCC-------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 321 1122346899999999999999999999999999999999999999764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=306.26 Aligned_cols=198 Identities=22% Similarity=0.315 Sum_probs=173.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEe-C-CCCEEEEEEecCCCc-hhhHHHHHHHhhccCCCc------eeeEEeeeecCCce
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI-P-NGETLAVKKMWSSDE-SGAFSSEIQTLGSIRHKN------IVRLLGWGSNKNLK 835 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~-~-~~~~vavK~~~~~~~-~~~~~~Ei~~l~~l~h~n------Iv~l~~~~~~~~~~ 835 (1001)
.++|++.+.||+|+||+||+|.. . +++.||||++..... .+.+.+|+++++.++|++ |+++++++...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 46899999999999999999986 3 688999999865432 367889999999987654 99999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC---------------
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP--------------- 900 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~--------------- 900 (1001)
++||||+ +++|.+++...+...+++..+..++.|++.|++|||++ +|+||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999 89999999887666789999999999999999999998 9999999999999987
Q ss_pred ----CCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 901 ----GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 901 ----~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDE----------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp EEESCCCEEECCCSSCEETTS----------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccCCCceEeeCcccccCcc----------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 66899999999986432 1223478999999999999999999999999999999999999998653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=309.03 Aligned_cols=216 Identities=27% Similarity=0.395 Sum_probs=178.4
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhc--cCCCceeeEEeeeecCC----ce
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGS--IRHKNIVRLLGWGSNKN----LK 835 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~--l~h~nIv~l~~~~~~~~----~~ 835 (1001)
..+.++|++.+.||+|+||+||+|++ +++.||||++... ..+.+.+|+++++. ++||||+++++++.... ..
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 44668999999999999999999998 5899999998543 34667888888877 78999999999988775 78
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeEEeCCCCCCeEECCCCcEEEe
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH--------HDCMPPILHGDVKAMNVLLGPGYQAYLA 907 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivH~Dlkp~NIll~~~~~~ki~ 907 (1001)
++||||+++|+|.+++++. .+++..++.++.|++.|++||| +. +|+||||||+||+++.++++||+
T Consensus 116 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp EEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEEC
T ss_pred EEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999753 4899999999999999999999 66 99999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCCCCCcccccccccCccccccC------CCCCccchHHHHHHHHHHHhC----------CCC
Q 001873 908 DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ------RITEKSDVYSFGVVLLEVLTG----------RHP 971 (1001)
Q Consensus 908 Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~il~elltg----------~~P 971 (1001)
|||++.......... ........||+.|+|||++.+. .++.++|||||||++|||+|| +.|
T Consensus 190 Dfg~~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 190 DLGLAVRHDSATDTI---DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp CCTTCEEEETTTTEE---EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred ECCCceecccccccc---ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999998765432110 0122345799999999998765 233689999999999999999 788
Q ss_pred CCCCCCCCcCcccchhh
Q 001873 972 LDPTLPGGAPLVQWTPL 988 (1001)
Q Consensus 972 f~~~~~~~~~l~~~~~~ 988 (1001)
|....+.+.....+...
T Consensus 267 ~~~~~~~~~~~~~~~~~ 283 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKV 283 (342)
T ss_dssp TTTTSCSSCCHHHHHHH
T ss_pred ccccCcCcccHHHHHHH
Confidence 88766555444444433
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=306.99 Aligned_cols=200 Identities=30% Similarity=0.464 Sum_probs=170.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCE--EEEEEecCC---CchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGET--LAVKKMWSS---DESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~--vavK~~~~~---~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv 838 (1001)
++|++.+.||+|+||.||+|+.. ++.. ||||++... ...+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67999999999999999999865 4554 499988642 2346789999999999 899999999999999999999
Q ss_pred EEccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcE
Q 001873 839 YDYLPNGSLSSLLHGAG--------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQA 904 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 904 (1001)
|||+++|+|.+++.+.+ ...+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999998643 23589999999999999999999998 99999999999999999999
Q ss_pred EEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 905 YLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 905 ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
||+|||+++..... .......+++.|+|||++.+..++.++||||+|+++|||++ |+.||.+..
T Consensus 182 kL~Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp EECCTTCEESSCEE--------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEcccCcCcccccc--------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999743211 11223357889999999988889999999999999999998 999997653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-31 Score=295.39 Aligned_cols=295 Identities=20% Similarity=0.260 Sum_probs=177.0
Q ss_pred ccceeccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEecc
Q 001873 248 RIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFS 327 (1001)
Q Consensus 248 ~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 327 (1001)
+++.++++++.++ .+|..+. ++|++|+|++|++++..+..|+++++|++|+|++|++++..|..++.+++|++|+++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 4455555555554 4555443 567777777777777666677777777777777777777667777777777777777
Q ss_pred CCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccC--ccCccccccCcccEEEeecCccCC
Q 001873 328 DNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISG--EIPADIGNINGLTLFFAWKNKLTG 405 (1001)
Q Consensus 328 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~l~~n~l~~ 405 (1001)
+|.++ .+|..+. ++|++|++++|++++..+..+..+++|++|++++|.+.. ..+..+.++++|+.|++++|+++.
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 77777 4554443 577777777777776666667777777777777777743 445556666666666666666653
Q ss_pred CCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCC
Q 001873 406 NIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGN 485 (1001)
Q Consensus 406 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 485 (1001)
+|..+. ++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+++|++|+|++|+++ .+|..+..
T Consensus 186 -l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 261 (330)
T 1xku_A 186 -IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261 (330)
T ss_dssp -CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred -CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhcc
Confidence 333322 45666666666665555555555555666666666555555555555555555555555555 45555555
Q ss_pred CCCcceeeccCcccccCCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCC--Ccccccccccccceee
Q 001873 486 LKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSG--SLAHSIGSLTELSKLL 563 (1001)
Q Consensus 486 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~ 563 (1001)
+++|++|++++|+|++..+..|.... +......++.|++++|.+.. +.|..|..+..++.++
T Consensus 262 l~~L~~L~l~~N~i~~~~~~~f~~~~----------------~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~ 325 (330)
T 1xku_A 262 HKYIQVVYLHNNNISAIGSNDFCPPG----------------YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 325 (330)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSS----------------CCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEE
T ss_pred CCCcCEEECCCCcCCccChhhcCCcc----------------cccccccccceEeecCcccccccCccccccccceeEEE
Confidence 55555555555555544444333210 00001223345555555542 4556677777888888
Q ss_pred ccCcc
Q 001873 564 LSKNQ 568 (1001)
Q Consensus 564 Ls~N~ 568 (1001)
|++|+
T Consensus 326 L~~N~ 330 (330)
T 1xku_A 326 LGNYK 330 (330)
T ss_dssp C----
T ss_pred ecccC
Confidence 88774
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-33 Score=303.22 Aligned_cols=201 Identities=28% Similarity=0.396 Sum_probs=171.3
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeee--cCCceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGS--NKNLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~--~~~~~~l 837 (1001)
.++|++.+.||+|+||+||+++.. +++.||+|++.... ..+.+.+|+.++++++||||+++++++. ..+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999975 68999999986433 2356889999999999999999999774 4668899
Q ss_pred EEEccCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-----eEEeCCCCCCeEECCCCcEEEeccc
Q 001873 838 FYDYLPNGSLSSLLHGAG--KGGADWEARYEVVLGVAHALAYLHHDCMPP-----ILHGDVKAMNVLLGPGYQAYLADFG 910 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~-----ivH~Dlkp~NIll~~~~~~ki~Dfg 910 (1001)
||||+++++|.+++.... ...+++..++.++.|++.|++|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997532 33489999999999999999999998 7 9999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.++...... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus 162 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 162 LARILNHDT-------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp HHHHC---C-------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hheeecccc-------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 998753211 1112346899999999999889999999999999999999999999865
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=305.05 Aligned_cols=200 Identities=24% Similarity=0.346 Sum_probs=173.0
Q ss_pred HhcccCCCeEeecCCeeEEEEEe--CCCCEEEEEEecCCC----chhhHHHHHHHhhcc---CCCceeeEEeeee-----
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI--PNGETLAVKKMWSSD----ESGAFSSEIQTLGSI---RHKNIVRLLGWGS----- 830 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l---~h~nIv~l~~~~~----- 830 (1001)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 36899999999999999999997 367899999885322 234677888888777 8999999999886
Q ss_pred cCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccc
Q 001873 831 NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFG 910 (1001)
Q Consensus 831 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfg 910 (1001)
.....++||||++ |+|.+++.......+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCc
Confidence 5567899999998 6999999887666689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.++..... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.+..
T Consensus 166 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (326)
T 1blx_A 166 LARIYSFQ--------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223 (326)
T ss_dssp SCCCCCGG--------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccCC--------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99765321 12234578999999999998899999999999999999999999998653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=9.8e-33 Score=309.26 Aligned_cols=207 Identities=29% Similarity=0.446 Sum_probs=163.2
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHH--hhccCCCceeeEEeeee-----cCCceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQT--LGSIRHKNIVRLLGWGS-----NKNLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~--l~~l~h~nIv~l~~~~~-----~~~~~~l 837 (1001)
.++|++.+.||+|+||+||+|+. +++.||||++.... ...+..|.++ ++.++||||+++++++. .....++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 36799999999999999999987 68999999985433 3344444444 55689999999998543 2335689
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeEEeCCCCCCeEECCCCcEEEecccc
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC------MPPILHGDVKAMNVLLGPGYQAYLADFGL 911 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~------~~~ivH~Dlkp~NIll~~~~~~ki~Dfgl 911 (1001)
||||+++|+|.++++.. ..++..+.+++.|++.|++|||+.+ .++|+||||||+||+++.++.+||+|||+
T Consensus 90 v~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp EECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred EEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 99999999999999754 3488999999999999999999862 23899999999999999999999999999
Q ss_pred cccccCCCCCCC-CCCCCCCcccccccccCcccccc-------CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 912 ARIVSGSGDDNC-SKTNQRPQLAGSYGYMAPEHASM-------QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 912 a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
|+.+........ ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 987654322110 11222334579999999999876 456678999999999999999988776543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=299.59 Aligned_cols=201 Identities=23% Similarity=0.347 Sum_probs=174.4
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----------chhhHHHHHHHhhccC-CCceeeEEee
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----------ESGAFSSEIQTLGSIR-HKNIVRLLGW 828 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----------~~~~~~~Ei~~l~~l~-h~nIv~l~~~ 828 (1001)
..+.++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.+++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 345678999999999999999999975 68999999986432 1246788999999995 9999999999
Q ss_pred eecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEec
Q 001873 829 GSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLAD 908 (1001)
Q Consensus 829 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~D 908 (1001)
+...+..++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred eccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999999863 3589999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCCCCCcccccccccCccccc------cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 909 FGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS------MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 909 fgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
||.+....... ......||+.|+|||++. ...++.++||||+|+++|||++|+.||...
T Consensus 168 fg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 168 FGFSCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp CTTCEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccchhhcCCCc--------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 99998764321 123347899999999874 456889999999999999999999999754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=300.61 Aligned_cols=200 Identities=29% Similarity=0.361 Sum_probs=168.0
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CC---CEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCce-EEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NG---ETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLK-LLF 838 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~---~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~-~lv 838 (1001)
.|+..++||+|+||+||+|++. ++ ..||+|++..... .+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4666789999999999999853 22 3799999865443 25788999999999999999999998766554 999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+.+|+|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999864 34579999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~ 973 (1001)
.. ..........+|+.|+|||.+.+..++.++||||+|+++|||++|..|+.
T Consensus 178 ~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~ 229 (298)
T 3pls_A 178 EY---YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229 (298)
T ss_dssp GG---GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred cc---cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC
Confidence 11 11122334568899999999999999999999999999999999665544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.2e-33 Score=314.64 Aligned_cols=198 Identities=17% Similarity=0.153 Sum_probs=152.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-----hhhHHHHHHHhhcc--CCCceeeEE-------eeee
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-----SGAFSSEIQTLGSI--RHKNIVRLL-------GWGS 830 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~Ei~~l~~l--~h~nIv~l~-------~~~~ 830 (1001)
..|++.+.||+|+||+||+|++. +++.||||++..... .+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45889999999999999999975 789999999976542 24577785544444 699988755 3333
Q ss_pred cC-----------------CceEEEEEccCCCCHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHhhCCCCCeE
Q 001873 831 NK-----------------NLKLLFYDYLPNGSLSSLLHGAGKGGADWEAR------YEVVLGVAHALAYLHHDCMPPIL 887 (1001)
Q Consensus 831 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~------~~i~~~i~~~l~yLH~~~~~~iv 887 (1001)
.+ ...++||||++ |+|.+++...+. ..++..+ ..++.||+.|++|||++ +|+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 32 23799999998 899999986422 2344445 67789999999999998 999
Q ss_pred EeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCcccccc--CCCCCccchHHHHHHHHHH
Q 001873 888 HGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM--QRITEKSDVYSFGVVLLEV 965 (1001)
Q Consensus 888 H~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~el 965 (1001)
||||||+||+++.++.+||+|||+|+.... ......+|+.|+|||++.+ ..++.++||||+||++|||
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~el 286 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT----------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC----------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHH
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC----------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHH
Confidence 999999999999999999999999986531 1113467799999999987 7899999999999999999
Q ss_pred HhCCCCCCCCCCC
Q 001873 966 LTGRHPLDPTLPG 978 (1001)
Q Consensus 966 ltg~~Pf~~~~~~ 978 (1001)
++|+.||....+.
T Consensus 287 ltg~~Pf~~~~~~ 299 (371)
T 3q60_A 287 WCLFLPFGLVTPG 299 (371)
T ss_dssp HHSSCSTTBCCTT
T ss_pred HhCCCCCCCcCcc
Confidence 9999999877543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=331.03 Aligned_cols=200 Identities=25% Similarity=0.379 Sum_probs=166.0
Q ss_pred ccCCC-eEeecCCeeEEEEEeC---CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 768 LTSAN-VIGTGSSGVVYRVTIP---NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 768 ~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
+.+.+ .||+|+||+||+|.++ ++..||||+++... ..+++.+|++++++++|||||++++++.. +..++|||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E 415 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 415 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence 33344 7999999999999864 45679999986532 34789999999999999999999999976 56899999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+.+.....
T Consensus 416 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 416 MAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp CCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred eCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 99999999999754 44589999999999999999999998 999999999999999999999999999987643221
Q ss_pred CCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
. ........+|+.|+|||++....++.++|||||||++|||++ |+.||....
T Consensus 492 ~----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 492 Y----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred e----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 1 111222346789999999999999999999999999999998 999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=306.42 Aligned_cols=203 Identities=27% Similarity=0.381 Sum_probs=170.2
Q ss_pred HhcccCCCeEeecCCeeEEEEEe------CCCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCce
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTI------PNGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~ 835 (1001)
.++|++.+.||+|+||.||+|++ .+++.||||++.... ...++.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 36899999999999999999984 257789999986433 235788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC---CCcEEEe
Q 001873 836 LLFYDYLPNGSLSSLLHGAGK-----GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP---GYQAYLA 907 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~ 907 (1001)
++||||+++|+|.+++..... ..+++..++.++.|++.|+.|||+. +|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999987532 3478999999999999999999998 9999999999999984 4569999
Q ss_pred cccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 908 DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 908 Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
|||+++....... ........||+.|+|||++.+..++.++||||||+++|||+| |+.||...
T Consensus 186 Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 186 DFGMARDIYRASY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp CCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccccccccccccc-----cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 9999986543221 112233468899999999988899999999999999999998 99999764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.3e-32 Score=298.00 Aligned_cols=199 Identities=29% Similarity=0.423 Sum_probs=169.1
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccC
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
+|....+||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3555568999999999999964 68899999986543 24678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC-CCcEEEecccccccccCCCCC
Q 001873 844 NGSLSSLLHGAG-KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP-GYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 844 ~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+++|.+++.... ....++..+..++.|++.|++|||++ +|+||||||+||+++. ++.+||+|||.++......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 999999998653 23467888999999999999999998 9999999999999987 8999999999998754221
Q ss_pred CCCCCCCCCcccccccccCccccccC--CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQ--RITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......||+.|+|||++... .++.++||||||+++|||++|+.||...
T Consensus 178 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 178 -----PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred -----CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 112334689999999998664 3789999999999999999999999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=311.96 Aligned_cols=200 Identities=24% Similarity=0.250 Sum_probs=172.2
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-hhhHHHHHHHhhccC-CC-----ceeeEEeeeecCCce
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-SGAFSSEIQTLGSIR-HK-----NIVRLLGWGSNKNLK 835 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~Ei~~l~~l~-h~-----nIv~l~~~~~~~~~~ 835 (1001)
+.++|++.+.||+|+||+||+|+.. +++.||||++..... ..++.+|+.+++.++ |+ +|+++++++...+..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 4578999999999999999999875 688999999965432 356778998888874 44 599999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC--CCCcEEEecccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG--PGYQAYLADFGLAR 913 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~ki~Dfgla~ 913 (1001)
++||||++ |+|.+++.......+++..+..++.|++.|+.|||++ ..+|+||||||+||+++ .++.+||+|||+|+
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 99999996 5999999877656789999999999999999999952 13999999999999995 57889999999998
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
..... .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.
T Consensus 210 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 210 QLGQR----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp ETTCC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecccc----------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 75321 22347899999999999999999999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=303.36 Aligned_cols=202 Identities=26% Similarity=0.349 Sum_probs=170.9
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
..++|++.+.||+|+||+||+|+.. +++.||+|++.... ..+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3468999999999999999999976 58999999985433 34788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++++|.+++.+. ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-- 170 (302)
T ss_dssp CCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--
T ss_pred eCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc--
Confidence 99999999998753 34589999999999999999999998 9999999999999999999999999987643211
Q ss_pred CCCCCCCCCCcccccccccCcccc-----ccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHA-----SMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
........||+.|+|||++ ....++.++||||+|+++|||++|+.||....
T Consensus 171 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 171 -----LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp -----HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -----ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 0112234689999999988 46778899999999999999999999998643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=303.55 Aligned_cols=204 Identities=25% Similarity=0.364 Sum_probs=162.6
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC----CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCC---
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP----NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKN--- 833 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~--- 833 (1001)
.++|++.+.||+|+||+||+|+.. .++.||||++..... .+.+.+|+.++++++||||+++++++.+.+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 367899999999999999999754 345899999864432 256889999999999999999999987654
Q ss_pred --ceEEEEEccCCCCHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEe
Q 001873 834 --LKLLFYDYLPNGSLSSLLHGA----GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLA 907 (1001)
Q Consensus 834 --~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~ 907 (1001)
..++||||+++|+|.+++... ....+++..++.++.|++.|+.|||++ +|+||||||+||+++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEe
Confidence 349999999999999998532 235589999999999999999999998 99999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 908 DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 908 Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 190 Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 190 DFGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp SCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ecCcceecccccc-----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 9999987643221 112233457889999999999999999999999999999999 899997653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=300.26 Aligned_cols=201 Identities=25% Similarity=0.358 Sum_probs=169.0
Q ss_pred hcccCCC-eEeecCCeeEEEEEe---CCCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSAN-VIGTGSSGVVYRVTI---PNGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~-~lG~G~fg~Vy~~~~---~~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
++|++.+ .||+|+||+||+|.+ ..++.||||++..... .+++.+|+.+++.++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 5688877 999999999999954 2468899999865432 36788999999999999999999999 5567899
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||+++++|.+++.+. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 95 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 99999999999999874 3489999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.... ........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||....
T Consensus 170 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 170 DENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp TCSE----EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CCCc----ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 3211 111223356789999999988889999999999999999999 999998643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=300.61 Aligned_cols=200 Identities=23% Similarity=0.324 Sum_probs=157.7
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCch----hhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDES----GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
.++|++.+.||+|+||+||+|+.. +++.||||++...... +.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 367999999999999999999974 7899999998654322 23444555588889999999999999999999999
Q ss_pred EccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 840 DYLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||++ |+|.+++... ....+++..+..++.|++.|++|||+++ +|+||||||+||+++.++++||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 5888877541 2456899999999999999999999852 899999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCcccc----ccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHA----SMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......||+.|+|||++ ....++.++||||+|+++|||++|+.||+..
T Consensus 163 ~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 163 D--------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred c--------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 2 112233699999999996 5677899999999999999999999999753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=305.47 Aligned_cols=199 Identities=24% Similarity=0.329 Sum_probs=148.7
Q ss_pred HHhcccCCC-eEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeec----CCceEE
Q 001873 764 VVRNLTSAN-VIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSN----KNLKLL 837 (1001)
Q Consensus 764 ~~~~~~~~~-~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~----~~~~~l 837 (1001)
+.++|++.+ +||+|+||+||+|+.. +++.||||++.... ....+....++.++||||+++++++.. ....++
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 457899855 6999999999999976 68999999985432 222233334566799999999998865 445799
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC---CCcEEEeccccccc
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP---GYQAYLADFGLARI 914 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~Dfgla~~ 914 (1001)
||||+++|+|.+++.+.....+++..++.++.|++.|++|||++ +|+||||||+||+++. ++.+||+|||+++.
T Consensus 104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 99999999999999977666799999999999999999999998 9999999999999976 45699999999986
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.... ......||+.|+|||++....++.++||||+|+++|+|++|+.||....
T Consensus 181 ~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 181 TTQN---------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp C-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cccc---------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 5321 1223478999999999988889999999999999999999999997654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-32 Score=305.60 Aligned_cols=205 Identities=24% Similarity=0.361 Sum_probs=170.2
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecC-----Cc
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNK-----NL 834 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~-----~~ 834 (1001)
+.++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3468999999999999999999975 689999999864332 25678999999999999999999987654 67
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.++||||++ |+|.+++.. ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 899999997 699999875 3589999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCCCCC---CCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 915 VSGSGDDNCS---KTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 915 ~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......... .........||+.|+|||++.. ..++.++||||+||++|||++|+.||.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 6543221110 0112234578999999998754 77899999999999999999999999865
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-32 Score=294.30 Aligned_cols=200 Identities=23% Similarity=0.340 Sum_probs=174.7
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceE
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
..+.++|++.+.||+|+||+||+|+.. +++.||||++... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 456789999999999999999999976 6899999998532 23467899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC---CcEEEecccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG---YQAYLADFGLAR 913 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~ki~Dfgla~ 913 (1001)
+||||+++++|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.+ +.+||+|||++.
T Consensus 98 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999999998764 3489999999999999999999998 99999999999999754 479999999998
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
..... .......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||...
T Consensus 173 ~~~~~--------~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (287)
T 2wei_A 173 CFQQN--------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (287)
T ss_dssp TBCCC--------SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCC--------CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence 65322 11233468999999998875 4889999999999999999999999764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=303.94 Aligned_cols=201 Identities=29% Similarity=0.410 Sum_probs=172.0
Q ss_pred hcccCCCeEeecCCeeEEEEEe-----CCCCEEEEEEecCCCc--hhhHHHHHHHhhccCCCceeeEEeeeecCC--ceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI-----PNGETLAVKKMWSSDE--SGAFSSEIQTLGSIRHKNIVRLLGWGSNKN--LKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~--~~~ 836 (1001)
++|++.+.||+|+||.||++++ .+++.||||++..... .+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 5689999999999999999983 3688999999865443 357899999999999999999999876543 679
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
+||||+++++|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 121 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 999999999999999875 34589999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
..... ........++..|+|||++.+..++.++||||+|+++|||+||+.||..
T Consensus 197 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 197 QDKEY----YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp SSCSE----EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred ccccc----cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 33211 1112234578889999999888899999999999999999999998864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=307.53 Aligned_cols=194 Identities=23% Similarity=0.332 Sum_probs=167.0
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCce---
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLK--- 835 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~--- 835 (1001)
+.++|++.+.||+|+||+||+|+.. +++.||||++..... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3468999999999999999999865 689999999865432 25788999999999999999999999877655
Q ss_pred ---EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccc
Q 001873 836 ---LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLA 912 (1001)
Q Consensus 836 ---~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla 912 (1001)
++||||++ ++|.+++.. .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 689888743 389999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 192 ~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 192 RHADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp ------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccC----------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 864321 233478999999999876 78899999999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=305.13 Aligned_cols=206 Identities=25% Similarity=0.360 Sum_probs=155.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc--hhhHHHHHHHhhccC-CCceeeEEeeee--------cCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE--SGAFSSEIQTLGSIR-HKNIVRLLGWGS--------NKN 833 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~Ei~~l~~l~-h~nIv~l~~~~~--------~~~ 833 (1001)
.+|++.++||+|+||+||+|++. +++.||||++..... .+.+.+|+.+++++. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 47999999999999999999965 689999998855443 367889999999996 999999999883 344
Q ss_pred ceEEEEEccCCCCHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEeCCCCCCeEECCCCcEEEeccc
Q 001873 834 LKLLFYDYLPNGSLSSLLHGA-GKGGADWEARYEVVLGVAHALAYLHHDCMPP--ILHGDVKAMNVLLGPGYQAYLADFG 910 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~ki~Dfg 910 (1001)
..++||||+. |+|.+++... ....+++..++.++.|++.|++|||++ + |+||||||+||+++.++++||+|||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCc
Confidence 5789999996 7999988652 234589999999999999999999998 7 9999999999999999999999999
Q ss_pred ccccccCCCCCCCCC-----CCCCCcccccccccCcccc---ccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 911 LARIVSGSGDDNCSK-----TNQRPQLAGSYGYMAPEHA---SMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 911 la~~~~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+++............ ........||+.|+|||++ .+..++.++|||||||++|||++|+.||...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 998765432211100 0112245699999999998 5677889999999999999999999999754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-32 Score=305.40 Aligned_cols=204 Identities=22% Similarity=0.247 Sum_probs=158.7
Q ss_pred HHHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCc----
Q 001873 761 IDDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNL---- 834 (1001)
Q Consensus 761 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~---- 834 (1001)
.....++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+|++.++.++||||+++++++...+.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 3455789999999999999999999975 68999999885543 34567888888999999999999998865333
Q ss_pred ---eEEEEEccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeEEeCCCCCCeEECC-CCcEEE
Q 001873 835 ---KLLFYDYLPNGSLSSLLHG--AGKGGADWEARYEVVLGVAHALAYLH--HDCMPPILHGDVKAMNVLLGP-GYQAYL 906 (1001)
Q Consensus 835 ---~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~yLH--~~~~~~ivH~Dlkp~NIll~~-~~~~ki 906 (1001)
.++||||+++ ++.+.+.. ......++..+..++.|++.|+.||| +. +|+||||||+||+++. ++.+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEE
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEE
Confidence 7899999985 55544432 23455789999999999999999999 77 9999999999999996 899999
Q ss_pred ecccccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 907 ADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 907 ~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+|||+++.+.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..
T Consensus 174 ~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 174 CDFGSAKKLSPSE--------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp CCCTTCBCCCTTS--------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeCCCceecCCCC--------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 9999998764321 2234478999999999865 458999999999999999999999998753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=328.80 Aligned_cols=195 Identities=25% Similarity=0.352 Sum_probs=163.7
Q ss_pred CeEeecCCeeEEEEEeC---CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIP---NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
+.||+|+||+||+|.+. .++.||||+++... ..+++.+|++++++++|||||++++++.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46789999986532 23679999999999999999999999975 457899999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.++++.. ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+.+......
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~--- 525 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--- 525 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc---
Confidence 9999999864 4589999999999999999999998 9999999999999999999999999999876543221
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
........+|+.|+|||++....++.++|||||||++|||++ |+.||.+..
T Consensus 526 -~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 526 -YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred -cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 112223457889999999999999999999999999999998 999998754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=301.00 Aligned_cols=206 Identities=24% Similarity=0.322 Sum_probs=168.0
Q ss_pred hcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeee----cCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGS----NKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~----~~~~~~lv 838 (1001)
++|++.+.||+|+||.||+++. .+++.||||++.... ..+.+.+|+.++++++||||+++++++. .....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 5799999999999999999997 478999999885433 3367889999999999999999999886 34477899
Q ss_pred EEccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 839 YDYLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
|||+++|+|.+++... ....+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++...
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 9999999999998752 235589999999999999999999998 99999999999999999999999999987642
Q ss_pred CCCCCCCC--CCCCCCcccccccccCccccccCC---CCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 917 GSGDDNCS--KTNQRPQLAGSYGYMAPEHASMQR---ITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 917 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
........ .........||+.|+|||++.... ++.++||||||+++|||++|+.||+.
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 11000000 000012235799999999987543 68899999999999999999999964
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-32 Score=299.99 Aligned_cols=201 Identities=22% Similarity=0.328 Sum_probs=163.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc--hhhHHHHHHHhhccCCCceeeEEeeee-----------
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE--SGAFSSEIQTLGSIRHKNIVRLLGWGS----------- 830 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~~~~~----------- 830 (1001)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999976 489999999865442 367889999999999999999999873
Q ss_pred ---cCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC-CCCcEEE
Q 001873 831 ---NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG-PGYQAYL 906 (1001)
Q Consensus 831 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ki 906 (1001)
+....++||||++ |+|.+++.+ ..+++..+..++.|++.|++|||++ +|+||||||+||+++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence 4467899999998 699999974 4588999999999999999999998 999999999999997 5679999
Q ss_pred ecccccccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 907 ADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 907 ~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+|||+++....... .........+|+.|+|||++.. ..++.++||||||+++|||++|+.||.+..
T Consensus 163 ~Dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 163 GDFGLARIMDPHYS----HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp CCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCccccccCCCcc----cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 99999987643211 1122334468999999998765 778999999999999999999999998654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=302.68 Aligned_cols=198 Identities=21% Similarity=0.281 Sum_probs=171.8
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CC-CEEEEEEecCCC-chhhHHHHHHHhhccCCCc------eeeEEeeeecCCce
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NG-ETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKN------IVRLLGWGSNKNLK 835 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~-~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~n------Iv~l~~~~~~~~~~ 835 (1001)
.++|++.+.||+|+||+||+|... ++ +.||||++.... ..+.+.+|+.++++++|++ ++.+.+++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 468999999999999999999875 34 689999986543 2367888999999997665 99999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEE-----------------
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL----------------- 898 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll----------------- 898 (1001)
++||||+ ++++.+++.......+++..+..++.||+.||+|||++ +|+||||||+||++
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 67888888776556789999999999999999999998 99999999999999
Q ss_pred --CCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 899 --GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 899 --~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHE----------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp EEESCCCEEECCCTTCEETTS----------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCCCcEEEeecCccccccc----------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 5678999999999986432 1233479999999999999999999999999999999999999998653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-32 Score=296.20 Aligned_cols=200 Identities=26% Similarity=0.419 Sum_probs=161.8
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeec----------
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSN---------- 831 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~---------- 831 (1001)
+.++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 4678999999999999999999975 78999999985432 23678899999999999999999998754
Q ss_pred ---CCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEec
Q 001873 832 ---KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLAD 908 (1001)
Q Consensus 832 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~D 908 (1001)
.+..++||||+++|+|.+++... ....++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence 45678999999999999999864 34568889999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCCC-------CCCCCCCcccccccccCccccccC-CCCCccchHHHHHHHHHHHh
Q 001873 909 FGLARIVSGSGDDNC-------SKTNQRPQLAGSYGYMAPEHASMQ-RITEKSDVYSFGVVLLEVLT 967 (1001)
Q Consensus 909 fgla~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt 967 (1001)
||+++.......... ..........||+.|+|||++.+. .++.++||||+||++|||++
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 999987643211000 001223345799999999998754 78999999999999999998
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-32 Score=307.26 Aligned_cols=198 Identities=22% Similarity=0.290 Sum_probs=169.1
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-chhhHHHHHHHhhccC-----------CCceeeEEeeeecC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-ESGAFSSEIQTLGSIR-----------HKNIVRLLGWGSNK 832 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~-----------h~nIv~l~~~~~~~ 832 (1001)
++|++.+.||+|+||+||+|+.. +++.||||++.... ..+.+.+|+.++++++ ||||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 57999999999999999999964 68999999986543 2367889999998886 89999999988754
Q ss_pred C----ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC------CCC
Q 001873 833 N----LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG------PGY 902 (1001)
Q Consensus 833 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~------~~~ 902 (1001)
+ ..++||||+ +++|.+++.......+++..+..++.||+.||+|||+++ +|+||||||+||+++ ..+
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcc
Confidence 4 789999999 899999998866667899999999999999999999953 899999999999994 445
Q ss_pred cEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 903 QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 903 ~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 176 ~~kl~Dfg~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eEEEcccccccccCCC----------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 8999999999875321 223478999999999999999999999999999999999999998754
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-35 Score=345.66 Aligned_cols=259 Identities=20% Similarity=0.168 Sum_probs=141.2
Q ss_pred cccceeccccccccccCccc-ccCCCCCceEeeecCcccC----CCCcccCCCCCCcEEEcCCCcccccCCCCcc-CCC-
Q 001873 247 ERIQTIAIYTSLLSGPIPEE-IGNCSELQNLYLYQNSISG----PIPGRIGALSKLKSLLLWQNSLVGAIPDELG-SCT- 319 (1001)
Q Consensus 247 ~~L~~L~l~~n~l~g~ip~~-l~~l~~L~~L~L~~N~i~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~- 319 (1001)
++|++|++++|.++...... +..+++|++|+|++|.++. .++..+..+++|++|+|++|.+++..+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 45666777766665433222 5666677777777776653 2344555666667777766666543332221 233
Q ss_pred ---CCCEEeccCCCCCC----CCCcccccccCccEEEcccccccCcCChhhcc-----ccccCEEeccCCcccCccCccc
Q 001873 320 ---ELTVVDFSDNLLTG----SIPRSFGNLLKLQELQLSVNQLSGTIPIEIAT-----CTALTHLEIDNNAISGEIPADI 387 (1001)
Q Consensus 320 ---~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~i~~~~~~~~ 387 (1001)
+|++|+|++|.++. .++..+..+++|++|+|++|++++..+..+.. .++|++|++++|++++....
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~-- 160 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE-- 160 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH--
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH--
Confidence 46666666666653 33555666666666666666665433333221 33566666666655542211
Q ss_pred cccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCccccc-----ccccceEEccCCcCCCC----CCCC
Q 001873 388 GNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFG-----LRNLTKLLLLSNDLSGF----IPPD 458 (1001)
Q Consensus 388 ~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~----~p~~ 458 (1001)
.++..+..+++|++|++++|.+++..+..+.. .++|++|++++|++++. ++..
T Consensus 161 ------------------~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 222 (461)
T 1z7x_W 161 ------------------PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 222 (461)
T ss_dssp ------------------HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred ------------------HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHH
Confidence 11333444555666666666555333333321 33566666666666542 2444
Q ss_pred CCCCCCcceEEccccccccCC-----CcccCCCCCcceeeccCcccccC----CcccccccccCceEEcccccCcc
Q 001873 459 IGNCTTLRRLRLNDNRLSGTI-----PSEMGNLKHLNFVDMSENHLVGG----IPPSVVGCQSLEFLDLHSNGLTG 525 (1001)
Q Consensus 459 l~~l~~L~~L~Ls~N~l~~~~-----p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ 525 (1001)
+..+++|++|++++|++++.. +..+..+++|++|++++|++++. ++..+..+++|++|++++|++++
T Consensus 223 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~ 298 (461)
T 1z7x_W 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD 298 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHH
T ss_pred HHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCch
Confidence 455566666666666665321 22233466677777777766643 45555566677777777776653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=298.22 Aligned_cols=201 Identities=27% Similarity=0.405 Sum_probs=162.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeC--CCC--EEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP--NGE--TLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
++|++.+.||+|+||+||+|++. +++ .||||++.... ..+.+.+|++++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 57999999999999999999853 333 68999885432 2367889999999999999999999988765 78
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
+||||+++++|.+++... ...+++..+.+++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 999999999999999764 23488999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
..... ........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...
T Consensus 173 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 173 QNDDH----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp C-CCE----EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccc----hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 33211 112223467889999999988889999999999999999999 99999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=302.31 Aligned_cols=194 Identities=23% Similarity=0.318 Sum_probs=166.2
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCc-----
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNL----- 834 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~----- 834 (1001)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... .+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999975 689999999865432 2568899999999999999999999877654
Q ss_pred -eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccc
Q 001873 835 -KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913 (1001)
Q Consensus 835 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~ 913 (1001)
.++||||++ ++|.+++.. .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 688888753 389999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..
T Consensus 175 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 175 HADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp C------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred CCCCC----------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 64321 223478999999999876 788999999999999999999999998643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=299.32 Aligned_cols=200 Identities=22% Similarity=0.325 Sum_probs=163.9
Q ss_pred HHHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--------chhhHHHHHHHhhcc----CCCceeeEEe
Q 001873 761 IDDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--------ESGAFSSEIQTLGSI----RHKNIVRLLG 827 (1001)
Q Consensus 761 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~Ei~~l~~l----~h~nIv~l~~ 827 (1001)
.+.+.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+|+.+++++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3455678999999999999999999864 68999999985442 224566799999988 8999999999
Q ss_pred eeecCCceEEEEEc-cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC-CCCcEE
Q 001873 828 WGSNKNLKLLFYDY-LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG-PGYQAY 905 (1001)
Q Consensus 828 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~k 905 (1001)
++...+..++|||| +++++|.+++.+. ..+++..+..++.|++.|++|||+. +|+||||||+||+++ .++.+|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence 99998999999999 7899999999864 3489999999999999999999998 999999999999999 889999
Q ss_pred EecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCC-CccchHHHHHHHHHHHhCCCCCCC
Q 001873 906 LADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRIT-EKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 906 i~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
|+|||+++..... ......||+.|+|||++.+..+. .++||||+|+++|||++|+.||..
T Consensus 181 l~dfg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 181 LIDFGSGALLHDE---------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp ECCCSSCEECCSS---------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEEcchhhhcccC---------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 9999999876432 12334689999999998776664 589999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=296.18 Aligned_cols=198 Identities=25% Similarity=0.360 Sum_probs=165.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC----chhhHHHHHHHhhccC--CCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD----ESGAFSSEIQTLGSIR--HKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~--h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||.||+++..+++.||||++.... ..+.+.+|+.++++++ ||||+++++++..++..++||
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 5799999999999999999998889999999986433 2267889999999997 599999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
| +.+++|.+++.+. ..+++..+..++.|++.|++|||++ +|+||||||+||++++ +.+||+|||+++.+....
T Consensus 108 e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 108 E-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp C-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred e-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 9 5578999999874 3589999999999999999999998 9999999999999964 899999999998764321
Q ss_pred CCCCCCCCCCCcccccccccCcccccc-----------CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASM-----------QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 181 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 181 T-----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred c-----cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 1 111234479999999999865 47888999999999999999999999764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=296.89 Aligned_cols=200 Identities=27% Similarity=0.349 Sum_probs=150.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCch---hhHHHHHH-HhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDES---GAFSSEIQ-TLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~Ei~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
++|++.+.||+|+||.||+|+.. +++.||||++...... .++.+|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 57899999999999999999975 6899999998654332 34556666 6778899999999999999999999999
Q ss_pred ccCCCCHHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 841 YLPNGSLSSLLHG---AGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 841 ~~~~gsL~~~l~~---~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
|++ |+|.+++.. .....+++..+.+++.|++.|+.|||+. ++|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 998 488877753 2245689999999999999999999995 2899999999999999999999999999986542
Q ss_pred CCCCCCCCCCCCCcccccccccCcccc----ccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHA----SMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.. ......||+.|+|||++ .+..++.++||||||+++|||++|+.||....
T Consensus 179 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 179 SI--------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp -----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred cc--------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 21 12233699999999998 45678999999999999999999999998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=300.21 Aligned_cols=198 Identities=21% Similarity=0.347 Sum_probs=171.5
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--------chhhHHHHHHHhhccC--CCceeeEEeeeecC
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--------ESGAFSSEIQTLGSIR--HKNIVRLLGWGSNK 832 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~Ei~~l~~l~--h~nIv~l~~~~~~~ 832 (1001)
+.++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++ ||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 3578999999999999999999864 68999999985432 2256778999999996 59999999999999
Q ss_pred CceEEEEEccCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC-CCCcEEEeccc
Q 001873 833 NLKLLFYDYLPN-GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG-PGYQAYLADFG 910 (1001)
Q Consensus 833 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ki~Dfg 910 (1001)
+..++||||+.+ ++|.+++.+. ..+++..+..++.|++.|++|||+. +|+||||||+||+++ +++.+||+|||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred CcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 999999999986 8999999863 4589999999999999999999998 999999999999999 78999999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRI-TEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...
T Consensus 196 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 196 SGALLKDT---------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp TCEECCSS---------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccccccc---------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 99876421 1223469999999999887666 68899999999999999999999753
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-35 Score=348.04 Aligned_cols=379 Identities=17% Similarity=0.133 Sum_probs=196.8
Q ss_pred CCCcEEeccCCcccCCCCcc-cCCccccccccccCCccCC----CCChhhhcccccceEEccCCcccCCCCcccc-CCc-
Q 001873 102 KSLKRLIISSCNLTGTIPKE-FGDYRELTFIDLSGNSLWG----EIPTEVCRLRKLESLYLNTNLLEGEIPSDIG-NLS- 174 (1001)
Q Consensus 102 ~~L~~L~l~~~~l~g~~p~~-~~~l~~L~~L~Ls~n~l~g----~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~-~L~- 174 (1001)
++|++|+|++|+++...... +..+++|++|+|++|++++ .+|..+..+++|++|+|++|.+++..+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 45677777777776433332 6667777777777777764 3456666777777777777777654444432 344
Q ss_pred ---cccceecccccccc----ccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCcccc--
Q 001873 175 ---SLAYLTLYDNQLSG----KIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGM-- 245 (1001)
Q Consensus 175 ---~L~~L~L~~n~l~g----~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~-- 245 (1001)
+|++|+|++|.++. .+|..+..+++|++|++++| .+.+..+..+..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n-------------------------~i~~~~~~~l~~~l 137 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN-------------------------LLGDAGLQLLCEGL 137 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSS-------------------------BCHHHHHHHHHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCC-------------------------cCchHHHHHHHHHH
Confidence 57777777777763 34555555555555555555 332221111111
Q ss_pred ---ccccceecccccccccc----CcccccCCCCCceEeeecCcccCCCCcccC-----CCCCCcEEEcCCCccccc---
Q 001873 246 ---LERIQTIAIYTSLLSGP----IPEEIGNCSELQNLYLYQNSISGPIPGRIG-----ALSKLKSLLLWQNSLVGA--- 310 (1001)
Q Consensus 246 ---l~~L~~L~l~~n~l~g~----ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~-----~l~~L~~L~L~~N~l~~~--- 310 (1001)
..+|++|++++|.+++. ++..+..+++|++|++++|.+++..+..+. .+++|++|+|++|++++.
T Consensus 138 ~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~ 217 (461)
T 1z7x_W 138 LDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR 217 (461)
T ss_dssp TSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH
T ss_pred hcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHH
Confidence 22344444444444432 234444555555555555555433333332 134555555555555532
Q ss_pred -CCCCccCCCCCCEEeccCCCCCCCC-----CcccccccCccEEEcccccccCc----CChhhccccccCEEeccCCccc
Q 001873 311 -IPDELGSCTELTVVDFSDNLLTGSI-----PRSFGNLLKLQELQLSVNQLSGT----IPIEIATCTALTHLEIDNNAIS 380 (1001)
Q Consensus 311 -~p~~l~~l~~L~~L~Ls~N~l~~~~-----p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~i~ 380 (1001)
++..+..+++|+.|++++|.+++.. +..+..+++|++|++++|+++.. ++..+..+++|++|++++|.++
T Consensus 218 ~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~ 297 (461)
T 1z7x_W 218 DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297 (461)
T ss_dssp HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCH
T ss_pred HHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCc
Confidence 3444445555555555555554321 11122345555555555555432 3444444555555555555554
Q ss_pred CccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCC----CCcccccccccceEEccCCcCCCCCC
Q 001873 381 GEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGP----IPKEIFGLRNLTKLLLLSNDLSGFIP 456 (1001)
Q Consensus 381 ~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p 456 (1001)
+..+..+... .....++|++|++++|.+++. ++..+..+++|++|++++|++++..+
T Consensus 298 ~~~~~~l~~~-------------------l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~ 358 (461)
T 1z7x_W 298 DEGARLLCET-------------------LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGV 358 (461)
T ss_dssp HHHHHHHHHH-------------------HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHH
T ss_pred hHHHHHHHHH-------------------hccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccH
Confidence 3322222211 000113555555555555533 23344445556666666665554322
Q ss_pred CCCCC-----CCCcceEEcccccccc----CCCcccCCCCCcceeeccCcccccCCccccc-----ccccCceEEccccc
Q 001873 457 PDIGN-----CTTLRRLRLNDNRLSG----TIPSEMGNLKHLNFVDMSENHLVGGIPPSVV-----GCQSLEFLDLHSNG 522 (1001)
Q Consensus 457 ~~l~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~ 522 (1001)
..+.. .++|++|+|++|++++ .+|..+..+++|++|++++|++++.....+. ...+|+.|++.++.
T Consensus 359 ~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~ 438 (461)
T 1z7x_W 359 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIY 438 (461)
T ss_dssp HHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCC
T ss_pred HHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccc
Confidence 22221 4567777777777764 5666666777777777777777643221111 12356666666665
Q ss_pred Cc
Q 001873 523 LT 524 (1001)
Q Consensus 523 l~ 524 (1001)
+.
T Consensus 439 ~~ 440 (461)
T 1z7x_W 439 WS 440 (461)
T ss_dssp CC
T ss_pred cC
Confidence 54
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=300.30 Aligned_cols=202 Identities=23% Similarity=0.332 Sum_probs=166.5
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
.++|++.+.||+|+||.||+|++.+ .||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 3578999999999999999999853 59999885432 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++++|.+++.+. ...+++..+..++.|++.|++|||++ +|+||||||+||+++ ++.+||+|||+++.......
T Consensus 110 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred cccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 99999999999864 34588999999999999999999998 999999999999998 67999999999876532211
Q ss_pred CCCCCCCCCCcccccccccCcccccc---------CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASM---------QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. ..........||+.|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 185 ~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 246 (319)
T 2y4i_B 185 G--RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred c--ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 11122334469999999998864 45788999999999999999999999764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=307.85 Aligned_cols=190 Identities=15% Similarity=0.126 Sum_probs=159.5
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc----------hhhHHHHHHHhhccC---------CCceeeE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE----------SGAFSSEIQTLGSIR---------HKNIVRL 825 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------~~~~~~Ei~~l~~l~---------h~nIv~l 825 (1001)
.++|++.+.||+|+||+||+|++ +++.||||++..... .+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999998 689999999864421 267889999998886 6666666
Q ss_pred Eee-----------------eec-------------CCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 001873 826 LGW-----------------GSN-------------KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHAL 875 (1001)
Q Consensus 826 ~~~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l 875 (1001)
.++ +.+ .+..++||||+++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 654 332 6789999999999977666643 4579999999999999999
Q ss_pred HHHh-hCCCCCeEEeCCCCCCeEECCCC--------------------cEEEecccccccccCCCCCCCCCCCCCCcccc
Q 001873 876 AYLH-HDCMPPILHGDVKAMNVLLGPGY--------------------QAYLADFGLARIVSGSGDDNCSKTNQRPQLAG 934 (1001)
Q Consensus 876 ~yLH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~g 934 (1001)
+||| +. +|+||||||+|||++.++ .+||+|||+|+.... ...+|
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------~~~~g 239 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------GIVVF 239 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------------TEEEC
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------------CcEEE
Confidence 9999 88 999999999999999887 999999999987642 13479
Q ss_pred cccccCccccccCCCCCccchHHHHHH-HHHHHhCCCCCCC
Q 001873 935 SYGYMAPEHASMQRITEKSDVYSFGVV-LLEVLTGRHPLDP 974 (1001)
Q Consensus 935 t~~y~aPE~~~~~~~~~~~Dv~SlG~i-l~elltg~~Pf~~ 974 (1001)
|+.|+|||++.+.. +.++||||++++ .+++++|..||..
T Consensus 240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 99999999998766 889999998777 7788899999853
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=310.19 Aligned_cols=203 Identities=24% Similarity=0.371 Sum_probs=158.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
+.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+++..++||||+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 345667889999999998776668999999998543 345678999999876 89999999999999999999999996
Q ss_pred CCHHHHhhcCCCCCC-----CHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC-------------CcEEE
Q 001873 845 GSLSSLLHGAGKGGA-----DWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG-------------YQAYL 906 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~-----~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~-------------~~~ki 906 (1001)
|+|.+++........ ++..+..++.||+.|++|||++ +|+||||||+||+++.+ +++||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 699999986532211 2234567999999999999998 99999999999999654 48999
Q ss_pred ecccccccccCCCCCCCCCCCCCCcccccccccCcccccc-------CCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 907 ADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-------QRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 907 ~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
+|||+|+.+...... .........||++|+|||++.+ ..++.++||||+||++|||+| |+.||+...
T Consensus 170 ~DFG~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 170 SDFGLCKKLDSGQSS---FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred cccccceecCCCCcc---ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 999999876533211 1112234579999999999865 678999999999999999999 999997653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=318.36 Aligned_cols=203 Identities=28% Similarity=0.432 Sum_probs=171.1
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeec------
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSN------ 831 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~------ 831 (1001)
....++|++.+.||+|+||.||+|.+. +++.||||++..... .+.+.+|++++++++||||+++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 345578999999999999999999874 689999999865432 3568899999999999999999998755
Q ss_pred CCceEEEEEccCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCc---EEEe
Q 001873 832 KNLKLLFYDYLPNGSLSSLLHGAGK-GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQ---AYLA 907 (1001)
Q Consensus 832 ~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~ki~ 907 (1001)
.+..++||||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++. +||+
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence 6778999999999999999987432 3578889999999999999999998 9999999999999987664 9999
Q ss_pred cccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 908 DFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 908 Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
|||.+....... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||.+.
T Consensus 167 DFG~a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 167 DLGYAKELDQGE--------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp SCCCCCBTTSCC--------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccccccc--------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 999998764321 223457999999999999999999999999999999999999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=322.48 Aligned_cols=200 Identities=28% Similarity=0.379 Sum_probs=168.8
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCC----CCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPN----GETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
.++|++.+.||+|+||+||+|++.. +..||||++..... .+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence 3578899999999999999998642 45799999865432 2678899999999999999999999854 56799
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||+++|+|.++++.. ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++++||+|||+++....
T Consensus 468 v~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 99999999999999864 34589999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.
T Consensus 544 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 544 STY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp ----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred Ccc------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 211 11223357889999999998999999999999999999997 99999764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=307.03 Aligned_cols=200 Identities=23% Similarity=0.369 Sum_probs=159.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
.+|+..++||+|+||+||.....+++.||||++.... ...+.+|+++++++ +|||||++++++.+.+..++||||++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC-FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT-EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 3588889999999999776555689999999986533 34577899999999 79999999999999999999999996
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC-----CCcEEEecccccccccCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP-----GYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~ki~Dfgla~~~~~~~ 919 (1001)
|+|.+++..... ...+..+..++.||+.|++|||+. +|+||||||+||+++. ...+||+|||+|+......
T Consensus 102 g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 102 ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 699999986532 344455678999999999999998 9999999999999953 2368899999998764322
Q ss_pred CCCCCCCCCCCcccccccccCccccc---cCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHAS---MQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
.. .......+||++|+|||++. ...++.++||||+||++|||++ |+.||...
T Consensus 178 ~~----~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 178 HS----FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred cc----eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 11 12233457999999999987 4667889999999999999999 99999654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=321.97 Aligned_cols=190 Identities=22% Similarity=0.299 Sum_probs=164.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC--CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCc-----e
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP--NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNL-----K 835 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~-----~ 835 (1001)
++|++.+.||+|+||+||++++. +++.||||++..... ...+.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 68999999999999999999975 589999999865433 2568899999999999999999999887665 6
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
|+||||++|++|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.+ .+||+|||+++..
T Consensus 160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 999999999999998754 589999999999999999999998 99999999999999985 9999999999875
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
... ....||++|+|||++.+. ++.++|||||||++|+|++|..||.+.
T Consensus 232 ~~~-----------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 232 NSF-----------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp TCC-----------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred ccC-----------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccc
Confidence 321 334799999999998765 488999999999999999999998764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-31 Score=290.47 Aligned_cols=199 Identities=25% Similarity=0.383 Sum_probs=151.5
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCch----hhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDES----GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
.++|++.+.||+|+||.||+|+.. +++.||||++...... +.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467899999999999999999975 6899999998655432 23444555678889999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+ ++.+..+.... ...+++..+..++.|++.|+.|||+++ +|+||||||+||+++.++++||+|||++......
T Consensus 104 e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD- 178 (318)
T ss_dssp CCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC-
Confidence 999 45666555432 345899999999999999999999831 8999999999999999999999999999765322
Q ss_pred CCCCCCCCCCCcccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHAS-----MQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......||+.|+|||++. ...++.++||||+|+++|||++|+.||...
T Consensus 179 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 179 -------KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred -------ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 1122346899999999984 567889999999999999999999999863
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-33 Score=342.46 Aligned_cols=432 Identities=13% Similarity=0.114 Sum_probs=262.2
Q ss_pred CCCccceEEeCCCCcEEEEEeccccccccCCcccccCCCCcEEeccCCcc---cCCCCcccC------------Cccccc
Q 001873 65 SPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNL---TGTIPKEFG------------DYRELT 129 (1001)
Q Consensus 65 ~~c~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~~~l---~g~~p~~~~------------~l~~L~ 129 (1001)
-|++|.++.+....++.- . ......++..+..+++|++|+|+++.. .|.+|..++ .+++|+
T Consensus 40 vck~W~~~~~~~~~~l~~---~-~~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~ 115 (592)
T 3ogk_B 40 VCRRWFKIDSETREHVTM---A-LCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK 115 (592)
T ss_dssp SCHHHHHHHHHHCCEEEE---S-CGGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred HhHHHHHhhhccccEEEE---e-eccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence 455899996543323221 1 112233344566788899999987532 245555544 567777
Q ss_pred cccccCCccCCCCChhhhcc--cccceEEccCCc-ccC-CCCccccCCccccceeccccccccc----cCCCccchhhhh
Q 001873 130 FIDLSGNSLWGEIPTEVCRL--RKLESLYLNTNL-LEG-EIPSDIGNLSSLAYLTLYDNQLSGK----IPKSIGALSKLQ 201 (1001)
Q Consensus 130 ~L~Ls~n~l~g~~p~~~~~l--~~L~~L~L~~n~-l~~-~ip~~l~~L~~L~~L~L~~n~l~g~----~p~~~~~l~~L~ 201 (1001)
+|+|++|.+++..+..++.+ ++|++|+|++|. ++. .++....++++|++|+|++|.+++. ++..+..+++|+
T Consensus 116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~ 195 (592)
T 3ogk_B 116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE 195 (592)
T ss_dssp EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCC
T ss_pred eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCcc
Confidence 77777777776666666653 347777777775 221 1222334677777777777776644 222333444455
Q ss_pred hhhhccCcCCCCCCCcccccCccchhccccccccc----cccCCccccccccceeccccccccccCcccccCCCCCceEe
Q 001873 202 VFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSIS----GNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLY 277 (1001)
Q Consensus 202 ~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~----~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~ 277 (1001)
+|++++| .+. +.++..+.++++|++|++.+|.+.+ +|..+.++++|++|+
T Consensus 196 ~L~L~~n-------------------------~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~ 249 (592)
T 3ogk_B 196 VLNFYMT-------------------------EFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFC 249 (592)
T ss_dssp EEECTTC-------------------------CCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEE
T ss_pred EEEeecc-------------------------CCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhc
Confidence 5555444 443 2233334455566666666666654 666777777777777
Q ss_pred eecCccc---CCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCC-cccccccCccEEEcccc
Q 001873 278 LYQNSIS---GPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIP-RSFGNLLKLQELQLSVN 353 (1001)
Q Consensus 278 L~~N~i~---~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N 353 (1001)
++.+... +..+..+..+++|+.|+++++.. +.+|..+..+++|++|+|++|.+++... ..+..+++|++|+++++
T Consensus 250 l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~ 328 (592)
T 3ogk_B 250 GGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNV 328 (592)
T ss_dssp ECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGG
T ss_pred ccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCc
Confidence 7654332 23445566677777777776533 3566666677777777777777654332 33566777777777733
Q ss_pred cccCcCChhhccccccCEEecc-----------CCcccCcc-CccccccCcccEEEeecCccCCCCCccccc-CcccceE
Q 001873 354 QLSGTIPIEIATCTALTHLEID-----------NNAISGEI-PADIGNINGLTLFFAWKNKLTGNIPESLSQ-CQELQAL 420 (1001)
Q Consensus 354 ~l~~~~p~~~~~l~~L~~L~L~-----------~N~i~~~~-~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~-l~~L~~L 420 (1001)
-..+.++.....+++|++|+++ .|.+++.. +.....+++|+.|+++.|++++..+..+.. +++|+.|
T Consensus 329 ~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L 408 (592)
T 3ogk_B 329 IGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDF 408 (592)
T ss_dssp GHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEE
T ss_pred cCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEE
Confidence 2222334444567777788777 35555332 222345677777777777777665555554 7777777
Q ss_pred eCc----CccccCC-----CCcccccccccceEEccCCc--CCCCCCCCCC-CCCCcceEEcccccccc-CCCcccCCCC
Q 001873 421 DFS----YNNLSGP-----IPKEIFGLRNLTKLLLLSND--LSGFIPPDIG-NCTTLRRLRLNDNRLSG-TIPSEMGNLK 487 (1001)
Q Consensus 421 ~Ls----~N~l~~~-----~~~~~~~l~~L~~L~L~~N~--l~~~~p~~l~-~l~~L~~L~Ls~N~l~~-~~p~~~~~l~ 487 (1001)
+++ .|.+++. ++..+.++++|++|++++|. +++..+..+. .+++|++|++++|++++ .++..+.+++
T Consensus 409 ~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 488 (592)
T 3ogk_B 409 RLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCP 488 (592)
T ss_dssp EEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCT
T ss_pred EEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCc
Confidence 775 5666653 23335567778888876433 4433332232 36778888888888775 3445567778
Q ss_pred CcceeeccCcccccC-CcccccccccCceEEcccccCcccC
Q 001873 488 HLNFVDMSENHLVGG-IPPSVVGCQSLEFLDLHSNGLTGSV 527 (1001)
Q Consensus 488 ~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~ 527 (1001)
+|++|++++|++++. ++..+..+++|++|++++|+++...
T Consensus 489 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~ 529 (592)
T 3ogk_B 489 NLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTG 529 (592)
T ss_dssp TCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTC
T ss_pred ccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHH
Confidence 888888888887654 3334456788888888888877543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-30 Score=279.01 Aligned_cols=172 Identities=15% Similarity=0.082 Sum_probs=151.8
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.++|++.+.||+|+||.||+|++. +++.||||++..... .+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999976 489999999965432 26789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||++|++|.++++.. ....++.+++.|++.|++|||++ +|+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 9999999999999642 45667888999999999999998 99999999999999999999998543
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~ 977 (1001)
|++ .++.++|||||||++|||+||+.||.+...
T Consensus 175 -------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 175 -------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp -------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred -------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 333 367899999999999999999999997654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-30 Score=280.43 Aligned_cols=180 Identities=24% Similarity=0.378 Sum_probs=155.9
Q ss_pred HHHHhcccCC-CeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHh-hccCCCceeeEEeeeec----CCc
Q 001873 762 DDVVRNLTSA-NVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTL-GSIRHKNIVRLLGWGSN----KNL 834 (1001)
Q Consensus 762 ~~~~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l-~~l~h~nIv~l~~~~~~----~~~ 834 (1001)
.++.++|.+. +.||+|+||.||++... +++.||||++.. ...+.+|+.++ +..+||||+++++++.. ...
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 3456778887 78999999999999874 689999999853 35678899987 55689999999998876 677
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC---CCcEEEecccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP---GYQAYLADFGL 911 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~Dfgl 911 (1001)
.++||||+++|+|.+++.......+++..+..++.|++.|++|||++ +|+||||||+||+++. ++.+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 89999999999999999987666799999999999999999999998 9999999999999997 78999999999
Q ss_pred cccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 912 ARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 912 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+.... +..++.++||||+||++|||++|+.||....
T Consensus 167 a~~~~-----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 167 AKETT-----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp CEECT-----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred ccccc-----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 87532 1346778999999999999999999997653
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=293.77 Aligned_cols=286 Identities=19% Similarity=0.216 Sum_probs=184.0
Q ss_pred CCCCCccceEEeCCCCcEEEEEeccccccccCCcccccCCCCcEEeccCCcccCCCCcccCCccccccccccCCccCCCC
Q 001873 63 ETSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEI 142 (1001)
Q Consensus 63 ~~~~c~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~ 142 (1001)
...+|.|.|+ |+- ++.+++ .+|..+. ++|++|++++|++++..+..|+++++|++|+|++|++++..
T Consensus 26 ~~~~C~~~~~-c~~---------~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 92 (353)
T 2z80_A 26 ASLSCDRNGI-CKG---------SSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIE 92 (353)
T ss_dssp -CCEECTTSE-EEC---------CSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEEC
T ss_pred cCCCCCCCeE-eeC---------CCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccC
Confidence 4567999998 762 122332 2455443 48999999999999766668999999999999999999877
Q ss_pred ChhhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccCC--CccchhhhhhhhhccCcCCCCCCCcccc
Q 001873 143 PTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPK--SIGALSKLQVFRAGGNQNLKGELPWEIG 220 (1001)
Q Consensus 143 p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~--~~~~l~~L~~L~l~~n~~l~~~lp~~l~ 220 (1001)
|..|+.+++|++|+|++|++++..+..++++++|++|+|++|.++ .+|. .++.+++|++|++++|..+.+..|..++
T Consensus 93 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~ 171 (353)
T 2z80_A 93 EDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171 (353)
T ss_dssp TTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTT
T ss_pred HhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHcc
Confidence 888999999999999999999544444899999999999999998 5665 6788888888888887445544455666
Q ss_pred cCccchhccccccccccccCCccccccccceeccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEE
Q 001873 221 NCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSL 300 (1001)
Q Consensus 221 ~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L 300 (1001)
++++|++|++++|.+.+..|..++.+++|++|++++|.++...+..+..+++|++|++++|.+++..+..+..
T Consensus 172 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~------- 244 (353)
T 2z80_A 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST------- 244 (353)
T ss_dssp TCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-----------
T ss_pred CCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc-------
Confidence 6777777776666666555555555555555555555543222222333455555555555555433332221
Q ss_pred EcCCCcccccCCCCccCCCCCCEEeccCCCCCC----CCCcccccccCccEEEcccccccCcCChhhccccccCEEeccC
Q 001873 301 LLWQNSLVGAIPDELGSCTELTVVDFSDNLLTG----SIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDN 376 (1001)
Q Consensus 301 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 376 (1001)
......++.++|+++.+++ .+|..+..+++|++|+|++|+++...+..|..+++|++|++++
T Consensus 245 --------------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 310 (353)
T 2z80_A 245 --------------GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHT 310 (353)
T ss_dssp ----------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred --------------ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeC
Confidence 1123445555555555543 2444555666666666666666632222245666666666666
Q ss_pred CcccCcc
Q 001873 377 NAISGEI 383 (1001)
Q Consensus 377 N~i~~~~ 383 (1001)
|.+.+..
T Consensus 311 N~~~~~~ 317 (353)
T 2z80_A 311 NPWDCSC 317 (353)
T ss_dssp SCBCCCH
T ss_pred CCccCcC
Confidence 6665443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-30 Score=283.39 Aligned_cols=250 Identities=22% Similarity=0.245 Sum_probs=157.2
Q ss_pred CccceEEeCCCCcEEEEEeccccccccCCcccccCCCCcEEeccCCcccCCCCc-ccCCccccccccccCCccC--CCCC
Q 001873 67 CKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPK-EFGDYRELTFIDLSGNSLW--GEIP 143 (1001)
Q Consensus 67 c~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~~~l~g~~p~-~~~~l~~L~~L~Ls~n~l~--g~~p 143 (1001)
|.|.+|.|+..+ +. .+|..+ .+++++|+|++|+++ .+|+ .|+++++|++|+|++|+++ +.+|
T Consensus 7 C~~~~l~c~~~~-----------l~-~ip~~~--~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 71 (306)
T 2z66_A 7 CSGTEIRCNSKG-----------LT-SVPTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71 (306)
T ss_dssp EETTEEECCSSC-----------CS-SCCSCC--CTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEE
T ss_pred eCCCEEEcCCCC-----------cc-cCCCCC--CCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcc
Confidence 899999997421 11 234322 257889999999998 4554 4789999999999999887 3347
Q ss_pred hhhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccC-CCccchhhhhhhhhccCcCCCCCCCcccccC
Q 001873 144 TEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIP-KSIGALSKLQVFRAGGNQNLKGELPWEIGNC 222 (1001)
Q Consensus 144 ~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p-~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l 222 (1001)
..+..+++|++|+|++|.++ .+|..+.++++|++|++++|.+++..+ ..+..+++|++|++++|
T Consensus 72 ~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n-------------- 136 (306)
T 2z66_A 72 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT-------------- 136 (306)
T ss_dssp HHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTS--------------
T ss_pred cccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCC--------------
Confidence 78888999999999999988 678888889999999999998874433 34555555555555554
Q ss_pred ccchhccccccccccccCCccccccccceeccccccccc-cCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEE
Q 001873 223 SNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSG-PIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLL 301 (1001)
Q Consensus 223 ~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g-~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~ 301 (1001)
.+.+..|..+..+++|++|++++|.+++ .+|..+..+++|++|+|++|++++..|..|..+++|++|+
T Consensus 137 -----------~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 205 (306)
T 2z66_A 137 -----------HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205 (306)
T ss_dssp -----------CCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred -----------cCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEE
Confidence 3333333333333334444444444433 3445555555555555555555555555555555555555
Q ss_pred cCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCccccccc-CccEEEcccccccC
Q 001873 302 LWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLL-KLQELQLSVNQLSG 357 (1001)
Q Consensus 302 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~ 357 (1001)
|++|++++..+..+..+++|+.|++++|.+++..|..+..++ +|++|+|++|.+.+
T Consensus 206 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp CTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred CCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence 555555554444555555555555555555555555555553 55555555555543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=291.64 Aligned_cols=260 Identities=22% Similarity=0.229 Sum_probs=198.1
Q ss_pred CEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCC
Q 001873 370 THLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSN 449 (1001)
Q Consensus 370 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 449 (1001)
..++.+++.++ .+|..+. ++++.|++++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 34444444444 3333332 44555666666666566667777777888888888877766777778888888888888
Q ss_pred cCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCc-ccccCCcccccccccCceEEcccccCcccCC
Q 001873 450 DLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSEN-HLVGGIPPSVVGCQSLEFLDLHSNGLTGSVP 528 (1001)
Q Consensus 450 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 528 (1001)
++++..+..|..+++|++|+|++|++++..+..|.++++|++|++++| .+....+..|.++++|++|++++|+++. +|
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~ 201 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP 201 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc
Confidence 888776777888888888888888888777778888888888888884 4444444577888888888888888762 22
Q ss_pred CCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchh
Q 001873 529 DTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLE 608 (1001)
Q Consensus 529 ~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 608 (1001)
.+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..+++|+
T Consensus 202 -----------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 258 (440)
T 3zyj_A 202 -----------------------NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLV 258 (440)
T ss_dssp -----------------------CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCC
T ss_pred -----------------------ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCC
Confidence 255678888999999999888888888899999999999999888888888999998
Q ss_pred hhhhcCCCcccccccccccccccccEEEecCCcCCCChhhhhcccccce
Q 001873 609 ISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVS 657 (1001)
Q Consensus 609 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~ 657 (1001)
. |+|++|+|++..+..|..+++|+.|+|++|++.|++...+-..+++.
T Consensus 259 ~-L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l~~l~~~~~~ 306 (440)
T 3zyj_A 259 E-INLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDILWLSWWIKD 306 (440)
T ss_dssp E-EECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTTHHHHHHHHT
T ss_pred E-EECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCchHHHHHHHh
Confidence 6 99999999988888899999999999999999998865444344443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-30 Score=294.45 Aligned_cols=196 Identities=19% Similarity=0.286 Sum_probs=153.1
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-----chhhHHHHHHHhhccCC-Cce---------------e
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIRH-KNI---------------V 823 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h-~nI---------------v 823 (1001)
+.|+..++||+|+||+||+|++. +|+.||||++.... ..+.+.+|+.+++.++| ++. +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 35777889999999999999954 69999999986322 23679999999999977 221 1
Q ss_pred e------EEeeeec-----CCceEEEEEccCCCCHHHHhh-----cCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 001873 824 R------LLGWGSN-----KNLKLLFYDYLPNGSLSSLLH-----GAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887 (1001)
Q Consensus 824 ~------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~iv 887 (1001)
. ++.++.. ...++++|+++ +++|.++++ ......+++..+..++.|+++||+|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 1 1111111 22456777766 689999985 22233467888999999999999999998 999
Q ss_pred EeCCCCCCeEECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCcccc----------ccCCCCCccchHH
Q 001873 888 HGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHA----------SMQRITEKSDVYS 957 (1001)
Q Consensus 888 H~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~S 957 (1001)
||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ ....++.++||||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 9999999999999999999999998864321 233467 999999998 5566888999999
Q ss_pred HHHHHHHHHhCCCCCCCCC
Q 001873 958 FGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 958 lG~il~elltg~~Pf~~~~ 976 (1001)
|||++|||++|+.||....
T Consensus 303 lGvil~elltg~~Pf~~~~ 321 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDA 321 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTG
T ss_pred HHHHHHHHHHCCCCCCCcc
Confidence 9999999999999998654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=290.60 Aligned_cols=242 Identities=22% Similarity=0.207 Sum_probs=180.1
Q ss_pred CcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEc
Q 001873 391 NGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRL 470 (1001)
Q Consensus 391 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 470 (1001)
++++.|++++|++++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 34555555555555555566666667777777777776666666677777777777777777666666777777777777
Q ss_pred cccccccCCCcccCCCCCcceeeccC-cccccCCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCc
Q 001873 471 NDNRLSGTIPSEMGNLKHLNFVDMSE-NHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSL 549 (1001)
Q Consensus 471 s~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~ 549 (1001)
++|++++..+..|.++++|++|++++ |.+....+..|.++++|++|++++|++++. |
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~--------------------- 212 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P--------------------- 212 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C---------------------
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c---------------------
Confidence 77777766666777777777777777 444434444577777777777777776631 1
Q ss_pred ccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCccccccccccccc
Q 001873 550 AHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGL 629 (1001)
Q Consensus 550 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l 629 (1001)
.+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..|..+..+++|+. |+|++|+|++..+..|..+
T Consensus 213 --~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l 289 (452)
T 3zyi_A 213 --NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVE-LNLAHNNLSSLPHDLFTPL 289 (452)
T ss_dssp --CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE-EECCSSCCSCCCTTSSTTC
T ss_pred --cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCE-EECCCCcCCccChHHhccc
Confidence 2556788889999999998888888999999999999999998888888989999986 9999999998888889999
Q ss_pred ccccEEEecCCcCCCChhhhhcccccce
Q 001873 630 TKLGILDLSHNKLSGDLDALASLQNLVS 657 (1001)
Q Consensus 630 ~~L~~L~Ls~N~l~~~~~~~~~l~~L~~ 657 (1001)
++|+.|+|++|++.|+++..+-..+++.
T Consensus 290 ~~L~~L~L~~Np~~CdC~~~~l~~~l~~ 317 (452)
T 3zyi_A 290 RYLVELHLHHNPWNCDCDILWLAWWLRE 317 (452)
T ss_dssp TTCCEEECCSSCEECSTTTHHHHHHHHH
T ss_pred cCCCEEEccCCCcCCCCCchHHHHHHHH
Confidence 9999999999999999875544444443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-32 Score=329.58 Aligned_cols=302 Identities=17% Similarity=0.129 Sum_probs=156.7
Q ss_pred hhhhcccccceEEccCCcc---cCCCCcccc------------CCccccceeccccccccccCCCccch--hhhhhhhhc
Q 001873 144 TEVCRLRKLESLYLNTNLL---EGEIPSDIG------------NLSSLAYLTLYDNQLSGKIPKSIGAL--SKLQVFRAG 206 (1001)
Q Consensus 144 ~~~~~l~~L~~L~L~~n~l---~~~ip~~l~------------~L~~L~~L~L~~n~l~g~~p~~~~~l--~~L~~L~l~ 206 (1001)
..+.++++|++|+|+++.. .+.+|..++ ++++|++|+|++|.+++..+..++.. ++|++|+++
T Consensus 67 ~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~ 146 (592)
T 3ogk_B 67 RLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLD 146 (592)
T ss_dssp HHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEE
T ss_pred HHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECc
Confidence 3344556666666655421 123333333 56666666666666665555555553 336666666
Q ss_pred cCcCCCC-CCCcccccCccchhccccccccccc----cCCccccccccceecccccccc----ccCcccccCCCCCceEe
Q 001873 207 GNQNLKG-ELPWEIGNCSNLVMLGLAETSISGN----VPSSIGMLERIQTIAIYTSLLS----GPIPEEIGNCSELQNLY 277 (1001)
Q Consensus 207 ~n~~l~~-~lp~~l~~l~~L~~L~l~~~~l~~~----~p~~i~~l~~L~~L~l~~n~l~----g~ip~~l~~l~~L~~L~ 277 (1001)
+|..++. .++....++++|++|++++|.+.+. ++.....+++|++|+++.|.++ +.++..+.++++|++|+
T Consensus 147 ~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~ 226 (592)
T 3ogk_B 147 KCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVK 226 (592)
T ss_dssp SCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEE
T ss_pred CCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEe
Confidence 6532111 1112223566777777777766544 2223345566666666666665 33444455666677777
Q ss_pred eecCcccCCCCcccCCCCCCcEEEcCCCccc---ccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEccccc
Q 001873 278 LYQNSISGPIPGRIGALSKLKSLLLWQNSLV---GAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQ 354 (1001)
Q Consensus 278 L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 354 (1001)
+++|.+.+ +|..+..+++|++|+++.+... +..+..+..+++|+.|+++++... .+|..+..+++|++|+|++|.
T Consensus 227 L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~ 304 (592)
T 3ogk_B 227 VGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYAL 304 (592)
T ss_dssp CSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCC
T ss_pred ccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCc
Confidence 77666664 4556666666676666643222 223344556666666666664332 455556666666666666666
Q ss_pred ccCcCC-hhhccccccCEEeccCCcccCccCccccccCcccEEEeec-----------CccCCCCC-cccccCcccceEe
Q 001873 355 LSGTIP-IEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWK-----------NKLTGNIP-ESLSQCQELQALD 421 (1001)
Q Consensus 355 l~~~~p-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~-----------n~l~~~~p-~~l~~l~~L~~L~ 421 (1001)
+++... ..+..+++|++|+++++...+.++.....+++|+.|++++ |.+++... .....+++|++|+
T Consensus 305 l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~ 384 (592)
T 3ogk_B 305 LETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMA 384 (592)
T ss_dssp CCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEE
T ss_pred CCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEE
Confidence 543322 2245566666666663222222333334455555555552 33332211 1123345555555
Q ss_pred CcCccccCCCCccccc-ccccceEEcc
Q 001873 422 FSYNNLSGPIPKEIFG-LRNLTKLLLL 447 (1001)
Q Consensus 422 Ls~N~l~~~~~~~~~~-l~~L~~L~L~ 447 (1001)
++.|.+++..+..+.. +++|++|+++
T Consensus 385 l~~~~l~~~~~~~l~~~~~~L~~L~l~ 411 (592)
T 3ogk_B 385 VYVSDITNESLESIGTYLKNLCDFRLV 411 (592)
T ss_dssp EEESCCCHHHHHHHHHHCCSCCEEEEE
T ss_pred eecCCccHHHHHHHHhhCCCCcEEEEe
Confidence 5555554433333332 4455555553
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-29 Score=276.76 Aligned_cols=287 Identities=22% Similarity=0.308 Sum_probs=230.6
Q ss_pred HHhCCCCCCccCCCCCC-CCCCCccceEEeC---CCCcEEEEEeccccccccCCcccccCCCCcEEeccCCcccCCCCcc
Q 001873 46 KNSLNSSTDALSSWNPA-ETSPCKWFGIHCS---SNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKE 121 (1001)
Q Consensus 46 k~~~~~~~~~l~sW~~~-~~~~c~w~gv~c~---~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~~~l~g~~p~~ 121 (1001)
|.++.|+..++.+|... ..|+|.|.++-|. ..+.+.. ..|. ... .++..
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~-------~~g~-------------------~~~-~~~~~ 74 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIET-------RTGR-------------------ALK-ATADL 74 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCC-------SHHH-------------------HHH-HHHHH
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccc-------cCCc-------------------chh-hhHHH
Confidence 44556777788899631 2578999998884 1111111 1110 000 11111
Q ss_pred c--CCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccCCCccchhh
Q 001873 122 F--GDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSK 199 (1001)
Q Consensus 122 ~--~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~ 199 (1001)
+ ...+++++|+|++|+++ .+|..++.+++|++|+|++|.++ .+|..++++++|++|+|++|.++ .+|..++++++
T Consensus 75 l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~ 151 (328)
T 4fcg_A 75 LEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNR 151 (328)
T ss_dssp HHHHTSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTT
T ss_pred HhcccccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcC
Confidence 1 23467889999999998 88888999999999999999998 88988999999999999999888 77877777777
Q ss_pred hhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCcccccCCCCCceEeee
Q 001873 200 LQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLY 279 (1001)
Q Consensus 200 L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~ 279 (1001)
|++|++++| ++.+.+|..+++ . .++..++++++|++|+|+
T Consensus 152 L~~L~L~~n-~~~~~~p~~~~~------------------------~---------------~~~~~~~~l~~L~~L~L~ 191 (328)
T 4fcg_A 152 LRELSIRAC-PELTELPEPLAS------------------------T---------------DASGEHQGLVNLQSLRLE 191 (328)
T ss_dssp CCEEEEEEE-TTCCCCCSCSEE------------------------E---------------C-CCCEEESTTCCEEEEE
T ss_pred CCEEECCCC-CCccccChhHhh------------------------c---------------cchhhhccCCCCCEEECc
Confidence 777777776 344455543322 0 123456789999999999
Q ss_pred cCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcC
Q 001873 280 QNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTI 359 (1001)
Q Consensus 280 ~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 359 (1001)
+|+++ .+|..++.+++|++|+|++|++++ +|..++.+++|++|+|++|.+.+.+|..|+.+++|++|+|++|++.+.+
T Consensus 192 ~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~ 269 (328)
T 4fcg_A 192 WTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTL 269 (328)
T ss_dssp EECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBC
T ss_pred CCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhc
Confidence 99999 889999999999999999999995 7778999999999999999999999999999999999999999999999
Q ss_pred ChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccC
Q 001873 360 PIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLT 404 (1001)
Q Consensus 360 p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~ 404 (1001)
|..+..+++|++|+|++|++.+.+|..++++++|+.+.+..+.+.
T Consensus 270 p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 270 PLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred chhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 999999999999999999999999999999999999999887665
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=282.61 Aligned_cols=272 Identities=19% Similarity=0.146 Sum_probs=202.8
Q ss_pred eccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCC
Q 001873 252 IAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLL 331 (1001)
Q Consensus 252 L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 331 (1001)
.+.+++.++ .+|..+. ++|++|++++|++++..+..|.++++|++|+|++|++++..|..|+++++|++|++++|.+
T Consensus 36 c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 112 (353)
T 2z80_A 36 CKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112 (353)
T ss_dssp EECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred eeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcC
Confidence 444555555 5666554 4788888888888877777888888888888888888877778888888888888888888
Q ss_pred CCCCCcccccccCccEEEcccccccCcCC-hhhccccccCEEeccCC-cccCccCccccccCcccEEEeecCccCCCCCc
Q 001873 332 TGSIPRSFGNLLKLQELQLSVNQLSGTIP-IEIATCTALTHLEIDNN-AISGEIPADIGNINGLTLFFAWKNKLTGNIPE 409 (1001)
Q Consensus 332 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~ 409 (1001)
++..+..|.++++|++|+|++|++++..+ ..+..+++|++|++++| .+.+..+..+.++++|+.|++++|++++..|.
T Consensus 113 ~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 192 (353)
T 2z80_A 113 SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK 192 (353)
T ss_dssp SSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred CcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHH
Confidence 86555558888888888888888885444 46788888888888888 46666667788888888888888888888888
Q ss_pred ccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCC---CCCCcceEEcccccccc----CCCcc
Q 001873 410 SLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIG---NCTTLRRLRLNDNRLSG----TIPSE 482 (1001)
Q Consensus 410 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~---~l~~L~~L~Ls~N~l~~----~~p~~ 482 (1001)
.+..+++|++|++++|+++...+..+..+++|++|++++|++++..+..+. ..+.++.++|++|.+++ .+|..
T Consensus 193 ~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~ 272 (353)
T 2z80_A 193 SLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKL 272 (353)
T ss_dssp TTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHH
T ss_pred HHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHH
Confidence 888888888888888888644333444678888888888888876555433 34567777777777764 35666
Q ss_pred cCCCCCcceeeccCcccccCCcccccccccCceEEcccccCccc
Q 001873 483 MGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGS 526 (1001)
Q Consensus 483 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 526 (1001)
+.++++|++|++++|+++...+..|..+++|++|++++|++++.
T Consensus 273 l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 273 LNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp HHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred HhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCc
Confidence 77777888888888887743333357777777777777777653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-29 Score=272.97 Aligned_cols=247 Identities=21% Similarity=0.215 Sum_probs=156.7
Q ss_pred eEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCC--CCcccccccCccEEEccc
Q 001873 275 NLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGS--IPRSFGNLLKLQELQLSV 352 (1001)
Q Consensus 275 ~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~ 352 (1001)
.++++++.++ .+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|.++.. .|..+..+++|++|+|++
T Consensus 11 ~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~ 87 (306)
T 2z66_A 11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87 (306)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred EEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence 4555555555 3343332 4566666666666533333455666666666666666522 244455566666666666
Q ss_pred ccccCcCChhhccccccCEEeccCCcccCccC-ccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccC-C
Q 001873 353 NQLSGTIPIEIATCTALTHLEIDNNAISGEIP-ADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSG-P 430 (1001)
Q Consensus 353 N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~ 430 (1001)
|++. .+|..+..+++|++|++++|++++..+ ..+..+++|+.|++++|.+++..+..+..+++|++|++++|.+++ .
T Consensus 88 n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 166 (306)
T 2z66_A 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 166 (306)
T ss_dssp CSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred Cccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccccc
Confidence 6665 344556666666666666666654433 455566666666666666666666666667777777777777765 4
Q ss_pred CCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCccccccc
Q 001873 431 IPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGC 510 (1001)
Q Consensus 431 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 510 (1001)
.|..+..+++|++|++++|++++..|..+..+++|++|+|++|++++..+..+..+++|++|++++|++++..|..+..+
T Consensus 167 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 246 (306)
T 2z66_A 167 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 246 (306)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCC
T ss_pred chhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhh
Confidence 56666777777777777777776666777777777777777777776666667777777777777777777777777766
Q ss_pred c-cCceEEcccccCcc
Q 001873 511 Q-SLEFLDLHSNGLTG 525 (1001)
Q Consensus 511 ~-~L~~L~Ls~N~l~~ 525 (1001)
+ +|++|++++|.+++
T Consensus 247 ~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 247 PSSLAFLNLTQNDFAC 262 (306)
T ss_dssp CTTCCEEECTTCCEEC
T ss_pred hccCCEEEccCCCeec
Confidence 3 67777777777764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=284.82 Aligned_cols=249 Identities=20% Similarity=0.228 Sum_probs=117.2
Q ss_pred CCCcEEeccCCcccCCCCcccCCccccccccccCCcc-CCCCChhhh-------cccccceEEccCCcccCCCCccc--c
Q 001873 102 KSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSL-WGEIPTEVC-------RLRKLESLYLNTNLLEGEIPSDI--G 171 (1001)
Q Consensus 102 ~~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l-~g~~p~~~~-------~l~~L~~L~L~~n~l~~~ip~~l--~ 171 (1001)
++|++|++++|.+ .+|+.+... |++|+|++|++ .+.+|..+. .+++|++|+|++|++++.+|..+ +
T Consensus 43 ~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~ 118 (312)
T 1wwl_A 43 RSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEA 118 (312)
T ss_dssp EECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSC
T ss_pred CCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHh
Confidence 3445555555555 445444333 55555555555 334444444 45555555555555555555544 5
Q ss_pred CCccccceeccccccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccce
Q 001873 172 NLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQT 251 (1001)
Q Consensus 172 ~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~ 251 (1001)
++++|++|+|++|++++. |..++.+... .+++|++|++++|.+.+..|..++.+++|++
T Consensus 119 ~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~--------------------~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 177 (312)
T 1wwl_A 119 TGPDLNILNLRNVSWATR-DAWLAELQQW--------------------LKPGLKVLSIAQAHSLNFSCEQVRVFPALST 177 (312)
T ss_dssp CSCCCSEEEEESCBCSSS-SSHHHHHHTT--------------------CCTTCCEEEEESCSCCCCCTTTCCCCSSCCE
T ss_pred cCCCccEEEccCCCCcch-hHHHHHHHHh--------------------hcCCCcEEEeeCCCCccchHHHhccCCCCCE
Confidence 555555555555555533 4444443000 0034444444444444333344444444444
Q ss_pred ecccccccccc--Ccccc--cCCCCCceEeeecCcccCC---CCcccCCCCCCcEEEcCCCcccccCC-CCccCCCCCCE
Q 001873 252 IAIYTSLLSGP--IPEEI--GNCSELQNLYLYQNSISGP---IPGRIGALSKLKSLLLWQNSLVGAIP-DELGSCTELTV 323 (1001)
Q Consensus 252 L~l~~n~l~g~--ip~~l--~~l~~L~~L~L~~N~i~~~---~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~ 323 (1001)
|++++|++.|. +|..+ +++++|++|+|++|++++. ....+..+++|++|+|++|++++.+| ..+..+++|++
T Consensus 178 L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~ 257 (312)
T 1wwl_A 178 LDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257 (312)
T ss_dssp EECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCE
T ss_pred EECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCE
Confidence 44444444332 22222 4555555555555555521 11223344555555555555554443 23344555555
Q ss_pred EeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCccc
Q 001873 324 VDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAIS 380 (1001)
Q Consensus 324 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~ 380 (1001)
|+|++|.++ .+|..+. ++|++|+|++|++++. |. +..+++|++|++++|+++
T Consensus 258 L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 258 LNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp EECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred EECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 555555555 4444443 4555555555555533 33 445555555555555544
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=266.62 Aligned_cols=253 Identities=23% Similarity=0.218 Sum_probs=185.6
Q ss_pred cEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEcccc
Q 001873 394 TLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDN 473 (1001)
Q Consensus 394 ~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 473 (1001)
+.++.+++.++ .+|..+ .++|++|++++|.+++..+..|..+++|++|++++|++++..|..|..+++|++|++++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 45556666665 334332 245666666666666555555666666666666666666555666666666666666666
Q ss_pred c-cccCCCcccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccc
Q 001873 474 R-LSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHS 552 (1001)
Q Consensus 474 ~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~ 552 (1001)
+ ++...|..+..+++|++|++++|++++..|..+.++++|++|++++|+++ +..+..
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~----------------------~~~~~~ 148 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ----------------------ALPDDT 148 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC----------------------CCCTTT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccc----------------------ccCHhH
Confidence 5 55444556666666666666666666555555566666666655555554 444556
Q ss_pred cccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccc
Q 001873 553 IGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKL 632 (1001)
Q Consensus 553 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L 632 (1001)
|..+++|+.|+|++|++++..+..+..+++|++|++++|++++..|..+..+++|+. |++++|++++..+..+..+++|
T Consensus 149 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-L~l~~n~l~~~~~~~~~~l~~L 227 (285)
T 1ozn_A 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT-LYLFANNLSALPTEALAPLRAL 227 (285)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE-EECCSSCCSCCCHHHHTTCTTC
T ss_pred hccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccE-eeCCCCcCCcCCHHHcccCccc
Confidence 778889999999999999777777889999999999999999888999999999996 9999999998888889999999
Q ss_pred cEEEecCCcCCCChhhhhcccccceeEcccCCCCCCCCCC
Q 001873 633 GILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNT 672 (1001)
Q Consensus 633 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~ 672 (1001)
+.|+|++|++.++++..+...+++.++.+.|.+.+..|..
T Consensus 228 ~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~~ 267 (285)
T 1ozn_A 228 QYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQR 267 (285)
T ss_dssp CEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGG
T ss_pred CEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCchH
Confidence 9999999999999887777788999999999998887753
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-28 Score=263.05 Aligned_cols=224 Identities=22% Similarity=0.282 Sum_probs=137.3
Q ss_pred ceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccc
Q 001873 274 QNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVN 353 (1001)
Q Consensus 274 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 353 (1001)
++++.+++.++ .+|..+ .++|++|++++|++++..+..|..+++|++|++++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 56777777776 345433 357777777777777666667777777777777777777666777777777777777777
Q ss_pred c-ccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCC
Q 001873 354 Q-LSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIP 432 (1001)
Q Consensus 354 ~-l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 432 (1001)
+ +....|..+..+++|++|++++|++++..|..+.++++|+.|++++|++++..+..
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~---------------------- 148 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT---------------------- 148 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT----------------------
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhH----------------------
Confidence 6 66555666666777777777776666554555555555555555555444444444
Q ss_pred cccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCccccccccc
Q 001873 433 KEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQS 512 (1001)
Q Consensus 433 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 512 (1001)
+..+++|++|++++|++++..+..+..+++|++|++++|++++..|..|.++++|+.|++++|++++..+..+..+++
T Consensus 149 --~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 226 (285)
T 1ozn_A 149 --FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226 (285)
T ss_dssp --TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred --hccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcc
Confidence 444455555555555554444444555555555555555555555555555555555666665555544445555566
Q ss_pred CceEEcccccCc
Q 001873 513 LEFLDLHSNGLT 524 (1001)
Q Consensus 513 L~~L~Ls~N~l~ 524 (1001)
|++|++++|.++
T Consensus 227 L~~L~l~~N~~~ 238 (285)
T 1ozn_A 227 LQYLRLNDNPWV 238 (285)
T ss_dssp CCEEECCSSCEE
T ss_pred cCEEeccCCCcc
Confidence 666666666555
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-27 Score=275.88 Aligned_cols=229 Identities=21% Similarity=0.215 Sum_probs=139.9
Q ss_pred CCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEc
Q 001873 271 SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQL 350 (1001)
Q Consensus 271 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 350 (1001)
+++++|+|++|+|++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 45556666666666555555666666666666666665555555555666666666666655444445555555666666
Q ss_pred ccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCC
Q 001873 351 SVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGP 430 (1001)
Q Consensus 351 s~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 430 (1001)
++|++....+..|..+++|++|++++|+. +....+..|.++++|++|++++|++++.
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~-----------------------l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKK-----------------------LEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTT-----------------------CCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCC-----------------------ccccChhhccCCCCCCEEECCCCccccc
Confidence 66555544444555555555555555322 2222223455566666666666666532
Q ss_pred CCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCccccccc
Q 001873 431 IPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGC 510 (1001)
Q Consensus 431 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 510 (1001)
| .+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..+..+
T Consensus 212 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 289 (452)
T 3zyi_A 212 -P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289 (452)
T ss_dssp -C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred -c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence 2 35566666666666666666666666667777777777777776666677777777777777777776666666677
Q ss_pred ccCceEEcccccCc
Q 001873 511 QSLEFLDLHSNGLT 524 (1001)
Q Consensus 511 ~~L~~L~Ls~N~l~ 524 (1001)
++|+.|+|++|.+.
T Consensus 290 ~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 290 RYLVELHLHHNPWN 303 (452)
T ss_dssp TTCCEEECCSSCEE
T ss_pred cCCCEEEccCCCcC
Confidence 77777777777765
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-27 Score=273.56 Aligned_cols=247 Identities=20% Similarity=0.216 Sum_probs=157.2
Q ss_pred CceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEccc
Q 001873 273 LQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSV 352 (1001)
Q Consensus 273 L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 352 (1001)
.+.++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 344555555554 3444333 3555555555555555555555555555555555555554445555555555566655
Q ss_pred ccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCc-cCCCCCcccccCcccceEeCcCccccCCC
Q 001873 353 NQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNK-LTGNIPESLSQCQELQALDFSYNNLSGPI 431 (1001)
Q Consensus 353 N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~-l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 431 (1001)
|+++...+..|..+++|++|+|++|+|++..+..+.++++|+.|++++|+ +....+..|.++++|++|++++|+++. +
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~ 200 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-I 200 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-C
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-c
Confidence 55554444455555556666666665554444455555555555555533 332333356677777777777777763 3
Q ss_pred CcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccc
Q 001873 432 PKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQ 511 (1001)
Q Consensus 432 ~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 511 (1001)
| .+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|++++..+..+..++
T Consensus 201 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 279 (440)
T 3zyj_A 201 P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279 (440)
T ss_dssp C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCT
T ss_pred c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcccc
Confidence 4 366777777777777777777777777777888888888888777777777788888888888888776667777777
Q ss_pred cCceEEcccccCc
Q 001873 512 SLEFLDLHSNGLT 524 (1001)
Q Consensus 512 ~L~~L~Ls~N~l~ 524 (1001)
+|+.|+|++|.+.
T Consensus 280 ~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 280 HLERIHLHHNPWN 292 (440)
T ss_dssp TCCEEECCSSCEE
T ss_pred CCCEEEcCCCCcc
Confidence 7888888777775
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=271.14 Aligned_cols=253 Identities=21% Similarity=0.187 Sum_probs=155.8
Q ss_pred ccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCccccc-----
Q 001873 194 IGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIG----- 268 (1001)
Q Consensus 194 ~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~----- 268 (1001)
++..++|+.|++++|. + .+|..+... |+.|++++|.+. .+.+|..+.
T Consensus 39 ~~~~~~L~~l~l~~n~-l--~~p~~~~~~--L~~L~L~~n~l~-----------------------~~~~~~~~~~~~~~ 90 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDT-E--ADLGQFTDI--IKSLSLKRLTVR-----------------------AARIPSRILFGALR 90 (312)
T ss_dssp EEEEEECTTHHHHCCT-T--CCCHHHHHH--HHHCCCCEEEEE-----------------------EEECBHHHHHHHHH
T ss_pred EccCCCceeEeecccc-c--ccHHHHHHH--Hhhccccccccc-----------------------CCCcCHHHHHHHHH
Confidence 4566677777777773 3 566555543 666666665542 234455444
Q ss_pred --CCCCCceEeeecCcccCCCCccc--CCCCCCcEEEcCCCcccccCCCCccCC-----CCCCEEeccCCCCCCCCCccc
Q 001873 269 --NCSELQNLYLYQNSISGPIPGRI--GALSKLKSLLLWQNSLVGAIPDELGSC-----TELTVVDFSDNLLTGSIPRSF 339 (1001)
Q Consensus 269 --~l~~L~~L~L~~N~i~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p~~l~~l-----~~L~~L~Ls~N~l~~~~p~~~ 339 (1001)
++++|++|+|++|++++.+|..+ +.+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|
T Consensus 91 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~ 169 (312)
T 1wwl_A 91 VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQV 169 (312)
T ss_dssp HHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTC
T ss_pred hcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHh
Confidence 67788888888888887777765 7778888888888888765 6666665 778888888888877766777
Q ss_pred ccccCccEEEcccccccCc--CChhh--ccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCc
Q 001873 340 GNLLKLQELQLSVNQLSGT--IPIEI--ATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQ 415 (1001)
Q Consensus 340 ~~l~~L~~L~Ls~N~l~~~--~p~~~--~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~ 415 (1001)
+++++|++|+|++|++.+. .|..+ ..+++|++|++++|+|++. +. .....+..++
T Consensus 170 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~--------------------~~~~~~~~l~ 228 (312)
T 1wwl_A 170 RVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP-SG--------------------VCSALAAARV 228 (312)
T ss_dssp CCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCH-HH--------------------HHHHHHHTTC
T ss_pred ccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcch-HH--------------------HHHHHHhcCC
Confidence 7788888888888876654 23333 6677777777777777621 10 0001123344
Q ss_pred ccceEeCcCccccCCCC-cccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeec
Q 001873 416 ELQALDFSYNNLSGPIP-KEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDM 494 (1001)
Q Consensus 416 ~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 494 (1001)
+|++|++++|++++..| ..+..+++|++|+|++|+++ .+|..+. ++|++|+|++|+|++. |. +..+++|++|++
T Consensus 229 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L 303 (312)
T 1wwl_A 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSL 303 (312)
T ss_dssp CCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEEC
T ss_pred CCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEec
Confidence 45555555555544332 23334455555555555555 3444443 5566666666666644 44 666666666666
Q ss_pred cCccccc
Q 001873 495 SENHLVG 501 (1001)
Q Consensus 495 s~N~l~~ 501 (1001)
++|++++
T Consensus 304 ~~N~l~~ 310 (312)
T 1wwl_A 304 KGNPFLD 310 (312)
T ss_dssp TTCTTTC
T ss_pred cCCCCCC
Confidence 6666653
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-29 Score=274.89 Aligned_cols=268 Identities=18% Similarity=0.235 Sum_probs=169.0
Q ss_pred CCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeec
Q 001873 321 LTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWK 400 (1001)
Q Consensus 321 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~ 400 (1001)
++..+++.+.+....+..+..+++|++|+|++|++++..|..|..+++|++|++++|++++..+ +.
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~------------ 77 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LE------------ 77 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ET------------
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hh------------
Confidence 4455667776664444455556677777777777776666677777777777777777764332 44
Q ss_pred CccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCC
Q 001873 401 NKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIP 480 (1001)
Q Consensus 401 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 480 (1001)
.+++|++|++++|++++. ...++|++|++++|++++..+.. +++|++|++++|++++..+
T Consensus 78 ------------~l~~L~~L~Ls~n~l~~l-----~~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~ 137 (317)
T 3o53_A 78 ------------SLSTLRTLDLNNNYVQEL-----LVGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRD 137 (317)
T ss_dssp ------------TCTTCCEEECCSSEEEEE-----EECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGG
T ss_pred ------------hcCCCCEEECcCCccccc-----cCCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccc
Confidence 444555555555555421 12255666666666665444332 4557777777777776666
Q ss_pred cccCCCCCcceeeccCcccccCCccccc-ccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCccccccccccc
Q 001873 481 SEMGNLKHLNFVDMSENHLVGGIPPSVV-GCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTEL 559 (1001)
Q Consensus 481 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L 559 (1001)
..+..+++|++|++++|++++..+..+. .+++|++|++++|++++..+....+.++.|+|++|+|++. |..+..+++|
T Consensus 138 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L 216 (317)
T 3o53_A 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGV 216 (317)
T ss_dssp BCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCEE-CGGGGGGTTC
T ss_pred hhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcCCcc-hhhhcccCcc
Confidence 6677777777777777777766555553 5677777777777776543333345555666666666643 3336677777
Q ss_pred ceeeccCccccccchhhhhccccccEEeccccccc-CCCCCccccccchhhhhhcC-CCccccccccc
Q 001873 560 SKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFS-GEIPKELGQISSLEISLNLS-SNQFSGEIPSE 625 (1001)
Q Consensus 560 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~~L~Ls-~N~l~~~~p~~ 625 (1001)
+.|+|++|+|+ .+|..+..+++|+.|++++|+++ +.+|..+..++.|+. ++++ .+.+++..|..
T Consensus 217 ~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~-l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT-VAKQTVKKLTGQNEEE 282 (317)
T ss_dssp SEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHH-HHHHHHHHHHSSSSCC
T ss_pred cEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceE-EECCCchhccCCchhc
Confidence 77777777777 45666777777777777777776 566666777777765 7766 34555554443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-28 Score=273.31 Aligned_cols=265 Identities=19% Similarity=0.191 Sum_probs=183.3
Q ss_pred ceeccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCC
Q 001873 250 QTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDN 329 (1001)
Q Consensus 250 ~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 329 (1001)
+..+++.+.+...++..+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+ +..+++|++|++++|
T Consensus 13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 333444444443444445566677777777777777766777777777777777777776544 777777777777777
Q ss_pred CCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCc
Q 001873 330 LLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPE 409 (1001)
Q Consensus 330 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~ 409 (1001)
.+++.. ..++|++|++++|++++..+. .+++|++|++++|++++..+..++.+++|+.|++++|++++..+.
T Consensus 91 ~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 162 (317)
T 3o53_A 91 YVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162 (317)
T ss_dssp EEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGG
T ss_pred cccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHH
Confidence 777422 336777777777777755443 256677777777777776666777777777777777777766666
Q ss_pred cc-ccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCC
Q 001873 410 SL-SQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKH 488 (1001)
Q Consensus 410 ~l-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 488 (1001)
.+ ..+++|++|++++|.+++. + ....+++|++|+|++|++++. |..+..+++|++|+|++|+++ .+|..+..+++
T Consensus 163 ~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~ 238 (317)
T 3o53_A 163 ELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238 (317)
T ss_dssp GGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTT
T ss_pred HHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCCC
Confidence 55 3577788888888877754 2 223477788888888877754 334777778888888888887 46667777788
Q ss_pred cceeeccCcccc-cCCcccccccccCceEEcc-cccCcccCC
Q 001873 489 LNFVDMSENHLV-GGIPPSVVGCQSLEFLDLH-SNGLTGSVP 528 (1001)
Q Consensus 489 L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p 528 (1001)
|+.|++++|+++ +.+|..+..+++|+.|+++ .+.++|..|
T Consensus 239 L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp CCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred CCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence 888888888887 6667777777778877777 344555444
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-26 Score=270.76 Aligned_cols=267 Identities=27% Similarity=0.341 Sum_probs=149.9
Q ss_pred CCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEc
Q 001873 271 SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQL 350 (1001)
Q Consensus 271 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 350 (1001)
.+++.|++++|.++ .+|..+. ++|++|+|++|+++ .+|. .+++|++|+|++|+++ .+|. .+++|++|+|
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEEC
Confidence 35777777777777 5566554 67777777777777 4554 4567777777777777 3454 5677777777
Q ss_pred ccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCC
Q 001873 351 SVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGP 430 (1001)
Q Consensus 351 s~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 430 (1001)
++|++++. |. .+++|+.|++++|+|++ +|.. +++|+.|++++|++++ +|. .+.+|+.|++++|.+++
T Consensus 109 s~N~l~~l-~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~- 175 (622)
T 3g06_A 109 FSNPLTHL-PA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS- 175 (622)
T ss_dssp CSCCCCCC-CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-
T ss_pred cCCcCCCC-CC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-
Confidence 77777743 33 45667777777777763 3332 2555555666655553 222 22455666666666653
Q ss_pred CCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCccccccc
Q 001873 431 IPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGC 510 (1001)
Q Consensus 431 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 510 (1001)
+| ..+++|+.|++++|+++++ |.. +++|+.|++++|.++ .+|.. +++|+.|++++|+|++ +| ..+
T Consensus 176 l~---~~~~~L~~L~Ls~N~l~~l-~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l 240 (622)
T 3g06_A 176 LP---MLPSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLP 240 (622)
T ss_dssp CC---CCCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCC
T ss_pred Cc---ccCCCCcEEECCCCCCCCC-CCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCC
Confidence 33 2345566666666665532 221 245566666666655 33322 2455555555555553 33 233
Q ss_pred ccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEeccc
Q 001873 511 QSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGN 590 (1001)
Q Consensus 511 ~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 590 (1001)
++|+.|++++|+|+ .+|. . +++|+.|+|++|+|+ .+|..+..+++|+.|+|++
T Consensus 241 ~~L~~L~Ls~N~L~-~lp~-~------------------------~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~ 293 (622)
T 3g06_A 241 SELKELMVSGNRLT-SLPM-L------------------------PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293 (622)
T ss_dssp TTCCEEECCSSCCS-CCCC-C------------------------CTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCS
T ss_pred CcCcEEECCCCCCC-cCCc-c------------------------cccCcEEeCCCCCCC-cCCHHHhhccccCEEEecC
Confidence 45555555555555 2332 2 344555555555555 4444555555555555555
Q ss_pred ccccCCCCCcccc
Q 001873 591 NRFSGEIPKELGQ 603 (1001)
Q Consensus 591 N~l~~~~p~~~~~ 603 (1001)
|++++.+|..+..
T Consensus 294 N~l~~~~~~~l~~ 306 (622)
T 3g06_A 294 NPLSERTLQALRE 306 (622)
T ss_dssp CCCCHHHHHHHHH
T ss_pred CCCCCcCHHHHHh
Confidence 5555444444433
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-26 Score=273.18 Aligned_cols=269 Identities=30% Similarity=0.406 Sum_probs=181.8
Q ss_pred CCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEec
Q 001873 295 SKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEI 374 (1001)
Q Consensus 295 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 374 (1001)
.+++.|++++|.++ .+|..+. ++|+.|+|++|.|+ .+|. .+++|++|+|++|++++ +|. .+++|++|++
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEEC
Confidence 35888999999888 6777665 68888899888888 4555 46788888888888873 444 5677888888
Q ss_pred cCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCC
Q 001873 375 DNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGF 454 (1001)
Q Consensus 375 ~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 454 (1001)
++|++++ +|. .+++|+.|++++|++++ +|.. +++|++|++++|++++.
T Consensus 109 s~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---------------------------l~~L~~L~Ls~N~l~~l 156 (622)
T 3g06_A 109 FSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---------------------------PPGLQELSVSDNQLASL 156 (622)
T ss_dssp CSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---------------------------CTTCCEEECCSSCCSCC
T ss_pred cCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---------------------------CCCCCEEECcCCcCCCc
Confidence 8777764 232 33445555555555543 2222 24445555555554432
Q ss_pred CCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCcccCCCCcccc
Q 001873 455 IPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTS 534 (1001)
Q Consensus 455 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 534 (1001)
|. .+++|+.|++++|++++ +| ..+++|+.|++++|+|++ +|.. +++|+.|++++|+++ .+|. ..+.
T Consensus 157 -~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~-~~~~ 222 (622)
T 3g06_A 157 -PA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPA-LPSG 222 (622)
T ss_dssp -CC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCC-CCTT
T ss_pred -CC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCC-CCCC
Confidence 22 12445555555555553 33 334556666666666653 3322 255666666666666 3333 2355
Q ss_pred cccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcC
Q 001873 535 LQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLS 614 (1001)
Q Consensus 535 l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls 614 (1001)
++.|++++|+|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+..+++|+. |+|+
T Consensus 223 L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~-L~L~ 292 (622)
T 3g06_A 223 LKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETT-VNLE 292 (622)
T ss_dssp CCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCE-EECC
T ss_pred CCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCE-EEec
Confidence 6667777777765 33 34688999999999999 4555 6789999999999999 88999999999996 9999
Q ss_pred CCcccccccccccccc
Q 001873 615 SNQFSGEIPSEFSGLT 630 (1001)
Q Consensus 615 ~N~l~~~~p~~~~~l~ 630 (1001)
+|++++.+|..+..++
T Consensus 293 ~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 293 GNPLSERTLQALREIT 308 (622)
T ss_dssp SCCCCHHHHHHHHHHH
T ss_pred CCCCCCcCHHHHHhcc
Confidence 9999999998887665
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-28 Score=291.55 Aligned_cols=182 Identities=20% Similarity=0.161 Sum_probs=129.0
Q ss_pred EeecCCeeEEEEE-eCCCCEEEEEEecCCC------------chhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEEE
Q 001873 774 IGTGSSGVVYRVT-IPNGETLAVKKMWSSD------------ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 774 lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~------------~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
.+.|++|.+..++ ...|+.||||.+.... ..++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566666666544 2358999999985432 124699999999999 7999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||++|++|.+++.+.+ .++.. +|+.||+.||+|+|++ |||||||||+|||++++|++||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~- 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD- 392 (569)
T ss_dssp ECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC-
Confidence 9999999999998753 35543 5889999999999999 9999999999999999999999999999876432
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~P 971 (1001)
.......+||++|||||++.+ .+..++|+||+|++++++.++..|
T Consensus 393 ------~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 ------CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ------CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 123445689999999999875 466789999999998877665444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.1e-27 Score=274.11 Aligned_cols=237 Identities=19% Similarity=0.189 Sum_probs=163.3
Q ss_pred CCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEE
Q 001873 269 NCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQEL 348 (1001)
Q Consensus 269 ~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 348 (1001)
.+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..| +..+++|++|+|++|.+++.. ..++|++|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEE
Confidence 34478888888888887777788888888888888888876655 777888888888888877432 23677888
Q ss_pred EcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccc-cCcccceEeCcCccc
Q 001873 349 QLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLS-QCQELQALDFSYNNL 427 (1001)
Q Consensus 349 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~-~l~~L~~L~Ls~N~l 427 (1001)
++++|++++..+. .+++|++|++++|.+++..|..++.+++|+.|++++|.+++..|..+. .+++|+.|+|++|.+
T Consensus 105 ~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 105 HAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp ECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred ECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 8888877765443 346777777777777776676777777777777777777766666654 567777777777777
Q ss_pred cCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccc-cCCccc
Q 001873 428 SGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLV-GGIPPS 506 (1001)
Q Consensus 428 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~ 506 (1001)
++..+ +..+++|++|+|++|++++..| .+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|++. +.+|..
T Consensus 182 ~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~ 257 (487)
T 3oja_A 182 YDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF 257 (487)
T ss_dssp CEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHH
T ss_pred ccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHH
Confidence 65422 2346667777777777765433 36666677777777777763 5556666677777777777766 455566
Q ss_pred ccccccCceEEcc
Q 001873 507 VVGCQSLEFLDLH 519 (1001)
Q Consensus 507 ~~~l~~L~~L~Ls 519 (1001)
+..++.|+.++++
T Consensus 258 ~~~l~~L~~l~~~ 270 (487)
T 3oja_A 258 FSKNQRVQTVAKQ 270 (487)
T ss_dssp HTTCHHHHHHHHH
T ss_pred HHhCCCCcEEecc
Confidence 6666666666554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.5e-27 Score=273.92 Aligned_cols=229 Identities=20% Similarity=0.242 Sum_probs=133.3
Q ss_pred CccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCc
Q 001873 344 KLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFS 423 (1001)
Q Consensus 344 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls 423 (1001)
+|++|+|++|++++..|..|..+++|++|+|++|.+++.. | +..+++|++|+|+
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~------------------------~--l~~l~~L~~L~Ls 88 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL------------------------D--LESLSTLRTLDLN 88 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEE------------------------E--CTTCTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCc------------------------c--cccCCCCCEEEec
Confidence 5666666666666555555566666666666666555332 2 4555566666666
Q ss_pred CccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCC
Q 001873 424 YNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGI 503 (1001)
Q Consensus 424 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 503 (1001)
+|.|++.. ..++|++|++++|.+++..+.. +++|+.|+|++|.+++..|..++++++|++|+|++|.+++..
T Consensus 89 ~N~l~~l~-----~~~~L~~L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 160 (487)
T 3oja_A 89 NNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160 (487)
T ss_dssp SSEEEEEE-----ECTTCCEEECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEE
T ss_pred CCcCCCCC-----CCCCcCEEECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcC
Confidence 66665322 2256666777777666554433 456777777777777777777777777888888888877777
Q ss_pred ccccc-ccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhcccc
Q 001873 504 PPSVV-GCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRK 582 (1001)
Q Consensus 504 p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 582 (1001)
|..+. .+++|+.|+|++|.|++..+....+.++.|+|++|+|++.++ .+..+++|+.|+|++|+|++ +|..+..+++
T Consensus 161 ~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~ 238 (487)
T 3oja_A 161 FAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQN 238 (487)
T ss_dssp GGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTT
T ss_pred hHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCC
Confidence 76665 677788888887777755333333444444444444443222 24455555555555555552 3444444555
Q ss_pred ccEEeccccccc-CCCCCccccccchh
Q 001873 583 LILLDIGNNRFS-GEIPKELGQISSLE 608 (1001)
Q Consensus 583 L~~L~Ls~N~l~-~~~p~~~~~l~~L~ 608 (1001)
|+.|++++|.++ +.+|..+..++.++
T Consensus 239 L~~L~l~~N~l~c~~~~~~~~~l~~L~ 265 (487)
T 3oja_A 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQ 265 (487)
T ss_dssp CCEEECTTCCBCHHHHHHHHTTCHHHH
T ss_pred CCEEEcCCCCCcCcchHHHHHhCCCCc
Confidence 555555555544 33333344444443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=5e-30 Score=310.77 Aligned_cols=398 Identities=13% Similarity=0.168 Sum_probs=196.9
Q ss_pred ccccCCCCcEEeccCCcccC---CCCcc------------cCCccccccccccCCccCCCCChhhh-cccccceEEccCC
Q 001873 97 IFQPLKSLKRLIISSCNLTG---TIPKE------------FGDYRELTFIDLSGNSLWGEIPTEVC-RLRKLESLYLNTN 160 (1001)
Q Consensus 97 ~~~~l~~L~~L~l~~~~l~g---~~p~~------------~~~l~~L~~L~Ls~n~l~g~~p~~~~-~l~~L~~L~L~~n 160 (1001)
.+..+++|++|+++++.... ..|.. ...+++|++|+|++|.+++..+..+. .+++|++|+|++|
T Consensus 61 ~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~ 140 (594)
T 2p1m_B 61 VIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSC 140 (594)
T ss_dssp HHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESC
T ss_pred HHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCc
Confidence 35567888999998875321 12221 23567888888888888877777776 6888888888888
Q ss_pred -cccCC-CCccccCCccccceeccccccccccCCCcc----chhhhhhhhhccCcCCCCCCC-----cccccCccchhcc
Q 001873 161 -LLEGE-IPSDIGNLSSLAYLTLYDNQLSGKIPKSIG----ALSKLQVFRAGGNQNLKGELP-----WEIGNCSNLVMLG 229 (1001)
Q Consensus 161 -~l~~~-ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~----~l~~L~~L~l~~n~~l~~~lp-----~~l~~l~~L~~L~ 229 (1001)
.++.. ++..+.++++|++|+|++|.+++..+..+. .+++|++|++++|. +.++ ..+.++++|+.|+
T Consensus 141 ~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~---~~~~~~~l~~l~~~~~~L~~L~ 217 (594)
T 2p1m_B 141 EGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA---SEVSFSALERLVTRCPNLKSLK 217 (594)
T ss_dssp EEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC---SCCCHHHHHHHHHHCTTCCEEE
T ss_pred CCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC---CcCCHHHHHHHHHhCCCCcEEe
Confidence 45432 444455788888888888887765444333 45567777777663 1222 1123345566666
Q ss_pred ccccccccccCCccccccccceeccccc-------cccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEc
Q 001873 230 LAETSISGNVPSSIGMLERIQTIAIYTS-------LLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLL 302 (1001)
Q Consensus 230 l~~~~l~~~~p~~i~~l~~L~~L~l~~n-------~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L 302 (1001)
+++|...+.+|..+..+++|+.|++..+ .+.+ ++..+.++++|+.|. .+
T Consensus 218 L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls-----------------------~~ 273 (594)
T 2p1m_B 218 LNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLS-----------------------GF 273 (594)
T ss_dssp CCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEE-----------------------CC
T ss_pred cCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCccccc-----------------------CC
Confidence 6555222224444444445555543222 1221 233444445554441 22
Q ss_pred CCCcccccCCCCccCCCCCCEEeccCCCCCCCCC-cccccccCccEEEcccccccCc-CChhhccccccCEEec------
Q 001873 303 WQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIP-RSFGNLLKLQELQLSVNQLSGT-IPIEIATCTALTHLEI------ 374 (1001)
Q Consensus 303 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L------ 374 (1001)
.+... +.++..+..+++|+.|++++|.+++... ..+..+++|++|++++| +... ++.....+++|++|++
T Consensus 274 ~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~ 351 (594)
T 2p1m_B 274 WDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPF 351 (594)
T ss_dssp BTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTT
T ss_pred cccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCccc
Confidence 22111 1222222334444444444444332111 11234444555555444 2211 1111123444555544
Q ss_pred ---cCCcccCccCcccc-ccCcccEEEeecCccCCCCCcccc-cCcccceEeCc--C----ccccCCC-----Ccccccc
Q 001873 375 ---DNNAISGEIPADIG-NINGLTLFFAWKNKLTGNIPESLS-QCQELQALDFS--Y----NNLSGPI-----PKEIFGL 438 (1001)
Q Consensus 375 ---~~N~i~~~~~~~~~-~l~~L~~L~l~~n~l~~~~p~~l~-~l~~L~~L~Ls--~----N~l~~~~-----~~~~~~l 438 (1001)
+.+.+++.....+. .+++|+.|.+..|++++..+..+. .+++|+.|+++ + |.+++.. +..+..+
T Consensus 352 g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~ 431 (594)
T 2p1m_B 352 VMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHC 431 (594)
T ss_dssp CSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHC
T ss_pred ccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhC
Confidence 22233322222221 244555555555555433333332 34555555555 2 3333111 1113445
Q ss_pred cccceEEccCCcCCCCCCCCCCC-CCCcceEEccccccccCCCccc-CCCCCcceeeccCcccccCCcc-cccccccCce
Q 001873 439 RNLTKLLLLSNDLSGFIPPDIGN-CTTLRRLRLNDNRLSGTIPSEM-GNLKHLNFVDMSENHLVGGIPP-SVVGCQSLEF 515 (1001)
Q Consensus 439 ~~L~~L~L~~N~l~~~~p~~l~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~ 515 (1001)
++|++|++++ .+++..+..+.. +++|+.|+|++|.+++..+..+ .++++|++|++++|++++.... .+..+++|+.
T Consensus 432 ~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~ 510 (594)
T 2p1m_B 432 KDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRS 510 (594)
T ss_dssp TTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSE
T ss_pred CCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCE
Confidence 5566666644 443322222322 5556666666666654433333 4466666666666666443332 2334666666
Q ss_pred EEcccccCc
Q 001873 516 LDLHSNGLT 524 (1001)
Q Consensus 516 L~Ls~N~l~ 524 (1001)
|++++|+++
T Consensus 511 L~l~~~~~~ 519 (594)
T 2p1m_B 511 LWMSSCSVS 519 (594)
T ss_dssp EEEESSCCB
T ss_pred EeeeCCCCC
Confidence 666666664
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=241.79 Aligned_cols=218 Identities=29% Similarity=0.302 Sum_probs=135.6
Q ss_pred CCCCccceEEeCCCCcEEEEEeccccccccCCcccccCCCCcEEeccCCcccCCCCcccCCccccccccccCCccCCCCC
Q 001873 64 TSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIP 143 (1001)
Q Consensus 64 ~~~c~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p 143 (1001)
.++|.|.|+.|+-.+.+.. +++++++++ .+|..+. +.|++|+|++|++++..|
T Consensus 2 ~~~C~~~~~~C~c~~~~~~------------------------l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~ 54 (270)
T 2o6q_A 2 EALCKKDGGVCSCNNNKNS------------------------VDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPS 54 (270)
T ss_dssp CCCBGGGTCSBEEETTTTE------------------------EECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCT
T ss_pred CccCCCCCCCCEeCCCCCE------------------------EEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCH
Confidence 4789999999963222233 444555555 3554443 456666666666664444
Q ss_pred hhhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCc
Q 001873 144 TEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCS 223 (1001)
Q Consensus 144 ~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~ 223 (1001)
..|..+++|++|+|++|.+++..+..++++++|++|+|++|.+++..+..++.+++|++|++++|
T Consensus 55 ~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n--------------- 119 (270)
T 2o6q_A 55 KAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRN--------------- 119 (270)
T ss_dssp TSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSS---------------
T ss_pred HHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCC---------------
Confidence 45666666666666666666333333456666666666666666444444455555555554444
Q ss_pred cchhccccccccccccCCccccccccceeccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcC
Q 001873 224 NLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLW 303 (1001)
Q Consensus 224 ~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~ 303 (1001)
.+++..|..|+++++|++|+|++|.+++..+..|..+++|++|+|+
T Consensus 120 ----------------------------------~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 165 (270)
T 2o6q_A 120 ----------------------------------QLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLY 165 (270)
T ss_dssp ----------------------------------CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred ----------------------------------ccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEec
Confidence 1111223345566677777777777776666667777777777777
Q ss_pred CCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccC
Q 001873 304 QNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSG 357 (1001)
Q Consensus 304 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 357 (1001)
+|++++..+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|.+..
T Consensus 166 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 166 NNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 777776666667777777777777777776555667777777777777777653
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-24 Score=233.98 Aligned_cols=205 Identities=21% Similarity=0.183 Sum_probs=114.7
Q ss_pred CCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEecc
Q 001873 296 KLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEID 375 (1001)
Q Consensus 296 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 375 (1001)
+|++|++++|++++..+..+.++++|++|++++|.+++..+..|.++++|++|+|++|++++..+..+..+++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 44445555555444444444445555555555555544444444555555555555555544444445555555555555
Q ss_pred CCcccCccCccccccCcccEEEeecCccCCC-CCcccccCcccceEeCcCccccCCCCcccccccccc----eEEccCCc
Q 001873 376 NNAISGEIPADIGNINGLTLFFAWKNKLTGN-IPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLT----KLLLLSND 450 (1001)
Q Consensus 376 ~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~L~~N~ 450 (1001)
+|++++..+..++.+++|+.|++++|++++. +|..+..+++|++|++++|++++..+..+..+.+|+ +|++++|+
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 5555544444455555555555555555542 466667777777777777777766666666666665 66666666
Q ss_pred CCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCccccc
Q 001873 451 LSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVG 501 (1001)
Q Consensus 451 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 501 (1001)
+++..+..+.. .+|++|+|++|++++..+..|..+++|+.|++++|++++
T Consensus 189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence 66544444333 356666666666665555555666666666666666653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-26 Score=269.49 Aligned_cols=189 Identities=14% Similarity=0.202 Sum_probs=145.5
Q ss_pred cCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc----------hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 769 TSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE----------SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 769 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
...+.||+|+||+||+++. .++.+|+|+...... .+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4466899999999999965 578999998643221 13478999999999999999666666677778999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++++|.+++++ +..++.|+++|++|||++ +|+||||||+||+++. ++||+|||+|+.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999975 458999999999999998 9999999999999999 9999999999976421
Q ss_pred CCCCCCCCCCCCcccccccccCcccccc--CCCCCccchHHHHHHHHHHHhCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASM--QRITEKSDVYSFGVVLLEVLTGRHPLD 973 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~il~elltg~~Pf~ 973 (1001)
...............||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1000000001235689999999999976 678888999999999998888887764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-28 Score=294.58 Aligned_cols=425 Identities=17% Similarity=0.167 Sum_probs=212.0
Q ss_pred cccCccchhcccccccccccc---CCc------------cccccccceeccccccccccCccccc-CCCCCceEeeecC-
Q 001873 219 IGNCSNLVMLGLAETSISGNV---PSS------------IGMLERIQTIAIYTSLLSGPIPEEIG-NCSELQNLYLYQN- 281 (1001)
Q Consensus 219 l~~l~~L~~L~l~~~~l~~~~---p~~------------i~~l~~L~~L~l~~n~l~g~ip~~l~-~l~~L~~L~L~~N- 281 (1001)
+..+++|+.|+++++...... |.. ...+++|++|++++|.+++..+..+. .+++|++|+|++|
T Consensus 62 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~ 141 (594)
T 2p1m_B 62 IRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCE 141 (594)
T ss_dssp HHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCE
T ss_pred HhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcC
Confidence 445677888888876532211 111 12334455555555555444444443 3455555555555
Q ss_pred cccCC-CCcccCCCCCCcEEEcCCCcccccCCCCcc----CCCCCCEEeccCCCCCCCCCcc----cccccCccEEEccc
Q 001873 282 SISGP-IPGRIGALSKLKSLLLWQNSLVGAIPDELG----SCTELTVVDFSDNLLTGSIPRS----FGNLLKLQELQLSV 352 (1001)
Q Consensus 282 ~i~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~----~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~ 352 (1001)
.++.. ++..+.++++|++|+|++|.+++..+.++. .+++|+.|++++|. ....... +..+++|++|+|++
T Consensus 142 ~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~ 220 (594)
T 2p1m_B 142 GFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLNR 220 (594)
T ss_dssp EEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCT
T ss_pred CCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecCC
Confidence 33221 222222445555555555554433322222 33455555555544 1000111 12234555555554
Q ss_pred c-cccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceE-eCcCccccCC
Q 001873 353 N-QLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQAL-DFSYNNLSGP 430 (1001)
Q Consensus 353 N-~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L-~Ls~N~l~~~ 430 (1001)
| .+. .+|..+..+++|++|+++.+... +..|.+.+ ++..+.++++|+.| .+.+... +.
T Consensus 221 ~~~~~-~l~~~~~~~~~L~~L~l~~~~~~-----------------~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~ 280 (594)
T 2p1m_B 221 AVPLE-KLATLLQRAPQLEELGTGGYTAE-----------------VRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AY 280 (594)
T ss_dssp TSCHH-HHHHHHHHCTTCSEEECSBCCCC-----------------CCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GG
T ss_pred CCcHH-HHHHHHhcCCcceEcccccccCc-----------------cchhhHHH-HHHHHhcCCCcccccCCcccch-hh
Confidence 4 222 24444444455555543322100 11112221 22234445555555 2222211 12
Q ss_pred CCcccccccccceEEccCCcCCCCCC-CCCCCCCCcceEEccccccccC-CCcccCCCCCcceeec---------cCccc
Q 001873 431 IPKEIFGLRNLTKLLLLSNDLSGFIP-PDIGNCTTLRRLRLNDNRLSGT-IPSEMGNLKHLNFVDM---------SENHL 499 (1001)
Q Consensus 431 ~~~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L---------s~N~l 499 (1001)
++..+..+++|++|++++|.+++... ..+..+++|++|++++| ++.. ++.....+++|++|++ +.|.+
T Consensus 281 l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l 359 (594)
T 2p1m_B 281 LPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVAL 359 (594)
T ss_dssp GGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCC
T ss_pred HHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCC
Confidence 33333345555555555555432111 11234555555555555 2211 1112223555555555 22344
Q ss_pred ccCCccccc-ccccCceEEcccccCcccCCCCc---ccccccccCC--C----CcCCCC-----cccccccccccceeec
Q 001873 500 VGGIPPSVV-GCQSLEFLDLHSNGLTGSVPDTL---PTSLQLVDLS--D----NRLSGS-----LAHSIGSLTELSKLLL 564 (1001)
Q Consensus 500 ~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~---~~~l~~L~Ls--~----N~l~~~-----~~~~~~~l~~L~~L~L 564 (1001)
++.....+. ++++|+.|+++.|++++.....+ .+.++.|+++ + |.+++. ++..+..+++|+.|++
T Consensus 360 ~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L 439 (594)
T 2p1m_B 360 TEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSL 439 (594)
T ss_dssp CHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEEC
T ss_pred CHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEee
Confidence 332222222 25556666555555554322222 1345555555 2 444421 1223556788999999
Q ss_pred cCccccccchhhhhc-cccccEEecccccccCCCCCcc-ccccchhhhhhcCCCcccccccc-cccccccccEEEecCCc
Q 001873 565 SKNQLSGRIPAEILS-CRKLILLDIGNNRFSGEIPKEL-GQISSLEISLNLSSNQFSGEIPS-EFSGLTKLGILDLSHNK 641 (1001)
Q Consensus 565 s~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~ 641 (1001)
++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+. |+|++|.+++.... ....+++|+.|++++|+
T Consensus 440 ~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~-L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~ 517 (594)
T 2p1m_B 440 SG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRK-LEIRDCPFGDKALLANASKLETMRSLWMSSCS 517 (594)
T ss_dssp CS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCE-EEEESCSCCHHHHHHTGGGGGGSSEEEEESSC
T ss_pred cC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCE-EECcCCCCcHHHHHHHHHhCCCCCEEeeeCCC
Confidence 77 777666666665 8889999999999876555554 56788886 99999998765554 34568999999999999
Q ss_pred CCCC-hhhh-hcccccceeEcccCCCCC
Q 001873 642 LSGD-LDAL-ASLQNLVSLNVSFNDFSG 667 (1001)
Q Consensus 642 l~~~-~~~~-~~l~~L~~L~ls~N~l~~ 667 (1001)
++.. ...+ ..+++|+...+..+.-..
T Consensus 518 ~~~~~~~~l~~~lp~l~i~~~~~~~~~~ 545 (594)
T 2p1m_B 518 VSFGACKLLGQKMPKLNVEVIDERGAPD 545 (594)
T ss_dssp CBHHHHHHHHHHCTTEEEEEECSSSCGG
T ss_pred CCHHHHHHHHHhCCCCEEEEecCCCccc
Confidence 8542 3344 567888877777665433
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-24 Score=234.48 Aligned_cols=226 Identities=21% Similarity=0.189 Sum_probs=194.6
Q ss_pred EEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCc
Q 001873 299 SLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNA 378 (1001)
Q Consensus 299 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 378 (1001)
..+..+.+++ .+|..+. ++|++|++++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|+
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 4556666666 5666554 579999999999998777789999999999999999998888889999999999999999
Q ss_pred ccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCC-CCcccccccccceEEccCCcCCCCCCC
Q 001873 379 ISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGP-IPKEIFGLRNLTKLLLLSNDLSGFIPP 457 (1001)
Q Consensus 379 i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~ 457 (1001)
+++..+..+.++++|+.|++++|++++..+..+..+++|++|++++|.+++. +|..+..+++|++|++++|++++..+.
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~ 167 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence 9988888999999999999999999988877899999999999999999864 588999999999999999999988777
Q ss_pred CCCCCCCcc----eEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCcccCC
Q 001873 458 DIGNCTTLR----RLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVP 528 (1001)
Q Consensus 458 ~l~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 528 (1001)
.+..+++|+ .|++++|++++..+..+.. .+|++|++++|++++..+..+..+++|+.|++++|++++..+
T Consensus 168 ~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp GGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred HhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 887777777 8999999999666555544 489999999999997777778889999999999999886443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-24 Score=232.28 Aligned_cols=207 Identities=19% Similarity=0.193 Sum_probs=98.4
Q ss_pred CCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEE
Q 001873 293 ALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHL 372 (1001)
Q Consensus 293 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 372 (1001)
.+++|+.|++++|.++. + ..+..+++|++|++++|.+++. ..+..+++|++|+|++|++++..+..+..+++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 114 (272)
T 3rfs_A 39 ELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKEL 114 (272)
T ss_dssp HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred cccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEE
Confidence 34444444444444431 1 1244444444444444444431 234444444444444444444444444444444444
Q ss_pred eccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCC
Q 001873 373 EIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLS 452 (1001)
Q Consensus 373 ~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 452 (1001)
++++|++++..+..++.+++|+.|++++|++++..+..+..+++|+.|++++|++++..+..+..+++|++|++++|+++
T Consensus 115 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (272)
T 3rfs_A 115 VLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK 194 (272)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred ECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence 44444444333333444444444444444444444444455555555555555555444444455555555555555555
Q ss_pred CCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCccccccc
Q 001873 453 GFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGC 510 (1001)
Q Consensus 453 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 510 (1001)
+..+..+..+++|+.|++++|.+.+. +++|+.++++.|+++|.+|..++.+
T Consensus 195 ~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 195 SVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred ccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccccc
Confidence 55444455555555555555554422 3345555555555555555554443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-24 Score=230.55 Aligned_cols=213 Identities=22% Similarity=0.196 Sum_probs=174.7
Q ss_pred cccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCc
Q 001873 266 EIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKL 345 (1001)
Q Consensus 266 ~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 345 (1001)
.+..+++|+.|++++|.++.. ..+..+++|++|++++|++++ + ..+..+++|++|++++|.+++..+..|.++++|
T Consensus 36 ~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 111 (272)
T 3rfs_A 36 TQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNL 111 (272)
T ss_dssp CHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred ccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCC
Confidence 355677788888888887632 357778888888888888875 2 367788888888888888887777777888888
Q ss_pred cEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCc
Q 001873 346 QELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYN 425 (1001)
Q Consensus 346 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N 425 (1001)
++|+|++|++++..+..+..+++|++|++++|++++..+..++.+++|+.|++++|++++..+..+..+++|++|++++|
T Consensus 112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (272)
T 3rfs_A 112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN 191 (272)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence 88888888888777777888888888888888888777777788888888888888888877778888999999999999
Q ss_pred cccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCc
Q 001873 426 NLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHL 489 (1001)
Q Consensus 426 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 489 (1001)
++++..+..+..+++|++|++++|.+.+. ++.|+.|++..|+++|.+|.+++.+...
T Consensus 192 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~~ 248 (272)
T 3rfs_A 192 QLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAPD 248 (272)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCGG
T ss_pred cCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCCC
Confidence 99988888888999999999999988743 5579999999999999999998877653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-23 Score=222.88 Aligned_cols=201 Identities=22% Similarity=0.273 Sum_probs=95.2
Q ss_pred CceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEccc
Q 001873 273 LQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSV 352 (1001)
Q Consensus 273 L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 352 (1001)
.+.+++++++++ .+|..+. ++|++|+|++|++++..+..|..+++|++|++++|.++...+..|.++++|++|+|++
T Consensus 18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 455666666665 3444332 3455555555555544444555555555555555555543333444455555555555
Q ss_pred ccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCC
Q 001873 353 NQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIP 432 (1001)
Q Consensus 353 N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 432 (1001)
|++++..+..|..+++|++|++++|+++ +..+..|..+++|++|++++|++++..+
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~------------------------~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 150 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNLAELRLDRNQLK------------------------SLPPRVFDSLTKLTYLSLGYNELQSLPK 150 (270)
T ss_dssp SCCCCCCTTTTTTCSSCCEEECCSSCCC------------------------CCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CcCCcCCHhHcccccCCCEEECCCCccC------------------------eeCHHHhCcCcCCCEEECCCCcCCccCH
Confidence 5554433333444444444444444443 3333334444444444555444443333
Q ss_pred cccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccc
Q 001873 433 KEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLV 500 (1001)
Q Consensus 433 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 500 (1001)
..|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|++.
T Consensus 151 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 151 GVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred hHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 33444444444444444444443444444444444444444444333334444444444444444443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=6.5e-23 Score=223.55 Aligned_cols=114 Identities=28% Similarity=0.361 Sum_probs=59.2
Q ss_pred ccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCc
Q 001873 410 SLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHL 489 (1001)
Q Consensus 410 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 489 (1001)
.+..+++|++|++++|+|++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|
T Consensus 95 ~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L 174 (290)
T 1p9a_G 95 LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL 174 (290)
T ss_dssp CTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTC
T ss_pred hhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCC
Confidence 33444444444444444444444444445555555555555554444445555555555555555554444445555555
Q ss_pred ceeeccCcccccCCcccccccccCceEEcccccCc
Q 001873 490 NFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLT 524 (1001)
Q Consensus 490 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 524 (1001)
++|+|++|+|+ .+|..+..+.+|+.|+|++|.+.
T Consensus 175 ~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 175 DTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 55555555555 44555555555666666666554
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=8e-23 Score=222.81 Aligned_cols=203 Identities=24% Similarity=0.243 Sum_probs=136.5
Q ss_pred cCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccC
Q 001873 291 IGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALT 370 (1001)
Q Consensus 291 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 370 (1001)
+.++++++.+++++|+++ .+|..+. ++++.|+|++|.+++..|..|.++++|++|+|++|++++..+. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 556677777777777777 4555443 4677777777777766666777777777777777777643332 5666777
Q ss_pred EEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCc
Q 001873 371 HLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSND 450 (1001)
Q Consensus 371 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 450 (1001)
+|++++|+++ .+|..+..+++|+.|++++|++++..|..|..+++|++|++++|++++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 7777777766 456666666677777777777766666666667777777777777766555556666677777777777
Q ss_pred CCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccc
Q 001873 451 LSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLV 500 (1001)
Q Consensus 451 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 500 (1001)
+++..+..|..+++|++|+|++|+++ .+|..+..+.+|+.++|++|++.
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 76655555666677777777777776 55666666666777777777664
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.1e-23 Score=221.49 Aligned_cols=191 Identities=26% Similarity=0.264 Sum_probs=116.2
Q ss_pred CCCccceEEeCCCCcEEEEEeccccccccCCcccccCCCCcEEeccCCcccCCCCcccCCccccccccccCCccCCCCCh
Q 001873 65 SPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPT 144 (1001)
Q Consensus 65 ~~c~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~ 144 (1001)
+||.|.|++|... .+++++++++++ .+|..+. +.+++|+|++|++++..|.
T Consensus 3 ~Cp~~~gC~C~~~--------------------------~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~ 53 (251)
T 3m19_A 3 TCETVTGCTCNEG--------------------------KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDA 53 (251)
T ss_dssp -CHHHHSSEEEGG--------------------------GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTT
T ss_pred cCCCCCceEcCCC--------------------------CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHh
Confidence 5889999999521 223455566666 5666554 4677888888888777777
Q ss_pred hhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCcc
Q 001873 145 EVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSN 224 (1001)
Q Consensus 145 ~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~ 224 (1001)
.|..+++|++|+|++|++++..|..++++++|++|+|++|.+++..|..++
T Consensus 54 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~----------------------------- 104 (251)
T 3m19_A 54 TFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFD----------------------------- 104 (251)
T ss_dssp TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTT-----------------------------
T ss_pred HhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhc-----------------------------
Confidence 777788888888888888766666677777777777777776633222222
Q ss_pred chhccccccccccccCCccccccccceeccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCC
Q 001873 225 LVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQ 304 (1001)
Q Consensus 225 L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~ 304 (1001)
.+++|++|+|++|++++..+..|..+++|++|+|++
T Consensus 105 --------------------------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 140 (251)
T 3m19_A 105 --------------------------------------------HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNT 140 (251)
T ss_dssp --------------------------------------------TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred --------------------------------------------ccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcC
Confidence 334444444444554444444445555555555555
Q ss_pred CcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccC
Q 001873 305 NSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSG 357 (1001)
Q Consensus 305 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 357 (1001)
|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+..
T Consensus 141 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 141 NQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred CcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 55554444445555555555555555554444455555555555555555553
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-24 Score=246.29 Aligned_cols=252 Identities=18% Similarity=0.139 Sum_probs=182.9
Q ss_pred ccccccccccCcccccCCCCCceEeeecCcccCCCC----cccCCCC-CCcEEEcCCCcccccCCCCccCC-----CCCC
Q 001873 253 AIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIP----GRIGALS-KLKSLLLWQNSLVGAIPDELGSC-----TELT 322 (1001)
Q Consensus 253 ~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l-----~~L~ 322 (1001)
.++.|.++|.+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|++++..+..+..+ ++|+
T Consensus 4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~ 83 (362)
T 3goz_A 4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83 (362)
T ss_dssp ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCcc
Confidence 455677777888777777778888888888887666 6777787 88888888888887767666664 8888
Q ss_pred EEeccCCCCCCCCCcccccc-----cCccEEEcccccccCcCChhhcc-----ccccCEEeccCCcccCccC----cccc
Q 001873 323 VVDFSDNLLTGSIPRSFGNL-----LKLQELQLSVNQLSGTIPIEIAT-----CTALTHLEIDNNAISGEIP----ADIG 388 (1001)
Q Consensus 323 ~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~i~~~~~----~~~~ 388 (1001)
+|+|++|.+++..+..+... ++|++|+|++|++++..+..+.. .++|++|+|++|++++..+ ..+.
T Consensus 84 ~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~ 163 (362)
T 3goz_A 84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILA 163 (362)
T ss_dssp EEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred EEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHh
Confidence 88888888887666644443 78888888888888666655443 3688888888888875433 3334
Q ss_pred ccC-cccEEEeecCccCCCCCcccc----cC-cccceEeCcCccccCC----CCccccc-ccccceEEccCCcCCCCCC-
Q 001873 389 NIN-GLTLFFAWKNKLTGNIPESLS----QC-QELQALDFSYNNLSGP----IPKEIFG-LRNLTKLLLLSNDLSGFIP- 456 (1001)
Q Consensus 389 ~l~-~L~~L~l~~n~l~~~~p~~l~----~l-~~L~~L~Ls~N~l~~~----~~~~~~~-l~~L~~L~L~~N~l~~~~p- 456 (1001)
..+ +|+.|++++|++++..+..+. .+ ++|++|+|++|.|++. ++..+.. .++|++|+|++|++++..+
T Consensus 164 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~ 243 (362)
T 3goz_A 164 AIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLE 243 (362)
T ss_dssp TSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHH
T ss_pred cCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHH
Confidence 444 788888888888777665443 34 5888888888888753 3444554 3478888888888876543
Q ss_pred ---CCCCCCCCcceEEccccccccCC-------CcccCCCCCcceeeccCcccccCCc
Q 001873 457 ---PDIGNCTTLRRLRLNDNRLSGTI-------PSEMGNLKHLNFVDMSENHLVGGIP 504 (1001)
Q Consensus 457 ---~~l~~l~~L~~L~Ls~N~l~~~~-------p~~~~~l~~L~~L~Ls~N~l~~~~p 504 (1001)
..+..+++|+.|+|++|.+.+.. +..+.++++|++||+++|++.+..+
T Consensus 244 ~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 244 NLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred HHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 34566788888888888855332 3356777888888888888876544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.3e-25 Score=248.74 Aligned_cols=252 Identities=20% Similarity=0.150 Sum_probs=173.5
Q ss_pred eEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCC----CCccCCC-CCCEEeccCCCCCCCCCcccccc-----cC
Q 001873 275 NLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIP----DELGSCT-ELTVVDFSDNLLTGSIPRSFGNL-----LK 344 (1001)
Q Consensus 275 ~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p----~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~ 344 (1001)
.++++.|.+++.+|..+...++|++|+|++|++++..+ ..+..++ +|++|+|++|.+++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46788899998888888877789999999999887666 6677788 89999999999987777777775 88
Q ss_pred ccEEEcccccccCcCChhhccc-----cccCEEeccCCcccCccCccccc-----cCcccEEEeecCccCCCCCcc----
Q 001873 345 LQELQLSVNQLSGTIPIEIATC-----TALTHLEIDNNAISGEIPADIGN-----INGLTLFFAWKNKLTGNIPES---- 410 (1001)
Q Consensus 345 L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~i~~~~~~~~~~-----l~~L~~L~l~~n~l~~~~p~~---- 410 (1001)
|++|+|++|++++..+..+... ++|++|++++|++++..+..+.. .++|+.|++++|++++..+..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999887766655443 78999999999887666554433 257778888887777544333
Q ss_pred cccCc-ccceEeCcCccccCCCCcccccc-----cccceEEccCCcCCCC----CCCCCCC-CCCcceEEccccccccCC
Q 001873 411 LSQCQ-ELQALDFSYNNLSGPIPKEIFGL-----RNLTKLLLLSNDLSGF----IPPDIGN-CTTLRRLRLNDNRLSGTI 479 (1001)
Q Consensus 411 l~~l~-~L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~----~p~~l~~-l~~L~~L~Ls~N~l~~~~ 479 (1001)
+..++ +|++|+|++|++++..+..+... ++|++|+|++|++++. ++..+.. .++|++|+|++|++++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 33444 77777777777776655544433 4777777777777652 2223333 346777777777776543
Q ss_pred C----cccCCCCCcceeeccCcccccCC-------cccccccccCceEEcccccCccc
Q 001873 480 P----SEMGNLKHLNFVDMSENHLVGGI-------PPSVVGCQSLEFLDLHSNGLTGS 526 (1001)
Q Consensus 480 p----~~~~~l~~L~~L~Ls~N~l~~~~-------p~~~~~l~~L~~L~Ls~N~l~~~ 526 (1001)
+ ..+..+++|+.|++++|.+.+.. +..+..+++|+.||+++|++...
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 3 33455666777777777644322 23455566666666666666544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-25 Score=251.57 Aligned_cols=269 Identities=15% Similarity=0.178 Sum_probs=183.6
Q ss_pred CCCCccceEEeCCCCcEEEEEeccccccccCCcccccC--CCCcEEeccCCcccCCCCcccCCccccccccccCCccCCC
Q 001873 64 TSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPL--KSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGE 141 (1001)
Q Consensus 64 ~~~c~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~l--~~L~~L~l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~ 141 (1001)
.-|..|.++.|+ ...+..+++++..+. |..+..+ +.++.|++++|.+++..++ +..+++|++|+|++|.+++.
T Consensus 34 ~vc~~W~~~~~~-~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~ 108 (336)
T 2ast_B 34 GVCKRWYRLASD-ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS 108 (336)
T ss_dssp SSCHHHHHHHTC-STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH
T ss_pred HHHHHHHHHhcC-chhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHH
Confidence 345589888876 334556666665554 3345555 6778888888888766554 55678888888888877755
Q ss_pred -CChhhhcccccceEEccCCcccCCCCccccCCccccceecccc-ccccc-cCCCccchhhhhhhhhccCcCCCCCCCcc
Q 001873 142 -IPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDN-QLSGK-IPKSIGALSKLQVFRAGGNQNLKGELPWE 218 (1001)
Q Consensus 142 -~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n-~l~g~-~p~~~~~l~~L~~L~l~~n~~l~~~lp~~ 218 (1001)
+|..+..+++|++|+|++|.+++..|..++++++|++|+|++| .+++. +|..++.+++|++|++++|.
T Consensus 109 ~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~--------- 179 (336)
T 2ast_B 109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF--------- 179 (336)
T ss_dssp HHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCT---------
T ss_pred HHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCC---------
Confidence 7777778888888888888877777777777888888888877 56642 55555666666666666553
Q ss_pred cccCccchhccccccccccc-cCCcccccc-ccceeccccc--ccc-ccCcccccCCCCCceEeeecCc-ccCCCCcccC
Q 001873 219 IGNCSNLVMLGLAETSISGN-VPSSIGMLE-RIQTIAIYTS--LLS-GPIPEEIGNCSELQNLYLYQNS-ISGPIPGRIG 292 (1001)
Q Consensus 219 l~~l~~L~~L~l~~~~l~~~-~p~~i~~l~-~L~~L~l~~n--~l~-g~ip~~l~~l~~L~~L~L~~N~-i~~~~p~~~~ 292 (1001)
.+++. ++..+..++ +|++|++++| .++ +.+|..+.++++|++|++++|. +++..+..+.
T Consensus 180 ---------------~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~ 244 (336)
T 2ast_B 180 ---------------DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFF 244 (336)
T ss_dssp ---------------TCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGG
T ss_pred ---------------CcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHh
Confidence 33322 333344455 5555555555 333 4567777788888888988888 7777777888
Q ss_pred CCCCCcEEEcCCCc-ccccCCCCccCCCCCCEEeccCCCCCCCCCccccccc-CccEEEcccccccCcCChhhcc
Q 001873 293 ALSKLKSLLLWQNS-LVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLL-KLQELQLSVNQLSGTIPIEIAT 365 (1001)
Q Consensus 293 ~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~ 365 (1001)
.+++|++|++++|. +.......++++++|+.|++++| ++ ...+..+. +++.|++++|++++..|..+..
T Consensus 245 ~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 245 QLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp GCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred CCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCcccc
Confidence 88889999998885 32222225778889999999988 33 22344443 4777788999998888876654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.6e-23 Score=229.55 Aligned_cols=228 Identities=20% Similarity=0.209 Sum_probs=161.5
Q ss_pred ccceEeCcCccccCCCCc---ccccccccceEEccCCcCCCCCCCCC--CCCCCcceEEccccccccCCC----cccCCC
Q 001873 416 ELQALDFSYNNLSGPIPK---EIFGLRNLTKLLLLSNDLSGFIPPDI--GNCTTLRRLRLNDNRLSGTIP----SEMGNL 486 (1001)
Q Consensus 416 ~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~p~~l--~~l~~L~~L~Ls~N~l~~~~p----~~~~~l 486 (1001)
.++.+.+.++.++...-. .+..+++|++|++++|++++..|..+ ..+++|++|+|++|++++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 355666666655421111 12245668888888888888888887 888889999999999887555 445678
Q ss_pred CCcceeeccCcccccCCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccC
Q 001873 487 KHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSK 566 (1001)
Q Consensus 487 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 566 (1001)
++|++|+|++|++++..|..+..+++|++|||++|++.+.... ..+..+..+++|++|+|++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~------------------~~~~~~~~l~~L~~L~Ls~ 206 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGL------------------MAALCPHKFPAIQNLALRN 206 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHH------------------HTTSCTTSSCCCCSCBCCS
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhh------------------hHHHhhhcCCCCCEEECCC
Confidence 8899999999999888888888889999999998887642000 0011234566777777777
Q ss_pred ccccccchh----hhhccccccEEecccccccCCCCCccccc---cchhhhhhcCCCcccccccccccccccccEEEecC
Q 001873 567 NQLSGRIPA----EILSCRKLILLDIGNNRFSGEIPKELGQI---SSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSH 639 (1001)
Q Consensus 567 N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 639 (1001)
|+++. ++. .+..+++|++|||++|++++..|..+..+ ++|+. |+|++|+|+ .+|..+. ++|++|||++
T Consensus 207 N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~-L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~ 281 (310)
T 4glp_A 207 TGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNS-LNLSFAGLE-QVPKGLP--AKLRVLDLSS 281 (310)
T ss_dssp SCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCC-EECCSSCCC-SCCSCCC--SCCSCEECCS
T ss_pred CCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCE-EECCCCCCC-chhhhhc--CCCCEEECCC
Confidence 77762 222 24566778888888888877767776666 57775 888888887 4565553 6888888888
Q ss_pred CcCCCChhhhhcccccceeEcccCCCCC
Q 001873 640 NKLSGDLDALASLQNLVSLNVSFNDFSG 667 (1001)
Q Consensus 640 N~l~~~~~~~~~l~~L~~L~ls~N~l~~ 667 (1001)
|++++.+. +..+++|+.|++++|+++.
T Consensus 282 N~l~~~~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 282 NRLNRAPQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCCCSCCC-TTSCCCCSCEECSSTTTSC
T ss_pred CcCCCCch-hhhCCCccEEECcCCCCCC
Confidence 88887533 6777888888888888764
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=214.71 Aligned_cols=131 Identities=16% Similarity=0.167 Sum_probs=63.3
Q ss_pred CCcEEEcCCCcccccCCCCccCCCCCCEEeccCCC-CCCCCCcccccccCccEEEccc-ccccCcCChhhccccccCEEe
Q 001873 296 KLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNL-LTGSIPRSFGNLLKLQELQLSV-NQLSGTIPIEIATCTALTHLE 373 (1001)
Q Consensus 296 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ 373 (1001)
+|++|++++|++++..+..|..+++|++|++++|. +++..+..|.++++|++|++++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 45555555555554444455555555555555554 4433334455555555555555 555544444455555555555
Q ss_pred ccCCcccCccCccccccCccc---EEEeecC-ccCCCCCcccccCcccc-eEeCcCcccc
Q 001873 374 IDNNAISGEIPADIGNINGLT---LFFAWKN-KLTGNIPESLSQCQELQ-ALDFSYNNLS 428 (1001)
Q Consensus 374 L~~N~i~~~~~~~~~~l~~L~---~L~l~~n-~l~~~~p~~l~~l~~L~-~L~Ls~N~l~ 428 (1001)
+++|++++ +|. +..+++|+ .|++++| ++++..+..|..+++|+ .|++++|+++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~ 169 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence 55555543 332 33333333 4444444 44433333444444444 4444444444
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.8e-22 Score=213.88 Aligned_cols=203 Identities=20% Similarity=0.279 Sum_probs=153.3
Q ss_pred cCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEccccc-ccCcCChhhccccccCEEeccC-CcccCccCccc
Q 001873 310 AIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQ-LSGTIPIEIATCTALTHLEIDN-NAISGEIPADI 387 (1001)
Q Consensus 310 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~-N~i~~~~~~~~ 387 (1001)
.+|. +. ++|++|++++|++++..+..|.++++|++|++++|+ ++...+..|.++++|++|++++ |++++..+..|
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 4555 33 378999999999997777788899999999999996 8866667888899999999998 88887667778
Q ss_pred cccCcccEEEeecCccCCCCCcccccCcccc---eEeCcCc-cccCCCCcccccccccc-eEEccCCcCCCCCCCCCCCC
Q 001873 388 GNINGLTLFFAWKNKLTGNIPESLSQCQELQ---ALDFSYN-NLSGPIPKEIFGLRNLT-KLLLLSNDLSGFIPPDIGNC 462 (1001)
Q Consensus 388 ~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~---~L~Ls~N-~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~l~~l 462 (1001)
.++++|+.|++++|++++ +|. |..+++|+ +|++++| ++++..+..|.++++|+ +|++++|+++.+.+..+..
T Consensus 102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~- 178 (239)
T 2xwt_C 102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG- 178 (239)
T ss_dssp ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-
T ss_pred CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-
Confidence 888888888888888886 555 77777777 8888888 77766666677777788 8888888777444444444
Q ss_pred CCcceEEccccc-cccCCCcccCCC-CCcceeeccCcccccCCcccccccccCceEEcccc
Q 001873 463 TTLRRLRLNDNR-LSGTIPSEMGNL-KHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSN 521 (1001)
Q Consensus 463 ~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 521 (1001)
++|++|+|++|+ +++..+..|.++ ++|+.|++++|++++. |.. .+++|+.|+++++
T Consensus 179 ~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 179 TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT 236 (239)
T ss_dssp CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence 677777777774 776666677777 7777777777777743 332 4566777777665
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-24 Score=247.69 Aligned_cols=243 Identities=19% Similarity=0.222 Sum_probs=121.4
Q ss_pred cCcccccCCCCCceEeeecCcccCCCC----cccCCCCCCcEEEcCCC---cccccCCCCc-------cCCCCCCEEecc
Q 001873 262 PIPEEIGNCSELQNLYLYQNSISGPIP----GRIGALSKLKSLLLWQN---SLVGAIPDEL-------GSCTELTVVDFS 327 (1001)
Q Consensus 262 ~ip~~l~~l~~L~~L~L~~N~i~~~~p----~~~~~l~~L~~L~L~~N---~l~~~~p~~l-------~~l~~L~~L~Ls 327 (1001)
.++..+..+++|++|+|++|.+++..+ ..+..+++|++|+|++| ++++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 455566666677777777776665422 33556666666666664 3334444433 455555555555
Q ss_pred CCCCCC----CCCcccccccCccEEEcccccccCcCChhhcc----c---------cccCEEeccCCccc-CccCccccc
Q 001873 328 DNLLTG----SIPRSFGNLLKLQELQLSVNQLSGTIPIEIAT----C---------TALTHLEIDNNAIS-GEIPADIGN 389 (1001)
Q Consensus 328 ~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~----l---------~~L~~L~L~~N~i~-~~~~~~~~~ 389 (1001)
+|.+++ .+|..+..+++|++|+|++|+++...+..+.. + ++|++|++++|+++ +.++.
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~---- 178 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE---- 178 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHH----
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHH----
Confidence 555554 23444555555555555555554322222222 2 44444444444443 11110
Q ss_pred cCcccEEEeecCccCCCCCcccccCcccceEeCcCccccC-----CCCcccccccccceEEccCCcCC----CCCCCCCC
Q 001873 390 INGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSG-----PIPKEIFGLRNLTKLLLLSNDLS----GFIPPDIG 460 (1001)
Q Consensus 390 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~----~~~p~~l~ 460 (1001)
+...+..+++|++|++++|+++. ..+..+..+++|++|+|++|.++ ..+|..+.
T Consensus 179 -----------------l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~ 241 (386)
T 2ca6_A 179 -----------------WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 241 (386)
T ss_dssp -----------------HHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGG
T ss_pred -----------------HHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHc
Confidence 00233344455555555555541 12224444555555555555553 23344445
Q ss_pred CCCCcceEEccccccccC----CCccc--CCCCCcceeeccCccccc----CCcccc-cccccCceEEcccccCcc
Q 001873 461 NCTTLRRLRLNDNRLSGT----IPSEM--GNLKHLNFVDMSENHLVG----GIPPSV-VGCQSLEFLDLHSNGLTG 525 (1001)
Q Consensus 461 ~l~~L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~ 525 (1001)
.+++|++|+|++|++++. ++..+ +.+++|+.|+|++|++++ .+|..+ .++++|++|++++|++++
T Consensus 242 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 242 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp GCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred cCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 555555555555555533 33444 235566666666666654 245444 345666666666666553
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=8.5e-23 Score=225.42 Aligned_cols=154 Identities=25% Similarity=0.311 Sum_probs=78.2
Q ss_pred cCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCC---C-CCCCCCCCCcceEEccccccccCCCc----ccC
Q 001873 413 QCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGF---I-PPDIGNCTTLRRLRLNDNRLSGTIPS----EMG 484 (1001)
Q Consensus 413 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~-p~~l~~l~~L~~L~Ls~N~l~~~~p~----~~~ 484 (1001)
.+++|++|++++|++++..+..+..+++|++|+|++|++.+. . +..+..+++|++|+|++|+++ .++. .++
T Consensus 143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~ 221 (310)
T 4glp_A 143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAA 221 (310)
T ss_dssp BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHH
T ss_pred hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHh
Confidence 344455555555555444444444455555555555544321 1 122345556666666666665 2222 235
Q ss_pred CCCCcceeeccCcccccCCccccccc---ccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccce
Q 001873 485 NLKHLNFVDMSENHLVGGIPPSVVGC---QSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSK 561 (1001)
Q Consensus 485 ~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~ 561 (1001)
++++|++|+|++|++++..|..+..+ ++|++|++++|+|+ .+|..+++.++.|+|++|+|++. |. +..+++|+.
T Consensus 222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 298 (310)
T 4glp_A 222 AGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLNRA-PQ-PDELPEVDN 298 (310)
T ss_dssp HTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred cCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence 55666666666666666555555554 46666666666666 44544444444455555555432 11 334444445
Q ss_pred eeccCcccc
Q 001873 562 LLLSKNQLS 570 (1001)
Q Consensus 562 L~Ls~N~l~ 570 (1001)
|+|++|+|+
T Consensus 299 L~L~~N~l~ 307 (310)
T 4glp_A 299 LTLDGNPFL 307 (310)
T ss_dssp EECSSTTTS
T ss_pred EECcCCCCC
Confidence 555555443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=6.3e-25 Score=250.63 Aligned_cols=246 Identities=19% Similarity=0.253 Sum_probs=132.5
Q ss_pred CCCcccCCccccccccccCCccCCCCCh----hhhcccccceEEccCC---cccCCCCccc-------cCCccccceecc
Q 001873 117 TIPKEFGDYRELTFIDLSGNSLWGEIPT----EVCRLRKLESLYLNTN---LLEGEIPSDI-------GNLSSLAYLTLY 182 (1001)
Q Consensus 117 ~~p~~~~~l~~L~~L~Ls~n~l~g~~p~----~~~~l~~L~~L~L~~n---~l~~~ip~~l-------~~L~~L~~L~L~ 182 (1001)
.++..+..+++|++|+|++|++.+..+. .+..+++|++|+|++| ++++.+|..+ .++++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 4566666777777777777777655333 3556777777777774 4455566554 566777777777
Q ss_pred cccccc----ccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceecccccc
Q 001873 183 DNQLSG----KIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSL 258 (1001)
Q Consensus 183 ~n~l~g----~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~ 258 (1001)
+|.+++ .+|..+..+++|++|++++| .+.+..+..++
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n-------------------------~l~~~~~~~l~-------------- 143 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNN-------------------------GLGPQAGAKIA-------------- 143 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSS-------------------------CCHHHHHHHHH--------------
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCC-------------------------CCCHHHHHHHH--------------
Confidence 777665 34545555555555555555 22211111111
Q ss_pred ccccCcccccCC---------CCCceEeeecCccc-CCCC---cccCCCCCCcEEEcCCCccc--c---cCCCCccCCCC
Q 001873 259 LSGPIPEEIGNC---------SELQNLYLYQNSIS-GPIP---GRIGALSKLKSLLLWQNSLV--G---AIPDELGSCTE 320 (1001)
Q Consensus 259 l~g~ip~~l~~l---------~~L~~L~L~~N~i~-~~~p---~~~~~l~~L~~L~L~~N~l~--~---~~p~~l~~l~~ 320 (1001)
..+..+ ++|++|+|++|+++ +.++ ..+..+++|++|+|++|+++ | ..|..+..+++
T Consensus 144 ------~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~ 217 (386)
T 2ca6_A 144 ------RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQE 217 (386)
T ss_dssp ------HHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTT
T ss_pred ------HHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCC
Confidence 111111 45555555555554 2222 23444555555555555554 1 23334555555
Q ss_pred CCEEeccCCCCC----CCCCcccccccCccEEEcccccccCc----CChhhcc--ccccCEEeccCCcccC----ccCcc
Q 001873 321 LTVVDFSDNLLT----GSIPRSFGNLLKLQELQLSVNQLSGT----IPIEIAT--CTALTHLEIDNNAISG----EIPAD 386 (1001)
Q Consensus 321 L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~--l~~L~~L~L~~N~i~~----~~~~~ 386 (1001)
|+.|+|++|.++ +.+|..+..+++|++|+|++|++++. ++..+.. +++|++|+|++|.+++ .+|..
T Consensus 218 L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~ 297 (386)
T 2ca6_A 218 LKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 297 (386)
T ss_dssp CCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHH
T ss_pred ccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHH
Confidence 555555555553 34455555555566666666655543 3333322 5566666666666654 24444
Q ss_pred c-cccCcccEEEeecCccCCCC
Q 001873 387 I-GNINGLTLFFAWKNKLTGNI 407 (1001)
Q Consensus 387 ~-~~l~~L~~L~l~~n~l~~~~ 407 (1001)
+ .++++|+.|++++|.+++..
T Consensus 298 l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 298 IDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHCTTCCEEECTTSBSCTTS
T ss_pred HHhcCCCceEEEccCCcCCcch
Confidence 4 44566666666666666544
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-21 Score=220.40 Aligned_cols=241 Identities=18% Similarity=0.124 Sum_probs=143.6
Q ss_pred ceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCC-cccccccCccE-EEcc
Q 001873 274 QNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIP-RSFGNLLKLQE-LQLS 351 (1001)
Q Consensus 274 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~-L~Ls 351 (1001)
++++.++++++ .+|..+ .+++++|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.+++++++ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 34555555555 344433 2355566666666654444455666666666666666544333 34555555443 4445
Q ss_pred cccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeec-CccCCCCCcccccCc-ccceEeCcCccccC
Q 001873 352 VNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWK-NKLTGNIPESLSQCQ-ELQALDFSYNNLSG 429 (1001)
Q Consensus 352 ~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~-n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~ 429 (1001)
.|+++...|..|..+++|++|++++|+|++..+..+....++..+++.+ +++....+..|..+. .++.|++++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 5666655555566666666666666666555444555555556666644 345544444555554 57778888888874
Q ss_pred CCCcccccccccceEEccC-CcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCccccc
Q 001873 430 PIPKEIFGLRNLTKLLLLS-NDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVV 508 (1001)
Q Consensus 430 ~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 508 (1001)
++...+...+|++|++.+ |.++.+.+..|..+++|++|+|++|+|+...+..|.++++|+.+++ +.++ .+| .+.
T Consensus 169 -i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~ 243 (350)
T 4ay9_X 169 -IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLE 243 (350)
T ss_dssp -ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTT
T ss_pred -CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-Cch
Confidence 444444556788888864 6666555567788888888888888888555555655555554443 2333 455 367
Q ss_pred ccccCceEEccccc
Q 001873 509 GCQSLEFLDLHSNG 522 (1001)
Q Consensus 509 ~l~~L~~L~Ls~N~ 522 (1001)
++++|+.++++++.
T Consensus 244 ~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 244 KLVALMEASLTYPS 257 (350)
T ss_dssp TCCSCCEEECSCHH
T ss_pred hCcChhhCcCCCCc
Confidence 78888888887653
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-23 Score=234.19 Aligned_cols=250 Identities=17% Similarity=0.151 Sum_probs=133.1
Q ss_pred CceEeeecCcccCCCCcccCCC--CCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCC-CCcccccccCccEEE
Q 001873 273 LQNLYLYQNSISGPIPGRIGAL--SKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGS-IPRSFGNLLKLQELQ 349 (1001)
Q Consensus 273 L~~L~L~~N~i~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~ 349 (1001)
++.+++++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|++++|.+++. +|..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 555666666554 3444444 5666666666666654443 34556666666666666543 555556666666666
Q ss_pred cccccccCcCChhhccccccCEEeccCC-cccCc-cCccccccCcccEEEeecC-ccCCC-CCcccccCc-ccceEeCcC
Q 001873 350 LSVNQLSGTIPIEIATCTALTHLEIDNN-AISGE-IPADIGNINGLTLFFAWKN-KLTGN-IPESLSQCQ-ELQALDFSY 424 (1001)
Q Consensus 350 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~i~~~-~~~~~~~l~~L~~L~l~~n-~l~~~-~p~~l~~l~-~L~~L~Ls~ 424 (1001)
|++|++++..+..+..+++|++|++++| .+++. ++..+.++++|+.|++++| .+++. ++..+..++ +|++|++++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 6666665555556666666666666666 45432 3444455555555555555 55432 344455566 666666666
Q ss_pred c--ccc-CCCCcccccccccceEEccCCc-CCCCCCCCCCCCCCcceEEccccc-cccCCCcccCCCCCcceeeccCccc
Q 001873 425 N--NLS-GPIPKEIFGLRNLTKLLLLSND-LSGFIPPDIGNCTTLRRLRLNDNR-LSGTIPSEMGNLKHLNFVDMSENHL 499 (1001)
Q Consensus 425 N--~l~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l 499 (1001)
| .++ +.++..+..+++|++|++++|. +++..+..+..+++|++|++++|. +.......+.++++|+.|++++| +
T Consensus 205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i 283 (336)
T 2ast_B 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-V 283 (336)
T ss_dssp CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-S
T ss_pred CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-c
Confidence 6 333 2344445555666666666665 444444455555666666666653 22111123455555666666555 2
Q ss_pred ccCCccccccc-ccCceEEcccccCcccCCCC
Q 001873 500 VGGIPPSVVGC-QSLEFLDLHSNGLTGSVPDT 530 (1001)
Q Consensus 500 ~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~ 530 (1001)
+. ..+..+ .+++.|++++|++++..|..
T Consensus 284 ~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~ 312 (336)
T 2ast_B 284 PD---GTLQLLKEALPHLQINCSHFTTIARPT 312 (336)
T ss_dssp CT---TCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred CH---HHHHHHHhhCcceEEecccCccccCCc
Confidence 21 122222 22444455555555544443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-22 Score=219.12 Aligned_cols=154 Identities=16% Similarity=0.127 Sum_probs=122.6
Q ss_pred cccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC--------------------chhhHHHHHHHhhccCCCceeeEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD--------------------ESGAFSSEIQTLGSIRHKNIVRLL 826 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------------------~~~~~~~Ei~~l~~l~h~nIv~l~ 826 (1001)
.|++.+.||+|+||.||+|++.+|+.||||.+.... ....+.+|+.++++++| +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence 355668999999999999999779999999985322 13458899999999984 5555
Q ss_pred eeeecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEE
Q 001873 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYL 906 (1001)
Q Consensus 827 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki 906 (1001)
+++.. +..++||||++||+|.+ +.. .....++.|++.|++|||+. +|+||||||+||+++ ++++||
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEE
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEE
Confidence 54443 45699999999999998 432 12346899999999999998 999999999999999 999999
Q ss_pred ecccccccccCCCCCCCCCCCCCCcccccccccCcccccc----------CCCCCccchHH
Q 001873 907 ADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM----------QRITEKSDVYS 957 (1001)
Q Consensus 907 ~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dv~S 957 (1001)
+|||+|+. +..|+|||.+.. +.|+..+|+|.
T Consensus 234 ~DFG~a~~--------------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 234 IDFPQSVE--------------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CCCTTCEE--------------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EECCCCeE--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99999864 345789998753 45566667765
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.7e-22 Score=238.44 Aligned_cols=100 Identities=25% Similarity=0.422 Sum_probs=70.4
Q ss_pred ccCCCCCCCCCCC-----ccceE-EeCCCCcEEEEEeccccccccCCcccccCCCCcEEeccCCcccCCCCcccCCcccc
Q 001873 55 ALSSWNPAETSPC-----KWFGI-HCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYREL 128 (1001)
Q Consensus 55 ~l~sW~~~~~~~c-----~w~gv-~c~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~~~l~g~~p~~~~~l~~L 128 (1001)
.+.+|.. +.++| .|.|+ .|.. ++++.|+|++|++++ +|+.+. ++|
T Consensus 32 ~l~~W~~-~~~~~~~~~~~~~~l~~C~~-------------------------~~L~~L~Ls~n~L~~-lp~~l~--~~L 82 (571)
T 3cvr_A 32 AWDKWEK-QALPGENRNEAVSLLKECLI-------------------------NQFSELQLNRLNLSS-LPDNLP--PQI 82 (571)
T ss_dssp HHHHHHT-TCCTTCCHHHHHHHHHHHHH-------------------------TTCSEEECCSSCCSC-CCSCCC--TTC
T ss_pred HHHHHhc-cCCccccccchhhhcccccc-------------------------CCccEEEeCCCCCCc-cCHhHc--CCC
Confidence 3567764 56778 79999 7852 145567777788775 777663 678
Q ss_pred ccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccCC
Q 001873 129 TFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPK 192 (1001)
Q Consensus 129 ~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~ 192 (1001)
++|+|++|+++ .+| ..+++|++|+|++|+|++ +|. +++ +|++|+|++|.+++ +|.
T Consensus 83 ~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~ 137 (571)
T 3cvr_A 83 TVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE 137 (571)
T ss_dssp SEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC
T ss_pred CEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC
Confidence 88888888887 677 456788888888888875 776 655 77777777777764 443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=1.6e-21 Score=214.64 Aligned_cols=195 Identities=23% Similarity=0.348 Sum_probs=113.7
Q ss_pred ccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCcc
Q 001873 267 IGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQ 346 (1001)
Q Consensus 267 l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 346 (1001)
+.++++|++|++++|.++. +| .+..+++|++|+|++|++++..+ +..+++|++|++++|.+++. + .+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCC
Confidence 3456667777777777664 33 46667777777777777664333 66667777777777776642 2 466666666
Q ss_pred EEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCcc
Q 001873 347 ELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNN 426 (1001)
Q Consensus 347 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 426 (1001)
+|+|++|++++. + .+..+++|++|++++|++++..+ +..+++|+.|++++|+
T Consensus 111 ~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--------------------------l~~l~~L~~L~l~~n~ 162 (308)
T 1h6u_A 111 TLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--------------------------LAGLTNLQYLSIGNAQ 162 (308)
T ss_dssp EEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--------------------------GGGCTTCCEEECCSSC
T ss_pred EEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--------------------------ccCCCCccEEEccCCc
Confidence 666666666643 2 25666666666666666653222 3444445555555555
Q ss_pred ccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCccccc
Q 001873 427 LSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVG 501 (1001)
Q Consensus 427 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 501 (1001)
+++..+ +..+++|++|++++|++++..+ +..+++|++|+|++|++++.. .+..+++|+.|++++|++++
T Consensus 163 l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 163 VSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred CCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 543222 4455555555555555554322 555566666666666666433 25666666666666666653
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.86 E-value=7.9e-21 Score=202.75 Aligned_cols=103 Identities=22% Similarity=0.207 Sum_probs=45.7
Q ss_pred CceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEccc
Q 001873 273 LQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSV 352 (1001)
Q Consensus 273 L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 352 (1001)
.++++++++.++ .+|..+. ++++.|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 445555555554 3333332 3444555555555444444444444444444444444444444444444444444444
Q ss_pred ccccCcCChhhccccccCEEeccCCc
Q 001873 353 NQLSGTIPIEIATCTALTHLEIDNNA 378 (1001)
Q Consensus 353 N~l~~~~p~~~~~l~~L~~L~L~~N~ 378 (1001)
|++++..+..|..+++|++|+|++|+
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~ 118 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQ 118 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CcccccChhHhcccCCCCEEEcCCCc
Confidence 44443333333333333333333333
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=3.3e-21 Score=212.21 Aligned_cols=210 Identities=23% Similarity=0.374 Sum_probs=160.2
Q ss_pred ceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccc
Q 001873 274 QNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVN 353 (1001)
Q Consensus 274 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 353 (1001)
..+.+..+.+++.. .+..+++|++|++++|.++. +| .+..+++|++|++++|.+++..+ +..+++|++|+|++|
T Consensus 22 ~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n 95 (308)
T 1h6u_A 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN 95 (308)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred HHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCC
Confidence 33445555554332 24467788888888888773 44 57777788888888887774433 777777777777777
Q ss_pred cccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCc
Q 001873 354 QLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPK 433 (1001)
Q Consensus 354 ~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~ 433 (1001)
++++. + .+..+++|++|++++|+++ +. + .+..+++|++|++++|++++..+
T Consensus 96 ~l~~~-~-~~~~l~~L~~L~l~~n~l~------------------------~~-~-~l~~l~~L~~L~l~~n~l~~~~~- 146 (308)
T 1h6u_A 96 PLKNV-S-AIAGLQSIKTLDLTSTQIT------------------------DV-T-PLAGLSNLQVLYLDLNQITNISP- 146 (308)
T ss_dssp CCSCC-G-GGTTCTTCCEEECTTSCCC------------------------CC-G-GGTTCTTCCEEECCSSCCCCCGG-
T ss_pred cCCCc-h-hhcCCCCCCEEECCCCCCC------------------------Cc-h-hhcCCCCCCEEECCCCccCcCcc-
Confidence 77642 2 4566666666666666654 22 2 26778899999999999986544
Q ss_pred ccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccC
Q 001873 434 EIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSL 513 (1001)
Q Consensus 434 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 513 (1001)
+..+++|++|++++|++++..+ +..+++|+.|++++|++++..+ +..+++|++|++++|++++..+ +..+++|
T Consensus 147 -l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L 219 (308)
T 1h6u_A 147 -LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219 (308)
T ss_dssp -GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTC
T ss_pred -ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCC
Confidence 8899999999999999997544 8999999999999999996544 8999999999999999997653 8999999
Q ss_pred ceEEcccccCcc
Q 001873 514 EFLDLHSNGLTG 525 (1001)
Q Consensus 514 ~~L~Ls~N~l~~ 525 (1001)
+.|++++|++++
T Consensus 220 ~~L~l~~N~i~~ 231 (308)
T 1h6u_A 220 FIVTLTNQTITN 231 (308)
T ss_dssp CEEEEEEEEEEC
T ss_pred CEEEccCCeeec
Confidence 999999999984
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.2e-21 Score=213.66 Aligned_cols=198 Identities=18% Similarity=0.125 Sum_probs=108.3
Q ss_pred EEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccC-ccccccCcccE-EEeec
Q 001873 323 VVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIP-ADIGNINGLTL-FFAWK 400 (1001)
Q Consensus 323 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~-L~l~~ 400 (1001)
.++.++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+| ..|.+++++.. +.+..
T Consensus 13 ~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp EEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred EEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 3444444444 3333331 344444444444443333344445555555555555443333 23444544432 34444
Q ss_pred CccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccC-CcCCCCCCCCCCCCC-CcceEEccccccccC
Q 001873 401 NKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLS-NDLSGFIPPDIGNCT-TLRRLRLNDNRLSGT 478 (1001)
Q Consensus 401 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~ 478 (1001)
|+++...|..|..+++|++|++++|++++..+..+....++..|++.+ |++....+..|..+. .++.|+|++|+|+.
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~- 168 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE- 168 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-
T ss_pred CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC-
Confidence 555555555666666666666666666655555555555566666643 455555555555553 46777777777773
Q ss_pred CCcccCCCCCcceeeccC-cccccCCcccccccccCceEEcccccCc
Q 001873 479 IPSEMGNLKHLNFVDMSE-NHLVGGIPPSVVGCQSLEFLDLHSNGLT 524 (1001)
Q Consensus 479 ~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 524 (1001)
+|.......+|+.+++++ |.++...+..|.++++|++||+++|+|+
T Consensus 169 i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~ 215 (350)
T 4ay9_X 169 IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215 (350)
T ss_dssp ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC
T ss_pred CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC
Confidence 444444456677777764 5555444456677777777777777777
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.6e-20 Score=219.95 Aligned_cols=188 Identities=26% Similarity=0.394 Sum_probs=110.9
Q ss_pred ccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEcc
Q 001873 368 ALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLL 447 (1001)
Q Consensus 368 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 447 (1001)
+|+.|++++|++++ +|..+. ++|+.|++++|+++ .+| ..+++|++|++++|+|++ +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 55555555555554 343332 44555555555555 344 234666677777777665 444 443 67777777
Q ss_pred CCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCcccC
Q 001873 448 SNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSV 527 (1001)
Q Consensus 448 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 527 (1001)
+|++++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|+|++ +|. +. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 777765 344 46677777777777774 444 45677777777777775 555 44 67777777777777 45
Q ss_pred CCCccccc-------ccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccc
Q 001873 528 PDTLPTSL-------QLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCR 581 (1001)
Q Consensus 528 p~~~~~~l-------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 581 (1001)
|. ++..+ +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..++
T Consensus 196 p~-~~~~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 196 PA-VPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp CC-CC--------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred hh-HHHhhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 54 44444 55666666665 3444455566666666666666666666555543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=7.1e-20 Score=189.34 Aligned_cols=160 Identities=21% Similarity=0.205 Sum_probs=66.7
Q ss_pred CCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeec
Q 001873 321 LTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWK 400 (1001)
Q Consensus 321 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~ 400 (1001)
|++|++++|.+++..+..|..+++|++|++++|++++..+..|..+++|++|++++|++++..+..+..+++|+.|++++
T Consensus 30 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 109 (208)
T 2o6s_A 30 TTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNT 109 (208)
T ss_dssp CSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCC
Confidence 33334444333333333333334444444444444333333333344444444444444322222233333333333333
Q ss_pred CccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCC
Q 001873 401 NKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIP 480 (1001)
Q Consensus 401 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 480 (1001)
|++++..+..|..+++|++|++++|++++..+..+..+++|++|++++|.+.+ .+++|++|+++.|+++|.+|
T Consensus 110 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip 182 (208)
T 2o6s_A 110 NQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVR 182 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBB
T ss_pred CcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceee
Confidence 33333333334444555555555555544333334444445555555544432 23345555555555555555
Q ss_pred cccCCCC
Q 001873 481 SEMGNLK 487 (1001)
Q Consensus 481 ~~~~~l~ 487 (1001)
.+++.++
T Consensus 183 ~~~~~l~ 189 (208)
T 2o6s_A 183 NSAGSVA 189 (208)
T ss_dssp CTTSSBC
T ss_pred ccCcccc
Confidence 5544443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=1e-19 Score=188.20 Aligned_cols=179 Identities=20% Similarity=0.170 Sum_probs=105.2
Q ss_pred CEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecC
Q 001873 322 TVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKN 401 (1001)
Q Consensus 322 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n 401 (1001)
+.++.+++.++ .+|..+ .++|++|++++|++++..+..|..+++|++|++++|++++..+..+..+++|+.|++++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 46677777776 445443 357788888888887666666777777777777777777555555556666666666666
Q ss_pred ccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCc
Q 001873 402 KLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPS 481 (1001)
Q Consensus 402 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 481 (1001)
++++..+..|..+++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+++|++|++++|.+.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~---- 162 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC---- 162 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence 6665544455555566666666665554444445555555555555555554444445555555555555554432
Q ss_pred ccCCCCCcceeeccCcccccCCccccccc
Q 001873 482 EMGNLKHLNFVDMSENHLVGGIPPSVVGC 510 (1001)
Q Consensus 482 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 510 (1001)
.+++|++|+++.|+++|.+|..++.+
T Consensus 163 ---~~~~l~~L~~~~n~~~g~ip~~~~~l 188 (208)
T 2o6s_A 163 ---TCPGIRYLSEWINKHSGVVRNSAGSV 188 (208)
T ss_dssp ---CTTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred ---CCCCHHHHHHHHHhCCceeeccCccc
Confidence 23344555555555555555444433
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-21 Score=239.67 Aligned_cols=264 Identities=23% Similarity=0.248 Sum_probs=112.6
Q ss_pred cHHHHHHHHHHHHhC-CCCCCccCCCCCCCCCCCccceEEeCCCCcEEEEEeccccccccCCcccccCCCCcEEeccCCc
Q 001873 35 LDEQGQALLTWKNSL-NSSTDALSSWNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCN 113 (1001)
Q Consensus 35 ~~~~~~aLl~~k~~~-~~~~~~l~sW~~~~~~~c~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~~~ 113 (1001)
.+.++++|+++..+. .+....-..|....+.++.|.+++++ +++|+.++|...++... +. ..++.++|+.+.
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s-~~~~~~l~L~~n~~~~~-~~-----~~l~~l~Ls~~~ 202 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVS-TPLTPKIELFANGKDEA-NQ-----ALLQHKKLSQYS 202 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceec-CCccceEEeeCCCCCcc-hh-----hHhhcCccCccc
Confidence 356889999999887 23233445776545666899999997 47889988877777653 32 223344444444
Q ss_pred ccC---------CCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceecccc
Q 001873 114 LTG---------TIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDN 184 (1001)
Q Consensus 114 l~g---------~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n 184 (1001)
+++ ..|..+..++.|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|++|++|++|+|++|
T Consensus 203 i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N 280 (727)
T 4b8c_D 203 IDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHN 280 (727)
T ss_dssp -------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTS
T ss_pred ccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCC
Confidence 432 34666778888888888888877 77777778888888888888887 77887888888888888888
Q ss_pred ccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccc-cceeccccccccccC
Q 001873 185 QLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLER-IQTIAIYTSLLSGPI 263 (1001)
Q Consensus 185 ~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~-L~~L~l~~n~l~g~i 263 (1001)
.++ .+|..|+.|++|++|+|++| .++ .+|.+++++++|+.|+|++|.+.+..|..+..+.. +..+++.+|.++|.+
T Consensus 281 ~l~-~lp~~~~~l~~L~~L~L~~N-~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~ 357 (727)
T 4b8c_D 281 RLT-SLPAELGSCFQLKYFYFFDN-MVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPL 357 (727)
T ss_dssp CCS-SCCSSGGGGTTCSEEECCSS-CCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_pred cCC-ccChhhcCCCCCCEEECCCC-CCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcC
Confidence 887 77888888888888888777 443 66777777777777777776666655555544321 122444445555444
Q ss_pred cccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCC
Q 001873 264 PEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLT 332 (1001)
Q Consensus 264 p~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 332 (1001)
|.. |+.|+++.|... -. ..+.+.+..+..+..+..+....+++|.+.
T Consensus 358 p~~------l~~l~l~~n~~~---~~-------------~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 358 PHE------RRFIEINTDGEP---QR-------------EYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp CCC---------------------------------------------------------------CCC
T ss_pred ccc------cceeEeeccccc---cc-------------ccCCccccccchhhcccccceeeeeccccc
Confidence 432 223333333100 00 011333334444555666667777777765
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.7e-21 Score=231.34 Aligned_cols=216 Identities=20% Similarity=0.185 Sum_probs=127.1
Q ss_pred CCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccCCCccchhhhhh
Q 001873 123 GDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQV 202 (1001)
Q Consensus 123 ~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~~ 202 (1001)
+.+++|+.|+|++|+++ .+|++++.|++|++|++++|.....+|. .+..+...+.+|..++.+++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhccc
Confidence 44555556666666554 5555555555555555544432111110 01112244556666666666666
Q ss_pred hh-hccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCcccccCCCCCceEeeecC
Q 001873 203 FR-AGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQN 281 (1001)
Q Consensus 203 L~-l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N 281 (1001)
|+ ++.| .+++|..+.+++|.+. + +|. ..|+.|+|++|
T Consensus 414 L~~l~~n------------~~~~L~~l~l~~n~i~------------------------~-l~~-----~~L~~L~Ls~n 451 (567)
T 1dce_A 414 VDPMRAA------------YLDDLRSKFLLENSVL------------------------K-MEY-----ADVRVLHLAHK 451 (567)
T ss_dssp HCGGGHH------------HHHHHHHHHHHHHHHH------------------------H-HHH-----TTCSEEECTTS
T ss_pred Ccchhhc------------ccchhhhhhhhccccc------------------------c-cCc-----cCceEEEecCC
Confidence 66 4444 2234445555444433 1 111 13667777777
Q ss_pred cccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcC-C
Q 001873 282 SISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTI-P 360 (1001)
Q Consensus 282 ~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p 360 (1001)
+|++ +|. |+.+++|+.|+|++|+++ .+|..++.+++|+.|+|++|.|++ +| .|+++++|++|+|++|+|++.. |
T Consensus 452 ~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p 526 (567)
T 1dce_A 452 DLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAI 526 (567)
T ss_dssp CCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTT
T ss_pred CCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCc
Confidence 7765 454 777777777777777777 666777777777777777777774 45 6777777777777777777665 6
Q ss_pred hhhccccccCEEeccCCcccCccCcc---ccccCcccEEE
Q 001873 361 IEIATCTALTHLEIDNNAISGEIPAD---IGNINGLTLFF 397 (1001)
Q Consensus 361 ~~~~~l~~L~~L~L~~N~i~~~~~~~---~~~l~~L~~L~ 397 (1001)
..+..+++|+.|+|++|++++.+|.. +..+++|+.|+
T Consensus 527 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 527 QPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp GGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred HHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence 77777777777777777776554422 22356666664
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=2e-19 Score=187.41 Aligned_cols=165 Identities=18% Similarity=0.181 Sum_probs=117.4
Q ss_pred ceEEccccccccCCCcccCCCCCcceeeccCcccccCCc-ccccccccCceEEcccccCcccCCCCcccccccccCCCCc
Q 001873 466 RRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIP-PSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNR 544 (1001)
Q Consensus 466 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~ 544 (1001)
+.+++++|.++ .+|..+. ..+++|+|++|+|++..| ..|..+++|++|+|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~------------------- 71 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD------------------- 71 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCE-------------------
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCE-------------------
Confidence 35566666665 3444332 234566666666665533 345666666666666666553
Q ss_pred CCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccc
Q 001873 545 LSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPS 624 (1001)
Q Consensus 545 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~ 624 (1001)
..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..+..+++|+. |+|++|+|++..|.
T Consensus 72 ---i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~-L~L~~N~l~~~~~~ 147 (220)
T 2v70_A 72 ---IEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRL-LSLYDNQITTVAPG 147 (220)
T ss_dssp ---ECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSE-EECTTSCCCCBCTT
T ss_pred ---ECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCE-EECCCCcCCEECHH
Confidence 23345666778888888888888777777888888888888888888777888888888886 88888888888888
Q ss_pred cccccccccEEEecCCcCCCChhhhhcccccc
Q 001873 625 EFSGLTKLGILDLSHNKLSGDLDALASLQNLV 656 (1001)
Q Consensus 625 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~ 656 (1001)
.|..+++|+.|+|++|+|+|+++..+-..+++
T Consensus 148 ~~~~l~~L~~L~L~~N~l~c~c~l~~l~~~~~ 179 (220)
T 2v70_A 148 AFDTLHSLSTLNLLANPFNCNCYLAWLGEWLR 179 (220)
T ss_dssp TTTTCTTCCEEECCSCCEECSGGGHHHHHHHH
T ss_pred HhcCCCCCCEEEecCcCCcCCCchHHHHHHHH
Confidence 99999999999999999999876544334443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2.6e-19 Score=186.59 Aligned_cols=97 Identities=20% Similarity=0.237 Sum_probs=62.3
Q ss_pred ccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCccccccccccccccc
Q 001873 552 SIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTK 631 (1001)
Q Consensus 552 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~ 631 (1001)
.|.++++|+.|+|++|+|+...+..|..+++|++|+|++|+|++..|..|..+++|+. |+|++|+|++..+..|..+++
T Consensus 75 ~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~ 153 (220)
T 2v9t_B 75 AFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNL-LSLYDNKLQTIAKGTFSPLRA 153 (220)
T ss_dssp TTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE-EECCSSCCSCCCTTTTTTCTT
T ss_pred HhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCE-EECCCCcCCEECHHHHhCCCC
Confidence 3444455555555555555433344455555666666666665555556666666664 666666666666677888899
Q ss_pred ccEEEecCCcCCCChhhh
Q 001873 632 LGILDLSHNKLSGDLDAL 649 (1001)
Q Consensus 632 L~~L~Ls~N~l~~~~~~~ 649 (1001)
|+.|+|++|+|.|+++..
T Consensus 154 L~~L~L~~N~~~c~c~l~ 171 (220)
T 2v9t_B 154 IQTMHLAQNPFICDCHLK 171 (220)
T ss_dssp CCEEECCSSCEECSGGGH
T ss_pred CCEEEeCCCCcCCCCccH
Confidence 999999999999987643
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.1e-19 Score=187.20 Aligned_cols=157 Identities=22% Similarity=0.266 Sum_probs=143.0
Q ss_pred CceEEcccccCcccCCCCcccccccccCCCCcCCCCcc-cccccccccceeeccCccccccchhhhhccccccEEecccc
Q 001873 513 LEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLA-HSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNN 591 (1001)
Q Consensus 513 L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 591 (1001)
-+.+++++|.++ .+|..++..++.|+|++|+|++..+ ..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|
T Consensus 13 ~~~l~~s~n~l~-~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 13 GTTVDCSNQKLN-KIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp TTEEECCSSCCS-SCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCEeEeCCCCcc-cCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 357888888888 5777888888889999999987754 56889999999999999999888889999999999999999
Q ss_pred cccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCC-hhhhhcccccceeEcccCCCCCCCC
Q 001873 592 RFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGD-LDALASLQNLVSLNVSFNDFSGELP 670 (1001)
Q Consensus 592 ~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~ls~N~l~~~~p 670 (1001)
++++..|..|..+++|+. |+|++|+|++..|..|.++++|++|+|++|++++. +..+..+++|++|++++|++++.|+
T Consensus 92 ~l~~~~~~~~~~l~~L~~-L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKT-LMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCCCCGGGGTTCSSCCE-EECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ccCccCHhHhcCCcCCCE-EECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 999888888999999997 99999999999999999999999999999999996 6789999999999999999998887
Q ss_pred C
Q 001873 671 N 671 (1001)
Q Consensus 671 ~ 671 (1001)
-
T Consensus 171 l 171 (220)
T 2v70_A 171 L 171 (220)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.9e-20 Score=222.46 Aligned_cols=217 Identities=16% Similarity=0.157 Sum_probs=163.7
Q ss_pred cCCccccceeccccccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccc
Q 001873 171 GNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQ 250 (1001)
Q Consensus 171 ~~L~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~ 250 (1001)
..+++|+.|+|++|+++ .+|.+++++++|+.|++++|.. +..+..+ +..+...+..|..++.+++|+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~-----------l~~l~~l-l~~~~~~~~~~~~l~~l~~L~ 412 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWC-----------LLTIILL-MRALDPLLYEKETLQYFSTLK 412 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHH-----------HHHHHHH-HHHHCTGGGHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchh-----------hhhHHHH-HHhcccccCCHHHHHHHHhcc
Confidence 45666777777777765 6677777777777777655420 0001100 112223344555666666666
Q ss_pred eec-cccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCC
Q 001873 251 TIA-IYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDN 329 (1001)
Q Consensus 251 ~L~-l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 329 (1001)
.|+ ++.|. +++|+.+.+++|.++...+ ..|+.|+|++|++++ +|. ++.+++|+.|+|++|
T Consensus 413 ~L~~l~~n~-----------~~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N 473 (567)
T 1dce_A 413 AVDPMRAAY-----------LDDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHN 473 (567)
T ss_dssp HHCGGGHHH-----------HHHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSS
T ss_pred cCcchhhcc-----------cchhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCcc
Confidence 665 44443 2457778888888875433 258999999999996 676 999999999999999
Q ss_pred CCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCcc-CccccccCcccEEEeecCccCCCCC
Q 001873 330 LLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEI-PADIGNINGLTLFFAWKNKLTGNIP 408 (1001)
Q Consensus 330 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~l~~n~l~~~~p 408 (1001)
.|+ .+|..|+++++|+.|+|++|+|++ +| .+..+++|+.|+|++|+|++.. |..++.+++|+.|++++|.+++.+|
T Consensus 474 ~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 474 RLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp CCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred ccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 999 789999999999999999999996 66 8999999999999999999887 9999999999999999999998766
Q ss_pred cc---cccCcccceEeC
Q 001873 409 ES---LSQCQELQALDF 422 (1001)
Q Consensus 409 ~~---l~~l~~L~~L~L 422 (1001)
.. +..+++|+.|++
T Consensus 551 ~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 551 IQERLAEMLPSVSSILT 567 (567)
T ss_dssp CTTHHHHHCTTCSEEEC
T ss_pred HHHHHHHHCcccCccCC
Confidence 42 345889999875
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=5.2e-19 Score=185.57 Aligned_cols=62 Identities=27% Similarity=0.277 Sum_probs=35.8
Q ss_pred cccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccccc
Q 001873 126 RELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLS 187 (1001)
Q Consensus 126 ~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~ 187 (1001)
++|++|+|++|++++..|..|..+++|++|+|++|++++..+..++++++|++|+|++|+++
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~ 101 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT 101 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCC
Confidence 45566666666666555555666666666666666665333334455666666666666555
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=7.7e-19 Score=209.80 Aligned_cols=170 Identities=21% Similarity=0.338 Sum_probs=93.1
Q ss_pred ccccceeccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEe
Q 001873 246 LERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVD 325 (1001)
Q Consensus 246 l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 325 (1001)
|.+|+.|++.+|.++. +| .++.+++|+.|+|++|++++..| +..+++|+.|+|++|++++ +| .+..+++|+.|+
T Consensus 42 L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~ 115 (605)
T 1m9s_A 42 LNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLS 115 (605)
T ss_dssp HTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEE
T ss_pred CCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEE
Confidence 3334444444444432 22 35566666666666666665443 5666666666666666653 22 456666666666
Q ss_pred ccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCC
Q 001873 326 FSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTG 405 (1001)
Q Consensus 326 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~ 405 (1001)
|++|.+++ + +.+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.|++..| +..+++|+.|++++|++++
T Consensus 116 Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~ 189 (605)
T 1m9s_A 116 LEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 189 (605)
T ss_dssp CTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred ecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC
Confidence 66666653 2 2355666666666666666543 445556666666666666654433 5555555555555555553
Q ss_pred CCCcccccCcccceEeCcCccccC
Q 001873 406 NIPESLSQCQELQALDFSYNNLSG 429 (1001)
Q Consensus 406 ~~p~~l~~l~~L~~L~Ls~N~l~~ 429 (1001)
. ..+..+++|+.|+|++|++++
T Consensus 190 l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 190 L--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp C--GGGTTCTTCSEEECCSEEEEC
T ss_pred C--hHHccCCCCCEEEccCCcCcC
Confidence 2 235555555555555555543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=4.6e-19 Score=199.74 Aligned_cols=161 Identities=25% Similarity=0.210 Sum_probs=86.1
Q ss_pred cceEEccccccccCCCcccC-CCCCcceeeccCcccccCCcccccccccCceEEcccccCcccCCCCcccccccccCCCC
Q 001873 465 LRRLRLNDNRLSGTIPSEMG-NLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDN 543 (1001)
Q Consensus 465 L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N 543 (1001)
++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|.++++|++|+|++|+|++.
T Consensus 41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~----------------- 103 (361)
T 2xot_A 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTL----------------- 103 (361)
T ss_dssp CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE-----------------
T ss_pred CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcC-----------------
Confidence 44555555555544444444 455555555555555544444455555555555555554422
Q ss_pred cCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCcc---ccccchhhhhhcCCCcccc
Q 001873 544 RLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKEL---GQISSLEISLNLSSNQFSG 620 (1001)
Q Consensus 544 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~~L~Ls~N~l~~ 620 (1001)
.+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+ ..+++|+. |+|++|+|++
T Consensus 104 -----~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~-L~L~~N~l~~ 177 (361)
T 2xot_A 104 -----DEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLML-LDLSSNKLKK 177 (361)
T ss_dssp -----CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCE-EECCSSCCCC
T ss_pred -----CHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCE-EECCCCCCCc
Confidence 12233444555555555555554445555555555555555555553222222 34555554 6666666665
Q ss_pred ccccccccccc--ccEEEecCCcCCCChhh
Q 001873 621 EIPSEFSGLTK--LGILDLSHNKLSGDLDA 648 (1001)
Q Consensus 621 ~~p~~~~~l~~--L~~L~Ls~N~l~~~~~~ 648 (1001)
..+..+..++. ++.|+|++|+|.|+++.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l 207 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred cCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence 55556666665 47899999999998764
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.77 E-value=4.8e-19 Score=184.54 Aligned_cols=155 Identities=23% Similarity=0.337 Sum_probs=142.2
Q ss_pred ceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccc
Q 001873 514 EFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRF 593 (1001)
Q Consensus 514 ~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 593 (1001)
+.+++++|+++ .+|..+++.++.|++++|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|+|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 92 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92 (220)
T ss_dssp TEEECTTSCCS-SCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred CEEEcCCCCcC-cCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence 67888888888 67878888899999999999988888999999999999999999988899999999999999999999
Q ss_pred cCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCCh-hhhhcccccceeEcccCCCCCCCC
Q 001873 594 SGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDL-DALASLQNLVSLNVSFNDFSGELP 670 (1001)
Q Consensus 594 ~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~ls~N~l~~~~p 670 (1001)
+...+..|..+++|+. |+|++|+|++..|..|..+++|+.|+|++|+++..+ ..+..+++|++|++++|++.+.|.
T Consensus 93 ~~l~~~~f~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 93 TELPKSLFEGLFSLQL-LLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CCCCTTTTTTCTTCCE-EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CccCHhHccCCCCCCE-EECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 9777777899999997 999999999999999999999999999999999965 468899999999999999987665
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.7e-18 Score=206.74 Aligned_cols=172 Identities=24% Similarity=0.317 Sum_probs=114.0
Q ss_pred ccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCcc
Q 001873 267 IGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQ 346 (1001)
Q Consensus 267 l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 346 (1001)
+..+++|+.|++++|.+... | .+..+++|+.|+|++|++++..| +..+++|+.|+|++|.+++ +| .+..+++|+
T Consensus 39 ~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~ 112 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLK 112 (605)
T ss_dssp HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCC
T ss_pred hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCC
Confidence 56678888888888888743 3 57888888888888888886544 7788888888888888874 33 577788888
Q ss_pred EEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCcc
Q 001873 347 ELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNN 426 (1001)
Q Consensus 347 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 426 (1001)
+|+|++|++.+. ..+..+++|+.|+|++|+|++. ..+..+++|+.|++++|++++..| +..+++|+.|+|++|+
T Consensus 113 ~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 113 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 186 (605)
T ss_dssp EEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCC
Confidence 888888888753 3577777777777777777643 445555555555555555554433 5555555555555555
Q ss_pred ccCCCCcccccccccceEEccCCcCC
Q 001873 427 LSGPIPKEIFGLRNLTKLLLLSNDLS 452 (1001)
Q Consensus 427 l~~~~~~~~~~l~~L~~L~L~~N~l~ 452 (1001)
|++. ..+..+++|+.|+|++|++.
T Consensus 187 i~~l--~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 187 ISDL--RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp CCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred CCCC--hHHccCCCCCEEEccCCcCc
Confidence 5432 23444444444444444444
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.6e-18 Score=189.01 Aligned_cols=191 Identities=21% Similarity=0.330 Sum_probs=110.6
Q ss_pred CCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEc
Q 001873 271 SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQL 350 (1001)
Q Consensus 271 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 350 (1001)
.++..+.+..+.+++.. .+..+++|+.|++++|.++.. + .+..+++|+.|++++|++++..+ +.++++|++|+|
T Consensus 24 ~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l 97 (291)
T 1h6t_A 24 AETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFL 97 (291)
T ss_dssp HHHHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred HHHHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEEC
Confidence 33445566666665432 234677777888877777643 3 36677777777777777775433 667777777777
Q ss_pred ccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCC
Q 001873 351 SVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGP 430 (1001)
Q Consensus 351 s~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 430 (1001)
++|++++ +| .+..+++|++|++++|++++. ..+..+++|+.|++++|++++.
T Consensus 98 ~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--------------------------~~l~~l~~L~~L~l~~n~l~~~ 149 (291)
T 1h6t_A 98 DENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--------------------------NGLVHLPQLESLYLGNNKITDI 149 (291)
T ss_dssp CSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--------------------------GGGGGCTTCCEEECCSSCCCCC
T ss_pred CCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--------------------------hhhcCCCCCCEEEccCCcCCcc
Confidence 7777664 22 355666666666666665431 2344455555555555555533
Q ss_pred CCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCccccc
Q 001873 431 IPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVG 501 (1001)
Q Consensus 431 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 501 (1001)
..+..+++|++|++++|++++..+ +..+++|++|++++|++++ ++ .+..+++|+.|++++|+++.
T Consensus 150 --~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 150 --TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp --GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred --hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence 345555555555555555554433 5555556666666665553 22 25555555555555555553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=5.1e-19 Score=192.85 Aligned_cols=192 Identities=20% Similarity=0.291 Sum_probs=141.0
Q ss_pred ccccceeccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEe
Q 001873 246 LERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVD 325 (1001)
Q Consensus 246 l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 325 (1001)
+.++..+.+..+.+++.. .+..+++|++|++++|.++.. + .+..+++|++|+|++|++++..+ +..+++|++|+
T Consensus 23 l~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~ 96 (291)
T 1h6t_A 23 FAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLF 96 (291)
T ss_dssp HHHHHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred HHHHHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEE
Confidence 455556666666666433 356789999999999999855 3 48899999999999999996544 99999999999
Q ss_pred ccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCC
Q 001873 326 FSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTG 405 (1001)
Q Consensus 326 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~ 405 (1001)
+++|.+++ +| .+..+++|++|+|++|++++. ..+..+++|++|++++|++++. ..+..+
T Consensus 97 l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l--------------- 155 (291)
T 1h6t_A 97 LDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRL--------------- 155 (291)
T ss_dssp CCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGC---------------
T ss_pred CCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccC---------------
Confidence 99999985 44 499999999999999999864 4688999999999999998753 344444
Q ss_pred CCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEcccccccc
Q 001873 406 NIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSG 477 (1001)
Q Consensus 406 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 477 (1001)
++|+.|++++|++++..+ +..+++|++|++++|++++. + .+..+++|+.|++++|+++.
T Consensus 156 ---------~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 156 ---------TKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp ---------TTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred ---------CCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 455555555555544332 45555555555555555543 2 35666677777777777664
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=8.5e-19 Score=178.51 Aligned_cols=174 Identities=25% Similarity=0.300 Sum_probs=147.1
Q ss_pred ceEEcccccCcccCCCCcccccccccCCCCcCCCCccc-ccccccccceeeccCccccccchhhhhccccccEEeccccc
Q 001873 514 EFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAH-SIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNR 592 (1001)
Q Consensus 514 ~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 592 (1001)
+.+++++|+++ .+|..++..++.|++++|+|++..+. .|..+++|++|+|++|+|++..|..|..+++|++|+|++|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 89 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred CEEEcCCCCcC-cCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCc
Confidence 67888888886 67777777888899999999877664 48999999999999999999989999999999999999999
Q ss_pred ccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCChhhhhcccccceeEcccCCCCCCCCCC
Q 001873 593 FSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNT 672 (1001)
Q Consensus 593 l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~ 672 (1001)
|++..|..+..+++|+. |+|++|+|++..|..|..+++|++|+|++|+|+|+++..+...+++...+.++...+.-|
T Consensus 90 l~~~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P-- 166 (192)
T 1w8a_A 90 IKEISNKMFLGLHQLKT-LNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP-- 166 (192)
T ss_dssp CCEECSSSSTTCTTCCE-EECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS--
T ss_pred CCccCHHHhcCCCCCCE-EECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC--
Confidence 99999999999999997 999999999999999999999999999999999998765555666666677766554444
Q ss_pred ccccCCCCCCCCCCCcccc
Q 001873 673 PFFRKLPLSDLASNRGLYI 691 (1001)
Q Consensus 673 ~~~~~~~~~~~~~n~~lc~ 691 (1001)
..+++.+..++..+.-.|.
T Consensus 167 ~~l~~~~l~~l~~~~~~C~ 185 (192)
T 1w8a_A 167 SKVRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp TTTTTSBGGGSCTTTCCCC
T ss_pred hHHcCCChhhCcHhhcCcC
Confidence 3456666677777666664
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.7e-18 Score=180.17 Aligned_cols=155 Identities=27% Similarity=0.323 Sum_probs=85.4
Q ss_pred CceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEeccccc
Q 001873 513 LEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNR 592 (1001)
Q Consensus 513 L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 592 (1001)
.+.+++++++++ .+|..+++.++.|+|++|+|++..+..|..+++|+.|+|++|+|+...+..|..+++|++|+|++|+
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCEeEccCCCcC-ccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 344555555554 4444555555555555555555555555555555555555555554444445555555555555555
Q ss_pred ccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCCh-hhhhcccccceeEcccCCCCCCCC
Q 001873 593 FSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDL-DALASLQNLVSLNVSFNDFSGELP 670 (1001)
Q Consensus 593 l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~ls~N~l~~~~p 670 (1001)
|++..+..+..+++|+. |+|++|+|+ .+|..+..+++|++|+|++|+++..+ ..+..+++|+.|++++|++++.|+
T Consensus 100 l~~l~~~~~~~l~~L~~-L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 100 LTVLPSAVFDRLVHLKE-LFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCCCCTTTTTTCTTCCE-EECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CCccChhHhCcchhhCe-EeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 55444444555555554 555555555 44555555555555555555555533 335555555555665555555554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.6e-18 Score=191.57 Aligned_cols=176 Identities=22% Similarity=0.160 Sum_probs=97.6
Q ss_pred ceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCcc-CCCCCCEEeccCCCCCCCCCcccccccCccEEEccc
Q 001873 274 QNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELG-SCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSV 352 (1001)
Q Consensus 274 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 352 (1001)
+.+++++|+++ .+|..+. +.++.|+|++|++++..+..+. .+++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 45666666665 3444333 2356666666666655555555 666666666666666655555566666666666666
Q ss_pred ccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCccc---ccCcccceEeCcCccccC
Q 001873 353 NQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESL---SQCQELQALDFSYNNLSG 429 (1001)
Q Consensus 353 N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l---~~l~~L~~L~Ls~N~l~~ 429 (1001)
|+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|++++|++++..+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 66665555556666666666666666655555555555555555555555554333333 345566666666666664
Q ss_pred CCCcccccccc--cceEEccCCcCC
Q 001873 430 PIPKEIFGLRN--LTKLLLLSNDLS 452 (1001)
Q Consensus 430 ~~~~~~~~l~~--L~~L~L~~N~l~ 452 (1001)
..+..+..++. ++.|+|++|.+.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 44444544444 244444444443
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.8e-18 Score=183.34 Aligned_cols=134 Identities=17% Similarity=0.216 Sum_probs=105.9
Q ss_pred ccCCCeEeecCCeeEEEEEe-CCCCE--EEEEEecCCCc--------------------------hhhHHHHHHHhhccC
Q 001873 768 LTSANVIGTGSSGVVYRVTI-PNGET--LAVKKMWSSDE--------------------------SGAFSSEIQTLGSIR 818 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~--------------------------~~~~~~Ei~~l~~l~ 818 (1001)
|++.+.||+|+||.||+|+. .+|+. ||||+++.... ...+.+|+..+++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 67888 99998643211 025788999999998
Q ss_pred CCce--eeEEeeeecCCceEEEEEccCC-C----CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEEeC
Q 001873 819 HKNI--VRLLGWGSNKNLKLLFYDYLPN-G----SLSSLLHGAGKGGADWEARYEVVLGVAHALAYLH-HDCMPPILHGD 890 (1001)
Q Consensus 819 h~nI--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH-~~~~~~ivH~D 890 (1001)
|++| +.++++ +..++||||+.+ | +|.++... .++..+..++.|++.|+.||| +. +|+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 8764 444442 356899999942 3 77776543 123456788999999999999 77 999999
Q ss_pred CCCCCeEECCCCcEEEecccccccc
Q 001873 891 VKAMNVLLGPGYQAYLADFGLARIV 915 (1001)
Q Consensus 891 lkp~NIll~~~~~~ki~Dfgla~~~ 915 (1001)
|||+|||+++ .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999764
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=3.8e-18 Score=182.92 Aligned_cols=169 Identities=18% Similarity=0.251 Sum_probs=91.6
Q ss_pred CCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEE
Q 001873 318 CTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFF 397 (1001)
Q Consensus 318 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 397 (1001)
+.++..+++++|.+++. + .+..+++|++|++++|+++. ++ .+..+++|++|++++|+|++..+ +..+++|+.|+
T Consensus 18 l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 44555666666666632 2 45566666666666666652 33 45566666666666666654332 44444444444
Q ss_pred eecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEcccccccc
Q 001873 398 AWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSG 477 (1001)
Q Consensus 398 l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 477 (1001)
+++|++++. |.. .. ++|++|++++|++++. +.+..+++|+.|+|++|++++
T Consensus 92 L~~N~l~~l-------------------------~~~-~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~ 142 (263)
T 1xeu_A 92 VNRNRLKNL-------------------------NGI-PS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS 142 (263)
T ss_dssp CCSSCCSCC-------------------------TTC-CC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB
T ss_pred CCCCccCCc-------------------------Ccc-cc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCC
Confidence 444444432 211 11 4455555555555542 235555556666666666553
Q ss_pred CCCcccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCcc
Q 001873 478 TIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTG 525 (1001)
Q Consensus 478 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 525 (1001)
. + .+..+++|++|++++|++++. ..+..+++|+.|++++|++++
T Consensus 143 ~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 143 I-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp C-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred C-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence 3 2 455566666666666666544 445566666666666666653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.9e-17 Score=177.54 Aligned_cols=128 Identities=22% Similarity=0.250 Sum_probs=60.3
Q ss_pred cccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCc
Q 001873 266 EIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKL 345 (1001)
Q Consensus 266 ~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 345 (1001)
.++.+++|++|+|++|++++..+ +..+++|++|+|++|++++ +|.. .. ++|+.|++++|++++. + .+..+++|
T Consensus 58 ~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L 130 (263)
T 1xeu_A 58 GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRDT-D-SLIHLKNL 130 (263)
T ss_dssp TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSBS-G-GGTTCTTC
T ss_pred HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEccCCccCCC-h-hhcCcccc
Confidence 34455555555555555554333 5555555555555555553 2221 11 4555555555555532 2 34555555
Q ss_pred cEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccC
Q 001873 346 QELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLT 404 (1001)
Q Consensus 346 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~ 404 (1001)
++|+|++|++++. + .+..+++|++|++++|++++. ..+..+++|+.|++++|.++
T Consensus 131 ~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 131 EILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp CEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEE
T ss_pred cEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCccc
Confidence 5555555555432 2 344455555555555555432 33333444444444444433
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.71 E-value=4.4e-18 Score=208.52 Aligned_cols=191 Identities=21% Similarity=0.221 Sum_probs=106.1
Q ss_pred CCCceEeeecCcccCCCCcccCCCCCC-----cEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCc
Q 001873 271 SELQNLYLYQNSISGPIPGRIGALSKL-----KSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKL 345 (1001)
Q Consensus 271 ~~L~~L~L~~N~i~~~~p~~~~~l~~L-----~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 345 (1001)
+.++.|+|.+|.+... +..+.....| ..++++.|.+. ..|+.+..++.|+.|+|++|.+. .+|..+.++++|
T Consensus 173 ~~~~~l~L~~n~~~~~-~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L 249 (727)
T 4b8c_D 173 PLTPKIELFANGKDEA-NQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFL 249 (727)
T ss_dssp ---------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSC
T ss_pred CccceEEeeCCCCCcc-hhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCC
Confidence 3456666666666542 2222221111 22334444444 55677778888888888888887 566666678888
Q ss_pred cEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCc
Q 001873 346 QELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYN 425 (1001)
Q Consensus 346 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N 425 (1001)
++|+|++|+|+ .+|..|..+++|++|+|++|+|+ .+|..++++++|+.|++++|.++ .+|..|+.+++|+.|+|++|
T Consensus 250 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N 326 (727)
T 4b8c_D 250 TRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGN 326 (727)
T ss_dssp SCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTS
T ss_pred CEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCC
Confidence 88888888887 67777888888888888888887 66777888888888888888876 66777888888888888888
Q ss_pred cccCCCCcccccccc-cceEEccCCcCCCCCCCCCCCCCCcceEEcccc
Q 001873 426 NLSGPIPKEIFGLRN-LTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDN 473 (1001)
Q Consensus 426 ~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 473 (1001)
.|++.+|..+..+.. +..++|++|.+++.+|.. |+.|+++.|
T Consensus 327 ~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n 369 (727)
T 4b8c_D 327 PLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTD 369 (727)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred ccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecc
Confidence 888877777765432 234677777777766653 455556655
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=5.2e-17 Score=166.10 Aligned_cols=152 Identities=13% Similarity=0.150 Sum_probs=87.4
Q ss_pred cCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccE
Q 001873 268 GNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQE 347 (1001)
Q Consensus 268 ~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 347 (1001)
+.+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|.+++..|..|+.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 45566777777777776 334 4666677777777777554 2335666677777777777776656666666777777
Q ss_pred EEcccccccCcCChhhccccccCEEeccCCc-ccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCcc
Q 001873 348 LQLSVNQLSGTIPIEIATCTALTHLEIDNNA-ISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNN 426 (1001)
Q Consensus 348 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 426 (1001)
|+|++|++++..|..+..+++|++|++++|+ ++ .+| .+..+++|+.|++++|++++. + .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcc
Confidence 7777777766566666666666666666666 43 222 334444444444444444321 1 33344444444444444
Q ss_pred c
Q 001873 427 L 427 (1001)
Q Consensus 427 l 427 (1001)
+
T Consensus 193 i 193 (197)
T 4ezg_A 193 I 193 (197)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.9e-17 Score=184.03 Aligned_cols=239 Identities=13% Similarity=0.051 Sum_probs=133.8
Q ss_pred CCCCceEeeecCccc--CCCCcccCCCCCCcEEEcCCCcccccCCCCccC--------CCCCCEEeccCCCCCCCCCccc
Q 001873 270 CSELQNLYLYQNSIS--GPIPGRIGALSKLKSLLLWQNSLVGAIPDELGS--------CTELTVVDFSDNLLTGSIPRSF 339 (1001)
Q Consensus 270 l~~L~~L~L~~N~i~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~--------l~~L~~L~Ls~N~l~~~~p~~~ 339 (1001)
+++|++|||++|+|. ...+..+ +.++.+.+..|.+ .+..|.+ +++|+.|+|.+ .++...+.+|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCccccc---ccccccccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 556667777776666 2222222 1233444444422 2233444 56666666665 5554444556
Q ss_pred ccccCccEEEcccccccCcCChhhccccccCEEeccCCcc----cCccCccccccC------------------------
Q 001873 340 GNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAI----SGEIPADIGNIN------------------------ 391 (1001)
Q Consensus 340 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i----~~~~~~~~~~l~------------------------ 391 (1001)
.++++|+.|++++|.+....+.+|.++.++..+.+..+.. .......|.+..
T Consensus 121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~ 200 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQ 200 (329)
T ss_dssp TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCC
T ss_pred hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccC
Confidence 6666666666666655545555555555555555444221 111122232233
Q ss_pred --cccEEEeecCccCCCCCccc-ccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcc-e
Q 001873 392 --GLTLFFAWKNKLTGNIPESL-SQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLR-R 467 (1001)
Q Consensus 392 --~L~~L~l~~n~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~-~ 467 (1001)
+++.+.+.++-.. .....+ ..+++|+.++|++|+++.+.+.+|.++.+|+.|++.+| ++.+.+.+|.++++|+ .
T Consensus 201 ~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~ 278 (329)
T 3sb4_A 201 PRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGT 278 (329)
T ss_dssp GGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEE
T ss_pred ccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEE
Confidence 3333333332111 000111 12667777777777777666666777777777777776 6666667777777777 7
Q ss_pred EEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccCceEEc
Q 001873 468 LRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDL 518 (1001)
Q Consensus 468 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 518 (1001)
+++.+ .++.+.+..|.++++|+.+++++|+++...+.+|.++++|+.++.
T Consensus 279 l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 279 LELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 77777 666566677777777777777777777666667777777777653
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.69 E-value=9.9e-18 Score=186.35 Aligned_cols=224 Identities=13% Similarity=0.075 Sum_probs=163.9
Q ss_pred ccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCC----CCCCCCcccc
Q 001873 265 EEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNL----LTGSIPRSFG 340 (1001)
Q Consensus 265 ~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~----l~~~~p~~~~ 340 (1001)
..+.+|++|+.|+|.+ .++.+.+.+|.++++|+.|++++|.+....+..|..+.++..+.+..+. ........|.
T Consensus 95 ~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~ 173 (329)
T 3sb4_A 95 GVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFI 173 (329)
T ss_dssp TEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEE
T ss_pred ccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccc
Confidence 3333388899999888 8887777888888899999998888887777788888777777776632 2223344566
Q ss_pred cccCcc-EEEcccccccCcCChhh----ccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCc
Q 001873 341 NLLKLQ-ELQLSVNQLSGTIPIEI----ATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQ 415 (1001)
Q Consensus 341 ~l~~L~-~L~Ls~N~l~~~~p~~~----~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~ 415 (1001)
++.+|+ .+.+.... .++..+ ....+++.+.+.++-...........+++|+.+++.+|+++...+.+|.+++
T Consensus 174 ~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~ 250 (329)
T 3sb4_A 174 EGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKK 250 (329)
T ss_dssp ESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCT
T ss_pred cccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCC
Confidence 666766 45444321 222221 1345666666665432211111112367888999998888877777899999
Q ss_pred ccceEeCcCccccCCCCcccccccccc-eEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeec
Q 001873 416 ELQALDFSYNNLSGPIPKEIFGLRNLT-KLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDM 494 (1001)
Q Consensus 416 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 494 (1001)
+|+.+++++| ++.+.+.+|.++.+|+ .+++.+ +++.+.+.+|.+|++|+.+++++|+++.+.+..|.++++|+.++.
T Consensus 251 ~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 251 YLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp TCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred CCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 9999999998 7777778899999999 999988 788788899999999999999999999788889999999998763
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=8.9e-17 Score=164.35 Aligned_cols=151 Identities=19% Similarity=0.282 Sum_probs=91.9
Q ss_pred ccccceeccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEe
Q 001873 246 LERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVD 325 (1001)
Q Consensus 246 l~~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 325 (1001)
+++|+.|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..++.+++|++|+
T Consensus 43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 118 (197)
T 4ezg_A 43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118 (197)
T ss_dssp HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence 344444444444444 344 4566666666666666554 233566666666666666666665666666666666777
Q ss_pred ccCCCCCCCCCcccccccCccEEEccccc-ccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccC
Q 001873 326 FSDNLLTGSIPRSFGNLLKLQELQLSVNQ-LSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLT 404 (1001)
Q Consensus 326 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~ 404 (1001)
+++|.+++..|..+..+++|++|+|++|+ ++ .+| .+..+++|++|++++|++++ ++ .+..+++|+.|++++|++.
T Consensus 119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred ecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 77666666556666666667777777666 44 334 46666677777777776664 22 5666677777777777664
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=6e-17 Score=164.75 Aligned_cols=140 Identities=21% Similarity=0.292 Sum_probs=123.0
Q ss_pred ceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccc
Q 001873 514 EFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRF 593 (1001)
Q Consensus 514 ~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 593 (1001)
+.+++++|+++ .+|..++..++.|++++|+|+ .+|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp TEEECTTSCCS-SCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CEEEcCCCCCC-cCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 57888888887 677777788888999999998 5668899999999999999999988888999999999999999999
Q ss_pred cCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCChhhhhcccccc
Q 001873 594 SGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLV 656 (1001)
Q Consensus 594 ~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~ 656 (1001)
++..|..|..+++|+. |+|++|+|++..+..|..+++|+.|+|++|+|.|+++..+-..+++
T Consensus 91 ~~i~~~~f~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l~~~~~ 152 (193)
T 2wfh_A 91 RCIPPRTFDGLKSLRL-LSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLSDWVK 152 (193)
T ss_dssp CBCCTTTTTTCTTCCE-EECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHHHH
T ss_pred CEeCHHHhCCCCCCCE-EECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHHHHHHHH
Confidence 9888889999999997 9999999998888889999999999999999999876543333433
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.64 E-value=6.3e-16 Score=157.19 Aligned_cols=111 Identities=23% Similarity=0.287 Sum_probs=72.6
Q ss_pred ccceEeCcCccccCCCCc-ccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeec
Q 001873 416 ELQALDFSYNNLSGPIPK-EIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDM 494 (1001)
Q Consensus 416 ~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 494 (1001)
+|++|++++|+|++..+. .|..+++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 556666666666554443 3556666666666666666666666666666666666666666666666666667777777
Q ss_pred cCcccccCCcccccccccCceEEcccccCccc
Q 001873 495 SENHLVGGIPPSVVGCQSLEFLDLHSNGLTGS 526 (1001)
Q Consensus 495 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 526 (1001)
++|+|++..|..+..+++|++|++++|.+++.
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 77777666666666666777777777766643
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=6.9e-16 Score=154.80 Aligned_cols=138 Identities=27% Similarity=0.298 Sum_probs=117.7
Q ss_pred cCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccc
Q 001873 512 SLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNN 591 (1001)
Q Consensus 512 ~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 591 (1001)
+.+.+++++|+++ .+|..+++.++.|++++|++++..+..|..+++|++|++++|+|++..+..+..+++|++|++++|
T Consensus 8 ~~~~l~~~~~~l~-~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 8 SGTEIRCNSKGLT-SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp ETTEEECCSSCCS-SCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEecCCCCc-cCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 3567888888887 566667778888888888888777778889999999999999999777777899999999999999
Q ss_pred cccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCChhhhhc
Q 001873 592 RFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALAS 651 (1001)
Q Consensus 592 ~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 651 (1001)
++++..+..+..+++|+. |++++|++++..+..|..+++|+.|+|++|+++++++.+..
T Consensus 87 ~l~~~~~~~~~~l~~L~~-L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l~~ 145 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKE-LALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 145 (177)
T ss_dssp CCCCCCTTTTTTCTTCCE-EECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHHHHH
T ss_pred CccccCHHHhhCCcccCE-EECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCccHHH
Confidence 999877778889999996 99999999987777788899999999999999998775443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.2e-15 Score=151.71 Aligned_cols=131 Identities=19% Similarity=0.161 Sum_probs=67.7
Q ss_pred ccceecccccccc-ccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEec
Q 001873 248 RIQTIAIYTSLLS-GPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDF 326 (1001)
Q Consensus 248 ~L~~L~l~~n~l~-g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 326 (1001)
+|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|++
T Consensus 25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 3444444444444 44555555555555555555555543 45555555555555555555444544444555555555
Q ss_pred cCCCCCCCC-CcccccccCccEEEcccccccCcCC---hhhccccccCEEeccCCccc
Q 001873 327 SDNLLTGSI-PRSFGNLLKLQELQLSVNQLSGTIP---IEIATCTALTHLEIDNNAIS 380 (1001)
Q Consensus 327 s~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~N~i~ 380 (1001)
++|.+++.. +..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+.
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 555555321 1445555555555555555553333 24555555555555555544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=4e-16 Score=172.54 Aligned_cols=133 Identities=11% Similarity=0.160 Sum_probs=99.2
Q ss_pred ccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC----------------chhh--------HHHHHHHhhccCCCcee
Q 001873 768 LTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD----------------ESGA--------FSSEIQTLGSIRHKNIV 823 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~--------~~~Ei~~l~~l~h~nIv 823 (1001)
|++.+.||+|+||.||+|..++|++||||+++... .... ..+|...+.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 88899999999999999999899999999864211 0011 23466667776544432
Q ss_pred --eEEeeeecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC
Q 001873 824 --RLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG 901 (1001)
Q Consensus 824 --~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~ 901 (1001)
..+++ . ..++||||++|++|.++... .....++.|++.++.|||+. +||||||||.|||++++
T Consensus 177 vp~p~~~--~--~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 177 VPEPIAQ--S--RHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE 241 (397)
T ss_dssp CCCEEEE--E--TTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred CCeeeec--c--CceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence 22222 1 23799999999888765431 12346789999999999998 99999999999999877
Q ss_pred C----------cEEEecccccccc
Q 001873 902 Y----------QAYLADFGLARIV 915 (1001)
Q Consensus 902 ~----------~~ki~Dfgla~~~ 915 (1001)
+ .+.|+||+.+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 6 3899999987653
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.7e-15 Score=148.98 Aligned_cols=108 Identities=22% Similarity=0.292 Sum_probs=53.6
Q ss_pred CCCceEeeecCccc-CCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEE
Q 001873 271 SELQNLYLYQNSIS-GPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQ 349 (1001)
Q Consensus 271 ~~L~~L~L~~N~i~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 349 (1001)
++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|++++|.+++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 45666666666665 44555555555555555555555533 4455555555555555555544444444445555555
Q ss_pred cccccccCcCC-hhhccccccCEEeccCCccc
Q 001873 350 LSVNQLSGTIP-IEIATCTALTHLEIDNNAIS 380 (1001)
Q Consensus 350 Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~i~ 380 (1001)
|++|++++..+ ..+..+++|++|++++|.++
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~ 133 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCc
Confidence 55554443211 33344444444444444443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.7e-14 Score=163.67 Aligned_cols=248 Identities=15% Similarity=0.154 Sum_probs=174.0
Q ss_pred ccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccC
Q 001873 265 EEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLK 344 (1001)
Q Consensus 265 ~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 344 (1001)
..|.++ +|+.+.+..+ ++.+...+|.+ .+|+.+.+.. .++..-+..|.++++|+.+++++|.++......|. ..+
T Consensus 130 ~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~ 204 (401)
T 4fdw_A 130 DAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAG 204 (401)
T ss_dssp TTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCC
T ss_pred hhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecc
Confidence 456664 6888888766 66666777877 4688888875 66666667788888888888888888855555665 578
Q ss_pred ccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcC
Q 001873 345 LQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSY 424 (1001)
Q Consensus 345 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~ 424 (1001)
|+.+.|..+ +..+...+|.++++|+.+++..| ++......|.+ .+|+.+.+ .+.++.....+|.+|++|+.+++.+
T Consensus 205 L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~ 280 (401)
T 4fdw_A 205 IEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYG 280 (401)
T ss_dssp CSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEES
T ss_pred cCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCC
Confidence 888888754 66566678888888888888865 55445556666 67787777 4556655666788888888888877
Q ss_pred cccc-----CCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCccc
Q 001873 425 NNLS-----GPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHL 499 (1001)
Q Consensus 425 N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 499 (1001)
|.+. ...+.+|.++++|+.+.+. +.++.+...+|.+|++|+.++|.+| ++.+.+..|.++ +|+.+++++|.+
T Consensus 281 ~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~ 357 (401)
T 4fdw_A 281 STFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTP 357 (401)
T ss_dssp SCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSC
T ss_pred ccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCC
Confidence 7664 3445667777777777777 3466566667777777777777544 554556677777 777777777777
Q ss_pred ccCCcccccccc-cCceEEcccccCc
Q 001873 500 VGGIPPSVVGCQ-SLEFLDLHSNGLT 524 (1001)
Q Consensus 500 ~~~~p~~~~~l~-~L~~L~Ls~N~l~ 524 (1001)
....+..|.+++ +++.|++..+.+.
T Consensus 358 ~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 358 PQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred cccccccccCCCCCccEEEeCHHHHH
Confidence 665566666663 5666666665543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.57 E-value=4e-15 Score=144.53 Aligned_cols=108 Identities=20% Similarity=0.266 Sum_probs=55.4
Q ss_pred CCCceEeeecCccc-CCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEE
Q 001873 271 SELQNLYLYQNSIS-GPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQ 349 (1001)
Q Consensus 271 ~~L~~L~L~~N~i~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 349 (1001)
++|++|++++|.++ +.+|..+..+++|++|++++|++++. ..++.+++|++|++++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45666666666665 45555555555555555555555543 4455555555555555555544444444455555555
Q ss_pred cccccccCc-CChhhccccccCEEeccCCccc
Q 001873 350 LSVNQLSGT-IPIEIATCTALTHLEIDNNAIS 380 (1001)
Q Consensus 350 Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~i~ 380 (1001)
+++|++++. .+..+..+++|++|++++|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~ 126 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGG
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCccc
Confidence 555554432 1233444444444444444443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.8e-15 Score=145.61 Aligned_cols=127 Identities=24% Similarity=0.270 Sum_probs=68.0
Q ss_pred CCCcEEEcCCCccc-ccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEe
Q 001873 295 SKLKSLLLWQNSLV-GAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLE 373 (1001)
Q Consensus 295 ~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 373 (1001)
++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45555555555555 45555555555555555555555543 4455555555555555555544555555555555555
Q ss_pred ccCCcccCc-cCccccccCcccEEEeecCccCCCCC---cccccCcccceEeCc
Q 001873 374 IDNNAISGE-IPADIGNINGLTLFFAWKNKLTGNIP---ESLSQCQELQALDFS 423 (1001)
Q Consensus 374 L~~N~i~~~-~~~~~~~l~~L~~L~l~~n~l~~~~p---~~l~~l~~L~~L~Ls 423 (1001)
+++|++++. .+..++.+++|+.|++++|.+++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 555555542 23455555555555555555554443 345555555555554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.3e-14 Score=143.64 Aligned_cols=112 Identities=25% Similarity=0.249 Sum_probs=66.3
Q ss_pred CCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEc
Q 001873 271 SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQL 350 (1001)
Q Consensus 271 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 350 (1001)
++|++|++++|++++..+..|..+++|++|++++|++++..+..+..+++|++|++++|.+++..+..|..+++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 45666666666666555555566666666666666666544455566666666666666666555555556666666666
Q ss_pred ccccccCcCChhhccccccCEEeccCCcccCc
Q 001873 351 SVNQLSGTIPIEIATCTALTHLEIDNNAISGE 382 (1001)
Q Consensus 351 s~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~ 382 (1001)
++|++++..+..+..+++|++|++++|.+.+.
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 66666644444455556666666666655543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.5e-14 Score=145.38 Aligned_cols=108 Identities=25% Similarity=0.307 Sum_probs=71.8
Q ss_pred ccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeecc
Q 001873 416 ELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMS 495 (1001)
Q Consensus 416 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 495 (1001)
+|++|++++|+|+ .+|..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 5666666666665 455666666666666666666666666666666667777777777766666666667777777777
Q ss_pred CcccccCCcccccccccCceEEcccccCc
Q 001873 496 ENHLVGGIPPSVVGCQSLEFLDLHSNGLT 524 (1001)
Q Consensus 496 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 524 (1001)
+|+|+...+..|..+++|+.|++++|.+.
T Consensus 111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 111 GNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 77776555555666677777777777665
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.7e-13 Score=155.46 Aligned_cols=242 Identities=11% Similarity=0.107 Sum_probs=185.3
Q ss_pred ccceeccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEecc
Q 001873 248 RIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFS 327 (1001)
Q Consensus 248 ~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 327 (1001)
+|+.+.+..+ ++..-...|.++ +|+.+.+.+ .++.+.+.+|.++++|+.+++++|+++......|. +++|+.+.|.
T Consensus 136 ~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp 211 (401)
T 4fdw_A 136 QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLP 211 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECC
T ss_pred CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeC
Confidence 4555554433 332334456664 688888875 66667778888888888888888888855555555 5788888887
Q ss_pred CCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccC---
Q 001873 328 DNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLT--- 404 (1001)
Q Consensus 328 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~--- 404 (1001)
.+ ++.....+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+ .+.++......|.++++|+.+.+.+|.+.
T Consensus 212 ~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~ 287 (401)
T 4fdw_A 212 VT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDP 287 (401)
T ss_dssp TT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCT
T ss_pred Cc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCc
Confidence 54 66566678888888888888875 55455566766 78888888 45566566778888888888888887765
Q ss_pred --CCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcc
Q 001873 405 --GNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSE 482 (1001)
Q Consensus 405 --~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 482 (1001)
...+.+|.+|++|+.+++. +.++.+...+|.++.+|+.+.+..| ++.+.+.+|.++ +|+.+++++|.+....+..
T Consensus 288 ~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~ 364 (401)
T 4fdw_A 288 EAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKV 364 (401)
T ss_dssp TCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSS
T ss_pred ccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCccccccc
Confidence 3556689999999999999 5587677788999999999999655 777778899999 9999999999998777788
Q ss_pred cCCCC-CcceeeccCcccc
Q 001873 483 MGNLK-HLNFVDMSENHLV 500 (1001)
Q Consensus 483 ~~~l~-~L~~L~Ls~N~l~ 500 (1001)
|.+++ .++.|.+..+.+.
T Consensus 365 F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 365 WYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CCCSCTTCCEEEECGGGHH
T ss_pred ccCCCCCccEEEeCHHHHH
Confidence 88884 7899999888765
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.5e-16 Score=162.71 Aligned_cols=83 Identities=23% Similarity=0.296 Sum_probs=54.6
Q ss_pred CCccccccccccCCccCCCCCh------hhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccCCCccc
Q 001873 123 GDYRELTFIDLSGNSLWGEIPT------EVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGA 196 (1001)
Q Consensus 123 ~~l~~L~~L~Ls~n~l~g~~p~------~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~~ 196 (1001)
.....++.++++.+.+.|.+|. .++.+++|++|+|++|.+++ +| .++++++|++|+|++|.++ .+|..++.
T Consensus 15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~ 91 (198)
T 1ds9_A 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV 91 (198)
T ss_dssp HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence 3445566666666666666555 77777777777777777774 66 6777777777777777776 56655555
Q ss_pred hhhhhhhhhccC
Q 001873 197 LSKLQVFRAGGN 208 (1001)
Q Consensus 197 l~~L~~L~l~~n 208 (1001)
+++|++|++++|
T Consensus 92 ~~~L~~L~L~~N 103 (198)
T 1ds9_A 92 ADTLEELWISYN 103 (198)
T ss_dssp HHHCSEEEEEEE
T ss_pred CCcCCEEECcCC
Confidence 555555555555
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.50 E-value=6.2e-16 Score=158.18 Aligned_cols=150 Identities=25% Similarity=0.309 Sum_probs=76.8
Q ss_pred CCcceEEccccccccCCCc------ccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCcccCCCCcccccc
Q 001873 463 TTLRRLRLNDNRLSGTIPS------EMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQ 536 (1001)
Q Consensus 463 ~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~ 536 (1001)
..++.++++.|.++|..|. .+..+++|++|++++|++++ +| .+..+++|++|++++|+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~------------ 83 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK------------ 83 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC------------
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc------------
Confidence 4455555555555555444 44444555555555555543 33 4444444444444444443
Q ss_pred cccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCC
Q 001873 537 LVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSN 616 (1001)
Q Consensus 537 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N 616 (1001)
.+|..+..+++|+.|++++|++++ +| .+..+++|++|++++|+++
T Consensus 84 -----------~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~---------------------- 128 (198)
T 1ds9_A 84 -----------KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKIT---------------------- 128 (198)
T ss_dssp -----------SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECC----------------------
T ss_pred -----------cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCC----------------------
Confidence 112233334555555555555553 23 3555555555555555554
Q ss_pred ccccccc-ccccccccccEEEecCCcCCCChhh-----------hhcccccceeEcccCCCC
Q 001873 617 QFSGEIP-SEFSGLTKLGILDLSHNKLSGDLDA-----------LASLQNLVSLNVSFNDFS 666 (1001)
Q Consensus 617 ~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~-----------~~~l~~L~~L~ls~N~l~ 666 (1001)
+..+ ..+..+++|++|++++|++++.++. +..+++|+.|| +|+++
T Consensus 129 ---~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 129 ---NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp ---CHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred ---chhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 3222 3455666666666666666654332 56677777766 55554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.47 E-value=8.1e-13 Score=150.50 Aligned_cols=100 Identities=14% Similarity=0.122 Sum_probs=48.9
Q ss_pred cccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccc
Q 001873 553 IGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKL 632 (1001)
Q Consensus 553 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L 632 (1001)
|....+|+.+.+.++ ++.+...+|.++.+|+.+++.++ ++..-...|.++.+|+. +++..| ++.+...+|.++++|
T Consensus 293 F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~-i~lp~~-l~~I~~~aF~~C~~L 368 (394)
T 4fs7_A 293 FYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSN-INFPLS-LRKIGANAFQGCINL 368 (394)
T ss_dssp TTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCE-ECCCTT-CCEECTTTBTTCTTC
T ss_pred ccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCE-EEECcc-ccEehHHHhhCCCCC
Confidence 444455555555433 33333445555555555555433 43333444555555553 555444 444555566666666
Q ss_pred cEEEecCCcCCCChhhhhcccccce
Q 001873 633 GILDLSHNKLSGDLDALASLQNLVS 657 (1001)
Q Consensus 633 ~~L~Ls~N~l~~~~~~~~~l~~L~~ 657 (1001)
+.+++..+ ++....++...++|+.
T Consensus 369 ~~i~lp~~-~~~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 369 KKVELPKR-LEQYRYDFEDTTKFKW 392 (394)
T ss_dssp CEEEEEGG-GGGGGGGBCTTCEEEE
T ss_pred CEEEECCC-CEEhhheecCCCCCcE
Confidence 66666544 2222233444444443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.46 E-value=8e-14 Score=139.46 Aligned_cols=133 Identities=17% Similarity=0.171 Sum_probs=69.2
Q ss_pred ccccccceEEccCCcCCCCCCCCCCCCC-CcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccCc
Q 001873 436 FGLRNLTKLLLLSNDLSGFIPPDIGNCT-TLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLE 514 (1001)
Q Consensus 436 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 514 (1001)
....+|++|++++|+++.. |. +..+. +|++|++++|++++. ..+..+++|++|++++|+|++..+..+..+++|+
T Consensus 16 ~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 16 TNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp ECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred CCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 3344445555555554422 22 22222 555555555555543 3455555666666666666544333345555666
Q ss_pred eEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchh----hhhccccccEEeccc
Q 001873 515 FLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPA----EILSCRKLILLDIGN 590 (1001)
Q Consensus 515 ~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~ 590 (1001)
+|++++|+++. +|. ...+..+++|+.|++++|+++ .+|. .+..+++|+.||+++
T Consensus 92 ~L~L~~N~i~~-~~~--------------------~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~ 149 (176)
T 1a9n_A 92 ELILTNNSLVE-LGD--------------------LDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQK 149 (176)
T ss_dssp EEECCSCCCCC-GGG--------------------GGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEE
T ss_pred EEECCCCcCCc-chh--------------------hHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCc
Confidence 66555555541 110 013455666666666666665 3344 266666666666666
Q ss_pred cccc
Q 001873 591 NRFS 594 (1001)
Q Consensus 591 N~l~ 594 (1001)
|.+.
T Consensus 150 n~~~ 153 (176)
T 1a9n_A 150 VKLK 153 (176)
T ss_dssp CCHH
T ss_pred CCHH
Confidence 6654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.46 E-value=7.4e-14 Score=139.71 Aligned_cols=110 Identities=21% Similarity=0.150 Sum_probs=69.7
Q ss_pred cccCCCCCceEeeecCcccCCCCcccCCCC-CCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccC
Q 001873 266 EIGNCSELQNLYLYQNSISGPIPGRIGALS-KLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLK 344 (1001)
Q Consensus 266 ~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 344 (1001)
.+.++++|++|++++|+++.. |. +..+. +|++|+|++|++++. ..+..+++|++|++++|.+++..+..|..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 355667777777777777743 43 44433 777777777777654 45666777777777777776544444466667
Q ss_pred ccEEEcccccccCcCCh--hhccccccCEEeccCCccc
Q 001873 345 LQELQLSVNQLSGTIPI--EIATCTALTHLEIDNNAIS 380 (1001)
Q Consensus 345 L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~i~ 380 (1001)
|++|+|++|+++ .+|. .+..+++|++|++++|.++
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 777777777665 3343 5556666666666666665
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.8e-12 Score=147.57 Aligned_cols=329 Identities=13% Similarity=0.088 Sum_probs=171.3
Q ss_pred ccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccC
Q 001873 265 EEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLK 344 (1001)
Q Consensus 265 ~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 344 (1001)
.+|.+|++|+.+.+.. .++.+...+|.++++|+.+++..+ ++..-...|.++++|+.+.+..+ +......+|.+...
T Consensus 65 ~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~ 141 (394)
T 4fs7_A 65 AAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDF 141 (394)
T ss_dssp TTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCC
T ss_pred HHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccc
Confidence 3566667777777653 355555666777777777777544 44344455666666766666544 33234445555543
Q ss_pred ccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcC
Q 001873 345 LQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSY 424 (1001)
Q Consensus 345 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~ 424 (1001)
++........ .....+|.++++|+.+.+.++.. ......|.+..+|+.+.+..| ++.....+|.++..|+.+.+..
T Consensus 142 ~~~~~~~~~~--~i~~~aF~~c~~L~~i~l~~~~~-~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~ 217 (394)
T 4fs7_A 142 KEITIPEGVT--VIGDEAFATCESLEYVSLPDSME-TLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPN 217 (394)
T ss_dssp SEEECCTTCC--EECTTTTTTCTTCCEEECCTTCC-EECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCT
T ss_pred cccccCcccc--ccchhhhcccCCCcEEecCCccc-eeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCC
Confidence 3333222222 12334566666677666654432 233445555555665555444 3333344566666666666655
Q ss_pred ccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCc
Q 001873 425 NNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIP 504 (1001)
Q Consensus 425 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 504 (1001)
+... +.+.+....+|+.+.+..+ ++.+....|..+..|+.+.+..+... .....|.++..++.+....+.+. .
T Consensus 218 ~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~ 290 (394)
T 4fs7_A 218 SLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---E 290 (394)
T ss_dssp TCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---T
T ss_pred CceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---c
Confidence 4432 2233334455666665433 23334455666666666666655443 44555666666666666554432 2
Q ss_pred ccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhcccccc
Q 001873 505 PSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLI 584 (1001)
Q Consensus 505 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 584 (1001)
..|.++.+|+.+.+..+ ++ .+...+|.++.+|+.+++.++ ++.+...+|.++.+|+
T Consensus 291 ~~F~~~~~L~~i~l~~~-i~----------------------~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~ 346 (394)
T 4fs7_A 291 KTFYGCSSLTEVKLLDS-VK----------------------FIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLS 346 (394)
T ss_dssp TTTTTCTTCCEEEECTT-CC----------------------EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCC
T ss_pred ccccccccccccccccc-cc----------------------eechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCC
Confidence 34555666666655433 33 222334555555555555433 4434444555555555
Q ss_pred EEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEE
Q 001873 585 LLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGIL 635 (1001)
Q Consensus 585 ~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L 635 (1001)
.+++..| ++..-...|.++.+|+. +++..+ ++ .+...|.+.++|+.+
T Consensus 347 ~i~lp~~-l~~I~~~aF~~C~~L~~-i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 347 NINFPLS-LRKIGANAFQGCINLKK-VELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp EECCCTT-CCEECTTTBTTCTTCCE-EEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred EEEECcc-ccEehHHHhhCCCCCCE-EEECCC-CE-EhhheecCCCCCcEE
Confidence 5555544 44344445555555553 555433 22 223456666666653
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.44 E-value=1.2e-13 Score=137.20 Aligned_cols=92 Identities=23% Similarity=0.245 Sum_probs=63.5
Q ss_pred cccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEE
Q 001873 557 TELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILD 636 (1001)
Q Consensus 557 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 636 (1001)
++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+. |+|++|+|++..+..|..+++|++|+
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~ 108 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQ-LSLNDNQLKSIPRGAFDNLKSLTHIW 108 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCE-EECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCE-EECCCCccCEeCHHHhcCCCCCCEEE
Confidence 45556666666666555566666666666666666666555555666666665 77777777766666788888999999
Q ss_pred ecCCcCCCChhhh
Q 001873 637 LSHNKLSGDLDAL 649 (1001)
Q Consensus 637 Ls~N~l~~~~~~~ 649 (1001)
|++|+++++++.+
T Consensus 109 L~~N~~~c~c~~l 121 (170)
T 3g39_A 109 LLNNPWDCACSDI 121 (170)
T ss_dssp CCSSCBCTTBGGG
T ss_pred eCCCCCCCCchhH
Confidence 9999999887543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.9e-13 Score=136.24 Aligned_cols=94 Identities=19% Similarity=0.242 Sum_probs=65.2
Q ss_pred cccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEE
Q 001873 557 TELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILD 636 (1001)
Q Consensus 557 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 636 (1001)
++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+. |+|++|+|++..+..|..+++|+.|+
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~-L~L~~N~l~~l~~~~~~~l~~L~~L~ 111 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQ-LDLNDNHLKSIPRGAFDNLKSLTHIY 111 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE-EECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhE-EECCCCccceeCHHHhccccCCCEEE
Confidence 45666666666666555666666666666666666666554555566667765 77777777766666688888999999
Q ss_pred ecCCcCCCChhhhhc
Q 001873 637 LSHNKLSGDLDALAS 651 (1001)
Q Consensus 637 Ls~N~l~~~~~~~~~ 651 (1001)
|++|+|.+++..+..
T Consensus 112 L~~N~~~c~~~~~~~ 126 (174)
T 2r9u_A 112 LYNNPWDCECRDIMY 126 (174)
T ss_dssp CCSSCBCTTBGGGHH
T ss_pred eCCCCcccccccHHH
Confidence 999999988764433
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.37 E-value=2e-12 Score=128.29 Aligned_cols=106 Identities=25% Similarity=0.289 Sum_probs=64.1
Q ss_pred CceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEccc
Q 001873 273 LQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSV 352 (1001)
Q Consensus 273 L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 352 (1001)
.+++++++|.++. +|..+. ++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 3556666666653 444442 5566666666666655566666666666666666666655555556666666666666
Q ss_pred ccccCcCChhhccccccCEEeccCCcccC
Q 001873 353 NQLSGTIPIEIATCTALTHLEIDNNAISG 381 (1001)
Q Consensus 353 N~l~~~~p~~~~~l~~L~~L~L~~N~i~~ 381 (1001)
|+|++..+..|..+++|++|+|++|.+..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 66665555556666666666666666553
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.35 E-value=3.5e-12 Score=127.03 Aligned_cols=104 Identities=22% Similarity=0.262 Sum_probs=64.9
Q ss_pred ceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccc
Q 001873 274 QNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVN 353 (1001)
Q Consensus 274 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 353 (1001)
+.+++++|+++ .+|..+. ++|+.|+|++|++++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45666666664 4454443 56666666666666666666666666666666666666544445566666666666666
Q ss_pred cccCcCChhhccccccCEEeccCCccc
Q 001873 354 QLSGTIPIEIATCTALTHLEIDNNAIS 380 (1001)
Q Consensus 354 ~l~~~~p~~~~~l~~L~~L~L~~N~i~ 380 (1001)
+|++..+..|..+++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 666544445666666666666666665
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.25 E-value=5.1e-12 Score=141.35 Aligned_cols=131 Identities=20% Similarity=0.136 Sum_probs=103.8
Q ss_pred cccCCCC-cCCCCcccccccccccceeeccC-ccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcC
Q 001873 537 LVDLSDN-RLSGSLAHSIGSLTELSKLLLSK-NQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLS 614 (1001)
Q Consensus 537 ~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls 614 (1001)
.++++++ +|++ +|. +..+++|+.|+|++ |+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+. |+|+
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~-L~l~ 88 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR-LNLS 88 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE-EECC
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCE-EeCC
Confidence 3566666 6764 566 88888999999996 9999888888999999999999999999888889999999996 9999
Q ss_pred CCcccccccccccccccccEEEecCCcCCCChhh--hhcccccceeEcccCCCCCCCCC
Q 001873 615 SNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDA--LASLQNLVSLNVSFNDFSGELPN 671 (1001)
Q Consensus 615 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~--~~~l~~L~~L~ls~N~l~~~~p~ 671 (1001)
+|+|++..+..|..++ |+.|+|++|+|.|+++. +..........+..++++...|.
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 9999988777777776 99999999999998753 33333333444555667666665
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.23 E-value=6e-12 Score=140.72 Aligned_cols=109 Identities=24% Similarity=0.260 Sum_probs=84.9
Q ss_pred CccceEEeCCCCcEEEEEeccccccccCCcccccCCCCcEEeccC-CcccCCCCcccCCccccccccccCCccCCCCChh
Q 001873 67 CKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISS-CNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTE 145 (1001)
Q Consensus 67 c~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~-~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~ 145 (1001)
|.|.+|.|+..+ +|.+ +|. +..+++|++|+|++ |.+++..|..|++|++|++|+|++|+|++..|..
T Consensus 8 C~~~~v~~~~~n----------~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 75 (347)
T 2ifg_A 8 HGSSGLRCTRDG----------ALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75 (347)
T ss_dssp SSSSCEECCSSC----------CCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTG
T ss_pred ccCCEEEcCCCC----------CCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHH
Confidence 899999996321 3443 677 88888888888886 8888777778888888888888888888878888
Q ss_pred hhcccccceEEccCCcccCCCCccccCCccccceecccccccc
Q 001873 146 VCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSG 188 (1001)
Q Consensus 146 ~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g 188 (1001)
|..|++|++|+|++|+|++..|..+..++ |++|+|++|.+..
T Consensus 76 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp GGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred hcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 88888888888888888854444445555 8888888888763
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=4.1e-13 Score=150.87 Aligned_cols=114 Identities=17% Similarity=0.177 Sum_probs=53.6
Q ss_pred CCcceEEccccccccCCCcccCC-----CCCcceeeccCcccccCCccccc-ccccCceEEcccccCcccCCCCcccccc
Q 001873 463 TTLRRLRLNDNRLSGTIPSEMGN-----LKHLNFVDMSENHLVGGIPPSVV-GCQSLEFLDLHSNGLTGSVPDTLPTSLQ 536 (1001)
Q Consensus 463 ~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~~l~ 536 (1001)
+.|+.|+|++|.++......+.. .++|++|+|++|.++......+. .+++|+.|+|++|+|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L----- 146 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDL----- 146 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHH-----
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHH-----
Confidence 45666666666665332222221 24566666666655433222222 23445555555555442111111
Q ss_pred cccCCCCcCCCCccccc-ccccccceeeccCcccccc----chhhhhccccccEEeccccccc
Q 001873 537 LVDLSDNRLSGSLAHSI-GSLTELSKLLLSKNQLSGR----IPAEILSCRKLILLDIGNNRFS 594 (1001)
Q Consensus 537 ~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 594 (1001)
...+ ...++|++|+|++|+|++. ++..+...++|++|||++|+|+
T Consensus 147 -------------~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 147 -------------RDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG 196 (372)
T ss_dssp -------------HHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCH
T ss_pred -------------HHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCC
Confidence 0011 1234566666666666532 2333345566666666666655
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=3.8e-11 Score=128.42 Aligned_cols=145 Identities=14% Similarity=0.107 Sum_probs=115.2
Q ss_pred HHHHhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCC--CchhhHHHHHHHhhccC-CCceeeEEeeeecCCceEEE
Q 001873 762 DDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSS--DESGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 762 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~~lv 838 (1001)
......|++....|.|+.+.||++... ++.+++|..... .....+.+|+.+++.+. +..+.++++++.+.+..|+|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 445677888888899999999999864 789999998542 33457999999999984 67788999999888889999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------------------------------------
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC------------------------------------ 882 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~------------------------------------ 882 (1001)
|||++|.++.+.... ......++.++++++..||+..
T Consensus 89 ~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 89 MSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 999999999876421 1123467889999999999810
Q ss_pred --------------------CCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 883 --------------------MPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 883 --------------------~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.+.++|+|++|.||+++++..+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 03589999999999998765667999998753
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.18 E-value=8.7e-10 Score=125.34 Aligned_cols=293 Identities=14% Similarity=0.208 Sum_probs=139.8
Q ss_pred cccCC-CCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCc---ccccCCCCccCCCCCCEEeccCCCCCCCCCccccc
Q 001873 266 EIGNC-SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNS---LVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGN 341 (1001)
Q Consensus 266 ~l~~l-~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~---l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 341 (1001)
+|.++ ..|+.+.+-.+ ++.+...+|.++++|+.+.+..|. ++..-...|..+.+|+.+.+..+ ++......|..
T Consensus 58 aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~ 135 (394)
T 4gt6_A 58 VFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHH 135 (394)
T ss_dssp TTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTT
T ss_pred hccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhh
Confidence 34444 23555555432 444555566666666666665442 44333445555666666555543 33233445566
Q ss_pred ccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEe
Q 001873 342 LLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALD 421 (1001)
Q Consensus 342 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~ 421 (1001)
+.+|+.+.+..+ +.......|..+.+|+.+.+..+ ++......|.. .+|+.+.+..+- +.....+|..+..++...
T Consensus 136 c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~-~~i~~~af~~c~~l~~~~ 211 (394)
T 4gt6_A 136 CEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKV-TRIGTNAFSECFALSTIT 211 (394)
T ss_dssp CTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTC-CEECTTTTTTCTTCCEEE
T ss_pred hcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcc-cccccchhhhccccceec
Confidence 666666666543 22234455666666666666543 22222223322 445555554332 223334555666666555
Q ss_pred CcCccccCCCCccccc--------------ccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCC
Q 001873 422 FSYNNLSGPIPKEIFG--------------LRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLK 487 (1001)
Q Consensus 422 Ls~N~l~~~~~~~~~~--------------l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 487 (1001)
...+.... +...+.. ...+..+.+. +.++.+...+|.+++.|+.+.+.++..+ .....|.+++
T Consensus 212 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~ 288 (394)
T 4gt6_A 212 SDSESYPA-IDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCP 288 (394)
T ss_dssp ECCSSSCB-SSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCT
T ss_pred cccccccc-ccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCccccccc
Confidence 54443331 1111111 1112222221 1222233345555555555555544333 4444555555
Q ss_pred CcceeeccCcccccCCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCc
Q 001873 488 HLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKN 567 (1001)
Q Consensus 488 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 567 (1001)
.|+.+.+. +.++.....+|.+|.+|+.+++..+ + +.+...+|.++.+|+.+.+..+
T Consensus 289 ~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v----------------------~~I~~~aF~~C~~L~~i~ip~s 344 (394)
T 4gt6_A 289 ALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-I----------------------TQILDDAFAGCEQLERIAIPSS 344 (394)
T ss_dssp TCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-C----------------------CEECTTTTTTCTTCCEEEECTT
T ss_pred ccccccCC-CcccccCceeecCCCCcCEEEeCCc-c----------------------cEehHhHhhCCCCCCEEEECcc
Confidence 55555554 2333344445555555555554332 2 2223345555666666666543
Q ss_pred cccccchhhhhccccccEEeccccc
Q 001873 568 QLSGRIPAEILSCRKLILLDIGNNR 592 (1001)
Q Consensus 568 ~l~~~~p~~~~~l~~L~~L~Ls~N~ 592 (1001)
++.+...+|.++++|+.+++.+|.
T Consensus 345 -v~~I~~~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 345 -VTKIPESAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp -CCBCCGGGGTTCTTCCEEEESSCH
T ss_pred -cCEEhHhHhhCCCCCCEEEECCce
Confidence 444445566666666666666554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=3.3e-13 Score=151.60 Aligned_cols=62 Identities=15% Similarity=0.135 Sum_probs=30.6
Q ss_pred CCCCEEeccCCCCCCCCCcccccc-----cCccEEEcccccccCcCChhh-ccccccCEEeccCCccc
Q 001873 319 TELTVVDFSDNLLTGSIPRSFGNL-----LKLQELQLSVNQLSGTIPIEI-ATCTALTHLEIDNNAIS 380 (1001)
Q Consensus 319 ~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~i~ 380 (1001)
+.|+.|+|++|.++......+... ++|++|+|++|+++......+ ..+++|++|+|++|.|+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~ 139 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG 139 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCC
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCC
Confidence 456666777766654333332222 456666666666543222222 23345555555555554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.1e-09 Score=124.38 Aligned_cols=273 Identities=11% Similarity=0.174 Sum_probs=153.8
Q ss_pred Cccccccccceecccccc---ccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccC
Q 001873 241 SSIGMLERIQTIAIYTSL---LSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGS 317 (1001)
Q Consensus 241 ~~i~~l~~L~~L~l~~n~---l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 317 (1001)
.++.++.+|+.+.+..+. ++..-...|.++.+|+.+.+..+ ++.+...+|..+.+|+.+.+..+ +.......|..
T Consensus 81 ~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~ 158 (394)
T 4gt6_A 81 NAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEG-VTSVADGMFSY 158 (394)
T ss_dssp TTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred HHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhcccccccccce-eeeecccceec
Confidence 344444444444444332 22122344666666666665543 34355556667777777777543 33244455666
Q ss_pred CCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCcccc---------
Q 001873 318 CTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIG--------- 388 (1001)
Q Consensus 318 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~--------- 388 (1001)
+.+|+.+.+..+ ++.....+|.. .+|+.+.+..+-.. ....+|..+.+++......+......-..+.
T Consensus 159 c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (394)
T 4gt6_A 159 CYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYAL 235 (394)
T ss_dssp CTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEE
T ss_pred ccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccceecccccccccccceeecccccccccc
Confidence 777777777654 33233344543 45666666554332 4445666666666666554443211100000
Q ss_pred ----ccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCC
Q 001873 389 ----NINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTT 464 (1001)
Q Consensus 389 ----~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 464 (1001)
....+..+.+. +.++.....+|.++..|+.+.+..+..+ ....+|.++.+|+.+.+. +.++.+...+|.++.+
T Consensus 236 ~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~ 312 (394)
T 4gt6_A 236 IRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCIS 312 (394)
T ss_dssp EECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTT
T ss_pred cccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCC
Confidence 11112222221 2223233456777777887777665443 555667777778877775 4555566667777888
Q ss_pred cceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccCceEEcccccC
Q 001873 465 LRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGL 523 (1001)
Q Consensus 465 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 523 (1001)
|+.+++..+ ++.+...+|.++.+|+.+.+..+ ++.+-..+|.+|++|+.+++.+|..
T Consensus 313 L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 313 LKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp CCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred cCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 888887654 55455667777888888877654 5555567777788888777776643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.08 E-value=1.2e-10 Score=124.34 Aligned_cols=129 Identities=20% Similarity=0.164 Sum_probs=98.9
Q ss_pred eecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccCCCc--eeeEEeeeecCCceEEEEEccCCCCHHHHhh
Q 001873 775 GTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKN--IVRLLGWGSNKNLKLLFYDYLPNGSLSSLLH 852 (1001)
Q Consensus 775 G~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 852 (1001)
+.|..+.||++...+|+.++||..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||++|.++. ..
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~ 105 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS 105 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC
Confidence 456669999998877888999987554 3467889999999986444 566888888878889999999998884 21
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------------------
Q 001873 853 GAGKGGADWEARYEVVLGVAHALAYLHHDC-------------------------------------------------- 882 (1001)
Q Consensus 853 ~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~-------------------------------------------------- 882 (1001)
. .+ ...++.+++..+..||+..
T Consensus 106 ~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (264)
T 1nd4_A 106 H-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 177 (264)
T ss_dssp C-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred c-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHh
Confidence 1 11 2256778888888888741
Q ss_pred -----CCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 883 -----MPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 883 -----~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.+.++|+|++|.||++++++.+.|+|||.+..
T Consensus 178 ~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 178 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01299999999999998776677999998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.91 E-value=3.4e-09 Score=118.78 Aligned_cols=139 Identities=15% Similarity=0.280 Sum_probs=106.4
Q ss_pred CCeEeecCCeeEEEEEeCCCCEEEEEEec--CCC---chhhHHHHHHHhhccC--CCceeeEEeeeecC---CceEEEEE
Q 001873 771 ANVIGTGSSGVVYRVTIPNGETLAVKKMW--SSD---ESGAFSSEIQTLGSIR--HKNIVRLLGWGSNK---NLKLLFYD 840 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~---~~~~~~~Ei~~l~~l~--h~nIv~l~~~~~~~---~~~~lv~e 840 (1001)
++.++.|.++.||+++.. +..+++|+.. ... ....+.+|+.+++.+. +..+++++.++.+. +..|+|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 456899999999999875 4788899875 322 2357889999999996 45688899988766 45799999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC-------------------------------------- 882 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~-------------------------------------- 882 (1001)
|++|..+.+.. ...++...+..++.+++.++..||+..
T Consensus 122 ~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 122 FVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred ecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99988775422 123677888889999999999999720
Q ss_pred -----------------CCCeEEeCCCCCCeEECCCCc--EEEeccccccc
Q 001873 883 -----------------MPPILHGDVKAMNVLLGPGYQ--AYLADFGLARI 914 (1001)
Q Consensus 883 -----------------~~~ivH~Dlkp~NIll~~~~~--~ki~Dfgla~~ 914 (1001)
.+.++|||++|.||+++.++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 146999999999999997653 68999998864
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.90 E-value=7.7e-08 Score=108.60 Aligned_cols=104 Identities=12% Similarity=0.100 Sum_probs=42.8
Q ss_pred cccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCc
Q 001873 266 EIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKL 345 (1001)
Q Consensus 266 ~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 345 (1001)
+|.+|++|+.++|..+ ++.+...+|.+. +|+.+.+..+ ++..-...|.. .+|+.+++..+... .....|.+. +|
T Consensus 64 aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp~~~~~-i~~~~F~~~-~l 137 (379)
T 4h09_A 64 NFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEFPGATTE-IGNYIFYNS-SV 137 (379)
T ss_dssp TTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEECCTTCCE-ECTTTTTTC-CC
T ss_pred HhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccCCCcccc-ccccccccc-ee
Confidence 4555555555555432 443444455544 4555544332 33222223332 24555555443221 222233322 34
Q ss_pred cEEEcccccccCcCChhhccccccCEEeccC
Q 001873 346 QELQLSVNQLSGTIPIEIATCTALTHLEIDN 376 (1001)
Q Consensus 346 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 376 (1001)
+.+.+..+ ++......|..+.+++.+.+..
T Consensus 138 ~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~ 167 (379)
T 4h09_A 138 KRIVIPKS-VTTIKDGIGYKAENLEKIEVSS 167 (379)
T ss_dssp CEEEECTT-CCEECSCTTTTCTTCCEEEECT
T ss_pred eeeeccce-eeccccchhccccccccccccc
Confidence 44433322 2223333444455555544443
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=1.3e-09 Score=119.11 Aligned_cols=192 Identities=18% Similarity=0.219 Sum_probs=123.2
Q ss_pred CCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccC-CCc--eeeEEeeeecCC---ceEEEEEccCC
Q 001873 771 ANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIR-HKN--IVRLLGWGSNKN---LKLLFYDYLPN 844 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~-h~n--Iv~l~~~~~~~~---~~~lv~e~~~~ 844 (1001)
++.++.|.+..||++. ..+++|+.........+.+|+++++.+. +.. +.+++.+....+ ..|+||||++|
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 4579999999999863 5688998654434467899999998883 332 445555543333 34789999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhC-------------------------------------------
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHD------------------------------------------- 881 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~------------------------------------------- 881 (1001)
.++.+.... .++..++..++.+++..+..||+.
T Consensus 101 ~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 101 VPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp EECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred eECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 888754331 256777788888888888888861
Q ss_pred ------------CCCCeEEeCCCCCCeEECC--CCcEEEecccccccccCCCCCCCCCCC---CC----CcccccccccC
Q 001873 882 ------------CMPPILHGDVKAMNVLLGP--GYQAYLADFGLARIVSGSGDDNCSKTN---QR----PQLAGSYGYMA 940 (1001)
Q Consensus 882 ------------~~~~ivH~Dlkp~NIll~~--~~~~ki~Dfgla~~~~~~~~~~~~~~~---~~----~~~~gt~~y~a 940 (1001)
..+.++|+|++|.||++++ ...+.|+||+.+..-.+..+-...... .. .......++..
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 1135799999999999998 456789999998753221100000000 00 00000001111
Q ss_pred -ccccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 001873 941 -PEHASMQRITEKSDVYSFGVVLLEVLTGRHPL 972 (1001)
Q Consensus 941 -PE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf 972 (1001)
|+... ......+.|+++.++|.+.+|+.+|
T Consensus 257 ~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 257 IPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 22111 1112358999999999999998765
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.86 E-value=1.6e-07 Score=106.08 Aligned_cols=246 Identities=9% Similarity=0.034 Sum_probs=116.9
Q ss_pred ccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCcc
Q 001873 267 IGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQ 346 (1001)
Q Consensus 267 l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 346 (1001)
+....+|+.+.+.. .++.+...+|.++.+|+.+.|..+ ++..-..+|.++ +|+.+.+..+ ++.....+|.. .+|+
T Consensus 42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~ 116 (379)
T 4h09_A 42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLD 116 (379)
T ss_dssp GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCS
T ss_pred cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcc
Confidence 33444555555532 344444556666666666666533 443444455554 4555555433 33233334433 3566
Q ss_pred EEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccC------------CCCCcccccC
Q 001873 347 ELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLT------------GNIPESLSQC 414 (1001)
Q Consensus 347 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~------------~~~p~~l~~l 414 (1001)
.+.+..+- .......|.++ +++.+.+..+ ++......+.....++...+..+... ......+...
T Consensus 117 ~i~lp~~~-~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (379)
T 4h09_A 117 DFEFPGAT-TEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAA 193 (379)
T ss_dssp EEECCTTC-CEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTT
T ss_pred cccCCCcc-ccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceecccccc
Confidence 66665442 21222333332 4444444332 22233344444555555544433221 0111123333
Q ss_pred cccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeec
Q 001873 415 QELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDM 494 (1001)
Q Consensus 415 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 494 (1001)
..+..+.+..+.- ......+....+|+.+.+..+ +..+...+|..+..|+.+.+..+ ++......|.++.+|+.+.+
T Consensus 194 ~~~~~~~~~~~~~-~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l 270 (379)
T 4h09_A 194 KTGTEFTIPSTVK-TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNF 270 (379)
T ss_dssp CCCSEEECCTTCC-EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEE
T ss_pred cccccccccccee-EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccc
Confidence 3444444333222 133344555556666665443 33344455666666666666554 44344556666666666666
Q ss_pred cCcccccCCcccccccccCceEEcccccCc
Q 001873 495 SENHLVGGIPPSVVGCQSLEFLDLHSNGLT 524 (1001)
Q Consensus 495 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 524 (1001)
..+ ++......|.++.+|+.+++.++.++
T Consensus 271 ~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~ 299 (379)
T 4h09_A 271 YAK-VKTVPYLLCSGCSNLTKVVMDNSAIE 299 (379)
T ss_dssp CCC-CSEECTTTTTTCTTCCEEEECCTTCC
T ss_pred ccc-ceeccccccccccccccccccccccc
Confidence 543 44344455666666666666655554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.78 E-value=2.6e-10 Score=120.14 Aligned_cols=159 Identities=17% Similarity=0.095 Sum_probs=86.6
Q ss_pred CCccceEEeCCCC-cEEEEEecc---ccccccCCc-ccccCCCCcEEeccCCcccCCCCc-ccCCcccccc--ccccCCc
Q 001873 66 PCKWFGIHCSSNG-EVVEISLKA---VDLQGSLPS-IFQPLKSLKRLIISSCNLTGTIPK-EFGDYRELTF--IDLSGNS 137 (1001)
Q Consensus 66 ~c~w~gv~c~~~~-~v~~l~l~~---~~l~~~~~~-~~~~l~~L~~L~l~~~~l~g~~p~-~~~~l~~L~~--L~Ls~n~ 137 (1001)
.|+|.|+.|+..| +|+.+...+ ..++|.+++ .+..++. .|...++.-++.++- .+...+.|.. ++++.|.
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR 154 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence 4899999998544 554433333 334444432 2222222 122233333333332 2444555555 5666664
Q ss_pred cCCCCChh----hhcccccceEEccCCcccC--CCCccccCCccccceeccccccccccCCCccchh--hhhhhhhccCc
Q 001873 138 LWGEIPTE----VCRLRKLESLYLNTNLLEG--EIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALS--KLQVFRAGGNQ 209 (1001)
Q Consensus 138 l~g~~p~~----~~~l~~L~~L~L~~n~l~~--~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~~l~--~L~~L~l~~n~ 209 (1001)
.. .++.. ...+++|++|+|++|+|++ .+|..++.+++|++|+|++|++++. ..+..++ +|++|+|++|
T Consensus 155 ~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~N- 230 (267)
T 3rw6_A 155 RS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGN- 230 (267)
T ss_dssp HH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTS-
T ss_pred HH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCC-
Confidence 32 22322 2456677777777777765 4556666777777777777777643 3445555 6777777777
Q ss_pred CCCCCCCc-------ccccCccchhccc
Q 001873 210 NLKGELPW-------EIGNCSNLVMLGL 230 (1001)
Q Consensus 210 ~l~~~lp~-------~l~~l~~L~~L~l 230 (1001)
.+++.+|. .+..+++|+.||=
T Consensus 231 pl~~~~~~~~~y~~~il~~~P~L~~LDg 258 (267)
T 3rw6_A 231 SLCDTFRDQSTYISAIRERFPKLLRLDG 258 (267)
T ss_dssp TTGGGCSSHHHHHHHHHHHCTTCCEESS
T ss_pred cCccccCcchhHHHHHHHHCcccCeECC
Confidence 45555552 2556677777653
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.77 E-value=4.1e-10 Score=125.25 Aligned_cols=169 Identities=14% Similarity=0.098 Sum_probs=91.0
Q ss_pred CCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccccccccCCCcc--chhhhhhhhhccCcCCCCCCCcc
Q 001873 141 EIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIG--ALSKLQVFRAGGNQNLKGELPWE 218 (1001)
Q Consensus 141 ~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g~~p~~~~--~l~~L~~L~l~~n~~l~~~lp~~ 218 (1001)
.++..+..+++|+.|+|++|.-. .+|. + .+++|++|+|..|.+.......++ .+++|++|+|+.+.+..+.-+ .
T Consensus 163 ~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~-~ 238 (362)
T 2ra8_A 163 DLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG-D 238 (362)
T ss_dssp BCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCS-C
T ss_pred CHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccch-h
Confidence 34555666777777777776311 2333 3 266777777776666543333333 456666666543211000000 0
Q ss_pred cccCccchhccccccccccccCCccccccccceeccccccccccCccccc---CCCCCceEeeecCcccCC----CCccc
Q 001873 219 IGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIG---NCSELQNLYLYQNSISGP----IPGRI 291 (1001)
Q Consensus 219 l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~---~l~~L~~L~L~~N~i~~~----~p~~~ 291 (1001)
+ ..+.. .. ....+++|+.|++.+|.+++..+..+. .+++|++|+|+.|.+++. ++..+
T Consensus 239 ~---~~l~~-----------~l-~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L 303 (362)
T 2ra8_A 239 M---NVFRP-----------LF-SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHV 303 (362)
T ss_dssp G---GGTGG-----------GS-CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTH
T ss_pred H---HHHHH-----------HH-hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhc
Confidence 0 00000 00 001245566666666655543333332 467889999988888763 33344
Q ss_pred CCCCCCcEEEcCCCcccccCCCCccC-CCCCCEEeccCCC
Q 001873 292 GALSKLKSLLLWQNSLVGAIPDELGS-CTELTVVDFSDNL 330 (1001)
Q Consensus 292 ~~l~~L~~L~L~~N~l~~~~p~~l~~-l~~L~~L~Ls~N~ 330 (1001)
..+++|+.|+|++|.++...-..+.. + ...++++.++
T Consensus 304 ~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 304 DKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred ccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 56788999999988877543333332 2 3568888887
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.74 E-value=2.3e-09 Score=119.23 Aligned_cols=163 Identities=15% Similarity=0.161 Sum_probs=79.9
Q ss_pred CcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCcc--CCCCCCEEeccC--CCCCCC----
Q 001873 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELG--SCTELTVVDFSD--NLLTGS---- 334 (1001)
Q Consensus 263 ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~--~l~~L~~L~Ls~--N~l~~~---- 334 (1001)
++..+..+++|+.|+|++|.-. .++. + .+++|+.|+|..|.+.......++ .+++|+.|+|+. |...+.
T Consensus 164 L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~ 240 (362)
T 2ra8_A 164 LSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMN 240 (362)
T ss_dssp CHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGG
T ss_pred HHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHH
Confidence 4455566677777777776311 1222 3 266777777776665533222332 566677776643 211111
Q ss_pred -CCccc--ccccCccEEEcccccccCcCChhhc---cccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCC
Q 001873 335 -IPRSF--GNLLKLQELQLSVNQLSGTIPIEIA---TCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIP 408 (1001)
Q Consensus 335 -~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p 408 (1001)
+...+ ..+++|++|+|++|++.+..+..+. .+++|++|+|+.|.+.+..+. .++
T Consensus 241 ~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~--------------------~L~ 300 (362)
T 2ra8_A 241 VFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGAR--------------------LLL 300 (362)
T ss_dssp GTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHH--------------------HHH
T ss_pred HHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHH--------------------HHH
Confidence 00111 1345566666666555432222222 244555555555555432111 122
Q ss_pred cccccCcccceEeCcCccccCCCCccccc-ccccceEEccCCc
Q 001873 409 ESLSQCQELQALDFSYNNLSGPIPKEIFG-LRNLTKLLLLSND 450 (1001)
Q Consensus 409 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~~N~ 450 (1001)
..+..+++|+.|++++|.|+......+.. + ...++++.++
T Consensus 301 ~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 301 DHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp TTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred hhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 23345667777777777766332222222 1 2456777766
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=2e-06 Score=93.68 Aligned_cols=136 Identities=20% Similarity=0.176 Sum_probs=95.8
Q ss_pred CCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccCCC---ceeeEEeeee-cCCceEEEEEccCCCC
Q 001873 771 ANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHK---NIVRLLGWGS-NKNLKLLFYDYLPNGS 846 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~---nIv~l~~~~~-~~~~~~lv~e~~~~gs 846 (1001)
++.++.|....||++ ++.++||+-........+.+|+++++.+.+. .|.+++.+.. ..+..++||||++|..
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 456899999999997 5778899854333346788999999999642 3566676664 4556789999999988
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhC---------------------------------------------
Q 001873 847 LSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHD--------------------------------------------- 881 (1001)
Q Consensus 847 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~--------------------------------------------- 881 (1001)
+.+.... .++......++.+++..+..||+.
T Consensus 100 l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 100 LGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp CHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred Cchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 8763221 134444455555555555555542
Q ss_pred ------------CCCCeEEeCCCCCCeEECC---CCc-EEEeccccccc
Q 001873 882 ------------CMPPILHGDVKAMNVLLGP---GYQ-AYLADFGLARI 914 (1001)
Q Consensus 882 ------------~~~~ivH~Dlkp~NIll~~---~~~-~ki~Dfgla~~ 914 (1001)
..+.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235699999999999987 455 48999998865
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.33 E-value=9.1e-08 Score=100.72 Aligned_cols=103 Identities=26% Similarity=0.338 Sum_probs=61.8
Q ss_pred cccccccce--eeccCccccccchh----hhhccccccEEecccccccC--CCCCccccccchhhhhhcCCCcccccccc
Q 001873 553 IGSLTELSK--LLLSKNQLSGRIPA----EILSCRKLILLDIGNNRFSG--EIPKELGQISSLEISLNLSSNQFSGEIPS 624 (1001)
Q Consensus 553 ~~~l~~L~~--L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~ 624 (1001)
|...+.|.. ++++.|+.. .++. ....+++|+.|+|++|+|++ .+|..+..+++|+. |+|++|+|++. +
T Consensus 137 l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~-L~Ls~N~i~~~--~ 212 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI-LNLSGNELKSE--R 212 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCE-EECTTSCCCSG--G
T ss_pred cCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCE-EECCCCccCCc--h
Confidence 344455555 666666433 2222 22346677777777777765 34455566666664 66666666654 2
Q ss_pred cccccc--cccEEEecCCcCCCCh--------hhhhcccccceeE
Q 001873 625 EFSGLT--KLGILDLSHNKLSGDL--------DALASLQNLVSLN 659 (1001)
Q Consensus 625 ~~~~l~--~L~~L~Ls~N~l~~~~--------~~~~~l~~L~~L~ 659 (1001)
.+..+. +|++|+|++|++.+.. ..+..+++|+.||
T Consensus 213 ~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 213 ELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 233333 7888888888887521 2467778888776
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.25 E-value=1.5e-07 Score=94.29 Aligned_cols=114 Identities=17% Similarity=0.187 Sum_probs=71.1
Q ss_pred ccccccccceeeccCc-ccccc----chhhhhccccccEEecccccccCC----CCCccccccchhhhhhcCCCccccc-
Q 001873 552 SIGSLTELSKLLLSKN-QLSGR----IPAEILSCRKLILLDIGNNRFSGE----IPKELGQISSLEISLNLSSNQFSGE- 621 (1001)
Q Consensus 552 ~~~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~~L~Ls~N~l~~~- 621 (1001)
.+...+.|++|+|++| .|... +...+...++|++|+|++|+|... +...+...+.|+. |+|++|.|...
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~-L~L~~N~i~~~g 109 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKS-LNVESNFISGSG 109 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCE-EECCSSCCCHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCE-EECcCCcCCHHH
Confidence 3444566666666666 66532 233344456666666666666532 2223333455664 66677666653
Q ss_pred ---ccccccccccccEEEe--cCCcCCCC-----hhhhhcccccceeEcccCCCC
Q 001873 622 ---IPSEFSGLTKLGILDL--SHNKLSGD-----LDALASLQNLVSLNVSFNDFS 666 (1001)
Q Consensus 622 ---~p~~~~~l~~L~~L~L--s~N~l~~~-----~~~~~~l~~L~~L~ls~N~l~ 666 (1001)
+...+...+.|++|+| ++|.+... ...+...+.|++|+|++|.+.
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3455666778999999 88998763 245566688999999999774
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.24 E-value=7.9e-08 Score=96.30 Aligned_cols=118 Identities=15% Similarity=0.200 Sum_probs=73.7
Q ss_pred CcccccCCCCCceEeeecC-cccCC----CCcccCCCCCCcEEEcCCCccccc----CCCCccCCCCCCEEeccCCCCCC
Q 001873 263 IPEEIGNCSELQNLYLYQN-SISGP----IPGRIGALSKLKSLLLWQNSLVGA----IPDELGSCTELTVVDFSDNLLTG 333 (1001)
Q Consensus 263 ip~~l~~l~~L~~L~L~~N-~i~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~ 333 (1001)
+...+...+.|++|+|++| .+... +...+...++|++|+|++|++... +...+...++|++|+|++|.|..
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3345666778888888888 77632 233455567777888887777532 23334455677777777777764
Q ss_pred C----CCcccccccCccEEEc--ccccccCc----CChhhccccccCEEeccCCccc
Q 001873 334 S----IPRSFGNLLKLQELQL--SVNQLSGT----IPIEIATCTALTHLEIDNNAIS 380 (1001)
Q Consensus 334 ~----~p~~~~~l~~L~~L~L--s~N~l~~~----~p~~~~~l~~L~~L~L~~N~i~ 380 (1001)
. +...+...++|++|+| ++|.|... +...+...++|++|+|++|.+.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3 2344555667777777 66777643 2233445567777777777664
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=2.9e-06 Score=90.69 Aligned_cols=135 Identities=19% Similarity=0.183 Sum_probs=97.7
Q ss_pred eEeecCCe-eEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccC-CCceeeEEeeeecCCceEEEEEccCCCCHHH
Q 001873 773 VIGTGSSG-VVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLKLLFYDYLPNGSLSS 849 (1001)
Q Consensus 773 ~lG~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 849 (1001)
.+..|..| .||+...+ ++..++||+-.. ....++.+|...++.+. +--|.++++++.+.+..++|||+++|.++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 45566666 69998765 467788998543 23457889999998884 3347788999988899999999999988877
Q ss_pred HhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------------------
Q 001873 850 LLHGAGKGGADWEARYEVVLGVAHALAYLHHDC----------------------------------------------- 882 (1001)
Q Consensus 850 ~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~----------------------------------------------- 882 (1001)
..... ......++.+++..+..||+..
T Consensus 110 ~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 110 VLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred cccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 65431 1122345566666666666420
Q ss_pred --------CCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 883 --------MPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 883 --------~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 02379999999999999877777999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=4.6e-06 Score=93.06 Aligned_cols=78 Identities=10% Similarity=0.105 Sum_probs=56.9
Q ss_pred CCeE-eecCCeeEEEEEeC-------CCCEEEEEEecCCC-----chhhHHHHHHHhhccC-C--CceeeEEeeeecC--
Q 001873 771 ANVI-GTGSSGVVYRVTIP-------NGETLAVKKMWSSD-----ESGAFSSEIQTLGSIR-H--KNIVRLLGWGSNK-- 832 (1001)
Q Consensus 771 ~~~l-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~-h--~nIv~l~~~~~~~-- 832 (1001)
.+.| +.|....+|+++.. +++.+++|...... ....+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3467 88889999998764 26788999764432 1357889999999884 3 3577888877655
Q ss_pred -CceEEEEEccCCCCHH
Q 001873 833 -NLKLLFYDYLPNGSLS 848 (1001)
Q Consensus 833 -~~~~lv~e~~~~gsL~ 848 (1001)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.77 E-value=6.4e-05 Score=83.07 Aligned_cols=139 Identities=17% Similarity=0.286 Sum_probs=80.9
Q ss_pred eEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccCC--CceeeEEe------eeecCCceEEEEEccCC
Q 001873 773 VIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRH--KNIVRLLG------WGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 773 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h--~nIv~l~~------~~~~~~~~~lv~e~~~~ 844 (1001)
.++.|..+.||++...++ .+++|+.... ..++..|..+++.+.. -.+.+++. +....+..++||+|++|
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~--~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G 115 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP--EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG 115 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC--HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC--HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence 456678899999987544 5899988652 3445566666666531 12333433 12345677899999998
Q ss_pred CCHH--------------HHhhc----CC-C-------CCCCHHHHH-------------------------------HH
Q 001873 845 GSLS--------------SLLHG----AG-K-------GGADWEARY-------------------------------EV 867 (1001)
Q Consensus 845 gsL~--------------~~l~~----~~-~-------~~~~~~~~~-------------------------------~i 867 (1001)
..+. ..++. .. . ....|...+ .+
T Consensus 116 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (346)
T 2q83_A 116 RPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGF 195 (346)
T ss_dssp BCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHH
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHH
Confidence 6432 11111 10 0 001222110 11
Q ss_pred HHHHHHHHHHHhh----------CCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 868 VLGVAHALAYLHH----------DCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 868 ~~~i~~~l~yLH~----------~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
..++..+++++++ ...+.++|+|+++.||+++.++.+.|+||+.+..
T Consensus 196 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 196 IEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1224445666653 0124899999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=8.7e-05 Score=83.92 Aligned_cols=73 Identities=14% Similarity=0.119 Sum_probs=49.2
Q ss_pred CCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---------chhhHHHHHHHhhccCC--C-ceeeEEeeeecCCceEE
Q 001873 771 ANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---------ESGAFSSEIQTLGSIRH--K-NIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~Ei~~l~~l~h--~-nIv~l~~~~~~~~~~~l 837 (1001)
.+.+|.|.++.||+++.. +++.|+||...... ...++..|.++++.+.. + .+.+++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 346899999999999754 46899999764221 22456789999887742 3 445666543 344589
Q ss_pred EEEccCCC
Q 001873 838 FYDYLPNG 845 (1001)
Q Consensus 838 v~e~~~~g 845 (1001)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00014 Score=78.69 Aligned_cols=137 Identities=17% Similarity=0.231 Sum_probs=93.4
Q ss_pred CCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccC---CCceeeEEeeeecCCceEEEEEccCCCCH
Q 001873 771 ANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIR---HKNIVRLLGWGSNKNLKLLFYDYLPNGSL 847 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 847 (1001)
.+.++.|....+|+++. ++..++||+.... ....+.+|...++.+. ...++++++++...+..++||||+++..+
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 45689999999999987 4778999986433 3567889999998884 35688899988888889999999998754
Q ss_pred H--------H---HhhcCCC-C-------------------CCCHHHHH---HHHH----------------HHH-HHHH
Q 001873 848 S--------S---LLHGAGK-G-------------------GADWEARY---EVVL----------------GVA-HALA 876 (1001)
Q Consensus 848 ~--------~---~l~~~~~-~-------------------~~~~~~~~---~i~~----------------~i~-~~l~ 876 (1001)
. . .++.... . .-+|...+ ++.. +++ ....
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 1 1 2232211 0 12454432 1111 111 1123
Q ss_pred HHhh-CCCCCeEEeCCCCCCeEECCCCcEEEeccc
Q 001873 877 YLHH-DCMPPILHGDVKAMNVLLGPGYQAYLADFG 910 (1001)
Q Consensus 877 yLH~-~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfg 910 (1001)
.|.. ...+.++|+|+.+.|++++.++ +.|+|+.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3432 1236899999999999999887 8899984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00021 Score=76.84 Aligned_cols=75 Identities=20% Similarity=0.357 Sum_probs=55.7
Q ss_pred ccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC--chhhHHHHHHHhhccCC---CceeeEEeeeecCCceEEEEEcc
Q 001873 768 LTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD--ESGAFSSEIQTLGSIRH---KNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h---~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
...++.+|.|..+.||+++..+|++|+||+-.... ....|.+|+..|+.+.. --+++++++. ..++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 44566799999999999999999999999865432 23568899999988842 2345555542 237899999
Q ss_pred CCCC
Q 001873 843 PNGS 846 (1001)
Q Consensus 843 ~~gs 846 (1001)
+++.
T Consensus 93 ~~~~ 96 (288)
T 3f7w_A 93 DERP 96 (288)
T ss_dssp CCCC
T ss_pred cccC
Confidence 8764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.41 E-value=2.1e-05 Score=76.61 Aligned_cols=34 Identities=12% Similarity=0.088 Sum_probs=18.9
Q ss_pred CCceEeeecCcccCCCCcccCCCCCCcEEEcCCC
Q 001873 272 ELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQN 305 (1001)
Q Consensus 272 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N 305 (1001)
+|++||++++.|+...-..+..+++|++|+|++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 4666666666655444444455555555555555
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.36 E-value=7.5e-05 Score=72.70 Aligned_cols=34 Identities=6% Similarity=0.073 Sum_probs=15.0
Q ss_pred CCcEEEcCCCcccccCCCCccCCCCCCEEeccCC
Q 001873 296 KLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDN 329 (1001)
Q Consensus 296 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 329 (1001)
+|+.|+++++.++..--..+..+++|+.|+|++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 4455555554444332233344444444444444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00012 Score=67.99 Aligned_cols=69 Identities=20% Similarity=0.263 Sum_probs=50.2
Q ss_pred EEeccccccc-CCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCChhhhhcccccc
Q 001873 585 LLDIGNNRFS-GEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLV 656 (1001)
Q Consensus 585 ~L~Ls~N~l~-~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~ 656 (1001)
.+|.+++.|+ ..+|..+. ++++. |+|++|+|+.+.+..|..+++|+.|+|++|+|.+++...+...+++
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~-L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~l~~wl~ 81 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTE-LVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLRAWLA 81 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSE-EECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHHHHHHHH
T ss_pred EEEeCCCCCccccCCCCCC--cCCCE-EECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHHHHHHHH
Confidence 5677777775 24554432 23554 8888888888888889999999999999999999887544444443
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.001 Score=75.59 Aligned_cols=71 Identities=17% Similarity=0.337 Sum_probs=45.5
Q ss_pred CCeEeecCCeeEEEEEeCCCCEEEEEEecC------CC-----chhhHHHHHHHhh-ccCCCceeeEEeeeecCCceEEE
Q 001873 771 ANVIGTGSSGVVYRVTIPNGETLAVKKMWS------SD-----ESGAFSSEIQTLG-SIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~------~~-----~~~~~~~Ei~~l~-~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.+.+|.|....||++.. +++.++||.... .. ....++.|+..+. ......+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 45689999999999975 568899994321 11 1223444444332 22335677777765 4566999
Q ss_pred EEcc-CC
Q 001873 839 YDYL-PN 844 (1001)
Q Consensus 839 ~e~~-~~ 844 (1001)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00094 Score=73.30 Aligned_cols=140 Identities=16% Similarity=0.181 Sum_probs=76.1
Q ss_pred CeEeecCCee-EEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccCC--CceeeEEeeeecCCceEEEEEccCCCCHH
Q 001873 772 NVIGTGSSGV-VYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRH--KNIVRLLGWGSNKNLKLLFYDYLPNGSLS 848 (1001)
Q Consensus 772 ~~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 848 (1001)
+.++.|+... +|+.+..+++.+++|...... ...+..|+.+++.+.. -.+.+++.+..+.+ +++||++.+..+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~-~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~ 100 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE-GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFT 100 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT-TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC-CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchH
Confidence 3465555444 778776447788887653321 1456677888777742 23566777654444 7899999776665
Q ss_pred HHhhcC---------------------CC---CCCCHHHHH-------H-------------HHHHHHHHHHHHhh---C
Q 001873 849 SLLHGA---------------------GK---GGADWEARY-------E-------------VVLGVAHALAYLHH---D 881 (1001)
Q Consensus 849 ~~l~~~---------------------~~---~~~~~~~~~-------~-------------i~~~i~~~l~yLH~---~ 881 (1001)
+++... .. ...+..... . ....+...++.+.. .
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 443211 00 011111100 0 00112222333311 1
Q ss_pred CCCCeEEeCCCCCCeEECCC----CcEEEeccccccc
Q 001873 882 CMPPILHGDVKAMNVLLGPG----YQAYLADFGLARI 914 (1001)
Q Consensus 882 ~~~~ivH~Dlkp~NIll~~~----~~~ki~Dfgla~~ 914 (1001)
..+.++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 12479999999999999874 6899999998865
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.001 Score=72.62 Aligned_cols=142 Identities=15% Similarity=0.139 Sum_probs=81.5
Q ss_pred CeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccCCCc--eeeEEee------eecCCceEEEEEccC
Q 001873 772 NVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKN--IVRLLGW------GSNKNLKLLFYDYLP 843 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~n--Iv~l~~~------~~~~~~~~lv~e~~~ 843 (1001)
+.++.|....+|+++..++ .+++|..........+..|+.+++.+.... +.+++.. ....+..+++|+|++
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~ 106 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 106 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence 3467788899999987655 688998765334456778888888774222 3333321 122456689999999
Q ss_pred CCCHHH--------------HhhcC----CCCC---C---CHHHHHH------------HHHHHHHHHHHHhhC----CC
Q 001873 844 NGSLSS--------------LLHGA----GKGG---A---DWEARYE------------VVLGVAHALAYLHHD----CM 883 (1001)
Q Consensus 844 ~gsL~~--------------~l~~~----~~~~---~---~~~~~~~------------i~~~i~~~l~yLH~~----~~ 883 (1001)
|..+.. .++.. .... . .|...+. +...+...++++++. ..
T Consensus 107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~ 186 (322)
T 2ppq_A 107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 186 (322)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence 764311 11211 1100 1 1222110 011244455555531 12
Q ss_pred CCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 884 PPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 884 ~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 4789999999999999876668999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0036 Score=68.36 Aligned_cols=140 Identities=13% Similarity=0.135 Sum_probs=82.5
Q ss_pred CeEeecCCeeEEEEEeCCCCEEEEEEecCC-CchhhHHHHHHHhhccCCC--ceeeEEee-----eecCCceEEEEEccC
Q 001873 772 NVIGTGSSGVVYRVTIPNGETLAVKKMWSS-DESGAFSSEIQTLGSIRHK--NIVRLLGW-----GSNKNLKLLFYDYLP 843 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~Ei~~l~~l~h~--nIv~l~~~-----~~~~~~~~lv~e~~~ 843 (1001)
+.++ |....||+++..+|+.+++|..... .....+..|..+++.+... .+++++.. ....+..++||+|++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 3466 8888999988777888999998643 3456777888888887422 24444443 123456688999998
Q ss_pred CCCHH-----HH---------hhc----CC---CCCCCHHHH----HHH---------------HHHHHHHHHHHhhC--
Q 001873 844 NGSLS-----SL---------LHG----AG---KGGADWEAR----YEV---------------VLGVAHALAYLHHD-- 881 (1001)
Q Consensus 844 ~gsL~-----~~---------l~~----~~---~~~~~~~~~----~~i---------------~~~i~~~l~yLH~~-- 881 (1001)
|..+. .+ ++. .. ....++... ..+ ...+...++.+.+.
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75321 10 111 00 011122111 000 01111223333221
Q ss_pred --CCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 882 --CMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 882 --~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 123678999999999999 4 899999988764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0021 Score=69.41 Aligned_cols=139 Identities=16% Similarity=0.161 Sum_probs=77.5
Q ss_pred ccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc-hhhHHHHHHHhhccCCCce-eeEEeeeecCCceEEEEEcc-CC
Q 001873 768 LTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE-SGAFSSEIQTLGSIRHKNI-VRLLGWGSNKNLKLLFYDYL-PN 844 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~Ei~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~-~~ 844 (1001)
+..++.++.|....+|++ +.+++|+...... .-...+|+.+++.+....+ .++++++.+ .-++|+||+ +|
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g 92 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGA 92 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTC
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCC
Confidence 333678999999999998 5688888754321 1234678888887742222 456655433 347899999 65
Q ss_pred CCHHH------------------HhhcCCCC---CCCH-HHHHHHHH--------------HHHHHH----HHHhh-CCC
Q 001873 845 GSLSS------------------LLHGAGKG---GADW-EARYEVVL--------------GVAHAL----AYLHH-DCM 883 (1001)
Q Consensus 845 gsL~~------------------~l~~~~~~---~~~~-~~~~~i~~--------------~i~~~l----~yLH~-~~~ 883 (1001)
.++.. .+|..... ..+. .....+.. .+...+ +.+.. ...
T Consensus 93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~ 172 (301)
T 3dxq_A 93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP 172 (301)
T ss_dssp EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence 44321 11111110 0111 11111100 011111 11111 112
Q ss_pred CCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 884 PPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 884 ~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
+.++|+|+.+.||+ ..++.+.++||..|..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 35899999999999 5566789999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0015 Score=74.28 Aligned_cols=71 Identities=13% Similarity=0.249 Sum_probs=49.9
Q ss_pred CeEeecCCeeEEEEEeCC--------CCEEEEEEecCCCchhhHHHHHHHhhccCCCc-eeeEEeeeecCCceEEEEEcc
Q 001873 772 NVIGTGSSGVVYRVTIPN--------GETLAVKKMWSSDESGAFSSEIQTLGSIRHKN-IVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~~ 842 (1001)
+.|+.|....||++...+ ++.|++|+.........+.+|..+++.+...+ ..++++.+.+ .+|+||+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l 154 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 154 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEe
Confidence 468889999999998753 57899998744322256678999998884333 3567766542 3899999
Q ss_pred CCCC
Q 001873 843 PNGS 846 (1001)
Q Consensus 843 ~~gs 846 (1001)
+|..
T Consensus 155 ~G~~ 158 (429)
T 1nw1_A 155 PSRP 158 (429)
T ss_dssp CEEE
T ss_pred CCcc
Confidence 8643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.001 Score=61.73 Aligned_cols=57 Identities=25% Similarity=0.352 Sum_probs=35.1
Q ss_pred ceEEcccccCc-ccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCcccc
Q 001873 514 EFLDLHSNGLT-GSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLS 570 (1001)
Q Consensus 514 ~~L~Ls~N~l~-~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 570 (1001)
..++.++++|+ ..+|..++..++.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 36777777775 3566666666666666666666555555555666666666655543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.83 E-value=0.00033 Score=69.46 Aligned_cols=115 Identities=18% Similarity=0.206 Sum_probs=61.6
Q ss_pred CCCCcceEEcccc-cccc----CCCcccCCCCCcceeeccCcccccCC----cccccccccCceEEcccccCcccCCCCc
Q 001873 461 NCTTLRRLRLNDN-RLSG----TIPSEMGNLKHLNFVDMSENHLVGGI----PPSVVGCQSLEFLDLHSNGLTGSVPDTL 531 (1001)
Q Consensus 461 ~l~~L~~L~Ls~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 531 (1001)
+-+.|++|+|++| +|.. .+.+.+..-+.|+.|+|++|+|.+.- ...+...+.|+.|+|++|+|+...-.
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~-- 116 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA-- 116 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH--
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH--
Confidence 3455777777764 5542 12334555566666666666665332 22333445566666666665421111
Q ss_pred ccccccccCCCCcCCCCcccccccccccceeeccCc---ccccc----chhhhhccccccEEecccccc
Q 001873 532 PTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKN---QLSGR----IPAEILSCRKLILLDIGNNRF 593 (1001)
Q Consensus 532 ~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N---~l~~~----~p~~~~~l~~L~~L~Ls~N~l 593 (1001)
.+.+.+..-+.|+.|+|++| .+... +.+.+..-+.|+.|+++.|.+
T Consensus 117 ----------------ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 117 ----------------RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp ----------------HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred ----------------HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 12233444456777777754 33322 334455567788888877764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.68 E-value=0.00021 Score=70.88 Aligned_cols=110 Identities=13% Similarity=0.103 Sum_probs=52.3
Q ss_pred CcccceEeCcCc-cccCC----CCcccccccccceEEccCCcCCCCC----CCCCCCCCCcceEEccccccccC----CC
Q 001873 414 CQELQALDFSYN-NLSGP----IPKEIFGLRNLTKLLLLSNDLSGFI----PPDIGNCTTLRRLRLNDNRLSGT----IP 480 (1001)
Q Consensus 414 l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~~----~p 480 (1001)
-+.|++|+|++| +|... +...+..-..|+.|+|++|++...- ...+...+.|+.|+|+.|.|... +.
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 345556666553 44321 2223333445555555555554221 12222345566666666666522 22
Q ss_pred cccCCCCCcceeeccCc---cccc----CCcccccccccCceEEcccccC
Q 001873 481 SEMGNLKHLNFVDMSEN---HLVG----GIPPSVVGCQSLEFLDLHSNGL 523 (1001)
Q Consensus 481 ~~~~~l~~L~~L~Ls~N---~l~~----~~p~~~~~l~~L~~L~Ls~N~l 523 (1001)
+.+..-+.|++|+|++| .+.. .+...+...+.|+.|+++.|.+
T Consensus 120 ~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 33444455666666544 2221 1223444455666666665544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0047 Score=68.53 Aligned_cols=139 Identities=15% Similarity=0.217 Sum_probs=82.4
Q ss_pred CeEeecCCeeEEEEEeC--------CCCEEEEEEecCC-CchhhHHHHHHHhhccC-CCceeeEEeeeecCCceEEEEEc
Q 001873 772 NVIGTGSSGVVYRVTIP--------NGETLAVKKMWSS-DESGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+.+..|-...+|+++.. +++.|++|+.-.. .....+.+|.++++.+. +.-..++++++.+ .+||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 45777888899998874 2578999986321 13456778999998884 3334667766643 389999
Q ss_pred cCCCCHHH-----------------HhhcCC---CCCCC--HHHHHHHHHHHH-------------------HHHHHHh-
Q 001873 842 LPNGSLSS-----------------LLHGAG---KGGAD--WEARYEVVLGVA-------------------HALAYLH- 879 (1001)
Q Consensus 842 ~~~gsL~~-----------------~l~~~~---~~~~~--~~~~~~i~~~i~-------------------~~l~yLH- 879 (1001)
++|..+.. .++... ..... +.++.++..++. ..++.+.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 99754421 112211 11122 344444443332 1233332
Q ss_pred ---hC-CCCCeEEeCCCCCCeEECCC----CcEEEeccccccc
Q 001873 880 ---HD-CMPPILHGDVKAMNVLLGPG----YQAYLADFGLARI 914 (1001)
Q Consensus 880 ---~~-~~~~ivH~Dlkp~NIll~~~----~~~ki~Dfgla~~ 914 (1001)
.. ....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 12368999999999999876 7899999998864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.012 Score=64.54 Aligned_cols=67 Identities=10% Similarity=0.212 Sum_probs=43.9
Q ss_pred ecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccC---CCceeeEEee------eecCCceEEEEEccCCCC
Q 001873 776 TGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIR---HKNIVRLLGW------GSNKNLKLLFYDYLPNGS 846 (1001)
Q Consensus 776 ~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~---h~nIv~l~~~------~~~~~~~~lv~e~~~~gs 846 (1001)
.|....||++...+| .+++|+...... .+|+..++.+. -|.|++++.. ....+..++||+|++|..
T Consensus 33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~ 107 (339)
T 3i1a_A 33 ADTNAFAYQADSESK-SYFIKLKYGYHD----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPN 107 (339)
T ss_dssp SCSSCEEEEEECSSC-EEEEEEEECSSC----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCB
T ss_pred CccccceEEEEeCCC-CEEEEEecCccc----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCc
Confidence 333679999988766 999998755432 35666666663 2224555432 234567799999999875
Q ss_pred H
Q 001873 847 L 847 (1001)
Q Consensus 847 L 847 (1001)
+
T Consensus 108 ~ 108 (339)
T 3i1a_A 108 G 108 (339)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0076 Score=67.04 Aligned_cols=71 Identities=11% Similarity=0.070 Sum_probs=43.9
Q ss_pred CeEeecCCeeEEEEEeCC---------CCEEEEEEecCCCch-hhHHHHHHHhhccCCCc-eeeEEeeeecCCceEEEEE
Q 001873 772 NVIGTGSSGVVYRVTIPN---------GETLAVKKMWSSDES-GAFSSEIQTLGSIRHKN-IVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~-~~~~~Ei~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e 840 (1001)
+.++.|..-.+|++...+ ++.+++|+....... ....+|..+++.+...+ +.++++.. . -++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 357788889999988753 268888886432211 23467888888884333 44666544 2 278999
Q ss_pred ccCCCC
Q 001873 841 YLPNGS 846 (1001)
Q Consensus 841 ~~~~gs 846 (1001)
|++|..
T Consensus 115 ~i~G~~ 120 (369)
T 3c5i_A 115 WLYGDP 120 (369)
T ss_dssp CCCSEE
T ss_pred EecCCc
Confidence 998753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.14 E-value=0.014 Score=66.47 Aligned_cols=72 Identities=11% Similarity=0.097 Sum_probs=47.3
Q ss_pred CCeEeecCCeeEEEEEeCC-CCEEEEEEecCCCc-hhhHHHHHHHhhccCCCce-eeEEeeeecCCceEEEEEccCCCC
Q 001873 771 ANVIGTGSSGVVYRVTIPN-GETLAVKKMWSSDE-SGAFSSEIQTLGSIRHKNI-VRLLGWGSNKNLKLLFYDYLPNGS 846 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~Ei~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gs 846 (1001)
++.|+.|-...+|++...+ ++.+++|+...... .-+..+|..+++.+...++ .++++++. + ..||||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3468889999999998764 47888887633221 1223689999988864444 56777663 2 35999998743
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.85 E-value=0.05 Score=61.12 Aligned_cols=71 Identities=8% Similarity=0.016 Sum_probs=48.1
Q ss_pred CeEeecCCeeEEEEEeCC--------CCEEEEEEecCCCc-hhhHHHHHHHhhccC-CCceeeEEeeeecCCceEEEEEc
Q 001873 772 NVIGTGSSGVVYRVTIPN--------GETLAVKKMWSSDE-SGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+.+..|-...+|++...+ ++.|++|+.....+ .-+..+|.++++.+. +.-..++++.+. + +.||||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEEEE
Confidence 457778889999988753 58899998643221 134568999988884 333456665432 2 789999
Q ss_pred cCCCC
Q 001873 842 LPNGS 846 (1001)
Q Consensus 842 ~~~gs 846 (1001)
++|..
T Consensus 152 I~G~~ 156 (424)
T 3mes_A 152 IDGEP 156 (424)
T ss_dssp CCSEE
T ss_pred eCCcc
Confidence 99864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=89.20 E-value=0.66 Score=46.13 Aligned_cols=100 Identities=17% Similarity=0.080 Sum_probs=64.4
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
-+|.++++.. +.+++++++|.++.|.+.++.-.-.+. .-..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 3799999865 557999999999999999987762210 111333456889999999988764 1110
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTG 968 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg 968 (1001)
.....+.|||... ...+.+.=|||+|+++|..+-=
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 0112466888763 3445677899999999987753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.62 E-value=1.8 Score=48.10 Aligned_cols=29 Identities=28% Similarity=0.403 Sum_probs=25.0
Q ss_pred eEEeCCCCCCeEE------CCCCcEEEeccccccc
Q 001873 886 ILHGDVKAMNVLL------GPGYQAYLADFGLARI 914 (1001)
Q Consensus 886 ivH~Dlkp~NIll------~~~~~~ki~Dfgla~~ 914 (1001)
++|+|+.+.||++ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999999864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.91 E-value=0.73 Score=45.81 Aligned_cols=124 Identities=10% Similarity=0.141 Sum_probs=83.7
Q ss_pred CCCceeeEEeeeecCCceEEEEEccCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCe
Q 001873 818 RHKNIVRLLGWGSNKNLKLLFYDYLPNG-SLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNV 896 (1001)
Q Consensus 818 ~h~nIv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NI 896 (1001)
.||+.++. .+-.+++.+.+.++.-+.+ +... ++ ..+...+++++.+|+....+++++ +|--+.|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence 57888866 4555566555555543322 2333 32 267889999999999988777654 7889999999
Q ss_pred EECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 897 LLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 897 ll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+++.++.+++.-.|+-..+ +|. ..+...=.-.+=+++..+++++..|+...
T Consensus 111 ~f~~~~~p~i~~RGik~~l------------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~ 161 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV------------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDALV 161 (215)
T ss_dssp EECTTSCEEESCCEETTTB------------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHH
T ss_pred EEcCCCCEEEEEccCccCC------------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHH
Confidence 9999999999988865433 121 11111123346678888999999988766
Q ss_pred CCCcCc
Q 001873 977 PGGAPL 982 (1001)
Q Consensus 977 ~~~~~l 982 (1001)
.|...+
T Consensus 162 ~G~lel 167 (215)
T 4ann_A 162 EGNLEL 167 (215)
T ss_dssp HSCGGG
T ss_pred cChHhh
Confidence 665555
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=84.74 E-value=1.4 Score=31.16 Aligned_cols=11 Identities=18% Similarity=0.404 Sum_probs=4.9
Q ss_pred Hhhhhhhhccc
Q 001873 729 AIYVLVRTRMA 739 (1001)
Q Consensus 729 ~~~~~~r~r~~ 739 (1001)
.+++|.|||+.
T Consensus 30 ~~~~~~RRR~~ 40 (44)
T 2jwa_A 30 VFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHHCS
T ss_pred HHHhheehhhh
Confidence 33444444443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.04 E-value=2.3 Score=30.20 Aligned_cols=26 Identities=23% Similarity=0.374 Sum_probs=10.4
Q ss_pred hhHHHHHHHHHHHHH-HHhhhhhhhcc
Q 001873 713 LVMSILVSASAVLVL-LAIYVLVRTRM 738 (1001)
Q Consensus 713 iv~~i~v~~~~ilvl-~~~~~~~r~r~ 738 (1001)
|..+++.++++++++ +.++++.|+|+
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 444444433333222 33344444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1001 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-50 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-49 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-44 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-43 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-43 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-42 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-42 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-36 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-33 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-33 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-32 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-29 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-29 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-07 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-16 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-24 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-24 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-10 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 7e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.001 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-50
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGA---FSSEIQTLGSIRHKNIVRLLG 827
+ +G G+ GVV++V+ P+G +A K + + E+Q L IV G
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
+ + +++ GSL +L AG+ + +V + V L YL I+
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH--KIM 127
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ 947
H DVK N+L+ + L DFG++ + S ++ G+ YM+PE
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---------VGTRSYMSPERLQGT 178
Query: 948 RITEKSDVYSFGVVLLEVLTGRHPLDPT 975
+ +SD++S G+ L+E+ GR+P+ P
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPP 206
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-49
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 772 NVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESG----AFSSEIQTLGSIRHKNIVRLLG 827
IG+GS G VY+ +AVK + + + AF +E+ L RH NI+ +G
Sbjct: 14 QRIGSGSFGTVYKGK--WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
+ + L + + SL LH + + ++ A + YLH I+
Sbjct: 72 YSTAPQL-AIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHA---KSII 126
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ 947
H D+K+ N+ L + DFGLA + S + + L+GS +MAPE MQ
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-----LSGSILWMAPEVIRMQ 181
Query: 948 R---ITEKSDVYSFGVVLLEVLTGRHPLD 973
+ +SDVY+FG+VL E++TG+ P
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYS 210
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 3e-48
Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 11/207 (5%)
Query: 772 NVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESG-AFSSEIQTLGSIRHKNIVRLLGWGS 830
+G G G V+ +AVK + S AF +E + ++H+ +VRL +
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 831 NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGD 890
+ + + +Y+ NGSL L ++ +A +A++ +H D
Sbjct: 79 QEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 134
Query: 891 VKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRIT 950
++A N+L+ +ADFGLAR++ + + APE + T
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA------KFPIKWTAPEAINYGTFT 188
Query: 951 EKSDVYSFGVVLLEVLTGRHPLDPTLP 977
KSDV+SFG++L E++T P +
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMT 215
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 7e-46
Identities = 64/240 (26%), Positives = 98/240 (40%), Gaps = 23/240 (9%)
Query: 764 VVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFS-SEIQTLGSIRHKNI 822
+ R + IG G G V+R GE +AVK S +E F +EI +RH+NI
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 59
Query: 823 VRLLGWGSNKNLKL----LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL 878
+ + + N L DY +GSL L+ + E ++ L A LA+L
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHL 116
Query: 879 HHDCM-----PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLA 933
H + + P I H D+K+ N+L+ +AD GLA + D N R
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR---V 173
Query: 934 GSYGYMAPE------HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQWTP 987
G+ YMAPE + +++D+Y+ G+V E+ P P
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 8e-46
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 772 NVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSN 831
IG G G V G +AVK + + + AF +E + +RH N+V+LLG
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 832 KNLKL-LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGD 890
+ L + +Y+ GSL L G+ + + L V A+ YL +H D
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRD 128
Query: 891 VKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRIT 950
+ A NVL+ A ++DFGL + S + D + APE ++ +
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----------LPVKWTAPEALREKKFS 178
Query: 951 EKSDVYSFGVVLLEVLTGRHPLDPTLP 977
KSDV+SFG++L E+ + P +P
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIP 205
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-45
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 11/204 (5%)
Query: 772 NVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESG-AFSSEIQTLGSIRHKNIVRLLGWGS 830
+G G G V+ T +A+K + S AF E Q + +RH+ +V+L S
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 82
Query: 831 NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGD 890
+ + + +Y+ GSL L G ++ +A +AY+ +H D
Sbjct: 83 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 138
Query: 891 VKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRIT 950
++A N+L+G +ADFGLAR++ + + R + APE A R T
Sbjct: 139 LRAANILVGENLVCKVADFGLARLIEDN------EYTARQGAKFPIKWTAPEAALYGRFT 192
Query: 951 EKSDVYSFGVVLLEVLTGRHPLDP 974
KSDV+SFG++L E+ T P
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYP 216
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-44
Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGA----FSSEIQTLGSIRHKNIVRLL 826
IGTGS G ++ +G+ L K++ + A SE+ L ++H NIVR
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 827 GWGSNKNLKLLF--YDYLPNGSLSSLLHGAGK--GGADWEARYEVVLGVAHALAYLH--H 880
++ L+ +Y G L+S++ K D E V+ + AL H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 881 DCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMA 940
D +LH D+K NV L L DFGLARI++ T+ G+ YM+
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-------HDTSFAKAFVGTPYYMS 182
Query: 941 PEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
PE + EKSD++S G +L E+ P
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-44
Identities = 49/201 (24%), Positives = 86/201 (42%), Gaps = 11/201 (5%)
Query: 772 NVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGA-FSSEIQTLGSIRHKNIVRLLGWGS 830
IG+G G+V+ N + +A+K + S F E + + + H +V+L G
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 831 NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGD 890
+ L ++++ +G LS L +G E + L V + + ++H D
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGM---AYLEEACVIHRD 126
Query: 891 VKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRIT 950
+ A N L+G ++DFG+ R V + + +PE S R +
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDD------QYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 951 EKSDVYSFGVVLLEVLTGRHP 971
KSDV+SFGV++ EV +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKI 201
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 8e-44
Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 759 FSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGA-----FSSEIQ 812
++++D +G G G VY + LA+K ++ + A E++
Sbjct: 3 WALED----FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 58
Query: 813 TLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVA 872
+RH NI+RL G+ + L +Y P G++ L K D + + +A
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELA 116
Query: 873 HALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQL 932
+AL+Y H ++H D+K N+LLG + +ADFG + S +R L
Sbjct: 117 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---------RRTTL 164
Query: 933 AGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
G+ Y+ PE + EK D++S GV+ E L G+ P +
Sbjct: 165 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 205
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-43
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 16/215 (7%)
Query: 760 SIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGA--FSSEIQTLGS 816
S+ D + T IG G+SG VY + G+ +A+++M + +EI +
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 817 IRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALA 876
++ NIV L + + +YL GSL+ ++ + D V AL
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALE 130
Query: 877 YLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSY 936
+LH + ++H D+K+ N+LLG L DFG ++ +R + G+
Sbjct: 131 FLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-------KRSTMVGTP 180
Query: 937 GYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+MAPE + + K D++S G++ +E++ G P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-43
Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 23/212 (10%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKM----WSSDESGAFSSEIQTLGSIRHKNIVRLL 826
IG GS VY+ +A ++ + E F E + L ++H NIVR
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 827 GWG----SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC 882
K +L + + +G+L + L + + L +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 883 MPPILHGDVKAMNVLL-GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAP 941
PPI+H D+K N+ + GP + D GLA + S + G+ +MAP
Sbjct: 133 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---------FAKAVIGTPEFMAP 182
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
E ++ E DVY+FG+ +LE+ T +P
Sbjct: 183 EMYE-EKYDESVDVYAFGMCMLEMATSEYPYS 213
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 7e-43
Identities = 53/219 (24%), Positives = 81/219 (36%), Gaps = 15/219 (6%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGA---FSSEIQTLGSIRHKNIVRLLG 827
+G G+ G V E +AVK + EI + H+N+V+ G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
N++ LF +Y G L + G + + YLH I
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG---IT 125
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ 947
H D+K N+LL ++DFGLA + + + + G+ Y+APE +
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-----MCGTLPYVAPELLKRR 180
Query: 948 RI-TEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQW 985
E DV+S G+VL +L G P D W
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 219
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 7e-43
Identities = 61/225 (27%), Positives = 88/225 (39%), Gaps = 25/225 (11%)
Query: 759 FSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGA-----FSSEIQ 812
F DD + + IG GS G VY + N E +A+KKM S + E++
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 813 TLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVA 872
L +RH N ++ G ++ L +Y + L K V G
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV--HKKPLQEVEIAAVTHGAL 125
Query: 873 HALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQL 932
LAYLH ++H DVKA N+LL L DFG A I+
Sbjct: 126 QGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----------APANSF 171
Query: 933 AGSYGYMAPEHA---SMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974
G+ +MAPE + K DV+S G+ +E+ + PL
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 8e-43
Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 12/210 (5%)
Query: 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESG-AFSSEIQTLGSIRHKNIVR 824
++LT +GTG GVV +A+K + S F E + + ++ H+ +V+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMP 884
L G + + + +Y+ NG L + L + + E+ V A+ YL
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---K 119
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHA 944
LH D+ A N L+ ++DFGL+R V + + PE
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD------EYTSSVGSKFPVRWSPPEVL 173
Query: 945 SMQRITEKSDVYSFGVVLLEVLT-GRHPLD 973
+ + KSD+++FGV++ E+ + G+ P +
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-42
Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 24/223 (10%)
Query: 758 DFSIDDVVRNLTSANVIGTGSSGVVYRVTI---PNGETLAVKKMWSSDESGA---FSSEI 811
+ I D+ +G G+ G V + +A+K + E E
Sbjct: 9 NLLIADIE--------LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 812 QTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGV 871
Q + + + IVRL+G + L +L + G L L G + E++ V
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQV 118
Query: 872 AHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQ 931
+ + YL +H D+ A NVLL + A ++DFGL++ + +++ +
Sbjct: 119 SMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK-- 173
Query: 932 LAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLD 973
+ APE + ++ + +SDV+S+GV + E L+ G+ P
Sbjct: 174 --WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 214
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 155 bits (392), Expect = 1e-42
Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 15/226 (6%)
Query: 754 YQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPN-GETLAVKKMWSSDESGA-FSSEI 811
Y K + D +T + +G G G VY T+AVK + F E
Sbjct: 9 YDKWEMERTD----ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 64
Query: 812 QTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGV 871
+ I+H N+V+LLG + + + +++ G+L L + + +
Sbjct: 65 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124
Query: 872 AHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQ 931
+ A+ YL +H D+ A N L+G + +ADFGL+R+++G +
Sbjct: 125 SSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA----- 176
Query: 932 LAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977
+ APE + + + KSDV++FGV+L E+ T P +
Sbjct: 177 -KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 221
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-42
Identities = 50/224 (22%), Positives = 96/224 (42%), Gaps = 26/224 (11%)
Query: 758 DFSIDDVVRNLTSANVIGTGSSGVVYRVTIPN---GETLAVKKMWSSDESGA----FSSE 810
+++D +G+G+ G V + +T+AVK + + A +E
Sbjct: 7 LLTLED--------KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 58
Query: 811 IQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG 870
+ + + IVR++G ++ +L + G L+ L + E+V
Sbjct: 59 ANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQ 115
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
V+ + YL +H D+ A NVLL + A ++DFGL++ + + + +
Sbjct: 116 VSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL----RADENYYKAQT 168
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLD 973
+ APE + + + KSDV+SFGV++ E + G+ P
Sbjct: 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 155 bits (393), Expect = 4e-42
Identities = 56/235 (23%), Positives = 98/235 (41%), Gaps = 17/235 (7%)
Query: 744 TADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSD 802
D W+ Q ++ D V+ + +GTG+ GVV+RVT G A K + +
Sbjct: 4 YVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH 63
Query: 803 ESG--AFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGAD 860
ES EIQT+ +RH +V L + N ++ Y+++ G L +
Sbjct: 64 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMS 122
Query: 861 WEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY--QAYLADFGLARIVSGS 918
+ E + V L ++H + +H D+K N++ + L DFGL +
Sbjct: 123 EDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179
Query: 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
+ G+ + APE A + + +D++S GV+ +L+G P
Sbjct: 180 QSVKVTT--------GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 7e-42
Identities = 52/210 (24%), Positives = 86/210 (40%), Gaps = 19/210 (9%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGA--FSSEIQTLGSIRHKNIVRLLGW 828
+G G+ G VY+ A K + + E + EI L S H NIV+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 829 GSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILH 888
+N + ++ G++ +++ + V AL YLH I+H
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHD---NKIIH 133
Query: 889 GDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE-----H 943
D+KA N+L LADFG++ + + +R G+ +MAPE
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-------RRDSFIGTPYWMAPEVVMCET 186
Query: 944 ASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
+ + K+DV+S G+ L+E+ P
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHH 216
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (382), Expect = 3e-41
Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 14/222 (6%)
Query: 758 DFSIDDVVRNLTSANVIGTGSSGVVYRVTIP----NGETLAVKKM---WSSDESGAFSSE 810
+F+ + + + VIG G G V + +A+K + ++ + F SE
Sbjct: 18 EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSE 77
Query: 811 IQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG 870
+G H N++ L G + ++ +++ NGSL S L G ++ G
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRG 136
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
+A + YL +H D+ A N+L+ ++DFGL+R + D +
Sbjct: 137 IAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSAL 191
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHP 971
+ APE ++ T SDV+S+G+V+ EV++ G P
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 233
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-40
Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 17/228 (7%)
Query: 755 QKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPN----GETLAVKKMWSSDESGA---F 807
Q + ++ + VIG G G VY T+ + AVK + + G F
Sbjct: 18 QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75
Query: 808 SSEIQTLGSIRHKNIVRLLGWGS-NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYE 866
+E + H N++ LLG ++ L+ Y+ +G L + +
Sbjct: 76 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF-IRNETHNPTVKDLIG 134
Query: 867 VVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKT 926
L VA + +H D+ A N +L + +ADFGLAR + D
Sbjct: 135 FGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY---DKEFDSV 188
Query: 927 NQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974
+ + +MA E Q+ T KSDV+SFGV+L E++T P P
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-40
Identities = 39/206 (18%), Positives = 78/206 (37%), Gaps = 16/206 (7%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKM-----WSSDESGAFSSEIQTLGSIRHKNIVRL 825
++G GS V + A+K + ++ + E + + H V+L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPP 885
+ Y NG L + G Y A ++ L +
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIVSALEYLHGKG 128
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945
I+H D+K N+LL + DFG A+++S + + G+ Y++PE +
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-----FVGTAQYVSPELLT 183
Query: 946 MQRITEKSDVYSFGVVLLEVLTGRHP 971
+ + SD+++ G ++ +++ G P
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (370), Expect = 1e-39
Identities = 55/249 (22%), Positives = 91/249 (36%), Gaps = 43/249 (17%)
Query: 754 YQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPN------GETLAVKKM---WSSDES 804
L++ ++ + IG G+ G V++ P +AVK + S+D
Sbjct: 5 LLSLEYPRNN----IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 805 GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGA----- 859
F E + + NIV+LLG + L ++Y+ G L+ L
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 860 -----------------DWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY 902
+ + VA +AYL +H D+ N L+G
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 177
Query: 903 QAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVL 962
+ADFGL+R + + A +M PE R T +SDV+++GVVL
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGN-----DAIPIRWMPPESIFYNRYTTESDVWAYGVVL 232
Query: 963 LEVLTGRHP 971
E+ +
Sbjct: 233 WEIFSYGLQ 241
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 4e-39
Identities = 66/278 (23%), Positives = 105/278 (37%), Gaps = 43/278 (15%)
Query: 739 ANNSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT------IPNGET 792
++N + D E K +F ++ L V+G+G+ G V T
Sbjct: 14 SDNEYFYVDFREYEYDLKWEFPREN----LEFGKVLGSGAFGKVMNATAYGISKTGVSIQ 69
Query: 793 LAVKKMWSSDESG---AFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLS 848
+AVK + +S A SE++ + + H+NIV LLG + L ++Y G L
Sbjct: 70 VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 129
Query: 849 SLLHGAGK---------------------GGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
+ L + +E VA + +L +
Sbjct: 130 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCV 186
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ 947
H D+ A NVL+ G + DFGLAR + S R +MAPE
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSD-----SNYVVRGNARLPVKWMAPESLFEG 241
Query: 948 RITEKSDVYSFGVVLLEVLTGRHPLDPTLPGGAPLVQW 985
T KSDV+S+G++L E+ + P +P A +
Sbjct: 242 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 146 bits (370), Expect = 5e-39
Identities = 42/233 (18%), Positives = 84/233 (36%), Gaps = 17/233 (7%)
Query: 746 DDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDES 804
+D W+ + Q ++ V +G+G+ GVV+R G K + +
Sbjct: 9 EDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL 68
Query: 805 G--AFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWE 862
+EI + + H ++ L +K +L ++L G L +
Sbjct: 69 DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEA 127
Query: 863 ARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL--GPGYQAYLADFGLARIVSGSGD 920
+ L ++H I+H D+K N++ + DFGLA +
Sbjct: 128 EVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL----- 179
Query: 921 DNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
+ + + APE + + +D+++ GV+ +L+G P
Sbjct: 180 ---NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 229
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (366), Expect = 5e-39
Identities = 45/204 (22%), Positives = 80/204 (39%), Gaps = 14/204 (6%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKM---WSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
+V+GTG+ V + +A+K + + G+ +EI L I+H NIV L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
+ L + G L + KG ++ V A+ YLH +
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRD 132
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ 947
+ L + ++DFGL+++ + G+ GY+APE + +
Sbjct: 133 LKPENLLYYSLDEDSKIMISDFGLSKMEDPG--------SVLSTACGTPGYVAPEVLAQK 184
Query: 948 RITEKSDVYSFGVVLLEVLTGRHP 971
++ D +S GV+ +L G P
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 7e-39
Identities = 61/241 (25%), Positives = 100/241 (41%), Gaps = 38/241 (15%)
Query: 752 TLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIPNGETL---AVKKM---WSSDESG 805
T+Y LD++ ++ +VIG G+ G V + I A+K+M S D+
Sbjct: 2 TIYPVLDWN------DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55
Query: 806 AFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHG----------- 853
F+ E++ L + H NI+ LLG ++ L +Y P+G+L L
Sbjct: 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 854 ---AGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFG 910
+ + VA + YL +H D+ A N+L+G Y A +ADFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 172
Query: 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRH 970
L+R + +MA E + T SDV+S+GV+L E+++
Sbjct: 173 LSRGQEVYVKKTMGR--------LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
Query: 971 P 971
Sbjct: 225 T 225
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-38
Identities = 66/271 (24%), Positives = 102/271 (37%), Gaps = 38/271 (14%)
Query: 741 NSFTADDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTI------PNGETLA 794
N++ D ++ K +F + L+ +G G+ G V T T+A
Sbjct: 2 NNYVYIDPTQLPYDHKWEFPRNR----LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVA 57
Query: 795 VKKMWSSDESG---AFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSL 850
VK + S A SE++ L + H NIV LLG + L+ +Y G L +
Sbjct: 58 VKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 117
Query: 851 LHGAGKGGA----------------DWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAM 894
L D E VA +A+L +H D+ A
Sbjct: 118 LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAAR 174
Query: 895 NVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSD 954
N+LL G + DFGLAR + N S + +MAPE T +SD
Sbjct: 175 NILLTHGRITKICDFGLARDI-----KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 229
Query: 955 VYSFGVVLLEVLTGRHPLDPTLPGGAPLVQW 985
V+S+G+ L E+ + P +P + +
Sbjct: 230 VWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 16/219 (7%)
Query: 767 NLTSANVIGTGSSGVVYRVTIPNGE-----TLAVKKM---WSSDESGAFSSEIQTLGSIR 818
+T VIG G G VY+ + +A+K + ++ + F E +G
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 819 HKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL 878
H NI+RL G S ++ +Y+ NG+L L G ++ G+A + YL
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 879 HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGY 938
+ +H D+ A N+L+ ++DFGL+R++ +D+ T +
Sbjct: 127 AN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL----EDDPEATYTTSGGKIPIRW 179
Query: 939 MAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLP 977
APE S ++ T SDV+SFG+V+ EV+T L
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 218
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 5e-37
Identities = 40/205 (19%), Positives = 80/205 (39%), Gaps = 16/205 (7%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKM-WSSDESGAFSSEIQTLGSIRHKNIVRLLGWGS 830
+G G G+V+R + +T K + + EI L RH+NI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 831 NKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGD 890
+ ++ ++++ + ++ + V V AL +LH I H D
Sbjct: 72 SMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFD 127
Query: 891 VKAMNVLLGP--GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR 948
++ N++ + +FG AR + + L + Y APE
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQL--------KPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 949 ITEKSDVYSFGVVLLEVLTGRHPLD 973
++ +D++S G ++ +L+G +P
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFL 204
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 18/216 (8%)
Query: 772 NVIGTGSSGVVYRVTIP----NGETLAVKKMWSSDESGA-----FSSEIQTLGSIRHKNI 822
+G GS GVV R ++AVK + S F E+ + S+ H+N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 823 VRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC 882
+RL G +K++ + P GSL +G + VA + YL
Sbjct: 74 IRLYGVVLTPPMKMV-TELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 129
Query: 883 MPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE 942
+H D+ A N+LL + DFGL R + + D + +++ + + APE
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK----VPFAWCAPE 184
Query: 943 HASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978
+ + SD + FGV L E+ T L G
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 137 bits (345), Expect = 2e-36
Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 19/211 (9%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGA-----FSSEIQTLGSIRHKNIVRLL 826
++G G V+ + +AVK + + F E Q ++ H IV +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 827 GWGSNKN----LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC 882
G + L + +Y+ +L ++H G + EV+ AL + H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ-- 129
Query: 883 MPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE 942
I+H DVK N+++ + DFG+AR ++ SG+ + G+ Y++PE
Sbjct: 130 -NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA----AVIGTAQYLSPE 184
Query: 943 HASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
A + +SDVYS G VL EVLTG P
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (346), Expect = 2e-36
Identities = 43/206 (20%), Positives = 73/206 (35%), Gaps = 8/206 (3%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSN 831
IG+GS G +Y T I GE +A+K + E + ++ + + W
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 73
Query: 832 KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDV 891
+ + L SL L + + + + + + Y+H +H DV
Sbjct: 74 EGDYNVMVMELLGPSLEDLFNFCSRKF-SLKTVLLLADQMISRIEYIHSKN---FIHRDV 129
Query: 892 KAMNVL---LGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR 948
K N L G Y+ DFGLA+ + + L G+ Y +
Sbjct: 130 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE 189
Query: 949 ITEKSDVYSFGVVLLEVLTGRHPLDP 974
+ + D+ S G VL+ G P
Sbjct: 190 QSRRDDLESLGYVLMYFNLGSLPWQG 215
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 137 bits (345), Expect = 4e-36
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 29/221 (13%)
Query: 759 FSIDD--VVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKM-----WSSDESGAFSSE 810
+S+ D ++R +GTGS G V+ + NG A+K + + + E
Sbjct: 1 YSLQDFQILR------TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 811 IQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLG 870
L + H I+R+ G + + DY+ G L SLL + + Y
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY----- 109
Query: 871 VAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRP 930
A L + I++ D+K N+LL + DFG A+ V +
Sbjct: 110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----------DVTY 159
Query: 931 QLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
L G+ Y+APE S + + D +SFG+++ E+L G P
Sbjct: 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 4e-36
Identities = 54/206 (26%), Positives = 82/206 (39%), Gaps = 18/206 (8%)
Query: 773 VIGTGSSGVVYRVTIPN----GETLAVKKMWSSDESGA---FSSEIQTLGSIRHKNIVRL 825
IG G G V++ + +A+K + F E T+ H +IV+L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPP 885
+G + + + + G L S K D + ++ ALAYL
Sbjct: 74 IGVITENPV-WIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTALAYLES---KR 128
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945
+H D+ A NVL+ L DFGL+R + S SK +MAPE +
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG------KLPIKWMAPESIN 182
Query: 946 MQRITEKSDVYSFGVVLLEVLTGRHP 971
+R T SDV+ FGV + E+L
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVK 208
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 6e-36
Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETL----AVKKMWSSDESGA---FSSEIQTLGSIRHKNIV 823
V+G+G+ G VY+ IP GE + A+K++ + A E + S+ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 824 RLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCM 883
RLLG ++L+ +P G L K + + +A + YL
Sbjct: 75 RLLGICLTSTVQLI-TQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYL---ED 129
Query: 884 PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEH 943
++H D+ A NVL+ + DFGLA+++ + ++ +MA E
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALES 184
Query: 944 ASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ T +SDV+S+GV + E++T
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSK 212
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-35
Identities = 48/207 (23%), Positives = 79/207 (38%), Gaps = 19/207 (9%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKM-----WSSDESGAFSSEIQTLG-SIRHKNIVR 824
++G GS G V+ + A+K + D+ E + L + H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 825 LLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMP 884
+ K +YL G L + K D + L +LH
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF--DLSRATFYAAEIILGLQFLHSKG-- 123
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHA 944
I++ D+K N+LL +ADFG+ + +N + G+ Y+APE
Sbjct: 124 -IVYRDLKLDNILLDKDGHIKIADFGMCK-------ENMLGDAKTNTFCGTPDYIAPEIL 175
Query: 945 SMQRITEKSDVYSFGVVLLEVLTGRHP 971
Q+ D +SFGV+L E+L G+ P
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (334), Expect = 6e-35
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 17/205 (8%)
Query: 772 NVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGA----FSSEIQTLGSIRHKNIVRLLG 827
IG G+ GVVY+ GET A+KK+ E EI L ++H NIV+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 828 WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
K +L +++L L +GG + +L + + +AY H +L
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 888 HGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE-HASM 946
H D+K N+L+ + +ADFGLAR + Y AP+
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL-------WYRAPDVLMGS 175
Query: 947 QRITEKSDVYSFGVVLLEVLTGRHP 971
++ + D++S G + E++ G
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPL 200
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 132 bits (333), Expect = 1e-34
Identities = 39/208 (18%), Positives = 78/208 (37%), Gaps = 10/208 (4%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSN 831
IG GS GV++ T + N + +A+K ++ E +T + + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71
Query: 832 KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDV 891
+ L + L SL LL G+ + + + +H +++ D+
Sbjct: 72 EGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM-AAKQMLARVQSIHE---KSLVYRDI 127
Query: 892 KAMNVLLGPGYQ-----AYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM 946
K N L+G Y+ DFG+ + ++ L+G+ YM+
Sbjct: 128 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187
Query: 947 QRITEKSDVYSFGVVLLEVLTGRHPLDP 974
+ + + D+ + G V + L G P
Sbjct: 188 REQSRRDDLEALGHVFMYFLRGSLPWQG 215
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 128 bits (323), Expect = 1e-33
Identities = 48/221 (21%), Positives = 82/221 (37%), Gaps = 32/221 (14%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESG-----------AFSSEIQTLGSIR- 818
++G G S VV R P + AVK + + A E+ L +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 819 HKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL 878
H NI++L L +D + G L L K + +++ + + L
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICAL 126
Query: 879 HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGY 938
H I+H D+K N+LL L DFG + + + ++ G+ Y
Sbjct: 127 HK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--------PGEKLREVCGTPSY 175
Query: 939 MAPEHAS------MQRITEKSDVYSFGVVLLEVLTGRHPLD 973
+APE ++ D++S GV++ +L G P
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 216
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-33
Identities = 59/258 (22%), Positives = 93/258 (36%), Gaps = 46/258 (17%)
Query: 746 DDTWEMTLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVTIP--------NGETLAVKK 797
D WE+ + + +G G+ G V +AVK
Sbjct: 5 DPRWEL---PRDRLVLGKP---------LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM 52
Query: 798 M---WSSDESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHG 853
+ + + SE++ + I +HKNI+ LLG + + +Y G+L L
Sbjct: 53 LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA 112
Query: 854 AGKGGA--------------DWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG 899
G + VA + YL +H D+ A NVL+
Sbjct: 113 RRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169
Query: 900 PGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFG 959
+ADFGLAR + + + +MAPE + T +SDV+SFG
Sbjct: 170 EDNVMKIADFGLARDIHHIDYYKKTTNGR-----LPVKWMAPEALFDRIYTHQSDVWSFG 224
Query: 960 VVLLEVLTGRHPLDPTLP 977
V+L E+ T P +P
Sbjct: 225 VLLWEIFTLGGSPYPGVP 242
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-33
Identities = 47/233 (20%), Positives = 92/233 (39%), Gaps = 31/233 (13%)
Query: 752 TLYQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGA---- 806
T++++ + +DD +G+G VV + G A K + +
Sbjct: 1 TVFRQEN--VDDYYDTG---EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 55
Query: 807 ----FSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWE 862
E+ L I+H N++ L NK +L + + G L L +
Sbjct: 56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 115
Query: 863 ARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLL----GPGYQAYLADFGLARIVSGS 918
+ + L +++ I H D+K N++L P + + DFGLA +
Sbjct: 116 TEF-----LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170
Query: 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
N+ + G+ ++APE + + + ++D++S GV+ +L+G P
Sbjct: 171 --------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-33
Identities = 52/222 (23%), Positives = 85/222 (38%), Gaps = 25/222 (11%)
Query: 767 NLTSANVIGTGSSGVVYRVT------IPNGETLAVKKMW---SSDESGAFSSEIQTLGSI 817
+T + +G GS G+VY +A+K + S E F +E +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 818 RHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGA--------DWEARYEVVL 869
++VRLLG S L+ + + G L S L A ++
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 870 GVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQR 929
+A +AYL+ +H D+ A N ++ + + DFG+ R + +
Sbjct: 141 EIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-----YETDYYRKG 192
Query: 930 PQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ +M+PE T SDV+SFGVVL E+ T
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 3e-33
Identities = 51/209 (24%), Positives = 83/209 (39%), Gaps = 19/209 (9%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGA---FSSEIQTLGSIRHKNIVRLLG 827
+ IG G+ G+V N +A+KK+ + EI+ L RH+NI+ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 828 WGSNKNLKLLFYDYL----PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCM 883
++ + YL L LL + + + L Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLK---TQHLSNDHICYFLYQILRGLKYIHS--- 127
Query: 884 PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEH 943
+LH D+K N+LL + DFGLAR+ D T + + Y APE
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT----EYVATRWYRAPEI 183
Query: 944 ASMQRI-TEKSDVYSFGVVLLEVLTGRHP 971
+ T+ D++S G +L E+L+ R
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 4e-33
Identities = 49/211 (23%), Positives = 78/211 (36%), Gaps = 21/211 (9%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGA-------FSSEIQTLGSIRHKNIV 823
+ +G G VY+ + +A+KK+ S A EI+ L + H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 824 RLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCM 883
LL +K+ L +D++ + + Y + L L +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAY-----MLMTLQGLEYLHQ 118
Query: 884 PPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEH 943
ILH D+K N+LL LADFGLA+ S + Y APE
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG-------SPNRAYTHQVVTRWYRAPEL 171
Query: 944 A-SMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
+ D+++ G +L E+L L
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLP 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 1e-32
Identities = 48/210 (22%), Positives = 83/210 (39%), Gaps = 23/210 (10%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSI-RHKNIVRLLGWG- 829
V+G G +G V ++ E A+K + + E++ + +IVR++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML---QDCPKARREVELHWRASQCPHIVRIVDVYE 75
Query: 830 ---SNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPI 886
+ + L+ + L G L S + G E++ + A+ YLH I
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---I 132
Query: 887 LHGDVKAMNVLL---GPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEH 943
H DVK N+L P L DFG A+ + N + Y+APE
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKE--------TTSHNSLTTPCYTPYYVAPEV 184
Query: 944 ASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
++ + D++S GV++ +L G P
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFY 214
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 54/206 (26%), Positives = 82/206 (39%), Gaps = 17/206 (8%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESG----AFSSEIQTLGSIRHKNIVRLL 826
IG G+ GVVY+ GE +A+KK+ E+ EI L + H NIV+LL
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPI 886
+N KL + L + + G + + LA+ H +
Sbjct: 68 DVIHTEN-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 123
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE-HAS 945
LH D+K N+L+ LADFGLAR + + Y APE
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE-------VVTLWYRAPEILLG 176
Query: 946 MQRITEKSDVYSFGVVLLEVLTGRHP 971
+ + D++S G + E++T R
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-32
Identities = 64/210 (30%), Positives = 89/210 (42%), Gaps = 23/210 (10%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGW-- 828
VIG GS GVVY+ +GE +A+KK+ + E+Q + + H NIVRL +
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--KNRELQIMRKLDHCNIVRLRYFFY 83
Query: 829 --GSNKNLKLLF--YDYLPNGSLSSLLHGA-GKGGADWEARYEVVLGVAHALAYLHHDCM 883
G K+ L DY+P H + K + + +LAY+H
Sbjct: 84 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 140
Query: 884 PPILHGDVKAMNVLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAP- 941
I H D+K N+LL P L DFG A+ + G+ N S R Y AP
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRY-------YRAPE 192
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
T DV+S G VL E+L G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 22/216 (10%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFS----SEIQTLGSIRHKNIVRLL 826
IG G+ G V++ G+ +A+KK+ +E F EI+ L ++H+N+V L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 827 G--------WGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL 878
+ K L +D+ + L + K R + L L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-----MQMLLNGL 130
Query: 879 HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGY 938
++ ILH D+KA NVL+ LADFGLAR S + + N+ + Y
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP---NRYTNRVVTLWY 187
Query: 939 MAPEHASMQR-ITEKSDVYSFGVVLLEVLTGRHPLD 973
PE +R D++ G ++ E+ T +
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 126 bits (318), Expect = 4e-32
Identities = 42/212 (19%), Positives = 72/212 (33%), Gaps = 24/212 (11%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWSS--------DESGAFSSEIQTLGSIRHKNI 822
+IG G G VY G+ A+K + + + + + I
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 823 VRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC 882
V + + D + G L L G + L ++H+
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHN-- 125
Query: 883 MPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE 942
+++ D+K N+LL ++D GLA S + G++GYMAPE
Sbjct: 126 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---------KPHASVGTHGYMAPE 175
Query: 943 H-ASMQRITEKSDVYSFGVVLLEVLTGRHPLD 973
+D +S G +L ++L G P
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-31
Identities = 46/213 (21%), Positives = 79/213 (37%), Gaps = 24/213 (11%)
Query: 772 NVIGTGSSGVVYRVT--IPNGETLAVKKMWSSDESGAFS-------SEIQTLGSIRHKNI 822
IG G+ G V++ G +A+K++ + ++ L + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 823 VRLLGWGSNKNLKLLFYDYLPN----GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYL 878
VRL + L L++ L + G E +++ + L +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 879 HHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGY 938
H ++H D+K N+L+ Q LADFGLARI S + + Y
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI--------YSFQMALTSVVVTLWY 181
Query: 939 MAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
APE D++S G + E+ +
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-31
Identities = 44/206 (21%), Positives = 74/206 (35%), Gaps = 18/206 (8%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKM-----WSSDESGAFSSEIQTLGSIRHKNIVRL 825
++G G+ G V V G A+K + + DE +E + L + RH + L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 826 LGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPP 885
+ +Y G L L + Y A ++ L +
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----GAEIVSALEYLHSRD 125
Query: 886 ILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHAS 945
+++ D+K N++L + DFGL + S G+ Y+APE
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEG-------ISDGATMKTFCGTPEYLAPEVLE 178
Query: 946 MQRITEKSDVYSFGVVLLEVLTGRHP 971
D + GVV+ E++ GR P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 4e-31
Identities = 44/208 (21%), Positives = 76/208 (36%), Gaps = 16/208 (7%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSS----EIQTLGSIRHKNIVRLL 826
IG G+ G V++ E +A+K++ D+ S EI L ++HKNIVRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPI 886
+ L +++ G + + + L L +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCHSRNV 122
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM 946
LH D+K N+L+ + LA+FGLAR ++ +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL------WYRPPDVLFGA 176
Query: 947 QRITEKSDVYSFGVVLLEVLTGRHPLDP 974
+ + D++S G + E+ PL P
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFP 204
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-29
Identities = 42/214 (19%), Positives = 77/214 (35%), Gaps = 26/214 (12%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGA--------FSSEIQTLGSIR--HKN 821
++G+G G VY + + +A+K + S E+ L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 822 IVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHD 881
++RLL W + +L + +G E V A+ + H+
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHN- 128
Query: 882 CMPPILHGDVKAMNVLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMA 940
+LH D+K N+L+ + L DFG ++ K G+ Y
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---------KDTVYTDFDGTRVYSP 177
Query: 941 PEHASMQR-ITEKSDVYSFGVVLLEVLTGRHPLD 973
PE R + V+S G++L +++ G P +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 117 bits (292), Expect = 3e-29
Identities = 81/313 (25%), Positives = 128/313 (40%), Gaps = 15/313 (4%)
Query: 32 CDALDEQGQALLTWKNSLNSSTDALSSWNPAETSPC--KWFGIHCSSNGE---VVEISLK 86
C+ + QALL K L + T LSSW P T C W G+ C ++ + V + L
Sbjct: 3 CN--PQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLS 58
Query: 87 AVDLQG--SLPSIFQPLKSLKRLIISSC-NLTGTIPKEFGDYRELTFIDLSGNSLWGEIP 143
++L +PS L L L I NL G IP +L ++ ++ ++ G IP
Sbjct: 59 GLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP 118
Query: 144 TEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVF 203
+ +++ L +L + N L G +P I +L +L +T N++SG IP S G+ SKL
Sbjct: 119 DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178
Query: 204 RAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPI 263
L G++P N + + +
Sbjct: 179 MTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSD--KNTQKIHLAKNSLAFD 236
Query: 264 PEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTV 323
++G L L L N I G +P + L L SL + N+L G IP + G+ V
Sbjct: 237 LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDV 295
Query: 324 VDFSDNLLTGSIP 336
+++N P
Sbjct: 296 SAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 92.1 bits (227), Expect = 8e-21
Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 3/257 (1%)
Query: 417 LQALDFSYNNLSG--PIPKEIFGLRNLTKLLLLSND-LSGFIPPDIGNCTTLRRLRLNDN 473
+ LD S NL PIP + L L L + + L G IPP I T L L +
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 474 RLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPT 533
+SG IP + +K L +D S N L G +PPS+ +L + N ++G++PD+ +
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 534 SLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRF 593
+L + + L+ + ++ A +L I +
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 594 SGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQ 653
S +S L+L +N+ G +P + L L L++S N L G++ +LQ
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQ 291
Query: 654 NLVSLNVSFNDFSGELP 670
+ N P
Sbjct: 292 RFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 86.7 bits (213), Expect = 6e-19
Identities = 71/263 (26%), Positives = 107/263 (40%), Gaps = 5/263 (1%)
Query: 340 GNLLKLQELQLSVNQLSGTIPI--EIATCTALTHLEIDNNA-ISGEIPADIGNINGLTLF 396
++ L LS L PI +A L L I + G IP I + L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 397 FAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIP 456
+ ++G IP+ LSQ + L LDFSYN LSG +P I L NL + N +SG IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 457 PDIGNCTTLRR-LRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEF 515
G+ + L + ++ NRL+G IP NL + +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 516 LDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPA 575
++ L +L +DL +NR+ G+L + L L L +S N L G IP
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP- 285
Query: 576 EILSCRKLILLDIGNNRFSGEIP 598
+ + ++ + NN+ P
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 79.4 bits (194), Expect = 2e-16
Identities = 72/263 (27%), Positives = 110/263 (41%), Gaps = 6/263 (2%)
Query: 268 GNCSELQNLYLYQNSISG--PIPGRIGALSKLKSLLLWQN-SLVGAIPDELGSCTELTVV 324
+ NL L ++ PIP + L L L + +LVG IP + T+L +
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 325 DFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIP 384
+ ++G+IP + L L S N LSGT+P I++ L + D N ISG IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 385 ADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKL 444
G+ + L L +D S N L G +N T+
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN-TQK 225
Query: 445 LLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIP 504
+ L+ + F +G L L L +NR+ GT+P + LK L+ +++S N+L G IP
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 505 PSVVGCQSLEFLDLHSN-GLTGS 526
Q + +N L GS
Sbjct: 286 QG-GNLQRFDVSAYANNKCLCGS 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 75.6 bits (184), Expect = 3e-15
Identities = 66/299 (22%), Positives = 104/299 (34%), Gaps = 32/299 (10%)
Query: 168 SDIGNLSSLAYLTLYDNQLSGK--IPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNL 225
+ L L L IP S+ L L GG NL G +P I + L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 226 VMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISG 285
L + T++SG +P + ++ + T+ + LSG +P I + L + N ISG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 286 PIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKL 345
IP G+ SKL + + + + + L VD S
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLS------------------ 205
Query: 346 QELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTG 405
+ + T +G L N++ G
Sbjct: 206 -------RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYG 258
Query: 406 NIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSND-LSGFIPPDIGNCT 463
+P+ L+Q + L +L+ S+NNL G IP + L+ +N L G P CT
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLP---ACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.0 bits (141), Expect = 8e-10
Identities = 24/86 (27%), Positives = 34/86 (39%), Gaps = 6/86 (6%)
Query: 139 WGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALS 198
+V + L L L N + G +P + L L L + N L G+IP G L
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQ 291
Query: 199 KLQVFRAGGNQNLKGE-LPWEIGNCS 223
+ V N+ L G LP C+
Sbjct: 292 RFDVSAYANNKCLCGSPLP----ACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 15/62 (24%), Positives = 31/62 (50%), Gaps = 3/62 (4%)
Query: 109 ISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYL--NTNLLEGEI 166
+ + + GT+P+ + L +++S N+L GEIP + L++ + N L +
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPL 309
Query: 167 PS 168
P+
Sbjct: 310 PA 311
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 4e-29
Identities = 57/228 (25%), Positives = 84/228 (36%), Gaps = 33/228 (14%)
Query: 772 NVIGTGSSGVVYRVT------IPNGETLAVKKMWSSDESG---AFSSEIQTLGSIRH-KN 821
+G G+ G V T+AVK + A SE++ L I H N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 822 IVRLLGWGSNKNLKLLF-YDYLPNGSLSSLLHGAG--------------KGGADWEARYE 866
+V LLG + L+ ++ G+LS+ L K E
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 867 VVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKT 926
VA + +L +H D+ A N+LL + DFGLAR + D
Sbjct: 139 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 927 NQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974
+MAPE + T +SDV+SFGV+L E+ + P
Sbjct: 196 -----ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 114 bits (287), Expect = 3e-28
Identities = 41/205 (20%), Positives = 76/205 (37%), Gaps = 21/205 (10%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGA-----FSSEIQTLGSIRHKNIVRLL 826
+GTGS G V V +G A+K + +E + L ++ +V+L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 827 GWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPI 886
+ + + +Y+ G + S L G + YLH +
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLD---L 162
Query: 887 LHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM 946
++ D+K N+L+ + DFG A+ + L G+ +APE
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK----------RVKGRTWTLCGTPEALAPEIILS 212
Query: 947 QRITEKSDVYSFGVVLLEVLTGRHP 971
+ + D ++ GV++ E+ G P
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 113 bits (282), Expect = 1e-27
Identities = 45/209 (21%), Positives = 78/209 (37%), Gaps = 23/209 (11%)
Query: 772 NVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFSSEIQTLGSIR-HKNIVRLLGWG 829
+G G V+ I N E + VK + + EI+ L ++R NI+ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-KIKREIKILENLRGGPNIITLADIV 99
Query: 830 SNKNLKLLF--YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPIL 887
+ + ++++ N L D++ R+ + + AL Y H I+
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLYQTLT----DYDIRF-YMYEILKALDYCHSMG---IM 151
Query: 888 HGDVKAMNVLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE-HAS 945
H DVK NV++ + L D+GLA + N S + PE
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR--------VASRYFKGPELLVD 203
Query: 946 MQRITEKSDVYSFGVVLLEVLTGRHPLDP 974
Q D++S G +L ++ + P
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFH 232
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-27
Identities = 50/225 (22%), Positives = 90/225 (40%), Gaps = 24/225 (10%)
Query: 755 QKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGAFS----S 809
K + + V R+L +G+G+ G V G +A+KK++ +S F+
Sbjct: 10 TKTAWEVRAVYRDL---QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 66
Query: 810 EIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGA--GKGGADWEARYEV 867
E++ L +RH+N++ LL + F D+ G + +
Sbjct: 67 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL 126
Query: 868 VLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTN 927
V + L Y+H + H D+K N+ + + + DFGLAR
Sbjct: 127 VYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV---- 179
Query: 928 QRPQLAGSYGYMAPEHA-SMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ Y APE + R T+ D++S G ++ E++TG+
Sbjct: 180 ------VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 112 bits (280), Expect = 4e-27
Identities = 79/387 (20%), Positives = 148/387 (38%), Gaps = 40/387 (10%)
Query: 126 RELTFIDLSGNSLWGEIP-TEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDN 184
E L ++ + T++ ++ L++ L ++G + L++L + +N
Sbjct: 22 AEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNN 76
Query: 185 QLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGN--------------CSNLVMLGL 230
QL+ P + L+KL NQ + N + L
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 231 AETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGR 290
+S N S I L + ++ + + + N + L+ L + N +
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKV--SDISV 192
Query: 291 IGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQL 350
+ L+ L+SL+ N + P + T L + + N L + +L L +L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 351 SVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPES 410
+ NQ+S P+ T LT L++ N IS P + + LT +N+L P
Sbjct: 249 ANNQISNLAPLS--GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPI- 303
Query: 411 LSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRL 470
S + L L +NN+S P + L L +L +N +S + N T + L
Sbjct: 304 -SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 471 NDNRLSGTIPSEMGNLKHLNFVDMSEN 497
N++S P + NL + + +++
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 111 bits (278), Expect = 8e-27
Identities = 78/408 (19%), Positives = 152/408 (37%), Gaps = 57/408 (13%)
Query: 269 NCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSD 328
+E L + +++ + L ++ +L + + D + LT ++FS+
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75
Query: 329 NLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIG 388
N LT P NL KL ++ ++ NQ++ P+ T L + +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 389 ---------NINGLTLFFAWKNKLTGNIPESLSQCQELQAL----DFSYNNLSGPIPKEI 435
I+ ++ + + ++ + L L ++ +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 436 FGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMS 495
L NL L+ +N +S P I T L L LN N+L + +L +L +D++
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 496 ENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGS 555
N + P S G L L L +N ++ P T+L ++L++N+
Sbjct: 250 NNQISNLAPLS--GLTKLTELKLGANQISNISPLAGLTALTNLELNENQ----------- 296
Query: 556 LTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSS 615
+ I + + L L + N S P + ++ L+ L ++
Sbjct: 297 ---------------LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQ-RLFFAN 338
Query: 616 NQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFN 663
N+ S S + LT + L HN++S L LA+L + L ++
Sbjct: 339 NKVSD--VSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 104 bits (260), Expect = 2e-24
Identities = 75/396 (18%), Positives = 151/396 (38%), Gaps = 32/396 (8%)
Query: 221 NCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQ 280
+ + L +T+++ V + L+++ T+ + + + + L +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75
Query: 281 NSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFG 340
N ++ P + L+KL +L+ N + + LT +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQ---------IADITPLANLTNLTGLTLFNNQITD 124
Query: 341 NLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWK 400
L+ +LS +I+ + LT L+ + + N+ L
Sbjct: 125 IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISS 184
Query: 401 NKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIG 460
NK++ ++ L++L + N +S P I NL +L L N L +
Sbjct: 185 NKVSDISVL--AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLA 238
Query: 461 NCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHS 520
+ T L L L +N++S P + L L + + N + P + G +L L+L+
Sbjct: 239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNE 294
Query: 521 NGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSC 580
N L P + +L + L N +S + SLT+L +L + N++S + + +
Sbjct: 295 NQLEDISPISNLKNLTYLTLYFNNISDI--SPVSSLTKLQRLFFANNKVSD--VSSLANL 350
Query: 581 RKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSN 616
+ L G+N+ S P L ++ + L L+
Sbjct: 351 TNINWLSAGHNQISDLTP--LANLTRIT-QLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 95.1 bits (235), Expect = 2e-21
Identities = 85/407 (20%), Positives = 137/407 (33%), Gaps = 105/407 (25%)
Query: 341 NLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWK 400
L + + L ++ T+ +T L+ D I
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--------------------- 56
Query: 401 NKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIP---- 456
+ G + L ++FS N L+ P L+NLTKL+ + + +
Sbjct: 57 KSIDG-----VEYLNNLTQINFSNNQLTDITP-----LKNLTKLVDILMNNNQIADITPL 106
Query: 457 --------------------------------------PDIGNCTTLRRLRLNDNRLSGT 478
DI + L L+ T
Sbjct: 107 ANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT 166
Query: 479 IPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLV 538
+ NL L +D+S N + + +LE L +N ++ P + T+L +
Sbjct: 167 DLKPLANLTTLERLDISSNKVSDISVLA--KLTNLESLIATNNQISDITPLGILTNLDEL 224
Query: 539 DLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIP 598
L+ N+L ++ SLT L+ L L+ NQ+S P + KL L +G N+ S P
Sbjct: 225 SLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 280
Query: 599 KELGQISSLEI-------------------SLNLSSNQFSGEIPSEFSGLTKLGILDLSH 639
+ L L N S P S LTKL L ++
Sbjct: 281 LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFAN 338
Query: 640 NKLSGDLDALASLQNLVSLNVSFNDFSGELP--NTPFFRKLPLSDLA 684
NK+S + +LA+L N+ L+ N S P N +L L+D A
Sbjct: 339 NKVSD-VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 90.4 bits (223), Expect = 9e-20
Identities = 76/389 (19%), Positives = 136/389 (34%), Gaps = 42/389 (10%)
Query: 172 NLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQ--NLKGELPWEIGNCSNLVMLG 229
L+ L ++ + ++ L ++ +A ++ G + +NL +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDG-----VEYLNNLTQIN 72
Query: 230 LAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIP- 288
+ ++ P + L ++ I + + ++ P L+ Q + P+
Sbjct: 73 FSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 130
Query: 289 --------------GRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGS 334
I ALS L SL L + T L +D S N S
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN--KVS 188
Query: 335 IPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLT 394
L L+ L + NQ+S P+ I T L L ++ N + + ++ LT
Sbjct: 189 DISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLT 244
Query: 395 LFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGF 454
N+++ P LS +L L N +S P + GL LT L L N
Sbjct: 245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ--LE 298
Query: 455 IPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLE 514
I N L L L N +S P + +L L + + N + S+ ++
Sbjct: 299 DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNIN 354
Query: 515 FLDLHSNGLTGSVPDTLPTSLQLVDLSDN 543
+L N ++ P T + + L+D
Sbjct: 355 WLSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 80.4 bits (197), Expect = 2e-16
Identities = 72/376 (19%), Positives = 131/376 (34%), Gaps = 54/376 (14%)
Query: 98 FQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYL 157
+ L +L ++ S+ LT P + +L I ++ N + P +L+
Sbjct: 62 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119
Query: 158 NTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPW 217
N + + + +I +S L + + ++
Sbjct: 120 NQITDIDPLKNL------------TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD 167
Query: 218 EIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLY 277
+ + L +S + S + L ++++ + +S P I + L L
Sbjct: 168 LKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELS 225
Query: 278 LYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPR 337
L N + L S T LT +D ++N ++ P
Sbjct: 226 LNGNQLKD--------------------------IGTLASLTNLTDLDLANNQISNLAP- 258
Query: 338 SFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFF 397
L KL EL+L NQ+S P+ T ++ N E + I N+ LT
Sbjct: 259 -LSGLTKLTELKLGANQISNISPLAGLTA----LTNLELNENQLEDISPISNLKNLTYLT 313
Query: 398 AWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPP 457
+ N ++ P +S +LQ L F+ N +S + L N+ L N +S P
Sbjct: 314 LYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP- 368
Query: 458 DIGNCTTLRRLRLNDN 473
+ N T + +L LND
Sbjct: 369 -LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 80.4 bits (197), Expect = 2e-16
Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 17/208 (8%)
Query: 171 GNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGL 230
L++L L +NQ+S P I + L GNQ + + + +NL L L
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQL---KDIGTLASLTNLTDLDL 248
Query: 231 AETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGR 290
A IS P + L ++ + + + +S P + + L NL L +N + P
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS 304
Query: 291 IGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQL 350
L L L L+ N++ P + S T+L + F++N ++ S NL + L
Sbjct: 305 N--LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 351 SVNQLSGTIPIEIATCTALTHLEIDNNA 378
NQ+S P +A T +T L +++ A
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQA 384
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 7e-27
Identities = 53/213 (24%), Positives = 83/213 (38%), Gaps = 24/213 (11%)
Query: 772 NVIGTGSSGVVYRV----TIPNGETLAVKKMWSSDESG------AFSSEIQTLGSIRHK- 820
V+GTG+ G V+ V G+ A+K + + +E Q L IR
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 821 NIVRLLGWGSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHH 880
+V L + L DY+ G L + L + V + V + L H
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEIVLALEH 144
Query: 881 DCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMA 940
I++ D+K N+LL L DFGL++ +T + G+ YMA
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA------DETERAYDFCGTIEYMA 198
Query: 941 PEHASMQR--ITEKSDVYSFGVVLLEVLTGRHP 971
P+ + D +S GV++ E+LTG P
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-25
Identities = 39/210 (18%), Positives = 78/210 (37%), Gaps = 27/210 (12%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKM----WSSDESGAFSSEIQTLGSIRHKNIVRLLG 827
IG+G+ G+V +A+KK+ + + E+ + + HKNI+ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 828 WGSNKNLK------LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHD 881
+ + L + + + + D E ++ + + +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 882 CMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAP 941
+ +H D+K N+++ + DFGLAR + + Y AP
Sbjct: 139 GI---IHRDLKPSNIVVKSDCTLKILDFGLART--------AGTSFMMTPYVVTRYYRAP 187
Query: 942 EHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
E E D++S G ++ E++ +
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (266), Expect = 2e-25
Identities = 45/219 (20%), Positives = 78/219 (35%), Gaps = 24/219 (10%)
Query: 773 VIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESG-AFSSEIQTLGSIRHKNIVRLLGWGS 830
+G G V+ + N +A+K + A EI+ L + + + G+
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 831 NKNLKLL--FYDYLPNGSL------------SSLLHGAGKGGADWEARYEVVLGVAHALA 876
N LKLL F PNG +L+ G ++ + L
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 877 YLHHDCMPPILHGDVKAMNVLLGP-GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGS 935
Y+H C I+H D+K NVL+ L +A + + C +
Sbjct: 140 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-----CWYDEHYTNSIQT 192
Query: 936 YGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974
Y +PE +D++S ++ E++TG +P
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 7e-25
Identities = 43/228 (18%), Positives = 89/228 (39%), Gaps = 25/228 (10%)
Query: 754 YQKLDFSIDDVVRNLTSANVIGTGSSGVVYRVT-IPNGETLAVKKMWSSDESGA----FS 808
Q+L+ +I +V + + +G+G+ G V G +AVKK+ +S
Sbjct: 6 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 65
Query: 809 SEIQTLGSIRHKNIVRLLGWGSNKN-----LKLLFYDYLPNGSLSSLLHGAGKGGADWEA 863
E++ L ++H+N++ LL + + +L L++++ +
Sbjct: 66 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDH 122
Query: 864 RYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923
++ + L Y+H + H D+K N+ + + + DFGLAR
Sbjct: 123 VQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV 179
Query: 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHP 971
+ + + + D++S G ++ E+LTGR
Sbjct: 180 ATR---------WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 103 bits (256), Expect = 2e-24
Identities = 52/279 (18%), Positives = 100/279 (35%), Gaps = 14/279 (5%)
Query: 310 AIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTAL 369
+P +L + ++D +N +T F NL L L L N++S P A L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 370 THLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSG 429
L + N + + L + K+ ++ L+Q ++ L + SG
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSG 140
Query: 430 PIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHL 489
G++ L+ + + +++ G +L L L+ N+++ + + L +L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 490 NFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTL-PTSLQLVDLSDNRLSG- 547
+ +S N + S+ L L L++N L +Q+V L +N +S
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAI 257
Query: 548 -----SLAHSIGSLTELSKLLLSKNQLS-GRIPAEILSC 580
S + L N + I C
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 101 bits (252), Expect = 4e-24
Identities = 50/258 (19%), Positives = 99/258 (38%), Gaps = 13/258 (5%)
Query: 297 LKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLS 356
L L N + + + L + +N ++ P +F L+KL+ L LS NQL
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 357 GTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQE 416
T L E + + + + + + L K +G + ++
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSSGIENGAFQGMKK 151
Query: 417 LQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLS 476
L + + N++ IP+ + +LT+L L N ++ + L +L L+ N +S
Sbjct: 152 LSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 477 GTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDT------ 530
+ N HL + ++ N LV +P + + ++ + LH+N ++ +
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 267
Query: 531 --LPTSLQLVDLSDNRLS 546
S V L N +
Sbjct: 268 NTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 99.7 bits (247), Expect = 2e-23
Identities = 52/268 (19%), Positives = 96/268 (35%), Gaps = 12/268 (4%)
Query: 382 EIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNL 441
++P D+ L NK+T + L L N +S P L L
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 442 TKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVG 501
+L L N L LR ++ ++ + + + + G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP-LKSSG 140
Query: 502 GIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSK 561
+ G + L ++ + +T ++P LP SL + L N+++ A S+ L L+K
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAK 199
Query: 562 LLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSG- 620
L LS N +S + + L L + NN+ ++P L +++ + L +N S
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV-VYLHNNNISAI 257
Query: 621 -----EIPSEFSGLTKLGILDLSHNKLS 643
P + + L N +
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 99.0 bits (245), Expect = 4e-23
Identities = 44/266 (16%), Positives = 90/266 (33%), Gaps = 17/266 (6%)
Query: 407 IPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLR 466
+P+ L + LD N ++ + L+NL L+L++N +S P L
Sbjct: 25 VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 467 RLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGS 526
RL L+ N+L L+ L + + + + +E L + +G
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGI 141
Query: 527 VPDTLP--TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLI 584
L + ++D ++ G L++L L N+++ A + L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTI---PQGLPPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 585 LLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSG 644
L + N S L L +N ++P + + ++ L +N +S
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHL--NNNKLVKVPGGLADHKYIQVVYLHNNNISA 256
Query: 645 -------DLDALASLQNLVSLNVSFN 663
+ +++ N
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSN 282
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.1 bits (222), Expect = 4e-20
Identities = 59/284 (20%), Positives = 103/284 (36%), Gaps = 15/284 (5%)
Query: 103 SLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLL 162
L+ + S L +PK+ + +DL N + + L+ L +L L N +
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 163 EGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNC 222
P L L L L NQL K L +L+V + K N
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL--NQ 125
Query: 223 SNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNS 282
+V LG SG + ++++ I I + ++ IP+ G L L+L N
Sbjct: 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNK 182
Query: 283 ISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNL 342
I+ + L+ L L L NS+ L + L + ++N L +P +
Sbjct: 183 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 241
Query: 343 LKLQELQLSVNQLSG------TIPIEIATCTALTHLEIDNNAIS 380
+Q + L N +S P + + + + +N +
Sbjct: 242 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 76.6 bits (187), Expect = 1e-15
Identities = 38/194 (19%), Positives = 66/194 (34%), Gaps = 26/194 (13%)
Query: 501 GGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELS 560
G + P C L + GL VP LP L+DL +N+++ +L L
Sbjct: 1 GPVCPFRCQC-HLRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLH 58
Query: 561 KLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLN-------- 612
L+L N++S P KL L + N+ K + L + N
Sbjct: 59 TLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKS 118
Query: 613 --------------LSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSL 658
+ + SG F G+ KL + ++ ++ L +L L
Sbjct: 119 VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTEL 176
Query: 659 NVSFNDFSGELPNT 672
++ N + +
Sbjct: 177 HLDGNKITKVDAAS 190
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 43.1 bits (100), Expect = 1e-04
Identities = 37/173 (21%), Positives = 62/173 (35%), Gaps = 9/173 (5%)
Query: 69 WFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYREL 128
+ + VVE+ + G FQ +K L + I+ N+T TIP+ L
Sbjct: 117 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSL 173
Query: 129 TFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSG 188
T + L GN + + L L L L+ N + + N L L L +N+L
Sbjct: 174 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 232
Query: 189 KIPKSIGALSKLQVFRAGGNQ-----NLKGELPWEIGNCSNLVMLGLAETSIS 236
K+P + +QV N + P ++ + L +
Sbjct: 233 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (228), Expect = 4e-21
Identities = 51/265 (19%), Positives = 91/265 (34%), Gaps = 6/265 (2%)
Query: 165 EIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSN 224
+P I ++ + L+ N++S S A L + N + + G
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 225 LVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSIS 284
+ + P++ L R+ T+ + L P + LQ LYL N++
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 285 GPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLK 344
L L L L N + L + N + P +F +L +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 345 LQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLT 404
L L L N LS +A AL +L +++N + A L F +++
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVP 261
Query: 405 GNIPESLSQCQELQALDFSYNNLSG 429
++P+ L + N+L G
Sbjct: 262 CSLPQRL---AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (214), Expect = 3e-19
Identities = 50/263 (19%), Positives = 81/263 (30%), Gaps = 29/263 (11%)
Query: 310 AIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQ--------------- 354
A+P + + N ++ SF L L L N
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 355 ----------LSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLT 404
L P L L +D + P + L + N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 405 GNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTT 464
++ L L N +S + GL +L +LLL N ++ P +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 465 LRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLT 524
L L L N LS + L+ L ++ +++N V + L+ S+ +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL-WAWLQKFRGSSSEVP 261
Query: 525 GSVPDTLPTSLQLVDLSDNRLSG 547
S+P L L L+ N L G
Sbjct: 262 CSLPQRL-AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (201), Expect = 1e-17
Identities = 60/270 (22%), Positives = 88/270 (32%), Gaps = 9/270 (3%)
Query: 420 LDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTI 479
L +P I ++ L N +S C L L L+ N L+
Sbjct: 16 TSCPQQGLQA-VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 480 PSEMGNLKHLNFVDMSENHLVGGIPPSVVG-CQSLEFLDLHSNGLTGSVPDTLP--TSLQ 536
+ L L +D+S+N + + P+ L L L GL P +LQ
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132
Query: 537 LVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGE 596
+ L DN L + L L+ L L N++S L L + NR +
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 597 IPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLV 656
P + L L +N S + L L L L+ N D A L
Sbjct: 193 HPHAFRDLGRLMTL-YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQ 251
Query: 657 SLNVSFNDFSGELPNTPFFRKLPLSDLASN 686
S ++ LP L LA+N
Sbjct: 252 KFRGSSSEVPCSLP--QRLAGRDLKRLAAN 279
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.4 bits (199), Expect = 3e-17
Identities = 59/264 (22%), Positives = 100/264 (37%), Gaps = 9/264 (3%)
Query: 407 IPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLR 466
+P + Q + N +S RNLT L L SN L+ L
Sbjct: 26 VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 467 RLRLNDNRLSGTI-PSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTG 525
+L L+DN ++ P+ L L+ + + L P G +L++L L N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 526 SVPDTLP--TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKL 583
DT +L + L NR+S + L L +LLL +N+++ P +L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 584 ILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLS 643
+ L + N S + L + +L+ L L+ N + + + L S +++
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQ-YLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVP 261
Query: 644 GDLDALASLQNLVSLNVSFNDFSG 667
L L ++ ND G
Sbjct: 262 CSLPQ--RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.1 bits (162), Expect = 1e-12
Identities = 52/288 (18%), Positives = 92/288 (31%), Gaps = 38/288 (13%)
Query: 73 HCSSNGEVVEISLKAVDLQG-SLPSIFQPL-KSLKRLIISSCNLTGTIPKEFGDYRELTF 130
C + +V L ++ + + +R+ + ++ F R LT
Sbjct: 7 VCYNEPKVT------TSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTI 60
Query: 131 IDLSGNSLWGEI-------------------------PTEVCRLRKLESLYLNTNLLEGE 165
+ L N L P L +L +L+L+ L+
Sbjct: 61 LWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL 120
Query: 166 IPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNL 225
P L++L YL L DN L + L L GN + +L
Sbjct: 121 GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN-RISSVPERAFRGLHSL 179
Query: 226 VMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISG 285
L L + ++ P + L R+ T+ ++ + LS E + LQ L L N
Sbjct: 180 DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239
Query: 286 PIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTG 333
R + L+ + + ++P L + + N L G
Sbjct: 240 DCRAR-PLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.9 bits (125), Expect = 6e-08
Identities = 40/196 (20%), Positives = 60/196 (30%), Gaps = 30/196 (15%)
Query: 505 PSVVGCQSLE--FLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKL 562
P C + GL +VP +P + Q + L NR+S A S + L+ L
Sbjct: 3 PGACVCYNEPKVTTSCPQQGLQ-AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTIL 61
Query: 563 LLSKNQ-------------------------LSGRIPAEILSCRKLILLDIGNNRFSGEI 597
L N L PA +L L +
Sbjct: 62 WLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG 121
Query: 598 PKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSG-DLDALASLQNLV 656
P +++L+ L N F L L L L N++S A L +L
Sbjct: 122 PGLFRGLAALQYL-YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD 180
Query: 657 SLNVSFNDFSGELPNT 672
L + N + P+
Sbjct: 181 RLLLHQNRVAHVHPHA 196
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.8 bits (209), Expect = 2e-19
Identities = 29/152 (19%), Positives = 49/152 (32%), Gaps = 11/152 (7%)
Query: 772 NVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSN 831
++G G V+ VK S E + G + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 832 KNLKLL-------FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMP 884
+ L+ L Y + N L L+ E EV+ + +A +H
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG-- 123
Query: 885 PILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916
I+HGD+ NVL+ ++ DF + V
Sbjct: 124 -IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVG 153
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.6 bits (153), Expect = 2e-11
Identities = 41/188 (21%), Positives = 65/188 (34%), Gaps = 6/188 (3%)
Query: 310 AIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTAL 369
A+P +L + T++ S+NLL + +L +L L +L+
Sbjct: 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81
Query: 370 THLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSG 429
L + + + + N+LT +L ELQ L N L
Sbjct: 82 LDLSHNQLQSLPLLGQTLPALTV---LDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138
Query: 430 PIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHL 489
P + L KL L +N+L+ + L L L +N L TIP L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197
Query: 490 NFVDMSEN 497
F + N
Sbjct: 198 PFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 40/240 (16%), Positives = 66/240 (27%), Gaps = 47/240 (19%)
Query: 510 CQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQL 569
S ++ LT ++P LP ++ LS+N L ++ T L++L L + +L
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 570 SGRIPAEILS--------------------------------------------CRKLIL 585
+ L +
Sbjct: 68 TKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQ 127
Query: 586 LDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGD 645
+P L + L+L++N + +GL L L L N L
Sbjct: 128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTI 187
Query: 646 LDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRGLYISGGVVSPTDSLPAG 705
L + N + F R L D A N ++ G V S A
Sbjct: 188 PKGFFGSHLLPFAFLHGNPWLCNCEILYFRRW--LQDNAENVYVWKQGVDVKAMTSNVAS 245
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 5e-08
Identities = 34/211 (16%), Positives = 60/211 (28%), Gaps = 11/211 (5%)
Query: 338 SFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLT-LF 396
+ E+ L+ +P ++ T L + N + A + LT L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 397 FAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIP 456
+ +L L +L N L+
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVS----FNRLTSLPL 117
Query: 457 PDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFL 516
+ L+ L L N L P + L + ++ N+L + G ++L+ L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 517 DLHSNGLTGSVPDTL--PTSLQLVDLSDNRL 545
L N L ++P L L N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 5e-08
Identities = 38/209 (18%), Positives = 73/209 (34%), Gaps = 8/209 (3%)
Query: 121 EFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLT 180
E ++ +L +P ++ + L+L+ NLL + + + L L
Sbjct: 5 EVSKVASHLEVNCDKRNL-TALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 181 LYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVP 240
L + + G L L NQ L + ++ + ++
Sbjct: 62 LDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVS--FNRLTSLPL 117
Query: 241 SSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSL 300
++ L +Q + + + L P + +L+ L L N+++ G + L L +L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 301 LLWQNSLVGAIPDELGSCTELTVVDFSDN 329
LL +NSL IP L N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 5e-05
Identities = 36/235 (15%), Positives = 61/235 (25%), Gaps = 32/235 (13%)
Query: 73 HCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGTIPKEFGDYRELTFID 132
S +E++ +L +LP K L +S L Y LT ++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 133 LSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPK 192
L L L L +L L+ N L+
Sbjct: 62 LDRAELT--KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTL-------------------- 99
Query: 193 SIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTI 252
L + L L L + P + +++ +
Sbjct: 100 ------PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153
Query: 253 AIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSL 307
++ + L+ + L L L +NS+ IP L L N
Sbjct: 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.9 bits (146), Expect = 2e-10
Identities = 44/281 (15%), Positives = 97/281 (34%), Gaps = 16/281 (5%)
Query: 250 QTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSL-V 308
QT+ + L + + + + ++ + P+ + +++ + L + + V
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV 60
Query: 309 GAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQEL--QLSVNQLSGTIPIEIATC 366
+ L C++L + L+ I + L L + +++C
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 367 TALTHL------EIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQAL 420
+ L L + + + I L L KN ++ + +C L L
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 421 DFSYNNLSGPIPKEIFGLRNLTKLLLLSN--DLSGFIPPDIGNCTTLRRLRLNDNRLSGT 478
D S + + + F N + L LS D+ ++G TL+ L++ GT
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 479 IPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLH 519
+ L HL + +H P++ ++ E +
Sbjct: 241 LQLLKEALPHLQI---NCSHFTTIARPTIGNKKNQEIWGIK 278
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 1e-09
Identities = 35/274 (12%), Positives = 86/274 (31%), Gaps = 20/274 (7%)
Query: 322 TVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPI-EIATCTALTHLEIDNNAIS 380
+D + L + G LL + + P+ E + + H+++ N+ I
Sbjct: 3 QTLDLTGKNLHPDVT---GRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59
Query: 381 GE-IPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSY--NNLSGPIPKEIFG 437
+ + + L +L+ I +L++ L L+ S + +
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119
Query: 438 LRNLTKL------LLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNF 491
L +L + + T L N + + + +L
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179
Query: 492 VDMSENHLVGGIPPSVVGCQS-LEFLDL-HSNGLTGSVPDTLP--TSLQLVDLSDNRLSG 547
+D+S++ ++ + L+ L L + L +L+ + + G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239
Query: 548 SLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCR 581
+L +L L ++ + + I + +
Sbjct: 240 TLQLLKEALPHLQ---INCSHFTTIARPTIGNKK 270
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 1e-06
Identities = 38/294 (12%), Positives = 93/294 (31%), Gaps = 39/294 (13%)
Query: 131 IDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKI 190
+DL+G +L ++ + + + + + ++ + + + ++ L ++ +
Sbjct: 5 LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS- 61
Query: 191 PKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQ 250
L + CS L L L +S + +++ +
Sbjct: 62 -----------------------TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLV 98
Query: 251 TIAIY--TSLLSGPIPEEIGNCSELQNLYLYQNSISG------PIPGRIGALSKLKSLLL 302
+ + + + + +CS L L L + +++L
Sbjct: 99 RLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 158
Query: 303 WQNSLVGAIPDELGSCTELTVVDFSDN-LLTGSIPRSFGNLLKLQELQLS-VNQLSGTIP 360
+N + + C L +D SD+ +L + F L LQ L LS +
Sbjct: 159 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETL 218
Query: 361 IEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQC 414
+E+ L L++ G + + L + + T ++
Sbjct: 219 LELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI---NCSHFTTIARPTIGNK 269
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 4e-06
Identities = 17/104 (16%), Positives = 43/104 (41%), Gaps = 3/104 (2%)
Query: 492 VDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTL-PTSLQLVDLSDNRLSG-SL 549
+D++ +L + ++ Q + + + + + P +Q +DLS++ + +L
Sbjct: 5 LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63
Query: 550 AHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRF 593
+ ++L L L +LS I + L+ L++
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSG 107
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 3e-05
Identities = 16/89 (17%), Positives = 34/89 (38%), Gaps = 5/89 (5%)
Query: 586 LDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGD 645
LD+ ++ L +S I+ + + FS ++ +DLS++ +
Sbjct: 5 LDLTGKNLHPDVTGRL--LSQGVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVS 61
Query: 646 --LDALASLQNLVSLNVSFNDFSGELPNT 672
L+ L +L++ S + NT
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNT 90
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 58.3 bits (139), Expect = 4e-10
Identities = 45/184 (24%), Positives = 72/184 (39%), Gaps = 6/184 (3%)
Query: 505 PSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSL-AHSIGSLTELSKLL 563
P++ C+ +D GL +P +P + L+DN L G L L KL
Sbjct: 3 PAMCHCEGTT-VDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLE 60
Query: 564 LSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIP 623
L +NQL+G P + L +G N+ K + L+ LNL NQ S +P
Sbjct: 61 LKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKT-LNLYDNQISCVMP 119
Query: 624 SEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDL 683
F L L L+L+ N + + + L +++ P R + + DL
Sbjct: 120 GSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP--SKVRDVQIKDL 177
Query: 684 ASNR 687
+
Sbjct: 178 PHSE 181
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 49.8 bits (117), Expect = 3e-07
Identities = 36/186 (19%), Positives = 63/186 (33%), Gaps = 8/186 (4%)
Query: 346 QELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEI-PADIGNINGLTLFFAWKNKLT 404
+ + L IP +I T T L +++N + G + L +N+LT
Sbjct: 11 TTVDCTGRGLK-EIPRDIPLHT--TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 405 GNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTT 464
G P + +Q L N + K GL L L L N +S +P + +
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 465 LRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLT 524
L L + + L ++ G P V + ++ DL +
Sbjct: 128 LTSLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFK 183
Query: 525 GSVPDT 530
S ++
Sbjct: 184 CSSENS 189
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.0 bits (89), Expect = 0.001
Identities = 31/166 (18%), Positives = 54/166 (32%), Gaps = 6/166 (3%)
Query: 190 IPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERI 249
IP+ I N+ + G +LV L L ++G P++ I
Sbjct: 23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 250 QTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVG 309
Q + + + + + +L+ L LY N IS +PG L+ L SL L N
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140
Query: 310 AIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQL 355
+ + P + +Q L ++
Sbjct: 141 NCHLAWFAEWLRK-KSLNGGAARCGAPSKVRD---VQIKDLPHSEF 182
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.8 bits (126), Expect = 7e-09
Identities = 20/122 (16%), Positives = 42/122 (34%), Gaps = 7/122 (5%)
Query: 536 QLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSG 595
+++ L+ L+ + L ++ L LS N+L P + L L++ +
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNA 54
Query: 596 EIPKELGQISSLEISLNLSSNQF-SGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQN 654
+ L L +N+ +L +L+L N L + L
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
Query: 655 LV 656
++
Sbjct: 115 ML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 8e-07
Identities = 24/126 (19%), Positives = 41/126 (32%), Gaps = 7/126 (5%)
Query: 323 VVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGE 382
V+ + LT + LL + L LS N+L P +A L L+ +N
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN-ALEN 57
Query: 383 IPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGP---IPKEIFGLR 439
+ L + L C L L+ N+L + L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 440 NLTKLL 445
+++ +L
Sbjct: 118 SVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 3e-06
Identities = 25/109 (22%), Positives = 41/109 (37%), Gaps = 6/109 (5%)
Query: 418 QALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSG 477
+ L ++ +L+ + + L +T L L N L PP + L L+ +DN
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNA--L 55
Query: 478 TIPSEMGNLKHLNFVDMSENHLVGGIPPSVVG-CQSLEFLDLHSNGLTG 525
+ NL L + + N L + C L L+L N L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 8e-06
Identities = 29/125 (23%), Positives = 47/125 (37%), Gaps = 14/125 (11%)
Query: 444 LLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGI 503
L L DL+ + + + L L+ NRL P+ + L+ L + S+N
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--LEN 57
Query: 504 PPSVVGCQSLEFLDLHSNGLTGSVPD---TLPTSLQLVDLSDNRLSG------SLAHSIG 554
V L+ L L +N L S L L++L N L LA +
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 555 SLTEL 559
S++ +
Sbjct: 118 SVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.2 bits (101), Expect = 1e-05
Identities = 18/113 (15%), Positives = 37/113 (32%), Gaps = 6/113 (5%)
Query: 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLW-QNSLVGAIPDELGSCTEL 321
+ + + +L L N + P L+ L+ L + + D + + L
Sbjct: 12 VLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNALENVDGVANLPRL 67
Query: 322 TVVDFSDNLLTG-SIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLE 373
+ +N L + + + +L L L N L I+ L +
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 2e-05
Identities = 25/109 (22%), Positives = 44/109 (40%), Gaps = 8/109 (7%)
Query: 562 LLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGE 621
L L+ L+ + + + LD+ +NR P +++L L ++ + E
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNALE 56
Query: 622 IPSEFSGLTKLGILDLSHNKLSG--DLDALASLQNLVSLNVSFNDFSGE 668
+ L +L L L +N+L + L S LV LN+ N E
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 6e-05
Identities = 23/77 (29%), Positives = 32/77 (41%), Gaps = 3/77 (3%)
Query: 611 LNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELP 670
L+L+ + + L + LDLSHN+L ALA+L+ L L S N
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 671 NTPFFRKLPLSDLASNR 687
R L L +NR
Sbjct: 61 VANLPRLQEL-LLCNNR 76
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.3 bits (91), Expect = 4e-04
Identities = 25/144 (17%), Positives = 43/144 (29%), Gaps = 29/144 (20%)
Query: 346 QELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTG 405
+ L L+ L T+ + +THL++ +N + PA + + L + A N
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--L 55
Query: 406 NIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTL 465
+ ++ LQ L N L + +C L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAA-----------------------IQPLVSCPRL 92
Query: 466 RRLRLNDNRLSGTIPSEMGNLKHL 489
L L N L L +
Sbjct: 93 VLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.8 bits (87), Expect = 0.001
Identities = 26/146 (17%), Positives = 45/146 (30%), Gaps = 29/146 (19%)
Query: 155 LYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGE 214
L+L L + + L + +L L N+L P ++ AL L+V +A N +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 215 LPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQ 274
+ L + N L + + +C L
Sbjct: 60 GVANLPRLQEL--------LLCNN------------------RLQQSAAIQPLVSCPRLV 93
Query: 275 NLYLYQNSISGPIPGRIGALSKLKSL 300
L L NS+ + L S+
Sbjct: 94 LLNLQGNSLCQEEGIQERLAEMLPSV 119
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.002
Identities = 15/60 (25%), Positives = 24/60 (40%), Gaps = 1/60 (1%)
Query: 634 ILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDLASNRGLYISG 693
+L L+H L+ L L L + L++S N P R L + + N + G
Sbjct: 2 VLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.003
Identities = 23/118 (19%), Positives = 38/118 (32%), Gaps = 25/118 (21%)
Query: 105 KRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPT-------------------- 144
+ L ++ +LT + +T +DLS N L P
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 145 -EVCRLRKLESLYLNTNLLEG-EIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKL 200
V L +L+ L L N L+ + + L L L N L L+++
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 3e-08
Identities = 38/240 (15%), Positives = 81/240 (33%), Gaps = 20/240 (8%)
Query: 426 NLSGPIP-KEIF---GLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPS 481
+++ P IF L N K+ ++++ + + + L ++
Sbjct: 2 SITQPTAINVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--E 57
Query: 482 EMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLS 541
+ L +L +++ +N + P + + L + ++ + +
Sbjct: 58 GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTST 117
Query: 542 DNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKEL 601
LA L + + + L L IGN + S P L
Sbjct: 118 QITDVTPLAGLSNLQV------LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP--L 169
Query: 602 GQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVS 661
+S L N+ S P + L L + L +N++S D+ LA+ NL + ++
Sbjct: 170 ANLSKLTTLKA-DDNKISDISP--LASLPNLIEVHLKNNQIS-DVSPLANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.0 bits (123), Expect = 8e-08
Identities = 29/227 (12%), Positives = 63/227 (27%), Gaps = 18/227 (7%)
Query: 269 NCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSD 328
+ + +++++ + L + +L + + + + L ++ D
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 329 NLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIG 388
N + + L + + T A +
Sbjct: 73 NQI---TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129
Query: 389 NINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLS 448
N+ L L I S N + L LT L
Sbjct: 130 NLQVLYLDLNQ-------ITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 449 NDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMS 495
N +S P + + L + L +N++S P + N +L V ++
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 5e-07
Identities = 37/228 (16%), Positives = 75/228 (32%), Gaps = 19/228 (8%)
Query: 149 LRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGN 208
L + + + + +L + L+ + ++ + + L+ L N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDN 73
Query: 209 QNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIG 268
Q + + L + + + + + + +
Sbjct: 74 QITDLAPLKNLTKITELEL-------SGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 269 NCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSD 328
S LQ LYL N I+ P + S+ Q S L + ++LT + D
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVS----DLTPLANLSKLTTLKADD 182
Query: 329 NLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDN 376
N ++ P +L L E+ L NQ+S P +A + L + + N
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 49.3 bits (116), Expect = 6e-07
Identities = 38/219 (17%), Positives = 71/219 (32%), Gaps = 26/219 (11%)
Query: 415 QELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNR 474
+ +N++ + + L +T L ++ + L L L DN+
Sbjct: 19 ANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74
Query: 475 LSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQS----------------LEFLDL 518
++ P + + + V I L
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 519 HSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEIL 578
+ + + L L LS S + +L++L+ L N++S P +
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192
Query: 579 SCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQ 617
S LI + + NN+ S P L S+L I + L +NQ
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFI-VTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 28/232 (12%), Positives = 68/232 (29%), Gaps = 18/232 (7%)
Query: 311 IPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALT 370
PD + + + +T ++ ++ +L + L ++ ++ L
Sbjct: 13 FPDP--ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQ--YLNNLI 66
Query: 371 HLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGP 430
LE+ +N I+ P K I S +
Sbjct: 67 GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 431 IPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLN 490
+ L + + L+G + + + + NL L
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD----------LTPLANLSKLT 176
Query: 491 FVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSD 542
+ +N + + +L + L +N ++ P ++L +V L++
Sbjct: 177 TLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 33/220 (15%), Positives = 64/220 (29%), Gaps = 27/220 (12%)
Query: 246 LERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQN 305
L IA S ++ + + + + L + ++ I G + L+ L L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT-IEG-VQYLNNLIGLELKDN 73
Query: 306 SLVGAIPDELGSCTELTVVDFSDNLLTGSIPR--------------SFGNLLKLQELQLS 351
+ P + + + + +I + L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 352 VNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESL 411
+ I + + N++ LT A NK++ P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 412 SQCQELQALDFSYNNLSGPIPKEIFGLRNLTKL--LLLSN 449
+ L + N +S P L N + L + L+N
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP-----LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 8/57 (14%), Positives = 21/57 (36%), Gaps = 3/57 (5%)
Query: 609 ISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDF 665
I + + + + + L + L ++ ++ + L NL+ L + N
Sbjct: 22 IKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.002
Identities = 33/225 (14%), Positives = 68/225 (30%), Gaps = 23/225 (10%)
Query: 172 NLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQ--NLKGELPWEIGNCSNLVMLG 229
L++ + + ++ + ++ L + A G ++G + +NL+ L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLE 69
Query: 230 LAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPG 289
L + I+ P ++ I + +
Sbjct: 70 LKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129
Query: 290 RIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQ 349
+ L + + + L + S S NL KL L+
Sbjct: 130 NLQVLYLDLNQITNISPL----------AGLTNLQYLSIGNAQVSDLTPLANLSKLTTLK 179
Query: 350 LSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLT 394
N++S P+ A+ L + + NN IS P + N + L
Sbjct: 180 ADDNKISDISPL--ASLPNLIEVHLKNNQISDVSP--LANTSNLF 220
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 3e-08
Identities = 21/92 (22%), Positives = 36/92 (39%), Gaps = 9/92 (9%)
Query: 564 LSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIP 623
N S I + L L++ NN+ E+P ++ L S N + E+P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL----IASFNHLA-EVP 320
Query: 624 SEFSGLTKLGILDLSHNKLSGDLDALASLQNL 655
L +L + +N L D S+++L
Sbjct: 321 ELPQNLKQL---HVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 6e-08
Identities = 20/93 (21%), Positives = 35/93 (37%), Gaps = 9/93 (9%)
Query: 399 WKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPD 458
+ N + I L+ L+ S N L +P L +L+ N L+ +P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFNHLAE-VPEL 322
Query: 459 IGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNF 491
N L++L + N L P +++ L
Sbjct: 323 PQN---LKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 25/99 (25%), Positives = 39/99 (39%), Gaps = 12/99 (12%)
Query: 422 FSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPS 481
+ N S I +L +L + +N L +P L RL + N L+ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVPE 321
Query: 482 EMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHS 520
NLK L + N L P +S+E L ++S
Sbjct: 322 LPQNLKQL---HVEYNPLR-EFPDIP---ESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 1e-06
Identities = 23/90 (25%), Positives = 35/90 (38%), Gaps = 7/90 (7%)
Query: 470 LNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPD 529
N S I S L +++S N L+ +P LE L N L VP+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE 321
Query: 530 TLPTSLQLVDLSDNRLSGSLAHSIGSLTEL 559
LP +L+ + + N L S+ +L
Sbjct: 322 -LPQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 1e-06
Identities = 21/91 (23%), Positives = 35/91 (38%), Gaps = 9/91 (9%)
Query: 112 CNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIG 171
+ I L +++S N L E+P +LE L + N L E+P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKL-IELPAL---PPRLERLIASFNHLA-EVPELPQ 324
Query: 172 NLSSLAYLTLYDNQLSGKIPKSIGALSKLQV 202
NL L + N L + P ++ L++
Sbjct: 325 NLK---QLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 55/329 (16%), Positives = 101/329 (30%), Gaps = 27/329 (8%)
Query: 295 SKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNL--LKLQELQL-S 351
+ L L L ++P+ L S N LT +P +L L + L +
Sbjct: 38 RQAHELELNNLGL-SSLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 352 VNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESL 411
++ L + + L L N+ +I N + L
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 412 SQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLN 471
+ ELQ L F + + L+ +++ + P++ N L + +
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 472 DNRL--------SGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGL 523
+N L S + N + G L + N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 524 TGSVPDTL--PTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCR 581
+ + P SL+ +++S+N+L L L L S N L+ +P +
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELP---Q 324
Query: 582 KLILLDIGNNRFSGEIPKELGQISSLEIS 610
L L + N E P + L ++
Sbjct: 325 NLKQLHVEYNPLR-EFPDIPESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 19/93 (20%), Positives = 32/93 (34%), Gaps = 10/93 (10%)
Query: 540 LSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPK 599
N S + L +L +S N+L +PA +L L N + E+P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPE 321
Query: 600 ELGQISSLEISLNLSSNQFSGEIPSEFSGLTKL 632
+ L++ N E P + L
Sbjct: 322 LPQNLK----QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 3e-06
Identities = 28/84 (33%), Positives = 40/84 (47%), Gaps = 9/84 (10%)
Query: 590 NNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDAL 649
N S EI SLE LN+S+N+ E+P+ L +L S N L+ ++ L
Sbjct: 269 LNASSNEIRSLCDLPPSLE-ELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPEL 322
Query: 650 ASLQNLVSLNVSFNDFSGELPNTP 673
QNL L+V +N E P+ P
Sbjct: 323 --PQNLKQLHVEYNPLR-EFPDIP 343
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.5 bits (98), Expect = 2e-04
Identities = 23/96 (23%), Positives = 37/96 (38%), Gaps = 10/96 (10%)
Query: 130 FIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGK 189
N+ EI + LE L ++ N L E+P+ L L N L+ +
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-E 318
Query: 190 IPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNL 225
+P+ L +L V N L+ E P + +L
Sbjct: 319 VPELPQNLKQLHV---EYNP-LR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.7 bits (96), Expect = 3e-04
Identities = 22/107 (20%), Positives = 41/107 (38%), Gaps = 13/107 (12%)
Query: 58 SWNPAETSPCKWFGIHCSSNGEVVEI----SLKAVDLQG-SLPSIFQPLKSLKRLIISSC 112
++ P + ++ SSN SL+ +++ L + L+RLI S
Sbjct: 255 IFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLERLIASFN 314
Query: 113 NLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNT 159
+L +P+ L + + N L E P +E L +N+
Sbjct: 315 HLA-EVPELPQ---NLKQLHVEYNPL-REFPDI---PESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.003
Identities = 19/65 (29%), Positives = 30/65 (46%), Gaps = 3/65 (4%)
Query: 510 CQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQL 569
+ L+L++ GL+ S+P+ LP L+ + S N L+ L SL L + L
Sbjct: 37 DRQAHELELNNLGLS-SLPE-LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
Query: 570 SGRIP 574
S P
Sbjct: 94 SDLPP 98
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 52.6 bits (124), Expect = 1e-07
Identities = 39/350 (11%), Positives = 97/350 (27%), Gaps = 54/350 (15%)
Query: 343 LKLQELQLSVNQLSG----TIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFA 398
++ L ++ ++ ++ + ++ + + N I E
Sbjct: 3 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAAR------------- 49
Query: 399 WKNKLTGNIPESLSQCQELQALDFSYN---NLSGPIPKEIFGLRNLTKLLLLSNDLSGFI 455
+ E+++ ++L+ +FS + IP+ + L + +
Sbjct: 50 -------WLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102
Query: 456 PPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEF 515
L+ + + L ++ + L
Sbjct: 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRS 162
Query: 516 LDLHSNGLT-GSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLS---- 570
+ N L GS+ + T L ++ + G L + L +L
Sbjct: 163 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDL 222
Query: 571 ----------GRIPAEILSCRKLILLDIGNNRFSGEIPKELGQI------SSLEISLNLS 614
+ + S L L + + S + L+ +L L
Sbjct: 223 QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQ-TLRLQ 281
Query: 615 SNQFSGEIPSE-----FSGLTKLGILDLSHNKLSGDLDALASLQNLVSLN 659
N+ + + L L+L+ N+ S + D + ++ + S
Sbjct: 282 YNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTR 331
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 35/331 (10%), Positives = 88/331 (26%), Gaps = 32/331 (9%)
Query: 262 PIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTEL 321
+ + ++ + L N+I + + + S +L
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIG--------------------TEAARWLSENIASKKDL 61
Query: 322 TVVDFSDN---LLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNA 378
+ +FSD + IP + LL+ ++ + + T + +
Sbjct: 62 EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 121
Query: 379 ISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGL 438
+ + + + + L+++ N L KE
Sbjct: 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181
Query: 439 RNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENH 498
+LL + I P+ L L + + + ++
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241
Query: 499 LVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGS--- 555
+ C + + + LQ + L N + ++ +
Sbjct: 242 WPNLRELGLNDCL---LSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 298
Query: 556 --LTELSKLLLSKNQLSGRIPAEILSCRKLI 584
+ +L L L+ N+ S + R++
Sbjct: 299 EKMPDLLFLELNGNRFSE-EDDVVDEIREVF 328
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.0 bits (112), Expect = 3e-06
Identities = 34/334 (10%), Positives = 79/334 (23%), Gaps = 17/334 (5%)
Query: 295 SKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTG----SIPRSFGNLLKLQELQL 350
K L ++ L + + S N + + + + L+ +
Sbjct: 7 GKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 351 SVNQLSGTIPIEIATCTALTHLEIDNNAIS---GEIPADIGNINGLTLFFAWKNKLTGNI 407
S L + + A + F K+ ++
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 408 PESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRR 467
+ + + K+ L ++ N L + R
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 468 LRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSV 527
L+ ++ G L L + ++
Sbjct: 187 -LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 245
Query: 528 PDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILS-----CRK 582
+ L + + + L L L N++ + +
Sbjct: 246 RELGLNDCLLSARGAAAVVDAFSK--LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 583 LILLDIGNNRFS--GEIPKELGQISSLEISLNLS 614
L+ L++ NRFS ++ E+ ++ S L
Sbjct: 304 LLFLELNGNRFSEEDDVVDEIREVFSTRGRGELD 337
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.0 bits (107), Expect = 2e-05
Identities = 42/310 (13%), Positives = 85/310 (27%), Gaps = 43/310 (13%)
Query: 407 IPESLSQCQELQALDFSYNNLSGP----IPKEIFGLRNLTKLLLLSNDLS---------- 452
+ L + ++ + S N + + + I ++L
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 453 GFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQS 512
+ + C L +RL+DN T + + + G+ P +
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142
Query: 513 LEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGR 572
+L N + P + + NRL + +LL + +
Sbjct: 143 RALQELAVNKKAKNAPPL-----RSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNG 197
Query: 573 IPAEILSCRKLILLD------------IGNNRFSGEIPKELGQISSLEISLNLSSNQFSG 620
I E + L L + L L+ S
Sbjct: 198 IRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 257
Query: 621 EIPS------EFSGLTKLGILDLSHNKLSGD-LDALAS-----LQNLVSLNVSFNDFSGE 668
+ L L L +N++ D + L + + +L+ L ++ N FS E
Sbjct: 258 RGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317
Query: 669 LPNTPFFRKL 678
R++
Sbjct: 318 DDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 46/311 (14%), Positives = 90/311 (28%), Gaps = 31/311 (9%)
Query: 102 KSLKRLIISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGE----IPTEVCRLRKLESLYL 157
KSLK I++ + ++ + + I LSGN++ E + + + LE
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 158 NTN---LLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGE 214
+ ++ EIP + L + + + + + L+
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 215 LPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIGNCSELQ 274
G + I L +G + E +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 275 NLYLYQNSI-----SGPIPGRIGALSKLKSLLLWQNSLV-------GAIPDELGSCTELT 322
L+ + G + L+ + L + A+ L S L
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 323 VVDFSDNLLTGSIPRSFGNLL------KLQELQLSVNQLSGTIPIEIAT-----CTALTH 371
+ +D LL+ + + LQ L+L N++ + T L
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 372 LEIDNNAISGE 382
LE++ N S E
Sbjct: 307 LELNGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 0.001
Identities = 14/93 (15%), Positives = 30/93 (32%), Gaps = 5/93 (5%)
Query: 604 ISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDL-----DALASLQNLVSL 658
I + L+ + + + + + + LS N + + + +AS ++L
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 659 NVSFNDFSGELPNTPFFRKLPLSDLASNRGLYI 691
S P +L L L L+
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 1e-07
Identities = 13/91 (14%), Positives = 27/91 (29%), Gaps = 5/91 (5%)
Query: 272 ELQNLYLYQNSIS-GPIPGRIGALSKLKSLLLWQNSL----VGAIPDELGSCTELTVVDF 326
++Q+L + +S + L + + + L L I L L ++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 327 SDNLLTGSIPRSFGNLLKLQELQLSVNQLSG 357
N L L+ ++ L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 6e-07
Identities = 15/95 (15%), Positives = 33/95 (34%), Gaps = 11/95 (11%)
Query: 534 SLQLVDLSDNRLSGS-LAHSIGSLTELSKLLLSKNQLSGR----IPAEILSCRKLILLDI 588
+Q +D+ LS + A + L + + L L+ I + + L L++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 589 GNNRFSGEIPKELGQI-----SSLEISLNLSSNQF 618
+N + Q ++ L+L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQ-KLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 6e-07
Identities = 18/81 (22%), Positives = 36/81 (44%), Gaps = 9/81 (11%)
Query: 533 TSLQLVDLSDNRLSG----SLAHSIGSLTELSKLLLSKNQLSGRIPAEILS-----CRKL 583
+ L+++ L+D +S SLA ++ + L +L LS N L +++ L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 584 ILLDIGNNRFSGEIPKELGQI 604
L + + +S E+ L +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 7e-07
Identities = 16/70 (22%), Positives = 27/70 (38%), Gaps = 7/70 (10%)
Query: 606 SLEI-SLNLSSNQFSGEIPSE-FSGLTKLGILDLSHNKLSGD-----LDALASLQNLVSL 658
SL+I SL++ + S +E L + ++ L L+ AL L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 659 NVSFNDFSGE 668
N+ N+
Sbjct: 61 NLRSNELGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 8e-07
Identities = 16/96 (16%), Positives = 29/96 (30%), Gaps = 13/96 (13%)
Query: 416 ELQALDFSYNNLSGPIPKEIF-GLRNLTKLLLLSNDLSG----FIPPDIGNCTTLRRLRL 470
++Q+LD LS E+ L+ + L L+ I + L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 471 NDNRLSGTIPSEMG--------NLKHLNFVDMSENH 498
N L + ++ L+ +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 2e-06
Identities = 15/113 (13%), Positives = 28/113 (24%), Gaps = 21/113 (18%)
Query: 343 LKLQELQLSVNQLSGTIPIEIATC-TALTHLEIDNNAISGEIPADIGNINGLTLFFAWKN 401
L +Q L + +LS E+ + +D+ ++ DI
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI-------------- 47
Query: 402 KLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGF 454
+L L L+ N L + + L
Sbjct: 48 ------SSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 20/82 (24%), Positives = 30/82 (36%), Gaps = 10/82 (12%)
Query: 559 LSKLLLSKNQLSGR----IPAEILSCRKLILLDIGNNRFSGEIPKELGQI-----SSLEI 609
L L L+ +S + A +L+ L LD+ NN +L + LE
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE- 429
Query: 610 SLNLSSNQFSGEIPSEFSGLTK 631
L L +S E+ L K
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 1e-05
Identities = 25/145 (17%), Positives = 46/145 (31%), Gaps = 23/145 (15%)
Query: 59 WNPAETSPCKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPLKSLKRLIISSCNLTGT- 117
++ L+ ++ + QP L+ L ++ C+++ +
Sbjct: 326 AACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 385
Query: 118 ---IPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLS 174
+ L +DLS N L ++ ES+ LLE
Sbjct: 386 CSSLAATLLANHSLRELDLSNNCLGDAGILQLV-----ESVRQPGCLLE----------- 429
Query: 175 SLAYLTLYDNQLSGKIPKSIGALSK 199
L LYD S ++ + AL K
Sbjct: 430 ---QLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 15/94 (15%), Positives = 31/94 (32%), Gaps = 10/94 (10%)
Query: 485 NLKHLNFVDMSENHLVGGIPPSVVGC-QSLEFLDLHSNGLTGSVPDTLP------TSLQL 537
+++ L D+ L ++ Q + + L GLT + + +L
Sbjct: 3 DIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 538 VDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSG 571
++L N L H + + + K L
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 15/83 (18%), Positives = 31/83 (37%), Gaps = 9/83 (10%)
Query: 317 SCTELTVVDFSDNLLTG----SIPRSFGNLLKLQELQLSVNQLSGTIPIEIAT-----CT 367
+ L V+ +D ++ S+ + L+EL LS N L +++
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 368 ALTHLEIDNNAISGEIPADIGNI 390
L L + + S E+ + +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 17/90 (18%), Positives = 28/90 (31%), Gaps = 11/90 (12%)
Query: 574 PAEILSCRKLILLDIGNNRFSGE----IPKELGQISSLEISLNLSSNQFSGEIPSEFSG- 628
L +L + + S + L SL L+LS+N +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR-ELDLSNNCLGDAGILQLVES 420
Query: 629 ----LTKLGILDLSHNKLSGDL-DALASLQ 653
L L L S ++ D L +L+
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 14/72 (19%), Positives = 26/72 (36%), Gaps = 10/72 (13%)
Query: 610 SLNLSSNQFSGE----IPSEFSGLTKLGILDLSHNKLSGD-----LDALASLQ-NLVSLN 659
L L+ S + + L LDLS+N L ++++ L L
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432
Query: 660 VSFNDFSGELPN 671
+ +S E+ +
Sbjct: 433 LYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 4e-05
Identities = 14/76 (18%), Positives = 28/76 (36%), Gaps = 5/76 (6%)
Query: 127 ELTFIDLSGNSLWGEIPTEVC-RLRKLESLYLNTNLLEGE----IPSDIGNLSSLAYLTL 181
++ +D+ L E+ L++ + + L+ L I S + +LA L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 182 YDNQLSGKIPKSIGAL 197
N+L +
Sbjct: 63 RSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 4e-05
Identities = 14/92 (15%), Positives = 31/92 (33%), Gaps = 10/92 (10%)
Query: 83 ISLKAVDLQG------SLPSIFQPLKSLKRLIISSCNLTG----TIPKEFGDYRELTFID 132
+ ++++D+Q + L+ + + + C LT I L ++
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 133 LSGNSLWGEIPTEVCRLRKLESLYLNTNLLEG 164
L N L V + + S + L+
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 4e-05
Identities = 17/91 (18%), Positives = 27/91 (29%), Gaps = 12/91 (13%)
Query: 586 LDIGNNRFSGEIPKEL-GQISSLEISLNLSSNQFSGE----IPSEFSGLTKLGILDLSHN 640
LDI S EL + + + L + I S L L+L N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQ-VVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 641 KLSGD-----LDALASLQ-NLVSLNVSFNDF 665
+L L L + + L++
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 15/112 (13%), Positives = 31/112 (27%), Gaps = 25/112 (22%)
Query: 384 PADIGNINGLTLFFAWKNKLTGN----IPESLSQCQELQALDFSYNNLSGPIPKEIF-GL 438
+ L + + ++ + + +L L+ LD S N L ++ +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 439 RNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLN 490
R L +L L D S + + L+
Sbjct: 422 RQ--------------------PGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 18/87 (20%), Positives = 32/87 (36%), Gaps = 5/87 (5%)
Query: 465 LRRLRLNDNRLSGTIPSEM-GNLKHLNFVDMSENHL----VGGIPPSVVGCQSLEFLDLH 519
++ L + LS +E+ L+ V + + L I ++ +L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 520 SNGLTGSVPDTLPTSLQLVDLSDNRLS 546
SN L + LQ +LS
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLS 90
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 15/95 (15%), Positives = 32/95 (33%), Gaps = 11/95 (11%)
Query: 480 PSEMGNLKHLNFVDMSENHL----VGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTL---- 531
L + +++ + + +++ SL LDL +N L + L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 532 ---PTSLQLVDLSDNRLSGSLAHSIGSLTELSKLL 563
L+ + L D S + + +L + L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 5e-04
Identities = 19/91 (20%), Positives = 32/91 (35%), Gaps = 10/91 (10%)
Query: 297 LKSLLLWQNSLVGA-IPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLK----LQELQLS 351
++SL + L A + L + VV D LT + + + L+ L EL L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 352 VNQLSGTIPIEIA-----TCTALTHLEIDNN 377
N+L + + L + N
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 2e-06
Identities = 31/240 (12%), Positives = 62/240 (25%), Gaps = 11/240 (4%)
Query: 408 PESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRR 467
+ C + + ++ IP ++ RN +L + L L +
Sbjct: 2 HHRICHCSN-RVFLCQESKVTE-IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 468 LRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNG----- 522
+ ++ N + I +++ + E L +
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 523 -LTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCR 581
+L L + + N + +G E L L+KN + +
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 582 KLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNK 641
L NN S L++S + L KL + K
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPV-ILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (101), Expect = 5e-05
Identities = 36/223 (16%), Positives = 70/223 (31%), Gaps = 11/223 (4%)
Query: 455 IPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLE 514
IP D+ LR +L L +++S+N ++ I V
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 515 FLDL----HSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLS 570
++ +LQ + +S+ + + L + N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 571 GRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSE-FSGL 629
I + + N+ + + LNLS N E+P++ F G
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 630 TKLGILDLSHNKLSG-DLDALASLQNLVSLNVSFNDFSGELPN 671
+ ILD+S ++ L +L+ L + + +LP
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 8e-05
Identities = 33/244 (13%), Positives = 63/244 (25%), Gaps = 19/244 (7%)
Query: 67 CKWFGIHCSSNGEVVEISLKAVDLQGSLPSIFQPL-KSLKRLIISSCNLTGTIPKEFGDY 125
C C + + I L ++ L L F +
Sbjct: 8 CSNRVFLCQESK---------------VTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGF 52
Query: 126 RELTFIDLSGNSLWGEIPTEVCRLRKLE---SLYLNTNLLEGEIPSDIGNLSSLAYLTLY 182
+L I++S N + I +V + NLL + + L
Sbjct: 53 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 112
Query: 183 DNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSS 242
I +L K+ + E +G V+L L + I +
Sbjct: 113 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172
Query: 243 IGMLERIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLL 302
+ + + L + S L + + I + L KL++
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
Query: 303 WQNS 306
+
Sbjct: 233 YNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 8e-05
Identities = 38/237 (16%), Positives = 66/237 (27%), Gaps = 8/237 (3%)
Query: 129 TFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSG 188
+ + EIP+++ R L L L + + N +
Sbjct: 11 RVFLCQESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 189 KIPKSIGALSKLQVFRAGGN-QNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLE 247
I + + NL P N NL L ++ T I
Sbjct: 68 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127
Query: 248 RIQTIAIYT--SLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQN 305
+ + I ++ + +G E L+L +N I + L N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 306 SLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIE 362
+L D + ++D S + NL KL+ S L +E
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLKKLPTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 37/239 (15%), Positives = 60/239 (25%), Gaps = 8/239 (3%)
Query: 312 PDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTH 371
+ C+ V ++ +T IP EL+ + +L + L
Sbjct: 2 HHRICHCSN-RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 372 LEIDNNAISGEI--PADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSG 429
+EI N + I + N L PE+ LQ L S +
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 430 PIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLR--RLRLNDNRLSGTIPSEMGNLK 487
L + N I + + L LN N + +
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 488 HLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLS 546
N+L G LD+ + L +L S L
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 4e-04
Identities = 34/216 (15%), Positives = 69/216 (31%), Gaps = 6/216 (2%)
Query: 310 AIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTAL 369
IP +L + F L +F L+++++S N + I ++ +
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 370 T---HLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNN 426
+E NN + A N L + + Q++ N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 427 LSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEM-GN 485
+ GL + +L L+ + I N T L L L+DN +P+++
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 486 LKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSN 521
+D+S + + + L ++
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 9e-04
Identities = 28/223 (12%), Positives = 61/223 (27%), Gaps = 9/223 (4%)
Query: 263 IPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELT 322
IP ++ L + G L+ + + QN ++ I ++ S
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 323 VVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGE 382
+ L ++ ++ +L + +D
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 383 IPADIGNINGLTLFFAW---KNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIF-GL 438
+ + GL+ I +L L+ S NN +P ++F G
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 439 RNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPS 481
L + + + N LR + + +P+
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 0.001
Identities = 24/238 (10%), Positives = 59/238 (24%), Gaps = 7/238 (2%)
Query: 143 PTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSGKIPKSIGALSKLQ- 201
+C L + + E IPSD+ + L +L + L+
Sbjct: 2 HHRICHCSNRVFLCQESKVTE--IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 202 --VFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLL 259
+ + + ++ ++ + + + + I+
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 260 SGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCT 319
+ + L ++ N + +G + L L +N +
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 320 ELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNN 377
+ +N L F L +S ++ + L N
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 2e-06
Identities = 38/183 (20%), Positives = 61/183 (33%), Gaps = 40/183 (21%)
Query: 516 LDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPA 575
+L +T +V S+ + +++ + I L ++KL L+ N+L+ P
Sbjct: 29 DNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKPL 86
Query: 576 EILSCRKLILLDIGNNRFSGE-------------------------------------IP 598
L + LD +
Sbjct: 87 ANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKI 146
Query: 599 KELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSL 658
++ +S L LS +GLTKL L LS N +S DL ALA L+NL L
Sbjct: 147 TDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVL 205
Query: 659 NVS 661
+
Sbjct: 206 ELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.5 bits (109), Expect = 4e-06
Identities = 33/226 (14%), Positives = 74/226 (32%), Gaps = 26/226 (11%)
Query: 277 YLYQNSISGPIPGRIG------ALSKLKSLLLWQNSLVGAIP-DELGSCTELTVVDFSDN 329
L +I+ P P I A ++ L + S+ A+ +EL S ++ +++
Sbjct: 2 PLGSETITVPTP--IKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQI---IANNS 56
Query: 330 LLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGN 389
+ L + +L L+ N+L+ P+ L+ + +
Sbjct: 57 DIKSVQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKL 114
Query: 390 INGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSN 449
+ + L +L++L N ++ +
Sbjct: 115 KSLSLEHNGI------SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLS----LE 164
Query: 450 DLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMS 495
D + T L+ L L+ N +S + LK+L+ +++
Sbjct: 165 DNQISDIVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 41/201 (20%), Positives = 79/201 (39%), Gaps = 15/201 (7%)
Query: 415 QELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNR 474
E + +++ + + L ++ +++ ++D+ I + +L LN N+
Sbjct: 24 AETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNK 79
Query: 475 LSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTS 534
L+ P + NLK+L ++ + EN + + L S + L
Sbjct: 80 LTDIKP--LANLKNLGWLFLDENK----VKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133
Query: 535 LQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFS 594
QL L + + LT+L L L NQ+S +P + KL L + N S
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191
Query: 595 GEIPKELGQISSLEISLNLSS 615
+ L + +L++ L L S
Sbjct: 192 D--LRALAGLKNLDV-LELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 3e-04
Identities = 38/212 (17%), Positives = 79/212 (37%), Gaps = 29/212 (13%)
Query: 113 NLTGTIPKEFGDY------RELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEI 166
+ T T+P E +L S+ + L ++ + N + ++
Sbjct: 5 SETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQ 62
Query: 167 PSDIGNLSSLAYLTLYDNQLSGKIPKS------IGALSKLQVFRAGGNQNLKGELPWEIG 220
I L ++ L L N+L+ P + L + +V ++LK +
Sbjct: 63 G--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLE 120
Query: 221 NCSNLVMLGLAETSISGNV---------PSSIGMLERIQTIAIYTSLLSGPIPEEIGNCS 271
+ + GL ++ + + L ++ T+++ + +S +P + +
Sbjct: 121 HNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLT 178
Query: 272 ELQNLYLYQNSISGPIPGRIGALSKLKSLLLW 303
+LQNLYL +N IS + L L L L+
Sbjct: 179 KLQNLYLSKNHISDLRA--LAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 7e-04
Identities = 12/76 (15%), Positives = 30/76 (39%), Gaps = 8/76 (10%)
Query: 597 IPKELGQISSLE-----ISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALAS 651
+P + QI S + I NL + + + L + + +++ + + +
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQGIQY 66
Query: 652 LQNLVSLNVSFNDFSG 667
L N+ L ++ N +
Sbjct: 67 LPNVTKLFLNGNKLTD 82
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (100), Expect = 3e-05
Identities = 19/135 (14%), Positives = 38/135 (28%), Gaps = 7/135 (5%)
Query: 338 SFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFF 397
+ N ++ +EL L ++ I AT ++ +N I + L
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLL 69
Query: 398 AWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPP 457
N++ +L L + N+L + L + +
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 458 D----IGNCTTLRRL 468
I +R L
Sbjct: 130 YRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 2e-04
Identities = 16/88 (18%), Positives = 34/88 (38%), Gaps = 4/88 (4%)
Query: 592 RFSGEIPKELGQISSLEI--SLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDAL 649
+ + E+ ++ Q ++ L+L + I + + L + +D S N++ LD
Sbjct: 2 KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGF 59
Query: 650 ASLQNLVSLNVSFNDFSGELPNTPFFRK 677
L+ L +L V+ N
Sbjct: 60 PLLRRLKTLLVNNNRICRIGEGLDQALP 87
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 6e-04
Identities = 12/60 (20%), Positives = 27/60 (45%), Gaps = 1/60 (1%)
Query: 624 SEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPNTPFFRKLPLSDL 683
++++ + LDL K+ + A+L +++ S N+ +L P R+L +
Sbjct: 12 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLV 70
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 22/134 (16%), Positives = 49/134 (36%), Gaps = 7/134 (5%)
Query: 294 LSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVN 353
+ + L L + I + + + +DFSDN + L +L+ L ++ N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNNN 73
Query: 354 QLSGTIPIEIATCTALTHLEIDNNAISG----EIPADIGNINGLTLFFAWKNKLTGNIPE 409
++ LT L + NN++ + A + ++ L +
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133
Query: 410 SLSQCQELQALDFS 423
+ + +++ LDF
Sbjct: 134 VIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.003
Identities = 12/72 (16%), Positives = 25/72 (34%), Gaps = 3/72 (4%)
Query: 457 PDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFL 516
N R L L ++ I + L + +D S+N + + L+ L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTL 68
Query: 517 DLHSNGLTGSVP 528
+++N +
Sbjct: 69 LVNNNRICRIGE 80
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 33/199 (16%), Positives = 71/199 (35%), Gaps = 17/199 (8%)
Query: 293 ALSKLKSLLLWQNSLVGAIP-DELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLS 351
AL++ +L + ++ + +L T L + G L L ++ S
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 70
Query: 352 VNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESL 411
NQL+ P++ T + + A + + +L
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130
Query: 412 SQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLN 471
++ + + LSG + + N ++ P + N TTL RL ++
Sbjct: 131 NRLELSSNTISDISALSGLTSLQQLNFSS--------NQVTDLKP--LANLTTLERLDIS 180
Query: 472 DNRLSG-TIPSEMGNLKHL 489
N++S ++ +++ NL+ L
Sbjct: 181 SNKVSDISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 41/199 (20%), Positives = 74/199 (37%), Gaps = 16/199 (8%)
Query: 461 NCTTLRRLRLNDNRLSGTIP-SEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLH 519
+ L ++ T+ +++ + L + + G V +L ++
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 70
Query: 520 SNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILS 579
+N LT P T L + +++N+++ + + L +I
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLT-------GLTLFNNQITDIDP 123
Query: 580 CRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSH 639
+ L L+ + + LN SSNQ + P + LT L LD+S
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 640 NKLSGDLDALASLQNLVSL 658
NK+S D+ LA L NL SL
Sbjct: 182 NKVS-DISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 10/59 (16%), Positives = 21/59 (35%), Gaps = 3/59 (5%)
Query: 609 ISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSG 667
+ L + + + L ++ L + +D + L NL +N S N +
Sbjct: 21 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLTD 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 35/209 (16%), Positives = 67/209 (32%), Gaps = 19/209 (9%)
Query: 430 PIPKEIF---GLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNL 486
PI +IF L K +L +++ + + + L+ + + + L
Sbjct: 7 PI-NQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYL 61
Query: 487 KHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLS 546
+L ++ S N + L+ L + L + T L +
Sbjct: 62 NNLTQINFSNNQ--------LTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTL 113
Query: 547 GSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISS 606
+ + + L S I L + + K L +++
Sbjct: 114 FNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTT 173
Query: 607 LEISLNLSSNQFSGEIPSEFSGLTKLGIL 635
LE L++SSN+ S S + LT L L
Sbjct: 174 LER-LDISSNKVSD--ISVLAKLTNLESL 199
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (92), Expect = 3e-04
Identities = 22/112 (19%), Positives = 37/112 (33%), Gaps = 3/112 (2%)
Query: 413 QCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDI-GNCTTLRRLRLN 471
L + + + G NLT+L + + + LR L +
Sbjct: 6 CPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 472 DNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGL 523
+ L P L+ +++S N L + V SL+ L L N L
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 4e-04
Identities = 24/154 (15%), Positives = 39/154 (25%), Gaps = 11/154 (7%)
Query: 317 SCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEI-ATCTALTHLEID 375
+ + + + L EL + Q + + L +L I
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 376 NNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEI 435
+ + P L+ N L ++ Q LQ L S N L
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCS----- 118
Query: 436 FGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLR 469
L L + G +P C L
Sbjct: 119 ---CALRWLQRWEEEGLGGVPEQKLQCHGQGPLA 149
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 38.9 bits (89), Expect = 0.001
Identities = 14/64 (21%), Positives = 26/64 (40%), Gaps = 7/64 (10%)
Query: 608 EISLNLSSNQFSGEIP------SEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVS 661
++ + G IP + S L L LS N + + +L+ ++NL L++
Sbjct: 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLG 78
Query: 662 FNDF 665
N
Sbjct: 79 RNLI 82
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.7 bits (86), Expect = 0.003
Identities = 30/195 (15%), Positives = 63/195 (32%), Gaps = 24/195 (12%)
Query: 311 IPDELGSCTELT---VVDFSDNLLTGSIPR------SFGNLLKLQELQLSVNQLSGTIPI 361
I D + E + L G IP + L + L LS N +
Sbjct: 7 IKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE----- 61
Query: 362 EIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALD 421
+I++ + + +L I + + + + TL W + + + L+ L
Sbjct: 62 KISSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLY 121
Query: 422 FSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPS 481
S N ++ + + + LLL+ + + + R +
Sbjct: 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVV----------K 171
Query: 482 EMGNLKHLNFVDMSE 496
+ NLK L+ + +
Sbjct: 172 RLPNLKKLDGMPVDV 186
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.003
Identities = 20/91 (21%), Positives = 32/91 (35%), Gaps = 2/91 (2%)
Query: 401 NKLTGNIPESLSQCQELQALDFSYNNLSG--PIPKEIFGLRNLTKLLLLSNDLSGFIPPD 458
+ + + EL +L+ S N L + + NL L L N+L D
Sbjct: 51 SSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELD 110
Query: 459 IGNCTTLRRLRLNDNRLSGTIPSEMGNLKHL 489
L L L+ N LS T + + +
Sbjct: 111 KIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1001 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.79 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.73 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.71 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.69 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.65 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.5 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.44 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.43 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.43 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.42 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.41 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.4 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.26 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.25 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.23 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.19 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.36 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.29 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.18 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.93 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.28 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.27 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.18 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.66 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.46 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.33 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.33 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.14 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=382.25 Aligned_cols=204 Identities=26% Similarity=0.373 Sum_probs=177.6
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
.++|++.+.||+|+||+||+|+++ +|+.||||++.... ..+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999975 68999999985433 23578999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+++|+|.++++.. ..+++..+..++.||++|++|||++ +|+||||||+|||+++++++||+|||+|+.+.....
T Consensus 84 y~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999999753 4589999999999999999999998 999999999999999999999999999987643321
Q ss_pred CCCCCCCCCCcccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQRI-TEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~elltg~~Pf~~~~~~ 978 (1001)
.......+||+.|||||++.+..+ +.++||||+||++|||+||+.||......
T Consensus 159 -----~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~ 212 (271)
T d1nvra_ 159 -----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212 (271)
T ss_dssp -----ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred -----cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH
Confidence 122345689999999999988776 57899999999999999999999865433
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=373.25 Aligned_cols=196 Identities=28% Similarity=0.471 Sum_probs=176.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC-----CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS-----SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||+||+|+.+ +++.||||++.. ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46999999999999999999975 689999998843 233467899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+++|+|.+++.+. ..+++..+..++.||+.|++|||++ +|+||||||+|||++.++++||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 999999999999864 3489999999999999999999998 9999999999999999999999999999865321
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......||+.|||||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus 160 --------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 160 --------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp --------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 223457999999999999999999999999999999999999999764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=379.39 Aligned_cols=199 Identities=26% Similarity=0.404 Sum_probs=178.4
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC--CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS--DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
.++|++.+.||+|+||+||+|+.. +|+.||||++... ...+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 467999999999999999999964 6999999998543 3446799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
++||+|.+++.+ ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+.+....
T Consensus 99 ~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-- 170 (293)
T d1yhwa1 99 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (293)
T ss_dssp CTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred cCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence 999999999875 3489999999999999999999998 99999999999999999999999999998764322
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+..
T Consensus 171 -----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 171 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp -----CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -----ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence 22334579999999999999999999999999999999999999997643
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.8e-43 Score=389.61 Aligned_cols=294 Identities=30% Similarity=0.500 Sum_probs=225.3
Q ss_pred CcHHHHHHHHHHHHhCCCCCCccCCCCCCCCCCC--ccceEEeCC---CCcEEEEEeccccccc--cCCcccccCCCCcE
Q 001873 34 ALDEQGQALLTWKNSLNSSTDALSSWNPAETSPC--KWFGIHCSS---NGEVVEISLKAVDLQG--SLPSIFQPLKSLKR 106 (1001)
Q Consensus 34 ~~~~~~~aLl~~k~~~~~~~~~l~sW~~~~~~~c--~w~gv~c~~---~~~v~~l~l~~~~l~~--~~~~~~~~l~~L~~ 106 (1001)
|.++|++||++||+++.||+ .+++|.. ++||| .|+||+|+. ++||++++|+++++.| .+|+.++.|++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHHCCCCC-cCCCCCC-CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence 67899999999999998875 7999985 78999 499999984 3489999998888887 46777888888888
Q ss_pred EeccC-CcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceeccccc
Q 001873 107 LIISS-CNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQ 185 (1001)
Q Consensus 107 L~l~~-~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~ 185 (1001)
|+|++ |+++|.+|++|++|++|++|||++|++.+..|..+..+.+|+++++++|.+.+.+|..++++++|+++++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 88876 67888888888888888888888888887777777788888888888888777788888888888888888888
Q ss_pred cccccCCCccchhhh-hhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCc
Q 001873 186 LSGKIPKSIGALSKL-QVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIP 264 (1001)
Q Consensus 186 l~g~~p~~~~~l~~L-~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip 264 (1001)
++|.+|..++.+.++ +.+++++| .++|..| ..++.+..+ .+++..+...|.+|
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n-~l~~~~~------------------------~~~~~l~~~-~l~l~~~~~~~~~~ 214 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRN-RLTGKIP------------------------PTFANLNLA-FVDLSRNMLEGDAS 214 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSS-EEEEECC------------------------GGGGGCCCS-EEECCSSEEEECCG
T ss_pred cccccccccccccccccccccccc-ccccccc------------------------ccccccccc-cccccccccccccc
Confidence 877777777666655 44555555 4444444 444444333 35555666677777
Q ss_pred ccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccC
Q 001873 265 EEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLK 344 (1001)
Q Consensus 265 ~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 344 (1001)
..++.+++|+.|++++|.+.+.+| .++.+++|+.|+|++|+++|.+|.+++++++|++|||++|+|+|.+|. ++++++
T Consensus 215 ~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~ 292 (313)
T d1ogqa_ 215 VLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQR 292 (313)
T ss_dssp GGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGG
T ss_pred cccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCC
Confidence 777778888888888888876544 577778888888888888888888888888888888888888877774 577788
Q ss_pred ccEEEccccc-ccC
Q 001873 345 LQELQLSVNQ-LSG 357 (1001)
Q Consensus 345 L~~L~Ls~N~-l~~ 357 (1001)
|+.+++++|+ +.|
T Consensus 293 L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 293 FDVSAYANNKCLCG 306 (313)
T ss_dssp SCGGGTCSSSEEES
T ss_pred CCHHHhCCCccccC
Confidence 8888888886 444
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=374.00 Aligned_cols=200 Identities=21% Similarity=0.346 Sum_probs=175.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC-----CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS-----SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||+||+|+.. +++.||||++.. ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46999999999999999999975 689999999853 334467999999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||++||+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999998864 3589999999999999999999998 99999999999999999999999999998764332
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......+||+.|||||++.+..|+.++||||+||++|||+||+.||...
T Consensus 163 ~-----~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 163 K-----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c-----ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 1 12233457999999999999999999999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-43 Score=383.58 Aligned_cols=198 Identities=27% Similarity=0.405 Sum_probs=176.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++|++.+.||+|+||+||+|++. +|+.||||++.... ..+++.+|+.++++++|||||++++++.+++..++||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 57999999999999999999975 68999999986432 236789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
|+||+|.+++.+. ..+++..+..++.|++.|+.|||+++ +|+||||||+|||+++++++||+|||+|+.+...
T Consensus 86 ~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 158 (322)
T d1s9ja_ 86 MDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158 (322)
T ss_dssp CTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence 9999999999864 34899999999999999999999732 8999999999999999999999999999876422
Q ss_pred CCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus 159 ------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 159 ------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp ------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2234589999999999999999999999999999999999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=370.82 Aligned_cols=203 Identities=28% Similarity=0.378 Sum_probs=164.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeec--CCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSN--KNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~--~~~~~lv 838 (1001)
++|++.+.||+|+||+||+|+.+ +|+.||||++..... .+.+.+|++++++++|||||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999875 689999999865432 2568899999999999999999998864 4567999
Q ss_pred EEccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 839 YDYLPNGSLSSLLHGA--GKGGADWEARYEVVLGVAHALAYLHHDC--MPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
|||+++|+|.+++.+. ....+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 2356899999999999999999999861 11499999999999999999999999999998
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+.... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||...
T Consensus 164 ~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~ 217 (269)
T d2java1 164 LNHDT-------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217 (269)
T ss_dssp C------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCC-------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC
Confidence 64321 1223458999999999999999999999999999999999999999764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=373.75 Aligned_cols=200 Identities=26% Similarity=0.325 Sum_probs=175.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
+.|++.+.||+|+||+||+|+++ +++.||||++.... ..+.+.+|++++++++|||||++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999975 68999999986543 3478999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
++|+|.+++.+. ...+++..+..++.||+.|++|||++ +|+||||||+|||++.++++||+|||+|+.....
T Consensus 92 ~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---- 163 (288)
T d2jfla1 92 AGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---- 163 (288)
T ss_dssp TTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH----
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC----
Confidence 999999998653 34589999999999999999999998 9999999999999999999999999999765321
Q ss_pred CCCCCCCCcccccccccCccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHAS-----MQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......+||+.|||||++. ...|+.++||||+||++|||+||+.||.+..
T Consensus 164 ---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~ 219 (288)
T d2jfla1 164 ---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219 (288)
T ss_dssp ---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ---cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC
Confidence 11223457999999999873 4668999999999999999999999998654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=369.33 Aligned_cols=199 Identities=31% Similarity=0.462 Sum_probs=167.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCC----CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSS----DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++|++.+.||+|+||+||+|+++ ..||||++... ...++|.+|+.++++++|||||++++++.+ +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 57899999999999999999874 46999998532 233689999999999999999999998765 457999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
|++|+|.++++.. ...+++..+..++.||++||+|||++ +||||||||+|||++.++++||+|||+|+......
T Consensus 85 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~-- 158 (276)
T d1uwha_ 85 CEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-- 158 (276)
T ss_dssp CCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccC--
Confidence 9999999999764 34589999999999999999999998 99999999999999999999999999998764321
Q ss_pred CCCCCCCCCcccccccccCcccccc---CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASM---QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.........||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+..
T Consensus 159 ---~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 159 ---GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ---CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence 1122345579999999999854 458899999999999999999999998653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=373.54 Aligned_cols=199 Identities=23% Similarity=0.280 Sum_probs=178.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC-----CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS-----SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++++.||+|+||+||+|+.+ +|+.||||++.. ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999975 799999999853 334467899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
|||+||+|.+++.+. ..+++..++.++.||+.|++|||++ +|+||||||+|||++++|++||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~- 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred eccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC-
Confidence 999999999999874 3489999999999999999999999 9999999999999999999999999999865422
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus 159 ------~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 159 ------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp ------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ------CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence 122345689999999999999999999999999999999999999997653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-42 Score=365.51 Aligned_cols=198 Identities=27% Similarity=0.424 Sum_probs=165.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++|++.+.||+|+||+||+|++.+++.||||++.... ..++|.+|++++++++|||||+++|++.+++..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 4688889999999999999999888999999986543 447899999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++... ...+++..+..++.|+|+|++|+|++ +|+||||||+||++++++++||+|||+|+.......
T Consensus 85 g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~---- 156 (263)
T d1sm2a_ 85 GCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---- 156 (263)
T ss_dssp CBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc----
Confidence 9999998764 34578999999999999999999998 999999999999999999999999999987643221
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhC-CCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTG-RHPLD 973 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg-~~Pf~ 973 (1001)
.......||+.|||||++.+..|+.++|||||||++|||+|+ +.||.
T Consensus 157 --~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~ 204 (263)
T d1sm2a_ 157 --TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred --eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC
Confidence 122334789999999999999999999999999999999995 44444
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=367.55 Aligned_cols=199 Identities=26% Similarity=0.401 Sum_probs=174.0
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++|++.+.||+|+||+||+|++++++.||||++.... ..++|.+|++++++++|||||+++|++.+ +..++||||+++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence 5788899999999999999999888899999986543 45789999999999999999999998865 456899999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++.......+++..+.+|+.||++|++|||++ +|+||||||+||++++++.+||+|||+|+.+....
T Consensus 92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~----- 163 (272)
T d1qpca_ 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----- 163 (272)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-----
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc-----
Confidence 9999988765455689999999999999999999998 99999999999999999999999999999764321
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
........||+.|||||++....|+.++|||||||++|||+||..|+..
T Consensus 164 -~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~ 212 (272)
T d1qpca_ 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212 (272)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred -cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 1223345789999999999989999999999999999999996655543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-42 Score=374.50 Aligned_cols=200 Identities=25% Similarity=0.348 Sum_probs=163.7
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
++.+.|++.+.||+|+||+||+|+++ +++.||||++.... ..+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 45677999999999999999999975 68999999986432 235688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC---CCCcEEEecccccccc
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG---PGYQAYLADFGLARIV 915 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~ki~Dfgla~~~ 915 (1001)
||||+||+|.+++.+. ..+++..+..++.||+.|++|||++ +|+||||||+||++. +++.+||+|||+|+..
T Consensus 86 mE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp ECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999999864 4589999999999999999999998 999999999999995 5789999999999865
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus 161 ~~~--------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 212 (307)
T d1a06a_ 161 DPG--------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212 (307)
T ss_dssp --------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCC--------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence 322 1233457999999999999999999999999999999999999999764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-41 Score=369.35 Aligned_cols=195 Identities=28% Similarity=0.398 Sum_probs=176.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC-----CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS-----SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++.+.||+|+||+||+|+++ +|+.||||++.. ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999975 699999999853 234467899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
|||+||++.+++... ...++..+..++.||+.|++|||++ +|+||||||+|||++.+|++||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc--
Confidence 999999999999874 4478888999999999999999998 999999999999999999999999999987532
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.
T Consensus 157 --------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 204 (316)
T d1fota_ 157 --------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 204 (316)
T ss_dssp --------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc
Confidence 223458999999999999999999999999999999999999999764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-42 Score=370.61 Aligned_cols=201 Identities=26% Similarity=0.403 Sum_probs=178.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
++|++.+.||+|+||+||+|+++ +++.||||++.... ..++|.+|++++++++|||||++++++.+++..++|||||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 96 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence 46888899999999999999976 58899999986543 44789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNC 923 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 923 (1001)
+|+|.+++.+.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+......
T Consensus 97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~---- 169 (287)
T d1opja_ 97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT---- 169 (287)
T ss_dssp TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS----
T ss_pred CcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCC----
Confidence 99999999877677789999999999999999999998 99999999999999999999999999998764321
Q ss_pred CCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 924 SKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 924 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
........||+.|||||++.+..|+.++|||||||++|||++|..||.+.
T Consensus 170 --~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~ 219 (287)
T d1opja_ 170 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219 (287)
T ss_dssp --SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred --ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc
Confidence 11223346899999999999999999999999999999999987776543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=361.12 Aligned_cols=193 Identities=26% Similarity=0.374 Sum_probs=166.6
Q ss_pred ccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeec----CCceEEE
Q 001873 768 LTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSN----KNLKLLF 838 (1001)
Q Consensus 768 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~----~~~~~lv 838 (1001)
|+..++||+|+||+||+|++. +++.||||++.... ..+.+.+|++++++++|||||++++++.+ +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356678999999999999975 68899999985432 23578999999999999999999998754 4467899
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eEEeCCCCCCeEEC-CCCcEEEecccccccc
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPP--ILHGDVKAMNVLLG-PGYQAYLADFGLARIV 915 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NIll~-~~~~~ki~Dfgla~~~ 915 (1001)
|||+++|+|.+++++. ..+++..+..++.||++|++|||++ + |+||||||+|||++ +++.+||+|||+|+..
T Consensus 91 mE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 9999999999999864 4589999999999999999999997 6 99999999999996 5789999999999864
Q ss_pred cCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 916 SGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.. ......+||+.|||||++.+ .|+.++||||+||++|||++|+.||...
T Consensus 166 ~~---------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 166 RA---------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp CT---------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cC---------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 21 22335689999999999875 6999999999999999999999999754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-41 Score=376.41 Aligned_cols=201 Identities=25% Similarity=0.386 Sum_probs=179.2
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc--hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE--SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
.+.++|++.+.||+|+||+||+|+.+ +|+.||||++..... .+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45678999999999999999999975 689999999866543 367889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC--CCCcEEEecccccccccC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG--PGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~ki~Dfgla~~~~~ 917 (1001)
|||+||+|.+++.+. ...+++..+..++.||+.||+|||++ +||||||||+|||++ .++.+||+|||+|+.+..
T Consensus 103 E~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 103 EFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999999654 34589999999999999999999998 999999999999996 467999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......||+.|||||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus 179 ~--------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 228 (350)
T d1koaa2 179 K--------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 228 (350)
T ss_dssp T--------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c--------cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence 2 2234468999999999999999999999999999999999999999764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-41 Score=369.15 Aligned_cols=195 Identities=29% Similarity=0.354 Sum_probs=172.4
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
.+.|+..+.||+|+||+||+|+.. +++.||||++..... .+.+.+|+.++++++|||||++++++.+++..++|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 456999999999999999999865 688999999865432 24688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
||||++|++..++... ..+++..+..++.||+.||+|||++ +||||||||+|||++.++++||+|||+|+....
T Consensus 94 ~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp EECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999998777653 4589999999999999999999998 999999999999999999999999999986432
Q ss_pred CCCCCCCCCCCCcccccccccCcccccc---CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASM---QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.....||+.|||||++.+ ..|+.++||||+||++|||++|+.||...
T Consensus 168 ----------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~ 217 (309)
T d1u5ra_ 168 ----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (309)
T ss_dssp ----------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ----------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC
Confidence 123479999999999853 56899999999999999999999999754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-41 Score=367.75 Aligned_cols=205 Identities=26% Similarity=0.404 Sum_probs=164.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC-C---CEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN-G---ETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
+.|++.++||+|+||+||+|+++. + ..||||++..... .++|.+|++++++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 568888999999999999999752 3 2589998865433 35799999999999999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
||||++|+|.+++... ...+++.++..++.||++||+|||++ +|+||||||+|||++.++++||+|||+|+.+...
T Consensus 106 ~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 9999999999998864 34589999999999999999999998 9999999999999999999999999999877543
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.... .........||+.|||||++.+..|+.++|||||||++|||+| |+.||....
T Consensus 182 ~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 182 TSDP--TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCcc--eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 2211 1112223468999999999999999999999999999999998 899997653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-41 Score=356.98 Aligned_cols=201 Identities=24% Similarity=0.384 Sum_probs=179.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++|+..++||+|+||+||+|++++++.||||+++... ..++|.+|+.++++++|||||+++|++.+++..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 4788999999999999999999888899999986543 457899999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|++.+++... ...+++..+.+++.|+++|++|||++ +|+||||||+||++++++.+||+|||+|+.+.....
T Consensus 84 g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~---- 155 (258)
T d1k2pa_ 84 GCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---- 155 (258)
T ss_dssp EEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC----
T ss_pred CcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc----
Confidence 9999997654 34578999999999999999999998 999999999999999999999999999987643221
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.......||+.|+|||.+.+..|+.++|||||||++|||+| |+.||+...
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~ 206 (258)
T d1k2pa_ 156 --TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206 (258)
T ss_dssp --CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred --eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC
Confidence 12223468999999999999999999999999999999998 899998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.9e-41 Score=372.49 Aligned_cols=201 Identities=19% Similarity=0.279 Sum_probs=178.9
Q ss_pred HHHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc--hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 763 DVVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE--SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 763 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
.+.++|++.+.||+|+||+||+|+.. +|+.||||++..... .+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 34578999999999999999999974 799999999865542 357889999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC--CCCcEEEecccccccccC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG--PGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~ki~Dfgla~~~~~ 917 (1001)
|||+||+|.+++... ...+++..+..|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.+..
T Consensus 106 E~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 106 EFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp ECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999999988654 34589999999999999999999998 999999999999998 678999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. .......||+.|||||++.+..|+.++||||+||++|||+||+.||.+.
T Consensus 182 ~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 231 (352)
T d1koba_ 182 D--------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 231 (352)
T ss_dssp T--------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred C--------CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 2 2234457999999999999999999999999999999999999999764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-41 Score=363.96 Aligned_cols=200 Identities=24% Similarity=0.331 Sum_probs=177.6
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--------chhhHHHHHHHhhccCCCceeeEEeeeecCCc
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--------ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNL 834 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~ 834 (1001)
+.++|++.+.||+|+||+||+|+.+ +|+.||||++.... ..+.+.+|++++++++|||||++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4468999999999999999999975 79999999885321 23678999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC----cEEEeccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY----QAYLADFG 910 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~ki~Dfg 910 (1001)
.++|||||++|+|.+++.+. ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++ .+|++|||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999999864 3589999999999999999999998 999999999999998776 59999999
Q ss_pred ccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 911 LARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 911 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 163 ~a~~~~~~--------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 163 LAHKIDFG--------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp TCEECTTS--------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhhcCCC--------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 99876432 22334579999999999999999999999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-41 Score=359.92 Aligned_cols=202 Identities=26% Similarity=0.388 Sum_probs=172.1
Q ss_pred hcccCCC-eEeecCCeeEEEEEeC---CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSAN-VIGTGSSGVVYRVTIP---NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
++|.+.+ +||+|+||+||+|.++ ++..||||++..... .++|.+|++++++++|||||+++|++.++ ..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence 3455666 4999999999999764 345799999865433 36799999999999999999999998754 57899
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
||||++|+|.+++... ...+++..+.+++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+|+.+...
T Consensus 87 mE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 9999999999998654 34589999999999999999999998 9999999999999999999999999999987543
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.. .........||+.|||||++....++.++|||||||++|||+| |+.||....
T Consensus 163 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 163 DS----YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp SC----EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cc----ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 22 1122334568999999999999999999999999999999998 999998654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-40 Score=368.00 Aligned_cols=195 Identities=22% Similarity=0.276 Sum_probs=177.0
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC-----CCchhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS-----SDESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFY 839 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 839 (1001)
++|++++.||+|+||+||+|+++ +|+.||||++.. ....+.+.+|+++++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 799999999853 233467899999999999999999999999999999999
Q ss_pred EccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCC
Q 001873 840 DYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 840 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~ 919 (1001)
||+.+|+|.+++.+. ..+++..+..++.||+.||.|||++ +||||||||+|||++.++++||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 999999999999864 3489999999999999999999998 9999999999999999999999999999876421
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.....||+.|||||++.+..|+.++||||+||++|||+||+.||.+.
T Consensus 195 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ---------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence 23457999999999999999999999999999999999999999764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=366.34 Aligned_cols=203 Identities=30% Similarity=0.405 Sum_probs=173.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC-C-----CEEEEEEecCCC---chhhHHHHHHHhhcc-CCCceeeEEeeeecCCce
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN-G-----ETLAVKKMWSSD---ESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~~---~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~ 835 (1001)
++|++.++||+|+||+||+|++.. + ..||||++.... ....+.+|+.+++++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578899999999999999998643 2 369999885432 336789999999998 899999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCC
Q 001873 836 LLFYDYLPNGSLSSLLHGAGK---------------------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAM 894 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~ 894 (1001)
++|||||++|+|.++++.... ..+++..++.++.||++||+|||++ +||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 999999999999999976432 2478899999999999999999998 9999999999
Q ss_pred CeEECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 001873 895 NVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLD 973 (1001)
Q Consensus 895 NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~ 973 (1001)
||+++.++++||+|||+|+....... ........||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccccccCCeEEEeeccccccccCCCc-----eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999987654321 112234578999999999999999999999999999999998 899998
Q ss_pred CCC
Q 001873 974 PTL 976 (1001)
Q Consensus 974 ~~~ 976 (1001)
+..
T Consensus 269 ~~~ 271 (325)
T d1rjba_ 269 GIP 271 (325)
T ss_dssp TCC
T ss_pred CCC
Confidence 654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=356.09 Aligned_cols=195 Identities=25% Similarity=0.359 Sum_probs=165.1
Q ss_pred CeEeecCCeeEEEEEeC---CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 772 NVIGTGSSGVVYRVTIP---NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 772 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++||+|+||+||+|.++ .++.||||++..... .++|.+|++++++++|||||+++|++..+ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 46999999999999864 346899999854322 35799999999999999999999998654 56899999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++++. ..+++..+.+++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+.+......
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~--- 163 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--- 163 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE---
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccc---
Confidence 9999999874 4589999999999999999999998 9999999999999999999999999999876433221
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
........||++|||||++.+..++.++|||||||++|||+| |+.||.+..
T Consensus 164 -~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 164 -YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp -EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred -cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 122334579999999999999999999999999999999998 899998653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-40 Score=359.73 Aligned_cols=199 Identities=23% Similarity=0.339 Sum_probs=175.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecC-----CCchhhHHHHHHHhh-ccCCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWS-----SDESGAFSSEIQTLG-SIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~~Ei~~l~-~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
++|++.++||+|+||+||+|+++ +++.||||++.. ....+.+.+|+.++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999975 689999999853 333456777777765 68999999999999999999999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
||||++|+|.++++.. ..+++..+..++.||+.|++|||++ +|+||||||+|||+++++++||+|||+|+.....
T Consensus 82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 9999999999999864 3489999999999999999999998 9999999999999999999999999999865422
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
........||+.|+|||++.+..|+.++||||+||++|||+||+.||.+..
T Consensus 157 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 157 -------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp -------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -------cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence 122334579999999999999999999999999999999999999998653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=357.28 Aligned_cols=200 Identities=29% Similarity=0.409 Sum_probs=170.1
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 844 (1001)
++|++.+.||+|+||+||+|+++++++||||++.... ..++|.+|+.++++++|||||+++|++.+ +..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 5799999999999999999999888899999986544 34689999999999999999999999865 457899999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|..++.......+++..+..++.||+.|++|||++ +|+||||||+|||++.++++||+|||+|+.+....
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~----- 167 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE----- 167 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC-----
Confidence 9999998765455689999999999999999999998 99999999999999999999999999998764321
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
........||+.|+|||++....++.++|||||||++|||+||..||...
T Consensus 168 -~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~ 217 (285)
T d1fmka3 168 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred -ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC
Confidence 12223357999999999999999999999999999999999976666544
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.6e-40 Score=364.96 Aligned_cols=197 Identities=21% Similarity=0.252 Sum_probs=170.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCC-----CchhhHHH---HHHHhhccCCCceeeEEeeeecCCceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSS-----DESGAFSS---EIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~---Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
++|++.++||+|+||+||+|+.. +|+.||||++... .....+.+ |+.+++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999975 6999999998432 12233444 467778889999999999999999999
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
+|||||+||+|.+++.+. ..+++..++.++.||+.|++|||++ +||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 84 ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999999864 4478999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccc-cCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHAS-MQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.. .....+||+.|||||++. +..|+.++||||+||++|||+||+.||....
T Consensus 159 ~~---------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 159 KK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp SS---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred CC---------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 32 223457999999999986 4678999999999999999999999998654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-40 Score=354.18 Aligned_cols=201 Identities=28% Similarity=0.414 Sum_probs=165.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCC-----CEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNG-----ETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
+.|+..++||+|+||+||+|.++.. ..||||++..... ..+|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3577889999999999999987532 3699999865433 2468899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
||||+++|++.+++... ...+++..+.+++.|++.|++|||++ +|+||||||+|||++.++++||+|||+|+.+..
T Consensus 87 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999988764 34589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
.... ........||+.|||||++.+..++.++|||||||++|||++|..||..
T Consensus 163 ~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 163 DPEA----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCcc----ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 3211 1122334689999999999999999999999999999999997666544
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-40 Score=361.29 Aligned_cols=201 Identities=20% Similarity=0.278 Sum_probs=178.1
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
+.++|++.+.||+|+||+||+|.++ +++.||||++..... ...+.+|++++++++|||||++++++.+++..|+||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 4578999999999999999999975 688999999976543 35688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCC--CcEEEecccccccccCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPG--YQAYLADFGLARIVSGSG 919 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~ki~Dfgla~~~~~~~ 919 (1001)
|+||+|.+++.+. ...+++.++..++.||+.|++|||++ +|+||||||+||+++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 9999999999764 23589999999999999999999998 99999999999999854 58999999999875321
Q ss_pred CCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 920 DDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 920 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
.......||+.|+|||...+..|+.++||||+||++|||++|+.||....
T Consensus 158 -------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~ 207 (321)
T d1tkia_ 158 -------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp -------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -------CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC
Confidence 22334579999999999999999999999999999999999999998654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-40 Score=364.14 Aligned_cols=200 Identities=24% Similarity=0.351 Sum_probs=173.8
Q ss_pred HHHhcccCCC-eEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhcc-CCCceeeEEeeeec----CCce
Q 001873 763 DVVRNLTSAN-VIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSI-RHKNIVRLLGWGSN----KNLK 835 (1001)
Q Consensus 763 ~~~~~~~~~~-~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~----~~~~ 835 (1001)
.+.++|++.+ .||+|+||+||+|++. +++.||||++.. ...+.+|+.++.++ +|||||++++++.+ +...
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC---cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3567898875 5999999999999974 789999999853 45688899987655 89999999998864 4668
Q ss_pred EEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC---CCcEEEeccccc
Q 001873 836 LLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP---GYQAYLADFGLA 912 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ki~Dfgla 912 (1001)
|+|||||+||+|.+++.+.+...+++..++.++.||+.|++|||++ +|+||||||+||+++. ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence 9999999999999999876666789999999999999999999998 9999999999999985 567999999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+..... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+..
T Consensus 162 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~ 217 (335)
T d2ozaa1 162 KETTSH--------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 217 (335)
T ss_dssp EECCCC--------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred eeccCC--------CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence 876432 22334579999999999999999999999999999999999999997653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=351.58 Aligned_cols=196 Identities=30% Similarity=0.458 Sum_probs=166.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeec-CCceEEEEEccCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSN-KNLKLLFYDYLPN 844 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~~~ 844 (1001)
++|++.+.||+|+||.||+|++ .|.+||||+++.+...+++.+|++++++++||||++++|++.+ ++..++||||+++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 4678889999999999999998 4789999999887778899999999999999999999998854 4668999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCCCC
Q 001873 845 GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDNCS 924 (1001)
Q Consensus 845 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 924 (1001)
|+|.+++.+.+...+++..+.+|+.||+.|+.|||+. +|+||||||+||+++.++++|++|||+++.....
T Consensus 86 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~------ 156 (262)
T d1byga_ 86 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------ 156 (262)
T ss_dssp EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC------
Confidence 9999999765444589999999999999999999998 9999999999999999999999999999865321
Q ss_pred CCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 925 KTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 925 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
.....+|+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~ 204 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC
Confidence 122357889999999999999999999999999999998 78887765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-39 Score=347.53 Aligned_cols=198 Identities=24% Similarity=0.356 Sum_probs=174.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-----------hhhHHHHHHHhhccC-CCceeeEEeeeecC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-----------SGAFSSEIQTLGSIR-HKNIVRLLGWGSNK 832 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----------~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~ 832 (1001)
++|++.+.||+|+||+||+|+.. +++.||||++..... .+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57999999999999999999974 789999999854321 135889999999997 99999999999999
Q ss_pred CceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccc
Q 001873 833 NLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLA 912 (1001)
Q Consensus 833 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla 912 (1001)
+..|+|||||++|+|.++++.. ..+++..++.++.||++|++|||++ +|+||||||+||+++.++.+||+|||+|
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 9999999999999999999864 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCcccccc------CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM------QRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+.+... ......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..
T Consensus 158 ~~~~~~--------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 158 CQLDPG--------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp EECCTT--------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eEccCC--------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 876432 12234579999999998753 457889999999999999999999998654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-39 Score=351.30 Aligned_cols=203 Identities=28% Similarity=0.442 Sum_probs=168.2
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-----hhhHHHHHHHhhccCCCceeeEEeeeecCC----c
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKN----L 834 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~----~ 834 (1001)
.++|++.+.||+|+||+||+|++. +++.||||++..... .+.+.+|++++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999964 799999999864322 246889999999999999999999886543 3
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.|+||||++||+|.+++... ..+++.++..++.||++|++|||++ +|+||||||+||+++.++..+++|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 78999999999999998764 3489999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
...... ........+||+.|||||++.+..|+.++||||+||++|||+||+.||....
T Consensus 161 ~~~~~~----~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 161 IADSGN----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp CC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hccccc----cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence 543221 1223445689999999999999999999999999999999999999997643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-39 Score=350.90 Aligned_cols=193 Identities=25% Similarity=0.274 Sum_probs=165.3
Q ss_pred CCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-------hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEcc
Q 001873 771 ANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-------SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDYL 842 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 842 (1001)
+++||+|+||+||+|+++ +|+.||||++..... .+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 568999999999999975 699999999854321 256889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
+++++..+... ...+++..+..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+|+......
T Consensus 83 ~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--- 154 (299)
T d1ua2a_ 83 ETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--- 154 (299)
T ss_dssp SEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC---
T ss_pred cchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc---
Confidence 98877766653 34588889999999999999999998 99999999999999999999999999998754321
Q ss_pred CCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
......+||+.|+|||++.. ..|+.++||||+||++|||+||+.||.+.
T Consensus 155 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 155 ----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp ----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 12234579999999998864 56899999999999999999999999754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-39 Score=345.27 Aligned_cols=200 Identities=28% Similarity=0.380 Sum_probs=162.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC----CCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN----GETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv 838 (1001)
++|++.+.||+|+||+||+|++.. +..||||++..... .+.+.+|+.++++++|||||++++++.+ +..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 578999999999999999998643 34689998854332 2578999999999999999999999864 567999
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCC
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~ 918 (1001)
|||+++|++.+++... ...+++..+..++.||++|++|||++ +|+||||||+||++++++.+||+|||+|+.....
T Consensus 86 ~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 9999999999988754 34589999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.. .......||+.|+|||++....|+.++|||||||++|||+| |+.||....
T Consensus 162 ~~------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 162 TY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cc------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence 21 12233468999999999999999999999999999999998 899998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-39 Score=351.71 Aligned_cols=201 Identities=25% Similarity=0.400 Sum_probs=168.3
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCC----EEEEEEecCC---CchhhHHHHHHHhhccCCCceeeEEeeeecCCceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGE----TLAVKKMWSS---DESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~l 837 (1001)
.+|++.++||+|+||+||+|++. +|+ +||||++... ...++|.+|++++++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35899999999999999999865 344 6899988543 2346899999999999999999999999865 4578
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
++||+.+|+|.+++... ...+++..+++++.|||.||+|||++ +|+||||||+||+++.++++||+|||+|+.+..
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 89999999999988765 45689999999999999999999998 999999999999999999999999999998654
Q ss_pred CCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.... .......||+.|||||++.++.|+.++|||||||++|||+| |+.||++..
T Consensus 164 ~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 164 EEKE-----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp TCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccc-----ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence 3221 12223468999999999999999999999999999999998 889988653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.3e-38 Score=343.45 Aligned_cols=208 Identities=20% Similarity=0.273 Sum_probs=182.6
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccCC-CceeeEEeeeecCCceEEEEEccC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIRH-KNIVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
++|++.++||+|+||+||+|++. +|+.||||++......+.+.+|++.++.++| +||+.+++++......++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 57999999999999999999965 6899999998776666788999999999965 89999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC-----CCcEEEecccccccccCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP-----GYQAYLADFGLARIVSGS 918 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~ki~Dfgla~~~~~~ 918 (1001)
+++|.++++.. ...+++.++..++.|++.|++|||++ +|+||||||+||+++. ++.+||+|||+|+.+...
T Consensus 84 ~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 84 GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 68999998765 34589999999999999999999998 9999999999999974 578999999999987655
Q ss_pred CCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001873 919 GDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978 (1001)
Q Consensus 919 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~ 978 (1001)
..............+||+.|||||++.+..++.++||||+||++|||+||+.||.+....
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~ 219 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch
Confidence 443333344455678999999999999999999999999999999999999999876544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-38 Score=345.75 Aligned_cols=199 Identities=27% Similarity=0.392 Sum_probs=171.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
++|++.+.||+|+||+||+|++. +++.||||++.... ..+++.+|++++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57999999999999999999974 79999999985432 24678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
|+. |++.+++.......+++..+..++.|++.|++|||++ +||||||||+|||++.++++||+|||.|+......
T Consensus 82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 997 4566666555566799999999999999999999998 99999999999999999999999999998764321
Q ss_pred CCCCCCCCCCcccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQR-ITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......||+.|+|||...... ++.++||||+||++|+|++|+.||.+.
T Consensus 157 ------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 157 ------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp ------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 2233457999999999876655 478999999999999999999999754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-39 Score=349.85 Aligned_cols=204 Identities=29% Similarity=0.372 Sum_probs=166.1
Q ss_pred HhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHH--HHHHHhhccCCCceeeEEeeeecCC----ceEEE
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFS--SEIQTLGSIRHKNIVRLLGWGSNKN----LKLLF 838 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~--~Ei~~l~~l~h~nIv~l~~~~~~~~----~~~lv 838 (1001)
.+.|...+.||+|+||+||+|++ +|+.||||++..... +.+. +|+..+..++|||||++++++.+++ ..++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 45788889999999999999997 689999999865433 3333 4555566789999999999987544 57899
Q ss_pred EEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeEEeCCCCCCeEECCCCcEEEecccccc
Q 001873 839 YDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC-----MPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~ 913 (1001)
||||++|+|.+++++. .+++..+.+++.|+|.|++|+|+.. .++||||||||+|||++.++++||+|||+++
T Consensus 80 ~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 9999999999999863 4899999999999999999999731 2499999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCccccccCC------CCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQR------ITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
........ ........+||++|||||++.+.. ++.++|||||||++|||+||..||....
T Consensus 157 ~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 157 RHDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp EEETTTTE---ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred cccCCCcc---eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 87543321 112233468999999999986542 5678999999999999999998886543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-38 Score=347.28 Aligned_cols=202 Identities=27% Similarity=0.406 Sum_probs=173.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCCceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
++|++.+.||+|+||+||+|+++ +++.||||++..... .++|.+|++++++++||||+++++++.+.+..+
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 92 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 92 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence 57999999999999999999864 357899999865443 357999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCC
Q 001873 837 LFYDYLPNGSLSSLLHGAG----------------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAM 894 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~ 894 (1001)
+||||+++|+|.++++... ...+++..+..|+.|++.|++|||++ +||||||||+
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~ 169 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATR 169 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEccc
Confidence 9999999999999997532 12468889999999999999999998 9999999999
Q ss_pred CeEECCCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCC-CCCC
Q 001873 895 NVLLGPGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGR-HPLD 973 (1001)
Q Consensus 895 NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~-~Pf~ 973 (1001)
||+++.++++||+|||+|+.+..... ........||+.|+|||.+.+..|+.++|||||||++|||++|. .||.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ceEECCCCcEEEccchhheeccCCcc-----ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 99999999999999999987643321 12233457899999999999999999999999999999999986 5676
Q ss_pred CC
Q 001873 974 PT 975 (1001)
Q Consensus 974 ~~ 975 (1001)
..
T Consensus 245 ~~ 246 (301)
T d1lufa_ 245 GM 246 (301)
T ss_dssp TS
T ss_pred CC
Confidence 54
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-39 Score=343.24 Aligned_cols=196 Identities=21% Similarity=0.347 Sum_probs=169.4
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC--------chhhHHHHHHHhhccC--CCceeeEEeeeecCCc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD--------ESGAFSSEIQTLGSIR--HKNIVRLLGWGSNKNL 834 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~Ei~~l~~l~--h~nIv~l~~~~~~~~~ 834 (1001)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ...++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999975 78999999985421 1245778999999986 8999999999999999
Q ss_pred eEEEEEccCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC-CCcEEEeccccc
Q 001873 835 KLLFYDYLPN-GSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP-GYQAYLADFGLA 912 (1001)
Q Consensus 835 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~ki~Dfgla 912 (1001)
.++||||+.+ +++.+++... ..+++..++.++.|++.|++|||++ +|+||||||+||+++. ++.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 6888888763 4589999999999999999999998 9999999999999985 579999999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCccccccCCC-CCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRI-TEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+.... .......||+.|||||++.+..+ +.++||||+||++|||+||+.||...
T Consensus 159 ~~~~~---------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 159 ALLKD---------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp EECCS---------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred eeccc---------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 86532 12334579999999999987766 57799999999999999999999763
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-39 Score=341.98 Aligned_cols=201 Identities=27% Similarity=0.397 Sum_probs=162.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeC--CC--CEEEEEEecCCC-----chhhHHHHHHHhhccCCCceeeEEeeeecCCceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP--NG--ETLAVKKMWSSD-----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
++|++.+.||+|+||+||+|++. ++ ..||||++.... ..++|.+|+.++++++|||||+++|++.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 56899999999999999999853 22 378999885421 236799999999999999999999999764 568
Q ss_pred EEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccccc
Q 001873 837 LFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVS 916 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~ 916 (1001)
+||||+++|++.+++... ...+++..+..++.|||.||+|||++ +|+||||||+||+++.++++||+|||+++.+.
T Consensus 87 lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 999999999999988754 34589999999999999999999998 99999999999999999999999999999864
Q ss_pred CCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 001873 917 GSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPT 975 (1001)
Q Consensus 917 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~ 975 (1001)
..... ........||..|+|||++.+..++.++|||||||++|||+| |+.||.+.
T Consensus 163 ~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 163 QNDDH----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp C-CCE----EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCCCc----ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence 43221 122234468889999999999999999999999999999998 89999754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.5e-38 Score=339.11 Aligned_cols=198 Identities=26% Similarity=0.370 Sum_probs=171.0
Q ss_pred hcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++|++.++||+|+||+||+|++++|+.||||++.... ..+.+.+|+.++++++|||||++++++.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5799999999999999999999999999999986543 236799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDD 921 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~ 921 (1001)
+.++.+..+.+. ...+++..+..++.||+.||+|||++ +||||||||+|||++.++.+|++|||.|.......
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (286)
T ss_dssp CSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc--
Confidence 987777666654 35589999999999999999999998 99999999999999999999999999998764322
Q ss_pred CCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 922 NCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 922 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 155 -----~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -----cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 12233468999999999865 55689999999999999999999999764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-38 Score=342.70 Aligned_cols=202 Identities=28% Similarity=0.350 Sum_probs=161.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCc---hhhHHHHHHHhhcc-CCCceeeEEeeeec-CCc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDE---SGAFSSEIQTLGSI-RHKNIVRLLGWGSN-KNL 834 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~-~~~ 834 (1001)
++|++.++||+|+||+||+|++. +++.||||++..... .+.+.+|+..+.++ +|+|||.+++++.+ ...
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 57999999999999999999853 246899999865432 35677888888777 68999999998765 456
Q ss_pred eEEEEEccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECC
Q 001873 835 KLLFYDYLPNGSLSSLLHGAG--------------KGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGP 900 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~ 900 (1001)
.++|||||++|+|.++++... ...+++..+..++.||++|++|||++ +||||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence 899999999999999997542 23478999999999999999999998 9999999999999999
Q ss_pred CCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCC-CCCCCC
Q 001873 901 GYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGR-HPLDPT 975 (1001)
Q Consensus 901 ~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~-~Pf~~~ 975 (1001)
++++||+|||+|+....... ........||+.|||||++.+..++.++|||||||++|||+||. .||...
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp GGCEEECC------CCSCTT-----SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCcEEEccCcchhhcccccc-----ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999987643322 12233457999999999999999999999999999999999975 567654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-37 Score=338.23 Aligned_cols=198 Identities=29% Similarity=0.417 Sum_probs=167.9
Q ss_pred CCeEeecCCeeEEEEEeCCC----CEEEEEEecCCC---chhhHHHHHHHhhccCCCceeeEEeeeec-CCceEEEEEcc
Q 001873 771 ANVIGTGSSGVVYRVTIPNG----ETLAVKKMWSSD---ESGAFSSEIQTLGSIRHKNIVRLLGWGSN-KNLKLLFYDYL 842 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~---~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~ 842 (1001)
.++||+|+||+||+|++.++ ..||||++.... ..++|.+|++++++++|||||+++|++.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997532 258999986432 23679999999999999999999999765 56789999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCCCC
Q 001873 843 PNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGDDN 922 (1001)
Q Consensus 843 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 922 (1001)
++|+|.++++.. ....++..+.+++.|++.|+.|+|+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~- 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD- 186 (311)
T ss_dssp TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC-
T ss_pred ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc-
Confidence 999999998864 44578888999999999999999998 9999999999999999999999999999877543221
Q ss_pred CCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 923 CSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 923 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.........||+.|+|||.+....++.++||||||+++|||+||+.||...
T Consensus 187 --~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 187 --SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp --CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred --cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 122233457999999999999999999999999999999999988887754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-38 Score=342.83 Aligned_cols=212 Identities=28% Similarity=0.366 Sum_probs=177.5
Q ss_pred hcccCCCeEeecCCeeEEEEEe------CCCCEEEEEEecCCCc---hhhHHHHHHHhhcc-CCCceeeEEeeeecCCce
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI------PNGETLAVKKMWSSDE---SGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLK 835 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~ 835 (1001)
++|++.++||+|+||+||+|++ .+++.||||++..... ..++.+|+.+++++ +|||||++++++.+++..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5788899999999999999985 2457899999965443 35688999999999 699999999999999999
Q ss_pred EEEEEccCCCCHHHHhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC
Q 001873 836 LLFYDYLPNGSLSSLLHGAGK----------------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG 899 (1001)
Q Consensus 836 ~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~ 899 (1001)
++|||||++|+|.+++++... ..+++..+.+++.||++|++|||++ +||||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 999999999999999976432 2478999999999999999999999 999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 001873 900 PGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPGG 979 (1001)
Q Consensus 900 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~ 979 (1001)
.++.+|++|||.++....... ........||+.|+|||++....++.++|||||||++|||+|+..||.......
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred ccCcccccccchheeccCCCc-----ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999987643322 122234579999999999999999999999999999999999655554444444
Q ss_pred cCcccc
Q 001873 980 APLVQW 985 (1001)
Q Consensus 980 ~~l~~~ 985 (1001)
..+.+.
T Consensus 255 ~~~~~~ 260 (311)
T d1t46a_ 255 SKFYKM 260 (311)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 333333
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-37 Score=336.62 Aligned_cols=208 Identities=21% Similarity=0.282 Sum_probs=174.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccCCCc-eeeEEeeeecCCceEEEEEccC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKN-IVRLLGWGSNKNLKLLFYDYLP 843 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~~~ 843 (1001)
++|++.+.||+|+||+||+|++. +|+.||||++......+++.+|++++++++|++ |+.+.++..+.+..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 47999999999999999999864 689999999877666678999999999998766 555556667888889999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC---CCCcEEEecccccccccCCCC
Q 001873 844 NGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG---PGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 844 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
++++.+.+... ...+++..+..++.|++.|++|||++ +|+||||||+||+++ .+..+|++|||+|+.+.....
T Consensus 86 ~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 86 GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 46777766544 34589999999999999999999998 999999999999986 355799999999998765543
Q ss_pred CCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTLPG 978 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~ 978 (1001)
.............||+.|||||++.+..++.++|||||||++|||+||+.||......
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~ 219 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchH
Confidence 3333334455678999999999999999999999999999999999999999876543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=338.76 Aligned_cols=203 Identities=28% Similarity=0.360 Sum_probs=170.2
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC--------CCEEEEEEecCCCc---hhhHHHHHHHhhcc-CCCceeeEEeeeecCC
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN--------GETLAVKKMWSSDE---SGAFSSEIQTLGSI-RHKNIVRLLGWGSNKN 833 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~---~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~ 833 (1001)
++|++.+.||+|+||+||+|+... +..||||++..... ..++.+|+..+.++ +|||||++++++.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 578899999999999999998532 24799999865543 25688899999888 8999999999999999
Q ss_pred ceEEEEEccCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEEC
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAGK--------------GGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLG 899 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~ 899 (1001)
..++||||+++|+|.+++..... ..+++.++.+++.||++|++|||+. +||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 99999999999999999976532 3479999999999999999999998 999999999999999
Q ss_pred CCCcEEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 001873 900 PGYQAYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLT-GRHPLDPTL 976 (1001)
Q Consensus 900 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt-g~~Pf~~~~ 976 (1001)
.++.+||+|||.++........ .......||+.|+|||.+.++.|+.++|||||||++|||++ |+.||....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTT-----CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCCeEeccchhhccccccccc-----cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 9999999999999877543221 22344578999999999999999999999999999999998 788887544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-37 Score=339.62 Aligned_cols=199 Identities=24% Similarity=0.331 Sum_probs=167.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-C-CCEEEEEEecCC----CchhhHHHHHHHhhcc---CCCceeeEEeeeec-----
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-N-GETLAVKKMWSS----DESGAFSSEIQTLGSI---RHKNIVRLLGWGSN----- 831 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~----~~~~~~~~Ei~~l~~l---~h~nIv~l~~~~~~----- 831 (1001)
++|++.++||+|+||+||+|++. + ++.||||++... .....+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 68999999999999999999974 4 567999988532 2235677888887776 79999999998742
Q ss_pred CCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccc
Q 001873 832 KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGL 911 (1001)
Q Consensus 832 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgl 911 (1001)
....+++|||++++++..... .....+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||.
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhh
Confidence 346789999998776655444 3356689999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 912 ARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 912 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
++.... ........||+.|||||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus 163 ~~~~~~--------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 163 ARIYSF--------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp CCCCCG--------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhhcc--------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 876432 223345689999999999999999999999999999999999999998653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-37 Score=339.64 Aligned_cols=199 Identities=29% Similarity=0.448 Sum_probs=168.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeCC-CC--EEEEEEecCC---CchhhHHHHHHHhhcc-CCCceeeEEeeeecCCceEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIPN-GE--TLAVKKMWSS---DESGAFSSEIQTLGSI-RHKNIVRLLGWGSNKNLKLLF 838 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~---~~~~~~~~Ei~~l~~l-~h~nIv~l~~~~~~~~~~~lv 838 (1001)
++|++.++||+|+||+||+|++++ +. .||||++... ...++|.+|+++++++ +|||||+++|++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578889999999999999999753 43 5788887432 2346799999999998 799999999999999999999
Q ss_pred EEccCCCCHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcE
Q 001873 839 YDYLPNGSLSSLLHGA--------------GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQA 904 (1001)
Q Consensus 839 ~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 904 (1001)
|||+++|+|.++++.. ....+++..+.+++.|||.|+.|+|++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999753 234589999999999999999999998 99999999999999999999
Q ss_pred EEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCC-CCCCCC
Q 001873 905 YLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGR-HPLDPT 975 (1001)
Q Consensus 905 ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~-~Pf~~~ 975 (1001)
||+|||+|+..... .......||..|+|||.+....|+.++|||||||++|||++|. .||...
T Consensus 167 kl~DfG~a~~~~~~--------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~ 230 (309)
T d1fvra_ 167 KIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 230 (309)
T ss_dssp EECCTTCEESSCEE--------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEcccccccccccc--------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC
Confidence 99999999864321 1122346899999999999999999999999999999999975 467654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-37 Score=335.66 Aligned_cols=202 Identities=25% Similarity=0.360 Sum_probs=172.9
Q ss_pred hcccCCCeEeecCCeeEEEEEeC------CCCEEEEEEecCCCch---hhHHHHHHHhhccCCCceeeEEeeeecCCceE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP------NGETLAVKKMWSSDES---GAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKL 836 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~---~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~ 836 (1001)
++|++.+.||+|+||+||+|.+. +++.||||++...... ..|.+|+.++++++|||||++++++..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 57888999999999999999863 3578999999654333 45889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEec
Q 001873 837 LFYDYLPNGSLSSLLHGA--------GKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLAD 908 (1001)
Q Consensus 837 lv~e~~~~gsL~~~l~~~--------~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~D 908 (1001)
+||||+++|+|.+++... .....++..+.+++.|+|+||.|||++ +|+||||||+|||+++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence 999999999999998642 123468999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCC-CCCCCC
Q 001873 909 FGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGR-HPLDPT 975 (1001)
Q Consensus 909 fgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~-~Pf~~~ 975 (1001)
||+|+.+..... ........||+.|+|||.+.+..++.++||||||+++|||+||+ .||...
T Consensus 177 FGla~~~~~~~~-----~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~ 239 (308)
T d1p4oa_ 177 FGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239 (308)
T ss_dssp TTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred cccceeccCCcc-----eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC
Confidence 999987643321 11223346899999999999999999999999999999999985 666543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=334.96 Aligned_cols=203 Identities=26% Similarity=0.314 Sum_probs=167.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeec--------
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSN-------- 831 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~-------- 831 (1001)
.++|++++.||+|+||+||+|++. +|+.||||++..+. ..+++.+|+.++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 578999999999999999999974 79999999985432 33678899999999999999999998754
Q ss_pred CCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccc
Q 001873 832 KNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGL 911 (1001)
Q Consensus 832 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgl 911 (1001)
++..++||||++++.+..+... ...+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecce
Confidence 3467999999987766655443 44588999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 912 ARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 912 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
|+.+..... .........+||+.|+|||++.+ ..|+.++||||+||++|||++|+.||.+.
T Consensus 164 ~~~~~~~~~---~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~ 225 (318)
T d3blha1 164 ARAFSLAKN---SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225 (318)
T ss_dssp CEECCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eeecccccc---cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence 987654322 12233344589999999999865 46899999999999999999999999754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=338.09 Aligned_cols=196 Identities=31% Similarity=0.362 Sum_probs=163.3
Q ss_pred cccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccCCCceeeEEeeeec------CCceEEEE
Q 001873 767 NLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNIVRLLGWGSN------KNLKLLFY 839 (1001)
Q Consensus 767 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~------~~~~~lv~ 839 (1001)
+|+..++||+|+||+||+|++. +|+.||||++..... ...+|++++++++||||+++++++.. ..+.++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 5888899999999999999975 699999999865433 34589999999999999999998743 33578999
Q ss_pred EccCCCCHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC-cEEEecccccccccC
Q 001873 840 DYLPNGSLSSLLHG-AGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY-QAYLADFGLARIVSG 917 (1001)
Q Consensus 840 e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~Dfgla~~~~~ 917 (1001)
|||+++.+....+. .....+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 99986644433321 2245689999999999999999999998 999999999999999775 899999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
. ......+||+.|+|||.+.+ ..|+.++||||+||++|||++|+.||...
T Consensus 176 ~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 176 G--------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp T--------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred C--------cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence 2 22334579999999998754 67899999999999999999999999754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-37 Score=335.56 Aligned_cols=203 Identities=27% Similarity=0.326 Sum_probs=173.7
Q ss_pred hcccCCCeEeecCCeeEEEEEeC----CCCEEEEEEecCC------CchhhHHHHHHHhhccCC-CceeeEEeeeecCCc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP----NGETLAVKKMWSS------DESGAFSSEIQTLGSIRH-KNIVRLLGWGSNKNL 834 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~------~~~~~~~~Ei~~l~~l~h-~nIv~l~~~~~~~~~ 834 (1001)
++|++.++||+|+||+||+|+.. +|+.||||++... ...+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 4789999988532 234678899999999976 899999999999999
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.++||||+++|+|.+++...+ ..++..+..++.|++.|++|+|++ +|+||||||+||+++.++.+||+|||+|+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999998753 467888899999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ--RITEKSDVYSFGVVLLEVLTGRHPLDPTLPGG 979 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~il~elltg~~Pf~~~~~~~ 979 (1001)
+... .........|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+
T Consensus 179 ~~~~------~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 179 FVAD------ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp CCGG------GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred hccc------ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 6432 12223445799999999998654 46789999999999999999999998765443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-36 Score=334.51 Aligned_cols=201 Identities=25% Similarity=0.326 Sum_probs=166.4
Q ss_pred hcccCCCeEeecCCeeEEEEEe-CCCCEEEEEEecCCCc---hhhHHHHHHHhhccCCCceeeEEeeeecCC----ceEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTI-PNGETLAVKKMWSSDE---SGAFSSEIQTLGSIRHKNIVRLLGWGSNKN----LKLL 837 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~----~~~l 837 (1001)
.+|++++.||+|+||+||+|+. .+|+.||||++..... .+++.+|+.++++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 5799999999999999999986 4799999999965433 257889999999999999999999886543 2345
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccC
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSG 917 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~ 917 (1001)
+++|+.+|+|.+++... .+++..+..++.|+++|++|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 88 l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 55667799999999753 589999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCCCCCCCCCCcccccccccCccccc-cCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 918 SGDDNCSKTNQRPQLAGSYGYMAPEHAS-MQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 918 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
... ........+||+.|+|||++. ...++.++||||+||++|||++|+.||....
T Consensus 162 ~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 162 DHD----HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp GGC----BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCc----cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 321 112234457999999999984 4567899999999999999999999997643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-36 Score=335.45 Aligned_cols=195 Identities=24% Similarity=0.352 Sum_probs=164.0
Q ss_pred HHhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeecCC-----
Q 001873 764 VVRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSNKN----- 833 (1001)
Q Consensus 764 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~----- 833 (1001)
+.++|++++.||+|+||+||+|++. +|+.||||++..... .+.+.+|++++++++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3468999999999999999999975 699999999965432 256889999999999999999999987654
Q ss_pred -ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccc
Q 001873 834 -LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLA 912 (1001)
Q Consensus 834 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla 912 (1001)
..++||||+ +.+|..+.+. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+|
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence 569999999 5788888764 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCcccccccccCcccccc-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 913 RIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASM-QRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
+.... .....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 169 ~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 169 RQADS----------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp EECCS----------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccCC----------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 87532 2234579999999999865 55689999999999999999999999765
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-36 Score=324.26 Aligned_cols=197 Identities=24% Similarity=0.323 Sum_probs=172.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCC----chhhHHHHHHHhhccCCCceeeEEeeeecCCceEEEEE
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSD----ESGAFSSEIQTLGSIRHKNIVRLLGWGSNKNLKLLFYD 840 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~Ei~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 840 (1001)
++|+++++||+|+||+||+|++. +++.||||+++... ...++.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999975 78999999985433 23678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccccccCCCC
Q 001873 841 YLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 841 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~~~~~~~ 920 (1001)
++.++++..+++.. ...++..+..++.|++.||+|||++ +|+||||||+||+++.++++||+|||.|+......
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~- 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC-
Confidence 99999998888754 4578999999999999999999998 99999999999999999999999999998764332
Q ss_pred CCCCCCCCCCcccccccccCccccccCC-CCCccchHHHHHHHHHHHhCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQR-ITEKSDVYSFGVVLLEVLTGRHPLDP 974 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~il~elltg~~Pf~~ 974 (1001)
.......+++.|+|||.+.... ++.++||||+||++|||++|+.||..
T Consensus 156 ------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp ------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred ------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 1222346788999999887654 68999999999999999999999754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-35 Score=326.40 Aligned_cols=194 Identities=21% Similarity=0.257 Sum_probs=167.8
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCchhhHHHHHHHhhccC-CCceeeEEeeeec--CCceEEEEEc
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDESGAFSSEIQTLGSIR-HKNIVRLLGWGSN--KNLKLLFYDY 841 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~--~~~~~lv~e~ 841 (1001)
++|++.++||+|+||+||+|+.. +++.||||++... ..+++.+|+++++.++ ||||+++++++.. ....++||||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 57999999999999999999974 6899999998643 4578899999999995 9999999999874 4568999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC-cEEEecccccccccCCCC
Q 001873 842 LPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY-QAYLADFGLARIVSGSGD 920 (1001)
Q Consensus 842 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~ki~Dfgla~~~~~~~~ 920 (1001)
+++++|.++.+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 114 ~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-- 183 (328)
T d3bqca1 114 VNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-- 183 (328)
T ss_dssp CCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT--
T ss_pred cCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC--
Confidence 99999987643 489999999999999999999998 999999999999998654 6999999999876432
Q ss_pred CCCCCCCCCCcccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 921 DNCSKTNQRPQLAGSYGYMAPEHASMQ-RITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 921 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
......+||+.|+|||.+.+. .++.++||||+||++|||++|+.||....
T Consensus 184 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 184 ------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp ------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ------CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 123345789999999997654 57999999999999999999999997653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-35 Score=326.32 Aligned_cols=195 Identities=22% Similarity=0.279 Sum_probs=158.9
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeec------CC
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSN------KN 833 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~------~~ 833 (1001)
.++|++.++||+|+||+||+|++. +|+.||||++..... .+++.+|+.++++++|||||++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 468999999999999999999976 699999999965432 2468899999999999999999999853 46
Q ss_pred ceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEecccccc
Q 001873 834 LKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913 (1001)
Q Consensus 834 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~ 913 (1001)
..|+||||+.++ +.+.+. ..+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+|++|||+++
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence 789999999755 444443 3479999999999999999999999 99999999999999999999999999988
Q ss_pred cccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 914 IVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 168 ~~~~~--------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 168 TAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp ---------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccc--------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 65322 2334457999999999999999999999999999999999999999754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-35 Score=326.29 Aligned_cols=195 Identities=23% Similarity=0.324 Sum_probs=164.1
Q ss_pred HhcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc----hhhHHHHHHHhhccCCCceeeEEeeeec-----CCc
Q 001873 765 VRNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE----SGAFSSEIQTLGSIRHKNIVRLLGWGSN-----KNL 834 (1001)
Q Consensus 765 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~Ei~~l~~l~h~nIv~l~~~~~~-----~~~ 834 (1001)
.++|++.+.||+|+||+||+|++. +|+.||||++..... .+++.+|++++++++|||||++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999964 799999999865432 2568899999999999999999998853 233
Q ss_pred eEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 835 KLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 835 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.+++++|+.+|+|.++++. ..+++..++.++.||+.|++|||++ +|+||||||+||+++.++.+|++|||.|..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 4667778889999999964 3589999999999999999999998 999999999999999999999999999975
Q ss_pred ccCCCCCCCCCCCCCCcccccccccCccccccC-CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001873 915 VSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQ-RITEKSDVYSFGVVLLEVLTGRHPLDPT 975 (1001)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~il~elltg~~Pf~~~ 975 (1001)
.. .......||+.|+|||...+. .++.++||||+||++|+|++|+.||.+.
T Consensus 171 ~~----------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 171 TD----------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp CT----------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cC----------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 42 122345799999999987664 5689999999999999999999999754
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.3e-31 Score=294.14 Aligned_cols=248 Identities=27% Similarity=0.444 Sum_probs=159.9
Q ss_pred CCcEEeccCCcccC--CCCcccCCccccccccccC-CccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccce
Q 001873 103 SLKRLIISSCNLTG--TIPKEFGDYRELTFIDLSG-NSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYL 179 (1001)
Q Consensus 103 ~L~~L~l~~~~l~g--~~p~~~~~l~~L~~L~Ls~-n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L 179 (1001)
+++.|+|++++++| .+|+++++|++|++|||++ |+++|.+|++|++|++|++|+|++|++.+..|..+.++.+|+++
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 56677777777776 4667777777777777775 67777777777777777777777777777667667777777777
Q ss_pred eccccccccccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCcccccccc-ceecccccc
Q 001873 180 TLYDNQLSGKIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERI-QTIAIYTSL 258 (1001)
Q Consensus 180 ~L~~n~l~g~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L-~~L~l~~n~ 258 (1001)
++++|.+.+.+|.+++++++|+++++++| .+.|.+|.. +..+..+ +.+++..|+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n-~l~~~ip~~------------------------~~~l~~l~~~l~~~~n~ 185 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGN-RISGAIPDS------------------------YGSFSKLFTSMTISRNR 185 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSS-CCEEECCGG------------------------GGCCCTTCCEEECCSSE
T ss_pred ccccccccccCchhhccCcccceeecccc-ccccccccc------------------------ccccccccccccccccc
Confidence 77777777666666666666666665555 333333333 3333332 334444555
Q ss_pred ccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcc
Q 001873 259 LSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRS 338 (1001)
Q Consensus 259 l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 338 (1001)
++|..|..+.++..+ .++++++...+.+|..+..+++|+.+++++|.+.+.+| .++.+++|+.|+|++|+++|.+|..
T Consensus 186 l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~ 263 (313)
T d1ogqa_ 186 LTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQG 263 (313)
T ss_dssp EEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGG
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChH
Confidence 666666666655443 46666666666666666666666666666666665443 4566666666666666666666666
Q ss_pred cccccCccEEEcccccccCcCChhhccccccCEEeccCCc
Q 001873 339 FGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNA 378 (1001)
Q Consensus 339 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 378 (1001)
|+++++|++|+|++|+|+|.+|. +..+++|+.+++++|+
T Consensus 264 l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 264 LTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp GGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred HhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 66666666666666666666653 4556666666666665
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=4.2e-31 Score=296.39 Aligned_cols=199 Identities=22% Similarity=0.259 Sum_probs=159.5
Q ss_pred hcccCCCeEeecCCeeEEEEEeC-CCCEEEEEEecCCCc-hhhHHHHHHHhhccC-----------CCceeeEEeeeec-
Q 001873 766 RNLTSANVIGTGSSGVVYRVTIP-NGETLAVKKMWSSDE-SGAFSSEIQTLGSIR-----------HKNIVRLLGWGSN- 831 (1001)
Q Consensus 766 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~Ei~~l~~l~-----------h~nIv~l~~~~~~- 831 (1001)
++|+++++||+|+||+||+|+.. +|+.||||++..... .+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 35999999999999999999974 799999999975532 356788999988875 5789999988754
Q ss_pred -CCceEEEEEccCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCC------c
Q 001873 832 -KNLKLLFYDYLPNG-SLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGY------Q 903 (1001)
Q Consensus 832 -~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~------~ 903 (1001)
....+++|+++..+ +.............++..+..++.||+.|++|||+.. +|+||||||+|||++.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccce
Confidence 34556666666544 3444444455567899999999999999999999831 999999999999998654 4
Q ss_pred EEEecccccccccCCCCCCCCCCCCCCcccccccccCccccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001873 904 AYLADFGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPEHASMQRITEKSDVYSFGVVLLEVLTGRHPLDPTL 976 (1001)
Q Consensus 904 ~ki~Dfgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~il~elltg~~Pf~~~~ 976 (1001)
+|++|||.|..... .....+||+.|+|||++....++.++||||+||+++||++|+.||.+..
T Consensus 171 ~kl~dfg~s~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 171 IKIADLGNACWYDE----------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEECCCTTCEETTB----------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eeEeeccccccccc----------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 99999999986432 1234579999999999999999999999999999999999999998754
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=5.1e-29 Score=281.64 Aligned_cols=354 Identities=25% Similarity=0.304 Sum_probs=196.3
Q ss_pred ccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCC
Q 001873 255 YTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGS 334 (1001)
Q Consensus 255 ~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 334 (1001)
..+.+++.++ ...+.+|++|++++|.|+.. +.+..+++|++|+|++|++++. | .++++++|++|++++|++++.
T Consensus 30 ~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i 103 (384)
T d2omza2 30 GKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADI 103 (384)
T ss_dssp TCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCC-c-cccCCcccccccccccccccc
Confidence 3344444333 23556677777777777643 3466777777888887777743 3 277777777888877777743
Q ss_pred CCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccC
Q 001873 335 IPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQC 414 (1001)
Q Consensus 335 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l 414 (1001)
. .++++++|+.|++++|.+++..+ ......+..+....|.+....+................. ....+...
T Consensus 104 ~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 174 (384)
T d2omza2 104 T--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT-----DLKPLANL 174 (384)
T ss_dssp G--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC-----CCGGGTTC
T ss_pred c--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc-----hhhhhccc
Confidence 2 26777777777777777764432 334456666666666665433332222222222222111 12234444
Q ss_pred cccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeec
Q 001873 415 QELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDM 494 (1001)
Q Consensus 415 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 494 (1001)
..........|... ....+..+++++.+++++|.+++..| +...++|+.|++++|+++. + ..+..+++|+.|++
T Consensus 175 ~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l 248 (384)
T d2omza2 175 TTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDL 248 (384)
T ss_dssp TTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEEC
T ss_pred cccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhcc
Confidence 45555555555543 34455667777777777777775543 3456677777777777763 2 35667777777777
Q ss_pred cCcccccCCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccch
Q 001873 495 SENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIP 574 (1001)
Q Consensus 495 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 574 (1001)
++|++++..+ +..+++|+.|++++|++++..+..-...++.+++++|++++. ..+..+++++.|++++|++++..
T Consensus 249 ~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~- 323 (384)
T d2omza2 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS- 323 (384)
T ss_dssp CSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG-
T ss_pred ccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc-
Confidence 7777775432 666677777777777776443322223334445555555431 22444555555555555555332
Q ss_pred hhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCC
Q 001873 575 AEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHN 640 (1001)
Q Consensus 575 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 640 (1001)
.+..+++|++|++++|+|++ ++ .+.++++|+. |++++|+|++.+| +.++++|+.|+|++|
T Consensus 324 -~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~-L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 324 -PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINW-LSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp -GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCE-EECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred -ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCE-EECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 24445555555555555542 22 3444444443 4444444443332 344444444444443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.3e-28 Score=278.17 Aligned_cols=355 Identities=25% Similarity=0.335 Sum_probs=170.2
Q ss_pred ccCCcccCCCCcccCCccccccccccCCccCCCCChhhhcccccceEEccCCcccCCCCccccCCccccceecccccccc
Q 001873 109 ISSCNLTGTIPKEFGDYRELTFIDLSGNSLWGEIPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDNQLSG 188 (1001)
Q Consensus 109 l~~~~l~g~~p~~~~~l~~L~~L~Ls~n~l~g~~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n~l~g 188 (1001)
++.+++++.++. ..+.+|++|++++++++ .+ +.+..|++|++|+|++|++++ +| .+++|++|++|++++|.+++
T Consensus 29 l~~~~~~~~~~~--~~l~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~ 102 (384)
T d2omza2 29 LGKTNVTDTVSQ--TDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIAD 102 (384)
T ss_dssp TTCSSTTSEECH--HHHTTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC
T ss_pred hCCCCCCCccCH--HHhCCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCCC-Cc-cccCCccccccccccccccc
Confidence 444444443332 34555666666666655 23 245566666666666666653 33 26666666666666666653
Q ss_pred ccCCCccchhhhhhhhhccCcCCCCCCCcccccCccchhccccccccccccCCccccccccceeccccccccccCccccc
Q 001873 189 KIPKSIGALSKLQVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETSISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIG 268 (1001)
Q Consensus 189 ~~p~~~~~l~~L~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~ 268 (1001)
++ .++++++|+.|++++| ..++.. .......+..+....+.+....+.............. .......+.
T Consensus 103 -i~-~l~~l~~L~~L~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 172 (384)
T d2omza2 103 -IT-PLANLTNLTGLTLFNN-QITDID--PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGN-----QVTDLKPLA 172 (384)
T ss_dssp -CG-GGTTCTTCCEEECCSS-CCCCCG--GGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEE-----SCCCCGGGT
T ss_pred -cc-cccccccccccccccc-cccccc--ccccccccccccccccccccccccccccccccccccc-----ccchhhhhc
Confidence 22 2555555655555555 222111 1122223333333333332211111111111110000 001112233
Q ss_pred CCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEE
Q 001873 269 NCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQEL 348 (1001)
Q Consensus 269 ~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 348 (1001)
..+.........|... ....+..+++++.+++++|.+++..| +...++|+.|++++|.++. + +.+..+++|+.|
T Consensus 173 ~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L 246 (384)
T d2omza2 173 NLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDL 246 (384)
T ss_dssp TCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEE
T ss_pred cccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchh
Confidence 3333333333333332 23334445555555555555553322 2334455555555555542 1 234445555555
Q ss_pred EcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCcccc
Q 001873 349 QLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLS 428 (1001)
Q Consensus 349 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 428 (1001)
++++|++++..+ +..+++|++|++++|++ ++.. .+..++.++.++++.|.++
T Consensus 247 ~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l------------------------~~~~--~~~~~~~l~~l~~~~n~l~ 298 (384)
T d2omza2 247 DLANNQISNLAP--LSGLTKLTELKLGANQI------------------------SNIS--PLAGLTALTNLELNENQLE 298 (384)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEECCSSCC------------------------CCCG--GGTTCTTCSEEECCSSCCS
T ss_pred ccccCccCCCCc--ccccccCCEeeccCccc------------------------CCCC--ccccccccccccccccccc
Confidence 555555543221 44444555555554444 4322 2444555566666666655
Q ss_pred CCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCccccc
Q 001873 429 GPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVV 508 (1001)
Q Consensus 429 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 508 (1001)
+ ...+..+++++.|++++|++++.. .+..+++|++|++++|+|++ ++ .+.++++|++|++++|+|++..| +.
T Consensus 299 ~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~ 370 (384)
T d2omza2 299 D--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LA 370 (384)
T ss_dssp C--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GT
T ss_pred c--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hc
Confidence 3 223555666666666666666542 25566666666666666663 33 46666677777777777665443 66
Q ss_pred ccccCceEEcccc
Q 001873 509 GCQSLEFLDLHSN 521 (1001)
Q Consensus 509 ~l~~L~~L~Ls~N 521 (1001)
++++|+.|++++|
T Consensus 371 ~l~~L~~L~L~~N 383 (384)
T d2omza2 371 NLTRITQLGLNDQ 383 (384)
T ss_dssp TCTTCSEEECCCE
T ss_pred cCCCCCEeeCCCC
Confidence 6677777777666
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.7e-25 Score=244.01 Aligned_cols=245 Identities=20% Similarity=0.324 Sum_probs=132.1
Q ss_pred ccceeccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEecc
Q 001873 248 RIQTIAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFS 327 (1001)
Q Consensus 248 ~L~~L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 327 (1001)
..++++.++..++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|+.|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 3455555555555 4555543 456666666666665545566666666666666666665556666666666666666
Q ss_pred CCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCC
Q 001873 328 DNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNI 407 (1001)
Q Consensus 328 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 407 (1001)
+|+++ .+|..+ ...++.|+++.|.+.+..+..+.....+..++...|.... ....
T Consensus 88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~----------------------~~~~ 142 (305)
T d1xkua_ 88 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS----------------------SGIE 142 (305)
T ss_dssp SSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG----------------------GGBC
T ss_pred CCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccc----------------------cCCC
Confidence 66666 334322 2355666666666655444445555555555555554321 1122
Q ss_pred CcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCC
Q 001873 408 PESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLK 487 (1001)
Q Consensus 408 p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 487 (1001)
+..+..+++|+.+++++|.++. +|..+ .++|++|++++|..++..+..|..++.++.|++++|.+++..+..+.+++
T Consensus 143 ~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~ 219 (305)
T d1xkua_ 143 NGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 219 (305)
T ss_dssp TTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGST
T ss_pred ccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccc
Confidence 2334444555555555555542 22221 34455555555555555555555555555555555555555555555555
Q ss_pred CcceeeccCcccccCCcccccccccCceEEcccccCc
Q 001873 488 HLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLT 524 (1001)
Q Consensus 488 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 524 (1001)
+|++|+|++|+|+ .+|.++.++++|++|+|++|+|+
T Consensus 220 ~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 220 HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp TCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred cceeeeccccccc-ccccccccccCCCEEECCCCccC
Confidence 5555555555555 33455555555555555555555
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=3.1e-25 Score=241.91 Aligned_cols=266 Identities=23% Similarity=0.337 Sum_probs=187.4
Q ss_pred cCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccC
Q 001873 369 LTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLS 448 (1001)
Q Consensus 369 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 448 (1001)
++.++-++++++ .+|..+. +++++|++++|+++...+..|.++++|++|++++|.+....|..|.++++|++|++++
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 344444444444 3333332 3455555555555544444566677777777777777766666677777777777777
Q ss_pred CcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccc--cCCcccccccccCceEEcccccCccc
Q 001873 449 NDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLV--GGIPPSVVGCQSLEFLDLHSNGLTGS 526 (1001)
Q Consensus 449 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~ 526 (1001)
|+++.. |.. ....++.|++++|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|.++ .
T Consensus 89 n~l~~l-~~~--~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~ 164 (305)
T d1xkua_ 89 NQLKEL-PEK--MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-T 164 (305)
T ss_dssp SCCSBC-CSS--CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-S
T ss_pred CccCcC-ccc--hhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-c
Confidence 777643 332 2346778888888888766666777778888888877544 334566778888999999999887 5
Q ss_pred CCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccc
Q 001873 527 VPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISS 606 (1001)
Q Consensus 527 ~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 606 (1001)
+|..+.+.++.|++++|.+++..+..|..++.++.|++++|++++..+..+..+++|++|+|++|+|+ .+|..+..+++
T Consensus 165 l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~ 243 (305)
T d1xkua_ 165 IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 243 (305)
T ss_dssp CCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSS
T ss_pred cCcccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccC
Confidence 66667777888888888888877888888888888888888888777888888888888888888887 56778888888
Q ss_pred hhhhhhcCCCccccccccccc------ccccccEEEecCCcCC
Q 001873 607 LEISLNLSSNQFSGEIPSEFS------GLTKLGILDLSHNKLS 643 (1001)
Q Consensus 607 L~~~L~Ls~N~l~~~~p~~~~------~l~~L~~L~Ls~N~l~ 643 (1001)
|+. |+|++|+|+.+....|. .+.+|+.|+|++|+++
T Consensus 244 L~~-L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 244 IQV-VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CCE-EECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred CCE-EECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 886 88888888765444443 4556666666666665
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.1e-25 Score=242.75 Aligned_cols=230 Identities=24% Similarity=0.265 Sum_probs=159.0
Q ss_pred cceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeecc-CcccccCCcccccccccCceEEcc
Q 001873 441 LTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMS-ENHLVGGIPPSVVGCQSLEFLDLH 519 (1001)
Q Consensus 441 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p~~~~~l~~L~~L~Ls 519 (1001)
+++|+|++|+|+++.+.+|.++++|++|++++|++.+..+..+.++..++.++.. .|.++...+..|.++++|++|+++
T Consensus 34 ~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~ 113 (284)
T d1ozna_ 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113 (284)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECT
T ss_pred CCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecC
Confidence 3444444444444333444444444444444444444444444444444444332 333443344444445555555555
Q ss_pred cccCcccCCCCc--ccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccccCCC
Q 001873 520 SNGLTGSVPDTL--PTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEI 597 (1001)
Q Consensus 520 ~N~l~~~~p~~~--~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 597 (1001)
+|.+....+..+ ...++.+++++|+|+++.+..|..+++|+.|++++|++++..+..|..+++|+++++++|++++..
T Consensus 114 ~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~ 193 (284)
T d1ozna_ 114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193 (284)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccC
Confidence 554443222222 133444555555555555667888889999999999999888889999999999999999999989
Q ss_pred CCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCChhhhhcccccceeEcccCCCCCCCCC
Q 001873 598 PKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPN 671 (1001)
Q Consensus 598 p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p~ 671 (1001)
|..|..+++|+. |++++|++++..|..|..+++|+.|+|++|++.|+++..+...+++.+....+++.+..|.
T Consensus 194 ~~~f~~l~~L~~-L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p~ 266 (284)
T d1ozna_ 194 PHAFRDLGRLMT-LYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ 266 (284)
T ss_dssp TTTTTTCTTCCE-EECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESG
T ss_pred hhHhhhhhhccc-ccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCCch
Confidence 999999999996 9999999999999999999999999999999999998777778899999999988876664
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=5.8e-25 Score=236.94 Aligned_cols=222 Identities=22% Similarity=0.288 Sum_probs=128.5
Q ss_pred EeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcc-ccc
Q 001873 276 LYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLS-VNQ 354 (1001)
Q Consensus 276 L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls-~N~ 354 (1001)
++.++++++ .+|..+. +.+++|+|++|+|+...+.+|.++++|++|++++|.+.+..+..+..+..++.+... .|.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 344444554 3444332 345666666666665444556666666666666666665555555666666665543 445
Q ss_pred ccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcc
Q 001873 355 LSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKE 434 (1001)
Q Consensus 355 l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~ 434 (1001)
++...+..|.++++|++|++++|.+....+..+....+|+.+++++|++++..+..|..+++|+.|++++|++++..+..
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~ 172 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred cccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhh
Confidence 55555556666666666666666665444445555555555555555555444555555666666666666666555555
Q ss_pred cccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccc
Q 001873 435 IFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLV 500 (1001)
Q Consensus 435 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 500 (1001)
|.++++|+++++++|++++..|..|..+++|++|++++|++.+..+..|+++++|++|++++|++.
T Consensus 173 f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred hccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 555666666666666665555555666666666666666666555555555666666666666555
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1e-22 Score=216.73 Aligned_cols=207 Identities=24% Similarity=0.249 Sum_probs=180.7
Q ss_pred ccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccCce
Q 001873 436 FGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEF 515 (1001)
Q Consensus 436 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 515 (1001)
.....+.+++.++++++. +|..+. +++++|+|++|+|++..+..|.++++|++|+|++|+|+. +| .++.+++|++
T Consensus 7 ~~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccc
Confidence 355667788999999995 576654 579999999999998777899999999999999999984 34 4678999999
Q ss_pred EEcccccCcccCCCCcc--cccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEecccccc
Q 001873 516 LDLHSNGLTGSVPDTLP--TSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRF 593 (1001)
Q Consensus 516 L~Ls~N~l~~~~p~~~~--~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 593 (1001)
|++++|++++. +..+. +.++.|++++|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+|
T Consensus 82 L~Ls~N~l~~~-~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 82 LDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp EECCSSCCSSC-CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred ccccccccccc-ccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 99999999854 43332 5688899999999988888999999999999999999988888888999999999999999
Q ss_pred cCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCChhhhh
Q 001873 594 SGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALA 650 (1001)
Q Consensus 594 ~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 650 (1001)
++..+..+..+++|+. |+|++|+|+ .+|+.+..+++|+.|+|++|+|.|++...+
T Consensus 161 ~~~~~~~~~~l~~L~~-L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~~~ 215 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDT-LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEILY 215 (266)
T ss_dssp SCCCTTTTTTCTTCCE-EECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGGHH
T ss_pred cccCccccccccccce-eecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcchHH
Confidence 9888888999999996 999999999 678888899999999999999999886543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=3.9e-22 Score=212.13 Aligned_cols=176 Identities=25% Similarity=0.252 Sum_probs=75.8
Q ss_pred CCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEee
Q 001873 320 ELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAW 399 (1001)
Q Consensus 320 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~ 399 (1001)
++++|+|++|+|++..+..|.++++|++|+|++|+|+. +| .+..+++|++|+|++|++++ .+..+..+++|+.|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECC
T ss_pred CCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccccccccccccc-ccccccccccccccccc
Confidence 34444444444443333444444444444444444442 22 12344444444444444442 22233333333333333
Q ss_pred cCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCC
Q 001873 400 KNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTI 479 (1001)
Q Consensus 400 ~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 479 (1001)
+|.+.+..+..+..+.++++|++++|.++...+..+..+++|+.+++++|++++..+..|..+++|++|+|++|+|+ .+
T Consensus 109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~l 187 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI 187 (266)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred ccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-cc
Confidence 33333333334444444444444444444333333444444444444444444444444444444444444444444 34
Q ss_pred CcccCCCCCcceeeccCccc
Q 001873 480 PSEMGNLKHLNFVDMSENHL 499 (1001)
Q Consensus 480 p~~~~~l~~L~~L~Ls~N~l 499 (1001)
|..+..+++|+.|+|++|++
T Consensus 188 p~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 188 PKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp CTTTTTTCCCSEEECCSCCB
T ss_pred ChhHCCCCCCCEEEecCCCC
Confidence 44444444444444444443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=2.9e-22 Score=201.61 Aligned_cols=161 Identities=17% Similarity=0.216 Sum_probs=118.6
Q ss_pred cCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCCc--------------------hhhHHHHHHHhhccCCCceeeEEee
Q 001873 769 TSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSDE--------------------SGAFSSEIQTLGSIRHKNIVRLLGW 828 (1001)
Q Consensus 769 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------------~~~~~~Ei~~l~~l~h~nIv~l~~~ 828 (1001)
.+.++||+|+||+||+|+..+|++||||+++.... .....+|+..+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45678999999999999988999999997642110 0234568888999999999988876
Q ss_pred eecCCceEEEEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEEeCCCCCCeEECCCCcEEEec
Q 001873 829 GSNKNLKLLFYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDCMPPILHGDVKAMNVLLGPGYQAYLAD 908 (1001)
Q Consensus 829 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ki~D 908 (1001)
.. .+++|||++++.+.+ ++.....+++.|++.|++|||+. +|+||||||+|||++++ .++++|
T Consensus 83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 32 379999998765543 23334567899999999999998 99999999999999965 589999
Q ss_pred ccccccccCCCCCCCCCCCCCCcccccccccCcc--c---cccCCCCCccchHHHHHH
Q 001873 909 FGLARIVSGSGDDNCSKTNQRPQLAGSYGYMAPE--H---ASMQRITEKSDVYSFGVV 961 (1001)
Q Consensus 909 fgla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE--~---~~~~~~~~~~Dv~SlG~i 961 (1001)
||.|.....+. ...|.... . +-.+.|+.++|+||..--
T Consensus 146 FG~a~~~~~~~---------------~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 146 FPQSVEVGEEG---------------WREILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CTTCEETTSTT---------------HHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred CCCcccCCCCC---------------cHHHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 99997643211 11122111 0 113678899999997543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=5.8e-19 Score=195.52 Aligned_cols=280 Identities=26% Similarity=0.302 Sum_probs=144.7
Q ss_pred CCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEc
Q 001873 271 SELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQL 350 (1001)
Q Consensus 271 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 350 (1001)
.++++|+|++|.++ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 35677777777776 45543 356777777777777 556543 46777777777776 33321 134777777
Q ss_pred ccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCC
Q 001873 351 SVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGP 430 (1001)
Q Consensus 351 s~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 430 (1001)
++|++. .+|. +..+++|++|++++|.+... +.. ...+..+.+.++... .+..+..++.++.+++++|.+...
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~ 177 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL 177 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSC
T ss_pred cccccc-cccc-hhhhccceeecccccccccc-ccc---cccccchhhcccccc--ccccccccccceeccccccccccc
Confidence 777776 3443 46677777777777776532 222 234445555444433 233455666677777777666532
Q ss_pred CCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCccccccc
Q 001873 431 IPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGC 510 (1001)
Q Consensus 431 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 510 (1001)
+.. ....+.+...++.+.. + ..+..++.|+.+++++|... .++.. ..++..+.+.+|++... +. ..
T Consensus 178 -~~~---~~~~~~l~~~~~~~~~-~-~~~~~l~~L~~l~l~~n~~~-~~~~~---~~~l~~~~~~~~~~~~~-~~---~~ 243 (353)
T d1jl5a_ 178 -PDL---PLSLESIVAGNNILEE-L-PELQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRDNYLTDL-PE---LP 243 (353)
T ss_dssp -CCC---CTTCCEEECCSSCCSS-C-CCCTTCTTCCEEECCSSCCS-SCCSC---CTTCCEEECCSSCCSCC-CC---CC
T ss_pred -ccc---cccccccccccccccc-c-cccccccccccccccccccc-ccccc---ccccccccccccccccc-cc---cc
Confidence 211 1223444555544442 2 23455666666666666655 23322 33455556666655421 21 12
Q ss_pred ccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccchhhhhccccccEEeccc
Q 001873 511 QSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGN 590 (1001)
Q Consensus 511 ~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 590 (1001)
..+...++..|.+.+.. .++......++..|.+.+. ...+++|++|+|++|+|+ .+|+. +++|+.|+|++
T Consensus 244 ~~l~~~~~~~~~~~~l~--~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~ 313 (353)
T d1jl5a_ 244 QSLTFLDVSENIFSGLS--ELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASF 313 (353)
T ss_dssp TTCCEEECCSSCCSEES--CCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCS
T ss_pred ccccccccccccccccc--cccchhcccccccCccccc----cccCCCCCEEECCCCccC-ccccc---cCCCCEEECCC
Confidence 34455555555444211 1112222334444444321 112344555555555554 23321 33444455555
Q ss_pred cccc
Q 001873 591 NRFS 594 (1001)
Q Consensus 591 N~l~ 594 (1001)
|+|+
T Consensus 314 N~L~ 317 (353)
T d1jl5a_ 314 NHLA 317 (353)
T ss_dssp SCCS
T ss_pred CcCC
Confidence 5444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=7.7e-19 Score=194.49 Aligned_cols=302 Identities=27% Similarity=0.273 Sum_probs=198.4
Q ss_pred CCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEec
Q 001873 295 SKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEI 374 (1001)
Q Consensus 295 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 374 (1001)
.++++|+|++|.++ .+|+. .++|++|+|++|+|+ .+|..+ .+|+.|++++|+++. ++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhh---ccccccccc
Confidence 36889999999998 57864 468999999999999 677654 578999999999873 3321 246999999
Q ss_pred cCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCC
Q 001873 375 DNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGF 454 (1001)
Q Consensus 375 ~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 454 (1001)
++|.+. .+|. ++.+++|+.+++++|.++... .. ...+..+.+..+... ....+..++.++.+.+++|.....
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~-~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~ 177 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLP-DL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL 177 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCC-CC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSC
T ss_pred cccccc-cccc-hhhhccceeeccccccccccc-cc---cccccchhhcccccc--ccccccccccceeccccccccccc
Confidence 999997 4553 578889999999988887433 22 345667777766654 345567788888888888887743
Q ss_pred CCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCcccCCCCcccc
Q 001873 455 IPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTS 534 (1001)
Q Consensus 455 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 534 (1001)
.. . ....+.+..+++.+. .++ .+..++.|+.+++++|.... .+. ...++..+++..|++... + .....
T Consensus 178 ~~-~---~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~-~-~~~~~ 245 (353)
T d1jl5a_ 178 PD-L---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDL-P-ELPQS 245 (353)
T ss_dssp CC-C---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCC-C-CCCTT
T ss_pred cc-c---ccccccccccccccc-ccc-cccccccccccccccccccc-ccc---cccccccccccccccccc-c-ccccc
Confidence 22 1 233566677766665 333 35678888888888887763 333 245677788888877632 2 22334
Q ss_pred cccccCCCCcCCCCcccccccc-cccceeeccCccccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhc
Q 001873 535 LQLVDLSDNRLSGSLAHSIGSL-TELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNL 613 (1001)
Q Consensus 535 l~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~L 613 (1001)
+...++..|.+.+. ..+ ......++..|.+.+. ...+++|++|+|++|+|+ .+|.. +++|+. |+|
T Consensus 246 l~~~~~~~~~~~~l-----~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~-L~L 311 (353)
T d1jl5a_ 246 LTFLDVSENIFSGL-----SELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPAL---PPRLER-LIA 311 (353)
T ss_dssp CCEEECCSSCCSEE-----SCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCCC---CTTCCE-EEC
T ss_pred cccccccccccccc-----ccccchhcccccccCccccc----cccCCCCCEEECCCCccC-ccccc---cCCCCE-EEC
Confidence 44555555555431 111 2445566666666532 223567778888888776 55544 344553 666
Q ss_pred CCCcccccccccccccccccEEEecCCcCCCCh
Q 001873 614 SSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDL 646 (1001)
Q Consensus 614 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 646 (1001)
++|+|+ .+|+. +++|++|+|++|+++..+
T Consensus 312 ~~N~L~-~l~~~---~~~L~~L~L~~N~L~~lp 340 (353)
T d1jl5a_ 312 SFNHLA-EVPEL---PQNLKQLHVEYNPLREFP 340 (353)
T ss_dssp CSSCCS-CCCCC---CTTCCEEECCSSCCSSCC
T ss_pred CCCcCC-ccccc---cCCCCEEECcCCcCCCCC
Confidence 777776 34432 345666666666666544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.79 E-value=7.2e-20 Score=183.96 Aligned_cols=175 Identities=25% Similarity=0.292 Sum_probs=155.5
Q ss_pred CceEEcccccCcccCCCCcccccccccCCCCcCCC-CcccccccccccceeeccCccccccchhhhhccccccEEecccc
Q 001873 513 LEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSG-SLAHSIGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNN 591 (1001)
Q Consensus 513 L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 591 (1001)
.+.++.++|+|+ .+|..++..++.|+|++|+|++ ..+..|.++++|+.|+|++|+++...+..+..+++|++|+|++|
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CCEEEEeCCCcC-ccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 467899999998 7888888889999999999986 44677899999999999999999999999999999999999999
Q ss_pred cccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEecCCcCCCChhhhhcccccceeEcccCCCCCCCCC
Q 001873 592 RFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLSHNKLSGDLDALASLQNLVSLNVSFNDFSGELPN 671 (1001)
Q Consensus 592 ~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p~ 671 (1001)
+|+...|..|.++++|+. |+|++|+|+++.|+.|..+++|++|+|++|++.++++..+...+++.+.+..|.+++..|.
T Consensus 89 ~l~~l~~~~F~~l~~L~~-L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKT-LNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCEECSSSSTTCTTCCE-EECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred cccccCHHHHhCCCcccc-cccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCCh
Confidence 999888899999999997 9999999999999999999999999999999999988777677889999999999877664
Q ss_pred CccccCCCCCCCCCCCcccc
Q 001873 672 TPFFRKLPLSDLASNRGLYI 691 (1001)
Q Consensus 672 ~~~~~~~~~~~~~~n~~lc~ 691 (1001)
.+++....++..|.-.|.
T Consensus 168 --~l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 168 --KVRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp --TTTTSBGGGSCTTTCCCC
T ss_pred --hhcCCEeeecCHhhCcCC
Confidence 356677778888876674
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=7.6e-19 Score=181.71 Aligned_cols=208 Identities=24% Similarity=0.346 Sum_probs=129.2
Q ss_pred CcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceee
Q 001873 414 CQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVD 493 (1001)
Q Consensus 414 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 493 (1001)
+.++..++++.+++++.. .+..+.+|++|++.+|+++.. ..+..+++|++|++++|++++..| +..+++|++++
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~ 91 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence 334455677777776543 456778888888888888754 357788888888888888875433 78888888888
Q ss_pred ccCcccccCCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccc
Q 001873 494 MSENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRI 573 (1001)
Q Consensus 494 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 573 (1001)
+++|.++. + +.+.++++|+.+++++|...+..+......+..+.++++.+.... .+...++|+.|++++|++++..
T Consensus 92 ~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~ 167 (227)
T d1h6ua2 92 LSGNPLKN-V-SAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT 167 (227)
T ss_dssp CCSCCCSC-C-GGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG
T ss_pred cccccccc-c-ccccccccccccccccccccccchhccccchhhhhchhhhhchhh--hhccccccccccccccccccch
Confidence 88888874 3 357788888888888888775444333445555666666665322 2455666666666666665332
Q ss_pred hhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCCcccccccccccccccccEEEec
Q 001873 574 PAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSNQFSGEIPSEFSGLTKLGILDLS 638 (1001)
Q Consensus 574 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 638 (1001)
.+..+++|+.|||++|++++ +| .+.++++|+. |+|++|++++..| +.++++|+.|+++
T Consensus 168 --~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~-L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 168 --PLANLSKLTTLKADDNKISD-IS-PLASLPNLIE-VHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp --GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCE-EECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred --hhcccccceecccCCCccCC-Ch-hhcCCCCCCE-EECcCCcCCCCcc--cccCCCCCEEEee
Confidence 25566666666666666653 22 2444444443 4444444443322 4444444444443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=3.5e-18 Score=178.59 Aligned_cols=218 Identities=18% Similarity=0.147 Sum_probs=123.5
Q ss_pred ceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCC-CcccccccCccEEEccc
Q 001873 274 QNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSI-PRSFGNLLKLQELQLSV 352 (1001)
Q Consensus 274 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~ 352 (1001)
+.++.+++.++ .+|+.+. +++++|+|++|+++...+..|.++++|++|++++|.+...+ +..|.++++++++.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 45566666655 4444332 35666666666666444445666666666666666665433 33566666666666543
Q ss_pred -ccccCcCChhhccccccCEEeccCCcccCccC-ccccccCcccEEEeecCccCCCCCcccccCc-ccceEeCcCccccC
Q 001873 353 -NQLSGTIPIEIATCTALTHLEIDNNAISGEIP-ADIGNINGLTLFFAWKNKLTGNIPESLSQCQ-ELQALDFSYNNLSG 429 (1001)
Q Consensus 353 -N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~ 429 (1001)
|++....+..|.++++|+++++++|++....+ ..+..+..+..+...++.+....+..|..++ .++.|++++|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 45555555666666666666666666653222 1233445555555555555544445555543 56667777777764
Q ss_pred CCCcccccccccceE-EccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeecc
Q 001873 430 PIPKEIFGLRNLTKL-LLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMS 495 (1001)
Q Consensus 430 ~~~~~~~~l~~L~~L-~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 495 (1001)
..+. .....+++.+ .+++|+++.+.+..|.++++|++|+|++|+|+...+..|.++++|+++++.
T Consensus 168 i~~~-~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 168 IHNC-AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp ECTT-TTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred cccc-cccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 3333 3333443333 456666665545556666667777776666664444556666666655553
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=1.7e-21 Score=224.39 Aligned_cols=376 Identities=19% Similarity=0.150 Sum_probs=169.1
Q ss_pred ccceecccccccccc-CcccccCCCCCceEeeecCcccC----CCCcccCCCCCCcEEEcCCCccccc----CCCCcc-C
Q 001873 248 RIQTIAIYTSLLSGP-IPEEIGNCSELQNLYLYQNSISG----PIPGRIGALSKLKSLLLWQNSLVGA----IPDELG-S 317 (1001)
Q Consensus 248 ~L~~L~l~~n~l~g~-ip~~l~~l~~L~~L~L~~N~i~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~l~-~ 317 (1001)
+|++|+++.+++++. +.+-+..++++++|+|++|.++. .+...+..+++|++|+|++|+++.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 456666666666542 13334455666666666666552 1233344555666666666655421 112222 1
Q ss_pred CCCCCEEeccCCCCCCC----CCcccccccCccEEEcccccccCcCChhhc-----cccccCEEeccCCcccCccCcccc
Q 001873 318 CTELTVVDFSDNLLTGS----IPRSFGNLLKLQELQLSVNQLSGTIPIEIA-----TCTALTHLEIDNNAISGEIPADIG 388 (1001)
Q Consensus 318 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~i~~~~~~~~~ 388 (1001)
..+|++|+|++|.++.. ++..+..+++|++|+|++|+++......+. ..............+......
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~--- 159 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE--- 159 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH---
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhc---
Confidence 23455556655555432 223344455555555555555421111111 011111222222111100000
Q ss_pred ccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCC----cccc-cccccceEEccCCcCCCCC----CCCC
Q 001873 389 NINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIP----KEIF-GLRNLTKLLLLSNDLSGFI----PPDI 459 (1001)
Q Consensus 389 ~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~----~~~~-~l~~L~~L~L~~N~l~~~~----p~~l 459 (1001)
.....+.....++.++++++.+..... ..+. .-.....+.+..+.+.... ...+
T Consensus 160 -----------------~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l 222 (460)
T d1z7xw1 160 -----------------PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 222 (460)
T ss_dssp -----------------HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHH
T ss_pred -----------------ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccc
Confidence 000112334455566666555431100 0011 1123445555555443210 0112
Q ss_pred CCCCCcceEEcccccccc-----CCCcccCCCCCcceeeccCcccccC----CcccccccccCceEEcccccCcccCCCC
Q 001873 460 GNCTTLRRLRLNDNRLSG-----TIPSEMGNLKHLNFVDMSENHLVGG----IPPSVVGCQSLEFLDLHSNGLTGSVPDT 530 (1001)
Q Consensus 460 ~~l~~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 530 (1001)
...+.++.+++++|++.. ..+........++.+++++|.+... ....+...+.++.+++++|.++......
T Consensus 223 ~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~ 302 (460)
T d1z7xw1 223 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 302 (460)
T ss_dssp HHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH
T ss_pred cccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccch
Confidence 234556666666666531 1223344456677777777766532 1223344566777777777665211111
Q ss_pred -------cccccccccCCCCcCCCCccccc----ccccccceeeccCcccccc----chhhhh-ccccccEEeccccccc
Q 001873 531 -------LPTSLQLVDLSDNRLSGSLAHSI----GSLTELSKLLLSKNQLSGR----IPAEIL-SCRKLILLDIGNNRFS 594 (1001)
Q Consensus 531 -------~~~~l~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~ 594 (1001)
....++.+++++|.++......+ ...++|++|+|++|+|++. +++.+. ..+.|++|+|++|+|+
T Consensus 303 l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~ 382 (460)
T d1z7xw1 303 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 382 (460)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred hhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCC
Confidence 11234556666666554332222 2334666777777766542 222222 2445666666666665
Q ss_pred CC----CCCccccccchhhhhhcCCCccccccccccc-----ccccccEEEecCCcCCC
Q 001873 595 GE----IPKELGQISSLEISLNLSSNQFSGEIPSEFS-----GLTKLGILDLSHNKLSG 644 (1001)
Q Consensus 595 ~~----~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~ 644 (1001)
+. ++..+...++|+. |||++|+|+......+. +...|+.|++++|.+..
T Consensus 383 ~~~~~~l~~~l~~~~~L~~-L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 383 DSSCSSLAATLLANHSLRE-LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp HHHHHHHHHHHHHCCCCCE-EECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred hHHHHHHHHHHhcCCCCCE-EECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 32 2233334455553 55555555543222221 22346666666666554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=3.5e-18 Score=176.60 Aligned_cols=202 Identities=22% Similarity=0.309 Sum_probs=114.4
Q ss_pred eccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCC
Q 001873 252 IAIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLL 331 (1001)
Q Consensus 252 L~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 331 (1001)
+++..+.+++.+ .+..+++|++|++.+|.|+.. + .+..+++|++|++++|++++..| +..+++|+++++++|.+
T Consensus 24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~ 97 (227)
T d1h6ua2 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97 (227)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc-h-hHhcCCCCcEeecCCceeecccc--ccccccccccccccccc
Confidence 334444444322 345566677777777776643 2 46667777777777776664332 56666666666666666
Q ss_pred CCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCccc
Q 001873 332 TGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESL 411 (1001)
Q Consensus 332 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l 411 (1001)
+ .++ .+.++++|+.+++++|+..+. ..+...+.++.+.++++.+... ..+
T Consensus 98 ~-~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--------------------------~~~ 147 (227)
T d1h6ua2 98 K-NVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--------------------------SPL 147 (227)
T ss_dssp S-CCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--------------------------GGG
T ss_pred c-ccc-ccccccccccccccccccccc--chhccccchhhhhchhhhhchh--------------------------hhh
Confidence 5 232 355666666666666655432 2244445555555555554321 123
Q ss_pred ccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcce
Q 001873 412 SQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNF 491 (1001)
Q Consensus 412 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 491 (1001)
..+++|+.|++++|.+++. ..+.++++|++|+|++|++++. + .++.+++|++|+|++|++++. + .+.++++|++
T Consensus 148 ~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~ 221 (227)
T d1h6ua2 148 AGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFI 221 (227)
T ss_dssp GGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCE
T ss_pred ccccccccccccccccccc--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCC-c-ccccCCCCCE
Confidence 4455555666666655432 2255566666666666666543 2 256666677777777776643 2 2667777777
Q ss_pred eecc
Q 001873 492 VDMS 495 (1001)
Q Consensus 492 L~Ls 495 (1001)
|+++
T Consensus 222 L~ls 225 (227)
T d1h6ua2 222 VTLT 225 (227)
T ss_dssp EEEE
T ss_pred EEee
Confidence 7765
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=8.1e-18 Score=175.79 Aligned_cols=219 Identities=13% Similarity=0.089 Sum_probs=140.1
Q ss_pred cEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcC-ChhhccccccCEEeccC
Q 001873 298 KSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTI-PIEIATCTALTHLEIDN 376 (1001)
Q Consensus 298 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~ 376 (1001)
+.++.+++.++ .+|..+. +++++|||++|+|+...+..|.++++|++|++++|.+...+ +..|..+++++++.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 56777777777 6666553 46888888888887555557888888888888888876544 34677788888887653
Q ss_pred -CcccCccCccccccCcccEEEeecCccCCCCCc-ccccCcccceEeCcCccccCCCCccccccc-ccceEEccCCcCCC
Q 001873 377 -NAISGEIPADIGNINGLTLFFAWKNKLTGNIPE-SLSQCQELQALDFSYNNLSGPIPKEIFGLR-NLTKLLLLSNDLSG 453 (1001)
Q Consensus 377 -N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~ 453 (1001)
|++....+..+.++++|+.+++++|+++...+. .+..++.+..+..+++.+....+..|.+++ .++.|++++|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 567666667777777788887777777643332 234455555556666666655555555543 56667777777765
Q ss_pred CCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccCceEEcc
Q 001873 454 FIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLH 519 (1001)
Q Consensus 454 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 519 (1001)
..+..+.....++.+++++|+++...+..|.++++|++|++++|+|+...+..|.++++|+.+++.
T Consensus 168 i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 168 IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 444443332223333456666664444456667777777777777765444556666666555543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=2.3e-20 Score=214.93 Aligned_cols=382 Identities=19% Similarity=0.172 Sum_probs=209.8
Q ss_pred cchhcccccccccccc-CCccccccccceeccccccccc----cCcccccCCCCCceEeeecCcccCC----CCcccC-C
Q 001873 224 NLVMLGLAETSISGNV-PSSIGMLERIQTIAIYTSLLSG----PIPEEIGNCSELQNLYLYQNSISGP----IPGRIG-A 293 (1001)
Q Consensus 224 ~L~~L~l~~~~l~~~~-p~~i~~l~~L~~L~l~~n~l~g----~ip~~l~~l~~L~~L~L~~N~i~~~----~p~~~~-~ 293 (1001)
+|+.|+++.+++++.. .+-++.++++++|++.+|.++. .++..+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6899999999998743 4556788999999999999873 4566778999999999999998632 222332 2
Q ss_pred CCCCcEEEcCCCccccc----CCCCccCCCCCCEEeccCCCCCCCCCcccc-----cccCccEEEcccccccCcC----C
Q 001873 294 LSKLKSLLLWQNSLVGA----IPDELGSCTELTVVDFSDNLLTGSIPRSFG-----NLLKLQELQLSVNQLSGTI----P 360 (1001)
Q Consensus 294 l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~----p 360 (1001)
..+|++|+|++|+++.. ++..+..+++|++|++++|.++......+. ..............+.... .
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 35899999999999753 455678899999999999998743222221 1223444555444433111 1
Q ss_pred hhhccccccCEEeccCCcccCccCcc----c-cccCcccEEEeecCccCCCC----CcccccCcccceEeCcCccccCC-
Q 001873 361 IEIATCTALTHLEIDNNAISGEIPAD----I-GNINGLTLFFAWKNKLTGNI----PESLSQCQELQALDFSYNNLSGP- 430 (1001)
Q Consensus 361 ~~~~~l~~L~~L~L~~N~i~~~~~~~----~-~~l~~L~~L~l~~n~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~~- 430 (1001)
..+.....++.++++++.+....... + ..-.....+.+..+.+.... ...+.....++.+++++|.+...
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 22445678889999888764321111 1 11123445566555543221 11234456667777777665321
Q ss_pred ----CCcccccccccceEEccCCcCCCCC----CCCCCCCCCcceEEccccccccCCCccc-----CCCCCcceeeccCc
Q 001873 431 ----IPKEIFGLRNLTKLLLLSNDLSGFI----PPDIGNCTTLRRLRLNDNRLSGTIPSEM-----GNLKHLNFVDMSEN 497 (1001)
Q Consensus 431 ----~~~~~~~l~~L~~L~L~~N~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N 497 (1001)
.+........++.+++++|.+.... ...+...+.++.+++++|.++......+ .....|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 1122223445666666666554221 1122334556666666665542211111 12235555666665
Q ss_pred ccccCCccc----ccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccc-cccccceeeccCcccccc
Q 001873 498 HLVGGIPPS----VVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIG-SLTELSKLLLSKNQLSGR 572 (1001)
Q Consensus 498 ~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~ 572 (1001)
.++...... +...++|++|||++|+++..... .++..+. ..+.|++|+|++|+|++.
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~------------------~l~~~l~~~~~~L~~L~Ls~n~i~~~ 384 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR------------------ELCQGLGQPGSVLRVLWLADCDVSDS 384 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH------------------HHHHHHTSTTCCCCEEECTTSCCCHH
T ss_pred chhhhhhhhcccccccccchhhhheeeecccCcccc------------------hhhhhhhcccCCCCEEECCCCCCChH
Confidence 554332222 22334555555555555421100 1111121 234466666666666532
Q ss_pred ----chhhhhccccccEEecccccccCCCCCccc-----cccchhhhhhcCCCcccccccc
Q 001873 573 ----IPAEILSCRKLILLDIGNNRFSGEIPKELG-----QISSLEISLNLSSNQFSGEIPS 624 (1001)
Q Consensus 573 ----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~~L~Ls~N~l~~~~p~ 624 (1001)
+++.+..+++|++|||++|+|+......+. +...|+. |++++|.+......
T Consensus 385 ~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~-l~l~~~~~~~~~~~ 444 (460)
T d1z7xw1 385 SCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ-LVLYDIYWSEEMED 444 (460)
T ss_dssp HHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCE-EECTTCCCCHHHHH
T ss_pred HHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCE-EECCCCCCCHHHHH
Confidence 333444556666666666666532222221 1123553 66666666544333
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.69 E-value=4.7e-17 Score=163.09 Aligned_cols=152 Identities=19% Similarity=0.207 Sum_probs=70.2
Q ss_pred ccceEeCcCccccCC-CCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeec
Q 001873 416 ELQALDFSYNNLSGP-IPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDM 494 (1001)
Q Consensus 416 ~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 494 (1001)
++++|+|++|+|++. .+..|.++++|++|+|++|++.+..+..|..+++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence 344444444444332 2233344444444444444444444444444555555555555555444444555555555555
Q ss_pred cCcccccCCcccccccccCceEEcccccCcccCCC-CcccccccccCCCCcCCCCcccccccccccceeeccCcccc
Q 001873 495 SENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPD-TLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLS 570 (1001)
Q Consensus 495 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 570 (1001)
++|+|++..|..|..+++|++|+|++|.+....+. .+...++.+.+..|.++...|.. +..++.++|+.|.++
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFK 183 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCC
T ss_pred CCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCChh---hcCCEeeecCHhhCc
Confidence 55555544444455555555555555554422111 11122333445555554433432 334445566666554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=7.2e-17 Score=164.19 Aligned_cols=165 Identities=24% Similarity=0.299 Sum_probs=91.7
Q ss_pred CCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEE
Q 001873 269 NCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQEL 348 (1001)
Q Consensus 269 ~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 348 (1001)
.+.+|++|++++|.++... .+..+++|++|+|++|++++. + .++.+++|++|++++|++++ +| .+.++++|+.|
T Consensus 44 ~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L 117 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (210)
T ss_dssp HHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred HhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-ccccccccccc
Confidence 3456666677766666432 255666666666666666642 2 24566666666666666663 33 35566666666
Q ss_pred EcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCcccc
Q 001873 349 QLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLS 428 (1001)
Q Consensus 349 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 428 (1001)
++++|.+.. ...+..+++++.+++++|.+++ +. .+..+++|+++++++|+++
T Consensus 118 ~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~------------------------~~~~l~~L~~l~l~~n~l~ 169 (210)
T d1h6ta2 118 SLEHNGISD--INGLVHLPQLESLYLGNNKITD--IT------------------------VLSRLTKLDTLSLEDNQIS 169 (210)
T ss_dssp ECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CG------------------------GGGGCTTCSEEECCSSCCC
T ss_pred ccccccccc--cccccccccccccccccccccc--cc------------------------ccccccccccccccccccc
Confidence 666666542 1235555566666666665542 12 2334455555555555555
Q ss_pred CCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEcc
Q 001873 429 GPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLN 471 (1001)
Q Consensus 429 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 471 (1001)
+. + .+.++++|++|+|++|+++.+ + .+..+++|++|+|+
T Consensus 170 ~i-~-~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 170 DI-V-PLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELF 208 (210)
T ss_dssp CC-G-GGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEE
T ss_pred cc-c-cccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEcc
Confidence 32 1 245555555556655555532 2 35566666666665
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=7e-17 Score=164.28 Aligned_cols=163 Identities=26% Similarity=0.347 Sum_probs=80.6
Q ss_pred cccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCCCCCCCCcceEEccccccccCCCcccCCCCCcceeec
Q 001873 415 QELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDM 494 (1001)
Q Consensus 415 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 494 (1001)
.+|++|++++|.+++.. .+..+++|++|++++|++++.. .++.+++|++|++++|++++ +| .+.++++|+.|++
T Consensus 46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccccc
Confidence 34445555555544221 2444555555555555554332 23445555555555555552 22 3555555555555
Q ss_pred cCcccccCCcccccccccCceEEcccccCcccCCCCcccccccccCCCCcCCCCcccccccccccceeeccCccccccch
Q 001873 495 SENHLVGGIPPSVVGCQSLEFLDLHSNGLTGSVPDTLPTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGRIP 574 (1001)
Q Consensus 495 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 574 (1001)
++|.+.. ...+..+++++.+++++|.+++..+....+.++.+++++|++++.. .+.++++|++|+|++|+|++ +|
T Consensus 120 ~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-l~ 194 (210)
T d1h6ta2 120 EHNGISD--INGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD-LR 194 (210)
T ss_dssp TTSCCCC--CGGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-CG
T ss_pred ccccccc--cccccccccccccccccccccccccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC-Ch
Confidence 5555542 1234555555555555555543222122233444444444444322 25556666666666666653 33
Q ss_pred hhhhccccccEEecc
Q 001873 575 AEILSCRKLILLDIG 589 (1001)
Q Consensus 575 ~~~~~l~~L~~L~Ls 589 (1001)
.+..+++|++|+|+
T Consensus 195 -~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 195 -ALAGLKNLDVLELF 208 (210)
T ss_dssp -GGTTCTTCSEEEEE
T ss_pred -hhcCCCCCCEEEcc
Confidence 46666666666665
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=1e-16 Score=161.50 Aligned_cols=162 Identities=23% Similarity=0.297 Sum_probs=88.3
Q ss_pred ccccccccccCcccccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCC
Q 001873 253 AIYTSLLSGPIPEEIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLT 332 (1001)
Q Consensus 253 ~l~~n~l~g~ip~~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 332 (1001)
.+..+.+++.++ ...+.++++|++++|.++.. +.+..+++|++|++++|++++..| ++++++|+.|++++|.+.
T Consensus 24 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~ 97 (199)
T d2omxa2 24 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 97 (199)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccc
Confidence 344444443332 23456677777777776632 235666677777777776664322 666666777777766665
Q ss_pred CCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCccCCCCCcccc
Q 001873 333 GSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNKLTGNIPESLS 412 (1001)
Q Consensus 333 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~ 412 (1001)
. ++ .+.++++|+.|++++|.+... ..+..+++|+.|++++|++.. + ..+..+++|+.|++.+|++++.. .++
T Consensus 98 ~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l~ 169 (199)
T d2omxa2 98 D-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PLA 169 (199)
T ss_dssp C-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GGT
T ss_pred c-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--ccc
Confidence 3 33 356666666666666666532 235556666666666666542 1 23444444555555554444321 244
Q ss_pred cCcccceEeCcCcccc
Q 001873 413 QCQELQALDFSYNNLS 428 (1001)
Q Consensus 413 ~l~~L~~L~Ls~N~l~ 428 (1001)
++++|++|++++|+++
T Consensus 170 ~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 170 NLTTLERLDISSNKVS 185 (199)
T ss_dssp TCTTCCEEECCSSCCC
T ss_pred CCCCCCEEECCCCCCC
Confidence 4445555555555444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.65 E-value=4.5e-16 Score=156.79 Aligned_cols=178 Identities=24% Similarity=0.353 Sum_probs=98.8
Q ss_pred EEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCc
Q 001873 299 SLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNA 378 (1001)
Q Consensus 299 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 378 (1001)
.+.++.+.+++.++ ...+.+++.|++++|.++. ++ .+..+++|++|++++|++++..| +.++++|++|++++|.
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence 34455555554332 2344556666666666652 22 35555556666666665553322 4555555555555555
Q ss_pred ccCccCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCccccCCCCcccccccccceEEccCCcCCCCCCCC
Q 001873 379 ISGEIPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYNNLSGPIPKEIFGLRNLTKLLLLSNDLSGFIPPD 458 (1001)
Q Consensus 379 i~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 458 (1001)
+.. ++ .+.+++.|+.|++++|.+... ..+..+++|+.|++++|++... +.
T Consensus 96 ~~~-------------------------~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~ 145 (199)
T d2omxa2 96 IAD-------------------------IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SA 145 (199)
T ss_dssp CCC-------------------------CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GG
T ss_pred ccc-------------------------cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--cc
Confidence 432 11 245556666666666655432 2355566666666666666532 24
Q ss_pred CCCCCCcceEEccccccccCCCcccCCCCCcceeeccCcccccCCcccccccccCceE
Q 001873 459 IGNCTTLRRLRLNDNRLSGTIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFL 516 (1001)
Q Consensus 459 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 516 (1001)
+..+++|++|++++|++++. + .++++++|++|++++|++++ ++ .++++++|+.|
T Consensus 146 l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 146 LSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp GTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred ccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 56666777777777776643 2 36677777777777777764 22 46666666654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.9e-16 Score=169.01 Aligned_cols=213 Identities=17% Similarity=0.139 Sum_probs=100.6
Q ss_pred CccccccccccCCccCCC-CChhhhcccccceEEccCCcccCCCCccccCCccccceecccc-ccccc-cCCCccchhhh
Q 001873 124 DYRELTFIDLSGNSLWGE-IPTEVCRLRKLESLYLNTNLLEGEIPSDIGNLSSLAYLTLYDN-QLSGK-IPKSIGALSKL 200 (1001)
Q Consensus 124 ~l~~L~~L~Ls~n~l~g~-~p~~~~~l~~L~~L~L~~n~l~~~ip~~l~~L~~L~~L~L~~n-~l~g~-~p~~~~~l~~L 200 (1001)
....|++|||+++.+.+. ++..+.++++|++|+|++|.+++..+..++++++|++|+|++| .++.. +..-...+
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~--- 120 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC--- 120 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHC---
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHH---
Confidence 344566666666665433 2333455666666666666665555556666666666666653 33311 11111223
Q ss_pred hhhhhccCcCCCCCCCcccccCccchhccccccc-cccccCCccccccccceeccccccccccCccccc-CCCCCceEee
Q 001873 201 QVFRAGGNQNLKGELPWEIGNCSNLVMLGLAETS-ISGNVPSSIGMLERIQTIAIYTSLLSGPIPEEIG-NCSELQNLYL 278 (1001)
Q Consensus 201 ~~L~l~~n~~l~~~lp~~l~~l~~L~~L~l~~~~-l~~~~p~~i~~l~~L~~L~l~~n~l~g~ip~~l~-~l~~L~~L~L 278 (1001)
++|++|++++|. +++. .++..+. .+++|+.|++
T Consensus 121 ----------------------~~L~~L~ls~c~~~~~~-----------------------~~~~~~~~~~~~L~~L~l 155 (284)
T d2astb2 121 ----------------------SRLDELNLSWCFDFTEK-----------------------HVQVAVAHVSETITQLNL 155 (284)
T ss_dssp ----------------------TTCCEEECCCCTTCCHH-----------------------HHHHHHHHSCTTCCEEEC
T ss_pred ----------------------Hhccccccccccccccc-----------------------cchhhhcccccccchhhh
Confidence 344444444321 1110 0111111 1234555555
Q ss_pred ecC--cccCC-CCcccCCCCCCcEEEcCCC-cccccCCCCccCCCCCCEEeccCC-CCCCCCCcccccccCccEEEcccc
Q 001873 279 YQN--SISGP-IPGRIGALSKLKSLLLWQN-SLVGAIPDELGSCTELTVVDFSDN-LLTGSIPRSFGNLLKLQELQLSVN 353 (1001)
Q Consensus 279 ~~N--~i~~~-~p~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N 353 (1001)
+++ .++.. +...+.++++|++|++++| .+++..+..+.++++|++|++++| .+++.....++++++|++|+++++
T Consensus 156 ~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 156 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 543 22211 1111234556666666554 345445555566666666666663 455444445666666777776665
Q ss_pred cccC-cCChhhccccccCEEeccCCcccCccCcccc
Q 001873 354 QLSG-TIPIEIATCTALTHLEIDNNAISGEIPADIG 388 (1001)
Q Consensus 354 ~l~~-~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~ 388 (1001)
++. .++.....+++ |.+..++++...+..++
T Consensus 236 -~~d~~l~~l~~~lp~---L~i~~~~ls~~~~~~~~ 267 (284)
T d2astb2 236 -VPDGTLQLLKEALPH---LQINCSHFTTIARPTIG 267 (284)
T ss_dssp -SCTTCHHHHHHHSTT---SEESCCCSCCTTCSSCS
T ss_pred -CCHHHHHHHHHhCcc---ccccCccCCCCCCCccC
Confidence 221 11111223333 34455666655444444
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=2.7e-15 Score=159.93 Aligned_cols=222 Identities=20% Similarity=0.238 Sum_probs=112.7
Q ss_pred ceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCC-CCcccccccCccEEEccc
Q 001873 274 QNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGS-IPRSFGNLLKLQELQLSV 352 (1001)
Q Consensus 274 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~ 352 (1001)
+.|||+++.+.......+.. ..+..+.++...+...+ .......+|++||+++|.++.. ++..+.++++|++|+|++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 36777777664221111111 13455666665554322 2233445677777777766533 233456667777777777
Q ss_pred ccccCcCChhhccccccCEEeccCC-cccCc-cCccccccCcccEEEeecCccCCCCCcccccCcccceEeCcCc-cccC
Q 001873 353 NQLSGTIPIEIATCTALTHLEIDNN-AISGE-IPADIGNINGLTLFFAWKNKLTGNIPESLSQCQELQALDFSYN-NLSG 429 (1001)
Q Consensus 353 N~l~~~~p~~~~~l~~L~~L~L~~N-~i~~~-~~~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~ 429 (1001)
|.+.+..+..++.+++|++|+++++ .++.. +... +..+++|++|+++++ .++.
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l------------------------~~~~~~L~~L~ls~c~~~~~ 136 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL------------------------LSSCSRLDELNLSWCFDFTE 136 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHH------------------------HHHCTTCCEEECCCCTTCCH
T ss_pred cCCCcHHHHHHhcCCCCcCccccccccccccccchh------------------------hHHHHhcccccccccccccc
Confidence 7666555666666677777777663 34321 1111 223445555555543 2221
Q ss_pred C-CCccccc-ccccceEEccCC--cCCCC-CCCCCCCCCCcceEEcccc-ccccCCCcccCCCCCcceeeccC-cccccC
Q 001873 430 P-IPKEIFG-LRNLTKLLLLSN--DLSGF-IPPDIGNCTTLRRLRLNDN-RLSGTIPSEMGNLKHLNFVDMSE-NHLVGG 502 (1001)
Q Consensus 430 ~-~~~~~~~-l~~L~~L~L~~N--~l~~~-~p~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~ 502 (1001)
. +...+.. .++|+.|+++++ .++.. +...+..+++|++|++++| .+++.....+.++++|++|++++ +.+++.
T Consensus 137 ~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~ 216 (284)
T d2astb2 137 KHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPE 216 (284)
T ss_dssp HHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGG
T ss_pred ccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChH
Confidence 1 1111211 244555555543 12211 1111234556666666654 35555555566666666666666 345555
Q ss_pred CcccccccccCceEEcccc
Q 001873 503 IPPSVVGCQSLEFLDLHSN 521 (1001)
Q Consensus 503 ~p~~~~~l~~L~~L~Ls~N 521 (1001)
....+.++++|+.|+++++
T Consensus 217 ~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 217 TLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GGGGGGGCTTCCEEECTTS
T ss_pred HHHHHhcCCCCCEEeeeCC
Confidence 5555666666666666655
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=6.2e-14 Score=135.18 Aligned_cols=112 Identities=20% Similarity=0.110 Sum_probs=81.2
Q ss_pred cccCCCCCceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCc
Q 001873 266 EIGNCSELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKL 345 (1001)
Q Consensus 266 ~l~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 345 (1001)
.+.++.+|++|+|++|+|+. ++..+..+++|+.|+|++|+++. ++ .+..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 35677788888888888874 46666778888888888888874 33 47778888888888888875545556677888
Q ss_pred cEEEcccccccCcCC-hhhccccccCEEeccCCccc
Q 001873 346 QELQLSVNQLSGTIP-IEIATCTALTHLEIDNNAIS 380 (1001)
Q Consensus 346 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~i~ 380 (1001)
++|++++|+++.... ..+..+++|++|++++|.++
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ccceeccccccccccccccccccccchhhcCCCccc
Confidence 888888888764322 35667777777777777765
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.43 E-value=2.4e-15 Score=165.63 Aligned_cols=38 Identities=26% Similarity=0.329 Sum_probs=24.1
Q ss_pred ccccEEEecCCcCCCC-----hhhhh-cccccceeEcccCCCCC
Q 001873 630 TKLGILDLSHNKLSGD-----LDALA-SLQNLVSLNVSFNDFSG 667 (1001)
Q Consensus 630 ~~L~~L~Ls~N~l~~~-----~~~~~-~l~~L~~L~ls~N~l~~ 667 (1001)
+.|++||+++|+++.+ ...+. ..+.|+.|++++|++..
T Consensus 273 ~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 273 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp CCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred CCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 4577777777776642 22332 45677777777777754
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.43 E-value=2.1e-13 Score=124.87 Aligned_cols=102 Identities=28% Similarity=0.392 Sum_probs=70.5
Q ss_pred ceEeeecCcccCCCCcccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccc
Q 001873 274 QNLYLYQNSISGPIPGRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVN 353 (1001)
Q Consensus 274 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 353 (1001)
|+|+|++|+++. ++ .+..+++|++|++++|+++ .+|..++.+++|+.|++++|.|++ +| .++++++|++|++++|
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 467777777763 33 3677777777777777776 456667777777777777777773 33 3677777777777777
Q ss_pred cccCcCC-hhhccccccCEEeccCCccc
Q 001873 354 QLSGTIP-IEIATCTALTHLEIDNNAIS 380 (1001)
Q Consensus 354 ~l~~~~p-~~~~~l~~L~~L~L~~N~i~ 380 (1001)
+++.... ..+..+++|+.|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 7764432 45667777777777777775
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.42 E-value=4e-15 Score=163.80 Aligned_cols=94 Identities=18% Similarity=0.177 Sum_probs=49.1
Q ss_pred cCcccccCCCCCceEeeecCcccCC----CCcccCCCCCCcEEEcCCCccccc----------CCCCccCCCCCCEEecc
Q 001873 262 PIPEEIGNCSELQNLYLYQNSISGP----IPGRIGALSKLKSLLLWQNSLVGA----------IPDELGSCTELTVVDFS 327 (1001)
Q Consensus 262 ~ip~~l~~l~~L~~L~L~~N~i~~~----~p~~~~~l~~L~~L~L~~N~l~~~----------~p~~l~~l~~L~~L~Ls 327 (1001)
.+...+.+.+.|++|+|++|.|... +-..+...++|+.|+++++..... +...+..+++|+.|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 3455666777788888888777532 223455566777777766543211 11123344555555555
Q ss_pred CCCCCCCCC----cccccccCccEEEcccccc
Q 001873 328 DNLLTGSIP----RSFGNLLKLQELQLSVNQL 355 (1001)
Q Consensus 328 ~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l 355 (1001)
+|.++.... ..+...++|++|++++|.+
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l 133 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL 133 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCC
T ss_pred ccccccccccchhhhhcccccchheecccccc
Confidence 555543211 1222344455555555544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=1.1e-13 Score=133.42 Aligned_cols=112 Identities=20% Similarity=0.211 Sum_probs=80.1
Q ss_pred ccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhcccccc
Q 001873 290 RIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTAL 369 (1001)
Q Consensus 290 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 369 (1001)
.|.+..+|++|+|++|+|+ .++..+..+++|+.|||++|.|+. ++ .|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 3556778899999999988 456666778889999999998884 43 47888888888998888886655666778888
Q ss_pred CEEeccCCcccCccC-ccccccCcccEEEeecCccC
Q 001873 370 THLEIDNNAISGEIP-ADIGNINGLTLFFAWKNKLT 404 (1001)
Q Consensus 370 ~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l~ 404 (1001)
++|++++|+|+.... ..+..+++|+.+++++|.++
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ccceeccccccccccccccccccccchhhcCCCccc
Confidence 888888888863211 23444444444444444443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.40 E-value=7.3e-13 Score=121.18 Aligned_cols=101 Identities=26% Similarity=0.411 Sum_probs=45.6
Q ss_pred EEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccccCEEeccCCcccCccCccccccCcccEEEeecCc
Q 001873 323 VVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTALTHLEIDNNAISGEIPADIGNINGLTLFFAWKNK 402 (1001)
Q Consensus 323 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~ 402 (1001)
+|||++|+++ .++ .+.++++|++|++++|+|+ .+|..+..+++|+.|++++|+|++ +| .++.+++|+.+++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 3444444444 222 2444444444444444444 233334444444444444444442 11 23344444444444444
Q ss_pred cCCCC-CcccccCcccceEeCcCcccc
Q 001873 403 LTGNI-PESLSQCQELQALDFSYNNLS 428 (1001)
Q Consensus 403 l~~~~-p~~l~~l~~L~~L~Ls~N~l~ 428 (1001)
++... ...+..+++|+.|++++|.++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 43221 234566666677777777665
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=4.9e-12 Score=120.77 Aligned_cols=108 Identities=20% Similarity=0.156 Sum_probs=85.7
Q ss_pred ccCCCCcCCCCcccccccccccceeeccCc-cccccchhhhhccccccEEecccccccCCCCCccccccchhhhhhcCCC
Q 001873 538 VDLSDNRLSGSLAHSIGSLTELSKLLLSKN-QLSGRIPAEILSCRKLILLDIGNNRFSGEIPKELGQISSLEISLNLSSN 616 (1001)
Q Consensus 538 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N 616 (1001)
++.+++.+. ..|..+..+++|++|++++| .|+.+.+..|..+++|+.|+|++|+|+...|..|..+++|+. |+|++|
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~-L~Ls~N 90 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR-LNLSFN 90 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE-EECCSS
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc-eeccCC
Confidence 555555555 34556777888889999766 488777778888999999999999998777888888999986 999999
Q ss_pred cccccccccccccccccEEEecCCcCCCChhh
Q 001873 617 QFSGEIPSEFSGLTKLGILDLSHNKLSGDLDA 648 (1001)
Q Consensus 617 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 648 (1001)
+|+...+..|..+ +|+.|+|++|+|.|++..
T Consensus 91 ~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~ 121 (156)
T d2ifga3 91 ALESLSWKTVQGL-SLQELVLSGNPLHCSCAL 121 (156)
T ss_dssp CCSCCCSTTTCSC-CCCEEECCSSCCCCCGGG
T ss_pred CCcccChhhhccc-cccccccCCCcccCCchH
Confidence 9986666666555 799999999999988754
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.25 E-value=1.6e-13 Score=137.04 Aligned_cols=45 Identities=24% Similarity=0.399 Sum_probs=29.0
Q ss_pred CCCcccCCCCCcceeeccCcccccCCcccccccccCceEEcccccCc
Q 001873 478 TIPSEMGNLKHLNFVDMSENHLVGGIPPSVVGCQSLEFLDLHSNGLT 524 (1001)
Q Consensus 478 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 524 (1001)
.++..+..+++|++|+|++|+|+. ++ .+.++++|++|++++|+|+
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~ 83 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK 83 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC
T ss_pred hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc
Confidence 344556666777777777777763 33 4666677777777777665
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.23 E-value=1.5e-13 Score=137.33 Aligned_cols=110 Identities=24% Similarity=0.259 Sum_probs=55.0
Q ss_pred cccCCCCCCcEEEcCCCcccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEcccccccCcCChhhccccc
Q 001873 289 GRIGALSKLKSLLLWQNSLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQLSVNQLSGTIPIEIATCTA 368 (1001)
Q Consensus 289 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 368 (1001)
.++..+++|++|+|++|+|+. ++ .+..+++|+.|+|++|.|+ .+|..+..+++|++|++++|+++.. ..+..+++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHH
T ss_pred hHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccccc
Confidence 445555555555555555552 22 3555555555566555555 3344344445566666666665532 23555556
Q ss_pred cCEEeccCCcccCccC-ccccccCcccEEEeecCcc
Q 001873 369 LTHLEIDNNAISGEIP-ADIGNINGLTLFFAWKNKL 403 (1001)
Q Consensus 369 L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l 403 (1001)
|+.|++++|+|+.... ..+..+++|+.|++++|.+
T Consensus 117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l 152 (198)
T d1m9la_ 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHH
T ss_pred ccccccccchhccccccccccCCCccceeecCCCcc
Confidence 6666666665543211 2334444444444444443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.19 E-value=1.9e-11 Score=116.54 Aligned_cols=106 Identities=18% Similarity=0.134 Sum_probs=54.6
Q ss_pred CCceEeeecCcccCCCCcccCCCCCCcEEEcCCC-cccccCCCCccCCCCCCEEeccCCCCCCCCCcccccccCccEEEc
Q 001873 272 ELQNLYLYQNSISGPIPGRIGALSKLKSLLLWQN-SLVGAIPDELGSCTELTVVDFSDNLLTGSIPRSFGNLLKLQELQL 350 (1001)
Q Consensus 272 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 350 (1001)
..+.++.+++.+. ..|..+..+++|++|++++| .++...+..|.++++|+.|+|++|+|+...|.+|..+++|++|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 3444555555554 33445555555555555444 255444445555555555555555555444555555555555555
Q ss_pred ccccccCcCChhhccccccCEEeccCCcc
Q 001873 351 SVNQLSGTIPIEIATCTALTHLEIDNNAI 379 (1001)
Q Consensus 351 s~N~l~~~~p~~~~~l~~L~~L~L~~N~i 379 (1001)
++|+|+...+..| ...+|++|+|++|.+
T Consensus 88 s~N~l~~l~~~~~-~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 88 SFNALESLSWKTV-QGLSLQELVLSGNPL 115 (156)
T ss_dssp CSSCCSCCCSTTT-CSCCCCEEECCSSCC
T ss_pred cCCCCcccChhhh-ccccccccccCCCcc
Confidence 5555553222222 223455555555555
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=2.9e-08 Score=94.67 Aligned_cols=109 Identities=21% Similarity=0.159 Sum_probs=71.2
Q ss_pred cccccccceeeccCccccccchhhhhccccccEEecccccccCCC--CCccccccchhhhhhcCCCcccccccccccccc
Q 001873 553 IGSLTELSKLLLSKNQLSGRIPAEILSCRKLILLDIGNNRFSGEI--PKELGQISSLEISLNLSSNQFSGEIPSEFSGLT 630 (1001)
Q Consensus 553 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~ 630 (1001)
+..+..+..++..+|... .++..+..+++|++|||++|+|+..- +..+..+++|+. |+|++|.|+...+-.+....
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~-L~Ls~N~i~~l~~l~~l~~~ 115 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI-LNLSGNELKSERELDKIKGL 115 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCC-CCCTTSCCCCGGGHHHHTTC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccc-cccccCccccchhhhhhhcc
Confidence 333444555555555443 44555566778888888888887432 345667777875 88888888765554444556
Q ss_pred cccEEEecCCcCCCCh--------hhhhcccccceeEcccCCC
Q 001873 631 KLGILDLSHNKLSGDL--------DALASLQNLVSLNVSFNDF 665 (1001)
Q Consensus 631 ~L~~L~Ls~N~l~~~~--------~~~~~l~~L~~L~ls~N~l 665 (1001)
+|+.|++++|+++... ..+..+|+|+.|| |+++
T Consensus 116 ~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 116 KLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp CCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred ccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence 7888999999987632 2356788888886 5544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.29 E-value=1.7e-06 Score=89.35 Aligned_cols=146 Identities=14% Similarity=0.113 Sum_probs=101.1
Q ss_pred HHHHHhcccCCCeEeecCCeeEEEEEeCCCCEEEEEEecCCC--chhhHHHHHHHhhccC-CCceeeEEeeeecCCceEE
Q 001873 761 IDDVVRNLTSANVIGTGSSGVVYRVTIPNGETLAVKKMWSSD--ESGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 761 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~~l 837 (1001)
......+|+..+..+.++.+.||+++. +++.++||+..... ....+.+|...++.+. +--+.+++.+..+++..++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 344556777666545555678999875 56778888875432 2346788999888774 4346788888888888899
Q ss_pred EEEccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------
Q 001873 838 FYDYLPNGSLSSLLHGAGKGGADWEARYEVVLGVAHALAYLHHDC----------------------------------- 882 (1001)
Q Consensus 838 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~yLH~~~----------------------------------- 882 (1001)
||++++|..+.+..... .. ..+++.++++.+..||+..
T Consensus 88 v~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 99999988876654321 11 2234555666666666420
Q ss_pred ---------------------CCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 883 ---------------------MPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 883 ---------------------~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
.+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 02378999999999999876677999998763
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.18 E-value=1.6e-07 Score=89.46 Aligned_cols=15 Identities=40% Similarity=0.496 Sum_probs=8.2
Q ss_pred cccceeeccCccccc
Q 001873 557 TELSKLLLSKNQLSG 571 (1001)
Q Consensus 557 ~~L~~L~Ls~N~l~~ 571 (1001)
.+|+.|++++|++..
T Consensus 115 ~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 115 LKLEELWLDGNSLSD 129 (162)
T ss_dssp CCCSSCCCTTSTTSS
T ss_pred cccceeecCCCCcCc
Confidence 345555566665553
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.93 E-value=1.1e-05 Score=82.71 Aligned_cols=130 Identities=22% Similarity=0.189 Sum_probs=86.7
Q ss_pred EeecCC-eeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccCC--CceeeEEeeeecCCceEEEEEccCCCCHHHH
Q 001873 774 IGTGSS-GVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRH--KNIVRLLGWGSNKNLKLLFYDYLPNGSLSSL 850 (1001)
Q Consensus 774 lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 850 (1001)
+..|.. +.||+++..++..+++|..... ....+.+|...++.+.. -.+.+++++..+++..++||+|++|.++.+.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~-~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~ 96 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSS 96 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTS
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCcc-CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccc
Confidence 445554 6899999888888889976433 34568889998887743 3367788888888888999999987654321
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHh---------------------------------------------------
Q 001873 851 LHGAGKGGADWEARYEVVLGVAHALAYLH--------------------------------------------------- 879 (1001)
Q Consensus 851 l~~~~~~~~~~~~~~~i~~~i~~~l~yLH--------------------------------------------------- 879 (1001)
. ... ...+.++++.+.-||
T Consensus 97 ~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 166 (255)
T d1nd4a_ 97 H-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 166 (255)
T ss_dssp C-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred c-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHH
Confidence 0 010 011122223333333
Q ss_pred hCC----CCCeEEeCCCCCCeEECCCCcEEEeccccccc
Q 001873 880 HDC----MPPILHGDVKAMNVLLGPGYQAYLADFGLARI 914 (1001)
Q Consensus 880 ~~~----~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~~ 914 (1001)
... .+.++|+|+.|.||+++++..+-|+||+.+..
T Consensus 167 ~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 167 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 211 12479999999999999876778999997753
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.28 E-value=4.4e-05 Score=72.26 Aligned_cols=115 Identities=18% Similarity=0.186 Sum_probs=63.8
Q ss_pred CCCCcceEEcccc-ccccC----CCcccCCCCCcceeeccCcccccCCc----ccccccccCceEEcccccCcccCCCCc
Q 001873 461 NCTTLRRLRLNDN-RLSGT----IPSEMGNLKHLNFVDMSENHLVGGIP----PSVVGCQSLEFLDLHSNGLTGSVPDTL 531 (1001)
Q Consensus 461 ~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 531 (1001)
+.++|++|+|+++ .++.. +-..+...+.|+.|+|++|.+..... ..+...+.|+.|+|++|.++.....
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~-- 90 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA-- 90 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH--
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH--
Confidence 3466777777763 45421 22345556667777777777653222 2333445666666666665521111
Q ss_pred ccccccccCCCCcCCCCcccccccccccceeeccCcccccc-------chhhhhccccccEEecccccc
Q 001873 532 PTSLQLVDLSDNRLSGSLAHSIGSLTELSKLLLSKNQLSGR-------IPAEILSCRKLILLDIGNNRF 593 (1001)
Q Consensus 532 ~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~l 593 (1001)
.+...+...+.|++|++++|++... +...+...+.|+.|+++.+..
T Consensus 91 ----------------~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 91 ----------------RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp ----------------HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred ----------------HHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 1223344456777888877765422 334445567788887776643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.27 E-value=0.00032 Score=76.17 Aligned_cols=74 Identities=15% Similarity=0.147 Sum_probs=48.6
Q ss_pred CCeEeecCCeeEEEEEeCC-CCEEEEEEecC------C---CchhhHHHHHHHhhccC-C--CceeeEEeeeecCCceEE
Q 001873 771 ANVIGTGSSGVVYRVTIPN-GETLAVKKMWS------S---DESGAFSSEIQTLGSIR-H--KNIVRLLGWGSNKNLKLL 837 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~------~---~~~~~~~~Ei~~l~~l~-h--~nIv~l~~~~~~~~~~~l 837 (1001)
.+.||.|....||+++..+ ++.|+||.-.. + ....+...|.+.++.+. + ..+++++.+.. +..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEE
Confidence 3468999999999998654 67899996421 1 12244567888887663 2 45666776543 44578
Q ss_pred EEEccCCCC
Q 001873 838 FYDYLPNGS 846 (1001)
Q Consensus 838 v~e~~~~gs 846 (1001)
||||+++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.18 E-value=6.7e-05 Score=70.99 Aligned_cols=17 Identities=0% Similarity=0.198 Sum_probs=8.0
Q ss_pred cCCCCCCEEeccCCCCC
Q 001873 316 GSCTELTVVDFSDNLLT 332 (1001)
Q Consensus 316 ~~l~~L~~L~Ls~N~l~ 332 (1001)
...+.|+.|+|++|.+.
T Consensus 41 ~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 41 CNSKHIEKFSLANTAIS 57 (167)
T ss_dssp TTCSCCCEEECTTSCCB
T ss_pred hhCCccceeeccccccc
Confidence 33444555555554443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.66 E-value=0.0019 Score=67.83 Aligned_cols=66 Identities=9% Similarity=0.086 Sum_probs=46.2
Q ss_pred eeEEEEEeCCCCEEEEEEecCCC-chhhHHHHHHHhhccCCCce--eeEEe-----eeecCCceEEEEEccCCC
Q 001873 780 GVVYRVTIPNGETLAVKKMWSSD-ESGAFSSEIQTLGSIRHKNI--VRLLG-----WGSNKNLKLLFYDYLPNG 845 (1001)
Q Consensus 780 g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~Ei~~l~~l~h~nI--v~l~~-----~~~~~~~~~lv~e~~~~g 845 (1001)
=.||+++.++|+.|++|...... ..+++..|...+..+....| +.... .....+..+.+++|++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 47999999999999999876543 44678889998888742222 11111 234566778999999764
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.46 E-value=0.00025 Score=66.77 Aligned_cols=114 Identities=14% Similarity=0.103 Sum_probs=58.8
Q ss_pred CCCcceEEccc-cccccC----CCcccCCCCCcceeeccCcccccCC----cccccccccCceEEcccccCcccCCCCcc
Q 001873 462 CTTLRRLRLND-NRLSGT----IPSEMGNLKHLNFVDMSENHLVGGI----PPSVVGCQSLEFLDLHSNGLTGSVPDTLP 532 (1001)
Q Consensus 462 l~~L~~L~Ls~-N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 532 (1001)
.++|++|+|++ +.++.. +-..+...++|++|++++|.++... ...+...++++.+++++|.++.....
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~--- 92 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL--- 92 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH---
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH---
Confidence 34555555554 334311 2233445566666666666665322 22333445666666666655421110
Q ss_pred cccccccCCCCcCCCCcccccccccccce--eeccCccccc----cchhhhhccccccEEecccccc
Q 001873 533 TSLQLVDLSDNRLSGSLAHSIGSLTELSK--LLLSKNQLSG----RIPAEILSCRKLILLDIGNNRF 593 (1001)
Q Consensus 533 ~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~--L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l 593 (1001)
.+...+...+.|+. |++++|++.. .+...+...++|+.|+++.|..
T Consensus 93 ---------------~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 93 ---------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp ---------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred ---------------HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 12234445566665 4445666653 2344455677888888776654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.33 E-value=0.0041 Score=67.21 Aligned_cols=72 Identities=13% Similarity=0.213 Sum_probs=50.0
Q ss_pred CCeEeecCCeeEEEEEeCC--------CCEEEEEEecCCCchhhHHHHHHHhhccC-CCceeeEEeeeecCCceEEEEEc
Q 001873 771 ANVIGTGSSGVVYRVTIPN--------GETLAVKKMWSSDESGAFSSEIQTLGSIR-HKNIVRLLGWGSNKNLKLLFYDY 841 (1001)
Q Consensus 771 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 841 (1001)
++.|+.|-.=.+|+++.++ .+.|.+++.-.....-...+|..+++.+. +.-..++++++.+ ++||||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 3468889999999998653 35677776643333445678999998884 4334577777642 689999
Q ss_pred cCCCC
Q 001873 842 LPNGS 846 (1001)
Q Consensus 842 ~~~gs 846 (1001)
++|..
T Consensus 123 i~g~~ 127 (395)
T d1nw1a_ 123 IPSRP 127 (395)
T ss_dssp CCEEE
T ss_pred ecccc
Confidence 98653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.33 E-value=0.0047 Score=64.40 Aligned_cols=152 Identities=14% Similarity=0.101 Sum_probs=82.3
Q ss_pred HHHHHhcccCCCe-----EeecCCeeEEEEEeCCCCEEEEEEecCCCchhhHHHHHHHhhccCCCce--eeEEe------
Q 001873 761 IDDVVRNLTSANV-----IGTGSSGVVYRVTIPNGETLAVKKMWSSDESGAFSSEIQTLGSIRHKNI--VRLLG------ 827 (1001)
Q Consensus 761 ~~~~~~~~~~~~~-----lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~Ei~~l~~l~h~nI--v~l~~------ 827 (1001)
++.+.++|.+.+. |..|---+.|+++..+| ++++|++......+++..|+.++..+...++ ...+.
T Consensus 8 l~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~ 86 (316)
T d2ppqa1 8 LRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGEL 86 (316)
T ss_dssp HHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCS
T ss_pred HHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceecCCCc
Confidence 4556677776544 44566678899988655 5899988654455677778888888743222 11111
Q ss_pred eeecCCceEEEEEccCCCCHHH--------------Hhhc----CC---CCCCCHH------------------HHHHHH
Q 001873 828 WGSNKNLKLLFYDYLPNGSLSS--------------LLHG----AG---KGGADWE------------------ARYEVV 868 (1001)
Q Consensus 828 ~~~~~~~~~lv~e~~~~gsL~~--------------~l~~----~~---~~~~~~~------------------~~~~i~ 868 (1001)
+....+..+.++.+..+..... .++. .. ....... .....+
T Consensus 87 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 166 (316)
T d2ppqa1 87 LGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEI 166 (316)
T ss_dssp CEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHH
T ss_pred ceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHH
Confidence 1223455567777776543210 0110 00 0000000 011112
Q ss_pred HHHHHHHHHHhh-CCCCCeEEeCCCCCCeEECCCCcEEEecccccc
Q 001873 869 LGVAHALAYLHH-DCMPPILHGDVKAMNVLLGPGYQAYLADFGLAR 913 (1001)
Q Consensus 869 ~~i~~~l~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~ki~Dfgla~ 913 (1001)
..+...+...+. ....++||+|+.++||+++.+...-|+||+.+.
T Consensus 167 ~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 167 RPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 222222222222 123489999999999999988777899999875
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.14 E-value=0.00021 Score=67.36 Aligned_cols=87 Identities=14% Similarity=0.106 Sum_probs=44.8
Q ss_pred cccccceEEccCCcCCCCC----CCCCCCCCCcceEEccccccccC----CCcccCCCCCcceee--ccCccccc----C
Q 001873 437 GLRNLTKLLLLSNDLSGFI----PPDIGNCTTLRRLRLNDNRLSGT----IPSEMGNLKHLNFVD--MSENHLVG----G 502 (1001)
Q Consensus 437 ~l~~L~~L~L~~N~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~--Ls~N~l~~----~ 502 (1001)
..++|++|++++|.++... ...+...+.++.+++++|.++.. +...+...+.|+.++ +++|.+.. .
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~ 123 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME 123 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHH
Confidence 3444555555555443211 11223345566666666665422 224455566666543 34566643 2
Q ss_pred CcccccccccCceEEcccccC
Q 001873 503 IPPSVVGCQSLEFLDLHSNGL 523 (1001)
Q Consensus 503 ~p~~~~~l~~L~~L~Ls~N~l 523 (1001)
+...+...++|+.|+++.+..
T Consensus 124 La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 124 IANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCCCcCEEeCcCCCC
Confidence 334455667777777766543
|